PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, XG; Jiao, JH; Cong, XF; Liu, L; Wu, XM				Chen, Xiaoguang; Jiao, Jinghua; Cong, Xuefeng; Liu, Lei; Wu, Xiaomei			A Comparison of the Performance of the I-gel (TM) vs. the LMA-S (TM) during Anesthesia: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							NON-PARALYZED PATIENTS; LMA SUPREME(TM); ANESTHETIZED PATIENTS; SUPRAGLOTTIC AIRWAY; ADULT PATIENTS; SURGERY; QUALITY	Background and Objective: Conflicting results were found between the I-gel (TM) and the LMA-Supreme (TM) during anesthesia, so we conducted a meta-analysis of randomized controlled trials (RCTs) to compare the effectiveness and safety of the I-gel (TM) vs. the LMA-Supreme (TM) during anesthesia. Methods: A comprehensive search was conducted using Pubmed, EMbase, ISI Web of Knowledge, the Cochrane Library, China Journal Full-text Database, Chinese Biomedical Database, Chinese Scientific Journals Full-text Database, CMA Digital Periodicals, and Google scholar to find RCTs that compare the LMA-S (TM) with the i-gel (TM) during anesthesia. Two reviewers independently selected trials, extracted data, and assessed the methodological qualities and evidence levels. Data were analyzed by RevMan 5.0 and comprehensive meta-analysis software. Results: Ten RCTs were included. There were no significant differences in oropharyngeal leak pressures (mean difference [MD] 0.72, 95% confidence interval [CI] -1.10 2.53), device placement time (MD -1.3, 95% CI -4.07 1.44), first attempt insertion success (risk ratio [RR] 1.01, 95% CI 0.9 1.14), grade 3 and 4 fiberoptic view (RR 0.89, 95% CI 0.65 1.21), and blood on removal (RR 0.62, 95% CI 0.32 1.22) between the i-gel (TM) and the LMA-Supreme (TM), respectively. However, the LMA-Supreme (TM) was associated with easier gastric tube insertion (RR 1.17, 95% CI 1.07 1.29), and more sore throat (RR 2.56, 95% CI 1.60 4.12) than the i-gel (TM) group. Conclusions: The LMA-Supreme (TM) and i-gel (TM) were similarly successful and rapidly inserted. However, the LMA-Supreme (TM) was shown to be easier for gastric tube insertion and associated with more sore throat compared with the i-gel (TM).	[Chen, Xiaoguang] China Med Univ, Hosp 1, Dept Anesthesiol, Shenyang, Peoples R China; [Jiao, Jinghua] Shengyang Med Coll, Fengtian Hosp, Dept Anesthesiol, Shenyang, Peoples R China; [Cong, Xuefeng] First Hosp Shenyang, Dept Neurosurg, Shenyang, Peoples R China; [Liu, Lei] China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China; [Wu, Xiaomei] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Med, Shenyang, Peoples R China	China Medical University; Shenyang Medical College; China Medical University; China Medical University	Chen, XG (corresponding author), China Med Univ, Hosp 1, Dept Anesthesiol, Shenyang, Peoples R China.	chenxiaoguangcxf@163.com						CAO J-B, 2012, J CHINESE PLA POSTGR, V33, P362; Chew EFF, 2010, ANAESTH INTENS CARE, V38, P1018, DOI 10.1177/0310057X1003800609; Cook TM, 2009, ANAESTHESIA, V64, P555, DOI 10.1111/j.1365-2044.2008.05824.x; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eschertzhuber S, 2009, ANAESTHESIA, V64, P79, DOI 10.1111/j.1365-2044.2008.05682.x; Gatward JJ, 2008, ANAESTHESIA, V63, P1124, DOI 10.1111/j.1365-2044.2008.05561.x; Helmy AM, 2010, SAUDI J ANAESTH, V4, P131, DOI 10.4103/1658-354X.71250; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Levitan RM, 2005, ANAESTHESIA, V60, P1022, DOI 10.1111/j.1365-2044.2005.04258.x; Mann V, 2012, ANAESTHESIA, V67, P1260, DOI 10.1111/j.1365-2044.2012.07303.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Ragazzi R, 2012, ANAESTHESIA, V67, P384, DOI 10.1111/j.1365-2044.2011.07002.x; Russo SG, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-18; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Sharma V, 2010, BRIT J ANAESTH, V105, P228, DOI 10.1093/bja/aeq118; Teoh WHL, 2010, ANAESTHESIA, V65, P1173, DOI 10.1111/j.1365-2044.2010.06534.x; Theiler LG, 2009, ANESTHESIOLOGY, V111, P55, DOI 10.1097/ALN.0b013e3181a4c6b9; Tiesmeier J, 2011, RESUSCITATION, V82, P1358, DOI 10.1016/j.resuscitation.2011.07.004; Timmermann A, 2009, ANESTHESIOLOGY, V110, P262, DOI 10.1097/ALN.0b013e3181942c4d; van Zundert A, 2008, ANAESTHESIA, V63, P209, DOI 10.1111/j.1365-2044.2007.05421.x; van Zundert TCRV, 2012, ACTA ANAESTH BELG, V63, P35; Verghese C, 2008, BRIT J ANAESTH, V101, P405, DOI 10.1093/bja/aen174; [喻震 YU Zhen], 2011, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V31, P223; 黎阳, 2011, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V31, P1146	26	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71910	10.1371/journal.pone.0071910	http://dx.doi.org/10.1371/journal.pone.0071910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951266	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300170
J	Figueiredo, AC; de Sanctis, D; Pereira, PJB				Figueiredo, Ana C.; de Sanctis, Daniele; Barbosa Pereira, Pedro Jose			The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FACTOR-XIII; ANTI-THROMBIN; CDNA LIBRARY; PROTEIN; COMPLEX; INHIBITORS; HIRUDIN; SALIVA; PURIFICATION	The cysteine-less peptidic anticoagulants madanin-1 and madanin-2 from the bush tick Haemaphysalis longicornis are the founding members of the MEROPS inhibitor family I53. It has been previously suggested that madanins exert their functional activity by competing with physiological substrates for binding to the positively charged exosite I (fibrinogen-binding exosite) of alpha-thrombin. We hereby demonstrate that competitive inhibition of a-thrombin by madanin-1 or madanin-2 involves binding to the enzyme's active site. Moreover, the blood coagulation factors IIa and Xa are shown to hydrolyze both inhibitors at different, although partially overlapping cleavage sites. Finally, the three-dimensional structure of the complex formed between human alpha-thrombin and a proteolytic fragment of madanin-1, determined by X-ray crystallography, elucidates the molecular details of madanin-1 recognition and processing by the proteinase. Taken together, the current findings establish the mechanism of action of madanins, natural anticoagulants that behave as cleavable competitive inhibitors of thrombin.	[Figueiredo, Ana C.; Barbosa Pereira, Pedro Jose] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [de Sanctis, Daniele] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France	Universidade do Porto; European Synchrotron Radiation Facility (ESRF)	Pereira, PJB (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ppereira@ibmc.up.pt	Figueiredo, Ana/K-1384-2013; Pereira, Pedro/F-8972-2011	Figueiredo, Ana/0000-0001-8386-8216; Pereira, Pedro/0000-0003-0969-5438	Fundacao para a Cieancia e a Tecnologia (Portugal) [PTDC/BIA-PRO/70627/2006]; EU-FEDER funding through the Operational Competitiveness Programme (COMPETE) [FCOMP-01-0124-FEDER-007076]; EU-FEDER funding through Programa Operacional Regional do Norte (ON.2 - O Novo Norte) [NORTE-07-0124-000003]; Quadro de Refereancia Estrategico Nacional (QREN));  [SFR/BPD/46722/2008]	Fundacao para a Cieancia e a Tecnologia (Portugal); EU-FEDER funding through the Operational Competitiveness Programme (COMPETE); EU-FEDER funding through Programa Operacional Regional do Norte (ON.2 - O Novo Norte); Quadro de Refereancia Estrategico Nacional (QREN)); 	This work was funded by national funds from Fundacao para a Cieancia e a Tecnologia (Portugal) through grants PTDC/BIA-PRO/70627/2006 (EU-FEDER funding through the Operational Competitiveness Programme (COMPETE) FCOMP-01-0124-FEDER-007076), and NORTE-07-0124-000003 - Cell Homeostasis Tissue Organization and Organism Biology (EU-FEDER funding through Programa Operacional Regional do Norte (ON.2 - O Novo Norte), under Quadro de Refereancia Estrategico Nacional (QREN)), and the postdoctoral fellowship SFR/BPD/46722/2008 (to A. C. F.). The funding bodies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Corral-Rodriguez MA, 2011, BLOOD, V117, P7164, DOI 10.1182/blood-2010-10-315309; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Cappello M, 1998, P NATL ACAD SCI USA, V95, P14290, DOI 10.1073/pnas.95.24.14290; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Cleary DB, 2002, ARCH BIOCHEM BIOPHYS, V403, P179, DOI 10.1016/S0003-9861(02)00220-5; Coons LB., 2008, ENCY ENTOMOLOGY, P3775; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueiredo AC, 2012, P NATL ACAD SCI USA, V109, pE3649, DOI 10.1073/pnas.1211614109; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Figueiredo AC, 2011, ACTA CRYSTALLOGR F, V67, P54, DOI 10.1107/S1744309110043472; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; Hsu HJ, 2008, J BIOL CHEM, V283, P12343, DOI 10.1074/jbc.M708843200; Iwanaga S, 2003, EUR J BIOCHEM, V270, P1926, DOI 10.1046/j.1432-1033.2003.03560.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Koh CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026367; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Liu CC, 2007, J AM CHEM SOC, V129, P10648, DOI 10.1021/ja0735002; Maritz-Olivier C, 2007, TRENDS PARASITOL, V23, P397, DOI 10.1016/j.pt.2007.07.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Nakajima C, 2005, J VET MED SCI, V67, P1127, DOI 10.1292/jvms.67.1127; Nakajima C, 2006, J VET MED SCI, V68, P447, DOI 10.1292/jvms.68.447; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rios-Steiner JL, 2007, J MOL BIOL, V371, P774, DOI 10.1016/j.jmb.2007.05.042; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang D, 2002, INSECT BIOCHEM MOLEC, V32, P321, DOI 10.1016/S0965-1748(01)00093-5	46	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71866	10.1371/journal.pone.0071866	http://dx.doi.org/10.1371/journal.pone.0071866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951260	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300166
J	Han, TL; Tumanov, S; Cannon, RD; Villas-Boas, SG				Han, Ting-Li; Tumanov, Sergey; Cannon, Richard D.; Villas-Boas, Silas G.			Metabolic Response of Candida albicans to Phenylethyl Alcohol under Hyphae-Inducing Conditions	PLOS ONE			English	Article							CARBON-DIOXIDE; ANTIBACTERIAL ACTIVITY; PHENETHYL ALCOHOL; AROMATIC ALCOHOLS; MORPHOGENESIS; DECARBOXYLASE; DEHYDROGENASE; CEREVISIAE; FARNESOL; YEASTS	Phenylethyl alcohol was one of the first quorum sensing molecules (QSMs) identified in C. albicans. This extracellular signalling molecule inhibits the hyphal formation of C. albicans at high cell density. Little is known, however, about the underlying mechanisms by which this QSM regulates the morphological switches of C. albicans. Therefore, we have applied metabolomics and isotope labelling experiments to investigate the metabolic changes that occur in C. albicans in response to phenylethyl alcohol under defined hyphae-inducing conditions. Our results showed a global upregulation of central carbon metabolism when hyphal development was suppressed by phenylethyl alcohol. By comparing the metabolic changes in response to phenylethyl alcohol to our previous metabolomic studies, we were able to short-list 7 metabolic pathways from central carbon metabolism that appear to be associated with C. albicans morphogenesis. Furthermore, isotope-labelling data showed that phenylethyl alcohol is indeed taken up and catabolised by yeast cells. Isotope-labelled carbon atoms were found in the majority of amino acids as well as in lactate and glyoxylate. However, isotope-labelled carbon atoms from phenylethyl alcohol accumulated mainly in the pyridine ring of NAD(+)/NADH and NADP(-)/NADPH molecules, showing that these nucleotides were the main products of phenylethyl alcohol catabolism. Interestingly, two metabolic pathways where these nucleotides play an important role, nitrogen metabolism and nicotinate/nicotinamide metabolism, were also short-listed through our previous metabolomics works as metabolic pathways likely to be closely associated with C. albicans morphogenesis.	[Han, Ting-Li; Tumanov, Sergey; Villas-Boas, Silas G.] Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand; [Cannon, Richard D.] Univ Otago, Dept Oral Sci, Dunedin, New Zealand	University of Auckland; University of Otago	Villas-Boas, SG (corresponding author), Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand.	s.villas-boas@auckland.ac.nz	Villas-Boas, Silas/AAS-5888-2020; Tumanov, Sergey/AAP-8003-2021; Villas-Boas, Silas/AAR-6748-2020	Villas-Boas, Silas/0000-0003-0148-5882; Cannon, Richard/0000-0002-5398-2066; Tumanov, Sergey/0000-0002-0557-3153	University of Auckland Faculty of Science Research Funding; University of Auckland Doctoral Scholarship	University of Auckland Faculty of Science Research Funding; University of Auckland Doctoral Scholarship	This work was supported by University of Auckland Faculty of Science Research Funding and by the University of Auckland Doctoral Scholarship to Ting-Li Han. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio RBM, 2010, BIOINFORMATICS, V26, P2969, DOI 10.1093/bioinformatics/btq567; Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; CORRE J, 1990, RES MICROBIOL, V141, P483, DOI 10.1016/0923-2508(90)90074-Z; Fabre CE, 1998, BIOTECHNOL PROGR, V14, P270, DOI 10.1021/bp9701022; Ghosh S, 2008, APPL ENVIRON MICROB, V74, P7211, DOI 10.1128/AEM.01614-08; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Han TL, 2012, FEMS YEAST RES, V12, P879, DOI 10.1111/j.1567-1364.2012.00837.x; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Han TL, 2012, METABOLOMICS, DOI [10.1007/s11306-11012-10416-11306, DOI 10.1007/S11306-11012-10416-11306]; HARAYAMA S, 1991, J BACTERIOL, V173, P7540, DOI 10.1128/jb.173.23.7540-7548.1991; Hornby JM, 2004, ANTIMICROB AGENTS CH, V48, P2305, DOI 10.1128/AAC.48.6.2305-2307.2004; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Lehninger A., 2005, LEHNINGER PRINCIPLES; LINGAPPA BT, 1969, SCIENCE, V163, P192, DOI 10.1126/science.163.3863.192; LUCCHINI JJ, 1990, RES MICROBIOL, V141, P499, DOI 10.1016/0923-2508(90)90075-2; Martins M, 2007, EUKARYOT CELL, V6, P2429, DOI 10.1128/EC.00252-07; MOCK RC, 1990, CAN J MICROBIOL, V36, P249, DOI 10.1139/m90-043; NEIDLE E, 1992, EUR J BIOCHEM, V204, P113, DOI 10.1111/j.1432-1033.1992.tb16612.x; OURA E, 1980, J GEN MICROBIOL, V118, P51; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Park HS, 2000, J BACTERIOL, V182, P573, DOI 10.1128/JB.182.3.573-580.2000; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; STOPPANI AOM, 1958, BIOCHEM J, V70, P438, DOI 10.1042/bj0700438; SUHARA K, 1969, ARCH BIOCHEM BIOPHYS, V130, P422, DOI 10.1016/0003-9861(69)90054-X; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	32	21	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71364	10.1371/journal.pone.0071364	http://dx.doi.org/10.1371/journal.pone.0071364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951145	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300108
J	Okuda, J; Niizuma, S; Shioi, T; Kato, T; Inuzuka, Y; Kawashima, T; Tamaki, Y; Kawamoto, A; Tanada, Y; Iwanaga, Y; Narazaki, M; Matsuda, T; Adachi, S; Soga, T; Takemura, G; Kondoh, H; Kita, T; Kimura, T				Okuda, Junji; Niizuma, Shinnichiro; Shioi, Tetsuo; Kato, Takao; Inuzuka, Yasutaka; Kawashima, Tsuneaki; Tamaki, Yodo; Kawamoto, Akira; Tanada, Yohei; Iwanaga, Yoshitaka; Narazaki, Michiko; Matsuda, Tetsuya; Adachi, Souichi; Soga, Tomoyoshi; Takemura, Genzou; Kondoh, Hiroshi; Kita, Toru; Kimura, Takeshi			Persistent Overexpression of Phosphoglycerate Mutase, a Glycolytic Enzyme, Modifies Energy Metabolism and Reduces Stress Resistance of Heart in Mice	PLOS ONE			English	Article							MYOCARDIAL FATTY-ACID; IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR HYPERTROPHY; MITOCHONDRIAL-FUNCTION; PROTEIN EXPRESSION; PRESSURE-OVERLOAD; RECEPTOR-ALPHA; COMPLEX-II; FAILURE; MECHANISMS	Background: Heart failure is associated with changes in cardiac energy metabolism. Glucose metabolism in particular is thought to be important in the pathogenesis of heart failure. We examined the effects of persistent overexpression of phosphoglycerate mutase 2 (Pgam2), a glycolytic enzyme, on cardiac energy metabolism and function. Methods and Results: Transgenic mice constitutively overexpressing Pgam2 in a heart-specific manner were generated, and cardiac energy metabolism and function were analyzed. Cardiac function at rest was normal. The uptake of analogs of glucose or fatty acids and the phosphocreatine/beta ATP ratio at rest were normal. A comprehensive metabolomic analysis revealed an increase in the levels of a few metabolites immediately upstream and downstream of Pgam2 in the glycolytic pathway, whereas the levels of metabolites in the initial few steps of glycolysis and lactate remained unchanged. The levels of metabolites in the tricarboxylic acid (TCA) cycle were altered. The capacity for respiration by isolated mitochondria in vitro was decreased, and that for the generation of reactive oxygen species (ROS) in vitro was increased. Impaired cardiac function was observed in response to dobutamine. Mice developed systolic dysfunction upon pressure overload. Conclusions: Constitutive overexpression of Pgam2 modified energy metabolism and reduced stress resistance of heart in mice.	[Okuda, Junji; Niizuma, Shinnichiro; Shioi, Tetsuo; Kato, Takao; Inuzuka, Yasutaka; Kawashima, Tsuneaki; Tamaki, Yodo; Kawamoto, Akira; Tanada, Yohei; Iwanaga, Yoshitaka; Kita, Toru; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Narazaki, Michiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Takemura, Genzou] Gifu Univ, Grad Sch Med, Div Cardiol, Gifu, Japan; [Kondoh, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Keio University; Gifu University; Kyoto University	Shioi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	tshioi@kuhp.kyoto-u.ac.jp	Tamaki, Yodo/AAF-8026-2020; Soga, Tomoyoshi/B-8105-2014	Tamaki, Yodo/0000-0003-0217-6598; Soga, Tomoyoshi/0000-0001-9502-2509; Kato, Takao/0000-0001-8213-7999	Japan Society for the Promotion of Science; Vehicle Racing Commemorative Foundation; Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology; Grants-in-Aid for Scientific Research [23390186] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Vehicle Racing Commemorative Foundation; Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, the Vehicle Racing Commemorative Foundation, and the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Baily CN, 2011, ARCH BIOCHEM BIOPHYS, V514, P68, DOI 10.1016/j.abb.2011.08.003; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; BOTTOMLEY PA, 1985, SCIENCE, V229, P769, DOI 10.1126/science.4023711; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chacko VP, 2000, AM J PHYSIOL-HEART C, V279, pH2218, DOI 10.1152/ajpheart.2000.279.5.H2218; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Durany N, 1996, COMP BIOCHEM PHYS B, V114, P217, DOI 10.1016/0305-0491(95)02135-3; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Ganesan B, 2007, J HEALTH SCI, V53, P671, DOI 10.1248/jhs.53.671; Hamilton EW, 2001, PLANT PHYSIOL, V126, P1266, DOI 10.1104/pp.126.3.1266; Hayashi D, 2013, J AM COLL CARDIOL, V61, P2007, DOI 10.1016/j.jacc.2013.01.074; HEALES SJR, 1995, NEUROCHEM RES, V20, P31; Heinke MY, 1999, ELECTROPHORESIS, V20, P2086, DOI 10.1002/(SICI)1522-2683(19990701)20:10<2086::AID-ELPS2086>3.0.CO;2-4; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; KELLY GJ, 1970, BIOCHIM BIOPHYS ACTA, V208, P360, DOI 10.1016/0304-4165(70)90207-2; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; O'Neill BT, 2007, CELL METAB, V6, P294, DOI 10.1016/j.cmet.2007.09.001; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; PALMER JW, 1977, J BIOL CHEM, V252, P8731; PAOLISSO G, 1994, METABOLISM, V43, P174, DOI 10.1016/0026-0495(94)90241-0; Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219; Rich MW, 2001, J GERONTOL A-BIOL, V56, pM88, DOI 10.1093/gerona/56.2.M88; Sheridan DJ, 2000, CARDIOVASC RES, V47, P133, DOI 10.1016/S0008-6363(00)00065-1; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sivakumar R, 2008, CHEM-BIOL INTERACT, V176, P227, DOI 10.1016/j.cbi.2008.08.008; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taylor M, 2001, J NUCL MED, V42, P55; Tuunanen H, 2008, CIRCULATION, V118, P1250, DOI 10.1161/CIRCULATIONAHA.108.778019; Wallhaus TR, 2001, CIRCULATION, V103, P2441; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053951; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7; Zhang JX, 2001, GENE, V264, P273, DOI 10.1016/S0378-1119(00)00597-7; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	59	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72173	10.1371/journal.pone.0072173	http://dx.doi.org/10.1371/journal.pone.0072173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951293	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300180
J	Olivera-Nappa, A; Reyes, F; Andrews, BA; Asenjo, JA				Olivera-Nappa, Alvaro; Reyes, Fernando; Andrews, Barbara A.; Asenjo, Juan A.			Cold Adaptation, Ca2+ Dependency and Autolytic Stability Are Related Features in a Highly Active Cold-Adapted Trypsin Resistant to Autoproteolysis Engineered for Biotechnological Applications	PLOS ONE			English	Article							HUMAN CATIONIC TRYPSINOGEN; PSYCHROPHILIC ENZYMES; ANTARCTIC KRILL; CLONING; AUTOACTIVATION; EXTREMOPHILES; PURIFICATION; PROTEINASES; DEBRIDEMENT; ENVIRONMENT	Pig trypsin is routinely used as a biotechnological tool, due to its high specificity and ability to be stored as an inactive stable zymogen. However, it is not an optimum enzyme for conditions found in wound debriding for medical uses and trypsinization processes for protein analysis and animal cell culturing, where low Ca2+ dependency, high activity in mild conditions and easy inactivation are crucial. We isolated and thermodynamically characterized a highly active cold-adapted trypsin for medical and laboratory use that is four times more active than pig trypsin at 10 degrees C and at least 50% more active than pig trypsin up to 50 degrees C. Contrary to pig trypsin, this enzyme has a broad optimum pH between 7 and 10 and is very insensitive to Ca2+ concentration. The enzyme is only distantly related to previously described cryophilic trypsins. We built and studied molecular structure models of this trypsin and performed molecular dynamic calculations. Key residues and structures associated with calcium dependency and cryophilicity were identified. Experiments indicated that the protein is unstable and susceptible to autoproteolysis. Correlating experimental results and structural predictions, we designed mutations to improve the resistance to autoproteolysis and conserve activity for longer periods after activation. One single mutation provided around 25 times more proteolytic stability. Due to its cryophilic nature, this trypsin is easily inactivated by mild denaturation conditions, which is ideal for controlled proteolysis processes without requiring inhibitors or dilution. We clearly show that cold adaptation, Ca2+ dependency and autolytic stability in trypsins are related phenomena that are linked to shared structural features and evolve in a concerted fashion. Hence, both structurally and evolutionarily they cannot be interpreted and studied separately as previously done.	[Olivera-Nappa, Alvaro; Reyes, Fernando; Andrews, Barbara A.; Asenjo, Juan A.] Univ Chile, Dept Chem Engn & Biotechnol, Ctr Biochem Engn & Biotechnol, Santiago, Chile	Universidad de Chile	Olivera-Nappa, A (corresponding author), Univ Chile, Dept Chem Engn & Biotechnol, Ctr Biochem Engn & Biotechnol, Santiago, Chile.	aolivera@ing.uchile.cl	Asenjo, Juan JAA/L-8336-2013; Andrews, Barbara/J-5070-2016; Olivera-Nappa, Alvaro/H-3769-2013; Olivera-Nappa, Alvaro/GPS-5388-2022	Asenjo, Juan JAA/0000-0002-3475-7664; Olivera-Nappa, Alvaro/0000-0001-6053-7019; Olivera-Nappa, Alvaro/0000-0001-6053-7019	Conicyt (FONDEF project, Chile) [D04I-1374]; Institute for Cell Dynamics and Biotechnology (ICM project, Chile) [P05-001-F]	Conicyt (FONDEF project, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Institute for Cell Dynamics and Biotechnology (ICM project, Chile)	This work was supported by Conicyt (FONDEF project # D04I-1374, Chile) and the Institute for Cell Dynamics and Biotechnology (ICM project # P05-001-F, Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo JP, 2008, J BIOTECHNOL, V133, P277, DOI 10.1016/j.jbiotec.2007.10.004; Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Aydin H, 2010, J ANIM VET ADV, V9, P1720; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BOURIOTIS V, 2001, BUS BRIEFING LIFE SC, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS M, 2006, PENAEUS VANNAMEI CUL; Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009; BUCHT A, 1991, POLAR BIOL, V11, P495; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Danhier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053324; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dias CL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118101; Dias CL, 2010, CRYOBIOLOGY, V60, P91, DOI 10.1016/j.cryobiol.2009.07.005; Ding JG, 2005, ACTA BIOCH BIOPH SIN, V37, P234, DOI 10.1111/j.1745-7270.2005.00040.x; Doerler M, 2012, J DTSCH DERMATOL GES, V10, P624, DOI 10.1111/j.1610-0387.2012.07952.x; Fein H, 2005, DERMATOL SURG, V31, P139, DOI 10.1097/00042728-200502000-00004; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Giovambattista N, 2009, J PHYS CHEM B, V113, P13723, DOI 10.1021/jp9018266; Glenn J, 2006, OSTOMY WOUND MANAG, V52, P94; Glyantsev S., 1997, J WOUND CARE, V6, P13, DOI [10.12968/jowc.1997.6.1.13, DOI 10.12968/JOWC.1997.6.1.13, DOI 10.12968/J0WC.1997.6.1.13]; Gomes J, 2004, FOOD TECHNOL BIOTECH, V42, P223; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hehemann JH, 2008, BIOCHEM BIOPH RES CO, V370, P566, DOI 10.1016/j.bbrc.2008.03.128; HELLGREN L, 1986, EXPERIENTIA, V42, P403, DOI 10.1007/BF02118628; Hernandez-Cortes P, 1999, BIOL CHEM, V380, P499, DOI 10.1515/BC.1999.065; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Huston AL, 2008, BBA-PROTEINS PROTEOM, V1784, P1865, DOI 10.1016/j.bbapap.2008.06.002; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Klein B, 1998, GENE, V216, P123, DOI 10.1016/S0378-1119(98)00331-X; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Min CK, 2011, J BIOTECHNOL, V151, P350, DOI 10.1016/j.jbiotec.2010.12.023; Olivera-Nappa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-122; Olsson MHM, 2011, PROTEINS, V79, P3333, DOI 10.1002/prot.23113; OSNES K, 1985, COMP BIOCH PHYSL B; PRIVALOV PL, 1989, PURE APPL CHEM, V61, P1097, DOI 10.1351/pac198961061097; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; Ramundo J, 2008, J WOUND OSTOMY CONT, V35, P273, DOI 10.1097/01.WON.0000319125.21854.78; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rudenskaya Galina N., 2004, BMC Structural Biology, V4; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V275, P668, DOI 10.1006/bbrc.2000.3355; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Salamanca MH, 2001, BIOSEPARATION, V10, P237, DOI 10.1023/A:1016383212244; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schellman JA, 1997, BIOPHYS J, V73, P2960, DOI 10.1016/S0006-3495(97)78324-3; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sheridan PP, 2000, BBA-PROTEIN STRUCT M, V1543, P417, DOI 10.1016/S0167-4838(00)00237-5; Shi W, 2008, J VIROL, V82, P6190, DOI 10.1128/JVI.02731-07; Shriver J., 2009, PROTEIN STRUCTURE ST; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sjodahl J, 2002, PROTEIN EXPRES PURIF, V26, P153, DOI 10.1016/S1046-5928(02)00519-3; Smith RE, 2007, BIOINFORMATICS, V23, P1099, DOI 10.1093/bioinformatics/btm073; Szenthe B, 2005, BBA-PROTEINS PROTEOM, V1748, P35, DOI 10.1016/j.bbapap.2004.12.006; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; TURKIEWICZ M, 1991, COMP BIOCHEM PHYS B, V99, P359, DOI 10.1016/0305-0491(91)90056-J; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zuo GH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031917	74	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72355	10.1371/journal.pone.0072355	http://dx.doi.org/10.1371/journal.pone.0072355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951314	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300192
J	Qiao, GF; Qian, Z; Sun, HL; Xu, WX; Yan, ZY; Liu, Y; Zhou, JY; Zhang, HC; Wang, LJ; Pan, XD; Fu, YL				Qiao, Guo-Fen; Qian, Zhao; Sun, Hong-Li; Xu, Wen-Xiao; Yan, Zhen-Yu; Liu, Yang; Zhou, Jia-Ying; Zhang, Hao-Cheng; Wang, Li-Juan; Pan, Xiao-Dong; Fu, Yili			Remodeling of Hyperpolarization-Activated Current, I-h, in Ah-Type Visceral Ganglion Neurons Following Ovariectomy in Adult Rats	PLOS ONE			English	Article							SENSORY NEURONS; NODOSE GANGLIA; CATION CHANNELS; VAGAL AFFERENTS; DIFFERENTIAL DISTRIBUTION; AORTIC BARORECEPTOR; EXCITABILITY; RECEPTOR; HYPERTENSION; WOMEN	Hyperpolarization-activated currents (I-h) mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels modulate excitability of myelinated A- and Ah-type visceral ganglion neurons (VGN). Whether alterations in I-h underlie the previously reported reduction of excitability of myelinated Ah-type VGNs following ovariectomy (OVX) has remained unclear. Here we used the intact nodose ganglion preparation in conjunction with electrophysiological approaches to examine the role of I-h remodeling in altering Ah-type neuron excitability following ovariectomy in adult rats. Ah-type neurons were identified based on their afferent conduction velocity. Ah-type neurons in nodose ganglia from non-OVX rats exhibited a voltage 'sag' as well as 'rebound' action potentials immediately following hyperpolarizing current injections, which both were suppressed by the I-h blocker ZD7288. Repetitive spike activity induced afterhyperpolarizations lasting several hundreds of milliseconds (termed post-excitatory membrane hyperpolarizations, PEMHs), which were significantly reduced by ZD7288, suggesting that they resulted from transient deactivation of I-h during the preceding spike trains. Ovariectomy reduced whole-cell I-h density, caused a hyperpolarizing shift of the voltage-dependence of I-h activation, and slowed I-h activation. OVX-induced I-h remodeling was accompanied by a flattening of the stimulus frequency/response curve and loss of PEMHs. Also, HCN1 mRNA levels were reduced by similar to 30% in nodose ganglia from OVX rats compared with their non-OVX counterparts. Acute exposure of nodose ganglia to 17beta-estradiol partly restored I-h density and accelerated I-h activation in Ah-type cells. In conclusion, I-h plays a significant role in modulating the excitability of myelinated Ah-type VGNs in adult female rats.	[Qiao, Guo-Fen; Fu, Yili] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150006, Heilongjiang, Peoples R China; [Qiao, Guo-Fen; Qian, Zhao; Yan, Zhen-Yu; Liu, Yang; Zhou, Jia-Ying; Zhang, Hao-Cheng; Wang, Li-Juan; Pan, Xiao-Dong] Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China; [Sun, Hong-Li] Harbin Med Univ, Dept Pharmacol, Da Qing, Heilongjiang, Peoples R China; [Xu, Wen-Xiao] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Medical University; Harbin Medical University; Harbin Medical University	Fu, YL (corresponding author), Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150006, Heilongjiang, Peoples R China.	fuyili2012@yahoo.com.cn			National Natural Science Foundation of China [30973532, 81173051, 31171122]; Education Department of China [20112307110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of China	This project was supported by research grants from National Natural Science Foundation of China (No.: 30973532; 81173051; 31171122) to G-F Q & B-Y L, and partially funded by the grant from Education Department of China (No.: 20112307110008) to B-Y L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Angelo K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00050; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bonin RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058679; Cho HJ, 2011, J NEUROPHYSIOL, V106, P2045, DOI 10.1152/jn.00798.2010; Clerc N, 1999, NEUROSCIENCE, V90, P279, DOI 10.1016/S0306-4522(98)00431-X; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gonzalo-Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036477; Grabauskas G, 2010, J PHYSIOL-LONDON, V588, P617, DOI 10.1113/jphysiol.2009.182147; Ito K, 2006, HYPERTENSION, V48, P651, DOI 10.1161/01.HYP.0000238125.21656.9e; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Li BY, 2008, AM J PHYSIOL-REG I, V295, pR1301, DOI 10.1152/ajpregu.90401.2008; Li BY, 2007, J NEUROSCI METH, V164, P75, DOI 10.1016/j.jneumeth.2007.04.003; Li BY, 2011, AM J PHYSIOL-CELL PH, V300, pC1393, DOI 10.1152/ajpcell.00278.2010; Li BY, 2002, J NEUROSCI METH, V115, P157, DOI 10.1016/S0165-0270(02)00010-9; Li BY, 2002, ACTA PHARMACOL SIN, V23, P481; Li YL, 2008, CARDIOVASC RES, V79, P715, DOI 10.1093/cvr/cvn141; McBride SM, 2005, ENDOCRINE, V28, P199, DOI 10.1385/ENDO:28:2:199; NAKAJIMA S, 1966, J PHYSIOL-LONDON, V187, P105, DOI 10.1113/jphysiol.1966.sp008078; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205; Oswald MJ, 2009, J PHYSIOL-LONDON, V587, P5879, DOI 10.1113/jphysiol.2009.177600; Parker D, 1996, J NEUROPHYSIOL, V76, P540, DOI 10.1152/jn.1996.76.1.540; Preston RA, 2007, CLIMACTERIC, V10, P32, DOI 10.1080/13697130601114909; Qiao GF, 2009, AM J PHYSIOL-CELL PH, V297, pC654, DOI 10.1152/ajpcell.00059.2009; Qiu J, 2003, J NEUROSCI, V23, P9529; Samad Z, 2008, CARDIOL REV, V16, P305, DOI 10.1097/CRD.0b013e31817f9350; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Sandberg K, 2008, HYPERTENSION, V52, P615, DOI 10.1161/HYPERTENSIONAHA.108.115063; Schild JH, 2012, AUTON NEUROSCI-BASIC, V172, P4, DOI 10.1016/j.autneu.2012.10.014; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tabarean IV, 2012, NEUROPHARMACOLOGY, V63, P171, DOI 10.1016/j.neuropharm.2012.02.006; Tu H, 2010, NEUROSCIENCE, V165, P39, DOI 10.1016/j.neuroscience.2009.10.002; Weng XC, 2012, PAIN, V153, P900, DOI 10.1016/j.pain.2012.01.019; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Ying SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042756; Zhou YH, 2010, CLIN EXP PHARMACOL P, V37, P852, DOI 10.1111/j.1440-1681.2010.05396.x	41	64	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71184	10.1371/journal.pone.0071184	http://dx.doi.org/10.1371/journal.pone.0071184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951107	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300096
J	Respondek, F; Gerard, P; Bossis, M; Boschat, L; Bruneau, A; Rabot, S; Wagner, A; Martin, JC				Respondek, Frederique; Gerard, Philippe; Bossis, Mathilde; Boschat, Laura; Bruneau, Aurelia; Rabot, Sylvie; Wagner, Anne; Martin, Jean-Charles			Short-Chain Fructo-Oligosaccharides Modulate Intestinal Microbiota and Metabolic Parameters of Humanized Gnotobiotic Diet Induced Obesity Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN SENSITIVITY; MASS-SPECTROMETRY; GENE-EXPRESSION; GUT MICROBIOTA; CEREAL-FIBER; LEPTIN; ACIDS; RATS; SECRETION	Prebiotic fibres like short-chain fructo-oligosaccharides (scFOS) are known to selectively modulate the composition of the intestinal microbiota and especially to stimulate Bifidobacteria. In parallel, the involvement of intestinal microbiota in host metabolic regulation has been recently highlighted. The objective of the study was to evaluate the effect of scFOS on the composition of the faecal microbiota and on metabolic parameters in an animal model of diet-induced obesity harbouring a human-type microbiota. Forty eight axenic C57BL/6J mice were inoculated with a sample of faecal human microbiota and randomly assigned to one of 3 diets for 7 weeks: a control diet, a high fat diet (HF, 60% of energy derived from fat)) or an isocaloric HF diet containing 10% of scFOS (HF-scFOS). Mice fed with the two HF gained at least 21% more weight than mice from the control group. Addition of scFOS partially abolished the deposition of fat mass but significantly increased the weight of the caecum. The analysis of the taxonomic composition of the faecal microbiota by FISH technique revealed that the addition of scFOS induced a significant increase of faecal Bifidobacteria and the Clostridium coccoides group whereas it decreased the Clostridium leptum group. In addition to modifying the composition of the faecal microbiota, scFOS most prominently affected the faecal metabolome (e. g. bile acids derivatives, hydroxyl monoenoic fatty acids) as well as urine, plasma hydrophilic and plasma lipid metabolomes. The increase in C. coccoides and the decrease in C. leptum, were highly correlated to these metabolic changes, including insulinaemia, as well as to the weight of the caecum (empty and full) but not the increase in Bifidobacteria. In conclusion scFOS induce profound metabolic changes by modulating the composition and the activity of the intestinal microbiota, that may partly explain their effect on the reduction of insulinaemia.	[Respondek, Frederique; Wagner, Anne] Tereos Syral, Innovat, Marckolsheim, France; [Respondek, Frederique; Bossis, Mathilde; Martin, Jean-Charles] Aix Marseille Univ, Fac Med, Marseille, France; [Respondek, Frederique; Bossis, Mathilde; Martin, Jean-Charles] INSERM, Nutr Obesite & Risque Trombot UMR1062, F-13258 Marseille, France; [Gerard, Philippe; Boschat, Laura; Bruneau, Aurelia; Rabot, Sylvie] INRA, Micalis UMR1319, Jouy En Josas, France; [Gerard, Philippe; Boschat, Laura; Bruneau, Aurelia; Rabot, Sylvie] AgroParisTech, UMR Micalis, Jouy En Josas, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Respondek, F (corresponding author), Tereos Syral, Innovat, Marckolsheim, France.	frederique.respondek@tereos.com	Gérard, Philippe/H-8138-2019	Gérard, Philippe/0000-0001-9521-0067; Rabot, Sylvie/0000-0002-4603-2038	company Beghin-Meiji; Les Termes de Brides les Bains	company Beghin-Meiji; Les Termes de Brides les Bains	The study was supported by the company Beghin-Meiji and by Les Termes de Brides les Bains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonsu NKA, 2011, J DIABETES, V3, P58, DOI 10.1111/j.1753-0407.2010.00099.x; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Boutron-Ruault MC, 2005, NUTR CANCER, V53, P160, DOI 10.1207/s15327914nc5302_5; Busserolles J, 2003, J NUTR, V133, P1903, DOI 10.1093/jn/133.6.1903; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dewulf EM, 2012, INSIGHT PREBIOTIC CO; Draper J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-227; Eriksson K, 2006, MULTI MEGAVARIATE 1, P419; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fukasawa T, 2010, J AGR FOOD CHEM, V58, P7007, DOI 10.1021/jf1006616; Gerard P, 2004, FEMS MICROBIOL ECOL, V47, P337, DOI 10.1016/S0168-6496(03)00285-X; Gerard P, 2008, J MOL MICROB BIOTECH, V14, P115, DOI 10.1159/000106090; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gourgue-Jeannot C, 2006, CAN J MICROBIOL, V52, P924, DOI 10.1139/W06-053; Grison S, 2012, J RADIAT RES, V53, P33, DOI 10.1269/jrr.11071; Hirayama Kazuhiro, 2005, Current Issues in Intestinal Microbiology, V6, P69; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hou CT, 2008, ASIA PAC J CLIN NUTR, V17, P192; Ishioka K, 2005, VET J, V169, P85, DOI 10.1016/j.tvjl.2004.01.003; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Blay G, 1999, J NUTR, V129, P2231, DOI 10.1093/jn/129.12.2231; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leibowitz SF, 2006, AM J PHYSIOL-ENDOC M, V290, pE258, DOI 10.1152/ajpendo.00609.2004; Lozupone C, 2012, GENOME RES; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.40; Martin JC, 2009, ATHEROSCLEROSIS, V206, P127, DOI 10.1016/j.atherosclerosis.2009.01.040; Murakami K, 2005, J NUTR SCI VITAMINOL, V51, P292, DOI 10.3177/jnsv.51.292; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Osipov Georgy A., 2009, Microbial Ecology in Health and Disease, V21, P159, DOI 10.3109/08910600903462657; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; PEARSON JR, 1974, J MED MICROBIOL, V7, P265, DOI 10.1099/00222615-7-2-265; Poppitt SD, 2006, EUR J CLIN NUTR, V60, P77, DOI 10.1038/sj.ejcn.1602270; Post RE, 2012, J AM BOARD FAM MED, V25, P16, DOI 10.3122/jabfm.2012.01.110148; Pyra KA, 2012, J NUTR, V142, P213, DOI 10.3945/jn.111.147132; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ravussin Y, 2011, OBESITY, DOI 10.1038; Respondek F, 2011, J ANIM SCI, V89, P77, DOI 10.2527/jas.2010-3108; Respondek F, 2008, J NUTR, V138, P1712, DOI 10.1093/jn/138.9.1712; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Robertson MD, 2007, P NUTR SOC, V66, P351, DOI 10.1017/S0029665107005617; Saulnier DMA, 2008, FEMS MICROBIOL ECOL, V66, P516, DOI 10.1111/j.1574-6941.2008.00561.x; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinoki A, 2011, BRIT J NUTR, V106, P1190, DOI 10.1017/S000711451100167X; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Sugatani J, 2008, EUR J NUTR, V47, P192, DOI 10.1007/s00394-008-0713-z; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Taras D, 2002, INT J SYST EVOL MICR, V52, P423, DOI 10.1099/00207713-52-2-423; Thabuis C, 2011, J LIPID RES, V52, P1373, DOI 10.1194/jlr.M013391; Tunaru S, 2012, P NATL ACAD SCI USA, V109, P9179, DOI 10.1073/pnas.1201627109; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; WALKER AW, 2010, ISME J; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Weickert MO, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-90; Weickert MO, 2005, DIABETOLOGIA, V48, P2343, DOI 10.1007/s00125-005-1941-x; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100	68	62	64	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71026	10.1371/journal.pone.0071026	http://dx.doi.org/10.1371/journal.pone.0071026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951074	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300078
J	Takeda, A; Iida, M; Ando, M; Nakamura, M; Tamano, H; Oku, N				Takeda, Atsushi; Iida, Masashi; Ando, Masaki; Nakamura, Masatoshi; Tamano, Haruna; Oku, Naoto			Enhanced Susceptibility to Spontaneous Seizures of Noda Epileptic Rats by Loss of Synaptic Zn2+	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; TEMPORAL-LOBE EPILEPSY; MOSSY FIBER ZINC; GLUTAMATE RELEASE; CHELATABLE ZINC; KINDLING MODEL; KAINIC ACID; BRAIN; EXCITABILITY; INHIBITION	Zinc homeostasis in the brain is associated with the etiology and manifestation of epileptic seizures. Adult Noda epileptic rats (NER, >12-week-old) exhibit spontaneously generalized tonic-clonic convulsion about once a day. To pursue the involvement of synaptic Zn2+ signal in susceptibility to spontaneous seizures, in the present study, the effect of zinc chelators on epileptogenesis was examined using adult NER. Clioquinol (CQ) and TPEN are lipophilic zinc chelotors, transported into the brain and reduce the levels of synaptic Zn2+. The incidence of tonic-clonic convulsion was markedly increased after i.p. injection of CQ (30-100 mg/kg) and TPEN (1 mg/kg). The basal levels of extracellular Zn2+ measured by ZnAF-2 were decreased before tonic-clonic convulsion was induced with zinc chelators. The hippocampal electroencephalograms during CQ (30 mg/kg)-induced convulsions were similar to those during sound-induced convulsions in NER reported previously. Exocytosis of hippocampal mossy fibers, which was measured with FM4-64, was significantly increased in hippocampal slices from CQ-injected NER that did not show tonic-clonic convulsion yet. These results indicate that the abnormal excitability of mossy fibers is induced prior to epileptic seizures by injection of zinc chelators into NER. The incidence of tonic-clonic convulsion induced with CQ (30 mg/kg) was significantly reduced by co-injection with aminooxyacetic acid (5-10 mg/kg), an anticonvulsant drug enhancing GABAergic activity, which did not affect locomotor activity. The present paper demonstrates that the abnormal excitability in the brain, especially in mossy fibers, which is potentially associated with the insufficient GABAergic neuron activity, may be a factor to reduce the threshold for epileptogenesis in NER.	[Takeda, Atsushi; Ando, Masaki; Tamano, Haruna] Univ Shizuoka, Sch Pharmaceut Sci, Dept Bioorgan Chem, Suruga Ku, Shizuoka 4228526, Japan; [Takeda, Atsushi; Iida, Masashi; Nakamura, Masatoshi; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan	University of Shizuoka; University of Shizuoka	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Bioorgan Chem, Suruga Ku, Global COE 21,52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172				Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bancila V, 2004, J NEUROCHEM, V90, P1243, DOI 10.1111/j.1471-4159.2004.02587.x; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Cohen-Kfir E, 2005, P NATL ACAD SCI USA, V102, P6154, DOI 10.1073/pnas.0501431102; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Coulter DA, 2000, EPILEPSIA, V41, pS96, DOI 10.1111/j.1528-1157.2000.tb01565.x; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; DURING MJ, 1993, LANCET, V341, P1607; Elsas SM, 2009, EPILEPSIA, V50, P870, DOI 10.1111/j.1528-1167.2008.01913.x; Foresti ML, 2008, EPILEPSY RES, V79, P166, DOI 10.1016/j.eplepsyres.2008.02.004; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Hanaya R, 2002, BRAIN RES, V950, P317, DOI 10.1016/S0006-8993(02)03195-5; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Jing Q, 2006, J NEUROSCI, V26, P6089, DOI 10.1523/JNEUROSCI.0475-06.2006; Kiura Y, 2003, J PHARMACOL SCI, V91, P137; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Lavoie N, 2007, J PHYSIOL-LONDON, V578, P275, DOI 10.1113/jphysiol.2006.121848; Lee JY, 2000, J NEUROSCI, V20; Lees GJ, 1998, BRAIN RES, V799, P108, DOI 10.1016/S0006-8993(98)00483-1; Meeusen JW, 2012, INORG CHEM, V51, P3625, DOI 10.1021/ic2025236; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; MITCHELL CL, 1990, BRAIN RES, V506, P327, DOI 10.1016/0006-8993(90)91273-J; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Noda A, 1998, EPILEPSIA, V39, P99, DOI 10.1111/j.1528-1157.1998.tb01281.x; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Sasa M, 1997, Nihon Shinkei Seishin Yakurigaku Zasshi, V17, P35; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; SEYFRIED TN, 1985, EPILEPSIA, V26, P143, DOI 10.1111/j.1528-1157.1985.tb05398.x; STERMAN MB, 1988, NUTR MODULATION NEUR, P307; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; SUZUKI J, 1976, EXPERIENTIA, V32, P336, DOI 10.1007/BF01940824; Takeda A, 2003, EPILEPSY RES, V57, P169, DOI 10.1016/j.eplepsyres.2003.11.003; Takeda A, 2003, EPILEPSY RES, V54, P123, DOI 10.1016/S0920-1211(03)00063-9; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Takeda A, 2007, NEUROCHEM INT, V50, P322, DOI 10.1016/j.neuint.2006.08.015; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; WILLIAMSON A, 1995, NEUROREPORT, V6, P1562, DOI 10.1097/00001756-199507310-00024; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	43	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71372	10.1371/journal.pone.0071372	http://dx.doi.org/10.1371/journal.pone.0071372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951148	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300110
J	Ozaki, T; Ishiguro, S; Hirano, S; Baba, A; Yamashita, T; Tomita, H; Nakazawa, M				Ozaki, Taku; Ishiguro, Sei-ichi; Hirano, Satoshi; Baba, Ayaka; Yamashita, Tetsuro; Tomita, Hiroshi; Nakazawa, Mitsuru			Inhibitory Peptide of Mitochondrial mu-Calpain Protects against Photoreceptor Degeneration in Rhodopsin Transgenic S334ter and P23H Rats	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; DOMINANT RETINITIS-PIGMENTOSA; ENDOPLASMIC-RETICULUM STRESS; INDUCED RETINAL DEGENERATION; ACUTE OPTIC NEURITIS; CELL-DEATH; CLINICAL EXPRESSION; ROYAL-COLLEGE; CROSS-TALK; RCS RAT	Mitochondrial mu-calpain and apoptosis-inducing factor (AIF)-dependent photoreceptor cell death has been seen in several rat and mouse models of retinitis pigmentosa (RP). Previously, we demonstrated that the specific peptide inhibitor of mitochondrial mu-calpain, Tat-mu CL, protected against retinal degeneration following intravitreal injection or topical eye-drop application in Mertk gene-mutated Royal College of Surgeons rats, one of the animal models of RP. Because of the high rate of rhodopsin mutations in RP patients, the present study was performed to confirm the protective effects of Tat-mu CL against retinal degeneration in rhodopsin transgenic S334ter and P23H rats. We examined the effects of intravitreal injection or topical application of the peptide on retinal degeneration in S334ter and P23H rats by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, electroretinogram (ERG), immunohistochemistry for AIF, and histological staining. In S334ter rats, we found that intravitreal injection or topical application of the peptide prevented photoreceptor cell death from postnatal (PN) 15 to 18 days, the time of early-stage retinal degeneration. Topical application of the peptide also delayed attenuation of ERG responses from PN 28 to 56 days. In P23H rats, topical application of the peptide protected against photoreceptor cell death and nuclear translocation of AIF on PN 30, 40, and 50 days, as the primary stages of degeneration. We observed that topical application of the peptide inhibited the thinning of the outer nuclear layer and delayed ERG attenuations from PN 30 to 90 days. Our results demonstrate that the mitochondrial mu-calpain and AIF pathway is involved in early-stage retinal degeneration in rhodopsin transgenic S334ter and P23H rats, and inhibition of this pathway shows curative potential for rhodopsin mutation-caused RP.	[Ozaki, Taku; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan; [Ozaki, Taku; Ishiguro, Sei-ichi; Hirano, Satoshi; Baba, Ayaka] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Dept Biol Chem, Morioka, Iwate 020, Japan; [Tomita, Hiroshi] Iwate Univ, Grad Sch Engn, Dept Chem & Bioengn, Morioka, Iwate 020, Japan	Hirosaki University; Hirosaki University; Iwate University; Iwate University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	mitsuru@cc.hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020; Tomita, Hiroshi/O-2135-2018	Nakazawa, Mitsuru/0000-0001-6095-5712; Tomita, Hiroshi/0000-0003-1051-2301; Ozaki, Taku/0000-0001-8183-5453	Hirosaki University; Kita-Tohoku Three National Universities; Japan Society for the Promotion of Science [C-24592616]	Hirosaki University; Kita-Tohoku Three National Universities; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding came from a grant for Exploratory Research by Young Scientists from Hirosaki University, http://www.hirosaki-u.ac.jp, a grant for Priority Research Designated by the President of Hirosaki University from Hirosaki University, http://www.hirosaki-u.ac.jp, a grant from the Kita-Tohoku Three National Universities, http://www.hirosaki-u.ac.jp, and a grant-in-aid for scientific research (C-24592616) from the Japan Society for the Promotion of Science, http://www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Das A, 2013, J NEUROCHEM, V124, P133, DOI 10.1111/jnc.12064; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Galy A, 2005, HUM MOL GENET, V14, P2547, DOI 10.1093/hmg/ddi258; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Huang W, 2010, INVEST OPHTH VIS SCI, V51, P3049, DOI 10.1167/iovs.09-4364; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Lee D, 2003, ADV EXP MED BIOL, V533, P297; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu JR, 2013, J GEN VIROL, V94, P1477, DOI 10.1099/vir.0.047753-0; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Martinez-Navarrete G, 2011, EXP EYE RES, V92, P227, DOI 10.1016/j.exer.2010.12.001; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Murakami Y, 2012, AM J PATHOL, V181, P1378, DOI 10.1016/j.ajpath.2012.06.026; Nakazawa M, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/292040; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Norberg E, 2010, FREE RADICAL BIO MED, V48, P791, DOI 10.1016/j.freeradbiomed.2009.12.020; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; Osborne NN, 2013, CURR OPIN PHARMACOL, V13, P16, DOI 10.1016/j.coph.2012.09.002; Ozaki T, 2008, BBA-MOL CELL RES, V1783, P1955, DOI 10.1016/j.bbamcr.2008.05.011; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Ozaki T, 2012, BBA-MOL BASIS DIS, V1822, P1783, DOI 10.1016/j.bbadis.2012.07.018; Ozaki T, 2011, ARCH BIOCHEM BIOPHYS, V507, P254, DOI 10.1016/j.abb.2010.12.003; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Polster BM, 2013, NEUROCHEM INT, V62, P695, DOI 10.1016/j.neuint.2012.12.002; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Rezaie T, 2012, INVEST OPHTH VIS SCI, V53, P7847, DOI 10.1167/iovs.12-10793; Ryu M, 2012, J NEUROSCI RES, V90, P802, DOI 10.1002/jnr.22800; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; SANDBERG MA, 1995, INVEST OPHTH VIS SCI, V36, P1934; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sato K, 2012, MOL VIS, V18, P1516; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Smith AW, 2011, INVEST OPHTH VIS SCI, V52, P4935, DOI 10.1167/iovs.10-7027; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1994, J NEUROSCI, V14, P5818; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Yamazaki H, 2002, INVEST OPHTH VIS SCI, V43, P919; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845	51	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71650	10.1371/journal.pone.0071650	http://dx.doi.org/10.1371/journal.pone.0071650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951212	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200064
J	Scheers, I; Lombard, C; Paganelli, M; Campard, D; Najimi, M; Gala, JL; Decottignies, A; Sokal, E				Scheers, Isabelle; Lombard, Catherine; Paganelli, Massimiliano; Campard, David; Najimi, Mustapha; Gala, Jean-Luc; Decottignies, Anabelle; Sokal, Etienne			Human Umbilical Cord Matrix Stem Cells Maintain Multilineage Differentiation Abilities and Do Not Transform during Long-Term Culture	PLOS ONE			English	Article							SPONTANEOUS MALIGNANT-TRANSFORMATION; LI-FRAUMENI-SYNDROME; IN-VITRO EXPANSION; CELLULAR SENESCENCE; BONE-MARROW; CROSS-CONTAMINATION; STROMAL CELLS; P53; CANCER; EXPRESSION	Umbilical cord matrix stem cells (UCMSC) have generated great interest in various therapeutic approaches, including liver regeneration. This article aims to analyze the specific characteristics and the potential occurrence of premalignant alterations of UCMSC during long-term expansion, which are important issues for clinical applications. UCMSC were isolated from the umbilical cord of 14 full-term newborns and expanded in vitro until senescence. We examined the long-term growth potential, senescence characteristics, immunophenotype and multilineage differentiation capacity of these cells. In addition, their genetic stability was assessed through karyotyping, telomerase maintenance mechanisms and analysis of expression and functionality of cell cycle regulation genes. The tumorigenic potential was also studied in immunocompromised mice. In vitro, UCMSC reached up to 33.7+/-2.1 cumulative population doublings before entering replicative senescence. Their immunophenotype and differentiation potential, notably into hepatocyte-like cells, remained stable over time. Cytogenetic analyses did not reveal any chromosomal abnormality and the expression of oncogenes was not induced. Telomere maintenance mechanisms were not activated. Just as UCMSC lacked transformed features in vitro, they could not give rise to tumors in vivo. UCMSC could be expanded in long-term cultures while maintaining stable genetic features and endodermal differentiation potential. UCMSC therefore represent safe candidates for liver regenerative medicine.	[Scheers, Isabelle; Lombard, Catherine; Paganelli, Massimiliano; Campard, David; Najimi, Mustapha; Sokal, Etienne] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium; [Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Appl Mol Technol, B-1200 Brussels, Belgium; [Decottignies, Anabelle] Catholic Univ Louvain, de Duve Inst, Genet & Epigenet Alterat Genomes Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Decottignies, A (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium.	isabelle.scheers@uclouvain.be		Lombard, Catherine/0000-0002-5653-9545; Sokal, Etienne/0000-0001-5597-4708; Paganelli, Massimiliano/0000-0001-8730-9622	Fondation Saint-Luc Grant; Grant Waleo/Metacor [516041]; Grant FNRS [7.4592.07.F]	Fondation Saint-Luc Grant; Grant Waleo/Metacor; Grant FNRS	This work was supported by a Fondation Saint-Luc Grant, Grant Waleo/Metacor (#516041) and by Grant FNRS (#7.4592.07.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299; Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; Dekairelle AF, 2005, CLIN CANCER RES, V11, P4724, DOI 10.1158/1078-0432.CCR-05-0140; Eicheler W, 2002, J HISTOCHEM CYTOCHEM, V50, P197, DOI 10.1177/002215540205000207; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sawada Rumi, 2006, J Artif Organs, V9, P179, DOI 10.1007/s10047-006-0338-z; SCHEERS I, 2011, OPEN TISSUE ENG REGE, V4, P48; Scheers I, 2012, CELL TRANSPLANT; Shaffer SML, 2009, INT SYSTEM HUMAN CYT; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; SOUCEK T, 1995, FEBS LETT, V373, P164, DOI 10.1016/0014-5793(95)01033-B; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tilman G, 2009, ONCOGENE, V28, P1682, DOI 10.1038/onc.2009.23; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Ulaner GA, 1998, CANCER RES, V58, P4168; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028	57	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71374	10.1371/journal.pone.0071374	http://dx.doi.org/10.1371/journal.pone.0071374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951150	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200043
J	Verschuren, JJW; Trompet, S; Sampietro, ML; Heijmans, BT; Koch, W; Kastrati, A; Houwing-Duistermaat, JJ; Slagboom, PE; Quax, PHA; Jukema, JW				Verschuren, Jeffrey J. W.; Trompet, Stella; Sampietro, M. Lourdes; Heijmans, Bastiaan T.; Koch, Werner; Kastrati, Adnan; Houwing-Duistermaat, Jeanine J.; Slagboom, P. Eline; Quax, Paul H. A.; Jukema, J. Wouter			Pathway Analysis Using Genome-Wide Association Study Data for Coronary Restenosis - A Potential Role for the PARVB Gene	PLOS ONE			English	Article							BIOLOGICAL PATHWAYS; ENRICHMENT ANALYSIS; BETA-PARVIN; INTERVENTION; POLYMORPHISM; DISEASES; RISK; SET; SCHIZOPHRENIA; HERITABILITY	Background: Coronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified. The goal of the current study was to perform gene-set analysis of biological pathways related to inflammation, proliferation, vascular function and transcriptional regulation on coronary restenosis to identify novel genes and pathways related to this condition. Methods: The GENetic DEterminants of Restenosis (GENDER) databank contains genotypic data of 556,099SNPs of 295 cases with restenosis and 571 matched controls. Fifty-four pathways, related to known restenosis-related processes, were selected. Gene-set analysis was performed using PLINK, GRASS and ALIGATOR software. Pathways with a p<0.01 were fine-mapped and significantly associated SNPs were analyzed in an independent replication cohort. Results: Six pathways (cell-extracellular matrix (ECM) interactions pathway, IL2 signaling pathway, IL6 signaling pathway, platelet derived growth factor pathway, vitamin D receptor pathway and the mitochondria pathway) were significantly associated in one or two of the software packages. Two SNPs in the cell-ECM interactions pathway were replicated in an independent restenosis cohort. No replication was obtained for the other pathways. Conclusion: With these results we demonstrate a potential role of the cell-ECM interactions pathway in the development of coronary restenosis. These findings contribute to the increasing knowledge of the genetic etiology of restenosis formation and could serve as a hypothesis-generating effort for further functional studies.	[Verschuren, Jeffrey J. W.; Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Sampietro, M. Lourdes] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Heijmans, Bastiaan T.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Leiden, Netherlands; [Koch, Werner; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Heijmans, Bastiaan T.; Slagboom, P. Eline; Jukema, J. Wouter] Leiden Univ, Netherlands Consortium Hlth Ageing, Med Ctr, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Sampietro, M. Lourdes; Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; German Heart Centre Munich; Technical University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jukema, JW (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands.	j.w.jukema@lumc.nl	Quax, Paul/W-8520-2019; Jukema, J. Wouter/ABD-6503-2021; , Kastrati/Y-2389-2019; Slagboom, P. Eline/R-4790-2016; Quax, Paul/ABD-5294-2020; Houwing-Duistermaat, Jeanne/V-9048-2018	Jukema, J. Wouter/0000-0002-3246-8359; Slagboom, P. Eline/0000-0002-2875-4723; Quax, Paul/0000-0002-6853-5760; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation [2001D032]	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community(European Commission); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Healthy Ageing (NCHA); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Ballard D, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-25; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Monraats PS, 2007, GENES IMMUN, V8, P44, DOI 10.1038/sj.gene.6364343; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Oguri M, 2007, ATHEROSCLEROSIS, V194, pE172, DOI 10.1016/j.atherosclerosis.2006.12.019; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pons D, 2009, DIS MARKERS, V26, P75, DOI [10.1155/2009/520653, 10.3233/DMA-2009-0609]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Sampietro ML, 2009, NETH HEART J, V17, P262, DOI 10.1007/BF03086261; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YV, 2012, HUM GENET, V131, P1677, DOI 10.1007/s00439-012-1198-7; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; van Tiel CM, 2009, CIRCULATION, V120, P669, DOI 10.1161/CIRCULATIONAHA.108.842179; Verschuren JJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042401; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70676	10.1371/journal.pone.0070676	http://dx.doi.org/10.1371/journal.pone.0070676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950981	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200015
J	Curia, CA; Ernesto, JI; Stein, P; Busso, D; Schultz, RM; Cuasnicu, PS; Cohen, DJ				Curia, Claudio A.; Ernesto, Juan I.; Stein, Paula; Busso, Dolores; Schultz, Richard M.; Cuasnicu, Patricia S.; Cohen, Debora J.			Fertilization Induces a Transient Exposure of Phosphatidylserine in Mouse Eggs	PLOS ONE			English	Article							CELL-CYCLE RESUMPTION; PLASMA-MEMBRANE BLOCK; PROTEIN-KINASE-C; CA2+ OSCILLATIONS; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; MAMMALIAN EGGS; SURFACE-CHARGE; SPERM CELLS; PLC-ZETA	Phosphatidylserine (PS) is normally localized to the inner leaflet of the plasma membrane and the requirement of PS translocation to the outer leaflet in cellular processes other than apoptosis has been demonstrated recently. In this work we investigated the occurrence of PS mobilization in mouse eggs, which express flippase Atp8a1 and scramblases Plscr1 and 3, as determined by RT-PCR; these enzyme are responsible for PS distribution in cell membranes. We find a dramatic increase in binding of flouresceinated-Annexin-V, which specifically binds to PS, following fertilization or parthenogenetic activation induced by SrCl2 treatment. This increase was not observed when eggs were first treated with BAPTA-AM, indicating that an increase in intracellular Ca2+ concentration was required for PS exposure. Fluorescence was observed over the entire egg surface with the exception of the regions overlying the meiotic spindle and sperm entry site. PS exposure was also observed in activated eggs obtained from CaMKII gamma null females, which are unable to exit metaphase II arrest despite displaying Ca2+ spikes. In contrast, PS exposure was not observed in TPEN-activated eggs, which exit metaphase II arrest in the absence of Ca2+ release. PS exposure was also observed when eggs were activated with ethanol but not with a Ca2+ ionophore, suggesting that the Ca2+ source and concentration are relevant for PS exposure. Last, treatment with cytochalasin D, which disrupts microfilaments, or jasplakinolide, which stabilizes microfilaments, prior to egg activation showed that PS externalization is an actin-dependent process. Thus, the Ca2+ rise during egg activation results in a transient exposure of PS in fertilized eggs that is not associated with apoptosis.	[Curia, Claudio A.; Ernesto, Juan I.; Cuasnicu, Patricia S.; Cohen, Debora J.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Stein, Paula; Schultz, Richard M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Busso, Dolores] Pontificia Univ Catolica Chile, Fac Med, Dept Nutr Diabet & Metab, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Pennsylvania; Pontificia Universidad Catolica de Chile	Cohen, DJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina.	dcohen@ibyme.conicet.gov.ar	Busso, Dolores/I-3047-2016; Stein, Paula/ABE-9388-2020; Busso, Dolores/AAF-2568-2020; Busso, Dolores/K-7375-2012	Busso, Dolores/0000-0003-2113-1926; Stein, Paula/0000-0002-2040-4593; Busso, Dolores/0000-0003-2113-1926	Fundacion Alberto J. Roemmers grant; Fulbright-CONICET Scholarship; National Agency of Scientific and Technological Promotion (ANPCyT) grant [PICT 2011-061]; National Research Council of Argentina (CONICET); NIH [HD022732]	Fundacion Alberto J. Roemmers grant; Fulbright-CONICET Scholarship; National Agency of Scientific and Technological Promotion (ANPCyT) grant; National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Fundacion Alberto J. Roemmers grant, a Fulbright-CONICET Scholarship, and a National Agency of Scientific and Technological Promotion (ANPCyT) grant (PICT 2011-061) to DJC. CAC and JIE were recipients of a fellowship from the National Research Council of Argentina (CONICET). The research conducted at the University of Pennsylvania was supported by a grant from NIH (HD022732) to RMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Baluch DP, 2004, DEV BIOL, V274, P45, DOI 10.1016/j.ydbio.2004.05.030; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Borges E, 2009, REPROD BIOMED ONLINE, V18, P45, DOI 10.1016/S1472-6483(10)60423-3; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; de Vries KJ, 2003, BIOL REPROD, V68, P2122, DOI 10.1095/biolreprod.102.012500; Deguchi R, 2000, DEV BIOL, V218, P299, DOI 10.1006/dbio.1999.9573; Eliyahu E, 2002, BIOL REPROD, V67, P189, DOI 10.1095/biolreprod67.1.189; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fairn GD, 2008, SCIENCE, V320, P458, DOI 10.1126/science.1158173; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; GORDESKY SE, 1973, BIOCHEM BIOPH RES CO, V50, P1027, DOI 10.1016/0006-291X(73)91509-X; Halet G, 2004, BBA-MOL CELL RES, V1742, P185, DOI 10.1016/j.bbamcr.2004.09.012; Hasegawa A, 2008, AM J REPROD IMMUNOL, V60, P187, DOI 10.1111/j.1600-0897.2008.00611.x; HORVATH PM, 1993, MOL REPROD DEV, V34, P65, DOI 10.1002/mrd.1080340111; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; Ito J, 2011, MOL REPROD DEV, V78, P846, DOI 10.1002/mrd.21359; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Kalive M, 2010, MOL REPROD DEV, V77, P95, DOI 10.1002/mrd.21112; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Malcuit C, 2007, ADV EXP MED BIOL, V591, P117; MARO B, 1990, International Journal of Developmental Biology, V34, P127; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; McAvey BA, 2002, BIOL REPROD, V67, P1342, DOI 10.1095/biolreprod67.4.1342; McGinnis LK, 2007, DEV BIOL, V306, P241, DOI 10.1016/j.ydbio.2007.03.024; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miao YL, 2012, P NATL ACAD SCI USA, V109, P4169, DOI 10.1073/pnas.1112333109; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; NAKAOKA T, 1995, J BIOL CHEM, V270, P12147, DOI 10.1074/jbc.270.20.12147; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Sengoku K, 1999, MOL REPROD DEV, V52, P183, DOI 10.1002/(SICI)1098-2795(199902)52:2<183::AID-MRD9>3.0.CO;2-6; Sette C, 2002, EMBO J, V21, P5386, DOI 10.1093/emboj/cdf553; SHIINA Y, 1993, J REPROD FERTIL, V97, P143, DOI 10.1530/jrf.0.0970143; Suzuki T, 2010, DEVELOPMENT, V137, P2659, DOI 10.1242/dev.049791; Swann K, 2006, SEMIN CELL DEV BIOL, V17, P264, DOI 10.1016/j.semcdb.2006.03.009; Talmor-Cohen A, 2004, REPRODUCTION, V127, P455, DOI 10.1530/rep.1.00104; Tejera A, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.11.056; Van Blerkom J, 1998, HUM REPROD, V13, P1317, DOI 10.1093/humrep/13.5.1317; VINCENT C, 1992, J CELL SCI, V103, P389; Walker G, 1996, EUR J CELL BIOL, V70, P165; Yanagimachi R., 1994, P189; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	58	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71995	10.1371/journal.pone.0071995	http://dx.doi.org/10.1371/journal.pone.0071995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951277	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700127
J	Kondo, T; Isoda, R; Ookusa, T; Kamijo, K; Hamao, K; Hosoya, H				Kondo, Tomo; Isoda, Rieko; Ookusa, Takayuki; Kamijo, Keiju; Hamao, Kozue; Hosoya, Hiroshi			Aurora B but Not Rho/MLCK Signaling Is Required for Localization of Diphosphorylated Myosin II Regulatory Light Chain to the Midzone in Cytokinesis	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; CONTRACTILE RING; CLEAVAGE FURROW; HELA-CELLS; MITOTIC SPINDLE; DIVIDING CELLS; CANCER-CELLS; PHOSPHORYLATION; COMPLEX; PROTEIN	Non-muscle myosin II is stimulated by monophosphorylation of its regulatory light chain (MRLC) at Ser19 (1P-MRLC). MRLC diphosphorylation at Thr18/Ser19 (2P-MRLC) further enhances the ATPase activity of myosin II. Phosphorylated MRLCs localize to the contractile ring and regulate cytokinesis as subunits of activated myosin II. Recently, we reported that 2P-MRLC, but not 1P-MRLC, localizes to the midzone independently of myosin II heavy chain during cytokinesis in cultured mammalian cells. However, the mechanism underlying the distinct localization of 1P- and 2P-MRLC during cytokinesis is unknown. Here, we showed that depletion of the Rho signaling proteins MKLP1, MgcRacGAP, or ECT2 inhibited the localization of 1P-MRLC to the contractile ring but not the localization of 2P-MRLC to the midzone. In contrast, depleting or inhibiting a midzone-localizing kinase, Aurora B, perturbed the localization of 2P-MRLC to the midzone but not the localization of 1P-MRLC to the contractile ring. We did not observe any change in the localization of phosphorylated MRLC in myosin light-chain kinase (MLCK)-inhibited cells. Furrow regression was observed in Aurora B- and 2P-MRLC-inhibited cells but not in 1P-MRLC-perturbed dividing cells. Furthermore, Aurora B bound to 2P-MRLC in vitro and in vivo. These results suggest that Aurora B, but not Rho/MLCK signaling, is essential for the localization of 2P-MRLC to the midzone in dividing HeLa cells.	[Kondo, Tomo; Isoda, Rieko; Ookusa, Takayuki; Hamao, Kozue; Hosoya, Hiroshi] Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima, Hiroshima 724, Japan; [Kamijo, Keiju] Tohoku Univ, Dept Anat & Anthropol, Grad Sch Med, Sendai, Miyagi 980, Japan	Hiroshima University; Tohoku University	Hosoya, H (corresponding author), Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima, Hiroshima 724, Japan.	hhosoya@hiroshima-u.ac.jp	Kondo, Tomo/ABB-7268-2020	Kondo, Tomo/0000-0003-2507-3399; Hamao, Kozue/0000-0002-9594-1940	Sasakawa Scientific Research Grant from The Japan Science Society; Japanese Ministry for Education, Culture, Sports, Science, and Technology	Sasakawa Scientific Research Grant from The Japan Science Society; Japanese Ministry for Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Sasakawa Scientific Research Grant from The Japan Science Society and a grant-in-aid for Research Fellow of Japan Society for the Promotion of Science to T.K., and a research grant from the Japanese Ministry for Education, Culture, Sports, Science, and Technology to H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Asano S, 2009, GENES CELLS, V14, P555, DOI 10.1111/j.1365-2443.2009.01288.x; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; FUJIWARA K, 1976, J CELL BIOL, V71, P848, DOI 10.1083/jcb.71.3.848; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Heissler S. M., 2012, CELL MOL LIFE SCI; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; IKEBE M, 1989, BIOCHEMISTRY-US, V28, P8750, DOI 10.1021/bi00448a011; IKEBE M, 1985, J BIOL CHEM, V260, P27; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kondo T, 2012, EXP CELL RES, V318, P915, DOI 10.1016/j.yexcr.2012.02.009; Kondo T, 2012, BIOCHEM BIOPH RES CO, V417, P686, DOI 10.1016/j.bbrc.2011.11.151; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Murata-Hori M, 1998, BIOMED RES-TOKYO, V19, P111, DOI 10.2220/biomedres.19.111; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Murata-Hori M, 2000, J BIOCHEM-TOKYO, V128, P903, DOI 10.1093/oxfordjournals.jbchem.a022840; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PERRY MM, 1971, EXP CELL RES, V65, P249, DOI 10.1016/S0014-4827(71)80075-7; PIRES E, 1974, FEBS LETT, V41, P292, DOI 10.1016/0014-5793(74)81232-9; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Preuss U, 2003, EUR J CELL BIOL, V82, P447, DOI 10.1078/0171-9335-00332; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SATTERWHITE L L, 1992, Current Opinion in Cell Biology, V4, P43, DOI 10.1016/0955-0674(92)90057-J; Schroeder T. E., 1968, Experimental Cell Research, V53, P272, DOI 10.1016/0014-4827(68)90373-X; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tatsuka M, 1998, CANCER RES, V58, P4811; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; UYEDA TQP, 1993, SCIENCE, V262, P1867, DOI 10.1126/science.8266074; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yokoyama T, 2005, GENES CELLS, V10, P127, DOI 10.1111/j.1365-2443.2005.00824.x; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	69	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70965	10.1371/journal.pone.0070965	http://dx.doi.org/10.1371/journal.pone.0070965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951055	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700070
J	Mullins, CS; Schneider, B; Stockhammer, F; Krohn, M; Classen, CF; Linnebacher, M				Mullins, Christina Susanne; Schneider, Bjorn; Stockhammer, Florian; Krohn, Mathias; Classen, Carl Friedrich; Linnebacher, Michael			Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BRAIN-TUMORS; IN-VITRO; DRUG DISCOVERY; XENOGRAFTS; MODELS; MULTIFORME; CRYOPRESERVATION; CANCER	Background: Development of clinically relevant tumor model systems for glioblastoma multiforme (GBM) is important for advancement of basic and translational biology. High molecular heterogeneity of GBM tumors is well recognized, forming the rationale for molecular tests required before administration of several of the novel therapeutics rapidly entering the clinics. One model that has gained wide acceptance is the primary cell culture model. The laborious and time consuming process is rewarded with a relative high success rate (about 60%). We here describe and evaluate a very simple cryopreservation procedure for GBM tissue prior to model establishment that will considerably reduce the logistic complexity. Methods: Twenty-seven GBM samples collected ad hoc were prepared for primary cell culture freshly from surgery (#1) and after cryopreservation (#2). Results: Take rates after cryopreservation (59%) were as satisfactory as from fresh tissue (63%; p = 1.000). We did not observe any relevant molecular or phenotypic differences between cell lines established from fresh or vitally frozen tissue. Further, sensitivity both towards standard chemotherapeutic agents (Temozolomide, BCNU and Vincristine) and novel agents like the receptor tyrosine kinase inhibitor Imatinib did not differ. Conclusions: Our simple cryopreservation procedure facilitates collection, long-time storage and propagation (modeling) of clinical GBM specimens (potentially also from distant centers) for basic research, (pre-) clinical studies of novel therapies and individual response prediction.	[Mullins, Christina Susanne; Classen, Carl Friedrich] Univ Hosp Rostock, Dept Pediat, Rostock, Germany; [Mullins, Christina Susanne; Krohn, Mathias; Linnebacher, Michael] Univ Hosp Rostock, Dept Surg, Rostock, Germany; [Schneider, Bjorn] Univ Hosp Rostock, Dept Pathol, Rostock, Germany; [Stockhammer, Florian] Univ Hosp Rostock, Dept Neurosurg, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Linnebacher, M (corresponding author), Univ Hosp Rostock, Dept Surg, Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021; Mullins, Christina/ABG-4821-2021	Linnebacher, Michael/0000-0001-8054-1402; Mullins, Christina/0000-0003-2296-2027; Stockhammer, Florian/0000-0002-0525-5956	Wilhelm Vaillant Stiftung; Verein zur Forderung krebskranker Kinder Rostock, e.V.; founding program of the university medicine Rostock (FORUN); state Mecklenburg-Vorpommern	Wilhelm Vaillant Stiftung; Verein zur Forderung krebskranker Kinder Rostock, e.V.; founding program of the university medicine Rostock (FORUN); state Mecklenburg-Vorpommern	This work was supported by the "Wilhelm Vaillant Stiftung", the "Verein zur Forderung krebskranker Kinder Rostock, e.V." and a founding program of the university medicine Rostock (FORUN). The state Mecklenburg-Vorpommern granted CSM a graduate scholarship to perform this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon H, 2010, PEDIATR BLOOD CANCER, V54, P519, DOI 10.1002/pbc.22319; Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Bigner SH, 1990, BRAIN PATHOL, V1, P12, DOI 10.1111/j.1750-3639.1990.tb00633.x; BIGNER SH, 1990, CANCER RES, V50, P8017; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; Farias-Eisner G, 2012, BRIT J NEUROSURG, V26, P189, DOI 10.3109/02688697.2011.629698; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Foong Charlene Shu Fen, 2011, Front Biosci (Schol Ed), V3, P698, DOI 10.2741/s181; Garson K, 2005, MOL CELL ENDOCRINOL, V239, P15, DOI 10.1016/j.mce.2005.03.019; Goike HM, 2000, NEUROPATH APPL NEURO, V26, P172, DOI 10.1046/j.1365-2990.2000.026002172.x; Hamilton MG, 2011, J NEURO-ONCOL, V102, P255, DOI 10.1007/s11060-010-0307-5; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Ogino S, 2006, MODERN PATHOL, V19, P1083, DOI 10.1038/modpathol.3800618; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Reyes G, 1996, CANCER RES, V56, P5713; SCHUSTER JM, 1991, NEUROL CLIN, V9, P375, DOI 10.1016/S0733-8619(18)30291-3; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; van den Bent MJ, 2007, J NEUROPATH EXP NEUR, V66, P1074, DOI 10.1097/nen.0b013e31815c39f1; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Xu JY, 2012, J NEURO-ONCOL, V107, P269, DOI 10.1007/s11060-011-0756-5	25	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71070	10.1371/journal.pone.0071070	http://dx.doi.org/10.1371/journal.pone.0071070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951083	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700075
J	Shimada, Y; Katsube, K; Kabasawa, Y; Morita, K; Omura, K; Yamaguchi, A; Sakamoto, K				Shimada, Yasuyuki; Katsube, Ken-ichi; Kabasawa, Yuji; Morita, Kei-ichi; Omura, Ken; Yamaguchi, Akira; Sakamoto, Kei			Integrated Genotypic Analysis of Hedgehog-Related Genes Identifies Subgroups of Keratocystic Odontogenic Tumor with Distinct Clinicopathological Features	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; SUPPRESSOR GENE; GORLIN-SYNDROME; CLINICAL-MANIFESTATIONS; DEVELOPMENTAL DEFECTS; NEVUS SYNDROME; HUMAN HOMOLOG; MICE; CANCER; MEDULLOBLASTOMA	Keratocystic odontogenic tumor (KCOT) arises as part of Gorlin syndrome (GS) or as a sporadic lesion. Gene mutations and loss of heterozygosity (LOH) of the hedgehog receptor PTCH1 plays an essential role in the pathogenesis of KCOT. However, some KCOT cases lack evidence for gene alteration of PTCH1, suggesting that other genes in the hedgehog pathway may be affected. PTCH2 and SUFU participate in the occurrence of GS-associated tumors, but their roles in KCOT development are unknown. To elucidate the roles of these genes, we enrolled 36 KCOT patients in a study to sequence their entire coding regions of PTCH1, PTCH2 and SUFU. LOH and immunohistochemical expression of these genes, as well as the downstream targets of hedgehog signaling, were examined using surgically-excised KCOT tissues. PTCH1 mutations, including four novel ones, were found in 9 hereditary KCOT patients, but not in sporadic KCOT patients. A pathogenic mutation of PTCH2 or SUFU was not found in any patients. LOH at PTCH1 and SUFU loci correlated with the presence of epithelial budding. KCOT harboring a germline mutation (Type 1) showed nuclear localization of GLI2 and frequent histological findings such as budding and epithelial islands, as well as the highest recurrence rate. KCOT with LOH but without a germline mutation (Type 2) less frequently showed these histological features, and the recurrence rate was lower. KCOT with neither germline mutation nor LOH (Type 3) consisted of two subgroups, Type 3A and 3B, which were characterized by nuclear and cytoplasmic GLI2 localization, respectively. Type 3B rarely exhibited budding and recurrence, behaving as the most amicable entity. The expression patterns of CCND1 and BCL2 tended to correlate with these subgroups. Our data indicates a significant role of PTCH1 and SUFU in the pathogenesis of KCOT, and the genotype-oriented subgroups constitute entities with different potential aggressiveness.	[Shimada, Yasuyuki; Kabasawa, Yuji; Omura, Ken] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Restitut, Div Oral Hlth Sci,Sect Oral & Maxillofacial Surg, Tokyo, Japan; [Shimada, Yasuyuki; Katsube, Ken-ichi; Yamaguchi, Akira; Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Restitut, Div Oral Hlth Sci, Tokyo, Japan; [Shimada, Yasuyuki; Omura, Ken; Yamaguchi, Akira] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan; [Morita, Kei-ichi; Omura, Ken] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Dept Adv Mol Diag & Maxillofacial Surg, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yamaguchi, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Restitut, Div Oral Hlth Sci, Tokyo, Japan.	akira.mpa@tmd.ac.jp; s-kei.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020	SHIMADA, YASUYUKI/0000-0001-9181-340X	Japan Society for the Promotion of Science [21659420, 22249061, 23659854]; Ministry of Health, Labour, and Welfare [21040101]; Global Center of Excellence (GCOE) Program; International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [25462915] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence (GCOE) Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21659420, No. 22249061, and No. 23659854) and Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (No. 21040101) to AY, and by the Global Center of Excellence (GCOE) Program; International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLFORS E, 1984, J ORAL MAXIL SURG, V42, P10, DOI 10.1016/0278-2391(84)90390-2; Aragaki T, 2010, HUM PATHOL, V41, P1718, DOI 10.1016/j.humpath.2010.05.007; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Durand KS, 2010, MODERN PATHOL, V23, P619, DOI 10.1038/modpathol.2009.185; EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; Grachtchouk M, 2006, AM J PATHOL, V169, P806, DOI 10.2353/ajpath.2006.060054; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Heby-Henricson K, 2012, MOL CARCINOGEN, V51, P754, DOI 10.1002/mc.20852; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kijima C, 2012, FAM CANCER, V11, P565, DOI 10.1007/s10689-012-9548-0; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; Ling G, 2001, ONCOGENE, V20, P7770, DOI 10.1038/sj.onc.1204946; Mancuso M, 2004, CANCER RES, V64, P934, DOI 10.1158/0008-5472.CAN-03-2460; Pan SA, 2010, CLIN CANCER RES, V16, P442, DOI 10.1158/1078-0432.CCR-09-2574; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Pazzaglia S, 2006, CANCER LETT, V234, P124, DOI 10.1016/j.canlet.2005.03.047; Philipsen HP., 2005, IARC ODONTOGENIC TUM, P306; RAYNER CRW, 1977, BRIT J PLAST SURG, V30, P62, DOI 10.1016/S0007-1226(77)90037-6; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Rutter M, 2010, AM J RESP CELL MOL, V42, P615, DOI 10.1165/rcmb.2008-0390OC; SCHOFIELD D, 1995, AM J PATHOL, V146, P472; SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312; Shimada Y, 2013, J ORAL PATHOL MED, V42, P275, DOI 10.1111/j.1600-0714.2012.01202.x; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Svard J, 2009, MOL CARCINOGEN, V48, P408, DOI 10.1002/mc.20479; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Wetmore C, 2000, CANCER RES, V60, P2239; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	48	129	130	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70995	10.1371/journal.pone.0070995	http://dx.doi.org/10.1371/journal.pone.0070995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951062	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700072
J	Tokiwa, T; Hashimoto, T; Yabe, T; Komatsu, N; Akao, N; Ohta, N				Tokiwa, Toshihiro; Hashimoto, Takuma; Yabe, Tatsuo; Komatsu, Noriyuki; Akao, Nobuaki; Ohta, Nobuo			First Report of Angiostrongylus cantonensis (Nematoda: Angiostrongylidae) Infections in Invasive Rodents from Five Islands of the Ogasawara Archipelago, Japan	PLOS ONE			English	Article							RATTUS-NORVEGICUS; METASTRONGYLIDAE; CHEN; LUNGWORM; RECORD; GENE	Background: Angiostrongylus cantonensis (Chen, 1935) is a parasite of murid rodents and causative agent of human neuro-angiostrongyliasis. In 2011, the Ogasawara Islands in the western North Pacific were assigned a World Natural Heritage site status. The occurrence of A. cantonensis is well documented in the Chichijima, Hahajima, and Anijima Islands. However, the occurrence of A. cantonensis in the other islands of the Ogasawara Islands has not been reported. Methodology/Principal Findings: Between March 2010 and July 2011, 57 Rattus norvegicus and 79 R. rattus were collected from 9 islands (the Hahajima group: Anejima, Imoutojima, Meijima, Mukohjima, and Hirajima; Chichijima group: Minamijima; Mukojima group: Nakoudojima and Yomejima; and Iwojima group: Iwojima). Adult nematodes were found in the pulmonary artery of 46 R. norvegicus collected in the 5 islands of the Hahajima group (Anejima, Meijima, Imoutojima, Hrajima, and Mukohjima Islands). These nematodes were identified by molecular analysis as A. cantonensis. Comparison of the mitochondrial DNA sequences confirmed that all the samples from the Ogasawara Islands shared only a single lineage of A. cantonensis, which has been previously detected in the Okinawa, Hawaii, and Brazil. Conclusions/Significance: We describe new endemic foci of rat angiostrongyliasis in the Hahajima group (Anejima, Meijima, Imoutojima, Hirajima, and Mukohjima Islands) of the Ogasawara Islands. These findings indicate that the endemic foci of A. cantonensis are widely distributed in the Ogasawara Islands. Although human cases have not yet been reported in the Ogasawara Islands, the widespread detection of A. cantonensis could be of importance from the perspective of public health.	[Tokiwa, Toshihiro; Akao, Nobuaki; Ohta, Nobuo] Tokyo Med & Dent Univ, Grad Sch, Sect Environm Parasitol, Tokyo, Japan; [Hashimoto, Takuma] Japan Wildlife Res Ctr, Tokyo, Japan; [Komatsu, Noriyuki] Civil Int Corp, Div Res & Dev, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Ohta, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Sect Environm Parasitol, Tokyo, Japan.	matata.vip@tmd.ac.jp	Tokiwaa, Toshihiro/B-4664-2015	Tokiwaa, Toshihiro/0000-0003-1943-5146	Ministry of Health, Labor and Welfare of Japan [H20-Sinkou-ippan-015]; Japan Society for the Promotion of Sciences [25460513]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in Aid from the Ministry of Health, Labor and Welfare of Japan (H20-Sinkou-ippan-015), and Grant-in Aid from Japan Society for the Promotion of Sciences (#25460513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR PH, 1981, AM J TROP MED HYG, V30, P963, DOI 10.4269/ajtmh.1981.30.963; ANDERSEN E, 1986, AM J TROP MED HYG, V35, P319, DOI 10.4269/ajtmh.1986.35.319; Archer CE, 2001, S AFR MED J, V101, P174; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caldeira RL, 2007, MEM I OSWALDO CRUZ, V102, P887, DOI 10.1590/S0074-02762007000700018; Chiba S, 2011, P NATL ACAD SCI USA, V108, P9496, DOI 10.1073/pnas.1100085108; Chikweto A, 2009, VET PARASITOL, V162, P160, DOI 10.1016/j.vetpar.2009.02.020; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Fontanilla IKC, 2008, ACTA TROP, V105, P181, DOI 10.1016/j.actatropica.2007.10.007; Foronda P, 2010, ACTA TROP, V114, P123, DOI 10.1016/j.actatropica.2010.02.004; Hashimoto T., 2009, EARTH ENV, V14, P93; HORI E, 1974, Japanese Journal of Parasitology, V23, P138; HORI E, 1973, Japanese Journal of Parasitology, V22, P347; Kanazawa T, 1984, J CHIBA MED SOC, V60, P377; Kanoh T, 1975, ANN REP TOKYO METR R, VPH26, P42; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KLIKS MM, 1982, AM J TROP MED HYG, V31, P1114, DOI 10.4269/ajtmh.1982.31.1114; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mead AR., 1961, GIANT AFRICAN SNAIL; Monte TCC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-248; Murata I., 1985, Annual Report of the Tokyo Metropolitan Research Laboratory of Public Health, V36, P23; Pipitgool V, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P190; PIPPIN WARREN F., 1966, J MED ENTOMOL, V2, P384, DOI 10.1093/jmedent/2.4.384; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Raccurt CP, 2003, TROP MED INT HEALTH, V8, P423, DOI 10.1046/j.1365-3156.2003.01035.x; Russell JC, 2005, NATURE, V437, P1107, DOI 10.1038/4371107a; Sasa M, 1969, INVESTIGATION REPORT, P1; Suzuki J., 2004, ANN REP TOKYO METR I, V55, P295; Tokiwa T, 2012, PARASITOL INT, V61, P431, DOI 10.1016/j.parint.2012.02.005; Tokiwa T, 2011, PARASITOL INT, V60, P324, DOI 10.1016/j.parint.2011.03.003; Tomiyama K, 1988, ANN REP OGASAWARA ST, V11, P2; UCHIKAWA R, 1984, J HELMINTHOL, V58, P231, DOI 10.1017/S0022149X00027024; Uchikawa R, 1986, KISEICHUGAKU ZASSHI, V36, P94; VARGAS M, 1992, TROP MED PARASITOL, V43, P253; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Yabe T., 2006, ANN REPORT OGASAWARA, V29, P19; Yabe T, 1982, MAMM STUDY, V9, P14; Yabe T, 2008, ANN REP OGASAWARA ST, V31, P49	40	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70729	10.1371/journal.pone.0070729	http://dx.doi.org/10.1371/journal.pone.0070729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950989	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700047
J	Cheung, ST; So, EY; Chang, D; Ming-Lum, A; Mui, ALF				Cheung, Sylvia T.; So, Eva Y.; Chang, David; Ming-Lum, Andrew; Mui, Alice L-F.			Interleukin-10 Inhibits Lipopolysaccharide Induced miR-155 Precursor Stability and Maturation	PLOS ONE			English	Article							TNF MESSENGER-RNA; GENE-EXPRESSION; MICRORNA-155; IL-10; CELLS; STAT3; SHIP; TRANSLATION; MACROPHAGES; ACTIVATION	The anti-inflammatory cytokine interleukin-10 (IL-10) is essential for attenuating the inflammatory response, which includes reducing the expression of pro-inflammatory microRNA-155 (miR-155) in lipopolysaccharide (LPS) activated macrophages. miR-155 enhances the expression of pro-inflammatory cytokines such as TNF alpha and suppresses expression of anti-inflammatory molecules such as SOCS1. Therefore, we examined the mechanism by which IL-10 inhibits miR-155. We found that IL-10 treatment did not affect the transcription of the miR-155 host gene nor the nuclear export of pre-miR-155, but rather destabilized both pri-miR-155 and pre-miR-155 transcripts, as well as interfered with the final maturation of miR-155. This inhibitory effect of IL-10 on miR-155 expression involved the contribution of both the STAT3 transcription factor and the phosphoinositol phosphatase SHIP1. This is the first report showing evidence that IL-10 regulates miRNA expression post-transcriptionally.	[Cheung, Sylvia T.; So, Eva Y.; Chang, David; Ming-Lum, Andrew; Mui, Alice L-F.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada; [Cheung, Sylvia T.; So, Eva Y.; Chang, David; Ming-Lum, Andrew; Mui, Alice L-F.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Cheung, Sylvia T.; Mui, Alice L-F.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1W5, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Mui, ALF (corresponding author), Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada.	alice.mui@ubc.ca			Canadian Institutes for Health Research (CIHR) [MOP-84539]; Michael Smith Foundation	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research)	This study was funded by Canadian Institutes for Health Research (CIHR) (MOP-84539 to ALM) STC and AML hold doctoral resarch awards from the CIHR and the Michael Smith Foundation. ES also holds a CIHR scholarship. The CIHR Transplantation Training Program provided graduate scholarships to STC, ES and AML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Asadullah K, 2001, J INVEST DERMATOL, V116, P975, DOI 10.1046/j.1523-1747.2001.01350.x; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Calame K, 2007, IMMUNITY, V27, P825, DOI 10.1016/j.immuni.2007.11.010; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan CS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.348599; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Louis E, 2009, GUT, V58, P1173, DOI 10.1136/gut.2008.169235; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Papadimitraki ED, 2007, J AUTOIMMUN, V29, P310, DOI 10.1016/j.jaut.2007.09.001; Pilotte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028446; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stamou P, 2010, CURR DIR AUTOIMMUN, V11, P61, DOI 10.1159/000289197; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tam W, 2006, GENE CHROMOSOME CANC, V45, P211, DOI 10.1002/gcc.20282; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	61	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71336	10.1371/journal.pone.0071336	http://dx.doi.org/10.1371/journal.pone.0071336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951138	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300106
J	Coppede, F; Grossi, E; Buscema, M; Migliore, L				Coppede, Fabio; Grossi, Enzo; Buscema, Massimo; Migliore, Lucia			Application of Artificial Neural Networks to Investigate One-Carbon Metabolism in Alzheimer's Disease and Healthy Matched Individuals	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; KEY FACTORS; RISK-FACTOR; HOMOCYSTEINE; FOLATE; POLYMORPHISMS; ASSOCIATION; CLASSIFIER; SELECTION; DEMENTIA	Folate metabolism, also known as one-carbon metabolism, is required for several cellular processes including DNA synthesis, repair and methylation. Impairments of this pathway have been often linked to Alzheimer's disease (AD). In addition, increasing evidence from large scale case-control studies, genome-wide association studies, and meta-analyses of the literature suggest that polymorphisms of genes involved in one-carbon metabolism influence the levels of folate, homocysteine and vitamin B12, and might be among AD risk factors. We analyzed a dataset of 30 genetic and biochemical variables (folate, homocysteine, vitamin B12, and 27 genotypes generated by nine common biallelic polymorphisms of genes involved in folate metabolism) obtained from 40 late-onset AD patients and 40 matched controls to assess the predictive capacity of Artificial Neural Networks (ANNs) in distinguish consistently these two different conditions and to identify the variables expressing the maximal amount of relevant information to the condition of being affected by dementia of Alzheimer's type. Moreover, we constructed a semantic connectivity map to offer some insight regarding the complex biological connections among the studied variables and the two conditions (being AD or control). TWIST system, an evolutionary algorithm able to remove redundant and noisy information from complex data sets, selected 16 variables that allowed specialized ANNs to discriminate between AD and control subjects with over 90% accuracy. The semantic connectivity map provided important information on the complex biological connections among one-carbon metabolic variables highlighting those most closely linked to the AD condition.	[Coppede, Fabio; Migliore, Lucia] Univ Pisa, Div Med Genet, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Grossi, Enzo] Bracco Fdn, Milan, Italy; [Grossi, Enzo; Buscema, Massimo] Seme Res Ctr, Rome, Italy; [Buscema, Massimo] Univ Colorado, Dept Math & Stat Sci, Denver, CO 80202 USA	University of Pisa; Bracco; University of Colorado System; University of Colorado Denver	Coppede, F (corresponding author), Univ Pisa, Div Med Genet, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	f.coppede@geog.unipi.it	Grossi, Enzo/AAF-7765-2020; Coppedè, Fabio/X-6085-2019	Coppede, Fabio/0000-0002-3081-6647; Buscema, Paolo Massimo/0000-0003-4356-0510	Italian Ministry of Health [GR-2009-1606229]	Italian Ministry of Health(Ministry of Health, Italy)	The study was funded by the Italian Ministry of Health (Project No. GR-2009-1606229 "Folate metabolism, epigenetics and Alzheimer's disease", FC Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bi XH, 2009, NEUROBIOL AGING, V30, P1601, DOI 10.1016/j.neurobiolaging.2007.12.010; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRILL FZ, 1992, IEEE T NEURAL NETWOR, V3, P324, DOI 10.1109/72.125874; Buri L, 2010, AM J GASTROENTEROL, V105, P1327, DOI 10.1038/ajg.2009.675; Buscema M, 2005, ARTIF INTELL MED, V34, P279, DOI 10.1016/j.artmed.2004.12.001; Buscema M, 2004, EXPERT SYST, V21, P63, DOI 10.1111/j.1468-0394.2004.00264.x; Buscema M, 1998, SUBST USE MISUSE, V33, P233, DOI 10.3109/10826089809115863; Buscema M., 2006, WSEAS Transactions on Information Science and Applications, V3, P885; Buscema M, 2010, CURR ALZHEIMER RES, V7, P173, DOI 10.2174/156720510790691137; Buscema M., 2013, J INTELL LEARN SYST, V5, P29, DOI DOI 10.4236/JILSA.2013.51004; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Buscema M, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/478560; Buscema M, 2008, INT J DATA MIN BIOIN, V2, P362, DOI 10.1504/IJDMB.2008.022159; CACCIAPUOTI F, 2012, J THROMB TH IN PRESS; Cleary J.G., 1995, K INSTANCE BASED LEA; Coppede F, 2012, ANTIOXID REDOX SIGN, V17, P195, DOI 10.1089/ars.2011.4368; Coppede F, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-42; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Faux NG, 2011, J ALZHEIMERS DIS, V27, P909, DOI 10.3233/JAD-2011-110752; Franceschi M, 2011, BEHAV NEUROL, V24, P149, DOI [10.3233/BEN-2011-0327, 10.1155/2011/754659]; Freund Y, 1996, ICML; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gironi M, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-1; Gonzalez A, 2001, IEEE T SYST MAN CY B, V31, P417, DOI 10.1109/3477.931534; Grossi E, 2007, DIGEST LIVER DIS, V39, P278, DOI 10.1016/j.dld.2006.10.003; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hinterberger M, 2013, J AM GERIATR SOC, V61, P648, DOI 10.1111/jgs.12178; Hinterberger M, 2013, J NEURAL TRANSM, V120, P211, DOI 10.1007/s00702-012-0822-y; Ho RCM, 2011, AM J GERIAT PSYCHIAT, V19, P607, DOI 10.1097/JGP.0b013e3181f17eed; Hua Y, 2011, INT J NEUROSCI, V121, P462, DOI 10.3109/00207454.2011.578778; HUANG CW, 2013, EUR J NEUROL; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Kageyama Mitsuyo, 2008, Asia Pac J Public Health, V20 Suppl, P111; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kudo M, 2000, PATTERN RECOGN, V33, P25, DOI 10.1016/S0031-3203(99)00041-2; Lahner E, 2008, WORLD J GASTROENTERO, V14, P563, DOI 10.3748/wjg.14.563; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Leahy P, 2008, J HYDROL, V355, P192, DOI 10.1016/j.jhydrol.2008.03.017; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Menendez JA, 2012, AGING-US, V4, P894; MOORE E, 2012, INT PSYCHOGERIATR; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; OPPEDE F, 2012, CURR ALZHEIMER RES, V9, P550; Pace F, 2010, EUR J GASTROEN HEPAT, V22, P1163, DOI 10.1097/MEG.0b013e32833a88b8; Parachikova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014015; Park LK, 2012, P NUTR SOC, V71, P75, DOI 10.1017/S0029665111003302; Penco S, 2005, ANN HUM GENET, V69, P693, DOI 10.1111/j.1529-8817.2005.00206.x; Penco S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-254; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Regland B, 1990, DEMENTIA, V1, P272, DOI DOI 10.1159/000107152; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Rotondano G, 2011, GASTROINTEST ENDOSC, V73, P218, DOI 10.1016/j.gie.2010.10.006; Street ME, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-24; Tabaton M, 2010, J ALZHEIMERS DIS, V19, P1035, DOI 10.3233/JAD-2010-1300; Tarlarini C, 2012, CLIN EXP GASTROENTER, V5, P159, DOI 10.2147/CEG.S32610; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Wald DS, 2011, ALZHEIMERS DEMENT, V7, P412, DOI 10.1016/j.jalz.2010.08.234; Zhuo JM, 2011, TRENDS PHARMACOL SCI, V32, P562, DOI 10.1016/j.tips.2011.05.003	69	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e74012	10.1371/journal.pone.0074012	http://dx.doi.org/10.1371/journal.pone.0074012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951366	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300211
J	Mahal, A; Karan, A; Fan, VY; Engelgau, M				Mahal, Ajay; Karan, Anup; Fan, Victoria Y.; Engelgau, Michael			The Economic Burden of Cancers on Indian Households	PLOS ONE			English	Article							CONSUMPTION; MORTALITY; DISEASES; INCOME; COSTS	We assessed the burden of cancer on households' out-of-pocket health spending, non-medical consumption, workforce participation, and debt and asset sales using data from a nationally representative health and morbidity survey in India for 2004 of nearly 74 thousand households. Propensity scores were used to match households containing a member diagnosed with cancer (i.e. cancer-affected households) to households with similar socioeconomic and demographic characteristics (controls). Our estimates are based on data from 1,645 households chosen through matching. Cancer-affected households experienced higher levels of outpatient visits and hospital admissions and increased out-of-pocket health expenditures per member, relative to controls. Cancer-affected households spent between Indian Rupees (INR) 66 and INR 85 more per member on healthcare over a 15-day reference period, than controls and additional expenditures (per member) incurred on inpatient care by cancer-affected households annually is equivalent to 36% to 44% of annual household expenditures of matched controls. Members without cancer in cancer-affected households used less health-care and spent less on healthcare. Overall, adult workforce participation rates were lower by between 2.4 and 3.2 percentage points compared to controls; whereas workforce participation rates among adult members without cancer were higher than in control households. Cancer-affected households also had significantly higher rates of borrowing and asset sales for financing outpatient care that were 3.3% to 4.0% higher compared to control households; and even higher for inpatient care.	[Mahal, Ajay] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Karan, Anup] Publ Hlth Fdn India, New Delhi, India; [Karan, Anup] Univ Oxford, Oxford, England; [Fan, Victoria Y.] Ctr Global Dev, Washington, DE USA; [Engelgau, Michael] World Bank, South Asia Human Dev Unit, Washington, DE USA	Monash University; Public Health Foundation of India; University of Oxford; The World Bank	Karan, A (corresponding author), Publ Hlth Fdn India, New Delhi, India.	anup.karan@dph.ox.ac.uk	Karan, Anup/AAK-2060-2020; Fan, Victoria/AGG-4359-2022; Harding, Richard/G-9729-2012	Fan, Victoria/0000-0001-7755-9425; 	Wellcome Trust Capacity Strengthening Strategic Award; consortium of United Kingdom universities	Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); consortium of United Kingdom universities	AK was supported by the Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of United Kingdom universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Australian Institute of Health and Welfare, 2012, HLTH SERV SER, V43; Bloom DE, 2011, GLOBAL EC BURDEN NON; Ciani E, 2012, LABOUR ECON, V19, P155, DOI 10.1016/j.labeco.2011.12.001; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; GLOBOCAN, 2008, GLOBOCAN PROJ; Government of India, 2012, EC SURV 2011 12; Harris A, 2008, 2508 MON U CTR HLTH; Institute for Health Metrics and Evaluation, 2013, GBD PROF IND; Islam A, 2012, J DEV ECON, V97, P232, DOI 10.1016/j.jdeveco.2011.05.003; John Jacob T, 2011, LANCET, V377, P252; John R, 2011, GLOBAL CANC FACTS FI; Jolliffe D, 1997, 39 INT FOOD POL RES; Lilly MB, 2010, J HEALTH ECON, V29, P895, DOI 10.1016/j.jhealeco.2010.08.007; Mahal A, 2010, INDIA HLTH REPORT, P109; Malhotra C, 2012, HLTH POLICY PLANNING, DOI [10.1093/heapol/czs051, DOI 10.1093/HEAP0L/CZS051]; Ministry of Labour and Employment, 2008, RSBY GUID GUIDELINES; Morena-Serra R, 2009, 0905 U YORK; Murthy NS, 2008, ASIAN PAC J CANCER P, V9, P671; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; Passey ME, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-16; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roberts A., 1992, J MENT HEALTH POLICY, V2, P183, DOI [10.1002/(SICI)1099-176X(199912)2:4&LT;183::AID-MHP62&GT;3. 0.CO;2-1, DOI 10.1002/(SICI)1099-176X(199912)2:4]; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shaw WS, 1997, ANN BEHAV MED, V19, P101, DOI 10.1007/BF02883326; Wagstaff A., 2008, MEASURING FINANCIAL; Yamano T, 2004, WORLD DEV, V32, P91, DOI 10.1016/j.worlddev.2003.07.004	31	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71853	10.1371/journal.pone.0071853	http://dx.doi.org/10.1371/journal.pone.0071853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951258	Green Published, gold			2022-12-27	WOS:000323097300165
J	Batchelor, PE; Skeers, P; Antonic, A; Wills, TE; Howells, DW; Macleod, MR; Sena, ES				Batchelor, Peter E.; Skeers, Peta; Antonic, Ana; Wills, Taryn E.; Howells, David W.; Macleod, Malcolm R.; Sena, Emily S.			Systematic Review and Meta-Analysis of Therapeutic Hypothermia in Animal Models of Spinal Cord Injury	PLOS ONE			English	Review							COMPRESSION INJURY; RAT; CONTUSION; OUTCOMES	Background: Therapeutic hypothermia is a clinically useful neuroprotective therapy for cardiac arrest and neonatal hypoxic ischemic encephalopathy and may potentially be useful for the treatment of other neurological conditions including traumatic spinal cord injury (SCI). The pre-clinical studies evaluating the effectiveness of hypothermia in acute SCI broadly utilise either systemic hypothermia or cooling regional to the site of injury. The literature has not been uniformly positive with conflicting studies of varying quality, some performed decades previously. Methods: In this study, we systematically review and meta-analyse the literature to determine the efficacy of systemic and regional hypothermia in traumatic SCI, the experimental conditions influencing this efficacy, and the influence of study quality on outcome. Three databases were utilised; PubMed, ISI Web of Science and Embase. Our inclusion criteria consisted of the (i) reporting of efficacy of hypothermia on functional outcome (ii) number of animals and (iii) mean outcome and variance in each group. Results: Systemic hypothermia improved behavioural outcomes by 24.5% (95% CI 10.2 to 38.8) and a similar magnitude of improvement was seen across a number of high quality studies. The overall behavioural improvement with regional hypothermia was 26.2%, but the variance was wide (95% CI 23.77 to 56.2). This result may reflect a preponderance of positive low quality data, although a preferential effect of hypothermia in ischaemic models of injury may explain some of the disparate data. Sufficient heterogeneity was present between studies of regional hypothermia to reveal a number of factors potentially influencing efficacy, including depth and duration of hypothermia, animal species, and neurobehavioural assessment. However, these factors could reflect the influence of earlier lower quality literature. Conclusion: Systemic hypothermia appears to be a promising potential method of treating acute SCI on the basis of metaanalysis of the pre-clinical literature and the results of high quality animal studies.	[Batchelor, Peter E.; Antonic, Ana; Wills, Taryn E.; Howells, David W.; Sena, Emily S.] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Batchelor, Peter E.; Skeers, Peta; Antonic, Ana; Wills, Taryn E.] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia; [Macleod, Malcolm R.; Sena, Emily S.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Edinburgh	Batchelor, PE (corresponding author), Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia.	batch@bigpond.net.au	Macleod, Malcolm Robert/B-2052-2010; Antonic-Baker, Ana/K-5968-2019; Anotnic-Baker, Ana/K-6361-2019	Macleod, Malcolm Robert/0000-0001-9187-9839; Anotnic-Baker, Ana/0000-0003-4275-7557; Sena, Emily S/0000-0002-3282-8502; Howells, David/0000-0002-2512-7724	National Health and Medical Research Council; Transport Accident Commission of Australia; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission of Australia; National Centre for the Replacement	Authors acknowledge the generous financial support of the National Health and Medical Research Council and the Transport Accident Commission of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2013, WORLD NEUROSURGERY; ALBIN MS, 1967, ANESTH ANAL CURR RES, V46, P8; ALBIN MS, 1968, J NEUROSURG, V29, P113, DOI 10.3171/jns.1968.29.2.0113; Batchelor PE, 2011, J NEUROTRAUM, V28, P809, DOI 10.1089/neu.2010.1622; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Casas C, 2003, SOC NEUR ABSTR VIEW; Casas CE, 2005, J NEUROSURG-SPINE, V2, P308, DOI 10.3171/spi.2005.2.3.0308; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Dididze M, 2012, SPINAL CORD; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 2009, CRIT CARE MED, V37, pS238, DOI 10.1097/CCM.0b013e3181aa5d85; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Farooque M, 1997, J NEUROTRAUM, V14, P63, DOI 10.1089/neu.1997.14.63; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; Hansebout R R, 1975, Surg Neurol, V4, P531; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Jou IM, 2000, SPINE, V25, P1878, DOI 10.1097/00007632-200008010-00004; Kwon BK, 2008, SPINE J, V8, P859, DOI 10.1016/j.spinee.2007.12.006; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2009, J CEREBR BLOOD F MET, V29, P221, DOI 10.1038/jcbfm.2008.101; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Martinez-Arizala A, 1995, SOC NEUR ABSTR; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morino T, 2008, SPINAL CORD, V46, P425, DOI 10.1038/sj.sc.3102163; Morochovic R, 2008, INT J NEUROSCI, V118, P555, DOI 10.1080/00207450601123456; Savovic J, 2012, ANN INTERNAL MED; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Tator CH, 1972, SURG FORUM, V23; Topuz K, 2010, ARCH MED RES, V41, P506, DOI 10.1016/j.arcmed.2010.10.004; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Yamamoto K, 1998, NEUROREPORT, V9, P1655, DOI 10.1097/00001756-199805110-00072; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu WR, 1999, ACTA NEUROPATHOL, V98, P15, DOI 10.1007/s004010051046	41	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71317	10.1371/journal.pone.0071317	http://dx.doi.org/10.1371/journal.pone.0071317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951131	Green Published, gold			2022-12-27	WOS:000326473200040
J	Hermant, P; Francius, C; Clotman, F; Michiels, T				Hermant, Pascale; Francius, Cedric; Clotman, Frederic; Michiels, Thomas			IFN-epsilon Is Constitutively Expressed by Cells of the Reproductive Tract and Is Inefficiently Secreted by Fibroblasts and Cell Lines	PLOS ONE			English	Article							I INTERFERON FAMILY; ANTIVIRAL ACTIVITY; VIRUS-REPLICATION; ALPHA-INTERFERON; RECEPTORS; LIMITIN; GENES; BETA	Type-I interferons (IFNs) form a large family of cytokines that primarily act to control the early development of viral infections. Typical type-I IFN genes, such as those encoding IFN-alpha or IFN-beta are upregulated by viral infection in many cell types. In contrast, the gene encoding IFN-epsilon was reported to be constitutively expressed by cells of the female reproductive tract and to contribute to the protection against vaginal infections with herpes simplex virus 2 and Chlamydia muridarum. Our data confirm the lack of induction of IFN-epsilon expression after viral infection and the constitutive expression of IFN-epsilon by cells of the female but also of the male reproductive organs. Interestingly, when expressed from transfected expression plasmids in 293T, HeLa or Neuro2A cells, the mouse and human IFN-epsilon precursors were inefficiently processed and secretion of IFN-epsilon was minimal. Analysis of chimeric constructs produced between IFN-epsilon and limitin (IFN-zeta) showed that both the signal peptide and the mature moiety of IFN-epsilon contribute to poor processing of the precursor. Immunofluorescent detection of FLAG-tagged IFN-epsilon in transfected cells suggested that IFN-epsilon and chimeric proteins were defective for progression through the secretory pathway. IFN-epsilon did not, however, act intracellularly and impart an antiviral state to producing cells. Given the constitutive expression of IFN-epsilon in specialized cells and the poor processing of IFN-epsilon precursor in fibroblasts and cell lines, we hypothesize that IFN-epsilon secretion may require a co-factor specifically expressed in cells of the reproductive organs, that might secure the system against aberrant release of this IFN.	[Hermant, Pascale; Michiels, Thomas] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Francius, Cedric; Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Michiels, T (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	thomas.michiels@uclouvain.be	Michiels, Thomas/ABE-3203-2021	Michiels, Thomas/0000-0001-9615-8053	National fund for scientific research (FNRS-FRSM); Belgian Science Policy Office [PAI-P7/45 BELVIR]; Interuniversity Attraction Poles Programme	National fund for scientific research (FNRS-FRSM)(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy Office(Belgian Federal Science Policy Office); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	PH was a research assistant with the Universite catholique de Louvain (UCL). This work was supported by the National fund for scientific research (FNRS-FRSM) and by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (PAI-P7/45 BELVIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; Day SL, 2008, J IMMUNOL, V180, P7158, DOI 10.4049/jimmunol.180.11.7158; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; DUKE GM, 1990, NATURE, V343, P474, DOI 10.1038/343474a0; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; Isaacs A, 1957, INTERFERON P R SOC B, V147, P258, DOI [10.1098/rspb.1957.0048, DOI 10.1098/RSPB.1957.0048]; Kawamoto SI, 2003, J VIROL, V77, P9622, DOI 10.1128/JVI.77.17.9622-9631.2003; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Michiels T, 1997, J VIROL, V71, P9549, DOI 10.1128/JVI.71.12.9549-9556.1997; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Peng FW, 2007, PROTEIN EXPRES PURIF, V53, P356, DOI 10.1016/j.pep.2006.12.013; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Sang YM, 2010, PHYSIOL GENOMICS, V42, P248, DOI 10.1152/physiolgenomics.00198.2009; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shaw-Jackson C, 1999, J VIROL, V73, P2729, DOI 10.1128/JVI.73.4.2729-2738.1999; Sommereyns C, 2006, J INTERF CYTOK RES, V26, P406, DOI 10.1089/jir.2006.26.406; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; van Pesch V, 2003, J BIOL CHEM, V278, P46321, DOI 10.1074/jbc.M302554200	28	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71320	10.1371/journal.pone.0071320	http://dx.doi.org/10.1371/journal.pone.0071320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951133	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200041
J	Le Bail, A; Scholz, S; Kost, B				Le Bail, Aude; Scholz, Sebastian; Kost, Benedikt			Evaluation of Reference Genes for RT qPCR Analyses of Structure-Specific and Hormone Regulated Gene Expression in Physcomitrella patens Gametophytes	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; QUANTITATIVE-PCR; ABSCISIC-ACID; LAND PLANTS; ABIOTIC STRESS; MOSS; NORMALIZATION; VALIDATION; AUXIN	The use of the moss Physcomitrella patens as a model system to study plant development and physiology is rapidly expanding. The strategic position of P. patens within the green lineage between algae and vascular plants, the high efficiency with which transgenes are incorporated by homologous recombination, advantages associated with the haploid gametophyte representing the dominant phase of the P. patens life cycle, the simple structure of protonemata, leafy shoots and rhizoids that constitute the haploid gametophyte, as well as a readily accessible high-quality genome sequence make this moss a very attractive experimental system. The investigation of the genetic and hormonal control of P. patens development heavily depends on the analysis of gene expression patterns by real time quantitative PCR (RT qPCR). This technique requires well characterized sets of reference genes, which display minimal expression level variations under all analyzed conditions, for data normalization. Sets of suitable reference genes have been described for most widely used model systems including e. g. Arabidopsis thaliana, but not for P. patens. Here, we present a RT qPCR based comparison of transcript levels of 12 selected candidate reference genes in a range of gametophytic P. patens structures at different developmental stages, and in P. patens protonemata treated with hormones or hormone transport inhibitors. Analysis of these RT qPCR data using GeNorm and NormFinder software resulted in the identification of sets of P. patens reference genes suitable for gene expression analysis under all tested conditions, and suggested that the two best reference genes are sufficient for effective data normalization under each of these conditions.	[Kost, Benedikt] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Erlangen Ctr Plant Sci ECROPS, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Kost, B (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	benedikt.kost@fau.de			FORMAS grant (The Swedish Research Council Formas) [229-2008-100]; DFG (Deutsche Forschungsgemeinschaft); FAU (Friedrich-Alexander-Universitat Erlangen-Nurnberg)	FORMAS grant (The Swedish Research Council Formas); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); FAU (Friedrich-Alexander-Universitat Erlangen-Nurnberg)	Funding provided by FORMAS grant #229-2008-100 (The Swedish Research Council Formas; http://www.formas.se/en/). The authors would like to thank the DFG (Deutsche Forschungsgemeinschaft) and FAU (Friedrich-Alexander-Universitat Erlangen-Nurnberg) for support within the funding program "Open Access Publishing". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoyama T, 2012, DEVELOPMENT, V139, P3120, DOI 10.1242/dev.076091; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Dong LM, 2011, MOL BIOL REP, V38, P5017, DOI 10.1007/s11033-010-0648-3; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Goossens K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-64; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; JOHRI MM, 1973, NATURE-NEW BIOL, V245, P223, DOI 10.1038/newbio245223a0; Khandelwal A, 2010, SCIENCE, V327, P546, DOI 10.1126/science.1183672; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro TT, 2011, GENET MOL RES, V10, P3291, DOI 10.4238/2011.November.17.4; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Qiu YL, 1999, TRENDS PLANT SCI, V4, P26, DOI 10.1016/S1360-1385(98)01361-2; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; RESKI R, 1985, PLANTA, V165, P354, DOI 10.1007/BF00392232; Richard O, 2005, J MOL EVOL, V61, P99, DOI 10.1007/s00239-004-0302-6; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Rother M, 2006, PLANT CELL ENVIRON, V29, P1801, DOI 10.1111/j.1365-3040.2006.01557.x; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schnepf E, 1997, J PLANT PHYSIOL, V151, P166, DOI 10.1016/S0176-1617(97)80149-6; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; Timmerhaus G, 2011, MOL PLANT, V4, P713, DOI 10.1093/mp/ssr009; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3	50	38	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70998	10.1371/journal.pone.0070998	http://dx.doi.org/10.1371/journal.pone.0070998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951063	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200029
J	Tripathi, V; Obermann, WMJ				Tripathi, Vishwadeepak; Obermann, Wolfgang M. J.			A Primate Specific Extra Domain in the Molecular Chaperone Hsp90	PLOS ONE			English	Article							COCHAPERONE AHA1; CYSTIC-FIBROSIS; ATPASE ACTIVITY; MIDDLE DOMAIN; IN-VIVO; ACTIVATION; BINDING; COMPLEX; CONTRIBUTES; HYDROLYSIS	Hsp90 (heat shock protein 90) is an essential molecular chaperone that mediates folding and quality control of client proteins. Many of them such as protein kinases, steroid receptors and transcription factors are involved in cellular signaling processes. Hsp90 undergoes an ATP hydrolysis dependent conformational cycle to assist folding of the client protein. The canonical Hsp90 shows a typical composition of three distinct domains and interacts with individual cochaperone partners such as Hop, Cdc37 and Aha1 (activator of Hsp90 ATPase) that regulate the reaction cycle of the molecular chaperone. A bioinformatic survey identified an additional domain of 122 amino acids in front of the canonical Hsp90 sequence. This extra domain (E domain) is specific to the Catarrhini or drooping nose monkeys, a subdivision of the higher primates that includes man, the great apes and the old world monkeys but is absent from all other species. Our biochemical analysis reveals that Hsp103 associates with cochaperone proteins such as Hop, Cdc37 and Aha1 similar to Hsp90. However, the extra domain reduces the ATP hydrolysis rate to about half when compared to Hsp90 thereby acting as a negative regulator of the molecular chaperones intrinsic ATPase activity.	[Tripathi, Vishwadeepak; Obermann, Wolfgang M. J.] Ruhr Univ Bochum, Inst Physiol, Bochum, Germany	Ruhr University Bochum	Obermann, WMJ (corresponding author), Ruhr Univ Bochum, Inst Physiol, Bochum, Germany.	Wolfgang.Obermann@rub.de	Obermann, Wolfgang/AAN-3896-2020		DFG grant [OB 163/1-1]; FoRUM grant [F743]	DFG grant(German Research Foundation (DFG)); FoRUM grant	This work was supported in part by DFG grant OB 163/1-1 (www.dfg.de) and by FoRUM grant F743 (www.rub.de) to WO. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	23	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71856	10.1371/journal.pone.0071856	http://dx.doi.org/10.1371/journal.pone.0071856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951259	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200075
J	Smeding, A; Darnon, C; Souchal, C; Toczek-Capelle, MC; Butera, F				Smeding, Annique; Darnon, Celine; Souchal, Carine; Toczek-Capelle, Marie-Christine; Butera, Fabrizio			Reducing the Socio-Economic Status Achievement Gap at University by Promoting Mastery-Oriented Assessment	PLOS ONE			English	Article							STEREOTYPE THREAT; GOALS; PERFORMANCE; MOTIVATION; FRAMEWORK; EDUCATION; STUDENTS	In spite of official intentions to reduce inequalities at University, students' socio-economic status (SES) is still a major determinant of academic success. The literature on the dual function of University suggests that University serves not only an educational function (i.e., to improve students' learning), but also a selection function (i.e., to compare people, and orient them towards different positions in society). Because current assessment practices focus on the selection more than on the educational function, their characteristics fit better with norms and values shared by dominant high-status groups and may favour high-SES students over low-SES students in terms of performances. A focus on the educational function (i.e., mastery goals), instead, may support low-SES students' achievement, but empirical evidence is currently lacking. The present research set out to provide such evidence and tested, in two field studies and a randomised field experiment, the hypothesis that focusing on University's educational function rather than on its selection function may reduce the SES achievement gap. Results showed that a focus on learning, mastery-oriented goals in the assessment process reduced the SES achievement gap at University. For the first time, empirical data support the idea that low-SES students can perform as well as high-SES students if they are led to understand assessment as part of the learning process, a way to reach mastery goals, rather than as a way to compare students to each other and select the best of them, resulting in performance goals. This research thus provides a theoretical framework to understand the differential effects of assessment on the achievement of high and low-SES students, and paves the way toward the implementation of novel, theory-driven interventions to reduce the SES-based achievement gap at University.	[Smeding, Annique; Butera, Fabrizio] Univ Lausanne, Lausanne, Switzerland; [Darnon, Celine; Souchal, Carine; Toczek-Capelle, Marie-Christine] Univ Blaise Pascal, Univ Clermont Ferrand 2, Clermont Ferrand, France; [Darnon, Celine] French Univ Inst, Clermont Ferrand, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Smeding, A (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Annique.Smeding@unil.ch		Butera, Fabrizio/0000-0002-8856-4374; Darnon, Celine/0000-0003-2613-689X	Swiss National Science Foundation; French Agence Nationale pour la Recherche [GENIM - ANR 11 INEG 002 01]; region Auvergne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); French Agence Nationale pour la Recherche(French National Research Agency (ANR)); region Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx), a project of the French Agence Nationale pour la Recherche (GENIM - ANR 11 INEG 002 01; http://www.agence-nationale-recherche.fr/) and a grant from the region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES C, 1992, J EDUC PSYCHOL, V84, P261, DOI 10.1037/0022-0663.84.3.261; Anderman EM, 2008, REV INT PSYCHOL SOC, V21, P155; Bourdieu P., 1990, REPROD ED SOC CULTUR; Brookhart SM, 1997, APPL MEAS EDUC, V10, P161, DOI 10.1207/s15324818ame1002_4; Croizet JC, 1998, PERS SOC PSYCHOL B, V24, P588, DOI 10.1177/0146167298246003; Darnon C, 2009, J PERS SOC PSYCHOL, V96, P119, DOI 10.1037/a0012824; Delandshere G., 2001, ASSESS EDUC, V8, P113, DOI DOI 10.1080/09695940123828; Deslauriers L, 2011, SCIENCE, V332, P862, DOI 10.1126/science.1201783; Dompnier B, 2009, PSYCHOL SCI, V20, P939, DOI 10.1111/j.1467-9280.2009.02384.x; Dornbusch SM, 1996, ANNU REV PSYCHOL, V47, P401, DOI 10.1146/annurev.psych.47.1.401; Duru-Bellat M, 2008, J EDUC POLICY, V23, P81, DOI 10.1080/02680930701754104; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Dweck's, 2005, HDB COMPETENCE MOTIV, P52; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Harackiewicz JM, 1998, EDUC PSYCHOL, V33, P1, DOI 10.1207/s15326985ep3301_1; Jackman M.R., 1994, VELVET GLOVE; Jagacinski C, 2008, MOTIV EMOTION, V32, P310, DOI 10.1007/s11031-008-9103-3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Kaplan A, 1999, CONTEMP EDUC PSYCHOL, V24, P330, DOI 10.1006/ceps.1999.0993; McMillan J. H., 1998, CLASSROOM ASSESSMENT; NICHOLLS JG, 1979, AM PSYCHOL, V34, P1071, DOI 10.1037/0003-066X.34.11.1071; Organisation for Economic Co-operation and Development, 2011, ED GLANC 2011 OECD I; Patrick H, 1999, LEARN INDIVID DIFFER, V11, P153, DOI 10.1016/S1041-6080(00)80003-5; Poortvliet PM, 2010, CURR DIR PSYCHOL SCI, V19, P324, DOI 10.1177/0963721410383246; Sackett PR, 2009, PSYCHOL BULL, V135, P1, DOI 10.1037/a0013978; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Stephens NM, 2012, J PERS SOC PSYCHOL, V102, P1178, DOI 10.1037/a0027143; Summers MF, 2006, SCIENCE, V311, P1870, DOI 10.1126/science.1125257; van Laar C., 2001, SOC PSYCHOL EDUC, V4, P235, DOI DOI 10.1023/A:1011302418327; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364; Willbrink B, 1997, STUD ED EVAL, V23, P31	34	60	60	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71678	10.1371/journal.pone.0071678	http://dx.doi.org/10.1371/journal.pone.0071678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23951219	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000070
J	Ou, LC; Sun, ZJ; Chang, YF; Chang, CS; Chao, TH; Kuo, PH; Lin, RM; Wu, CH				Ou, Ling-Chun; Sun, Zih-Jie; Chang, Yin-Fan; Chang, Chin-Sung; Chao, Ting-Hsing; Kuo, Po-Hsiu; Lin, Ruey-Mo; Wu, Chih-Hsing			Epidemiological Survey of Quantitative Ultrasound in Risk Assessment of Falls in Middle-Aged and Elderly People	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; HIP FRACTURE; MULTIFACTORIAL INTERVENTION; PREDICTION; WOMEN; OSTEOPOROSIS; FRAGILITY; CALCANEUS; DENSITY; OUTDOOR	The risk assessment of falls is important, but still unsatisfactory and time-consuming. Our objective was to assess quantitative ultrasound (QUS) in the risk assessment of falls. Our study was designed as epidemiological cross-sectional study occurring from March 2009 to February 2010 by community survey at a medical center. The participants were collected from systemic sample of 1,200 community-dwelling people (Male/Female = 524/676) 40 years old and over in Yunlin County, Mid-Taiwan. Structural questionnaires including socioeconomic status, living status, smoking and drinking habits, exercise and medical history were completed. Quantitative ultrasound (QUS) at the non-dominant distal radial area (QUS-R) and the left calcaneal area (QUS-C) were measured. The overall prevalence of falls was 19.8%. In men, the independently associated factors for falls were age (OR: 1.04; 95%CI: 1.01 similar to 1.06), fracture history (OR: 1.89; 95%CI: 1.12 similar to 3.19), osteoarthritis history (OR: 3.66; 95%CI: 1.15 similar to 11.64) and speed of sound (OR: 0.99; 95%CI: 0.99 similar to 1.00; p<0.05) by QUS-R. In women, the independently associated factors for falls were current drinking (OR: 3.54; 95%CI: 1.35 similar to 9.31) and broadband ultrasound attenuation (OR: 0.98; 95%CI: 0.97 similar to 0.99; p<0.01) by QUS-C. The cutoffs at -2.5<T-score<-1 derived using QUS-R (OR: 2.85; 95%CI: 1.64 similar to 4.96; p<0.01) in men or T-score <=-2.5 derived using QUS-C (OR: 2.72; 95%CI: 1.42 similar to 5.21; p<0.01) in women showed an independent association with falls. The lowest T-score derived using either QUS-R or QUS-C was also revealed as an independent factor for falls in both men (OR: 2.13; 95%CI: 1.03 similar to 4.43; p<0.05) and women (OR: 2.36; 95%CI: 1.13 similar to 4.91; p<0.05). Conclusions: Quantitative ultrasounds, measured either at the radial or calcaneal area, are convenient tools by which to assess the risk of falls in middle-aged and elderly people.	[Ou, Ling-Chun; Sun, Zih-Jie; Chao, Ting-Hsing] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Internal Med, Yunlin, Taiwan; [Chang, Yin-Fan; Chang, Chin-Sung; Wu, Chih-Hsing] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Lin, Ruey-Mo] Natl Cheng Kung Univ Hosp, Dou Liou Branch, Dept Orthopad, Yunlin, Taiwan; [Sun, Zih-Jie; Wu, Chih-Hsing] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan 70101, Taiwan; [Wu, Chih-Hsing] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan 70101, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Taiwan University; National Taiwan University	Wu, CH (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	paulo@mail.ncku.edu.tw	Kuo, Po-Hsiu/H-9882-2013	Kuo, Po-Hsiu/0000-0003-0365-3587	Bureau of Health Promotion, Department of Health R.O.C. (Taiwan) [DOH98-HP-A9802-6]	Bureau of Health Promotion, Department of Health R.O.C. (Taiwan)	This work was supported by the Bureau of Health Promotion, Department of Health R.O.C. (Taiwan), Grant Number: DOH98-HP-A9802-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aama T, 2011, CAN FAM PHYSICIAN, V57, P771; [Anonymous], 2001, South Med J, V94, P569; [Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Bhatt T, 2011, ARCH PHYS MED REHAB, V92, P799, DOI 10.1016/j.apmr.2010.12.032; Bischoff HA, 2001, ARCH PHYS MED REHAB, V82, P801, DOI 10.1053/apmr.2001.22339; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Burrows S, 2012, ACCIDENT ANAL PREV, V45, P99, DOI 10.1016/j.aap.2011.11.010; Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874; Chang CS, 2012, J CLIN DENSITOM; Chang HJ., 2010, TAIWAN GERIATR GERON, V5, P50; Cho KH, 2012, ANN REHABIL MED-ARM, V36, P386, DOI 10.5535/arm.2012.36.3.386; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; Drake MT, 2012, ENDOCRIN METAB CLIN, V41, P629, DOI 10.1016/j.ecl.2012.05.001; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Granacher U, 2011, GERONTOLOGY, V57, P304, DOI 10.1159/000320250; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Haentjens P, 2003, J BONE JOINT SURG AM, V85A, P1936, DOI 10.2106/00004623-200310000-00011; Hans D, 2003, J CLIN DENSITOM, V6, P163, DOI 10.1385/JCD:6:2:163; Heuberger Roschelle A., 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P315, DOI 10.1080/21551197.2011.623931; Huang HC, 2008, J CLIN NURS, V17, P2275, DOI 10.1111/j.1365-2702.2008.02337.x; Huang Hui-Chi, 2004, J Nurs Res, V12, P131; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Krieg MA, 2008, J CLIN DENSITOM, V11, P163, DOI 10.1016/j.jocd.2007.12.011; Lee HD, 2010, J ULTRAS MED, V29, P1083, DOI 10.7863/jum.2010.29.7.1083; Leung A, 2010, HEALTH SOC CARE COMM, V18, P272, DOI 10.1111/j.1365-2524.2009.00900.x; Manty M, 2009, AGE AGEING, V38, P757, DOI 10.1093/ageing/afp178; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Mueller TL, 2009, BONE, V45, P882, DOI 10.1016/j.bone.2009.06.031; Muller M, 2008, MED ENG PHYS, V30, P761, DOI 10.1016/j.medengphy.2007.08.006; Nguyen TV, 2004, OSTEOPOROSIS INT, V15, P942, DOI 10.1007/s00198-004-1717-z; Njeh CF, 2001, OSTEOPOROSIS INT, V12, P1; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Patel S, 2005, AGE AGEING, V34, P67, DOI 10.1093/ageing/afh238; Peeters G, 2009, BEST PRACT RES CL RH, V23, P797, DOI 10.1016/j.berh.2009.09.004; Sakazaki Takahiko, 2012, Environmental Health and Preventive Medicine, V17, P394, DOI 10.1007/s12199-012-0267-9; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Sherrington C, 2010, J REHABIL MED, V42, P482, DOI 10.2340/16501977-0550; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Williams SB, 2010, ARCH PHYS MED REHAB, V91, P106, DOI 10.1016/j.apmr.2009.08.150; Youm T, 1999, Am J Orthop (Belle Mead NJ), V28, P190; Zochling J, 2002, OSTEOPOROSIS INT, V13, P882, DOI 10.1007/s001980200121	46	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71053	10.1371/journal.pone.0071053	http://dx.doi.org/10.1371/journal.pone.0071053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951077	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700074
J	Sun, HQ; Wang, F; Fan, HZ; Yan, QZ; Cui, KY; Yuan, W; Zhao, FS; Zhao, LL; Yuan, J; Yang, FD; Kosten, TR; Zhang, XY				Sun, Hongqiang; Wang, Fan; Fan, Hongzhen; Yan, Quanzhi; Cui, Kaiyan; Yuan, Wei; Zhao, Fushuai; Zhao, Lili; Yuan, Jie; Yang, Fude; Kosten, Thomas R.; Zhang, Xiang Yang			The Interaction of Polymorphisms of IL10 and DBH Was Associated with General Symptoms of PANSS with TD in Chinese Han Schizophrenic Patients	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; TARDIVE-DYSKINESIA; INSERTION/DELETION POLYMORPHISM; LINKAGE DISEQUILIBRIUM; PROMOTER POLYMORPHISM; GENETIC INTERACTIONS; ELDERLY-WOMEN; INTERLEUKIN-10; POPULATION; REGION	Objective: Tardive dyskinesia (TD) is a human hyperkinetic movement disorder as a result of potentially irreversible long-term chronic first-generation antipsychotic medications. Unfortunately, mechanisms involved in the development of TD have been poorly understood. Previous studies have indicated that some genetic polymorphisms of immune system and dopamine beta-hydroxylase (DBH) genes may be involved in the pathogenesis of TD. Rs1800872 and rs72393728 are located on the promoter of interleukin-10 (IL10) and DBH gene, respectively. The genetic association between the rs1800872 and TD is unclear. Previous studies have indicated that genetic variations of IL 10 and DBH are implicated in the positive and negative symptoms in schizophrenia. However, the interaction of two variations with severity of TD and symptoms of schizophrenic patients with TD has not been reported. The present study investigated whether these variations and their interaction were associated with clinical phenotypes of TD with schizophrenia in a genetically homogeneous northern Chinese Han population. Methods: Rs1800872 and rs72393728 were genotyped in schizophrenic patients with TD (n = 372) and without TD (NTD; n = 412). The Abnormal Involuntary Movement Scale (AIMS) and Positive and Negative Syndrome Scale (PANSS) were applied to assess the severity of TD and psychopathology of schizophrenia, respectively. Results: The allele and genotype frequencies of rs1800872 and rs72393728 did not significantly differ between TD and NTD patients (p > 0.05). No significant difference was found in the AIMS total score among the genotypes of two loci (p > 0.05). Interestingly, the interaction of rs1800872 and rs72393728 showed a significant association with the PANSS general score (p = 0.011), and a trend toward to the PANSS total score (p = 0.055). Conclusion: These findings suggest that the interaction of rs1800872 and rs72393728 variants may play a role in psychopathology of the general symptoms on PANSS in schizophrenic patients with TD in a northern Chinese Han population.	[Sun, Hongqiang; Wang, Fan; Fan, Hongzhen; Yang, Fude; Zhang, Xiang Yang] Peking Univ, Beijing Hui Long Guan Hosp, Beijing 100871, Peoples R China; [Yan, Quanzhi] Inner Mongolia Med Univ, Sch Basic Med Sci, Hohhot, Inner Mongolia, Peoples R China; [Cui, Kaiyan; Yuan, Wei] Shandong Mental Hlth Ctr, Dept Psychiat, Jinan, Shandong, Peoples R China; [Zhao, Fushuai; Zhao, Lili] Sixth Hosp Changchun City, Dept Psychiat, Changchun, Jilin Province, Peoples R China; [Yuan, Jie] Hulunbuir City Mental Hlth Ctr, Dept Psychiat, Hulunbuir, Inner Mongolia, Peoples R China; [Sun, Hongqiang; Kosten, Thomas R.; Zhang, Xiang Yang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Peking University; Inner Mongolia Medical University; Baylor College of Medicine	Sun, HQ (corresponding author), Peking Univ, Beijing Hui Long Guan Hosp, Beijing 100871, Peoples R China.	sunhongqiang0620@126.com; xyzhang@bcm.edu	Kosten, Thomas/AAI-5998-2021		Natural Science Foundation of China [81100993, 81271475]; United States National Institute of Health [U01-MH79639, K05-DA0454, P50-DA18827]; Department of Veterans Affairs; VISN 16; Mental Illness Research, Education and Clinical Center (MIRECC); Beijing Municipal Natural Science Foundation [7072035]; Stanley Medical Research Institute [03T-459, 05T-726]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000454] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); VISN 16; Mental Illness Research, Education and Clinical Center (MIRECC); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Stanley Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Natural Science Foundation of China (81100993) and (81271475), and the United States National Institute of Health (U01-MH79639, K05-DA0454 and P50-DA18827), the Department of Veterans Affairs, VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC), the Beijing Municipal Natural Science Foundation (ID: 7072035), and the Stanley Medical Research Institute (03T-459 and 05T-726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellay J, 2011, GENOME RES, V21, P1375, DOI 10.1101/gr.117176.110; Blasi G, 2011, P NATL ACAD SCI USA, V108, P1158, DOI 10.1073/pnas.1013535108; Browne S, 1996, ACTA PSYCHIAT SCAND, V94, P118, DOI 10.1111/j.1600-0447.1996.tb09835.x; Cazzullo CL, 1998, PROG NEURO-PSYCHOPH, V22, P947, DOI 10.1016/S0278-5846(98)00059-1; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Cloninger CR, 2002, P NATL ACAD SCI USA, V99, P13365, DOI 10.1073/pnas.222532599; Combarros O, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-162; Correll CU, 2004, AM J PSYCHIAT, V161, P414, DOI 10.1176/appi.ajp.161.3.414; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cubells JF, 1998, HUM GENET, V102, P533, DOI 10.1007/s004390050736; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; de Oliveira JG, 2012, DIG DIS SCI; Fernandez F, 2006, J NEUROL SCI, V251, P118, DOI 10.1016/j.jns.2006.09.013; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Freudenreich O, 2010, PSYCHIAT RES, V176, P99, DOI 10.1016/j.psychres.2008.11.007; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Hui L, 2012, J PSYCHIATR RES, V46, P733, DOI 10.1016/j.jpsychires.2012.02.016; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; Kaminska T, 2001, ARCH IMMUNOL THER EX, V49, P439; Kopeckova M, 2006, FOLIA BIOL-PRAGUE, V52, P194; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Liu HB, 2012, PSYCHIAT RES, V198, P329, DOI 10.1016/j.psychres.2012.01.002; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Lung FW, 2011, PSYCHIAT RES, V188, P294, DOI 10.1016/j.psychres.2010.12.025; Margolese HC, 2005, CAN J PSYCHIAT, V50, P541, DOI 10.1177/070674370505000907; Mittleman BB, 1997, J IMMUNOL, V159, P2994; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Mustapic M, 2007, AM J MED GENET B, V144B, P1087, DOI 10.1002/ajmg.b.30526; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Ozbey U, 2009, WORLD J BIOL PSYCHIA, V10, P461, DOI 10.1080/15622970802626580; Paul-Samojedny M, 2010, J MOL NEUROSCI, V42, P112, DOI 10.1007/s12031-010-9365-6; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Srivastava V, 2010, NEUROPSYCHOBIOLOGY, V61, P64, DOI 10.1159/000265131; Steinke JW, 2004, J IMMUNOL, V173, P3215, DOI 10.4049/jimmunol.173.5.3215; Tian W, 2006, IMMUNOGENETICS, V58, P113, DOI 10.1007/s00251-006-0093-6; Togsverd M, 2008, J AFFECT DISORDERS, V106, P169, DOI 10.1016/j.jad.2007.06.010; Togsverd M, 2007, INT J GERIATR PSYCH, V22, P883, DOI 10.1002/gps.1756; Tsutsumi A, 2009, PSYCHIAT INVEST, V6, P222, DOI 10.4306/pi.2009.6.3.222; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Wang F, 2012, PROG NEURO-PSYCHOPH, V37, P106, DOI 10.1016/j.pnpbp.2011.12.007; Wang XF, 2010, HUM HERED, V70, P269, DOI 10.1159/000321967; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; YASSA R, 1992, SCHIZOPHRENIA BULL, V18, P701, DOI 10.1093/schbul/18.4.701; Yu L, 2004, SCHIZOPHR RES, V71, P179, DOI 10.1016/j.schres.2004.01.001; Zhang JP, 2010, AM J PSYCHIAT, V167, P763, DOI 10.1176/appi.ajp.2009.09040598; Zhang YM, 2012, GENET MOL RES, V11, P3389, DOI 10.4238/2012.September.25.7	50	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70963	10.1371/journal.pone.0070963	http://dx.doi.org/10.1371/journal.pone.0070963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951054	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700069
J	Nogiec, CD; Kasif, S				Nogiec, Christopher D.; Kasif, Simon			To Supplement or Not to Supplement: A Metabolic Network Framework for Human Nutritional Supplements	PLOS ONE			English	Article							AMINO-ACID LEVELS; FLUX ANALYSIS; RECONSTRUCTION; FOREARM; BALANCE; MUSCLE	Flux balance analysis and constraint based modeling have been successfully used in the past to elucidate the metabolism of single cellular organisms. However, limited work has been done with multicellular organisms and even less with humans. The focus of this paper is to present a novel use of this technique by investigating human nutrition, a challenging field of study. Specifically, we present a steady state constraint based model of skeletal muscle tissue to investigate amino acid supplementation's effect on protein synthesis. We implement several in silico supplementation strategies to study whether amino acid supplementation might be beneficial for increasing muscle contractile protein synthesis. Concurrent with published data on amino acid supplementation's effect on protein synthesis in a post resistance exercise state, our results suggest that increasing bioavailability of methionine, arginine, and the branched-chain amino acids can increase the flux of contractile protein synthesis. The study also suggests that a common commercial supplement, glutamine, is not an effective supplement in the context of increasing protein synthesis and thus, muscle mass. Similar to any study in a model organism, the computational modeling of this research has some limitations. Thus, this paper introduces the prospect of using systems biology as a framework to formally investigate how supplementation and nutrition can affect human metabolism and physiology.	[Nogiec, Christopher D.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Nogiec, Christopher D.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kasif, Simon] Boston Univ, Dept Bioengn, Boston, MA 02215 USA; [Kasif, Simon] Harvard MIT, Div Hlth Sci & Technol CHIP HST, Childrens Hosp Informat Program, Boston, MA USA	Boston University; Harvard University; Joslin Diabetes Center, Inc.; Boston University; Harvard University; Boston Children's Hospital	Nogiec, CD (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	nogiec@bu.edu		Nogiec, Christopher/0000-0002-0851-8360				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; AOKI TT, 1976, AM J CLIN NUTR, V29, P340, DOI 10.1093/ajcn/29.4.340; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Gleeson M, 2008, J NUTR, V138, p2045S, DOI 10.1093/jn/138.10.2045S; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; MacLaren DPM, 2000, MED SCI SPORT EXER, V32, P1244, DOI 10.1097/00005768-200007000-00010; Mo ML, 2009, TRENDS BIOTECHNOL, V27, P37, DOI 10.1016/j.tibtech.2008.09.007; Niklas J, 2010, CURR OPIN BIOTECH, V21, P63, DOI 10.1016/j.copbio.2010.01.011; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Paddon-Jones D, 2004, J NUTR, V134, p2888S, DOI 10.1093/jn/134.10.2888S; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Ramakrishna R, 2001, AM J PHYSIOL-REG I, V280, pR695, DOI 10.1152/ajpregu.2001.280.3.R695; Shimomura Y, 2006, J NUTR, V136, p529S, DOI 10.1093/jn/136.2.529S; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Tessari P, 1996, J CLIN INVEST, V98, P1361, DOI 10.1172/JCI118923	21	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2013	8	8							e68751	10.1371/journal.pone.0068751	http://dx.doi.org/10.1371/journal.pone.0068751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218XC	23967053	Green Published, Green Submitted, gold			2022-12-27	WOS:000324465000009
J	Lee, JH; Park, DY; Lee, KJ; Kim, YK; So, YK; Ryu, JS; Oh, SH; Han, YS; Ko, K; Choo, YK; Park, SJ; Brodzik, R; Lee, KK; Oh, DB; Hwang, KA; Koprowski, H; Lee, YS; Ko, K				Lee, Jeong-Hwan; Park, Da-Young; Lee, Kyung-Jin; Kim, Young-Kwan; So, Yang-Kang; Ryu, Jae-Sung; Oh, Seung-Han; Han, Yeon-Soo; Ko, Kinarm; Choo, Young-Kug; Park, Sung-Joo; Brodzik, Robert; Lee, Kyoung-Ki; Oh, Doo-Byoung; Hwang, Kyung-A; Koprowski, Hilary; Lee, Yong Seong; Ko, Kisung			Intracellular Reprogramming of Expression, Glycosylation, and Function of a Plant-Derived Antiviral Therapeutic Monoclonal Antibody	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; N-GLYCOSYLATION; RABIES VACCINE; DC-SIGN; RETENTION; GLYCANS; APPARATUS; LYMPHOMA; PROTEINS; SEQUENCE	Plant genetic engineering, which has led to the production of plant-derived monoclonal antibodies (mAb(s)(P)), provides a safe and economically effective alternative to conventional antibody expression methods. In this study, the expression levels and biological properties of the anti-rabies virus mAb(P) SO57 with or without an endoplasmic reticulum(ER)-retention peptide signal (Lys-Asp-Glu-Leu; KDEL) in transgenic tobacco plants (Nicotiana tabacum) were analyzed. The expression levels of mAb(P) SO57 with KDEL (mAb(P)K) were significantly higher than those of mAb(P) SO57 without KDEL (mAb(P)) regardless of the transcription level. The Fc domains of both purified mAb(P) and mAb(P)K and hybridoma-derived mAb (mAb(H)) had similar levels of binding activity to the Fc gamma RI receptor (CD64). The mAb(P)K had glycan profiles of both oligomannose (OM) type (91.7%) and Golgi type (8.3%), whereas the mAb(P) had mainly Golgi type glycans (96.8%) similar to those seen with mAb(H). Confocal analysis showed that the mAb(P)K was co-localized to ER-tracker signal and cellular areas surrounding the nucleus indicating accumulation of the mAb(P) with KDEL in the ER. Both mAb(P) and mAb(P)K disappeared with similar trends to mAb(H) in BALB/c mice. In addition, mAb(P)K was as effective as mAb(H) at neutralizing the activity of the rabies virus CVS-11. These results suggest that the ER localization of the recombinant mAb(P) by KDEL reprograms OM glycosylation and enhances the production of the functional antivirus therapeutic antibody in the plant.	[Lee, Jeong-Hwan; Park, Da-Young; Lee, Kyung-Jin; So, Yang-Kang; Ko, Kisung] Chung Ang Univ, Coll Med, Dept Med, Med Res Inst, Seoul 156756, South Korea; [Oh, Doo-Byoung] Korean Res Inst Biosci & Biotechnol, Taejon, South Korea; [Ryu, Jae-Sung; Choo, Young-Kug] Wonkwang Univ, Coll Nat Sci, Dept Biol Sci, Inst Biotechnol, Iksan, South Korea; [Oh, Seung-Han; Han, Yeon-Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Kwangju, South Korea; [Ko, Kinarm] Konkuk Univ, Sch Med, Dept Neurosci, Seoul, South Korea; [Kim, Young-Kwan; Park, Sung-Joo] Wonkwang Univ, Sch Oriental Med, Dept Herbol, Iksan, South Korea; [Brodzik, Robert; Koprowski, Hilary] Thomas Jefferson Univ, Biotechnol Fdn Labs, Philadelphia, PA 19107 USA; [Lee, Kyoung-Ki] Natl Vet Res & Quarantine Serv, Anyang, South Korea; [Hwang, Kyung-A] RDA, Natl Acad Agr Sci, Dept Agrofood Resources, Suwon, South Korea; [Lee, Yong Seong] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Urol, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Wonkwang University; Chonnam National University; Konkuk University; Konkuk University Medical Center; Wonkwang University; Jefferson University; Animal & Plant Quarantine Agency; Rural Development Administration (RDA); Hallym University	Lee, YS (corresponding author), Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Urol, Seoul, South Korea.	novavia@hallym.or.kr; ksko@cau.ac.kr		Oh, Doo-Byoung/0000-0002-4432-0941; Lee, Yongseok/0000-0002-8687-589X	Cooperative Research Program for Agriculture Science & Technology Development [PJ009419022013, PJ0090622013]; Rural Development Administration; Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry & Fisheries (IPET) [111096-3]; (MEST) from National Research Foundation, Republic of Korea [NRF-2010-0024259]	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry & Fisheries (IPET); (MEST) from National Research Foundation, Republic of Korea	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009419022013 and PJ0090622013)"; Rural Development Administration and Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry & Fisheries (IPET) (111096-3); and grants (MEST) (NRF-2010-0024259) from National Research Foundation, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, TRANSGENIC RES, V17, P881, DOI 10.1007/s11248-008-9173-8; Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Barbin K, 2006, J IMMUNOTHER, V29, P122, DOI 10.1097/01.cji.0000175684.28615.7b; Brodzik R, 2006, P NATL ACAD SCI USA, V103, P8804, DOI 10.1073/pnas.0603043103; Cabanes-Macheteau M, 1999, GLYCOBIOLOGY, V9, P365, DOI 10.1093/glycob/9.4.365; Cliquet F, 2007, VACCINE, V25, P3409, DOI 10.1016/j.vaccine.2006.12.054; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Conrad U, 1998, PLANT MOL BIOL, V38, P101, DOI 10.1023/A:1006029617949; De Neve M, 1999, MOL GEN GENET, V260, P582, DOI 10.1007/s004380050932; DIETZSCHOLD B, 1987, P NATL ACAD SCI USA, V84, P9165, DOI 10.1073/pnas.84.24.9165; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; Jamal A, 2009, BIOTECHNOL ADV, V27, P914, DOI 10.1016/j.biotechadv.2009.07.004; JOWETT AK, 1994, J ANAT, V185, P85; Ko K, 2005, P NATL ACAD SCI USA, V102, P7026, DOI 10.1073/pnas.0502533102; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Kogelberg H, 2007, GLYCOBIOLOGY, V17, P36, DOI 10.1093/glycob/cwl053; Koprowski H, 2005, VACCINE, V23, P1757, DOI 10.1016/j.vaccine.2004.11.001; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee KJ, 2009, BIOCHEM BIOPH RES CO, V380, P223, DOI 10.1016/j.bbrc.2009.01.070; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; McCormick AA, 1999, P NATL ACAD SCI USA, V96, P703, DOI 10.1073/pnas.96.2.703; Mechref Yehia, 2009, V534, P53, DOI 10.1007/978-1-59745-022-5_4; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Pagny S, 2000, PLANT CELL, V12, P739, DOI 10.1105/tpc.12.5.739; PAQUETTE RL, 1995, MOL IMMUNOL, V32, P841, DOI 10.1016/0161-5890(95)00056-K; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TOLSON ND, 1988, CAN J VET RES, V52, P58; Triguero A, 2011, PLANT BIOTECHNOL J, V9, P1120, DOI 10.1111/j.1467-7652.2011.00638.x; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Wilde H, 1996, ANN INTERN MED, V125, P233, DOI 10.7326/0003-4819-125-3-199608010-00012; Wilson IBH, 1998, GLYCOCONJUGATE J, V15, P1055, DOI 10.1023/A:1006960401562; Yasuda H, 2005, PLANTA, V222, P118, DOI 10.1007/s00425-005-1522-8	45	73	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e68772	10.1371/journal.pone.0068772	http://dx.doi.org/10.1371/journal.pone.0068772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967055	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000003
J	Stojadinovic, O; Minkiewicz, J; Sawaya, A; Bourne, JW; Torzilli, P; Vaccari, JPD; Dietrich, WD; Keane, RW; Tomic-Canic, M				Stojadinovic, Olivera; Minkiewicz, Julia; Sawaya, Andrew; Bourne, Jonathan W.; Torzilli, Peter; Vaccari, Juan Pablo de Rivero; Dietrich, W. Dalton; Keane, Robert W.; Tomic-Canic, Marjana			Deep Tissue Injury in Development of Pressure Ulcers: A Decrease of Inflammasome Activation and Changes in Human Skin Morphology in Response to Aging and Mechanical Load	PLOS ONE			English	Article							CONNECTIVE-TISSUE; NEGATIVE-PRESSURE; COLLAGEN; DERMIS; AGE; INTERLEUKIN-1-BETA; KERATINOCYTES; THERAPY; STRESS; MICE	Molecular mechanisms leading to pressure ulcer development are scarce in spite of high mortality of patients. Development of pressure ulcers that is initially observed as deep tissue injury is multifactorial. We postulate that biomechanical forces and inflammasome activation, together with ischemia and aging, may play a role in pressure ulcer development. To test this we used a newly-developed bio-mechanical model in which ischemic young and aged human skin was subjected to a constant physiological compressive stress (load) of 300 kPa (determined by pressure plate analyses of a person in a reclining position) for 0.5-4 hours. Collagen orientation was assessed using polarized light, whereas inflammasome proteins were quantified by immunoblotting. Loaded skin showed marked changes in morphology and NLRP3 inflammasome protein expression. Sub-epidermal separations and altered orientation of collagen fibers were observed in aged skin at earlier time points. Aged skin showed significant decreases in the levels of NLRP3 inflammasome proteins. Loading did not alter NLRP3 inflammasome proteins expression in aged skin, whereas it significantly increased their levels in young skin. We conclude that aging contributes to rapid morphological changes and decrease in inflammasome proteins in response to tissue damage, suggesting that a decline in the innate inflammatory response in elderly skin could contribute to pressure ulcer pathogenesis. Observed morphological changes suggest that tissue damage upon loading may not be entirely preventable. Furthermore, newly developed model described here may be very useful in understanding the mechanisms of deep tissue injury that may lead towards development of pressure ulcers.	[Stojadinovic, Olivera; Sawaya, Andrew; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Minkiewicz, Julia; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Bourne, Jonathan W.; Torzilli, Peter] Hosp Special Surg, Tissue Engn Regenerat & Repair Program, New York, NY 10021 USA; [Vaccari, Juan Pablo de Rivero; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	MTCanic@med.miami.edu	de Rivero Vaccari, Juan Pablo/H-5718-2019; de Rivero Vaccari, Juan Pablo/ABE-3248-2020	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; Bourne, Jonathan/0000-0003-3297-0135	National Institutes of Health from the Weill-Cornell Clinical and Translational Science Center [AG030673, DK086364, AR060562, NS059836, TL1RR024998]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, TL1TR000459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030673] Funding Source: NIH RePORTER	National Institutes of Health from the Weill-Cornell Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from National Institutes of Health AG030673, DK086364, AR060562(MT-C), NS059836 (RWK), TL1RR024998 (JWB) from the Weill-Cornell Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; Ankrom Michael A, 2005, Adv Skin Wound Care, V18, P35, DOI 10.1097/00129334-200501000-00016; Bansal C, 2005, INT J DERMATOL, V44, P805, DOI 10.1111/j.1365-4632.2005.02636.x; Barone EJ, 1998, PLAST RECONSTR SURG, V102, P1023, DOI 10.1097/00006534-199809040-00015; Baumgarten M, 2006, J GERONTOL A-BIOL, V61, P749, DOI 10.1093/gerona/61.7.749; Beckrich K, 1999, NURS ECON, V17, P263; Bonomo SR, 2000, ARCH SURG-CHICAGO, V135, P1148, DOI 10.1001/archsurg.135.10.1148; Bosboom EMH, 2001, MED ENG PHYS, V23, P195, DOI 10.1016/S1350-4533(01)00034-0; Braga IA, 2013, J HOSP INFECT, V83, P314, DOI 10.1016/j.jhin.2012.11.008; Brem Harold, 2003, Surg Technol Int, V11, P161; Bronneberg D, 2007, EXP DERMATOL, V16, P567, DOI 10.1111/j.1600-0625.2007.00566.x; Brophy RH, 2009, FOOT ANKLE INT, V30, P405, DOI 10.3113/FAI.2009.0405; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Cornelissen LH, 2009, ANN BIOMED ENG, V37, P1007, DOI 10.1007/s10439-009-9652-y; de la Garza-Rodea AS, 2011, DERMATOLOGY, V223, P266, DOI 10.1159/000334628; Demiot C, 2011, J INVEST DERMATOL, V131, P2316, DOI 10.1038/jid.2011.211; Derrick KL, 2008, INT WOUND J, V5, P615, DOI 10.1111/j.1742-481X.2008.00544.x; Dinarello CA, 2006, AM J CLIN NUTR, V83, p447S; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Ducker Angela, 2002, Case Manager, V13, P61, DOI 10.1067/mcm.2002.126432; Edsberg LE, 2007, OSTOMY WOUND MANAG, V53, P40; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; Foglia E, 2012, J Prev Med Hyg, V53, P30; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Goldstein B, 1998, ARCH PHYS MED REHAB, V79, P265, DOI 10.1016/S0003-9993(98)90005-3; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Ichioka S, 2008, WOUND REPAIR REGEN, V16, P460, DOI 10.1111/j.1524-475X.2008.00390.x; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Khorramizadeh MR, 1999, MOL CELL BIOCHEM, V194, P99, DOI 10.1023/A:1006909021352; Kopfnagel V, 2011, EXP DERMATOL, V20, P1027, DOI 10.1111/j.1600-0625.2011.01382.x; KOSIAK M, 1959, Arch Phys Med Rehabil, V40, P62; Ladwig GP, 2002, WOUND REPAIR REGEN, V10, P26, DOI 10.1046/j.1524-475X.2002.10903.x; Lin F, 2010, J TISSUE VIABILITY, V19, P67, DOI 10.1016/j.jtv.2009.11.009; Linder-Ganz E, 2007, Technol Health Care, V15, P195; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; NOLA GT, 1980, PLAST RECONSTR SURG, V66, P728, DOI 10.1097/00006534-198011000-00008; Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469, DOI 10.1177/002215540205001106; OIKARINEN A, 1994, PHOTODERMATOL PHOTO, V10, P47; Orgill DP, 2011, PLAST RECONSTR SURG, V127, p105S, DOI 10.1097/PRS.0b013e318200a427; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Qureshi AA, 2011, PLAST RECONSTR SURG, V128, p721E, DOI 10.1097/PRS.0b013e318230c7d1; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Salcido R, 2007, J SPINAL CORD MED, V30, P107, DOI 10.1080/10790268.2007.11753921; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Salskov-Iversen ML, 2011, J INVEST DERMATOL, V131, P670, DOI 10.1038/jid.2010.370; Services UDoHaH, 2004, GUID SURV LONG TERM; Sisco M, 2007, WOUND REPAIR REGEN, V15, P203, DOI 10.1111/j.1524-475X.2007.00206.x; Sjogren F, 2009, ACTA DERM-VENEREOL, V89, P459, DOI 10.2340/00015555-0683; Smith A M, 1990, Decubitus, V3, P20; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Suter MM, 2009, VET DERMATOL, V20, P515, DOI 10.1111/j.1365-3164.2009.00819.x; Taverna D, 2011, WOUND REPAIR REGEN, V19, P734, DOI 10.1111/j.1524-475X.2011.00738.x; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Tomic-Canic M, 2004, DERM CLIN BAS SCI, P25; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Torzilli PA, 2011, CARTILAGE, V2, P364, DOI 10.1177/1947603511407484; Torzilli PA, 1997, J BIOMECH, V30, P1, DOI 10.1016/S0021-9290(96)00117-0; UITTO J, 1986, DERMATOL CLIN, V4, P433, DOI 10.1016/S0733-8635(18)30806-4; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x; WITKOWSKI JA, 1982, J AM ACAD DERMATOL, V6, P1014, DOI 10.1016/S0190-9622(82)70085-4; Youm YH, 2012, CELL REP, V1, P56, DOI 10.1016/j.celrep.2011.11.005	74	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69223	10.1371/journal.pone.0069223	http://dx.doi.org/10.1371/journal.pone.0069223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967056	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500004
J	Dona, MG; Paolini, F; Benevolo, M; Vocaturo, A; Latini, A; Giglio, A; Venuti, A; Giuliani, M				Dona, Maria Gabriella; Paolini, Francesca; Benevolo, Maria; Vocaturo, Amina; Latini, Alessandra; Giglio, Amalia; Venuti, Aldo; Giuliani, Massimo			Identification of Episomal Human Papillomavirus and Other DNA Viruses in Cytological Anal Samples of HIV-Uninfected Men Who Have Sex with Men	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; TORQUE TENO VIRUS; CERVICAL-CANCER; PHYSICAL STATUS; INFECTION; PREVALENCE; TYPE-16; RISK; AMPLIFICATION; TRANSCRIPTS	To date, there have been only few studies that investigated integration of anal Human Papillomavirus (HPV). Most of them were conducted on HIV-infected individuals and mainly analyzed samples from high-grade lesions and invasive cancer. We aimed to investigate HPV physical status in HIV-negative men who have sex with men (MSM) with a detectable anal HPV infection, irrespective of the presence of lesions. We also sought to explore the presence of other circular DNA viruses in the anal region. Study participants were attendees of an STI screening program, which were also screened for anal HPV infection and cytological abnormalities. HPV physical status was assessed using multiply-primed RCA. HPV16-positive samples were also analyzed using E2/E6 multiplex PCR, qRT-PCR and APOT assay. RCA and virus-specific PCR were employed to investigate the presence of other DNA viruses. Anal HPV infection was detected in 76.9% of the 230 MSM enrolled. The anal cytological reports were: 129 NILM, 37 ASC-US and 28 L-SIL (36 samples were inadequate for interpretation). HPV physical status was evaluated in the 109 anal specimens that harbored one or two different HPV genotypes. Integration was observed only in one HPV16-positive sample (0.9%), in which integrate-derived viral transcripts of type B were detected. Integration occurred in chromosome 14 q. In 22 of the 53 (41.5%) mucosal HPV-negative samples, RCA restriction results would seem to indicate the presence of circular DNA viruses. Indeed, cutaneous HPV (4 samples), MCPyV (5 samples) and TTV (4 samples) were detected. In conclusion, anal HPV integration was rarely evidenced in HIV-uninfected MSM with no or mild anal cytological abnormalities, although the integration rate may have been underestimated because of the limitations of the employed assays. Other DNA viruses were detected in the anal samples of these individuals, although the significance of this occurrence needs to be assessed.	[Dona, Maria Gabriella; Latini, Alessandra; Giuliani, Massimo] San Gallicano Dermatol Inst, Sexually Transmitted Infect STI Unit, Rome, Italy; [Paolini, Francesca; Venuti, Aldo] Regina Elena Inst Canc Res, Virol Lab, Rome, Italy; [Paolini, Francesca; Venuti, Aldo] Regina Elena Inst Canc Res, HPV Unit, Rome, Italy; [Benevolo, Maria; Vocaturo, Amina] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Giglio, Amalia] San Gallicano Dermatol Inst, Microbiol & Clin Pathol Dept, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Venuti, A (corresponding author), Regina Elena Inst Canc Res, Virol Lab, Rome, Italy.	venuti@ifo.it	Giuliani, Massimo/J-2788-2018; Dona', Maria Gabriella/J-7336-2018; Benevolo, Maria/J-8491-2018; latini, alessandra/J-8186-2018; Paolini, Francesca/B-2864-2018; Venuti, Aldo/K-9637-2016	Giuliani, Massimo/0000-0002-4523-8261; Dona', Maria Gabriella/0000-0003-3250-1726; Benevolo, Maria/0000-0003-1994-0935; Paolini, Francesca/0000-0002-7384-6248; Venuti, Aldo/0000-0003-2322-6857; GIGLIO, AMALIA/0000-0002-5717-8526; Latini, Alessandra/0000-0002-9421-6560	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro (AIRC) [12916]	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro (AIRC)	This work was supported by the Italian Ministry of Health ("5 per Mille"). The new experiments have been performed using grant funds from the Associazione Italiana per la Ricerca sul Cancro (AIRC)-Investigator Grant (IG) 12916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaracco G, 2005, INT J ONCOL, V27, P161; Badaracco G, 2007, ONCOL REP, V17, P931; BERKHOUT RJM, 1995, J CLIN MICROBIOL, V33, P690, DOI 10.1128/JCM.33.3.690-695.1995; Canadas MP, 2010, SEX TRANSM DIS, V37, P311, DOI 10.1097/OLQ.0b013e3181c9c23f; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; De Marco F, 2003, ANTICANCER RES, V23, P1449; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Dona MG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-476; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2012, 2 C EM ONC VIR SAN P; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Huang LW, 2008, J CLIN PATHOL, V61, P627, DOI 10.1136/jcp.2007.052027; IARC, 2007, HUM PAP; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Klaes R, 1999, CANCER RES, V59, P6132; Lace MJ, 2011, J VIROL, V85, P1645, DOI 10.1128/JVI.02093-10; Leppik L, 2007, J VIROL, V81, P9346, DOI 10.1128/JVI.00781-07; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Nagao S, 2002, J CLIN MICROBIOL, V40, P863, DOI 10.1128/JCM.40.3.863-867.2002; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Okamoto H, 2001, VIROLOGY, V288, P358, DOI 10.1006/viro.2001.1097; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Paolini F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-108; Paolini F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-103; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Pierangeli A, 2012, J INFECTION, V65, P255, DOI 10.1016/j.jinf.2012.05.004; Pinho-Nascimento CA, 2011, J MED VIROL, V83, P1107, DOI 10.1002/jmv.22024; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Roperto S, 2009, J DAIRY SCI, V92, P5928, DOI 10.3168/jds.2009-2265; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72228	10.1371/journal.pone.0072228	http://dx.doi.org/10.1371/journal.pone.0072228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951299	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300184
J	Eggers, R; de Winter, F; Hoyng, SA; Roet, KCD; Ehlert, EM; Malessy, MJA; Verhaagen, J; Tannemaat, MR				Eggers, Ruben; de Winter, Fred; Hoyng, Stefan A.; Roet, Kasper C. D.; Ehlert, Erich M.; Malessy, Martijn J. A.; Verhaagen, Joost; Tannemaat, Martijn R.			Lentiviral Vector-Mediated Gradients of GDNF in the Injured Peripheral Nerve: Effects on Nerve Coil Formation, Schwann Cell Maturation and Myelination	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; VENTRAL ROOT AVULSION; AXONAL REGENERATION; SPINAL-CORD; GENE-THERAPY; MOTONEURONS; OVEREXPRESSION; IMPLANTATION; SURVIVAL; NEURONS	Although the peripheral nerve is capable of regeneration, only a small minority of patients regain normal function after surgical reconstruction of a major peripheral nerve lesion, resulting in a severe and lasting negative impact on the quality of life. Glial cell-line derived neurotrophic factor (GDNF) has potent survival-and outgrowth-promoting effects on motoneurons, but locally elevated levels of GDNF cause trapping of regenerating axons and the formation of nerve coils. This phenomenon has been called the "candy store" effect. In this study we created gradients of GDNF in the sciatic nerve after a ventral root avulsion. This approach also allowed us to study the effect of increasing concentrations of GDNF on Schwann cell proliferation and morphology in the injured peripheral nerve. We demonstrate that lentiviral vectors can be used to create a 4 cm long GDNF gradient in the intact and lesioned rat sciatic nerve. Nerve coils were formed throughout the gradient and the number and size of the nerve coils increased with increasing GDNF levels in the nerve. In the nerve coils, Schwann cell density is increased, their morphology is disrupted and myelination of axons is severely impaired. The total number of regenerated and surviving motoneurons is not enhanced after the distal application of a GDNF gradient, but increased sprouting does result in higher number of motor axon in the distal segment of the sciatic nerve. These results show that lentiviral vector mediated overexpression of GDNF exerts multiple effects on both Schwann cells and axons and that nerve coil formation already occurs at relatively low concentrations of exogenous GDNF. Controlled expression of GDNF, by using a viral vector with regulatable GDNF expression, may be required to avoid motor axon trapping and to prevent the effects on Schwann cell proliferation and myelination.	[Eggers, Ruben; de Winter, Fred; Hoyng, Stefan A.; Roet, Kasper C. D.; Ehlert, Erich M.; Malessy, Martijn J. A.; Verhaagen, Joost; Tannemaat, Martijn R.] Inst Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands; [de Winter, Fred; Hoyng, Stefan A.; Malessy, Martijn J. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Tannemaat, Martijn R.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Tannemaat, MR (corresponding author), Inst Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands.	m.r.tannemaat@lumc.nl	Malessy, Martijn/AAZ-9996-2021; Eggers, Ruben/N-3619-2019; Tannemaat, Martijn/S-3445-2016; eggers, ruben/B-8937-2008; Verhaagen, Joost/G-4773-2012; De Winter, Fred/AAZ-8671-2020	Malessy, Martijn/0000-0003-1936-3664; Eggers, Ruben/0000-0001-7017-0791; Tannemaat, Martijn/0000-0003-2929-0390; eggers, ruben/0000-0001-7017-0791; De Winter, Fred/0000-0002-3042-2429; Hoyng, Stefan/0000-0001-8371-3871	Netherlands Institute for Neuroscience, an institute of the Royal Academy of Arts and Sciences; Leiden University Medical Center	Netherlands Institute for Neuroscience, an institute of the Royal Academy of Arts and Sciences; Leiden University Medical Center	This research was funded by the Netherlands Institute for Neuroscience, an institute of the Royal Academy of Arts and Sciences and Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Batchelor PE, 2000, EUR J NEUROSCI, V12, P3462, DOI 10.1046/j.1460-9568.2000.00239.x; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Chu TH, 2009, J NEUROPATH EXP NEUR, V68, P94, DOI 10.1097/NEN.0b013e31819344a9; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gilbert A, 2006, MICROSURG, V26, P334, DOI 10.1002/micr.20248; Hase A, 2005, J NEUROCHEM, V95, P537, DOI 10.1111/j.1471-4159.2005.03391.x; Heermann S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-92; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hendriks WTJ, 2007, RESTOR NEUROL NEUROS, V25, P585; Hoang TX, 2006, NEUROSCIENCE, V138, P1149, DOI 10.1016/j.neuroscience.2005.11.066; Hoke A, 2003, J NEUROSCI, V23, P561; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346; Magill CK, 2010, J NEUROSURG, V113, P102, DOI 10.3171/2009.10.JNS091092; Mai L, 2002, J NEUROCHEM, V82, P75, DOI 10.1046/j.1471-4159.2002.00939.x; Mason MRJ, 2011, CURR GENE THER, V11, P75; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Ossevoort M, 2003, GENE THER, V10, P2020, DOI 10.1038/sj.gt.3302098; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; WU WT, 1994, EXP NEUROL, V129, P335, DOI 10.1006/exnr.1994.1176; Zaldumbide A, 2010, BIOTECHNOL LETT, V32, P749, DOI 10.1007/s10529-010-0218-8; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840; Zwick M, 2001, EXP NEUROL, V171, P342, DOI 10.1006/exnr.2001.7753	37	61	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71076	10.1371/journal.pone.0071076	http://dx.doi.org/10.1371/journal.pone.0071076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951085	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300085
J	Li, YP; Li, YX; Wu, QL; Ye, HY; Sun, LM; Ye, BP; Wang, DY				Li, Yiping; Li, Yinxia; Wu, Qiuli; Ye, Huayue; Sun, Lingmei; Ye, Boping; Wang, Dayong			High Concentration of Vitamin E Decreases Thermosensation and Thermotaxis Learning and the Underlying Mechanisms in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							ENVIRONMENTAL RELEVANT CONCENTRATIONS; MICROCYSTIN-LR EXPOSURE; INDUCED MEMORY DEFICITS; ALPHA-TOCOPHEROL; C-ELEGANS; LIFE-SPAN; BEHAVIORAL DEFECTS; OXIDATIVE STRESS; METAL EXPOSURE; END-POINTS	alpha-tocopherol is a powerful liposoluble antioxidant and the most abundant isoform of vitamin E in the body. Under normal physiological conditions, adverse effects of relatively high concentration of vitamin E on organisms and the underlying mechanisms are still largely unclear. In the present study, we used the nematode Caenorhabditis elegans as an in vivo assay system to investigate the possible adverse effects of high concentration of vitamin E on thermosensation and thermotaxis learning and the underlying mechanisms. Our data show that treatment with 100-200 mu g/mL of vitamin E did not noticeably influence both thermosensation and thermotaxis learning; however, treatment with 400 mu g/mL of vitamin E altered both thermosensation and thermotaxis learning. The observed decrease in thermotaxis learning in 400 mu g/mL of vitamin E treated nematodes might be partially due to the moderate but significant deficits in thermosensation, but not due to deficits in locomotion behavior or perception to food and starvation. Treatment with 400 mu g/mL of vitamin E did not noticeably influence the morphology of GABAergic neurons, but significantly decreased fluorescent intensities of the cell bodies in AFD sensory neurons and AIY interneurons, required for thermosensation and thermotaxis learning control. Treatment with 400 mu g/mL of vitamin E affected presynaptic function of neurons, but had no remarkable effects on postsynaptic function. Moreover, promotion of synaptic transmission by activating PKC-1 effectively retrieved deficits in both thermosensation and thermotaxis learning induced by 400 mu g/mL of vitamin E. Therefore, relatively high concentrations of vitamin E administration may cause adverse effects on thermosensation and thermotaxis learning by inducing damage on the development of specific neurons and presynaptic function under normal physiological conditions in C. elegans.	[Li, Yiping; Li, Yinxia; Wu, Qiuli; Ye, Huayue; Sun, Lingmei; Wang, Dayong] Southeast Univ, Sch Med, Key Lab Dev Genes & Human Dis Minist Educ, Nanjing, Jiangsu, Peoples R China; [Ye, Huayue; Ye, Boping] China Pharmaceut Univ, Coll Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University	Wang, DY (corresponding author), Southeast Univ, Sch Med, Key Lab Dev Genes & Human Dis Minist Educ, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn			National Natural Science Foundation of China [81172698, 30870810]; Ministry of Education in China [20120092120064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education in China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 81172698, 30870810), and the Doctoral Fund of Ministry of Education in China (20120092120064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2000, J GERONTOL A-BIOL, V55, pB280, DOI 10.1093/gerona/55.6.B280; Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Antoshechkin I, 2007, NAT REV GENET, V8, P518, DOI 10.1038/nrg2105; Avila D, 2012, HUM EXP TOXICOL, V31, P236, DOI 10.1177/0960327110392084; Ballatori N, 2002, TOXICOL APPL PHARM, V183, P207, DOI 10.1006/taap.2002.9488; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Chakraborty S, 2012, J TRACE ELEM MED BIO, V26, P183, DOI 10.1016/j.jtemb.2012.03.011; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Delwing D, 2006, BEHAV BRAIN RES, V168, P185, DOI 10.1016/j.bbr.2005.08.014; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Ernst IMA, 2013, AGEING RES REV, V12, P365, DOI 10.1016/j.arr.2012.10.002; Galbussera A, 2006, NEUROL SCI, V27, P190, DOI 10.1007/s10072-006-0668-x; GOLBE LI, 1988, ARCH NEUROL-CHICAGO, V45, P1350, DOI 10.1001/archneur.1988.00520360068014; GOLDSTEIN P, 1994, TOXICOL APPL PHARM, V124, P212, DOI 10.1006/taap.1994.1025; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guerrero AL, 1999, NEUROREPORT, V10, P1689, DOI 10.1097/00001756-199906030-00012; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; Hasanein P, 2010, NEUROBIOL LEARN MEM, V93, P472, DOI 10.1016/j.nlm.2010.01.004; Hoss S, 2011, ENVIRON SCI TECHNOL, V45, P10219, DOI 10.1021/es2027136; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Jiang GCT, 2007, TOXICOL SCI, V99, P553, DOI 10.1093/toxsci/kfm171; Jones D, 1996, TOXICOLOGY, V109, P119, DOI 10.1016/0300-483X(96)03316-1; Ju JJ, 2013, ENVIRON SCI POLLUT R, V20, P1823, DOI 10.1007/s11356-012-1151-2; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; KOTEGAWA M, 1993, J MOL CELL CARDIOL, V25, P1067, DOI 10.1006/jmcc.1993.1119; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Li YH, 2009, J ENVIRON SCI, V21, P971, DOI 10.1016/S1001-0742(08)62370-0; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Mazlan M, 2006, J NEUROL SCI, V243, P5, DOI 10.1016/j.jns.2005.10.006; Mello C, 1995, METHOD CELL BIOL, V48, P451; Milatovic D, 2011, TOXICOL APPL PHARM, V256, P219, DOI 10.1016/j.taap.2011.06.001; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Reis EA, 2002, METAB BRAIN DIS, V17, P211, DOI 10.1023/A:1019982223034; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Sasakura H, 2013, CURR OPIN NEUROBIOL, V23, P92, DOI 10.1016/j.conb.2012.09.005; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shashikumar S, 2011, INDIAN J BIOCHEM BIO, V48, P191; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Then SM, 2009, CELL MOL NEUROBIOL, V29, P485, DOI 10.1007/s10571-008-9340-8; Tome AR, 2010, NEUROCHEM RES, V35, P580, DOI 10.1007/s11064-009-0102-x; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; VanDuyn N, 2010, TOXICOL SCI, V118, P613, DOI 10.1093/toxsci/kfq285; Wang Da-Yong, 2007, Environmental Bioindicators, V2, P89, DOI 10.1080/15555270701457695; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang Y, 2007, ENVIRON TOXICOL CHEM, V26, P2405, DOI 10.1897/06-646R1.1; Williams PL, 2000, J TOXICOL ENV HEAL A, V61, P641, DOI 10.1080/00984100050195125; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Wu QL, 2012, J HAZARD MATER, V243, P161, DOI 10.1016/j.jhazmat.2012.10.013; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Wu QL, 2012, J ENVIRON SCI-CHINA, V24, P733, DOI 10.1016/S1001-0742(11)60835-8; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Xing XJ, 2009, ARCH ENVIRON CON TOX, V56, P732, DOI 10.1007/s00244-009-9307-x; Xing X-J, 2009, J ENVIRON SCI, V21, P1784; Xing XJ, 2009, ECOTOX ENVIRON SAFE, V72, P1819, DOI 10.1016/j.ecoenv.2009.06.006; Xing XJ, 2009, ENVIRON TOXICOL PHAR, V28, P104, DOI 10.1016/j.etap.2009.03.006; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Ye BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014052; Ye Hua-Yue, 2006, Neurosci Bull, V22, P355; Ye Hua-Yue, 2008, Neurosci Bull, V24, P49, DOI 10.1007/s12264-008-0808-9; Ye Hua-Yue, 2008, Neurosci Bull, V24, P1, DOI 10.1007/s12264-008-0920-x; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Yun JS, 2005, TOXICOLOGY, V216, P140, DOI 10.1016/j.tox.2005.08.017; Zhang YF, 2010, ARCH ENVIRON CON TOX, V59, P129, DOI 10.1007/s00244-009-9456-y; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c; Zou SG, 2007, MECH AGEING DEV, V128, P222, DOI 10.1016/j.mad.2006.11.026	99	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71180	10.1371/journal.pone.0071180	http://dx.doi.org/10.1371/journal.pone.0071180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951104	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300094
J	Raihani, NJ; Mace, R; Lamba, S				Raihani, Nichola J.; Mace, Ruth; Lamba, Shakti			The Effect of $1, $5 and $10 Stakes in an Online Dictator Game	PLOS ONE			English	Article							MODEL SELECTION; GENDER; REGRESSION; FAIRNESS	The decision rules underpinning human cooperative behaviour are often investigated under laboratory conditions using monetary incentives. A major concern with this approach is that stake size may bias subjects' decisions. This concern is particularly acute in online studies, where stakes are often far lower than those used in laboratory or field settings. We address this concern by conducting a Dictator Game using Amazon Mechanical Turk. In this two-player game, one player (the dictator) determines the division of an endowment between himself and the other player. We recruited subjects from India and the USA to play an online Dictator Game. Dictators received endowments of $1, $5 or $10. We collected two batches of data over two consecutive years. We found that players from India were less generous when playing with a $10 stake. By contrast, the effect of stake size among players from the USA was very small. This study indicates that the effects of stake size on decision making in economic games may vary across populations.	[Raihani, Nichola J.] UCL, Dept Genet Evolut & Environm, London, England; [Mace, Ruth; Lamba, Shakti] UCL, Dept Anthropol, London, England; [Lamba, Shakti] Univ Exeter, Ctr Ecol & Conservat, Exeter EX4 4QJ, Devon, England	University of London; University College London; University of London; University College London; University of Exeter	Raihani, NJ (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	nicholaraihani@gmail.com	Raihani, Nichola J/C-2083-2015	Raihani, Nichola J/0000-0003-2339-9889; Mace, Ruth/0000-0002-6137-7739	Royal Society University Research Fellowship; European Research Council	Royal Society University Research Fellowship(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	NR is funded by a Royal Society University Research Fellowship. RM and SL are funded by the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Barton K, 2020, MUMIN MULTIMODEL INF; BOLTON GE, 1995, ECON LETT, V48, P287, DOI 10.1016/0165-1765(94)00621-8; BROWNKRUSE J, 1993, J ECON BEHAV ORGAN, V22, P255, DOI 10.1016/0167-2681(93)90001-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gilligan C., 2016, DIFFERENT VOICE PSYC; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAHNEMAN D, 1986, AM ECON REV, V76, P728; MASON CF, 1991, J ECON BEHAV ORGAN, V15, P215, DOI 10.1016/0167-2681(91)90030-2; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; NOWELL C, 1994, J ECON BEHAV ORGAN, V25, P25, DOI 10.1016/0167-2681(94)90084-1; Ortmann A, 1999, J ECON BEHAV ORGAN, V39, P327, DOI 10.1016/S0167-2681(99)00038-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Rapoport A, 1965, PRISONERS DILEMMA; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Shampanier K, 2007, MARKET SCI, V26, P742, DOI 10.1287/mksc.1060.0254; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6	30	35	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73131	10.1371/journal.pone.0073131	http://dx.doi.org/10.1371/journal.pone.0073131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951342	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300203
J	Takanashi, K; Quyen, DT; Le Hoa, NT; Khan, NC; Yasuoka, J; Jimba, M				Takanashi, Kumiko; Dao To Quyen; Nguyen Thi Le Hoa; Nguyen Cong Khan; Yasuoka, Junko; Jimba, Masamine			Long-Term Impact of Community-Based Information, Education and Communication Activities on Food Hygiene and Food Safety Behaviors in Vietnam: A Longitudinal Study	PLOS ONE			English	Article							DIARRHEA; INTERVENTION; SANITATION; PROMOTION; CHILDREN; WATER; COUNTRIES; CHANNELS; HANOI; WOMEN	Background: Ingestion of contaminated water or food is a major contributor to childhood diarrhea in developing countries. In Vietnam, the use of community-based information, education and communication (IEC) activities could be a sustainable strategy to improve food hygiene and food safety behaviors. This study thus examined the long-term impact of community-based IEC activities on food hygiene and food safety behaviors. Methods: In this longitudinal study, we interviewed caregivers of children aged between six months and four years in suburban Hanoi. Baseline data were collected in January 2006 (n = 125). After conducting IEC interventions, we collected a 1st set of evaluation data in January 2007 (n = 132). To examine the long-term impact of the interventions, we then collected a 2nd set of evaluation data in January 2008 (n = 185). Changes in childhood diarrhea prevalence, IEC coverage, and food hygiene and food safety behaviors were assessed over a two-year period using bivariate and logistic regression analyses. Effective IEC channels were determined through multiple linear regression analysis. Results: Childhood diarrhea was significantly reduced from 21.6% at baseline to 7.6% at the 1st post-intervention evaluation (P = 0.002), and to 5.9% at the 2nd evaluation. Among 17 food hygiene and food safety behaviors measured, a total of 11 behaviors were improved or maintained by the 2nd evaluation. Handwashing after toilet use was significantly improved at both evaluation points. Overall, 3 food safety behaviors and 7 food hygiene behaviors were found to have significantly improved at the 1st and at the 2nd evaluations, respectively. Flip chart communication administered by community groups was identified to be the most effective IEC channel for effecting behavior change (P = 0.018). Conclusions: Flip chart communication administered by community groups is effective for improving multiple food hygiene and food safety behaviors in sustainable ways, and should be included in water and health promotion programs.	[Takanashi, Kumiko; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Takanashi, Kumiko] Int Life Sci Inst Japan, Ctr Hlth Promot, Tokyo, Japan; [Dao To Quyen; Nguyen Thi Le Hoa] Natl Inst Nutr, Dept Food Sci & Safety, Hanoi, Vietnam; [Nguyen Cong Khan] Minist Hlth, Dept Sci & Training Management, Hanoi, Vietnam	University of Tokyo	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022		Japan International Cooperation Agency	Japan International Cooperation Agency	This study was funded by the Grassroots Partner Project Fund from Japan International Cooperation Agency (http://www.jica.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED NU, 1993, SOC SCI MED, V37, P159, DOI 10.1016/0277-9536(93)90452-A; Bajracharya D, 2003, INT J ENVIRON HEAL R, V13, pS141, DOI 10.1080/0960312031000102903; Cairncross S, 2005, SOC SCI MED, V61, P2212, DOI 10.1016/j.socscimed.2005.04.019; Center for Rural Water Supply and Sanitation Ministry of Agriculture and Rural Development, 2003, GUID INF ED COMM RUR; Chase C, 2012, HANDWASHING BEHAV CH; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V, 2001, B WORLD HEALTH ORGAN, V79, P518; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Ejemot-Nwadiaro RI, 2012, HAND WASHING PREVENT, P1; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P467; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Food and Nutrition Technical Assistance, 1999, WAT SAN IND MEAS GUI; Hornik R., 2002, PUBLIC HLTH COMMUNIC; Hunter PR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-219; Joint FAO/WHO Codex Alimentarius Commission, 2003, FOOD HYG BAS TEXTS, P1; Lanata CF, 2003, INT J ENVIRON HEAL R, V13, pS175, DOI 10.1080/0960312031000102921; Laverack G., 2003, HLTH ED, V103, P363, DOI DOI 10.1108/09654280310502852; LOEVINSOHN BP, 1990, INT J EPIDEMIOL, V19, P788, DOI 10.1093/ije/19.4.788; Ministry of Health Center for Preventive Medicine of Nam Dinh Province, 2003, KAP PRES REP ASS KNO, P1; Nguyen TVH, 2008, WATER SCI TECHNOL, V58, P2403, DOI 10.2166/wst.2008.435; Nguyen TV, 2006, INT J INFECT DIS, V10, P298, DOI 10.1016/j.ijid.2005.05.009; Pinfold JV, 1996, T ROY SOC TROP MED H, V90, P366, DOI 10.1016/S0035-9203(96)90507-6; Pinfold JV, 1999, HEALTH EDUC RES, V14, P629, DOI 10.1093/her/14.5.629; Scott BE, 2008, HEALTH EDUC RES, V23, P392, DOI 10.1093/her/cym056; Sheth Mini, 2004, Indian Journal of Pediatrics, V71, P879, DOI 10.1007/BF02830824; Takanashi K, 2009, J HEALTH POPUL NUTR, V27, P602; Toure O, 2011, FOOD CONTROL, V22, P1565, DOI 10.1016/j.foodcont.2011.03.012; [UNICEF WHO], 2009, DIARRH WHY CHILDR ST; UNICEF Vietnam, 2002, EFF INF ED COMM VIET; van den Berg LM, 2003, ENVIRON URBAN, V15, P35, DOI 10.1177/095624780301500122; [Vietnam Ministry of Health UNICEF], 2011, SUMM REP STUD CORRE; Vietnam Ministry of Health, 2005, 142005QDBYT VIET MIN; Waterkeyn J, 2005, SOC SCI MED, V61, P1958, DOI 10.1016/j.socscimed.2005.04.012; WHO, 2006, 5 KEYS SAF FOOD MAN; WILSON JM, 1993, T ROY SOC TROP MED H, V87, P615, DOI 10.1016/0035-9203(93)90260-W; World Health Organization, 1996, BAS PRINC PREP SAF F; World Health Organization, 2001, INF ED COMM LESS PER	39	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70654	10.1371/journal.pone.0070654	http://dx.doi.org/10.1371/journal.pone.0070654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23950978	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300038
J	Chakona, A; Swartz, ER; Gouws, G				Chakona, Albert; Swartz, Ernst R.; Gouws, Gavin			Evolutionary Drivers of Diversification and Distribution of a Southern Temperate Stream Fish Assemblage: Testing the Role of Historical Isolation and Spatial Range Expansion	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; SEA-LEVEL CHANGES; RIVER CAPTURE; POPULATION-GENETICS; NATURAL-SELECTION; SPECIES COMPLEX; CAPE GALAXIAS; PHYLOGEOGRAPHY; PATTERNS; CLADOGENESIS	This study used phylogenetic analyses of mitochondrial cytochrome b sequences to investigate genetic diversity within three broadly co-distributed freshwater fish genera (Galaxias, Pseudobarbus and Sandelia) to shed some light on the processes that promoted lineage diversification and shaped geographical distribution patterns. A total of 205 sequences of Galaxias, 177 sequences of Pseudobarbus and 98 sequences of Sandelia from 146 localities across nine river systems in the south-western Cape Floristic Region (South Africa) were used. The data were analysed using phylogenetic and haplotype network methods and divergence times for the clades retrieved were estimated using *BEAST. Nine extremely divergent (3.5-25.3%) lineages were found within Galaxias. Similarly, deep phylogeographic divergence was evident within Pseudobarbus, with four markedly distinct (3.8-10.0%) phylogroups identified. Sandelia had two deeply divergent (5.5-5.9%) lineages, but seven minor lineages with strong geographical congruence were also identified. The Miocene-Pliocene major sea-level transgression and the resultant isolation of populations in upland refugia appear to have driven widespread allopatric divergence within the three genera. Subsequent coalescence of rivers during the Pleistocene major sea-level regression as well as intermittent drainage connections during wet periods are proposed to have facilitated range expansion of lineages that currently occur across isolated river systems. The high degree of genetic differentiation recovered from the present and previous studies suggest that freshwater fish diversity within the south-western CFR may be vastly underestimated, and taxonomic revisions are required.	[Chakona, Albert; Swartz, Ernst R.; Gouws, Gavin] South African Inst Aquat Biodivers, Grahamstown, South Africa; [Chakona, Albert] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa	National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Rhodes University	Chakona, A (corresponding author), South African Inst Aquat Biodivers, Grahamstown, South Africa.	achakona@yahoo.com	Gouws, Gavin/K-4597-2012; Chakona, Albert/M-4265-2017	Gouws, Gavin/0000-0003-2770-940X; Chakona, Albert/0000-0001-6844-7501	International Foundation for Science [A/4174-2]; Rufford Small Grants for Nature Conservation [59.04.08]; WWF Prince Bernhard Scholarship; National Research Foundation (South Africa); Claude Leon Foundation	International Foundation for Science(International Foundation for Science); Rufford Small Grants for Nature Conservation; WWF Prince Bernhard Scholarship; National Research Foundation (South Africa)(National Research Foundation - South Africa); Claude Leon Foundation	Funding was provided by the International Foundation for Science (grant no. A/4174-2; www.ifs.se), The Rufford Small Grants for Nature Conservation (RSG reference 59.04.08; www.rufford.org), WWF Prince Bernhard Scholarship (wwf.panda.org), National Research Foundation (South Africa; www.nrf.ac.za) and the Claude Leon Foundation (www.leonfoundation.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez OA, 2011, BIOL J LINN SOC, V103, P336, DOI 10.1111/j.1095-8312.2011.01651.x; [Anonymous], 2000, STRELITZIA; [Anonymous], VERH INT VER THEOR A; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barber BR, 2010, P ROY SOC B-BIOL SCI, V277, P2675, DOI 10.1098/rspb.2010.0343; Barber BR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-343; Barnard K. H., 1943, ANN S AFRICAN MUS, V36, P101; Berendzen PB, 2008, J FISH BIOL, V73, P2021, DOI 10.1111/j.1095-8649.2008.02046.x; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bloomer P, 2000, J HERED, V91, P122, DOI 10.1093/jhered/91.2.122; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Burridge CP, 2006, EVOLUTION, V60, P1038; Burridge CP, 2007, MOL ECOL, V16, P1883, DOI 10.1111/j.1365-294X.2006.03196.x; Chakona A, 2013, J BIOGEOGR, V40, P1399, DOI 10.1111/jbi.12104; Chakona A, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-19; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooke GM, 2012, J EVOLUTION BIOL, V25, P1305, DOI 10.1111/j.1420-9101.2012.02514.x; Cooke GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048800; Cooke GM, 2012, MOL ECOL, V21, P2410, DOI 10.1111/j.1365-294X.2012.05540.x; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Craw D, 2008, J BIOGEOGR, V35, P1790, DOI 10.1111/j.1365-2699.2008.01936.x; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; Deacon H.J., 1992, ECOLOGY FYNBOS NUTR, P6; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ponce JF, 2011, BIOL J LINN SOC, V103, P363, DOI 10.1111/j.1095-8312.2011.01653.x; Fu YX, 1997, GENETICS, V147, P915; Hawlitschek O, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-142; HENDEY QB, 1983, FYNBOS PALAEOECOLOGY, P35; Klaus S, 2013, J BIOGEOGR, V40, P63, DOI 10.1111/j.1365-2699.2012.02771.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; Marlow JR, 2000, SCIENCE, V290, P2288; McCulloch GA, 2010, EVOLUTION, V64, P2033, DOI 10.1111/j.1558-5646.2010.00980.x; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Near TJ, 2004, EVOLUTION, V58, P2798; Near TJ, 2003, EVOLUTION, V57, P1610; Partridge TC, 1999, QUATERN INT, V57-8, P207, DOI 10.1016/S1040-6182(98)00061-5; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P3; PARTRIDGE TC, 1987, S AFR J GEOL, V90, P179; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price BW, 2007, MOL ECOL, V16, P2574, DOI 10.1111/j.1365-294X.2007.03328.x; Rambaut A, 2007, TRACER V 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos H, 2004, THESIS U PRETORIA S; Ruber L, 2006, SYST BIOL, V55, P374, DOI 10.1080/10635150500541664; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P514, DOI 10.1111/j.1095-8312.2011.01682.x; SIESSER WG, 1981, J GEOL, V89, P83, DOI 10.1086/628565; Siesser WG, 1978, INITIAL REP DEEP SEA, V40, P965; Skelton P.H., 1986, Palaeoecology of Africa and the Surrounding Islands, V17, P211; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; Swartz ER, 2004, J FISH BIOL, V64, P1153, DOI 10.1111/j.0022-1112.2004.00375.x; SWARTZ ER, 2005, THESIS U PRETORIA S; Swartz ER, 2007, J BIOGEOGR, V34, P2086, DOI 10.1111/j.1365-2699.2007.01768.x; Swartz ER, 2009, MOL PHYLOGENET EVOL, V51, P75, DOI 10.1016/j.ympev.2008.10.017; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thacker CE, 2007, J BIOGEOGR, V34, P1518, DOI 10.1111/j.1365-2699.2007.01711.x; Thieme ML, 2005, FRESHWATER ECOREGION; TYSON PD, 2000, OX MG GEOL, P371, DOI DOI 10.1016/J.PALAE0.2007.10.018; Van Niekerk R, 2004, THESIS U PRETORIA S; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Waters JM, 1997, J FISH BIOL, V50, P1329, DOI 10.1006/jfbi.1997.0404; Waters JM, 2006, BIOL J LINN SOC, V88, P367, DOI 10.1111/j.1095-8312.2004.00622.x; Wishart Marcus, 2006, African Journal of Aquatic Science, V31, P99, DOI 10.2989/16085910609503876; Wishart MJ, 2001, FRESHWATER BIOL, V46, P479, DOI 10.1046/j.1365-2427.2001.00691.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	78	43	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70953	10.1371/journal.pone.0070953	http://dx.doi.org/10.1371/journal.pone.0070953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951050	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200025
J	Manna, M; Mukhopadhyay, C				Manna, Moutusi; Mukhopadhyay, Chaitali			Binding, Conformational Transition and Dimerization of Amyloid-beta Peptide on GM1-Containing Ternary Membrane: Insights from Molecular Dynamics Simulation	PLOS ONE			English	Article							A-BETA; PROTEIN; CHOLESTEROL; BILAYER; OLIGOMERS; ORGANIZATION; GANGLIOSIDES; NUCLEATION; MECHANISM; MICELLES	Interactions of amyloid-beta (A beta) with neuronal membrane are associated with the progression of Alzheimer's disease (AD). Ganglioside GM1 has been shown to promote the structural conversion of A beta and increase the rate of peptide aggregation; but the exact nature of interaction driving theses processes remains to be explored. In this work, we have carried out atomistic-scale computer simulations (totaling 2.65 mu s) to investigate the behavior of A beta monomer and dimers in GM1-containing raft-like membrane. The oligosaccharide head-group of GM1 was observed to act as scaffold for A beta-binding through sugar-specific interactions. Starting from the initial helical peptide conformation, a beta-hairpin motif was formed at the C-terminus of the GM1-bound A beta-monomer; that didn't appear in absence of GM1 (both in fluid POPC and liquid-ordered cholesterol/POPC bilayers and also in aqueous medium) within the simulation time span. For A beta-dimers, the beta-structure was further enhanced by peptide-peptide interactions, which might influence the propensity of A beta to aggregate into higher-ordered structures. The salt-bridges and inter-peptide hydrogen bonds were found to account for dimer stability. We observed spontaneous formation of intra-peptide D-23-K-28 salt-bridge and a turn at V(24)GSN(27) region - long been accepted as characteristic structural-motifs for amyloid self-assembly. Altogether, our results provide atomistic details of A beta-GM1 and A beta-A beta interactions and demonstrate their importance in the early-stages of GM1-mediated A beta-oligomerisation on membrane surface.	[Manna, Moutusi; Mukhopadhyay, Chaitali] Univ Calcutta, Dept Chem, Kolkata, India; [Manna, Moutusi] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Calcutta; Tampere University	Mukhopadhyay, C (corresponding author), Univ Calcutta, Dept Chem, Kolkata, India.	chaitalicu@yahoo.com	Manna, Moutusi/GZL-7999-2022	Manna, Moutusi/0000-0001-9472-1594	Council of Scientific and Industrial Research (CSIR), India [09/028(0690)/2007-EMR-I]; Department of Science and Technology (DST), India [SR/S1/PC-60/2009]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), India(Department of Science & Technology (India))	This work was supported by the research fellowship to MM (09/028(0690)/2007-EMR-I) by the Council of Scientific and Industrial Research (CSIR), India and also by financial support to CM (SR/S1/PC-60/2009) from the Department of Science and Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Baftizadeh F, 2012, J AM CHEM SOC, V134, P3886, DOI 10.1021/ja210826a; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Chi EY, 2007, BIOCHEMISTRY-US, V46, P1913, DOI 10.1021/bi062177x; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Davis CH, 2010, PROTEINS, V78, P2533, DOI 10.1002/prot.22763; Davis CH, 2009, J PHYS CHEM B, V113, P14480, DOI 10.1021/jp905889z; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Jang S, 2006, J PHYS CHEM B, V110, P1955, DOI 10.1021/jp055568e; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jedlovszky P, 2009, J PHYS CHEM B, V113, P4876, DOI 10.1021/jp808199p; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kagan BL, 2010, ADV EXP MED BIOL, V677, P150; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kittner M, 2010, J PHYS CHEM B, V114, P15288, DOI 10.1021/jp1065264; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lemkul JA, 2011, PROTEIN SCI, V20, P1530, DOI 10.1002/pro.678; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Manna M, 2011, PHYS CHEM CHEM PHYS, V13, P20188, DOI 10.1039/c1cp21793c; Manna M, 2011, LANGMUIR, V27, P3713, DOI 10.1021/la104046z; Manna M, 2009, LANGMUIR, V25, P12235, DOI 10.1021/la902660q; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Mikhalyov I, 2010, BIOPHYS J, V99, P1510, DOI 10.1016/j.bpj.2010.06.043; Mondal S, 2008, LANGMUIR, V24, P10298, DOI 10.1021/la8015589; NAGAI Y, 1995, BEHAV BRAIN RES, V66, P99, DOI 10.1016/0166-4328(94)00130-8; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Nikolic A, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.22854; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; Polyansky AA, 2005, J PHYS CHEM B, V109, P15052, DOI 10.1021/jp0510185; Qiu LM, 2011, J PHYS CHEM B, V115, P9795, DOI 10.1021/jp2012842; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; RYCKAERT JP, 1975, CHEM PHYS LETT, V30, P123, DOI 10.1016/0009-2614(75)85513-8; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QM, 2010, LANGMUIR, V26, P3308, DOI 10.1021/la903070y; Wei GH, 2010, PHYS CHEM CHEM PHYS, V12, P3622, DOI 10.1039/c000755m; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yagi-Utsumi M, 2011, INT J ALZHEIMERS DIS, DOI [10.4061/2011/925073, DOI 10.4061/2011/925073)]; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yu X, 2012, J MOL BIOL, V421, P561, DOI 10.1016/j.jmb.2011.11.006; Zhao LN, 2011, J PHYS CHEM B, V115, P12247, DOI 10.1021/jp2065985; Zhu XX, 2012, J PHYS CHEM B, V116, P4405, DOI 10.1021/jp210019h	74	47	47	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71308	10.1371/journal.pone.0071308	http://dx.doi.org/10.1371/journal.pone.0071308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951128	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200039
J	Corzo, CA; Culhane, M; Dee, S; Morrison, RB; Torremorell, M				Corzo, Cesar A.; Culhane, Marie; Dee, Scott; Morrison, Robert B.; Torremorell, Montserrat			Airborne Detection and Quantification of Swine Influenza A Virus in Air Samples Collected Inside, Outside and Downwind from Swine Barns	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; RISK-FACTORS; TRANSMISSION; INFECTION; PIG; H1N1; PREVALENCE; PATHOGENS; TRANSPORT; RECOVERY	Airborne transmission of influenza A virus (IAV) in swine is speculated to be an important route of virus dissemination, but data are scarce. This study attempted to detect and quantify airborne IAV by virus isolation and RRT-PCR in air samples collected under field conditions. This was accomplished by collecting air samples from four acutely infected pig farms and locating air samplers inside the barns, at the external exhaust fans and downwind from the farms at distances up to 2.1 km. IAV was detected in air samples collected in 3 out of 4 farms included in the study. Isolation of IAV was possible from air samples collected inside the barn at two of the farms and in one farm from the exhausted air. Between 13% and 100% of samples collected inside the barns tested RRT-PCR positive with an average viral load of 3.20E+05 IAV RNA copies/m(3) of air. Percentage of exhaust positive air samples also ranged between 13% and 100% with an average viral load of 1.79E+04 RNA copies/m(3) of air. Influenza virus RNA was detected in air samples collected between 1.5 and 2.1 Km away from the farms with viral levels significantly lower at 4.65E+03 RNA copies/m(3). H1N1, H1N2 and H3N2 subtypes were detected in the air samples and the hemagglutinin gene sequences identified in the swine samples matched those in aerosols providing evidence that the viruses detected in the aerosols originated from the pigs in the farms under study. Overall our results indicate that pigs can be a source of IAV infectious aerosols and that these aerosols can be exhausted from pig barns and be transported downwind. The results from this study provide evidence of the risk of aerosol transmission in pigs under field conditions.	[Corzo, Cesar A.; Culhane, Marie; Morrison, Robert B.; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Culhane, Marie] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA; [Dee, Scott] Pipestone Vet Clin, Pipestone, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu	Culhane, Marie/H-3143-2019; Dee, Scott/V-8876-2019		Rapid Agricultural Response Fund - Minnesota Agricultural Experiment Station; University of Minnesota Swine Disease Eradication Center	Rapid Agricultural Response Fund - Minnesota Agricultural Experiment Station; University of Minnesota Swine Disease Eradication Center	Funding for this study was provided by the Rapid Agricultural Response Fund - Minnesota Agricultural Experiment Station and the University of Minnesota Swine Disease Eradication Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; CHRISTENSEN LS, 1993, VET REC, V132, P317, DOI 10.1136/vr.132.13.317; CHRISTENSEN LS, 1990, VET REC, V127, P471; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Corzo CA, 2012, VET J, DOI [10.1016/j.tvjl.2012.09.024, DOI 10.1016/J.TVJL.2012.09.024.EPUB]; Corzo CA, 2012, AVIAN DIS, V56, P488, DOI 10.1637/10037-121211-Reg.1; Davis J, 2009, TRANSBOUND EMERG DIS, V56, P31, DOI 10.1111/j.1865-1682.2008.01060.x; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; GOODWIN RFW, 1977, VET REC, V101, P419, DOI 10.1136/vr.101.21.419; GRANT RH, 1994, INT J BIOMETEOROL, V38, P33, DOI 10.1007/BF01241802; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Hermann JR, 2008, CAN J VET RES, V72, P367; Jiang Y, 2009, BUILD SIMUL-CHINA, V2, P281, DOI 10.1007/s12273-009-9325-7; Karasin AI, 2000, J CLIN MICROBIOL, V38, P2453; Loeffen WLA, 2011, VET MICROBIOL, V152, P304, DOI 10.1016/j.vetmic.2011.05.027; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; MOHAN R, 1981, AVIAN DIS, V25, P11, DOI 10.2307/1589822; MOORE BE, 1979, APPL ENVIRON MICROB, V38, P688, DOI 10.1128/AEM.38.4.688-693.1979; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Olsen CW, 2006, SWINE INFLUENZA, P469; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Palese P., 2007, FIELDS VIROLOGY, P1647; Poljak Z, 2008, CAN J VET RES, V72, P7; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Prickett John R., 2010, Animal Health Research Reviews, V11, P207, DOI 10.1017/S1466252310000010; Ramirez A, 2012, PREV VET MED, V104, P292, DOI 10.1016/j.prevetmed.2011.11.008; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; SCHULMAN JL, 1967, J EXP MED, V125, P479, DOI 10.1084/jem.125.3.479; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Torremorell M, 1997, AM J VET RES, V58, P828; Yao ML, 2011, BERL MUNCH TIERARZTL, V124, P136, DOI 10.2376/0005-9366-124-136; Yee KS, 2009, VIROLOGY, V394, P19, DOI 10.1016/j.virol.2009.08.017	41	53	53	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71444	10.1371/journal.pone.0071444	http://dx.doi.org/10.1371/journal.pone.0071444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951164	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000058
J	Ge, J; Woodward, LA; Li, QX; Wang, J				Ge, Jing; Woodward, Lee Ann; Li, Qing X.; Wang, Jun			Distribution, Sources and Risk Assessment of Polychlorinated Biphenyls in Soils from the Midway Atoll, North Pacific Ocean	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ORGANOCHLORINE PESTICIDES; PCBS; ACCUMULATION	Concentrations of 28 polychlorinated biphenyls (PCBs) were assessed in soils from the Midway Atoll in the central North Pacific Ocean. The analytical procedure involved the application of accelerated solvent extraction (ASE) and gas chromatography coupled with ion trap mass spectrometric detection (GC/ITMS) for identification and quantification. Among the 28 PCB congeners studied, 26 of them, except CB195 and CB209, were detected in the analyzed samples at different frequencies. The total concentrations of 28 indicator PCBs (Sigma PCBs) ranged from 2.6 to 148.8 ng g(-1) with an average value of 50.7 ng g(-1) and median of 39.5 ng g(-1). Sources and congeners' pattern of PCB were investigated in the soil of Midway Atoll. The principal component analysis indicated that the compositions of PCBs in most of the soil samples were similar. The total concentrations of PCBs were used to assess the cancer risk probabilities in humans via ingestion, dermal contact and inhalation of soil particles. Very low cancer risk was found in all soil samples caused by Sigma PCBs.	[Ge, Jing; Wang, Jun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Woodward, Lee Ann] US Fish & Wildlife Serv, Pacific Reefs NWRC, Honolulu, HI USA; [Li, Qing X.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; United States Department of the Interior; US Fish & Wildlife Service; University of Hawaii System; University of Hawaii Manoa	Li, QX (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	qingl@hawaii.edu; wangjun@wbgcas.cn	Wang, Jun/H-5837-2015; Li, Qing/AAO-3938-2020; Wang, Jun/AAN-4446-2021	Wang, Jun/0000-0002-7574-9468	U.S. Fish and Wildlife Service; Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology; Chinese Academy of Sciences	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology; Chinese Academy of Sciences(Chinese Academy of Sciences)	This project was supported in part by the U.S. Fish and Wildlife Service (QXL) and Open Funding Project of the Key Laboratory of Aquatic Botany and Watershed Ecology (JW), Chinese Academy of Sciences. The funders played a role in study design and preparation of the manuscript.	Aliyeva G, 2012, ENVIRON SCI POLLUT R, V19, P1953, DOI 10.1007/s11356-012-0944-7; [Anonymous], 1997, EXPOSURE FACTORS HDB; [ATSDR New York State Department of Health under cooperative agreement with the Agency for Toxic Substances and Disease Registry], 1995, NEW YORK STAT DEP HL; Ben Hassine S, 2012, CHEMOSPHERE, V89, P369, DOI 10.1016/j.chemosphere.2012.05.035; BROWN JF, 1994, ENVIRON SCI TECHNOL, V28, P2295, DOI 10.1021/es00062a013; Caccamise SAL, 2012, ECOL INDIC, V20, P75, DOI 10.1016/j.ecolind.2012.01.023; Cachada A, 2009, ENVIRON POLLUT, V157, P511, DOI 10.1016/j.envpol.2008.09.002; Connell D, 1988, REV ENVIRON CONTAM T, V14, P587; de Boer J, 1998, NATURE, V394, P28, DOI 10.1038/27798; EPA, 1999, POL BIPH PCBS UPD IM; Falandysz J, 2001, ARCH ENVIRON CON TOX, V40, P173, DOI 10.1007/s002440010160; Hope B, 1997, MAR POLLUT BULL, V34, P548, DOI 10.1016/S0025-326X(96)00180-4; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Klanova J, 2008, ENVIRON POLLUT, V152, P416, DOI 10.1016/j.envpol.2007.06.026; Manz M, 2001, SCI TOTAL ENVIRON, V277, P187, DOI 10.1016/S0048-9697(00)00877-9; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Motelay-Massei A, 2004, CHEMOSPHERE, V55, P555, DOI 10.1016/j.chemosphere.2003.11.054; QUENSEN JF, 1988, SCIENCE, V242, P752, DOI 10.1126/science.242.4879.752; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; Tanabe S, 2002, MAR POLLUT BULL, V45, P69, DOI 10.1016/S0025-326X(02)00175-3; [U. S EPA Environmental Protection Agency], 1989, EPA540189; [U.S EPA Environmental Protection Agency W], 2009, POL BIPH PCBS BAS IN; U.S EPA, 2009, EPA540R070002; USFWS, 2010, COMB PREL ASS SIT IN; Wilcke W, 2006, ENVIRON POLLUT, V141, P327, DOI 10.1016/j.envpol.2005.08.038	25	19	20	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71521	10.1371/journal.pone.0071521	http://dx.doi.org/10.1371/journal.pone.0071521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951182	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000064
J	Jiang, M; Zeng, GM; Zhang, C; Ma, XY; Chen, M; Zhang, JC; Lu, LH; Yu, Q; Hu, LP; Liu, LF				Jiang, Min; Zeng, Guangming; Zhang, Chang; Ma, Xiaoying; Chen, Ming; Zhang, Jiachao; Lu, Lunhui; Yu, Qian; Hu, Langping; Liu, Lifeng			Assessment of Heavy Metal Contamination in the Surrounding Soils and Surface Sediments in Xiawangang River, Qingshuitang District	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; PRINCIPAL COMPONENT ANALYSIS; TRACE-METALS; ECOLOGICAL RISK; SPECIATION; POLLUTION; FRACTIONATION; SNOW; PB; ANTARCTICA	Xiawanggang River region is considered to be one of the most polluted areas in China due to its huge amount discharge of pollutants and accumulation for years. As it is one branch of Xiang River and the area downstream is Changsha city, the capital of Hunan Province, the ecological niche of Xiawangang River is very important. The pollution treatment in this area was emphasized in the Twelfth Five-Year Plan of Chinese government for Xiang River Water Environmental Pollution Control. In order to assess the heavy metal pollution and provide the base information in this region for The Twelfth Five-Year Plan, contents and fractions of four heavy metals (Cd, Cu, Pb and Zn) covering both sediments and soils were analyzed to study their contamination state. Three different indexes were applied to assess the pollution extent. The results showed this area was severely polluted by the four heavy metals, and the total concentrations exceeded the Chinese environmental quality standard for soil, grade III, especially for Cd. Moreover, Cd, rated as being in high risk, had a high mobility as its great contents of exchangeable and carbonates fractions in spite of its relative low content. Regression analysis revealed clay could well explain the regression equation for Cd, Cu and Zn while pH and sand could significantly interpret the regression equation for Pb. Moreover, there was a significant correlation between Non-residual fraction and I-geo for all the four metals. Correlation analysis showed four metals maybe had similar pollution sources.	[Jiang, Min; Zeng, Guangming; Zhang, Chang; Chen, Ming; Lu, Lunhui; Yu, Qian; Hu, Langping; Liu, Lifeng] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Jiang, Min; Zeng, Guangming; Zhang, Chang; Chen, Ming; Lu, Lunhui; Yu, Qian; Hu, Langping; Liu, Lifeng] Hunan Univ, Key Lab Environm Biol & Pollut Control, Minist Educ, Changsha 410082, Hunan, Peoples R China; [Ma, Xiaoying] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Zhang, Jiachao] Hunan Agr Univ, Coll Resources & Environm, Changsha, Hunan, Peoples R China	Hunan University; Hunan University; University of Waterloo; Hunan Agricultural University	Zeng, GM (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.	zgming@hnu.edu.cn; zhangchang@hnu.edu.cn	zhang, chang/H-5712-2016; Jiang, Min/AFL-7440-2022; Zhang, jiachao/L-1332-2013; Jiang, Min/AAG-7389-2022	Zhang, jiachao/0000-0001-8099-6749; Zhang, Jiachao/0000-0002-3339-7345	Xiangjiang Water Environmental Pollution Control Project [2009ZX07212-001-02, 2009ZX07212-001-06]; National Natural Science Foundation of China [51179068, 51039001]; Hunan Provincial Natural Science Foundation of China [10JJ7005]; Research Fund for the Doctoral Program of Higher Education of China [20100161110012]	Xiangjiang Water Environmental Pollution Control Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was financially supported by Xiangjiang Water Environmental Pollution Control Project Subjected to the National Key Science and Technology Project for Water Environmental Pollution Control (2009ZX07212-001-02 and 2009ZX07212-001-06), the National Natural Science Foundation of China (51179068, 51039001), the Hunan Provincial Natural Science Foundation of China (10JJ7005), and the Research Fund for the Doctoral Program of Higher Education of China (20100161110012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo P, 2003, GEODERMA, V117, P347, DOI 10.1016/S0016-7061(03)00133-2; Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Amir S, 2005, CHEMOSPHERE, V59, P801, DOI 10.1016/j.chemosphere.2004.11.016; Arias R, 2008, J HAZARD MATER, V151, P78, DOI 10.1016/j.jhazmat.2007.05.048; Barona A, 1996, SOIL TECHNOL, V8, P303, DOI 10.1016/0933-3630(95)00029-1; Bhuiyan MAH, 2010, J HAZARD MATER, V173, P384, DOI 10.1016/j.jhazmat.2009.08.085; Bleeker EAJ, 2007, ENVIRON POLLUT, V148, P824, DOI 10.1016/j.envpol.2007.01.034; Cai JN, 2011, J ENVIRON MONITOR, V13, P2450, DOI 10.1039/c1em10062a; CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989; Chabukdhara M, 2012, CHEMOSPHERE, V87, P945, DOI 10.1016/j.chemosphere.2012.01.055; Das S, 2013, ECOTOX ENVIRON SAFE, V92, P252, DOI 10.1016/j.ecoenv.2013.02.016; EVANS LJ, 1989, ENVIRON SCI TECHNOL, V23, P1046, DOI 10.1021/es00067a001; Fernandes HM, 1997, ENVIRON POLLUT, V97, P317, DOI 10.1016/S0269-7491(97)00004-3; Forstner U., 1981, METAL POLLUTION AQUA, DOI [10.1007/978-3-642-69385-4, DOI 10.1007/978-3-642-69385-4]; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; GORLACH U, 1992, J ATMOS CHEM, V14, P205, DOI 10.1007/BF00115234; Henry L., 2009, Journal of Wetlands Ecology, V3, P68; Hur SD, 2007, ATMOS ENVIRON, V41, P8567, DOI 10.1016/j.atmosenv.2007.07.012; Ikem A, 2011, CHEMOSPHERE, V82, P259, DOI 10.1016/j.chemosphere.2010.09.048; Jain CK, 2004, WATER RES, V38, P569, DOI 10.1016/j.watres.2003.10.042; Li XD, 2001, MAR POLLUT BULL, V42, P215, DOI 10.1016/S0025-326X(00)00145-4; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Liu JL, 2009, ECOTOXICOLOGY, V18, P748, DOI 10.1007/s10646-009-0345-y; LOBINSKI R, 1994, ENVIRON SCI TECHNOL, V28, P1467, DOI 10.1021/es00057a014; Lu I, 2000, SOIL AGR CHEM ANAL M; Luo MB, 2008, J ENVIRON SCI, V20, P161, DOI 10.1016/S1001-0742(08)60025-X; Luo YM, 1998, J ENVIRON QUAL, V27, P335, DOI 10.2134/jeq1998.00472425002700020013x; MODAK DP, 1992, WATER RES, V26, P1541, DOI 10.1016/0043-1354(92)90075-F; MULLER G, 1979, UMSCHAU, V79, P778; Nemati K, 2011, J HAZARD MATER, V192, P402, DOI 10.1016/j.jhazmat.2011.05.039; Nemati K, 2009, MICROCHEM J, V91, P227, DOI 10.1016/j.microc.2008.12.001; Passos ED, 2010, MICROCHEM J, V96, P50, DOI 10.1016/j.microc.2010.01.018; Ramos L, 1999, B ENVIRON CONTAM TOX, V62, P301, DOI 10.1007/s001289900874; Rodriguez L, 2009, J ENVIRON MANAGE, V90, P1106, DOI 10.1016/j.jenvman.2008.04.007; SALOMONS W, 1980, ENVIRON TECHNOL LETT, V1, P506, DOI 10.1080/09593338009384007; Shao MF, 2009, WATER RES, V43, P2961, DOI 10.1016/j.watres.2009.04.016; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; Sin SN, 2001, ENVIRON INT, V26, P297, DOI 10.1016/S0160-4120(01)00003-4; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Sizmur T, 2011, ENVIRON POLLUT, V159, P742, DOI 10.1016/j.envpol.2010.11.033; Stephens SR, 2001, ENVIRON POLLUT, V114, P407, DOI 10.1016/S0269-7491(00)00231-1; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Van de Velde K, 2005, EARTH PLANET SC LETT, V232, P95, DOI 10.1016/j.epsl.2005.01.007; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Wang FY, 2009, ENVIRON SCI TECHNOL, V43, P7252, DOI 10.1021/es8034973; Wei F.S., 2002, STANDARD METHODS WAT; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Zhejazkova VD, 2003, SCI TOTAL ENVIRON, V302, P13, DOI 10.1016/S0048-9697(02)00390-X	50	55	61	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71176	10.1371/journal.pone.0071176	http://dx.doi.org/10.1371/journal.pone.0071176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951103	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000042
J	Newman, MEJ; Ferrario, CR				Newman, M. E. J.; Ferrario, Carrie R.			Interacting Epidemics and Coinfection on Contact Networks	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HIV-1 TRANSMISSION; INFECTION; STAGE	The spread of certain diseases can be promoted, in some cases substantially, by prior infection with another disease. One example is that of HIV, whose immunosuppressant effects significantly increase the chances of infection with other pathogens. Such coinfection processes, when combined with nontrivial structure in the contact networks over which diseases spread, can lead to complex patterns of epidemiological behavior. Here we consider a mathematical model of two diseases spreading through a single population, where infection with one disease is dependent on prior infection with the other. We solve exactly for the sizes of the outbreaks of both diseases in the limit of large population size, along with the complete phase diagram of the system. Among other things, we use our model to demonstrate how diseases can be controlled not only by reducing the rate of their spread, but also by reducing the spread of other infections upon which they depend.	[Newman, M. E. J.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Newman, M. E. J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Ferrario, Carrie R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Newman, MEJ (corresponding author), Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA.	mejn@umich.edu	Ferrario, Carrie R/L-7372-2016	Ferrario, Carrie R/0000-0002-9673-7028	US National Science Foundation [DMS-1107796]; Division Of Mathematical Sciences [1107796] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded in part by the US National Science Foundation (www.nsf.gov) under grant DMS-1107796. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ANDERSON R M, 1991; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; CastilloChavez C, 1996, SIAM J APPL MATH, V56, P494, DOI 10.1137/S003613999325419X; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Karrer B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036106; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Sartori E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-166; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	20	62	67	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71321	10.1371/journal.pone.0071321	http://dx.doi.org/10.1371/journal.pone.0071321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951134	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000048
J	Saunders, LE; Green, JM; Petticrew, MP; Steinbach, R; Roberts, H				Saunders, Lucinda E.; Green, Judith M.; Petticrew, Mark P.; Steinbach, Rebecca; Roberts, Helen			What Are the Health Benefits of Active Travel? A Systematic Review of Trials and Cohort Studies	PLOS ONE			English	Review							TIME PHYSICAL-ACTIVITY; CORONARY-HEART-DISEASE; AGED FINNISH MEN; LEISURE-TIME; LONGITUDINAL ASSOCIATIONS; CARDIOVASCULAR RISK; NORTHERN-IRELAND; SCHOOL-CHILDREN; UNTRAINED MEN; WALKING	Background: Increasing active travel (primarily walking and cycling) has been widely advocated for reducing obesity levels and achieving other population health benefits. However, the strength of evidence underpinning this strategy is unclear. This study aimed to assess the evidence that active travel has significant health benefits. Methods: The study design was a systematic review of (i) non-randomised and randomised controlled trials, and (ii) prospective observational studies examining either (a) the effects of interventions to promote active travel or (b) the association between active travel and health outcomes. Reports of studies were identified by searching 11 electronic databases, websites, reference lists and papers identified by experts in the field. Prospective observational and intervention studies measuring any health outcome of active travel in the general population were included. Studies of patient groups were excluded. Results: Twenty-four studies from 12 countries were included, of which six were studies conducted with children. Five studies evaluated active travel interventions. Nineteen were prospective cohort studies which did not evaluate the impact of a specific intervention. No studies were identified with obesity as an outcome in adults; one of five prospective cohort studies in children found an association between obesity and active travel. Small positive effects on other health outcomes were found in five intervention studies, but these were all at risk of selection bias. Modest benefits for other health outcomes were identified in five prospective studies. There is suggestive evidence that active travel may have a positive effect on diabetes prevention, which may be an important area for future research. Conclusions: Active travel may have positive effects on health outcomes, but there is little robust evidence to date of the effectiveness of active transport interventions for reducing obesity. Future evaluations of such interventions should include an assessment of their impacts on obesity and other health outcomes.	[Saunders, Lucinda E.; Green, Judith M.; Petticrew, Mark P.; Steinbach, Rebecca] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Roberts, Helen] UCL Inst Child Hlth, Gen & Adolescent Paediat Unit, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Petticrew, MP (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England.	Mark.Petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021	Roberts, Helen/0000-0002-6319-061X; Steinbach, Rebecca/0000-0002-5674-2455; Green, Judith/0000-0002-2315-5326	National Institute for Health Research Public Health Research programme [09/3001/13]; National Institute for Health Research [09/3001/13] Funding Source: researchfish	National Institute for Health Research Public Health Research programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/13). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in the design, conduct or reporting of project findings.	Andersen LB, 2011, J PHYS ACT HEALTH, V8, P1025, DOI 10.1123/jpah.8.8.1025; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Barengo NC, 2005, J HYPERTENS, V23, P293, DOI 10.1097/00004872-200502000-00011; Barengo NC, 2004, EUR HEART J, V25, P2204, DOI 10.1016/j.ehj.2004.10.009; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Batty GD, 2001, EUR J EPIDEMIOL, V17, P863, DOI 10.1023/A:1015609909969; Bere E, 2011, INT J PEDIATR OBES, V6, P182, DOI 10.3109/17477166.2011.583656; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Bostock L, 2001, HEALTH SOC CARE COMM, V9, P11, DOI 10.1046/j.1365-2524.2001.00275.x; Bunn F, 2003, Cochrane Database Syst Rev, pCD003110; Chillon P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-10; Cooper AR, 2008, PREV MED, V47, P324, DOI 10.1016/j.ypmed.2008.06.009; Crum AJ, 2007, PSYCHOL SCI, V18, P165, DOI 10.1111/j.1467-9280.2007.01867.x; de Geus B, 2008, SCAND J MED SCI SPOR, V18, P498, DOI 10.1111/j.1600-0838.2007.00729.x; de Geus B, 2007, BRIT J SPORT MED, V41, P8, DOI 10.1136/bjsm.2006.027615; de Geus B, 2009, SCAND J MED SCI SPOR, V19, P179, DOI 10.1111/j.1600-0838.2008.00776.x; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Department of Health, 2011, START ACT STAY ACT R; Dombois OT, 2007, HEALTH PLACE, V13, P757, DOI 10.1016/j.healthplace.2006.12.002; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Effective Public Health Practice Project, 2009, QUAL ASS TOOL QUANT; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Ford P, 2007, PEDIATR EXERC SCI, V19, P393, DOI 10.1123/pes.19.4.393; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Hayashi T, 1999, ANN INTERN MED, V131, P21, DOI 10.7326/0003-4819-131-1-199907060-00005; Health Survey for England, 2009, HLTH SURV ENGL 2008; Heelan KA, 2005, CHILD CARE HLTH DEV, V31, P341, DOI 10.1111/j.1365-2214.2005.00513.x; Hendriksen IJM, 2000, MED SCI SPORT EXER, V32, P504, DOI 10.1097/00005768-200002000-00037; Hosking J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005575.pub3; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c; Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; Lee MC, 2008, J PHYS ACT HEALTH, V5, P930, DOI 10.1123/jpah.5.6.930; Lofgren B, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-25; Lubans DR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-5; Luoto R, 2000, EUR J EPIDEMIOL, V16, P973, DOI 10.1023/A:1010847311422; Macintyre S, 2010, J EPIDEMIOLOGY COMMU; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Metcalf B, 2004, BMJ-BRIT MED J, V329, P832, DOI 10.1136/bmj.38169.688102.F71; Moayyeri A, 2010, BONE, V47, P693, DOI 10.1016/j.bone.2010.06.023; MORRIS JN, 1953, LANCET, V265, P1053; Mutrie N, 2002, J EPIDEMIOL COMMUN H, V56, P407, DOI 10.1136/jech.56.6.407; Oja P, 1998, PATIENT EDUC COUNS, V33, pS87, DOI 10.1016/S0738-3991(98)00013-5; OJA P, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P151; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Pabayo R, 2010, PREV MED, V50, pS59, DOI 10.1016/j.ypmed.2009.08.014; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rosenberg DE, 2006, OBESITY, V14, P1771, DOI 10.1038/oby.2006.204; SALLIS JF, 1992, PREV MED, V21, P237, DOI 10.1016/0091-7435(92)90022-A; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Santos MP, 2009, PREV MED, V49, P497, DOI 10.1016/j.ypmed.2009.09.021; Sato KK, 2007, DIABETES CARE, V30, P2296, DOI 10.2337/dc07-0090; Sirard JR, 2008, J NUTR EDUC BEHAV, V40, P324, DOI 10.1016/j.jneb.2007.12.002; SLEAP M, 1993, CHILD CARE HLTH DEV, V19, P99, DOI 10.1111/j.1365-2214.1993.tb00717.x; Wagner A, 2003, EUR J EPIDEMIOL, V18, P321, DOI 10.1023/A:1023625110856; Wagner A, 2002, CIRCULATION, V105, P2247, DOI 10.1161/01.CIR.0000016345.58696.4F; Wagner A, 2001, INT J OBESITY, V25, P940, DOI 10.1038/sj.ijo.0801635; Wanless D., 2004, SECURING GOOD HLTH W; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2016, OB OV	65	210	215	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e69912	10.1371/journal.pone.0069912	http://dx.doi.org/10.1371/journal.pone.0069912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204OU	23967064	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323378000005
J	Villegas-Amtmann, S; Jeglinski, JWE; Costa, DP; Robinson, PW; Trillmich, F				Villegas-Amtmann, Stella; Jeglinski, Jana W. E.; Costa, Daniel P.; Robinson, Patrick W.; Trillmich, Fritz			Individual Foraging Strategies Reveal Niche Overlap between Endangered Galapagos Pinnipeds	PLOS ONE			English	Article							NORTHERN FUR SEALS; INTRA-SPECIFIC COMPETITION; INTERSPECIFIC COMPETITION; CALLORHINUS-URSINUS; CHINSTRAP PENGUINS; OXYGEN STORES; LIONS; BEHAVIOR; DIET; PREY	Most competition studies between species are conducted from a population-level approach. Few studies have examined inter-specific competition in conjunction with intra-specific competition, with an individual-based approach. To our knowledge, none has been conducted on marine top predators. Sympatric Galapagos fur seals (Arctocephalus galapagoensis) and sea lions (Zalophus wollebaeki) share similar geographic habitats and potentially compete. We studied their foraging niche overlap at Cabo Douglas, Fernandina Island from simultaneously collected dive and movement data to examine spatial and temporal inter-and intra-specific competition. Sea lions exhibited 3 foraging strategies (shallow, intermediate and deep) indicating intra-specific competition. Fur seals exhibited one foraging strategy, diving predominantly at night, between 0-80 m depth and mostly at 19-22 h. Most sea lion dives also occurred at night (63%), between 0-40 m, within fur seals' diving depth range. 34% of sea lions night dives occurred at 19-22 h, when fur seals dived the most, but most of them occurred at dawn and dusk, when fur seals exhibited the least amount of dives. Fur seals and sea lions foraging behavior overlapped at 19 and 21 h between 0-30 m depths. Sea lions from the deep diving strategy exhibited the greatest foraging overlap with fur seals, in time (19 h), depth during overlapping time (21-24 m), and foraging range (37.7%). Fur seals foraging range was larger. Cabo Douglas northwest coastal area, region of highest diving density, is a foraging "hot spot" for both species. Fur seals and sea lions foraging niche overlap occurred, but segregation also occurred; fur seals primarily dived at night, while sea lions exhibited night and day diving. Both species exploited depths and areas exclusive to their species. Niche breadth generally increases with environmental uncertainty and decreased productivity. Potential competition between these species could be greater during warmer periods when prey availability is reduced.	[Villegas-Amtmann, Stella; Jeglinski, Jana W. E.; Trillmich, Fritz] Univ Bielefeld, Dept Behav Biol, D-33615 Bielefeld, North Rhine Wes, Germany; [Villegas-Amtmann, Stella; Costa, Daniel P.; Robinson, Patrick W.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of Bielefeld; University of California System; University of California Santa Cruz	Villegas-Amtmann, S (corresponding author), Univ Bielefeld, Dept Behav Biol, D-33615 Bielefeld, North Rhine Wes, Germany.	stella.villegas@gmail.com	Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782	German Science Foundation [TR 105/19-1]; National Geographic [8682-09]; Office of Naval Research [N00014-08-1-1195]; E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; UC Santa Cruz Open Access Fund	German Science Foundation(German Research Foundation (DFG)); National Geographic(National Geographic Society); Office of Naval Research(Office of Naval Research); E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; UC Santa Cruz Open Access Fund	This work was funded by the German Science Foundation (grant No TR 105/19-1), National Geographic (grant No 8682-09), the Office of Naval Research grant N00014-08-1-1195 and the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers. Funding for Open Access provided by the UC Santa Cruz Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELIS GA, 1990, CAN J ZOOL, V68, P150, DOI 10.1139/z90-022; Aumann T, 2001, WILDLIFE RES, V28, P379, DOI 10.1071/WR99092; Aurioles D., 2008, ZALOPHUS WOLLEBAEKI; Aurioles-Gamboa David, 2007, Aquatic Mammals, V33, P315, DOI 10.1578/AM.33.3.2007.315; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Begon M, 1996, POPULATION ECOLOGY U; Blanchet MA, 2013, MAR ECOL PROG SER, V477, P285, DOI 10.3354/meps10110; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Calder WA., 1984, SIZE FUNCTION LIFE H; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE MR, 1980, J ZOOL, V190, P211, DOI 10.1111/j.1469-7998.1980.tb07767.x; Cody M. L., 1975, ECOLOGY EVOLUTION CO; Costa Daniel P., 1993, Symposia of the Zoological Society of London, V66, P293; Costa DP, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P344; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; Edwards JW, 1998, J WILDLIFE MANAGE, V62, P354, DOI 10.2307/3802299; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Himes JG, 2003, J HERPETOL, V37, P126, DOI 10.1670/0022-1511(2003)037[0126:IAICAT]2.0.CO;2; Horning M, 1997, BEHAVIOUR, V134, P1211, DOI 10.1163/156853997X00133; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Jeglinski JWE, 2013, J ANIM ECOL; Johannesen E, 2003, ANN ZOOL FENN, V40, P35; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kooyman G.L., 1986, P186; Kooyman G.L, 1986, DIVING BEHAV GALAPAG; KREBS RA, 1991, AUST J ZOOL, V39, P579, DOI 10.1071/ZO9910579; KUHN CE, 2006, MEASURING FEEDING RA; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Morin P., 1999, COMMUNITY ECOL; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Pegg J, 2011, FISH RES, V112, P8, DOI 10.1016/j.fishres.2011.08.003; Ronconi RA, 2011, CAN J ZOOL, V89, P356, DOI 10.1139/Z11-006; Roughgarden J, 1986, COMMUNITY ECOL, P333; Sakamoto CM, 1998, DEEP-SEA RES PT II, V45, P1055, DOI 10.1016/S0967-0645(98)00013-7; SALAZAR SK, 2005, VARIACION TEMPORAL E; Schmitt RJ, 2003, ECOL LETT, V6, P898, DOI 10.1046/j.1461-0248.2003.00514.x; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Szteren Diana, 2004, Latin American Journal of Aquatic Mammals, V3, P119; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Trillmich F., 1986, P196; Trillmich F., 1986, P168; Trillmich F., 1991, EFFECTS EL NINO PINN; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2010, FUNCT ECOL, V24, P785, DOI 10.1111/j.1365-2435.2009.01685.x; Waite JN, 2012, CAN J ZOOL, V90, P110, DOI 10.1139/Z11-117; Waite JN, 2012, J EXP MAR BIOL ECOL, V416, P41, DOI 10.1016/j.jembe.2012.02.009; Weise MJ, 2007, J EXP BIOL, V210, P278, DOI 10.1242/jeb.02643; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x; Wolf JBW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-150; Young HS, 2010, MAR ECOL PROG SER, V416, P285, DOI 10.3354/meps08756	66	30	30	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70748	10.1371/journal.pone.0070748	http://dx.doi.org/10.1371/journal.pone.0070748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967096	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323378000014
J	Bachle, C; Icks, A; Strassburger, K; Flechtner-Mors, M; Hungele, A; Beyer, P; Placzek, K; Hermann, U; Schumacher, A; Freff, M; Stahl-Pehe, A; Holl, RW; Rosenbauer, J				Baechle, Christina; Icks, Andrea; Strassburger, Klaus; Flechtner-Mors, Marion; Hungele, Andreas; Beyer, Peter; Placzek, Kerstin; Hermann, Ulrich; Schumacher, Andrea; Freff, Markus; Stahl-Pehe, Anna; Holl, Reinhard W.; Rosenbauer, Joachim		DPV Initiative; German BMBF Competence Network	Direct Diabetes-Related Costs in Young Patients with Early-Onset, Long-Lasting Type 1 Diabetes	PLOS ONE			English	Article							METABOLIC-CONTROL; EXCESS COSTS; ADOLESCENTS; CHILDREN; CARE; GERMANY; ADULTS; RISK; AGE; COMPLICATIONS	Objective: To estimate diabetes-related direct health care costs in pediatric patients with early-onset type 1 diabetes of long duration in Germany. Research Design and Methods: Data of a population-based cohort of 1,473 subjects with type 1 diabetes onset at 0-4 years of age within the years 1993-1999 were included (mean age 13.9 (SD 2.2) years, mean diabetes duration 10.9 (SD 1.9) years, as of 31.12.2007). Diabetes-related health care services utilized in 2007 were derived from a nationwide prospective documentation system (DPV). Health care utilization was valued in monetary terms based on inpatient and outpatient medical fees and retail prices (perspective of statutory health insurance). Multiple regression models were applied to assess associations between direct diabetes-related health care costs per patient-year and demographic and clinical predictors. Results: Mean direct diabetes-related health care costs per patient-year were (sic)3,745 (inter-quartile range: 1,943-4,881). Costs for glucose self-monitoring were the main cost category (28.5%), followed by costs for continuous subcutaneous insulin infusion (25.0%), diabetes-related hospitalizations (22.1%) and insulin (18.4%). Female gender, pubertal age and poor glycemic control were associated with higher and migration background with lower total costs. Conclusions: Main cost categories in patients with on average 11 years of diabetes duration were costs for glucose self-monitoring, insulin pump therapy, hospitalization and insulin. Optimization of glycemic control in particular in pubertal age through intensified care with improved diabetes education and tailored insulin regimen, can contribute to the reduction of direct diabetes-related costs in this patient group.	[Baechle, Christina; Icks, Andrea; Strassburger, Klaus; Stahl-Pehe, Anna; Rosenbauer, Joachim] Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany; [Icks, Andrea] Univ Dusseldorf, Fac Med, Dept Publ Hlth, D-40225 Dusseldorf, Germany; [Flechtner-Mors, Marion; Hungele, Andreas; Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Beyer, Peter] Evangel Krankenhaus, Clin Children & Adolescents, Oberhausen, Germany; [Placzek, Kerstin] Univ Halle Wittenberg, Univ Hosp, D-06108 Halle, Germany; [Schumacher, Andrea] Klin Eichert, Clin Child & Adolescent Med, Goppingen, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ulm University; Martin Luther University Halle Wittenberg	Bachle, C (corresponding author), Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany.	christina.baechle@ddz.uni-duesseldorf.de		Holl, Reinhard/0000-0003-1395-4842	Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research [FKZ 01GI0802, 01GI1109A, 01GI0859, 01GI1106]; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia; European Foundation for the Study of Diabetes (EFSD); Dr. Burger-Busing Foundation; Novo Nordisk Germany	Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia; European Foundation for the Study of Diabetes (EFSD); Dr. Burger-Busing Foundation; Novo Nordisk Germany(Novo Nordisk)	This study was supported by the Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research (www.kompetenznetz-diabetes-mellitus.net/index.php/en; FKZ 01GI0802, 01GI1109A, 01GI0859, 01GI1106). The German Diabetes Center is institutionally funded by the German Ministry of Health and the Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia. The DPV initiative is supported by the European Foundation for the Study of Diabetes (EFSD), the Dr. Burger-Busing Foundation, and by a research grant of Novo Nordisk Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachle CC, 2012, DIABETIC MED, V29, P1327, DOI 10.1111/j.1464-5491.2012.03645.x; Ballesta Garcia M J, 2005, Rev Clin Esp, V205, P523; Busch K, 2007, GKV VERSICHERTE NACH; Chodick Gabriel, 2005, Eur J Health Econ, V6, P166, DOI 10.1007/s10198-004-0269-7; Colagiuri S, 2009, DIABCO T AUSTR TYPE; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Dost A, 2008, DIABETES CARE, V31, P720, DOI 10.2337/dc07-0824; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Govan L, 2011, DIABETOLOGIA, V54, P2000, DOI 10.1007/s00125-011-2176-7; Grulich-Henn J, 2010, DIABETIC MED, V27, P709, DOI 10.1111/j.1464-5491.2010.02965.x; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Icks A, 2004, EXP CLIN ENDOCR DIAB, V112, P302, DOI 10.1055/s-2004-820909; Johnson JA, 2006, DIABETES CARE, V29, P2403, DOI 10.2337/dc06-0735; Jonsson PM, 2000, DIABETES RES CLIN PR, V50, P35, DOI 10.1016/S0168-8227(00)00161-3; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P836, DOI 10.1007/s00103-007-0247-1; Karges B, 2011, KLIN PADIATR, V223, P70, DOI 10.1055/s-0030-1269884; KILPATRICK ES, 1994, BMJ-BRIT MED J, V309, P983, DOI 10.1136/bmj.309.6960.983; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Koster I, 2006, DEUT MED WOCHENSCHR, V131, P804, DOI 10.1055/s-2006-939850; Krishnan S, 2012, GENDER MED, V9, P251, DOI 10.1016/j.genm.2012.05.003; Marshall SM, 2000, ANN CLIN BIOCHEM, V37, P45, DOI 10.1258/0004563001901506; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; Neu A, 2009, DIABETES CARE, V32, P1647, DOI 10.2337/dc09-0553; Nishimura R, 2003, AM J KIDNEY DIS, V42, P117, DOI 10.1016/S0272-6386(03)00414-1; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Raile K, 2007, DIABETES CARE, V30, P2523, DOI 10.2337/dc07-0282; Rewers M, 2009, PEDIATR DIABETES, V10, P71, DOI 10.1111/j.1399-5448.2009.00582.x; Rosenbauer J, 1999, DIABETOLOGIA, V42, P1055, DOI 10.1007/s001250051270; Rosenbauer J, 2010, DIABETOLOGE, V6, P177, DOI 10.1007/s11428-009-0497-7; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soltesz G, 2009, DIABETES YOUNG GLOBA; Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501; Tao BT, 2010, ENDOCRIN METAB CLIN, V39, P499, DOI 10.1016/j.ecl.2010.05.004; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; von Ferber L, 2007, EXP CLIN ENDOCR DIAB, V115, P97, DOI 10.1055/s-2007-949152; Wirehn AB, 2008, DIABETIC MED, V25, P732, DOI 10.1111/j.1464-5491.2008.02444.x; Ying AK, 2011, PEDIATR DIABETES, V12, P177, DOI 10.1111/j.1399-5448.2010.00680.x; Zhang P, 2007, EXPERT OPIN PHARMACO, V8, P49, DOI 10.1517/14656566.8.1.49; Ziegler R, 2011, PEDIATR DIABETES, V12, P11, DOI 10.1111/j.1399-5448.2010.00650.x	47	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70567	10.1371/journal.pone.0070567	http://dx.doi.org/10.1371/journal.pone.0070567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967077	Green Published, Green Submitted, gold			2022-12-27	WOS:000323115800007
J	Jiang, Y; Zou, L; Lu, WQ; Zhang, Y; Shen, AG				Jiang, Ying; Zou, Lin; Lu, Wei-Qi; Zhang, Yong; Shen, Ai-Guo			Foxo3a Expression Is a Prognostic Marker in Breast Cancer	PLOS ONE			English	Article								The forkhead box transcription factor Foxo3a has been implicated to play a critical role in various cancers by suppressing tumor growth. Recent studies have identified Foxo3a as a key regulator of Estrogen Receptor-alpha (ER alpha). In the present study, we examined the expression of Foxo3a, and investigated its clinical significance and correlation with ER and prognostic role in patients with breast cancer. Immunohistochemical analysis was performed on tumors from 70 breast cancer patients. Interpretable Foxo3a expression was analyzed along with major clinicopathologic variables, and a comparison was made with corresponding 5-year clinical follow-up data. Foxo3a protein expression correlated with ER positivity (P < 0.001), histologic grade (1, 2) (P = 0.002), axillary lymph node negativity (P < 0.001) and TNM stage (1, 2) (P < 0.001). Moreover, the Kaplan-Meier survival curves of the study population showed that a high expression level of Foxo3a was significantly correlated with long-term survival (P < 0.0001). In a multivariate analysis, Foxo3a expression was identified as a favorable independent prognostic factor in overall survival (P = 0.038). In conclusion, our results indicated that Foxo3a expression is a favorable prognostic marker in breast cancer. In addition, Foxo3a staining could potentially be used in patient stratification in conjunction with other prognostic markers.	[Jiang, Ying; Lu, Wei-Qi; Zhang, Yong] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Jiang, Ying] Nantong Univ, Affiliated Hosp, Dept Gen Surg, Nantong, Jiangsu, Peoples R China; [Zou, Lin] Nantong Univ, Peoples Hosp Yancheng 1, Dept Pathol, Yancheng, Jiangsu, Peoples R China; [Shen, Ai-Guo] Nantong Univ, Dept Pathol, Nantong, Peoples R China	Fudan University; Nantong University; Nantong University; Nantong University	Jiang, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	jiangyzs@163.com; luwqzs@yeah.net		Jiang, Ying/0000-0002-2644-3964	National Natural Science Foundation of China [30972937]; Specialized Research Fund for the Doctoral Program of Higher Education [20070246131]; Natural Science Foundation of Jiangsu province [BK2006546]; Jiangsu "six personnel peak'' talent-funded projects [2006113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Jiangsu "six personnel peak'' talent-funded projects	This work was supported by the National Natural Science Foundation of China (No. 30972937); Specialized Research Fund for the Doctoral Program of Higher Education (for new teachers, No. 20070246131); Natural Science Foundation of Jiangsu province (No. BK2006546); and Jiangsu "six personnel peak'' talent-funded projects (No. 2006113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; ALGHANEM AA, 1986, J SURG ONCOL, V31, P218, DOI 10.1002/jso.2930310317; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Allred DC, 1998, MODERN PATHOL, V11, P155; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chappuis PO, 2005, ANN ONCOL, V16, P735, DOI 10.1093/annonc/mdi149; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Christinat A, 2013, J THORAC DIS, V5, pS36, DOI 10.3978/j.issn.2072-1439.2013.05.25; CLARK GM, 1983, BREAST CANCER RES TR, V3, pS69, DOI 10.1007/BF01855130; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Esteva FJ, 2002, SEMIN RADIAT ONCOL, V12, P319, DOI 10.1053/srao.2002.35251; FUQUA SAW, 1993, J CELL BIOCHEM, V51, P135, DOI 10.1002/jcb.240510204; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197, DOI 10.1200/JCO.1996.14.8.2197; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ishikawa T, 2012, J THORAC DIS, V4, P650, DOI 10.3978/j.issn.2072-1439.2012.10.17; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Leake R, 1999, J Epidemiol Biostat, V4, P129; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Simpson JF, 2000, J CLIN ONCOL, V18, P2059, DOI 10.1200/JCO.2000.18.10.2059; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Ticchioni M, 2007, ONCOGENE, V26, P7081, DOI 10.1038/sj.onc.1210519; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	44	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70746	10.1371/journal.pone.0070746	http://dx.doi.org/10.1371/journal.pone.0070746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967095	gold, Green Submitted, Green Published			2022-12-27	WOS:000323115800018
J	Secrier, M; Schneider, R				Secrier, Maria; Schneider, Reinhard			PhenoTimer: Software for the Visual Mapping of Time-Resolved Phenotypic Landscapes	PLOS ONE			English	Article							NETWORK INTEGRATION; CELL-CYCLE; GENE; VISUALIZATION; IDENTIFICATION; DATABASE; GENOME; CHIP; TOOL; INFORMATION	Timing common and specific modulators of disease progression is crucial for treatment, but the understanding of the underlying complex system of interactions is limited. While attempts at elucidating this experimentally have produced enormous amounts of phenotypic data, tools that are able to visualize and analyze them are scarce and the insight obtained from the data is often unsatisfactory. Linking and visualizing processes from genes to phenotypes and back, in a temporal context, remains a challenge in systems biology. We introduce PhenoTimer, a 2D/3D visualization tool for the mapping of time-resolved phenotypic links in a genetic context. It uses a novel visualization approach for relations between morphological defects, pathways or diseases, to enable fast pattern discovery and hypothesis generation. We illustrate its capabilities of tracing dynamic motifs on cell cycle datasets that explore the phenotypic order of events upon perturbations of the system, transcriptional activity programs and their connection to disease. By using this tool we are able to fine-grain regulatory programs for individual time points of the cell cycle and better understand which patterns arise when these programs fail. We also illustrate a way to identify common mechanisms of misregulation in diseases and drug abuse.	[Secrier, Maria; Schneider, Reinhard] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Schneider, Reinhard] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Bioinformat Core Facil, Esch Sur Alzette, Luxembourg	European Molecular Biology Laboratory (EMBL); University of Luxembourg	Secrier, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	secrier@embl.de	Schneider, Reinhard/C-5441-2009	Schneider, Reinhard/0000-0002-8278-1618; Secrier, Maria/0000-0003-2758-1741	TAMAHUD [LSHC-CT-2007-037472]; FORSYS-ViroQuant; EMBL PhD Program	TAMAHUD; FORSYS-ViroQuant; EMBL PhD Program	This work was supported by TAMAHUD (LSHC-CT-2007-037472) and FORSYS-ViroQuant. MS was supported by the EMBL PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Cho YS, 2012, BIOORGAN MED CHEM, V20, P1922, DOI 10.1016/j.bmc.2011.11.021; Curtis RE, 2011, BIOINFORMATICS, V27, P1880, DOI 10.1093/bioinformatics/btr273; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hitchler MJ, 2011, METHODS MOL BIOL, V767, P253, DOI 10.1007/978-1-61779-201-4_19; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Kincaid R, 2008, BIOINFORMATICS, V24, P2112, DOI 10.1093/bioinformatics/btn368; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lefrancois P, 2010, METHOD ENZYMOL, V470, P77, DOI 10.1016/S0076-6879(10)70004-5; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Leushacke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023381; Longabaugh WJR, 2012, METHODS MOL BIOL, V786, P359, DOI 10.1007/978-1-61779-292-2_21; MacArthur BD, 2010, BIOINFORMATICS, V26, P143, DOI 10.1093/bioinformatics/btp628; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Pavlopoulos GA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-104; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Safran M, 2010, GENECARDS VERSION 3, V2010; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schwartz WJ, 2000, NEUROSCIENCE, V98, P535, DOI 10.1016/S0306-4522(00)00140-8; Secrier M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-45; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tominski C, 2008, IEEE INT CONF INF VI, P120, DOI 10.1109/IV.2008.23; Tory M, 2006, IEEE T VIS COMPUT GR, V12, P2, DOI 10.1109/TVCG.2006.17; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72361	10.1371/journal.pone.0072361	http://dx.doi.org/10.1371/journal.pone.0072361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951317	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300194
J	Shen, ZY; Chen, L; Hong, Q; Xie, H; Qiu, JL; Liu, RM				Shen, Zhenyao; Chen, Lei; Hong, Qian; Xie, Hui; Qiu, Jiali; Liu, Ruimin			Vertical Variation of Nonpoint Source Pollutants in the Three Gorges Reservoir Region	PLOS ONE			English	Article							SOURCE POLLUTION; PARAMETER UNCERTAINTY; SOURCE NITROGEN; UPPER REACH; MODEL; SEDIMENT; IMPACTS; AREA; PHOSPHORUS; MANAGEMENT	Nonpoint source (NPS) pollution is considered the main reason for water deterioration, but there has been no attempt to incorporate vertical variations of NPS pollution into watershed management, especially in mountainous areas. In this study, the vertical variations of pollutant yields were explored in the Three Gorges Reservoir Region (TGRR) and the relationships between topographic attributes and pollutant yields were established. Based on our results, the pollutant yields decreased significantly from low altitude to median altitude and leveled off rapidly from median altitude to high altitude, indicating logarithmic relationships between pollutant yields and altitudes. The pollutant yields peaked at an altitude of 200-500 m, where agricultural land and gentle slopes (0-8 degrees) are concentrated. Unlike the horizontal distributions, these vertical variations were not always related to precipitation patterns but did vary obviously with land uses and slopes. This paper also indicates that altitude data and proportions of land use could be a reliable estimate of NPS yields at different altitudes, with significant implications for land use planning and watershed management.	[Shen, Zhenyao; Chen, Lei; Hong, Qian; Xie, Hui; Qiu, Jiali; Liu, Ruimin] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University	Shen, ZY (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	zyshen@bnu.edu.cn	Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Shen, Zhenyao/0000-0002-6620-1943; Xie, Hui/0000-0002-8648-0177	National Science Foundation for Distinguished Young Scholars [51025933]; National Science Foundation for Innovative Research Group [51121003]; National Basic Research Program of China (973 Project) [2010CB429003]	National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation for Innovative Research Group; National Basic Research Program of China (973 Project)(National Basic Research Program of China)	The study was supported by the National Science Foundation for Distinguished Young Scholars (No. 51025933), the National Science Foundation for Innovative Research Group (No. 51121003) and the National Basic Research Program of China (973 Project, 2010CB429003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour K.C., 2008, SWAT CUP2 SWAT CALIB; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; BICKNELL BR, 1993, EPA600R93174 ENV RES; Bingner R, 2001, ANNAGNPS TECHN UNPUB; Brown L.C., 1987, ENHANCED STREAM WATE; Bryan BA, 2003, LANDSCAPE URBAN PLAN, V65, P237, DOI 10.1016/S0169-2046(03)00059-8; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Ding XW, 2010, J HYDROL, V383, P233, DOI 10.1016/j.jhydrol.2009.12.039; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Dowd BM, 2008, AGR ECOSYST ENVIRON, V128, P151, DOI 10.1016/j.agee.2008.05.014; Ghimire M, 2011, NAT HAZARDS, V56, P299, DOI 10.1007/s11069-010-9569-7; Guo SL, 2002, J HYDROL, V268, P1, DOI 10.1016/S0022-1694(02)00075-6; Hauck M, 2012, ENVIRON POLLUT, V164, P132, DOI 10.1016/j.envpol.2012.01.026; Hong Q, 2012, INT J ENVIRON SCI TE, V9, P595, DOI 10.1007/s13762-012-0094-y; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Li QF, 2011, J HYDROL, V403, P224, DOI 10.1016/j.jhydrol.2011.03.043; Lin KR, 2010, J HYDROL, V394, P370, DOI 10.1016/j.jhydrol.2010.09.012; Livne E, 2011, INT J GEOGR INF SCI, V25, P473, DOI 10.1080/13658816.2010.517752; Ma X, 2011, SCI TOTAL ENVIRON, V412, P154, DOI 10.1016/j.scitotenv.2011.09.034; Moreau-Guigon E, 2007, ENVIRON SCI TECHNOL, V41, P2172, DOI 10.1021/es062705s; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nelson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038558; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Ouyang W, 2010, SCI TOTAL ENVIRON, V408, P1358, DOI 10.1016/j.scitotenv.2009.10.062; Pourghasemi HR, 2012, CATENA, V97, P71, DOI 10.1016/j.catena.2012.05.005; Shen ZY, 2012, HYDROL EARTH SYST SC, V16, P121, DOI 10.5194/hess-16-121-2012; Shen ZY, 2010, SCI TOTAL ENVIRON, V408, P1971, DOI 10.1016/j.scitotenv.2009.12.007; Shen ZY, 2013, J HAZARD MATER, V252, P45, DOI 10.1016/j.jhazmat.2013.02.039; Shen ZY, 2013, STOCH ENV RES RISK A, V27, P235, DOI 10.1007/s00477-012-0579-8; Shen ZY, 2012, J HYDROL, V472, P205, DOI 10.1016/j.jhydrol.2012.09.019; Shen ZY, 2011, SEP PURIF TECHNOL, V9, P595; Shi ZH, 2012, J HYDROL, V438, P156, DOI 10.1016/j.jhydrol.2012.03.016; Short JS, 2012, ENVIRON SCI TECHNOL, V46, P1316, DOI 10.1021/es2020499; Somura H, 2012, J HYDROL, V450, P25, DOI 10.1016/j.jhydrol.2012.05.032; USDA-SCS, 1972, SOIL CONS SERV NAT E; Williams J.R., 1969, T ASAE, V12, P100, DOI DOI 10.13031/2013.38772; Wong MS, 2009, SENSORS-BASEL, V9, P4380, DOI 10.3390/s90604380; Woznicki SA, 2011, T ASABE, V54, P171; Wu JX, 2009, AGR ECOSYST ENVIRON, V129, P523, DOI 10.1016/j.agee.2008.11.008; Wu S, 2008, WATER RESOUR MANAG, V22, P959, DOI 10.1007/s11269-007-9204-x; Xu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039762; YOUNG RA, 1989, J SOIL WATER CONSERV, V44, P168; Zhang QF, 2011, ENVIRON SCI POLICY, V14, P1132, DOI 10.1016/j.envsci.2011.07.008	43	15	18	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71194	10.1371/journal.pone.0071194	http://dx.doi.org/10.1371/journal.pone.0071194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951110	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300099
J	Xiong, ZQ; Tu, XR; Wei, SJ; Huang, L; Li, XH; Lu, H; Tu, GQ				Xiong, Zhi-Qiang; Tu, Xiao-Rong; Wei, Sai-Jin; Huang, Lin; Li, Xun-Hang; Lu, Hui; Tu, Guo-Quan			The Mechanism of Antifungal Action of a New Polyene Macrolide Antibiotic Antifungalmycin 702 from Streptomyces padanus JAU4234 on the Rice Sheath Blight Pathogen Rhizoctonia solani	PLOS ONE			English	Article							FUNGICHROMIN	Antifungalmycin 702, a new polyene macrolide antibiotic produced by Streptomyces padanus JAU4234, has a broad antifungal activity and may have potential future agricultural and/or clinical applications. However, the mechanism of antifungal action of antifungalmycin 702 remains unknown. Antifungalmycin 702 strongly inhibited mycelial growth and sclerotia formation/germination of Rhizoctonia solani. When treated with antifungalmycin 702, the hyphae morphology of R. solani became more irregular. The membrane and the cellular organelles were disrupted and there were many vacuoles in the cellular space. The lesion in the plasma membrane was detected through the increase of membrane permeability, lipid peroxidation and leakage of cell constituents. In summary, antifungalmycin 702 may exert its antifungal activity against R. solani by changing the structure of cell membranes and the cytoskeleton and interacting with the organelles.	[Tu, Xiao-Rong; Wei, Sai-Jin; Huang, Lin; Li, Xun-Hang; Lu, Hui; Tu, Guo-Quan] Jiangxi Agr Univ, Coll Biosci & Bioengn, Nanchang, Peoples R China; [Xiong, Zhi-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiong, ZQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China.	zhqxiong@sibs.ac.cn; tuguoquan@263.net		Xiong, Zhi-Qiang/0000-0002-7984-3662	National Natural Science Foundation of China [30960011, 31071724]; Natural Science Foundation of Jiangxi Province, China [2009GZN0030, 2010GZN0037]; Key Technology R&D Program of Jiangxi Province, China [2007BN14002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province, China(Natural Science Foundation of Jiangxi Province); Key Technology R&D Program of Jiangxi Province, China	This work was supported by the National Natural Science Foundation of China (grants no. 30960011 and 31071724), Natural Science Foundation of Jiangxi Province, China (grants no. 2009GZN0030 and 2010GZN0037) and Key Technology R&D Program of Jiangxi Province, China (grant no. 2007BN14002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Chen XL, 2011, J ANTIBIOT, V64, P563, DOI 10.1038/ja.2011.55; Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i; GALE EF, 1984, MACROLIDE ANTIBIOTIC, P425; Hoster F, 2005, APPL MICROBIOL BIOT, V66, P434, DOI 10.1007/s00253-004-1664-9; Liu H, 2012, BIOTECHNOL LETT, V34, P2291, DOI 10.1007/s10529-012-1035-z; Liu J, 2010, CURR MICROBIOL, V61, P274, DOI 10.1007/s00284-010-9607-4; MULKS MH, 1990, ANTIMICROB AGENTS CH, V34, P1762, DOI 10.1128/AAC.34.9.1762; OMURA S, 1984, MACROLIDE ANTIBIOTIC, P351; Shih HD, 2003, J AGR FOOD CHEM, V51, P95, DOI 10.1021/jf025879b; Stodulkova E, 2011, J ANTIBIOT, V64, P717, DOI 10.1038/ja.2011.81; Tian J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030147, 10.1371/journal.pone.0035164]; Xiong ZQ, 2012, APPL ENVIRON MICROB, V78, P589, DOI 10.1128/AEM.06561-11; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zheng LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032033	16	15	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73884	10.1371/journal.pone.0073884	http://dx.doi.org/10.1371/journal.pone.0073884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951364	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300209
J	Hindle, AG; Martin, SL				Hindle, Allyson G.; Martin, Sandra L.			Cytoskeletal Regulation Dominates Temperature-Sensitive Proteomic Changes of Hibernation in Forebrain of 13-Lined Ground Squirrels	PLOS ONE			English	Article							MICROTUBULE CATASTROPHE; MAMMALIAN HIBERNATION; NEURONAL PLASTICITY; RYANODINE RECEPTORS; PROTEIN; BRAIN; AROUSAL; METABOLISM; MODULATION; MECHANISMS	13-lined ground squirrels, Ictidomys tridecemlineatus, are obligate hibernators that transition annually between summer homeothermy and winter heterothermy - wherein they exploit episodic torpor bouts. Despite cerebral ischemia during torpor and rapid reperfusion during arousal, hibernator brains resist damage and the animals emerge neurologically intact each spring. We hypothesized that protein changes in the brain underlie winter neuroprotection. To identify candidate proteins, we applied a sensitive 2D gel electrophoresis method to quantify protein differences among forebrain extracts prepared from ground squirrels in two summer, four winter and fall transition states. Proteins that differed among groups were identified using LC-MS/MS. Only 84 protein spots varied significantly among the defined states of hibernation. Protein changes in the forebrain proteome fell largely into two reciprocal patterns with a strong body temperature dependence. The importance of body temperature was tested in animals from the fall; these fall animals use torpor sporadically with body temperatures mirroring ambient temperatures between 4 and 21 degrees C as they navigate the transition between summer homeothermy and winter heterothermy. Unlike cold-torpid fall ground squirrels, warm-torpid individuals strongly resembled the homeotherms, indicating that the changes observed in torpid hibernators are defined by body temperature, not torpor per se. Metabolic enzymes were largely unchanged despite varied metabolic activity across annual and torpor-arousal cycles. Instead, the majority of the observed changes were cytoskeletal proteins and their regulators. While cytoskeletal structural proteins tended to differ seasonally, i.e., between summer homeothermy and winter heterothermy, their regulatory proteins were more strongly affected by body temperature. Changes in the abundance of various isoforms of the microtubule assembly and disassembly regulatory proteins dihydropyrimidinase-related protein and stathmin suggested mechanisms for rapid cytoskeletal reorganization on return to euthermy during torpor-arousal cycles.	[Hindle, Allyson G.; Martin, Sandra L.] Univ Colorado, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Hindle, AG (corresponding author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.	allyson.hindle@ucdenver.edu			National Institutes of Health [HL-089049, P30 CA-046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-089049 to S. L. Martin and P30 CA-046934 to the Mass Spectrometry and Proteomics Core Facility of the Univ. Colorado Cancer Center, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Diaz-Uriarte R., 2010, VARSELRF VARIABLE SE; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1; Epperson LE, 2010, J COMP PHYSIOL B, V180, P599, DOI 10.1007/s00360-009-0422-9; Farrell EF, 2003, J BIOL CHEM, V278, P34660, DOI 10.1074/jbc.M305931200; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1999, ACT NEUR S, V73, P57; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Grabek KR, 2011, PHYSIOL GENOMICS, V43, P1263, DOI 10.1152/physiolgenomics.00125.2011; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Hindle AG, 2011, AM J PHYSIOL-REG I, V301, pR1440, DOI 10.1152/ajpregu.00298.2011; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; Lokuta AJ, 1997, J BIOL CHEM, V272, P25333, DOI 10.1074/jbc.272.40.25333; Lyman C.P., 1982, HIBERNATION TORPOR M; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Martin SL, 2008, AM J PHYSIOL-REG I, V295, pR316, DOI 10.1152/ajpregu.00418.2007; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; PENGELLEY E, 1961, CAN J ZOOLOG, V39, P105, DOI 10.1139/z61-013; Pickel VM, 1997, J COMP NEUROL, V386, P625, DOI 10.1002/(SICI)1096-9861(19971006)386:4<625::AID-CNE8>3.0.CO;2-4; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; R Development Core Team, 2012, R LANG ENV STAT COMP; Roelandse M, 2004, J NEUROSCI, V24, P7843, DOI 10.1523/JNEUROSCI.2872-04.2004; Russell RL, 2010, J COMP PHYSIOL B, V180, P1165, DOI 10.1007/s00360-010-0484-8; Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Schwartz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058427; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; van Breukelen F, 2002, J APPL PHYSIOL, V92, P2640, DOI 10.1152/japplphysiol.01007.2001; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yan J, 2008, PHYSIOL GENOMICS, V32, P170, DOI 10.1152/physiolgenomics.00075.2007; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729	59	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71627	10.1371/journal.pone.0071627	http://dx.doi.org/10.1371/journal.pone.0071627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951209	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200062
J	Li, XY; Chen, YT; Josson, S; Mukhopadhyay, NK; Kim, J; Freeman, MR; Huang, WC				Li, Xiangyan; Chen, Yi-Ting; Josson, Sajni; Mukhopadhyay, Nishit K.; Kim, Jayoung; Freeman, Michael R.; Huang, Wen-Chin			MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; ELEMENT-BINDING PROTEINS; ANDROGEN RECEPTOR; CHOLESTEROL-SYNTHESIS; KINASE-A; PROGRESSION; ACTIVATION; EXPRESSION; LIPOGENESIS; GROWTH	MicroRNA (miRNA or miR) inhibition of oncogenic related pathways has been shown to be a promising therapeutic approach for cancer. Aberrant lipid and cholesterol metabolism is involved in prostate cancer development and progression to end-stage disease. We recently demonstrated that a key transcription factor for lipogenesis, sterol regulatory element-binding protein-1 (SREBP-1), induced fatty acid and lipid accumulation and androgen receptor (AR) transcriptional activity, and also promoted prostate cancer cell growth and castration resistance. SREBP-1 was overexpressed in human prostate cancer and castration-resistant patient specimens. These experimental and clinical results indicate that SREBP-1 is a potential oncogenic transcription factor in prostate cancer. In this study, we identified two miRNAs, miR-185 and 342, that control lipogenesis and cholesterogenesis in prostate cancer cells by inhibiting SREBP-1 and 2 expression and downregulating their targeted genes, including fatty acid synthase (FASN) and 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR). Both miR-185 and 342 inhibited tumorigenicity, cell growth, migration and invasion in prostate cancer cell culture and xenograft models coincident with their blockade of lipogenesis and cholesterogenesis. Intrinsic miR-185 and 342 expression was significantly decreased in prostate cancer cells compared to non-cancerous epithelial cells. Restoration of miR-185 and 342 led to caspase-dependent apoptotic death in prostate cancer cells. The newly identified miRNAs, miR-185 and 342, represent a novel targeting mechanism for prostate cancer therapy.	[Li, Xiangyan; Chen, Yi-Ting; Josson, Sajni; Huang, Wen-Chin] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mukhopadhyay, Nishit K.; Kim, Jayoung; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Surg, Canc Biol Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mukhopadhyay, Nishit K.; Kim, Jayoung; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Med, Canc Biol Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mukhopadhyay, Nishit K.; Kim, Jayoung; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Biomed Sci, Canc Biol Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Huang, WC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	wen-chin.huang@cshs.org	Huang, Wen-Chin/X-5879-2019; Chen, Yi/HIR-2608-2022	Huang, Wen-Chin/0000-0003-2342-9099	Department of Defense [W81XWH-08-1-0321]; Cedars-Sinai Garber Awards for Cancer Science (WCH); NATIONAL CANCER INSTITUTE [R01CA143777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Cedars-Sinai Garber Awards for Cancer Science (WCH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Department of Defense (W81XWH-08-1-0321) and the Cedars-Sinai Garber Awards for Cancer Science (WCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Di Vizio D, 2008, TUMORI J, V94, P633; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Henry JC, 2011, PHARM RES-DORDR, V28, P3030, DOI 10.1007/s11095-011-0548-9; Hime GR, 2009, CELL ADHES MIGR, V3, P425, DOI 10.4161/cam.3.4.9913; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Huang WC, 2008, CLIN CANCER RES, V14, P5341, DOI 10.1158/1078-0432.CCR-08-0793; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Huang WC, 2010, J BIOL CHEM, V285, P7947, DOI 10.1074/jbc.M109.092759; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nomura T, 2006, CLIN CANCER RES, V12, P7294, DOI 10.1158/1078-0432.CCR-06-2060; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Saini S, 2011, CANCER RES, V71, P6208, DOI 10.1158/0008-5472.CAN-11-0073; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Taplin ME, 2008, EXPERT REV ANTICANC, V8, P1495, DOI 10.1586/14737140.8.9.1495; Thalmann GN, 2000, PROSTATE, V44, P91; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036	55	93	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70987	10.1371/journal.pone.0070987	http://dx.doi.org/10.1371/journal.pone.0070987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951060	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200028
J	Hobbs, JPA; Frisch, AJ; Ford, BM; Thums, M; Saenz-Agudelo, P; Furby, KA; Berumen, ML				Hobbs, Jean-Paul A.; Frisch, Ashley J.; Ford, Benjamin M.; Thums, Michele; Saenz-Agudelo, Pablo; Furby, Kathryn A.; Berumen, Michael L.			Taxonomic, Spatial and Temporal Patterns of Bleaching in Anemones Inhabited by Anemonefishes	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; SCLERACTINIAN CORALS; CLIMATE-CHANGE; SEA-ANEMONES; THERMAL-STRESS; HOST; GROWTH; REPRODUCTION; MORTALITY	Background: Rising sea temperatures are causing significant destruction to coral reef ecosystems due to coral mortality from thermally-induced bleaching (loss of symbiotic algae and/or their photosynthetic pigments). Although bleaching has been intensively studied in corals, little is known about the causes and consequences of bleaching in other tropical symbiotic organisms. Methodology/Principal Findings: This study used underwater visual surveys to investigate bleaching in the 10 species of anemones that host anemonefishes. Bleaching was confirmed in seven anemone species (with anecdotal reports of bleaching in the other three species) at 10 of 19 survey locations spanning the Indo-Pacific and Red Sea, indicating that anemone bleaching is taxonomically and geographically widespread. In total, bleaching was observed in 490 of the 13,896 surveyed anemones (3.5%); however, this percentage was much higher (19-100%) during five major bleaching events that were associated with periods of elevated water temperatures and coral bleaching. There was considerable spatial variation in anemone bleaching during most of these events, suggesting that certain sites and deeper waters might act as refuges. Susceptibility to bleaching varied between species, and in some species, bleaching caused reductions in size and abundance. Conclusions/Significance: Anemones are long-lived with low natural mortality, which makes them particularly vulnerable to predicted increases in severity and frequency of bleaching events. Population viability will be severely compromised if anemones and their symbionts cannot acclimate or adapt to rising sea temperatures. Anemone bleaching also has negative effects to other species, particularly those that have an obligate relationship with anemones. These effects include reductions in abundance and reproductive output of anemonefishes. Therefore, the future of these iconic and commercially valuable coral reef fishes is inextricably linked to the ability of host anemones to cope with rising sea temperatures associated with climate change.	[Hobbs, Jean-Paul A.; Ford, Benjamin M.; Thums, Michele] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Hobbs, Jean-Paul A.; Ford, Benjamin M.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Hobbs, Jean-Paul A.; Thums, Michele] Australian Inst Marine Sci, Oceans Inst, Perth, WA, Australia; [Frisch, Ashley J.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Thums, Michele] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Thums, Michele] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Saenz-Agudelo, Pablo; Berumen, Michael L.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Berumen, Michael L.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; James Cook University; University of Western Australia; University of Western Australia; King Abdullah University of Science & Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution	Hobbs, JPA (corresponding author), Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia.	jean-paul.hobbs@uwa.edu.au	Berumen, Michael L/F-7745-2011; Hobbs, Jean-Paul/I-8743-2012; Thums, Michele/A-3850-2013	Berumen, Michael L/0000-0003-2463-2742; Hobbs, Jean-Paul/0000-0003-0331-354X; Thums, Michele/0000-0002-8669-8440; Saenz-Agudelo, Pablo/0000-0001-8197-2861	Red Sea Research Center at the King Abdullah University of Science and Technology (KAUST); ARC Centre of Excellence for Coral Reef Studies; National Science Foundation [OCE 0424688]; Coral Reef Initiatives for the Pacific (CRISP); TOTAL Foundation; Populations Fractionees et Insulares (PPF EPHE); Connectivity Working Group of the Global University of Queensland - World Bank - Global Environmental Facility Project; Coral Reef Target Research and Capacity Building for Management; Great Barrier Reef Marine Park Authority; Australian Government Department of Sustainability, Environment, Water, Population and Communities; UWA-AIMS-CSIRO fellowship	Red Sea Research Center at the King Abdullah University of Science and Technology (KAUST); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); Coral Reef Initiatives for the Pacific (CRISP); TOTAL Foundation(Total SA); Populations Fractionees et Insulares (PPF EPHE); Connectivity Working Group of the Global University of Queensland - World Bank - Global Environmental Facility Project; Coral Reef Target Research and Capacity Building for Management; Great Barrier Reef Marine Park Authority; Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); UWA-AIMS-CSIRO fellowship	This work was supported by funding from the Red Sea Research Center at the King Abdullah University of Science and Technology (KAUST), The ARC Centre of Excellence for Coral Reef Studies, the National Science Foundation (OCE 0424688), the Coral Reef Initiatives for the Pacific (CRISP), the TOTAL Foundation, Populations Fractionees et Insulares (PPF EPHE), the Connectivity Working Group of the Global University of Queensland - World Bank - Global Environmental Facility Project, Coral Reef Target Research and Capacity Building for Management, Great Barrier Reef Marine Park Authority, and the Australian Government Department of Sustainability, Environment, Water, Population and Communities. J-P Hobbs is supported by a UWA-AIMS-CSIRO fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Gerald R., 2010, Aqua, V16, P129; Allen Gerald R., 2008, Aqua (Miradolo Terme), V14, P105; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bridge T, 2012, CORAL REEFS, V31, P1057, DOI 10.1007/s00338-012-0916-x; Brown BE, 1997, CORAL REEFS, V16, P129; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chadwick N.E., 2008, IMPROBABLE GULF HIST, P209, DOI [10.1016/j.anbehav.2009.06.001, DOI 10.1016/J.ANBEHAV.2009.06.001]; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Edmunds PJ, 2005, OECOLOGIA, V146, P350, DOI 10.1007/s00442-005-0210-5; Edmunds PJ, 2003, CORAL REEFS, V22, P54, DOI 10.1007/s00338-003-0278-5; Fautin D. G., 1992, FIELD GUIDE ANEMONEF; Frisch AJ, 2009, RES PUBLICATION GREA, V94; Furby KA, 2013, CORAL REEFS, V32, P505, DOI 10.1007/s00338-012-0998-5; Gates RD, 2011, J EXP MAR BIOL ECOL, V408, P94, DOI 10.1016/j.jembe.2011.07.029; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hattori A, 2005, ICHTHYOL RES, V52, P57, DOI 10.1007/s10228-004-0253-3; Hattori A, 2002, J ANIM ECOL, V71, P824, DOI 10.1046/j.1365-2656.2002.00649.x; Hill R, 2012, CORAL REEFS, V31, P273, DOI 10.1007/s00338-011-0848-x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Huebner LK, 2012, MAR ECOL PROG SER, V464, P1, DOI 10.3354/meps09964; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iluz David, 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/281038; Kai S, 2008, MAR ECOL PROG SER, V354, P133, DOI 10.3354/meps07216; Kerswell AP, 2003, MAR ECOL PROG SER, V253, P145, DOI 10.3354/meps253145; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2009, ENVIRON MANAGE, V44, P1, DOI 10.1007/s00267-009-9295-7; McClanahan T. R., 2009, V205, P121; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Oliver J, 2004, GLOBAL PROTOCOL ASSE; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Development Core Team, 2012, R LANG ENV STAT COMP; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Saenz-Agudelo P, 2011, CORAL REEFS, V30, P497, DOI 10.1007/s00338-010-0716-0; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sebastian CR, 2009, MAR BIOL, V156, P2049, DOI 10.1007/s00227-009-1236-8; Shuman CS, 2005, CORAL REEFS, V24, P564, DOI 10.1007/s00338-005-0027-z; Srinivasan M, 1999, MAR ECOL PROG SER, V186, P283, DOI 10.3354/meps186283; Turton C, 2007, TENDING OUR REEFS RE; van Woesik R, 2012, CORAL REEFS, V31, P633, DOI 10.1007/s00338-012-0911-2; Ward S., 2002, P1123; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037	60	42	47	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70966	10.1371/journal.pone.0070966	http://dx.doi.org/10.1371/journal.pone.0070966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951056	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000323124000035
J	Nishi, H; Arai, H; Momiyama, T				Nishi, Haruhisa; Arai, Hirokazu; Momiyama, Toshihiko			NCI-H295R, a Human Adrenal Cortex-Derived Cell Line, Expresses Purinergic Receptors Linked to Ca2+-Mobilization/Influx and Cortisol Secretion	PLOS ONE			English	Article							ADRENOCORTICAL-FASCICULATA CELLS; GLOMERULOSA CELLS; CALCIUM-CHANNELS; ALDOSTERONE PRODUCTION; ADENYLATE-CYCLASE; MESSENGER-RNA; STEROIDOGENESIS; ATP; PURINOCEPTORS; PATHWAYS	Purinergic receptor expression and involvement in steroidogenesis were examined in NCI-H295R (H295R), a human adrenal cortex cell line which expresses all the key enzymes necessary for steroidogenesis. mRNA/protein for multiple P1 (A(2A) and A(2B)), P2X (P2X(5) and P2X(7)), and P2Y (P2Y(1), P2Y(2), P2Y(6), P2Y(12), P2Y(13), and P2Y(14)) purinergic receptors were detected in H295R. 2MeS-ATP (10-1000 mu M), a P2Y(1) agonist, induced glucocorticoid (GC) secretion in a dose-dependent manner, while other extracellular purine/pyrimidine agonists (1-1000 mu M) had no distinct effect on GC secretion. Extracellular purines, even non-steroidogenic ones, induced Ca2+-mobilization in the cells, independently of the extracellular Ca2+ concentration. Increases in intracellular Ca2+ concentration induced by extracellular purine agonists were transient, except when induced by ATP or 2MeS-ATP. Angiotensin II (AngII: 100 nM) and dibutyryl-cyclic AMP (db-cAMP: 500 mu M) induced both GC secretion and Ca2+-mobilization in the presence of extracellular Ca2+ (1.2 mM). GC secretion by AngII was reduced by nifedipine (10-100 mu M); whereas the Ca2+ channel blocker did not inhibit GC secretion by 2MeS-ATP. Thapsigargin followed by extracellular Ca2+ exposure induced Ca2+-influx in H295R, and the cells expressed mRNA/protein of the component molecules for store-operated calcium entry (SOCE): transient receptor C (TRPC) channels, calcium release-activated calcium channel protein 1 (Orai-1), and the stromal interaction molecule 1 (STIM1). In P2Y(1)-knockdown, 2MeS-ATP-induced GC secretion was significantly inhibited. These results suggest that H295R expresses a functional P2Y(1) purinergic receptor for intracellular Ca2+-mobilization, and that P2Y(1) is linked to SOCE-activation, leading to Ca2+-influx which might be necessary for glucocorticoid secretion.	[Nishi, Haruhisa; Arai, Hirokazu; Momiyama, Toshihiko] Jikei Univ, Sch Med, Tokyo, Japan	Jikei University	Nishi, H (corresponding author), Jikei Univ, Sch Med, Tokyo, Japan.	harrywestjpjp@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20019030, 21500374]; Jikei University Research Fund	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University Research Fund(Jikei University)	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 20019030 & 21500374) to TM and The Jikei University Research Fund to HN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki O, 2008, EUR J PHARMACOL, V584, P424, DOI 10.1016/j.ejphar.2008.02.001; Aritomi S, 2011, HYPERTENS RES, V34, P193, DOI 10.1038/hr.2010.191; Belloni AS, 2007, INT J MOL MED, V20, P859; BIRD IM, 1995, ENDOCR RES, V21, P169, DOI 10.3109/07435809509030432; BIRD IM, 1995, ENDOCRINOLOGY, V136, P5677, DOI 10.1210/en.136.12.5677; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CALDERWOOD SK, 1988, RADIAT RES, V113, P414, DOI 10.2307/3577239; Chen YC, 2008, INT J BIOCHEM CELL B, V40, P2815, DOI 10.1016/j.biocel.2008.05.016; Clerc RG, 2010, J HYPERTENS, V28, P1676, DOI 10.1097/HJH.0b013e32833b1f8e; Condon J, 1998, J CLIN ENDOCR METAB, V83, P4490, DOI 10.1210/jc.83.12.4490; DOYLE MP, 1994, AM J PHYSIOL, V266, pH2042, DOI 10.1152/ajpheart.1994.266.5.H2042; Enyeart JA, 2010, MOL PHARMACOL, V77, P469, DOI 10.1124/mol.109.061861; GalloPayet N, 1996, J CLIN INVEST, V98, P460, DOI 10.1172/JCI118812; GAZDAR AF, 1990, CANCER RES, V50, P5488; Gill DL, 1996, BIOSCIENCE REP, V16, P139, DOI 10.1007/BF01206203; Guibert C, 1996, AM J PHYSIOL-LUNG C, V270, pL637, DOI 10.1152/ajplung.1996.270.4.L637; HOEY ED, 1994, ENDOCRINOLOGY, V134, P1553, DOI 10.1210/en.134.3.1553; Imagawa K, 2006, J CARDIOVASC PHARM, V47, P133, DOI 10.1097/01.fjc.0000197539.12685.f5; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; KAWAMURA M, 1991, JPN J PHARMACOL, V56, P543, DOI 10.1254/jjp.56.543; Kawamura M, 2003, J PHARMACOL SCI, V91, P23, DOI 10.1254/jphs.91.23; Kawamura M, 2001, JPN J PHARMACOL, V85, P376, DOI 10.1254/jjp.85.376; KIMURA T, 1981, MOL CELL BIOCHEM, V36, P105, DOI 10.1007/BF02354909; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; Liu H, 2007, AM J PHYSIOL-CELL PH, V293, pC682, DOI 10.1152/ajpcell.00087.2007; MATSUOKA H, 1990, EXPERIENTIA, V46, P726, DOI 10.1007/BF01939947; MATUTE C, 1994, P NATL ACAD SCI USA, V91, P3774, DOI 10.1073/pnas.91.9.3774; NIITSU A, 1992, JPN J PHARMACOL, V60, P269, DOI 10.1254/jjp.60.269; Nishi H, 2004, LIFE SCI, V74, P1181, DOI 10.1016/j.lfs.2003.08.008; Nishi H, 2002, BRIT J PHARMACOL, V137, P177, DOI 10.1038/sj.bjp.0704847; Nishi H, 1999, JPN J PHARMACOL, V81, P194, DOI 10.1254/jjp.81.194; PASTAN I, 1967, J BIOL CHEM, V242, P5757; Qin HX, 2009, J ENDOCRINOL, V202, P77, DOI 10.1677/JOE-09-0119; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; SLAVINSKI EA, 1976, J ENDOCRINOL, V69, P385, DOI 10.1677/joe.0.0690385; SPAT A, 1988, J STEROID BIOCHEM, V29, P443, DOI 10.1016/0022-4731(88)90256-7; Suda N, 2011, ENDOCRINOLOGY, V152, P2266, DOI 10.1210/en.2010-1232; Tkachenko IV, 2011, STEROIDS, V76, P1103, DOI 10.1016/j.steroids.2011.04.018; UKENA D, 1986, LIFE SCI, V38, P797, DOI 10.1016/0024-3205(86)90596-5; Xing YW, 2011, ENDOCRINOLOGY, V152, P751, DOI 10.1210/en.2010-1049; Zhou XP, 1996, J PHYSIOL-LONDON, V496, P719, DOI 10.1113/jphysiol.1996.sp021722; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	47	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71022	10.1371/journal.pone.0071022	http://dx.doi.org/10.1371/journal.pone.0071022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951072	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000037
J	Zaehle, T; Becke, A; Naue, N; Machts, J; Abdulla, S; Petri, S; Kollewe, K; Dengler, R; Heinze, HJ; Vielhaber, S; Muller, NG				Zaehle, Tino; Becke, Andreas; Naue, Nicole; Machts, Judith; Abdulla, Susanne; Petri, Susanne; Kollewe, Katja; Dengler, Reinhard; Heinze, Hans-Jochen; Vielhaber, Stefan; Mueller, Notger G.			Working Memory in ALS Patients: Preserved Performance but Marked Changes in Underlying Neuronal Networks	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; FRONTAL-LOBE FUNCTION; SPAN AGE-DIFFERENCES; COGNITIVE IMPAIRMENT; PREFRONTAL CORTEX; BASAL GANGLIA; VERBAL FLUENCY; VISUAL MEMORY	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease which affects the motor system but also other frontal brain regions. In this study we investigated changes in functional neuronal networks including posterior brain regions that are not directly affected by the neurodegenerative process. To this end, we analyzed the contralateral delay activity (CDA), an ERP component considered an online marker of memory storage in posterior cortex, while 23 ALS patients and their controls performed a delayed-matching-to-sample working memory (WM) task. The task required encoding of stimuli in the cued hemifield whilst ignoring stimuli in the other hemifield. Despite their unimpaired behavioral performance patients displayed several changes in the neuronal markers of the memory processes. Their CDA amplitude was smaller; it showed less load-dependent modulation and lacked the reduction observed when controls performed the same task three months later. The smaller CDA in the patients could be attributed to more ipsilateral cortical activity which may indicate that ALS patients unnecessarily processed the irrelevant stimuli as well. The latter is presumably related to deterioration of the frontal cortex in the patient group which was indicated by slight deficits in tests of their executive functions that increased over time. The frontal pathology presumably affected their top-down control of memory storage in remote regions in the posterior brain. In sum, the present results demonstrate functional changes in neuronal networks, i.e. neuroplasticity, in ALS that go well beyond the known structural changes. They also show that at least in WM tasks, in which strategic top-down control demands are relatively low, the frontal deficit can be compensated for by intact low level processes in posterior brain regions.	[Zaehle, Tino; Becke, Andreas; Abdulla, Susanne; Heinze, Hans-Jochen; Vielhaber, Stefan; Mueller, Notger G.] Otto Von Guericke Univ, Sch Med, Dept Neurol, Magdeburg, Germany; [Zaehle, Tino; Heinze, Hans-Jochen] Leibniz Inst Neurobiol, Magdeburg, Germany; [Naue, Nicole; Machts, Judith; Abdulla, Susanne; Heinze, Hans-Jochen; Vielhaber, Stefan; Mueller, Notger G.] German Ctr Neurodegenerat Dis, Magdeburg, Germany; [Petri, Susanne; Kollewe, Katja; Dengler, Reinhard] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Naue, Nicole] Magdeburg Hosp GmbH, Dept Psychiat, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Hannover Medical School	Muller, NG (corresponding author), Otto Von Guericke Univ, Sch Med, Dept Neurol, Magdeburg, Germany.	notger.mueller@dzne.de	Zaehle, Tino/A-5088-2019; Machts, Judith/J-2508-2019; Petri, Susanne/AID-7665-2022	Zaehle, Tino/0000-0003-3673-4869; Machts, Judith/0000-0002-8660-095X; Mueller, Notger/0000-0002-5483-6423	Foundation of Medical Research, Frankfurt/Main, Germany;  [DFG Mu 1364/4-1]	Foundation of Medical Research, Frankfurt/Main, Germany; 	This work was supported by the following grants: DFG Mu 1364/4-1 to NGM and the Foundation of Medical Research, Frankfurt/Main, Germany to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS S, 1995, J NEUROL SCI, V129, P44, DOI 10.1016/0022-510X(95)00060-F; Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Arend AM, 2012, NEUROPSYCHOLOGIA, V50, P2379, DOI 10.1016/j.neuropsychologia.2012.06.007; Arend AM, 2011, J COGNITIVE NEUROSCI, V23, P4048, DOI 10.1162/jocn_a_00068; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Floel A, 2002, NERVENARZT, V73, P1144, DOI 10.1007/s00115-002-1383-3; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Gratton G, 1998, PSYCHOPHYSIOLOGY, V35, P638, DOI 10.1111/1469-8986.3560638; Hammer A, 2011, BRAIN RES, V1421, P90, DOI 10.1016/j.brainres.2011.09.010; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Iwanaga K, 1997, J NEUROL SCI, V146, P139, DOI 10.1016/S0022-510X(96)00297-3; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; KEW JJM, 1993, BRAIN, V116, P1399, DOI 10.1093/brain/116.6.1399; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mitchell DJ, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00018; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Qureshi M, 2009, AMYOTROPH LATERAL SC, V10, P324, DOI 10.3109/17482960903009054; Raaphorst J, 2011, J NEUROL NEUROSUR PS, V82, P170, DOI 10.1136/jnnp.2009.204446; Raaphorst J, 2010, AMYOTROPH LATERAL SC, V11, P27, DOI 10.3109/17482960802645008; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Robitaille N, 2009, PSYCHOPHYSIOLOGY, V46, P1090, DOI 10.1111/j.1469-8986.2009.00837.x; Sander MC, 2012, NEUROSCI BIOBEHAV R, V36, P2007, DOI 10.1016/j.neubiorev.2012.06.004; Sander MC, 2011, CEREB CORTEX, V21, P2809, DOI 10.1093/cercor/bhr076; Sayala S, 2006, CEREB CORTEX, V16, P609, DOI 10.1093/cercor/bhj007; Schneiders JA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00173; Teichmann E, 1935, Z GESAMTE NEUROL PSY, V154, P32; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tsubomi H, 2013, J NEUROSCI, V33, P8257, DOI 10.1523/JNEUROSCI.5348-12.2013; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; WECHSLER IS, 1932, ARCH NEUROL PSYCHIAT, V27, P857; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	49	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71973	10.1371/journal.pone.0071973	http://dx.doi.org/10.1371/journal.pone.0071973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951274	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000075
J	Bonthuis, M; Jager, KJ; Abu-Hanna, A; Verrina, E; Schaefer, F; van Stralen, KJ				Bonthuis, Marjolein; Jager, Kitty J.; Abu-Hanna, Ameen; Verrina, Enrico; Schaefer, Franz; van Stralen, Karlijn J.			Application of Body Mass Index According to Height-Age in Short and Tall Children	PLOS ONE			English	Article							BONE MASS; CHILDHOOD; OBESITY; PERCENTILES; ADIPOSITY; ADULTS	Background: In children with either delayed or accelerated growth, expressing the body mass index (BMI) to chronological age might lead to invalid body composition estimates. Reference to height-age has been suggested for such populations; however its validity has not been demonstrated. Methods: Anthropometric data of healthy children were obtained from the German KiGGS survey. We selected three samples with different height distributions representing short stature (mean height SDS: -1.6), normal stature (height SDS: 0), and tall stature (height SDS: +1.6), and compared BMI-for-age and BMI-for-height-age between these samples across the paediatric age range. Differences between samples were tested using Kruskal-Wallis one-way analysis of variance and permutation tests. Results: At a given age, BMI was distributed towards lower values in short, and towards higher values in tall subjects as compared to a population with average height distribution. Expressing BMI to height-age eliminated these differences in boys with a short stature from 4 years to 14 years of age, in tall boys from 4 to 16 years, in short girls aged 2-10 years or tall girls aged 2-17 years. Conclusion: From late infancy to adolescent age, BMI distribution co-varies with height distribution and referencing to height-age appears appropriate within this age period. However, caution is needed when data about pubertal status are absent.	[Bonthuis, Marjolein; Jager, Kitty J.; van Stralen, Karlijn J.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, European Registry Paediat Nephrol,ERA EDTA Regist, NL-1105 AZ Amsterdam, Netherlands; [Jager, Kitty J.; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Verrina, Enrico] Gaslini Childrens Hosp, Dept Pediat Nephrol, Genoa, Italy; [Schaefer, Franz] Univ Childrens Hosp, Dept Pediat Nephrol, Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Genoa; IRCCS Istituto Giannina Gaslini; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	van Stralen, KJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, European Registry Paediat Nephrol,ERA EDTA Regist, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	K.J.vanStralen@amc.uva.nl	Verrina, Enrico/AAA-7317-2020	Jager, Kitty/0000-0003-0444-8569; Verrina, Enrico Eugenio/0000-0002-5178-1949; Abu-Hanna, Ameen/0000-0003-4324-7954; van Stralen, Karlijn/0000-0002-3243-2970	European Renal Association and European Dialysis and Transplant Association (ERA-EDTA); European Society of Pediatric Nephrology (ESPN); European Agency for Health and Consumers of the European Commission [ESPNFY_2013]	European Renal Association and European Dialysis and Transplant Association (ERA-EDTA); European Society of Pediatric Nephrology (ESPN); European Agency for Health and Consumers of the European Commission	The ESPN/ERA-EDTA registry is funded by the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) and the European Society of Pediatric Nephrology (ESPN), and the European Agency for Health and Consumers of the European Commission (grant no. ESPNFY_2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, AM J KIDNEY DIS, V53, pS11, DOI 10.1053/j.ajkd.2008.11.017; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Burnham JM, 2005, AM J CLIN NUTR, V82, P413, DOI 10.1093/ajcn/82.2.413; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Freedman DS, 2005, CURR OPIN CLIN NUTR, V8, P618, DOI 10.1097/01.mco.0000171128.21655.93; Freedman DS, 2004, OBES RES, V12, P846, DOI 10.1038/oby.2004.102; Gao T, 2012, CLIN J AM SOC NEPHRO, V7, P558, DOI 10.2215/CJN.09710911; Goran MI, 1998, PEDIATRICS, V101, P505; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Public Use File KiGGS, 2008, KIND UND JUG 2003 20; Reilly JJ, 2000, INT J OBESITY, V24, P1623, DOI 10.1038/sj.ijo.0801436; Rosario AS, 2010, EUR J CLIN NUTR, V64, P341, DOI 10.1038/ejcn.2010.8; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348; Schaefer F, 2000, PEDIATR NEPHROL, V14, P673, DOI 10.1007/s004670000353; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Zemel BS, 2010, J CLIN ENDOCR METAB, V95, P1265, DOI 10.1210/jc.2009-2057	20	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72068	10.1371/journal.pone.0072068	http://dx.doi.org/10.1371/journal.pone.0072068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951283	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700130
J	Tacchi, L; Larragoite, E; Salinas, I				Tacchi, Luca; Larragoite, Erin; Salinas, Irene			Discovery of J Chain in African Lungfish (Protopterus dolloi, Sarcopterygii) Using High Throughput Transcriptome Sequencing: Implications in Mucosal Immunity	PLOS ONE			English	Article							POLYMERIC IG RECEPTOR; EDWARDSIELLA-ICTALURI; AUSTRALIAN LUNGFISH; EXPRESSION; CELLS; POPULATION; COELACANTH; TRANSPORT; PATHOLOGY; ANTIBODY	J chain is a small polypeptide responsible for immunoglobulin (Ig) polymerization and transport of Igs across mucosal surfaces in higher vertebrates. We identified a J chain in dipnoid fish, the African lungfish (Protopterus dolloi) by high throughput sequencing of the transcriptome. P. dolloi J chain is 161 aa long and contains six of the eight Cys residues present in mammalian J chain. Phylogenetic studies place the lungfish J chain closer to tetrapod J chain than to the coelacanth or nurse shark sequences. J chain expression occurs in all P. dolloi immune tissues examined and it increases in the gut and kidney in response to an experimental bacterial infection. Double fluorescent in-situ hybridization shows that 88.5% of IgM(+) cells in the gut co-express J chain, a significantly higher percentage than in the pre-pyloric spleen. Importantly, J chain expression is not restricted to the B-cell compartment since gut epithelial cells also express J chain. These results improve our current view of J chain from a phylogenetic perspective.	[Tacchi, Luca; Larragoite, Erin; Salinas, Irene] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	University of New Mexico	Salinas, I (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.	isalinas@unm.edu		Larragoite, Erin T./0000-0001-5061-2521	National Institutes of Health COBRE [P20GM103452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health COBRE Grant # P20GM103452, http://www.nigms.nih.gov/Training/IDeA/COBRE.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; BJERKE K, 1990, CLIN EXP IMMUNOL, V82, P411; BLAZER VS, 1985, J FISH BIOL, V27, P167, DOI 10.1111/j.1095-8649.1985.tb04018.x; Braathen R, 2007, J IMMUNOL, V178, P1589, DOI 10.4049/jimmunol.178.3.1589; BRANDTZAEG P, 1984, CLIN EXP IMMUNOL, V58, P709; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; CHARTRAND SL, 1971, J IMMUNOL, V107, P1; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; Hohman VS, 1997, MOL IMMUNOL, V34, P995, DOI 10.1016/S0161-5890(97)82768-X; Hohman VS, 2000, IMMUNOGENETICS, V51, P587, DOI 10.1007/s002510000169; Hohman VS, 2003, J IMMUNOL, V170, P6016, DOI 10.4049/jimmunol.170.12.6016; Horimoto S, 2002, NIHON U DENT J, V76, P135; Iwanowicz LR, 2006, DIS AQUAT ORGAN, V70, P219, DOI 10.3354/dao070219; Iwata A, 2002, IMMUNOGENETICS, V54, P513, DOI 10.1007/s00251-002-0492-2; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kallberg E, 2008, IMMUNOLOGY, V123, P590, DOI 10.1111/j.1365-2567.2007.02733.x; Klimovich VB, 2008, J EVOL BIOCHEM PHYS+, V44, P151, DOI 10.1134/S0022093008020023; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liang D, 2013, MOL BIOL EVOL; MARCHALONIS JJ, 1969, AUST J EXP BIOL MED, V47, P405, DOI 10.1038/icb.1969.46; NILSSEN DE, 1992, CLIN EXP IMMUNOL, V87, P237; Orjalo A, 2011, NAT METH, V8; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAFN S, 1981, ZOOL SCR, V10, P223, DOI 10.1111/j.1463-6409.1981.tb00498.x; Ross DA, 1998, IMMUNOL REV, V166, P143, DOI 10.1111/j.1600-065X.1998.tb01259.x; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; Tacchi L, 2010, COMP BIOCHEM PHYS B, V157, P364, DOI 10.1016/j.cbpb.2010.08.004; Takahashi T, 1996, P NATL ACAD SCI USA, V93, P1886, DOI 10.1073/pnas.93.5.1886; Takahashi T, 2000, IMMUNOGENETICS, V51, P85, DOI 10.1007/s002510050016; Vaerman JP, 1998, EUR J IMMUNOL, V28, P171, DOI 10.1002/(SICI)1521-4141(199801)28:01<171::AID-IMMU171>3.0.CO;2-#; Xu Z, 2009, VET IMMUNOL IMMUNOP, V131, P268, DOI 10.1016/j.vetimm.2009.04.001; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	36	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70650	10.1371/journal.pone.0070650	http://dx.doi.org/10.1371/journal.pone.0070650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967082	Green Submitted, gold, Green Published			2022-12-27	WOS:000323221500019
J	Bozzo, L; Puyal, J; Chatton, JY				Bozzo, Luigi; Puyal, Julien; Chatton, Jean-Yves			Lactate Modulates the Activity of Primary Cortical Neurons through a Receptor-Mediated Pathway	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; SENSITIVE K+ CHANNELS; CEREBRAL-ISCHEMIA; OREXIN NEURONS; GLUCOSENSING NEURONS; BRAIN LACTATE; METABOLISM; ACID; HYPOGLYCEMIA; TRANSPORT	Lactate is increasingly described as an energy substrate of the brain. Beside this still debated metabolic role, lactate may have other effects on brain cells. Here, we describe lactate as a neuromodulator, able to influence the activity of cortical neurons. Neuronal excitability of mouse primary neurons was monitored by calcium imaging. When applied in conjunction with glucose, lactate induced a decrease in the spontaneous calcium spiking frequency of neurons. The effect was reversible and concentration dependent (IC50 similar to 4.2 mM). To test whether lactate effects are dependent on energy metabolism, we applied the closely related substrate pyruvate (5 mM) or switched to different glucose concentrations (0.5 or 10 mM). None of these conditions reproduced the effect of lactate. Recently, a G(i) protein-coupled receptor for lactate called HCA1 has been introduced. To test if this receptor is implicated in the observed lactate sensitivity, we incubated cells with pertussis toxin (PTX) an inhibitor of G(i)-protein. PTX prevented the decrease of neuronal activity by L-lactate. Moreover 3,5-dyhydroxybenzoic acid, a specific agonist of the HCA1 receptor, mimicked the action of lactate. This study indicates that lactate operates a negative feedback on neuronal activity by a receptor-mediated mechanism, independent from its intracellular metabolism.	[Bozzo, Luigi; Puyal, Julien; Chatton, Jean-Yves] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Chatton, Jean-Yves] Univ Lausanne, Cellular Imaging Facil, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Chatton, JY (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	jean-yves.chatton@unil.ch	Puyal, Julien P/G-4210-2018	Puyal, Julien P/0000-0002-8140-7026; Chatton, Jean-Yves/0000-0002-8911-0315	Swiss National Science Foundation [31003A-135720]; Swiss League Against Epilepsy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss League Against Epilepsy	This work was supported by grant #31003A-135720 from the Swiss National Science Foundation to JY Chatton as well as by the Swiss League Against Epilepsy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Barros LF, 2013, TRENDS NEUROSCI; Bergersen Linda H, 2012, Front Neuroenergetics, V4, P5, DOI 10.3389/fnene.2012.00005; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Blad CC, 2011, ADV PHARMACOL, V62, P219, DOI 10.1016/B978-0-12-385952-5.00005-1; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Chatton JY, 2001, J PHARMACOL EXP THER, V299, P1161; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Dienel GA, 2007, J NEUROCHEM, V102, P466, DOI 10.1111/j.1471-4159.2007.04595.x; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Evans ML, 2004, DIABETES, V53, P2542, DOI 10.2337/diabetes.53.10.2542; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Flick MJ, 2002, BIOCHEM BIOPH RES CO, V295, P910, DOI 10.1016/S0006-291X(02)00768-4; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gonzalez JA, 2008, DIABETES, V57, P2569, DOI 10.2337/db08-0548; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Hu YB, 1997, J NEUROCHEM, V69, P1484; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Lauritzen KH, 2013, CEREB CORTE IN PRESS; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; NEDERGAARD M, 1993, AM J PHYSIOL, V265, pR282, DOI 10.1152/ajpregu.1993.265.2.R282; Parsons MP, 2010, J NEUROSCI, V30, P8061, DOI 10.1523/JNEUROSCI.5741-09.2010; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Schurr A, 1997, J NEUROCHEM, V69, P423; SCHURR A, 1988, BRAIN RES, V438, P311, DOI 10.1016/0006-8993(88)91354-6; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Venner A, 2011, J PHYSIOL-LONDON, V589, P5701, DOI 10.1113/jphysiol.2011.217000; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011	46	122	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71721	10.1371/journal.pone.0071721	http://dx.doi.org/10.1371/journal.pone.0071721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951229	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300147
J	Corral, R; Lewinger, JP; Joshi, AD; Levine, AJ; Vandenberg, DJ; Haile, RW; Stern, MC				Corral, Roman; Lewinger, Juan Pablo; Joshi, Amit D.; Levine, A. Joan; Vandenberg, David J.; Haile, Robert W.; Stern, Mariana C.			Genetic Variation in the Base Excision Repair Pathway, Environmental Risk Factors, and Colorectal Adenoma Risk	PLOS ONE			English	Article							COLI ENDONUCLEASE III; CANCER-RISK; ALCOHOL-CONSUMPTION; DNA-REPAIR; CIGARETTE-SMOKING; HUMAN HOMOLOG; HUMAN NTH1; POLYMORPHISMS; FOLATE; POLYPS	Cigarette smoking, high alcohol intake, and low dietary folate levels are risk factors for colorectal adenomas. Oxidative damage caused by these three factors can be repaired through the base excision repair pathway (BER). We hypothesized that genetic variation in BER might modify colorectal adenoma risk. In a sigmoidoscopy-based study, we examined associations between 182 haplotype tagging SNPs in 14 BER genes, and colorectal adenoma risk, and examined their potential role as modifiers of the effect cigarette smoking, alcohol intake, and dietary folate levels. Among all individuals, no statistically significant associations between BER SNPs and adenoma risk persisted after correction for multiple comparisons. However, among Asian-Pacific Islanders we observed two SNPs in FEN1 and one in NTHL1, and among African-Americans one SNP in APEX1 that were associated with colorectal adenoma risk. Significant associations were also observed between SNPs in the NEIL2 gene and rectal adenoma risk. Three SNPS modified the effect of smoking (MUTYH interaction p = 0.002; OGG1 interaction p = 0.013); FEN1 interaction p = 0.013)), one SNP in LIG3 modified the effect of alcohol consumption (interaction p = 0.024) and two SNPs in LIG3 modified the effect of dietary folate (interaction p = 0.001 and p = 0.08) on colorectal adenoma risk. These findings support a role for genetic variants in the BER pathway as potential modifiers of colorectal adenoma risk. Our findings strengthen the role of oxidative damage induced by key lifestyle and dietary risk factors in colorectal adenoma formation.	[Corral, Roman; Lewinger, Juan Pablo; Joshi, Amit D.; Levine, A. Joan; Vandenberg, David J.; Haile, Robert W.; Stern, Mariana C.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med USC, Dept Prevent Med, Los Angeles, CA 90033 USA; [Joshi, Amit D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Levine, A. Joan; Haile, Robert W.] Stanford Sch Med, Dept Med, Div Oncol, Stanford, CA USA	University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Stern, MC (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med USC, Dept Prevent Med, Los Angeles, CA 90033 USA.	marianas@usc.edu	Van Den Berg, David J/G-8598-2017	Van Den Berg, David J/0000-0002-5404-5218	National Cancer Institute, National Institutes of Health [1R01 CA096830, 5P01 CA42710]; American Cancer Society [RSF-09-020-01-CNE]; National Institute of Environmental Health Sciences [5P30 ES07048]; National Cancer Institute [P30CA014089]; NIH [T32GM067587]; NATIONAL CANCER INSTITUTE [P30CA014089, P01CA042710, R01CA096830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute, National Institutes of Health under 1R01 CA096830 and 5P01 CA42710. Dr. Stern received support from grant RSF-09-020-01-CNE from the American Cancer Society and from award number 5P30 ES07048 from the National Institute of Environmental Health Sciences and award number P30CA014089 from the National Cancer Institute. Roman Corral received support from NIH grant T32GM067587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2011, COL CANC FACTS FIG 2; American Institute for Cancer Research World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P, pxxv; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Baron JA, 1998, J NATL CANCER I, V90, P57, DOI 10.1093/jnci/90.1.57; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barry KH, 2011, ENVIRON HEALTH PERSP, V119, P1726, DOI 10.1289/ehp.1103454; Berndt SI, 2007, CANCER RES, V67, P1395, DOI 10.1158/0008-5472.CAN-06-1390; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Brevik A, 2010, CANCER EPIDEM BIOMAR, V19, P3167, DOI 10.1158/1055-9965.EPI-10-0606; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Cheadle JP, 2007, DNA REPAIR, V6, P274, DOI 10.1016/j.dnarep.2006.11.001; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Duthie SJ, 2004, P NUTR SOC, V63, P571, DOI 10.1079/PNS2004; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; FOUTCH PG, 1991, DIGEST DIS SCI, V36, P924, DOI 10.1007/BF01297142; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Gao Y, 2011, CARCINOGENESIS, V32, P882, DOI 10.1093/carcin/bgr071; Goroll AH, 2009, PRIMARY CARE MED OFF, pxxix; Gsur A, 2011, CANCER EPIDEMIOL, V35, pE38, DOI 10.1016/j.canep.2011.03.005; Haile RW, 1997, INT J CANCER, V73, P497, DOI 10.1002/(SICI)1097-0215(19971114)73:4<497::AID-IJC7>3.0.CO;2-V; Hansen R, 2005, CANCER LETT, V229, P85, DOI 10.1016/j.canlet.2005.04.019; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Kasahara M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-49; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; KUNE GA, 1992, NUTR CANCER, V18, P97, DOI 10.1080/01635589209514210; Levine AJ, 2011, CANCER CAUSE CONTROL, V22, P541, DOI 10.1007/s10552-011-9726-7; LIN HJ, 1995, CANCER RES, V55, P1224; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P275, DOI 10.1097/00001648-199605000-00010; Luna L, 2000, MUTAT RES-DNA REPAIR, V460, P95, DOI 10.1016/S0921-8777(00)00015-X; Mannino DM, 2003, NICOTINE TOB RES, V5, P357, DOI 10.1080/1462220031000094330; Mason JB, 2009, NUTR REV, V67, P206, DOI 10.1111/j.1753-4887.2009.00190.x; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Pryor WA, 1997, ENVIRON HEALTH PERSP, V105, P875, DOI 10.2307/3433297; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Seitz HK, 2005, DIGEST DIS, V23, P297, DOI 10.1159/000090177; SEITZ HK, 1990, GASTROENTEROLOGY, V98, P406, DOI 10.1016/0016-5085(90)90832-L; Simonelli V, 2012, MUTAT RES-FUND MOL M, V731, P1, DOI 10.1016/j.mrfmmm.2011.10.012; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-67; Stern MC, 2006, CANCER EPIDEM BIOMAR, V15, P2384, DOI 10.1158/1055-9965.EPI-06-0381; Stern MC, 2005, CANCER EPIDEM BIOMAR, V14, P609, DOI 10.1158/1055-9965.EPI-04-0189; Stewart SL, 2006, CANCER-AM CANCER SOC, V107, P1128, DOI 10.1002/cncr.22010; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Terry MB, 2002, CANCER EPIDEM BIOMAR, V11, P622; Winawer SJ, 2001, J CLIN ONCOL, V19, p6S; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	59	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71211	10.1371/journal.pone.0071211	http://dx.doi.org/10.1371/journal.pone.0071211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951112	Green Published, gold			2022-12-27	WOS:000323097300101
J	Fehr, A; Walther, E; Schmidt-Posthaus, H; Nufer, L; Wilson, A; Svercel, M; Richter, D; Segner, H; Pospischil, A; Vaughan, L				Fehr, Alexander; Walther, Elisabeth; Schmidt-Posthaus, Heike; Nufer, Lisbeth; Wilson, Anthony; Svercel, Miroslav; Richter, Denis; Segner, Helmut; Pospischil, Andreas; Vaughan, Lloyd			Candidatus Syngnamydia Venezia, a Novel Member of the phylum Chlamydiae from the Broad Nosed Pipefish, Syngnathus typhle	PLOS ONE			English	Article							CLAVOCHLAMYDIA-SALMONICOLA; INTRACELLULAR BACTERIUM; ORDER CHLAMYDIALES; ATLANTIC SALMON; EPITHELIOCYSTIS; WATER; SYMBIONTS; GENOME; STRAIN	Chlamydia are obligate intracellular bacteria and important pathogens of humans and animals. Chlamydia-related bacteria are also major fish pathogens, infecting epithelial cells of the gills and skin to cause the disease epitheliocystis. Given the wide distribution, ancient origins and spectacular diversity of bony fishes, this group offers a rich resource for the identification and isolation of novel Chlamydia. The broad-nosed pipefish (Syngnathus typhle) is a widely distributed and genetically diverse temperate fish species, susceptible to epitheliocystis across much of its range. We describe here a new bacterial species, Candidatus Syngnamydia venezia; epitheliocystis agent of S. typhle and close relative to other chlamydial pathogens which are known to infect diverse hosts ranging from invertebrates to humans.	[Fehr, Alexander; Walther, Elisabeth; Nufer, Lisbeth; Svercel, Miroslav; Richter, Denis; Pospischil, Andreas; Vaughan, Lloyd] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Schmidt-Posthaus, Heike; Segner, Helmut] Univ Bern, Ctr Fish & Wildlife Hlth, Vetsuisse Fac, Bern, Switzerland; [Wilson, Anthony] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich; University of Bern; University of Zurich	Vaughan, L (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.	vaughanl@vetpath.uzh.ch	Vaughan, Lloyd/GNP-4888-2022; Schmidt-Posthaus, Heike/G-2328-2014; Svercel, Miroslav/A-9728-2010; Vaughan, L/E-6528-2011; Segner, Helmut/D-5714-2014; Wilson, Anthony B/D-2907-2011	Svercel, Miroslav/0000-0002-7845-290X; Vaughan, L/0000-0003-3474-9426; Schmidt-Posthaus, Heike/0000-0003-2628-4454; Wilson, Anthony/0000-0002-2848-8816	SBF Project as part of COST Action 867: Fish Welfare in European Aquaculture [C09.0039]	SBF Project as part of COST Action 867: Fish Welfare in European Aquaculture	This study was supported by SBF Project C09.0039 to L. Vaughan as part of COST Action 867: Fish Welfare in European Aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Casson N, 2008, EMERG INFECT DIS, V14, P168, DOI 10.3201/eid1401.070980; Clarke IN, 2011, ANN NY ACAD SCI, V1230, pE11, DOI 10.1111/j.1749-6632.2011.06194.x; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Franzoi P., 2004, Biologia Marina Mediterranea, V11, P592; Friedman MG, 1999, EPIDEMIOL INFECT, V122, P117, DOI 10.1017/S095026889800185X; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Israelsson O, 2007, J INVERTEBR PATHOL, V96, P213, DOI 10.1016/j.jip.2007.05.002; Kahane S, 2002, MICROBIOL-SGM, V148, P735, DOI 10.1099/00221287-148-3-735; Karlsen M, 2008, ENVIRON MICROBIOL, V10, P208, DOI 10.1111/j.1462-2920.2007.01445.x; Kostanjsek R, 2004, INT J SYST EVOL MICR, V54, P543, DOI 10.1099/ijs.0.02802-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lienard J, 2011, MICROBES INFECT, V13, P1232, DOI 10.1016/j.micinf.2011.07.003; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Meijer A, 2006, APPL ENVIRON MICROB, V72, P284, DOI 10.1128/AEM.72.1.284-290.2006; Mitchell CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-442; Mitchell CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000903; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; Mobley KB, 2011, J FISH BIOL, V78, P1624, DOI 10.1111/j.1095-8649.2011.02967.x; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Oliveira F, 2007, ESTUAR COAST SHELF S, V72, P337, DOI 10.1016/j.ecss.2006.11.003; Polkinghorne A, 2010, DIS AQUAT ORGAN, V91, P75, DOI 10.3354/dao02255; Poppert S, 2002, APPL ENVIRON MICROB, V68, P4081, DOI 10.1128/AEM.68.8.4081-4089.2002; REIMER LW, 1994, DIS AQUAT ORGAN, V18, P77, DOI 10.3354/dao018077; Schmidt-Posthaus H, 2012, ENVIRON MICROBIOL, V14, P2048, DOI 10.1111/j.1462-2920.2011.02670.x; Segner H, 2012, FISH PHYSIOL BIOCHEM, V38, P85, DOI 10.1007/s10695-011-9517-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Vaughan L, 2010, P 12 INT HUM CHLAM C, P357; Vaughan L, 2013, FREE LIVING IN PRESS; Waycott M, 2005, MAR POLLUT BULL, V51, P343, DOI 10.1016/j.marpolbul.2005.01.017; Wilson AB, 2011, J FISH BIOL, V78, P1603, DOI 10.1111/j.1095-8649.2011.02988.x; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x	49	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70853	10.1371/journal.pone.0070853	http://dx.doi.org/10.1371/journal.pone.0070853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951025	Green Accepted, Green Published, gold			2022-12-27	WOS:000323097300059
J	Kiesewetter, J; Ebersbach, R; Gorlitz, A; Holzer, M; Fischer, MR; Schmidmaier, R				Kiesewetter, Jan; Ebersbach, Rene; Goerlitz, Anja; Holzer, Matthias; Fischer, Martin R.; Schmidmaier, Ralf			Cognitive Problem Solving Patterns of Medical Students Correlate with Success in Diagnostic Case Solutions	PLOS ONE			English	Article							WORKED EXAMPLES	Context: Problem-solving in terms of clinical reasoning is regarded as a key competence of medical doctors. Little is known about the general cognitive actions underlying the strategies of problem-solving among medical students. In this study, a theory-based model was used and adapted in order to investigate the cognitive actions in which medical students are engaged when dealing with a case and how patterns of these actions are related to the correct solution. Methods: Twenty-three medical students worked on three cases on clinical nephrology using the think-aloud method. The transcribed recordings were coded using a theory-based model consisting of eight different cognitive actions. The coded data was analysed using time sequences in a graphical representation software. Furthermore the relationship between the coded data and accuracy of diagnosis was investigated with inferential statistical methods. Results: The observation of all main actions in a case elaboration, including evaluation, representation and integration, was considered a complete model and was found in the majority of cases (56%). This pattern significantly related to the accuracy of the case solution (phi = 0.55; p < .001). Extent of prior knowledge was neither related to the complete model nor to the correct solution. Conclusions: The proposed model is suitable to empirically verify the cognitive actions of problem-solving of medical students. The cognitive actions evaluation, representation and integration are crucial for the complete model and therefore for the accuracy of the solution. The educational implication which may be drawn from this study is to foster students reasoning by focusing on higher level reasoning.	[Kiesewetter, Jan; Ebersbach, Rene; Goerlitz, Anja; Holzer, Matthias; Fischer, Martin R.] Univ Munich, Klinikum Univ Munchen, Lehrstuhl Didakt & Ausbildungsforsch Med, Munich, Germany; [Schmidmaier, Ralf] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany	University of Munich; University of Munich	Kiesewetter, J (corresponding author), Univ Munich, Klinikum Univ Munchen, Lehrstuhl Didakt & Ausbildungsforsch Med, Munich, Germany.	jan.kiesewetter@med.lmu.de	Kiesewetter, Jan/AFQ-5216-2022	Kiesewetter, Jan/0000-0001-8165-402X	Dr. med. Hildegard Hampp Trust	Dr. med. Hildegard Hampp Trust	Funds for this project were provided by Dr. med. Hildegard Hampp Trust administered by LMU Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Barrows H., 1980, PROBLEM BASED LEARNI; Borleffs JCC, 2003, ACAD MED, V78, P322, DOI 10.1097/00001888-200303000-00017; Bugdahl V, 1995, KREATIVES PROBLEMLOS; Charlin B, 2007, MED EDUC, V41, P1178, DOI 10.1111/j.1365-2923.2007.02924.x; Charlin B, 2012, MED EDUC, V46, P454, DOI 10.1111/j.1365-2923.2012.04242.x; Davis MH, 1999, MED TEACH, V21, P130, DOI 10.1080/01421599979743; Dewey J., 1997, WE THINK MINEOLA WE; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Elstein AS, 1978, MED PROBLEM SOLVING; Ericsson K.A., 1993, PROTOCOL ANAL VERBAL; Eva KW, 2007, MED EDUC, V41, P1152, DOI 10.1111/j.1365-2923.2007.02923.x; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Fischer M.R., 2000, Z HOCHSCHULDIDAKTIK, V1, P87; Fischer MR, 2005, MED EDUC, V39, P890, DOI 10.1111/j.1365-2929.2005.02243.x; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fletcher L, 2012, PHILOS T ROYAL SOC B, V369; Frensch P.A., 2014, COMPLEX PROBLEM SOLV; Funke J., 2003, PROBLEM SOLVING THIN; Gigerenzer G, 2011, BETTER DOCTORS BETTE; Gigerenzer G, 2011, HEURISTICS, V1, P241; Grasel C, 1993, FORDERUNG ERWERBS DI; Groves M, 2012, MED EDUC, V46, P444, DOI 10.1111/j.1365-2923.2012.04244.x; Harasym PH, 2008, KAOHSIUNG J MED SCI, V24, P341, DOI 10.1016/S1607-551X(08)70131-1; Kassirer JP., 2009, LEARNING CLIN REASON; Kopp V, 2008, MED EDUC, V42, P823, DOI 10.1111/j.1365-2923.2008.03122.x; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Marewski JN, 2011, PSYCHOL REV, V118, P393, DOI 10.1037/a0024143; Mayring P., 2004, COMPANION QUAL RES, P159; NEUFELD VR, 1981, MED EDUC, V15, P315, DOI 10.1111/j.1365-2923.1981.tb02495.x; Norman G, 2006, NEW ENGL J MED, V355, P2251, DOI 10.1056/NEJMe068134; Paas F, 2006, LEARN INSTR, V16, P87, DOI 10.1016/j.learninstruc.2006.02.004; Polya G, 1945, SOLVE IT; Rogers Carl R, 2013, BECOMING EFFECTIVE T; Schmidmaier R, 2011, MED EDUC, V45, P1101, DOI 10.1111/j.1365-2923.2011.04043.x; Schoenfeld A.H., 1985, MATH PROBLEM SOLVING; van Gog T, 2004, INSTR SCI, V32, P83, DOI 10.1023/B:TRUC.0000021810.70784.b0; Weidenmann B, 2006, PADAGOGISCHE PSYCHOL; Wimmers PF, 2007, ADV HEALTH SCI EDUC, V12, P299, DOI 10.1007/s10459-006-9002-x; Wood DF, 2003, BMJ-BRIT MED J, V326, P328, DOI 10.1136/bmj.326.7384.328	40	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71486	10.1371/journal.pone.0071486	http://dx.doi.org/10.1371/journal.pone.0071486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951175	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300122
J	Koda, H; Lemasson, A; Oyakawa, C; Rizaldi; Pamungkas, J; Masataka, N				Koda, Hiroki; Lemasson, Alban; Oyakawa, Chisako; Rizaldi; Pamungkas, Joko; Masataka, Nobuo			Possible Role of Mother-Daughter Vocal Interactions on the Development of Species-Specific Song in Gibbons	PLOS ONE			English	Article							ACOUSTIC FEATURES; DUET SONGS; CALL; EVOLUTION; PRIMATE; COMMUNICATION; COMBINATIONS; FEEDBACK	Mother-infant vocal interactions play a crucial role in the development of human language. However, comparatively little is known about the maternal role during vocal development in nonhuman primates. Here, we report the first evidence of mother-daughter vocal interactions contributing to vocal development in gibbons, a singing and monogamous ape species. Gibbons are well known for their species-specific duets sung between mates, yet little is known about the role of intergenerational duets in gibbon song development. We observed singing interactions between free-ranging mothers and their sub-adult daughters prior to emigration. Daughters sang simultaneously with their mothers at different rates. First, we observed significant acoustic variation between daughters. Co-singing rates between mother and daughter were negatively correlated with the temporal precision of the song's synchronization. In addition, songs of daughters who co-sang less with their mothers were acoustically more similar to the maternal song than any other adult female's song. All variables have been reported to be influenced by social relationships of pairs. Therefore those correlations would be mediated by mother-daughter social relationship, which would be modifiable in daughter's development. Here we hypothesized that daughters who co-sing less often, well-synchronize, and converge acoustically with the maternal acoustic pattern would be at a more advanced stage of social independence in sub-adult females prior to emigration. Second, we observed acoustic matching between mothers and daughters when co-singing, suggesting short-term vocal flexibility. Third, we found that mothers adjusted songs to a more stereotyped pattern when co-singing than when singing alone. This vocal adjustment was stronger for mothers with daughters who co-sang less. These results indicate the presence of socially mediated vocal flexibility in gibbon sub-adults and adults, and that mother-daughter co-singing interactions may enhance vocal development. More comparative work, notably longitudinal and experimental, is now needed to clarify maternal roles during song development.	[Koda, Hiroki; Oyakawa, Chisako; Rizaldi; Masataka, Nobuo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Lemasson, Alban] Univ Rennes 1, Stn Biol Paimpont, EthoS Ethol Anim & Humaine CNRS UMR6552, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France; [Oyakawa, Chisako] Tohoku Univ, Grad Sch Agr Sci, Furukawa, Miyagi, Japan; [Rizaldi] Andalas Univ, Dept Biol, Padang, West Sumatra, Indonesia; [Pamungkas, Joko] Bogor Agr Univ, Primate Res Ctr, Bogor, Indonesia	Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France; Tohoku University; Universitas Andalas; Bogor Agricultural University	Koda, H (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	koda.hiroki.7a@kyoto-u.ac.jp	Pamungkas, Joko/GPK-3471-2022		JSPS [1955281, 22330200]; Young Researcher Overseas Visits Programme for the Vitalizing Brain Circulation from the Primate Research Institute, Kyoto University; Global Centres of Excellence Program [A06]; French program (CNRS - PICS); French program (ANR ORILANG);  [25730092];  [20405016]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Young Researcher Overseas Visits Programme for the Vitalizing Brain Circulation from the Primate Research Institute, Kyoto University; Global Centres of Excellence Program; French program (CNRS - PICS); French program (ANR ORILANG)(French National Research Agency (ANR)); ; 	This study was supported by a Grant-in-Aid for young scientists (25730092) to H. K., a JSPS fellowship (1955281) to C.O., a Grant-in-Aid for overseas research (B) (20405016) to Hirohisa Hirai (HK joined as a co-PI), a JSPS Grant-in-Aid for Scientific Research (B)(22330200) to Nobuyuki Kawai (HK joined as a co-PI), Young Researcher Overseas Visits Programme for the Vitalizing Brain Circulation from the Primate Research Institute, Kyoto University and JSPS (PI: Hirohisa Hirai), a grant from the Global Centres of Excellence Program (A06) to Kyoto University, and two French programs (CNRS - PICS, ANR ORILANG).	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; BROCKELMAN WY, 1984, NATURE, V312, P634, DOI 10.1038/312634a0; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2007, CURR BIOL, V17, pR521, DOI 10.1016/j.cub.2007.04.053; Candiotti A, 2012, BIOL LETTERS, V8, P382, DOI 10.1098/rsbl.2011.1182; Clarke E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000073; Corballis MC, 2002, HAND MOUTH ORIGINS L; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Elowson AM, 1998, BEHAVIOUR, V135, P643, DOI 10.1163/156853998792897905; Falk D, 2004, BEHAV BRAIN SCI, V27, P491; Farabaugh S.M., 1982, ACOUSTIC COMMUNICATI, V2, DOI DOI 10.2307/25063377); Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Geissmann T, 2002, BIOL REV, V77, P57, DOI 10.1017/S1464793101005826; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Geissmann T, 1999, BEHAVIOUR, V136, P1005, DOI 10.1163/156853999501694; Gittins S.P., 1984, P354; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Goldstein MH, 2008, PSYCHOL SCI, V19, P515, DOI 10.1111/j.1467-9280.2008.02117.x; Haimoff E, 1984, LESSER APES EVOLUTIO; Hall ML, 2007, CURR BIOL, V17, pR406, DOI 10.1016/j.cub.2007.04.022; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT, P93; Jusczyk P. W., 1992, PHONOLOGICAL DEV MOD, P17; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; Langmore N. E., 2002, TRENDS ECOL EVOL, V17, P451, DOI DOI 10.1016/S0169-5347(02)02611-3; Lappan S., 2009, GIBBONS NEW PERSPECT; Lemasson A, 2005, J COMP PSYCHOL, V119, P220, DOI 10.1037/0735-7036.119.2.220; Lemasson A, 2004, J COMP PSYCHOL, V118, P347, DOI 10.1037/0735-7036.118.3.347; Lemasson A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00022; Lemasson A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-362; Lemasson A, 2011, ADV INTERACT STUD, V1, P39; Lemasson A, 2010, BIOL LETTERS, V6, P325, DOI 10.1098/rsbl.2009.0875; Locke J. L., 1995, CHILDS PATH SPOKEN L; MacLeod CE, 2003, J HUM EVOL, V44, P401, DOI 10.1016/S0047-2484(03)00028-9; Marshall J., 1986, P137; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; Masataka N., 2003, ONSET LANGUAGE; Merker B, 1999, FOLIA PRIMATOL, V70, P97, DOI 10.1159/000021680; MITANI JC, 1992, AM J PRIMATOL, V27, P233, DOI 10.1002/ajp.1350270402; MITANI JC, 1994, ETHOLOGY, V96, P233, DOI 10.1111/j.1439-0310.1994.tb01012.x; Oller D. K., 2008, EVOLUTION COMMUNICAT; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Oyakawa C, 2007, AM J PRIMATOL, V69, P777, DOI 10.1002/ajp.20390; Reichard U. H., 2003, MONOGAMY MATING STRA; Egnor SER, 2006, J EXP BIOL, V209, P3652, DOI 10.1242/jeb.02420; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Snowdon CT, 1999, ETHOLOGY, V105, P893, DOI 10.1046/j.1439-0310.1999.00483.x; Sugiura H, 1998, ANIM BEHAV, V55, P673, DOI 10.1006/anbe.1997.0602; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; Zuberbuhler K, 2009, HDB BEHAV NEUROSCIEN, P505; [No title captured]	53	67	69	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71432	10.1371/journal.pone.0071432	http://dx.doi.org/10.1371/journal.pone.0071432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951160	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300116
J	Villalta, D; Bizzaro, N; Bassi, N; Zen, M; Gatto, M; Ghirardello, A; Iaccarino, L; Punzi, L; Doria, A				Villalta, Danilo; Bizzaro, Nicola; Bassi, Nicola; Zen, Margherita; Gatto, Mariele; Ghirardello, Anna; Iaccarino, Luca; Punzi, Leonardo; Doria, Andrea			Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease	PLOS ONE			English	Article							DOUBLE-STRANDED DNA; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; SLE DIAGNOSIS; ASSOCIATION; AUTOANTIBODIES; POLYMYOSITIS; ACTIVATION; VARIABLES; RELAPSES	Objectives: To evaluate the role of serum IgG, IgM and IgA anti-dsDNA antibody isotypes in the diagnosis of systemic lupus erythematosus (SLE), and their association with clinical features and disease activity, in a large cohort of SLE patients. Methods: Sera of 200 SLE patients (mean age 34+/-10.3 years; 26 male and 174 female; median duration of disease 115 months, range 7-378), and of 206 controls, including 19 Sjogren's syndrome, 27 rheumatoid arthritis, 26 psoriatic arthritis, 15 idiopathic inflammatory myopathies (IIM), 13 systemic sclerosis, 49 infectious diseases and 57 healthy subjects, were tested for anti-dsDNA IgG, IgM and IgA isotypes. Results: Selecting a cutoff corresponding to 95% specificity, the sensitivity of IgG, IgM and IgA anti-dsDNA antibodies in SLE was 55%, 30% and 49%, respectively; 12.5%, 1% and 7.5% of SLE patients had positive IgG, IgM or IgA isotype alone, respectively. SLE patients with glomerulonephritis showed higher levels of IgA anti-dsDNA (p = 0.0002), anti-dsDNA IgG/IgM (p = 0.001) and IgA/IgM (p < 0.0001) ratios than patients without renal disease. No significant associations have been found between anti-dsDNA isotypes and other clinical features. IgA anti-dsDNA (p = 0.01) (but not IgG or IgM) and IgG/IgM ratio (p = 0.005) were significantly higher in patients with more active disease (ECLAM score >4). Conclusions: The detection of IgA anti-dsDNA autoantibodies seems to improve our ability to diagnose SLE and to define lupus nephritis phenotype and active disease. By contrast, IgM anti-dsDNA antibodies might be protective for renal involvement. These data support the hypothesis that anti-dsDNA antibody class clustering may help to refine SLE diagnosis and prognosis.	[Villalta, Danilo] Azienda Osped S Maria degli Angeli, Pordenone, Italy; [Bizzaro, Nicola] San Antonio Hosp, Clin Pathol Lab, Tolmezzo, Italy; [Bassi, Nicola; Zen, Margherita; Gatto, Mariele; Ghirardello, Anna; Iaccarino, Luca; Punzi, Leonardo; Doria, Andrea] Univ Padua, Div Rheumatol, Dept Med, Padua, Italy	University of Padua	Doria, A (corresponding author), Univ Padua, Div Rheumatol, Dept Med, Padua, Italy.	adoria@unipd.it		Doria, Andrea/0000-0003-0548-4983; PUNZI, LEONARDO/0000-0002-8853-516X; GATTO, MARIELE/0000-0003-4012-1248				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Atta AM, 2009, CLIN RHEUMATOL, V28, P693, DOI 10.1007/s10067-009-1134-y; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BOOTSMA H, 1995, LANCET, V345, P1595, DOI 10.1016/S0140-6736(95)90114-0; Bootsma H, 1997, ANN RHEUM DIS, V56, P661, DOI 10.1136/ard.56.11.661; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Doria A, 2012, LUPUS, V21, P1492, DOI 10.1177/0961203312462267; Doria A, 2010, AUTOIMMUN REV, V10, P55, DOI 10.1016/j.autrev.2010.08.014; EHRENSTEIN MR, 1995, KIDNEY INT, V48, P705, DOI 10.1038/ki.1995.341; Forger F, 2004, LUPUS, V13, P36, DOI 10.1191/0961203304lu485oa; Gatto M, 2013, AUTOIMMUN REV, V12, P523, DOI 10.1016/j.autrev.2012.09.003; Ghirardello A, 2004, J AUTOIMMUN, V22, P235, DOI 10.1016/j.jaut.2003.12.005; Ghirardello A, 2011, CLIN EXP RHEUMATOL, V29, P50; Grootscholten C, 2003, ARTHRITIS RHEUM, V48, P1355, DOI 10.1002/art.10974; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Hamann D, 2007, AUTOANTIBODIES, 2ND EDITION, P159, DOI 10.1016/B978-044452763-9/50025-1; Hasegawa M, 1998, ANN RHEUM DIS, V57, P470, DOI 10.1136/ard.57.8.470; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; KRIPPNER H, 1984, Z RHEUMATOL, V43, P265; MCGRATH H, 1985, ARTHRITIS RHEUM-US, V28, P425, DOI 10.1002/art.1780280411; MILTENBURG AMM, 1993, J RHEUMATOL, V20, P53; OHNISHI K, 1994, INT IMMUNOL, V6, P817, DOI 10.1093/intimm/6.6.817; Pisetsky DS, 2012, SCAND J IMMUNOL, V76, P223, DOI 10.1111/j.1365-3083.2012.02728.x; Putova I, 2007, ANN NY ACAD SCI, V1109, P275, DOI 10.1196/annals.1398.033; Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; Smeenk Ruud J. T., 1996, P227, DOI 10.1016/B978-044482383-0/50034-0; SWAAK AJG, 1979, ARTHRITIS RHEUM, V22, P226, DOI 10.1002/art.1780220304; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Villalta D, 2003, LUPUS, V12, P31, DOI 10.1191/0961203303lu277oa; Villalta D, 2002, J CLIN LAB ANAL, V16, P227, DOI 10.1002/jcla.10045; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; VITALI C, 1992, CLIN EXP RHEUMATOL, V10, P541; WALLACE DJ, 1994, ARTHRITIS RHEUM, V37, P1795, DOI 10.1002/art.1780371213; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Werwitzke S, 2005, ARTHRITIS RHEUM-US, V52, P3629, DOI 10.1002/art.21379; Witte T, 1998, RHEUMATOL INT, V18, P85, DOI 10.1007/s002960050063; Witte T, 1998, RHEUMATOL INT, V18, P63, DOI 10.1007/s002960050059; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Zen M, 2012, CLIN EXP RHEUMATOL, V30, P856	44	57	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71458	10.1371/journal.pone.0071458	http://dx.doi.org/10.1371/journal.pone.0071458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951169	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300120
J	Zhang, C; Li, Y; Wang, C; Lv, RL; Song, T				Zhang, Cheng; Li, Yue; Wang, Chao; Lv, Ruili; Song, Tao			Extremely Low-Frequency Magnetic Exposure Appears to Have No Effect on Pathogenesis of Alzheimer's Disease in Aluminum-Overloaded Rat	PLOS ONE			English	Article							BRAIN-BARRIER PERMEABILITY; ELECTROMAGNETIC-FIELDS; OCCUPATIONAL-EXPOSURE; NERVOUS-SYSTEM; RISK; EPIDEMIOLOGY; DEMENTIA; FEATURES	Objective: Extremely low-frequency magnetic field (ELF-MF) has been reported to be of potential pathogenetic relevance to Alzheimer's disease (AD) for years. However, evidence confirming this function remains inconclusive. Chronic Al treatment has been identified as a contributing factor to cognitive function impairment in AD. This study aims to examine whether or not ELF-MF and Al have synergistic effects toward AD pathogenesis by investigating the effects of ELF-MF with or without chronic Al treatment on SD rats. Methods: Sprague-Dawley (SD) rats were subjected one of the following treatments: sham (control group), oral Al (Al group), ELF-MF (100 mu T at 50 Hz) with oral Al (MF+Al group), or ELF-MF (100 mu T at 50 Hz) without oral Al (MF group). Results: After 12 wk of treatment, oral Al treatment groups (Al and MF+Al groups) showed learning and memory impairment as well as morphological hallmarks, including neuronal cell loss and high density of amyloid-beta (A beta) in the hippocampus and cerebral cortex. ELF-MF without Al treatment showed no significant effect on AD pathogenesis. ELF-MF+Al treatment induced no more damage than Al treatment did. Conclusions: Our results showed no evidence of any association between ELF-MF exposure (100 mu T at 50 Hz) and AD, and ELF-MF exposure does not influence the pathogenesis of AD induced by Al overload.	[Zhang, Cheng; Li, Yue; Wang, Chao; Lv, Ruili; Song, Tao] Chinese Acad Sci, Inst Elect Engn, Beijing Key Lab Bioelectromagnetism, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Electrical Engineering, CAS	Song, T (corresponding author), Chinese Acad Sci, Inst Elect Engn, Beijing Key Lab Bioelectromagnetism, Beijing, Peoples R China.	songtao@mail.iee.ac.cn	Song, Tao/AAE-2145-2022	song, tao/0000-0001-7070-7819	National Natural Science of China [51037006]; National Natural Science Foundation of China [31070755]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Program of National Natural Science of China (51037006) and National Natural Science Foundation of China (31070755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Andel R, 2010, J GERONTOL A-BIOL, V65, P1220, DOI 10.1093/gerona/glq112; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Bhasin P, 2012, ENV TOXICOL; Brody H, 2011, NATURE, V475, pS1, DOI 10.1038/475S1a; Chen XS, 2010, J ALZHEIMERS DIS, V22, P1289, DOI 10.3233/JAD-2010-101323; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Empting LD, 2009, TOXICOL IND HEALTH, V25, P577, DOI 10.1177/0748233709348393; Fattoretti P, 2003, J ALZHEIMERS DIS, V5, P437, DOI 10.3233/JAD-2003-5603; Feychting M, 2003, EPIDEMIOLOGY, V14, P413, DOI 10.1097/01.EDE.0000071409.23291.7b; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Fu Y, 2008, CLIN EXP PHARMACOL P, V35, P797, DOI 10.1111/j.1440-1681.2008.04922.x; Gulturk S, 2010, BIOELECTROMAGNETICS, V31, P262, DOI 10.1002/bem.20557; HEWITT CD, 1990, CLIN LAB MED, V10, P403, DOI 10.1016/S0272-2712(18)30576-6; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Johansen C, 2000, EPIDEMIOLOGY, V11, P539, DOI 10.1097/00001648-200009000-00009; Kawahara M, 2005, J ALZHEIMERS DIS, V8, P171; KREWSKI D, 2007, J TOXICOL ENV HEA S1, V0010; Liu TT, 2008, NEUROREPORT, V19, P549, DOI 10.1097/WNR.0b013e3282f8b1a0; Luo Y, 2009, MECH AGEING DEV, V130, P248, DOI 10.1016/j.mad.2008.12.005; Miu AC, 2004, J ALZHEIMERS DIS, V6, P315; Miu AC, 2006, J ALZHEIMERS DIS, V10, P179; Noonan CW, 2002, SCAND J WORK ENV HEA, V28, P42, DOI 10.5271/sjweh.645; Oztas B, 2004, BIOELECTROMAGNETICS, V25, P400, DOI 10.1002/bem.20030; Perl DP, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2006.090613; Qiu CX, 2004, EPIDEMIOLOGY, V15, P687, DOI 10.1097/01.ede.0000142147.49297.9d; Rao RR, 2002, BIOELECTROCHEMISTRY, V57, P9, DOI 10.1016/S1567-5394(02)00004-X; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Richard F, 2001, EUR J PHARMACOL, V412, P1, DOI 10.1016/S0014-2999(00)00903-1; Seidler A, 2007, OCCUP ENVIRON MED, V64, P108, DOI 10.1136/oem.2005.024190; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P486, DOI 10.1002/(SICI)1521-186X(1998)19:8<486::AID-BEM6>3.0.CO;2-K; SOBEL E, 1995, AM J EPIDEMIOL, V142, P515, DOI 10.1093/oxfordjournals.aje.a117669; Sobel E, 1996, NEUROLOGY, V47, P1477, DOI 10.1212/WNL.47.6.1477; Suay Llopis Loreto, 2002, Rev. Esp. Salud Publica, V76, P645, DOI 10.1590/S1135-57272002000600002; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WHO Media centre, 2007, EL FIELDS PUBL HLTH; WHO-World Health Organization, 2007, ENV HLTH CRIT SER, P187; Zhang ZJ, 2003, LIFE SCI, V73, P2443, DOI 10.1016/S0024-3205(03)00649-0; Zheng W, 2001, J TOXICOL-CLIN TOXIC, V39, P711, DOI 10.1081/CLT-100108512	41	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71087	10.1371/journal.pone.0071087	http://dx.doi.org/10.1371/journal.pone.0071087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951088	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300088
J	Fang, Y; Yu, S; Ma, YY; Sun, P; Ma, DX; Ji, CY; Kong, BH				Fang, Yan; Yu, Shuang; Ma, Yuyan; Sun, Ping; Ma, Daoxin; Ji, Chunyan; Kong, Beihua			Association of Dll4/Notch and HIF-1a-VEGF Signaling in the Angiogenesis of Missed Abortion	PLOS ONE			English	Article							GROWTH-FACTOR; RECURRENT MISCARRIAGE; EMBRYONIC LETHALITY; TYROSINE KINASE; ORF VIRUS; EXPRESSION; VEGF; DLL4; RECEPTOR; HYPOXIA	Background: Dll4/Notch and HIF-1a-VEGF have been shown to play an important role during angiogenesis, but there are no data about their roles and association in missed abortion. In this study, we investigated the association of Dll4/Notch and HIF-1a-VEGF signaling in missed abortion. Methods: Women with missed abortion (n = 27) and healthy controls (n = 26) were included in the study. Real-time Reverse Transcription-PCR Analyses (RT-PCR) was used to analyze the mRNA levels of Dll4/Notch and HIF-1a-VEGF signaling molecules. The protein level for Dll4 was measured by immunohistochemistry. Results: Compared with induced abortion, the expression of VEGF was statistically reduced while the level of VEGFR1 and Notch1 was significantly up-regulated in missed abortion. Though other molecules (VEGFR2 and Dll4) were marginally higher in missed abortion, no statistical difference was observed. The expression of HIF-1a was significantly up-regulated, and close negatively correlated with VEGF in missed abortion. Both in induced abortion and missed abortion, Dll4 was positively correlated with Notch1. Conclusions: The early pregnancy is in a hypoxic environment, this may encourage the angiogenesis, but severe hypoxic may inhibit the angiogenesis. Aberrant Dll4/Notch and HIF-1a-VEGF signaling may have a role in missed abortion.	[Fang, Yan; Ma, Yuyan; Sun, Ping; Kong, Beihua] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yu, Shuang; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Dept Hematol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daoxinma@sdu.edu.cn; kongbeihua@sdu.edu.cn			National Natural Science Foundation [30600680, 81070407, 81170515, 81100425]; Shandong Technological Development Project [2005BS03022, Q2008C07, BS2009SW014]; SRF for ROCS, SEM; IIFSDU [2009TS063]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); IIFSDU	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070407, 81170515, 81100425), the Shandong Technological Development Project (2005BS03022, Q2008C07 and BS2009SW014), the SRF for ROCS, SEM and IIFSDU (2009TS063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Griebel CP, 2005, AM FAM PHYSICIAN, V72, P1243; HATASAKA HH, 1994, CLIN OBSTET GYNECOL, V37, P625, DOI 10.1097/00003081-199409000-00016; Hayashi M, 2005, ENDOCRINOLOGY, V146, P4682, DOI 10.1210/en.2005-0416; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lim KH, 1997, AM J PATHOL, V151, P1809; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Rajakumar A, 2000, BIOL REPROD, V63, P559, DOI 10.1095/biolreprod63.2.559; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Schaffer L, 2006, AM J PHYSIOL-REG I, V290, pR844, DOI 10.1152/ajpregu.00237.2005; Shutter JR, 2000, GENE DEV, V14, P1313; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Vuorela P, 2000, MOL HUM REPROD, V6, P276, DOI 10.1093/molehr/6.3.276; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Zhang P, 2009, GRAEF ARCH CLIN EXP, V247, P633, DOI 10.1007/s00417-008-1031-0	37	43	51	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70667	10.1371/journal.pone.0070667	http://dx.doi.org/10.1371/journal.pone.0070667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950980	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200014
J	Jiang, XQ; Sun, L; Qiu, JJ; Sun, XJ; Li, S; Wang, XY; So, CWE; Dong, SO				Jiang, Xueqing; Sun, Lin; Qiu, Jihui Julia; Sun, Xiujing; Li, Sen; Wang, Xiyin; So, Chi Wai Eric; Dong, Shuo			A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia	PLOS ONE			English	Article							HELICOBACTER-PYLORI; FUSION PROTEIN; PROMYELOCYTIC LEUKEMIA; DIFFERENTIATION; ESTABLISHMENT; RECRUITMENT; RESISTANCE; AML1-ETO; DOMAIN; CELLS	Acute myeloid leukemia (AML) is the most common malignant myeloid disorder of progenitor cells in myeloid hematopoiesis and exemplifies a genetically heterogeneous disease. The patients with AML also show a heterogeneous response to therapy. Although all-trans retinoic acid (ATRA) has been successfully introduced to treat acute promyelocytic leukemia (APL), it is rather ineffective in non-APL AML. In our present study, 1200 off-patent marketed drugs and natural compounds that have been approved by the Food and Drug Administration (FDA) were screened for anti-leukemia activity using the retrovirus transductiontransformation assay (RTTA). Furazolidone (FZD) was shown to inhibit bone marrow transformation mediated by several leukemia fusion proteins, including AML1-ETO. Furazolidone has been used in the treatment of certain bacterial and protozoan infections in human and animals for more than sixty years. We investigated the anti-leukemic activity of FZD in a series of AML cells. FZD displayed potent antiproliferative properties at submicromolar concentrations and induced apoptosis in AML cell lines. Importantly, FZD treatment of certain AML cells induced myeloid cell differentiation by morphology and flow cytometry for CD11b expression. Furthermore, FZD treatment resulted in increased stability of tumor suppressor p53 protein in AML cells. Our in vitro results suggest furazolidone as a novel therapeutic strategy in AML patients.	[Jiang, Xueqing; Sun, Lin] Cent Hosp Wuhan, Dept Thyroid & Breast Surg, Wuhan, Hubei, Peoples R China; [Jiang, Xueqing; Sun, Lin; Qiu, Jihui Julia; Sun, Xiujing; Li, Sen; Wang, Xiyin; Dong, Shuo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Jiang, Xueqing; Sun, Lin; Qiu, Jihui Julia; Sun, Xiujing; Li, Sen; Wang, Xiyin; Dong, Shuo] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Qiu, Jihui Julia] Temple Univ, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19122 USA; [So, Chi Wai Eric] Kings Coll London, Dept Haematol Med, London, England	Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of London; King's College London	Dong, SO (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	sdong@bcm.edu	Wang, Xiyin/AAF-4747-2019	Wang, Xiyin/0000-0002-3642-9373	Albert and Margaret Alkek Foundation; Leukemia Research Foundation (LRF); Ladies Leukemia League (LLL); MRC [G0800892] Funding Source: UKRI; Medical Research Council [G0800892] Funding Source: researchfish; Worldwide Cancer Research [11-0729] Funding Source: researchfish	Albert and Margaret Alkek Foundation; Leukemia Research Foundation (LRF); Ladies Leukemia League (LLL); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	This work was supported, in part, by funds from the Albert and Margaret Alkek Foundation, Leukemia Research Foundation (LRF) and Ladies Leukemia League (LLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 1999, VET RES COMMUN, V23, P343, DOI 10.1023/A:1006333608012; [Anonymous], 1993, World Health Organ Tech Rep Ser, V832, P1; Burnett AK, 2012, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2012.1.1; Chylicki K, 2000, CELL GROWTH DIFFER, V11, P315; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; Ehinger M, 1997, CELL GROWTH DIFFER, V8, P1127; Eisig JN, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-38; Eisig Jaime Natan, 2011, Arq. Gastroenterol., V48, P261, DOI 10.1590/S0004-28032011000400008; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Jin X, 2011, TOXICOL LETT, V201, P205, DOI 10.1016/j.toxlet.2010.12.021; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Qiu JHJ, 2010, BLOOD, V115, P643, DOI 10.1182/blood-2009-07-232652; RABBANI GH, 1991, ANTIMICROB AGENTS CH, V35, P1864, DOI 10.1128/AAC.35.9.1864; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Stone Richard M, 2004, Hematology Am Soc Hematol Educ Program, P98; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Treiber G, 2002, HELICOBACTER, V7, P225, DOI 10.1046/j.1523-5378.2002.00087.x; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; ZHENG ZT, 1992, J GASTROEN HEPATOL, V7, P533, DOI 10.1111/j.1440-1746.1992.tb01034.x; Zullo A, 2012, SAUDI J GASTROENTERO, V18, P11, DOI 10.4103/1319-3767.91729	26	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72335	10.1371/journal.pone.0072335	http://dx.doi.org/10.1371/journal.pone.0072335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951311	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200080
J	Twyffels, L; Wauquier, C; Soin, R; Decaestecker, C; Gueydan, C; Kruys, V				Twyffels, Laure; Wauquier, Corinne; Soin, Romuald; Decaestecker, Christine; Gueydan, Cyril; Kruys, Veronique			A Masked PY-NLS in Drosophila TIS11 and Its Mammalian Homolog Tristetraprolin	PLOS ONE			English	Article							MESSENGER-RNA TURNOVER; ZINC-FINGER PROTEINS; AU-RICH ELEMENTS; NUCLEAR IMPORT; EXPORT SIGNALS; DEADENYLATION; TRANSPORTIN; BINDING; FAMILY; IDENTIFICATION	Many RNA-binding proteins (RBPs) dynamically shuttle between the nucleus and the cytoplasm, often exerting different functions in each compartment. Therefore, the nucleo-cytoplasmic distribution of RBPs has a strong impact on their activity. Here we describe the localization and the shuttling properties of the tandem zinc finger RBP dTIS11, which is the Drosophila homolog of mammalian TIS11 proteins. Drosophila and mammalian TIS11 proteins act as destabilizing factors in ARE-mediated decay. At equilibrium, dTIS11 is concentrated mainly in the cytoplasm. We show that dTIS11 is a nucleocytoplasmic shuttling protein whose nuclear export is mediated by the exportin CRM1 through the recognition of a nuclear export signal (NES) located in a different region comparatively to its mammalian homologs. We also identify a cryptic Transportin-dependent PY nuclear localization signal (PY-NLS) in the tandem zinc finger region of dTIS11 and show that it is conserved across the TIS11 protein family. This NLS partially overlaps the second zinc finger ZnF2. Importantly, mutations disrupting the capacity of the ZnF2 to coordinate a Zinc ion unmask dTIS11 and TTP NLS and promote nuclear import. All together, our results indicate that the nuclear export of TIS11 proteins is mediated by CRM1 through diverging NESs, while their nuclear import mechanism may rely on a highly conserved PY-NLS whose activity is negatively regulated by ZnF2 folding.	[Twyffels, Laure; Wauquier, Corinne; Soin, Romuald; Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium; [Twyffels, Laure; Decaestecker, Christine; Kruys, Veronique] Ctr Microscopy & Mol Imaging, Gosselies, Belgium; [Decaestecker, Christine] Univ Libre Bruxelles, Ecole Polytech Bruxelles, Lab Image Synth & Anal, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Kruys, V (corresponding author), Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium.	vkruys@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Decaestecker, Christine/0000-0002-5495-1931; Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403	Fund for Medical Scientific Research (Belgium) [2.4.511.00.F]; Fonds Brachet and Van Buuren; Actions de Recherches Concertees [AV.06/11-345]; FEDER program of the Walloon region; "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium); European Regional Development Fund; Walloon Region	Fund for Medical Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Brachet and Van Buuren; Actions de Recherches Concertees; FEDER program of the Walloon region; "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); European Regional Development Fund(European Commission); Walloon Region	This work was supported by the Fund for Medical Scientific Research (Belgium, grant 2.4.511.00.F), the Fonds Brachet and Van Buuren, the "Actions de Recherches Concertees" (grants AV.06/11-345) and the FEDER program (2008-2013) of the Walloon region. L. Twyffels and R. Soin were funded by the "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium). C. Decaestecker is a Senior Research Associate with the "Fonds National de la Recherche Scientifique" (FNRS, Brussels, Belgium). The CMMI is supported by the European Regional Development Fund and the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Chook Y. M., 2010, BIOCHIM BIOPHYS ACTA, V1813, P1593; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fasken MB, 2000, J BIOL CHEM, V275, P1878, DOI 10.1074/jbc.275.3.1878; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lippai M, 2000, GENETICS, V156, P1889; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Prouteau M, 2008, EMBO J, V27, P2966, DOI 10.1038/emboj.2008.212; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Quan Y, 2008, MOL CELL PROTEOMICS, V7, P1254, DOI 10.1074/mcp.M700511-MCP200; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Su YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034250; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vergara SV, 2011, MOL CELL BIOL, V31, P417, DOI 10.1128/MCB.00754-10; Vindry C, 2012, J BIOL CHEM, V287, P35527, DOI 10.1074/jbc.M112.356188; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106	47	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71686	10.1371/journal.pone.0071686	http://dx.doi.org/10.1371/journal.pone.0071686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951221	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200067
J	Schulte, JD; Srikanth, M; Das, S; Zhang, JN; Lathia, JD; Yin, LH; Rich, JN; Olson, EC; Kessler, JA; Chenn, A				Schulte, Jessica D.; Srikanth, Maya; Das, Sunit; Zhang, Jianing; Lathia, Justin D.; Yin, Lihui; Rich, Jeremy N.; Olson, Eric C.; Kessler, John A.; Chenn, Anjen			Cadherin-11 Regulates Motility in Normal Cortical Neural Precursors and Glioblastoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-ADHESION; N-CADHERIN; STEM-CELLS; EXPRESSION; BETA; NEURONS; PROLIFERATION; ANGIOGENESIS; PROGRESSION	Metastasizing tumor cells undergo a transformation that resembles a process in normal development when non-migratory epithelial cells modulate the expression of cytoskeletal and adhesion proteins to promote cell motility. Here we find a mesenchymal cadherin, Cadherin-11 (CDH11), is increased in cells exiting the ventricular zone (VZ) neuroepithelium during normal cerebral cortical development. When overexpressed in cortical progenitors in vivo, CDH11 causes premature exit from the neuroepithelium and increased cell migration. CDH11 expression is elevated in human brain tumors, correlating with higher tumor grade and decreased patient survival. In glioblastoma, CDH11-expressing tumor cells can be found localized near tumor vasculature. Endothelial cells stimulate TGF beta signaling and CDH11 expression in glioblastoma cells. TGF beta promotes glioblastoma cell motility, and knockdown of CDH11 expression in primary human glioblastoma cells inhibits TGF beta-stimulated migration. Together, these findings show that Cadherin-11 can promote cell migration in neural precursors and glioblastoma cells and suggest that endothelial cells increase tumor aggressiveness by co-opting mechanisms that regulate normal neural development.	[Schulte, Jessica D.; Zhang, Jianing; Yin, Lihui; Chenn, Anjen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Srikanth, Maya; Das, Sunit; Kessler, John A.] Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lathia, Justin D.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Olson, Eric C.] SUNY Syracuse, Dept Neurosci & Physiol, Syracuse, NY USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Cleveland Clinic Foundation; Cleveland Clinic Foundation; State University of New York (SUNY) System	Chenn, A (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	achenn@uic.edu	Lathia, Justin/AHB-8296-2022; Das, Sunit/J-3903-2015; Rich, Jeremy/AAM-1445-2021; Graham, Maya/AAC-1957-2021	Das, Sunit/0000-0002-2146-4168; Graham, Maya/0000-0003-4748-974X	March of Dimes Research Scholars [1-FY10-504]; Wendy Will Case Fund; Brain Research Fund Seed Grant; Cancer Center [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553, R21CA149388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER	March of Dimes Research Scholars(March of Dimes); Wendy Will Case Fund; Brain Research Fund Seed Grant; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by March of Dimes Research Scholars Grant number 1-FY10-504, the Wendy Will Case Fund (Chicago, IL), and a Brain Research Fund Seed Grant (Chicago, IL) to AC, the Northwestern University Flow Cytometry Facility and the Northwestern University Cell Imaging Facility both supported by a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; BARAMI K, 1994, NEURON, V13, P567, DOI 10.1016/0896-6273(94)90026-4; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cameron DA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-90; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MERZAK A, 1994, CANCER RES, V54, P3988; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard S, 2009, CELL STEM CELL, V5, P468, DOI 10.1016/j.stem.2009.10.016; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stocker AM, 2009, DEV BIOL, V328, P66, DOI 10.1016/j.ydbio.2009.01.010; Stocker AM, 2006, BRAIN RES; Sullivan DP, 2013, AM J PATHOL, V182, P1031, DOI 10.1016/j.ajpath.2012.11.037; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yoshida T, 2012, PATHOL INT, V62, P463, DOI 10.1111/j.1440-1827.2012.02823.x; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	43	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70962	10.1371/journal.pone.0070962	http://dx.doi.org/10.1371/journal.pone.0070962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951053	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700068
J	Somveille, M; Manica, A; Butchart, SHM; Rodrigues, ASL				Somveille, Marius; Manica, Andrea; Butchart, Stuart H. M.; Rodrigues, Ana S. L.			Mapping Global Diversity Patterns for Migratory Birds	PLOS ONE			English	Article							SPECIES RICHNESS; NORTH-AMERICA; CONSERVATION; HOTSPOTS; ENERGY; VERTEBRATES; AVIFAUNA; ENDEMISM; ECOLOGY; TRENDS	Nearly one in five bird species has separate breeding and overwintering distributions, and the regular migrations of these species cause a substantial seasonal redistribution of avian diversity across the world. However, despite its ecological importance, bird migration has been largely ignored in studies of global avian biodiversity, with few studies having addressed it from a macroecological perspective. Here, we analyse a dataset on the global distribution of the world's birds in order to examine global spatial patterns in the diversity of migratory species, including: the seasonal variation in overall species diversity due to migration; the contribution of migratory birds to local bird diversity; and the distribution of narrow-range and threatened migratory birds. Our analyses reveal a striking asymmetry between the Northern and Southern hemispheres, evident in all of the patterns investigated. The highest migratory bird diversity was found in the Northern Hemisphere, with high inter-continental turnover in species composition between breeding and non-breeding seasons, and extensive regions (at high latitudes) where migratory birds constitute the majority of the local avifauna. Threatened migratory birds are concentrated mainly in Central and Southern Asia, whereas narrow-range migratory species are mainly found in Central America, the Himalayas and Patagonia. Overall, global patterns in the diversity of migratory birds indicate that bird migration is mainly a Northern Hemisphere phenomenon. The asymmetry between the Northern and Southern hemispheres could not have easily been predicted from the combined results of regional scale studies, highlighting the importance of a global perspective.	[Somveille, Marius; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England; [Somveille, Marius; Rodrigues, Ana S. L.] CNRS, Ctr Ecol Fonct & Evolut, CEFE, UMR5175, F-34033 Montpellier, France; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; BirdLife International	Somveille, M (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ms2008@cam.ac.uk	Butchart, Stuart HM/Y-2711-2018; Rodrigues, Ana S.L./A-5914-2009; Manica, Andrea/B-5497-2008; Butchart, Stuart/AAJ-1852-2021; Rodrigues, Ana/GYQ-6273-2022; Manica, Andrea/N-9013-2019	Rodrigues, Ana S.L./0000-0003-4775-0127; Manica, Andrea/0000-0003-1895-450X; Butchart, Stuart/0000-0002-1140-4049; Manica, Andrea/0000-0003-1895-450X; Somveille, Marius/0000-0002-6868-5080				Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; [Anonymous], [No title captured]; Barcena S, 2004, BIODIVERS CONSERV, V13, P1997, DOI 10.1023/B:BIOC.0000040000.23854.b9; BirdLife International, 2000, THREAT BIRDS WORLD; Birdlife International NatureServe, 2012, BIRD SPEC DISTR MAPS; Birdlife International NatureServe, 2011, BIRD SPEC DISTR MAPS; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Carnicer J, 2008, ACTA OECOL, V33, P253, DOI 10.1016/j.actao.2007.12.001; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chesser RT, 1998, J ANIM ECOL; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Elliott A., 1992, HDB BIRDS WORLD ALIV; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Greenberg R., 2010, BIRD CONSERV INT, V4, P115; Greenberg R, 2008, J BIOGEOGR, V35, P2049, DOI 10.1111/j.1365-2699.2008.01954.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN, 2012, IUCN RED LIST THREAT; Jenkins KD, 2002, AUK, V119, P539, DOI 10.1642/0004-8038(2002)119[0539:EODMBS]2.0.CO;2; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Moore JL, 2003, CONSERV BIOL, V17, P217; Newton I, 1996, J ANIM ECOL, V65, P137, DOI 10.2307/5716; Newton I, 1996, AUK, V113, P626, DOI 10.2307/4088983; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I, 1997, J BIOGEOGR, V24, P781, DOI 10.1046/j.1365-2699.1997.00153.x; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Sahr K., 2003, CARTOGR GEOGR INF SC, V30, P121, DOI [10.1559/152304003100011090, DOI 10.1559/152304003100011090]; Salewski V, 2007, NATURWISSENSCHAFTEN, V94, P268, DOI 10.1007/s00114-006-0186-y; SAUER JR, 2011, N AM BREEDING BIRD S; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; STRATTERSFIELD AJ, 1998, BIRDLIFE CONSERVATIO, V7; Tourenq C, 2005, BIOL CONSERV, V121, P1, DOI 10.1016/j.biocon.2004.03.031; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003	44	77	81	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70907	10.1371/journal.pone.0070907	http://dx.doi.org/10.1371/journal.pone.0070907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951037	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700061
J	Ybarra, ML; Bull, SS; Prescott, TL; Korchmaros, JD; Bangsberg, DR; Kiwanuka, JP				Ybarra, Michele L.; Bull, Sheana S.; Prescott, Tonya L.; Korchmaros, Josephine D.; Bangsberg, David R.; Kiwanuka, Julius P.			Adolescent Abstinence and Unprotected Sex in CyberSenga, an Internet-Based HIV Prevention Program: Randomized Clinical Trial of Efficacy	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; INFORMATION; MOTIVATION; INTERVENTION; HEALTH; TRENDS; YOUTH; MEN	Context: Cost-effective, scalable programs are urgently needed in countries deeply affected by HIV. Methods: This parallel-group RCT was conducted in four secondary schools in Mbarara, Uganda. Participants were 12 years and older, reported past-year computer or Internet use, and provided informed caregiver permission and youth assent. The intervention, CyberSenga, was a five-hour online healthy sexuality program. Half of the intervention group was further randomized to receive a booster at four-months post-intervention. The control arm received 'treatment as usual' (i.e., school-delivered sexuality programming). The main outcome measures were: 1) condom use and 2) abstinence in the past three months at six-months' post-intervention. Secondary outcomes were: 1) condom use and 2) abstinence at three-month's post-intervention; and 6-month outcomes by booster exposure. Analyses were intention to treat. Results: All 416 eligible youth were invited to participate, 88% (n = 366) of whom enrolled. Participants were randomized to the intervention (n = 183) or control (n = 183) arm; 91 intervention participants were further randomized to the booster. No statistically significant results were noted among the main outcomes. Among the secondary outcomes: At three-month follow-up, trends suggested that intervention participants (81%) were more likely to be abstinent than control participants (74%; p = 0.08), and this was particularly true among youth who were abstinent at baseline (88% vs. 77%; p = 0.02). At six-month follow-up, those in the booster group (80%) reported higher rates of abstinence than youth in the intervention, no booster (57%) and control (55%) groups (p = 0.15); they also reported lower rates of unprotected sex (5%) compared to youth in the intervention, no booster (24%) and control (21%) groups (p = 0.21) among youth sexually active at baseline. Conclusions: The CyberSenga program may affect HIV preventive behavior among abstinent youth in the short term and, with the booster, may also promote HIV preventive behavior among sexually active youth in the longer term.	[Ybarra, Michele L.; Prescott, Tonya L.; Korchmaros, Josephine D.] Ctr Innovat Publ Hlth Res, San Clemente, CA USA; [Bull, Sheana S.] Colorado Sch Publ Hlth, Dept Community & Behav Hlth, Aurora, CO USA; [Bangsberg, David R.] Mbarara Univ Sci & Technol, Ragon Inst Massachusetts Gen Hosp Massachusetts I, Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kiwanuka, Julius P.] Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda	Colorado School of Public Health; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Mbarara University of Science & Technology	Ybarra, ML (corresponding author), Ctr Innovat Publ Hlth Res, San Clemente, CA USA.	Michele@InnovativePublicHealth.org			National Institute of Mental Health [R01MH080662]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080662] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by Award Number R01MH080662 from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth R. P, 1996, REDUCING RISK, V3rd; Biraro S, 2009, SEX TRANSM INFECT, V85, pI3, DOI 10.1136/sti.2008.033928; Bryan AD, 2000, AIDS, V14, P756, DOI 10.1097/00002030-200004140-00021; Bull Sheana, 2010, East Afr J Public Health, V7, P58; Centers for Disease Control and Prevention, 2007, BEC RESP TEEN BART; Darabi L, 2008, PROTECTING NEXT GENE, V8; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; FISHER JD, 1994, HEALTH PSYCHOL, V13, P238, DOI 10.1037/0278-6133.13.3.238; Fritz K, 2011, AIDS BEHAV, V15, P1732, DOI 10.1007/s10461-011-9922-1; Government of Uganda, 2010, BUDG MON REP; Gupta N, 2003, ARCH SEX BEHAV, V32, P41, DOI 10.1023/A:1021841312539; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Hobbs A, 2002, TEENAGERS TOOLKIT YO; Intersol Inc, 2010, LANG AFR; Kabiru Caroline W, 2007, Afr J Reprod Health, V11, P111, DOI 10.2307/25549735; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Ndyanabangi Bannet, 2004, Afr J Reprod Health, V8, P55, DOI 10.2307/3583393; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Shisana O., 2002, N MANDELA HSRC STUDY; Simbayi LC, 2004, AIDS CARE, V16, P605, DOI 10.1080/09540120410001716405; StataCorp, 2021, STATA STAT SOFTWARE; Uganda Bureau of Statistics, 2010, STAT ABSTR; Uganda Ministry of Health, 2012, UG AIDS IND SURV 201; UNALDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2005, EP FACT SHEETS HIV A; Ybarra ML, 2006, PLOS MED, V3, P2104, DOI 10.1371/journal.pmed.0030433; Ybarra ML, 2013, AIDS BEHAV, V17, P1116, DOI 10.1007/s10461-012-0137-x; Ybarra ML, 2012, CIN-COMPUT INFORM NU, V30, P587, DOI 10.1097/NXN.0b013e318266cb0e; Ybarra ML, AIDS CARE IN PRESS	29	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70083	10.1371/journal.pone.0070083	http://dx.doi.org/10.1371/journal.pone.0070083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967069	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500014
J	Devaux, Y; Vausort, M; McCann, GP; Kelly, D; Collignon, O; Ng, LL; Wagner, DR; Squire, IB				Devaux, Yvan; Vausort, Melanie; McCann, Gerry P.; Kelly, Dominic; Collignon, Olivier; Ng, Leong L.; Wagner, Daniel R.; Squire, Iain B.			A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction	PLOS ONE			English	Article								Background: Prediction of clinical outcome after acute myocardial infarction (AMI) is challenging and would benefit from new biomarkers. We investigated the prognostic value of 4 circulating microRNAs (miRNAs) after AMI. Methods: We enrolled 150 patients after AMI. Blood samples were obtained at discharge for determination of N-terminal pro-brain natriuretic peptide (Nt-proBNP) and levels of miR-16, miR-27a, miR-101 and miR-150. Patients were assessed by echocardiography at 6 months follow-up and the wall motion index score (WMIS) was used as an indicator of left ventricular (LV) contractility. We assessed the added predictive value of miRNAs against a multi-parameter clinical model including Nt-proBNP. Results: Patients with anterior AMI and elevated Nt-proBNP levels at discharge from the hospital were at high risk of subsequent impaired LV contractility (follow-up WMIS > 1.2, n = 71). A combination of the 4 miRNAs (miR-16/27a/101/150) improved the prediction of LV contractility based on clinical variables (P = 0.005). Patients with low levels of miR-150 (odds ratio [95% confidence interval] 0.08 [0.01-0.48]) or miR-101 (0.19 [0.04-0.97]) and elevated levels of miR-16 (15.9 [2.63-95.91]) or miR-27a (4.18 [1.36-12.83]) were at high risk of impaired LV contractility. The 4 miRNA panel reclassified a significant proportion of patients with a net reclassification improvement of 66% (P = 0.00005) and an integrated discrimination improvement of 0.08 (P = 0.001). Conclusion: Our results indicate that panels of miRNAs may aid in prognostication of outcome after AMI.	[Devaux, Yvan; Vausort, Melanie; Wagner, Daniel R.] Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [McCann, Gerry P.; Kelly, Dominic; Ng, Leong L.; Squire, Iain B.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [McCann, Gerry P.; Kelly, Dominic; Ng, Leong L.; Squire, Iain B.] Glenfield Gen Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester LE3 9QP, Leics, England; [Collignon, Olivier] Ctr Rech Publ Sante, Competences Ctr Methodol & Stat, Luxembourg, Luxembourg; [Wagner, Daniel R.] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Luxembourg Institute of Health; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Luxembourg Institute of Health; Luxembourg Hospital Center	Devaux, Y (corresponding author), Ctr Rech Publ Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020	Devaux, Yvan/0000-0002-5321-8543; McCann, Gerry/0000-0002-5542-8448; Ng, Leong/0000-0002-6553-5749	Society for Research on Cardiovascular Diseases; Ministry of Culture, Health and Higher Education; National Fund for Research of Luxembourg; NIHR Leicester Cardiovascular Biomedical Research Unit; National Institute for Health Research [PDF-2011-04-051] Funding Source: researchfish	Society for Research on Cardiovascular Diseases; Ministry of Culture, Health and Higher Education; National Fund for Research of Luxembourg; NIHR Leicester Cardiovascular Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Society for Research on Cardiovascular Diseases, the Ministry of Culture, Health and Higher Education, and the National Fund for Research of Luxembourg. Profs. Ng and Squire and Drs. McCann and Razvi received support from the NIHR Leicester Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Devaux Y, 2013, CIRC-CARDIOVASC GENE, DOI [1.DOI 10.1161/circgenetics, DOI 10.1161/CIRCGENETICS]; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Fedorov V, 2009, PHARM STAT, V8, P50, DOI 10.1002/pst.331; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goretti E, 2013, J LEUKOC BI IN PRESS; Kelly D, 2007, EUR HEART J, V28, P711, DOI 10.1093/eurheartj/ehm003; Mann DL, 2012, J AM COLL CARDIOL, V60, P2465, DOI 10.1016/j.jacc.2012.06.062; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Pan Z, 2012, CIRCULATION, DOI [10.1161/circulationaha, DOI 10.1161/CIRCULATI0NAHA]; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Talwar S, 2000, EUR HEART J, V21, P1514, DOI 10.1053/euhj.1999.2045; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Torabi A, 2008, EUR HEART J, V29, P859, DOI 10.1093/eurheartj/ehn096; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zile MR, 2011, CIRC-CARDIOVASC GENE, V4, P614, DOI 10.1161/CIRCGENETICS.111.959841	30	105	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70644	10.1371/journal.pone.0070644	http://dx.doi.org/10.1371/journal.pone.0070644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967079	Green Published, Green Submitted, gold			2022-12-27	WOS:000323115800008
J	Andersen, S; Baar, C; Fladvad, T; Laugsand, EA; Skorpen, F				Andersen, Sonja; Baar, Cecilie; Fladvad, Torill; Laugsand, Eivor Alette; Skorpen, Frank			The N-Terminally Truncated mu 3 and mu 3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene	PLOS ONE			English	Article							ALTERNATIVELY SPLICED VARIANTS; OPIATE RECEPTOR; IDENTIFICATION; MORPHINE; MOR-1; INTERNALIZATION; BINDING; MOUSE; EXPRESSION; PROTEIN	The human m opioid receptor gene, OPRM1, produces a multitude of alternatively spliced transcripts encoding full-length or truncated receptor variants with distinct pharmacological properties. The majority of these transcripts are transcribed from the main promoter upstream of exon 1, or from alternate promoters associated with exons 11 and 13. Two distinct transcripts encoding six transmembrane domain (6TM) hMOR receptors, mu 3 and mu 3-like, have been reported, both starting with the first nucleotide in exon 2. However, no mechanism explaining their initiation at exon 2 has been presented. Here we have used RT-PCR with RNA from human brain tissues to demonstrate that the mu 3 and mu 3-like transcripts contain nucleotide sequences from the intron 1-exon 2 boundary and are transcribed from a novel promoter located upstream of exon 2. Reporter gene assays confirmed the ability of the novel promoter to drive transcription in human cells, albeit at low levels. We also report the identification of a "full-length" seven transmembrane domain (7TM) version of mu 3, hMOR-1A2, which also contains exon 1, and a novel transcript, hMOR-1Y2, with the potential to encode the previously reported hMOR-1Y receptor, but with exon Y spliced to exon 4 instead of exon 5 as in hMOR-1Y. Heterologous expression of GFP-tagged hMOR variants in HEK 293 cells showed that both 6TM receptors were retained in the intracellular compartment and were unresponsive to exogenous opioid exposure as assessed by their ability to redistribute or affect cellular cAMP production, or to promote intracellular Ca2+ release. Co-staining with an antibody specific for endoplasmic reticulum (ER) indicated that the mu 3-like receptor was retained at the ER after synthesis. 7TM receptors hMOR-1A2 and hMOR-1Y2 resided in the plasma membrane, and were responsive to opioids. Notably, hMOR-1A2 exhibits novel functional properties in that it did not internalize in response to the opioid peptide [D-Ala2, N-Me-Phe4, Gly-ol5]enkephalin (DAMGO).	[Andersen, Sonja; Laugsand, Eivor Alette] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; [Andersen, Sonja; Laugsand, Eivor Alette] Norwegian Univ Sci & Technol NTNU, Fac Med, European Palliat Care Res Ctr, Trondheim, Norway; [Baar, Cecilie; Fladvad, Torill; Skorpen, Frank] Norwegian Univ Sci & Technol NTNU, Fac Med, Childrens & Womens Hlth & European Palliat Care R, Dept Lab Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skorpen, F (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Childrens & Womens Hlth & European Palliat Care R, Dept Lab Med, Trondheim, Norway.	frank.skorpen@ntnu.no		Skorpen, Frank/0000-0001-7093-8000	Research Council of Norway; Norwegian University of Science and Technology; Central Norway Health Authority	Research Council of Norway(Research Council of Norway); Norwegian University of Science and Technology; Central Norway Health Authority	This work was supported by grants from The Research Council of Norway (www.forskningsradet.no), Norwegian University of Science and Technology (www.ntnu.no), and the Central Norway Health Authority (http://www.helse-midt.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Abbadie C, 2004, NEUROSCIENCE, V127, P419, DOI 10.1016/j.neuroscience.2004.03.033; Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Bolan EA, 2004, SYNAPSE, V51, P11, DOI 10.1002/syn.10277; Burford NT, 1998, EUR J PHARMACOL, V342, P123, DOI 10.1016/S0014-2999(97)01556-2; Cadet P, 2003, J IMMUNOL, V170, P5118, DOI 10.4049/jimmunol.170.10.5118; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; Chen LW, 2003, LIFE SCI, V73, P115, DOI 10.1016/S0024-3205(03)00250-9; Choi HS, 2006, BIOCHEM BIOPH RES CO, V343, P1132, DOI 10.1016/j.bbrc.2006.03.084; Du Y.-L., 1997, Society for Neuroscience Abstracts, V23, P1206; Fricchione G, 2008, MED SCI MONITOR, V14, pCS45; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; HAHN EF, 1982, J NEUROSCI, V2, P572; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2003, BIOCHEM BIOPH RES CO, V301, P1057, DOI 10.1016/S0006-291X(03)00089-5; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pasternak DA, 2004, J NEUROCHEM, V91, P881, DOI 10.1111/j.1471-4159.2004.02767.x; PASTERNAK GW, 1980, SCIENCE, V208, P514, DOI 10.1126/science.6245448; PASTERNAK GW, 1975, NATURE, V253, P563, DOI 10.1038/253563a0; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; PASTERNAK GW, 1980, J PHARMACOL EXP THER, V214, P455; Shabalina SA, 2009, HUM MOL GENET, V18, P1037, DOI 10.1093/hmg/ddn439; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Thakker DR, 2003, METH MOLEC MED, V84, P29; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71024	10.1371/journal.pone.0071024	http://dx.doi.org/10.1371/journal.pone.0071024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951073	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300077
J	Han, J; Kubota, S; Li, GX; Yao, XY; Yang, XG; Shu, DG; Li, Y; Kinoshita, S; Sasaki, O; Komiya, T; Yan, G				Han, Jian; Kubota, Shin; Li, Guoxiang; Yao, Xiaoyong; Yang, Xiaoguang; Shu, Degan; Li, Yong; Kinoshita, Shunichi; Sasaki, Osamu; Komiya, Tsuyoshi; Yan, Gang			Early Cambrian Pentamerous Cubozoan Embryos from South China	PLOS ONE			English	Article							BOX JELLYFISH CNIDARIA; LIFE-CYCLE; CARYBDEA-SIVICKISI; EVOLUTION; PHYLOGENY; SCYPHOZOA; SHAANXI; REPRODUCTION; MICROANATOMY; ECHINODERMS	Background: Extant cubozoans are voracious predators characterized by their square shape, four evenly spaced outstretched tentacles and well-developed eyes. A few cubozoan fossils are known from the Middle Cambrian Marjum Formation of Utah and the well-known Carboniferous Mazon Creek Formation of Illinois. Undisputed cubozoan fossils were previously unknown from the early Cambrian; by that time probably all representatives of the living marine phyla, especially those of basal animals, should have evolved. Methods: Microscopic fossils were recovered from a phosphatic limestone in the Lower Cambrian Kuanchuanpu Formation of South China using traditional acetic-acid maceration. Seven of the pre-hatched pentamerous cubozoan embryos, each of which bears five pairs of subumbrellar tentacle buds, were analyzed in detail through computed microtomography (Micro-CT) and scanning electron microscopy (SEM) without coating. Results: The figured microscopic fossils are unequivocal pre-hatching embryos based on their spherical fertilization envelope and the enclosed soft-tissue that has preserved key anatomical features arranged in perfect pentaradial symmetry, allowing detailed comparison with modern cnidarians, especially medusozoans. A combination of features, such as the claustrum, gonad-lamella, suspensorium and velarium suspended by the frenula, occur exclusively in the gastrovascular system of extant cubozoans, indicating a cubozoan affinity for these fossils. Additionally, the interior anatomy of these embryonic cubozoan fossils unprecedentedly exhibits the development of many new septum-derived lamellae and well-partitioned gastric pockets unknown in living cubozoans, implying that ancestral cubozoans had already evolved highly specialized structures displaying unexpected complexity at the dawn of the Cambrian. The well-developed endodermic lamellae and gastric pockets developed in the late embryonic stages of these cubozoan fossils are comparable with extant pelagic juvenile cubomedusae rather than sessile cubopolyps, whcih indicates a direct development in these fossil taxa, lacking characteristic stages of a typical cnidarian metagenesis such as planktonic planula and sessile polyps.	[Han, Jian; Yang, Xiaoguang; Shu, Degan] Northwest Univ, Early Life Inst, Xian, Peoples R China; [Han, Jian; Yang, Xiaoguang; Shu, Degan] Northwest Univ, Dept Geol, Xian, Peoples R China; [Han, Jian] Northwest Univ, State Key Lab Continental Dynam, Xian, Peoples R China; [Kubota, Shin] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Li, Guoxiang] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Yao, Xiaoyong; Li, Yong] Changan Univ, Minist Educ, Sch Earth Sci & Land Resources, Key Lab Western Chinas Mineral Resources & Geol E, Xian, Peoples R China; [Komiya, Tsuyoshi] Tohoku Univ, Tohoku Univ Museum, Aoba Ku, Sendai, Miyagi 980, Japan; [Yan, Gang] Univ Tokyo, Graduated Sch Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo, Japan; China Natl Petr Corp, Key Lab Unconvent Oil & Gas, Langfang, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Northwest University Xi'an; Kyoto University; Chinese Academy of Sciences; Chang'an University; Tohoku University; University of Tokyo; China National Petroleum Corporation	Han, J (corresponding author), Northwest Univ, Early Life Inst, Xian, Peoples R China.	elihanj@nwu.edu.cn	Kinoshita, Shunichi/AAJ-3599-2020; Komiya, Tsuyoshi/A-3704-2009; Han, Jian/AAU-4500-2021	Kinoshita, Shunichi/0000-0003-0777-9435; Komiya, Tsuyoshi/0000-0002-4000-0617; Han, Jian/0000-0002-2134-4078; yao, xiaoyong/0000-0002-9329-8955	Natural Science Foundation of China [41272019]; Chinese Academy of Science [KZCX2-EW-115]; Ph.D. Programs Foundation of the Ministry of Education of China [20116101130002]; 973 project [2013CB835002, 2013CB837100]; 111 project [P201102007]; MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); 973 project(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University	This work was supported by the Natural Science Foundation of China (http://www.nsfc.gov.cn) grant 41272019 to J. Han; the Chinese Academy of Science (http://www.cas.ac.cn/) grant KZCX2-EW-115 to G,-X. Li; the Ph.D. Programs Foundation of the Ministry of Education of China (http://www.moe.edu.cn) grant 20116101130002 to D.-59 G. Shu; "973 project" (http://www.most.gov.cn) grants 2013CB835002, 2013CB837100 to J. Han and X.Y. Yao, "111 project" (http://www.safea.gov.cn) grant P201102007 to D. G. Shu, and the MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University http://geology.nwu.edu.cn) to J. Han and D.-G. Shu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; BERRILL M, 1963, CAN J ZOOLOG, V41, P741, DOI 10.1139/z63-046; BERRILL NJ, 1949, BIOL REV, V24, P393, DOI 10.1111/j.1469-185X.1949.tb00581.x; Burkenroad MD, 1931, BIOL BULL-US, V61, P115, DOI 10.2307/1537049; Byrne M, 2002, PHYLUM ECHINODERMATA, P481; Byrum C.A., 2004, P33; Caron JB, 2010, PLOS ONE, V5, pA189, DOI 10.1371/journal.pone.0009586; Cartwright P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001121; CHAPMAN DM, 1978, HELGOLAND WISS MEER, V31, P128, DOI 10.1007/BF02296994; Chapman DM, 1999, CAN J ZOOL, V77, P34, DOI 10.1139/cjz-77-1-34; Chapman DM, 2001, CAN J ZOOL, V79, P623, DOI 10.1139/cjz-79-4-623; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins Allen G., 2009, Smithsonian Contributions to the Marine Sciences, P139; Conant F. S., 1898, CUBOMEDUSAE MEMORIAL; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dong X.-P., 2013, P ROYAL SOC B, P280; Dong Xi-ping, 2009, Acta Palaeontologica Sinica, V48, P390; Emlet R, 2002, PHYLUM ECHINODERMATA, P531; Gershwin L., 2005, Memoirs of the Queensland Museum, V51, P501; Gershwin Lisa-Ann, 2006, Beagle, V22, P15; Han JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013276; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Hua H, 2004, CHINESE SCI BULL, V49, P487, DOI 10.1007/BF02900970; Hyman LH., 1940, INVERTEBRATES; Jarms G, 1999, SARSIA, V84, P55, DOI 10.1080/00364827.1999.10420451; Kouchinsky A, 2009, J SYST PALAEONTOL, V7, P241, DOI 10.1017/S1477201909002715; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Marques AC, 2004, INVERTEBR BIOL, V123, P23; McEdward L, 2002, PHYLUM ECHINODERMATA, P499; MOORE S J, 1988, Beagle, V5, P1; Morandini AC, 2004, HYDROBIOLOGIA, V530, P347, DOI 10.1007/s10750-004-2694-0; [钱逸 QIAN Yi], 2007, [微体古生物学报, Acta Micropalaeontologica Sinica], V24, P222; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Scrutton Colin, 1999, Geology Today, V15, P184, DOI 10.1046/j.1365-2451.1999.1505005.x; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Steiner M, 2004, GEOBIOS-LYON, V37, P259, DOI 10.1016/j.geobios.2003.08.001; Thiel H, 1966, EVOLUTION SCYPHOZOA, P77; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Uchida T., 1933, Journal of the Faculty of Science Hokkaido Zoology, V2, P135; Uchida T., 1928, ANNOTATIONES ZOOLOGI, V2, P373; UCHIDA TOHRU, 1929, JAPANESE JOUR ZOOL, V2, P103; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Yamaguchi M., 1980, P11; Yao XY, 2011, GONDWANA RES, V20, P844, DOI 10.1016/j.gr.2011.04.003; Young Graham A., 2010, Palaeoworld, V19, P212, DOI 10.1016/j.palwor.2010.09.014; Yue Z., 1999, LETHAIA, V32, P181, DOI DOI 10.1111/J.1502-3931.1999.TB00538.X; Zhao Y, 2010, J INFORM, V84	54	31	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70741	10.1371/journal.pone.0070741	http://dx.doi.org/10.1371/journal.pone.0070741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950993	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300043
J	Humbert, JF; Barbe, V; Latifi, A; Gugger, M; Calteau, A; Coursin, T; Lajus, A; Castelli, V; Oztas, S; Samson, G; Longin, C; Medigue, C; de Marsac, NT				Humbert, Jean-Francois; Barbe, Valerie; Latifi, Amel; Gugger, Muriel; Calteau, Alexandra; Coursin, Therese; Lajus, Aurelie; Castelli, Vanina; Oztas, Sophie; Samson, Gaelle; Longin, Cyrille; Medigue, Claudine; de Marsac, Nicole Tandeau			A Tribute to Disorder in the Genome of the Bloom-Forming Freshwater Cyanobacterium Microcystis aeruginosa	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; TOXIC CYANOBACTERIUM; GENETIC DIVERSITY; PROCHLOROCOCCUS; EVOLUTION; ECOLOGY; BIOSYNTHESIS; POPULATIONS; POLYKETIDE; PHYSIOLOGY	Microcystis aeruginosa is one of the most common bloom-forming cyanobacteria in freshwater ecosystems worldwide. This species produces numerous secondary metabolites, including microcystins, which are harmful to human health. We sequenced the genomes of ten strains of M. aeruginosa in order to explore the genomic basis of their ability to occupy varied environments and proliferate. Our findings show that M. aeruginosa genomes are characterized by having a large open pangenome, and that each genome contains similar proportions of core and flexible genes. By comparing the GC content of each gene to the mean value of the whole genome, we estimated that in each genome, around 11% of the genes seem to result from recent horizontal gene transfer events. Moreover, several large gene clusters resulting from HGT (up to 19 kb) have been found, illustrating the ability of this species to integrate such large DNA molecules. It appeared also that all M. aeruginosa displays a large genomic plasticity, which is characterized by a high proportion of repeat sequences and by low synteny values between the strains. Finally, we identified 13 secondary metabolite gene clusters, including three new putative clusters. When comparing the genomes of Microcystis and Prochlorococcus, one of the dominant picocyanobacteria living in marine ecosystems, our findings show that they are characterized by having almost opposite evolutionary strategies, both of which have led to ecological success in their respective environments.	[Humbert, Jean-Francois; Gugger, Muriel; Coursin, Therese; de Marsac, Nicole Tandeau] Inst Pasteur, CNRS, Unite Rech Associee 2172, Unite Cyanobacteries, Paris, France; [Barbe, Valerie; Castelli, Vanina; Oztas, Sophie; Samson, Gaelle] Commissariat Energie Atom & Energies Alternat Gen, Inst Genom, Evry, France; [Latifi, Amel; de Marsac, Nicole Tandeau] Aix Marseille Univ, CNRS, Lab Chim Bacterienne, Unite Mixte Rech 7283, Marseille, France; [Calteau, Alexandra; Lajus, Aurelie; Longin, Cyrille; Medigue, Claudine] CNRS, Commissariat Energie Atom & Energies Alternat Gen, Lab Anal Bioinformat Genom & Metab, Unite Mixte Rech 8030, Evry, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Humbert, JF (corresponding author), INRA, Unite Mixte Rech Bioemco, Paris, France.	humbert@biologie.ens.fr		CALTEAU, Alexandra/0000-0002-5871-9347; Gugger, Muriel/0000-0001-6728-1976; Humbert, Jean-Francois/0000-0002-1519-5651				Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guljamow A, 2007, CURR BIOL, V17, pR757, DOI 10.1016/j.cub.2007.06.063; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Handel A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-236; Hu JH, 2009, MOL BIOL EVOL, V26, P5, DOI 10.1093/molbev/msn217; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kim DK, 2007, ECOL MODEL, V203, P147, DOI 10.1016/j.ecolmodel.2006.03.040; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kuiper-Goodman T., 1999, TOXIC CYANOBACTERIA, P125; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Luo HW, 2011, MOL BIOL EVOL, V28, P2751, DOI 10.1093/molbev/msr081; Malmstrom RR, 2013, ISME J, V7, P184, DOI 10.1038/ismej.2012.89; Martins J, 2009, APPL MICROBIOL BIOT, V82, P951, DOI 10.1007/s00253-009-1877-z; Mendonca AG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001082; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Nishizawa A, 2007, J GEN APPL MICROBIOL, V53, P17, DOI 10.2323/jgam.53.17; Otsuka Shigeto, 1998, Physiological Research, V46, P45, DOI 10.1046/j.1440-1835.1998.00124.x; Paul S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-103; Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z; Portmann C, 2008, J NAT PROD, V71, P1193, DOI 10.1021/np800118g; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Straub C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016208; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Vicente M, 2008, ENVIRON MICROBIOL, V10, P1663, DOI 10.1111/j.1462-2920.2008.01635.x; Welker M, 2004, MICROBIOL-SGM, V150, P1785, DOI 10.1099/mic.0.26947-0; Welker M, 2006, PEPTIDES, V27, P2090, DOI 10.1016/j.peptides.2006.03.014; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Ziemert N, 2010, APPL ENVIRON MICROB, V76, P3568, DOI 10.1128/AEM.02858-09; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205	58	110	110	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70747	10.1371/journal.pone.0070747	http://dx.doi.org/10.1371/journal.pone.0070747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950996	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300045
J	Kidwai, AS; Mushamiri, I; Niemann, GS; Brown, RN; Adkins, JN; Heffron, F				Kidwai, Afshan S.; Mushamiri, Ivy; Niemann, George S.; Brown, Roslyn N.; Adkins, Joshua N.; Heffron, Fred			Diverse Secreted Effectors Are Required for Salmonella Persistence in a Mouse Infection Model	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL VIRULENCE GENES; III SECRETION; PATHOGENICITY ISLAND-2; TRANSLOCATED EFFECTORS; HOST; PROTEIN; IDENTIFICATION; ACTIN; SYSTEM	Salmonella enterica serovar Typhimurium causes typhoid-like disease in mice and is a model of typhoid fever in humans. One of the hallmarks of typhoid is persistence, the ability of the bacteria to survive in the host weeks after infection. Virulence factors called effectors facilitate this process by direct transfer to the cytoplasm of infected cells thereby subverting cellular processes. Secretion of effectors to the cell cytoplasm takes place through multiple routes, including two separate type III secretion (T3SS) apparati as well as outer membrane vesicles. The two T3SS are encoded on separate pathogenicity islands, SPI-1 and -2, with SPI-1 more strongly associated with the intestinal phase of infection, and SPI-2 with the systemic phase. Both T3SS are required for persistence, but the effectors required have not been systematically evaluated. In this study, mutations in 48 described effectors were tested for persistence. We replaced each effector with a specific DNA barcode sequence by allelic exchange and co-infected with a wild-type reference to calculate the ratio of wildtype parent to mutant at different times after infection. The competitive index (CI) was determined by quantitative PCR in which primers that correspond to the barcode were used for amplification. Mutations in all but seven effectors reduced persistence demonstrating that most effectors were required. One exception was CigR, a recently discovered effector that is widely conserved throughout enteric bacteria. Deletion of cigR increased lethality, suggesting that it may be an anti-virulence factor. The fact that almost all Salmonella effectors are required for persistence argues against redundant functions. This is different from effector repertoires in other intracellular pathogens such as Legionella.	[Kidwai, Afshan S.; Mushamiri, Ivy; Niemann, George S.; Heffron, Fred] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Brown, Roslyn N.] Washington State Univ, Ctr Bioprod & Bioenergy, Richland, WA USA; [Adkins, Joshua N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Oregon Health & Science University; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Heffron, F (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	heffronf@ohsu.edu	MUSHAMIRI, IVY/AAJ-4612-2021	Adkins, Joshua/0000-0003-0399-0700	 [RO1 AI 022933];  [UO1 GM 094623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094623] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by RO1 AI 022933 and UO1 GM 094623 (PSI Biology of secreted effectors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Brumell JH, 2001, TRAFFIC, V2, P643, DOI 10.1034/j.1600-0854.2001.20907.x; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; DUNLAP NE, 1992, MICROB PATHOGENESIS, V13, P181, DOI 10.1016/0882-4010(92)90019-K; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Gog JR, 2012, J R SOC INTERFACE, V9, P2696, DOI 10.1098/rsif.2012.0163; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; GULIG PA, 1992, MOL MICROBIOL, V6, P1395, DOI 10.1111/j.1365-2958.1992.tb00860.x; GUNN JS, 1995, J BACTERIOL, V177, P5040, DOI 10.1128/jb.177.17.5040-5047.1995; Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3; Heffron F, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P187; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Jiang XJ, 2004, MOL MICROBIOL, V54, P1186, DOI 10.1111/j.1365-2958.2004.04344.x; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee AH, 2002, CELL MICROBIOL, V4, P739, DOI 10.1046/j.1462-5822.2002.00225.x; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P396, DOI 10.1099/00221287-16-2-396; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Unsworth KE, 2000, PHILOS T R SOC B, V355, P613, DOI 10.1098/rstb.2000.0602; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Weigele BA, 2010, CELL HOST MICROBE, V7, P421, DOI 10.1016/j.chom.2010.06.001; Wood MW, 2000, CELL MICROBIOL, V2, P293, DOI 10.1046/j.1462-5822.2000.00054.x; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10; Yoon H, 2011, INFECT IMMUN, V79, P360, DOI 10.1128/IAI.00873-10; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	84	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70753	10.1371/journal.pone.0070753	http://dx.doi.org/10.1371/journal.pone.0070753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950998	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300047
J	Luo, QL; Qu, C				Luo, Qiuling; Qu, Chen			Comparison Enhances Size Sensitivity: Neural Correlates of Outcome Magnitude Processing	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; MEDIAL FRONTAL-CORTEX; BRAIN POTENTIALS; RESPONSES; STIMULI; VALENCE; ABSENCE; LOSSES; SYSTEM; GAINS	Magnitude is a critical feature of outcomes. In the present study, two event-related potential (ERP) experiments were implemented to explore the neural substrates of outcome magnitude processing. In Experiment 1, we used an adapted gambling paradigm where physical area symbols were set to represent potential relative outcome magnitudes in order to exclude the possibility that the participants would be ignorant of the magnitudes. The context was manipulated as total monetary amount: (sic)4 and (sic)40. In these two contexts, the relative outcome magnitudes were (sic)1 versus (sic)3, and (sic)10 versus (sic)30, respectively. Experiment 2, which provided two area symbols with similar outcome magnitudes, was conducted to exclude the possible interpretation of physical area symbol for magnitude effect of feedback-related negativity (FRN) in Experiment 1. Our results showed that FRN responded to the relative outcome magnitude but not to the context or area symbol, with larger amplitudes for relatively small outcomes. A larger FRN effect (the difference between losses and wins) was found for relatively large outcomes than relatively small outcomes. Relatively large outcomes evoked greater positive ERP waves (P300) than relatively small outcomes. Furthermore, relatively large outcomes in a high amount context elicited a larger P300 than those in a low amount context. The current study indicated that FRN is sensitive to variations in magnitude. Moreover, relative magnitude was integrated in both the early and late stages of feedback processing, while the monetary amount context was processed only in the late stage of feedback processing.	[Luo, Qiuling; Qu, Chen] S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University	Qu, C (corresponding author), S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.	chenqu@scnu.edu.cn			National Natural Science Foundation [31000504]; Humanities and Social Science Research Foundation of the Ministry of Education of China [09YJXL008]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Research Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation (Grant No. 31000504), the Humanities and Social Science Research Foundation of the Ministry of Education of China (Grant No. 09YJXL008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellebaum C, 2010, NEUROPSYCHOLOGIA, V48, P3343, DOI 10.1016/j.neuropsychologia.2010.07.023; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; Chen R, 2005, MARKET LETT, V16, P5, DOI 10.1007/s11002-005-1137-7; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gu R, 2011, NEUROPSYCHOLOGIA; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; HOGARTH RM, 1990, MANAGE SCI, V36, P780, DOI 10.1287/mnsc.36.7.780; Holroyd CB, 2002, SCIENCE, V296, P1610, DOI 10.1126/science.296.5573.1610; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Jia SW, 2007, NEUROREPORT, V18, P1385, DOI 10.1097/WNR.0b013e3282c48a90; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Leng Y, 2010, NEUROPSYCHOLOGIA, V48, P448, DOI 10.1016/j.neuropsychologia.2009.10.002; Li P, 2011, PSYCHOPHYSIOLOGY, V48, P1129, DOI 10.1111/j.1469-8986.2011.01182.x; [李小平 LI Xiao-Ping], 2009, [心理学报, Acta Psychologica Sinica], V41, P196; Ma QG, 2011, NEUROIMAGE, V54, P2472, DOI 10.1016/j.neuroimage.2010.10.045; Markowitz H, 1952, J POLIT ECON, V60, P151, DOI 10.1086/257177; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Shenhav A, 2010, NEURON, V67, P667, DOI 10.1016/j.neuron.2010.07.020; Stoppel CM, 2011, BRAIN RES; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yu RJ, 2007, PROG NAT SCI-MATER, V17, P136	33	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71186	10.1371/journal.pone.0071186	http://dx.doi.org/10.1371/journal.pone.0071186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951108	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300097
J	Springall, R; Amezcua-Guerra, LM; Gonzalez-Pacheco, H; Furuzawa-Carballeda, J; Gomez-Garcia, L; Marquez-Velasco, R; Mejia-Dominguez, AM; Cossio-Aranda, J; Martinez-Sanchez, C; Bojalil, R				Springall, Rashidi; Amezcua-Guerra, Luis M.; Gonzalez-Pacheco, Hector; Furuzawa-Carballeda, Janette; Gomez-Garcia, Lorena; Marquez-Velasco, Ricardo; Maria Mejia-Dominguez, Ana; Cossio-Aranda, Jorge; Martinez-Sanchez, Carlos; Bojalil, Rafael			Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; INFLUENZA VACCINATION; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE-9; PLAQUE; EXPRESSION; INFECTION; OUTCOMES; ENGLAND; EVENTS	Acute coronary syndromes (ACS) may be triggered by acute infections. Systemic production of interferon gamma (IFN-gamma) is induced during infection and regulates the production of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), both important in plaque stability. This study evaluates the effect of IFN-gamma on the MMPs/TIMP-1 ratio in cultured monocytes from 30 patients with stable coronary artery disease (CAD), 30 with unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI), and 30 healthy blood donors. Supernatant concentrations of MMP-1, -2, -9, and TIMP-1 were measured by enzyme-linked immunoassays. Basal concentration of MMP-1 and TIMP-1 was similar between groups, while MMP-2 was higher in healthy individuals and MMP-9 in patients with UA/NSTEMI. Upon IFN-gamma stimulation, MMP-9 secretion increased in all groups, while TIMP-1 decreased only in patients with CAD, which in turn result in a strikingly elevation in their mean MMP-9/TIMP-1 ratio. MMP-1/TIMP-1 and MMP-2/TIMP-1 ratios were <1.0 in basal conditions and after stimulation in all groups. Our results suggest that nonstimulated monocytes from patients with stable CAD show a similar behavior than those from healthy individuals. However, stimulation with IFN-gamma induces an increase on the MMP-9/TIMP-1 ratio as high as that found in patients with ACS. Thus, it may bring biological plausibility to the association between acute infections and the development of ACS.	[Springall, Rashidi; Amezcua-Guerra, Luis M.; Gomez-Garcia, Lorena; Marquez-Velasco, Ricardo; Bojalil, Rafael] Inst Nacl Cardiol Ignacio, Dept Immunol, Mexico City, DF, Mexico; [Gonzalez-Pacheco, Hector; Martinez-Sanchez, Carlos] Inst Nacl Cardiol Ignacio, Coronary Care Unit, Mexico City, DF, Mexico; [Furuzawa-Carballeda, Janette] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Maria Mejia-Dominguez, Ana] Inst Nacl Cardiol Ignacio, Blood Bank Unit, Mexico City, DF, Mexico; [Cossio-Aranda, Jorge] Inst Nacl Cardiol Ignacio, Cardiol Outpatient Clin, Mexico City, DF, Mexico; [Bojalil, Rafael] Univ Autonoma Metropolitana Xochimilco, Dept Hlth Care, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma Metropolitana - Mexico	Bojalil, R (corresponding author), Inst Nacl Cardiol Ignacio, Dept Immunol, Mexico City, DF, Mexico.	bojraf@yahoo.com	Furuzawa-Carballeda, Janette/AAC-5382-2019; Amezcua-Guerra, Luis Manuel/AAH-7127-2020; Gonzalez-Pacheco, Hector/AAO-1965-2021	Furuzawa-Carballeda, Janette/0000-0001-5804-7221; Amezcua-Guerra, Luis Manuel/0000-0002-6258-5732; Gonzalez-Pacheco, Hector/0000-0002-4370-9963	Biomedical Research PhD Program at Universidad Nacional Autonoma de Mexico (UNAM); CONACyT scholarship	Biomedical Research PhD Program at Universidad Nacional Autonoma de Mexico (UNAM); CONACyT scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	RS is in the Biomedical Research PhD Program at Universidad Nacional Autonoma de Mexico (UNAM), and was recipient of a CONACyT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Bench TJ, 2011, PHARMACOL RES, V64, P561, DOI 10.1016/j.phrs.2011.05.002; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Cheng M, 2008, CAN J CARDIOL, V24, P385, DOI 10.1016/S0828-282X(08)70602-0; Choudhary S, 2006, ARTERIOSCL THROM VAS, V26, P2351, DOI 10.1161/01.ATV.0000239461.87113.0b; Ciszewski A, 2008, EUR HEART J, V29, P1350, DOI 10.1093/eurheartj/ehm581; de Oliveira RTD, 2009, INT J CARDIOL, V136, P17, DOI 10.1016/j.ijcard.2008.04.009; Gurfinkel EP, 2004, EUR HEART J, V25, P25, DOI 10.1016/j.ehj.2003.10.018; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; HANSON MA, 2013, CLIN PERINATOL, V40, P1, DOI DOI 10.1016/J.P0P.2012.12.001.PUBMED:23402459; Sánchez-Diaz Carlos Jerjes, 2012, Arch. Cardiol. Méx., V82, P14; Kelly D, 2008, EUR HEART J, V29, P2116, DOI 10.1093/eurheartj/ehn315; Kelly D, 2007, EUR HEART J, V28, P711, DOI 10.1093/eurheartj/ehm003; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Natarajan P, 2011, EUR HEART J, V32, P1701, DOI 10.1093/eurheartj/ehr053; Pedersen ER, 2011, ARTERIOSCL THROM VAS, V31, P698, DOI 10.1161/ATVBAHA.110.219329; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; SHAPIRO SD, 1990, J CLIN INVEST, V86, P1204, DOI 10.1172/JCI114826; Siriwardena AN, 2012, J INFECT DIS, V206, P1636, DOI 10.1093/infdis/jis598; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Werba JP, 2008, ATHEROSCLEROSIS, V196, P835, DOI 10.1016/j.atherosclerosis.2007.01.033; Zhang L, 2011, EUR J CARDIO-THORAC, V40, P17, DOI 10.1016/j.ejcts.2010.09.019; Zhou J, 1999, SCAND J CLIN LAB INV, V59, P3	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72291	10.1371/journal.pone.0072291	http://dx.doi.org/10.1371/journal.pone.0072291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951304	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300186
J	Ssemwanga, D; Nsubuga, RN; Mayanja, BN; Lyagoba, F; Magambo, B; Yirrell, D; Van der Paal, L; Grosskurth, H; Kaleebu, P				Ssemwanga, Deogratius; Nsubuga, Rebecca N.; Mayanja, Billy N.; Lyagoba, Frederick; Magambo, Brian; Yirrell, Dave; Van der Paal, Lieve; Grosskurth, Heiner; Kaleebu, Pontiano			Effect of HIV-1 Subtypes on Disease Progression in Rural Uganda: A Prospective Clinical Cohort Study	PLOS ONE			English	Article							GENETIC SUBTYPES; RAKAI DISTRICT; VIRAL SUBTYPE; TYPE-1; INDIVIDUALS; SURVIVAL; EPIDEMIOLOGY; CHALLENGE; DIVERSITY; INFECTION	Objective: We examined the association of HIV-1 subtypes with disease progression based on three viral gene regions. Design: A prospective HIV-1 clinical cohort study in rural Uganda. Methods: Partial gag, env and pol genes were sequenced. Cox proportional hazard regression modelling was used to estimate adjusted hazard ratios (aHRs) of progression to: CD4 <= 250, AIDS onset and death, adjusted for sex, age and CD4 count at enrolment. Results: Between 1990 and 2010, 292 incident cases were subtyped: 25% had subtype A, 45% had D, 26% had A/D recombinants, 1% had C and 4% were other recombinant forms. Of the 278 incident cases included in the disease progression analysis, 62% progressed to CD4 <= 250, 32% to AIDS, and 34% died with a higher proportion being among subtype D cases. The proportions of individuals progressing to the three endpoints were significantly higher among individuals infected with subtype D. Throughout the study period, individuals infected with subtype D progressed faster to CD4 <= 250, adjusted HR (aHR), (95% CI) = 1.72 (1.16-2.54), but this was mainly due to events in the period before antiretroviral therapy (ART) introduction, when individuals infected with subtype D significantly progressed faster to CD4 <= 250 than subtype A cases; aHR (95% CI) = 1.78 (1.01-3.14). Conclusions: In this population, HIV-1 subtype D was the most prevalent and was associated with faster HIV-1 disease progression than subtype A. Further studies are needed to examine the effect of HIV-1 subtypes on disease progression in the ART period and their effect on the virological and immunological ART outcomes.	[Ssemwanga, Deogratius; Nsubuga, Rebecca N.; Mayanja, Billy N.; Lyagoba, Frederick; Magambo, Brian; Grosskurth, Heiner; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Yirrell, Dave] Ninewells Hosp, Dept Med Microbiol, Dundee DD1 9SY, Scotland; [Van der Paal, Lieve] Int Rescue Comm, Dar Es Salaam, Tanzania; [Grosskurth, Heiner; Kaleebu, Pontiano] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Uganda Virus Research Institute; University of Dundee; University of London; London School of Hygiene & Tropical Medicine	Kaleebu, P (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	Pontiano.Kaleebu@mrcuganda.org	Mayanja, Billy/AAL-5087-2021	Grosskurth, Heiner/0000-0001-9960-7280; Ssemwanga, Deogratius/0000-0001-9675-4234	Medical Research Council UK; Medical Research Council [MC_U950097144, MC_U950080928, MC_U950080937] Funding Source: researchfish; MRC [MC_U950080937, MC_U950080928, MC_U950097144] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Medical Research Council UK. (http://www.mrcuganda.org/home.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 1999, AIDS, V13, P901, DOI 10.1097/00002030-199905280-00005; Alaeus A, 2000, SCAND J INFECT DIS, V32, P455, DOI 10.1080/003655400458695; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Carr JK, 2006, CURR OPIN HIV AIDS, V1, P294, DOI 10.1097/01.COH.0000232344.23533.be; Conroy SA, 2010, AIDS RES HUM RETROV, V26, P1087, DOI 10.1089/aid.2010.0054; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hoffman T L, 1998, AIDS, V12 Suppl A, pS17; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Kaleebu P, 2000, AIDS RES HUM RETROV, V16, P393, DOI 10.1089/088922200309052; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kapaata A, 2012, AIDS RES HUMAN RETRO; Kitchen Maria, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P17, DOI 10.1177/1545109707303989; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Lutalo T, 2007, AIDS, V21, pS15, DOI 10.1097/01.aids.0000299406.44775.de; Mbulaiteye SM, 2002, INT J EPIDEMIOL, V31, P961, DOI 10.1093/ije/31.5.961; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Metallidis S TO, 2013, INT J INFECT DIS, DOI [00110.01016/j.ijid.02013.00102.00023, DOI 10.01016/J.IJID.02013.00102.00023.[]; Ministry of Health Republic of Uganda, 2003, NAT ANT TREATM CAR G; Ministry of Health Republic of Uganda, 2008, NAT ANT TREATM CAR G; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; MULDER DW, 1994, AIDS, V8, P87, DOI 10.1097/00002030-199401000-00013; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; [World Health Organization; WHO UNAIDS UNICEF], 2011, EP UPD HLTH SECT PRO; Wright E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019902; Yirrell DL, 2004, INT J STD AIDS, V15, P103, DOI 10.1258/095646204322764299; Yirrell DL, 2002, AIDS, V16, P279, DOI 10.1097/00002030-200201250-00018	45	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71768	10.1371/journal.pone.0071768	http://dx.doi.org/10.1371/journal.pone.0071768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951241	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323097300155
J	Al-Saraireh, YMJ; Sutherland, M; Springett, BR; Freiberger, F; Morais, GR; Loadman, PM; Errington, RJ; Smith, PJ; Fukuda, M; Gerardy-Schahn, R; Patterson, LH; Shnyder, SD; Falconer, RA				Al-Saraireh, Yousef M. J.; Sutherland, Mark; Springett, Bradley R.; Freiberger, Friedrich; Morais, Goreti Ribeiro; Loadman, Paul M.; Errington, Rachel J.; Smith, Paul J.; Fukuda, Minoru; Gerardy-Schahn, Rita; Patterson, Laurence H.; Shnyder, Steven D.; Falconer, Robert A.			Pharmacological Inhibition of polysialyltransferase ST8SiaII Modulates Tumour Cell Migration	PLOS ONE			English	Article							ADHESION MOLECULE POLYSIALYLATION; POLYSIALIC ACID SYNTHESIS; IN-VITRO; NEURONAL DIFFERENTIATION; NCAM POLYSIALYLATION; II STX; EXPRESSION; GROWTH; CANCER; BIOSYNTHESIS	Polysialic acid (polySia), an alpha-2,8-glycosidically linked polymer of sialic acid, is a developmentally regulated post-translational modification predominantly found on NCAM (neuronal cell adhesion molecule). Whilst high levels are expressed during development, peripheral adult organs do not express polySia-NCAM. However, tumours of neural crest-origin re-express polySia-NCAM: its occurrence correlates with aggressive and invasive disease and poor clinical prognosis in different cancer types, notably including small cell lung cancer (SCLC), pancreatic cancer and neuroblastoma. In neuronal development, polySia-NCAM biosynthesis is catalysed by two polysialyltransferases, ST8SiaII and ST8SiaIV, but it is ST8SiaII that is the prominent enzyme in tumours. The aim of this study was to determine the effect of ST8SiaII inhibition by a small molecule on tumour cell migration, utilising cytidine monophosphate (CMP) as a tool compound. Using immunoblotting we showed that CMP reduced ST8iaII-mediated polysialylation of NCAM. Utilizing a novel HPLC-based assay to quantify polysialylation of a fluorescent acceptor (DMB-DP3), we demonstrated that CMP is a competitive inhibitor of ST8SiaII (K-i = 10 mu M). Importantly, we have shown that CMP causes a concentration-dependent reduction in tumour cell-surface polySia expression, with an absence of toxicity. When ST8SiaII-expressing tumour cells (SH-SY5Y and C6-STX) were evaluated in 2D cell migration assays, ST8SiaII inhibition led to significant reductions in migration, while CMP had no effect on cells not expressing ST8SiaII (DLD-1 and C6-WT). The study demonstrates for the first time that a polysialyltransferase inhibitor can modulate migration in ST8SiaII-expressing tumour cells. We conclude that ST8SiaII can be considered a druggable target with the potential for interfering with a critical mechanism in tumour cell dissemination in metastatic cancers.	[Al-Saraireh, Yousef M. J.; Sutherland, Mark; Springett, Bradley R.; Morais, Goreti Ribeiro; Loadman, Paul M.; Patterson, Laurence H.; Shnyder, Steven D.; Falconer, Robert A.] Univ Bradford, Inst Canc Therapeut, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Freiberger, Friedrich; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, Hannover, Germany; [Errington, Rachel J.; Smith, Paul J.] Cardiff Univ, Sch Med, Inst Canc & Genet, Cardiff CF10 3AX, S Glam, Wales; [Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, Ctr Canc, La Jolla, CA USA	University of Bradford; Hannover Medical School; Cardiff University; Sanford Burnham Prebys Medical Discovery Institute	Falconer, RA (corresponding author), Univ Bradford, Inst Canc Therapeut, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.	r.a.falconer1@bradford.ac.uk	Shnyder, Steven D/B-9084-2009; Morais, Goreti Ribeiro/K-3362-2012; Falconer, Robert A/I-8350-2012	Morais, Goreti Ribeiro/0000-0002-5097-4933; Falconer, Robert A/0000-0002-6426-4430; Loadman, Paul/0000-0002-4259-8616; Shnyder, Steven/0000-0002-4647-2340	Jordanian government; Engineering and Physical Sciences Research Council; Association for International Cancer Research; Yorkshire Cancer Research	Jordanian government; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Association for International Cancer Research; Yorkshire Cancer Research	This work was supported, in part, by a PhD studentship awarded by the Jordanian government (to YMJA) and grants from the Engineering and Physical Sciences Research Council (to RAF), Association for International Cancer Research (to RAF) and Yorkshire Cancer Research (to LHP, PML, SDS and RAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Bork K, 2007, J NEUROCHEM, V103, P65, DOI 10.1111/j.1471-4159.2007.04711.x; Brooks SA, 2008, ANTI-CANCER AGENT ME, V8, P2, DOI 10.2174/187152008783330860; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Campodonico PB, 2010, MOL CARCINOGEN, V49, P386, DOI 10.1002/mc.20611; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Charter NW, 2002, J BIOL CHEM, V277, P9255, DOI 10.1074/jbc.M111619200; Cheung IY, 2006, INT J CANCER, V119, P152, DOI 10.1002/ijc.21789; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; Daniel L, 2000, CANCER RES, V60, P80; Daniel L, 2001, ONCOGENE, V20, P997, DOI 10.1038/sj.onc.1204176; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Eggers K, 2011, J CELL SCI, V124, P3279, DOI 10.1242/jcs.084863; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jokilammi A, 2004, J IMMUNOL METHODS, V295, P149, DOI 10.1016/j.jim.2004.10.006; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; Kojima N, 1996, J BIOL CHEM, V271, P22058, DOI 10.1074/jbc.271.36.22058; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Li J, 2011, GLYCOBIOLOGY, V21, P1010, DOI 10.1093/glycob/cwr020; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LIPINSKI M, 1987, INT J CANCER, V40, P81, DOI 10.1002/ijc.2910400115; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; Mayanil CSK, 2000, J BIOL CHEM, V275, P23259, DOI 10.1074/jbc.M002975200; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Miyazaki T, 2008, GLYCOBIOLOGY, V18, P187, DOI 10.1093/glycob/cwm132; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Pon RA, 2007, GLYCOBIOLOGY, V17, P249, DOI 10.1093/glycob/cwl075; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Schreiber SC, 2008, GASTROENTEROLOGY, V134, P1555, DOI 10.1053/j.gastro.2008.02.023; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Shriver Z, 2004, NAT REV DRUG DISCOV, V3, P863, DOI 10.1038/nrd1521; Storms SD, 1998, J BIOL CHEM, V273, P27124, DOI 10.1074/jbc.273.42.27124; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tanaka F, 2000, CANCER RES, V60, P3072; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; THOMPSON MG, 2011, PUBMED, V286, P4525, DOI DOI 10.1074/JBC.M110.200386; Valentiner U, 2011, INT J ONCOL, V39, P417, DOI 10.3892/ijo.2011.1038; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yarema KJ, 2001, GENOME BIOL, V2; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	71	40	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73366	10.1371/journal.pone.0073366	http://dx.doi.org/10.1371/journal.pone.0073366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951351	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000326473200089
J	Xie, P				Xie, Ping			Dynamics of Forward and Backward Translocation of mRNA in the Ribosome	PLOS ONE			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI; GTP HYDROLYSIS; HYBRID-STATE; TRANSLATION; MOVEMENT; MECHANISMS; COMPLEXES; CYTOPLASM; VISCOSITY	Translocation of the mRNA-tRNA complex in the ribosome, which is catalyzed by elongation factor EF-G, is one of critical steps in the elongation cycle of protein synthesis. Besides this conventional forward translocation, the backward translocation can also occur, which can be catalyzed by elongation factor LepA. However, the molecular mechanism of the translocation remains elusive. To understand the mechanism, here we study theoretically the dynamics of the forward translocation under various nucleotide states of EF-G and the backward translocation in the absence of and in the presence of LepA. We present a consistent explanation of spontaneous forward translocations in the absence of EF-G, the EF-G-catalyzed forward translocations in the presence of a non-hydrolysable GTP analogue and in the presence of GTP, and the spontaneous and LepA-catalyzed backward translocation. The theoretical results provide quantitative explanations of a lot of different, independent experimental data, and also provide testable predictions.	[Xie, Ping] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100080, Peoples R China; [Xie, Ping] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Xie, P (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, POB 603, Beijing 100080, Peoples R China.	pxie@aphy.iphy.ac.cn						Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Gardiner C. W., 1983, HDB STOCHASTIC METHO; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Xie P, 2013, EUR BIOPHYS J BIOPHY, V42, P347, DOI 10.1007/s00249-012-0879-4; Xie P, 2013, J THEOR BIOL, V316, P49, DOI 10.1016/j.jtbi.2012.09.023; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70789	10.1371/journal.pone.0070789	http://dx.doi.org/10.1371/journal.pone.0070789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951009	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200020
J	Nishijima, T; Gatanaga, H; Shimbo, T; Komatsu, H; Endo, T; Horiba, M; Koga, M; Naito, T; Itoda, I; Tei, M; Fujii, T; Takada, K; Yamamoto, M; Miyakawa, T; Tanabe, Y; Mitsuya, H; Oka, S				Nishijima, Takeshi; Gatanaga, Hiroyuki; Shimbo, Takuro; Komatsu, Hirokazu; Endo, Tomoyuki; Horiba, Masahide; Koga, Michiko; Naito, Toshio; Itoda, Ichiro; Tei, Masanori; Fujii, Teruhisa; Takada, Kiyonori; Yamamoto, Masahiro; Miyakawa, Toshikazu; Tanabe, Yoshinari; Mitsuya, Hiroaki; Oka, Shinichi		SPARE Study Team	Switching Tenofovir/Emtricitabine plus Lopinavir/r to Raltegravir plus Darunavir/r in Patients with Suppressed Viral Load Did Not Result in Improvement of Renal Function but Could Sustain Viral Suppression: A Randomized Multicenter Trial	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HIV-INFECTED PATIENTS; NAIVE HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL-NAIVE; TUBULAR DYSFUNCTION; CREATININE CLEARANCE; SPARING REGIMEN; SAFETY; EFFICACY; EFAVIRENZ	Background: Whether tenofovir nephrotoxicity is reversible after its withdrawal is unknown. Furthermore, there are no data on the viral efficacy of raltegravir (RAL) plus ritonavir-boosted Darunavir (DRV/r) in patients with suppressed viral load. Methods: This multicenter, randomized trial compared renal function and viral efficacy in patients with suppressed viral load treated with RAL+DRV/r and ritonavir-boosted lopinavir (LPV/r) plus tenofovir/emtricitabine (TVD), who had been previously on LPV/r+TVD. The primary endpoint was the proportion of patients with >10% improvement in estimated glomerular filtration rate (eGFR) at 48 weeks calculated with Cockcroft-Gault equation. Results: 58 randomized and treatment-exposed patients were analyzed (28 on RAL+DRV/r and 30 on LPV/r+TVD). Greater than 10% improvement in eGFR was noted in 6 (25%) out of 24 with RAL+DRV/r and 3 (11%) of 28 with LPV/r+TVD, and the difference was not statistically significant (p=0.272, 95% CI -0.067 to 0.354). Sensitivity analyses using three other equations for eGFR showed the same results. Urinary beta 2 microglobulin, a sensitive marker of tenofovir tubulopathy, significantly improved with RAL+DRV/r than with LPV/r+TVD (-271 versus -64 mu g/gCr, p=0.026). Per protocol analysis showed that the HIV-RNA was <50 copies/mL at week 48 in all patients of both arms (24 in RAL+DRV and 29 in LPV/r+TVD). Conclusions: Switching LPV/r+TVD to RAL+DRV/r did not significantly increase the proportion of patients who showed >10% improvement in renal function among those with relatively preserved eGFR. However, the switch improved urinary beta 2 microglobulin, suggesting that discontinuation of TDF might be beneficial in the long-term. RAL +DRV/r showed favorable viral efficacy in patients with suppressed viral load.	[Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Sch Med, Ctr AIDS Res, Kumamoto 860, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Study & Informat, Tokyo, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan; [Endo, Tomoyuki] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Hokkaido 060, Japan; [Horiba, Masahide] Higashisaitama Natl Hosp, Div Resp Med, Saitama, Japan; [Koga, Michiko] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo, Japan; [Naito, Toshio] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 113, Japan; [Itoda, Ichiro] Shirakaba Clin, Tokyo, Japan; [Tei, Masanori] Saku Cent Hosp, Dept Integrated Med, Nagano, Japan; [Fujii, Teruhisa] Hiroshima Univ Hosp, Div Blood Transfus, Hiroshima, Japan; [Takada, Kiyonori] Ehime Univ Hosp, Postgrad Clin Training Ctr, Matsuyama, Ehime, Japan; [Yamamoto, Masahiro] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Fukuoka, Japan; [Miyakawa, Toshikazu; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Infect Dis & Hematol, Kumamoto 860, Japan; [Tanabe, Yoshinari] Niigata Univ, Med & Dent Hosp, Div Infect Control & Prevent, Niigata, Japan; [Mitsuya, Hiroaki] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA	National Center for Global Health & Medicine - Japan; Kumamoto University; National Center for Global Health & Medicine - Japan; Hokkaido University; University of Tokyo; Juntendo University; Hiroshima University; Ehime University; Kumamoto University; Niigata University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Oka, S (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	oka@acc.ncgm.go.jp	Naito, Toshio/AAR-5071-2021	Naito, Toshio/0000-0003-1646-9930; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor, and Welfare of Japan [H22-AIDS-001]; NATIONAL CANCER INSTITUTE [ZIASC006738] Funding Source: NIH RePORTER	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Grant-in-Aid for the research on HIV/AIDS (H22-AIDS-001) from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Bonjoch A, 2012, ANTIVIR RES, V96, P65, DOI 10.1016/j.antiviral.2012.07.009; Bredeek UF, 2012, 52 INT C ANT AG CHEM; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Dauchy FA, 2011, KIDNEY INT, V80, P302, DOI 10.1038/ki.2011.124; Fux CA, 2007, ANTIVIR THER, V12, P1165; Fux CA, 2008, ANTIVIR THER, V13, P1077; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Kinai E, 2009, AIDS RES HUM RETROV, V25, P387, DOI 10.1089/aid.2008.0202; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Kudo K, 2011, CLIN EXP NEPHROL, V15, P235, DOI 10.1007/s10157-010-0392-y; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moyle G, 2000, CLIN THER, V22, P911, DOI 10.1016/S0149-2918(00)80064-8; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2013, J INFECT CHEMOTHER; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Nolan D, 2004, ANTIVIR THER, V9, P849; Ofotokun I, 2012, AIDS RES HUM RETROV, V28, P1196, DOI 10.1089/aid.2011.0336; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Taiwo B, 2012, 19 INT AIDS C WASH D; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tressler R, 2012, DRUGS, V72, P2051, DOI 10.2165/11640830-000000000-00000; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Winston A, 2006, HIV MED, V7, P105, DOI 10.1111/j.1468-1293.2006.00349.x	46	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e73639	10.1371/journal.pone.0073639	http://dx.doi.org/10.1371/journal.pone.0073639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951362	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000097
J	Cifuentes, M; Rivard, M; Pereira, L; Chelysheva, L; Mercier, R				Cifuentes, Marta; Rivard, Maud; Pereira, Lucie; Chelysheva, Liudmila; Mercier, Raphael			Haploid Meiosis in Arabidopsis: Double-Strand Breaks Are Formed and Repaired but Without Synapsis and Crossovers	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; THALIANA; PLANTS; GENE; BRASSICA; YEAST; RICE; SEGREGATION	Two hallmark features of meiosis are i) the formation of crossovers (COs) between homologs and ii) the production of genetically-unique haploid spores that will fuse to restore the somatic ploidy level upon fertilization. In this study we analysed meiosis in haploid Arabidopsis thaliana plants and a range of haploid mutants to understand how meiosis progresses without a homolog. Extremely low chiasma frequency and very limited synapsis occurred in wild-type haploids. The resulting univalents segregated in two uneven groups at the first division, and sister chromatids segregated to opposite poles at the second division, leading to the production of unbalanced spores. DNA double-strand breaks that initiate meiotic recombination were formed, but in half the number compared to diploid meiosis. They were repaired in a RAD51- and REC8-dependent manner, but independently of DMC1, presumably using the sister chromatid as a template. Additionally, turning meiosis into mitosis (MiMe genotype) in haploids resulted in the production of balanced haploid gametes and restoration of fertility. The variability of the effect on meiosis of the absence of homologous chromosomes in different organisms is then discussed.	[Cifuentes, Marta; Rivard, Maud; Pereira, Lucie; Chelysheva, Liudmila; Mercier, Raphael] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Cifuentes, Marta; Rivard, Maud; Pereira, Lucie; Chelysheva, Liudmila; Mercier, Raphael] AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Mercier, R (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France.	raphael.mercier@versailles.inra.fr	mercier, Raphael/L-1497-2016	mercier, Raphael/0000-0001-6508-6608; Cifuentes, Marta/0000-0002-3347-0178; Chelysheva, Liudmila/0000-0002-7538-2184	INRA BAP department; European Research Council [ERC 2011 StG 281659 MeioSight]	INRA BAP department; European Research Council(European Research Council (ERC)European Commission)	RM thanks INRA BAP department and the European Research Council (FP7 "Ideas" Specific programme ERC 2011 StG 281659 MeioSight) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K, 1981, THEOR APPL GENET, V52, P49; ARMSTRONG KC, 1982, CAN J GENET CYTOL, V24, P735, DOI 10.1139/g82-079; Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Bai XF, 1999, PLANT CELL, V11, P417, DOI 10.1105/tpc.11.3.417; Bhatt AM, 1999, PLANT J, V19, P463, DOI 10.1046/j.1365-313X.1999.00548.x; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Callender TL, 2010, GENETICS, V185, P771, DOI 10.1534/genetics.110.117523; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Chelysheva L, 2010, CYTOGENET GENOME RES, V129, P143, DOI 10.1159/000314096; Chelysheva L, 2007, PLOS GENET, V3, P802, DOI 10.1371/journal.pgen.0030083; Chromosomes Rice, 2005, BMC BIOL, V3, P20, DOI [10.1186/1741-7007-3-20, DOI 10.1186/1741-7007-3-20]; Cifuentes M, 2010, PLANT CELL, V22, P2265, DOI 10.1105/tpc.109.072991; Cifuentes M, 2010, NEW PHYTOL, V186, P29, DOI 10.1111/j.1469-8137.2009.03084.x; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; d'Erfurth I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000274; d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; De Muyt A., 2009, V5, P14, DOI 10.1159/000166616; De Muyt A, 2007, EMBO J, V26, P4126, DOI 10.1038/sj.emboj.7601815; De Muyt A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000654; DEMASSY B, 1994, P NATL ACAD SCI USA, V91, P11929, DOI 10.1073/pnas.91.25.11929; Ferdous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002507; Germana MA, 2011, PLANT CELL REP, V30, P839, DOI 10.1007/s00299-011-1061-7; GILLIES CB, 1974, CHROMOSOMA, V48, P441, DOI 10.1007/BF00290998; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Gong ZY, 2011, CHROMOSOMA, V120, P47, DOI 10.1007/s00412-010-0288-3; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Heyman J, 2011, PLANT CELL, V23, P4394, DOI 10.1105/tpc.111.091793; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Jauhar PP, 1999, J HERED, V90, P437, DOI 10.1093/jhered/90.4.437; Jenczewski E, 2004, CRIT REV PLANT SCI, V23, P21, DOI 10.1080/07352680490273239; Jenczewski E, 2003, GENETICS, V164, P645; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; LOIDL J, 1991, CHROMOSOMA, V100, P221, DOI 10.1007/BF00344155; Loidl J, 1997, GENETICS, V146, P79; Marimuthu MPA, 2011, SCIENCE, V331, P876, DOI 10.1126/science.1199682; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Martinez M, 2005, CYTOGENET GENOME RES, V109, P210, DOI 10.1159/000082402; Mercier R, 2008, CYTOGENET GENOME RES, V120, P281, DOI 10.1159/000121077; Mercier R, 2005, CURR BIOL, V15, P692, DOI 10.1016/j.cub.2005.02.056; Osman K, 2011, NEW PHYTOL, V190, P523, DOI 10.1111/j.1469-8137.2011.03665.x; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Pradillo M, 2012, PLANT J, V69, P921, DOI 10.1111/j.1365-313X.2011.04845.x; Pradillo M, 2011, CHROMOSOMA, V120, P447, DOI 10.1007/s00412-011-0336-7; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Sadasivaiah R, 1971, CHROMOSOMA, V263, P247; SANTOS JL, 1994, HEREDITY, V73, P580, DOI 10.1038/hdy.1994.165; Stacey NJ, 2006, PLANT J, V48, P206, DOI 10.1111/j.1365-313X.2006.02867.x; Vignard J, 2007, PLOS GENET, V3, P1894, DOI 10.1371/journal.pgen.0030176; Voelkel-Meiman K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002993; WAGSTAFF JE, 1982, P NATL ACAD SCI-BIOL, V79, P2986, DOI 10.1073/pnas.79.9.2986; Wang M, 2010, PLANT CELL, V22, P417, DOI 10.1105/tpc.109.070789; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Youds JL, 2011, J CELL SCI, V124, P501, DOI 10.1242/jcs.074427; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	60	35	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72431	10.1371/journal.pone.0072431	http://dx.doi.org/10.1371/journal.pone.0072431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951324	Green Published, gold			2022-12-27	WOS:000323109700137
J	El-Remessy, AB; Franklin, T; Ghaley, N; Yang, JL; Brands, MW; Caldwell, RB; Behzadian, MA				El-Remessy, Azza B.; Franklin, Telina; Ghaley, Nagla; Yang, Jinling; Brands, Michael W.; Caldwell, Ruth B.; Behzadian, Mohamed Ali			Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; UROKINASE PLASMINOGEN-ACTIVATOR; BETA-CATENIN; TYROSINE NITRATION; EXTRACELLULAR-MATRIX; PEPTIDE INHIBITOR; VEGF EXPRESSION; RECEPTOR SYSTEM; CELL; RETINOPATHY	Diabetes-induced breakdown of the blood-retinal barrier (BRB) has been linked to hyperglycemia-induced expression of vascular endothelial growth factor (VEGF) and is likely mediated by an increase in oxidative stress. We have shown that VEGF increases permeability of retinal endothelial cells (REC) by inducing expression of urokinase plasminogen activator receptor (uPAR). The purpose of this study was to define the role of superoxide anion in VEGF/uPAR expression and BRB breakdown in diabetes. Studies were performed in streptozotocin diabetic rats and mice and high glucose (HG) treated REC. The superoxide dismutase (SOD) mimetic tempol blocked diabetes-induced permeability and uPAR expression in rats and the cell permeable SOD inhibited HG-induced expression of uPAR and VEGF in REC. Inhibiting VEGFR blocked HG-induced expression of VEGF and uPAR and GSK-3 beta phosphorylation in REC. HG caused beta-catenin translocation from the plasma membrane into the cytosol and nucleus. Treatment with HG-conditioned media increased REC paracellular permeability that was blocked by anti-uPA or anti-uPAR antibodies. Moreover, deletion of uPAR blocked diabetes-induced BRB breakdown and activation of MMP-9 in mice. Together, these data indicate that diabetes-induced oxidative stress triggers BRB breakdown by a mechanism involving uPAR expression through VEGF-induced activation of the GSK3 beta/beta-catenin signaling pathway.	[El-Remessy, Azza B.; Franklin, Telina; Ghaley, Nagla; Yang, Jinling; Caldwell, Ruth B.; Behzadian, Mohamed Ali] Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA 30904 USA; [El-Remessy, Azza B.; Yang, Jinling; Caldwell, Ruth B.; Behzadian, Mohamed Ali] Georgia Regents Univ, Med Coll Georgia, Culver Vis Discovery Inst, Augusta, GA USA; [Caldwell, Ruth B.] Georgia Regents Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA; [Brands, Michael W.] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [El-Remessy, Azza B.] Univ Georgia, Augusta, GA USA; [El-Remessy, Azza B.; Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caldwell, RB (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA 30904 USA.	rcaldwel@gru.edu	El-Remessy, Azza B./AAA-3771-2020	El-Remessy, Azza B./0000-0003-4386-1989; Caldwell, Ruth/0000-0003-0168-0354; Yang, Jinling/0000-0003-2748-2161	National Institutes of Health [EY04618, EY11766]; American Heart Association; NATIONAL EYE INSTITUTE [R01EY004618, R01EY011766, R01EY022408] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants: EY04618, EY11766 and pre-doctoral and post-doctoral fellowships from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Ali TK, 2009, PHARMACOTHERAPY, V29, P182, DOI 10.1592/phco.29.2.182; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Behzadian MA, 2001, INVEST OPHTH VIS SCI, V42, P853; Brands MW, 2004, HYPERTENSION, V43, P57, DOI 10.1161/01.HYP.0000104524.25807.EE; BROWN DM, 2013, OPHTHALMOLOGY, P6949; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Caldwell RB, 2005, CURR DRUG TARGETS, V6, P511, DOI 10.2174/1389450054021981; Chintala SK, 2006, EXP EYE RES, V82, P5, DOI 10.1016/j.exer.2005.07.013; Chronopoulos A, 2010, DIABETES, V59, P3159, DOI 10.2337/db10-0365; CUNHAVAZ JG, 1978, BRIT J OPHTHALMOL, V62, P351, DOI 10.1136/bjo.62.6.351; Das A, 2004, ARCH OPHTHALMOL-CHIC, V122, P1844, DOI 10.1001/archopht.122.12.1844; Das A, 1999, INVEST OPHTH VIS SCI, V40, P809; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; El-Remessy AB, 2003, INVEST OPHTH VIS SCI, V44, P3135, DOI 10.1167/iovs.02-1022; El-Remessy AB, 2003, AM J PATHOL, V162, P1995, DOI 10.1016/S0002-9440(10)64332-5; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Elner SG, 2003, EXP EYE RES, V76, P585, DOI 10.1016/S0014-4835(03)00028-9; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Goto H, 2008, BIOCHEM BIOPH RES CO, V366, P814, DOI 10.1016/j.bbrc.2007.12.041; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; Kowluru RA, 2011, DIABETES, V60, P3023, DOI 10.2337/db11-0816; Kowluru RA, 2010, INVEST OPHTH VIS SCI, V51, P4320, DOI 10.1167/iovs.09-4851; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mohamed IN, 2012, MOL VIS, V18, P1457; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; MURATA T, 1995, OPHTHALMIC RES, V27, P48, DOI 10.1159/000267567; Navaratna D, 2008, FASEB J, V22, P3310, DOI 10.1096/fj.08-110155; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Noda K, 2003, INVEST OPHTH VIS SCI, V44, P2163, DOI 10.1167/iovs.02-0662; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P1732, DOI 10.1167/iovs.02-0809; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Tilton RG, 2002, MICROSC RES TECHNIQ, V57, P390, DOI 10.1002/jemt.10092; Yang JL, 2012, EXP EYE RES, V100, P101, DOI 10.1016/j.exer.2012.03.011; Yang JL, 2010, INVEST OPHTH VIS SCI, V51, P3273, DOI 10.1167/iovs.08-2878; Zou MH, 2011, AM J PATHOL, V179, P2835, DOI 10.1016/j.ajpath.2011.08.041	48	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71868	10.1371/journal.pone.0071868	http://dx.doi.org/10.1371/journal.pone.0071868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951261	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700121
J	Fox, SJ; Shelton, BT; Kruppa, MD				Fox, Sean J.; Shelton, Bryce T.; Kruppa, Michael D.			Characterization of Genetic Determinants That Modulate Candida albicans Filamentation in the Presence of Bacteria	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-GORDONII; ESCHERICHIA-COLI; LARGE-SCALE; RESISTANCE; SUSCEPTIBILITY; ANNOTATION; EXPRESSION	In the human body, fungi and bacteria share many niches where the close contact of these organisms maintains a balance among the microbial population. However, when this microbial balance is disrupted, as with antibiotic treatment, other bacteria or fungi can grow uninhibited. C. albicans is the most common opportunistic fungal pathogen affecting humans and can uniquely control its morphogenesis between yeast, pseudohyphal, and hyphal forms. Numerous studies have shown that C. albicans interactions with bacteria can impact its ability to undergo morphogenesis; however, the genetics that govern this morphological control via these bacterial interactions are still relatively unknown. To aid in the understanding of the cross-kingdom interactions of C. albicans with bacteria and the impact on morphology we utilized a haploinsufficiency based C. albicans mutant screen to test for the ability of C. albicans to produce hyphae in the presence of three bacterial species (Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus). Of the 18,144 mutant strains tested, 295 mutants produced hyphae in the presence of all three bacterial species. The 295 mutants identified 132 points of insertion, which included identified/predicted genes, major repeat sequences, and a number of non-coding/unannotated transcripts. One gene, CDR4, displayed increased expression when co-cultured with S. aureus, but not E. coli or P. aeruginosa. Our data demonstrates the ability to use a large scale library screen to identify genes involved in Candida-bacterial interactions and provides the foundation for comprehending the genetic pathways relating to bacterial control of C. albicans morphogenesis.	[Fox, Sean J.; Shelton, Bryce T.; Kruppa, Michael D.] E Tennessee State Univ, Quillen Dishner Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA	East Tennessee State University	Kruppa, MD (corresponding author), E Tennessee State Univ, Quillen Dishner Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.	Kruppa@etsu.edu	Kruppa, Michael D/B-6052-2009	Kruppa, Michael D/0000-0002-1747-2333	East Tennessee State University School of Graduate Studies Research Grant	East Tennessee State University School of Graduate Studies Research Grant	This study was undertaken with faculty startup funding to MK and an East Tennessee State University School of Graduate Studies Research Grant to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344; Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09; Bandara HMHN, 2012, CRIT REV MICROBIOL, V38, P217, DOI 10.3109/1040841X.2011.652065; Bernstein DA, 2012, P NATL ACAD SCI USA, V109, P523, DOI 10.1073/pnas.1118859109; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; CARLSON E, 1983, INFECT IMMUN, V39, P193, DOI 10.1128/IAI.39.1.193-197.1983; CARLSON E, 1982, INFECT IMMUN, V38, P921, DOI 10.1128/IAI.38.3.921-924.1982; Chibana H, 2009, FUTURE MICROBIOL, V4, P171, DOI 10.2217/17460913.4.2.171; Collart MA, 2001, CURR PROTOC MOL BIOL; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; FONZI WA, 1993, GENETICS, V134, P717; Franz R, 1998, GENE, V220, P91, DOI 10.1016/S0378-1119(98)00412-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Hartmann A, 2012, J CHEM ECOL, V38, P704, DOI 10.1007/s10886-012-0141-7; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006; Jarosz LM, 2009, EUKARYOT CELL, V8, P1658, DOI 10.1128/EC.00070-09; Klaerner HG, 1997, J SURG RES, V70, P161, DOI 10.1006/jsre.1997.5110; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LEVISON ME, 1987, J INFECT DIS, V155, P841, DOI 10.1093/infdis/155.5.841; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Li Z, 2012, PROTEIN SCI, V21, P1403, DOI 10.1002/pro.2132; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murzyn A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012050; NEELY AN, 1986, INFECT IMMUN, V52, P200, DOI 10.1128/IAI.52.1.200-204.1986; Nobbs AH, 2010, EUKARYOT CELL, V9, P1622, DOI 10.1128/EC.00103-10; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Prasad R, 2005, INT REV CYTOL, V242, P215; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Staab JF, 2011, YEAST, V28, P1, DOI 10.1002/yea.1814; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Vilchez R, 2010, CHEMBIOCHEM, V11, P1552, DOI 10.1002/cbic.201000086; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Zhao XM, 2007, FUNGAL GENET BIOL, V44, P1298, DOI 10.1016/j.fgb.2007.05.004; Zhao X, 2007, MED MYCOL, V45, P429, DOI 10.1080/13693780701377162	58	13	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71939	10.1371/journal.pone.0071939	http://dx.doi.org/10.1371/journal.pone.0071939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951271	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700123
J	Chang, JC; Brennan, KC; He, DD; Huang, HX; Miura, RM; Wilson, PL; Wylie, JJ				Chang, Joshua C.; Brennan, Kevin C.; He, Dongdong; Huang, Huaxiong; Miura, Robert M.; Wilson, Phillip L.; Wylie, Jonathan J.			A Mathematical Model of the Metabolic and Perfusion Effects on Cortical Spreading Depression	PLOS ONE			English	Article							CEREBRAL-ARTERIES; BLOOD-FLOW; MECHANISMS; POTASSIUM; ASTROCYTES; DIFFUSION; ISCHEMIA; NEURONS; VOLUME; OXYGEN	Cortical spreading depression (CSD) is a slow-moving ionic and metabolic disturbance that propagates in cortical brain tissue. In addition to massive cellular depolarizations, CSD also involves significant changes in perfusion and metabolism-aspects of CSD that had not been modeled and are important to traumatic brain injury, subarachnoid hemorrhage, stroke, and migraine. In this study, we develop a mathematical model for CSD where we focus on modeling the features essential to understanding the implications of neurovascular coupling during CSD. In our model, the sodium-potassium-ATPase, mainly responsible for ionic homeostasis and active during CSD, operates at a rate that is dependent on the supply of oxygen. The supply of oxygen is determined by modeling blood flow through a lumped vascular tree with an effective local vessel radius that is controlled by the extracellular potassium concentration. We show that during CSD, the metabolic demands of the cortex exceed the physiological limits placed on oxygen delivery, regardless of vascular constriction or dilation. However, vasoconstriction and vasodilation play important roles in the propagation of CSD and its recovery. Our model replicates the qualitative and quantitative behavior of CSD-vasoconstriction, oxygen depletion, extracellular potassium elevation, prolonged depolarization-found in experimental studies. We predict faster, longer duration CSD in vivo than in vitro due to the contribution of the vasculature. Our results also help explain some of the variability of CSD between species and even within the same animal. These results have clinical and translational implications, as they allow for more precise in vitro, in vivo, and in silico exploration of a phenomenon broadly relevant to neurological disease.	[Chang, Joshua C.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Brennan, Kevin C.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [He, Dongdong] City Univ Hong Kong, Dept Math, Kowloon Tong, Hong Kong, Peoples R China; [Huang, Huaxiong] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Miura, Robert M.] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Miura, Robert M.] New Jersey Inst Technol, Ctr Appl Math & Stat, Newark, NJ 07102 USA; [Wilson, Phillip L.] Univ Canterbury, Dept Math & Stat, Christchurch 1, New Zealand; [Wylie, Jonathan J.] City Univ Hong Kong, Dept Math, Kowloon Tong, Hong Kong, Peoples R China	University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; City University of Hong Kong; York University - Canada; New Jersey Institute of Technology; New Jersey Institute of Technology; University of Canterbury; City University of Hong Kong	Chang, JC (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	chang.1166@mbi.osu.edu		Brennan, K.C./0000-0003-4193-5841; WYLIE, Jonathan James/0000-0001-8314-9764; Chang, Joshua/0000-0001-9690-9179; Wilson, Phillip/0000-0002-4563-9399	National Institute of General Medical Sciences [T32GM008185]; Army Research Office [58386MA]; National Institutes of Health [NINDS NS059072, NS070084]; Department of Defense [CDMRP PR100060]; Natural Sciences and Engineering Research Council of Canada; Mathematics in Technology and Complex Systems; National Science Foundation [DMS-1022848, 0635561]; Research Grants Council of the Hong Kong Special Administrative Region, China [CityU 104211]; Direct For Mathematical & Physical Scien [1022848] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070084, K08NS059072] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mathematics in Technology and Complex Systems; National Science Foundation(National Science Foundation (NSF)); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank grant number T32GM008185 from the National Institute of General Medical Sciences and grant number 58386MA from the Army Research Office (JCC); the National Institutes of Health (NINDS NS059072 and NS070084) and the Department of Defense (CDMRP PR100060) (KCB); the Natural Sciences and Engineering Research Council of Canada and the Mathematics in Technology and Complex Systems (HH), the National Science Foundation through grant DMS-1022848 (RMM, HH, JJW), and agreement No. 0635561 (JCC), and the Research Grants Council of the Hong Kong Special Administrative Region, China, CityU 104211 (JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Aperia A, 2001, Curr Hypertens Rep, V3, P165, DOI 10.1007/s11906-001-0032-8; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bennett MR, 2008, BIOPHYS J, V95, P5648, DOI 10.1529/biophysj.108.137190; Brennan KC, 2010, CURR OPIN NEUROL, V23, P266, DOI 10.1097/WCO.0b013e32833821c1; Bures J., 1974, MECH APPL LEAOS SPRE; Busija DW, 2008, PROG NEUROBIOL, V86, P379, DOI 10.1016/j.pneurobio.2008.09.008; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Farr H, 2011, J THEOR BIOL, V286, P13, DOI 10.1016/j.jtbi.2011.07.006; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hansen A, 2008, ACTA PHYSL SCANDINAV, V113, P437; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Keener JP, 2009, MATH PHYSL; Klein J, 2003, PRINCIPLES CEREBRAL, P291; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KRAIG RP, 2002, CEREBROVASC DIS, P142; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331, DOI 10.1001/archneurpsyc.1941.02280200137007; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Mazel T, 2002, PHYSIOL RES, V51, pS85; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Sakadzic S, 2009, APPL OPTICS, V48, pD169, DOI 10.1364/AO.48.00D169; Shapiro BE, 2001, J COMPUT NEUROSCI, V10, P99, DOI 10.1023/A:1008924227961; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SOMJEN GG, 1975, ANNU REV PHYSIOL, V37, P163, DOI 10.1146/annurev.ph.37.030175.001115; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Sukhotinsky I, 2011, CEPHALALGIA, V31, P1601, DOI 10.1177/0333102411425865; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tfelt-Hansen PC, 2010, CEPHALALGIA, V30, P780, DOI 10.1111/j.1468-2982.2009.02015.x; TUCKWELL HC, 1978, BIOPHYS J, V23, P257, DOI 10.1016/S0006-3495(78)85447-2; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Yao W, 2011, B MATH BIOL, V73, P2773, DOI 10.1007/s11538-011-9647-3; Zamir M., 2000, PHYS PULSATILE FLOW	47	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70469	10.1371/journal.pone.0070469	http://dx.doi.org/10.1371/journal.pone.0070469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967075	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500016
J	Pichiri, G; Coni, P; Nemolato, S; Cabras, T; Fanari, MU; Sanna, A; Di Felice, E; Messana, I; Castagnola, M; Faa, G				Pichiri, Giuseppina; Coni, Pierpaolo; Nemolato, Sonia; Cabras, Tiziana; Fanari, Mattia Umberto; Sanna, Alice; Di Felice, Eliana; Messana, Irene; Castagnola, Massimo; Faa, Gavino			Cellular Trafficking of Thymosin Beta-4 in HEPG2 Cells Following Serum Starvation	PLOS ONE			English	Article							INDUCED APOPTOSIS; LIVING CELLS; F-ACTIN; NUCLEAR; BETA(4); POLYMERIZATION; EXPRESSION; PROTEINS; SEQUENCE; PEPTIDE	Thymosin beta-4 (T beta 4) is an ubiquitous multi-functional regenerative peptide, related to many critical biological processes, with a dynamic and flexible conformation which may influence its functions and its subcellular distribution. For these reasons, the intracellular localization and trafficking of T beta 4 is still not completely defined and is still under investigation in in vivo as well as in vitro studies. In the current study we used HepG2 cells, a human hepatoma cell line; cells growing in normal conditions with fetal bovine serum expressed high levels of T beta 4, restricted to the cytoplasm until 72 h. At 84 h, a diffuse T beta 4 cytoplasmic immunostaining shifted to a focal perinuclear and nuclear reactivity. In the absence of serum, nuclear reactivity was localized in small granules, evenly dispersed throughout the entire nuclear envelop, and was observed as earlier as at 48 h. Cytoplasmic immunostaining for T beta 4 in HepG2 cells under starvation appeared significantly lower at 48 h and decreased progressively at 72 and at 84 h. At these time points, the decrease in cytoplasmic staining was associated with a progressive increase in nuclear reactivity, suggesting a possible translocation of the peptide from the cytoplasm to the nuclear membrane. The normal immunocytochemical pattern was restored when culture cells submitted to starvation for 84 h received a new complete medium for 48 h. Mass spectrometry analysis, performed on the nuclear and cytosolic fractions of HepG2 growing with and without serum, showed that T beta 4 was detectable only in the cytosolic and not in the intranuclear fraction. These data suggest that T beta 4 is able to translocate from different cytoplasmic domains to the nuclear membrane and back, based on different stress conditions within the cell. The punctuate pattern of nuclear T beta 4 immunostaining associated with T beta 4 absence in the nucleoplasm suggest that this peptide might be localized in the nuclear pores, where it could regulate the pore permeability.	[Pichiri, Giuseppina; Coni, Pierpaolo; Nemolato, Sonia; Fanari, Mattia Umberto; Sanna, Alice; Di Felice, Eliana; Faa, Gavino] Univ Cagliari, Div Anat Patol, Dipartimento Citomorfol, Cagliari, Italy; [Cabras, Tiziana; Messana, Irene] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Castagnola, Massimo] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, Rome, Italy; [Castagnola, Massimo] CNR, Ist Chim Riconoscimento Mol, Rome, Italy	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Pichiri, G (corresponding author), Univ Cagliari, Div Anat Patol, Dipartimento Citomorfol, Cagliari, Italy.	pichiri@unica.it	Cabras, Tiziana/AAF-6231-2020; Castagnola, Massimo/AAB-2825-2019; Castagnola, Massimo/AAM-6355-2021; Messana, Irene/L-2478-2019	Castagnola, Massimo/0000-0002-0959-7259; Messana, Irene/0000-0002-1436-6105; Coni, Pierpaolo/0000-0001-5602-8887; Pichiri, Giuseppina/0000-0001-8700-8854; Faa, Gavino/0000-0002-6129-0975	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy(Fondazione Banco di Sardegna)	Government and University grants. Financial support from Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; David C, 2010, ANN NY ACAD SCI, V1194, P179; Galan JA, 2011, J AM SOC MASS SPECTR, V22, P319, DOI 10.1007/s13361-010-0030-7; Gettemans J, 2005, TRAFFIC, V6, P847, DOI 10.1111/j.1600-0854.2005.00326.x; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; HANNAPPEL E, 1985, ARCH BIOCHEM BIOPHYS, V240, P236, DOI 10.1016/0003-9861(85)90028-1; Hsiao HL, 2006, CARCINOGENESIS, V27, P936, DOI 10.1093/carcin/bgi316; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Inzitari R, 2009, J SEP SCI, V32, P57, DOI 10.1002/jssc.200800496; Kang S, 2003, EUR J ENDOCRINOL, V148, P147, DOI 10.1530/eje.0.1480147; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; McCormack SA, 1999, AM J PHYSIOL-CELL PH, V276, pC459, DOI 10.1152/ajpcell.1999.276.2.C459; Nemolato S, 2011, EUR J HISTOCHEM, V55, P131, DOI 10.4081/ejh.2011.e25; Nemolato S, 2012, CANCER BIOL THER, V13, DOI 10.4161/cbt.13.4.18691; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Qiu P, 2011, FASEB J, V25, P1815, DOI 10.1096/fj.10-167940; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Su HQ, 2007, ANN NY ACAD SCI, V1112, P45; WATTS JD, 1990, EUR J BIOCHEM, V192, P643, DOI 10.1111/j.1432-1033.1990.tb19271.x; WODNARFILIPOWICZ A, 1984, P NATL ACAD SCI-BIOL, V81, P2295, DOI 10.1073/pnas.81.8.2295; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012; Zoubek RE, 2007, ANN NY ACAD SCI, V1112, P442, DOI 10.1196/annals.1415.031	32	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e67999	10.1371/journal.pone.0067999	http://dx.doi.org/10.1371/journal.pone.0067999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967050	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500003
J	Lei, X; Zhang, WT; Liu, TY; Xiao, HY; Liang, WM; Xia, WL; Zhang, J				Lei, Xi; Zhang, Wenting; Liu, Tengyuan; Xiao, Hongyan; Liang, Weimin; Xia, Weiliang; Zhang, Jun			Perinatal Supplementation with Omega-3 Polyunsaturated Fatty Acids Improves Sevoflurane-Induced Neurodegeneration and Memory Impairment in Neonatal Rats	PLOS ONE			English	Article								Objectives: To investigate if perinatal Omega-3 polyunsaturated fatty acids (n-3 PUFAs) supplementation can improve sevoflurane-induced neurotoxicity and cognitive impairment in neonatal rats. Methods: Female Sprague-Dawley rats (n = 3 each group) were treated with or without an n-3 PUFAs (fish oil) enriched diet from the second day of pregnancy to 14 days after parturition. The offspring rats (P7) were treated with six hours sevoflurane administration (one group without sevoflurane/prenatal n-3 PUFAs supplement as control). The 5-bromodeoxyuridine (Brdu) was injected intraperitoneally during and after sevoflurane anesthesia to assess dentate gyrus (DG) progenitor proliferation. Brain tissues were harvested and subjected to Western blot and immunohistochemistry respectively. Morris water maze spatial reference memory, fear conditioning, and Morris water maze memory consolidation were tested at P35, P63 and P70 (n = 9), respectively. Results: Six hours 3% sevoflurane administration increased the cleaved caspase-3 in the thalamus, parietal cortex but not hippocampus of neonatal rat brain. Sevoflurane anesthesia also decreased the neuronal precursor proliferation of DG in rat hippocampus. However, perinatal n-3 PUFAs supplement could decrease the cleaved caspase-3 in the cerebral cortex of neonatal rats, and mitigate the decrease in neuronal proliferation in their hippocampus. In neurobehavioral studies, compared with control and n-3 PUFAs supplement groups, we did not find significant spatial cognitive deficit and early long-term memory impairment in sevoflurane anesthetized neonatal rats at their adulthood. However, sevoflurane could impair the immediate fear response and working memory and short-term memory. And n-3 PUFAs could improve neurocognitive function in later life after neonatal sevoflurane exposure. Conclusion: Our study demonstrated that neonatal exposure to prolonged sevoflurane could impair the immediate fear response, working memory and short-term memory of rats at their adulthood, which may through inducing neuronal apoptosis and decreasing neurogenesis. However, these sevoflurane-induced unfavorable neuronal effects can be mitigated by perinatal n-3 PUFAs supplementation.	[Lei, Xi; Xiao, Hongyan; Liang, Weimin; Zhang, Jun] Fudan Univ, Huashan Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Zhang, Wenting] Fudan Univ, Natl Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Liu, Tengyuan; Xia, Weiliang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Tengyuan; Xia, Weiliang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xia, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	weiliangxia@gmail.com; snapzhang@yahoo.com.cn	XIA, WEILIANG/AEA-0835-2022; Xia, Weiliang/C-2650-2008	XIA, WEILIANG/0000-0002-0256-4219; Xia, Weiliang/0000-0002-0256-4219	Natural Science Foundation of China [81171020]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (to Jun Zhang, Grant No. 81171020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Alkire MT, 2008, ANESTHESIOLOGY, V109, P768, DOI 10.1097/ALN.0b013e31818aa6f2; Beltz BS, 2007, NEUROSCI LETT, V415, P154, DOI 10.1016/j.neulet.2007.01.010; Bertrand PC, 2006, J NUTR, V136, P1570, DOI 10.1093/jn/136.6.1570; Bianchi P, 2010, J NEUROSCI, V30, P8769, DOI 10.1523/JNEUROSCI.0534-10.2010; Dallasen RM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-27; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Engelhard K, 2007, ANESTH ANALG, V104, P898, DOI 10.1213/01.ane.0000255730.73018.31; Fang F, 2012, NEUROSCIENCE B; Feng ZH, 2012, ANTIOXID REDOX SIGN, V16, P275, DOI 10.1089/ars.2010.3750; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; He FQ, 2011, BRAIN RES, V1384, P89, DOI 10.1016/j.brainres.2011.01.103; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kodama M, 2011, ANESTHESIOLOGY, V115, P979, DOI 10.1097/ALN.0b013e318234228b; Lei X, 2012, INT J MOL SCI, V13, P6772, DOI 10.3390/ijms13066772; Liu XS, 2010, NEUROBIOL LEARN MEM, V94, P461, DOI 10.1016/j.nlm.2010.08.011; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Olsen SF, 2005, BJOG, V107, P382; Patel SS, 1996, DRUGS, V51, P658, DOI 10.2165/00003495-199651040-00009; Richardson HN, 2009, NEUROBIOL DIS, V36, P1, DOI 10.1016/j.nbd.2009.05.021; Sable PS, 2012, NEUROSCIENCE, V217, P46, DOI 10.1016/j.neuroscience.2012.05.001; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Shih J, 2012, ANESTHESIOLOGY, V116, P586, DOI 10.1097/ALN.0b013e318247564d; Stratmann G, 2010, ANESTH ANALG, V110, P431, DOI 10.1213/ane.0b013e3181af8015; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Tung A, 2008, ANESTH ANALG, V106, P1772, DOI 10.1213/ane.0b013e31816f2004; Tuzun F, 2012, INT J DEV NEUROSCI, V30, P315, DOI 10.1016/j.ijdevneu.2012.01.007; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Yon JH, 2006, NEUROBIOL DIS, V21, P522, DOI 10.1016/j.nbd.2005.08.011; Zhang J, 2011, ANESTH ANALG, V113, P1468, DOI 10.1213/ANE.0b013e31822e913c; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XL, 2013, ANESTHESIOLOGY, V118, P537, DOI 10.1097/ALN.0b013e3182833fae; Zhou H., 2013, CELL BIOCH BIOPHYS, P1; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	52	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70645	10.1371/journal.pone.0070645	http://dx.doi.org/10.1371/journal.pone.0070645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967080	Green Submitted, gold, Green Published			2022-12-27	WOS:000323115800009
J	Beyeler, A; Rao, G; Ladepeche, L; Jacques, A; Simmers, J; Le Ray, D				Beyeler, Anna; Rao, Guillaume; Ladepeche, Laurent; Jacques, Andre; Simmers, John; Le Ray, Didier			Vestibular Lesion-Induced Developmental Plasticity in Spinal Locomotor Networks during Xenopus laevis Metamorphosis	PLOS ONE			English	Article							RETICULOSPINAL NEURONS; NEURAL PLASTICITY; MUSCLE SYNERGIES; GUINEA-PIG; RECOVERY; HEMILABYRINTHECTOMY; COMPENSATION; SYSTEM; PATHWAYS; PATTERNS	During frog metamorphosis, the vestibular sensory system remains unchanged, while spinal motor networks undergo a massive restructuring associated with the transition from the larval to adult biomechanical system. We investigated in Xenopus laevis the impact of a pre- (tadpole stage) or post-metamorphosis (juvenile stage) unilateral labyrinthectomy (UL) on young adult swimming performance and underlying spinal locomotor circuitry. The acute disruptive effects on locomotion were similar in both tadpoles and juvenile frogs. However, animals that had metamorphosed with a preceding UL expressed restored swimming behavior at the juvenile stage, whereas animals lesioned after metamorphosis never recovered. Whilst kinematic and electrophysiological analyses of the propulsive system showed no significant differences in either juvenile group, a 3D biomechanical simulation suggested that an asymmetry in the dynamic control of posture during swimming could account for the behavioral restoration observed in animals that had been labyrinthectomized before metamorphosis. This hypothesis was subsequently supported by in vivo electromyography during free swimming and in vitro recordings from isolated brainstem/spinal cord preparations. Specifically, animals lesioned prior to metamorphosis at the larval stage exhibited an asymmetrical propulsion/posture coupling as a post-metamorphic young adult. This developmental alteration was accompanied by an ipsilesional decrease in propriospinal coordination that is normally established in strict left-right symmetry during metamorphosis in order to synchronize dorsal trunk muscle contractions with bilateral hindlimb extensions in the swimming adult. Our data thus suggest that a disequilibrium in descending vestibulospinal information during Xenopus metamorphosis leads to an altered assembly of adult spinal locomotor circuitry. This in turn enables an adaptive compensation for the dynamic postural asymmetry induced by the vestibular imbalance and the restoration of functionally-effective behavior.	[Beyeler, Anna; Ladepeche, Laurent; Simmers, John; Le Ray, Didier] Univ Bordeaux, CNRS UMR INCIA 5287, Bordeaux, France; [Rao, Guillaume; Jacques, Andre] Aix Marseille Univ, CNRS UMR ISM 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite	Le Ray, D (corresponding author), Univ Bordeaux, CNRS UMR INCIA 5287, Bordeaux, France.	didier.leray@u-bordeaux2.fr	RAO, Guillaume/A-3971-2010; Beyeler, Anna/V-9934-2019; Le Ray, Didier/C-2625-2008; Ladépêche, Laurent/G-3418-2015	RAO, Guillaume/0000-0002-7751-6959; Le Ray, Didier/0000-0003-2089-9861; Ladépêche, Laurent/0000-0002-2566-1206; /0000-0003-2371-5706	Centre National de la Recherche Scientifique (ATIP "Jeunes chercheurs"); French Ministere de l'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique (ATIP "Jeunes chercheurs"); French Ministere de l'Enseignement Superieur et de la Recherche	This work was partially funded by the Centre National de la Recherche Scientifique (ATIP "Jeunes chercheurs"). A. B. was funded by a doctoral studentship from the French Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	[Anonymous], 2005, DEV NERVOUS SYSTEM; Bent LR, 2005, EXERC SPORT SCI REV, V33, P107, DOI 10.1097/00003677-200507000-00002; Beyeler A, 2008, J NEUROPHYSIOL, V100, P1372, DOI 10.1152/jn.00023.2008; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Clancy L.J., 1975, AERODYNAMICS; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 1997, J EXP BIOL, V200, P1459; DEWAELE C, 1989, EXP BRAIN RES, V77, P166, DOI 10.1007/BF00250579; DIERINGER N, 1995, PROG NEUROBIOL, V46, P97, DOI 10.1016/0301-0082(94)00063-N; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; Dutheil S, 2009, NEUROSCIENCE, V164, P1444, DOI 10.1016/j.neuroscience.2009.09.048; Dutheil S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022262; Einum JF, 2004, J NEUROPHYSIOL, V92, P1384, DOI 10.1152/jn.00625.2003; Fanardjian VV, 1999, NEUROSCIENCE, V94, P845, DOI 10.1016/S0306-4522(99)00329-2; Fetter Michael, 2007, Dev Ophthalmol, V40, P35; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; KERKUT GA, 1995, PROG NEUROBIOL, V46, P1, DOI 10.1016/0301-0082(94)00055-M; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Lacour M, 2009, ANN NY ACAD SCI, V1164, P268, DOI 10.1111/j.1749-6632.2008.03731.x; Lambert FM, 2013, J NEUROSCI, V33, P6845, DOI 10.1523/JNEUROSCI.4842-12.2013; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Liu H, 1996, J EXP BIOL, V199, P1245; Marder E, 2002, NATURE, V416, P131, DOI 10.1038/416131a; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pearson KG, 2008, BRAIN RES REV, V57, P222, DOI 10.1016/j.brainresrev.2007.06.014; PETROSINI L, 1984, PHYSIOL BEHAV, V33, P799, DOI 10.1016/0031-9384(84)90050-7; Quick QA, 2005, DEV DYNAM, V234, P791, DOI 10.1002/dvdy.20610; Rauscent A, 2006, J PHYSIOLOGY-PARIS, V100, P317, DOI 10.1016/j.jphysparis.2007.05.009; RAYER B, 1986, J COMP PHYSIOL A, V159, P887, DOI 10.1007/BF00603742; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Sanchez-Camacho C, 2001, J COMP NEUROL, V434, P186, DOI 10.1002/cne.1172; Soffe SR, 2009, J PHYSIOL-LONDON, V587, P4829, DOI 10.1113/jphysiol.2009.175208; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Straka H, 2002, J NEUROPHYSIOL, V88, P2287, DOI 10.1152/jn.00370.2002; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; STRAKA H, 1995, J NEUROPHYSIOL, V73, P1617, DOI 10.1152/jn.1995.73.4.1617; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vallois HV, 1922, TRANSFORMATIONS MUSC; Vibert N, 1997, PROG NEUROBIOL, V51, P243, DOI 10.1016/S0301-0082(96)00057-3; Vibert N, 1999, NEUROSCIENCE, V93, P413, DOI 10.1016/S0306-4522(99)00172-4; Vibert N, 1999, NEUROSCIENCE, V94, P1, DOI 10.1016/S0306-4522(99)00323-1; Vidal P. P., 2004, Neuroembryology and Aging, V3, P194, DOI 10.1159/000096797	48	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71013	10.1371/journal.pone.0071013	http://dx.doi.org/10.1371/journal.pone.0071013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951071	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300076
J	Czaprowski, D; Leszczewska, J; Kolwicz, A; Pawlowska, P; Kedra, A; Janusz, P; Kotwicki, T				Czaprowski, Dariusz; Leszczewska, Justyna; Kolwicz, Aleksandra; Pawlowska, Paulina; Kedra, Agnieszka; Janusz, Piotr; Kotwicki, Tomasz			The Comparison of the Effects of Three Physiotherapy Techniques on Hamstring Flexibility in Children: A Prospective, Randomized, Single-Blind Study	PLOS ONE			English	Article							LOW-BACK-PAIN; STRAIGHT-LEG RAISE; CONTROLLED-TRIAL; RISK-FACTORS; MUSCLE; RELIABILITY; TIGHTNESS; MOTION; RANGE; STIFFNESS	The aim of the study was to evaluate changes in hamstring flexibility in 120 asymptomatic children who participated in a 6-week program consisting of one physiotherapy session per week and daily home exercises. The recruitment criteria included age (10-13 years), no pain, injury or musculoskeletal disorder throughout the previous year, physical activity limited to school sport. Subjects were randomly assigned to one of the three groups: (1) post-isometric relaxation - PIR (n = 40), (2) static stretch combined with stabilizing exercises - SS (n = 40) and (3) stabilizing exercises - SE (n = 40). Hamstring flexibility was assessed with straight leg raise (SLR), popliteal angle (PA) and finger-to-floor (FTF) tests. The examinations were conducted by blinded observers twice, prior to the program and a week after the last session with the physiotherapist. Twenty-six children who did not participate in all six exercise sessions with physiotherapists were excluded from the analysis. The results obtained by 94 children were analyzed (PIR, n = 32; SS, n = 31; SE, n = 31). In the PIR and SS groups, a significant (P<0.01) increase in SLR, PA, FTF results was observed. In the SE group, a significant (P<0.001) increase was observed in the SLR but not in the PA and FTF (P>0.05). SLR result in the PIR and SS groups was significantly (P<0.001) higher than in the SE group. As far as PA results are concerned, a significant difference was observed only between the SS and SE groups (P = 0.014). There were no significant (P = 0.15) differences regarding FTF results between the three groups. Post-isometric muscle relaxation and static stretch with stabilizing exercises led to a similar increase in hamstring flexibility and trunk forward bend in healthy 10-13-year-old children. The exercises limited to straightening gluteus maximus improved the SLR result, but did not change the PA and FTF results.	[Czaprowski, Dariusz; Leszczewska, Justyna; Kolwicz, Aleksandra; Pawlowska, Paulina] Jozef Rusiecki Univ Coll, Dept Physiotherapy, Olsztyn, Poland; [Czaprowski, Dariusz] Rehasport Clin, Poznan, Poland; [Kedra, Agnieszka] Jozef Pilsudski Univ Phys Educ, Fac Phys Educ & Sport Biala Podlaska, Warsaw, Poland; [Janusz, Piotr; Kotwicki, Tomasz] Univ Med Sci, Dept Pediat Orthoped & Traumatol, Poznan, Poland	Jozef Pilsudski University Physical Education in Warsaw	Czaprowski, D (corresponding author), Jozef Rusiecki Univ Coll, Dept Physiotherapy, Olsztyn, Poland.	dariusz.czaprowski@interia.pl		Janusz, Piotr/0000-0001-5702-4933				[Anonymous], 2004, PHYSIOTHERAPY, DOI DOI 10.1016/J.PHYSI0.2004.02.009; Atamaz F, 2011, J SPORT MED PHYS FIT, V51, P689; Ballantyne F, 2003, J OSTEOPATH MED, V6, P59, DOI [10.1016/S1443-8461(03)80015-1, DOI 10.1016/S1443-8461(03)80015-1]; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Boyd BS, 2012, PHYSIOTHERAPY, V98, P174, DOI 10.1016/j.physio.2011.04.352; Brodersen A, 1994, Ugeskr Laeger, V156, P2243; Chaitow L, 2006, MUSCLE ENERGY TECHNI; Davis DS, 2005, J STRENGTH COND RES, V19, P27; de Weijer VC, 2003, J ORTHOP SPORT PHYS, V33, P727, DOI 10.2519/jospt.2003.33.12.727; Decoster LC, 2005, J ORTHOP SPORT PHYS, V35, P377, DOI 10.2519/jospt.2005.35.6.377; Fasen JM, 2009, J STRENGTH COND RES, V23, P660, DOI 10.1519/JSC.0b013e318198fbd1; Feland JB, 2001, PHYS THER SPORT, V2, P186, DOI DOI 10.1054/PTSP.2001.0076; Feldman DE, 2001, AM J EPIDEMIOL, V154, P30, DOI 10.1093/aje/154.1.30; FISK JW, 1984, AM J PHYS MED REHAB, V63, P18; GAJDOSIK R, 1983, PHYS THER, V63, P1085, DOI 10.1093/ptj/63.7.1085; GAJDOSIK RL, 1994, J ORTHOP SPORT PHYS, V20, P213, DOI 10.2519/jospt.1994.20.4.213; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; Harreby M, 1999, EUR SPINE J, V8, P444, DOI 10.1007/s005860050203; Jozwiak M, 1997, DEV MED CHILD NEUROL, V39, P481; Kendall F.P., 2005, MUSCLES TESTING FUNC, Vfifth; Kisner C, 2012, THERAPEUTIC EXERCISE, V6th; Lewit K, 1999, MANIPULATIVE THERAPY; Magnusson SP, 1996, ARCH PHYS MED REHAB, V77, P373, DOI 10.1016/S0003-9993(96)90087-8; Marshall PWM, 2011, J SCI MED SPORT, V14, P535, DOI 10.1016/j.jsams.2011.05.003; Medina FMS, 2007, J SPORT MED PHYS FIT, V47, P304; MIERAU D, 1989, SPINE, V14, P526, DOI 10.1097/00007632-198905000-00010; Milne R., 1979, J MANIP PHYSIOL THER, V2, P146; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Mottram SL, 2006, TXB MUSCULOSKELETAL, P469; Nelson RT, 2004, J ATHL TRAINING, V39, P254; Reid DA, 2004, MED SCI SPORT EXER, V36, P1944, DOI 10.1249/01.MSS.0000145462.36207.20; Richardson C, 1990, Aust J Physiother, V36, P6, DOI 10.1016/S0004-9514(14)60514-6; Richardson C.A., 1999, THERAPEUTIC EXERCISE; Rodriguez PL, 2008, SCI SPORT, V23, P170, DOI 10.1016/j.scispo.2007.12.013; Sahrmann SBN, 2011, MOVEMENT SYSTEM IMPA, P1; SEWALL L, 1986, J PEDIATR ORTHOPED, V6, P143, DOI 10.1097/01241398-198603000-00004; Sjolie AN, 2004, SCAND J MED SCI SPOR, V14, P168, DOI 10.1111/j.1600-0838.2003.00334.x; Smith M, 2008, J BODYW MOV THER, V12, P312, DOI 10.1016/j.jbmt.2008.06.011; Solberg G, 2008, DIAGNOSIS PREVENTION; TAKATA K, 1994, J BONE JOINT SURG BR, V76B, P220, DOI 10.1302/0301-620X.76B2.8113280; Wagner T, 2010, J ORTHOP SPORT PHYS, V40, P112, DOI 10.2519/jospt.2010.3110; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801; Yuktasir B, 2009, J BODYW MOV THER, V13, P11, DOI 10.1016/j.jbmt.2007.10.001; Zakas A, 2002, J BODYW MOV THER, V6, P170, DOI DOI 10.1054/JBMT.2001.0275; Zhu QS, 2006, SPINE, V31, P1810, DOI 10.1097/01.brs.0000226047.83475.e4	45	18	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72026	10.1371/journal.pone.0072026	http://dx.doi.org/10.1371/journal.pone.0072026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951281	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300175
J	Jiang, YB; Guo, K; Chen, MT; Bao, J; Shen, CX; Li, YG				Jiang, Yibo; Guo, Kai; Chen, Mantian; Bao, Jun; Shen, Chengxing; Li, Yigang			Serum Lipoprotein(a) Positively Correlates with Coronary Artery Calcification in Low-Risk Chinese Han Patients: A Study from a Single Center	PLOS ONE			English	Article							64-SLICE COMPUTED-TOMOGRAPHY; CARDIOVASCULAR RISK; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; HEART-DISEASE; TASK-FORCE; CALCIUM; ATHEROSCLEROSIS; ASSOCIATION; QUANTIFICATION	Background: Elevated plasma levels of lipoprotein(a) (Lp(a)) and a higher degree of coronary artery calcification (CAC) are both considered to be risk factors for atherosclerosis. However, previous studies have demonstrated that the relationship between Lp(a) levels and the degree of CAC indicates significant heterogeneity that may be due to varying ethnicities. The purpose of this study was to examine the predictive power of Lp(a) for CAC as measured by multidetector computed tomography (MDCT) in the Han ethnic group of China. Methods: A total of 1082 subjects were recruited in this study. The patients were divided into four groups: patients without hypertension or diabetes were group 1, patients with hypertension were group 2, patients with diabetes were group 3 and patients with both hypertension and diabetes were group 4. CAC score (CACs), lipid profiles (Lp(a), LDL, HDL, TG, TC), HbA1C, glucose, personal health history and body morphology were measured in all participants. The predictive power of Lp(a) for calcified atherosclerotic plaque was determined by correlations and ordinal logistic regression. Results: There was no significant difference in the CACs between group 2 and group 3 (z = 1.790, p = 0.736), and there were significant differences among the other groups. However, there was no significant difference in the total Lp(a) among the 4 groups (chi(2) = 0.649, p = 0.885). Only In group 1, Lp(a) was a statistically significant predictor of the presence of calcified coronary plaque using ordinal logistic regression. Conclusions: Levels of Lp(a) positively correlate with CACs among Chinese Han people who are without diabetes and hypertension, suggesting that Lp(a) may be an important risk factor for the presence of calcified atheromas.	[Jiang, Yibo; Guo, Kai; Chen, Mantian; Shen, Chengxing; Li, Yigang] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Jiang, Yibo] Yangzhou Univ, Taixing Hosp, Dept Cardiol, Taixing, Peoples R China; [Bao, Jun] Southeast Univ, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Yangzhou University; Southeast University - China	Shen, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	shenchengxingx@163.com; drliyigang@yahoo.com.cn						AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Budoff MJ, 2006, ATHEROSCLEROSIS, V187, P343, DOI 10.1016/j.atherosclerosis.2005.09.013; CAMBILLAU M, 1992, ARTERIOSCLER THROMB, V12, P1346, DOI 10.1161/01.ATV.12.11.1346; Cassidy AE, 2004, MED SCI MONITOR, V10, pCR493; 김동희, 2008, Korean Circulation Journal, V38, P29; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Godsland IF, 2010, ATHEROSCLEROSIS, V213, P570, DOI 10.1016/j.atherosclerosis.2010.09.002; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Greif M, 2013, EUR J INTERN MED, V24, P75, DOI 10.1016/j.ejim.2012.08.014; Guerra R, 2005, CIRCULATION, V111, P1471, DOI 10.1161/01.CIR.0000159263.50305.BD; Hartmann M, 2006, J AM COLL CARDIOL, V48, P446, DOI 10.1016/j.jacc.2006.03.047; Kitagawa T, 2007, AM HEART J, V154, P1191, DOI 10.1016/j.ahj.2007.07.020; Kitagawa T, 2009, JACC-CARDIOVASC IMAG, V2, P153, DOI 10.1016/j.jcmg.2008.09.015; Koulaouzidis G, 2012, ANGIOLOGY; Kramer CK, 2009, DIABETES CARE, V32, P141, DOI 10.2337/dc08-1360; Kullo IJ, 2004, MAYO CLIN PROC, V79, P1258, DOI 10.4065/79.10.1258; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Lee TC, 2003, J AM COLL CARDIOL, V41, P39, DOI 10.1016/S0735-1097(02)02618-9; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Morena M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036175; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Qasim AN, 2011, INT J CARDIOL, V150, P17, DOI 10.1016/j.ijcard.2010.02.021; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Sharma A, 2011, J CARDIOVASC TRANSL, V4, P470, DOI 10.1007/s12265-011-9273-3; Viera AJ, 2012, HYPERTENSION, V59, P1157, DOI 10.1161/HYPERTENSIONAHA.112.191536; Wu ZS, 2001, CIRCULATION, V103, P462	33	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71673	10.1371/journal.pone.0071673	http://dx.doi.org/10.1371/journal.pone.0071673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951216	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300140
J	Luo, HT; Sun, SL; Li, P; Bu, DC; Cao, HM; Zhao, Y				Luo, Haitao; Sun, Silong; Li, Ping; Bu, Dechao; Cao, Haiming; Zhao, Yi			Comprehensive Characterization of 10,571 Mouse Large Intergenic Noncoding RNAs from Whole Transcriptome Sequencing	PLOS ONE			English	Article							HUMAN GENOME; HUMAN-CELLS; REVEALS; ANNOTATION; SEQ; EXPRESSION; DIFFERENTIATION; QUANTIFICATION; IDENTIFICATION; LANDSCAPE	Large intergenic noncoding RNAs (lincRNAs) have been recognized in recent years to constitute a significant portion of the mammalian transcriptome, yet their biological functions remain largely elusive. This is partly due to an incomplete annotation of tissue-specific lincRNAs in essential model organisms, particularly in mice, which has hindered the genetic annotation and functional characterization of these novel transcripts. In this report, we performed ab initio assembly of 1.9 billion tissue-specific RNA-sequencing reads across six tissue types, and identified 3,965 novel expressed lincRNAs in mice. Combining these with 6,606 documented lincRNAs, we established a comprehensive catalog of 10,571 transcribed lincRNAs. We then systemically analyzed all mouse lincRNAs to reveal that some of them are evolutionally conserved and that they exhibit striking tissue-specific expression patterns. We also discovered that mouse lincRNAs carry unique genomic signatures, and that their expression level is correlated with that of neighboring protein-coding transcripts. Finally, we predicted that a large portion of tissue-specific lincRNAs are functionally associated with essential biological processes including the cell cycle and cell development, and that they could play a key role in regulating tissue development and functionality. Our analyses provide a framework for continued discovery and annotation of tissue-specific lincRNAs in model organisms, and our transcribed mouse lincRNA catalog will serve as a roadmap for functional analyses of lincRNAs in genetic mouse models.	[Luo, Haitao; Sun, Silong; Bu, Dechao; Zhao, Yi] Chinese Acad Sci, Inst Comp Technol, Adv Comp Res Lab, Bioinformat Res Grp, Beijing, Peoples R China; [Li, Ping; Cao, Haiming] NHLBI, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Institute of Computing Technology, CAS; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cao, HM (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	haiming.cao@nih.gov; biozy@ict.ac.cn	Cao, Haiming/P-4634-2016; Zhao, Yi/A-2962-2011; bu, dechao/Q-5701-2018	Zhao, Yi/0000-0001-6046-8420; Sun, Silong/0000-0002-4541-9126	National High Technology Research and Development Program of China (863 Program) [2012AA022501]; Division of Intramural Research of the National Heart Lung and Blood Institute of the NIH, USA [HL006103-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006103] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Division of Intramural Research of the National Heart Lung and Blood Institute of the NIH, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA022501); Ping Li and Haiming Cao are funded by the Division of Intramural Research of the National Heart Lung and Blood Institute (HL006103-02) of the NIH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bu D., 2011, NUCL ACIDS RES; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen G, 2012, HUM MUTAT; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Howald C, 2012, GENOME RES, V22, P1698, DOI 10.1101/gr.134478.111; Karolchik D, 2011, CURR PROTOC HUM GENE; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Liao Q, 2011, NUCLEIC ACIDS RES, V39, pW118, DOI 10.1093/nar/gkr432; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Sun L, 2013, SCI CHINA LIFE SCI, V56, P324, DOI 10.1007/s11427-013-4460-x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116	37	40	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70835	10.1371/journal.pone.0070835	http://dx.doi.org/10.1371/journal.pone.0070835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951020	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300057
J	Rigter, A; Widjaja, I; Versantvoort, H; Coenjaerts, FEJ; Van Roosmalen, M; Leenhouts, K; Rottier, PJM; Haijema, BJ; de Haan, CAM				Rigter, Alan; Widjaja, Ivy; Versantvoort, Hanneke; Coenjaerts, Frank E. J.; Van Roosmalen, Maarten; Leenhouts, Kees; Rottier, Peter J. M.; Haijema, Bert Jan; de Haan, Cornelis A. M.			A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL-VIRUS; 2 DISTINCT SITES; FUSION PROTEIN; G-GLYCOPROTEIN; COTTON RATS; PULMONARY HISTOPATHOLOGY; ATTACHMENT GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; LACTOCOCCUS-LACTIS; STRUCTURAL BASIS	Respiratory syncytial virus (RSV) is an important cause of respiratory tract disease in infants and the elderly. Currently, no licensed vaccine against RSV is available. Here we describe the development of a safe and effective intranasal subunit vaccine that is based on recombinant fusion (F) protein bound to the surface of immunostimulatory bacterium-like particles (BLPs) derived from the food-grade bacterium Lactococcus lactis. Different variants of F were analyzed with respect to their conformation and reactivity with neutralizing antibodies, assuming that F proteins mimicking the metastable prefusion form of RSV F expose a more extensive and relevant epitope repertoire than F proteins corresponding to the postfusion structure. Our results indicate that the recombinant soluble ectodomain of RSV F readily adopts a postfusion conformation, generation of which cannot be prevented by C-terminal addition of a trimerization motif, but whose formation is prevented by mutation of the two furin cleavage sites in F. While the putative postfusion form of F is recognized well by the monoclonal antibody Palivizumab, this is much less so for the more potently neutralizing, prefusion-specific antibodies D25 and AM22. Both addition of the trimerization motif and mutation of the furin cleavage sites increased the reactivity of F with D25 and AM22, with the highest reactivity being observed for F proteins in which both these features were combined. Intranasal vaccination of mice or cotton rats with BLPs loaded with this latter prefusion-like F protein (BLP-F), resulted in the potent induction of F-specific immunoglobulins and in significantly decreased virus titers in the lungs upon RSV challenge. Moreover, and in contrast to animals vaccinated with formalin-inactivated RSV, animals that received BLP-F exhibited high levels of F-specific secretory IgA in the nose and RSV-neutralizing antibodies in sera, but did not show symptoms of enhanced disease after challenge with RSV.	[Rigter, Alan; Widjaja, Ivy; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Virol, Utrecht, Netherlands; [Rigter, Alan; Widjaja, Ivy; Versantvoort, Hanneke; Van Roosmalen, Maarten; Leenhouts, Kees; Haijema, Bert Jan] Mucosis BV, Groningen, Netherlands; [Coenjaerts, Frank E. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Haijema, BJ (corresponding author), Mucosis BV, Groningen, Netherlands.	Haijema@Mucosis.com; c.a.m.dehaan@uu.nl		Tripp, Ralph/0000-0002-2924-9956; de Haan, Cornelis/0000-0002-4459-9874	Mucosis B. V.	Mucosis B. V.	This study was funded in part by Mucosis B. V. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audouy SAL, 2007, VACCINE, V25, P2497, DOI 10.1016/j.vaccine.2006.09.026; Audouy SAL, 2006, VACCINE, V24, P5434, DOI 10.1016/j.vaccine.2006.03.054; Beaumont T., 2012, Patent No. [US/2012/0070446 A1, 20120070446]; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093; Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; de Haan A, 2012, VACCINE, V30, P4884, DOI 10.1016/j.vaccine.2012.04.032; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Groothuis JR, 2011, ADV THER, V28, P91, DOI 10.1007/s12325-010-0100-z; Groothuis JR, 2011, ADV THER, V28, P110, DOI 10.1007/s12325-010-0101-y; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HENDRICKS DA, 1988, J VIROL, V62, P2228, DOI 10.1128/JVI.62.7.2228-2233.1988; Hurwitz JL, 2011, EXPERT REV VACCINES, V10, P1415, DOI [10.1586/erv.11.120, 10.1586/ERV.11.120]; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Kwilas S, 2009, J VIROL, V83, P10710, DOI 10.1128/JVI.00986-09; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Magro M, 2010, J VIROL, V84, P7970, DOI 10.1128/JVI.00447-10; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2013, SCIENCE; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nganou-Makamdop K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-50; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040; Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; Ruiz-Arguello MB, 2004, J GEN VIROL, V85, P3677, DOI 10.1099/vir.0.80318-0; Ruiz-Arguello MB, 2002, VIROLOGY, V298, P317, DOI 10.1006/viro.2002.1497; Saluja V, 2010, AAPS J, V12, P109, DOI 10.1208/s12248-009-9168-2; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weltzin R, 1996, J INFECT DIS, V174, P256, DOI 10.1093/infdis/174.2.256; WERTZ GW, 1989, J VIROL, V63, P4767, DOI 10.1128/JVI.63.11.4767-4776.1989; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	59	58	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71072	10.1371/journal.pone.0071072	http://dx.doi.org/10.1371/journal.pone.0071072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951084	Green Published, gold			2022-12-27	WOS:000323097300084
J	Steen, AD; Jorgensen, BB; Lomstein, BA				Steen, Andrew D.; Jorgensen, Bo Barker; Lomstein, Bente Aa.			Abiotic Racemization Kinetics of Amino Acids in Marine Sediments	PLOS ONE			English	Article							MAJOR BACTERIAL CONTRIBUTION; ASPARTIC-ACID; GEOCHRONOLOGY; ISOLEUCINE; MARGIN	The ratios of D-versus L-amino acids can be used to infer the sources and composition of sedimentary organic matter. Such inferences, however, rely on knowing the rates at which amino acids in sedimentary organic matter racemize abiotically between the D-and the L-forms. Based on a heating experiment, we report kinetic parameters for racemization of aspartic acid, glutamic acid, serine, and alanine in bulk sediment from Aarhus Bay, Denmark, taken from the surface, 30 cm, and 340 cm depth below seafloor. Extrapolation to a typical cold deep sea sediment temperature of 3 degrees C suggests racemization rate constants of 0.5x10(-5) - 11x10(-5) yr(-1). These results can be used in conjunction with measurements of sediment age to predict the ratio of D: L amino acids due solely to abiotic racemization of the source material, deviations from which can indicate the abundance and turnover of active microbial populations.	[Steen, Andrew D.; Jorgensen, Bo Barker; Lomstein, Bente Aa.] Aarhus Univ, Ctr Geomicrobiol, Aarhus, Denmark; [Steen, Andrew D.; Lomstein, Bente Aa.] Aarhus Univ, Dept Biosci, Aarhus, Denmark	Aarhus University; Aarhus University	Steen, AD (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	asteen1@utk.edu	Lomstein, Bente/I-7684-2013; Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027; Steen, Andrew/0000-0003-4297-4332	Danish National Research Foundation; German Max Planck Society; Danish Natural Science Research Council [272-07-0456]	Danish National Research Foundation(Danmarks Grundforskningsfond); German Max Planck Society(Max Planck Society); Danish Natural Science Research Council(Danish Natural Science Research Council)	Salary support for ADS was provided by the Danish National Research Foundation (http://dg.dk/) and the German Max Planck Society (http://www.mpg.de/en). Funding for the project was provided by the Danish Natural Science Research Council grant number 272-07-0456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bada J.L., 1971, NONEQUILIBRIUM SYSTE; BADA JL, 1982, INTERDISCIPL SCI REV, V7, P30, DOI 10.1179/030801882789801304; BADA JL, 1972, EARTH PLANET SC LETT, V15, P1, DOI 10.1016/0012-821X(72)90022-2; BADA JL, 1972, J AM CHEM SOC, V94, P1371, DOI 10.1021/ja00759a064; BADA JL, 1975, NATURWISSENSCHAFTEN, V62, P71, DOI 10.1007/BF00592179; BRINTON KL, 1995, GEOCHIM COSMOCHIM AC, V59, P415, DOI 10.1016/0016-7037(94)00324-F; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ENGEL MH, 1977, ANAL BIOCHEM, V82, P415, DOI 10.1016/0003-2697(77)90179-8; Goodfriend GA, 1997, GEOCHIM COSMOCHIM AC, V61, P1931, DOI 10.1016/S0016-7037(97)00067-7; Grutters M, 2002, LIMNOL OCEANOGR, V47, P1521, DOI 10.4319/lo.2002.47.5.1521; Harada N, 1996, ORG GEOCHEM, V24, P921, DOI 10.1016/S0146-6380(96)00065-4; Hubert C, 2009, SCIENCE, V325, P1541, DOI 10.1126/science.1174012; Jensen JB, 2009, CONT SHELF RES, V29, P775, DOI 10.1016/j.csr.2008.08.007; Jorgensen B. B., 1996, COASTAL ESTUARINE ST, P137, DOI DOI 10.1029/CE052P0137; Kaiser K, 2005, LIMNOL OCEANOGR-METH, V3, P318, DOI 10.4319/lom.2005.3.318; Kaiser K, 2008, LIMNOL OCEANOGR, V53, P99, DOI 10.4319/lo.2008.53.1.0099; KRIAUSAKUL N, 1978, SCIENCE, V201, P1011, DOI 10.1126/science.201.4360.1011; Krishna MS, 2010, ORG GEOCHEM, V41, P363, DOI 10.1016/j.orggeochem.2009.12.006; KVENVOLDEN KA, 1970, SCIENCE, V169, P1079, DOI 10.1126/science.169.3950.1079; Langerhuus AT, 2012, GEOCHIMICA COSMOCHIM, V99; LEE C, 1977, LIMNOL OCEANOGR, V22, P502, DOI 10.4319/lo.1977.22.3.0502; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; Lomstein BA, 2006, GEOCHIM COSMOCHIM AC, V70, P2970, DOI 10.1016/j.gca.2006.03.015; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; Pedersen AGU, 2001, LIMNOL OCEANOGR, V46, P1358, DOI 10.4319/lo.2001.46.6.1358; RAFALSKA JK, 1991, GEOCHIM COSMOCHIM AC, V55, P3669, DOI 10.1016/0016-7037(91)90065-D; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SMITH GG, 1989, J ORG CHEM, V54, P4529, DOI 10.1021/jo00280a017; Vandewiele S, 2009, DEEP-SEA RES PT II, V56, P376, DOI 10.1016/j.dsr2.2008.05.035; WILLIAMS KM, 1977, ORIGINS LIFE EVOL B, V8, P91, DOI 10.1007/BF00927978; ZUMBERGE JE, 1979, GEOCHIM COSMOCHIM AC, V43, P1443, DOI 10.1016/0016-7037(79)90138-8	32	24	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71648	10.1371/journal.pone.0071648	http://dx.doi.org/10.1371/journal.pone.0071648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951211	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300138
J	Zeng, JQ; Zhang, MY; Sun, XJ				Zeng, Jiqing; Zhang, Mingyong; Sun, Xuejun			Molecular Hydrogen Is Involved in Phytohormone Signaling and Stress Responses in Plants	PLOS ONE			English	Article							ABSCISIC-ACID; DEFENSE SYSTEM; SALICYLIC-ACID; RECEPTOR; RICE; ANTIOXIDANT; METABOLISM; INDUCTION; TOLERANCE; ETHYLENE	Molecular hydrogen (H-2) metabolism in bacteria and algae has been well studied from an industrial perspective because H-2 is viewed as a potential future energy source. A number of clinical trials have recently reported that H-2 is a therapeutic antioxidant and signaling molecule. Although H-2 metabolism in higher plants was reported in some early studies, its biological effects remain unclear. In this report, the biological effects of H-2 and its involvement in plant hormone signaling pathways and stress responses were determined. Antioxidant enzyme activity was found to be increased and the transcription of corresponding genes altered when the effects of H-2 on the germination of mung bean seeds treated with phytohormones was investigated. In addition, upregulation of several phytohormone receptor genes and genes that encode a few key factors involved in plant signaling pathways was detected in rice seedlings treated with HW. The transcription of putative rice hydrogenase genes, hydrogenase activity, and endogenous H-2 production were also determined. H-2 production was found to be induced by abscisic acid, ethylene, and jasmonate acid, salt, and drought stress and was consistent with hydrogenase activity and the expression of putative hydrogenase genes in rice seedlings. Together, these results suggest that H-2 may have an effect on rice stress tolerance by modulating the output of hormone signaling pathways.	[Zeng, Jiqing; Zhang, Mingyong] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Key Lab South China Agr Plant Genet & Breeding, Guangzhou, Guangdong, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Dept Diving Med, Shanghai, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Naval Medical University	Zeng, JQ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Key Lab South China Agr Plant Genet & Breeding, Guangzhou, Guangdong, Peoples R China.	zengjq@scib.ac.cn; zhangmy@scib.ac.cn	sun, xuejun/A-5561-2010; Zhang, Mingyong/GQZ-6217-2022	sun, xuejun/0000-0003-2387-5531; Zeng, Jiqing/0000-0003-3022-6003	NSFC (Natural Science Foundation of China) [31071352]; Chinese Academy of Science [KSCX3-EW-M-07]	NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This research was supported by NSFC (Natural Science Foundation of China) grant (31071352) and grant (KSCX3-EW-M-07) of the Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Choi J, 2012, PLANT CELL PHYSIOL, V53, P1334, DOI 10.1093/pcp/pcs079; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DOLE M, 1975, SCIENCE, V190, P152, DOI 10.1126/science.1166304; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Eroglu E, 2011, BIORESOURCE TECHNOL, V102, P8403, DOI 10.1016/j.biortech.2011.03.026; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fukushima Y, 2011, BIORESOURCE TECHNOL, V102, P8550, DOI 10.1016/j.biortech.2011.04.014; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; GRAY CT, 1965, SCIENCE, V148, P186, DOI 10.1126/science.148.3667.186; Hong Y, 2010, J INT MED RES, V38, P1893, DOI 10.1177/147323001003800602; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Itoh T, 2011, BIOCHEM BIOPH RES CO, V411, P143, DOI 10.1016/j.bbrc.2011.06.116; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kar RK, 2011, PLANT SIGNAL BEHAV, V6, P1741, DOI 10.4161/psb.6.11.17729; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Liu WW, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-13; Liu Y, 2005, SCI CHINA SER C, V48, P202, DOI 10.1360/04yc0088; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; MAIONE TE, 1986, PLANT PHYSIOL, V80, P360, DOI 10.1104/pp.80.2.360; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2006, INT J HYDROGEN ENERG, V31, P1563, DOI 10.1016/j.ijhydene.2006.06.038; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Nakai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P774, DOI 10.1271/bbb.100819; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241, DOI 10.2174/138161211797052664; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; PECK HD, 1956, J BACTERIOL, V71, P70, DOI 10.1128/JB.71.1.70-80.1956; RENWICK GM, 1964, PLANT PHYSIOL, V39, P303, DOI 10.1104/pp.39.3.303; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; TORRES V, 1986, ARCH BIOCHEM BIOPHYS, V245, P174, DOI 10.1016/0003-9861(86)90202-X; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1787, DOI 10.4161/psb.6.11.17685; Wi SJ, 2010, MOL CELLS, V30, P37, DOI 10.1007/s10059-010-0086-z; Xia XJ, 2011, NEW PHYTOL, V191, P706, DOI 10.1111/j.1469-8137.2011.03745.x; Xie YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049800; Yau CP, 2004, J EXP BOT, V55, P547, DOI 10.1093/jxb/erh055; YU L, 1969, J BACTERIOL, V98, P51, DOI 10.1128/JB.98.1.51-55.1969; Zhao L, 2009, BIOL PLANTARUM, V53, P728, DOI 10.1007/s10535-009-0132-x	51	45	57	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71038	10.1371/journal.pone.0071038	http://dx.doi.org/10.1371/journal.pone.0071038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951075	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300079
J	Chakraborty, R; Kumar, A; Bhowal, SS; Mandal, AK; Tiwary, BK; Mukherjee, S				Chakraborty, Ranadhir; Kumar, Arvind; Bhowal, Suparna Saha; Mandal, Amit Kumar; Tiwary, Bipransh Kumar; Mukherjee, Shriparna			Diverse Gene Cassettes in Class 1 Integrons of Facultative Oligotrophic Bacteria of River Mahananda, West Bengal, India	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SOIL BACTERIA; ENUMERATION; METAGENOME; STRAIN; PLANT	Background: In this study a large random collection (n = 2188) of facultative oligotrophic bacteria, from 90 water samples gathered in three consecutive years (2007-2009) from three different sampling sites of River Mahananda in Siliguri, West Bengal, India, were investigated for the presence of class 1 integrons and sequences of the amplification products. Methodology/Principal Findings: Replica plating method was employed for determining the antibiotic resistance profile of the randomly assorted facultative oligotrophic isolates. Genomic DNA from each isolate was analyzed by PCR for the presence of class 1 integron. Amplicons were cloned and sequenced. Numerical taxonomy and 16S rRNA gene sequence analyses were done to ascertain putative genera of the class 1 integron bearing isolates. Out of 2188 isolates, 1667 (76.19%) were antibiotic-resistant comprising of both single-antibiotic resistance (SAR) and multiple-antibiotic resistant (MAR), and 521 (23.81%) were sensitive to all twelve different antibiotics used in this study. Ninety out of 2188 isolates produced amplicon(s) of varying sizes from 0.15 to 3.45 KB. Chi-square (chi(2)) test revealed that the possession of class 1 integron in sensitive, SAR and MAR is not equally probable at the 1% level of significance. Diverse antibiotic-resistance gene cassettes, aadA1, aadA2, aadA4, aadA5, dfrA1, dfrA5, dfrA7, dfrA12, dfrA16, dfrA17, dfrA28, dfrA30, dfr-IIe, blaIMP-9, aacA4, Ac-69-Ib, oxa1, oxa10 and arr2 were detected in 64 isolates. The novel cassettes encoding proteins unrelated to any known antibiotic resistance gene function were identified in 26 isolates. Antibiotic-sensitive isolates have a greater propensity to carry gene cassettes unrelated to known antibiotic-resistance genes. The integron-positive isolates under the class Betaproteobacteria comprised of only two genera, Comamonas and Acidovorax of family Comamonadaceae, while isolates under class Gammaproteobacteria fell under the families, Moraxellaceae, Pseudomonadaceae, Aeromonadaceae and Enterobacteriaceae. Conclusions: Oligotrophic bacteria are good sources of novel genes as well as potential reservoirs of antibiotic resistance gene casettes.	[Chakraborty, Ranadhir; Kumar, Arvind; Bhowal, Suparna Saha; Mandal, Amit Kumar; Tiwary, Bipransh Kumar; Mukherjee, Shriparna] Univ N Bengal, Om Lab, Dept Biotechnol, Siliguri, W Bengal, India	University of North Bengal	Chakraborty, R (corresponding author), Univ N Bengal, Om Lab, Dept Biotechnol, Siliguri, W Bengal, India.	rcnbu2003@yahoo.com	CHAKRABORTY, RANADHIR/M-4439-2016; Mandal, Amit/AAP-3437-2020	Mandal, Amit/0000-0001-9249-5052; Tiwary, Bipransh/0000-0002-9479-8740; Kumar, Arvind/0000-0003-3405-2426	Department of Biotechnology DBT, India [Biotechnology/PR-164/BCE/08/448/2006];  [DBT-JRF/05-06/71/29.08.05.];  [Fellow/3726/R-2007];  [Biotechnology/BIO-CARe/06/141/2010-2011]	Department of Biotechnology DBT, India(Department of Biotechnology (DBT) India); ; ; 	The research work was supported from a major research grant (grant number Biotechnology/PR-164/BCE/08/448/2006) from (Department of Biotechnology DBT, India). Two of the authors, AK and AKM were provided with independent Ph.D fellowships (Award No. DBT-JRF/05-06/71/29.08.05.) North Bengal University Junior Research Fellow/3726/R-2007 respectively) and BKT was provided with fellowship funded by Biotechnology/BIO-CARe/06/141/2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Furuhata K., 2006, Nihon Bokin Bobai Gakkai Shi - Journal of Antibacterial and Antifungal Agents, V34, P323; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Han SH, 2012, PLANT PATHOLOGY J, V28, P68, DOI 10.5423/PPJ.NT.11.2011.0218; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Hu Yuan-sen, 2007, Weishengwu Xuebao, V47, P882; ISHIDA Y, 1981, MICROBIAL ECOL, V7, P123, DOI 10.1007/BF02032494; Ishii S, 2011, APPL ENVIRON MICROB, V77, P338, DOI 10.1128/AEM.02189-10; Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233; Kimura Y., 1995, Technical Bulletin of the Faculty of Agriculture, Kagawa University, V47, P121; Kumar A, 2013, INT J SYST EVOL MICR; Kumar A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-19; Kumar A, 2010, MICROB DRUG RESIST, V16, P29, DOI 10.1089/mdr.2009.0111; KUZNETSOV SI, 1979, ANNU REV MICROBIOL, V33, P377, DOI 10.1146/annurev.mi.33.100179.002113; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Loy A, 2005, APPL ENVIRON MICROB, V71, P3624, DOI 10.1128/AEM.71.7.3624-3632.2005; MALLORY LM, 1977, CAN J MICROBIOL, V23, P733, DOI 10.1139/m77-110; Massa S, 1998, WORLD J MICROB BIOT, V14, P727, DOI 10.1023/A:1008893627877; Miyake D., 2003, MICROBES ENVIRON, V18, P24, DOI [10.1264/jsme2.18.24, DOI 10.1264/JSME2.18.24]; Mukherjee S, 2006, RES MICROBIOL, V157, P220, DOI 10.1016/j.resmic.2005.08.003; Mukherjee S, 2013, INDIAN J BIOTECHNOL, V12, P80; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; NIKITIN D I, 1988, Mikrobiologiya, V57, P262; Oh H, 2009, WATER SCI TECHNOL, V59, P347, DOI 10.2166/wst.2009.857; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pramanik A, 2003, CURR SCI INDIA, V84, P1550; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schluter A, 2007, APPL ENVIRON MICROB, V73, P1952, DOI 10.1128/AEM.02159-06; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; TADA Y, 1995, J CLIN MICROBIOL, V33, P493, DOI 10.1128/JCM.33.2.493-494.1995; Zlatkin IV, 2012, MICROBIOLOGY+, V81, P35, DOI 10.1134/S002626171201016X; ZLATKIN IV, 1991, ANTIBIOT KHIMIOTERAP, V36, P34	36	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71753	10.1371/journal.pone.0071753	http://dx.doi.org/10.1371/journal.pone.0071753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951238	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200071
J	Nicholson, TL; Shore, SM; Smith, TC; Fraena, TS				Nicholson, Tracy L.; Shore, Sarah M.; Smith, Tara C.; Fraena, Timothy S.			Livestock-Associated Methicillin-Resistant Staphylococcus aureus (LA-MRSA) Isolates of Swine Origin Form Robust Biofilms	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; GENE-EXPRESSION; EXTRACELLULAR DNA; MOLECULAR CHARACTERIZATION; NASAL COLONIZATION; IN-VITRO; PIGS; PREVALENCE; ST398; CC398	Methicillin-resistant Staphylococcus aureus (MRSA) colonization of livestock animals is common and prevalence rates for pigs have been reported to be as high as 49%. Mechanisms contributing to the persistent carriage and high prevalence rates of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) strains in swine herds and production facilities have not been investigated. One explanation for the high prevalence of MRSA in swine herds is the ability of these organisms to exist as biofilms. In this report, the ability of swine LA-MRSA strains, including ST398, ST9, and ST5, to form biofilms was quantified and compared to several swine and human isolates. The contribution of known biofilm matrix components, polysaccharides, proteins and extracellular DNA (eDNA), was tested in all strains as well. All MRSA swine isolates formed robust biofilms similar to human clinical isolates. The addition of Dispersin B had no inhibitory effect on swine MRSA isolates when added at the initiation of biofilm growth or after pre-established mature biofilms formed. In contrast, the addition of proteinase K inhibited biofilm formation in all strains when added at the initiation of biofilm growth and was able to disperse pre-established mature biofilms. Of the LA-MRSA strains tested, we found ST398 strains to be the most sensitive to both inhibition of biofilm formation and dispersal of pre-formed biofilms by DNaseI. Collectively, these findings provide a critical first step in designing strategies to control or eliminate MRSA in swine herds.	[Nicholson, Tracy L.; Shore, Sarah M.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Smith, Tara C.] Univ Iowa, Ctr Emerging Infect Dis, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Fraena, Timothy S.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA USA	United States Department of Agriculture (USDA); University of Iowa; Iowa State University	Nicholson, TL (corresponding author), ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA.	tracy.nicholson@ars.usda.gov		Smith, Tara C./0000-0003-3747-1116	congressionally appropriated funds; U.S. Department of Agriculture, Agriculture Research Service	congressionally appropriated funds; U.S. Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the U.S. Department of Agriculture, Agriculture Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; BARBER M, 1961, J CLIN PATHOL, V14, P385, DOI 10.1136/jcp.14.4.385; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; BEENKEN KE, 2010, PLOS ONE, V5, DOI DOI 10.1371/J0URNAL.P0NE.0010790.PUBMED:20520723; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cassat James E., 2007, V391, P127; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; CHESNEAU O, 1993, MOL CELL PROBE, V7, P301, DOI 10.1006/mcpr.1993.1044; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; FELSSER AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI DOI 10.1128/AEM.00561-11.PUBMED:21724898; Franca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037480; Franca Angela, 2011, BMC Res Notes, V4, P572, DOI 10.1186/1756-0500-4-572; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Karlsson A, 2002, INFECT IMMUN, V70, P4239, DOI 10.1128/IAI.70.8.4239-4246.2002; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; KBCK R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI DOI 10.1007/S10096-009-0795-4.PUBMED:19701815; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kolar SL, 2013, MICROBIOLOGYOPEN, V2, P18, DOI 10.1002/mbo3.55; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Leonard FC, 2008, VET J, V175, P27, DOI 10.1016/j.tvjl.2006.11.008; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lozano C, 2011, EMERG INFECT DIS, V17, P138, DOI 10.3201/eid1701.100307; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Moormeier DE, 2013, APPL ENVIRON MICROB, V79, P3413, DOI 10.1128/AEM.00395-13; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; OBRIEN AM, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0030092.PUBMED:22276147; Pomba C, 2010, J ANTIMICROB CHEMOTH, V65, P2479, DOI 10.1093/jac/dkq330; Price LB, 2012, HOST ADAPTATION EMER, VCC398, P3, DOI DOI 10.1128/MBI0.00305-11; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; Sadykov MR, 2012, CURR OPIN MICROBIOL, V15, P211, DOI 10.1016/j.mib.2011.12.010; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz S, 2008, J ANTIMICROB CHEMOTH, V61, P282, DOI 10.1093/jac/dkm487; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; SMITH PB, 1969, APPL MICROBIOL, V18, P991, DOI 10.1128/AEM.18.6.991-993.1969; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tang JN, 2008, FEMS MICROBIOL LETT, V284, P176, DOI 10.1111/j.1574-6968.2008.01194.x; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Weese JS, 2010, CAN VET J, V51, P749; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Welinder-Olsson C, 2008, EMERG INFECT DIS, V14, P1271, DOI 10.3201/eid1408.071427; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	108	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73376	10.1371/journal.pone.0073376	http://dx.doi.org/10.1371/journal.pone.0073376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951352	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200090
J	Schwartz, MW; Dolanc, CR; Gao, H; Strauss, SY; Schwartz, AC; Williams, JN; Tang, Y				Schwartz, Mark W.; Dolanc, Christopher R.; Gao, Hui; Strauss, Sharon Y.; Schwartz, Ari C.; Williams, John N.; Tang, Ya			Forest Structure, Stand Composition, and Climate-Growth Response in Montane Forests of Jiuzhaigou National Nature Reserve, China	PLOS ONE			English	Article							FIR ABIES-FARGESII; SPATIAL VARIABILITY; TREE GROWTH; MOUNTAINS; DYNAMICS; RECONSTRUCTION; PATTERNS; PROGRAM; SICHUAN; AREA	Montane forests of western China provide an opportunity to establish baseline studies for climate change. The region is being impacted by climate change, air pollution, and significant human impacts from tourism. We analyzed forest stand structure and climate-growth relationships from Jiuzhaigou National Nature Reserve in northwestern Sichuan province, along the eastern edge of the Tibetan plateau. We conducted a survey to characterize forest stand diversity and structure in plots occurring between 2050 and 3350 m in elevation. We also evaluated seedling and sapling recruitment and tree-ring data from four conifer species to assess: 1) whether the forest appears in transition toward increased hardwood composition; 2) if conifers appear stressed by recent climate change relative to hardwoods; and 3) how growth of four dominant species responds to recent climate. Our study is complicated by clear evidence of 20th century timber extraction. Focusing on regions lacking evidence of logging, we found a diverse suite of conifers (Pinus, Abies, Juniperus, Picea, and Larix) strongly dominate the forest overstory. We found population size structures for most conifer tree species to be consistent with self-replacement and not providing evidence of shifting composition toward hardwoods. Climate-growth analyses indicate increased growth with cool temperatures in summer and fall. Warmer temperatures during the growing season could negatively impact conifer growth, indicating possible seasonal climate water deficit as a constraint on growth. In contrast, however, we found little relationship to seasonal precipitation. Projected warming does not yet have a discernible signal on trends in tree growth rates, but slower growth with warmer growing season climates suggests reduced potential future forest growth.	[Schwartz, Mark W.; Dolanc, Christopher R.; Williams, John N.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Dolanc, Christopher R.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA; [Gao, Hui; Tang, Ya] Sichuan Univ Chengdu, Dept Environm, Chengdu, Sichuan, Peoples R China; [Strauss, Sharon Y.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Schwartz, Ari C.] Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA	University of California System; University of California Davis; University of Montana System; University of Montana; Sichuan University; University of California System; University of California Davis; Oberlin College	Schwartz, MW (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	mwschwartz@ucdavis.edu	Strauss, Sharon/J-1827-2012; Schwartz, Mark/G-1066-2011; gao, huile/G-8290-2012	Strauss, Sharon/0000-0002-6117-4085; Schwartz, Mark/0000-0002-3739-6542; gao, huile/0000-0002-5355-7238	International Program of the Ministry of Science and Technology of China [2010DFA91280]; 111 Project [B08037]	International Program of the Ministry of Science and Technology of China; 111 Project(Ministry of Education, China - 111 Project)	This study was funded by the International Program of the Ministry of Science and Technology of China (2010DFA91280) and 111 Project (B08037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBAL FOREST RESOUR; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biondi F., 1997, Dendrochronologia, V15, P139; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Bunn AG, 2011, CLIMATIC CHANGE, V105, P627, DOI 10.1007/s10584-010-0005-5; Cao JX, 2012, J FOOD AGRIC ENVIRON, V10, P1341; Chen ZJ, 2011, PALAEOGEOGR PALAEOCL, V302, P301, DOI 10.1016/j.palaeo.2011.01.018; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dang HS, 2007, FOREST ECOL MANAG, V240, P143, DOI 10.1016/j.foreco.2006.12.021; Dang HS, 2009, CAN J FOREST RES, V39, P1848, DOI 10.1139/X09-106; Dang HS, 2009, PLANT ECOL, V201, P67, DOI 10.1007/s11258-008-9491-1; Dong XW, 2011, CHINESE GEOGR SCI, V21, P119, DOI 10.1007/s11769-011-0445-5; Drumond A, 2011, CLIM RES, V50, P215, DOI 10.3354/cr01043; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Fan ZX, 2009, FOREST ECOL MANAG, V258, P306, DOI 10.1016/j.foreco.2009.04.017; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; Fang KY, 2010, EUR J FOREST RES, V129, P1181, DOI 10.1007/s10342-010-0408-x; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Li WJ, 2006, ENVIRON MANAGE, V38, P572, DOI 10.1007/s00267-004-0299-z; Li WJ, 2005, ENVIRON MONIT ASSESS, V108, P279, DOI 10.1007/s10661-005-4327-0; Liang E, 2008, J VEG SCI, V19, P393, DOI 10.3170/2008-8-18379; Liang E, 2010, CAN J FOREST RES, V40, P200, DOI 10.1139/X09-186; Liang EY, 2010, TREES-STRUCT FUNCT, V24, P363, DOI 10.1007/s00468-009-0406-0; Liu HY, 2008, CALL OF PAPER PROCEEDINGS OF 2008 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING, P1077; Qian WH, 2003, THEOR APPL CLIMATOL, V76, P13, DOI 10.1007/s00704-003-0009-4; RONBERG B, 1987, J CLIMATOL, V7, P391, DOI 10.1002/joc.3370070406; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Shaoying L, 2007, BIODIVERSITY JIUZHAI; Shen CM, 2008, CLIM DYNAM, V31, P463, DOI 10.1007/s00382-007-0323-0; Shi JF, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000547; Stokes M.A., 1968, INTRO TREE RING DATI; Sykes MT, 1996, CLIMATIC CHANGE, V34, P161, DOI 10.1007/BF00224628; Tang CQ, 2002, PLANT ECOL, V161, P215, DOI 10.1023/A:1020395830795; Tang GP, 2010, DIVERS DISTRIB, V16, P144, DOI 10.1111/j.1472-4642.2009.00628.x; Team RDC, 2008, R LANG ENV STAT COMP; Wang T, 2006, GLOBAL ECOL BIOGEOGR, V15, P406, DOI 10.1111/j.1466-822x.2006.00233.x; Weng ES, 2006, ENVIRON MODEL ASSESS, V11, P45, DOI 10.1007/s10666-005-9019-1; Winkler D, 1988, PLANT RES DEV, V47, P184; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zhang J, 2008, SEVENTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, VOLS I-III, P3113; Zhao ZJ, 2012, AUST J BOT, V60, P602, DOI 10.1071/BT12051	47	9	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71559	10.1371/journal.pone.0071559	http://dx.doi.org/10.1371/journal.pone.0071559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951188	gold, Green Published			2022-12-27	WOS:000326473200054
J	Sun, F; Jin, KL; Uteshev, VV				Sun, Fen; Jin, Kunlin; Uteshev, Victor V.			A Type-II Positive Allosteric Modulator of alpha 7 nAChRs Reduces Brain Injury and Improves Neurological Function after Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CULTURED CORTICAL-NEURONS; ALZHEIMERS-DISEASE; BINDING-SITES; IN-VIVO; MEDIATED NEUROPROTECTION; NEUROGENIC VASODILATION; CHOLINERGIC-RECEPTORS; COGNITIVE IMPROVEMENT; THERAPEUTIC TARGETS	In the absence of clinically-efficacious therapies for ischemic stroke there is a critical need for development of new therapeutic concepts and approaches for prevention of brain injury secondary to cerebral ischemia. This study tests the hypothesis that administration of PNU-120596, a type-II positive allosteric modulator (PAM-II) of alpha 7 nicotinic acetylcholine receptors (nAChRs), as long as 6 hours after the onset of focal cerebral ischemia significantly reduces brain injury and neurological deficits in an animal model of ischemic stroke. Focal cerebral ischemia was induced by a transient (90 min) middle cerebral artery occlusion (MCAO). Animals were then subdivided into two groups and injected intravenously (i.v.) 6 hours post-MCAO with either 1 mg/kg PNU-120596 (treated group) or vehicle only (untreated group). Measurements of cerebral infarct volumes and neurological behavioral tests were performed 24 hrs post-MCAO. PNU-120596 significantly reduced cerebral infarct volume and improved neurological function as evidenced by the results of Bederson, rolling cylinder and ladder rung walking tests. These results forecast a high therapeutic potential for PAMs-II as effective recruiters and activators of endogenous alpha 7 nAChR-dependent cholinergic pathways to reduce brain injury and improve neurological function after cerebral ischemic stroke.	[Sun, Fen; Jin, Kunlin; Uteshev, Victor V.] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Uteshev, VV (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	Victor.Uteshev@unthsc.edu		SUN, FEN/0000-0003-2094-9494	National Institutes of Health [DK-082625]; UNTHSC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNTHSC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health Grant DK-082625 and the Start-Up funds from UNTHSC to V.V. Uteshev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blair LAC, 1999, J NEUROSCI, V19, P1940; Boess FG, 2007, J PHARMACOL EXP THER, V321, P716, DOI 10.1124/jpet.106.118976; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Brott T, 2000, NEW ENGL J MED, V343, P710, DOI 10.1056/NEJM200009073431007; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Chilton M, 2004, LIFE SCI, V74, P3133, DOI 10.1016/j.lfs.2003.11.012; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; COLLINS F, 1991, J NEUROSCI, V11, P2582; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; DeMuth JE., BASIC STAT PHARM STA; DJURICIC B, 1991, J CEREBR BLOOD F MET, V11, P308, DOI 10.1038/jcbfm.1991.63; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Freitas K, 2013, BRIT J PHARMACOL, V169, P567, DOI 10.1111/j.1476-5381.2012.02226.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Fucile S, 2004, NEUROSCIENCE, V127, P53, DOI 10.1016/j.neuroscience.2004.04.017; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Fujiki M, 2005, BRAIN RES, V1043, P236, DOI 10.1016/j.brainres.2005.02.063; Furlan AJ, 2002, CLEV CLIN J MED, V69, P730, DOI 10.3949/ccjm.69.9.730; Gasull T, 2000, J BIOL CHEM, V275, P18350, DOI 10.1074/jbc.M910468199; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Gusev AG, 2010, J PHARMACOL EXP THER, V332, P588, DOI 10.1124/jpet.109.162099; Guseva MV, 2008, NEUROTRAUMA, V25, P975, DOI [10.1089/neu.2008.0516, DOI 10.1089/NEU.2008.0516]; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jenden DJ, 1996, LIFE SCI, V58, P2003, DOI 10.1016/0024-3205(96)00191-9; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalappa BI, 2013, BR J PHARM; Kalappa BI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013964; Kaneko S, 1997, BRAIN RES, V765, P135, DOI 10.1016/S0006-8993(97)00556-8; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Kelso ML, 2011, PROG MOL BIOL TRANSL, V98, P85, DOI 10.1016/B978-0-12-385506-0.00003-X; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; KLEIN J, 1993, BRAIN RES, V630, P337, DOI 10.1016/0006-8993(93)90674-C; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; MARTIN EJ, 1994, DRUG DEVELOP RES, V31, P135, DOI 10.1002/ddr.430310208; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; McLean SL, 2012, J PSYCHOPHARMACOL, V26, P1265, DOI 10.1177/0269881111431747; McLean SL, 2011, EUR NEUROPSYCHOPHARM, V21, P333, DOI 10.1016/j.euroneuro.2010.06.003; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V284, P1026; Munro G, 2012, BR J PHARM; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parada E, 2013, ANTIOXID REDOX SIGN, P2; PERRY EK, 1995, NEUROSCIENCE, V64, P385, DOI 10.1016/0306-4522(94)00410-7; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Quik M, 2009, BIOCHEM PHARMACOL, V78, P677, DOI 10.1016/j.bcp.2009.05.003; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Rosa AO, 2006, J MOL NEUROSCI, V30, P61, DOI 10.1385/JMN:30:1:61; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Si ML, 2001, J PHARMACOL EXP THER, V298, P122; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Sun F, 2012, RESTOR NEUROL NEUROS, V30, P491, DOI 10.3233/RNN-2012-120254; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tatsumi R, 2006, J MED CHEM, V49, P4374, DOI 10.1021/jm060249c; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Uteshev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032951; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Weavers A, 2000, ACTA NEUROL SCAND, V102, P42; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; WOODRUFFPAK DS, 1994, BRAIN RES, V645, P309, DOI 10.1016/0006-8993(94)91665-9	116	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73581	10.1371/journal.pone.0073581	http://dx.doi.org/10.1371/journal.pone.0073581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951360	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200095
J	Wu, GY; Yao, J; Hu, B; Zhang, HM; Li, YD; Li, X; Li, Q; Sui, JF				Wu, Guang-yan; Yao, Juan; Hu, Bo; Zhang, Hui-ming; Li, Yi-ding; Li, Xuan; Li, Qiong; Sui, Jian-feng			Reevaluating the Role of the Hippocampus in Delay Eyeblink Conditioning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NICTITATING-MEMBRANE RESPONSE; RABBITS ORYCTOLAGUS-CUNICULUS; PONTINE NUCLEI; EYE-BLINK; UNCONDITIONED STIMULUS; PAVLOVIAN EYEBLINK; AUDITORY THALAMUS; DISRUPTS TRACE; MEMORY TRACES	The role of the hippocampus in delay eyeblink conditioning (DEC) remains controversial. Here, we investigated the involvement of the hippocampus in DEC with a soft tone as the conditioned stimulus (CS) by using electrolytic lesions or muscimol inactivation of guinea pig dorsal hippocampus. Interestingly, when a soft tone was used as a CS, electrolytic lesions of the hippocampus significantly retarded acquisition of the conditioned response (CR), and muscimol infusions into hippocampus distinctly inhibited the acquisition and expression of CR, but had no significant effect on consolidation of well-learned CR. In contrast, both electrolytic lesions and muscimol inactivation of hippocampus produced no significant deficits in the CR when a loud tone was used as the CS. These results demonstrate that the hippocampus is essential for the DEC when the delay task was rendered more difficult.	[Wu, Guang-yan; Hu, Bo; Zhang, Hui-ming; Sui, Jian-feng] Third Mil Med Univ, Dept Physiol, Coll Basic Med Sci, Chongqing, Peoples R China; [Wu, Guang-yan; Yao, Juan; Li, Yi-ding; Li, Xuan; Li, Qiong; Sui, Jian-feng] Third Mil Med Univ, Coll Basic Med Sci, Expt Ctr Basic Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Sui, JF (corresponding author), Third Mil Med Univ, Dept Physiol, Coll Basic Med Sci, Chongqing, Peoples R China.	jfsui2003@163.com	Zhang, Hui/HHN-8494-2022					AITKIN LM, 1978, HEARING RES, V1, P67, DOI 10.1016/0378-5955(78)90010-2; AKASE E, 1989, BEHAV NEUROSCI, V103, P935, DOI 10.1037/0735-7044.103.5.935; BERGER TW, 1978, BRAIN RES, V145, P323, DOI 10.1016/0006-8993(78)90866-1; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Beylin AV, 1998, BEHAV NEUROSCI, V112, P1327, DOI 10.1037/0735-7044.112.6.1327; BOYD J, 1976, NEUROSCI LETT, V3, P259, DOI 10.1016/0304-3940(76)90052-5; Campolattaro MM, 2007, LEARN MEMORY, V14, P152, DOI 10.1101/lm.465507; Chachich M, 1998, NEUROSCI LETT, V257, P151, DOI 10.1016/S0304-3940(98)00832-5; Christian KM, 2005, BEHAV NEUROSCI, V119, P526, DOI 10.1037/0735-7044.119.2.526; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Freeman JH, 2003, LEARN MEMORY, V10, P337, DOI 10.1101/lm.63703; Freeman JH, 2007, LEARN MEMORY, V14, P842, DOI 10.1101/lm.716107; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Green JT, 2007, NEUROBIOL LEARN MEM, V87, P269, DOI 10.1016/j.nlm.2006.08.014; Halverson HE, 2008, LEARN MEMORY, V15, P532, DOI 10.1101/lm.1002508; Halverson HE, 2010, J NEUROSCI, V30, P8787, DOI 10.1523/JNEUROSCI.0208-10.2010; Halverson HE, 2010, NEUROBIOL LEARN MEM, V93, P92, DOI 10.1016/j.nlm.2009.08.008; Hu B, 2009, NEUROSCI LETT, V459, P41, DOI 10.1016/j.neulet.2009.04.061; Kalmbach BE, 2010, J NEUROPHYSIOL, V104, P627, DOI 10.1152/jn.00169.2010; Kalmbach BE, 2009, LEARN MEMORY, V16, P86, DOI 10.1101/lm.1178309; Kotani S, 2003, EUR J NEUROSCI, V17, P1445, DOI 10.1046/j.1460-9568.2003.02566.x; Leal-Campanario R, 2007, P NATL ACAD SCI USA, V104, P11459, DOI 10.1073/pnas.0704548104; Lee T, 2004, J NEUROSCI, V24, P3242, DOI 10.1523/JNEUROSCI.5382-03.2004; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; McLaughlin J, 2002, BEHAV NEUROSCI, V116, P37, DOI 10.1037//0735-7044.116.1.37; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Oswald BB, 2008, BEHAV NEUROSCI, V122, P841, DOI 10.1037/0735-7044.122.4.841; Oswald BB, 2007, BEHAV BRAIN RES, V179, P111, DOI 10.1016/j.bbr.2007.01.016; Oswald BB, 2010, NEUROBIOL LEARN MEM, V93, P37, DOI 10.1016/j.nlm.2009.08.001; Oswald B, 2006, BEHAV NEUROSCI, V120, P1033, DOI 10.1037/0735-7044.120.5.1033; Oswald BB, 2009, PHYSIOL BEHAV, V96, P67, DOI 10.1016/j.physbeh.2008.08.013; Plakke B, 2009, NEUROBIOL LEARN MEM, V92, P335, DOI 10.1016/j.nlm.2009.04.001; PORT RL, 1985, BEHAV NEUROSCI, V99, P200, DOI 10.1037/0735-7044.99.2.200; Powell DA, 2005, BEHAV NEUROSCI, V119, P180, DOI 10.1037/0735-7044.119.1.180; Powell DA, 2001, BEHAV NEUROSCI, V115, P1029, DOI 10.1037//0735-7044.115.5.1029; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Rapisarda C, 1977, Arch Sci Biol (Bologna), V61, P1; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Simon B, 2005, J NEUROSCI, V25, P10740, DOI 10.1523/JNEUROSCI.3003-05.2005; SOLOMON PR, 1975, J COMP PHYSIOL PSYCH, V89, P1192, DOI 10.1037/h0077183; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Tam SKE, 2012, BEHAV BRAIN RES, V230, P259, DOI 10.1016/j.bbr.2012.02.016; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Wada N, 2007, P NATL ACAD SCI USA, V104, P16690, DOI 10.1073/pnas.0708165104; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Weeks ACW, 2007, LEARN MEMORY, V14, P385, DOI 10.1101/lm.348307; Weible AP, 2003, J NEUROPHYSIOL, V90, P599, DOI 10.1152/jn.01097.2002; Weible AP, 2000, BEHAV NEUROSCI, V114, P1058, DOI 10.1037/0735-7044.114.6.1058; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006; Wu GY, 2012, NEUROBIOL LEARN MEM, V97, P277, DOI 10.1016/j.nlm.2012.02.001	56	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71249	10.1371/journal.pone.0071249	http://dx.doi.org/10.1371/journal.pone.0071249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951119	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200034
J	Amaro, S; Llull, L; Urra, X; Obach, V; Cervera, A; Chamorro, A				Amaro, Sergio; Llull, Laura; Urra, Xabier; Obach, Victor; Cervera, Alvaro; Chamorro, Angel			Risks and Benefits of Early Antithrombotic Therapy after Thrombolytic Treatment in Patients with Acute Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; RANDOMIZED CONTROLLED-TRIAL; INTRAVENOUS THROMBOLYSIS; ARTERIAL REOCCLUSION; ATRIAL-FIBRILLATION; WRITING COMMITTEE; HEPARIN; RECANALIZATION; ALTEPLASE	Background: Current guidelines recommend withholding antithrombotic therapy (ATT) for at least 24 h in patients with acute ischemic stroke treated with thrombolytic therapy. Herein, we report a retrospective analysis of a single-centre experience on the safety and efficacy of antithrombotic therapy (ATT) started before or after 24 h of intravenous thrombolysis in a cohort of acute ischemic stroke patients. Methods: A total of 139 patients (Rapid ATT group) received antithrombotic therapy before 24 h of thrombolysis, and 33 patients (Standard ATT group) after 24 h. The brain parenchyma and vessel status were assessed using simple CT scan on admission, multimodal CT scan at the end of thrombolysis, and angio-CT/MRI scan at day 3. Functional outcome was scored using the modified Rankin Scale (mRS) at day 90. Results: The two ATT groups had similar demographics, stroke subtypes, baseline NIHSS, thrombolytic strategies, vessel-patency rates at the end of thrombolysis, and incidence of bleeding complications at follow up. At day 3, the Rapid ATT group had a non-significant improved vessel-patency rate than the Standard ATT group. At day 90, a greater proportion of patients in the rapid ATT group had shifted down the mRS, and had improved in the NIHSS score. Conclusions: ATT initiated before 24 h of intravenous thrombolytic therapy in acute stroke patients disclosed no safety concerns compared with a conventional antithrombotic therapy delay of 24 h and showed better functional outcome at follow up. The value of early initiation of ATT after thrombolysis deserves further assessment in randomized controlled trials.	[Amaro, Sergio; Llull, Laura; Urra, Xabier; Obach, Victor; Cervera, Alvaro; Chamorro, Angel] Hosp Clin Barcelona, Funct Unit Cerebrovasc Dis, Barcelona, Spain; [Amaro, Sergio; Urra, Xabier; Cervera, Alvaro; Chamorro, Angel] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Chamorro, Angel] Univ Barcelona, Sch Med, Dept Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Chamorro, A (corresponding author), Hosp Clin Barcelona, Funct Unit Cerebrovasc Dis, Barcelona, Spain.	achamorro@ub.edu	Urra, Xabier/B-7637-2019	Urra, Xabier/0000-0002-4763-5252				Abilleira S, 2011, STROKE, V42, P2001, DOI 10.1161/STROKEAHA.110.605030; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Cervera A, 2004, J NEUROSCI RES, V77, P565, DOI 10.1002/jnr.20186; Chamorro A, 2005, CEREBROVASC DIS, V19, P402, DOI 10.1159/000086100; Chamorro A, 1999, ARCH NEUROL-CHICAGO, V56, P1098, DOI 10.1001/archneur.56.9.1098; Chamorro A, 2006, STROKE, V37, P3052, DOI 10.1161/01.STR.0000248952.59078.7a; Demchuk AM, 2001, NEUROLOGY, V57, P474, DOI 10.1212/WNL.57.3.474; Grond M, 1998, STROKE, V29, P1544, DOI 10.1161/01.STR.29.8.1544; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Janjua N, 2008, AM J NEURORADIOL, V29, P253, DOI 10.3174/ajnr.A0825; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Molina CA, 2004, STROKE, V35, P151, DOI 10.1161/01.STR.0000106485.04500.4A; Multicentre Acute Stroke Trial-Italy Group, 1995, LANCET, V346, P1509; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Sanak D, 2012, EUR NEUROL, V67, P52, DOI 10.1159/000333064; Schmulling S, 2003, CEREBROVASC DIS, V16, P183, DOI 10.1159/000071114; SEIFRIED E, 1989, THROMB HAEMOSTASIS, V61, P497; The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, N ENGL J MED, V312, P932; Zinkstok SM, 2012, LANCET, V380, P731, DOI 10.1016/S0140-6736(12)60949-0	26	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71132	10.1371/journal.pone.0071132	http://dx.doi.org/10.1371/journal.pone.0071132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951093	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000040
J	Gonnissen, HKJ; Mazuy, C; Rutters, F; Martens, EAP; Adam, TC; Westerterp-Plantenga, MS				Gonnissen, Hanne K. J.; Mazuy, Claire; Rutters, Femke; Martens, Eveline A. P.; Adam, Tanja C.; Westerterp-Plantenga, Margriet S.			Sleep Architecture When Sleeping at an Unusual Circadian Time and Associations with Insulin Sensitivity	PLOS ONE			English	Article							SLOW-WAVE SLEEP; HORMONE; GLUCOSE; PROPENSITY; METABOLISM; PROTEIN; RHYTHM; DIET	Circadian misalignment affects total sleep time, but it may also affect sleep architecture. The objectives of this study were to examine intra-individual effects of circadian misalignment on sleep architecture and inter-individual relationships between sleep stages, cortisol levels and insulin sensitivity. Thirteen subjects (7 men, 6 women, age: 24.3 +/- 2.5 y; BMI: 23.6 +/- 1.7 kg/m(2)) stayed in a time blinded respiration chamber during three light-entrained circadian cycles (3x21h and 3x27h) resulting in a phase advance and a phase delay. Sleep was polysomnographically recorded. Blood and salivary samples were collected to determine glucose, insulin and cortisol concentrations. Intra-individually, a phase advance decreased rapid eye movement (REM) sleep and slow-wave sleep (SWS), increased time awake, decreased sleep and REM sleep latency compared to the 24h cycle. A phase delay increased REM sleep, decreased stage 2 sleep, increased time awake, decreased sleep and REM sleep latency compared to the 24h cycle. Moreover, circadian misalignment changed REM sleep distribution with a relatively shorter REM sleep during the second part of the night. Inter-individually, REM sleep was inversely associated with cortisol levels and HOMA-IR index. Circadian misalignment, both a phase advance and a phase delay, significantly changed sleep architecture and resulted in a shift in rem sleep. Inter-individually, shorter REM sleep during the second part of the night was associated with dysregulation of the HPA-axis and reduced insulin sensitivity.	[Gonnissen, Hanne K. J.; Mazuy, Claire; Rutters, Femke; Martens, Eveline A. P.; Adam, Tanja C.; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Gonnissen, HKJ (corresponding author), Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands.	hkj.gonnissen@maastrichtuniversity.nl		Mazuy, Claire/0000-0003-4068-6839				Adam TC, 2011, DIABETES CARE, V34, P994, DOI 10.2337/dc10-1593; AKERSTEDT T, 1986, PSYCHOPHYSIOLOGY, V23, P293, DOI 10.1111/j.1469-8986.1986.tb00635.x; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Brass SD, 2009, J CLIN SLEEP MED, V5, P386; BRUNNER DP, 1993, SLEEP, V16, P100, DOI 10.1093/sleep/16.2.100; Carskadon M.A., 2011, PRINCIPLES PRACTICE, V5th edition, P16, DOI DOI 10.1016/B978-1-4160-6645-3.00002-5; CZEISLER CA, 1980, SCIENCE, V210, P1264, DOI 10.1126/science.7434029; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Gonnissen HKJ, 2012, AM J CLIN NUTR, V96, P689, DOI 10.3945/ajcn.112.037192; Hampton SM, 1996, J ENDOCRINOL, V151, P259, DOI 10.1677/joe.0.1510259; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Horne J, 2009, NEUROSCI BIOBEHAV R, V33, P466, DOI 10.1016/j.neubiorev.2008.12.002; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Koren D, 2011, DIABETES CARE, V34, P2442, DOI 10.2337/dc11-1093; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Lemmens SG, 2011, AM J CLIN NUTR, V94, P717, DOI 10.3945/ajcn.110.008631; Lemmens SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016826; Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Nedeltcheva AV, 2009, AM J CLIN NUTR, V89, P126, DOI 10.3945/ajcn.2008.26574; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rutters F, 2012, INT J OBESITY, V36, P1346, DOI 10.1038/ijo.2011.250; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; TILLEY AJ, 1984, PSYCHOPHYSIOLOGY, V21, P406, DOI 10.1111/j.1469-8986.1984.tb00217.x; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Veldhorst MAB, 2009, PHYSIOL BEHAV, V96, P675, DOI 10.1016/j.physbeh.2009.01.004; WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037; Westerterp-Plantenga MS, 2009, PHYSIOL BEHAV, V97, P414, DOI 10.1016/j.physbeh.2009.03.010; Willi SM, 1998, PEDIATRICS, V101, P61, DOI 10.1542/peds.101.1.61; Wu H, 2010, PHYSIOL RES, V59, P821, DOI 10.33549/physiolres.931895; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	34	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72877	10.1371/journal.pone.0072877	http://dx.doi.org/10.1371/journal.pone.0072877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951335	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000091
J	Johnson, EK; Li, B; Yoon, JH; Flanigan, KM; Martin, PT; Ervasti, J; Montanaro, F				Johnson, Eric K.; Li, Bin; Yoon, Jung Hae; Flanigan, Kevin M.; Martin, Paul T.; Ervasti, James; Montanaro, Federica			Identification of New Dystroglycan Complexes in Skeletal Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ACETYLCHOLINE-RECEPTOR AGGREGATION; DECOY SEARCH STRATEGY; MDX MOUSE MUSCLE; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; ABNORMAL GLYCOSYLATION; NEUROMUSCULAR-JUNCTION	The dystroglycan complex contains the transmembrane protein beta-dystroglycan and its interacting extracellular mucin-like protein a-dystroglycan. In skeletal muscle fibers, the dystroglycan complex plays an important structural role by linking the cytoskeletal protein dystrophin to laminin in the extracellular matrix. Mutations that affect any of the proteins involved in this structural axis lead to myofiber degeneration and are associated with muscular dystrophies and congenital myopathies. Because loss of dystrophin in Duchenne muscular dystrophy (DMD) leads to an almost complete loss of dystroglycan complexes at the myofiber membrane, it is generally assumed that the vast majority of dystroglycan complexes within skeletal muscle fibers interact with dystrophin. The residual dystroglycan present in dystrophin-deficient muscle is thought to be preserved by utrophin, a structural homolog of dystrophin that is up-regulated in dystrophic muscles. However, we found that dystroglycan complexes are still present at the myofiber membrane in the absence of both dystrophin and utrophin. Our data show that only a minority of dystroglycan complexes associate with dystrophin in wild type muscle. Furthermore, we provide evidence for at least three separate pools of dystroglycan complexes within myofibers that differ in composition and are differentially affected by loss of dystrophin. Our findings indicate a more complex role of dystroglycan in muscle than currently recognized and may help explain differences in disease pathology and severity among myopathies linked to mutations in DAPC members.	[Johnson, Eric K.; Yoon, Jung Hae; Flanigan, Kevin M.; Martin, Paul T.; Montanaro, Federica] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH USA; [Johnson, Eric K.; Yoon, Jung Hae; Flanigan, Kevin M.; Martin, Paul T.; Montanaro, Federica] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Johnson, Eric K.; Montanaro, Federica] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Li, Bin; Ervasti, James] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Flanigan, Kevin M.; Martin, Paul T.; Montanaro, Federica] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University	Montanaro, F (corresponding author), Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH USA.	montanaf@pediatrics.ohio-state.edu	Ervasti, James/AAZ-4786-2020; Montanaro, Federica/GRJ-5139-2022; Martin, Paul T/E-3599-2011	Montanaro, Federica/0000-0002-3338-0498; Martin, Paul/0000-0002-0674-6191; Flanigan, Kevin/0000-0001-6440-3376	Research Institute at Nationwide Children's Hospital; Parent Project Muscular Dystrophy; American Heart Association; National Institute of Arthritis and Musculoskeletal and Skin Disorders [R01 AR042423, R01 AR060949]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042423, R01AR060949] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); Parent Project Muscular Dystrophy; American Heart Association(American Heart Association); National Institute of Arthritis and Musculoskeletal and Skin Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by The Research Institute at Nationwide Children's Hospital (internal funds to F. M.); Parent Project Muscular Dystrophy (to F. M.), the American Heart Association (fellowship to E.K.J.); the National Institute of Arthritis and Musculoskeletal and Skin Disorders (R01 AR042423 to J.E.; and R01 AR060949 to P. T. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; BEWICK GS, 1993, NEUROMUSCULAR DISORD, V3, P503, DOI 10.1016/0960-8966(93)90105-S; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Buraei Z, 2012, BIOCH BIOPHYS ACTA; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; Chandrasekharan K, 2010, METHOD ENZYMOL, V479, P291, DOI 10.1016/S0076-6879(10)79017-0; Cluchague N, 2004, FEBS LETT, V572, P216, DOI 10.1016/j.febslet.2004.07.032; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; CORRADO K, 1994, FEBS LETT, V344, P255, DOI 10.1016/0014-5793(94)00397-1; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Crosbie RH, 1999, J CELL BIOL, V145, P153, DOI 10.1083/jcb.145.1.153; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Galvin J, 2010, J NEUROSCI RES, V88, P3295, DOI 10.1002/jnr.22484; GEE SH, 1993, J BIOL CHEM, V268, P14972; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; Hosokawa H, 2002, J CELL SCI, V115, P1487; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jacobson C, 1998, J NEUROSCI, V18, P6340; Jarad G, 2009, GENESIS, V47, P1, DOI 10.1002/dvg.20447; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Johnson EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043515; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Masuda-Hirata M, 2009, GENES CELLS, V14, P835, DOI 10.1111/j.1365-2443.2009.01315.x; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller G, 2012, HUM MOL GENET, V21, P4508, DOI 10.1093/hmg/dds293; Montanaro F, 1998, J NEUROSCI, V18, P1250; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Pereon Y, 1997, BBA-MOL BASIS DIS, V1362, P201, DOI 10.1016/S0925-4439(97)00079-3; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Repetto S, 1999, BIOCHEM BIOPH RES CO, V261, P547, DOI 10.1006/bbrc.1999.1055; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Russo K, 2000, BIOCHEM BIOPH RES CO, V274, P93, DOI 10.1006/bbrc.2000.3103; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sabatelli P, 2003, BBA-MOL BASIS DIS, V1638, P57, DOI 10.1016/S0925-4439(03)00040-1; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sharma P, 2010, J CELL SCI, V123, P3061, DOI 10.1242/jcs.066712; Shibuya S, 2002, NEUROSCI LETT, V325, P171, DOI 10.1016/S0304-3940(02)00267-7; Shim JY, 2003, YONSEI MED J, V44, P15, DOI 10.3349/ymj.2003.44.1.15; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Singhal N, 2012, MOL CELL NEUROSCI, V51, P112, DOI 10.1016/j.mcn.2012.08.014; Sirour C, 2011, MOL BIOL CELL, V22, P2957, DOI 10.1091/mbc.E11-01-0074; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Straub V, 1998, AM J PATHOL, V153, P1623, DOI 10.1016/S0002-9440(10)65751-3; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; Tadayoni R, 2011, MOL NEUROBIOL; TAKEMITSU M, 1991, BIOCHEM BIOPH RES CO, V180, P1179, DOI 10.1016/S0006-291X(05)81320-8; TANAKA H, 1991, HISTOCHEMISTRY, V96, P1, DOI 10.1007/BF00266753; Tremblay MR, 2006, J BIOL CHEM, V281, P13365, DOI 10.1074/jbc.M600912200; Xiong YM, 2009, J CELL PHYSIOL, V219, P402, DOI 10.1002/jcp.21684; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoon JH, 2012, J PROTEOME RES, V11, P4413, DOI 10.1021/pr300328r; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; Zhan YG, 2005, J BIOL CHEM, V280, P18015, DOI 10.1074/jbc.M409682200; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	93	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e73224	10.1371/journal.pone.0073224	http://dx.doi.org/10.1371/journal.pone.0073224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951345	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000094
J	Pelosse, P; Kribs-Zaleta, CM; Ginoux, M; Rabinovich, JE; Gourbiere, S; Menu, F				Pelosse, Perrine; Kribs-Zaleta, Christopher M.; Ginoux, Marine; Rabinovich, Jorge E.; Gourbiere, Sebastien; Menu, Frederic			Influence of Vectors' Risk-Spreading Strategies and Environmental Stochasticity on the Epidemiology and Evolution of Vector-Borne Diseases: The Example of Chagas' Disease	PLOS ONE			English	Article							DOMICILIATED TRIATOMA-DIMIDIATA; CONTACT PROCESS SATURATION; TRYPANOSOMA-CRUZI; POPULATION-DYNAMICS; YUCATAN PENINSULA; SYLVATIC TRANSMISSION; DENSITY REGULATION; ADAPTIVE DYNAMICS; LIFE-CYCLES; VIRULENCE	Insects are known to display strategies that spread the risk of encountering unfavorable conditions, thereby decreasing the extinction probability of genetic lineages in unpredictable environments. To what extent these strategies influence the epidemiology and evolution of vector-borne diseases in stochastic environments is largely unknown. In triatomines, the vectors of the parasite Trypanosoma cruzi, the etiological agent of Chagas' disease, juvenile development time varies between individuals and such variation most likely decreases the extinction risk of vector populations in stochastic environments. We developed a simplified multi-stage vector-borne SI epidemiological model to investigate how vector risk-spreading strategies and environmental stochasticity influence the prevalence and evolution of a parasite. This model is based on available knowledge on triatomine biodemography, but its conceptual outcomes apply, to a certain extent, to other vector-borne diseases. Model comparisons between deterministic and stochastic settings led to the conclusion that environmental stochasticity, vector risk-spreading strategies (in particular an increase in the length and variability of development time) and their interaction have drastic consequences on vector population dynamics, disease prevalence, and the relative short-term evolution of parasite virulence. Our work shows that stochastic environments and associated risk-spreading strategies can increase the prevalence of vector-borne diseases and favor the invasion of more virulent parasite strains on relatively short evolutionary timescales. This study raises new questions and challenges in a context of increasingly unpredictable environmental variations as a result of global climate change and human interventions such as habitat destruction or vector control.	[Pelosse, Perrine; Ginoux, Marine; Menu, Frederic] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; [Pelosse, Perrine; Kribs-Zaleta, Christopher M.] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA; [Pelosse, Perrine] Publ Hlth England, London, England; [Gourbiere, Sebastien] Univ Perpignan, CNRS, Ecol & Evolut Interact UMR 5244, F-66025 Perpignan, France; [Gourbiere, Sebastien] Univ Sussex, Ctr Study Evolut, Sch Life Sci, Brighton, E Sussex, England; [Rabinovich, Jorge E.] Univ Nacl La Plata, Ctr Estudios Parasitol & Vectores, La Plata, Buenos Aires, Argentina	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Texas System; University of Texas Arlington; Public Health England; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; University of Sussex; National University of La Plata	Pelosse, P (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France.	perrine.pelosse@gmail.com	Gourbière, Sébastien/C-4320-2011; MENU, Frédéric/C-3107-2016; Kribs, Christopher/ABE-3287-2021; Kribs, Christopher/A-5431-2015	Gourbiere, Sebastien/0000-0002-6701-4795	French National Research Agency [ANR-08-MIE-007]; National Science Foundation [DMS-1020880]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [PICT2008-0035]	French National Research Agency(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT)	This work has been supported by the French National Research Agency (grant reference "ANR-08-MIE-007"), by the National Science Foundation (grant reference "DMS-1020880"), and by the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (grant reference PICT2008-0035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Andre JB, 2005, EVOLUTION, V59, P1406, DOI 10.1111/j.0014-3820.2005.tb01791.x; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; CARCAVALLO RU, 1972, CAN ENTOMOL, V104, P699, DOI 10.4039/Ent104699-5; Castanera MB, 2003, ECOL MODEL, V162, P33, DOI 10.1016/S0304-3800(02)00388-5; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; CHRISTIANSEN FB, 1991, AM NAT, V138, P37, DOI 10.1086/285203; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Cooper VS, 2002, P ROY SOC B-BIOL SCI, V269, P1161, DOI 10.1098/rspb.2002.1976; Danks HV, 1987, INSECT DORMANCY ECOL; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; Devillers H, 2008, J THEOR BIOL, V255, P307, DOI 10.1016/j.jtbi.2008.08.023; Dieckmann U, 2002, CA ST AD DY, V2, P39; Dumonteil E, 2004, MEM I OSWALDO CRUZ, V99, P253, DOI 10.1590/S0074-02762004000300002; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; ESHEL I, 1981, THEOR POPUL BIOL, V19, P420, DOI 10.1016/0040-5809(81)90029-0; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Garcia da Silva I, 1989, MEMORIAS I OSWALD S4, V84, P499; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GOODMAN D, 1984, THEOR POPUL BIOL, V25, P1, DOI 10.1016/0040-5809(84)90002-9; GORLA D E, 1985, Bulletin of the Society of Vector Ecologists, V10, P107; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Gourbiere S, 2009, EVOLUTION, V63, P1879, DOI 10.1111/j.1558-5646.2009.00731.x; Guarneri AA, 2000, J MED ENTOMOL, V37, P373, DOI 10.1603/0022-2585(2000)037[0373:IOTBMS]2.0.CO;2; Guilhem R, 2012, J R SOC INTERFACE, V9, P2936, DOI 10.1098/rsif.2012.0358; Hall CA, 2010, J PARASITOL, V96, P371, DOI 10.1645/GE-2296.1; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; HANSKI I, 1988, ANN ZOOL FENN, V25, P37; Heitzmann-Fontenelle TJ, 1984, MEM I BUTANTAN, V47, P165; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; KAKEHASHI M, 1992, ECOL RES, V7, P235, DOI 10.1007/BF02347092; Kribs-Zaleta C, 2006, MATH POPUL STUD, V13, P135, DOI 10.1080/08898480600788576; Kribs-Zaleta C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000656; Kribs-Zaleta CM, 2004, MATH BIOSCI, V192, P137, DOI 10.1016/j.mbs.2004.11.001; Lambert RC, 2008, GEOSPATIAL HEALTH, V2, P227, DOI 10.4081/gh.2008.246; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; LENT H, 1977, Revista Brasileira de Biologia, V37, P325; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LIVDAHL TP, 1979, AM NAT, V113, P835, DOI 10.1086/283439; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; Luckhart S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000566; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; Maynard Smith J., 1982, pi; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; Menu F, 2000, AM NAT, V155, P724, DOI 10.1086/303355; Menu F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000691; Metz J. A., 1995, STOCHASTIC SPATIAL S, P183; Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Pelosse P, 2012, J THEOR BIOL, V312, P133, DOI 10.1016/j.jtbi.2012.07.028; RABINOVICH JE, 1972, J MED ENTOMOL, V9, P351, DOI 10.1093/jmedent/9.4.351; RABINOVICH JE, 1990, ECOL MODEL, V52, P249, DOI 10.1016/0304-3800(90)90019-D; Rajon E, 2009, J EVOLUTION BIOL, V22, P2094, DOI 10.1111/j.1420-9101.2009.01825.x; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rascalou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036858; Read JM, 2007, ECOL LETT, V10, P818, DOI 10.1111/j.1461-0248.2007.01078.x; REAL LA, 1980, AM NAT, V115, P623, DOI 10.1086/283588; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Ross R., 1911, PREVENTION MALARIA; Pacheco-Tucuch FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036207; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; SCHOFIELD CJ, 1980, T ROY SOC TROP MED H, V74, P761, DOI 10.1016/0035-9203(80)90196-0; SCHOFIELD CJ, 1982, B ENTOMOL RES, V72, P617, DOI 10.1017/S0007485300008646; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Solomon S, 2008, 4 IPCC; Szumlewicz A. P., 1976, Scientific Publication, Pan American Health Organization, P63; Tanowitz HB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001136; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TULJAPURKAR SD, 1980, THEOR POPUL BIOL, V18, P314, DOI 10.1016/0040-5809(80)90057-X; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; VELASCOHERNANDEZ JX, 1994, THEOR POPUL BIOL, V46, P1, DOI 10.1006/tpbi.1994.1017; YOSHIMURA J, 1993, ADAPTATION STOCHASTI; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	83	18	18	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70830	10.1371/journal.pone.0070830	http://dx.doi.org/10.1371/journal.pone.0070830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951018	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000029
J	Bood, RJ; Nijssen, M; van der Kamp, J; Roerdink, M				Bood, Robert Jan; Nijssen, Marijn; van der Kamp, John; Roerdink, Melvyn			The Power of Auditory-Motor Synchronization in Sports: Enhancing Running Performance by Coupling Cadence with the Right Beats	PLOS ONE			English	Article							SYNCHRONOUS MUSIC; SENSORIMOTOR SYNCHRONIZATION; EXERCISE DOMAIN; WALKING; COORDINATION; MOVEMENT	Acoustic stimuli, like music and metronomes, are often used in sports. Adjusting movement tempo to acoustic stimuli (i.e., auditory-motor synchronization) may be beneficial for sports performance. However, music also possesses motivational qualities that may further enhance performance. Our objective was to examine the relative effects of auditory-motor synchronization and the motivational impact of acoustic stimuli on running performance. To this end, 19 participants ran to exhaustion on a treadmill in 1) a control condition without acoustic stimuli, 2) a metronome condition with a sequence of beeps matching participants' cadence (synchronization), and 3) a music condition with synchronous motivational music matched to participants' cadence (synchronization+motivation). Conditions were counterbalanced and measurements were taken on separate days. As expected, time to exhaustion was significantly longer with acoustic stimuli than without. Unexpectedly, however, time to exhaustion did not differ between metronome and motivational music conditions, despite differences in motivational quality. Motivational music slightly reduced perceived exertion of sub-maximal running intensity and heart rates of (near-)maximal running intensity. The beat of the stimuli -which was most salient during the metronome condition-helped runners to maintain a consistent pace by coupling cadence to the prescribed tempo. Thus, acoustic stimuli may have enhanced running performance because runners worked harder as a result of motivational aspects (most pronounced with motivational music) and more efficiently as a result of auditory-motor synchronization (most notable with metronome beeps). These findings imply that running to motivational music with a very prominent and consistent beat matched to the runner's cadence will likely yield optimal effects because it helps to elevate physiological effort at a high perceived exertion, whereas the consistent and correct cadence induced by auditory-motor synchronization helps to optimize running economy.	[Bood, Robert Jan; Nijssen, Marijn; van der Kamp, John; Roerdink, Melvyn] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [van der Kamp, John] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China	Vrije Universiteit Amsterdam; University of Hong Kong	Roerdink, M (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands.	m.roerdink@vu.nl		Roerdink, Melvyn/0000-0002-8534-1124; van der Kamp, John/0000-0002-3826-1973	Netherlands Organization for Scientific Research (NWO) [451-09-024]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The contribution of Melvyn Roerdink was supported by the Netherlands Organization for Scientific Research (NWO, Veni Grant 451-09-024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, J CARDIOPUL REHABILI, DOI DOI 10.1097/00008483-199009000-00002; Bacon CJ, 2012, J SPORT MED PHYS FIT, V52, P359; Bishop DT., 2010, SPORT EXERC PSYCHOL, V6, P35; Borg G., 1998, BORGS PERCEIVED EXER; BOUTCHER SH, 1990, J SPORT EXERCISE PSY, V12, P167, DOI 10.1123/jsep.12.2.167; Esteve-Lanao J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002943; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; Karageorghis C. I., 1997, Journal of Sport Behavior, V20, P54; Karageorghis C.I., 2011, INSIDE SPORT PSYCHOL; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Karageorghis CI, 2012, J SPORT SCI, V30, P953, DOI 10.1080/02640414.2012.676665; Karageorghis CI, 2009, J SPORT EXERCISE PSY, V31, P18, DOI 10.1123/jsep.31.1.18; Kudo K, 2006, J EXP PSYCHOL HUMAN, V32, P599, DOI 10.1037/0096-1523.32.3.599; Lamoth CJC, 2007, GAIT POSTURE, V26, pS96; Large EW, 2000, HUM MOVEMENT SCI, V19, P527, DOI 10.1016/S0167-9457(00)00026-9; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006; Moens B, 2010, D JOGGER SYNCING MUS; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Nethery VM, 2002, J SPORT MED PHYS FIT, V42, P172; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peper CE, 2012, GAIT POSTURE, V36, P378, DOI 10.1016/j.gaitpost.2012.03.032; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Roerdink M, 2012, ANN BIOMED IN PRESS; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Tenenbaum G, 2004, PSYCHOL SPORT EXERC, V5, P89, DOI 10.1016/S1469-0292(02)00041-9; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; Thaut M, 2008, RHYTHM MUSIC BRAIN; van der Vlist B, 2011, APPL PSYCHOPHYS BIOF, V36, P135, DOI 10.1007/s10484-011-9149-y; Westerink JHDM, 2011, PHILIPS RES BOOK SER, V12, P121, DOI 10.1007/978-90-481-3258-4_8; Wijnalda G, 2005, IEEE PERVAS COMPUT, V4, P26, DOI 10.1109/MPRV.2005.47; Williams W, 2005, INT J AUDIOL, V44, P231, DOI 10.1080/14992020500057673; Wilson EMF, 2002, INT J PSYCHOPHYSIOL, V44, P177, DOI 10.1016/S0167-8760(01)00203-3; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	39	73	74	5	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70758	10.1371/journal.pone.0070758	http://dx.doi.org/10.1371/journal.pone.0070758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951000	gold, Green Submitted, Green Published			2022-12-27	WOS:000323109700052
J	Magi, R; Manning, S; Yousseif, A; Pucci, A; Santini, F; Karra, E; Querci, G; Pelosini, C; McCarthy, MI; Lindgren, CM; Batterham, RL				Maegi, Reedik; Manning, Sean; Yousseif, Ahmed; Pucci, Andrea; Santini, Ferruccio; Karra, Efthimia; Querci, Giorgia; Pelosini, Caterina; McCarthy, Mark I.; Lindgren, Cecilia M.; Batterham, Rachel L.			Contribution of 32 GWAS-Identified Common Variants to Severe Obesity in European Adults Referred for Bariatric Surgery	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; CHILDHOOD OBESITY; EARLY-ONSET; FAT MASS; GENE FTO; LOCI; RISK	The prevalence of severe obesity, defined as body mass index (BMI) >= 35.0 kg/m(2), is rising rapidly. Given the disproportionately high health burden and healthcare costs associated with this condition, understanding the underlying aetiology, including predisposing genetic factors, is a biomedical research priority. Previous studies have suggested that severe obesity represents an extreme tail of the population BMI variation, reflecting shared genetic factors operating across the spectrum. Here, we sought to determine whether a panel of 32 known common obesity-susceptibility variants contribute to severe obesity in patients (n = 1,003, mean BMI 48.4 +/- 8.1 kg/m(2)) attending bariatric surgery clinics in two European centres. We examined the effects of these 32 common variants on obesity risk and BMI, both as individual markers and in combination as a genetic risk score, in a comparison with normal-weight controls (n = 1,809, BMI 18.0-24.9 kg/m(2)); an approach which, to our knowledge, has not been previously undertaken in the setting of a bariatric clinic. We found strong associations with severe obesity for SNP rs9939609 within the FTO gene (P = 9.3x10(-8)) and SNP rs2815752 near the NEGR1 gene (P = 3.6x10(-4)), and directionally consistent nominal associations (P < 0.05) for 12 other SNPs. The genetic risk score associated with severe obesity (P = 8.3x10(-11)) but, within the bariatric cohort, this score did not associate with BMI itself (P = 0.264). Our results show significant effects of individual BMI-associated common variants within a relatively small sample size of bariatric patients. Furthermore, the burden of such low-penetrant risk alleles contributes to severe obesity in this population. Our findings support that severe obesity observed in bariatric patients represents an extreme tail of the population BMI variation. Moreover, future genetic studies focused on bariatric patients may provide valuable insights into the pathogenesis of obesity at a population level.	[Maegi, Reedik; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maegi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Manning, Sean; Yousseif, Ahmed; Pucci, Andrea; Karra, Efthimia; Batterham, Rachel L.] UCL, Dept Med, Rayne Inst, Obes Res Ctr, London, England; [Manning, Sean; Batterham, Rachel L.] UCL, Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Manning, Sean; Batterham, Rachel L.] Univ Coll London Hosp, Ctr Weight Loss Metab & Endocrine Surg, London, England; [Pucci, Andrea; Santini, Ferruccio; Querci, Giorgia; Pelosini, Caterina] Univ Hosp Pisa, Endocrinol Unit, Obes Ctr, Pisa, Italy; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England	University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; University of London; King's College London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Oxford; University of Oxford	Batterham, RL (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	r.batterham@ucl.ac.uk	Mägi, Reedik/AAJ-9679-2021; Santini, Ferruccio/J-9272-2018; McCarthy, Mark/M-3763-2015	Santini, Ferruccio/0000-0002-1706-0822; Batterham, Rachel/0000-0002-5477-8585; Lindgren, Cecilia/0000-0002-4903-9374; McCarthy, Mark/0000-0002-4393-0510; Magi, Reedik/0000-0002-2964-6011	Rosetrees Trust; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust [090367MA, GR069224MA, 068545/Z/02]; Framework 7: ENGAGE [HEALTH-F4-2007-201413]; UK Medical Research Council [G0000934]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome TrustEuropean Commission); Framework 7: ENGAGE; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Rosetrees Trust, the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Wellcome Trust (090367MA) and Framework 7: ENGAGE (HEALTH-F4-2007-201413). C.M.L. is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). M.I.M is a Wellcome Trust Senior Investigator (Welcome 098381). E.K. is a Wellcome Trust Clinical Research Training Fellow. The British 1958 Birth Cohort collection was funded by the UK Medical Research Council grant G0000934 and Wellcome Trust grant (GR069224MA, 068545/Z/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Berndt SI, 2013, NAT GENET; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Day FR, 2011, J NUTRIGENET NUTRIGE, V4, P222, DOI 10.1159/000332158; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Lee AWS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041537; Llewellyn CH, 2013, INT J OBES LOND; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mitchell JA, 2013, OBESITY; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sturm R, 2012, INT J OBES LOND; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wheeler E, 2013, NAT GENET; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia Q, 2013, ANN N Y ACAD SCI; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237	41	34	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70735	10.1371/journal.pone.0070735	http://dx.doi.org/10.1371/journal.pone.0070735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950990	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700048
J	Miyaji, K; Tanimoto, J; Wang, Z; Hagishima, A; Ikegaya, N				Miyaji, Kohei; Tanimoto, Jun; Wang, Zhen; Hagishima, Aya; Ikegaya, Naoki			Direct Reciprocity in Spatial Populations Enhances R-Reciprocity As Well As ST-Reciprocity	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; NETWORK RECIPROCITY; SNOWDRIFT GAMES; COOPERATION; EVOLUTION; IMITATION; DYNAMICS; BEHAVIOR	As is well-known, spatial reciprocity plays an important role in facilitating the emergence of cooperative traits, and the effect of direct reciprocity is also obvious for explaining the cooperation dynamics. However, how the combination of these two scenarios influences cooperation is still unclear. In the present work, we study the evolution of cooperation in 262 games via considering both spatial structured populations and direct reciprocity driven by the strategy with 1-memory length. Our results show that cooperation can be significantly facilitated on the whole parameter plane. For prisoner's dilemma game, cooperation dominates the system even at strong dilemma, where maximal social payoff is still realized. In this sense, R-reciprocity forms and it is robust to the extremely strong dilemma. Interestingly, when turning to chicken game, we find that ST-reciprocity is also guaranteed, through which social average payoff and cooperation is greatly enhanced. This reciprocity mechanism is supported by mean-field analysis and different interaction topologies. Thus, our study indicates that direct reciprocity in structured populations can be regarded as a more powerful factor for the sustainability of cooperation.	[Miyaji, Kohei; Tanimoto, Jun; Hagishima, Aya; Ikegaya, Naoki] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon, Hong Kong, Peoples R China	Kyushu University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Tanimoto, J (corresponding author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan.	tanimoto@cm.kyushu-u.ac.jp; zhenwang0@gmail.com	Hagishima, Aya/A-1360-2016; Hagishima, Aya/GRE-6546-2022	Hagishima, Aya/0000-0002-8342-6570; Hagishima, Aya/0000-0002-8342-6570; Ikegaya, Naoki/0000-0002-7458-426X; Tanimoto, Jun/0000-0002-4092-3219	JSPS [23651156]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research by JSPS #23651156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brede M, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/30003; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056016; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2007, INT J BIFURCAT CHAOS, V17, P4223, DOI 10.1142/S0218127407019779; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pierre B, 2012, PHYS REV E, V86; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; ROBINSON RW, 1994, RANDOM STRUCT ALGOR, V5, P363, DOI 10.1002/rsa.3240050209; Roca CP, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48005; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38002; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tang CL, 2006, EUR PHYS J B, V53, P411, DOI 10.1140/epjb/e2006-00395-2; Tang CB, 2012, J THEOR BIOL, V306, P1, DOI 10.1016/j.jtbi.2012.04.024; Tanimoto J, 2007, BIOSYSTEMS, V90, P728, DOI 10.1016/j.biosystems.2007.03.001; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Tanimoto J, 2012, PHYSICA A, V391, P680, DOI 10.1016/j.physa.2011.08.039; Tanimoto J, 2011, SOCIOBIOLOGY, V58, P315; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2011, PHYSICA A, V390, P1234, DOI 10.1016/j.physa.2010.12.003; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu Z.-X., 2009, PHYS REV E, V80; Xia CY, 2011, PHYS SCRIPTA, V84, DOI 10.1088/0031-8949/84/02/025802; Xia CY, 2012, PHYSICA A, V391, P6440, DOI 10.1016/j.physa.2012.07.065; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2011, PHYSICA A, V390, P4602, DOI 10.1016/j.physa.2011.06.064; Xia CY, 2012, CHAOS SOLITON FRACT, V45, P1239, DOI 10.1016/j.chaos.2012.06.014; Xu ZJ, 2010, J THEOR BIOL, V264, P19, DOI 10.1016/j.jtbi.2010.01.025; Yamauchi A, 2011, BIOSYSTEMS, V103, P85, DOI 10.1016/j.biosystems.2010.10.006; Yamauchi A, 2010, BIOSYSTEMS, V102, P82, DOI 10.1016/j.biosystems.2010.07.017; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023; Zhang HF, 2010, PHYSICA A, V389, P1099, DOI 10.1016/j.physa.2009.11.029; Zheng DF, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/18002	63	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71961	10.1371/journal.pone.0071961	http://dx.doi.org/10.1371/journal.pone.0071961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951272	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700124
J	Mahendra, A; Peyron, I; Dollinger, C; Gilardin, L; Sharma, M; Wootla, B; Padiolleau-Lefevre, S; Friboulet, A; Boquet, D; Legendre, C; Kaveri, SV; Thaunat, O; Lacroix-Desmazes, S				Mahendra, Ankit; Peyron, Ivan; Dollinger, Cecile; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Padiolleau-Lefevre, Severine; Friboulet, Alain; Boquet, Didier; Legendre, Christophe; Kaveri, Srinivas V.; Thaunat, Olivier; Lacroix-Desmazes, Sebastien			IVIg Treatment Reduces Catalytic Antibody Titers of Renal Transplanted Patients	PLOS ONE			English	Article							LONG-TERM GRAFT; FACTOR-VIII; INTRAVENOUS IMMUNOGLOBULIN; IGG; AUTOANTIBODIES; LYMPHOCYTES; HYDROLYSIS; DESENSITIZATION; SUPPRESSION; AUTOIMMUNE	Catalytic antibodies are immunoglobulins endowed with enzymatic activity. Catalytic IgG has been reported in several human autoimmune and inflammatory diseases. In particular, low levels of catalytic IgG have been proposed as a prognostic marker for chronic allograft rejection in patients undergoing kidney transplant. Kidney allograft is a treatment of choice for patients with end-stage renal failure. Intravenous immunoglobulins, a therapeutic pool of human IgG, is used in patients with donor-specific antibodies, alone or in conjunction with other immunosuppressive treatments, to desensitize the patients and prevent the development of acute graft rejection. Here, we followed for a period of 24 months the levels of catalytic IgG towards the synthetic peptide Pro-Phe-Arg-methylcoumarinimide in a large cohort of patients undergoing kidney transplantation. Twenty-four percent of the patients received IVIg at the time of transplantation. Our results demonstrate a marked reduction in levels of catalytic antibodies in all patients three months following kidney transplant. The decrease was significantly pronounced in patients receiving adjunct IVIg therapy. The results suggests that prevention of acute graft rejection using intravenous immunoglobulins induces a transient reduction in the levels of catalytic IgG, thus potentially jeopardizing the use of levels of catalytic antibodies as a prognosis marker for chronic allograft nephropathy.	[Mahendra, Ankit; Peyron, Ivan; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] Univ Paris 06, Ctr Rech Cordeliers, Unite Mixte Rech S 872, Paris, France; [Mahendra, Ankit; Peyron, Ivan; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] Univ Paris 05, Unite Mixte Rech S 872, Paris, France; [Mahendra, Ankit; Peyron, Ivan; Gilardin, Laurent; Sharma, Meenu; Wootla, Bharath; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] INSERM, U872, Paris, France; [Dollinger, Cecile] Hosp Civils Lyon, Hop Edouard Herriot, Serv Transplantat Nephrol & Immunol Clin, Lyon, France; [Padiolleau-Lefevre, Severine; Friboulet, Alain] Univ Technol Compiegne, CNRS, UMR 6022, Compiegne, France; [Boquet, Didier] Commissariat Energie Atom, Serv Pharmacol & Immunoanal, Inst Biol & Technol Saclay, Lab Ingn Anticorps Sante, Gif Sur Yvette, France; [Legendre, Christophe] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Transplantat Renale & Soins Intensifs, Paris, France; [Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] INSERM, Lab Int Associe, Paris, France; [Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien] Indian Council Med Res, New Delhi, India; [Thaunat, Olivier] INSERM, U851, F-69008 Lyon, France; [Thaunat, Olivier] Univ Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Indian Council of Medical Research (ICMR); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lacroix-Desmazes, S (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, Unite Mixte Rech S 872, Paris, France.	Sebastien.Lacroix-Desmazes@crc.jussieu.fr	Thaunat, Olivier/M-2423-2014; Sharma, Meenu/GWM-5030-2022; Peyron, Ivan/AAQ-1685-2021; Gilardin, Laurent/AAS-1145-2020; WOOTLA, Bharath/E-5882-2015	Gilardin, Laurent/0000-0001-9212-0859; Thaunat, Olivier/0000-0002-3648-8963; Peyron, Ivan/0000-0002-3843-642X; Kaveri, Srini/0000-0002-0837-4053; Severine, PADIOLLEAU/0000-0002-5475-1358; BOQUET, Didier/0000-0002-4048-7867; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; WOOTLA, Bharath/0000-0001-7522-1121	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Indo-French Center for Promotion of Advanced Research [4103-2]; Agence Nationale de la Recherche [ANR-09-GENO-028]; Japan Sciences and Technology Agency (Tokyo, Japan); Agence de la Biomedecine	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Indo-French Center for Promotion of Advanced Research; Agence Nationale de la Recherche(French National Research Agency (ANR)); Japan Sciences and Technology Agency (Tokyo, Japan); Agence de la Biomedecine	This work was supported by Centre National de la Recherche Scientifique, by Institut National de la Sante et de la Recherche Medicale, by Universite Pierre et Marie Curie, and by grants from the Indo-French Center for Promotion of Advanced Research (Reference No: 4103-2), from Agence Nationale de la Recherche (ANR-09-GENO-028), from the Japan Sciences and Technology Agency (Tokyo, Japan) and from the Agence de la Biomedecine. OT and CL are members of the CENTAURE Transplantation Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalle B, 1998, FASEB J, V12, P1055, DOI 10.1096/fasebj.12.11.1055; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; de Grandmont MJ, 2003, BLOOD, V101, P3065, DOI 10.1182/blood-2002-06-1684; DIETRICH G, 1993, EUR J IMMUNOL, V23, P2945, DOI 10.1002/eji.1830231133; Fernandez-Fresnedo G, 2004, NEPHROL DIAL TRANSPL, V19, P47, DOI 10.1093/ndt/gfh1015; Glotz D, 2002, AM J TRANSPLANT, V2, P758, DOI 10.1034/j.1600-6143.2002.20809.x; GRABAR P, 1975, CLIN IMMUNOL IMMUNOP, V4, P453, DOI 10.1016/0090-1229(75)90087-2; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kohler H, 1998, IMMUNOL TODAY, V19, P221, DOI 10.1016/S0167-5699(97)01234-6; KONDO N, 1991, J CLIN IMMUNOL, V11, P152, DOI 10.1007/BF00918683; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 2002, NEW ENGL J MED, V346, P662, DOI 10.1056/NEJMoa011979; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; LI L, 1995, J IMMUNOL, V154, P3328; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Mayer L, 1989, Int Rev Immunol, V5, P189, DOI 10.3109/08830188909061986; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; Nevinsky GA, 2000, APPL BIOCHEM BIOTECH, V83, P115, DOI 10.1385/ABAB:83:1-3:115; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Prasad NKA, 1998, J IMMUNOL, V161, P3781; Rebellato Lorita M, 2011, Clin Transpl, P337; RUSSELL PS, 1994, J IMMUNOL, V152, P5135; Salvadori M, 2006, TRANSPLANTATION, V81, P202, DOI 10.1097/01.tp.0000188135.04259.2e; Seite JF, 2008, AUTOIMMUN REV, V7, P435, DOI 10.1016/j.autrev.2008.04.012; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; Thaunat O, 2012, TRANSPL IMMUNOL, V26, P101, DOI 10.1016/j.trim.2011.11.003; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Wootla B, 2008, J IMMUNOL, V180, P8455, DOI 10.4049/jimmunol.180.12.8455; Wootla B, 2008, J IMMUNOL, V180, P7714, DOI 10.4049/jimmunol.180.11.7714; Wootla B, 2006, BLOOD COAGUL FIBRIN, V17, P229, DOI 10.1097/01.mbc.0000224840.40839.5a; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009; Zhuang QL, 2002, J ALLERGY CLIN IMMUN, V110, P480, DOI 10.1067/mai.2002.127284	45	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70731	10.1371/journal.pone.0070731	http://dx.doi.org/10.1371/journal.pone.0070731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967092	gold, Green Published, Green Submitted			2022-12-27	WOS:000323378000013
J	Lustig, A; Ketter-Katz, H; Katzir, G				Lustig, Avichai; Ketter-Katz, Hadas; Katzir, Gadi			Relating Lateralization of Eye Use to Body Motion in the Avoidance Behavior of the Chameleon (Chamaeleo chameleon)	PLOS ONE			English	Article							SOCIAL-STIMULI; HEAD MOVEMENTS; TELEOST FISH; BRAIN; PREFERENCES; FOOT; ACCOMMODATION; INSPECTION; DOMINANCE; RESPONSES	Lateralization is mostly analyzed for single traits, but seldom for two or more traits while performing a given task (e. g. object manipulation). We examined lateralization in eye use and in body motion that co-occur during avoidance behaviour of the common chameleon, Chamaeleo chameleon. A chameleon facing a moving threat smoothly repositions its body on the side of its perch distal to the threat, to minimize its visual exposure. We previously demonstrated that during the response (i) eye use and body motion were, each, lateralized at the tested group level (N = 26), (ii) in body motion, we observed two similarsized sub-groups, one exhibiting a greater reduction in body exposure to threat approaching from the left and one - to threat approaching from the right (left-and right-biased subgroups), (iii) the left-biased sub-group exhibited weak lateralization of body exposure under binocular threat viewing and none under monocular viewing while the right-biased sub-group exhibited strong lateralization under both monocular and binocular threat viewing. In avoidance, how is eye use related to body motion at the entire group and at the sub-group levels? We demonstrate that (i) in the left-biased subgroup, eye use is not lateralized, (ii) in the right-biased sub-group, eye use is lateralized under binocular, but not monocular viewing of the threat, (iii) the dominance of the right-biased sub-group determines the lateralization of the entire group tested. We conclude that in chameleons, patterns of lateralization of visual function and body motion are inter-related at a subtle level. Presently, the patterns cannot be compared with humans' or related to the unique visual system of chameleons, with highly independent eye movements, complete optic nerve decussation and relatively few interhemispheric commissures. We present a model to explain the possible inter-hemispheric differences in dominance in chameleons' visual control of body motion during avoidance.	[Lustig, Avichai; Ketter-Katz, Hadas] Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Marine Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Biol, Tivon, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Lustig, A (corresponding author), Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel.	Lustigavi@gmail.com			Israel Academy of Sciences and Humanities - Israel Science Foundation [20978009]	Israel Academy of Sciences and Humanities - Israel Science Foundation	The research was funded by the Israel Academy of Sciences and Humanities - Israel Science Foundation (#20978009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni O, 2010, MACH VISION APPL, P1; Baciadonna L, 2010, BEHAV PROCESS, V83, P130, DOI 10.1016/j.beproc.2009.09.004; BENNIS M, 1994, BRAIN BEHAV EVOLUT, V43, P173, DOI 10.1159/000113633; Bisazza A, 1997, BEHAV BRAIN RES, V89, P237, DOI 10.1016/S0166-4328(97)00061-2; Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Bisazza A, 2001, PHYSIOL BEHAV, V72, P575, DOI 10.1016/S0031-9384(01)00417-6; Bisazza A, 1997, BRAIN COGNITION, V2, P49; Bonati B, 2008, BEHAV PROCESS, V79, P171, DOI 10.1016/j.beproc.2008.07.007; Bourassa D C, 1996, Laterality, V1, P5, DOI 10.1080/713754206; Csermely D, 2010, LATERALITY, V15, P535, DOI 10.1080/13576500903051619; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; De Santi A, 2001, ANIM BEHAV, V61, P305, DOI 10.1006/anbe.2000.1566; Deckel AW, 1997, J EXP ZOOL, V278, P9, DOI 10.1002/(SICI)1097-010X(19970501)278:1<9::AID-JEZ2>3.0.CO;2-T; HARKNESS L, 1977, NATURE, V267, P346, DOI 10.1038/267346a0; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Izawa EI, 2005, BEHAV PROCESS, V69, P357, DOI 10.1016/j.beproc.2005.02.001; Lustig A, 2012, ANIM COGN, V15, P609, DOI 10.1007/s10071-012-0489-7; Lustig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037875; Malashichev YB, 2004, BIOESSAYS, V26, P512, DOI 10.1002/bies.20036; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; McGavin Sharon, 2009, Notornis, V56, P139; NACHSHON I, 1983, INT J NEUROSCI, V18, P1, DOI 10.3109/00207458308985872; Nedellec-Bienvenue D, 2005, FOLIA PRIMATOL, V76, P234, DOI 10.1159/000086026; Ott M, 2006, J COMP PHYSIOL A, V192, P97, DOI 10.1007/s00359-005-0049-6; Ott M, 2001, EXP BRAIN RES, V139, P173, DOI 10.1007/s002210100774; PORAC C, 1975, PERCEPT MOTOR SKILL, V40, P763, DOI 10.2466/pms.1975.40.3.763; PRATT DW, 1982, J EXP BIOL, V97, P217; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Randler C, 2011, LATERALITY, V16, P201, DOI 10.1080/13576500903513188; Reddon AR, 2010, BEHAV PROCESS, V85, P68, DOI 10.1016/j.beproc.2010.06.008; Robins A, 1998, ANIM BEHAV, V56, P875, DOI 10.1006/anbe.1998.0877; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2001, PHYSIOL BEHAV, V74, P237, DOI 10.1016/S0031-9384(01)00552-2; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Zucca P, 2008, CORTEX, V44, P13, DOI 10.1016/j.cortex.2006.01.002	39	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70761	10.1371/journal.pone.0070761	http://dx.doi.org/10.1371/journal.pone.0070761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967099	gold, Green Published, Green Submitted			2022-12-27	WOS:000323221500026
J	Trabzuni, D; Ryten, M; Emmett, W; Ramasamy, A; Lackner, KJ; Zeller, T; Walker, R; Smith, C; Lewis, PA; Mamais, A; de Silva, R; Vandrovcova, J; Hernandez, D; Nalls, MA; Sharma, M; Garnier, S; Lesage, S; Simon-Sanchez, J; Gasser, T; Heutink, P; Brice, A; Singleton, A; Cai, HB; Schadt, E; Wood, NW; Bandopadhyay, R; Weale, ME; Hardy, J; Plagnol, V				Trabzuni, Daniah; Ryten, Mina; Emmett, Warren; Ramasamy, Adaikalavan; Lackner, Karl J.; Zeller, Tanja; Walker, Robert; Smith, Colin; Lewis, Patrick A.; Mamais, Adamantios; de Silva, Rohan; Vandrovcova, Jana; Hernandez, Dena; Nalls, Michael A.; Sharma, Manu; Garnier, Sophie; Lesage, Suzanne; Simon-Sanchez, Javier; Gasser, Thomas; Heutink, Peter; Brice, Alexis; Singleton, Andrew; Cai, Huaibin; Schadt, Eric; Wood, Nicholas W.; Bandopadhyay, Rina; Weale, Michael E.; Hardy, John; Plagnol, Vincent		Int Parkinson Dis Genomics	Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus	PLOS ONE			English	Article								Association studies have identified several signals at the LRRK2 locus for Parkinson's disease (PD), Crohn's disease (CD) and leprosy. However, little is known about the molecular mechanisms mediating these effects. To further characterize this locus, we fine-mapped the risk association in 5,802 PD and 5,556 controls using a dense genotyping array (ImmunoChip). Using samples from 134 post-mortem control adult human brains (UK Human Brain Expression Consortium), where up to ten brain regions were available per individual, we studied the regional variation, splicing and regulation of LRRK2. We found convincing evidence for a common variant PD association located outside of the LRRK2 protein coding region (rs117762348, A>G, P = 2.56 x 10(-8), case/control MAF 0.083/0.074, odds ratio 0.86 for the minor allele with 95% confidence interval [0.80-0.91]). We show that mRNA expression levels are highest in cortical regions and lowest in cerebellum. We find an exon quantitative trait locus (QTL) in brain samples that localizes to exons 32-33 and investigate the molecular basis of this eQTL using RNA-Seq data in n = 8 brain samples. The genotype underlying this eQTL is in strong linkage disequilibrium with the CD associated non-synonymous SNP rs3761863 (M2397T). We found two additional QTLs in liver and monocyte samples but none of these explained the common variant PD association at rs117762348. Our results characterize the LRRK2 locus, and highlight the importance and difficulties of fine-mapping and integration of multiple datasets to delineate pathogenic variants and thus develop an understanding of disease mechanisms.	[Trabzuni, Daniah; Ryten, Mina; Lewis, Patrick A.; Mamais, Adamantios; de Silva, Rohan; Vandrovcova, Jana; Wood, Nicholas W.; Bandopadhyay, Rina; Hardy, John] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Emmett, Warren; Plagnol, Vincent] UCL, Genet Inst, London, England; [Ramasamy, Adaikalavan; Weale, Michael E.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London, England; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Zeller, Tanja] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Walker, Robert; Smith, Colin] Univ Edinburgh, Dept Neuropathol, MRC Sudden Death Brain Bank Project, Edinburgh, Midlothian, Scotland; [Lewis, Patrick A.] Univ Reading, Sch Pharm, Reading, Berks, England; [Mamais, Adamantios; de Silva, Rohan; Vandrovcova, Jana; Bandopadhyay, Rina; Hardy, John] Reta Lila Weston Inst Neurol Studies, London, England; [Hernandez, Dena; Nalls, Michael A.; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Sharma, Manu; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Div Neurodegenerat Disorders, Tubingen, Germany; [Garnier, Sophie] Univ Paris 06, INSERM, UMRS 937, Paris, France; [Lesage, Suzanne; Brice, Alexis] Univ Paris 06, CRICM, CNRS,UMR 7225, INSERM,Hosp Pitie Salpetriere,UMRS 975, Paris, France; [Simon-Sanchez, Javier; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands; [Cai, Huaibin] NIA, Unit Transgenesis, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Schadt, Eric] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY USA	University of London; University College London; King Faisal Specialist Hospital & Research Center; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Edinburgh; University of Reading; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai	Plagnol, V (corresponding author), UCL, Genet Inst, London, England.	v.plagnol@ucl.ac.uk	Cai, Huaibin/H-3359-2013; Singleton, Andrew B/C-3010-2009; Brice, Alexis/A-2170-2009; Hardy, John/C-2451-2009; Ramasamy, Adaikalavan/G-2632-2010; Wood, Nicholas W/C-2505-2009; Lewis, Patrick A./C-3674-2009; brice, alexis/AAE-8275-2019; Ryten, Mina/Q-8419-2016; Weale, Michael E/F-2587-2010; Gasser, Thomas/GNH-5293-2022; Trabzuni, Daniah M/C-4034-2012; Bandopadhyay, Rina/C-7926-2009; de Silva, Rohan/C-1734-2008; Trabzuni, Daniah/AAI-2037-2021; Sharma, Manu/AAX-2594-2020	Cai, Huaibin/0000-0002-8596-6108; Hardy, John/0000-0002-3122-0423; Ramasamy, Adaikalavan/0000-0002-7598-2892; Wood, Nicholas W/0000-0002-9500-3348; brice, alexis/0000-0002-0941-3990; Weale, Michael E/0000-0003-4593-1186; Gasser, Thomas/0000-0002-1069-1146; Trabzuni, Daniah M/0000-0003-4826-9570; de Silva, Rohan/0000-0002-5052-5775; Trabzuni, Daniah/0000-0003-4826-9570; Walker, Robert/0000-0001-7383-7846; Schulte, Claudia/0000-0003-4006-1265; Simon Sanchez, Javier/0000-0001-5141-5829; Lewis, Patrick/0000-0003-4537-0489; Mamais, Adamantios/0000-0002-5546-7084; Garnier, Sophie/0000-0002-7492-1617; Heutink, Peter/0000-0001-5218-1737; Zeller, Tanja/0000-0003-3379-2641; Plagnol, Vincent/0000-0002-5597-9215	Medical Research Council (MRC) through the MRC Sudden Death Brain Bank; King Faisal Specialist Hospital and Research Centre, Saudi Arabia; Michael J. Fox Foundation LRRK2 consortium grant; Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; Department of Health's NIHR Biomedical Research Centres funding scheme; National Institute on Aging; National Institute of Neurological Disorders and Stroke; National Institute of Environmental Health Sciences; National Human Genome Research Institute; National Institutes of Health; Department of Health and Human Services [Z01 AG000949-02, Z01-ES101986]; US Department of Defense [W81XWH-09-2-0128]; National Institutes of Health [NS057105, RR024992]; American Parkinson Disease Association (APDA); Barnes Jewish Hospital Foundation; Greater St. Louis Chapter of the APDA; Forschungszentrumfur-Umwelt und Gesundheit (GSF); German Federal Ministry of Education, Science, Research, and Technology; State of Bavaria; German National Genome Network [01GS08134]; German Ministry for Education and Research; German Federal Ministry of Education and Research (BMBF) NGFN [01GR0468]; ERA-Net NEURON [01GW0908]; Helmholtz Alliance Mental Health in an Ageing Society (HelMA) [HA-215]; Initiative and Networking Fund of the Helmholtz Association; Hersenstichting Nederland; Neuroscience Campus Amsterdam; section of Medical genomics, the Prinses Beatrix Fonds;  [G0901254];  [G0802462];  [F1002]; MRC [MC_G1000735, MR/K01417X/1, G1100616, G0802462, MR/L016400/1, G0901254, G0501560, G0701075] Funding Source: UKRI; Medical Research Council [G1100616, MR/L016400/1, G0501560, MC_G1000735, G0802462, G0701075, G0901254, MR/K01417X/1, MR/J006742/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [J-0804, G-0907] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000949, Z01AG000949, ZIAAG000957, ZIAAG000944, ZIAAG000928, ZIAAG000932] Funding Source: NIH RePORTER	Medical Research Council (MRC) through the MRC Sudden Death Brain Bank; King Faisal Specialist Hospital and Research Centre, Saudi Arabia; Michael J. Fox Foundation LRRK2 consortium grant; Wellcome Trust/MRC Joint Call in Neurodegeneration award; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association (APDA); Barnes Jewish Hospital Foundation; Greater St. Louis Chapter of the APDA; Forschungszentrumfur-Umwelt und Gesundheit (GSF); German Federal Ministry of Education, Science, Research, and Technology; State of Bavaria; German National Genome Network; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF) NGFN(Federal Ministry of Education & Research (BMBF)); ERA-Net NEURON; Helmholtz Alliance Mental Health in an Ageing Society (HelMA); Initiative and Networking Fund of the Helmholtz Association; Hersenstichting Nederland; Neuroscience Campus Amsterdam; section of Medical genomics, the Prinses Beatrix Fonds; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Medical Research Council (MRC) through the MRC Sudden Death Brain Bank (C. S.) and by a Project Grant (G0901254 to J.H. and M. W.) and Training Fellowship (G0802462 to M. R.). D. T. was supported by the King Faisal Specialist Hospital and Research Centre, Saudi Arabia. P. A. L. is a Parkinson's UK research fellow (fellowship F1002). A. M. and C. M. are supported by a Michael J. Fox Foundation LRRK2 consortium grant to P. A. L. and R. B. This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee. This work was undertaken in part at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. This US work was supported in part by the Intramural Research Programs of the National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services; project numbers Z01 AG000949-02 and Z01-ES101986. In addition this study was supported by the US Department of Defense, award number W81XWH-09-2-0128. Funding to support collection of a portion of the samples was obtained from the National Institutes of Health (grants NS057105 and RR024992), the American Parkinson Disease Association (APDA), Barnes Jewish Hospital Foundation, and the Greater St. Louis Chapter of the APDA. The KORA research platform (KORA: Cooperative Research in the Region of Augsburg; http://www.gsf.de/KORA) was initiated and financed by the Forschungszentrumfur-Umwelt und Gesundheit (GSF), which is funded by the German Federal Ministry of Education, Science, Research, and Technology and by the State of Bavaria. The study was additionally funded by the German National Genome Network (NGFNplus #01GS08134; German Ministry for Education and Research) and by the German Federal Ministry of Education and Research (BMBF) NGFN (01GR0468) and in the frame of ERA-Net NEURON (01GW0908). This work was also supported by the Helmholtz Alliance Mental Health in an Ageing Society (HelMA, HA-215) funded by the Initiative and Networking Fund of the Helmholtz Association. The authors also want to thank the Hersenstichting Nederland (http://www.hersenstichting.nl), the Neuroscience Campus Amsterdam and the section of Medical genomics, the Prinses Beatrix Fonds (http://www.prinsesbeatrixfonds.nl) for sponsoring this work. The authors have no conflicting financial, personal, or professional interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Lewis PA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002680; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sharma S, 2011, NEUROPATH APPL NEURO, V37, P777, DOI 10.1111/j.1365-2990.2011.01187.x; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Vitte J, 2010, J NEUROPATH EXP NEUR, V69, P959, DOI 10.1097/NEN.0b013e3181efc01c; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	37	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70724	10.1371/journal.pone.0070724	http://dx.doi.org/10.1371/journal.pone.0070724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967090	Green Submitted, gold, Green Published			2022-12-27	WOS:000323115800015
J	Cho, S; Kim, BY; Ahn, K; Jun, Y				Cho, Sunglim; Kim, Bo Young; Ahn, Kwangseog; Jun, Youngsoo			The C-Terminal Amino Acid of the MHC-I Heavy Chain Is Critical for Binding to Derlin-1 in Human Cytomegalovirus US11-Induced MHC-I Degradation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; UBIQUITIN LIGASES; DISLOCATION; ER; COMPLEX; RETROTRANSLOCATION	Derlin-1 plays a critical role in endoplasmic reticulum-associated protein degradation (ERAD) of a particular subset of proteins. Although it is generally accepted that Derlin-1 mediates the export of ERAD substrates from the ER to the cytosol, little is known about how Derlin-1 interacts with these substrates. Human cytomegalovirus (HCMV) US11 exploits Derlin-1-dependent ERAD to degrade major histocompatibility complex class I (MHC-I) molecules and evade immune surveillance. US11 requires the cytosolic tail of the MHC-I heavy chain to divert MHC-I molecules into the ERAD pathway for degradation; however, the underlying mechanisms remain unknown. Here, we show that the cytosolic tail of the MHC-I heavy chain, although not required for interaction with US11, is required for tight binding to Derlin-1 and thus for US11-induced dislocation of the MHC-I heavy chain to the cytosol for proteasomal degradation. Surprisingly, deletion of a single C-terminal amino acid from the cytosolic tail disrupted the interaction between MHC-I molecules and Derlin-1, rendering mutant MHC-I molecules resistant to US11-induced degradation. Consistently, deleting the C-terminal cytosolic region of Derlin-1 prevented it from binding to MHC-I molecules. Taken together, these results suggest that the cytosolic region of Derlin-1 is involved in ERAD substrate binding and that this interaction is critical for the Derlin-1-mediated dislocation of the MHC-I heavy chain to the cytosol during US11-induced MHC-I degradation.	[Cho, Sunglim; Kim, Bo Young; Jun, Youngsoo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Cho, Sunglim; Kim, Bo Young; Jun, Youngsoo] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Ahn, Kwangseog] Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Initiat Ctr Antigen Presentat, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU)	Jun, Y (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea.	junys@gist.ac.kr	Jun, Youngsoo/Q-3624-2018	Jun, Youngsoo/0000-0002-2387-032X	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2012R1A1A2041775]; Cell Dynamics Research Center through the National Research Foundation of Korea (NRF) [NRF-2011-0007165]; Korean government	Basic Science Research Program through the National Research Foundation of Korea (NRF); Cell Dynamics Research Center through the National Research Foundation of Korea (NRF); Korean government(Korean Government)	This work was supported by Basic Science Research Program (NRF-2012R1A1A2041775) and Cell Dynamics Research Center Grant (NRF-2011-0007165) through the National Research Foundation of Korea (NRF) funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; Bennett EM, 1999, J IMMUNOL, V162, P5049; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Cho S, 2013, BIOCHEM BIOPH RES CO, V430, P787, DOI 10.1016/j.bbrc.2012.11.068; Cho S, 2011, BIOCHEM BIOPH RES CO, V413, P616, DOI 10.1016/j.bbrc.2011.09.013; Cho S, 2011, TRAFFIC, V12, P42, DOI 10.1111/j.1600-0854.2010.01132.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Fu LW, 2003, J CELL BIOL, V160, P157, DOI 10.1083/jcb.200210086; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; HAMPTON RY, 2012, CURR OPIN CELL BIOL; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Schust DJ, 1998, J EXP MED, V188, P497, DOI 10.1084/jem.188.3.497; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang F, 2012, J BIOL CHEM, V287, P10482, DOI 10.1074/jbc.M111.312223; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72356	10.1371/journal.pone.0072356	http://dx.doi.org/10.1371/journal.pone.0072356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951315	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300193
J	Gruber, R; Bosshardt, DD; Miron, RJ; Gemperli, AC; Buser, D; Sculean, A				Gruber, Reinhard; Bosshardt, Dieter D.; Miron, Richard J.; Gemperli, Anja C.; Buser, Daniel; Sculean, Anton			Enamel Matrix Derivative Inhibits Adipocyte Differentiation of 3T3-L1 Cells via Activation of TGF-beta RI Kinase Activity	PLOS ONE			English	Article							HUMAN PERIODONTAL-LIGAMENT; GENE-EXPRESSION PROFILES; CONNECTIVE-TISSUE GRAFT; MARROW STROMAL CELLS; GROWTH-FACTOR-BETA; PROTEINS IN-VITRO; STEM-CELLS; REGENERATION; FIBROBLASTS; EMDOGAIN	Enamel matrix derivative (EMD), an extract of fetal porcine enamel, and TGF-beta can both suppress adipogenic differentiation. However, there have been no studies that functionally link the role of EMD and TGF-beta in vitro. Herein, we examined whether TGF-beta signaling contributes to EMD-induced suppression of adipogenic differentiation. Adipogenesis was studied with 3T3-L1 preadipocytes in the presence of SB431542, an inhibitor of TGF-beta RI kinase activity. SB431542 reversed the inhibitory effect of EMD on adipogenic differentiation, based on Oil Red O staining and mRNA expression of lipid regulated genes. SB431542 also reduced EMD-stimulated expression of connective tissue growth factor (CTGF), an autocrine inhibitor of adipogenic differentiation. Moreover, short interfering (si) RNAs for CTGF partially reversed the EMD-induced suppression of lipid regulated genes. We conclude that the TGF-beta RI - CTGF axis is involved in the anti-adipogenic effects of EMD in vitro.	[Gruber, Reinhard; Bosshardt, Dieter D.; Miron, Richard J.; Sculean, Anton] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Gruber, Reinhard; Bosshardt, Dieter D.; Miron, Richard J.; Buser, Daniel] Univ Bern, Sch Dent Med, Dept Oral Surg & Stomatol, Bern, Switzerland; [Gruber, Reinhard] Univ Bern, Sch Dent Med, Lab Oral Cell Biol, Bern, Switzerland; [Bosshardt, Dieter D.] Univ Bern, Sch Dent Med, Robert K Schenk Lab Oral Histol, Bern, Switzerland; [Gemperli, Anja C.] Inst Straumann, Basel, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; Institut Straumann AG	Gruber, R (corresponding author), Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.	reinhard.gruber@zmk.unibe.ch	Gruber, Reinhard/A-8053-2012; Bosshardt, Dieter D/C-9442-2012; Miron, Richard/J-4995-2012; Buser, Daniel/D-3971-2011	Gruber, Reinhard/0000-0001-5400-9009	Straumann Institute	Straumann Institute	This work was supported in part by Straumann Institute. No additional external funding was received for this study. The authors clearly state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HD, 2012, ACTA BIOMATER; Aoyama E, 2012, FEBS LETT, V586, P4270, DOI 10.1016/j.febslet.2012.10.038; Aroca S, 2010, J CLIN PERIODONTOL, V37, P88, DOI 10.1111/j.1600-051X.2009.01492.x; Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x; Brett PM, 2002, J DENT RES, V81, P776, DOI 10.1177/154405910208101111; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Hama H, 2008, J PERIODONTAL RES, V43, P179, DOI 10.1111/j.1600-0765.2007.01010.x; Heng NHM, 2007, J PERIODONTOL, V78, P2369, DOI 10.1902/jop.2007.070130; Henriques Paulo S G, 2010, J Oral Sci, V52, P463; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kapferer I, 2011, J PERIODONTAL RES, V46, P118, DOI 10.1111/j.1600-0765.2010.01321.x; Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x; Kawase T, 2001, J PERIODONTAL RES, V36, P367, DOI 10.1034/j.1600-0765.2001.360604.x; Koop R, 2012, J PERIODONTOL, V83, P707, DOI 10.1902/jop.2011.110266; Kumar A, 2012, ENDOCRINOLOGY, V153, P254, DOI 10.1210/en.2011-1169; Liu YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028915; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Mitrano TI, 2010, J PERIODONTOL, V81, P917, DOI 10.1902/jop.2010.090566; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Mrozik KM, 2012, CLIN ORAL INVEST, V16, P867, DOI 10.1007/s00784-011-0558-3; Nagano T, 2004, J PERIODONTAL RES, V39, P249, DOI 10.1111/j.1600-0765.2004.00733.x; Ohyama M, 2002, J PERIODONTOL, V73, P543, DOI 10.1902/jop.2002.73.5.543; Parkar MH, 2004, J PERIODONTOL, V75, P1539, DOI 10.1902/jop.2004.75.11.1539; Philips BJ, 2012, EXPERT OPIN BIOL TH, V12, P155, DOI 10.1517/14712598.2012.644533; Rasperini G, 2000, INT J PERIODONT REST, V20, P269; Rasperini G, 2011, INT J PERIODONT REST, V31, P133; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sculean A, 2011, CLIN ADV PERIODONTIC, V1, P101, DOI 10.1902/cap.2011.110047; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Wada Y, 2008, J PERIODONTOL, V79, P341, DOI [10.1902/jop.2008.070197, 10.1902/jop.2008.070197 ]; Wang XJ, 2011, CELL PROLIFERAT, V44, P274, DOI 10.1111/j.1365-2184.2011.00750.x; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou SH, 2005, J BIOL CHEM, V280, P22688, DOI 10.1074/jbc.M412953200	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71046	10.1371/journal.pone.0071046	http://dx.doi.org/10.1371/journal.pone.0071046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951076	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300080
J	Krohn, SC; Bonvin, P; Proudfoot, AEI				Krohn, Sonja C.; Bonvin, Pauline; Proudfoot, Amanda E. I.			CCL18 Exhibits a Regulatory Role through Inhibition of Receptor and Glycosaminoglycan Binding	PLOS ONE			English	Article							C-C CHEMOKINE; T-CELLS; NATURAL ANTAGONIST; DENDRITIC CELLS; PULMONARY; MACROPHAGES; MONOCYTES; ALPHA; IDENTIFICATION; INVOLVEMENT	CCL18 has been reported to be present constitutively at high levels in the circulation, and is further elevated during inflammatory diseases. Since it is a rather poor chemoattractant, we wondered if it may have a regulatory role. CCL18 has been reported to inhibit cellular recruitment mediated by CCR3, and we have shown that whilst it is a competitive functional antagonist as assessed by Schild plot analysis, it only binds to a subset of CCR3 receptor populations. We have extended this inhibitory activity to other receptors and have shown that CCL18 is able to inhibit CCR1, CCR2, CCR4 and CCR5 mediated chemotaxis, but has no effect on CCR7 and CCR9, nor the CXC receptors that we have tested. Whilst CCL18 is able to bind to CCR3, it does not bind to the other receptors that it inhibits. We therefore tested the hypothesis that it may displace glycosaminoglycan (GAG) chemokines bound either in cis- on the leukocyte, or in trans-presentation on the endothelial surface, thereby inhibiting the recruitment of leukocytes into the site of inflammation. We show that CCL18 selectivity displaces heparin bound chemokines, and that chemokines from all four chemokine sub-classes displace cell bound CCL18. We propose that CCL18 has regulatory properties inhibiting chemokine function when GAG-mediated presentation plays a role in receptor activation.	[Krohn, Sonja C.; Bonvin, Pauline; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, Dept Immunol, Geneva, Switzerland	Merck KGaA; EMD Serono Inc.	Proudfoot, AEI (corresponding author), Merck Serono Geneva Res Ctr, Dept Immunol, Geneva, Switzerland.	amandapf@orange.fr			European Community's Seventh Framework Programme TIMER [HEALTH-F4-2011-281608]	European Community's Seventh Framework Programme TIMER	The research leading to these results has received funding from the European Community's Seventh Framework Programme TIMER [FP7-2007-2013] under grant agreement noHEALTH-F4-2011-281608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Ali S, 2003, TRANSPLANTATION, V75, P1773, DOI 10.1097/01.TP.0000065805.97974.93; Arunlakshana O, 1959, SOME QUANTITATIVE US, P48; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Blanpain C, 1999, BLOOD, V94, P1899; Burns JM, 1998, J EXP MED, V188, P1917, DOI 10.1084/jem.188.10.1917; Catusse J, 2010, J CELL PHYSIOL, V225, P792, DOI 10.1002/jcp.22284; Chang Y, 2010, FASEB J, V24, P5063, DOI 10.1096/fj.10-162560; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chenivesse C, 2012, J IMMUNOL, V189, P128, DOI 10.4049/jimmunol.1003616; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Guan P, 1999, GENOMICS, V56, P296, DOI 10.1006/geno.1998.5635; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Hieshima K, 1997, J IMMUNOL, V159, P1140; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kenakin P, 1900, PHARM PRIMER; Kodelja V, 1998, J IMMUNOL, V160, P1411; Krohn S, 2013, FRONTIERS I IN PRESS; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Li H, United States Patent, Patent No. [5,504,003, 5504003]; Lindhout E, 2001, J IMMUNOL, V166, P3284, DOI 10.4049/jimmunol.166.5.3284; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Nibbs RJB, 2000, J IMMUNOL, V164, P1488, DOI 10.4049/jimmunol.164.3.1488; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Proudfoot AEI, 2000, METH MOL B, V138, P75; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; SCHILD HO, 1949, BRIT J PHARM CHEMOTH, V4, P277, DOI 10.1111/j.1476-5381.1949.tb00548.x; Schraufstatter I, 2004, AM J PHYSIOL-LUNG C, V286, pL494, DOI 10.1152/ajplung.00323.2002; Schraufstatter IU, 2012, IMMUNOLOGY, V135, P287, DOI 10.1111/j.1365-2567.2011.03541.x; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Schutyser E, 2001, EUR J IMMUNOL, V31, P3755, DOI 10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Severin IC, 2012, PROTEIN ENG DES SEL, V25, P213, DOI 10.1093/protein/gzs008; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Wells TNC, 1997, J LEUKOCYTE BIOL, V61, P545, DOI 10.1002/jlb.61.5.545; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	44	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72321	10.1371/journal.pone.0072321	http://dx.doi.org/10.1371/journal.pone.0072321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951310	Green Published, gold			2022-12-27	WOS:000323097300190
J	Yang, HD; Xiong, H; Yu, RJ; Wang, CM; Zheng, YQ; Zhang, XY				Yang, Haidi; Xiong, Hao; Yu, Rongjun; Wang, Changming; Zheng, Yiqing; Zhang, Xueyuan			The Characteristic and Changes of the Event-Related Potentials (ERP) and Brain Topographic Maps before and after Treatment with rTMS in Subjective Tinnitus Patients	PLOS ONE			English	Article							SINGLE UNITS; CORTEX; CLASSIFICATION; NEUROSCIENCE; STIMULATION; EXPRESSION; ATTENTION; PATTERNS; SOUNDS; MMN	Objectives: To compare the event-related potentials (ERPs) and brain topographic maps characteristic and change in normal controls and subjective tinnitus patients before and after repetitive transcranial magnetic stimulation (rTMS) treatment. Methods and Participants: The ERPs and brain topographic maps elicited by target stimulus were compared before and after 1-week treatment with rTMS in 20 subjective tinnitus patients and 16 healthy controls. Results: Before rTMS, target stimulus elicited a larger N1 component than the standard stimuli (repeating sounds) in control group but not in tinnitus patients. Instead, the tinnitus group pre-treatment exhibited larger amplitude of N1 in response to standard stimuli than to deviant stimuli. Furthermore tinnitus patients had smaller mismatch negativity (MMN) and late discriminative negativity (LDN) component at Fz compared with the control group. After rTMS treatment, tinnitus patients showed increased N1 response to deviant stimuli and larger MMN and LDN compared with pre-treatment. The topographic maps for the tinnitus group before rTMS-treatment demonstrated global asymmetry between the left and right cerebral hemispheres with more negative activities in left side and more positive activities in right side. In contrast, the brain topographic maps for patients after rTMS-treatment and controls seem roughly symmetrical. The ERP amplitudes and brain topographic maps in post-treatment patient group showed no significant difference with those in controls. Conclusions: The characterical changes in ERP and brain topographic maps in tinnitus patients maybe related with the electrophysiological mechanism of tinnitus induction and development. It can be used as an objective biomarker for the evaluation of auditory central in subjective tinnitus patients. These findings support the notion that rTMS treatment in tinnitus patients may exert a beneficial effect.	[Yang, Haidi; Xiong, Hao; Zheng, Yiqing; Zhang, Xueyuan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Haidi; Xiong, Hao; Zheng, Yiqing; Zhang, Xueyuan] Sun Yat Sen Univ, Inst Hearing & Speech Language Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wang, Changming] Beijing Normal Univ, Coll Informat Sci & Technol, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; South China Normal University; South China Normal University; Beijing Normal University	Zheng, YQ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol, Guangzhou 510275, Guangdong, Peoples R China.	yiqingzheng@hotmail.com	Yu, Rongjun/AAV-2615-2020; Wang, Changming/U-8527-2019	Yu, Rongjun/0000-0003-0123-1524; zheng, yiqing/0000-0002-3641-1640	National Natural Science Foundation of China [81170921, 81200743]; Natural Science Foundation of Guangdong Province, China [S2011010004576]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China awarded to Y. Zheng (Grant No. 81170921) and H. Xiong (Grant No. 81200743) and Natural Science Foundation of Guangdong Province, China awarded to Y. Zheng (Grant No. S2011010004576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; De Ridder Dirk, 2007, Int J Med Sci, V4, P237; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Gene-Cos N, 2005, EPILEPTIC DISORD, V7, P363; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Henry, 1995, Int Tinnitus J, V1, P85; Horvath J, 2008, PSYCHOPHYSIOLOGY, V45, P60, DOI 10.1111/j.1469-8986.2007.00599.x; Horvath J, 2009, NEUROSCI LETT, V461, P262, DOI 10.1016/j.neulet.2009.06.035; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jacobson Gary P, 2003, J Am Acad Audiol, V14, P393; Kaltenbach JA, 2005, HEARING RES, V206, P200, DOI 10.1016/j.heares.2005.02.013; Khedr EM, 2010, EUR J NEUROL, V17, P976, DOI 10.1111/j.1468-1331.2010.02965.x; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lorenz I, 2010, J NEUROPHYSIOL, V104, P1497, DOI 10.1152/jn.00370.2010; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Mueller V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-18; Myatchin I, 2009, EPILEPSY RES, V86, P183, DOI 10.1016/j.eplepsyres.2009.06.004; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Norena A, 1999, CLIN NEUROPHYSIOL, V110, P666, DOI 10.1016/S1388-2457(98)00034-0; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rossi S, 2007, J NEUROL NEUROSUR PS, V78, P857, DOI 10.1136/jnnp.2006.105007; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; WallhausserFranke E, 1997, NEUROREPORT, V8, P725, DOI 10.1097/00001756-199702100-00029; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Wetzel N, 2006, CLIN NEUROPHYSIOL, V117, P2191, DOI 10.1016/j.clinph.2006.06.717	37	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70831	10.1371/journal.pone.0070831	http://dx.doi.org/10.1371/journal.pone.0070831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951019	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300056
J	Zhou, WB; Liang, MD; Pan, H; Liu, XA; Jiang, YN; Wang, YF; Ling, LJ; Ding, Q; Wang, S				Zhou, Wenbin; Liang, Mengdi; Pan, Hong; Liu, Xiaoan; Jiang, Yanni; Wang, Yufeng; Ling, Lijun; Ding, Qiang; Wang, Shui			Comparison of Ablation Zones among Different Tissues Using 2450-MHz Cooled-Shaft Microwave Antenna: Results in Ex Vivo Porcine Models	PLOS ONE			English	Article							SMALL BREAST CANCERS; IN-VIVO; RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; COAGULATION; LIVER; METASTASIS; THERAPY; BOVINE; LUNG	Background: For complete tumor ablation in different tissues, it is necessary to investigate the exact coagulation zone of microwave ablation in different tissues. The aim of this study was to compare the extent of microwave ablation zone in muscle, liver and adipose tissue in ex vivo porcine models and assess the shape of microwave coagulation zone among these tissues. Materials and Methods: Microwave ablations were performed in ex vivo porcine muscle, liver and adipose tissue using 2450-MHz cooled-shaft microwave antenna. The content of water, fat and protein in these three tissues was determined. Two power increments (40 and 80 W) and five time increments (1, 3, 5, 7, and 10 minutes) were used in this study. Diameters and shapes of the ablation zones were assessed on gross specimens. Results: The average percentages of water, fat and protein in these three tissues were significantly different (P < 0.001), respectively. The long-axis and short-axis diameters among these three tissues at each time-power combination were not significantly different (P > 0.05). The coagulation zones were all elliptical in muscle, liver and adipose tissue. When microwave ablation was performed in the tissue containing both muscle and adipose tissue, the coagulation zone was also elliptical. Regardless of the output power, the ellipticity index (EI) value of 1 minute treatment duration was higher than that of 10 minutes treatment duration (P < 0.05). Furthermore, the EI value did not decrease significantly when the treatment duration was more than 5 minutes (P > 0.05). Conclusion: The extent of microwave ablation zones was not significantly different among completely different tissues. Microwave ablations with >= 5 minutes time duration can induce coagulation zones with clinical desirable shape. Future clinical studies are still required to determine the role of microwave ablation in different tissues.	[Zhou, Wenbin; Liang, Mengdi; Pan, Hong; Liu, Xiaoan; Ling, Lijun; Ding, Qiang; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Jiang, Yanni] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yufeng] Jiangsu Yurun Meat Ind Grp Co Ltd, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172505, 81202077, 81272916]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (81071753, 81172505, 81202077 and 81272916), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008) and a project funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2011, KOREAN J RADIOL, V12, P525, DOI 10.3348/kjr.2011.12.5.525; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P135, DOI 10.1067/j.cpradiol.2007.10.001; Dong BW, 1998, AM J ROENTGENOL, V171, P449, DOI 10.2214/ajr.171.2.9694473; Dooley WC, 2010, ANN SURG ONCOL, V17, P1076, DOI 10.1245/s10434-009-0872-z; Dowlatshahi K, 2002, AM J SURG, V184, P359, DOI 10.1016/S0002-9610(02)00942-X; Fan WJ, 2012, AM J ROENTGENOL, V198, pW46, DOI 10.2214/AJR.11.6707; Gao YY, 2010, EUR J RADIOL, V75, P87, DOI 10.1016/j.ejrad.2009.03.009; Hines-Peralta AU, 2006, RADIOLOGY, V239, P94, DOI 10.1148/radiol.2383050262; Ji Q, 2011, ACAD RADIOL, V18, P1151, DOI 10.1016/j.acra.2011.05.004; Lazebnik M, 2007, PHYS MED BIOL, V52, P2637, DOI 10.1088/0031-9155/52/10/001; Liang P, 2005, RADIOLOGY, V235, P299, DOI 10.1148/radiol.2351031944; Manenti G, 2009, RADIOLOGY, V251, P339, DOI 10.1148/radiol.2512080905; Merckel LG, 2012, RADIOLOGY, V265, P322, DOI 10.1148/radiol.12121033; Minami Y, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/104685; Minisini AM, 2009, ANTI-CANCER DRUG, V20, P503, DOI 10.1097/CAD.0b013e3283243df3; Mulier S, 2007, ANN SURG ONCOL, V14, P1381, DOI 10.1245/s10434-006-9033-9; Oshima F, 2008, RADIAT MED, V26, P408, DOI 10.1007/s11604-008-0251-x; Pfleiderer SOR, 2005, INVEST RADIOL, V40, P472, DOI 10.1097/01.rli.0000166935.56971.ff; Shi WY, 2011, EUR J RADIOL, V79, P214, DOI 10.1016/j.ejrad.2010.03.015; Simon CJ, 2005, RADIOGRAPHICS, V25, pS69, DOI 10.1148/rg.25si055501; Sommer CM, 2011, J VASC INTERV RADIOL, V22, P1751, DOI 10.1016/j.jvir.2011.07.020; Sun YY, 2012, EUR J RADIOL, V81, P553, DOI 10.1016/j.ejrad.2011.02.013; Sun YY, 2009, AM J ROENTGENOL, V192, P508, DOI 10.2214/AJR.07.3828; Tanaka T, 2012, CARDIOVASC INTER RAD, V35, P914, DOI 10.1007/s00270-011-0253-4; Vogl TJ, 2011, RADIOLOGY, V261, P643, DOI 10.1148/radiol.11101643; Walser EM, 2005, J VASC INTERV RADIOL, V16, P1427, DOI 10.1097/01.RVI.0000188755.61481.E8; Wang Y, 2009, INT J HYPERTHER, V25, P455, DOI 10.1080/02656730903066608; Wolf FJ, 2008, RADIOLOGY, V247, P871, DOI 10.1148/radiol.2473070996; Wu YZ, 2011, WORLD J GASTROENTERO, V17, P4143, DOI 10.3748/wjg.v17.i36.4143; Yu J, 2011, EUR J RADIOL, V79, P124, DOI 10.1016/j.ejrad.2009.12.009; Zhou Q, 2011, CHINESE MED J-PEKING, V124, P3386, DOI 10.3760/cma.j.issn.0366-6999.2011.20.032; Zhou WB, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-97; Zhou WB, 2012, RADIOLOGY, V263, P364, DOI 10.1148/radiol.12111901	33	31	34	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71873	10.1371/journal.pone.0071873	http://dx.doi.org/10.1371/journal.pone.0071873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951262	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300167
J	Chen, KN; Deng, SY; Lu, HZ; Zheng, YY; Yang, GD; Kim, D; Cao, QL; Wu, JQ				Chen, Kenian; Deng, Shuyun; Lu, Hezuo; Zheng, Yiyan; Yang, Guodong; Kim, Dong; Cao, Qilin; Wu, Jia Qian			RNA-Seq Characterization of Spinal Cord Injury Transcriptome in Acute/Subacute Phases: A Resource for Understanding the Pathology at the Systems Level	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; GENE-EXPRESSION; FUNCTIONAL RECOVERY; LIPOPROTEIN-LIPASE; LOCOMOTOR RECOVERY; LIPID-METABOLISM; PRECURSOR CELLS; HUB PROTEINS; MICROARRAYS; OLIGODENDROCYTE	Spinal cord injury (SCI) is a devastating neurological disease without effective treatment. To generate a comprehensive view of the mechanisms involved in SCI pathology, we applied RNA-Sequencing (RNA-Seq) technology to characterize the temporal changes in global gene expression after contusive SCI in mice. We sequenced tissue samples from acute and subacute phases (2 days and 7 days after injury) and systematically characterized the transcriptomes with the goal of identifying pathways and genes critical in SCI pathology. The top enriched functional categories include "inflammation response," " neurological disease," "cell death and survival" and " nervous system development." The top enriched pathways include LXR/RXR Activation and Atherosclerosis Signaling, etc. Furthermore, we developed a systems-based analysis framework in order to identify key determinants in the global gene networks of the acute and sub-acute phases. Some candidate genes that we identified have been shown to play important roles in SCI, which demonstrates the validity of our approach. There are also many genes whose functions in SCI have not been well studied and can be further investigated by future experiments. We have also incorporated pharmacogenomic information into our analyses. Among the genes identified, the ones with existing drug information can be readily tested in SCI animal models. Therefore, in this study we have described an example of how global gene profiling can be translated to identifying genes of interest for functional tests in the future and generating new hypotheses. Additionally, the RNA-Seq enables splicing isoform identification and the estimation of expression levels, thus providing useful information for increasing the specificity of drug design and reducing potential side effect. In summary, these results provide a valuable reference data resource for a better understanding of the SCI process in the acute and sub-acute phases.	[Chen, Kenian; Deng, Shuyun; Lu, Hezuo; Zheng, Yiyan; Yang, Guodong; Kim, Dong; Cao, Qilin; Wu, Jia Qian] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX USA; [Chen, Kenian; Deng, Shuyun; Lu, Hezuo; Zheng, Yiyan; Yang, Guodong; Kim, Dong; Cao, Qilin; Wu, Jia Qian] UT Brown Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Cao, QL (corresponding author), Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX USA.	Qi-Lin.Cao@uth.tmc.edu; Jiaqian.wu@uth.tmc.edu	CHEN, KENIAN/L-8899-2019; CHEN, KENIAN/F-8240-2019	CHEN, KENIAN/0000-0002-4083-841X; Kim, Dong/0000-0002-1523-6396	National Institutes of Health; Staman Ogilvie Fund-Memorial Hermann Foundation; Senator Lloyd & B. A. Bentsen Center for Stroke Research; NIH [NS061975]; TIRR foundation through Mission Connect; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Staman Ogilvie Fund-Memorial Hermann Foundation; Senator Lloyd & B. A. Bentsen Center for Stroke Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TIRR foundation through Mission Connect; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JQW, KC and SD were supported by grants from the National Institutes of Health, The Staman Ogilvie Fund-Memorial Hermann Foundation, and the Senator Lloyd & B. A. Bentsen Center for Stroke Research. QC and HL were supported by the grant from NIH NS061975 and the TIRR foundation through Mission Connect. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzemovic MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039794; Agnello D, 2000, J NEUROIMMUNOL, V109, P105, DOI 10.1016/S0165-5728(00)00279-4; Andrews S, 2012, AM J PATHOL, V181, P1165, DOI 10.1016/j.ajpath.2012.06.027; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Barrie ES, 2012, MOL PHARMACOL, V81, P620, DOI 10.1124/mol.111.076604; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Blain Jean-Francois, 2004, ScientificWorldJournal, V4, P531; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Carbajal KS, 2011, GLIA, V59, P1813, DOI 10.1002/glia.21225; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Cho N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-134; Correia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028352; Cuzzocrea S, 2008, SHOCK, V29, P362, DOI 10.1097/shk.0b013e31814545dc; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Fan CL, 2013, INT J BIOL SCI, V9, P78, DOI 10.7150/ijbs.5626; Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f; Freria CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-240; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He BL, 2013, NEUROPEPTIDES, V47, P1, DOI 10.1016/j.npep.2012.06.001; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hill RL, 2009, J NEUROTRAUM, V26, P1, DOI 10.1089/neu.2008.0543; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Huey PU, 1998, J LIPID RES, V39, P2135; Jaerve A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049812; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kleibeuker W, 2008, BRAIN BEHAV IMMUN, V22, P200, DOI 10.1016/j.bbi.2007.07.009; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee GYF, 2006, J NEUROSURG-SPINE, V4, P123, DOI 10.3171/spi.2006.4.2.123; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu Cheng-long, 2003, Chin J Traumatol, V6, P18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Liverman CT, 2005, PINAL CORD INJURY PR; Luchetti S, 2010, J NEUROTRAUM, V27, P411, DOI 10.1089/neu.2009.0930; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matsumura T, 2009, J BIOCHEM, V146, P375, DOI 10.1093/jb/mvp080; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pal S, 2012, PHARMACOL THERAPEUT, V136, P283, DOI 10.1016/j.pharmthera.2012.08.005; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Plunkett JA, 2001, EXP NEUROL, V168, P144, DOI 10.1006/exnr.2000.7604; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Ries A, 2007, J NEUROCHEM, V103, P1491, DOI 10.1111/j.1471-4159.2007.04858.x; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Schwammle V, 2010, BIOINFORMATICS, V26, P2841, DOI 10.1093/bioinformatics/btq534; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wang H, 2012, ANNU REV NUTR, V32, P147, DOI 10.1146/annurev-nutr-071811-150703; Wang XJ, 2010, NEUROPATHOLOGY, V30, P131, DOI 10.1111/j.1440-1789.2009.01061.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zendedel A, 2012, BRAIN RES, V1473, P214, DOI 10.1016/j.brainres.2012.07.037; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018	84	52	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72567	10.1371/journal.pone.0072567	http://dx.doi.org/10.1371/journal.pone.0072567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951329	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200084
J	Brand, TM; Iida, M; Luthar, N; Wleklinski, MJ; Starr, MM; Wheeler, DL				Brand, Toni M.; Iida, Mari; Luthar, Neha; Wleklinski, Matthew J.; Starr, Megan M.; Wheeler, Deric L.			Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ERBB SIGNALING NETWORK; CELL LUNG-CANCER; BREAST-CANCER; ACQUIRED-RESISTANCE; TRANSCRIPTION FACTOR; INHIBITOR GEFITINIB; IONIZING-RADIATION; PROGNOSTIC VALUE; EGF RECEPTOR	Nuclear localized HER family receptor tyrosine kinases (RTKs) have been observed in primary tumor specimens and cancer cell lines for nearly two decades. Inside the nucleus, HER family members (EGFR, HER2, and HER3) have been shown to function as co-transcriptional activators for various cancer-promoting genes. However, the regions of each receptor that confer transcriptional potential remain poorly defined. The current study aimed to map the putative transactivation domains (TADs) of the HER3 receptor. To accomplish this goal, various intracellular regions of HER3 were fused to the DNA binding domain of the yeast transcription factor Gal4 (Gal4DBD) and tested for their ability to transactivate Gal4 UAS-luciferase. Results from these analyses demonstrated that the C-terminal domain of HER3 (CTD, amino acids distal to the tyrosine kinase domain) contained potent transactivation potential. Next, nine HER3-CTD truncation mutants were constructed to map minimal regions of transactivation potential using the Gal4 UAS-luciferase based system. These analyses identified a bipartite region of 34 (B-1) and 27 (B-2) amino acids in length that conferred the majority of HER3's transactivation potential. Next, we identified full-length nuclear HER3 association and regulation of a 122 bp region of the cyclin D1 promoter. To understand how the B-1 and B-2 regions influenced the transcriptional functions of nuclear HER3, we performed cyclin D1 promoter-luciferase assays in which HER3 deleted of the B-1 and B-2 regions was severely hindered in regulating this promoter. Further, the overexpression of HER3 enhanced cyclin D1 mRNA expression, while HER3 deleted of its identified TADs was hindered at doing so. Thus, the ability for HER3 to function as a transcriptional co-activator may be dependent on specific C-terminal TADs.	[Brand, Toni M.; Iida, Mari; Luthar, Neha; Wleklinski, Matthew J.; Starr, Megan M.; Wheeler, Deric L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wheeler, DL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53706 USA.	dlwheeler@wisc.edu			National Cancer Institute [P30CA014520]; Clinical and Translational Science Award (CTSA) program [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; American Cancer Society (DLW) [RSG-10-193-01-TBG]; NIH from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases (TMB) [T32 GM08.1061-01A2]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Cancer Society (DLW)(American Cancer Society); NIH from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases (TMB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported, in part, by grant P30CA014520 from the National Cancer Institute, by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021, grant RSG-10-193-01-TBG from the American Cancer Society (DLW), and by NIH grant T32 GM08.1061-01A2 from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases (TMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2011, J NEUROSCI, V31, P5106, DOI 10.1523/JNEUROSCI.5635-10.2011; ALTMANN H, 1994, P NATL ACAD SCI USA, V91, P3901, DOI 10.1073/pnas.91.9.3901; Andrique L, 2012, CELL SIGNAL, V24, P1074, DOI 10.1016/j.cellsig.2012.01.002; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Brand TM, 2011, DISCOV MED, V12, P419; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chiu CG, 2010, ANN SURG, V251, P1107, DOI 10.1097/SLA.0b013e3181dbb77e; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Dittmann K, 2011, RADIOTHER ONCOL, V99, P317, DOI 10.1016/j.radonc.2011.06.001; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li CF, 2011, ANN SURG ONCOLOGY; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Mapp AK, 2007, ACS CHEM BIOL, V2, P62, DOI 10.1021/cb600463w; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2009, CANCER BIOL THER, V8, P696, DOI 10.4161/cbt.8.8.7903; Wu Kenneth K., 2006, V338, P281; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	48	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71518	10.1371/journal.pone.0071518	http://dx.doi.org/10.1371/journal.pone.0071518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951180	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000062
J	Chen, JX; Chen, MX; Ai, L; Xu, XN; Jiao, JM; Zhu, TJ; Su, HY; Zang, W; Luo, JJ; Guo, YH; Lv, S; Zhou, XN				Chen, Jia-Xu; Chen, Mu-Xin; Ai, Lin; Xu, Xue-Nian; Jiao, Jian-Ming; Zhu, Ting-Jun; Su, Hui-Yong; Zang, Wei; Luo, Jia-Jun; Guo, Yun-Hai; Lv, Shan; Zhou, Xiao-Nong			An Outbreak of Human Fascioliasis gigantica in Southwest China	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; HEPATICA; PROVINCE; SHEEP	Fascioliasis is a common parasitic disease in livestock in China. However, human fascioliasis is rarely reported in the country. Here we describe an outbreak of human fascioliasis in Yunnan province. We reviewed the complete clinical records of 29 patients and performed an epidemiological investigation on the general human population and animals in the outbreak locality. Our findings support an outbreak due to Fasciola gigantica with a peak in late November, 2011. The most common symptoms were remittent fever, epigastric tenderness, and hepatalgia. Eosinophilia and tunnel-like lesions in ultrasound imaging in the liver were also commonly seen. Significant improvement of patients' condition was achieved by administration of triclabendazole (R). Fasciola spp. were discovered in local cattle (28.6%) and goats (26.0%). Molecular evidence showed a coexistence of F. gigantica and F. hepatica. However, all eggs seen in humans were confirmed to be F. gigantica. Herb (Houttuynia cordata) was most likely the source of infections. Our findings indicate that human fascioliasis is a neglected disease in China. The distribution of triclabendazole (R), the only efficacious drug against human fascioliasis, should be promoted.	[Chen, Jia-Xu; Chen, Mu-Xin; Ai, Lin; Xu, Xue-Nian; Zhu, Ting-Jun; Zang, Wei; Guo, Yun-Hai; Lv, Shan; Zhou, Xiao-Nong] Natl Inst Parasit Dis, Shanghai, Peoples R China; [Chen, Jia-Xu; Chen, Mu-Xin; Ai, Lin; Xu, Xue-Nian; Zhu, Ting-Jun; Zang, Wei; Guo, Yun-Hai; Lv, Shan; Zhou, Xiao-Nong] WHO Collaborating Ctr Malaria Schistosomiasis & F, Minist Hlth, Key Lab Biol Parasite & Vector, Shanghai, Peoples R China; [Jiao, Jian-Ming] Dali Univ, Affiliated Hosp, Dali, Peoples R China; [Su, Hui-Yong] Peoples Hosp Dali Prefecture, Dali, Peoples R China; [Luo, Jia-Jun] Dali Inst Schistosomiasis Control, Dali, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization; Dali University	Lv, S (corresponding author), Natl Inst Parasit Dis, Shanghai, Peoples R China.	lvshan000@126.com; ipdzhouxn@sh163.net			Program for the International Development Research Centre, Canada [105509-00001002]; National S & T Major Program [2012ZX10004-220, 2008ZX10004-011, 2009ZX10004-302, 2009ZX10004-201]; National Key Technology R D Program [2008BAI56B03]; China Postdoctoral Science Foundation [2012M520353]; Shanghai Postdoctoral Sustentation Fund [12R21416500]	Program for the International Development Research Centre, Canada; National S & T Major Program; National Key Technology R D Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund	The Program for the International Development Research Centre, Canada (Project No. 105509-00001002), National S & T Major Program (grant nos. 2012ZX10004-220, 2008ZX10004-011, 2009ZX10004-302 and 2009ZX10004-201), National Key Technology R & D Program (Grant No. 2008BAI56B03), and China Postdoctoral Science Foundation (Grant No. 2012M520353), Shanghai Postdoctoral Sustentation Fund (Grant No. 12R21416500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2010, ANN TROP MED PARASIT, V104, P65, DOI 10.1179/136485910X12607012373713; Andrews SJ, 1999, FASCIOLOSIS, P1; BJORLAND J, 1995, CLIN INFECT DIS, V21, P1228, DOI 10.1093/clinids/21.5.1228; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Chen M G, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P356; Chen MX, 2010, HYBRIDOMA, V29, P447, DOI 10.1089/hyb.2010.0008; [范东 FAN Dong], 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P191; Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283; Huang WY, 2004, VET PARASITOL, V120, P75, DOI 10.1016/j.vetpar.2003.12.006; Huang ZhengMei, 2006, China Tropical Medicine, V6, P1624; Huang ZM, 2009, PARASIT INFECT DIS, V7, P172; ISHIDA K, 1992, PARASITE IMMUNOL, V14, P633, DOI 10.1111/j.1365-3024.1992.tb00035.x; JACQUIER P, 1991, J CLIN MICROBIOL, V29, P1831, DOI 10.1128/JCM.29.9.1831-1835.1991; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTON K, 1992, MOL BIOCHEM PARASIT, V56, P323, DOI 10.1016/0166-6851(92)90181-I; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S., 2004, SE ASIAN J TROP MED, V35, P1; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Menard A, 2000, PARASITE, V7, P77, DOI 10.1051/parasite/2000072077; Moghaddam AS, 2004, PARASITOL RES, V94, P61, DOI 10.1007/s00436-004-1169-6; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Nithiuthai S, 2004, VET PARASITOL, V126, P167, DOI 10.1016/j.vetpar.2004.09.018; Robinson MW, 2009, PHILOS T R SOC B, V364, P2763, DOI 10.1098/rstb.2009.0089; SANTIAGO N, 1988, J PARASITOL, V74, P810, DOI 10.2307/3282259; Scott PR, 2005, VET J, V170, P325, DOI 10.1016/j.tvjl.2004.08.010; Shimalov VV, 2000, PARASITOL RES, V86, P527, DOI 10.1007/s004360050707; Shu FF, 2012, J PARASITOL, V98, P889, DOI 10.1645/GE-2974.1; Song Hui-qun, 2009, Zhongguo Shouyi Kexue, V39, P487; Spithill TW, 1998, PARASITOL TODAY, V14, P224, DOI 10.1016/S0169-4758(98)01245-9; Xu L.Q., 1999, DISTRIBUTION PATHOGE; Zhou XN, 2012, INFECT DIS POVERTY, V1, DOI [10.1186/2049-9957-1181-1181, DOI 10.1186/2049-9957-1181-1181]; Zhou XN, 2013, INFECT DIS POVERTY, V2, DOI [10.1186/2049-9957-1182-1181, DOI 10.1186/2049-9957-1182-1181]	35	45	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71520	10.1371/journal.pone.0071520	http://dx.doi.org/10.1371/journal.pone.0071520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951181	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000063
J	Gideon, HP; Hamilton, MS; Wood, K; Pepper, D; Oni, T; Seldon, R; Banwell, C; Langford, PR; Wilkinson, RJ; Wilkinson, KA				Gideon, Hannah Priyadarshini; Hamilton, Melissa Shea; Wood, Kathryn; Pepper, Dominique; Oni, Tolu; Seldon, Ronnett; Banwell, Claire; Langford, Paul R.; Wilkinson, Robert J.; Wilkinson, Katalin A.			Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay	PLOS ONE			English	Article							T-CELL RESPONSES; EX-VIVO; ANTIGENS; DIAGNOSIS; PROTEIN; IMMUNODIAGNOSIS; IDENTIFICATION; VACCINATION; REACTIVITY; INFECTION	Studies on Mycobacterium tuberculosis (MTB) antigens are of interest in order to improve vaccine efficacy and to define biomarkers for diagnosis and treatment monitoring. The methodologies used for these investigations differ greatly between laboratories and discordant results are common. The IFN-gamma response to two well characterized MTB antigens ESAT-6 and CFP-10, in the form of recombinant proteins and synthetic peptides, was evaluated in HIV-1 uninfected persons in both long-term (7 day) and 24 hour, commercially available QuantiFERON TB Gold in Tube (QFT-GIT), whole blood assays. Our findings showed differences in the IFN-gamma response between 24 hour and 7 day cultures, with recombinant proteins inducing a significantly higher response than the peptide pools in 7 day whole blood assays. The activity of peptides and recombinant proteins did not differ in 24 hour whole blood or peripheral blood mononuclear cell (PBMC) based assays, nor in the ELISpot assay. Further analysis by SELDI-TOF mass spectrometry showed that the peptides are degraded over the course of 7 days of incubation in whole blood whilst the recombinant proteins remain intact. This study therefore demonstrates that screening antigenic candidates as synthetic peptides in long-term whole blood assays may underestimate immunogenicity.	[Gideon, Hannah Priyadarshini; Wood, Kathryn; Pepper, Dominique; Oni, Tolu; Seldon, Ronnett; Banwell, Claire; Wilkinson, Robert J.; Wilkinson, Katalin A.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Hamilton, Melissa Shea; Langford, Paul R.; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Robert J.; Wilkinson, Katalin A.] MRC Natl Inst Med Res, London, England	University of Cape Town; Imperial College London; MRC National Institute for Medical Research	Wilkinson, KA (corresponding author), Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Katalin.Wilkinson@uct.ac.za	Langford, Paul/AAU-4189-2020; Wilkinson, Katalin/AAF-6805-2020; Wilkinson, Katalin/AAQ-7713-2021	Langford, Paul/0000-0002-6368-4724; Wilkinson, Katalin/0000-0002-9796-2040; Gideon, Hannah/0000-0002-4443-2134; Oni, Tolu/0000-0003-4499-1910; Wilkinson, Robert/0000-0002-2753-1800	European Union [SANTE/2005/105-061-102]; Wellcome Trust [084323, 088316]; Medical research Council of the UK [U1175.02.002.00014.01]	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded with grants from the European Union SANTE/2005/105-061-102, The Wellcome Trust 084323, 088316, and the Medical research Council of the UK (U1175.02.002.00014.01). ESAT-6 (HYB 76-8CS) and CFP-10 (K8493) antibodies were kindly provided by the Statens Serum Institute, Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2004, J INFECT DIS, V189, P812, DOI 10.1086/381679; Agger EM, 2003, IMMUNOLOGY, V110, P507, DOI 10.1111/j.1365-2567.2003.01763.x; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Bowman MAH, 2011, AM J CARDIOVASC DIS, V1, P92; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chen JZ, 2009, MICROBES INFECT, V11, P876, DOI 10.1016/j.micinf.2009.05.008; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; Connell TG, 2007, CLIN VACCINE IMMUNOL, V14, P847, DOI 10.1128/CVI.00041-07; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Ewer K, 2006, CLIN VACCINE IMMUNOL, V13, P90, DOI 10.1128/CVI.13.1.90-97.2006; Geluk A, 2008, CLIN VACCINE IMMUNOL, V15, P522, DOI 10.1128/CVI.00432-07; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Jurcevic S, 1996, CLIN EXP IMMUNOL, V105, P416, DOI 10.1046/j.1365-2249.1996.d01-791.x; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin MY, 2009, INFECT IMMUN, V77, P5071, DOI 10.1128/IAI.00457-09; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nusslein K, 2006, MICROBIOL-SGM, V152, P1913, DOI 10.1099/mic.0.28812-0; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Rangaka MX, 2007, CLIN INFECT DIS, V44, P1639, DOI 10.1086/518234; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scholvinck E, 2004, J CLIN MICROBIOL, V42, P829, DOI 10.1128/JCM.42.2.829-831.2004; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Sidders B, 2008, INFECT IMMUN, V76, P3932, DOI 10.1128/IAI.00150-08; Sinha S, 2008, MICROBIOL-SGM, V154, P217, DOI 10.1099/mic.0.2007/010496-0; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0; Wilkinson RJ, 1997, J CLIN MICROBIOL, V35, P553, DOI 10.1128/JCM.35.3.553-557.1997; Wilkinson RJ, 1998, J INFECT DIS, V178, P760, DOI 10.1086/515336; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883, DOI 10.1128/AAC.46.12.3883-3891.2002	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71351	10.1371/journal.pone.0071351	http://dx.doi.org/10.1371/journal.pone.0071351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951140	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000052
J	Prince, JF; Smits, MLJ; van Herwaarden, JA; Arntz, MJ; Vonken, EJPA; van den Bosch, MAAJ; de Borst, GJ				Prince, Jip F.; Smits, Maarten L. J.; van Herwaarden, Joost A.; Arntz, Mark J.; Vonken, Evert-Jan P. A.; van den Bosch, Maurice A. A. J.; de Borst, Gert Jan			Endovascular Treatment of Internal Iliac Artery Stenosis in Patients with Buttock Claudication	PLOS ONE			English	Article							ANGIOPLASTY	Aim: To assess the technical feasibility and clinical outcome of percutaneous transluminal angioplasty (PTA) with and without stent placement for treatment of buttock claudication caused by internal iliac artery (IIA) stenosis. Methods: Between September 2001 and July 2011, thirty-four patients with buttock claudication underwent endovascular treatment. After angiographic lesion evaluation PTA with or without stent placement was performed. Technical success was recorded. Clinical outcome post-treatment was assessed at three months post-intervention and was classified as: 1) complete relief of symptoms, 2) partial relief, or 3) no relief of symptoms. Complications during follow-up were recorded. Results: Forty-four lesions in 34 symptomatic patients were treated with PTA. Eight lesions were treated with additional stent placement. Technical success was achieved in 40/44 lesions (91%). Three procedure-related minor complications occurred, i.e. asymptomatic conservatively treated intimal dissections. After a median of 2.9 months, patients experienced no relief of symptoms in 7/34 cases (21%), partial relief in 14/34 cases (41%), and complete relief in 13/34 cases (38%). Six patients required a reintervention during follow-up. Conclusion: Endovascular treatment of IIA stenosis has a high technical success rate and a low complication rate. Complete or partial relief of symptoms is achieved in the majority (79%) of patients.	[Prince, Jip F.; Smits, Maarten L. J.; Arntz, Mark J.; Vonken, Evert-Jan P. A.; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van Herwaarden, Joost A.; de Borst, Gert Jan] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Borst, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands.	G.J.deBorst-2@umcutrecht.nl	Demchuk, Andrew M/E-1103-2012; Arntz, M./L-4177-2015	Demchuk, Andrew M/0000-0002-4930-7789; van Herwaarden, Joost/0000-0003-1165-5179				Adlakha S, 2009, CATHETER CARDIO INTE, V74, P257, DOI 10.1002/ccd.21966; Bachoo P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003228.pub2; Batt M, 2006, J VASC SURG, V43, P987, DOI 10.1016/j.jvs.2006.01.024; Donas KP, 2009, J VASC SURG, V49, P1447, DOI 10.1016/j.jvs.2009.02.207; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; Huetink K, 2008, CARDIOVASC INTER RAD, V31, P391, DOI 10.1007/s00270-006-0106-8; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; MORSE SS, 1986, CARDIOVASC INTER RAD, V9, P136, DOI 10.1007/BF02577922; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; SMITH G, 1992, CLIN ORTHOP RELAT R, P176; Thompson K, 2010, ANN VASC SURG, V24, P23, DOI 10.1016/j.avsg.2009.05.005	12	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e73331	10.1371/journal.pone.0073331	http://dx.doi.org/10.1371/journal.pone.0073331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951349	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000095
J	Kemmling, A; Lev, MH; Payabvash, S; Betensky, RA; Qian, J; Masrur, S; Schwamm, LH				Kemmling, Andre; Lev, Michael H.; Payabvash, Seyedmehdi; Betensky, Rebecca A.; Qian, Jing; Masrur, Shihab; Schwamm, Lee H.			Hospital Acquired Pneumonia Is Linked to Right Hemispheric Peri-Insular Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; LATERALIZATION; CORTEX; COMPLICATIONS; INFECTION; IMMUNODEPRESSION; CONSEQUENCES; LOCALIZATION; PREDICTORS; ACTIVATION	Purpose: Hospital acquired pneumonia (HAP) is a major complication of stroke. We sought to determine associations between infarction of specific brain regions and HAP. Methods: 215 consecutive acute stroke patients with HAP (2003-2009) were carefully matched with 215 non-pneumonia controls by gender, then NIHSS, then age. Admission imaging and binary masks of infarction were registered to MNI-152 space. Regional atlas and voxel-based log-odds were calculated to assess the relationship between infarct location and the likelihood of HAP. An independently validated penalized conditional logistic regression model was used to identify HAP associated imaging regions. Results: The HAP and control patients were well matched by gender (100%), age (95% within 5-years), NIHSS (98% within 1-point), infarct size, dysphagia, and six other clinical variables. Right hemispheric infarcts were more frequent in patients with HAP versus controls (43.3% vs. 34.0%, p = 0.054), whereas left hemispheric infarcts were more frequent in controls (56.7% vs. 44.7%, p = 0.012); there was no significant difference between groups in the rate of brainstem strokes (p = 1.0). Of the 10 most infarcted regions, only right insular cortex volume was different in HAP versus controls (20 vs. 12 ml, p = 0.02). In univariate analyses, the highest log-odds regions for pneumonia were right hemisphere, cerebellum, and brainstem. The best performing multivariate model selected 7 brain regions of infarction and 2 infarct volume-based variables independently associated with HAP. Conclusions: HAP is associated with right hemispheric peri-insular stroke. These associations may be related to autonomic modulation of immune mechanisms, supporting recent hypotheses of stroke mediated immune suppression.	[Kemmling, Andre; Lev, Michael H.; Payabvash, Seyedmehdi] Harvard Univ, Sch Med, Dept Radiol, Div Neuroradiol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Betensky, Rebecca A.; Qian, Jing] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kemmling, Andre] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Masrur, Shihab; Schwamm, Lee H.] Harvard Univ, Dept Neurol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Qian, Jing] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Amherst	Kemmling, A (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Div Neuroradiol,Massachusetts Gen Hosp, Boston, MA 02115 USA.	a.kemmling@uke.de	Payabvash, Sam/I-1859-2019	Payabvash, Sam/0000-0003-4628-0370; Schwamm, Lee/0000-0003-0592-9145	National Institutes of Health [NIH CA075971]; NATIONAL CANCER INSTITUTE [R01CA075971, R29CA075971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported in part by the National Institutes of Health (NIH CA075971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Kalra L, 1995, STROKE J CEREBRAL CI; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Kim H, 2000, ARCH NEUROL-CHICAGO, V57, P478, DOI 10.1001/archneur.57.4.478; Koch HJ, 2006, NEUROIMMUNOMODULAT, V13, P8, DOI 10.1159/000092108; Masrur S, 2013, J STROKE CEREBROVASC; Meader KJ, 1999, NEUROLOGY, V52, P1183, DOI 10.1212/WNL.52.6.1183; Meador KJ, 2004, ANN NEUROL, V55, P840, DOI 10.1002/ana.20105; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meyer S, 2004, NEUROREPORT, V15, P357, DOI 10.1097/00001756-200402090-00029; Minnerup J, 2009, J NEUROL NEUROSUR PS, P1; Neveu P. J., 1992, BRAIN RES REV; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Ovbiagele Bruce, 2006, J Stroke Cerebrovasc Dis, V15, P209; Pittock Sean J, 2003, J Stroke Cerebrovasc Dis, V12, P175, DOI 10.1016/S1052-3057(03)00078-8; Pittock Sean J, 2003, J Stroke Cerebrovasc Dis, V12, P1; SANDER D, 1995, J NEUROL, V242, P313, DOI 10.1007/BF00878874; Steinhagen V, 2009, STROKE, V40, P1903, DOI 10.1161/STROKEAHA.108.535468; Tarkowski E, 1998, SCAND J IMMUNOL, V47, P30; TARKOWSKI E, 1991, J NEUROIMMUNOL, V34, P61, DOI 10.1016/0165-5728(91)90099-S; Upadya A, 2004, J CRIT CARE, V19, P16, DOI 10.1016/j.jcrc.2004.02.004; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Weimar C, 2002, STROKE, V33, P2053, DOI 10.1161/01.STR.0000022808.21776.BF; Weimar C, 2002, EUR NEUROL, V48, P133, DOI 10.1159/000065512	39	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71141	10.1371/journal.pone.0071141	http://dx.doi.org/10.1371/journal.pone.0071141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951094	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700081
J	Loguercio, S; Good, BM; Su, AI				Loguercio, Salvatore; Good, Benjamin M.; Su, Andrew I.			Dizeez: An Online Game for Human Gene-Disease Annotation	PLOS ONE			English	Article							WIKI	Structured gene annotations are a foundation upon which many bioinformatics and statistical analyses are built. However the structured annotations available in public databases are a sparse representation of biological knowledge as a whole. The rate of biomedical data generation is such that centralized biocuration efforts struggle to keep up. New models for gene annotation need to be explored that expand the pace at which we are able to structure biomedical knowledge. Recently, online games have emerged as an effective way to recruit, engage and organize large numbers of volunteers to help address difficult biological challenges. For example, games have been successfully developed for protein folding (Foldit), multiple sequence alignment (Phylo) and RNA structure design (EteRNA). Here we present Dizeez, a simple online game built with the purpose of structuring knowledge of gene-disease associations. Preliminary results from game play online and at scientific conferences suggest that Dizeez is producing valid gene-disease annotations not yet present in any public database. These early results provide a basic proof of principle that online games can be successfully applied to the challenge of gene annotation. Dizeez is available at http://genegames.org.	[Loguercio, Salvatore; Good, Benjamin M.; Su, Andrew I.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Su, AI (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	asu@scripps.edu		Su, Andrew I./0000-0002-9859-4104	National Institutes of Health [GM083924, GM089820]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083924, R01GM089820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (GM083924 and GM089820 to AIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Camon EB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S17; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Good BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-603; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huss JW, 2010, NUCLEIC ACIDS RES, V38, pD633, DOI 10.1093/nar/gkp760; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Peng K, 2012, NUCL ACIDS RES; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; von Ahn L., 2006, P SIGCHI C HUMAN FAC, P55, DOI DOI 10.1145/1124772.1124782; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719	17	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71171	10.1371/journal.pone.0071171	http://dx.doi.org/10.1371/journal.pone.0071171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951102	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700084
J	Masala, G; Assedi, M; Bendinelli, B; Ermini, I; Occhini, D; Sieri, S; Brighenti, F; del Turco, MR; Ambrogetti, D; Palli, D				Masala, Giovanna; Assedi, Melania; Bendinelli, Benedetta; Ermini, Ilaria; Occhini, Daniela; Sieri, Sabina; Brighenti, Furio; del Turco, Marco Rosselli; Ambrogetti, Daniela; Palli, Domenico			Glycemic Index, Glycemic Load and Mammographic Breast Density: The EPIC Florence Longitudinal Study	PLOS ONE			English	Article							IGF-BINDING PROTEIN-3; GROWTH-FACTOR; CANCER RISK; PARENCHYMAL PATTERNS; DIET; PREMENOPAUSAL; ASSOCIATIONS	A few studies have evaluated the association between diet and mammographic breast density (MBD) and results are inconsistent. MBD, a well-recognized risk factor for breast cancer, has been proposed as a marker of cumulative exposure to hormones and growth factors. Diets with a high glycemic index (GI) or glycemic load (GL) may increase breast cancer risk, via an effect on the insulin-like growth factor axis. We have investigated the association between carbohydrate intake, GI, GL and MBD in a prospective study. We identified a large series of women, in the frame of the EPIC-Florence cohort, with a mammogram taken five years after enrolment, when detailed information on dietary and lifestyle habits and anthropometric measurements had been collected. Mammograms have been retrieved (1,668, 83%) and MBD assessed according to Wolfe's classification. We compared women with high MBD (P2+DY Wolfe's categories) with those with low MBD (N1+P1) through logistic models adjusted for age, education, body mass index, menopause, number of children, breast feeding, physical activity, non-alcohol energy, fibers, saturated fat and alcohol. A direct association between GL and high MBD emerged in the highest quintile of intake in comparison with the lowest quintile (OR = 1.73, 95% CI 1.13-2.67, p for trend = 0.048) while no association with glycemic index was evident. These results were confirmed after exclusion of women reporting to be on a diet or affected with diabetes, and when Hormone Replacement Therapy at the date of mammographic examination used to assess MBD was considered. The effect was particularly evident among leaner women, although no interaction was found. A positive association was suggested for increasing simple sugar and total carbohydrates intakes limited to the highest quintiles. In this Italian population we observed an association between glycemic load, total and rapidly absorbed carbohydrates and high MBD. These novel results warrant further investigations.	[Masala, Giovanna; Assedi, Melania; Bendinelli, Benedetta; Ermini, Ilaria; Occhini, Daniela; Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutrit Epidemiol Unit, Florence, Italy; [Sieri, Sabina] Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Dept Prevent & Predict Med, Milan, Italy; [Brighenti, Furio] Univ Parma, Dept Publ Hlth, I-43100 Parma, Italy; [del Turco, Marco Rosselli] European Sch Oncol ESO Consultant, Milan, Italy; [Ambrogetti, Daniela] Canc Res & Prevent Inst ISPO, Canc Screening Unit, Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Parma; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Masala, G (corresponding author), Canc Res & Prevent Inst ISPO, Mol & Nutrit Epidemiol Unit, Florence, Italy.	g.masala@ispo.toscana.it	Masala, Giovanna/AAC-5474-2022; brighenti, furio/E-4174-2010; brighenti, furio/T-4444-2019; Sieri, Sabina/K-4667-2016	Masala, Giovanna/0000-0002-5758-9069; brighenti, furio/0000-0001-8441-4611; brighenti, furio/0000-0001-8441-4611; Sieri, Sabina/0000-0001-5201-172X; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X; Bendinelli, Benedetta/0000-0002-4796-1517	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy); World Cancer Research Fund; PIO (Programma Integrato Oncologia) Regione Toscana, Ministero della Salute, Rome Italy	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); PIO (Programma Integrato Oncologia) Regione Toscana, Ministero della Salute, Rome Italy	This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy), the World Cancer Research Fund and PIO (Programma Integrato Oncologia) Regione Toscana, Ministero della Salute, Rome Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Brand-Miller J, 2009, J AM COLL NUTR, V28, p446S, DOI 10.1080/07315724.2009.10718110; Bremnes Y, 2007, CANCER EPIDEM BIOMAR, V16, P57, DOI 10.1158/1055-9965.EPI-06-0788; Byrne C, 2000, CANCER RES, V60, P3744; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; Dong JY, 2011, BREAST CANCER RES TR, V126, P287, DOI 10.1007/s10549-011-1343-3; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Masala G, 2006, INT J CANCER, V118, P1782, DOI 10.1002/ijc.21558; Masala G, 2009, INT J CANCER, V124, P1654, DOI 10.1002/ijc.24099; Maskarinec G, 2007, INT J CANCER, V121, P1786, DOI 10.1002/ijc.22834; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mulholland HG, 2008, BRIT J CANCER, V99, P1170, DOI 10.1038/sj.bjc.6604618; Nagata C, 2005, CANCER EPIDEM BIOMAR, V14, P2877, DOI 10.1158/1055-9965.EPI-05-0160; Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Qureshi SA, 2011, NUTR CANCER, V63, P1011, DOI 10.1080/01635581.2011.605983; Sala E, 2000, BRIT J CANCER, V83, P121, DOI 10.1054/bjoc.2000.1151; Salvini S., 1998, BANCA DATI COMPOSIZI; Sieri S, 2013, NUTR METAB CARDIOVAS, V23, P628, DOI 10.1016/j.numecd.2012.01.001; Sieri S, 2007, AM J CLIN NUTR, V86, P1160, DOI 10.1093/ajcn/86.4.1160; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Silva ID, 2006, CANCER EPIDEM BIOMAR, V15, P449, DOI 10.1158/1055-9965.EPI-05-0555; Tseng M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1781; Ursin G, 2006, NUTR CANCER, V56, P128, DOI 10.1207/s15327914nc5602_2; Vachon CM, 2000, CANCER EPIDEM BIOMAR, V9, P151; Walker K, 2009, CANCER RES, V69, P6490, DOI 10.1158/0008-5472.CAN-09-0280; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70943	10.1371/journal.pone.0070943	http://dx.doi.org/10.1371/journal.pone.0070943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951047	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700066
J	Pires, W; Wanner, SP; Lima, MRM; Fonseca, IAT; Fumega, U; Haibara, AS; Coimbra, CC; Lima, NRV				Pires, Washington; Wanner, Samuel P.; Lima, Milene R. M.; Fonseca, Ivana A. T.; Fumega, Ubirajara; Haibara, Andrea S.; Coimbra, Candido C.; Lima, Nilo R. V.			Physical Exercise Performance in Temperate and Warm Environments Is Decreased by an Impaired Arterial Baroreflex	PLOS ONE			English	Article							BLOOD-PRESSURE; SINOAORTIC DENERVATION; HEAT-LOSS; CARDIOVASCULAR ADJUSTMENTS; AORTIC BAROREFLEXES; FATIGUE; REFLEX; VASOPRESSIN; MODULATION; HUMANS	The present study aimed to investigate whether running performance in different environments is dependent on intact arterial baroreceptor reflexes. We also assessed the exercise-induced cardiovascular and thermoregulatory responses in animals lacking arterial baroafferent signals. To accomplish these goals, male Wistar rats were subjected to sinoaortic denervation (SAD) or sham surgery (SHAM) and had a catheter implanted into the ascending aorta to record arterial pressure and a telemetry sensor implanted in the abdominal cavity to record core temperature. After recovering from these surgeries, the animals were subjected to constant-or incremental-speed exercises performed until the voluntary interruption of effort under temperate (25 degrees C) and warm (35 degrees C) conditions. During the constant-speed exercises, the running time until the rats were fatigued was shorter in SAD rats in both environments. Although the core temperature was not significantly different between the groups, tail skin temperature was higher in SAD rats under temperate conditions. The denervated rats also displayed exaggerated increases in blood pressure and double product compared with the SHAM rats; in particular, in the warm environment, these exaggerated cardiovascular responses in the SAD rats persisted until they were fatigued. These SAD-mediated changes occurred in parallel with increased variability in the very low and low components of the systolic arterial pressure power spectrum. The running performance was also affected by SAD during the incremental-speed exercises, with the maximal speed attained being decreased by approximately 20% in both environments. Furthermore, at the maximal power output tolerated during the incremental exercises, the mean arterial pressure, heart rate and double product were exaggerated in the SAD relative to SHAM rats. In conclusion, the chronic absence of the arterial baroafferents accelerates exercise fatigue in temperate and warm environments. Our findings also suggest that an augmented cardiovascular strain accounted for the early interruption of exercise in the SAD rats.	[Pires, Washington; Wanner, Samuel P.; Lima, Milene R. M.; Fonseca, Ivana A. T.; Fumega, Ubirajara; Lima, Nilo R. V.] Univ Fed Minas Gerais, Exercise Physiol Lab, Dept Phys Educ, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Haibara, Andrea S.; Coimbra, Candido C.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Inst Biol Sci, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lima, NRV (corresponding author), Univ Fed Minas Gerais, Exercise Physiol Lab, Dept Phys Educ, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil.	nilo@ufmg.br	Wanner, Samuel P./F-9654-2012; Malheiros-Lima, Milene R/F-9323-2017	Wanner, Samuel P./0000-0002-4659-1032; Coimbra, Candido/0000-0001-8981-6724; Malheiros-Lima, Milene Rodrigues/0000-0001-5163-8424	Coordenadoria de Apoio ao Pessoal de Nivel Superior (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [PRI-00118-13]; Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais	Coordenadoria de Apoio ao Pessoal de Nivel Superior (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais	WP, MRML and IATF were recipients of fellowships from Coordenadoria de Apoio ao Pessoal de Nivel Superior (Brazil). The authors are indebted to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (PRI-00118-13), and Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez JA, 2012, LECT NOTES BUS INF P, V103, P340, DOI 10.1113/expphysiol.2011.058701; Balthazar CH, 2009, PHARMACOL BIOCHEM BE, V93, P465, DOI 10.1016/j.pbb.2009.06.009; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128; CERUTTI C, 1994, AM J PHYSIOL, V266, pH1993, DOI 10.1152/ajpheart.1994.266.5.H1993; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; COLLINS HL, 1993, J APPL PHYSIOL, V75, P114, DOI 10.1152/jappl.1993.75.1.114; Collins HL, 2001, CLIN EXP HYPERTENS, V23, P657, DOI 10.1081/CEH-100107395; Cruz JC, 2013, EXP PHYSIOL, V98, P386, DOI 10.1113/expphysiol.2012.065888; Dworkin BR, 2000, AM J PHYSIOL-REG I, V279, pR1922, DOI 10.1152/ajpregu.2000.279.5.R1922; Dworkin BR, 2000, AM J PHYSIOL-REG I, V279, pR1910, DOI 10.1152/ajpregu.2000.279.5.R1910; Fadel PJ, 2008, MED SCI SPORT EXER, V40, P2055, DOI 10.1249/MSS.0b013e318180bc80; Gallagher KM, 2006, EXP PHYSIOL, V91, P79, DOI 10.1113/expphysiol.2005.032110; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Julien C, 2003, AM J PHYSIOL-REG I, V285, pR834, DOI 10.1152/ajpregu.00102.2003; KOLLAI M, 1977, BRAIN RES, V138, P159, DOI 10.1016/0006-8993(77)90791-0; KOSHIYA N, 1994, AM J PHYSIOL, V267, pR508, DOI 10.1152/ajpregu.1994.267.2.R508; KREGEL KC, 1990, HYPERTENSION, V15, P497, DOI 10.1161/01.HYP.15.5.497; Krieger EM, 1998, BIOL RES, V31, P273; KRIEGER EM, 1964, CIRC RES, V15, P511, DOI 10.1161/01.RES.15.6.511; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lieberman DE, 2007, SPORTS MED, V37, P288, DOI 10.2165/00007256-200737040-00004; Lima MRM, 2013, NEUROSCI LETT, V537, P11, DOI 10.1016/j.neulet.2013.01.013; Marcora S, 2010, J APPL PHYSIOL, V108, P454, DOI 10.1152/japplphysiol.00976.2009a; Martinez-Nieves B, 2000, AM J PHYSIOL-REG I, V278, pR1634, DOI 10.1152/ajpregu.2000.278.6.R1634; Noakes TD, 2000, SCAND J MED SCI SPOR, V10, P123, DOI 10.1034/j.1600-0838.2000.010003123.x; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Nybo L, 2008, J APPL PHYSIOL, V104, P1543, DOI 10.1152/japplphysiol.90427.2008; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pires W, 2007, J PHYSIOL PHARMACOL, V58, P3; Pires W, 2010, BRAIN RES, V1366, P120, DOI 10.1016/j.brainres.2010.09.110; Potts JT, 2006, EXP PHYSIOL, V91, P59, DOI 10.1113/expphysiol.2005.032227; Radaelli A, 2006, AM J PHYSIOL-HEART C, V290, pH357, DOI 10.1152/ajpheart.00773.2005; Raven PB, 2008, MED SCI SPORT EXER, V40, P2033, DOI 10.1249/MSS.0b013e318180bc41; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; Sanz C, 2010, DIABETES METAB, V36, P346, DOI 10.1016/j.diabet.2010.06.001; SCHREIHOFER AM, 1994, AM J PHYSIOL, V266, pR1705, DOI 10.1152/ajpregu.1994.266.5.R1705; Shan ZZ, 2004, J CARDIOVASC PHARM, V43, P234, DOI 10.1097/00005344-200402000-00011; STEBBINS CL, 1993, AM J PHYSIOL, V264, pH1701, DOI 10.1152/ajpheart.1993.264.5.H1701; Straznicky NE, 2008, CURR HYPERTENS REP, V10, P440, DOI 10.1007/s11906-008-0083-1; WADE CE, 1984, MED SCI SPORT EXER, V16, P506, DOI 10.1249/00005768-198410000-00015; Waki H, 2006, EXP PHYSIOL, V91, P201, DOI 10.1113/expphysiol.2005.031716; Waki H, 2003, EXP PHYSIOL, V88, P517, DOI 10.1113/eph8802545; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004; Wanner SP, 2011, NEUROSCI LETT, V488, P210, DOI 10.1016/j.neulet.2010.11.031; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826	51	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72005	10.1371/journal.pone.0072005	http://dx.doi.org/10.1371/journal.pone.0072005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951278	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700129
J	Sak, B; Petrzelkova, KJ; Kvetonova, D; Mynarova, A; Shutt, KA; Pomajbikova, K; Kalousova, B; Modry, D; Benavides, J; Todd, A; Kvac, M				Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Mynarova, Anna; Shutt, Kathryn A.; Pomajbikova, Katerina; Kalousova, Barbora; Modry, David; Benavides, Julio; Todd, Angelique; Kvac, Martin			Long-Term Monitoring of Microsporidia, Cryptosporidium and Giardia Infections in Western Lowland Gorillas (Gorilla gorilla gorilla) at Different Stages of Habituation in Dzanga Sangha Protected Areas, Central African Republic	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; FREE-RANGING GORILLAS; ENTEROCYTOZOON-BIENEUSI; MOUNTAIN GORILLAS; MOLECULAR CHARACTERIZATION; GREAT APES; EPIDEMIOLOGY; GENOTYPES; PRIMATES; IDENTIFICATION	Background: Infectious diseases pose one of the greatest threats to endangered species, and a risk of gastrointestinal parasite transmission from humans to wildlife has always been considered as a major concern of tourism. Increased anthropogenic impact on primate populations may result in general changes in communities of their parasites, and also in a direct exchange of parasites between humans and primates. Aims: To evaluate the impact of close contact with humans on the occurrence of potentially zoonotic protists in great apes, we conducted a long-term monitoring of microsporidia, Cryptosporidium and Giardia infections in western lowland gorillas at different stages of the habituation process, humans, and other wildlife in Dzanga-Sangha Protected Areas in the Central African Republic. Results: We detected Encephalitozoon cuniculi genotypes I and II (7.5%), Enterocytozoon bieneusi genotype D and three novel genotypes (gorilla 1-3) (4.0%), Giardia intestinalis subgroup A II (2.0%) and Cryptosporidium bovis (0.5%) in gorillas, whereas in humans we found only G. intestinalis subgroup A II (2.1%). In other wild and domestic animals we recorded E. cuniculi genotypes I and II (2.1%), G. intestinalis assemblage E (0.5%) and C. muris TS03 (0.5%). Conclusion: Due to the non-specificity of E. cuniculi genotypes we conclude that detection of the exact source of E. cuniculi infection is problematic. As Giardia intestinalis was recorded primarily in gorilla groups with closer human contact, we suggest that human-gorilla transmission has occurred. We call attention to a potentially negative impact of habituation on selected pathogens which might occur as a result of the more frequent presence of humans in the vicinity of both gorillas under habituation and habituated gorillas, rather than as a consequence of the close contact with humans, which might be a more traditional assumption. We encourage to observe the sections concerning hygiene from the IUCN best practice guidelines for all sites where increased human-gorilla contact occurs.	[Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Modry, David; Kvac, Martin] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Petrzelkova, Klara J.] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Petrzelkova, Klara J.] Liberec Zoo, Liberec, Czech Republic; [Petrzelkova, Klara J.; Pomajbikova, Katerina; Kalousova, Barbora; Modry, David] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Pathol & Parasitol, Brno, Czech Republic; [Mynarova, Anna] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Shutt, Kathryn A.] Univ Durham, Dept Anthropol, Durham, England; [Kalousova, Barbora] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Modry, David] Univ Vet & Pharmaceut Sci, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Benavides, Julio] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Benavides, Julio] Univ Montpellier 2, CNRS Inst Sci Evolut Montpellier, Montpellier, France; [Todd, Angelique] WWF, Dzanga Sangha Protected Areas, Bangui, Cent Afr Republ; [Kvac, Martin] Univ South Bohemia, Fac Agr, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Veterinary Sciences Brno; University of South Bohemia Ceske Budejovice; Durham University; Masaryk University Brno; University of Veterinary Sciences Brno; Montana State University System; Montana State University Bozeman; Universite de Montpellier; World Wildlife Fund; University of South Bohemia Ceske Budejovice	Sak, B (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	casio@paru.cas.cz	Kvac, Martin/AAT-9533-2020; Sak, Bohumil/G-9262-2014; Jirků (Pomajbíková), Katerina/G-9858-2014; Kvac, Martin/G-7299-2014; Modry, David/G-7815-2014; Pafčo, Barbora/A-4395-2018; Petrzelkova, Klara Judita/G-7111-2014; Todd, Angelique/AAR-3087-2021	Jirků (Pomajbíková), Katerina/0000-0001-5411-6082; Kvac, Martin/0000-0003-0013-6090; Modry, David/0000-0001-9649-6255; Pafčo, Barbora/0000-0003-1395-0841; Todd, Angelique/0000-0002-9207-4925; Benavides, Julio/0000-0002-3920-9165	Grant Agency of the Czech Republic [206/09/0927]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was supported by the grant of Grant Agency of the Czech Republic (number 206/09/0927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Samra N, 2013, COMP IMMUNOL MICROB, V36, P295, DOI 10.1016/j.cimid.2012.07.004; Adams WM, 2003, WORLD DEV, V31, P177, DOI 10.1016/S0305-750X(02)00149-3; Ando Chieko, 2008, African Study Monographs Supplementary Issue, V39, P55; Ayinmode AB, 2010, PARASITOL RES, V107, P1019, DOI 10.1007/s00436-010-1972-1; Blom A, 2001, AFR J ECOL, V39, P98, DOI 10.1046/j.0141-6707.2000.00280.x; Brauer I, 2003, AGR ECOSYST ENVIRON, V98, P483, DOI 10.1016/S0167-8809(03)00107-5; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Butynski Thomas M., 1990, Primate Conservation, V11, P31; Butynski Thomas M., 1993, Oryx, V27, P214; Butynski Thomas M., 1998, P294, DOI 10.1002/9781444313598.ch12; CANNING EU, 1987, PARASITOL TODAY, V3, P267, DOI 10.1016/0169-4758(87)90103-7; Carroll R.W., 1986, Primate Conservation, P38; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Cipolletta C, 2003, INT J PRIMATOL, V24, P1207, DOI 10.1023/B:IJOP.0000005988.52177.45; Cranfield MR, 2008, AM J PRIMATOL, V70, P751, DOI 10.1002/ajp.20564; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Fayer R, 2005, J PARASITOL, V91, P624, DOI 10.1645/GE-3435; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Franzen C., 2008, OPEN PARASITOL J, V2, P1, DOI [10.2174/1874421400802010001, DOI 10.2174/1874421400802010001]; Gillespie TR, 2009, ECOHEALTH, V6, P557, DOI 10.1007/s10393-010-0283-4; Goldsmith ML, 2000, AM J PHYS ANTHROPOL, P161; Goldsmith ML, 2005, GORILLA J, V30, P14; Gomez MS, 2000, PARASITOL RES, V86, P318, DOI 10.1007/s004360050049; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Higham JES, 2011, TOURISM MANAGE, V32, P1290, DOI 10.1016/j.tourman.2010.12.006; Hofer H, 1998, ADV STUD BEHAV, V27, P405; Hudson Helen R., 1992, Gorilla Conservation News, V6, P8; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kamis A, 2006, RECENSEMENT POPULATI; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; Kotkova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060941; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Langhout MV, 2010, J ZOO WILDLIFE MED, V41, P210, DOI 10.1638/2009-0051R1.1; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Macfie EJ, 2010, BEST PRACTICE GUIDEL; Maikai BV, 2011, VET PARASITOL, V178, P241, DOI 10.1016/j.vetpar.2010.12.048; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; McNeeley J. A., 1990, CONSERVING WORLDS BI; Nizeyi JB, 2002, AM J TROP MED HYG, V66, P442, DOI 10.4269/ajtmh.2002.66.442; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; PERRINGS C, 1992, AMBIO, V21, P201; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Plumptre AJ, 2002, GORILLA BIOL MULTIDI, P414; Reetz J, 1993, Tierarztl Prax, V21, P429; Remis MJ, 2012, AM J PRIMATOL, V74, P602, DOI 10.1002/ajp.22012; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, VET PARASITOL, V168, P196, DOI 10.1016/j.vetpar.2009.11.012; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Salzer JS, 2007, J PARASITOL, V93, P439, DOI 10.1645/GE-970R1.1; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Thompson RCA, 2004, WORLD CL PARASITES, V8, P1; Travis DA, 2008, AM J PRIMATOL, V70, P745, DOI 10.1002/ajp.20566; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Walsh PD, 2008, IUCN 2012 IUCN RED L; Williamson EA, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P213; Williamson Elizabeth A., 2003, P25; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yanai T, 2000, VET PATHOL, V37, P472, DOI 10.1354/vp.37-5-472	82	60	62	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71840	10.1371/journal.pone.0071840	http://dx.doi.org/10.1371/journal.pone.0071840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951255	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323109700120
J	Westmuckett, AD; Siefert, JC; Tesiram, YA; Pinson, DM; Moore, KL				Westmuckett, Andrew D.; Siefert, Joseph C.; Tesiram, Yasvir A.; Pinson, David M.; Moore, Kevin L.			Salivary Gland Hypofunction in tyrosylprotein sulfotransferase-2 Knockout Mice Is Due to Primary Hypothyroidism	PLOS ONE			English	Article							TYROSINE O-SULFATION; GLYCOPROTEIN HORMONE-RECEPTORS; TYROSYLPROTEIN SULFOTRANSFERASE; POSTTRANSLATIONAL MODIFICATION; SUBMANDIBULAR-GLAND; MOLECULAR-CLONING; EXPRESSION; PROTEINS; ENZYME; SPERM	Background: Protein-tyrosine sulfation is a post-translational modification of an unknown number of secreted and membrane proteins mediated by two known Golgi tyrosylprotein sulfotransferases (TPST-1 and TPST-2). We reported that Tpst2-/- mice have mild-moderate primary hypothyroidism, whereas Tpst1-/- mice are euthyroid. While using magnetic resonance imaging (MRI) to look at the thyroid gland we noticed that the salivary glands in Tpst2-/- mice appeared smaller than in wild type mice. This prompted a detailed analysis to compare salivary gland structure and function in wild type, Tpst1-/-, and Tpst2 -/- mice. Methodology/Principal Findings: Quantitative MRI imaging documented that salivary glands in Tpst2-/- females were = 30% smaller than wild type or Tpst1-/- mice and that the granular convoluted tubules in Tpst2-/- submandibular glands were less prominent and were almost completely devoid of exocrine secretory granules compared to glands from wild type or Tpst1-/- mice. In addition, pilocarpine-induced salivary flow and salivary alpha-amylase activity in Tpst2-/- mice of both sexes was substantially lower than in wild type and Tpst1-/- mice. Anti-sulfotyrosine Western blots of salivary gland extracts and saliva showed no differences between wild type, Tpst1-/-, and Tpst2-/- mice, suggesting that the salivary gland hypofunction is due to factor(s) extrinsic to the salivary glands. Finally, we found that all indicators of hypothyroidism (serum T4, body weight) and salivary gland hypofunction (salivary flow, salivary alpha-amylase activity, histological changes) were restored to normal or near normal by thyroid hormone supplementation. Conclusions/Significance: Our findings conclusively demonstrate that low body weight and salivary gland hypofunction in Tpst2-/- mice is due solely to primary hypothyroidism.	[Westmuckett, Andrew D.; Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Siefert, Joseph C.; Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Tesiram, Yasvir A.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Pinson, David M.] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Queensland; University of Illinois System; University of Illinois Peoria; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Westmuckett, AD (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	Andrew-Westmuckett@omrf.org	Tesiram, Yasvir A/B-7332-2016	Tesiram, Yasvir A/0000-0003-3008-2927; Siefert, Joseph/0000-0001-5584-8672	National Institute of Health [HD056022]; Oklahoma Medical Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Medical Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Health Grant HD056022 (to K. L. M.) and institutional funds from the Oklahoma Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BETTELHEIM FR, 1954, J AM CHEM SOC, V76, P2838, DOI 10.1021/ja01639a073; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Cabras T, 2007, J PROTEOME RES, V6, P2472, DOI 10.1021/pr0700706; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Han SW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2157; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; HORTIN G, 1986, J BIOL CHEM, V261, P5827; HUTTNER WB, 1982, NATURE, V299, P273, DOI 10.1038/299273a0; Huttner WB, 1988, MODERN CELL BIOL, V6, P97; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; JUNQUEIRA LC, 1949, J CELL COMPAR PHYSL, V34, P129, DOI 10.1002/jcp.1030340109; Kasinathan C, 2007, INT J BIOL SCI, V3, P237; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Lacassacne A, 1940, CR SOC BIOL, V133, P180; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Mishiro E, 2006, J BIOCHEM, V140, P731, DOI 10.1093/jb/mvj206; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; MUHLER J C, 1956, J Dent Res, V35, P922; MUHLER JC, 1956, P SOC EXP BIOL MED, V93, P328; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; Sasaki N, 2007, MOL ENDOCRINOL, V21, P1713, DOI 10.1210/me.2007-0040; SHAFER WG, 1958, P SOC EXP BIOL MED, V98, P245, DOI 10.3181/00379727-98-24004; SHAFER WILLIAM G., 1960, ANN NEW YORK ACAD SCI, V85, P215, DOI 10.1111/j.1749-6632.1960.tb49960.x; Sherry DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039702; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977	34	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71822	10.1371/journal.pone.0071822	http://dx.doi.org/10.1371/journal.pone.0071822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951251	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700118
J	Lee, AR; Pechenino, AS; Dong, H; Hammock, BD; Knowlton, AA				Lee, Alison R.; Pechenino, Angela S.; Dong, Hua; Hammock, Bruce D.; Knowlton, Anne A.			Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)	PLOS ONE			English	Article								Inflammation is a key element in many cardiovascular diseases. Both estrogen loss, caused by menopause, and aging have inflammatory consequences. Epoxyeicosatrienoic acids (EETs) are anti-inflammatory molecules synthesized by various cytochrome P450 (Cyp) enzymes from arachidonic acid. EETs are in the third (Cytochrome P450) pathway of arachindonic acid metabolism, others being cyclooxygenases and lipoxygenases. We hypothesized that aging and estrogen loss would reduce levels of anti-inflammatory EETs. Adult (6 mo) and aged (22 mo) ovariectomized rats with (OP) and without (Ovx) 17-there exists-estradiol replacement were used in this study. Mass spectrometry was used to measure levels of EETs and their metabolites, dihydroxyeicosatrienoic acids (DHETs). Levels of Cyp2C2, Cyp2C6, and Cyp2J2, the principal Cyps responsible for EETs synthesis, as well as soluble epoxide hydrolase (sEH), which metabolizes EETS to DHETs, were determined via western blot. Overall Cyp levels decreased with age, though Cyp2C6 increased in the liver. sEH was increased in the kidney with estrogen replacement. Despite protein changes, no differences were measured in plasma or aortic tissue levels of EETs. However, plasma 14,15 DHET was increased in aged Ovx, and 5,6 DHET in adult OP. In conclusion neither aging nor estrogen loss decreased the anti-inflammatory EETs in the cardiovascular system.	[Lee, Alison R.; Pechenino, Angela S.; Knowlton, Anne A.] Univ Calif Davis, Dept Med, Div Cardiovasc, Davis, CA 95616 USA; [Knowlton, Anne A.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entymol, Davis, CA 95616 USA; [Knowlton, Anne A.] Northern Calif VA, Dept Vet Affairs, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Knowlton, AA (corresponding author), Univ Calif Davis, Dept Med, Div Cardiovasc, Davis, CA 95616 USA.	aaknowlton@ucdavis.edu			U.S. Department of Veterans' Affairs [5101BX000839]; Office of Research and Development; Biomedical Laboratory Research Program; NIH [T32 86350]; HHMI-MIG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	U.S. Department of Veterans' Affairs(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI-MIG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a Merit Award(5101BX000839) from the U.S. Department of Veterans' Affairs, Office of Research and Development, Biomedical Laboratory Research Program (AAK), NIH T32 86350(ARL and ASP) and HHMI-MIG (ARL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 2002, ARTERIOSCL THROM VAS, V22, P1859, DOI 10.1161/01.ATV.0000042202.42136.D0; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Douglas G, 2006, J PHYSIOL-LONDON, V571, P477, DOI 10.1113/jphysiol.2005.104125; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Fleming I, 2007, TRENDS PHARMACOL SCI, V28, P448, DOI 10.1016/j.tips.2007.08.002; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601, DOI 10.1097/FJC.0b013e318159cbe3; Georgiadou P, 2009, ADV CLIN CHEM, V47, P59, DOI 10.1016/S0065-2423(09)47003-3; Gross GJ, 2009, AM J PHYSIOL-HEART C, V297, pH47, DOI 10.1152/ajpheart.01084.2008; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; KARARA A, 1991, J BIOL CHEM, V266, P7561; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Kozak W, 2003, EXP BIOL MED, V228, P786, DOI 10.1177/15353702-0322807-03; LAETHEM RM, 1992, MOL PHARMACOL, V42, P958; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mahn K, 2005, FASEB J; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Nagarajan S, 2008, J NUTR, V138, P332, DOI 10.1093/jn/138.2.332; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Ogborn MR, 2010, EXP BIOL MED, V235, P1315, DOI 10.1258/ebm.2010.010059; Oparil S, 1997, CIRCULATION, V95, P1301; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Pechenino AS, 2011, PHYSIOL GENOMICS, V43, P1065, DOI 10.1152/physiolgenomics.00228.2010; Pfister SL, 2011, HYPERTENSION, V57, P825, DOI 10.1161/HYPERTENSIONAHA.110.168716; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Register TC, 2005, J CLIN ENDOCR METAB, V90, P1734, DOI 10.1210/jc.2004-0939; Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099; Ross JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038425; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; Smith PJW, 2000, CIRCULATION, V102, P2983; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Stice JP, 2009, ENDOCRINOLOGY, V150, P212, DOI 10.1210/en.2008-0640; Stice JP, 2008, FUTURE CARDIOLOGY, P151; Sunday L, 2007, AM J PHYSIOL-HEART C, V292, pH2333, DOI 10.1152/ajpheart.01057.2006; Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725; Ulu A, 2008, J CARDIOVASCULAR PHA, V52; Vecera R, 2011, BIOPHARM DRUG DISPOS, V32, P482, DOI 10.1002/bdd.774; Virdis A, 2010, PFLUG ARCH EUR J PHY, V459, P1015, DOI 10.1007/s00424-009-0783-7; Voss MR, 2003, AM J PHYSIOL-HEART C, V285, pH687, DOI 10.1152/ajpheart.01000.2002; VOSS MR, 2005, AM J PHYSIOL-HEART C, pH687; Walsh BA, 1999, ARTERIOSCL THROM VAS, V19, P840, DOI 10.1161/01.ATV.19.4.840; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Yan GJ, 2008, CARDIOVASC RES, V78, P308, DOI 10.1093/cvr/cvn006; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244; Zheng XP, 2011, INT J CARDIOL, V151, P290, DOI 10.1016/j.ijcard.2010.05.059; Zhu P, 2011, J CHROMATOGR B, V879, P2487, DOI 10.1016/j.jchromb.2011.06.042; Zivkovic AM, 2012, METABOLOMICS, V8, P1102, DOI 10.1007/s11306-012-0417-5	70	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70719	10.1371/journal.pone.0070719	http://dx.doi.org/10.1371/journal.pone.0070719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967089	Green Published, Green Submitted, gold			2022-12-27	WOS:000323115800014
J	Lovf, M; Thomassen, GOS; Mertens, F; Cerveira, N; Teixeira, MR; Lothe, RA; Skotheim, RI				Lovf, Marthe; Thomassen, Gard O. S.; Mertens, Fredrik; Cerveira, Nuno; Teixeira, Manuel R.; Lothe, Ragnhild A.; Skotheim, Rolf I.			Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray	PLOS ONE			English	Article							MYXOID LIPOSARCOMA; CANCER; TRANSCRIPTS; IMPACT; TUMORS; EWS	Sarcomas are relatively rare malignancies and include a large number of histological subgroups. Based on morphology alone, the differential diagnoses of sarcoma subtypes can be challenging, but the identification of specific fusion genes aids correct diagnostication. The presence of individual fusion products are routinely investigated in Pathology labs. However, the methods used are time-consuming and based on prior knowledge about the expected fusion gene and often the most likely break-point. In this study, 16 sarcoma samples, representing seven different sarcoma subtypes with known fusion gene status from a diagnostic setting, were investigated using a fusion gene microarray. The microarray was designed to detect all possible exon-exon breakpoints between all known fusion genes in a single analysis. An automated scoring of the microarray data from the 38 known sarcoma-related fusion genes identified the correct fusion gene among the top-three hits in 11 of the samples. The analytical sensitivity may be further optimised, but we conclude that a sarcoma-fusion gene microarray is suitable as a time-saving screening tool to identify the majority of the correct fusion genes.	[Lovf, Marthe; Thomassen, Gard O. S.; Lothe, Ragnhild A.; Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Lovf, Marthe; Thomassen, Gard O. S.; Teixeira, Manuel R.; Lothe, Ragnhild A.; Skotheim, Rolf I.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Lovf, Marthe; Lothe, Ragnhild A.] Univ Oslo, Dept Biosci, Oslo, Norway; [Mertens, Fredrik] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Cerveira, Nuno; Teixeira, Manuel R.] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4100 Oporto, Portugal	University of Oslo; University of Oslo; University of Oslo; Lund University; Skane University Hospital; Portuguese Institute of Oncology; Universidade do Porto	Skotheim, RI (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway.	rolf.i.skotheim@rr-research.no	Teixeira, Manuel António Rodrigues/E-4885-2011; Skotheim, Rolf I./H-6192-2017; Teixeira, Manuel AC/AAZ-7251-2020	Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Skotheim, Rolf I./0000-0002-5609-4048; Teixeira, Manuel AC/0000-0002-1959-0624; Thomassen, Gard Olav Sundby/0000-0002-6979-8474; Cerveira, Nuno/0000-0001-5098-3840; Mertens, Fredrik/0000-0002-6278-5232; Lothe, Ragnhild A./0000-0002-1693-1032	Molecular Life Science, University of Oslo; Norwegian Cancer Society [PR-2006-0442, PR-2007-0166]	Molecular Life Science, University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society)	ML is supported as a PhD student by Molecular Life Science, University of Oslo and the study is supported by the Norwegian Cancer Society (PR-2006-0442, RAL; PR-2007-0166, RIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2001, CLIN CANCER RES, V7, P3977; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cancer Registry of Norway, 2011, CANC NORW 2009 CANC; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Lazar Alexander J F, 2007, Curr Oncol Rep, V9, P309, DOI 10.1007/s11912-007-0038-8; Lovf M, 2011, GENE CHROMOSOME CANC, V50, P348, DOI 10.1002/gcc.20860; Luo W, 2012, EMBO MOL MED, V4, P453, DOI 10.1002/emmm.201200225; Meier VS, 1998, DIAGN MOL PATHOL, V7, P29, DOI 10.1097/00019606-199802000-00006; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; MITELMAN F, 2009, MITELMAN DATABASE CH, P2093; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Panagopoulos I, 2001, GENE CHROMOSOME CANC, V31, P362, DOI 10.1002/gcc.1155; Panagopoulos I, 2001, INT J CANCER, V93, P769, DOI 10.1002/ijc.1415; Panagopoulos I, 2002, GENE CHROMOSOME CANC, V35, P340, DOI 10.1002/gcc.10127; Panagopoulos I, 1996, ONCOGENE, V12, P489; Panagopoulos L, 2004, GENE CHROMOSOME CANC, V40, P218, DOI 10.1002/gcc.20037; Skotheim RI, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-5; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Toguchida J, 2009, CANCER SCI, V100, P1573, DOI 10.1111/j.1349-7006.2009.01232.x; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70649	10.1371/journal.pone.0070649	http://dx.doi.org/10.1371/journal.pone.0070649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967081	gold, Green Published, Green Submitted			2022-12-27	WOS:000323115800010
J	Arends, I; Bultmann, U; van Rhenen, W; Groen, H; van der Klink, JJL				Arends, Iris; Bultmann, Ute; van Rhenen, Willem; Groen, Henk; van der Klink, Jac J. L.			Economic Evaluation of a Problem Solving Intervention to Prevent Recurrent Sickness Absence in Workers with Common Mental Disorders	PLOS ONE			English	Article							COST-EFFECTIVENESS; LISTED EMPLOYEES; ACTIVATING INTERVENTION; WORKPLACE INTERVENTION; HEALTH; DEPRESSION; IMPACT; PERFORMANCE; DISABILITY; RECOVERY	Objectives: Workers with common mental disorders (CMDs) frequently experience recurrent sickness absence but scientifically evaluated interventions to prevent recurrences are lacking. The objectives of this study are to evaluate the cost-effectiveness and cost-benefit of a problem solving intervention aimed at preventing recurrent sickness absence in workers with CMDs compared to care as usual. Methods: An economic evaluation was conducted alongside a cluster-randomised controlled trial with 12 months follow-up. Treatment providers were randomised to either a 2-day training in the SHARP-at work intervention, i.e. a problem solving intervention, or care as usual. Effect outcomes were the incidence of recurrent sickness absence and time to recurrent sickness absence. Self-reported health care utilisation was measured by questionnaires. A cost-effectiveness analysis (CEA) from the societal perspective and a cost-benefit analysis (CBA) from the employer's perspective were conducted. Results: The CEA showed that the SHARP-at work intervention was more effective but also more expensive than care as usual. The CBA revealed that employer's occupational health care costs were significantly higher in the intervention group compared to care as usual. Overall, the SHARP-at work intervention showed no economic benefit compared to care as usual. Conclusions: As implementation of the SHARP-at work intervention might require additional investments, health care policy makers need to decide if these investments are worthwhile considering the results that can be accomplished in reducing recurrent sickness absence.	[Arends, Iris; Bultmann, Ute; van der Klink, Jac J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [van Rhenen, Willem] Business Univ Nyenrode, Ctr Human Resource Org & Management Effectiveness, Breukelen, Netherlands; [van Rhenen, Willem] Occupat Hlth Serv, Utrecht, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	Arends, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands.	i.arends@umcg.nl	van Rhenen, Willem/AAS-9406-2021; Groen, Henk/B-2163-2013	Groen, Henk/0000-0002-6629-318X; Bultmann, Ute/0000-0001-9589-9220	Stichting Instituut GAK, a Dutch funding agency	Stichting Instituut GAK, a Dutch funding agency	This project was supported by a grant from Stichting Instituut GAK, a Dutch funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Arends I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-132; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Brouwers EPM, 2007, EUR J PUBLIC HEALTH, V17, P214, DOI 10.1093/eurpub/ckl099; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; Glozier N, 2002, OCCUP ENVIRON MED, V59, P714, DOI 10.1136/oem.59.10.714; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hees HL, 2013, OCCUP ENVIRON MED, V70, P252, DOI 10.1136/oemed-2012-100789; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; Lerner D, 2012, J OCCUP ENVIRON MED, V54, P128, DOI 10.1097/JOM.0b013e31824409d8; Lerner D, 2010, AM J HEALTH PROMOT, V24, P205, DOI 10.4278/ajhp.090313-QUAN-103; Noordik E, 2011, DISABIL REHABIL, V33, P1625, DOI 10.3109/09638288.2010.541547; OECD, 2008, PHOT CHEM WAT DIR PH, V316, P1; OECD, 2012, SICK JOB MYTHS REAL; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebergen DS, 2009, J OCCUP ENVIRON MED, V51, P313, DOI 10.1097/JOM.0b013e3181990d8e; Stansfeld SA, 2011, OCCUP ENVIRON MED, V68, P408, DOI 10.1136/oem.2010.056994; Tompa E, 2009, J OCCUP ENVIRON MED, V51, P1004, DOI 10.1097/JOM.0b013e3181b34f60; Uegaki K, 2010, J AFFECT DISORDERS, V120, P177, DOI 10.1016/j.jad.2009.04.012; van der Klink JJL, 2003, OCCUP ENVIRON MED, V60, P429, DOI 10.1136/oem.60.6.429; Van der Klink JJL, 2007, RICHTLIJN HANDELEN B; van Oostrom SH, 2010, OCCUP ENVIRON MED, V67, P596, DOI 10.1136/oem.2009.050849; van Oostrom SH, 2010, OCCUP ENVIRON MED, V67, P603, DOI 10.1136/oem.2009.051979; VANDERKLINK J, 2000, GUIDELINE MANAGEMENT; Virtanen M, 2011, OCCUP ENVIRON MED, V68, P791, DOI 10.1136/oem.2010.061101; Wang JL, 2006, AM J IND MED, V49, P514, DOI 10.1002/ajim.20319; Willert MV, 2011, SCAND J WORK ENV HEA, V37, P186, DOI 10.5271/sjweh.3130; *Z IND, 2006, G STAND	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71937	10.1371/journal.pone.0071937	http://dx.doi.org/10.1371/journal.pone.0071937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951270	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300172
J	Saavedra, YGL; Zhang, JB; Seidah, NG				Saavedra, Yascara Grisel Luna; Zhang, Jianbing; Seidah, Nabil G.			PCSK9 Prosegment Chimera as Novel Inhibitors of LDLR Degradation	PLOS ONE			English	Article							PROPROTEIN CONVERTASES; RICH DOMAIN; CHOLESTEROL; RECEPTOR; HYPERCHOLESTEROLEMIA; ACTIVATION; EXPRESSION; MUTATIONS; SECRETION; CLEAVAGE	The proprotein convertase PCSK9, a target for the treatment of hypercholesterolemia, is a negative regulator of the LDL receptor (LDLR) leading to its degradation in endosomes/lysosomes and up-regulation of plasma LDL-cholesterol levels. The proprotein convertases, a family of nine secretory serine proteases, are first synthesized as inactive zymogens. Except for PCSK9, all other convertases are activated following the autocatalytic excision of their inhibitory N-terminal prosegment. PCSK9 is unique since the mature enzyme exhibits a cleaved prosegment complexed with the catalytic subunit and has no protease activity towards other substrates. Similar to other convertases, we hypothesized that the in trans presence of the PCSK9 prosegment would interfere with PCSK9's activity on the LDLR. Since the prosegment cannot be secreted alone, we engineered a chimeric protein using the Fc-region of human IgG1 fused to the PCSK9 prosegment. The expression of such Fcpro-fusion protein in HEK293 and HepG2 cells resulted in a secreted protein that binds PCSK9 and markedly inhibits its activity on the LDLR. This was observed by either intracellular co-expression of PCSK9 and Fcpro or by an extracellular in vitro co-incubation of Fcpro with PCSK9. Structure-function studies revealed that the inhibitory function of Fcpro does not require the acidic N-terminal stretch (residues 31-58) nor the C-terminal Gln(152) of the prosegment. Fcpro likely interacts with the prosegment and/orcatalytic subunit of the prosegment PCSK9 complex thereby allosterically modulating its function. Our data suggest a novel strategic approach for the design and isolation of PCSK9 inhibitors.	[Saavedra, Yascara Grisel Luna; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ, Canada; [Zhang, Jianbing] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Research Council Canada	Seidah, NG (corresponding author), Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	CIHR [MOP-102741, CTP-82946]; Strauss Foundation; Canada Chair [216684]	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by CIHR grants MOP-102741 and CTP-82946, a Strauss Foundation grant, and a Canada Chair # 216684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Lo KM, 1998, PROTEIN ENG, V11, P495, DOI 10.1093/protein/11.6.495; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, CURR PHARM DESIGN, V19, P3161; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72113	10.1371/journal.pone.0072113	http://dx.doi.org/10.1371/journal.pone.0072113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951290	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300179
J	Trajcevski, KE; O'Neill, HM; Wang, DC; Thomas, MM; Al-Sajee, D; Steinberg, GR; Ceddia, RB; Hawke, TJ				Trajcevski, Karin E.; O'Neill, Hayley M.; Wang, David C.; Thomas, Melissa M.; Al-Sajee, Dhuha; Steinberg, Gregory R.; Ceddia, Rolando B.; Hawke, Thomas J.			Enhanced Lipid Oxidation and Maintenance of Muscle Insulin Sensitivity Despite Glucose Intolerance in a Diet-Induced Obesity Mouse Model	PLOS ONE			English	Article							HIGH-FAT DIET; HUMAN SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; ACID OXIDATION; WEIGHT-LOSS; RESISTANCE; INFLAMMATION; EXPRESSION; INCREASES	Background: Diet-induced obesity is a rising health concern which can lead to the development of glucose intolerance and muscle insulin resistance and, ultimately, type II diabetes mellitus. This research investigates the associations between glucose intolerance or muscle insulin resistance and tissue specific changes during the progression of diet-induced obesity. Methodology: C57BL/6J mice were fed a normal or high-fat diet (HFD; 60% kcal fat) for 3 or 8 weeks. Disease progression was monitored by measurements of body/tissue mass changes, glucose and insulin tolerance tests, and ex vivo glucose uptake in intact muscles. Lipid metabolism was analyzed using metabolic chambers and ex vivo palmitate assays in intact muscles. Skeletal muscle, liver and adipose tissues were analyzed for changes in inflammatory gene expression. Plasma was analyzed for insulin levels and inflammatory proteins. Histological techniques were used on muscle and liver cryosections to assess metabolic and morphological changes. Principal Findings/Conclusions: A rapid shift in whole body metabolism towards lipids was observed with HFD. Following 3 weeks of HFD, elevated total lipid oxidation and an oxidative fiber type shift had occurred in the skeletal muscle, which we propose was responsible for delaying intramyocellular lipid accumulation and maintaining muscle's insulin sensitivity. Glucose intolerance was present after three weeks of HFD and was associated with an enlarged adipose tissue depot, adipose tissue inflammation and excess hepatic lipids, but not hepatic inflammation. Furthermore, HFD did not significantly increase systemic or muscle inflammation after 3 or 8 weeks of HFD suggesting that early diet-induced obesity does not cause inflammation throughout the whole body. Overall these findings indicate skeletal muscle did not contribute to the development of HFD-induced impairments in whole-body glucose tolerance following 3 weeks of HFD.	[Trajcevski, Karin E.; Wang, David C.; Thomas, Melissa M.; Al-Sajee, Dhuha; Hawke, Thomas J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [O'Neill, Hayley M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Ceddia, Rolando B.; Hawke, Thomas J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada	McMaster University; McMaster University; York University - Canada	Hawke, TJ (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	hawke@mcmaster.ca		O'Neill, Hayley/0000-0001-6812-6580; Steinberg, Gregory/0000-0001-5425-8275; Wang, David Chenhan/0000-0002-4754-9493; Hawke, Thomas/0000-0003-4974-4820	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation/Ontario Ministry of Research Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation/Ontario Ministry of Research Innovation	This work was funded by grants to TJH from the Natural Sciences and Engineering Research Council of Canada and the Canadian Foundation for Innovation/Ontario Ministry of Research Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chanseaume E, 2007, OBESITY, V15, P50, DOI 10.1038/oby.2007.511; CRAIG BW, 1989, MECH AGEING DEV, V49, P147, DOI 10.1016/0047-6374(89)90098-5; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Duncan GE, 2006, ARCH PEDIAT ADOL MED, V160, P523, DOI 10.1001/archpedi.160.5.523; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Fenicchia LM, 2004, METABOLISM, V53, P284, DOI 10.1016/j.metabol.2003.10.007; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hoeks J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027274; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Houmard JA, 2002, DIABETES, V51, P2959, DOI 10.2337/diabetes.51.10.2959; Kewalramani G, 2010, CURR OPIN CLIN NUTR, V13, P382, DOI 10.1097/MCO.0b013e32833aabd9; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LaPensee CR, 2008, ENDOCRINOLOGY, V149, P5415, DOI 10.1210/en.2008-0549; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li CY, 2009, DIABETES CARE, V32, P342, DOI 10.2337/dc08-1128; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Ohinmaa A, 2004, CAN J DIABETES, V28; Peters SJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE980, DOI 10.1152/ajpendo.1998.275.6.E980; Phielix E, 2012, DIABETES, V61, P2472, DOI 10.2337/db11-1832; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schrauwen P, 2000, DIABETES, V49, P640, DOI 10.2337/diabetes.49.4.640; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Slentz CA, 2009, OBESITY, V17, pS27, DOI 10.1038/oby.2009.385; So M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-99; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wood RJ, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/268197; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010	54	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71747	10.1371/journal.pone.0071747	http://dx.doi.org/10.1371/journal.pone.0071747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951235	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300152
J	Zeitler, B; Diaz, AH; Dangel, A; Thellmann, M; Meyer, H; Sattler, M; Lindermayr, C				Zeitler, Benjamin; Diaz, Areli Herrera; Dangel, Alexandra; Thellmann, Martha; Meyer, Helge; Sattler, Michael; Lindermayr, Christian			De-Novo Design of Antimicrobial Peptides for Plant Protection	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CATIONIC PEPTIDE; PHYTOPATHOGENIC BACTERIA; BIOLOGICAL-ACTIVITY; DISEASE CONTROL; PORE FORMATION; MAGAININ-II; CECROPIN-B; RESISTANCE; EXPRESSION	This work describes the de-novo design of peptides that inhibit a broad range of plant pathogens. Four structurally different groups of peptides were developed that differ in size and position of their charged and hydrophobic clusters and were assayed for their ability to inhibit bacterial growth and fungal spore germination. Several peptides are highly active at concentrations between 0,1 and 1 mg/ml against plant pathogenic bacteria, such as Pseudomonas syringae, Pectobacterium carotovorum, and Xanthomonas vesicatoria. Importantly, no hemolytic activity could be detected for these peptides at concentrations up to 200 mg/ml. Moreover, the peptides are also active after spraying on the plant surface demonstrating a possible way of application. In sum, our designed peptides represent new antimicrobial agents and with the increasing demand for antimicrobial compounds for production of "healthy" food, these peptides might serve as templates for novel antibacterial and antifungal agents.	[Zeitler, Benjamin; Diaz, Areli Herrera; Dangel, Alexandra; Thellmann, Martha; Lindermayr, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Dept Environm Sci, Munich, Germany; [Meyer, Helge; Sattler, Michael] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biol Struct, Munich, Germany; [Meyer, Helge; Sattler, Michael] Tech Univ Munich, Dept Chem, Chair Biomol NMR, Munich Ctr Integrated Prot Sci, Garching, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lindermayr, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, Dept Environm Sci, Munich, Germany.	lindermayr@helmholtz-muenchen.de	Zhou, Man/S-4256-2016; Dangel, Alexandra/Y-8811-2019; Sattler, Michael/A-2407-2012; Lindermayr, Christian/M-7338-2014	Dangel, Alexandra/0000-0001-6737-5681; Sattler, Michael/0000-0002-1594-0527; Lindermayr, Christian/0000-0002-9343-4996; Meyer, Niels Helge/0000-0003-1018-4942	Deutsche Forschungsgemeinschaft [SPP 1110 Innate Immunity]; Bayerisches Staatsministerium fur Umwelt, Gesundheit und Verbraucherschutz.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerisches Staatsministerium fur Umwelt, Gesundheit und Verbraucherschutz.	This work was supported by Deutsche Forschungsgemeinschaft (SPP 1110 Innate Immunity) and by Bayerisches Staatsministerium fur Umwelt, Gesundheit und Verbraucherschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Alan AR, 2002, MOL PLANT MICROBE IN, V15, P701, DOI 10.1094/MPMI.2002.15.7.701; Ali GS, 2000, MOL PLANT MICROBE IN, V13, P847, DOI 10.1094/MPMI.2000.13.8.847; ALVAREZBRAVO J, 1994, BIOCHEM J, V302, P535, DOI 10.1042/bj3020535; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; Avrahami D, 2001, BIOCHEMISTRY-US, V40, P12591, DOI 10.1021/bi0105330; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2009, APPL ENVIRON MICROB, V75, P5563, DOI 10.1128/AEM.00711-09; Bahnweg G, 1998, ANAL BIOCHEM, V262, P79, DOI 10.1006/abio.1998.2769; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; Bolintineanu DS, 2011, PEPTIDES, V32, P188, DOI 10.1016/j.peptides.2010.10.006; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bucki R, 2004, ANTIMICROB AGENTS CH, V48, P1526, DOI 10.1128/AAC.48.5.1526-1533.2004; Cavallarin L, 1998, MOL PLANT MICROBE IN, V11, P218, DOI 10.1094/MPMI.1998.11.3.218; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Dalmau M., 2002, International Microbiology, V5, P73, DOI 10.1007/s10123-002-0063-2; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Friedrich CL, 2001, J BIOL CHEM, V276, P24015, DOI 10.1074/jbc.M009691200; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Guell I, 2011, APPL ENVIRON MICROB, V77, P2667, DOI 10.1128/AEM.02759-10; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Jones RW, 2002, PHYTOPATHOLOGY, V92, P33, DOI 10.1094/PHYTO.2002.92.1.33; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Lopez-Garcia B, 2000, MOL PLANT MICROBE IN, V13, P837, DOI 10.1094/MPMI.2000.13.8.837; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Martinez-de-Anda A, 2010, POULTRY SCI, V89, P1622, DOI 10.3382/ps.2010-00763; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2008, CHEM BIODIVERS, V5, P1225, DOI 10.1002/cbdv.200890111; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Oard SV, 2006, PLANT CELL REP, V25, P561, DOI 10.1007/s00299-005-0102-5; Olbrich M, 2010, ENVIRON POLLUT, V158, P1043, DOI 10.1016/j.envpol.2009.09.020; Ostberg N, 2005, PEPTIDES, V26, P197, DOI 10.1016/j.peptides.2004.09.020; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Osusky M, 2004, TRANSGENIC RES, V13, P181, DOI 10.1023/B:TRAG.0000026076.72779.60; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Postollec F, 2011, FOOD MICROBIOL, V28, P848, DOI 10.1016/j.fm.2011.02.008; Pusey PL, 2008, PHYTOPATHOLOGY, V98, P1136, DOI 10.1094/PHYTO-98-10-1136; Quezada T, 2000, COMP BIOCHEM PHYS C, V125, P265, DOI 10.1016/S0742-8413(99)00107-3; Rezzonico F, 2009, ANTIMICROB AGENTS CH, V53, P3173, DOI 10.1128/AAC.00036-09; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; Stipani V, 2001, BIOPHYS J, V81, P3332, DOI 10.1016/S0006-3495(01)75966-8; Stockwell VO, 2010, PHYTOPATHOLOGY, V100, P1330, DOI 10.1094/PHYTO-03-10-0097; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wiedemann I, 2004, J BACTERIOL, V186, P3259, DOI 10.1128/JB.186.10.3259-3261.2004; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; Yevtushenko DP, 2005, J EXP BOT, V56, P1685, DOI 10.1093/jxb/eri165; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024677	83	38	43	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71687	10.1371/journal.pone.0071687	http://dx.doi.org/10.1371/journal.pone.0071687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951222	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300143
J	Brodziak, F; Meharg, C; Blaut, M; Loh, G				Brodziak, Frances; Meharg, Caroline; Blaut, Michael; Loh, Gunnar			Differences in Mucosal Gene Expression in the Colon of Two Inbred Mouse Strains after Colonization with Commensal Gut Bacteria	PLOS ONE			English	Article							MICROBIOTA COMPOSITION; INTESTINAL MICROBIOTA; PROFILES; IMPACT; A(2); CD14; IBD	The host genotype has been proposed to contribute to individually composed bacterial communities in the gut. To provide deeper insight into interactions between gut bacteria and host, we associated germ-free C3H and C57BL/10 mice with intestinal bacteria from a C57BL/10 donor mouse. Analysis of microbiota similarity between the animals with denaturing gradient gel electrophoresis revealed the development of a mouse strain-specific microbiota. Microarray-based gene expression analysis in the colonic mucosa identified 202 genes whose expression differed significantly by a factor of more than 2. Application of bioinformatics tools demonstrated that functional terms including signaling/secretion, lipid degradation/catabolism, guanine nucleotide/guanylate binding and immune response were significantly enriched in differentially expressed genes. We had a closer look at the 56 genes with expression differences of more than 4 and observed a higher expression in C57BL/10 mice of the genes coding for Tlr1 and Ang4 which are involved in the recognition and response to gut bacteria. A higher expression of Pla2g2a was detected in C3H mice. In addition, a number of interferon-inducible genes were higher expressed in C3H than in C57BL/10 mice including Gbp1, Mal, Oasl2, Ifi202b, Rtp4, Ly6g6c, Ifi27l2a, Usp18, Ifit1, Ifi44, and Ly6g indicating that interferons may play an essential role in microbiota regulation. However, genes coding for interferons, their receptors, factors involved in interferon expression regulation or signaling pathways were not differentially expressed between the two mouse strains. Taken together, our study confirms that the host genotype is involved in the establishment of host-specific bacterial communities in the gut. Based on expression differences after colonization with the same bacterial inoculum, we propose that Pla2g2a and interferon-dependent genes may contribute to this phenomenon.	[Brodziak, Frances; Blaut, Michael; Loh, Gunnar] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany; [Meharg, Caroline] Queens Univ, Inst Global Food Secur, Belfast, Antrim, North Ireland	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Queens University Belfast	Loh, G (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany.	loh@dife.de		Meharg, Caroline/0000-0003-0573-9528; Blaut, Michael/0000-0002-6628-2907	German Research Foundation [LO1184/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (LO1184/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blaut M, 2011, CURR TOP MICROBIOL I; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; de Buhr MF, 2009, INFLAMM BOWEL DIS, V15, P1824, DOI 10.1002/ibd.21030; De Groot PJ, 2008, GENES NUTR, V3, P143, DOI 10.1007/s12263-008-0093-2; Diboun I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-252; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jussi V, 2005, ANTON LEEUW INT J G, V88, P67, DOI 10.1007/s10482-004-7837-9; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Lindbom J, 2002, J INTERF CYTOK RES, V22, P947, DOI 10.1089/10799900260286650; Loh G, 2008, ENVIRON MICROBIOL, V10, P709, DOI 10.1111/j.1462-2920.2007.01493.x; Loh G, 2012, GUT MICROBES, V3, P544, DOI 10.4161/gmic.22156; Markova M, 2005, ONCOGENE, V24, P6450, DOI 10.1038/sj.onc.1208791; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Mutch DM, 2004, PHYSIOL GENOMICS, V19, P22, DOI 10.1152/physiolgenomics.00105.2004; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Scott KP, 2012, PHARM RES, V69, P52; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; STAEHELI P, 1984, VIROLOGY, V137, P135, DOI 10.1016/0042-6822(84)90016-3; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vazeille E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021199; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	46	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72317	10.1371/journal.pone.0072317	http://dx.doi.org/10.1371/journal.pone.0072317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951309	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200079
J	Chiang, JK; Lin, YL; Chen, CL; Ouyang, CM; Wu, YT; Chi, YC; Huang, KC; Yang, WS				Chiang, Jui-Kun; Lin, Ying-Lung; Chen, Chi-Ling; Ouyang, Chung-Mei; Wu, Ying-Tai; Chi, Yu-Chiao; Huang, Kuo-Chin; Yang, Wei-Shiung			Reduced Risk for Metabolic Syndrome and Insulin Resistance Associated with Ovo-Lacto-Vegetarian Behavior in Female Buddhists: A Case-Control Study	PLOS ONE			English	Article							LIFE-STYLE; WEIGHT MANAGEMENT; PHYSICAL-ACTIVITY; DIETARY PATTERNS; CHOLESTEROL; DISEASE; VEGAN; SENSITIVITY; HEALTH	Introduction: The association of vegetarian status with the risk of metabolic syndrome (MetS) is not clear. In Asia, Buddhists often have vegetarian behavior for religious rather than for health reasons. We hypothesize that the vegetarian in Buddhism is associated with better metabolic profiles, lower risk for the MetS and insulin resistance (IR). Methods: We enrolled 391 female vegetarians (similar to 80% lacto-ovo-vegetarians) and 315 non-vegetarians from health-checkup clinics at a Buddhist hospital in Taiwan. Results: The vegetarian status was associated with lower body mass index, smaller waist circumference, lower total cholesterol, lower low density lipoprotein-cholesterol (LDL-C), and lower HDL-C in multivariate linear regression analyses. Despite having lower HDL-C level, the vegetarians had significantly lower total cholesterol/HDL-C and LDL-C/HDL-C ratios. After adjusting the other covariates, the risks for the MetS were lower for ovo-lacto-vegetarians of 1-11 years and >11 years respectively by 54% (odds ratio [OR] = 0.46, 95%C.I.:0.26-0.79) and 57% (OR = 0.43, 95%C.I.: 0.23-0.76) compared to non-vegetarians by the IDF criteria. Likewise, they were lower respectively by 45% (OR = 0.55, 95%C.I.:0.32-0.92) and 42% (OR = 0.58, 95%C.I.:0.33-0.997), for the MetS by the modified NCEP criteria. In the subgroup of non-diabetic subjects, the vegetarians also had lower risk for IR by HOMA compared to the non-vegetarians (OR = 0.71, 95%C.I.:0.48-1.06). Conclusion: The vegetarian behavior, mainly lacto-ovo-vegetarian, related to Buddhism, although not meant for its health effects, is associated with reduced risk for the MetS and IR and may potentially provide metabolic and cardiovascular protective effects in women.	[Chiang, Jui-Kun; Lin, Ying-Lung] Buddhist Tzuchi Med Fdn, Dalin Tzuchi Hosp, Dept Family Med, Chiayi, Taiwan; [Chen, Chi-Ling; Chi, Yu-Chiao; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Ying-Tai] Natl Taiwan Univ, Coll Med, Grad Inst Phys Therapy, Taipei 10764, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Ouyang, Chung-Mei] Natl Taiwan Univ Hosp, Dept Dietet, Taipei, Taiwan; [Huang, Kuo-Chin] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yang, WS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan.	wsyang@ntu.edu.tw		Ouyang, Chung-Mei/0000-0002-1377-772X; YANG, WEI-SHIUNG/0000-0001-5087-373X; HUANG, KUO-CHIN/0000-0002-6029-5520	Buddhist Dalin Tzu Chi General Hospital [DTCRD 96-13, 97-18, 98 (2)-07]; National Taiwan University Hospital [MG151]	Buddhist Dalin Tzu Chi General Hospital; National Taiwan University Hospital(National Taiwan University)	JKC received research grants from Buddhist Dalin Tzu Chi General Hospital (DTCRD 96-13, 97-18, and 98 (2)-07) and WSY had a Research Supportive Fund from the National Taiwan University Hospital (MG151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balkau B, 2002, DIABETES METAB, V28, P364; Ballantyne CM, 2003, AM HEART J, V146, P227, DOI 10.1016/S0002-8703(02)94701-0; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Berkow SE, 2006, NUTR REV, V64, P175, DOI [10.1301/nr.2006.apr.175-188, 10.1111/j.1753-4887.2006.tb00200.x]; Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294; Burke LE, 2006, OBESITY, V14, P2007, DOI 10.1038/oby.2006.235; Chen CW, 2008, EUR J CLIN NUTR, V62, P138, DOI 10.1038/sj.ejcn.1602689; Chien M.-Y., 2003, FORMOSAN J PHYS THER, V28, P1; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Fontana L, 2007, REJUV RES, V10, P225, DOI 10.1089/rej.2006.0529; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Goff LM, 2005, EUR J CLIN NUTR, V59, P291, DOI 10.1038/sj.ejcn.1602076; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hung CJ, 2006, BRIT J NUTR, V95, P129, DOI 10.1079/BJN20051588; Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Klein S, 2004, AM J CLIN NUTR, V80, P257, DOI 10.1093/ajcn/80.2.257; Kuo CS, 2004, EUR J CLIN NUTR, V58, P312, DOI 10.1038/sj.ejcn.1601783; Lee YJ, 2009, ASIA PAC J CLIN NUTR, V18, P265; Lin CK, 2010, J HEALTH POPUL NUTR, V28, P470; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Reaven G, 2006, ARCH INTERN MED, V166, P249, DOI 10.1001/archinte.166.2.249-a; Rizzo NS, 2011, DIABETES CARE, V34, P1225, DOI 10.2337/dc10-1221; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Trapp CB, 2010, CURR DIABETES REP, V10, P152, DOI 10.1007/s11892-010-0093-7; Waldmann A, 2005, ANN NUTR METAB, V49, P366, DOI 10.1159/000088888	30	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71799	10.1371/journal.pone.0071799	http://dx.doi.org/10.1371/journal.pone.0071799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951247	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200074
J	Wolf, A; Doughty, CE; Malhi, Y				Wolf, Adam; Doughty, Christopher E.; Malhi, Yadvinder			Lateral Diffusion of Nutrients by Mammalian Herbivores in Terrestrial Ecosystems	PLOS ONE			English	Article							LANDSCAPE-SCALE; BODY-SIZE; PHOSPHORUS; PATTERNS; NITROGEN; MASS; BIOGEOCHEMISTRY; EXPLANATION; GRASSLAND; DYNAMICS	Animals translocate nutrients by consuming nutrients at one point and excreting them or dying at another location. Such lateral fluxes may be an important mechanism of nutrient supply in many ecosystems, but lack quantification and a systematic theoretical framework for their evaluation. This paper presents a mathematical framework for quantifying such fluxes in the context of mammalian herbivores. We develop an expression for lateral diffusion of a nutrient, where the diffusivity is a biologically determined parameter depending on the characteristics of mammals occupying the domain, including size-dependent phenomena such as day range, metabolic demand, food passage time, and population size. Three findings stand out: (a) Scaling law-derived estimates of diffusion parameters are comparable to estimates calculated from estimates of each coefficient gathered from primary literature. (b) The diffusion term due to transport of nutrients in dung is orders of magnitude large than the coefficient representing nutrients in bodymass. (c) The scaling coefficients show that large herbivores make a disproportionate contribution to lateral nutrient transfer. We apply the diffusion equation to a case study of Kruger National Park to estimate the conditions under which mammal-driven nutrient transport is comparable in magnitude to other (abiotic) nutrient fluxes (inputs and losses). Finally, a global analysis of mammalian herbivore transport is presented, using a comprehensive database of contemporary animal distributions. We show that continents vary greatly in terms of the importance of animal-driven nutrient fluxes, and also that perturbations to nutrient cycles are potentially quite large if threatened large herbivores are driven to extinction.	[Wolf, Adam] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Doughty, Christopher E.; Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England	Princeton University; University of Oxford	Wolf, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	adamwolf@princeton.edu		Doughty, Christopher/0000-0003-3985-7960	Carbon Mitigation Initiative of Princeton University; Gordon and Betty Moore Foundation; Jackson Foundation	Carbon Mitigation Initiative of Princeton University(Princeton University); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Jackson Foundation	AW was supported by the Carbon Mitigation Initiative of Princeton University. CD was supported by the Gordon and Betty Moore Foundation, and YM was supported by the Jackson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2012, OIKOS, V121, P1271, DOI 10.1111/j.1600-0706.2011.20103.x; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Buendia C, 2010, BIOGEOSCIENCES, V7, P2025, DOI 10.5194/bg-7-2025-2010; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Calix M., 2018, EUROPEAN RED LIST SA; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Damuth J, 2007, AM NAT, V169, P621, DOI 10.1086/513495; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Doughty CE, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044001; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FRANK DA, 1994, BIOGEOCHEMISTRY, V26, P163, DOI 10.1007/BF00002905; Grant C. C., 2000, African Journal of Range and Forage Science, V17, P81, DOI 10.2989/10220110009485743; Hartshorn AS, 2009, CHEM GEOL, V267, P24, DOI 10.1016/j.chemgeo.2009.03.021; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hutchinson GE, 1950, BIOGEOCHEMISTRY VERT, V3; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Khomo L, 2008, THESIS U WITWATERSRA; Kitchell JF, 1999, LIMNOL OCEANOGR, V44, P828, DOI 10.4319/lo.1999.44.3_part_2.0828; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; MAY RM, 1978, SCI AM, V239, P160, DOI 10.1038/scientificamerican0978-160; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Ovaskainen O., 2009, SPATIAL ECOLOGY, P85; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Palmer Anthony Riordan, 2006, Secheresse (Montrouge), V17, P362; PLETSCHER DH, 1989, AM MIDL NAT, V121, P302, DOI 10.2307/2426034; Porder S, 2007, ECOSYSTEMS, V10, P158, DOI 10.1007/s10021-006-9011-x; Prienaar U. de V., 1963, Koedoe, VNo. 6, P1; SCHOLES MC, 2003, KRUGER EXPERIENCE EC, P130; Seydack A. H., 2012, Koedoe, V54, P1047; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Smit IPJ, 2010, BIOL CONSERV, V143, P2172, DOI 10.1016/j.biocon.2010.06.001; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Stevenson PR, 2010, AM J PRIMATOL, V72, P992, DOI 10.1002/ajp.20852; Venter F. J., 1986, Koedoe, V29, P125; Vitousek, 2004, NUTR CYCLING LIMITAT; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White KAJ, 1996, J THEOR BIOL, V178, P29, DOI 10.1006/jtbi.1996.0004; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; WOODMANSEE RG, 1978, BIOSCIENCE, V28, P448, DOI 10.2307/1307227; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	50	40	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71352	10.1371/journal.pone.0071352	http://dx.doi.org/10.1371/journal.pone.0071352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951141	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200042
J	Xia, L; Chen, GH; Li, ZH; Jiang, S; Shen, JH				Xia, Lan; Chen, Gui-Hai; Li, Zhi-Hua; Jiang, Song; Shen, Jianhua			Alterations in Hypothalamus-Pituitary-Adrenal/Thyroid Axes and Gonadotropin-Releasing Hormone in the Patients with Primary Insomnia: A Clinical Research	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ADRENAL AXIS; HPA-AXIS; POSTMENOPAUSAL WOMEN; NOCTURNAL CORTISOL; SLEEP DISORDERS; STRESS SYSTEM; SECRETION; DYSFUNCTION; NEURONS	The hypothalamus-pituitary-target gland axis is thought to be linked with insomnia, yet there has been a lack of further systematic studies to prove this. This study included 30 patients with primary insomnia (PI), 30 patients with depression-comorbid insomnia (DCI), and 30 healthy controls for exploring the alterations in the hypothalamus-pituitary-adrenal/thyroid axes' hormones and gonadotropin-releasing hormone (GnRH). The Pittsburgh Sleep Quality Index was used to evaluate sleep quality in all subjects. The serum concentrations of corticotrophin-releasing hormone (CRH), thyrotrophin-releasing hormone (TRH), GnRH, adrenocorticotropic hormone (ACTH), thyroid stimulating hormone (TSH), cortisol, total triiodothyronine (TT3), and total thyroxine (TT4) in the morning (between 0730 h and 0800 h) were detected. Compared to the controls, all hormonal levels were elevated in the insomniacs, except ACTH and TSH in the PI group. Compared to the DCI patients, the PI patients had higher levels of CRH, cortisol, TT3, and TT4 but lower levels of TRH, GnRH, and ACTH. Spearman's correlation analysis indicated that CRH, TRH, GnRH, TSH, cortisol, TT4, and TT3 were positively correlated with the severity of insomnia. The linear regression analysis showed that only CRH, GnRH, cortisol, and TT3 were affected by the PSQI scores among all subjects, and only CRH was included in the regression model by the "stepwise" method in the insomnia patients. Our results indicated that PI patients may have over-activity of the hypothalamus-pituitary-adrenal/thyroid axes and an elevated level of GnRH in the morning.	[Xia, Lan; Chen, Gui-Hai; Li, Zhi-Hua; Jiang, Song] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China; [Xia, Lan] Anhui Med Univ, Affiliated Hosp 2, Dept Neurol, Hefei, Peoples R China; [Shen, Jianhua] Univ Toronto, Dept Psychiat, Sleep Res Lab, Univ Hlth Network, Toronto, ON, Canada	Anhui Medical University; Anhui Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Chen, GH (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China.	chenguihai1964@163.com			First Affiliated Hospital of Anhui Medical University and its central laboratory	First Affiliated Hospital of Anhui Medical University and its central laboratory	This study was supported by the First Affiliated Hospital of Anhui Medical University and its central laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; [Anonymous], 1999, RATING SCALES MENTAL, V375-378, P220; Antonijevic IA, 2000, AM J OBSTET GYNECOL, V182, P277, DOI 10.1016/S0002-9378(00)70211-0; Association AP, 2000, DIAGNOSTIC STAT MANU, P599; Bastien CH, 2011, NEUROPSYCHOL REV, V21, P22, DOI 10.1007/s11065-011-9160-3; Bonnet M H, 1997, Sleep Med Rev, V1, P97, DOI 10.1016/S1087-0792(97)90012-5; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Bunevicius R, 2009, CURR OPIN PSYCHIATR, V22, P391, DOI 10.1097/YCO.0b013e328329e1ae; Ciechanowska M, 2011, REPROD FERT DEVELOP, V23, P780, DOI 10.1071/RD10341; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P4128, DOI 10.1210/en.2012-1467; Dickerman AL, 2012, AM J PSYCHIAT, V169, P127, DOI 10.1176/appi.ajp.2011.11040631; Fliers E, 2006, PROG BRAIN RES, V153, P189, DOI 10.1016/S0079-6123(06)53011-0; Fountoulakis KN, 2006, WORLD J BIOL PSYCHIA, V7, P131, DOI 10.1080/15622970500474739; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Gutierrez-Mariscal M, 2012, REGUL PEPTIDES, V179, P61, DOI 10.1016/j.regpep.2012.08.010; Jin PH, 2009, MED STAT METHODS, P223; Kessing LV, 2011, PSYCHONEUROENDOCRINO, V36, P19, DOI 10.1016/j.psyneuen.2010.05.007; Kotronoulas G, 2009, HORM-INT J ENDOCRINO, V8, P232, DOI 10.14310/horm.2002.1239; Lattova Z, 2011, J PSYCHIATR RES, V45, P1223, DOI 10.1016/j.jpsychires.2011.03.013; Masek K, 2003, INT IMMUNOPHARMACOL, V3, P1235, DOI 10.1016/S1567-5769(03)00015-8; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003; Olff M, 2006, PSYCHONEUROENDOCRINO, V31, P1220, DOI 10.1016/j.psyneuen.2006.09.003; Peteranderl C, 2002, J PSYCHIAT RES, V36, P189, DOI 10.1016/S0022-3956(02)00004-3; Pigeon WR, 2010, INDIAN J MED RES, V131, P321; Rasgon NL, 2007, PSYCHONEUROENDOCRINO, V32, P279, DOI 10.1016/j.psyneuen.2006.12.014; Riemann D, 2002, PSYCHIAT RES, V113, P17, DOI 10.1016/S0165-1781(02)00249-4; Rodenbeck A, 2002, NEUROSCI LETT, V324, P159, DOI 10.1016/S0304-3940(02)00192-1; Roth T, 2007, SLEEP MED REV, V11, P71, DOI 10.1016/j.smrv.2006.06.002; Schatzberg A., 2002, NEUROPSYCHOPHARMACOL, P1039; Schussler P, 2008, PSYCHONEUROENDOCRINO, V33, P1124, DOI 10.1016/j.psyneuen.2008.05.013; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seidman SN, 2003, J CLIN PSYCHIAT, V64, P31; Steiger A, 2007, J PSYCHIATR RES, V41, P537, DOI 10.1016/j.jpsychires.2006.04.007; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Thomson F, 2008, NEUROCHEM RES, V33, P691, DOI 10.1007/s11064-007-9518-3; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Vgontzas AN, 1998, J PSYCHOSOM RES, V45, P21, DOI 10.1016/S0022-3999(97)00302-4; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Waite E, 2009, J NEUROENDOCRINOL, V21, P737, DOI 10.1111/j.1365-2826.2009.01900.x; Wittmann G, 2005, BRAIN RES, V1039, P53, DOI 10.1016/j.brainres.2005.01.090; Wu EL, 2013, J PSYCHOSOM RES, V74, P233, DOI 10.1016/j.jpsychores.2012.12.016	44	33	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71065	10.1371/journal.pone.0071065	http://dx.doi.org/10.1371/journal.pone.0071065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951080	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200031
J	Zhuang, X; Qu, M; Zhang, X; Ding, SX				Zhuang, Xuan; Qu, Meng; Zhang, Xiang; Ding, Shaoxiong			A Comprehensive Description and Evolutionary Analysis of 22 Grouper (Perciformes, Epinephelidae) Mitochondrial Genomes with Emphasis on Two Novel Genome Organizations	PLOS ONE			English	Article							DNA CONTROL REGION; COMPLETE NUCLEOTIDE-SEQUENCE; TRANSFER-RNA GENES; TANDEM REPEATS; PHYLOGENETIC-RELATIONSHIPS; LENGTH HETEROPLASMY; UNIQUE FEATURES; RIBOSOMAL-RNA; FISH; REARRANGEMENTS	Groupers of the family Epinephelidae are a diverse and economically valuable group of reef fishes. To investigate the evolution of their mitochondrial genomes we characterized and compared these genomes among 22 species, 17 newly sequenced. Among these fishes we identified three distinct genome organizations, two of them never previously reported in vertebrates. In 19 of these species, mitochondrial genomes followed the typical vertebrate canonical organization with 13 protein-coding genes, 22 tRNAs, two rRNAs, and a non-coding control region. Differing from this, members of genus Variola have an extra tRNA-Ile between tRNA-Val and 16S rRNA. Evidence suggests that this evolved from tRNA-Val via a duplication event due to slipped strand mispairing during replication. Additionally, Cephalopholis argus has an extra tRNA-Asp in the midst of the control region, likely resulting from long-range duplication of the canonical tRNA-Asp through illicit priming of mitochondrial replication by tRNAs. Along with their gene contents, we characterized the regulatory elements of these mitochondrial genomes' control regions, including putative termination-associated sequences and conserved sequence blocks. Looking at the mitochondrial genomic constituents, rRNA and tRNA are the most conserved, followed by protein-coding genes, and non-coding regions are the most divergent. Divergence rates vary among the protein-coding genes, and the three cytochrome oxidase subunits (COI, II, III) are the most conserved, while NADH dehydrogenase subunit 6 (ND6) and the ATP synthase subunit 8 (ATP8) are the most divergent. We then tested the phylogenetic utility of this new mt genome data using 12 protein-coding genes of 48 species from the suborder Percoidei. From this, we provide further support for the elevation of the subfamily Epinephelinae to family Epinephelidae, the resurrection of the genus Hyporthodus, and the combination of the monotypic genera Anyperodon and Cromileptes to genus Epinephelus, and Aethaloperca to genus Cephalopholis.	[Zhuang, Xuan; Qu, Meng; Zhang, Xiang; Ding, Shaoxiong] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Qu, Meng; Zhang, Xiang; Ding, Shaoxiong] Xiamen Univ, Lab Marine Biodivers & Global Change, Xiamen, Peoples R China; [Zhuang, Xuan] Univ Illinois, Dept Anim Biol, Champaign, IL USA	Xiamen University; Xiamen University; University of Illinois System; University of Illinois Urbana-Champaign	Ding, SX (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	sxding@xmu.edu.cn		Zhuang, Xuan/0000-0002-1919-9764	Program for New Century Excellent Talents in University; National Basic Research Special Foundation of China [2013FY110700]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Special Foundation of China	This study was supported by Program for New Century Excellent Talents in University 2012 and National Basic Research Special Foundation of China (2013FY110700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2012, MOL PHYLOGENET EVOL; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Breines R, 2008, POLAR BIOL, V31, P1245, DOI 10.1007/s00300-008-0463-7; BROUGHTON RE, 1994, GENETICS, V138, P179; Broughton RE, 1997, MOL BIOL EVOL, V14, P1187, DOI 10.1093/oxfordjournals.molbev.a025728; BUROKER NE, 1990, GENETICS, V124, P157; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Catanese G, 2010, GENE, V452, P35, DOI 10.1016/j.gene.2009.12.004; CECCONI F, 1995, GENE, V160, P149, DOI 10.1016/0378-1119(95)00232-U; Chen CA, 2004, ZOOL STUD, V43, P803; Cheng J, 2012, GENE, V491, P210, DOI 10.1016/j.gene.2011.09.020; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Coucheron DH, 2011, CURR GENET, V57, P213, DOI 10.1007/s00294-011-0338-2; Craig M. T, 2011, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; Craig MT, 2001, MOL PHYLOGENET EVOL, V19, P121, DOI 10.1006/mpev.2000.0913; Cui ZX, 2011, MOL BIOL REP, V38, P1103, DOI 10.1007/s11033-010-0207-y; Cui ZX, 2010, CHIN J OCEANOL LIMN, V28, P785, DOI 10.1007/s00343-010-9091-5; Cui Z, 2009, GENE, V432, P33, DOI 10.1016/j.gene.2008.11.024; Ding SX, 2006, SCI CHINA SER C, V49, P235, DOI 10.1007/s11427-006-0235-y; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Gilles A, 2000, CR ACAD SCI III-VIE, V323, P195, DOI 10.1016/S0764-4469(00)00114-1; Gower DJ, 2006, MOL BIOL EVOL, V23, P227, DOI DOI 10.1093/M0LBEV/MSJ025; Guo XH, 2003, AQUACULTURE, V224, P25, DOI 10.1016/S0044-8486(03)00168-6; Han J, 2011, MOL ECOL RESOUR, V11, P215, DOI 10.1111/j.1755-0998.2010.02911.x; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V16; Hirayama M, 2010, GENE, V457, P13, DOI 10.1016/j.gene.2010.02.012; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2003, MOL BIOL EVOL, V20, P1917, DOI 10.1093/molbev/msg206; Inoue JG, 2001, FISHERIES SCI, V67, P828, DOI 10.1046/j.1444-2906.2001.00329.x; IUCN, 2012, IUCN RED LIST THREAT; JACOBS HT, 1989, CURR GENET, V15, P193, DOI 10.1007/BF00435506; Jondeung A, 2010, MITOCHONDR DNA, V21, P36, DOI 10.3109/19401731003622529; Kong XY, 2009, GENOME, V52, P975, DOI 10.1139/G09-069; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; LEE WJ, 1995, J MOL EVOL, V41, P54; LEIS JM, 1986, B MAR SCI, V38, P525; Liu M, 2013, J FISH BIOL, V82, P1684, DOI 10.1111/jfb.12112; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mabuchi K, 2004, J MOL EVOL, V59, P287, DOI 10.1007/s00239-004-2621-z; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Oh DJ, 2010, MITOCHONDR DNA, V21, P151, DOI 10.3109/19401736.2010.503241; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Orti G, 1996, J MOL EVOL, V42, P169, DOI 10.1007/BF02198843; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Ponce M, 2008, GENE, V409, P44, DOI 10.1016/j.gene.2007.11.004; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ravago RG, 2002, MAR BIOTECHNOL, V4, P40, DOI 10.1007/s10126-001-0076-4; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Smith WML, 2009, AM MUS NOVIT, P1; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; SOUTHERN SO, 1988, J MOL EVOL, V28, P32, DOI 10.1007/BF02143495; Stepien Carol A., 1997, P1, DOI 10.1016/B978-012417540-2/50002-6; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TZENG CS, 1992, NUCLEIC ACIDS RES, V20, P4853, DOI 10.1093/nar/20.18.4853; Wang HY, 2002, MOL BIOL EVOL, V19, P138, DOI 10.1093/oxfordjournals.molbev.a004066; Williams EP, 2012, J FISH BIOL, V80, P110, DOI 10.1111/j.1095-8649.2011.03158.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174; Zhang Y, 2011, BIOCHEM SYST ECOL, V39, P627, DOI 10.1016/j.bse.2011.05.008; Zhu ZY, 2008, AQUACULTURE, V276, P44, DOI 10.1016/j.aquaculture.2008.02.008; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026; Zhuang X, 2009, MOL ECOL RESOUR, V9, P1551, DOI 10.1111/j.1755-0998.2009.02716.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	81	39	43	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73561	10.1371/journal.pone.0073561	http://dx.doi.org/10.1371/journal.pone.0073561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951357	Green Submitted, gold, Green Published			2022-12-27	WOS:000326473200093
J	Aguilar-Hernandez, V; Medina, J; Aguilar-Henonin, L; Guzman, P				Aguilar-Hernandez, Victor; Medina, Juliana; Aguilar-Henonin, Laura; Guzman, Plinio			Expansion and Diversification of BTL Ring-H2 Ubiquitin Ligases in Angiosperms: Putative Rabring7/BCA2 Orthologs	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; E3; PROTEIN; GENE; FAMILY; EVOLUTION; INTRONS; SYSTEM; DOMAIN	RING finger E3 ligases are components of the ubiquitin proteasome system (UPS) that mediate the transfer of ubiquitin to substrates. Single-subunit RING finger E3s binds the E2 ubiquitin-conjugating enzyme and contains recognition sequences for the substrate within the same polypeptide. Here we describe the characterization of a class of RING finger E3 ligases that is conserved among eukaryotes. This class encodes a RING-H2 domain related in sequence to the ATL RING-H2 domain, another class of E3 ligases, and a C2/C2 zing finger at the amino-terminus, formerly described as BZF. In viridiplantae (green algae and land plants), we designed this family as BTL for BZF ATLs. BTLs are putative orthologs of the mammalian Rabring7/BCA2 RING-H2 E3s that have expanded in angiosperms. They are found in numbers ranging from three to thirty-one, which is in contrast to the one to three members normally found in animals, fungi, and protists. Furthermore, the number of sequence LOGOs generated in angiosperms is four times greater than that in other eukaryotes. In contrast to ATLs, which show expansion by tandem duplication, tandemly duplicated BTLs are scarce. The mode of action of Rabring7/BCA2 and BTLs may be similar since both the Rabring7/BCA2 BZF and the ath|BTL4 BZF are likely to mediate the binding of ubiquitin. This study introduces valuable information on the evolution and domain structure of the Rabring7/BCA2/BTL class of E3 ligases which may be important for core eukaryotic genes.	[Aguilar-Hernandez, Victor; Medina, Juliana; Aguilar-Henonin, Laura; Guzman, Plinio] Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Unidad Irapuato, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Guzman, P (corresponding author), Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Unidad Irapuato, Guanajuato, Mexico.	pguzman@ira.cinvestav.mx	Aguilar-Hernández, Victor/Q-9860-2019	Aguilar-Hernández, Victor/0000-0001-7308-4047	Consejo Nacional de Ciencia y Tecnolog a Mexico [177528]	Consejo Nacional de Ciencia y Tecnolog a Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Grant 177528 from Consejo Nacional de Ciencia y Tecnolog a Mexico (http://www.conacyt.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Arvas M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-325; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bacopulos S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-63; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Connor MK, 2005, MOL CANCER RES, V3, P453, DOI 10.1158/1541-7786.MCR-04-0166; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Hu KJ, 2006, MOL PHYLOGENET EVOL, V38, P685, DOI 10.1016/j.ympev.2005.09.005; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Jiang KN, 2010, PLANTA, V231, P411, DOI 10.1007/s00425-009-1059-3; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim SJ, 2012, BIOCH BIOPHYSICAL RE; Krasnov AN, 2005, NUCLEIC ACIDS RES, V33, P6654, DOI 10.1093/nar/gki969; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Mizuno K, 2003, MOL BIOL CELL, V14, P3741, DOI 10.1091/mbc.E02-08-0495; Narita R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041891; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Robinson Richard, 2006, PLoS Biol, V4, pe304, DOI 10.1371/journal.pbio.0040304; Sakane A, 2007, BIOCHEM BIOPH RES CO, V357, P1058, DOI 10.1016/j.bbrc.2007.04.052; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinogradov AE, 2012, J MOL EVOL, V75, P25, DOI 10.1007/s00239-012-9516-1	43	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72729	10.1371/journal.pone.0072729	http://dx.doi.org/10.1371/journal.pone.0072729			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951330	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000087
J	Goyal, P; Pandey, D; Brunnert, D; Hammer, E; Zygmunt, M; Siess, W				Goyal, Pankaj; Pandey, Dharmendra; Bruennert, Daniela; Hammer, Elke; Zygmunt, Marek; Siess, Wolfgang			Cofilin Oligomer Formation Occurs In Vivo and Is Regulated by Cofilin Phosphorylation	PLOS ONE			English	Article							THROMBIN-STIMULATED PLATELETS; ACTIN DYNAMICS; ENDOTHELIAL-CELLS; CROSS-LINKING; PROTEIN; ADF/COFILIN; DEPHOSPHORYLATION; MECHANISM; KINASE; POLYMERIZATION	Background: ADF/cofilin proteins are key regulators of actin dynamics. Their function is inhibited by LIMK-mediated phosphorylation at Ser-3. Previous in vitro studies have shown that dependent on its concentration, cofilin either depolymerizes F-actin (at low cofilin concentrations) or promotes actin polymerization (at high cofilin concentrations). Methodology/Principal Findings: We found that after in vivo cross-linking with different probes, a cofilin oligomer (65 kDa) could be detected in platelets and endothelial cells. The cofilin oligomer did not contain actin. Notably, ADF that only depolymerizes F-actin was present mainly in monomeric form. Furthermore, we found that formation of the cofilin oligomer is regulated by Ser-3 cofilin phosphorylation. Cofilin but not phosphorylated cofilin was present in the endogenous cofilin oligomer. In vitro, formation of cofilin oligomers was drastically reduced after phosphorylation by LIMK2. In endothelial cells, LIMK-mediated cofilin phosphorylation after thrombin-stimulation of EGFP- or DsRed2-tagged cofilin transfected cells reduced cofilin aggregate formation, whereas inhibition of cofilin phosphorylation after Rho-kinase inhibitor (Y27632) treatment of endothelial cells promoted formation of cofilin aggregates. In platelets, cofilin dephosphorylation after thrombin-stimulation and Y27632 treatment led to an increased formation of the cofilin oligomer. Conclusion/Significance: Based on our results, we propose that an equilibrium exists between the monomeric and oligomeric forms of cofilin in intact cells that is regulated by cofilin phosphorylation. Cofilin phosphorylation at Ser-3 may induce conformational changes on the protein-protein interacting surface of the cofilin oligomer, thereby preventing and/or disrupting cofilin oligomer formation. Cofilin oligomerization might explain the dual action of cofilin on actin dynamics in vivo.	[Goyal, Pankaj; Pandey, Dharmendra; Siess, Wolfgang] Univ Munich, Klinikum Innenstadt, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, D-80539 Munich, Germany; [Goyal, Pankaj; Bruennert, Daniela; Zygmunt, Marek] Univ Med, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Greifswald, Germany; [Hammer, Elke] Univ Med Greifswald, Interfak Inst Genet & Funkt Genomforsch, Greifswald, Germany	University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Greifswald Medical School	Goyal, P (corresponding author), Cent Univ Rajasthan, Sch Life Sci, Dept Biotechnol, Bandar Sindri, Rajasthan, India.	pankaj.goyal@uni-greifswald.de	Siess, Wolfgang/A-6430-2009; Brünnert, Daniela/AAL-9784-2020; Pandey, Dharmendra/O-9158-2017	Siess, Wolfgang/0000-0003-0698-6416; Brünnert, Daniela/0000-0003-0870-9578; Pandey, Dharmendra/0000-0002-3172-5923; Pandey, Dharmendra/0000-0003-4871-964X; Hammer, Elke/0000-0002-1507-0402	Deutsche Forschungsgemeinschaft [Si 274/11, GRK 438]; August-Lenz-Stiftung; Friedrich-Baur-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); August-Lenz-Stiftung; Friedrich-Baur-Stiftung	This study was supported by the August-Lenz-Stiftung, Friedrich-Baur-Stiftung, and Deutsche Forschungsgemeinschaft (Si 274/11; and the Graduate Program "Vascular Biology in Medicine" GRK 438 to D. P. and P. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou Fabrice, 2004, Methods Mol Biol, V261, P427; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Braakman I, 2001, ANAL DISULFIDE BOND; FOX JEB, 1993, ADV EXP MED BIOL, V344, P175; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Goyal P, 2005, J BIOL CHEM, V280, P27569, DOI 10.1074/jbc.M504448200; Gruarin P, 1997, BIOCHEM J, V328, P635, DOI 10.1042/bj3280635; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Markus M, 1999, J BIOL CHEM, V274, P1040, DOI 10.1074/jbc.274.2.1040; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; OHTA Y, 1989, J BIOL CHEM, V264, P16143; Ottemann KM, 1996, J BACTERIOL, V178, P156, DOI 10.1128/jb.178.1.156-162.1996; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	34	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71769	10.1371/journal.pone.0071769	http://dx.doi.org/10.1371/journal.pone.0071769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951242	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000073
J	Scott, JA; Klutho, PJ; El Accaoui, R; Nguyen, E; Venema, AN; Xie, LT; Jiang, SX; Dibbern, M; Scroggins, S; Prasad, AM; Luczak, ED; Davis, MK; Li, WW; Guan, XQ; Backs, J; Schlueter, AJ; Weiss, RM; Miller, FJ; Anderson, ME; Grumbach, IM				Scott, Jason A.; Klutho, Paula J.; El Accaoui, Ramzi; Nguyen, Emily; Venema, Ashlee N.; Xie, Litao; Jiang, Shuxia; Dibbern, Megan; Scroggins, Sabrina; Prasad, Anand M.; Luczak, Elisabeth D.; Davis, Melissa K.; Li, Weiwei; Guan, Xiaoqun; Backs, Johannes; Schlueter, Annette J.; Weiss, Robert M.; Miller, Francis J.; Anderson, Mark E.; Grumbach, Isabella M.			The Multifunctional Ca2+/Calmodulin-Dependent Kinase II delta (CaMKII delta) Regulates Arteriogenesis in a Mouse Model of Flow-Mediated Remodeling	PLOS ONE			English	Article							ARTERY GROWTH ARTERIOGENESIS; BLOOD-FLOW; MATRIX METALLOPROTEINASES; RABBIT HINDLIMB; CELLS; MACROPHAGES; INVOLVEMENT; ACTIVATION; EXPRESSION; MICE	Objective: Sustained hemodynamic stress mediated by high blood flow promotes arteriogenesis, the outward remodeling of existing arteries. Here, we examined whether Ca2+/calmodulin-dependent kinase II (CaMKII) regulates arteriogenesis. Methods and Results: Ligation of the left common carotid led to an increase in vessel diameter and perimeter of internal and external elastic lamina in the contralateral, right common carotid. Deletion of CaMKII delta (CaMKII delta(-/-)) abolished this outward remodeling. Carotid ligation increased CaMKII expression and was associated with oxidative activation of CaMKII in the adventitia and endothelium. Remodeling was abrogated in a knock-in model in which oxidative activation of CaMKII is abolished. Early after ligation, matrix metalloproteinase 9 (MMP9) was robustly expressed in the adventitia of right carotid arteries of WT but not CaMKII delta(-/-) mice. MMP9 mainly colocalized with adventitial macrophages. In contrast, we did not observe an effect of CaMKII delta deficiency on other proposed mediators of arteriogenesis such as expression of adhesion molecules or smooth muscle proliferation. Transplantation of WT bone marrow into CaMKII delta(-/-) mice normalized flow-mediated remodeling. Conclusion: CaMKII delta is activated by oxidation under high blood flow conditions and is required for flow-mediated remodeling through a mechanism that includes increased MMP9 expression in bone marrow-derived cells invading the arterial wall.	[Scott, Jason A.; Klutho, Paula J.; El Accaoui, Ramzi; Nguyen, Emily; Venema, Ashlee N.; Xie, Litao; Jiang, Shuxia; Dibbern, Megan; Prasad, Anand M.; Luczak, Elisabeth D.; Davis, Melissa K.; Li, Weiwei; Guan, Xiaoqun; Weiss, Robert M.; Miller, Francis J.; Anderson, Mark E.; Grumbach, Isabella M.] Univ Iowa, Dept Med, Carver Coll Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Scroggins, Sabrina; Schlueter, Annette J.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Scott, Jason A.; Xie, Litao; Miller, Francis J.; Grumbach, Isabella M.] Iowa City VA Med Ctr, Iowa City, IA USA; [Backs, Johannes] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Ruprecht Karls University Heidelberg	Grumbach, IM (corresponding author), Univ Iowa, Dept Med, Carver Coll Med, Iowa City, IA 52242 USA.	isabella-grumbach@uiowa.edu	Miller Jr, Francis/N-7312-2015	Miller Jr, Francis/0000-0001-5822-0549; El Accaoui, Ramzi/0000-0002-5515-5427; Grumbach, Isabella/0000-0002-2285-3157; Schlueter, Annette/0000-0003-2442-7079; Weiss, Robert/0000-0003-1307-2647	American Heart Association [0930086N]; National Institutes of Health (NIH) [RO1 HL 108932]; Department of Veterans Affairs; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research and Development [1BX000163-01]; NIH [RO1 HL 079031, R01 HL 070250, RO1 AA 019568]; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070250, R01HL096652, T32HL007121, R01HL079031, R01HL108932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019568] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000163] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by the American Heart Association Scientist Development Grant 0930086N, National Institutes of Health (NIH) RO1 HL 108932, Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research and Development grant 1BX000163-01 (to IMG); NIH RO1 HL 079031, R01 HL 070250 (to MEA); RO1 AA 019568 (to AJS); NIH (to AMP); NIH (to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bakker ENTP, 2008, CARDIOVASC RES, V78, P341, DOI 10.1093/cvr/cvn050; Berry CJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-16; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; De Chantemele EJ, 2009, MICROCIRCULATION, V16, P391, DOI 10.1080/10739680902816301; de Groot D, 2011, J MOL CELL CARDIOL, V50, P25, DOI 10.1016/j.yjmcc.2010.08.006; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Haas TL, 2007, AM J PHYSIOL-HEART C, V293, pH2429, DOI 10.1152/ajpheart.00100.2007; He BJ, 2011, NAT MED; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Herold J, 2004, HUM GENE THER, V15, P1, DOI 10.1089/10430340460732517; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713; Hoefer IE, 2004, CIRC RES, V94, P1179, DOI 10.1161/01.RES.0000126922.18222.F0; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Ito WD, 1997, CIRC RES, V80, P829; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lu X, 2011, J APPL PHYSIOL, V110, P520, DOI 10.1152/japplphysiol.00786.2009; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Luo SF, 2009, TOXICOL APPL PHARM, V237, P8, DOI 10.1016/j.taap.2009.02.025; Matlung HL, 2009, ANTIOXID REDOX SIGN, V11, P1699, DOI [10.1089/ars.2008.2408, 10.1089/ARS.2008.2408]; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Ota R, 2009, J CEREBR BLOOD F MET, V29, P1547, DOI 10.1038/jcbfm.2009.77; Pandey D, 2011, MOL PHARM; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; Scott JA, 2012, AM J PHYSL HEART CIR; Swaminathan PD, 2011, J CLIN INVEST; Tang PCY, 2008, J EXP MED, V205, P3159, DOI 10.1084/jem.20081298; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; van Royen N, 2009, J AM COLL CARDIOL, V55, P17, DOI 10.1016/j.jacc.2009.06.058; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang W, 2010, J CARDIOVASC PHARM, V55, P96, DOI 10.1097/FJC.0b013e3181c9548b	47	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71550	10.1371/journal.pone.0071550	http://dx.doi.org/10.1371/journal.pone.0071550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951185	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000066
J	van den Berg, JP; Westerbeek, EAM; van der Klis, FRM; Berbers, GAM; Lafeber, HN; van Elburg, RM				van den Berg, Jolice P.; Westerbeek, Elisabeth A. M.; van der Klis, Fiona R. M.; Berbers, Guy A. M.; Lafeber, Harrie N.; van Elburg, Ruurd M.			Neutral and Acidic Oligosaccharides Supplementation Does Not Increase the Vaccine Antibody Response in Preterm Infants in a Randomized Clinical Trial	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; COMBINATION VACCINE; SERUM ANTIBODIES; PERTUSSIS; IMMUNOGENICITY; PREMATURE; FORMULA; GUT; REACTOGENICITY; IMMUNIZATION	Background: In preterm infants, a decreased immunological response and lower serological effectiveness are observed after immunizations due to ineffectiveness of both humoral and cellular immune mechanisms. Objective: To determine the effect of 80% neutral oligosaccharides [small-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (scGOS/lcFOS)] in combination with 20% pectin-derived acidic oligosaccharides (pAOS) on antibody concentrations after DTaP-IPV-Hib immunization in preterm infants. Design: In this randomized clinical trial, preterm infants with gestational age <32 weeks and/or birth weight <1500 g received enteral supplementation with scGOS/lcFOS/pAOS or placebo (maltodextrin) between days 3 and 30 of life. Blood samples were collected at 5 and 12 months of age. Results: In total, 113 infants were included. Baseline and nutritional characteristics were not different in both groups. Geometric mean titers were not different after prebiotic supplementation at 5 months, Ptx (37/44 EU/ml), FHA (78/96 EU/ ml), Prn (78/80 EU/ml), Diphtheria (0.40/0.57 IU/ml), Tetanus (0.74/0.99 IU/ml) and Hib (0.35/0.63 mu g/ml), and at 12 months Ptx (55/66 EU/ml), FHA (122/119 EU/ml), Prn (116/106 Eu/ml), Diphtheria (0.88/1.11 IU/ml), Tetanus (1.64/1.79 IU/ml) and Hib (2.91/2.55 mu g/ml). Conclusions: Enteral supplementation of neutral (scGOS/lcFOS) and acidic oligosaccharides (pAOS) does not improve the immunization response in preterm infants.	[van den Berg, Jolice P.; Westerbeek, Elisabeth A. M.; Lafeber, Harrie N.; van Elburg, Ruurd M.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat, Div Neonatol, Amsterdam, Netherlands; [van der Klis, Fiona R. M.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [van Elburg, Ruurd M.] Ctr Specialised Nutr Danone Res Wageningen, Wageningen, Netherlands	Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment; Danone Nutricia	van Elburg, RM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Paediat, Div Neonatol, Amsterdam, Netherlands.	rm.vanelburg@vumc.nl	Van Elburg, Roelof/AAX-1053-2020	van Elburg, Ruurd M/0000-0003-0310-6540				[Anonymous], 1993, IMMUNOLOGICAL BASIS; Benyacoub J, 2008, J NUTR, V138, P123, DOI 10.1093/jn/138.1.123; Berrington JE, 2006, PEDIATRICS, V117, pE717, DOI 10.1542/peds.2005-0348; Blewett HJH, 2008, ADV FOOD NUTR RES, V54, P45, DOI 10.1016/S1043-4526(07)00002-2; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; Boehm G, 2008, J NUTR, V138, p1818S, DOI 10.1093/jn/138.9.1818S; Borrow R., 2007, IMMUNOLOGICAL BASIS; D'Angio Carl T, 2007, Paediatr Drugs, V9, P17, DOI 10.2165/00148581-200709010-00003; David S, 2008, VACCINE, V26, P5883, DOI 10.1016/j.vaccine.2008.07.105; de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Heath PT, 2003, ARCH DIS CHILD, V88, P206, DOI 10.1136/adc.88.3.206; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kapiki A, 2007, EARLY HUM DEV, V83, P335, DOI 10.1016/j.earlhumdev.2006.07.003; KAYHTY H, 1983, J INFECT DIS, V147, P1100; Langkamp DL, 1996, J PEDIATR-US, V128, P654, DOI 10.1016/S0022-3476(96)80131-4; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; LONG SS, 1990, J INFECT DIS, V161, P480, DOI 10.1093/infdis/161.3.480; Mihatsch WA, 2006, ACTA PAEDIATR, V95, P843, DOI 10.1080/08035250500486652; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Ninonuevo MR, 2009, NUTR REV, V67, pS216, DOI 10.1111/j.1753-4887.2009.00243.x; Olivier C, 2008, VACCINE, V26, P3142, DOI 10.1016/j.vaccine.2007.11.096; Pabst HF, 1997, PEDIATR INFECT DIS J, V16, P991, DOI 10.1097/00006454-199710000-00017; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Schloesser RL, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.5.e60; Singhal A, 2006, NUTR REV, V64, pS44, DOI 10.1301/nr.2006.may.S44-S49; Slack MH, 2001, J INFECT DIS, V184, P1617, DOI 10.1086/324666; Srinivasjois R, 2009, CLIN NUTR, V28, P237, DOI 10.1016/j.clnu.2009.03.008; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; van den Berg A, 2005, AM J CLIN NUTR, V81, P1397; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Oosten M, 2006, EUROSURVEILLANCE, V11; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Vos AP, 2010, INT IMMUNOPHARMACOL, V10, P619, DOI 10.1016/j.intimp.2010.02.014; Westerbeek EAM, 2013, EUR J CLIN MICROBIOL, V32, P269, DOI 10.1007/s10096-012-1739-y; Westerbeek EA, 2009, AM J CLIN NUTR; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002	40	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70904	10.1371/journal.pone.0070904	http://dx.doi.org/10.1371/journal.pone.0070904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951035	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000030
J	Wu, YC; Chang, IC; Wang, CL; Chen, TD; Chen, YT; Liu, HP; Chu, Y; Chiu, YT; Wu, TH; Chou, LH; Chen, YR; Huang, SF				Wu, Yi-Cheng; Chang, Il-Chi; Wang, Chi-Liang; Chen, Tai-Di; Chen, Ya-Ting; Liu, Hui-Ping; Chu, Yen; Chiu, Yu-Ting; Wu, Tzu-Hua; Chou, Li-Hui; Chen, Yi-Rong; Huang, Shiu-Feng			Comparison of IHC, FISH and RT-PCR Methods for Detection of ALK Rearrangements in 312 Non-Small Cell Lung Cancer Patients in Taiwan	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; POLYMERASE CHAIN-REACTION; EML4-ALK FUSION GENE; TYROSINE KINASE; NPM-ALK; MUTATIONS; EGFR; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; INHIBITOR	Background: Recently Echinoderm microtubule-associated protein-like 4- anaplastic lymphoma kinase (EML4-ALK) fusion gene has become an important biomarker for ALK tyrosine kinase inhibitor (crizotinib) treatment in NSCLC. However, the best detection method and the significance of EML4-ALK variant types remain uncertain. Methods: Reverse transcriptase-polymerase chain reaction (RT-PCR), fluorescence in Situ hybridization (FISH) and Immunohistochemical (IHC) stain were performed on tumor tissues of 312 NSCLC patients for detection of ALK rearrangements. Mutation analyses for EGFR and KRAS genes were also performed. Results: Thirteen of the 312 patients (4.17%) had ALK rearrangements detected by RT-PCR. If RT-PCR data was used as the gold standard, FISH tests had a low sensitivity (58.33%), but very good specificity (99.32%). IHC stain had better sensitivity (91.67%) than FISH, but lower specificity (79.52%), when the cut off was IHC2+. All of the 8 patients with high abundance of EML4-ALK positive cells in tumor tissues (assessed by the signal intensities of the RT-PCR product), were also have high expression of ALK protein (IHC3+), and positive for FISH, except one failed in FISH. Variants 3a+3b (4/5, 80%) of EML4-ALK fusion gene were more common to have high abundance of EML4-ALK positive cells in tumor tissues than variant 1 (1/3, 33.3%). Meta-analysis of the published data of 2273 NSCLC patients revealed that variant 3 (23/44, 52.3%) was the most common type in Chinese population, while variant 1 (28/37, 75.7%) was most common in Caucasian. Conclusions: Among the three detection methods, RT-PCR could detect not only the presence of EML4-ALK fusion gene and their variant types, but also the abundance of EML4-ALK positive cells in NSCLC tumor tissues. The latter two factors might affect the treatment response to anti-ALK inhibitor. Including RT-PCR as a diagnostic test for ALK inhibitor treatment in the prospective clinical trials is recommended.	[Wu, Yi-Cheng; Liu, Hui-Ping; Chu, Yen] Chang Gung Mem Hosp Linko, Dept Cardiovasc & Thorac Surg, Taoyuan, Taiwan; [Wu, Yi-Cheng; Liu, Hui-Ping; Chu, Yen] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Il-Chi; Chen, Ya-Ting; Chiu, Yu-Ting; Wu, Tzu-Hua; Chen, Yi-Rong; Huang, Shiu-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Wang, Chi-Liang] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linko, Div Pulmonol,Dept Med, Taoyuan, Taiwan; [Chen, Tai-Di; Huang, Shiu-Feng] Chang Gung Mem Hosp Linko, Dept Pathol, Taoyuan, Taiwan; [Chou, Li-Hui] Natl Hlth Res Inst, Inst Canc Res, Miaoli, Taiwan; [Huang, Shiu-Feng] Buddhist Tzu Chi Med Ctr, Dept Pathol, Taipei Branch, New Taipei, Taiwan; [Huang, Shiu-Feng] Tzu Chi Univ, Coll Med, Dept Med, Hualien, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Buddhist Tzu Chi General Hospital; Tzu Chi University	Huang, SF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.	sfhuang@nhri.org.tw	Chen, Yi-Rong/CAH-7991-2022; Chow, Lihui/F-7726-2011; Chen, Yi-Rong/CAF-2186-2022; Chen, Yi-Rong/E-3991-2010; Huang, Shiu-Feng Kathy/E-3977-2010	Chen, Yi-Rong/0000-0002-4307-3002; Chow, Lihui/0000-0002-0909-8089; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Tai-Di/0000-0002-4231-7677; Chu, Yen/0000-0002-7712-8331	National Health Research Institutes [NHRI-A1-MG-100-PP-04, NHRI-A1-MG-101-PP-04]; National Science Council [NSC97-2320-B-400-006-MY3]; Pfizer [WS2084622]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Pfizer(Pfizer)	This work was supported by grants from National Health Research Institutes (NHRI-A1-MG-100-PP-04, NHRI-A1-MG-101-PP-04), and National Science Council (NSC97-2320-B-400-006-MY3) for Dr. Shiu-Feng Huang. The fluorescence in situ hybridization (FISH) study was supported by a grant from Pfizer (WS2084622) for Dr. Yi-Cheng Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Camidge DR, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.2501; Chen Tai-Di, 2012, Chang Gung Med J, V35, P309; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; CRINO L, 2011, J CLIN ONCOL S, V1005, P29; Ellis PM, 2011, J THORAC ONCOL, V6, P1379, DOI 10.1097/JTO.0b013e318220cb8e; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Hofman P, 2012, ANN ONCOL, V23, P1738, DOI 10.1093/annonc/mdr535; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jokoji R, 2010, J CLIN PATHOL, V63, P1066, DOI 10.1136/jcp.2010.081166; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamant L, 1996, BLOOD, V87, P284; LI Y, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0077864; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ou SHI, 2011, DRUG DES DEV THER, V5, P471, DOI 10.2147/DDDT.S19045; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sanders HR, 2011, CANCER GENET-NY, V204, P45, DOI 10.1016/j.cancergencyto.2010.08.024; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Shinmura K, 2008, LUNG CANCER, V61, P163, DOI 10.1016/j.lungcan.2007.12.013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Togashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031323; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wong DWS, 2011, CANCER-AM CANCER SOC, V117, P2709, DOI 10.1002/cncr.25843; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188	48	78	86	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70839	10.1371/journal.pone.0070839	http://dx.doi.org/10.1371/journal.pone.0070839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951022	gold, Green Submitted, Green Published			2022-12-27	WOS:000323109700056
J	Bourdin, CM; Moignot, B; Wang, LX; Murillo, L; Juchaux, M; Quinchard, S; Lapied, B; Guerineau, NC; Dong, K; Legros, C				Bourdin, Celine M.; Moignot, Benedicte; Wang, Lingxin; Murillo, Laurence; Juchaux, Marjorie; Quinchard, Sophie; Lapied, Bruno; Guerineau, Nathalie C.; Dong, Ke; Legros, Christian			Intron Retention in mRNA Encoding Ancillary Subunit of Insect Voltage-Gated Sodium Channel Modulates Channel Expression, Gating Regulation and Drug Sensitivity	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; OXADIAZINE INSECTICIDE; MEMBRANE-PROTEIN; LIDOCAINE BLOCK; BETA-SUBUNITS; COEXPRESSION; OOCYTES; CLONING; RAT; INDOXACARB	Insect voltage-gated sodium (Na-v) channels are formed by a well-known pore-forming a-subunit encoded by para-like gene and ancillary subunits related to TipE from the mutation "temperature-induced-paralysis locus E." The role of these ancillary subunits in the modulation of biophysical and pharmacological properties of Na+ currents are not enough documented. The unique neuronal ancillary subunit TipE-homologous protein 1 of Drosophila melanogaster (DmTEH1) strongly enhances the expression of insect Na-v channels when heterologously expressed in Xenopus oocytes. Here we report the cloning and functional expression of two neuronal DmTEH1-homologs of the cockroach, Periplaneta americana, PaTEH1A and PaTEH1B, encoded by a single bicistronic gene. In PaTEH1B, the second exon encoding the last 11-amino-acid residues of PaTEH1A is shifted to 3'UTR by the retention of a 96-bp intron-containing coding-message, thus generating a new C-terminal end. We investigated the gating and pharmacological properties of the Drosophila Na-v channel variant (DmNa(v)1-1) co-expressed with DmTEH1, PaTEH1A, PaTEH1B or a truncated mutant PaTEH1 Delta(270-280) in Xenopus oocytes. PaTEH1B caused a 2.2-fold current density decrease, concomitant with an equivalent a-subunit incorporation decrease in the plasma membrane, compared to PaTEH1A and PaTEH1 Delta(270-280). PaTEH1B positively shifted the voltage-dependences of activation and slow inactivation of DmNa(v)1-1 channels to more positive potentials compared to PaTEH1A, suggesting that the C-terminal end of both proteins may influence the function of the voltage-sensor and the pore of Na-v channel. Interestingly, our findings showed that the sensitivity of DmNa(v)1-1 channels to lidocaine and to the pyrazoline-type insecticide metabolite DCJW depends on associated TEH1-like subunits. In conclusion, our work demonstrates for the first time that density, gating and pharmacological properties of Na-v channels expressed in Xenopus oocytes can be modulated by an intron retention process in the transcription of the neuronal TEH1-like ancillary subunits of P. americana.	[Bourdin, Celine M.; Moignot, Benedicte; Murillo, Laurence; Quinchard, Sophie; Lapied, Bruno; Legros, Christian] Univ Angers, UFR Sci, SFR QUASAV 4207, USC INRA 1330,UPRES EA 2647,Lab Recepteurs & Cana, Angers, France; [Wang, Lingxin; Dong, Ke] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA; [Wang, Lingxin; Dong, Ke] Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA; [Murillo, Laurence] Univ La Rochelle, Inst Littoral & Environm, UMR CNRS 7266, Lab LIttoral ENvironm & Soc LIENSs, La Rochelle, France; [Juchaux, Marjorie] Univ Angers, IMAC, SFR QUASAV 4207, Beaucouze, France; [Guerineau, Nathalie C.; Legros, Christian] Univ Angers, UFR Sci Med, Lab Biol Neurovasc & Mitochondriale Integree, UMR CNRS 6214,INSERM 1083, Angers, France	INRAE; Universite d'Angers; Michigan State University; Michigan State University; La Rochelle Universite; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Legros, C (corresponding author), Univ Angers, UFR Sci, SFR QUASAV 4207, USC INRA 1330,UPRES EA 2647,Lab Recepteurs & Cana, Angers, France.	christian.legros@univ-angers.fr	Legros, Christian/K-1346-2015; Wang, Lingxin/ABC-7603-2020	quinchard, sophie/0000-0002-2137-8374; LEGROS, Christian/0000-0002-3346-7059; Guerineau, Nathalie/0000-0003-2517-4210; MURILLO, Laurence/0000-0002-0934-4227; Lapied, Bruno/0000-0002-0354-4375	INRA; Region Pays de la Loire	INRA; Region Pays de la Loire(Region Pays de la Loire)	This work was supported by INRA and the Region Pays de la Loire (Ph.D. fellowships of Benedicte Moignot and Celine Bourdin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser JR, 1996, J GEN PHYSIOL, V107, P643, DOI 10.1085/jgp.107.5.643; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; Chevrier P, 2004, BRIT J PHARMACOL, V142, P576, DOI 10.1038/sj.bjp.0705796; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; DibHajj SD, 1995, FEBS LETT, V377, P485, DOI 10.1016/0014-5793(95)01400-4; Fan XR, 2010, ACTA PHARMACOL SIN, V31, P297, DOI 10.1038/aps.2010.8; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Goldin AL, 2002, J EXP BIOL, V205, P575; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lapied B, 2001, BRIT J PHARMACOL, V132, P587, DOI 10.1038/sj.bjp.0703853; Lavialle-Defaix C, 2006, J NEUROPHYSIOL, V96, P2437, DOI 10.1152/jn.00588.2006; Lavialle-Defaix C, 2010, J PHARMACOL EXP THER, V333, P264, DOI 10.1124/jpet.109.163519; Lenkowski PW, 2003, EUR J PHARMACOL, V467, P23, DOI 10.1016/S0014-2999(03)01595-4; Makielski JC, 1999, CARDIOVASC RES, V42, P503, DOI 10.1016/S0008-6363(99)00024-3; Makielski JC, 1996, MOL PHARMACOL, V49, P30; Meacham CA, 2008, TOXICOL APPL PHARM, V231, P273, DOI 10.1016/j.taap.2008.04.017; Moignot B, 2009, INSECT BIOCHEM MOLEC, V39, P814, DOI 10.1016/j.ibmb.2009.09.006; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; Qin N, 2003, EUR J BIOCHEM, V270, P4762, DOI 10.1046/j.1432-1033.2003.03878.x; SALGADO VL, 1992, MOL PHARMACOL, V41, P120; Sheets MF, 2003, J GEN PHYSIOL, V121, P163, DOI 10.1085/jgp.20028651; Silver KS, 2010, PESTIC BIOCHEM PHYS, V97, P87, DOI 10.1016/j.pestbp.2009.09.001; Silver KS, 2009, NEUROTOXICOLOGY, V30, P613, DOI 10.1016/j.neuro.2009.03.009; Silver KS, 2005, PESTIC BIOCHEM PHYS, V81, P136, DOI 10.1016/j.pestbp.2004.09.003; Song WZ, 2011, INSECT BIOCHEM MOLEC, V41, P36, DOI 10.1016/j.ibmb.2010.09.010; Song WZ, 2006, NEUROTOXICOLOGY, V27, P237, DOI 10.1016/j.neuro.2005.10.004; Szafranski K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r154; Tan JG, 2011, PESTIC BIOCHEM PHYS, V101, P256, DOI 10.1016/j.pestbp.2011.10.003; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Wing KD, 2000, CROP PROT, V19, P537, DOI 10.1016/S0261-2194(00)00070-3; Zhao XL, 2005, NEUROTOXICOLOGY, V26, P455, DOI 10.1016/j.neuro.2005.03.007	44	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e67290	10.1371/journal.pone.0067290	http://dx.doi.org/10.1371/journal.pone.0067290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967047	gold, Green Published, Green Submitted			2022-12-27	WOS:000323378000001
J	Ralph, AP; Waramori, G; Pontororing, GJ; Kenangalem, E; Wiguna, A; Tjitra, E; Sandjaja; Lolong, DB; Yeo, TW; Chatfield, MD; Soemanto, RK; Bastian, I; Lumb, R; Maguire, GP; Eisman, J; Price, RN; Morris, PS; Kelly, PM; Anstey, NM				Ralph, Anna P.; Waramori, Govert; Pontororing, Gysje J.; Kenangalem, Enny; Wiguna, Andri; Tjitra, Emiliana; Sandjaja; Lolong, Dina B.; Yeo, Tsin W.; Chatfield, Mark D.; Soemanto, Retno K.; Bastian, Ivan; Lumb, Richard; Maguire, Graeme P.; Eisman, John; Price, Ric N.; Morris, Peter S.; Kelly, Paul M.; Anstey, Nicholas M.			L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; PAPUA PROVINCE; D DEFICIENCY; WEIGHT-GAIN; SMEAR; RISK; CATHELICIDIN; MECHANISMS; CONVERSION; EXPRESSION	Background: Vitamin D (vitD) and L-arginine have important antimycobacterial effects in humans. Adjunctive therapy with these agents has the potential to improve outcomes in active tuberculosis (TB). Methods: In a 4-arm randomised, double-blind, placebo-controlled factorial trial in adults with smear-positive pulmonary tuberculosis (PTB) in Timika, Indonesia, we tested the effect of oral adjunctive vitD 50,000 IU 4-weekly or matching placebo, and L-arginine 6.0 g daily or matching placebo, for 8 weeks, on proportions of participants with negative 4-week sputum culture, and on an 8-week clinical score (weight, FEV1, cough, sputum, haemoptysis). All participants with available endpoints were included in analyses according to the study arm to which they were originally assigned. Adults with new smear-positive PTB were eligible. The trial was registered at ClinicalTrials.gov NCT00677339. Results: 200 participants were enrolled, less than the intended sample size: 50 received L-arginine + active vitD, 49 received L-arginine + placebo vit D, 51 received placebo L-arginine + active vitD and 50 received placebo L-arginine + placebo vitD. According to the factorial model, 99 people received arginine, 101 placebo arginine, 101 vitamin D, 99 placebo vitamin D. Results for the primary endpoints were available in 155 (4-week culture) and 167 (clinical score) participants. Sputum culture conversion was achieved by week 4 in 48/76 (63%) participants in the active L-arginine versus 48/79 (61%) in placebo L-arginine arms (risk difference -3%, 95% CI -19 to 13%), and in 44/75 (59%) in the active vitD versus 52/80 (65%) in the placebo vitD arms (risk difference 7%, 95% CI -9 to 22%). The mean clinical outcome score also did not differ between study arms. There were no effects of the interventions on adverse event rates including hypercalcaemia, or other secondary outcomes. Conclusion: Neither vitD nor L-arginine supplementation, at the doses administered and with the power attained, affected TB outcomes.	[Ralph, Anna P.; Yeo, Tsin W.; Chatfield, Mark D.; Price, Ric N.; Morris, Peter S.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Ralph, Anna P.; Price, Ric N.; Anstey, Nicholas M.] Royal Darwin Hosp, Dept Med, Darwin, NT, Australia; [Waramori, Govert] PT Freeport Indonesia, Publ Hlth & Malaria Control Dept, Timika, Papua Province, Indonesia; [Pontororing, Gysje J.; Kenangalem, Enny] Natl Inst Hlth Res & Dev Res Program, Menzies Sch Hlth Res, Timika, Papua Province, Indonesia; [Kenangalem, Enny] Dist Hlth Author, Timika, Papua Province, Indonesia; [Wiguna, Andri] Int SOS, Timika, Papua Province, Indonesia; [Tjitra, Emiliana; Sandjaja; Lolong, Dina B.] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Soemanto, Retno K.] Univ Indonesia, Fac Med, Dept Microbiol, Jakarta, Indonesia; [Bastian, Ivan; Lumb, Richard] Inst Med & Vet Pathol, Adelaide, SA, Australia; [Maguire, Graeme P.] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Maguire, Graeme P.] Baker IDI Heart & Diabet Inst, Alice Springs, NT, Australia; [Eisman, John] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Kelly, Paul M.] ACT Hlth, Canberra, ACT, Australia	Charles Darwin University; Menzies School of Health Research; Freeport Indonesia; International SOS; National Institute of Health Research & Development - Indonesia; University of Indonesia; Institute Medical & Veterinary Science Australia; James Cook University; Baker Heart and Diabetes Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Ralph, AP (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	anna.ralph@menzies.edu.au	Chatfield, Mark D/N-2278-2013; Ralph, Anna/AAB-6103-2021; Eisman, John A/C-2886-2014; Yeo, Tsin Wen/F-9505-2015	Chatfield, Mark D/0000-0002-0004-6274; Price, Richard/0000-0003-2000-2874	Australian Respiratory Council, a Royal Australasian College of Physicians Covance Award; National Health and Medical Research Council (NHMRC) of Australia [605806, 496600]; Wellcome Trust Senior Research Fellowship	Australian Respiratory Council, a Royal Australasian College of Physicians Covance Award; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Senior Research Fellowship(Wellcome Trust)	Funding was provided by the Australian Respiratory Council, a Royal Australasian College of Physicians Covance Award to APR, and the National Health and Medical Research Council (NHMRC) of Australia (Grants 605806 and 496600; Scholarship to APR, Fellowships to APR, TWY, PMK, NMA). RNP is supported by a Wellcome Trust Senior Research Fellowship. Views expressed in this publication are those of the authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], TIM WEATH; Ardian M, 2007, INT J TUBERC LUNG D, V11, P1101; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Byth Karen, 2004, Clin Trials, V1, P315; Chang JM, 2004, J LAB CLIN MED, V143, P14, DOI 10.1016/j.lab.2003.08.002; Conesa-Botella A, 2012, CLIN INFECT DIS; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Davies P, 2010, AM J RESP CRIT CARE, V181, P94, DOI 10.1164/ajrccm.181.1.94a; Diamond TH, 2005, MED J AUSTRALIA, V182, P281, DOI 10.5694/j.1326-5377.2005.tb06701.x; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Gill M, 2006, J ASTHMA, V43, P731, DOI 10.1080/02770900601031045; Grant CC, 2009, PUBLIC HEALTH NUTR, P1; Grasemann H, 2006, AM J RESP CRIT CARE, V174, P208, DOI 10.1164/rccm.200509-1439OC; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P61, DOI 10.5588/ijtld.12.0369; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Jones Paul W, 2005, COPD, V2, P75; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; KHARITONOV SA, 1995, CLIN SCI, V88, P135, DOI 10.1042/cs0880135; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; Lugo-Villarino G, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00043; Lumb R, 2006, INT J TUBERC LUNG D, V10, P172; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Martineau AR, 2009, INT J TUBERC LUNG D, V13, P119; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineau AR, 2007, AM J RESP CRIT CARE; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; Narang N K, 1984, J Assoc Physicians India, V32, P185; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Onyebujoh P, 2006, LANCET, V367, P940, DOI 10.1016/S0140-6736(06)68385-2; Pessanha AP, 2012, FEMS IMMUNOL MED MIC; Pontororing GJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-362; Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Ralph AP, 2013, J INFEC IN PRESS FEB; Rizzoli R, 2006, INT J CLIN PRACT, V60, P1013, DOI 10.1111/j.1742-1241.2006.01066.x; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Schon T, 2011, TUBERCULOSIS, V91, P370, DOI 10.1016/j.tube.2011.06.002; Schon T, 2003, EUR RESPIR J, V21, P483, DOI 10.1183/09031936.03.00090702; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub3; Talat N, 2010, EMERG INFECT DIS, V16, P853, DOI 10.3201/eid1605.091693; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; Tostmann A, 2010, INT J TUBERC LUNG D, V14, P1147; Vasantha M, 2009, Indian J Tuberc, V56, P5; Vieth R, 2011, LANCET, V377, P189, DOI 10.1016/S0140-6736(10)62300-8; Wejse C, 2009, AM J RESP CRIT CARE; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zea AH, 2006, J INFECT DIS, V194, P1385, DOI 10.1086/508200	60	80	83	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70032	10.1371/journal.pone.0070032	http://dx.doi.org/10.1371/journal.pone.0070032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967066	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000323221500011
J	D'Agostino, VG; Adami, V; Provenzani, A				D'Agostino, Vito G.; Adami, Valentina; Provenzani, Alessandro			A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex Formation	PLOS ONE			English	Article							ALPHA MESSENGER-RNA; AU-RICH ELEMENT; 3'-UNTRANSLATED REGION; TNF-ALPHA; BINDING; MITOXANTRONE; STABILITY; SEQUENCE	The RNA binding protein HuR/ELAVL1 binds to AU-rich elements (AREs) promoting the stabilization and translation of a number of mRNAs into the cytoplasm, dictating their fate. We applied the AlphaScreen technology using purified human HuR protein, expressed in a mammalian cell-based system, to characterize in vitro its binding performance towards a ssRNA probe whose sequence corresponds to the are present in TNF alpha 3' untranslated region. We optimized the method to titrate ligands and analyzed the kinetic in saturation binding and time course experiments, including competition assays. The method revealed to be a successful tool for determination of HuR binding kinetic parameters in the nanomolar range, with calculated Kd of 2.5+/-0.60 nM, k(on) of 2.76+/-0.56* 10(6) M-1 min(-1), and k(off) of 0.007+/-0.005 min(-1). We also tested the HuR-RNA complex formation by fluorescent probe-based RNA-EMSA. Moreover, in a 384-well plate format we obtained a Z-factor of 0.84 and an averaged coefficient of variation between controls of 8%, indicating that this biochemical assay fulfills criteria of robustness for a targeted screening approach. After a screening with 2000 small molecules and secondary verification with RNA-EMSA we identified mitoxantrone as an interfering compound with rHuR and TNF alpha probe complex formation. Notably, this tool has a large versatility and could be applied to other RNA Binding Proteins recognizing different RNA, DNA, or protein species. In addition, it opens new perspectives in the identification of small-molecule modulators of RNA binding proteins activity.	[D'Agostino, Vito G.; Provenzani, Alessandro] Univ Trento, Ctr Integrat Biol, Lab Genom Screening, Mattarello, Trento, Italy; [Adami, Valentina] Univ Trento, Ctr Integrat Biol, High Throughput Screening Core Facil, Mattarello, Trento, Italy	University of Trento; University of Trento	Provenzani, A (corresponding author), Univ Trento, Ctr Integrat Biol, Lab Genom Screening, Mattarello, Trento, Italy.	provenzani@science.unitn.it	D'Agostino, Vito/AAS-4260-2020	D'Agostino, Vito/0000-0003-3379-2254; Provenzani, Alessandro/0000-0003-1652-3415	University of Trento, CIBIO start-up funds	University of Trento, CIBIO start-up funds	This project has been carried out by using University of Trento, CIBIO start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; ALBERTS DS, 1980, CANCER CHEMOTH PHARM, V5, P11, DOI 10.1007/BF00578556; Basu A, 2010, J BIOL CHEM, V285, P25196, DOI 10.1074/jbc.M110.119446; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chae MJ, 2009, EXP MOL MED, V41, P824, DOI 10.3858/emm.2009.41.11.088; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Edan G, 2004, J NEUROL SCI, V223, P35, DOI 10.1016/j.jns.2004.04.017; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; KAPUSCINSKI J, 1986, P NATL ACAD SCI USA, V83, P6302, DOI 10.1073/pnas.83.17.6302; KAPUSCINSKI J, 1981, BIOCHEM PHARMACOL, V30, P231, DOI 10.1016/0006-2952(81)90083-6; Kim Y, 1996, BIOCHEM J, V316, P455, DOI 10.1042/bj3160455; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Meisner NC, NAT CHEM BIOL, V8, P508; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; Sakai K, 1999, FEBS LETT, V446, P157, DOI 10.1016/S0014-5793(99)00206-9; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Wang H, 2011, ACTA CRYSTALLOGR F, V67, P546, DOI 10.1107/S1744309110052930; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng SX, 2009, CHEM BIOL, V16, P557, DOI 10.1016/j.chembiol.2009.03.009	34	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72426	10.1371/journal.pone.0072426	http://dx.doi.org/10.1371/journal.pone.0072426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951323	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300198
J	Vallieres, C; Fisher, N; Meunier, B				Vallieres, Cindy; Fisher, Nicholas; Meunier, Brigitte			Reconstructing the Q(o) Site of Plasmodium falciparum bc(1) Complex in the Yeast Enzyme	PLOS ONE			English	Article							CYTOCHROME-B MUTATIONS; SACCHAROMYCES-CEREVISIAE; ATOVAQUONE RESISTANCE; CONFERRING RESISTANCE; RESPIRATORY-CHAIN; MOLECULAR-BASIS; BINDING POCKET; MALARIA; PROPHYLAXIS; INHIBITORS	The bc(1) complex of the mitochondrial respiratory chain is essential for Plasmodium falciparum proliferation, the causative agent of human malaria. Therefore, this enzyme is an attractive target for antimalarials. However, biochemical investigations of the parasite enzyme needed for the study of new drugs are challenging. In order to facilitate the study of new compounds targeting the enzyme, we are modifying the inhibitor binding sites of the yeast Saccharomyces cerevisiae to generate a complex that mimics the P. falciparum enzyme. In this study we focused on its Q(o) pocket, the site of atovaquone binding which is a leading antimalarial drug used in treatment and causal prophylaxis. We constructed and studied a series of mutants with modified Q(o) sites where yeast residues have been replaced by P. falciparum equivalents, or, for comparison, by human equivalents. Mitochondria were prepared from the yeast Plasmodium-like and human-like Q(o) mutants. We measured the bc(1) complex sensitivity to atovaquone, azoxystrobin, a Q(o) site targeting fungicide active against P. falciparum and RCQ06, a quinolone-derivative inhibitor of P. falciparum bc(1) complex. The data obtained highlighted variations in the Q(o) site that could explain the differences in inhibitor sensitivity between yeast, plasmodial and human enzymes. We showed that the yeast Plasmodium-like Q(o) mutants could be useful and easy-to-use tools for the study of that class of antimalarials.	[Vallieres, Cindy; Meunier, Brigitte] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Fisher, Nicholas] Michigan State Univ, Plant Res Lab, E Lansing, MI 48824 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Michigan State University	Meunier, B (corresponding author), CNRS, Ctr Genet Mol, Gif Sur Yvette, France.	meunier@cgm.cnrs-gif.fr	Vallieres, Cindy/AAV-3381-2020	Vallieres, Cindy/0000-0001-6409-1296; Meunier, Brigitte/0000-0002-6988-4663	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The work was supported by a Centre National de la Recherche Scientifique (CNRS) studentship to CV and CNRS recurrent funding to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Berry EA, 2011, BBA-BIOENERGETICS, V1807, P1349, DOI 10.1016/j.bbabio.2011.04.005; Biagini GA, 2008, MOL PHARMACOL, V73, P1347, DOI 10.1124/mol.108.045120; Biagini GA, 2012, P NATL ACAD SCI USA, V109, P8298, DOI 10.1073/pnas.1205651109; Cowley R, 2012, MEDCHEMCOMM, V3, P39, DOI 10.1039/c1md00183c; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Doggett JS, 2012, P NATL ACAD SCI USA, V109, P15936, DOI 10.1073/pnas.1208069109; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Fivelman Quinton L, 2002, Malar J, V1, P1; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Hughes LM, 2011, MOL BIOCHEM PARASIT, V177, P12, DOI 10.1016/j.molbiopara.2011.01.002; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kazanjian P, 2001, J INFECT DIS, V183, P819, DOI 10.1086/318835; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; Kessl JJ, 2004, J BIOL CHEM, V279, P2817, DOI 10.1074/jbc.M309984200; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Lee DW, 2011, J BIOL CHEM, V286, P18139, DOI 10.1074/jbc.M110.214460; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Mather MW, 2005, J BIOL CHEM, V280, P27458, DOI 10.1074/jbc.M502319200; McFadden DC, 2000, MOL BIOCHEM PARASIT, V108, P1, DOI 10.1016/S0166-6851(00)00184-5; Musset L, 2007, MOL BIOL EVOL, V24, P1582, DOI 10.1093/molbev/msm087; Musset L, 2006, MICROBES INFECT, V8, P2599, DOI 10.1016/j.micinf.2006.07.011; Nam TG, 2011, ACS CHEM BIOL, V6, P1214, DOI 10.1021/cb200105d; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich PR, 2004, BBA-BIOENERGETICS, V1658, P165, DOI 10.1016/j.bbabio.2004.04.021; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Syafruddin D, 1999, MOL BIOCHEM PARASIT, V104, P185, DOI 10.1016/S0166-6851(99)00148-6; Vallieres C, 2012, ANTIMICROB AGENTS CH, V56, P3739, DOI 10.1128/AAC.00486-12; Walker DJ, 1998, J INFECT DIS, V178, P1767, DOI 10.1086/314509; Witschel M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001805	39	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71726	10.1371/journal.pone.0071726	http://dx.doi.org/10.1371/journal.pone.0071726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951230	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300148
J	Wennier, ST; Brinkmann, K; Steinhauser, C; Maylander, N; Mnich, C; Wielert, U; Dirmeier, U; Hausmann, J; Chaplin, P; Steigerwald, R				Wennier, Sonia T.; Brinkmann, Kay; Steinhaeuser, Charlotte; Maylaender, Nicole; Mnich, Claudia; Wielert, Ursula; Dirmeier, Ulrike; Hausmann, Juergen; Chaplin, Paul; Steigerwald, Robin			A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses	PLOS ONE			English	Article							ATTENUATED SMALLPOX VACCINE; EARLY TRANSCRIPTION FACTOR; T-CELL DETERMINANTS; COMPLEX PATHOGENS; HOST-RANGE; IN-VITRO; IMMUNOGENICITY; REPLICATION; PROTEIN; VECTOR	Modified vaccinia virus Ankara (MVA) has been shown to be suitable for the generation of experimental vaccines against cancer and infectious diseases, eliciting strong humoral and cellular immune responses. In viral vectored vaccines, strong recombinant antigen expression and timing of expression influence the quantity and quality of the immune response. Screening of synthetic and native poxvirus promoters for strong protein expression in vitro and potent immune responses in vivo led to the identification of the MVA13.5L promoter, a unique and novel naturally occurring tandem promoter in MVA composed of two 44 nucleotide long repeated motifs, each containing an early promoter element. The MVA13.5L gene is highly conserved across orthopoxviruses, yet its function is unknown. The unique structure of its promoter is not found for any other gene in the MVA genome and is also conserved in other orthopoxviruses. Comparison of the MVA13.5L promoter activity with synthetic poxviral promoters revealed that the MVA13.5L promoter produced higher levels of protein early during infection in HeLa cells and particularly in MDBK cells, a cell line in which MVA replication stops at an early stage before the expression of late genes. Finally, a recombinant antigen expressed under the control of this novel promoter induced high antibody titers and increased CD8 T cell responses in homologous prime-boost immunization compared to commonly used promoters. In particular, the recombinant antigen specific CD8 T cell responses dominated over the immunodominant B8R vector-specific responses after three vaccinations and even more during the memory phase. These results have identified the native MVA13.5L promoter as a new potent promoter for use in MVA vectored preventive and therapeutic vaccines.	[Wennier, Sonia T.; Brinkmann, Kay; Steinhaeuser, Charlotte; Maylaender, Nicole; Mnich, Claudia; Wielert, Ursula; Dirmeier, Ulrike; Hausmann, Juergen; Chaplin, Paul; Steigerwald, Robin] Bavarian Nord GmbH, Div Infect Dis, Martinsried, Germany	Bavarian Nordic	Steigerwald, R (corresponding author), Bavarian Nord GmbH, Div Infect Dis, Martinsried, Germany.	robin.steigerwald@bavarian-nordic.com			Bavarian Nordic GmbH	Bavarian Nordic GmbH	Bavarian Nordic GmbH funded this study and all authors are employees and/or shareholders of Bavarian Nordic GmbH. RS and KB are named inventors in a patent application relating to the PrMVA13.5 promoters (U.S. Patent Application No. 61/719,429). RS, KB, UD and PC are named inventors in a patent application relating to the PRS5E and Pr4LS5E (U.S. Patent Application No. 61/663,238). The authors declare no further conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Baur K, 2010, J VIROL, V84, P8743, DOI 10.1128/JVI.00604-10; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; BROYLES SS, 1991, J BIOL CHEM, V266, P15539; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Cassetti MC, 1996, P NATL ACAD SCI USA, V93, P7540, DOI 10.1073/pnas.93.15.7540; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; FUNAHASHI SI, 1991, J VIROL, V65, P5584, DOI 10.1128/JVI.65.10.5584-5588.1991; Gomez CE, 2011, CURR GENE THER, V11, P189; Greenberg RN, 2013, J INFECT DIS, V207, P749, DOI 10.1093/infdis/jis753; Howley PM, 1996, GENE, V172, P233, DOI 10.1016/0378-1119(96)00192-8; HRUBY DE, 1980, J GEN VIROL, V47, P485, DOI 10.1099/0022-1317-47-2-485; JIN NY, 1994, ARCH VIROL, V138, P315, DOI 10.1007/BF01379134; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MAYR A, 1964, ZENTBL BAKTERIOLOG P, V195, P24; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meisinger-Henschel C, 2010, J VIROL, V84, P9907, DOI 10.1128/JVI.00756-10; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Moutaftsi M, 2010, FUTURE MICROBIOL, V5, P221, DOI [10.2217/fmb.09.110, 10.2217/FMB.09.110]; Orubu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040167; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Sancho MC, 2002, J VIROL, V76, P8318, DOI 10.1128/JVI.76.16.8318-8334.2002; Schweneker M, 2012, J VIROL, V86, P2323, DOI 10.1128/JVI.06166-11; Sette A, 2009, VACCINE, V27, pG21, DOI 10.1016/j.vaccine.2009.10.011; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; Walsh SR, 2009, VACCINE, V27, P4990, DOI 10.1016/j.vaccine.2009.05.077; Wilck MB, 2010, J INFECT DIS, V201, P1361, DOI 10.1086/651561; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	49	20	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73511	10.1371/journal.pone.0073511	http://dx.doi.org/10.1371/journal.pone.0073511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951355	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300206
J	Duff, G; Argaw, A; Cecyre, B; Cherif, H; Tea, N; Zabouri, N; Casanova, C; Ptito, M; Bouchard, JF				Duff, Gabriel; Argaw, Anteneh; Cecyre, Bruno; Cherif, Hosni; Tea, Nicolas; Zabouri, Nawal; Casanova, Christian; Ptito, Maurice; Bouchard, Jean-Francois			Cannabinoid Receptor CB2 Modulates Axon Guidance	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; GROWTH CONE GUIDANCE; ADULT-RAT RETINA; COLORECTAL-CANCER; PLASMA-MEMBRANE; MESSENGER-RNA; RECRUITS DCC; OPTIC-NERVE; CYCLIC-AMP; NETRIN-1	Navigation of retinal projections towards their targets is regulated by guidance molecules and growth cone transduction mechanisms. Here, we present in vitro and in vivo evidences that the cannabinoid receptor 2 (CB2R) is expressed along the retino-thalamic pathway and exerts a modulatory action on axon guidance. These effects are specific to CB2R since no changes were observed in mice where the gene coding for this receptor was altered (cnr2(-/-)). The CB2R induced morphological changes observed at the growth cone are PKA dependent and require the presence of the netrin-1 receptor, Deleted in Colorectal Cancer. Interfering with endogenous CB2R signalling using pharmacological agents increased retinal axon length and induced aberrant projections. Additionally, cnr2(-/-) mice showed abnormal eye-specific segregation of retinal projections in the dorsal lateral geniculate nucleus (dLGN) indicating CB2R's implication in retinothalamic development. Overall, this study demonstrates that the contribution of endocannabinoids to brain development is not solely mediated by CB1R, but also involves CB2R.	[Duff, Gabriel; Argaw, Anteneh; Cecyre, Bruno; Cherif, Hosni; Tea, Nicolas; Zabouri, Nawal; Casanova, Christian; Ptito, Maurice; Bouchard, Jean-Francois] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Duff, Gabriel; Bouchard, Jean-Francois] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Argaw, Anteneh] Univ Montreal, Fac Med, Dept Biomed Sci, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Bouchard, JF (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	Jean-Francois.Bouchard@umontreal.ca	Ptito, Maurice/G-3422-2013	Ptito, Maurice/0000-0002-5173-5862; CHERIF, Hosni/0000-0002-0703-3898	Canadian Institutes of Health Research (CIHR) [MOP-86495]; National Sciences and Engineering Research Council of Canada (NSERC) [311892-2010]; E.A. Baker Foundation; Institute of Neuroscience, Mental Health and Addiction (INMHA) of the CIHR; Fonds de recherche en sante du Quebec (FRSQ); FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); E.A. Baker Foundation; Institute of Neuroscience, Mental Health and Addiction (INMHA) of the CIHR; Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work is supported by grants to JFB from the Canadian Institutes of Health Research (CIHR, MOP-86495) and National Sciences and Engineering Research Council of Canada (NSERC, 311892-2010). AA was supported by a doctoral research award from E.A. Baker Foundation and The Institute of Neuroscience, Mental Health and Addiction (INMHA) of the CIHR. GD was supported by a fellowship from the Fonds de recherche en sante du Quebec (FRSQ). JFB is a scholar Junior 2 of the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw A, 2008, EXP NEUROL, V211, P494, DOI 10.1016/j.expneurol.2008.02.014; Argaw A, 2011, J NEUROSCI, V31, P1489, DOI 10.1523/JNEUROSCI.4134-09.2011; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; BHIDE PG, 1991, J NEUROSCI, V11, P485; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Bovolenta P, 2005, J NEUROBIOL, V64, P405, DOI 10.1002/neu.20161; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Fernandez-Ruiz J, 2000, TRENDS NEUROSCI, V23, P14, DOI 10.1016/S0166-2236(99)01491-5; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Greenhough A, 2007, INT J CANCER, V121, P2172, DOI 10.1002/ijc.22917; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lopez EM, 2011, SYNAPSE, V65, P388, DOI 10.1002/syn.20856; Lu QJ, 2000, VISUAL NEUROSCI, V17, P91, DOI 10.1017/S0952523800171093; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Ono M, 2001, J HISTOCHEM CYTOCHEM, V49, P305, DOI 10.1177/002215540104900304; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Prather Paul L., 2008, P75, DOI 10.1007/978-0-387-74349-3_6; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; ROBINSON SR, 1990, BRAIN BEHAV EVOLUT, V36, P177, DOI 10.1159/000115306; Ross RA, 2001, NEUROPHARMACOLOGY, V40, P221, DOI 10.1016/S0028-3908(00)00135-0; Salzet M, 2000, BRAIN RES REV, V34, P69, DOI 10.1016/S0165-0173(00)00041-2; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; SHOLL DA, 1953, J ANAT, V87, P387; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V229, P58, DOI 10.1006/bbrc.1996.1757; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vitalis T, 2008, EUR J NEUROSCI, V28, P1705, DOI 10.1111/j.1460-9568.2008.06484.x; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhou D, 2001, J NEUROSCI RES, V65, P346, DOI 10.1002/jnr.1160	60	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70849	10.1371/journal.pone.0070849	http://dx.doi.org/10.1371/journal.pone.0070849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951024	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200022
J	Lim, JY; Ra, JC; Shin, IS; Jang, YH; An, HY; Choi, JS; Kim, WC; Kim, YM				Lim, Jae-Yol; Ra, Jeong Chan; Shin, Il Seob; Jang, Yun Ho; An, Hye-Young; Choi, Jeong-Seok; Kim, Woo Cheol; Kim, Young-Mo			Systemic Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells for the Regeneration of Irradiation-Induced Salivary Gland Damage	PLOS ONE			English	Article							STROMAL CELLS; ENGRAFTMENT; RESCUE; HEAD	Objectives: Cell-based therapy has been reported to repair or restore damaged salivary gland (SG) tissue after irradiation. This study was aimed at determining whether systemic administration of human adipose-derived mesenchymal stem cells (hAdMSCs) can ameliorate radiation-induced SG damage. Methods: hAdMSCs (1x10(6)) were administered through a tail vein of C3H mice immediately after local irradiation, and then this infusion was repeated once a week for 3 consecutive weeks. At 12 weeks after irradiation, functional evaluations were conducted by measuring salivary flow rates (SFRs) and salivation lag times, and histopathologic and immunofluorescence histochemistry studies were performed to assay microstructural changes, apoptosis, and proliferation indices. The engraftment and in vivo differentiation of infused hAdMSCs were also investigated, and the transdifferentiation of hAdMSCs into amylase-producing SG epithelial cells (SGCs) was observed in vitro using a co-culture system. Results: The systemic administration of hAdMSCs exhibited improved SFRs at 12 weeks after irradiation. hAdMSC-transplanted SGs showed fewer damaged and atrophied acinar cells and higher mucin and amylase production levels than untreated irradiated SGs. Immunofluorescence TUNEL assays revealed fewer apoptotic cells in the hAdMSC group than in the untreated group. Infused hAdMSCs were detected in transplanted SGs at 4 weeks after irradiation and some cells were found to have differentiated into SGCs. In vitro, a low number of co-cultured hAdMSCs (13%-18%) were observed to transdifferentiate into SGCs. Conclusion: The findings of this study indicate that hAdMSCs have the potential to protect against irradiation-induced cell loss and to transdifferentiate into SGCs, and suggest that hAdMSC administration should be viewed as a candidate therapy for the treatment of radiation-induced SG damage.	[Lim, Jae-Yol; Jang, Yun Ho; An, Hye-Young; Choi, Jeong-Seok; Kim, Young-Mo] Inha Univ Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [Ra, Jeong Chan; Shin, Il Seob] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea; [Kim, Woo Cheol] Inha Univ Sch Med, Dept Radiat Oncol, Inchon, South Korea	Inha University; Inha University	Kim, YM (corresponding author), Inha Univ Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea.	ymk416@inha.ac.kr		im, jaeyeol/0000-0002-9757-6414	National Research Foundation of Korea (NRF); Korea government (MEST) [NRF-2012R1A1A2006712]; Inha Research Grant	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Inha Research Grant	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (NRF-2012R1A1A2006712) and an Inha Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aframian DJ, 2008, TISSUE ENG PART B-RE, V14, P187, DOI 10.1089/ten.teb.2008.0044; Baum BJ, 2010, ORAL ONCOL, V46, P4, DOI 10.1016/j.oraloncology.2009.09.004; Chambers MS, 2004, HEAD NECK-J SCI SPEC, V26, P796, DOI 10.1002/hed.20045; Choi EW, 2011, J GENE MED, V13, P3, DOI 10.1002/jgm.1531; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Gao ZM, 2012, CYTOTHERAPY, V14, P267, DOI 10.3109/14653249.2011.616194; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Kang HM, 2009, STEM CELLS, V27, P1999, DOI 10.1002/stem.127; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2008, CLIN CANCER RES, V14, P7741, DOI 10.1158/1078-0432.CCR-08-1449; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Saito T, 2002, ANN THORAC SURG, V74, P19, DOI 10.1016/S0003-4975(02)03591-9; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Sugito T, 2004, CELL TRANSPLANT, V13, P691, DOI 10.3727/000000004783983567; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Tran SD, 2011, INT J BIOCHEM CELL B, V43, P5, DOI 10.1016/j.biocel.2010.10.010; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Zhou B, 2011, CLIN IMMUNOL, V141, P328, DOI 10.1016/j.clim.2011.08.014	28	81	83	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71167	10.1371/journal.pone.0071167	http://dx.doi.org/10.1371/journal.pone.0071167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951100	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200033
J	Morgan, DR; Arrow, J; Smith, MP				Morgan, David R.; Arrow, Jane; Smith, Mark P.			Combining Aspirin with Cholecalciferol (Vitamin D-3) - A Potential New Tool for Controlling Possum Populations	PLOS ONE			English	Article							ACETYLSALICYLIC-ACID; INTRODUCED MAMMALS; CALCIUM-CARBONATE; BRUSHTAIL POSSUM; SALICYLIC-ACID; RODENT CONTROL; TISSUE FACTOR; NEW-ZEALAND; TROPONIN-I; PHARMACOKINETICS	The introduced Australian brushtail possum is a major vertebrate pest in New Zealand, with impacts on conservation and agriculture being managed largely through poisoning operations. Cholecalciferol (vitamin D-3) is registered for use in controlling possums and despite its many advantages it is expensive and relatively inhumane. Combination of a high proportion of aspirin with a low proportion of cholecalciferol was effective in killing high proportions of groups of acclimatised, caged possums: this is attributed to both an unexpectedly high toxicity of the type of cholecalciferol used, and a proposed synergistic mechanism between the two compounds. Death was caused by localised damage to heart ventricles by aspirin, and inhibition of tissue repair by both aspirin and cholecalciferol. The observed toxicosis had lower impact on the welfare of possums than either compound administered alone, particularly aspirin alone. Residue analyses of bait remains in the GI tract suggested a low risk of secondary poisoning by either compound. The combination of cholecalciferol and aspirin has the potential to meet key requirements of cost-effectiveness and humaneness in controlling possum populations, but the effect of the combination in non-target species has yet to be tested.	[Morgan, David R.; Arrow, Jane] Landcare Res, Canterbury, New Zealand; [Smith, Mark P.] Canterbury Dist Hlth Board, Canterbury, New Zealand	Landcare Research - New Zealand	Morgan, DR (corresponding author), Landcare Res, Canterbury, New Zealand.	morgand@landcareresearch.co.nz			Animal Health Board [R-10657, R-10657-01, R-10657-02]; Ministry of Business, Innovation and Employment [C09X1007]	Animal Health Board; Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	The research was funded by the Animal Health Board (grant numbers R-10657, R-10657-01, and R-10657-02), and the Foundation for Research, Science and Technology (now Ministry of Business, Innovation and Employment) (grant number C09X1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; [Anonymous], 2012, ANN REPORT 2011 12; [Anonymous], 2000, BRUSHTAIL POSSUM BIO; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Beausoleil NJ, 2010, VERTEBRATE TOXIC AGE, P11; BEDFORD C, 1965, BRIT J PHARM CHEMOTH, V24, P418, DOI 10.1111/j.1476-5381.1965.tb01729.x; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bikle DD, 2011, EXP DERMATOL, V20, P7, DOI 10.1111/j.1600-0625.2010.01202.x; BOYD EM, 1959, TOXICOL APPL PHARM, V1, P229, DOI 10.1016/0041-008X(59)90107-3; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Carmeliet G, 2003, BEST PRACT RES CL EN, V17, P529, DOI 10.1016/j.beem.2003.08.001; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Eason CT, 2010, INTEGR ZOOL, V5, P31, DOI 10.1111/j.1749-4877.2010.00183.x; EASON CT, 1993, NEW ZEAL J ZOOL, V20, P329, DOI 10.1080/03014223.1993.10420354; EASON CT, 1996, P 17 VERT PEST CONTR, P54; Eason CT, 2011, EUR VERT PEST MAN C, P146; EASON CT, 2001, VERTEBRATE PESTICIDE; *ERMA, 2007, REASS 1080; ETIEVENT JP, 1995, ANN THORAC SURG, V59, P1192, DOI 10.1016/0003-4975(95)00129-9; Fisher NG, 2001, EUR J HEART FAIL, V3, P373, DOI 10.1016/S1388-9842(01)00125-8; Franeta JT, 2002, FARMACO, V57, P709, DOI 10.1016/S0014-827X(02)01265-X; Glisson JK, 2011, SOUTH MED J, V104, P225, DOI 10.1097/SMJ.0b013e318205e548; Green W, 2011, J R SOC NZ, V42, P1, DOI [10.1080/03036758.2011.556130, DOI 10.1080/03036758.2011.556130.4.ERMA]; Hall JE., 2011, TXB MED PHYSL; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hickman PE, 2010, CLIN CHIM ACTA, V411, P318, DOI 10.1016/j.cca.2009.12.009; Hiroyuki K, 1985, BIOCHEM PHARMACOL, V34, P1901, DOI [10.1016/0006-2952(85)90306-5, DOI 10.1016/0006-2952(85)90306-5]; Hix S, 2012, NEW ZEAL J AGR RES, V55, P207, DOI 10.1080/00288233.2012.665806; JOLLY SE, 1995, WILDLIFE RES, V22, P579, DOI 10.1071/WR9950579; JOLLY SE, 1993, PESTIC BIOCHEM PHYS, V47, P159, DOI 10.1006/pest.1993.1074; KATO Y, 1982, TOXICOL APPL PHARM, V64, P64, DOI 10.1016/0041-008X(82)90322-2; Kerins, 2002, COMP CLIN PATHOL, V11, P59, DOI DOI 10.1007/S580-002-8083-9; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; Liamis G, 2010, DRUG SAFETY, V33, P371, DOI 10.2165/11533790-000000000-00000; Littin KE, 2009, WILDLIFE RES, V36, P709, DOI 10.1071/WR09009; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; Marshall EF., 1984, P 11 VERT PEST C, P95; Mason G, 2003, ANIM WELFARE, V12, P1; Mauldin RE, 1999, J AOAC INT, V82, P792; Meerburg BG, 2008, PEST MANAG SCI, V64, P1205, DOI 10.1002/ps.1623; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; MORGAN DR, 1981, NEW ZEAL J FOR SCI, V11, P271; Morgan DR, 2000, POSSUMS NZ BIOL IMPA, P143; Nadir MA, 2010, CARDIOVASC THER, V28, pe5, DOI 10.1111/j.1755-5922.2010.00192.x; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012; O'Connor CE, 2003, LC0203158; Ohsawa M, 2000, CIRCULATION, V102, P2867; Parkes J, 2003, NEW ZEAL J ZOOL, V30, P335, DOI 10.1080/03014223.2003.9518346; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Scragg R, 2011, VITAMIN D AND CANCER, P115, DOI 10.1007/978-1-4419-7188-3_6; Shaffer JF, 2010, PHYSIOL GENOMICS, V42, P406, DOI 10.1152/physiolgenomics.00055.2010; SHORT CR, 1991, J VET PHARMACOL THER, V14, P70, DOI 10.1111/j.1365-2885.1991.tb00806.x; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; TOMODA T, 1994, LIVER, V14, P103	63	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70683	10.1371/journal.pone.0070683	http://dx.doi.org/10.1371/journal.pone.0070683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23950982	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200016
J	Stalmans, S; Wynendaele, E; Bracke, N; Gevaert, B; D'Hondt, M; Peremans, K; Burvenich, C; De Spiegeleer, B				Stalmans, Sofie; Wynendaele, Evelien; Bracke, Nathalie; Gevaert, Bert; D'Hondt, Matthias; Peremans, Kathelijne; Burvenich, Christian; De Spiegeleer, Bart			Chemical-Functional Diversity in Cell-Penetrating Peptides	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; HIV-1 TAT PROTEIN; MOLECULAR TRANSPORTERS; PLASMA-MEMBRANE; IN-VITRO; DELIVERY; ANALOGS; INTERNALIZATION; ARGININE; QUANTIFICATION	Cell-penetrating peptides (CPPs) are a promising tool to overcome cell membrane barriers. They have already been successfully applied as carriers for several problematic cargoes, like e. g. plasmid DNA and (si) RNA, opening doors for new therapeutics. Although several hundreds of CPPs are already described in the literature, only a few commercial applications of CPPs are currently available. Cellular uptake studies of these peptides suffer from inconsistencies in used techniques and other experimental conditions, leading to uncertainties about their uptake mechanisms and structural properties. To clarify the structural characteristics influencing the cell-penetrating properties of peptides, the chemical-functional space of peptides, already investigated for cellular uptake, was explored. For 186 peptides, a new cell-penetrating (CP)-response was proposed, based upon the scattered quantitative results for cellular influx available in the literature. Principal component analysis (PCA) and a quantitative structure-property relationship study (QSPR), using chemo-molecular descriptors and our newly defined CP-response, learned that besides typical well-known properties of CPPs, i.e. positive charge and amphipathicity, the shape, structure complexity and the 3D-pattern of constituting atoms influence the cellular uptake capacity of peptides.	[Stalmans, Sofie; Wynendaele, Evelien; Bracke, Nathalie; Gevaert, Bert; D'Hondt, Matthias; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Peremans, Kathelijne; Burvenich, Christian] Univ Ghent, Dept Med Imaging & Comparat Physiol & Biometr, Fac Vet Med, Merelbeke, Belgium	Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108	Special Research Fund (BOF) of Ghent University [01D38811, 01J22510]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [121512, 101529]	Special Research Fund (BOF) of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund (BOF) of Ghent University (http://www.ugent.be/en/research/funding/phd/bof/fjd/jointdoctorate.htm) to SS (01D38811) and EW (01J22510); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen: http://www.iwt.be/english/funding) to BG (121512) and MD (101529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2012, CURR PROTEIN PEPT SC, V13, P658, DOI 10.2174/138920312804142174; Alves ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024096; Amand HL, 2008, BIOCHEM BIOPH RES CO, V371, P621, DOI 10.1016/j.bbrc.2008.04.039; Aubry S, 2010, BBA-BIOMEMBRANES, V1798, P2182, DOI 10.1016/j.bbamem.2009.11.011; Balayssac S, 2006, BIOCHEMISTRY-US, V45, P1408, DOI 10.1021/bi0518390; Bodor N, 2007, J PHARM PHARMACOL, V59, P1065, DOI 10.1211/jpp.59.8.0003; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; CHOU PY, 1977, TRENDS BIOCHEM SCI, V2, P128, DOI 10.1016/0968-0004(77)90440-6; D'Hondt M, 2013, J PHARM ANAL, V3, P93; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Drin G, 2001, EUR J BIOCHEM, V268, P1304, DOI 10.1046/j.1432-1327.2001.01997.x; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Duchardt F, 2009, J BIOL CHEM, V284, P36099, DOI 10.1074/jbc.M109.036426; El-Andaloussi S, 2007, MOL THER, V15, P1820, DOI 10.1038/sj.mt.6300255; El-Andaloussi S, 2007, BIOCHEM J, V407, P285, DOI 10.1042/BJ20070507; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; Elmquist A, 2006, BBA-BIOMEMBRANES, V1758, P721, DOI 10.1016/j.bbamem.2006.05.013; Eriksson L, 2006, MULTI MEGAVARIATE DA, P39; Fischer PM, 2000, J PEPT RES, V55, P163, DOI 10.1034/j.1399-3011.2000.00163.x; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; Foged C, 2008, BBA-BIOMEMBRANES, V1778, P2487, DOI 10.1016/j.bbamem.2008.06.020; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Geisler IM, 2011, PHARM RES-DORDR, V28, P2797, DOI 10.1007/s11095-011-0493-7; Gomez JA, 2010, PHARMACEUTICALS, V3, P3594, DOI 10.3390/ph3123594; Hallbrink M, 2005, INT J PEPT RES THER, V11, P249, DOI 10.1007/s10989-005-9393-1; Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009; Hansen M, 2008, ADV DRUG DELIVER REV, V60, P572, DOI 10.1016/j.addr.2007.09.003; Holm T, 2005, FEBS LETT, V579, P5217, DOI 10.1016/j.febslet.2005.07.099; Jarver P, 2006, BBA-BIOMEMBRANES, V1758, P260, DOI 10.1016/j.bbamem.2006.02.012; Johansson HJ, 2008, MOL THER, V16, P115, DOI 10.1038/sj.mt.6300346; Jones S, 2012, BIOCONJUGATE CHEM, V23, P47, DOI 10.1021/bc2002924; Jones S, 2010, CHEM BIOL, V17, P735, DOI 10.1016/j.chembiol.2010.05.018; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kalafut D, 2012, BIOORG MED CHEM LETT, V22, P561, DOI 10.1016/j.bmcl.2011.10.077; Karelson M, 2011, EXPERT OPIN DRUG DIS, V6, P783, DOI 10.1517/17460441.2011.586689; Letoha T, 2005, J PEPT SCI, V11, P805, DOI 10.1002/psc.678; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Lindgren ME, 2004, BIOCHEM J, V377, P69, DOI 10.1042/BJ20030760; Lundberg P, 2006, INT J PEPT RES THER, V12, P105, DOI 10.1007/s10989-005-9007-y; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Maiolo JR, 2005, BBA-BIOMEMBRANES, V1712, P161, DOI 10.1016/j.bbamem.2005.04.010; Manceur A, 2007, ANAL BIOCHEM, V364, P51, DOI 10.1016/j.ab.2007.02.015; Martin I, 2011, CHEMBIOCHEM, V12, P896, DOI 10.1002/cbic.201000679; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Myrberg H, 2007, BIOCONJUGATE CHEM, V18, P170, DOI 10.1021/bc060266g; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Neundorf I, 2009, PHARMACEUTICALS, V2, P49, DOI 10.3390/ph2020049; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Ostlund P, 2005, INT J PEPT RES THER, V11, P237, DOI 10.1007/s10989-005-9329-9; Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029; Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006; Paramelle D, 2010, ANGEW CHEM INT EDIT, V49, P8240, DOI 10.1002/anie.201003347; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sanders WS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002101; Scheller A, 1999, J PEPT SCI, V5, P185, DOI 10.1002/(SICI)1099-1387(199904)5:4<185::AID-PSC184>3.0.CO;2-9; Song JJ, 2011, PEPTIDES, V32, P1934, DOI 10.1016/j.peptides.2011.07.018; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Sugita T, 2008, BRIT J PHARMACOL, V153, P1143, DOI 10.1038/sj.bjp.0707678; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Todeschini R., 2003, HDB CHEMOINFORMATICS, P1004, DOI [10.1002/9783527618279.ch37, DOI 10.1002/9783527618279.CH37]; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; Vergote V, 2009, J PEPT SCI, V15, P697, DOI 10.1002/psc.1167; Vives E, 1997, LETT PEPT SCI, V4, P429, DOI 10.1023/A:1008850300184; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wada S, 2011, BIOORG MED CHEM LETT, V21, P5688, DOI 10.1016/j.bmcl.2011.08.030; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Walther C, 2009, BIOPOLYMERS, V92, P445, DOI 10.1002/bip.21218; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	72	38	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71752	10.1371/journal.pone.0071752	http://dx.doi.org/10.1371/journal.pone.0071752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951237	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200070
J	Leon-Mimila, P; Villamil-Ramirez, H; Villalobos-Comparan, M; Villarreal-Molina, T; Romero-Hidalgo, S; Lopez-Contreras, B; Gutierrez-Vidal, R; Vega-Badillo, J; Jacobo-Albavera, L; Posadas-Romeros, C; Canizalez-Roman, A; Del Rio-Navarro, B; Campos-Perez, F; Acuna-Alonzo, V; Aguilar-Salinas, C; Canizales-Quinteros, S				Leon-Mimila, Paola; Villamil-Ramirez, Hugo; Villalobos-Comparan, Marisela; Villarreal-Molina, Teresa; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Jacobo-Albavera, Leonor; Posadas-Romeros, Carlos; Canizalez-Roman, Adrian; Del Rio-Navarro, Blanca; Campos-Perez, Francisco; Acuna-Alonzo, Victor; Aguilar-Salinas, Carlos; Canizales-Quinteros, Samuel			Contribution of Common Genetic Variants to Obesity and Obesity-Related Traits in Mexican Children and Adults	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FTO GENE; MC4R; CHILDHOOD; RISK; LOCI; REPLICATION; POPULATIONS; MESTIZO	Background: Several studies have identified multiple obesity-associated loci mainly in European populations. However, their contribution to obesity in other ethnicities such as Mexicans is largely unknown. The aim of this study was to examine 26 obesity-associated single-nucleotide polymorphisms (SNP) in a sample of Mexican mestizos. Methods: 9 SNPs in biological candidate genes showing replications (PPARG, ADRB3, ADRB2, LEPR, GNB3, UCP3, ADIPOQ, UCP2, and NR3C1), and 17 SNPs in or near genes associated with obesity in first, second and third wave GWAS (INSIG2, FTO, MC4R, TMEM18, FAIM2/BCDIN3, BDNF, SH2B1, GNPDA2, NEGR1, KCTD15, SEC16B/RASAL2, NPC1, SFRF10/ETV5, MAF, PRL, MTCH2, and PTER) were genotyped in 1,156 unrelated Mexican-Mestizos including 683 cases (441 obese class I/II and 242 obese class III) and 473 normal-weight controls. In a second stage we selected 12 of the SNPs showing nominal associations with obesity, to seek associations with quantitative obesity-related traits in 3 cohorts including 1,218 Mexican Mestizo children, 945 Mexican Mestizo adults, and 543 Indigenous Mexican adults. Results: After adjusting for age, sex and admixture, significant associations with obesity were found for 6 genes in the case-control study (ADIPOQ, FTO, TMEM18, INSIG2, FAIM2/BCDIN3 and BDNF). In addition, SH2B1 was associated only with class I/II obesity and MC4R only with class III obesity. SNPs located at or near FAIM2/BCDIN3, TMEM18, INSIG2, GNPDA2 and SEC16B/RASAL2 were significantly associated with BMI and/or WC in the combined analysis of Mexican-mestizo children and adults, and FTO locus was significantly associated with increased BMI in Indigenous Mexican populations. Conclusions: Our findings replicate the association of 8 obesity-related SNPs with obesity risk in Mexican adults, and confirm the role of some of these SNPs in BMI in Mexican adults and children.	[Villamil-Ramirez, Hugo; Lopez-Contreras, Blanca; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Inst Nacl Med Genom INMEGEN, Fac Quim, Unidad Genom Poblac Aplicada Salud, Mexico City 04510, DF, Mexico; [Leon-Mimila, Paola; Villamil-Ramirez, Hugo; Gutierrez-Vidal, Roxana; Vega-Badillo, Joel; Canizales-Quinteros, Samuel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Villalobos-Comparan, Marisela; Romero-Hidalgo, Sandra] INMEGEN, Dept Genom Computac, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa; Jacobo-Albavera, Leonor] INMEGEN, Lab Enfermedades Cardiovasc, Mexico City, DF, Mexico; [Posadas-Romeros, Carlos] Inst Nacl Cardiol Ignacio Chavez INCICh, Dept Endocrinol, Mexico City, DF, Mexico; [Canizalez-Roman, Adrian] Univ Autonoma Sinaloa, Fac Med, Culiacan, Mexico; [Del Rio-Navarro, Blanca] Hosp Infantil Mexico Dr Federico Gomez, Dept Alergia & Inmunol Clin, Mexico City, DF, Mexico; [Campos-Perez, Francisco] Hosp Ruben Lenero, Clin Obesidad, Mexico City, DF, Mexico; [Acuna-Alonzo, Victor] Escuela Nacl Antropol & Hist, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos] INCMNSZ, Dept Endocrinol & Metabol, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico; Universidad Autonoma de Sinaloa; Hospital Infantil de Mexico Federico Gomez	Canizales-Quinteros, S (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Med Genom INMEGEN, Fac Quim, Unidad Genom Poblac Aplicada Salud, Mexico City 04510, DF, Mexico.	cani@unam.mx	Canizalez-Roman, Adrian/B-7621-2019; Salinas, Carlos A Aguilar/AAL-4491-2020; Leon-Mimila, Paola/U-2375-2019; Aradillas Garcia, Celia/B-5830-2014	Canizalez-Roman, Adrian/0000-0001-8605-0639; Leon, Paola/0000-0001-6334-1492; Vega-Badillo, Joel/0000-0002-7110-6377; Jacobo-Albavera, Leonor/0000-0001-5129-8108; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Aradillas Garcia, Celia/0000-0003-3643-6992; Romero-Hidalgo, Sandra/0000-0003-3077-7825	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [11386]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant 11386 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastarrachea RA, 2007, HUM BIOL, V79, P121, DOI 10.1353/hub.2007.0021; Bressler J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-56; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Canizales-Quinteros S, 2007, HUM BIOL, V79, P111, DOI 10.1353/hub.2007.0022; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Day FR, 2011, J NUTRIGENET NUTRIGE, V4, P222, DOI 10.1159/000332158; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Dorajoo R, 2012, INT J OBESITY, V36, P159, DOI 10.1038/ijo.2011.86; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Flores-Dorantes T, 2010, CLIN CHIM ACTA, V411, P1214, DOI 10.1016/j.cca.2010.04.025; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gray J, 2006, DANCING TIMES, V96, P55; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hotta K, 2008, J HUM GENET, V53, P857, DOI 10.1007/s10038-008-0317-8; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Li XH, 2006, OBESITY, V14, P1192, DOI 10.1038/oby.2006.136; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Maes HH, 2007, BEHAV GENET, V27, P325; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Mejia-Benitez A, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-21; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Secretaria de Salud-Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Villalobos-Comparan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039037; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	50	78	80	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70640	10.1371/journal.pone.0070640	http://dx.doi.org/10.1371/journal.pone.0070640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950976	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000024
J	Liu, YL; Strecker, S; Wang, LP; Kronenberg, MS; Wang, W; Rowe, DW; Maye, P				Liu, Yaling; Strecker, Sara; Wang, Liping; Kronenberg, Mark S.; Wang, Wen; Rowe, David W.; Maye, Peter			Osterix-Cre Labeled Progenitor Cells Contribute to the Formation and Maintenance of the Bone Marrow Stroma	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DIFFUSION-CHAMBERS; MURINE BONE; PRECURSOR CELLS; DIFFERENTIATION; MICE; TRANSPLANTS; EXPRESSION; CARTILAGE; GROWTH	We have carried out fate mapping studies using Osterix-EGFPCre and Osterix-CreERt animal models and found Cre reporter expression in many different cell types that make up the bone marrow stroma. Constitutive fate mapping resulted in the labeling of different cellular components located throughout the bone marrow, whereas temporal fate mapping at E14.5 resulted in the labeling of cells within a region of the bone marrow. The identity of cell types marked by constitutive and temporal fate mapping included osteoblasts, adipocytes, vascular smooth muscle, perineural, and stromal cells. Prolonged tracing of embryonic precursors labeled at E14.5dpc revealed the continued existence of their progeny up to 10 months of age, suggesting that fate mapped, labeled embryonic precursors gave rise to long lived bone marrow progenitor cells. To provide further evidence for the marking of bone marrow progenitors, bone marrow cultures derived from Osterix-EGFPCre/Ai9 mice showed that stromal cells retained Cre reporter expression and yielded a FACS sorted population that was able to differentiate into osteoblasts, adipocytes, and chondrocytes in vitro and into osteoblasts, adipocytes, and perivascular stromal cells after transplantation. Collectively, our studies reveal the developmental process by which Osterix-Cre labeled embryonic progenitors give rise to adult bone marrow progenitors which establish and maintain the bone marrow stroma.	[Liu, Yaling; Strecker, Sara; Wang, Liping; Kronenberg, Mark S.; Wang, Wen; Rowe, David W.; Maye, Peter] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT USA	University of Connecticut	Maye, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT USA.	pmaye@neuron.uchc.edu	Wang, Wen Maxwell/T-5393-2019	Wang, Wen Maxwell/0000-0003-3215-3020; Maye, Peter/0000-0003-0098-4399; Strecker, Sara/0000-0001-6425-2184	NIAMS/NIH [1R21 AR060899-01A1]; NIDCR/NIH [T32 E007302-15/T90DE021989-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007302] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The project described was supported by the following grants: 1R21 AR060899-01A1 from NIAMS/NIH and T32 E007302-15/T90DE021989-01 from the NIDCR/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAB I, 1986, J CELL SCI, V84, P139; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Dexter T M, 1984, Prog Clin Biol Res, V148, P13; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MARDON HJ, 1987, CELL TISSUE RES, V250, P157, DOI 10.1007/BF00214667; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Phinney DG, 2006, STEM CELLS, V24, P186, DOI 10.1634/stemcells.2004-0236; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Strecker S., 2012, GENESIS; Strecker S, 2012, STEM CELLS CANC STEM, P231	29	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71318	10.1371/journal.pone.0071318	http://dx.doi.org/10.1371/journal.pone.0071318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951132	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000047
J	Natoli, R; Valter, K; Barbosa, M; Dahlstrom, J; Rutar, M; Kent, A; Provis, J				Natoli, Riccardo; Valter, Krisztina; Barbosa, Marconi; Dahlstrom, Jane; Rutar, Matt; Kent, Alison; Provis, Jan			670nm Photobiomodulation as a Novel Protection against Retinopathy of Prematurity: Evidence from Oxygen Induced Retinopathy Models	PLOS ONE			English	Article							NEAR-INFRARED LIGHT; CYTOCHROME-C-OXIDASE; ABSORPTION-MEASUREMENTS; RISK-FACTORS; CHILDREN; PRETERM; RETINA; PHOTOTHERAPY; PATHOGENESIS; MECHANISMS	Introduction: To investigate the validity of using 670nm red light as a preventative treatment for Retinopathy of Prematurity in two animal models of oxygen-induced retinopathy (OIR). Materials and Methods: During and post exposure to hyperoxia, C57BL/6J mice or Sprague-Dawley rats were exposed to 670nm light for 3 minutes a day (9J/cm(2)). Whole mounted retinas were investigated for evidence of vascular abnormalities, while sections of neural retina were used to quantify levels of cell death using the TUNEL technique. Organs were removed, weighed and independent histopathology examination performed. Results: 670nm light reduced neovascularisation, vaso-obliteration and abnormal peripheral branching patterns of retinal vessels in OIR. The neural retina was also protected against OIR by 670nm light exposure. OIR-exposed animals had severe lung pathology, including haemorrhage and oedema, that was significantly reduced in 670nm +OIR light-exposed animals. There were no significance differences in the organ weights of animals in the 670nm light-exposed animals, and no adverse effects of exposure to 670nm light were detected. Discussion: Low levels of exposure to 670nm light protects against OIR and lung damage associated with exposure to high levels of oxygen, and may prove to be a non-invasive and inexpensive preventative treatment for ROP and chronic lung disease associated with prematurity.	[Natoli, Riccardo; Valter, Krisztina; Barbosa, Marconi; Dahlstrom, Jane; Rutar, Matt; Provis, Jan] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Natoli, Riccardo; Valter, Krisztina; Barbosa, Marconi; Rutar, Matt; Provis, Jan] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Natoli, Riccardo; Valter, Krisztina; Dahlstrom, Jane; Kent, Alison; Provis, Jan] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia; [Dahlstrom, Jane] Canberra Hosp, Dept Anat Pathol, Woden, ACT, Australia; [Kent, Alison] Canberra Hosp, Dept Neonatol, Woden, ACT, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital	Natoli, R (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	riccardo.natoli@anu.edu.au	Kent, Alison/AAC-9063-2019; Valter, Krisztina/L-3015-2016; Provis, Jan/C-9529-2009; Dahlstrom, Jane/E-4683-2018	Provis, Jan/0000-0002-6405-2868; Natoli, Riccardo/0000-0002-9350-0439; Dahlstrom, Jane/0000-0001-5608-693X; Rutar, Matthew/0000-0002-8893-5120; Valter, Krisztina/0000-0002-2033-0408	Australian Research Council Centres of Excellence Program Grant [CE0561903]; Canberra Hospital Private Practice Fund	Australian Research Council Centres of Excellence Program Grant(Australian Research Council); Canberra Hospital Private Practice Fund	Australian Research Council Centres of Excellence Program Grant (CE0561903); Canberra Hospital Private Practice Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula JD, 2010, DOC OPHTHALMOL, V120, P41, DOI 10.1007/s10633-009-9198-1; Albarracin R, 2012, PHOTOCHEM PHOTOBIOL; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Alpay A, 2012, TURKISH J PEDIATR, V54, P113; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dave HB, 2012, AM J OPHTHALMOL, V154, P750, DOI 10.1016/j.ajo.2012.04.003; Dembinska O, 2002, INVEST OPHTH VIS SCI, V43, P2481; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Fierson WM, 1997, PEDIATRICS, V100, P273, DOI 10.1542/peds.100.2.273; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fletcher EL, 2010, DOC OPHTHALMOL, V120, P67, DOI 10.1007/s10633-009-9193-6; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Giusti B, 2012, FREE RADICAL RES, V46, P1130, DOI 10.3109/10715762.2012.692787; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hakeem AHAA, 2012, MIDDLE EAST AFR J OP, V19, P289, DOI 10.4103/0974-9233.97927; Heckmann M, 2008, OPHTHALMOLOGE, V105, P1101, DOI 10.1007/s00347-008-1789-9; Hentschke VS, 2013, LASER MED SCI, V28, P1007, DOI 10.1007/s10103-012-1190-4; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Larsson E, 2006, BRIT J OPHTHALMOL, V90, P87, DOI 10.1136/bjo.2005.081653; Larsson E, 2004, J PEDIAT OPHTH STRAB, V41, P39, DOI 10.3928/0191-3913-20040101-10; Larsson EK, 2005, ARCH OPHTHALMOL-CHIC, V123, P825, DOI 10.1001/archopht.123.6.825; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Meirelles GCS, 2008, PHOTOMED LASER SURG, V26, P159, DOI 10.1089/pho.2007.2052; Natoli R, 2010, MOL VIS, V16, P1801; Noell W K, 1966, Invest Ophthalmol, V5, P450; O'Connor AR, 2002, ARCH OPHTHALMOL-CHIC, V120, P767; Quinn GE, 2010, CHINESE MED J-PEKING, V123, P2929, DOI 10.3760/cma.j.issn.0366-6999.2010.20.033; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semo M, 2001, EUR J NEUROSCI, V13, P1257, DOI 10.1046/j.0953-816x.2001.01495.x; SHVEDOVA AA, 1983, CURR EYE RES, V2, P683, DOI 10.3109/02713688209019997; Silveira PCL, 2007, J PHOTOCH PHOTOBIO B, V86, P279, DOI 10.1016/j.jphotobiol.2006.10.002; Simons BD, 1999, INT OPHTHALMOL CLIN, V39, P29, DOI 10.1097/00004397-199903920-00004; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2004, GROWTH HORM IGF RES, V14, pS140, DOI 10.1016/j.ghir.2004.03.030; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057	49	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72135	10.1371/journal.pone.0072135	http://dx.doi.org/10.1371/journal.pone.0072135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951291	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000079
J	Santana, VC; Diniz, MO; Cariri, FAMO; Ventura, AM; Cunha-Neto, E; Almeida, RR; Campos, MA; Lima, GK; Ferreira, LCS				Santana, Vinicius C.; Diniz, Mariana O.; Cariri, Francisco A. M. O.; Ventura, Armando M.; Cunha-Neto, Edecio; Almeida, Rafael R.; Campos, Marco A.; Lima, Graciela K.; Ferreira, Luis C. S.			Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8(+) T Cell Responses and Protective Immunity	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; HERPESVIRUS ENTRY MEDIATOR; NF-KAPPA-B; GLYCOPROTEIN-D; VIRUS TYPE-1; DOUBLE-BLIND; TNFR FAMILY; GENE; VACCINATION; EXPRESSION	Millions of people worldwide are currently infected with human papillomavirus (HPV), herpes simplex virus (HSV) or human immunodeficiency virus (HIV). For this enormous contingent of people, the search for preventive and therapeutic immunological approaches represents a hope for the eradication of latent infection and/or virus-associated cancer. To date, attempts to develop vaccines against these viruses have been mainly based on a monovalent concept, in which one or more antigens of a virus are incorporated into a vaccine formulation. In the present report, we designed and tested an immunization strategy based on DNA vaccines that simultaneously encode antigens for HIV, HSV and HPV. With this purpose in mind, we tested two bicistronic DNA vaccines (pIRES I and pIRES II) that encode the HPV-16 oncoprotein E7 and the HIV protein p24 both genetically fused to the HSV-1 gD envelope protein. Mice i.m. immunized with the DNA vaccines mounted antigen-specific CD8(+) T cell responses, including in vivo cytotoxic responses, against the three antigens. Under experimental conditions, the vaccines conferred protective immunity against challenges with a vaccinia virus expressing the HIV-derived protein Gag, an HSV-1 virus strain and implantation of tumor cells expressing the HPV-16 oncoproteins. Altogether, our results show that the concept of a trivalent HIV, HSV, and HPV vaccine capable to induce CD8(+) T cell-dependent responses is feasible and may aid in the development of preventive and/or therapeutic approaches for the control of diseases associated with these viruses.	[Santana, Vinicius C.; Diniz, Mariana O.; Cariri, Francisco A. M. O.; Ventura, Armando M.; Ferreira, Luis C. S.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil; [Cunha-Neto, Edecio; Almeida, Rafael R.] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil; [Campos, Marco A.; Lima, Graciela K.] Fiocruz MS, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Ferreira, LCS (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.	lcsf@usp.br	Cunha-Neto, Edecio/B-4157-2009; Campos, Marco Antonio/AAU-6229-2021; Campos, Marco A/C-4000-2013; Ferreira, Luis Carlos S/M-3954-2014; Almeida, Rafael Ribeiro/F-8014-2014	Cunha-Neto, Edecio/0000-0002-3699-3345; Campos, Marco Antonio/0000-0003-4683-0176; Campos, Marco A/0000-0003-4683-0176; Ferreira, Luis Carlos S/0000-0002-4883-1693; Almeida, Rafael Ribeiro/0000-0003-3984-7527	CNPq (INCTV); FAPESP; USP (Vaccine Research Core)	CNPq (INCTV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USP (Vaccine Research Core)	This work was supported by CNPq (INCTV), FAPESP and USP (Vaccine Research Core) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045267; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Benvenisti L, 2001, VACCINE, V19, P3885, DOI 10.1016/S0264-410X(01)00125-6; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; DiMenna L, 2010, J IMMUNOL, V184, P5475, DOI 10.4049/jimmunol.0903808; Diniz MO, 2011, BRAZ J MED BIOL RES, V44, P421, DOI [10.1590/S0100-879X2011000500007, 10.1590/S0100-879X2011007500039]; Diniz MO, 2010, CLIN VACCINE IMMUNOL, V17, P1576, DOI 10.1128/CVI.00264-10; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Granger SW, 2003, CYTOKINE GROWTH F R, V14, P289, DOI 10.1016/S1359-6101(03)00031-5; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kong WP, 2003, J VIROL, V77, P12764, DOI 10.1128/JVI.77.23.12764-12772.2003; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Kwissa M, 2000, J MOL MED-JMM, V78, P495, DOI 10.1007/s001090000135; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Lasaro MO, 2011, MOL THER, V19, P1727, DOI 10.1038/mt.2011.88; Lasaro MO, 2009, HUM VACCINES, V5, P6, DOI 10.4161/hv.5.1.6399; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; Liang R, 2007, VACCINE, V25, P5994, DOI 10.1016/j.vaccine.2007.05.036; Lin K, 2010, IMMUNOL RES, V47, P86, DOI 10.1007/s12026-009-8141-6; Lin KY, 1996, CANCER RES, V56, P21; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; Manoj S, 2003, VIROLOGY, V313, P296, DOI 10.1016/S0042-6822(03)00325-8; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moniz M, 2003, FRONT BIOSCI-LANDMRK, V8, pD55, DOI 10.2741/936; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Nikolic DS, 2010, J INVEST DERMATOL, V130, P352, DOI 10.1038/jid.2009.227; Orr MT, 2007, CELL HOST MICROBE, V2, P172, DOI 10.1016/j.chom.2007.06.013; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Porchia BFMM, 2011, MOL PHARMACEUT, V8, P2320, DOI 10.1021/mp200194s; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sciortino MT, 2008, CELL MICROBIOL, V10, P2297, DOI 10.1111/j.1462-5822.2008.01212.x; Sciortino MT, 2008, BIOCHEM PHARMACOL, V76, P1522, DOI 10.1016/j.bcp.2008.07.030; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Shkreta L, 2004, VACCINE, V23, P114, DOI 10.1016/j.vaccine.2004.05.002; Shoji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030302; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; van Steenwijk PJD, 2012, CANCER IMMUNOL IMMUN, V61, P1485, DOI 10.1007/s00262-012-1292-7; Wang SD, 2004, MICROBES INFECT, V6, P759, DOI 10.1016/j.micinf.2004.03.007; WATSON RJ, 1982, SCIENCE, V218, P381, DOI 10.1126/science.6289440; World Health Organization (WHO), 2012, GLOB REP UNAIDS REP; Zhang HY, 2008, VACCINE, V26, P769, DOI 10.1016/j.vaccine.2007.11.093	54	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71322	10.1371/journal.pone.0071322	http://dx.doi.org/10.1371/journal.pone.0071322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951135	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000049
J	Tang, XL; Xin, Y; Wang, HH; Li, WX; Zhang, Y; Liang, SW; He, JZ; Wang, NB; Ma, M; Chen, Q				Tang, Xiaolong; Xin, Ying; Wang, Huihui; Li, Weixin; Zhang, Yang; Liang, Shiwei; He, Jianzheng; Wang, Ningbo; Ma, Ming; Chen, Qiang			Metabolic Characteristics and Response to High Altitude in Phrynocephalus erythrurus (Lacertilia: Agamidae), a Lizard Dwell at Altitudes Higher Than Any Other Living Lizards in the World	PLOS ONE			English	Article							MITOCHONDRIAL PROTON LEAK; SKELETAL-MUSCLE; LIVER-MITOCHONDRIA; ENZYME-ACTIVITIES; ADAPTATION; HYPOXIA; MECHANISMS; PLASTICITY; ACCLIMATIZATION; RESPIRATION	Metabolic response to high altitude remains poorly explored in reptiles. In the present study, the metabolic characteristics of Phrynocephalus erythrurus (Lacertilia: Agamidae), which inhabits high altitudes (4500 m) and Phrynocephalus przewalskii (Lacertilia: Agamidae), which inhabits low altitudes, were analysed to explore the metabolic regulatory strategies for lizards living at high-altitude environments. The results indicated that the mitochondrial respiratory rates of P. erythrurus were significantly lower than those of P. przewalskii, and that proton leak accounts for 74 similar to 79% of state 4 and 7 similar to 8% of state3 in P. erythrurus vs. 43 similar to 48% of state 4 and 24 similar to 26% of state3 in P. przewalskii. Lactate dehydrogenase (LDH) activity in P. erythrurus was lower than in P. przewalskii, indicating that at high altitude the former does not, relatively, have a greater reliance on anaerobic metabolism. A higher activity related to beta-hydroxyacyl coenzyme A dehydrogenase (HOAD) and the HOAD/citrate synthase (CS) ratio suggested there was a possible higher utilization of fat in P. erythrurus. The lower expression of PGC-1 alpha and PPAR-gamma in P. erythrurus suggested their expression was not influenced by cold and low PO2 at high altitude. These distinct characteristics of P. erythrurus are considered to be necessary strategies in metabolic regulation for living at high altitude and may effectively compensate for the negative influence of cold and low PO2.	[Tang, Xiaolong; Xin, Ying; Wang, Huihui; Li, Weixin; Zhang, Yang; Liang, Shiwei; He, Jianzheng; Wang, Ningbo; Ma, Ming; Chen, Qiang] Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China	Lanzhou University	Chen, Q (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China.	chenq@lzu.edu.cn	wang, hui/GRS-4730-2022; chen, qiang/HGU-5418-2022	Wang, Ningbo/0000-0003-1622-7819	National Natural Science Foundation of China [31272313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research funding was supported by the National Natural Science Foundation of China (No. 31272313 to Q. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNARD RJ, 1969, J APPL PHYSIOL, V27, P691, DOI 10.1152/jappl.1969.27.5.691; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; BENNETT AF, 1975, COMP BIOCHEM PHYSIOL, V50, P105, DOI 10.1016/S0010-406X(75)80209-X; Boutilier RG, 2002, J EXP BIOL, V205, P2287; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; de Souza SCR, 2004, J EXP BIOL, V207, P307, DOI 10.1242/jeb.00756; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Guderley H, 2011, J COMP PHYSIOL B, V181, P53, DOI 10.1007/s00360-010-0499-1; He JZ, 2013, COMP BIOCHEM PHYS A, V165, P207, DOI 10.1016/j.cbpa.2013.03.007; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; Hochachka PW, 1998, J EXP BIOL, V201, P1243; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Hulbert AJ, 2002, J COMP PHYSIOL B, V172, P387, DOI 10.1007/s00360-002-0264-1; Jin YT, 2010, MOL PHYLOGENET EVOL, V54, P933, DOI 10.1016/j.ympev.2009.11.003; JOHNALDER HB, 1991, GEN COMP ENDOCR, V81, P120, DOI 10.1016/0016-6480(91)90132-P; Kennedy SL, 2001, J APPL PHYSIOL, V90, P17, DOI 10.1152/jappl.2001.90.1.17; Kuang LD, 2010, BIOCHEM GENET, V48, P418, DOI 10.1007/s10528-009-9322-7; LEONVELARDE F, 1993, J COMP PHYSIOL B, V163, P52, DOI 10.1007/BF00309665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muleme HM, 2006, PHYSIOL BIOCHEM ZOOL, V79, P474, DOI 10.1086/501053; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PEARSON OP, 1976, COPEIA, P155, DOI 10.2307/1443786; PEARSON OP, 1954, COPEIA, P111, DOI 10.2307/1440329; Pierce VA, 1997, SCIENCE, V276, P256, DOI 10.1126/science.276.5310.256; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rey B, 2008, J EXP BIOL, V211, P1456, DOI 10.1242/jeb.012328; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Sheafor BA, 2003, J EXP BIOL, V206, P1241, DOI 10.1242/jeb.00226; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; St-Pierre J, 2000, J EXP BIOL, V203, P1469; St-Pierre J, 2000, AM J PHYSIOL-REG I, V279, pR1205, DOI 10.1152/ajpregu.2000.279.4.R1205; St-Pierre J, 2001, PHYSIOL BIOCHEM ZOOL, V74, P390, DOI 10.1086/320428; STAUDTE HW, 1973, PFLUG ARCH EUR J PHY, V344, P159, DOI 10.1007/BF00586549; Storey KB, 1996, COMP BIOCHEM PHYS B, V113, P23, DOI 10.1016/0305-0491(95)02043-8; Storey KB, 2003, ADV EXP MED BIOL, V543, P21; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Wood SC, 1996, COMP BIOCHEM PHYS B, V113, P37, DOI 10.1016/0305-0491(95)02045-4; Zhao E, 1993, HERPETOLOGY CHINA, V10	48	25	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71976	10.1371/journal.pone.0071976	http://dx.doi.org/10.1371/journal.pone.0071976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951275	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700126
J	Francius, C; Harris, A; Rucchin, V; Hendricks, TJ; Stam, FJ; Barber, M; Kurek, D; Grosveld, FG; Pierani, A; Goulding, M; Clotman, F				Francius, Cedric; Harris, Audrey; Rucchin, Vincent; Hendricks, Timothy J.; Stam, Floor J.; Barber, Melissa; Kurek, Dorota; Grosveld, Frank G.; Pierani, Alessandra; Goulding, Martyn; Clotman, Frederic			Identification of Multiple Subsets of Ventral Interneurons and Differential Distribution along the Rostrocaudal Axis of the Developing Spinal Cord	PLOS ONE			English	Article							MOTOR-NEURON DIVERSITY; ONECUT TRANSCRIPTION FACTORS; CENTRAL-NERVOUS-SYSTEM; SONIC HEDGEHOG; RENSHAW CELLS; REGULATORY NETWORK; LOCOMOTOR-ACTIVITY; SUBTYPE IDENTITY; V2 INTERNEURONS; GENE-EXPRESSION	The spinal cord contains neuronal circuits termed Central Pattern Generators (CPGs) that coordinate rhythmic motor activities. CPG circuits consist of motor neurons and multiple interneuron cell types, many of which are derived from four distinct cardinal classes of ventral interneurons, called V0, V1, V2 and V3. While significant progress has been made on elucidating the molecular and genetic mechanisms that control ventral interneuron differentiation, little is known about their distribution along the antero-posterior axis of the spinal cord and their diversification. Here, we report that V0, V1 and V2 interneurons exhibit distinct organizational patterns at brachial, thoracic and lumbar levels of the developing spinal cord. In addition, we demonstrate that each cardinal class of ventral interneurons can be subdivided into several subsets according to the combinatorial expression of different sets of transcription factors, and that these subsets are differentially distributed along the rostrocaudal axis of the spinal cord. This comprehensive molecular profiling of ventral interneurons provides an important resource for investigating neuronal diversification in the developing spinal cord and for understanding the contribution of specific interneuron subsets on CPG circuits and motor control.	[Francius, Cedric; Harris, Audrey; Rucchin, Vincent; Clotman, Frederic] Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium; [Hendricks, Timothy J.; Stam, Floor J.; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Barber, Melissa; Pierani, Alessandra] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592,Sorbonne Paris Cite, Paris, France; [Kurek, Dorota; Grosveld, Frank G.] Erasmus MC, Dept Cell Biol, Erasmus MC Stem Cell Inst, Rotterdam, Netherlands	Universite Catholique Louvain; Salk Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC	Clotman, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, Lab Neural Differentiat, B-1200 Brussels, Belgium.	frederic.clotman@uclouvain.be	Pierani, Alessandra/O-6136-2017	Pierani, Alessandra/0000-0002-4872-4791; Kurek, Dorota/0000-0002-7168-8944; Stam, Floor/0000-0003-2017-6911; Barber, Melissa/0000-0003-4430-085X	"Fonds speciaux de recherche" (FSR) of the Universite catholique de Louvain; Credit au chercheur [1.5.085.10.F]; Fund for Scientific Medical Research of the Fonds de la Recherche Scientifique (FRS) [3.4.538.10.F]; Association Belge contre les Maladies neuro-Musculaires asbl" (ABMM); "Actions de Recherche Concertees (ARC)" of the "Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique - Direction de la Recherche scientifique - Communaute francaise de Belgique" [10/15-026]; Academie universitaire 'Louvain'; NeRF (Neuropole de recherche francilien); FSR (Universite catholique de Louvain)	"Fonds speciaux de recherche" (FSR) of the Universite catholique de Louvain; Credit au chercheur; Fund for Scientific Medical Research of the Fonds de la Recherche Scientifique (FRS)(Fonds de la Recherche Scientifique - FNRS); Association Belge contre les Maladies neuro-Musculaires asbl" (ABMM); "Actions de Recherche Concertees (ARC)" of the "Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique - Direction de la Recherche scientifique - Communaute francaise de Belgique"; Academie universitaire 'Louvain'; NeRF (Neuropole de recherche francilien); FSR (Universite catholique de Louvain)	This work was supported by a grant from the "Fonds speciaux de recherche" (FSR) of the Universite catholique de Louvain, by a "Credit au chercheur" #1.5.085.10.F and a grant from the Fund for Scientific Medical Research #3.4.538.10.F of the Fonds de la Recherche Scientifique (FRS), by the "Association Belge contre les Maladies neuro-Musculaires asbl" (ABMM), and by the "Actions de Recherche Concertees (ARC)" #10/15-026 of the "Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique - Direction de la Recherche scientifique - Communaute francaise de Belgique" and granted by the "Academie universitaire 'Louvain'" to FC. MB was the recipient of a fellowship from NeRF (Neuropole de recherche francilien); AP is a CNRS (Centre National de la Recherche Scientifique) Investigator; CF is supported by the FSR (Universite catholique de Louvain); FC is a Research Associate of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Alvarez FJ, 1999, J PHYSIOL-LONDON, V515, P787, DOI 10.1111/j.1469-7793.1999.787ab.x; Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Arimatsu Y, 2003, J COMP NEUROL, V466, P180, DOI 10.1002/cne.10875; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Benito-Gonzalez A, 2012, J NEUROSCI, V32, P1156, DOI 10.1523/JNEUROSCI.3630-12.2012; Berkowitz A, 2001, J NEUROPHYSIOL, V86, P1026, DOI 10.1152/jn.2001.86.2.1026; Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brunelli S, 2003, GENE EXPR PATTERNS, V3, P755, DOI 10.1016/S1567-133X(03)00135-2; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; Cazalets Jr, 2000, CONT NEUROS, P89; Chanut Francoise, 2006, PLoS Biol, V4, pe280, DOI 10.1371/journal.pbio.0040280; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063; Cooper KL, 2003, DEV BIOL, V253, P200, DOI 10.1016/S0012-1606(02)00018-0; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; England S, 2011, DEVELOPMENT, V138, P5121, DOI 10.1242/dev.066159; Espana A, 2012, J COMP NEUROL, V520, P1424, DOI 10.1002/cne.22803; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Francius C, 2010, NEUROSCIENCE, V165, P116, DOI 10.1016/j.neuroscience.2009.09.076; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; Grothe C, 2004, NEUROBIOL DIS, V17, P163, DOI 10.1016/j.nbd.2004.07.007; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hu J, 2012, J NEUROSCI, V32, P5362, DOI 10.1523/JNEUROSCI.6239-11.2012; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; JOHNSON IP, 1988, J ANAT, V161, P171; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011; Jovanovic K, 2004, CAN J PHYSIOL PHARM, V82, P628, DOI 10.1139/Y04-055; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Karunaratne A, 2002, DEV BIOL, V249, P30, DOI 10.1006/dbio.2002.0754; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Komai T, 2009, GENE EXPR PATTERNS, V9, P503, DOI 10.1016/j.gep.2009.07.005; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Kyriakatos A, 2011, J NEUROSCI, V31, P8422, DOI 10.1523/JNEUROSCI.1012-11.2011; Lammi J, 2008, MOL CELL ENDOCRINOL, V295, P87, DOI 10.1016/j.mce.2008.08.023; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li YM, 2011, NEUROSCI LETT, V488, P49, DOI 10.1016/j.neulet.2010.10.078; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu B, 2007, DEV DYNAM, V236, P829, DOI 10.1002/dvdy.21061; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Marthiens V, 2002, MOL CELL NEUROSCI, V20, P458, DOI 10.1006/mcne.2002.1130; Marthiens W, 2005, MOL CELL NEUROSCI, V28, P715, DOI 10.1016/j.mcn.2004.12.001; Matise MP, 1997, J NEUROSCI, V17, P7805; McDonagh JC, 1999, J PHYSIOL-PARIS, V93, P3, DOI 10.1016/S0928-4257(99)80131-4; McDonagh JC, 1998, J COMP NEUROL, V400, P544, DOI 10.1002/(SICI)1096-9861(19981102)400:4<544::AID-CNE8>3.0.CO;2-A; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morikawa Y, 2009, NEUROSCIENCE, V162, P1150, DOI 10.1016/j.neuroscience.2009.05.022; Morikawa Y, 2009, DEV NEUROSCI-BASEL, V31, P511, DOI 10.1159/000243715; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Panayi H, 2010, J NEUROSCI, V30, P12274, DOI 10.1523/JNEUROSCI.2402-10.2010; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; ROBERTS VJ, 1995, MECH DEVELOP, V51, P193, DOI 10.1016/0925-4773(95)00364-9; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; RYALL RW, 1971, J NEUROPHYSIOL, V34, P700, DOI 10.1152/jn.1971.34.4.700; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Schotland JL, 1997, EXP BRAIN RES, V116, P283, DOI 10.1007/PL00005756; Siembab VC, 2010, J COMP NEUROL, V518, P4675, DOI 10.1002/cne.22441; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; Smith E, 2002, DEV DYNAM, V224, P231, DOI 10.1002/dvdy.10093; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Takahashi K, 2008, J NEUROSCI RES, V86, P3106, DOI 10.1002/jnr.21770; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Tam WY, 2011, NEUROSCIENCE, V172, P562, DOI 10.1016/j.neuroscience.2010.10.023; Tamura S, 2003, GENE EXPR PATTERNS, V3, P193, DOI 10.1016/S1567-133X(03)00003-6; Todd KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031176; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wilson L, 2004, DEV BIOL, V269, P433, DOI 10.1016/j.ydbio.2004.01.034; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhou YH, 2000, DEVELOPMENT, V127, P3829	132	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70325	10.1371/journal.pone.0070325	http://dx.doi.org/10.1371/journal.pone.0070325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967072	Green Submitted, Green Published, gold			2022-12-27	WOS:000323378000006
J	Balakirev, ES; Romanov, NS; Mikheev, PB; Ayala, FJ				Balakirev, Evgeniy S.; Romanov, Nikolai S.; Mikheev, Pavel B.; Ayala, Francisco J.			Mitochondrial DNA Variation and Introgression in Siberian Taimen Hucho taimen	PLOS ONE			English	Article							GENETIC DIVERSITY; NUCLEAR DISCORDANCE; BRACHYMYSTAX-LENOK; MOSAIC STRUCTURE; SICHUAN-TAIMEN; CONTROL REGION; RECOMBINATION; GENOME; HYBRIDIZATION; POLYMORPHISM	Siberian taimen Hucho taimen is the largest representative of the family Salmonidae inhabiting rivers of northern Eurasia. The species is under intensive aquaculture activity. To monitor natural taimen populations we have sequenced a portion (8,141 bp) of the mitochondrial (mt) genome in 28 specimens of H. taimen from six localities in the Amur River basin. Nucleotide variability is low (pi = 0.0010), but structured in two divergent haplotype groups. A comparison of the data with the GenBank H. taimen mt genome (HQ897271) reveals significant differences between them in spite of the fact that the fish specimens come from neighboring geographical areas. The distribution of divergence is non-uniform with two highly pronounced divergent regions centered on two genes, ND3 and ND6. To clarify the pattern of divergence we sequenced the corresponding portion of the mt genome of lenok Brachymystax tumensis and analyzed the GenBank complete mt genomes of related species. We have found that the first and second divergent regions are identical between the GenBank H. taimen and two lenok subspecies, B. lenok and B. lenok tsinlingensis, respectively. Consequently, both divergent regions represent introgressed mtDNA resulting from intergeneric hybridization between the two lenok subspecies and H. taimen. Introgression is, however, not detected in our specimens. This plus the precise identity of the introgressed fragments between the donor and the recipient GenBank sequence suggests that the introgression is local and very recent, probably due to artificial manipulations involving taimen -lenok intergeneric hybridization. Human-mediated hybridization may become a major threat to aquatic biodiversity. Consequently we suggest that due attention needs to be given to this threat by means of responsible breeding program management, so as to prevent a potential spread of hybrid fishes that could jeopardize the resilience of locally adapted gene pools of the native H. taimen populations.	[Balakirev, Evgeniy S.; Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Balakirev, Evgeniy S.; Romanov, Nikolai S.] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Mikheev, Pavel B.] Pacific Res Fisheries Ctr TINRO Ctr, Amur River Salmon Sect, Khabarovsk Branch, Khabarovsk, Russia	University of California System; University of California Irvine; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Research lnstitute of Fisheries & Oceanography	Balakirev, ES (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	balakire@uci.edu	Mikheev, Pavel/F-5455-2015; Balakirev, Evgeniy Stanislavovich/O-1462-2017; Mikheev, Pavel/AAT-5512-2020	Mikheev, Pavel/0000-0002-0934-6935; 	University of California Irvine	University of California Irvine(University of California System)	This study was supported by Bren Professor Funds at the University of California Irvine to Francisco J. Ayala and Evgeniy S. Balakirev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Allendorf F, 2013, CONSERV GENET, V2nd; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; AVISE JC, 1984, GENETICS, V108, P237; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Balakirev ES, 2003, GENETICS, V164, P533; Balakirev ES, 2008, P NATL ACAD SCI USA, V105, P16218, DOI 10.1073/pnas.0807860105; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Campton D.E., 1987, POPULATION GENETICS, P161; Chereshnev IA, 1998, BIOGEOGRAPHY FRESH W; Ciborowski KL, 2007, BIOLOGY LETT, V3, P554, DOI 10.1098/rsbl.2007.0290; Coyne J.A., 2004, SPECIATION; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Esteve M, 2009, ENVIRON BIOL FISH, V84, P185, DOI 10.1007/s10641-008-9407-x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; FROESE R., 2012, FISHBASE; Frolov SV, 2000, RUSS J GENET+, V36, P175; Froufe E, 2005, J FISH BIOL, V67, P1040, DOI 10.1111/j.0022-1112.2005.00807.x; Froufe E, 2003, DIVERS DISTRIB, V9, P269, DOI 10.1046/j.1472-4642.2003.00024.x; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Geist J, 2009, J FISH BIOL, V75, P1063, DOI 10.1111/j.1095-8649.2009.02377.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gilroy DJ, 2010, ECOL FRESHW FISH, V19, P545, DOI 10.1111/j.1600-0633.2010.00434.x; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Gosset CC, 2013, J EVOLUTION BIOL, V26, P14, DOI 10.1111/jeb.12046; Grant WS, 2012, ENVIRON BIOL FISH, V94, P325, DOI 10.1007/s10641-011-9929-5; HOLCIK J, 1995, ENVIRON BIOL FISH, V43, P105, DOI 10.1007/BF00001822; Holuik J., 1988, EURASIAN HUCHEN HUCH; HUDSON RR, 1985, GENETICS, V111, P147; Jaramillo-Correa JP, 2005, GENETICS, V171, P1951, DOI 10.1534/genetics.105.042770; Jiang Zuo-fa, 2003, Journal of Fisheries of China, V27, P590; Kuang You-Yi, 2009, Acta Ecologica Sinica, V29, P92; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Liang Li-qun, 2004, Journal of Fisheries of China, V28, P241; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindberg GU, 1972, GREAT FLUCTUATIONS O; Liu Bo, 2011, Zoological Research, V32, P597, DOI 10.3724/SP.J.1141.2011.06597; Lou YD, 2006, J FISH SCI CHINA, V1, P159; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Matveyev AN, 1998, J GREAT LAKES RES, V24, P905, DOI 10.1016/S0380-1330(98)70871-8; McLennan DA., 2008, J ICHTHYOL, V48, P1031, DOI [10.1134/S0032945208110040, DOI 10.1134/S0032945208110040]; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Nei M., 1987, MOL EVOLUTIONARY GEN; Nikolsky, 1956, RYBY BASSEINA AMURA; Ocock J, 2006, REGIONAL RED LIST SE, V4; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Pilgrim BL, 2012, GENET MOL RES, V11, P3466, DOI 10.4238/2012.September.26.2; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rand PS, 2012, ENVIRON BIOL FISH, V94, P1, DOI 10.1007/s10641-012-9987-3; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Shedko SV, 2012, PHYLOGENETIC RELATIO; Shedko SV, 2003, THESIS VLADIVOSTOK; Si SJ, 2012, MITOCHONDR DNA, V23, P338, DOI 10.3109/19401736.2012.690749; SMITH GR, 1992, SYST BIOL, V41, P41, DOI 10.2307/2992505; SMITH JM, 1992, J MOL EVOL, V34, P126; Sun Y, 2010, CHINESE J FISH, V23, P46; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor Eric B., 2004, P232; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; [佟广香 TONG Guang-xiang], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P833; Tong Guang-xing, 2008, Acta Agriculturae Universitatis Jiangxiensis, V30, P405; Tong GX, 2006, MOL ECOL NOTES, V6, P1099, DOI 10.1111/j.1471-8286.2006.01447.x; [王俊 WANG Jun], 2011, [中国水产科学, Journal of Fishery Sciences of China], V18, P547; Wang Y, 2011, MITOCHONDR DNA, V22, P111, DOI 10.3109/19401736.2011.624605; Wang Y, 2011, MAR GENOM, V4, P221, DOI 10.1016/j.margen.2011.06.003; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei Wei, 2009, Journal of Fisheries of China, V33, P996; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Weiss S, 2011, HYDROBIOLOGIA, V658, P103, DOI 10.1007/s10750-010-0453-y; Wu XC, 2006, BIOCHEM GENET, V44, P177, DOI 10.1007/s10528-006-9021-6; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia YZ, 2006, ZOOL STUD, V45, P190; Xie ZY, 1959, ACTA HYDROBIOL SINIC, V3, P215; Xu Ge-feng, 2010, Shanghai Haiyang Daxue Xuebao, V19, P178; Xu Ling-xue, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P1187; Xu Wei, 2008, Shanghai Shuichan Daxue Xuebao, V17, P452; Xu Wei, 2003, Journal of Fishery Sciences of China, V10, P26; Xu X, 2004, CHINESE J FISH, V2, P69; Yang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017729; Yue P. Q., 1998, CHINA RED DATA BOOK; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; Zolotukhin SF, 2000, TAIMEN LENOK RUSSIAN; Zwickl DJ., 2006, THESIS	106	16	19	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71147	10.1371/journal.pone.0071147	http://dx.doi.org/10.1371/journal.pone.0071147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951096	gold, Green Published			2022-12-27	WOS:000323097300091
J	Betsch, M; Schneppendahl, J; Thuns, S; Herten, M; Sager, M; Jungbluth, P; Hakimi, M; Wild, M				Betsch, Marcel; Schneppendahl, Johannes; Thuns, Simon; Herten, Monika; Sager, Martin; Jungbluth, Pascal; Hakimi, Mohssen; Wild, Michael			Bone Marrow Aspiration Concentrate and Platelet Rich Plasma for Osteochondral Repair in a Porcine Osteochondral Defect Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; BETA-TRICALCIUM PHOSPHATE; ARTICULAR-CARTILAGE; GROWTH-FACTOR; ANIMAL-MODELS; IN-VITRO; CLINICAL-USE; PROLIFERATION; REGENERATION	Background: Bone marrow aspiration concentrate (BMAC) may possess a high potency for cartilage and osseous defect healing because it contains stem cells and multiple growth factors. Alternatively, platelet rich plasma (PRP), which contains a cocktail of multiple growth factors released from enriched activated thrombocytes may potentially stimulate the mesenchymal stem cells (MSCs) in bone marrow to proliferate and differentiate. Methods: A critical size osteochondral defect (1066 mm) in both medial femoral condyles was created in 14 Goettinger mini-pigs. All animals were randomized into the following four groups: biphasic scaffold alone (TRUFIT BGS, Smith & Nephew, USA), scaffold with PRP, scaffold with BMAC and scaffold in combination with BMAC and PRP. After 26 weeks all animals were euthanized and histological slides were cut, stained and evaluated using a histological score and immunohistochemistry. Results: The thrombocyte number was significantly increased (p = 0.049) in PRP compared to whole blood. In addition the concentration of the measured growth factors in PRP such as BMP-2, BMP-7, VEGF, TGF-beta 1 and PDGF were significantly increased when compared to whole blood (p < 0.05). In the defects of the therapy groups areas of chondrogenic tissue were present, which stained blue with toluidine blue and positively for collagen type II. Adding BMAC or PRP in a biphasic scaffold led to a significant improvement of the histological score compared to the control group, but the combination of BMAC and PRP did not further enhance the histological score. Conclusions: The clinical application of BMAC or PRP in osteochondral defect healing is attractive because of their autologous origin and cost-effectiveness. Adding either PRP or BMAC to a biphasic scaffold led to a significantly better healing of osteochondral defects compared with the control group. However, the combination of both therapies did not further enhance healing.	[Betsch, Marcel; Schneppendahl, Johannes; Thuns, Simon; Jungbluth, Pascal; Hakimi, Mohssen] Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Herten, Monika] Univ Hosp Muenster, Clin Vasc & Endovasc Surg, Munster, Germany; [Sager, Martin] Univ Hosp Duesseldorf, Cent Anim Res Facil, Dusseldorf, Germany; [Wild, Michael] Klinikum Darmstadt, Dept Trauma & Orthopaed Surg, Darmstadt, Germany	University of Munster; Klinikum Darmstadt	Schneppendahl, J (corresponding author), Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany.	johannes.schneppendahl@med.uni-duesseldorf.de	Jungbluth, Pascal/L-6703-2017; Herten, Monika/J-1547-2015	Herten, Monika/0000-0001-9697-0287; Wild, Michael/0000-0002-6306-4867	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	This study was funded by a research grant of the Medical Faculty, Heinrich Heine University Duesseldorf, Germany. The TRUFIT BGS scaffolds were provided by the company Smith&Nephew, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008; Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008; Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b; Bekkers JE, 2013, AM J SPORTS MED; Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543; Borzini P, 2005, TRANSFUSION, V45, P1759, DOI 10.1111/j.1537-2995.2005.00600.x; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Castillo TN, 2011, AM J SPORT MED, V39, P266, DOI 10.1177/0363546510387517; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Djouad F, 2006, REGEN MED, V1, P529, DOI 10.2217/17460751.1.4.529; Drengk A, 2009, CELLS TISSUES ORGANS, V189, P317, DOI 10.1159/000151290; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Gaissmaier C, 2005, BIOMATERIALS, V26, P1953, DOI 10.1016/j.biomaterials.2004.06.031; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011; Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x; Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041; Ham O, 2012, BIOMATERIALS, V33, P4500, DOI 10.1016/j.biomaterials.2012.03.025; Hatzokos I, 2011, J BONE JOINT SURG AM, V93A, P671, DOI 10.2106/JBJS.J.00514; Hendrich C, 2009, ORTHOP REV, V1, P99, DOI 10.4081/or.2009.e32; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Herten M, 2013, VET COMP ORTHOPAED, V26, P34, DOI 10.3415/VCOT-11-11-0165; Hindle P, 2013, KNEE SURG SPORTS TRA; Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001; Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193; Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585; Jung M, 2009, LAB ANIM-UK, V43, P191, DOI 10.1258/la.2008.007149; Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Marx R E, 2001, Implant Dent, V10, P225; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013; Mishra A, 2009, TISSUE ENG PART C-ME, V15, P431, DOI 10.1089/ten.tec.2008.0534; Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1; Pieri F, 2009, J ORAL MAXIL SURG, V67, P265, DOI 10.1016/j.joms.2008.06.036; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi YY, 2009, CELL TRANSPLANT, V18, P1161, DOI 10.3727/096368909X12483162197169; Rudert M, 2005, ARCH ORTHOP TRAUM SU, V125, P598, DOI 10.1007/s00402-005-0008-2; Rudert M, 2002, CELLS TISSUES ORGANS, V171, P229, DOI 10.1159/000063125; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4; Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717; Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4; Spreafico A, 2009, J CELL BIOCHEM, V108, P1153, DOI 10.1002/jcb.22344; Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2; Tanaka T, 2005, TISSUE ENG, V11, P331, DOI 10.1089/ten.2005.11.331; Veronesi F, 2013, STEM CELLS DEV, V22, P181, DOI 10.1089/scd.2012.0373; Wei LC, 2012, MED SCI MONITOR, V18, pHY47, DOI 10.12659/MSM.883254; Weibrich G, 2005, INT J ORAL MAX IMPL, V20, P118; Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010; Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zaky SH, 2008, J TISSUE ENG REGEN M, V2, P472, DOI 10.1002/term.119	58	51	58	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71602	10.1371/journal.pone.0071602	http://dx.doi.org/10.1371/journal.pone.0071602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951201	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300135
J	Han, W; Zhou, YL; Zhong, R; Wu, C; Song, RR; Liu, L; Zou, L; Qiao, Y; Zhai, K; Chang, J; Huang, LM; Liu, L; Lu, XZ; Lou, J; Yu, DK; Tan, W; Zhang, JZ; Wang, HM; Miao, XP				Han, Wei; Zhou, Yuling; Zhong, Rong; Wu, Chen; Song, Ranran; Liu, Li; Zou, Li; Qiao, Yan; Zhai, Kan; Chang, Jiang; Huang, Liming; Liu, Li; Lu, Xuzai; Lou, Jiao; Yu, Dianke; Tan, Wen; Zhang, Jinzhe; Wang, Huanmin; Miao, Xiaoping			Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAS LIGAND EXPRESSION; PATHWAY GENES FAS; PROGNOSTIC-SIGNIFICANCE; FAMILIAL NEUROBLASTOMA; APO-1/CD95 GENE; CELL-DEATH; PROMOTER; SUSCEPTIBILITY; CANCER	The FAS and FASL system plays a substantial role in apoptosis and immune escape of cells. Three polymorphisms located in the promoter regions of FAS (-1377G/A and -670A/G) and FASL (-844T/C) have been shown to alter the transcriptional activity of the genes, respectively. This study was conducted to evaluate the effects of these polymorphisms on the susceptibility of neuroblastoma in the Chinese population. A total of 203 patients with neuroblastoma and 411 controls were recruited in this case-control study. Polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) was applied for genotyping. Unconditional logistic regression was used to estimate cancer risk by calculating odds ratios (ORs) and their 95% confidence intervals (95% CIs). It was observed that significantly increased risks of neuroblastoma associated with FAS -1377G/A and FASL -844T/C polymorphisms, with ORs equal to 1.55 (95% CI, 1.10-2.20) for FAS -1377 A allele and 2.90 (95% CI, 2.04-4.12) for FASL -844CC genotype carriers compared with non-carriers, respectively. However, no association was found between the polymorphisms of FAS -670A/G and risk of neuroblastoma. In addition, the cumulative effect of FAS and FASL polymorphisms on risk of neuroblastoma was observed (P for trend = 2.502x10(-10)), with OR for the carriers of both FAS -1377A allele and FASL -8 44CC genotypes equaled to 3.95 (95% CI, 2.40-6.51). This work reveals that polymorphisms of FAS -1377G/A and FASL -844T/C but not FAS -670A/G are associated with risk of neuroblastoma in Chinese. These findings support the hypothesis that genetic polymorphism in FAS/FASL death system may influence individual susceptibility to neuroblastoma.	[Han, Wei; Zhang, Jinzhe; Wang, Huanmin] Capital Med Univ, Beijing Childrens Hosp, Dept Surg Oncol, Beijing, Peoples R China; [Zhou, Yuling; Wu, Chen; Qiao, Yan; Zhai, Kan; Chang, Jiang; Huang, Liming; Yu, Dianke; Tan, Wen] Chinese Acad Med Sci, Inst Canc, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China; [Zhou, Yuling; Wu, Chen; Qiao, Yan; Zhai, Kan; Chang, Jiang; Huang, Liming; Yu, Dianke; Tan, Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhong, Rong; Liu, Li; Zou, Li; Lu, Xuzai; Lou, Jiao; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zhong, Rong; Liu, Li; Zou, Li; Lu, Xuzai; Lou, Jiao; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhong, Rong; Song, Ranran; Miao, Xiaoping] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University	Wang, HM (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Surg Oncol, Beijing, Peoples R China.	hamiwang@yahoo.com.cn; miaoxp@mail.hust.edu.cn	miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X; Wu, Chen/0000-0003-4954-1011	Program for New Century Excellent Talents in University [NCET-10-0388]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Program for New Century Excellent Talents in University NCET-10-0388 to Xiaoping Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MW, 1998, J IMMUNOL, V160, P5669; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Gratas C, 1998, CANCER RES, V58, P2057; Gross N, 2001, MED PEDIATR ONCOL, V36, P111, DOI 10.1002/1096-911X(20010101)36:1<111::AID-MPO1026>3.0.CO;2-3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho T, 2008, HEAD NECK-J SCI SPEC, V30, P297, DOI 10.1002/hed.20699; Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3; Kase S, 2002, INT J ONCOL, V20, P291; KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Lanciotti M, 2005, PHARMACOGENET GENOM, V15, P423, DOI 10.1097/01213011-200506000-00008; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Lee SH, 1999, CANCER RES, V59, P3068; Liang G, 2004, CARCINOGENESIS, V25, P773, DOI 10.1093/carcin/bgh053; Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Perfumo C, 2009, PEDIATR BLOOD CANCER, V53, P576, DOI 10.1002/pbc.22132; Peters AMJ, 1999, EXP HEMATOL, V27, P868, DOI 10.1016/S0301-472X(99)00033-8; Shibakita M, 1999, CLIN CANCER RES, V5, P2464; Shurin GV, 1998, NAT IMMUN, V16, P263, DOI 10.1159/000069452; Sibley K, 2003, CANCER RES, V63, P4327; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Ueda M, 2005, GYNECOL ONCOL, V98, P129, DOI 10.1016/j.ygyno.2005.04.001; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Yang J, 2013, MOL NEUROBIOLOGY; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang ZZ, 2009, EUR J HUM GENET, V17, P1294, DOI 10.1038/ejhg.2009.45; Zhong R, 2013, CARCINOGENESIS	42	29	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71656	10.1371/journal.pone.0071656	http://dx.doi.org/10.1371/journal.pone.0071656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951214	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300139
J	Imai, T; Koyanagi, N; Ogawa, R; Shindo, K; Suenaga, T; Sato, A; Arii, J; Kato, A; Kiyono, H; Arase, H; Kawaguchi, Y				Imai, Takahiko; Koyanagi, Naoto; Ogawa, Ryo; Shindo, Keiko; Suenaga, Tadahiro; Sato, Ayuko; Arii, Jun; Kato, Akihisa; Kiyono, Hiroshi; Arase, Hisashi; Kawaguchi, Yasushi			Us3 Kinase Encoded by Herpes Simplex Virus 1 Mediates Downregulation of Cell Surface Major Histocompatibility Complex Class I and Evasion of CD8(+) T Cells	PLOS ONE			English	Article							MHC CLASS-I; HOST SHUTOFF PROTEIN; ADAPTIVE IMMUNE-RESPONSES; ANTIGEN PRESENTATION; GLYCOPROTEIN-B; INFECTED-CELLS; POSTTRANSLATIONAL MODIFICATION; PRIMARY ENVELOPMENT; CATALYTIC-ACTIVITY; GENE-EXPRESSION	Detection and elimination of virus-infected cells by CD8(+) cytotoxic T lymphocytes (CTLs) depends on recognition of virus-derived peptides presented by major histocompatibility complex class I (MHC-I) molecules on the surface of infected cells. In the present study, we showed that inactivation of the activity of viral kinase Us3 encoded by herpes simplex virus 1 (HSV-1), the etiologic agent of several human diseases and a member of the alphaherpesvirinae, significantly increased cell surface expression of MHC-I, thereby augmenting CTL recognition of infected cells in vitro. Overexpression of Us3 by itself had no effect on cell surface expression of MHC-I and Us3 was not able to phosphorylate MHC-I in vitro, suggesting that Us3 indirectly downregulated cell surface expression of MHC-I in infected cells. We also showed that inactivation of Us3 kinase activity induced significantly more HSV-1-specific CD8(+) T cells in mice. Interestingly, depletion of CD8(+) T cells in mice significantly increased replication of a recombinant virus encoding a kinase-dead mutant of Us3, but had no effect on replication of a recombinant virus in which the kinase-dead mutation was repaired. These results indicated that Us3 kinase activity is required for efficient downregulation of cell surface expression of MHC-I and mediates evasion of HSV-1-specific CD8(+) T cells. Our results also raised the possibility that evasion of HSV-1-specific CD8(+) T cells by HSV-1 Us3-mediated inhibition of MHC-I antigen presentation might in part contribute to viral replication in vivo.	[Imai, Takahiko; Koyanagi, Naoto; Ogawa, Ryo; Shindo, Keiko; Arii, Jun; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Imai, Takahiko; Koyanagi, Naoto; Ogawa, Ryo; Shindo, Keiko; Arii, Jun; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Viral Infect,Dept Infect Dis Control, Tokyo, Japan; [Imai, Takahiko] Nippon Inst Biol Sci, Ome, Tokyo, Japan; [Sato, Ayuko; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Kiyono, Hiroshi; Arase, Hisashi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 565, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Suita, Osaka, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Osaka University; Osaka University	Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp	Arase, Hisashi/C-8442-2009; Kiyono, Hiroshi/AAC-6735-2022	Arase, Hisashi/0000-0002-1153-3166; Kawaguchi, Yasushi/0000-0001-8232-6925	Funding Program for Next Generation World-Leading Researchers; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Science, Sports and Technology of Japan; Takeda Science Foundation; Naito Foundation; Sumitomo Foundation; Waksman Foundation of Japan; Tokyo Biochemical Research Foundation; JSPS; Nippon Institute for Biological Science; Grants-in-Aid for Scientific Research [25670143] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Sumitomo Foundation; Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Tokyo Biochemical Research Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Institute for Biological Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Funding Program for Next Generation World-Leading Researchers and Grants for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases and Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine -For personalized medicine and the control of worldwide infectious diseases-" from the Ministry of Education, Culture, Science, Sports and Technology of Japan, and grants from the Takeda Science Foundation, the Naito Foundation, the Sumitomo Foundation, the Waksman Foundation of Japan and the Tokyo Biochemical Research Foundation. TI was supported by research fellowships from JSPS for Young Scientists and from Nippon Institute for Biological Science and AS was supported by a research fellowships from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; [Anonymous], 2007, FIELDS VIROLOGY; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Cartier A, 2004, SCAND J IMMUNOL, V60, P592, DOI 10.1111/j.0300-9475.2004.01523.x; Cartier A, 2003, CELL DEATH DIFFER, V10, P1320, DOI 10.1038/sj.cdd.4401308; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Deruelle MJ, 2009, VIROLOGY, V395, P172, DOI 10.1016/j.virol.2009.09.019; Dudek T, 2008, VIROLOGY, V372, P165, DOI 10.1016/j.virol.2007.10.014; Eisfeld AJ, 2007, J VIROL, V81, P9034, DOI 10.1128/JVI.00711-07; Everly DN, 2002, J VIROL, V76, P8560, DOI 10.1128/JVI.76.17.8560-8571.2002; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Goldsmith K, 1998, J EXP MED, V187, P341, DOI 10.1084/jem.187.3.341; GUILD BC, 1984, J BIOL CHEM, V259, P3504; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HILL AB, 1994, J IMMUNOL, V152, P2736; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Jarosinski KW, 2010, VIROLOGY, V405, P457, DOI 10.1016/j.virol.2010.06.041; Jugovic P, 1998, J VIROL, V72, P5076, DOI 10.1128/JVI.72.6.5076-5084.1998; Kassim SH, 2009, J VIROL, V83, P3175, DOI 10.1128/JVI.01907-08; Kato A, 2005, J VIROL, V79, P9325, DOI 10.1128/JVI.79.14.9325-9331.2005; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kato A, 2009, J VIROL, V83, P250, DOI 10.1128/JVI.01451-08; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Leopardi R, 1997, P NATL ACAD SCI USA, V94, P7891, DOI 10.1073/pnas.94.15.7891; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Ma GG, 2012, J VIROL, V86, P3554, DOI 10.1128/JVI.06994-11; MEIGNIER B, 1988, VIROLOGY, V162, P251, DOI 10.1016/0042-6822(88)90417-5; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Munger J, 2001, P NATL ACAD SCI USA, V98, P10410, DOI 10.1073/pnas.181344498; Murphy JA, 2003, J VIROL, V77, P9337, DOI 10.1128/JVI.77.17.9337-9345.2003; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ogg PD, 2004, VIROLOGY, V319, P212, DOI 10.1016/j.virol.2003.10.019; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; PURVES FC, 1991, J VIROL, V65, P5757, DOI 10.1128/JVI.65.11.5757-5764.1991; Rao P, 2011, J VIROL, V85, P8093, DOI 10.1128/JVI.02689-10; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Sagou K, 2009, J VIROL, V83, P5773, DOI 10.1128/JVI.00103-09; Said A, 2012, J VIROL, V86, P8059, DOI 10.1128/JVI.00891-12; Samady L, 2003, J VIROL, V77, P3768, DOI 10.1128/JVI.77.6.3768-3776.2003; Sen J, 2013, VIROLOGY, V439, P65, DOI 10.1016/j.virol.2013.01.026; Sloan DD, 2003, J IMMUNOL, V171, P6733, DOI 10.4049/jimmunol.171.12.6733; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Tanaka M, 2012, J VIROL, V86, P5264, DOI 10.1128/JVI.06913-11; Tigges MA, 1996, J IMMUNOL, V156, P3901; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	64	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72050	10.1371/journal.pone.0072050	http://dx.doi.org/10.1371/journal.pone.0072050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951282	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300176
J	Lopes, G; Pinto, E; Andrade, PB; Valentao, P				Lopes, Graciliana; Pinto, Eugenia; Andrade, Paula B.; Valentao, Patricia			Antifungal Activity of Phlorotannins against Dermatophytes and Yeasts: Approaches to the Mechanism of Action and Influence on Candida albicans Virulence Factor	PLOS ONE			English	Article							OXIDATIVE STRESS; PATHWAYS; HYPERPOLARIZATION; MITOCHONDRIA; PERFORMANCE; INHIBITION; APOPTOSIS	In the last few decades, fungal infections, particularly nosocomial, increased all around the world. This increment stimulated the search for new antifungal agents, especially those derived from nature. Among natural products, those from marine sources have gained prominence in the last years. Purified phlorotannins extracts from three brown seaweeds (Cystoseira nodicaulis (Withering) M. Roberts, Cystoseira usneoides (Linnaeus) M. Roberts and Fucus spiralis Linnaeus) were screened for their antifungal activity against human pathogenic yeast and filamentous fungi. The purified phlorotannins extracts from the studied seaweeds displayed fungistatic and fungicidal activity against yeast and dermatophytes, respectively, pointing to their interest as anti-dermatophyte agent. C. albicans ATCC 10231 was the most susceptible among yeast, while Epidermophyton floccosum and Trichophyton rubrum were the most susceptible among dermatophytes. Since the antifungal mechanism constitutes an important strategy for limiting the emergence of resistance to the commercially available agents, the mechanism of action of purified phlorotannins extracts was approached. C. nodicaulis and C. usneoides seem to act by affecting the ergosterol composition of the cell membrane of yeast and dermatophyte, respectively. F. spiralis influenced the dermatophyte cell wall composition by reducing the levels of chitin. Phlorotannins also seem to affect the respiratory chain function, as all of the studied species significantly increased the activity of mitochondrial dehydrogenases and increased the incorporation of rhodamine 123 by yeast cells. Phlorotannins from F. spiralis inhibited the dimorphic transition of Candida albicans, leading to the formation of pseudohyphae with diminished capacity to adhere to epithelial cells. This finding is associated with a decrease of C. albicans virulence and capacity to invade host cells and can be potentially interesting for combined antifungal therapy, namely for the control of invasive candidiasis.	[Lopes, Graciliana; Andrade, Paula B.; Valentao, Patricia] Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, P-4100 Oporto, Portugal; [Pinto, Eugenia] Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED Lab Microbiol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Pinto, E (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED Lab Microbiol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	epinto@ff.up.pt	Pinto, Maria Eugénia Ribeiro/K-5788-2014; Lopes, Graciliana/U-1992-2019; Andrade, Paula B/A-5900-2008; Valentão, Patrícia/D-4818-2013	Pinto, Maria Eugénia Ribeiro/0000-0003-2948-5809; Andrade, Paula B/0000-0002-9764-3920; Valentão, Patrícia/0000-0002-0740-4396	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011, Pest-OE/SAV/UI4040/2011]; FCT [SFRH/BD/61565/2009]; Programa Operacional Potencial Humano (POPH); Fundo Social Europeu (FSE)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano (POPH); Fundo Social Europeu (FSE)(European Social Fund (ESF))	The authors are grateful to Fundacao para a Ciencia e a Tecnologia (FCT) through grant no. PEst-C/EQB/LA0006/2011 and no. Pest-OE/SAV/UI4040/2011. G. Lopes (SFRH/BD/61565/2009) is indebted to FCT, Fundo Social Europeu (FSE) and Programa Operacional Potencial Humano (POPH) for the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Bramono K, 2006, JPN J INFECT DIS, V59, P73; Cao J, 2007, FREE RADICAL BIO MED, V43, P968, DOI 10.1016/j.freeradbiomed.2007.06.006; Carrillo-Munoz AJ, 2003, MYCOSES, V46, P467, DOI 10.1046/j.0933-7407.2003.00921.x; Chapman SW, 2003, CLIN MYCOLOGY, P33; CLSI, 2008, M27A3 CLSI; Como J., 2003, CLIN MYCOLOGY, P64; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Kumar V, 2014, ROBBINS BASIC PATHOL, V9th, P1; Lee MH, 2010, J KOREAN SOC APPL BI, V53, P504, DOI 10.3839/jksabc.2010.076; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Lima-Neto RG, 2011, MYCOSES, V54, P23, DOI 10.1111/j.1439-0507.2009.01757.x; Lopes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031145; Lopes G, 2011, J PHYCOL, V47, P1210, DOI 10.1111/j.1529-8817.2011.01028.x; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Martins VD, 2011, J BIOENERG BIOMEMBR, V43, P81, DOI 10.1007/s10863-011-9331-1; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Moon HE, 2011, BIOSCI BIOTECH BIOCH, V75, P1472, DOI 10.1271/bbb.110137; Pinto E, 2008, BIOORGAN MED CHEM, V16, P8172, DOI 10.1016/j.bmc.2008.07.042; Pinto E, 2011, CHEM BIOL DRUG DES, V77, P212, DOI 10.1111/j.1747-0285.2010.01072.x; Pinton P, 1998, BIOFACTORS, V8, P243, DOI 10.1002/biof.5520080312; Richardson MD., 2012, FUNGAL INFECT DIAGNO, V4th ed.; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Thomas NV, 2011, ENVIRON TOXICOL PHAR, V32, P325, DOI 10.1016/j.etap.2011.09.004; Valentin E, 2000, Contrib Microbiol, V5, P138; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237	34	77	79	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72203	10.1371/journal.pone.0072203	http://dx.doi.org/10.1371/journal.pone.0072203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951297	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300183
J	Tran, MTD; Elberling, J; Skovbjerg, S; Berg, ND; Sosted, H; Johansen, JD; Lysdal, SH				Marie Thi Dao Tran; Elberling, Jesper; Skovbjerg, Sine; Berg, Nikolaj Drimer; Sosted, Heidi; Johansen, Jeanne Duus; Lysdal, Susan Hovmand			Chemical Intolerance among Hairdressers in Denmark	PLOS ONE			English	Article							HAND ECZEMA; SENSITIVITY; PREVALENCE; SYMPTOMS	Objectives: To investigate the prevalence and the severity of fragrance-related symptoms among hairdressers in Denmark compared with the Danish general population. Further, to characterize former hairdressers who are severely chemically intolerant to fragranced products in relation to sex, age and health-and work-related reasons for leaving the hairdressing profession. Methods: The study population consisted of all hairdressers who graduated from the public vocational schools in Denmark during 1985 and 2007 (n = 7840) and a random sample of individuals from the Danish general population (n = 6000). Both populations received a postal questionnaire on symptoms from inhalation of fragranced products and the resultant behavioural consequences. All former hairdressers also answered additional questions on health-and work-related reasons for leaving the profession. Results: No differences were found in the prevalence (OR = 1.0, CI = 0.89-1.14) or the severity (OR = 1.1, CI = 0.80-1.51) of symptoms from inhalation of fragranced products in hairdressers compared with the general population. Among hairdressers, however, experience of fragrance-related symptoms (OR = 1.2, CI = 1.01-1.31) and adjustments of social (OR = 1.8, CI = 1.12-2.80) and occupational conditions (OR = 2.8, CI = 1.84-4.25) were reported significantly more often by former hairdressers than current hairdressers. Conclusions: The prevalence and the severity of fragrance-related symptoms were similar in hairdressers and the general population. Former hairdressers were more affected by fragranced products than current hairdressers were. Although fragrance-related symptoms did not seem to be more frequent among hairdressers, the hairdressing profession might pose a problem for those who are chemically intolerant.	[Marie Thi Dao Tran; Elberling, Jesper; Skovbjerg, Sine] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Danish Res Ctr Chem Sensitiv, Gentofte, Denmark; [Berg, Nikolaj Drimer] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Sosted, Heidi; Lysdal, Susan Hovmand] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Res Ctr Hairdressers & Beauticians, Gentofte, Denmark; [Johansen, Jeanne Duus] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Gentofte, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Tran, MTD (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Danish Res Ctr Chem Sensitiv, Gentofte, Denmark.	marie.thi.dao.tran@regionh.dk	Johansen, Jeanne/AAM-6382-2021	Johansen, Jeanne/0000-0002-3537-8463; Elberling, Jesper/0000-0002-8925-4722	Danish Ministry of the Environment; Danish Working Environment Research Fund	Danish Ministry of the Environment; Danish Working Environment Research Fund	The study was funded by the Danish Ministry of the Environment and the Danish Working Environment Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailer J, 2008, J PSYCHOSOM RES, V65, P425, DOI 10.1016/j.jpsychores.2008.05.006; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Berg ND, 2011, INT J HYG ENVIR HEAL, V214, P239, DOI 10.1016/j.ijheh.2011.01.003; Bolt HM, 2002, TOXICOL LETT, V128, P99, DOI 10.1016/S0378-4274(01)00537-9; Caress SM, 2003, ENVIRON HEALTH PERSP, V111, P1490, DOI 10.1289/ehp.5940; CULLEN MR, 1992, TOXICOL IND HEALTH, V8, P15; CULLEN MR, 1987, OCCUP MED, V2, P655; Elberling J, 2005, CLIN EXP ALLERGY, V35, P75, DOI 10.1111/j.1365-2222.2005.02138.x; Elberling J, 2004, BRIT J DERMATOL, V151, P1197, DOI 10.1111/j.1365-2133.2004.06251.x; Fiedler N, 1996, N J Med, V93, P39; Gibson PR, 2003, ENVIRON HEALTH PERSP, V111, P1498, DOI 10.1289/ehp.5936; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; Hausteiner C, 2005, INT J HYG ENVIR HEAL, V208, P271, DOI 10.1016/j.ijheh.2005.03.006; Hu H, 1999, TOXICOL IND HEALTH, V15, P582, DOI 10.1191/074823399678846952; Johansson A, 2005, INT ARCH OCC ENV HEA, V78, P559, DOI 10.1007/s00420-005-0616-8; Labarge AS, 2000, NEUROPSYCHOL REV, V10, P183, DOI 10.1023/A:1026460726965; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Lax MB, 1995, ARCH ENVIRON HEALTH, V50, P425, DOI 10.1080/00039896.1995.9935978; Lysdal SH, 2012, CONTACT DERMATITIS, V66, P72, DOI 10.1111/j.1600-0536.2011.01997.x; Lysdal SH, 2011, CONTACT DERMATITIS, V65, P151, DOI 10.1111/j.1600-0536.2011.01935.x; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; Miller C, 1997, EMPIRICAL APPROACHES; MILLER CS, 1995, ARCH ENVIRON HEALTH, V50, P119, DOI 10.1080/00039896.1995.9940889; MOOSER SB, 1987, OCCUP MED, V2, P663; NETHERCOTT JR, 1993, ARCH ENVIRON HEALTH, V48, P19, DOI 10.1080/00039896.1993.9938389; ROSS GH, 1992, TOXICOL IND HEALTH, V8, P21; Shorter E, 1997, SCAND J WORK ENV HEA, V23, P35; SIMON GE, 1994, TOXICOL IND HEALTH, V10, P487; Skovbjerg S, 2009, SCAND J PUBLIC HLTH; Winder C, 2002, TOXICOL LETT, V128, P85, DOI 10.1016/S0378-4274(01)00536-7; Winters W, 2003, PSYCHOSOM MED, V65, P332, DOI 10.1097/01.PSY.0000041468.75064.BE	31	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71241	10.1371/journal.pone.0071241	http://dx.doi.org/10.1371/journal.pone.0071241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951117	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300104
J	Wang, ZJ; Chen, JH; Liu, WD; Luo, ZS; Wang, PK; Zhang, YJ; Zheng, RH; Shi, JS				Wang, Zhanjun; Chen, Jinhui; Liu, Weidong; Luo, Zhanshou; Wang, Pengkai; Zhang, Yanjuan; Zheng, Renhua; Shi, Jisen			Transcriptome Characteristics and Six Alternative Expressed Genes Positively Correlated with the Phase Transition of Annual Cambial Activities in Chinese Fir (Cunninghamia lanceolata (Lamb.) Hook)	PLOS ONE			English	Article							CELL-WALL FORMATION; III HD-ZIP; HOUSEKEEPING GENES; VASCULAR CAMBIUM; SEASONAL-CHANGES; CANDIDATE GENES; HOMEOBOX GENE; PICEA-ABIES; ARABIDOPSIS; POPULUS	Background: The molecular mechanisms that govern cambial activity in angiosperms are well established, but little is known about these molecular mechanisms in gymnosperms. Chinese fir (Cunninghamia lanceolata (Lamb.) Hook), a diploid (2n = 2x = 22) gymnosperm, is one of the most important industrial and commercial timber species in China. Here, we performed transcriptome sequencing to identify the repertoire of genes expressed in cambium tissue of Chinese fir. Methodology/Principal Findings: Based on previous studies, the four stage-specific cambial tissues of Chinese fir were defined using transmission electron microscopy (TEM). In total, 20 million sequencing reads (3.6 Gb) were obtained using Illumina sequencing from Chinese fir cambium tissue collected at active growth stage, with a mean length of 131 bp and a N50 of 90 bp. SOAPdenovo software was used to assemble 62,895 unigenes. These unigenes were further functionally annotated by comparing their sequences to public protein databases. Expression analysis revealed that the altered expression of six homologous genes (ClWOX1, ClWOX4, ClCLV1-like, ClCLV-like, ClCLE12, and ClPIN1-like) correlated positively with changes in cambial activities; moreover, these six genes might be directly involved in cambial function in Chinese fir. Further, the full-length cDNAs and DNAs for ClWOX1 and ClWOX4 were cloned and analyzed. Conclusions: In this study, a large number of tissue/stage-specific unigene sequences were generated from the active growth stage of Chinese fir cambium. Transcriptome sequencing of Chinese fir not only provides extensive genetic resources for understanding the molecular mechanisms underlying cambial activities in Chinese fir, but also is expected to be an important foundation for future genetic studies of Chinese fir. This study indicates that ClWOX1 and ClWOX4 could be possible reverse genetic target genes for revealing the molecular mechanisms of cambial activities in Chinese fir.	[Wang, Zhanjun; Chen, Jinhui; Liu, Weidong; Luo, Zhanshou; Wang, Pengkai; Zhang, Yanjuan; Shi, Jisen] Nanjing Forestry Univ, Minist Educ China, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zheng, Renhua] Minist Forestry, Southen Mt Timber Forest Cultivat Lab, Fujian Acad Forestry, Fuzhou, Peoples R China	Ministry of Education, China; Nanjing Forestry University	Shi, JS (corresponding author), Nanjing Forestry Univ, Minist Educ China, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China.	jshi@njfu.edu.cn			National Science Foundation of China [30930077, 30901156, 31170619]; 'Pandeng' Scholar grant of Jiangsu Province [BK2008051]; Public welfare projects of Chinese National Forest Bureau [201004049]; Forest Tree Seeds and Seedlings Science and Technique Foundation of Fujian Province grants Fujian Forestry [2009-4]; Jiangsu Provincial Graduate Student Innovation Project [CXZZ11_0507]; Doctorate Fellowship Foundation of Nanjing Forestry University [2011YB017]; Priority Academic Program Development of Jiangsu Higher Education Institutions fund (PAPD)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Pandeng' Scholar grant of Jiangsu Province; Public welfare projects of Chinese National Forest Bureau; Forest Tree Seeds and Seedlings Science and Technique Foundation of Fujian Province grants Fujian Forestry; Jiangsu Provincial Graduate Student Innovation Project; Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions fund (PAPD)	This work was supported by grants from National Science Foundation of China grant 30930077, 30901156, 31170619; 'Pandeng' Scholar grant of Jiangsu Province BK2008051; Public welfare projects of Chinese National Forest Bureau (201004049); Forest Tree Seeds and Seedlings Science and Technique Foundation of Fujian Province grants Fujian Forestry (2009-4); Jiangsu Provincial Graduate Student Innovation Project grant CXZZ11_0507; Doctorate Fellowship Foundation of Nanjing Forestry University grant 2011YB017; and Priority Academic Program Development of Jiangsu Higher Education Institutions fund (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-106; Allsopp A, 1940, BIOCHEM J, V34, P1078, DOI 10.1042/bj0341078; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BAILEY IW, 1952, SCIENCE, V115, P255, DOI 10.1126/science.115.2984.255; Baima S, 1995, DEVELOPMENT, V121, P4171; Begum S, 2013, PHYSIOL PLANTARUM, V147, P46, DOI 10.1111/j.1399-3054.2012.01663.x; Berta M, 2010, PLANT BIOLOGY, V12, P341, DOI 10.1111/j.1438-8677.2009.00320.x; CATESSON AM, 1994, INT J PLANT SCI, V155, P251, DOI 10.1086/297165; Celedon PAF, 2007, PROTEOMICS, V7, P2258, DOI 10.1002/pmic.200600989; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Carvalho MCDG, 2008, TREE PHYSIOL, V28, P905, DOI 10.1093/treephys/28.6.905; Delseny M, 2010, PLANT SCI, V179, P407, DOI 10.1016/j.plantsci.2010.07.019; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Emiliani G, 2011, J INTEGR PLANT BIOL, V53, P783, DOI 10.1111/j.1744-7909.2011.01069.x; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Farrar JJ, 1997, TREES-STRUCT FUNCT, V11, P191, DOI 10.1007/s004680050076; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Hossain Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030425; Huang ZQ, 2005, CHINESE SCI BULL, V50, P2581, DOI 10.1360/982005-1141; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Itoh T, 1971, WOOD RES, V51, P33; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson P, 1994, VASCULAR CAMBIUM, P594; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liang HY, 2011, TREE GENET GENOMES, V7, P941, DOI 10.1007/s11295-011-0386-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Lu Ye, 2007, Journal of Nanjing Forestry University (Natural Sciences Edition), V31, P113; LULIN H, 2012, PLOS ONE, V0007; Ma Z, 2006, GENETICA, V126, P343, DOI 10.1007/s10709-005-1358-y; Mackay J. J., 2011, Genetics, genomics and breeding of conifers, P323; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Micheli F, 2000, PLANT PHYSIOL, V124, P191, DOI 10.1104/pp.124.1.191; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nardmann J, 2012, PLANT MOL BIOL, V78, P123, DOI 10.1007/s11103-011-9851-4; Nardmann J, 2009, MOL BIOL EVOL, V26, P1745, DOI 10.1093/molbev/msp084; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Oribe Y, 1997, TREE PHYSIOL, V17, P81; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Palovaara J, 2010, NEW PHYTOL, V188, P122, DOI 10.1111/j.1469-8137.2010.03336.x; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peiffer GA, 2012, PLANT PHYSIOL, V158, P1745, DOI 10.1104/pp.111.189860; Peng Y, 2000, THESIS, P14; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rathgeber CBK, 2011, ANN BOT-LONDON, V108, P429, DOI 10.1093/aob/mcr168; Rigault P, 2011, PLANT PHYSIOL, V157, P14, DOI 10.1104/pp.111.179663; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; RUBERY PH, 1968, NATURE, V219, P1230, DOI 10.1038/2191230a0; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Savidge RA, 2001, J PLANT GROWTH REGUL, V20, P52, DOI 10.1007/s003440010002; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; SHENG WT, 1992, RES SITE DEGRADATION, P1, DOI DOI 10.1016/J.ECOLIND.2010.02.008; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi JS, 2010, J EXP BOT, V61, P2367, DOI 10.1093/jxb/erq066; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandenbussche M, 2009, PLANT CELL, V21, P2269, DOI 10.1105/tpc.109.065862; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang C, 2010, PLANT MOL BIOL REP, V28, P438, DOI 10.1007/s11105-009-0172-6; Wang GF, 2007, GENOME, V50, P1141, DOI 10.1139/G07-091; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035719; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin YF, 2002, ACTA BOT SIN, V44, P1268; Zhang X, 2010, J INTEGR PLANT BIOL, V52, P1016, DOI 10.1111/j.1744-7909.2010.00982.x; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zheng J, 2013, PLANT MOL BIOL REP, V31, P75, DOI 10.1007/s11105-012-0478-7; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zhou J, 2011, GENESIS, V49, P885, DOI 10.1002/dvg.20795; Zytynska SE, 2012, TREE GENET GENOMES, V8, P431, DOI 10.1007/s11295-011-0453-8	105	17	20	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71562	10.1371/journal.pone.0071562	http://dx.doi.org/10.1371/journal.pone.0071562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951189	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300128
J	Woudenberg-Vrenken, TE; de la Rosa, LC; Buist-Homan, M; Faber, KN; Moshage, H				Woudenberg-Vrenken, Titia E.; de la Rosa, Laura Conde; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han			Metformin Protects Rat Hepatocytes against Bile Acid-Induced Apoptosis	PLOS ONE			English	Article							FACTOR-KAPPA-B; FATTY LIVER-DISEASE; KINASE ACTIVATION; MAMMALIAN TARGET; AMPK; MTOR; INHIBITION; PATHWAY; DEATH; STIMULATION	Background: Metformin is used in the treatment of Diabetes Mellitus type II and improves liver function in patients with non-alcoholic fatty liver disease (NAFLD). Metformin activates AMP-activated protein kinase (AMPK), the cellular energy sensor that is sensitive to changes in the AMP/ATP-ratio. AMPK is an inhibitor of mammalian target of rapamycin (mTOR). Both AMPK and mTOR are able to modulate cell death. Aim: To evaluate the effects of metformin on hepatocyte cell death. Methods: Apoptotic cell death was induced in primary rat hepatocytes using either the bile acid glycochenodeoxycholic acid (GCDCA) or TNF alpha in combination with actinomycin D (actD). AMPK, mTOR and phosphoinositide-3 kinase (PI3K)/Akt were inhibited using pharmacological inhibitors. Apoptosis and necrosis were quantified by caspase activation, acridine orange staining and Sytox green staining respectively. Results: Metformin dose-dependently reduces GCDCA-induced apoptosis, even when added 2 hours after GCDCA, without increasing necrotic cell death. Metformin does not protect against TNF alpha/ActD-induced apoptosis. The protective effect of metformin is dependent on an intact PI3-kinase/Akt pathway, but does not require AMPK/mTOR-signaling. Metformin does not inhibit NF-kappa B activation. Conclusion: Metformin protects against bile acid-induced apoptosis and could be considered in the treatment of chronic liver diseases accompanied by inflammation.	[Woudenberg-Vrenken, Titia E.; de la Rosa, Laura Conde; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands	University of Groningen	Moshage, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	a.j.moshage@umcg.nl		Moshage, Han/0000-0002-4764-0246; Conde de la Rosa, Laura/0000-0001-9392-7320	Dutch Digestive Foundation; J.K. de Cock Foundation	Dutch Digestive Foundation; J.K. de Cock Foundation	This work was supported by the Dutch Digestive Foundation and the J.K. de Cock Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; Angelico F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005166.pub2; Angulo P, 2002, BEST PRACT RES CL GA, V16, P797, DOI 10.1053/bega.2002.0327; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Bugianesi E, 2004, BEST PRACT RES CL GA, V18, P1105, DOI 10.1016/j.bpg.2004.06.025; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Dranoff JA, 1999, HEPATOLOGY, V29, P1912, DOI 10.1002/hep.510290643; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kim DS, 2010, IMMUNOPHARM IMMUNOT, V32, P251, DOI 10.3109/08923970903252220; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Klein J, 2004, J ENDOCRINOL, V183, P299, DOI 10.1677/joe.1.05646; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Miyoshi H, 2001, AM J PATHOL, V158, P967, DOI 10.1016/S0002-9440(10)64043-6; Mori M, 2003, J CELL PHYSIOL, V195, P290, DOI 10.1002/jcp.10245; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Proud CG, 2004, DNA REPAIR, V3, P927, DOI 10.1016/j.dnarep.2004.03.012; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Rattan R, 2005, J BIOL CHEM; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reiter AK, 2005, AM J PHYSIOL-ENDOC M, V288, pE980, DOI 10.1152/ajpendo.00333.2004; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2004, CLIN SCI, V107, P13, DOI 10.1042/CS20040090; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Webster CRL, 2001, HEPATOLOGY, V33, P608, DOI 10.1053/jhep.2001.22756; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	53	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71773	10.1371/journal.pone.0071773	http://dx.doi.org/10.1371/journal.pone.0071773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951244	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300157
J	Zhang, SG; Rahman, M; Zhang, S; Song, L; Herwald, H; Thorlacius, H				Zhang, Songen; Rahman, Milladur; Zhang, Su; Song, Lei; Herwald, Heiko; Thorlacius, Henrik			Targeting Rac1 Signaling Inhibits Streptococcal M1 Protein-Induced CXC Chemokine Formation, Neutrophil Infiltration and Lung Injury	PLOS ONE			English	Article							PULMONARY RECRUITMENT; ALVEOLAR MACROPHAGES; ABDOMINAL SEPSIS; RHO-GTPASES; P-SELECTIN; MICE; INFLAMMATION; DAMAGE; LIVER	Infections with Streptococcus pyogenes exhibit a wide spectrum of infections ranging from mild pharyngitis to severe Streptococcal toxic shock syndrome (STSS). The M1 serotype of Streptococcus pyogenes is most commonly associated with STSS. In the present study, we hypothesized that Rac1 signaling might regulate M1 protein-induced lung injury. We studied the effect of a Rac1 inhibitor (NSC23766) on M1 protein-provoked pulmonary injury. Male C57BL/6 mice received NSC23766 prior to M1 protein challenge. Bronchoalveolar fluid and lung tissue were harvested for quantification of neutrophil recruitment, edema and CXC chemokine formation. Neutrophil expression of Mac-1 was quantified by use of flow cytometry. Quantitative RT-PCR was used to determine gene expression of CXC chemokines in alveolar macrophages. Treatment with NSC23766 decreased M1 protein-induced neutrophil infiltration, edema formation and tissue injury in the lung. M1 protein challenge markedly enhanced Mac-1 expression on neutrophils and CXC chemokine levels in the lung. Inhibition of Rac1 activity had no effect on M1 protein-induced expression of Mac-1 on neutrophils. However, Rac1 inhibition markedly decreased M1 protein-evoked formation of CXC chemokines in the lung. Moreover, NSC23766 completely inhibited M1 protein-provoked gene expression of CXC chemokines in alveolar macrophages. We conclude that these novel results suggest that Rac1 signaling is a significant regulator of neutrophil infiltration and CXC chemokine production in the lung. Thus, targeting Rac1 activity might be a potent strategy to attenuate streptococcal M1 protein-triggered acute lung damage.	[Zhang, Songen; Rahman, Milladur; Zhang, Su; Song, Lei; Thorlacius, Henrik] Lund Univ, Dept Clin Sci, Sect Surg, Malmo, Sweden; [Herwald, Heiko] Lund Univ, Sect Clin & Expt Infect Med, Lund, Sweden	Lund University; Lund University	Thorlacius, H (corresponding author), Lund Univ, Dept Clin Sci, Sect Surg, Malmo, Sweden.	henrik.thorlacius@med.lu.se	Rahman, Milladur/ABF-9885-2021; Herwald, Heiko/AAN-3708-2021	Rahman, Milladur/0000-0002-8883-4848; Herwald, Heiko/0000-0002-8111-2842	Swedish Medical Research Council [2012-3685]; Crafoordska stiftelsen; Einar och Inga Nilssons stiftelse; Harald och Greta Jaenssons stiftelse; Greta och Johan Kocks stiftelser; Froken Agnes Nilssons stiftelse; Franke och Margareta Bergqvists stiftelse for framjande av cancerforskning; Magnus Bergvalls stiftelse; Mossfelts stiftelse; Nanna Svartz stiftelse; Ruth och Richard Julins stiftelse; Svenska Lakaresallskapet; Allmana sjukhusets i Malmo stiftelse for bekampande av cancer; MAS fonder; Malmo University Hospital; Lund University	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoordska stiftelsen; Einar och Inga Nilssons stiftelse; Harald och Greta Jaenssons stiftelse; Greta och Johan Kocks stiftelser; Froken Agnes Nilssons stiftelse; Franke och Margareta Bergqvists stiftelse for framjande av cancerforskning; Magnus Bergvalls stiftelse; Mossfelts stiftelse; Nanna Svartz stiftelse; Ruth och Richard Julins stiftelse; Svenska Lakaresallskapet; Allmana sjukhusets i Malmo stiftelse for bekampande av cancer; MAS fonder; Malmo University Hospital; Lund University	This work was supported by grants from the Swedish Medical Research Council (2012-3685), Crafoordska stiftelsen, Einar och Inga Nilssons stiftelse, Harald och Greta Jaenssons stiftelse, Greta och Johan Kocks stiftelser, Froken Agnes Nilssons stiftelse, Franke och Margareta Bergqvists stiftelse for framjande av cancerforskning, Magnus Bergvalls stiftelse, Mossfelts stiftelse, Nanna Svartz stiftelse, Ruth och Richard Julins stiftelse, Svenska Lakaresallskapet, Allmana sjukhusets i Malmo stiftelse for bekampande av cancer, MAS fonder, Malmo University Hospital and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2008, SHOCK, V30, P254, DOI [10.1097/SHK.0b013e318162c567, 10.1097/shk.0b013e318162c567]; Asaduzzaman M, 2009, BRIT J PHARMACOL, V156, P307, DOI 10.1111/j.1476-5381.2008.00021.x; Beltowski J, 2009, CURR DRUG SAF, V4, P209, DOI 10.2174/157488609789006949; Binker MG, 2008, EXP PHYSIOL, V93, P1091, DOI 10.1113/expphysiol.2008.043141; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Harada N, 2003, SURGERY, V134, P480, DOI 10.1067/S0039-6060(03)00256-3; Hasan Z, 2013, AM J PHYSIOL-LUNG C, V304, pL221, DOI 10.1152/ajplung.00199.2012; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310; Pahlman LI, 2006, J IMMUNOL, V177, P1221, DOI 10.4049/jimmunol.177.2.1221; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stevens Dennis L., 2003, Curr Infect Dis Rep, V5, P379, DOI 10.1007/s11908-003-0017-7; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Yao HY, 2011, BBA-GEN SUBJECTS, V1810, P666, DOI 10.1016/j.bbagen.2011.03.020; Zhang SE, 2013, SHOCK, V39, P293, DOI 10.1097/SHK.0b013e3182844523; Zhang SG, 2012, INFECT IMMUN, V80, P3952, DOI 10.1128/IAI.00696-12; Zhang SE, 2012, J INNATE IMMUN, V4, P399, DOI 10.1159/000336182; Zhang SE, 2012, J LEUKOCYTE BIOL, V91, P137, DOI 10.1189/jlb.0511268; Zhang SG, 2011, AM J PHYSIOL-LUNG C, V300, pL930, DOI 10.1152/ajplung.00422.2010; Zhang S, 2011, SHOCK, V35, P86, DOI 10.1097/SHK.0b013e3181ea4476	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71080	10.1371/journal.pone.0071080	http://dx.doi.org/10.1371/journal.pone.0071080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951087	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300087
J	Corbett, NJ; Gabbott, PL; Klementiev, B; Davies, HA; Colyer, FM; Novikova, T; Stewart, MG				Corbett, Nicola J.; Gabbott, Paul L.; Klementiev, Boris; Davies, Heather A.; Colyer, Frances M.; Novikova, Tatiana; Stewart, Michael G.			Amyloid-Beta Induced CA1 Pyramidal Cell Loss in Young Adult Rats Is Alleviated by Systemic Treatment with FGL, a Neural Cell Adhesion Molecule-Derived Mimetic Peptide	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MILD ALZHEIMER-DISEASE; NEURONAL LOSS; HIPPOCAMPAL-NEURONS; SENILE DEMENTIA; CEREBRAL-CORTEX; IN-VITRO; COGNITIVE IMPAIRMENT; ENTORHINAL CORTEX; RECEPTOR AGONIST	Increased levels of neurotoxic amyloid-beta in the brain are a prominent feature of Alzheimer's disease. FG-Loop (FGL), a neural cell adhesion molecule-derived peptide that corresponds to its second fibronectin type III module, has been shown to provide neuroprotection against a range of cellular insults. In the present study impairments in social recognition memory were seen 24 days after a 5 mu g/15 ml amyloid-beta((25-35)) injection into the right lateral ventricle of the young adult rat brain. This impairment was prevented if the animal was given a systemic treatment of FGL. Unbiased stereology was used to investigate the ability of FGL to alleviate the deleterious effects on CA1 pyramidal cells of the amyloid-beta((25-35)) injection. NeuN, a neuronal marker (for nuclear staining) was used to identify pyramidal cells, and immunocytochemistry was also used to identify inactive glycogen synthase kinase 3beta (GSK3 beta) and to determine the effects of amyloid-beta((25-35)) and FGL on the activation state of GSK3 beta, since active GSK3 beta has been shown to cause a range of AD pathologies. The cognitive deficits were not due to hippocampal atrophy as volume estimations of the entire hippocampus and its regions showed no significant loss, but amyloid-beta caused a 40% loss of pyramidal cells in the dorsal CA1 which was alleviated partially by FGL. However, FGL treatment without amyloid-beta was also found to cause a 40% decrease in CA1 pyramidal cells. The action of FGL may be due to inactivation of GSK3 beta, as an increased proportion of CA1 pyramidal neurons contained inactive GSK3 beta after FGL treatment. These data suggest that FGL, although potentially disruptive in nonpathological conditions, can be neuroprotective in disease-like conditions.	[Corbett, Nicola J.; Gabbott, Paul L.; Davies, Heather A.; Colyer, Frances M.; Stewart, Michael G.] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England; [Klementiev, Boris; Novikova, Tatiana] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark	Open University - UK; University of Copenhagen	Corbett, NJ (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England.	nicola_j_corbett@rush.edu		Corbett, Nicola/0000-0002-7531-7462	European Union FPVI "Promemoria" programme grant [512012]; BBSRC; Biotechnology and Biological Sciences Research Council [BB/I020330/1, BB/J021687/1] Funding Source: researchfish; BBSRC [BB/I020330/1, BB/J021687/1] Funding Source: UKRI	European Union FPVI "Promemoria" programme grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the European Union FPVI "Promemoria" programme grant (contract number 512012) and the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P., 2007, HIPPOCAMPUS BOOK; [Anonymous], 1981, J MICROSC-PARIS, V121, P131, DOI [DOI 10.1111/j.1365-2818.1981.tb01205.x, 10.1111/j.1365-2818.1981.tb01205.x, DOI 10.1111/J.1365-2818.1981.TB01205.X]; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Borcela E, 2008, BEHAV PHARMACOL, V19, P41, DOI 10.1097/FBP.0b013e3282f3fca9; Broe M, 2001, ACTA NEUROPATHOL, V101, P616; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; Delobette S, 1997, EUR J PHARMACOL, V319, P1, DOI 10.1016/S0014-2999(96)00922-3; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Fukutani Y, 1996, NEUROSCI LETT, V214, P33; Giannakopoulos P, 1996, J NEUROPATH EXP NEUR, V55, P1210, DOI 10.1097/00005072-199612000-00004; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HANSEN LA, 1988, NEUROLOGY, V38, P48, DOI 10.1212/WNL.38.1.48; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; HUBBARD BM, 1985, NEUROPATH APPL NEURO, V11, P369, DOI 10.1111/j.1365-2990.1985.tb00033.x; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Kerchner GA, 2010, NEUROLOGY, V75, P1381, DOI 10.1212/WNL.0b013e3181f736a1; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kong LN, 2005, ACTA PHARMACOL SIN, V26, P666, DOI 10.1111/j.1745-7254.2005.00129.x; MANN DMA, 1985, J NEUROL SCI, V69, P139, DOI 10.1016/0022-510X(85)90129-7; MANN DMA, 1985, NEUROSCI LETT, V56, P51, DOI 10.1016/0304-3940(85)90439-2; MANN DMA, 1986, HUM NEUROBIOL, V5, P147; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Ojo B, 2013, NEUROCHEM RES, V38, P1208, DOI 10.1007/s11064-012-0908-9; Ojo B, 2012, BRAIN BEHAV IMMUN, V26, P778, DOI 10.1016/j.bbi.2011.09.013; Ojo B, 2011, EXP NEUROL, V232, P318, DOI 10.1016/j.expneurol.2011.09.025; Olariu A, 2001, J NEURAL TRANSM, V108, P1065, DOI 10.1007/s007020170025; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Popov VI, 2008, EUR J NEUROSCI, V27, P301, DOI 10.1111/j.1460-9568.2007.06004.x; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rossler M, 2002, ACTA NEUROPATHOL, V103, P363, DOI 10.1007/s00401-001-0475-7; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Secher T, 2009, BEHAV BRAIN RES, V199, P288, DOI 10.1016/j.bbr.2008.12.012; Skibo GG, 2005, EUR J NEUROSCI, V22, P1589, DOI 10.1111/j.1460-9568.2005.04345.x; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Stewart MG, 2008, EXPERT OPIN PHARMACO, V9, P2553, DOI 10.1517/14656566.9.14.2553 ; Stoub TR, 2006, P NATL ACAD SCI USA, V103, P10041, DOI 10.1073/pnas.0603414103; Suh EC, 2008, NEUROTOXICOLOGY, V29, P691, DOI 10.1016/j.neuro.2008.04.001; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TERRY RD, 1964, AM J PATHOL, V44, P269; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; West MJ, 2000, ANN NY ACAD SCI, V908, P255	63	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71479	10.1371/journal.pone.0071479	http://dx.doi.org/10.1371/journal.pone.0071479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951173	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000326473200050
J	Chiu, KW; Nakano, T; Chen, KD; Lai, CY; Hsu, LW; Chiu, HC; Huang, CY; Cheng, YF; Goto, S; Chen, CL				Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Lai, Chia-Yun; Hsu, Li-Wen; Chiu, Ho-Ching; Huang, Ching-Yin; Cheng, Yu-Fan; Goto, Shigeru; Chen, Chao-Long			Pyrosequencing to Identify Homogeneous Phenomenon When Using Recipients/Donors with Different CYP3A5*3 Genotypes in Living Donor Liver Transplantation	PLOS ONE			English	Article							CYP2C19 GENOTYPES; LANSOPRAZOLE; POLYMORPHISM; TACROLIMUS; CYP3A5; GRAFT; PHARMACOKINETICS; CYCLOSPORINE; EXPRESSION	This study used pyrosequencing to determine the proportional distribution of CYP3A5*3 genotypes to further confirm the homogeneous phenomenon that is observed when recipients and donors in living donor liver transplantation (LDLT) have a different single nucleotide polymorphism (SNP) genotype. We enrolled 42 recipient/living donor pairs and the SNPs of CYP3A5*3 were identified by polymerase chain reaction-restriction fragment length polymorphism. We performed 120 liver graft biopsies as part of clinical investigations after LDLT. Pyrosequencing of the CYP3A5*3 SNPs revealed that among the 16 recipients with the G/G genotype, 94.68% had the G and 5.32% the A allele. Among the 14 recipients with the A/G genotype, 78.08% had the G and 21.92% the A allele, and among the 12 recipients with the A/A genotype, 18.45% had the G and 81.55% the A allele. Among the 12 donors with the G/G genotype, 93.85% had the G and 6.14% the A allele. Among the 26 donors with the A/G genotype, 75.73% had the G and 24.27% the A allele, and among the 4 donors with the A/A genotype, 11.09% had the G and 88.91% the A allele. There were a total of 120 liver graft biopsy samples; among the 37 recipients with the G/G genotype, 89.74% had the G and 10.26% the A allele, among the 70 recipients with the A/G genotype, 71.57% had the G and 28.43% the A allele, and among the 13 recipients with the A/A genotype, 48.25% had the G and 51.75% the A allele. The proportional distribution of G and A alleles of the CYP3A5*3 SNP between recipients/donors and liver grafts after LDLT was significantly different (p < 0.001). Pyrosequencing was useful in identifying detailed proportional changes of the CYP3A5*3 SNP allele distribution, and to confirm the homogeneous phenomenon when recipients and donors in LDLT have a different genotype.	[Chiu, King-Wah] Kaohsiung Chang Gung Mem Hosp, Liver Transplant Program, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Liver Transplant Program, Kaohsiung, Taiwan.	c471026@ms6.hinet.net; clchen@cgmh.org.tw		Nakano, Toshiaki/0000-0003-3701-3449; Chiu, King-Wah/0000-0003-2108-6539	Chang Gung Memorial Hospital of Taiwan [CMRPG8A0631]	Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by a grant from the Chang Gung Memorial Hospital (CMRPG8A0631 to KWC) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu KW, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-6; Chiu KW, 2012, HEPATO-GASTROENTEROL, V59, P805, DOI 10.5754/hge09722; Chiu KW, 2012, EUR J CLIN INVEST, V42, P352, DOI 10.1111/j.1365-2362.2011.02589.x; Chiu KW, 2010, ANN TRANSPL, V15, P38; Chiu KW, 2010, CLIN TRANSPLANT, V24, P830, DOI 10.1111/j.1399-0012.2010.01220.x; Chiu KW, 2005, HEPATO-GASTROENTEROL, V52, P1825; Eriksson S, 2002, ASSAY DRUG DEV TECHN, V1, P49, DOI 10.1089/154065802761001301; Flagler K, 2008, GENE THER, V15, P1035, DOI 10.1038/gt.2008.31; Fukushima-Uesaka Hiromi, 2004, Hum Mutat, V23, P100, DOI 10.1002/humu.9210; Hosohata K, 2008, DRUG METAB PHARMACOK, V23, P134, DOI 10.2133/dmpk.23.134; Hosohata K, 2009, DRUG METAB DISPOS, V37, P821, DOI 10.1124/dmd.108.025833; Hu YF, 2007, XENOBIOTICA, V37, P315, DOI 10.1080/00498250601149206; Hu YF, 2006, CLIN EXP PHARMACOL P, V33, P1093, DOI 10.1111/j.1440-1681.2006.04492.x; Kang JM, 2008, J GASTROEN HEPATOL, V23, P1287, DOI 10.1111/j.1440-1746.2008.05392.x; Kawamura M, 2007, J GASTROEN HEPATOL, V22, P222, DOI 10.1111/j.1440-1746.2006.04419.x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Takahashi K, 2004, ANN PHARMACOTHER, V38, P791, DOI 10.1345/aph.1D366; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156; Yu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025933	19	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71314	10.1371/journal.pone.0071314	http://dx.doi.org/10.1371/journal.pone.0071314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951129	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000046
J	Elabdeen, HRZ; Mustafa, M; Szklenar, M; Ruhl, R; Ali, R; Bolstad, AI				Elabdeen, Hager R. Zein; Mustafa, Manal; Szklenar, Monika; Ruehl, Ralph; Ali, Raouf; Bolstad, Anne Isine			Ratio of Pro-Resolving and Pro-Inflammatory Lipid Mediator Precursors as Potential Markers for Aggressive Periodontitis	PLOS ONE			English	Article							MAMMALIAN LIPOXYGENASES; MOLECULAR-CLONING; PROSTAGLANDIN E-2; CREVICULAR FLUID; FATTY-ACIDS; HUMAN-SKIN; BONE LOSS; RESOLUTION; DISEASE; PATHOGENESIS	Aggressive periodontitis (AgP) is a rapidly progressing type of periodontal disease in otherwise healthy individuals which causes destruction of the supporting tissues of the teeth. The disease is initiated by pathogenic bacteria in the dental biofilm, and the severity of inflammation and attachment loss varies with the host response. Recently, there has been an increased interest in determining the role of lipid mediators in inflammatory events and the concept of pro-inflammatory and pro-resolution lipid mediators has been brought into focus also in periodontal disease. The present study aimed to determine the profile of omega-3 or n3-as well as omega-6 or n6-polyunsaturated fatty acids (PUFAs) and PUFA-metabolites of linoleic acid, arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in gingival crevicular fluid (GCF), saliva and serum in AgP patients and healthy controls. In total, 60 selected n3- and n6-PUFAs and various PUFA metabolites were measured using high performance liquid chromatography-tandem electrospray ionisation mass spectrometry (HPLC-ESI-MS-MS). Of these, 51 could be quantified in this study. The concentrations of the majority were low in saliva samples compared with serum and GCF, but were mainly higher in AgP patients compared with healthy controls in all three kinds of sample. Ratios of n3-to n6-PUFAs (DHA + EPA)/AA were significantly lower in the GCF of AgP patients than in the healthy controls. Furthermore, various ratios of the direct precursors of the pro-resolution lipid mediators (precursors of resolvins and protectins) were calculated against the precursors of mainly pro-inflammatory lipid mediators. These ratios were mainly lower in GCF and saliva of AgP patients, compared with healthy controls, but only reached significance in GCF (P<0.05). To conclude, the ratios of precursors of pro-resolution/ pro-inflammatory lipid mediators seem to be more relevant for describing the disease status of AgP than the concentration of specific lipid mediators.	[Elabdeen, Hager R. Zein; Mustafa, Manal; Bolstad, Anne Isine] Univ Bergen, Dept Clin Dent Periodont, Bergen, Norway; [Szklenar, Monika; Ruehl, Ralph] Paprika Bioanalyt Bt, Debrecen, Hungary; [Ruehl, Ralph] Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary; [Ali, Raouf] Univ Sci & Technol, Fac Dent, Omdurman, Sudan	University of Bergen; University of Debrecen	Ruhl, R (corresponding author), Paprika Bioanalyt Bt, Debrecen, Hungary.	ralphruehl@web.de						Arita M, 2006, J BIOL CHEM, V281, P22847, DOI 10.1074/jbc.M603766200; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CAMP RDR, 1983, BRIT J PHARMACOL, V80, P497, DOI 10.1111/j.1476-5381.1983.tb10721.x; EI-Sharkawy H, 2010, J PERIODONTOL, V81, P1635, DOI 10.1902/jop.2010.090628; Figueredo CM, 2013, J PERIODONTOL, V84, P675, DOI 10.1902/jop.2012.120171; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Griffiths GS, 2003, PERIODONTOL 2000, V31, P32, DOI 10.1034/j.1600-0757.2003.03103.x; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Johnson RD, 1998, AM J OBSTET GYNECOL, V178, P54, DOI 10.1016/S0002-9378(98)70626-X; Kornman KS, 2008, J PERIODONTOL, V79, P1560, DOI 10.1902/jop.2008.080213; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Meng HX, 2011, PERIODONTOL 2000, V56, P87, DOI 10.1111/j.1600-0757.2010.00367.x; MIYASAKI KT, 1991, J PERIODONTOL, V62, P761, DOI 10.1902/jop.1991.62.12.761; Mrsny RJ, 2004, P NATL ACAD SCI USA, V101, P7421, DOI 10.1073/pnas.0400832101; OFFENBACHER S, 1984, J PERIODONTAL RES, V19, P1, DOI 10.1111/j.1600-0765.1984.tb01190.x; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Pearson T, 2010, J HYPERTENS, V28, P2429, DOI 10.1097/HJH.0b013e32833e86aa; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Requirand P, 2000, CLIN NUTR, V19, P271, DOI 10.1054/clnu.2000.0107; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SERHAN CN, 1994, BBA-LIPID LIPID MET, V1212, P1, DOI 10.1016/0005-2760(94)90185-6; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; SIGAL E, 1988, J BIOL CHEM, V263, P5328; Szklenar M, 2013, J VASC RES IN PRESS; Tsai CC, 1998, J DENT, V26, P97, DOI 10.1016/S0300-5712(96)00084-X; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e	45	45	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70838	10.1371/journal.pone.0070838	http://dx.doi.org/10.1371/journal.pone.0070838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951021	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300058
J	Fabbro, A; Sucapane, A; Toma, FM; Calura, E; Rizzetto, L; Carrieri, C; Roncaglia, P; Martinelli, V; Scaini, D; Masten, L; Turco, A; Gustincich, S; Prato, M; Ballerini, L				Fabbro, Alessandra; Sucapane, Antonietta; Toma, Francesca Maria; Calura, Enrica; Rizzetto, Lisa; Carrieri, Claudia; Roncaglia, Paola; Martinelli, Valentina; Scaini, Denis; Masten, Lara; Turco, Antonio; Gustincich, Stefano; Prato, Maurizio; Ballerini, Laura			Adhesion to Carbon Nanotube Conductive Scaffolds Forces Action-Potential Appearance in Immature Rat Spinal Neurons	PLOS ONE			English	Article							UNION-OF-PHARMACOLOGY; GENE-EXPRESSION; NEURITE OUTGROWTH; TIME-LAPSE; GROWTH; PROTEINS; CELLS; AXONS; DIFFERENTIATION; BIOMATERIALS	In the last decade, carbon nanotube growth substrates have been used to investigate neurons and neuronal networks formation in vitro when guided by artificial nano-scaled cues. Besides, nanotube-based interfaces are being developed, such as prosthesis for monitoring brain activity. We recently described how carbon nanotube substrates alter the electrophysiological and synaptic responses of hippocampal neurons in culture. This observation highlighted the exceptional ability of this material in interfering with nerve tissue growth. Here we test the hypothesis that carbon nanotube scaffolds promote the development of immature neurons isolated from the neonatal rat spinal cord, and maintained in vitro. To address this issue we performed electrophysiological studies associated to gene expression analysis. Our results indicate that spinal neurons plated on electro-conductive carbon nanotubes show a facilitated development. Spinal neurons anticipate the expression of functional markers of maturation, such as the generation of voltage dependent currents or action potentials. These changes are accompanied by a selective modulation of gene expression, involving neuronal and non-neuronal components. Our microarray experiments suggest that carbon nanotube platforms trigger reparative activities involving microglia, in the absence of reactive gliosis. Hence, future tissue scaffolds blended with conductive nanotubes may be exploited to promote cell differentiation and reparative pathways in neural regeneration strategies.	[Fabbro, Alessandra; Sucapane, Antonietta; Scaini, Denis; Masten, Lara; Ballerini, Laura] Univ Trieste, Dept Life Sci, Trieste, Italy; [Toma, Francesca Maria; Turco, Antonio; Prato, Maurizio] Univ Trieste, Dept Chem & Pharmaceut Sci, Trieste, Italy; [Calura, Enrica] Univ Padua, Dept Biol, Padua, Italy; [Rizzetto, Lisa] Univ Florence, Dept Neurosci Psychol Drug Res & Childs Hlth, Florence, Italy; [Rizzetto, Lisa] Fdn Edmund Mach, Innovat & Res Ctr, Trento, Italy; [Carrieri, Claudia] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy; [Roncaglia, Paola; Gustincich, Stefano] Int Sch Adv Studies SISSA, Trieste, Italy; [Roncaglia, Paola] European Bioinformat Inst EMBL EBI, Hinxton, England; [Martinelli, Valentina] ICGEB, Trieste, Italy; [Scaini, Denis] ELETTRA Synchrotron Light Source, SENIL, Trieste, Italy	University of Trieste; University of Trieste; University of Padua; University of Florence; Fondazione Edmund Mach; European Molecular Biology Laboratory (EMBL); International School for Advanced Studies (SISSA); European Molecular Biology Laboratory (EMBL); International Center for Genetic Engineering & Biotechnology (ICGEB); Elettra Sincrotrone Trieste	Prato, M (corresponding author), Univ Trieste, Dept Chem & Pharmaceut Sci, Trieste, Italy.	prato@units.it; lballerini@units.it	Toma, Francesca/AAH-4991-2021; Turco, Antonio/E-2291-2015; Calura, Enrica/AAA-1847-2021; Scaini, Denis/HGU-4752-2022; Rizzetto, Lisa/C-7304-2016; Prato, Maurizio/G-7067-2012; Toma, Francesca Maria/AAH-6326-2021	Turco, Antonio/0000-0002-7344-0563; Calura, Enrica/0000-0001-8463-2432; Rizzetto, Lisa/0000-0002-2170-9276; Prato, Maurizio/0000-0002-8869-8612; Toma, Francesca Maria/0000-0003-2332-0798; Carrieri, Claudia/0000-0002-9454-1021; Roncaglia, Paola/0000-0002-2825-0621; Gustincich, Stefano/0000-0002-2749-2514; BALLERINI, Laura/0000-0001-8420-0787; Scaini, Denis/0000-0001-8398-8074	 [NEURONANO-NMP4-CT-2006-031847 CARBONANOBRIDGE-ERC-2008-227135]		Funding provided by NEURONANO-NMP4-CT-2006-031847 CARBONANOBRIDGE-ERC-2008-227135 http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003; BAIRD DH, 1992, J NEUROSCI, V12, P619; Biella G, 2007, NEUROSCIENCE, V149, P38, DOI 10.1016/j.neuroscience.2007.07.021; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Braisted JE, 2009, CEREB CORTEX, V19, pI144, DOI 10.1093/cercor/bhp035; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cellot G, 2011, J NEUROSCI, V31, P12945, DOI 10.1523/JNEUROSCI.1332-11.2011; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DARCANGELO G, 1993, J CELL BIOL, V122, P915, DOI 10.1083/jcb.122.4.915; de Luca A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006848; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabbro A, 2012, ACS CHEM NEUROSCI, V3, P611, DOI 10.1021/cn300048q; Fabbro A, 2012, ACS NANO, V6, P2041, DOI 10.1021/nn203519r; Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georgakilas V, 2002, J AM CHEM SOC, V124, P14318, DOI 10.1021/ja0260869; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d; Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim M, 2011, DEV BIOL, V358, P181, DOI 10.1016/j.ydbio.2011.07.025; Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025; Kuenzel T, 2007, EUR J NEUROSCI, V25, P974, DOI 10.1111/j.1460-9568.2007.05343.x; Lewandowski NM, 2005, J NEUROSCI, V25, P10341, DOI 10.1523/JNEUROSCI.4006-05.2005; Li GZ, 2008, AM J PHYSIOL-CELL PH, V295, pC1550, DOI 10.1152/ajpcell.90605.2007; Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007; Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m; Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c; Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Mikule K, 2002, J NEUROSCI, V22, P4932, DOI 10.1523/JNEUROSCI.22-12-04932.2002; Mistry SK, 2002, P NATL ACAD SCI USA, V99, P1621, DOI 10.1073/pnas.022646599; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Orozco-Cabal L, 2006, J NEUROSCI METH, V151, P148, DOI 10.1016/j.jneumeth.2005.07.002; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Pruss H, 2010, HISTOCHEM CELL BIOL, V133, P301, DOI 10.1007/s00418-009-0668-z; Qin Q, 2008, PROSTAG LEUKOTR ESS, V79, P201, DOI 10.1016/j.plefa.2008.09.022; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008; Rezaie P, 2002, EXP CELL RES, V274, P68, DOI 10.1006/excr.2001.5431; SAIZ E, 2012, DENT MATER, P1861; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; Uboldi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035423; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Vasanthan KS, 2012, BIOTECHNOL ADV, V30, P742, DOI 10.1016/j.biotechadv.2012.01.004; Vasilyev DV, 2003, J PHYSIOL-LONDON, V547, P859, DOI 10.1113/jphysiol.2002.036889; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wang K, 2009, CELL MOL NEUROBIOL, V29, P1131, DOI 10.1007/s10571-009-9404-4; Xia YX, 2000, NEUROSCI LETT, V280, P220, DOI 10.1016/S0304-3940(00)00782-5; Yamamoto N, 1997, J NEUROSCI, V17, P3653; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	85	44	45	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73621	10.1371/journal.pone.0073621	http://dx.doi.org/10.1371/journal.pone.0073621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951361	Green Published, gold			2022-12-27	WOS:000323097300208
J	Pomati, F; Kraft, NJB; Posch, T; Eugster, B; Jokela, J; Ibelings, BW				Pomati, Francesco; Kraft, Nathan J. B.; Posch, Thomas; Eugster, Bettina; Jokela, Jukka; Ibelings, Bas W.			Individual Cell Based Traits Obtained by Scanning Flow-Cytometry Show Selection by Biotic and Abiotic Environmental Factors during a Phytoplankton Spring Bloom	PLOS ONE			English	Article							FUNCTIONAL TRAITS; COMMUNITY ECOLOGY; PLANKTOTHRIX-RUBESCENS; COMPETITIVE-EXCLUSION; SPECIES-DIVERSITY; AMAZONIAN FOREST; FRESH-WATERS; SINGLE-CELL; LAKE ZURICH; PEG-MODEL	In ecology and evolution, the primary challenge in understanding the processes that shape biodiversity is to assess the relationship between the phenotypic traits of organisms and the environment. Here we tested for selection on physio-morphological traits measured by scanning flow-cytometry at the individual level in phytoplankton communities under a temporally changing biotic and abiotic environment. Our aim was to study how high-frequency temporal changes in the environment influence biodiversity dynamics in a natural community. We focused on a spring bloom in Lake Zurich (Switzerland), characterized by rapid changes in phytoplankton, water conditions, nutrients and grazing (mainly mediated by herbivore ciliates). We described bloom dynamics in terms of taxonomic and trait-based diversity and found that diversity dynamics of trait-based groups were more pronounced than those of identified phytoplankton taxa. We characterized the linkage between measured phytoplankton traits, abiotic environmental factors and abundance of the main grazers and observed weak but significant correlations between changing abiotic and biotic conditions and measured size-related and fluorescence-related traits. We tested for deviations in observed community-wide distributions of focal traits from random patterns and found evidence for both clustering and even spacing of traits, occurring sporadically over the time series. Patterns were consistent with environmental filtering and phenotypic divergence under herbivore pressure, respectively. Size-related traits showed significant even spacing during the peak of herbivore abundance, suggesting that morphology-related traits were under selection from grazing. Pigment distribution within cells and colonies appeared instead to be associated with acclimation to temperature and water chemistry. We found support for trade-offs among grazing resistance and environmental tolerance traits, as well as for substantial periods of dynamics in which our measured traits were not under selection.	[Pomati, Francesco; Ibelings, Bas W.] Swiss Fed Inst Aquat Sci & Technol Eawag, Dept Aquat Ecol, Dubendorf, Switzerland; [Pomati, Francesco; Jokela, Jukka] ETH, Inst Integrat Biol, Dept Environm Syst Sci, Zurich, Switzerland; [Kraft, Nathan J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Posch, Thomas; Eugster, Bettina] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Ibelings, Bas W.] Univ Geneva, Inst FA Forel, Versoix, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Maryland; University of Maryland College Park; University of Zurich; University of Geneva	Pomati, F (corresponding author), Swiss Fed Inst Aquat Sci & Technol Eawag, Dept Aquat Ecol, Dubendorf, Switzerland.	francesco.pomati@eawag.ch	Kraft, Nathan J. B./A-2817-2012	Kraft, Nathan J. B./0000-0001-8867-7806; Jokela, Jukka/0000-0002-1731-727X; Posch, Thomas/0000-0001-5145-3761	Swiss National Science Foundation (SNSF) R'Equip program [316030_121331]; EAWAG; Schure-Beijerinck Popping Fonds	Swiss National Science Foundation (SNSF) R'Equip program(Swiss National Science Foundation (SNSF)); EAWAG; Schure-Beijerinck Popping Fonds	This research was funded by the Swiss National Science Foundation (SNSF) R'Equip program (project no. 316030_121331), EAWAG (to F. P.), and Schure-Beijerinck Popping Fonds (to B. W. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; American Water Works Association, 2012, STANDARD METHODS EXA; Anneville O, 2004, FRESHWATER BIOL, V49, P98, DOI 10.1046/j.1365-2426.2003.01167.x; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Collier JL, 2000, J PHYCOL, V36, P628, DOI 10.1046/j.1529-8817.2000.99215.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dubelaar GBJ, 2004, J ENVIRON MONITOR, V6, P946, DOI 10.1039/b409350j; Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.0.CO;2-9; Edwards KF, 2012, ECOLOGY LET IN PRESS; Foladori P, 2008, WATER RES, V42, P3757, DOI 10.1016/j.watres.2008.06.026; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hubbell Stephen P., 2001, V32, pi; IBELINGS BW, 1994, NEW PHYTOL, V128, P407, DOI 10.1111/j.1469-8137.1994.tb02987.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kruk C, 2010, FRESHWATER BIOL, V55, P614, DOI 10.1111/j.1365-2427.2009.02298.x; Kurmayer R, 1999, J PLANKTON RES, V21, P659, DOI 10.1093/plankt/21.4.659; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Malkassian A, 2011, CYTOM PART A, V79A, P263, DOI 10.1002/cyto.a.21035; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Merico A, 2009, ECOL MODEL, V220, P3001, DOI 10.1016/j.ecolmodel.2009.05.005; Muller H, 1999, AQUAT MICROB ECOL, V17, P49, DOI 10.3354/ame017049; Padisak J, 2009, HYDROBIOLOGIA, V621, P1, DOI 10.1007/s10750-008-9645-0; Paine CET, 2011, OIKOS, V120, P720, DOI 10.1111/j.1600-0706.2010.19110.x; Peeters F, 2007, GLOBAL CHANGE BIOL, V13, P1898, DOI 10.1111/j.1365-2486.2007.01412.x; Peeters F, 2007, LIMNOL OCEANOGR, V52, P286, DOI 10.4319/lo.2007.52.1.0286; Pfister G, 1999, AQUAT MICROB ECOL, V18, P95, DOI 10.3354/ame018095; Pomati F, 2013, ECOTOXICOLOGY; Pomati F, 2012, OIKOS, V121, P1317, DOI 10.1111/j.1600-0706.2011.20055.x; Pomati F, 2011, ENVIRON SCI TECHNOL, V45, P9658, DOI 10.1021/es201934n; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/nclimate1581, 10.1038/NCLIMATE1581]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Ross ON, 2009, MAR ECOL PROG SER, V383, P53, DOI 10.3354/meps07961; Salmaso N, 2007, HYDROBIOLOGIA, V578, P97, DOI 10.1007/s10750-006-0437-0; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Sosik HM, 2010, DEVEL APPL PHYCOL, V4, P171, DOI 10.1007/978-90-481-9268-7_8; Suding KN, 2008, NEW PHYTOL, V180, P559, DOI 10.1111/j.1469-8137.2008.02650.x; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; ter Braak CJF, 2012, ECOLOGY IN PRESS; Tirok K, 2006, J PLANKTON RES, V28, P361, DOI 10.1093/plankt/fbi121; Tirok K, 2007, AQUAT MICROB ECOL, V49, P87, DOI 10.3354/ame01127; Tirok K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027357; Toepel J, 2005, J PHYCOL, V41, P1099, DOI 10.1111/j.1529-8817.2005.00137.x; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Walsby AE, 2001, AQUAT SCI, V63, P326, DOI 10.1007/PL00001358; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056	61	37	37	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71677	10.1371/journal.pone.0071677	http://dx.doi.org/10.1371/journal.pone.0071677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951218	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000323097300141
J	Lee, SJ; Lindsey, S; Graves, B; Yoo, S; Olson, JM; Langhans, SA				Lee, Seung Joon; Lindsey, Stephan; Graves, Bruce; Yoo, Soonmoon; Olson, James M.; Langhans, Sigrid A.			Sonic Hedgehog-Induced Histone Deacetylase Activation Is Required for Cerebellar Granule Precursor Hyperplasia in Medulloblastoma	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOUSE MODEL; INHIBITOR; SURVIVAL; SUBTYPES; ORIGINS; GROWTH; CELLS	Medulloblastoma, the most common pediatric brain tumor, is thought to arise from deregulated proliferation of cerebellar granule precursor (CGP) cells. Sonic hedgehog (Shh) is the primary mitogen that regulates proliferation of CGP cells during the early stages of postnatal cerebellum development. Aberrant activation of Shh signaling during this time has been associated with hyperplasia of CGP cells and eventually may lead to the development of medulloblastoma. The molecular targets of Shh signaling involved in medulloblastoma formation are still not well-understood. Here, we show that Shh regulates sustained activation of histone deacetylases (HDACs) and that this activity is required for continued proliferation of CGP cells. Suppression of HDAC activity not only blocked the Shh-induced CGP proliferation in primary cell cultures, but also ameliorated aberrant CGP proliferation at the external germinal layer (EGL) in a medulloblastoma mouse model. Increased levels of mRNA and protein of several HDAC family members were found in medulloblastoma compared to wild type cerebellum suggesting that HDAC activity is required for the survival/progression of tumor cells. The identification of a role of HDACs in the early steps of medulloblastoma formation suggests there may be a therapeutic potential for HDAC inhibitors in this disease.	[Lee, Seung Joon; Lindsey, Stephan; Graves, Bruce; Yoo, Soonmoon; Langhans, Sigrid A.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Olson, James M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Nemours Alfred I. duPont Hospital for Children; Fred Hutchinson Cancer Center	Langhans, SA (corresponding author), Nemours Alfred I duPont Hosp Children, Wilmington, DE USA.	langhans@nemoursresearch.org		Lee, Seung Joon/0000-0001-6690-2830; Yoo, Soonmoon/0000-0002-1645-6809; Langhans, Sigrid/0000-0003-4695-7468	American Cancer Society Research Grant [RSG-09-021-01-CNE]; Nemours Foundation;  [NCRR-5P20RR016472-12];  [NIGMS-8P20GM103446-12]; NATIONAL CANCER INSTITUTE [R01CA114567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	American Cancer Society Research Grant(American Cancer Society); Nemours Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Cancer Society Research Grant RSG-09-021-01-CNE, NCRR-5P20RR016472-12, NIGMS-8P20GM103446-12, and funds from the Nemours Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman J, 1997, DEV CEREBELLAR SYSTE; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ellison DW, 2003, EUR J PAEDIATR NEURO, V7, P53, DOI 10.1016/S1090-3798(03)00014-X; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hagelkruys Astrid, 2011, Handb Exp Pharmacol, V206, P13, DOI 10.1007/978-3-642-21631-2_2; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hassig CA, 2008, MOL CANCER THER, V7, P1054, DOI 10.1158/1535-7163.MCT-07-2347; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Komuro H, 1998, J NEUROSCI, V18, P1478; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marks BD, 2011, J BIOMOL SCREEN, V16, P1247, DOI 10.1177/1087057111422102; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Raffel C, 1997, CANCER RES, V57, P842; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sonnemann J, 2006, INT J ONCOL, V28, P755; Spiller SE, 2008, J NEURO-ONCOL, V87, P133, DOI 10.1007/s11060-007-9505-1; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71455	10.1371/journal.pone.0071455	http://dx.doi.org/10.1371/journal.pone.0071455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951168	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200048
J	Pellkofer, HL; Havla, J; Hauer, D; Schelling, G; Azad, SC; Kuempfel, T; Magerl, W; Huge, V				Pellkofer, Hannah L.; Havla, Joachim; Hauer, Daniela; Schelling, Gustav; Azad, Shahnaz C.; Kuempfel, Tania; Magerl, Walter; Huge, Volker			The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica	PLOS ONE			English	Article							SPINAL-CORD-INJURY; PARADOXICAL HEAT SENSATION; SENSORY TESTING QST; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; NEUROGENIC HYPERALGESIA; CANNABINOID RECEPTORS; CENTRAL SENSITIZATION; IMMUNOGLOBULIN-G; LESIONS	Recurrent myelitis is one of the predominant characteristics in patients with neuromyelitis optica (NMO). While paresis, visual loss, sensory deficits, and bladder dysfunction are well known symptoms in NMO patients, pain has been recognized only recently as another key symptom of the disease. Although spinal cord inflammation is a defining aspect of neuromyelitis, there is an almost complete lack of data on altered somatosensory function, including pain. Therefore, eleven consecutive patients with NMO were investigated regarding the presence and clinical characteristics of pain. All patients were examined clinically as well as by Quantitative Sensory Testing (QST) following the protocol of the German Research Network on Neuropathic Pain (DFNS). Additionally, plasma endocannabinoid levels and signs of chronic stress and depression were determined. Almost all patients (10/11) suffered from NMO-associated neuropathic pain for the last three months, and 8 out of 11 patients indicated relevant pain at the time of examination. Symptoms of neuropathic pain were reported in the vast majority of patients with NMO. Psychological testing revealed signs of marked depression. Compared to age and gender-matched healthy controls, QST revealed pronounced mechanical and thermal sensory loss, strongly correlated to ongoing pain suggesting the presence of deafferentation-induced neuropathic pain. Thermal hyperalgesia correlated to MRI-verified signs of spinal cord lesion. Heat hyperalgesia was highly correlated to the time since last relapse of NMO. Patients with NMO exhibited significant mechanical and thermal dysesthesia, namely dynamic mechanical allodynia and paradoxical heat sensation. Moreover, they presented frequently with either abnormal mechanical hypoalgesia or hyperalgesia, which depended significantly on plasma levels of the endogenous cannabinoid 2-arachidonoylglycerole (2-AG). These data emphasize the high prevalence of neuropathic pain and hyperalgesia in patients with NMO. The degree of mechanical hyperalgesia reflecting central sensitization of nociceptive pathways seems to be controlled by the major brain endocannabinoid 2-AG.	[Pellkofer, Hannah L.; Havla, Joachim; Kuempfel, Tania] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Pellkofer, Hannah L.] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Pellkofer, Hannah L.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Hauer, Daniela; Schelling, Gustav; Azad, Shahnaz C.; Huge, Volker] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Magerl, Walter] Heidelberg Univ, Chair Neurophysiol, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany	University of Munich; University of Munich; University of Gottingen; University of Munich; Ruprecht Karls University Heidelberg	Huge, V (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	vhuge@med.uni-muenchen.de	Kümpfel, Tania/ABH-1780-2021; Schelling, Gustav/U-2603-2018	Schelling, Gustav/0000-0002-6538-0652	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [01EM 0118, 01EM 0506]; German Research Foundation (Deutsche Forschungsgemeinschaft DFG) [FOR926, Ma1251/9-1, Ma1251/9-2]; nationwide German Research Network on Neuropathic Pain (DFNS)	German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft DFG)(German Research Foundation (DFG)); nationwide German Research Network on Neuropathic Pain (DFNS)	This work was supported by the German Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung; BMBF) [grant number 01EM 0118 and 01EM 0506]. Part of this work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) FOR926, grant Ma1251/9-1 and 2 to WM. This research was supported by the nationwide German Research Network on Neuropathic Pain (DFNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Bar KJ, 2003, J PSYCHIATR RES, V37, P345, DOI 10.1016/S0022-3956(03)00051-7; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Benedetti F, 2011, NAT MED, V17, P1228, DOI 10.1038/nm.2435; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Boivie J, 2003, EUR J PAIN, V7, P339, DOI 10.1016/S1090-3801(03)00046-6; BOIVIE J, 1989, PAIN, V38, P121, DOI 10.1016/0304-3959(89)90229-7; Boneschi FM, 2008, MULT SCLER, V14, P514, DOI 10.1177/1352458507085551; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Bukhari W, 2012, INT J MOL SCI, V13, P12970, DOI 10.3390/ijms131012970; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Clifford Allbutt T, 1870, LANCET, V95, P76; Cruccu G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000045; Devic E., 1894, B MED, V8, P1033; Eschenfelder S, 2000, PAIN, V87, P213, DOI 10.1016/S0304-3959(00)00285-2; Fields HL, 1998, NEUROBIOL DIS, V5, P209, DOI 10.1006/nbdi.1998.0204; Finnerup NB, 2003, BRAIN, V126, P57, DOI 10.1093/brain/awg007; Finnerup NB, 2003, SOMATOSENS MOT RES, V20, P71, DOI 10.1080/0899022031000083843; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gierthmuhlen J, 2012, PAIN, V153, P765, DOI 10.1016/j.pain.2011.11.009; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Hald A, 2009, CELL MOL NEUROBIOL, V29, P609, DOI 10.1007/s10571-009-9390-6; Hansen C, 1996, BRAIN, V119, P1729, DOI 10.1093/brain/119.5.1729; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Huge V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018775; Hulsebosch CE, 2008, EXP NEUROL, V214, P6, DOI 10.1016/j.expneurol.2008.07.016; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051208; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; Kato A, 2012, J PHYSIOL-LONDON, V590, P4717, DOI 10.1113/jphysiol.2012.234229; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kim JS, 1997, NEUROLOGY, V49, P1557, DOI 10.1212/WNL.49.6.1557; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; Magerl W, 1998, PAIN, V74, P257, DOI 10.1016/S0304-3959(97)00177-2; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Nakamura M, 2008, J NEUROL, V255, P163, DOI 10.1007/s00415-008-0545-z; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Osterberg A, 2005, EUR J PAIN, V9, P531, DOI 10.1016/j.ejpain.2004.11.005; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Qian P, 2012, ARCH NEUROL-CHICAGO, P1; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sandhir R, 2011, NEUROCHEM RES, V36, P856, DOI 10.1007/s11064-011-0414-5; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Solaro C, 2004, NEUROLOGY, V63, P919, DOI 10.1212/01.WNL.0000137047.85868.D6; Sticht MA, 2012, BRIT J PHARMACOL, V165, P2425, DOI 10.1111/j.1476-5381.2011.01407.x; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Toth CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-16; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Vogeser M, 2006, CLIN CHEM LAB MED, V44, P488, DOI 10.1515/CCLM.2006.065; Vogeser M, 2007, CLIN CHEM LAB MED, V45, P1023, DOI 10.1515/CCLM.2007.197; Voscopoulos C, 2010, BRIT J ANAESTH, V105, pI69, DOI 10.1093/bja/aeq323; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Willis CL, 2012, METHODS MOL BIOL, V814, P515, DOI 10.1007/978-1-61779-452-0_34; Willis CL, 2011, TOXICOL PATHOL, V39, P172, DOI 10.1177/0192623310385830; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Woolf CJ, 1996, PAIN, V66, P105, DOI 10.1097/00006396-199608000-00001; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270; Zhang X, 2011, NEUROSCIENCE, V199, P452, DOI 10.1016/j.neuroscience.2011.10.017	86	26	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71500	10.1371/journal.pone.0071500	http://dx.doi.org/10.1371/journal.pone.0071500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951176	Green Submitted, gold, Green Published			2022-12-27	WOS:000326473200051
J	Zhang, L; Ding, H; Wang, DH; Zhang, YL; Baskys, A; Chan, P; Zhong, Y; Cai, YN				Zhang, Lan; Ding, Hui; Wang, Dan-Hui; Zhang, Yan-Li; Baskys, Andrius; Chan, Piu; Zhong, Yu; Cai, Yan-Ning			Calpastatin Gene (CAST) Is Not Associated with Late Onset Sporadic Parkinson's Disease in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CALPAIN; EXPRESSION; SNPS	Recent studies point to an association between the late-onset sporadic Parkinson's disease (PD) and single nucleotide polymorphisms (SNPs) rs1559085 and rs27852 in Ca2+-dependent protease calpain inhibitor calpastatin (CAST) gene. This finding is of interest since loss of CAST activity could result in over activated calpain, potentially leading to Ca2+ dysregulation and loss of substantia nigra neurons in PD. We explored the association between CAST SNPs and late-onset sporadic PD in the Han Chinese population. The study included 615 evaluable patients (363 male, 252 female) with PD and 636 neurologically healthy controls (380 male, 256 female) matched for age, gender, ethnicity, and area of residence. PD cases were identified from the PD cohort of the Chinese National Consortium on Neurodegenerative Diseases (www.chinapd.cn). A total of 24 tag-SNPs were genotyped capturing 95% of the genetic variation across the CAST gene. There was no association found between any of the polymorphisms and PD in all models tested (co-dominant, dominant-effect and recessive-effect). Similarly, none of the common haplotypes was associated with a risk for PD. Our data do not support a significant association between the CAST gene polymorphisms and late onset sporadic PD in the Han Chinese population.	[Zhang, Lan] Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing, Peoples R China; [Ding, Hui; Wang, Dan-Hui; Zhang, Yan-Li; Chan, Piu; Cai, Yan-Ning] Capital Med Univ, Xuanwu Hosp, Dept Neurobiol, Beijing, Peoples R China; [Ding, Hui; Wang, Dan-Hui; Zhang, Yan-Li; Chan, Piu; Cai, Yan-Ning] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Wang, Dan-Hui; Zhang, Yan-Li; Cai, Yan-Ning] Lab Chronobiol & Chronomed, Beijing, Peoples R China; [Baskys, Andrius] Riverside Cty Dept Mental Hlth, Tyler Village Wellness & Recovery Clin Older Adul, Riverside, CA USA; [Baskys, Andrius] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Zhong, Yu] Bioyong Beijing Technol Co Ltd, Beijing, Peoples R China	Capital Medical University; Capital Medical University; University of California System; University of California Riverside	Baskys, A (corresponding author), Riverside Cty Dept Mental Hlth, Tyler Village Wellness & Recovery Clin Older Adul, Riverside, CA USA.	abaskys@ucr.edu; yanningcai@yahoo.com	Chan, Piu/I-4580-2016	Chan, Piu/0000-0003-1346-881X	National Natural Science Foundation of China [81071011]; National 973 Project Grant of China [2011CBA00408]; Key Projects in the National Science and Technology Pillar Program [2012BAI09B04]; Beijing Natural Science Foundation [7112061]; Program for New Century Excellent Talents in University [NCET-10-0013]; Beijing Health and Technical Personal of High-Level Plan [2009-3-66]; New Century Talented Person Project [008-0014]; Science foundation of Ministry of Education of China [11120066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project Grant of China(National Basic Research Program of China); Key Projects in the National Science and Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Health and Technical Personal of High-Level Plan; New Century Talented Person Project; Science foundation of Ministry of Education of China(Ministry of Education, China)	The authors thank Jingyan Song for helpful discussion. Research support was provided by the National Natural Science Foundation of China (81071011), the National 973 Project Grant of China (2011CBA00408), Key Projects in the National Science and Technology Pillar Program (2012BAI09B04), Beijing Natural Science Foundation (number 7112061), the Program for New Century Excellent Talents in University (NCET-10-0013), Beijing Health and Technical Personal of High-Level Plan (number 2009-3-66), New Century Talented Person Project (number 008-0014) and the Science foundation of Ministry of Education of China (11120066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2010, AM J MED GENET B, V153B, P973, DOI 10.1002/ajmg.b.31061; Allen AS, 2009, GENET EPIDEMIOL, V33, P657, DOI 10.1002/gepi.20417; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Kumar KR, 2012, ARCH NEUROL-CHICAGO, V69, P1360, DOI 10.1001/archneurol.2011.3367; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lesage S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.006; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; LEWONTIN RC, 1988, GENETICS, V120, P849; Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Paleacu D, 2005, NEUROLOGY, V64, P1712, DOI 10.1212/01.WNL.0000161872.85903.8E; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	34	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70935	10.1371/journal.pone.0070935	http://dx.doi.org/10.1371/journal.pone.0070935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951044	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200023
J	Shastri, S; Boregowda, PH; Rewari, BB; Tanwar, S; Shet, A; Kumar, AMV				Shastri, Suresh; Boregowda, Pavithra Hatna; Rewari, Bharat B.; Tanwar, Sukarma; Shet, Anita; Kumar, Ajay M. V.			Scaling Up Antiretroviral Treatment Services in Karnataka, India: Impact on CD4 Counts of HIV-Infected People	PLOS ONE			English	Article							LATE PRESENTERS; THERAPY; CARE	Setting: Twelve antiretroviral treatment centres under National AIDS Control Programme (NACP), Karnataka State, India. Objective: For the period 2004-2011, to describe the trends in the numbers of people living with HIV (PLHIV) registered for care and their median baseline CD4 counts, disaggregated by age and sex. Design: Descriptive study involving analysis of routinely captured data (year of registration, age, sex, baseline CD4 count) under NACP. Results: 34,882 (97% of total eligible) PLHIV were included in analysis. The number registered for care has increased by over 12 times during 2004-11; with increasing numbers among females. The median baseline CD4 cell count rose from 125 in 2004 to 235 in 2011 - the increase was greater among females as compared to males. However, about two-thirds still presented at CD4 cell counts less than 350. Conclusion: We found an increasing trend of median CD4 counts among PLHIV presenting to ART centres in Karnataka, an indicator of enhanced and early access to HIV care. Equal proportion of females and higher baseline CD4 counts among them allays any fear of differential access by gender. Despite this relative success, a substantial proportion still presented at low CD4 cell counts indicating possibly delayed HIV diagnosis and delayed linkage to HIV care. Universal HIV testing at health care facilities and strengthening early access to care are required to bridge the gap.	[Shastri, Suresh] Karnataka State AIDS Prevent Soc, Bangalore, Karnataka, India; [Boregowda, Pavithra Hatna] Indira Gandhi Inst Child Hlth, Ctr Excellence, Bangalore, Karnataka, India; [Rewari, Bharat B.; Tanwar, Sukarma] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Shet, Anita] St Johns Med Coll, Bangalore, Karnataka, India; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India	St. John's National Academy of Health Sciences; St. John's Medical College	Kumar, AMV (corresponding author), South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India.	akumar@theunion.org		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Shet, Anita/0000-0002-7204-8164	DFID, United Kingdom	DFID, United Kingdom	While the study itself was not funded by any external source, the protocol of the study was developed in an Operational Research Training Course which was funded by DFID, United Kingdom. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 2007, ANT THER GUID HIV IN; Bachani D, 2010, NATL MED J INDIA, V23, P7; Borghi V, 2008, JAIDS-J ACQ IMM DEF, V49, P282, DOI 10.1097/QAI.0b013e318186eabc; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buchacz K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/869841; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Krentz HB, 2010, AIDS, V24, P2750, DOI 10.1097/QAD.0b013e32833f9e1d; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mojumdar K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-416; *NAT AIDS CONTR OR, 2013, TECHN REP IND HIV ES; Parrott FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027917; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P288; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2008, REP GLOB AIDS EP; Velasco M, 2007, EUR J INTERN MED, V18, P400, DOI 10.1016/j.ejim.2006.12.013; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Vives N, 2012, INT J STD AIDS, V23, P475, DOI 10.1258/ijsa.2011.011280; WHO, 2010, ANT THER HIV INF AD; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2010, UN ACC SCAL PRIOR HI	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72188	10.1371/journal.pone.0072188	http://dx.doi.org/10.1371/journal.pone.0072188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951294	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000081
J	Zhao, DL; Tu, YF; Wan, L; Bu, LH; Huang, T; Sun, XL; Wang, K; Shen, BZ				Zhao, Dongliang; Tu, Yingfeng; Wan, Lin; Bu, Lihong; Huang, Tao; Sun, Xilin; Wang, Kai; Shen, Baozhong			In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR ANGIOGENESIS; MICRORNAS; VEGF; EXPRESSION	MicroRNA-21 (miR-21) is overexpressed in a wide range of cancers and involved in tumor proliferation and metastasis. However, the potential function of miR-21 in regulating tumor angiogenesis has been little disclosed. In this study, we treated the cultured 4T1 murine breast cancer cells and human umbilical vein endothelial cells (HUVECs) with miR-21 mimic, antagomir-21 or negative control (scramble), which were subjected to MTT, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), quantitative Reverse Transcriptase PCR (qRT-PCR) and immunoblotting analysis. In addition, 4T1 cells were implanted beneath the right breast fat pad of the VEGFR2-luc transgenic mice, which were randomly divided into three groups and received saline, antagomir-21 or scramble treatment once respectively after tumor model establishment. Bioluminescent imaging was used to monitor tumor growth and angiogenesis in vivo at 0d, 3d, 5d, 7d, 10d, and 14d after treatment. Mice were killed at the end of study and tumor tissues were collected for use. The results showed that knockdown of miR-21 by antagomir-21 decreased cell proliferation and induced apoptosis via targeting PTEN both in 4T1 cells and HUVECs. We also found the anti-angiogenesis and anti-tumor effects of antagomir-21 in the VEGFR2-luc transgenic mouse model using bioluminescent imaging. Moreover, the Western blotting data revealed that antagomir-21 inhibited tumor angiogenesis through suppressing HIF-1 alpha/VEGF/VEGFR2-associated signaling pathway. In conclusion, the results from current study demonstrate that antagomir-21 can effectively suppress tumor growth and angiogenesis in VEGFR2-luc mouse breast tumor model and bioluminescent imaging can be used as a tool for noninvasively and continuously monitoring tumor angiogenesis in vivo.	[Zhao, Dongliang; Tu, Yingfeng; Wan, Lin; Bu, Lihong; Huang, Tao; Sun, Xilin; Wang, Kai; Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Zhao, Dongliang; Tu, Yingfeng; Wan, Lin; Bu, Lihong; Huang, Tao; Sun, Xilin; Wang, Kai; Shen, Baozhong] Coll Heilongjiang Prov, Key Lab Mol Imaging, Harbin, Heilongjiang, Peoples R China; [Tu, Yingfeng] Harbin Med Univ, Hosp 4, Dept Cardiol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Shen, BZ (corresponding author), Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China.	shenbzh@vip.sina.com			Key Program of National Natural Science Foundation of China [81130028]; Ph.D. Programs Foundation of Ministry of Education of China [2.01123E+13]; Technology Foundation for Selected Overseas Chinese Scholar of Ministry of Personnel of China [[2007]275]; Key Grant Project of Heilongjiang Province [GA12C302]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Technology Foundation for Selected Overseas Chinese Scholar of Ministry of Personnel of China; Key Grant Project of Heilongjiang Province	This paper is supported by the Key Program of National Natural Science Foundation of China (81130028), the Ph.D. Programs Foundation of Ministry of Education of China (2.01123E+13), the Technology Foundation for Selected Overseas Chinese Scholar of Ministry of Personnel of China ([2007]275), and the Key Grant Project of Heilongjiang Province (GA12C302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2008, CURR PHARM DESIGN, V14, P3810, DOI 10.2174/138161208786898644; Angst E, 2010, MOL IMAGING BIOL, V12, P570, DOI 10.1007/s11307-010-0310-4; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; De Jong KP, 1998, HEPATOLOGY, V28, P971, DOI 10.1002/hep.510280411; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kafousi M, 2012, PATHOL ONCOL RES, V18, P33, DOI 10.1007/s12253-011-9413-8; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Palmowski M, 2008, MOL CANCER THER, V7, P101, DOI 10.1158/1535-7163.MCT-07-0409; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ribatti D, 2011, CANCER TREAT REV, V37, P344, DOI 10.1016/j.ctrv.2011.02.002; Ribatti D, 2009, CURR PHARM DESIGN, V15, P345, DOI 10.2174/138161209787315855; Rodriguez S, 2012, J ONCOL, V2012, DOI 10.1155/2012/141236; Shi M, 2009, CANCER TREAT REV, V35, P328, DOI 10.1016/j.ctrv.2008.12.002; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Willmann JK, 2008, RADIOLOGY, V249, P212, DOI 10.1148/radiol.2491072050; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Zhang N, 2004, BLOOD, V103, P617, DOI 10.1182/blood-2003-06-1820; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906	31	45	47	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71472	10.1371/journal.pone.0071472	http://dx.doi.org/10.1371/journal.pone.0071472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951172	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000061
J	Kato-Shimizu, M; Onishi, K; Kanazawa, T; Hinobayashi, T				Kato-Shimizu, Mayuko; Onishi, Kenji; Kanazawa, Tadahiro; Hinobayashi, Toshihiko			Preschool Children's Behavioral Tendency toward Social Indirect Reciprocity	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; NEURAL BASIS; COOPERATION; EVOLUTION; RECONCILIATION; ALTRUISM; PEER; REINFORCEMENT; AGGRESSION; FRIENDSHIP	Social indirect reciprocity seems to be crucial in enabling large-scale cooperative networks among genetically unrelated individuals in humans. However, there are relatively few studies on social indirect reciprocity in children compared to adults. Investigating whether young children have a behavioral tendency toward social indirect reciprocity will help us understand how and when the fundamental ability to form cooperative relationships among adults is acquired. Using naturalistic observation at a nursery school, this study examined whether 5- to 6-year-olds show a behavioral tendency to engage in social indirect reciprocity in response to their peers' prosocial behavior toward a third party. The results revealed that bystander children tended to display prosocial behavior toward their peers more frequently after observing these peers' prosocial behavior toward third-party peers, compared with control situations; this suggests that 5- to 6-year-olds may have an essential behavioral tendency to establish social indirect reciprocity when interacting with peers in their daily lives. In addition, bystanders tended to display affiliative behavior after observing focal children's prosocial behavior. In other words, observing peers' prosocial behavior toward third-party peers evoked bystanders' positive emotions toward the helpers. Considering both the present results and previous findings, we speculate that in preschoolers, such positive emotions might mediate the increase in the bystander's prosocial behavior toward the helper. In addition, an intuitional emotional process plays an important role in the preschooler's behavioral tendency toward social indirect reciprocity in natural interactions with peers.	[Kato-Shimizu, Mayuko; Onishi, Kenji; Kanazawa, Tadahiro; Hinobayashi, Toshihiko] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan	Osaka University	Onishi, K (corresponding author), Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan.	o-nishi@hus.osaka-u.ac.jp	Onishi, Kenji/G-2215-2010	Onishi, Kenji/0000-0001-5072-032X	 [22-3450]; Grants-in-Aid for Scientific Research [23730581] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Mayuko Kato-Shimizu was financially supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows (No. 22-3450, JSPS, http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2495; Anderson JR, 2013, COGNITION, V127, P140, DOI 10.1016/j.cognition.2012.12.007; BARRETT DE, 1977, CHILD DEV, V48, P475, DOI 10.1111/j.1467-8624.1977.tb01186.x; BIRCH LL, 1986, CHILD DEV, V57, P387, DOI 10.1111/j.1467-8624.1986.tb00038.x; Butovskaya M, 1999, AGGRESSIVE BEHAV, V25, P125, DOI 10.1002/(SICI)1098-2337(1999)25:2<125::AID-AB5>3.0.CO;2-X; CAPLAN MZ, 1989, J CHILD PSYCHOL PSYC, V30, P231, DOI 10.1111/j.1469-7610.1989.tb00237.x; Cassidy KW, 2003, SOC DEV, V12, P198, DOI 10.1111/1467-9507.00229; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Damon W., 1977, SOCIAL WORLD CHILD; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DREMAN SB, 1973, CHILD DEV, V44, P61, DOI 10.2307/1127680; EISENBERG N, 1985, DEV PSYCHOL, V21, P325, DOI 10.1037/0012-1649.21.2.325; EISENBERG N, 1981, DEV PSYCHOL, V17, P773, DOI 10.1037/0012-1649.17.6.773; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; ELLIOTT R, 1970, J EXP CHILD PSYCHOL, V10, P8, DOI 10.1016/0022-0965(70)90038-X; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fujisawa KK, 2008, INT J BEHAV DEV, V32, P89, DOI 10.1177/0165025407084055; Fujisawa KK, 2006, J COMP PSYCHOL, V120, P48, DOI 10.1037/0735-7036.120.1.48; Fujisawa KK, 2005, AGGRESSIVE BEHAV, V31, P138, DOI 10.1002/ab.20076; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; GUARDO CJ, 1969, CHILD DEV, V40, P143, DOI 10.2307/1127163; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; HARTUP WW, 1967, CHILD DEV, V38, P1003, DOI 10.1111/j.1467-8624.1967.tb04376.x; Hay DF, 1999, J CHILD PSYCHOL PSYC, V40, P905, DOI 10.1111/1469-7610.00508; HAY DF, 1994, J CHILD PSYCHOL PSYC, V35, P29, DOI 10.1111/j.1469-7610.1994.tb01132.x; Howes C., 1988, MONOGRAPHS SOC RES C, V53, P1, DOI DOI 10.2307/1166062; Kenward B, 2011, DEV PSYCHOL, V47, P1054, DOI 10.1037/a0023869; Kishimoto T, 2007, INFANT BEHAV DEV, V30, P562, DOI 10.1016/j.infbeh.2007.04.001; Kopp C.B., 2007, SOCIOEMOTIONAL DEV T, P101; Laursen Brett, 2002, New Dir Child Adolesc Dev, P27; LEVITT MJ, 1985, DEV PSYCHOL, V21, P122, DOI 10.1037/0012-1649.21.1.122; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; OWENS CR, 1991, J GENET PSYCHOL, V152, P341, DOI 10.1080/00221325.1991.9914691; Persson GEB, 2005, SOC DEV, V14, P206, DOI 10.1111/j.1467-9507.2005.00299.x; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Piaget J., 1965, MORAL JUDGEMENT CHIL; RHEINGOLD HL, 1976, CHILD DEV, V47, P1148, DOI 10.2307/1128454; RHINE RJ, 1967, CHILD DEV, V38, P1035, DOI 10.1111/j.1467-8624.1967.tb04379.x; Ross H.S., 1992, SOC DEV, V1, P1, DOI DOI 10.1111/J.1467-9507.1992.TB00131.X; Russell YI, 2008, BEHAV PROCESS, V78, P108, DOI 10.1016/j.beproc.2007.10.009; Rutte C, 2009, CURR SCI INDIA, V97, P1573; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; SCHALL R, 1991, BIOMETRIKA, V78, P719; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Sebanc AM, 2003, SOC DEV, V12, P249, DOI 10.1111/1467-9507.00232; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wedekind C, 2002, CURR BIOL, V12, P1012, DOI 10.1016/S0960-9822(02)00890-4; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Youniss J., 1980, PARENTS PEERS SOCIAL	65	19	19	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70915	10.1371/journal.pone.0070915	http://dx.doi.org/10.1371/journal.pone.0070915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951040	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700062
J	Mastanaiah, N; Johnson, JA; Roy, S				Mastanaiah, Navya; Johnson, Judith A.; Roy, Subrata			Effect of Dielectric and Liquid on Plasma Sterilization Using Dielectric Barrier Discharge Plasma	PLOS ONE			English	Article							INACTIVATION; SPORES; CELLS	Plasma sterilization offers a faster, less toxic and versatile alternative to conventional sterilization methods. Using a relatively small, low temperature, atmospheric, dielectric barrier discharge surface plasma generator, we achieved >= 6 log reduction in concentration of vegetative bacterial and yeast cells within 4 minutes and >= 6 log reduction of Geobacillus stearothermophilus spores within 20 minutes. Plasma sterilization is influenced by a wide variety of factors. Two factors studied in this particular paper are the effect of using different dielectric substrates and the significance of the amount of liquid on the dielectric surface. Of the two dielectric substrates tested (FR4 and semi-ceramic (SC)), it is noted that the FR4 is more efficient in terms of time taken for complete inactivation. FR4 is more efficient at generating plasma as shown by the intensity of spectral peaks, amount of ozone generated, the power used and the speed of killing vegetative cells. The surface temperature during plasma generation is also higher in the case of FR4. An inoculated FR4 or SC device produces less ozone than the respective clean devices. Temperature studies show that the surface temperatures reached during plasma generation are in the range of 30 degrees C-66 degrees C (for FR4) and 20 degrees C-49 degrees C (for SC). Surface temperatures during plasma generation of inoculated devices are lower than the corresponding temperatures of clean devices. pH studies indicate a slight reduction in pH value due to plasma generation, which implies that while temperature and acidification may play a minor role in DBD plasma sterilization, the presence of the liquid on the dielectric surface hampers sterilization and as the liquid evaporates, sterilization improves.	[Mastanaiah, Navya; Johnson, Judith A.; Roy, Subrata] Univ Florida, Dept Mech & Aerosp Engn, APRG, Gainesville, FL 32610 USA; [Johnson, Judith A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Johnson, Judith A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Roy, S (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, APRG, Gainesville, FL 32610 USA.	roy@ufl.edu			Sestar Medical	Sestar Medical	The authors are highly grateful to Sestar Medical for their generous financial support in funding this research. Sestar Medical had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayan H, 2009, IEEE T PLASMA SCI, V37, P113, DOI 10.1109/TPS.2008.2006899; Conrads H, 2000, PLASMA SOURCES SCI T, V9, P441, DOI 10.1088/0963-0252/9/4/301; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Gallagher MJ, 2007, IEEE T PLASMA SCI, V35, P1501, DOI 10.1109/TPS.2007.905209; Hury S, 1998, LETT APPL MICROBIOL, V26, P417; Jin Y, 2006, PLASMA SCI TECHNOL, V8, P720, DOI 10.1088/1009-0630/8/6/21; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R; Lerouge S., 2000, PLASMAS POLYM, V5, P31, DOI [10.1023/A:1009504209276, DOI 10.1023/A:1009504209276]; MACKEY BM, 1991, J GEN MICROBIOL, V137, P2361, DOI 10.1099/00221287-137-10-2361; Mastanaiah N, 2011, 49 AIAA AER SCI M EX; Menashi W.P., 1968, US Patent, Patent No. [3,383,163, 3383163]; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Pearse R. W. B., 1976, IDENTIFICATION MOL S; Sladek REJ, 2007, LETT APPL MICROBIOL, V45, P318, DOI 10.1111/j.1472-765X.2007.02194.x; Yu H, 2005, IEEE T PLASMA SCI, V33, P1405, DOI 10.1109/TPS.2005.851961	22	19	20	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70840	10.1371/journal.pone.0070840	http://dx.doi.org/10.1371/journal.pone.0070840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951023	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700057
J	Pazvakawambwa, L; Indongo, N; Kazembe, LN				Pazvakawambwa, Lillian; Indongo, Nelago; Kazembe, Lawrence N.			Explaining Marital Patterns and Trends in Namibia: A Regression Analysis of 1992, 2000 and 2006 Demographic and Survey Data	PLOS ONE			English	Article							MARRIAGE; COHABITATION; CHILDBEARING; TRANSITIONS; EDUCATION; DIVORCE; QUALITY; WOMENS; STATES; BIRTH	Background: Marriage is a significant event in life-course of individuals, and creates a system that characterizes societal and economic structures. Marital patterns and dynamics over the years have changed a lot, with decreasing proportions of marriage, increased levels of divorce and co-habitation in developing countries. Although, such changes have been reported in African societies including Namibia, they have largely remained unexplained. Objectives and Methods: In this paper, we examined trends and patterns of marital status of women of marriageable age: 15 to 49 years, in Namibia using the 1992, 2000 and 2006 Demographic and Health Survey (DHS) data. Trends were established for selected demographic variables. Two binary logistic regression models for ever-married versus never married, and cohabitation versus married were fitted to establish factors associated with such nuptial systems. Further a multinomial logistic regression models, adjusted for bio-demographic and socio-economic variables, were fitted separately for each year, to establish determinants of type of union (never married, married and cohabitation). Results and Conclusions: Findings indicate a general change away from marriage, with a shift in singulate mean age at marriage. Cohabitation was prevalent among those less than 30 years of age, the odds were higher in urban areas and increased since 1992. Be as it may marriage remained a persistent nuptiality pattern, and common among the less educated and employed, but lower odds in urban areas. Results from multinomial model suggest that marital status was associated with age at marriage, total children born, region, place of residence, education level and religion. We conclude that marital patterns have undergone significant transformation over the past two decades in Namibia, with a coexistence of traditional marriage framework with co-habitation, and sizeable proportion remaining unmarried to the late 30s. A shift in the singulate mean age is becoming distinctive in the Namibian society.	[Pazvakawambwa, Lillian; Kazembe, Lawrence N.] Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia; [Indongo, Nelago] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia	University of Namibia; University of Namibia	Pazvakawambwa, L (corresponding author), Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia.	lpazvakawambwa@unam.na	Indongo, Nelago/GQI-2465-2022	PAZVAKAWAMBWA, LILLIAN/0000-0003-0523-5063	University of Namibia	University of Namibia	The authors acknowledge funding from the University of Namibia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaldo C., 2004, African Population Studies, V19, P143; Berrington A, 2000, J ROY STAT SOC A STA, V163, P127, DOI 10.1111/1467-985X.00162; BRACHER M, 1993, POP STUD-J DEMOG, V47, P403, DOI 10.1080/0032472031000147216; Burgess S, 2003, J POPUL ECON, V16, P455, DOI 10.1007/s00148-003-0124-7; Caltabiano M, 2008, INT FAM PLAN PERSPEC, V34, P30, DOI [10.1363/3403008, 10.1363/ifpp.34.030.08]; Ermisch J, 2000, J ROY STAT SOC A STA, V163, P153, DOI 10.1111/1467-985X.00163; Fahrmeir L., 1994, MULTIVARIATE STAT MO, V425; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Government of the Republic of Namibia, 2001, ED ALL NAT PLAN ACT; Government of the Republic of Namibia, 2008, 2 MILL DEV GOALS REP; Howse K, 1989, FAMILY MATTERS GUIDE; Indongo N, 2008, AFR SOCIOL REV, V12, P98; Kalmijn M, 2007, POP STUD-J DEMOG, V61, P243, DOI 10.1080/00324720701571806; Kravdal O, 1999, POP STUD-J DEMOG, V53, P63, DOI 10.1080/00324720308067; LARSON JH, 1994, FAM RELAT, V43, P228, DOI 10.2307/585327; Lehrer EL, 2008, J POPUL ECON, V21, P366; Marston M, 2009, SEX TRANSM INFECT, V85, pI64, DOI 10.1136/sti.2008.034249; Moreels S, 2011, J FAM HIST, V36, P72, DOI 10.1177/0363199010390615; Mumcu A, 2008, JASSS-J ARTIF SOC S, V11; Musick K, 2012, J MARRIAGE FAM, V74, P53, DOI 10.1111/j.1741-3737.2011.00879.x; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; Sayer LC, 2011, AM J SOCIOL, V116, P1982, DOI 10.1086/658173; Shemeikka R, 2005, DEMOGR RES, V13, P83, DOI 10.4054/DemRes.2005.13.4; Steele F, 2005, DEMOGRAPHY, V42, P647, DOI 10.1353/dem.2005.0038; Steele F, 2006, POP STUD-J DEMOG, V60, P137, DOI 10.1080/00324720600598009; Tan P C, 1990, Sojourn, V5, P163; Torr BM, 2011, J FAM HIST, V36, P483, DOI 10.1177/0363199011416760; van Roode T, 2012, PERSPECT SEX REPRO H, V44, P48, DOI 10.1363/4404812; Vignoli D, 2009, DEMOGR RES, V20, P11, DOI 10.4054/DemRes.2009.20.4; Wolfinger NH, 2008, SOC FORCES, V86, P1311, DOI 10.1353/sof.0.0023	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70394	10.1371/journal.pone.0070394	http://dx.doi.org/10.1371/journal.pone.0070394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204OU	23967073	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000007
J	da Luz, JMR; Paes, SA; Nunes, MD; da Silva, MDS; Kasuya, MCM				Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Nunes, Mateus Dias; Soares da Silva, Marliane de Cassia; Megumi Kasuya, Maria Catarina			Degradation of Oxo-Biodegradable Plastic by Pleurotus ostreatus	PLOS ONE			English	Article							MANGANESE PEROXIDASE; TRAMETES-VERSICOLOR; FUNGAL BIOMASS; POLYETHYLENE; ERGOSTEROL; DECOLORIZATION; POLYMERS; LACCASE; DYES; DEGRADABILITY	Growing concerns regarding the impact of the accumulation of plastic waste over several decades on the environmental have led to the development of biodegradable plastic. These plastics can be degraded by microorganisms and absorbed by the environment and are therefore gaining public support as a possible alternative to petroleum-derived plastics. Among the developed biodegradable plastics, oxo-biodegradable polymers have been used to produce plastic bags. Exposure of this waste plastic to ultraviolet light (UV) or heat can lead to breakage of the polymer chains in the plastic, and the resulting compounds are easily degraded by microorganisms. However, few studies have characterized the microbial degradation of oxo-biodegradable plastics. In this study, we tested the capability of Pleurotus ostreatus to degrade oxo-biodegradable (D2W) plastic without prior physical treatment, such as exposure to UV or thermal heating. After 45 d of incubation in substrate-containing plastic bags, the oxo-biodegradable plastic, which is commonly used in supermarkets, developed cracks and small holes in the plastic surface as a result of the formation of hydroxyl groups and carbon-oxygen bonds. These alterations may be due to laccase activity. Furthermore, we observed the degradation of the dye found in these bags as well as mushroom formation. Thus, P. ostreatus degrades oxo-biodegradable plastics and produces mushrooms using this plastic as substrate.	[Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Nunes, Mateus Dias; Soares da Silva, Marliane de Cassia; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	de Cássia S da Silva, Marliane/G-4068-2012; Kasuya, Maria Catarina Megumi/E-1123-2013; da Luz, José Maria/B-2276-2018	de Cássia S da Silva, Marliane/0000-0003-4678-7876; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; da Luz, José Maria/0000-0001-9826-7982	Brazilian Financial Agency: CAPES; Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	Brazilian Financial Agency: CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Financial Agency: CNPq; Brazilian Financial Agency: FAPEMIG	This research was supported by Brazilian Financial Agencies: CAPES, CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora DS, 2002, INT BIODETER BIODEGR, V50, P115, DOI 10.1016/S0964-8305(02)00064-1; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Barajas-Aceves M, 2002, J MICROBIOL METH, V50, P227, DOI 10.1016/S0167-7012(02)00031-3; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavallazzi JRP, 2004, J FOOD AGRIC ENVIRON, V2, P291; Chattopadhyay S, 2003, J APPL POLYM SCI, V89, P2579, DOI 10.1002/app.12403; Chiellini E, 2007, POLYM DEGRAD STABIL, V92, P1378, DOI 10.1016/j.polymdegradstab.2007.03.007; Coutinho Fernanda M. B., 2003, Polímeros, V13, P01, DOI 10.1590/S0104-14282003000100005; Fabiyi JS, 2011, COMPOS PART A-APPL S, V42, P501, DOI 10.1016/j.compositesa.2011.01.009; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Gu JD, 2003, INT BIODETER BIODEGR, V52, P69, DOI 10.1016/S0964-8305(02)00177-4; Harazono K, 2005, CHEMOSPHERE, V59, P63, DOI 10.1016/j.chemosphere.2004.09.104; Heinfling A, 1997, APPL MICROBIOL BIOT, V48, P261, DOI 10.1007/s002530051048; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Ishigaki T, 2004, CHEMOSPHERE, V54, P225, DOI 10.1016/S0045-6535(03)00750-1; Jakubowicz I, 2003, POLYM DEGRAD STABIL, V80, P39, DOI 10.1016/S0141-3910(02)00380-4; Kamida WM, 2005, QUIM NOVA, V28, P629; Khabbaz F, 1999, POLYM DEGRAD STABIL, V63, P127, DOI 10.1016/S0141-3910(98)00082-2; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Maalej-Kammoun M, 2009, INT BIODETER BIODEGR, V63, P600, DOI 10.1016/j.ibiod.2009.04.003; Majcherczyk A, 1998, ENZYME MICROB TECH, V22, P335, DOI 10.1016/S0141-0229(97)00199-3; MANDELS M, 1976, BIOTECHNOL BIOENG, P21; Mille-Lindblom C, 2004, J MICROBIOL METH, V59, P253, DOI 10.1016/j.mimet.2004.07.010; Murugesan K, 2007, ENZYME MICROB TECH, V40, P1662, DOI 10.1016/j.enzmictec.2006.08.028; Niemenmaa O, 2008, INT BIODETER BIODEGR, V62, P125, DOI 10.1016/j.ibiod.2007.12.009; Nunes M. D., 2012, Journal of Food Research, V1, P113; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; Palmieri G, 2005, ENZYME MICROB TECH, V36, P17, DOI 10.1016/j.enzmictec.2004.03.026; Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002; Richardson MD, 1997, J AGR FOOD CHEM, V45, P3903, DOI 10.1021/jf970117f; da Luz JMR, 2012, BRAZ J MICROBIOL, V43, P1508, DOI [10.1590/S1517-83822012000400035, 10.1590/S1517-838220120004000035]; da Luz JMR, 2013, LWT-FOOD SCI TECHNOL, V50, P575, DOI 10.1016/j.lwt.2012.08.006; Roldan-Carrillo T, 2003, BIORESOURCE TECHNOL, V86, P1, DOI 10.1016/S0960-8524(02)00142-6; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; Smit E, 2003, FEMS MICROBIOL ECOL, V45, P49, DOI 10.1016/S0168-6496(03)00109-0; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Wen JW, 2011, INT BIODETER BIODEGR, V65, P600, DOI 10.1016/j.ibiod.2011.03.003; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wood TM, 1990, BIODEGRADATION, V1, P147, DOI 10.1007/BF00058833; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0; Yamada-Onodera K, 2001, POLYM DEGRAD STABIL, V72, P323, DOI 10.1016/S0141-3910(01)00027-1; Yang ZH, 2007, APPL ENVIRON MICROB, V73, P7947, DOI 10.1128/AEM.00842-07	44	44	45	9	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e69386	10.1371/journal.pone.0069386	http://dx.doi.org/10.1371/journal.pone.0069386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967057	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000004
J	Hamalisto, S; Pouwels, J; de Franceschi, N; Saari, M; Ivarsson, Y; Zimmermann, P; Brech, A; Stenmark, H; Ivaska, J				Hamalisto, Saara; Pouwels, Jeroen; de Franceschi, Nicola; Saari, Markku; Ivarsson, Ylva; Zimmermann, Pascale; Brech, Andreas; Stenmark, Harald; Ivaska, Johanna			A ZO-1/alpha 5 beta 1-Integrin Complex Regulates Cytokinesis Downstream of PKC epsilon in NCI-H460 Cells Plated on Fibronectin	PLOS ONE			English	Article							PROTEIN ZO-1; EXPRESSION; RECEPTOR; INTEGRINS; BETA-1-INTEGRINS; PHOSPHATASE; PROGRESSION; PHENOTYPE; JUNCTIONS; ADHESION	Recently, we demonstrated that integrin adhesion to the extracellular matrix at the cleavage furrow is essential for cytokinesis of adherent cells. Here, we report that tight junction protein ZO-1 (Zonula Occludens-1) is required for successful cytokinesis in NCI-H460 cells plated on fibronectin. This function of ZO-1 involves interaction with the cytoplasmic domain of alpha 5-integrin to facilitate recruitment of active fibronectin-binding integrins to the base of the cleavage furrow. In the absence of ZO-1, or a functional ZO-1/alpha 5 beta 1-integrin complex, proper actin-dependent constriction between daughter cells is impaired and cells fail cytokinesis. Super-resolution microscopy reveals that in ZO-1 depleted cells the furrow becomes delocalized from the matrix. We also show that PKC epsilon-dependent phosphorylation at Serine168 is required for ZO-1 localization to the furrow and successful cell division. Altogether, our results identify a novel regulatory pathway involving the interplay between ZO-1, alpha 5-integrin and PKC epsilon in the late stages of mammalian cell division.	[Hamalisto, Saara; Pouwels, Jeroen; de Franceschi, Nicola; Saari, Markku; Ivaska, Johanna] Univ Turku, Ctr Biotechnol, Turku, Finland; [Pouwels, Jeroen; de Franceschi, Nicola; Ivaska, Johanna] VTT Tech Res Ctr Finland, Turku, Finland; [Ivarsson, Ylva; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Brech, Andreas; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Turku; VTT Technical Research Center Finland; KU Leuven; University of Oslo; University of Turku	Ivaska, J (corresponding author), Univ Turku, Ctr Biotechnol, Turku, Finland.	Johanna.Ivaska@utu.fi	Zimmermann, Pascale/P-4190-2017; Stenmark, Harald/B-8868-2008; Ivarsson, Ylva/HGE-0283-2022; De Franceschi, Nicola/S-8194-2016	Ivarsson, Ylva/0000-0002-7081-3846; De Franceschi, Nicola/0000-0002-7221-613X; Ivaska, Johanna/0000-0002-6295-6556; Pouwels, Jeroen/0000-0002-5388-6103; Brech, Andreas/0000-0002-9803-1774	ERC; Academy of Finland; Finnish Cancer Organizations; Instrumentarium; Sigrid Juselius Foundation	ERC(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Instrumentarium; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study has been supported by grants from ERC (http://erc.europa.eu/), Academy of Finland (ww.aka.fi), Finnish Cancer Organizations (www.cancer.fi/en/), Instrumentarium (www.instrufoundation.fi) and Sigrid Juselius Foundation (www.sigridjuselius.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, CLIN CANCER RES, V6, P96; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BAKER J, 1993, J CELL SCI, V104, P415; BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gatti M, 2000, MICROSC RES TECHNIQ, V49, P202, DOI 10.1002/(SICI)1097-0029(20000415)49:2<202::AID-JEMT13>3.0.CO;2-8; Harrington RJ, 2002, DEVELOPMENT, V129, P2141; Huo L, 2011, EMBO J, V30, P665, DOI 10.1038/emboj.2010.353; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Meerschaert K, 2009, CELL MOL LIFE SCI, V66, P3951, DOI 10.1007/s00018-009-0156-6; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; ORLY J, 1979, CELL, V17, P295, DOI 10.1016/0092-8674(79)90155-7; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Saito T, 1996, BRIT J CANCER, V73, P327, DOI 10.1038/bjc.1996.57; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Saurin AT, 2009, CELL CYCLE, V8, P549, DOI 10.4161/cc.8.4.7653; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Thullberg M, 2007, P NATL ACAD SCI USA, V104, P20338, DOI 10.1073/pnas.0706609105; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352	39	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70696	10.1371/journal.pone.0070696	http://dx.doi.org/10.1371/journal.pone.0070696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967087	Green Submitted, gold, Green Published			2022-12-27	WOS:000323115800012
J	Cuchillo-Ibanez, I; Balmaceda, V; Botella-Lopez, A; Rabano, A; Avila, J; Saez-Valero, J				Cuchillo-Ibanez, Inmaculada; Balmaceda, Valeria; Botella-Lopez, Arancha; Rabano, Alberto; Avila, Jesus; Saez-Valero, Javier			Beta-Amyloid Impairs Reelin Signaling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TAU-PHOSPHORYLATION; LIPOPROTEIN RECEPTORS; ALZHEIMERS-DISEASE; PROTEIN; GLYCOSYLATION; EXPRESSION; BINDING; BRAIN; GAMMA	Reelin is a signaling protein increasingly associated with the pathogenesis of Alzheimer's disease that relevantly modulates tau phosphorylation. We have previously demonstrated that beta-amyloid peptide (A beta) alters reelin expression. We have now attempted to determine whether abnormal reelin triggered by A beta will result in signaling malfunction, contributing to the pathogenic process. Here, we show that reelin forms induced by beta-amyloid are less capable of down-regulating tau phosphorylation via disabled-1 and GSK3 beta kinase. We also demonstrate that the scaffold protein 14-3-3 that increases tau phosphorylation by modulating GSK3 beta activity, is up-regulated during defective reelin signaling. Binding of reelin to its receptor, mainly ApoER2 in the brain, relays the signal into the cell. We associate the impaired reelin signaling with inefficiency of reelin in forming active homodimers and decreased ability to bind efficiently to its receptor, ApoER2. More remarkably, reelin from Alzheimer cortex shows a tendency to form large complexes instead of homodimers, the active form for signaling. Our results suggest that reelin expression is altered by A beta leading to impaired reelin signaling.	[Cuchillo-Ibanez, Inmaculada; Balmaceda, Valeria; Botella-Lopez, Arancha; Saez-Valero, Javier] Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alicante, Spain; [Cuchillo-Ibanez, Inmaculada; Balmaceda, Valeria; Botella-Lopez, Arancha; Rabano, Alberto; Avila, Jesus; Saez-Valero, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Rabano, Alberto] Alzheimer Ctr Reina Sofia Fdn, Carlos III Inst Hlth, CIEN Fdn, Banco Tejidos Fdn CIEN, Madrid, Spain; [Avila, Jesus] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; Instituto de Salud Carlos III; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Saez-Valero, J (corresponding author), Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alicante, Spain.	j.saez@umh.es	Botella-López, Arancha/L-4471-2014; Avila, Jesus/I-2610-2015; Sáez, Javier/K-5756-2014; cuchillo, inmaculada/P-2975-2019	Botella-López, Arancha/0000-0002-3952-144X; Avila, Jesus/0000-0002-6288-0571; Sáez, Javier/0000-0001-7480-320X; /0000-0002-3689-5518	Fondo de Investigaciones Sanitarias [PS09/00684, PI12/00593]; Fundacion Ramon Areces; CIBERNED, Instituto de Salud Carlos III from Spain; CSIC, Spain; Fondo Social Europeo (FSE), E.C	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Ramon Areces; CIBERNED, Instituto de Salud Carlos III from Spain; CSIC, Spain; Fondo Social Europeo (FSE), E.C	This work was supported by grants from Fondo de Investigaciones Sanitarias (PS09/00684; PI12/00593), Fundacion Ramon Areces, and CIBERNED, Instituto de Salud Carlos III from Spain. VB is supported by a JAE-Predoctoral fellowship from the CSIC, Spain, co-financed by the Fondo Social Europeo (FSE), E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; Brich J, 2003, J NEUROSCI, V23, P187; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323; Garcia-Ayllon MS, 2007, J NEUROCHEM, V101, P1701, DOI 10.1111/j.1471-4159.2007.04461.x; Gozal YM, 2009, J PROTEOME RES, V8, P5069, DOI 10.1021/pr900474t; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Melander F, 2004, BIOCHEM BIOPH RES CO, V317, P1000, DOI 10.1016/j.bbrc.2004.03.147; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pennings MTT, 2007, J THROMB HAEMOST, V5, P369, DOI 10.1111/j.1538-7836.2007.02310.x; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Saez-Valero J, 2003, J NEUROSCI RES, V72, P132, DOI 10.1002/jnr.10554; Santa-Maria I, 2010, NEUROSCI LETT, V468, P225, DOI 10.1016/j.neulet.2009.11.002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Serfozo Z, 2012, NEUROCHEM INT, V60, P605, DOI 10.1016/j.neuint.2012.02.019; Sidera C, 2005, PROTEOMICS, V5, P1533, DOI 10.1002/pmic.200401185; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Wang JZ, 1996, NAT MED, V2, P871, DOI 10.1038/nm0896-871; Xu L, 2009, J BIOL CHEM, V284, P27265, DOI 10.1074/jbc.M109.022855; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200	42	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72297	10.1371/journal.pone.0072297	http://dx.doi.org/10.1371/journal.pone.0072297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951306	Green Published, gold			2022-12-27	WOS:000323097300188
J	Hagan, CC; Woods, W; Johnson, S; Green, GGR; Young, AW				Hagan, Cindy C.; Woods, Will; Johnson, Sam; Green, Gary G. R.; Young, Andrew W.			Involvement of Right STS in Audio-Visual Integration for Affective Speech Demonstrated Using MEG	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; HUMAN BRAIN; IMPAIRED RECOGNITION; OBJECT RECOGNITION; CROSSMODAL BINDING; EMOTIONAL SIGNALS; AUDITORY-CORTEX; GAMMA-ACTIVITY; VISUAL SPEECH; PERCEPTION	Speech and emotion perception are dynamic processes in which it may be optimal to integrate synchronous signals emitted from different sources. Studies of audio-visual (AV) perception of neutrally expressed speech demonstrate supra-additive (i.e., where AV>[unimodal auditory+unimodal visual]) responses in left STS to crossmodal speech stimuli. However, emotions are often conveyed simultaneously with speech; through the voice in the form of speech prosody and through the face in the form of facial expression. Previous studies of AV nonverbal emotion integration showed a role for right (rather than left) STS. The current study therefore examined whether the integration of facial and prosodic signals of emotional speech is associated with supra-additive responses in left (cf. results for speech integration) or right (due to emotional content) STS. As emotional displays are sometimes difficult to interpret, we also examined whether supra-additive responses were affected by emotional incongruence (i.e., ambiguity). Using magnetoencephalography, we continuously recorded eighteen participants as they viewed and heard AV congruent emotional and AV incongruent emotional speech stimuli. Significant supra-additive responses were observed in right STS within the first 250 ms for emotionally incongruent and emotionally congruent AV speech stimuli, which further underscores the role of right STS in processing crossmodal emotive signals.	[Hagan, Cindy C.; Green, Gary G. R.; Young, Andrew W.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Hagan, Cindy C.; Woods, Will; Johnson, Sam; Green, Gary G. R.; Young, Andrew W.] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Hagan, Cindy C.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England; [Woods, Will] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Melbourne, Vic, Australia	University of York - UK; University of York - UK; University of Cambridge; Swinburne University of Technology	Hagan, CC (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	cindy.hagan@gmail.com	Young, Andy/G-2189-2011; Green, Gary GR/D-3543-2009	Young, Andy/0000-0002-1202-6297; Green, Gary GR/0000-0003-1977-7509; Hagan, Cindy/0000-0002-4576-7120; Woods, William/0000-0001-6653-6105				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; BLONDER LX, 1991, BRAIN, V114, P1115, DOI 10.1093/brain/114.3.1115; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chen YH, 2010, EUR J NEUROSCI, V31, P1818, DOI 10.1111/j.1460-9568.2010.07203.x; Classen J, 1998, J NEUROPHYSIOL, V79, P1567, DOI 10.1152/jn.1998.79.3.1567; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; De Gelder B, 1996, NATO ASI SERIES F, V150, P179; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Fingelkurts Alexander A, 2007, Cogn Process, V8, P183, DOI 10.1007/s10339-007-0175-x; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Hagan CC, 2009, P NATL ACAD SCI USA, V106, P20010, DOI 10.1073/pnas.0905792106; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Herdman AT, 2006, NEUROSCI LETT, V399, P61, DOI 10.1016/j.neulet.2006.01.069; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hocking J, 2008, CEREB CORTEX, V18, P2439, DOI 10.1093/cercor/bhn007; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Klasen M, 2012, REV NEUROSCIENCE, V23, P381, DOI 10.1515/revneuro-2012-0040; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stein BE., 1993, MERGING SENSES; STEIN BE, 2004, HDB MULTISENSORY PRO, P243; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	52	17	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70648	10.1371/journal.pone.0070648	http://dx.doi.org/10.1371/journal.pone.0070648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950977	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000323097300037
J	Iyori, M; Nakaya, H; Inagaki, K; Pichyangkul, S; Yamamoto, DS; Kawasaki, M; Kwak, K; Mizukoshi, M; Goto, Y; Matsuoka, H; Matsumoto, M; Yoshida, S				Iyori, Mitsuhiro; Nakaya, Hiroki; Inagaki, Katsuya; Pichyangkul, Sathit; Yamamoto, Daisuke S.; Kawasaki, Masanori; Kwak, Kyungtak; Mizukoshi, Masami; Goto, Yoshihiro; Matsuoka, Hiroyuki; Matsumoto, Makoto; Yoshida, Shigeto			Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein	PLOS ONE			English	Article							CD8+ T-CELLS; MALARIA VACCINE; IMMUNE-RESPONSES; IMMUNOGENICITY; SAFETY; TRANSMISSION; IMMUNIZATION; INTERFERON; CHALLENGES; ANTIBODIES	We have previously developed a new malaria vaccine delivery system based on the baculovirus dual expression system (BDES). In this system, expression of malaria antigens is driven by a dual promoter consisting of the baculovirus-derived polyhedrin and mammal-derived cytomegalovirus promoters. To test this system for its potential as a vaccine against human malaria parasites, we investigated immune responses against the newly developed BDES-based Plasmodium falciparum circumsporozoite protein vaccines (BDES-PfCSP) in mice and Rhesus monkeys. Immunization of mice with BDESPfCSP induced Th1/Th2-mixed type immune responses with high PfCSP-specific antibody (Ab) titers, and provided significant protection against challenge from the bites of mosquitoes infected with a transgenic P. berghei line expressing PfCSP. Next, we evaluated the immunogenicity of the BDES-PfCSP vaccine in a rhesus monkey model. Immunization of BDES-PfCSP elicited high levels of anti-PfCSP Ab responses in individual monkeys. Moreover, the sera from the immunized monkeys remarkably blocked sporozoite invasion of HepG2 cells. Taken together with two animal models, our results indicate that this novel vaccine platform (BDES) has potential clinical application as a vaccine against malaria.	[Iyori, Mitsuhiro; Nakaya, Hiroki; Yoshida, Shigeto] Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kanazawa, Ishikawa, Japan; [Inagaki, Katsuya; Kawasaki, Masanori; Kwak, Kyungtak; Mizukoshi, Masami; Goto, Yoshihiro; Matsumoto, Makoto] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Tokushima 77101, Japan; [Pichyangkul, Sathit] USAMC AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Yamamoto, Daisuke S.; Matsuoka, Hiroyuki] Jichi Med Univ, Dept Infect & Immun, Div Med Zool, Shimotsuke, Tochigi, Japan	Kanazawa University; Otsuka Pharmaceutical; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Jichi Medical University	Yoshida, S (corresponding author), Kanazawa Univ, Sch Pharm, Lab Vaccinol & Appl Immunol, Kanazawa, Ishikawa, Japan.	shigeto@p.kanazawa-u.ac.jp	IYORI, MITSUHIRO/D-8395-2015	IYORI, MITSUHIRO/0000-0001-9940-7342; Matsuoka, Hiroyuki/0000-0001-8839-0012	Young Scientists from the Hokuriku Bank, Ltd. [21390126]; Waksman Foundation; Otsuka Pharmaceutical Co. Ltd.	Young Scientists from the Hokuriku Bank, Ltd.; Waksman Foundation; Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	This work was supported in part from a Grant-in-Aid for Young Scientists from the Hokuriku Bank, Ltd.,(http://www.hokuhoku-fg.co.jp/english/) and Grants-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 21390126) (http://www.jsps.go.jp/english/e-grants/index.html), grants from the Waksman Foundation (http://www.waksman.or.jp/)and Otsuka Pharmaceutical Co. Ltd. (http://www.otsuka.co.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2010, CURR GENE THER, V10, P226, DOI 10.2174/156652310791321279; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Agnandji ST, 2012, N ENGL J MED; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bergmann-Leitner ES, 2005, INT IMMUNOL, V17, P245, DOI 10.1093/intimm/dxh205; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kubler-Kielb J, 2010, P NATL ACAD SCI USA, V107, P1172, DOI 10.1073/pnas.0913374107; Lu HY, 2012, BIOENGINEERED, V3, P271, DOI 10.4161/bioe.20679; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Palma C, 2011, VACCINE, V29, P1683, DOI 10.1016/j.vaccine.2010.12.040; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022; Pumpuni CB, 1997, J PARASITOL, V83, P652, DOI 10.2307/3284242; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schuldt NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024147; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Sumitani M, 2012, INSECT MOL IN PRESS; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824; Yoshida S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013727; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09; Yoshida S, 2009, INFECT IMMUN, V77, P1782, DOI 10.1128/IAI.01226-08	41	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70819	10.1371/journal.pone.0070819	http://dx.doi.org/10.1371/journal.pone.0070819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951015	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300054
J	Mewton, L; Sachdev, PS; Andrews, G				Mewton, Louise; Sachdev, Perminder S.; Andrews, Gavin			A Naturalistic Study of the Acceptability and Effectiveness of Internet-Delivered Cognitive Behavioural Therapy for Psychiatric Disorders in Older Australians	PLOS ONE			English	Article							MENTAL-HEALTH; ANXIETY	Objectives: The current study investigates the acceptability, effectiveness and uptake of internet-delivered cognitive behavioural therapy (iCBT) amongst older individuals (>60 years) seeking psychiatric treatment in general practice. Methods: The sample consisted of 2413 (mean age 39.5; range 18-83 years) patients prescribed iCBT through This Way Up clinic by their primary care clinician. The intervention consisted of six fully automated, unassisted online lessons specific to four disorders major depression, generalised anxiety disorder, panic disorder or social phobia. Patients were categorised into five age groups (18-29 years, 30-39 years, 40-49 years, 50-59 years, 60 years and above). 225 (9.3%) patients were aged over 60 years. Analyses were conducted across the four disorders to ensure sufficient sample sizes in the 60 years and older age group. Age differences in adherence to the six lesson courses were assessed to demonstrate acceptability. Age-based reductions in psychological distress (Kessler Psychological Distress Scale; K10) and disability (the World Health Organisation Disability Assessment Schedule; WHODAS-II) were compared to demonstrate effectiveness. To evaluate the uptake of iCBT, the age distribution of those commencing iCBT was compared with the prevalence of these disorders in the 2007 Australian National Survey of Mental Health and Well-Being. Results: Older adults were more likely to complete all six lessons when compared with their younger counterparts. Marginal model analyses indicated that there were significant reductions in the K10 and WHODAS-II from baseline to post-intervention, regardless of age (p<0.001). The measurement occasion by age interactions were not significant, indicating that individuals showed similar reductions in the K10 and WHODAS-II regardless of age. In general, the age distribution of individuals commencing the iCBT courses matched the age distribution of the four diagnoses in the Australian general population, indicating that iCBT successfully captures older individuals who need treatment. Conclusion: iCBT is effective and acceptable for use in older populations.	[Mewton, Louise; Sachdev, Perminder S.; Andrews, Gavin] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain & Ageing CHeBA, Sydney, NSW, Australia; [Mewton, Louise; Andrews, Gavin] St Vincents Hosp, CRUfAD, Sydney, NSW 2010, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney	Mewton, L (corresponding author), Univ New S Wales, Sch Psychiat, Ctr Hlth Brain & Ageing CHeBA, Sydney, NSW, Australia.	louisem@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220	Australian National Health and Medical Research Council [350833]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This paper was supported by an Australian National Health and Medical Research Council program grant no. 350833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Australian Bureau of Statistics, 2011, AUSTR SOC TRENDS ONL; Baron M, 2008, ARTHRIT RHEUM-ARTHR, V59, P382, DOI 10.1002/art.23314; Blaschke CM, 2009, BRIT J SOC WORK, V39, P641, DOI 10.1093/bjsw/bcp025; Christensen H, 2004, J MED INTERNET RES, V6, P13, DOI 10.2196/jmir.6.4.e46; Commonwealth of Australia, 2010, AUSTR 2050 FUT CHALL; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Hilvert-Bruce Z, 2012, BEHAV RES THER, V50, P463, DOI 10.1016/j.brat.2012.04.001; Karel MJ, 2012, AM PSYCHOL, V67, P184, DOI 10.1037/a0025393; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klein B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1918; Mewton L, 2012, DEPRESS ANXIETY, V29, P843, DOI 10.1002/da.21995; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Sunderland M, 2012, BEHAV RES THERAPY; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Trollor JN, 2007, AM J GERIAT PSYCHIAT, V15, P455, DOI 10.1097/JGP.0b013e3180590ba9; West B. T., 2006, LINEAR MIXED MODELS, P180; Williams AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057447; Wims E, 2010, AUST NZ J PSYCHIAT, V44, P599, DOI 10.3109/00048671003614171; Zickuhr K., 2012, OLDER ADULTS INTERNE	27	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71825	10.1371/journal.pone.0071825	http://dx.doi.org/10.1371/journal.pone.0071825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951253	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300161
J	Raz, Y; Miller, Y				Raz, Yoav; Miller, Yifat			Interactions between A beta and Mutated Tau Lead to Polymorphism and Induce Aggregation of A beta-Mutated Tau Oligomeric Complexes	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; MOLECULAR-DYNAMICS SIMULATION; PARTICLE MESH EWALD; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; MICROTUBULE-BINDING; AMYLOID-BETA; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; CONFORMATIONAL SELECTION	One of the main hallmarks of the fronto-temporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) is the accumulation of neurofibrillary tangles in the brain as an outcome of the aggregation of mutated tau protein. This process occurs due to a number of genetic mutations in the MAPT gene. One of these mutations is the Delta K280 mutation in the tau R2 repeat domain, which promotes the aggregation vis-a-vis that for the wild-type tau. Experimental studies have shown that in Alzheimer's disease A beta peptide forms aggregates both with itself and with wild-type tau. By analogy, in FTDP-17, it is likely that there are interactions between A beta and mutated tau, but the molecular mechanisms underlying such interactions remain to be elucidated. Thus, to investigate the interactions between A beta and mutated tau, we constructed fourteen Delta K280 mutated tau-A beta(17-42) oligomeric complexes. In seven of the mutated tau-A beta(17-42) oligoemric complexes the mutated tau oligomers exhibited hydrophobic interactions in their core domain, and in the other seven mutated tau-A beta(17-42) oligoemric complexes the mutated tau oligomers exhibited salt-bridge interactions in their core domain. We considered two types of interactions between mutated tau oligomers and A beta oligomers: interactions of one monomer of the A beta oligomer with one monomer of the mutated tau oligomer to form a single-layer conformation, and interactions of the entire A beta oligomer with the entire mutated tau oligomer to form a double-layer conformation. We also considered parallel arrangements of A beta trimers alternating with mutated tau trimers in a single-layer conformation. Our results demonstrate that in the interactions of A beta and mutated tau oligomers, polymorphic mutated tau-A beta(17-42) oligomeric complexes were observed, with a slight preference for the double-layer conformation. A beta trimers alternating with mutated tau trimers constituted a structurally stable confined beta-structure, albeit one that was energetically less stable than all the other constructed models.	[Raz, Yoav; Miller, Yifat] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel; [Raz, Yoav; Miller, Yifat] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Miller, Y (corresponding author), Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel.	ymiller@bgu.ac.il	Atsmon-Raz, Yoav/H-1763-2013	Atsmon-Raz, Yoav/0000-0001-6476-9845	FP7-PEOPLE-2011-CIG [303741]	FP7-PEOPLE-2011-CIG	This project is funded by the FP7-PEOPLE-2011-CIG, research grant no. 303741. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce FT, 2011, SOFT MATTER, V7, P5267, DOI 10.1039/c1sm05162h; Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barrantes A, 2009, J ALZHEIMERS DIS, V18, P141, DOI 10.3233/JAD-2009-1130; Berhanu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041479; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Gotz J, 2010, NEURODEGENER DIS, V7, P10, DOI 10.1159/000283475; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wei GH, 2010, PHYS CHEM CHEM PHYS, V12, P3622, DOI 10.1039/c000755m; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wu C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000693; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	78	41	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73303	10.1371/journal.pone.0073303	http://dx.doi.org/10.1371/journal.pone.0073303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951348	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300205
J	Romero, M; Caniffi, C; Bouchet, G; Elesgaray, R; Mac Laughlin, M; Tomat, A; Arranz, C; Costa, MA				Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Elesgaray, Rosana; Mac Laughlin, Myriam; Tomat, Analia; Arranz, Cristina; Costa, Maria A.			Sex Differences in the Beneficial Cardiac Effects of Chronic Treatment with Atrial Natriuretic Peptide In Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; NITRIC-OXIDE PATHWAY; OXIDATIVE STRESS; BLOOD-PRESSURE; GENDER-DIFFERENCES; ENDOTHELIAL DYSFUNCTION; HEART-FAILURE; KEY MEDIATOR; HYPERTROPHY; REDUCTION	Introduction: The aim of this study was to investigate both the effects of chronic treatment with atrial natriuretic peptide (ANP) on systolic blood pressure (SBP), cardiac nitric oxide (NO) system, oxidative stress, hypertrophy, fibrosis and apoptosis in spontaneously hypertensive rats (SHR), and sex-related differences in the response to the treatment. Methods: 10 week-old male and female SHR were infused with ANP (100 ng/hr/rat) or saline (NaCl 0.9%) for 14 days (subcutaneous osmotic pumps). SBP was recorded and nitrites and nitrates excretion (NOx) were determined. After treatment, NO synthase (NOS) activity, eNOS expression, thiobarbituric acid-reactive substances (TBARS) and glutathione concentration were determined in left ventricle, as well as the activity of glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD). Morphological studies in left ventricle were performed in slices stained with hematoxylin-eosin or Sirius red to identify collagen as a fibrosis indicator; immunohistochemistry was employed for identification of transforming growth factor beta; and apoptosis was evaluated by Tunel assay. Results: Female SHR showed lower SBP, higher NO-system activity and less oxidative stress, fibrosis and hypertrophy in left ventricle, as well as higher cardiac NOS activity, eNOS protein content and NOx excretion than male SHR. Although ANP treatment lowered blood pressure and increased NOS activity and eNOS expression in both sexes, cardiac NOS response to ANP was more marked in females. In left ventricle, ANP reduced TBARS and increased glutathione concentration and activity of CAT and SOD enzymes in both sexes, as well as GPx activity in males. ANP decreased fibrosis and apoptosis in hearts from male and female SHR but females showed less end-organ damage in heart. Chronic ANP treatment would ameliorate hypertension and end-organ damage in heart by reducing oxidative stress, increasing NO-system activity, and diminishing fibrosis and hypertrophy.	[Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Elesgaray, Rosana; Mac Laughlin, Myriam; Tomat, Analia; Arranz, Cristina; Costa, Maria A.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiol, Inst Quim & Metab Farm,Consejo Nacl Invest Cient, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Costa, MA (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiol, Inst Quim & Metab Farm,Consejo Nacl Invest Cient, RA-1113 Buenos Aires, DF, Argentina.	Mcosta@Ffyb.Uba.Ar			UBACYT from Universidad de Buenos Aires [20020100100060 (2011-2014)]; CONICET [1122011010058101 (211-2014)]; IQUIMEFA-CONICET, Argentina [1122011010058101 (211-2014)]	UBACYT from Universidad de Buenos Aires; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); IQUIMEFA-CONICET, Argentina	This study was partially supported by grants: UBACYT Number 20020100100060 (2011-2014) from Universidad de Buenos Aires; and PIP Number 1122011010058101 (211-2014) from CONICET and IQUIMEFA-CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barp J, 2002, BRAZ J MED BIOL RES, V35, P1075, DOI 10.1590/S0100-879X2002000900008; Belo NO, 2004, REGUL PEPTIDES, V117, P53, DOI 10.1016/j.regpep.2003.10.007; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes RP, 1997, LIFE SCI, V60, P391, DOI 10.1016/S0024-3205(96)00663-7; BROSNIHAN KB, 1994, AM J HYPERTENS, V7, P576, DOI 10.1093/ajh/7.7.576; Buege J A, 1978, Methods Enzymol, V52, P302; Capek P, 2006, Cas Lek Cesk, V145, P93; Alvarez MC, 2008, HYPERTENS RES, V31, P1465, DOI 10.1291/hypres.31.1465; Chan V, 2011, J CARDIOVASC PHARM, V57, P469, DOI 10.1097/FJC.0b013e3182102c3b; Chang HR, 2005, CHINESE J PHYSIOL, V48, P15; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Clerico A, 1998, J ENDOCRINOL INVEST, V21, P170, DOI 10.1007/BF03347297; Costa MA, 2006, LIFE SCI, V78, P1543, DOI 10.1016/j.lfs.2005.07.024; Costa MA, 2004, J HYPERTENS, V22, pS183, DOI 10.1097/00004872-200406002-00634; Costa MA, 2010, AM J PHYSIOL-HEART C, V298, pH778, DOI 10.1152/ajpheart.00488.2009; Costa MD, 2004, REGUL PEPTIDES, V118, P151, DOI 10.1016/j.regpep.2003.12.009; Costa MD, 2000, HYPERTENSION, V35, P1119, DOI 10.1161/01.HYP.35.5.1119; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; De Vito P, 2010, PEPTIDES, V31, P1412, DOI 10.1016/j.peptides.2010.04.001; Diez J, 1997, HYPERTENSION, V30, P1029, DOI 10.1161/01.HYP.30.5.1029; Elesgaray R, 2012, AM J PHYSIOL-RENAL, V302, pF1385, DOI 10.1152/ajprenal.00624.2011; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Hall JE, 2008, HYPERTENSION, V51, P951, DOI 10.1161/HYPERTENSIONAHA.107.009813; Huang A, 1997, HYPERTENSION, V29, P1351, DOI 10.1161/01.HYP.29.6.1351; Huang A, 1998, AM J PHYSIOL-REG I, V275, pR1571, DOI 10.1152/ajpregu.1998.275.5.R1571; Jensen KT, 1997, SCAND J CLIN LAB INV, V57, P529, DOI 10.3109/00365519709084604; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Leskinen H, 1997, ENDOCRINOLOGY, V138, P1893, DOI 10.1210/en.138.5.1893; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Pelzer T, 2000, BIOCHEM BIOPH RES CO, V268, P192, DOI 10.1006/bbrc.2000.2073; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Rakhit RD, 2001, HEART, V86, P368, DOI 10.1136/heart.86.4.368; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Saha S, 2008, J MOL CELL CARDIOL, V44, P336, DOI 10.1016/j.yjmcc.2007.11.003; Shono M, 2007, CIRC J, V71, P1040, DOI 10.1253/circj.71.1040; Smith RS, 2005, LIFE SCI, V76, P2457, DOI 10.1016/j.lfs.2004.11.028; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tomat AL, 2007, LIFE SCI, V80, P1292, DOI 10.1016/j.lfs.2006.12.035; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Wassmann S, 2001, CIRCULATION, V103, P435; Wu CF, 1997, J BIOL CHEM, V272, P14860, DOI 10.1074/jbc.272.23.14860; Yang SM, 2000, J CARDIOVASC PHARM, V36, P242, DOI 10.1097/00005344-200008000-00015; ZHANG F, 1994, AM J PHYSIOL, V266, pC975, DOI 10.1152/ajpcell.1994.266.4.C975; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	53	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71992	10.1371/journal.pone.0071992	http://dx.doi.org/10.1371/journal.pone.0071992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951276	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300173
J	Tao, YJ; Pan, MZ; Liu, SF; Fang, F; Lu, RX; Lu, CY; Zheng, M; An, JH; Xu, HJ; Zhao, FX; Chen, JF; Qu, J; Zhou, XT				Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Chen, Jiang-fan; Qu, Jia; Zhou, Xiangtian			cAMP Level Modulates Scleral Collagen Remodeling, a Critical Step in the Development of Myopia	PLOS ONE			English	Article							DIRECT-CURRENT ELECTRORETINOGRAM; FORM DEPRIVATION MYOPIA; ADENYLYL-CYCLASE; AXIAL MYOPIA; GUINEA-PIGS; TREE SHREW; INTRAOCULAR-PRESSURE; INCREASES OUTFLOW; EYE; INHIBITION	The development of myopia is associated with decreased ocular scleral collagen synthesis in humans and animal models. Collagen synthesis is, in part, under the influence of cyclic adenosine monophosphate (cAMP). We investigated the associations between cAMP, myopia development in guinea pigs, and collagen synthesis by human scleral fibroblasts (HSFs). Form-deprived myopia (FDM) was induced by unilateral masking of guinea pig eyes. Scleral cAMP levels increased selectively in the FDM eyes and returned to normal levels after unmasking and recovery. Unilateral subconjunctival treatment with the adenylyl cyclase (AC) activator forskolin resulted in a myopic shift accompanied by reduced collagen mRNA levels, but it did not affect retinal electroretinograms. The AC inhibitor SQ22536 attenuated the progression of FDM. Moreover, forskolin inhibited collagen mRNA levels and collagen secretion by HSFs. The inhibition was reversed by SQ22536. These results demonstrate a critical role of cAMP in control of myopia development. Selective regulation of cAMP to control scleral collagen synthesis may be a novel therapeutic strategy for preventing and treating myopia.	[Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Chen, Jiang-fan; Qu, Jia; Zhou, Xiangtian] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Chen, Jiang-fan; Qu, Jia; Zhou, Xiangtian] Wenzhou Med Coll, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Qu, Jia; Zhou, Xiangtian] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Qu, Jia; Zhou, Xiangtian] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Tao, Yijin; Pan, Miaozhen; Liu, Shufeng; Fang, Fang; Lu, Runxia; Lu, Chanyi; Zheng, Min; An, Jianhong; Xu, Hongjia; Zhao, Fuxin; Qu, Jia; Zhou, Xiangtian] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Chen, Jiang-fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Wenzhou Medical University; Wenzhou Medical University; Boston University	Qu, J (corresponding author), Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	jqu@wz.zj.cn; zxt-dr@wz.zj.cn	zhou, xt/GWZ-9212-2022	Zhao, Fuxin/0000-0002-1006-6180; Chen, Jiang-Fan/0000-0002-0446-3956	National Basic Research Program of China (973 project) [2011CB504602]; National Natural Science Foundation of China [81271039, 81070751]; Zhejiang Provincial Natural Science Foundation [Z2100065]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents from the National Ministry; Education Grant from the National Ministry [NCET-10-0977]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents from the National Ministry; Education Grant from the National Ministry	This study was supported by funding from National Basic Research Program of China (973 project, 2011CB504602 to JQ), National Natural Science Foundation of China (81271039 and 81070751 to JQ), Zhejiang Provincial Natural Science Foundation (Z2100065 to XZ), and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, and an Education Grant from the National Ministry (NCET-10-0977 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAGADOTTIR R, 1995, DOC OPHTHALMOL, V90, P291, DOI 10.1007/BF01203864; Burford NT, 1996, BIOCHEM J, V315, P883, DOI 10.1042/bj3150883; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chua WH, 2006, OPHTHALMOLOGY, V113, P2285, DOI 10.1016/j.ophtha.2006.05.062; CURTIN B J, 1958, Trans Am Acad Ophthalmol Otolaryngol, V62, P777; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Dong F, 2011, MOL VIS, V17, P2824; FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Gao YS, 2001, EUR J PHARMACOL, V418, P111, DOI 10.1016/S0014-2999(01)00929-3; GOH WSH, 1994, OPHTHAL PHYSL OPT, V14, P378, DOI 10.1111/j.1475-1313.1994.tb00128.x; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; JARKMAN S, 1987, DOC OPHTHALMOL, V67, P305, DOI 10.1007/BF00143948; Jiang LQ, 2009, INVEST OPHTH VIS SCI, V50, P1013, DOI 10.1167/iovs.08-2463; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Lai NC, 2008, J AM COLL CARDIOL, V51, P1490, DOI 10.1016/j.jacc.2008.01.015; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; LEECH EM, 1995, OPHTHAL PHYSL OPT, V15, P351, DOI 10.1016/0275-5408(95)00074-N; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Lu F, 2006, EXP EYE RES, V82, P628, DOI 10.1016/j.exer.2005.09.001; Lu F, 2007, CURR EYE RES, V32, P319, DOI 10.1080/02713680701215322; Lu F, 2009, EXP EYE RES, V89, P101, DOI 10.1016/j.exer.2009.02.019; Manny RE, OPTOM VIS SCI, V88, P1445; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mons N, 2003, NEUROBIOL LEARN MEM, V79, P226, DOI 10.1016/S1074-7427(03)00005-4; NAOI N, 1990, INVEST OPHTH VIS SCI, V31, P54; NEUFELD AH, 1975, INVEST OPHTH VISUAL, V14, P40; NEUFELD AH, 1974, INVEST OPHTH VISUAL, V13, P475; NEUFELD AH, 1975, INVEST OPHTH VISUAL, V14, P688; Nickla DL, 2010, EXP EYE RES, V91, P715, DOI 10.1016/j.exer.2010.08.021; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Puell-Marin M C, 1997, J Am Optom Assoc, V68, P657; Qiong L, 2007, MOL VIS, V13, P1234; Qu J, 2006, CURR EYE RES, V31, P587, DOI 10.1080/02713680600770609; QUINN GE, 1995, OPHTHALMOLOGY, V102, P180; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; RICKERS M, 1995, EXP EYE RES, V61, P509, DOI 10.1016/S0014-4835(05)80147-2; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Wrobel LJ, 2011, NEUROSCIENCE, V172, P177, DOI 10.1016/j.neuroscience.2010.10.006; Wu PC, 2011, J OCUL PHARMACOL TH, V27, P461, DOI 10.1089/jop.2011.0027; YAMAMOTO M, 1994, BRAIN RES, V653, P335, DOI 10.1016/0006-8993(94)90409-X; Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1; Zejmo M, 2009, MED SCI MONITOR, V15, pRA199; Zhou XT, 2006, VISION RES, V46, P2815, DOI 10.1016/j.visres.2006.01.027; Zhou XT, 2010, INVEST OPHTH VIS SCI, V51, P4362, DOI 10.1167/iovs.09-3998	56	34	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71441	10.1371/journal.pone.0071441	http://dx.doi.org/10.1371/journal.pone.0071441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951163	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300117
J	Weitman, ES; Aschen, SZ; Farias-Eisner, G; Albano, N; Cuzzone, DA; Ghanta, S; Zampell, JC; Thorek, D; Mehrara, BJ				Weitman, Evan S.; Aschen, Seth Z.; Farias-Eisner, Gina; Albano, Nicholas; Cuzzone, Daniel A.; Ghanta, Swapna; Zampell, Jamie C.; Thorek, Daniel; Mehrara, Babak J.			Obesity Impairs Lymphatic Fluid Transport and Dendritic Cell Migration to Lymph Nodes	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; HIGH-RESOLUTION; STEADY-STATE; MICE; ACCUMULATION; DYSFUNCTION; ACTIVATION; CONTRIBUTE; ATROPHY; FAT	Introduction: Obesity is a major cause of morbidity and mortality resulting in pathologic changes in virtually every organ system. Although the cardiovascular system has been a focus of intense study, the effects of obesity on the lymphatic system remain essentially unknown. The purpose of this study was to identify the pathologic consequences of diet induced obesity (DIO) on the lymphatic system. Methods: Adult male wild-type or RAG C57B6-6J mice were fed a high fat (60%) or normal chow diet for 8-10 weeks followed by analysis of lymphatic transport capacity. In addition, we assessed migration of dendritic cells (DCs) to local lymph nodes, lymph node architecture, and lymph node cellular make up. Results: High fat diet resulted in obesity in both wild-type and RAG mice and significantly impaired lymphatic fluid transport and lymph node uptake; interestingly, obese wild-type but not obese RAG mice had significantly impaired migration of DCs to the peripheral lymph nodes. Obesity also resulted in significant changes in the macro and microscopic anatomy of lymph nodes as reflected by a marked decrease in size of inguinal lymph nodes (3.4-fold), decreased number of lymph node lymphatics (1.6-fold), loss of follicular pattern of B cells, and dysregulation of CCL21 expression gradients. Finally, obesity resulted in a significant decrease in the number of lymph node T cells and increased number of B cells and macrophages. Conclusions: Obesity has significant negative effects on lymphatic transport, DC cell migration, and lymph node architecture. Loss of T and B cell inflammatory reactions does not protect from impaired lymphatic fluid transport but preserves DC migration capacity. Future studies are needed to determine how the interplay between diet, obesity, and the lymphatic system modulate systemic complications of obesity.	[Weitman, Evan S.; Aschen, Seth Z.; Farias-Eisner, Gina; Albano, Nicholas; Cuzzone, Daniel A.; Ghanta, Swapna; Zampell, Jamie C.; Thorek, Daniel; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org		Cuzzone, Daniel/0000-0003-1131-7305	National Institute of Health [1R01HL111130-01A1]; Plastic Surgery Foundation; Society of Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE [T32CA009501, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Society of Memorial Sloan Kettering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institute of Health (nih.gov) #1R01HL111130-01A1 (Mechanisms of fibrosis and lymphatic dysfunction in post-surgical lymphedema). Plastic Surgery Foundation (http://www.thepsf.org). Society of Memorial Sloan Kettering (http://mskcc.convio.net/site/PageServer?pagename=soc_home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arngrim N, 2012, INT J OBES LOND; Avraham T, 2012, FASEB J; Avraham T, 2013, FASEB J, V27, P1114, DOI 10.1096/fj.12-222695; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Greene AK, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1201684; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kim CS, 2008, OBESITY, V16, P1261, DOI 10.1038/oby.2008.55; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rocha VZ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/529061; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Thorek DLJ, 2012, J NUCL MED, V53, P1438, DOI 10.2967/jnumed.112.104349; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011	29	111	119	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70703	10.1371/journal.pone.0070703	http://dx.doi.org/10.1371/journal.pone.0070703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950984	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300041
J	Guy, E; Lautier, M; Chabannes, M; Roux, B; Lauber, E; Arlat, M; Noel, LD				Guy, Endrick; Lautier, Martine; Chabannes, Matthieu; Roux, Brice; Lauber, Emmanuelle; Arlat, Matthieu; Noel, Laurent D.			xopAC-triggered Immunity against Xanthomonas Depends on Arabidopsis Receptor-Like Cytoplasmic Kinase Genes PBL2 and RIPK	PLOS ONE			English	Article							DISEASE RESISTANCE; III EFFECTOR; RALSTONIA-SOLANACEARUM; FUNCTIONAL-ANALYSIS; PROTEIN-KINASE; HOST TARGET; PLANT; CAMPESTRIS; FLAGELLIN; PERCEPTION	Xanthomonas campestris pv. campestris (Xcc) colonizes the vascular system of Brassicaceae and ultimately causes black rot. In susceptible Arabidopsis plants, XopAC type III effector inhibits by uridylylation positive regulators of the PAMP-triggered immunity such as the receptor-like cytoplasmic kinases (RLCK) BIK1 and PBL1. In the resistant ecotype Col-0, xopAC is a major avirulence gene of Xcc. In this study, we show that both the RLCK interaction domain and the uridylyl transferase domain of XopAC are required for avirulence. Furthermore, xopAC can also confer avirulence to both the vascular pathogen Ralstonia solanacearum and the mesophyll-colonizing pathogen Pseudomonas syringae indicating that xopAC-specified effector-triggered immunity is not specific to the vascular system. In planta, XopAC-YFP fusions are localized at the plasma membrane suggesting that XopAC might interact with membrane-localized proteins. Eight RLCK of subfamily VII predicted to be localized at the plasma membrane and interacting with XopAC in yeast two-hybrid assays have been isolated. Within this subfamily, PBL2 and RIPK RLCK genes but not BIK1 are important for xopAC-specified effector-triggered immunity and Arabidopsis resistance to Xcc.	[Guy, Endrick; Lautier, Martine; Chabannes, Matthieu; Roux, Brice; Lauber, Emmanuelle; Arlat, Matthieu; Noel, Laurent D.] INRA, LIPM, UMR 441, F-31326 Castanet Tolosan, France; [Guy, Endrick; Lautier, Martine; Chabannes, Matthieu; Roux, Brice; Lauber, Emmanuelle; Arlat, Matthieu; Noel, Laurent D.] CNRS, LIPM, UMR 2594, Castanet Tolosan, France; [Lautier, Martine; Arlat, Matthieu] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Noel, LD (corresponding author), INRA, LIPM, UMR 441, F-31326 Castanet Tolosan, France.	laurent.noel@toulouse.inra.fr	Arlat, Matthieu/CAH-3310-2022; Lauber, Emmanuelle/ABB-3077-2021; noel, laurent/A-4885-2009; Chabannes, Matthieu/AAR-7769-2021	Lauber, Emmanuelle/0000-0001-5933-4476; noel, laurent/0000-0002-0110-1423; Chabannes, Matthieu/0000-0001-5754-5982; Arlat, Matthieu/0000-0001-6196-4856	French Ministry of National Education and 16 Research; French Guyana; LABEX TULIP [ANR-10-LABX-41]; INRA-SPE 17 post-doctoral fellowship; Jeunes Chercheurs grant from the Agence Nationale de 18 la Recherche [Xopaque ANR-10-JCJC-1703-01]	French Ministry of National Education and 16 Research; French Guyana; LABEX TULIP; INRA-SPE 17 post-doctoral fellowship; Jeunes Chercheurs grant from the Agence Nationale de 18 la Recherche(French National Research Agency (ANR))	This work was supported by a PhD grant from the French Ministry of National Education and 16 Research and French Guyana to EG, the LABEX TULIP (ANR-10-LABX-41), an INRA-SPE 17 post-doctoral fellowship to MC and a Jeunes Chercheurs grant from the Agence Nationale de 18 la Recherche (Xopaque ANR-10-JCJC-1703-01) to LDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Afzal AJ, 2011, PLANT CELL, V23, P3798, DOI 10.1105/tpc.111.088708; Al-Daoude A, 2005, PLANT CELL, V17, P1016, DOI 10.1105/tpc.104.028720; ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014555; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guy E, 2013, MBIO, P4; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KING EO, 1954, J LAB CLIN MED, V44, P301; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Meyer D, 2006, J BACTERIOL, V188, P4903, DOI 10.1128/JB.00180-06; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Remigi P, 2011, NEW PHYTOL, V192, P976, DOI 10.1111/j.1469-8137.2011.03854.x; Rivas S, 2004, EMBO J, V23, P2156, DOI 10.1038/sj.emboj.7600224; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stael S, 2011, FEBS LETT, V585, P517, DOI 10.1016/j.febslet.2011.01.001; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Vicente JG, 2013, MOL PLANT PATHOL, V14, P2, DOI 10.1111/j.1364-3703.2012.00833.x; Warren RF, 1999, GENETICS, V152, P401; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; YU GL, 1993, MOL PLANT MICROBE IN, V6, P434, DOI 10.1094/MPMI-6-434; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	68	39	50	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73469	10.1371/journal.pone.0073469	http://dx.doi.org/10.1371/journal.pone.0073469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951354	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200092
J	Ramiro-Cortes, Y; Israely, I				Ramiro-Cortes, Yazmin; Israely, Inbal			Long Lasting Protein Synthesis- and Activity-Dependent Spine Shrinkage and Elimination after Synaptic Depression	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CA1 PYRAMIDAL NEURONS; FRAGILE-X-SYNDROME; TERM DEPRESSION; DENDRITIC SPINES; HIPPOCAMPAL SYNAPSES; MENTAL-RETARDATION; KNOCKOUT MICE; PLASTICITY; LTP	Neuronal circuits modify their response to synaptic inputs in an experience-dependent fashion. Increases in synaptic weights are accompanied by structural modifications, and activity dependent, long lasting growth of dendritic spines requires new protein synthesis. When multiple spines are potentiated within a dendritic domain, they show dynamic structural plasticity changes, indicating that spines can undergo bidirectional physical modifications. However, it is unclear whether protein synthesis dependent synaptic depression leads to long lasting structural changes. Here, we investigate the structural correlates of protein synthesis dependent long-term depression (LTD) mediated by metabotropic glutamate receptors (mGluRs) through two-photon imaging of dendritic spines on hippocampal pyramidal neurons. We find that induction of mGluR-LTD leads to robust and long lasting spine shrinkage and elimination that lasts for up to 24 hours. These effects depend on signaling through group I mGluRs, require protein synthesis, and activity. These data reveal a mechanism for long lasting remodeling of synaptic inputs, and offer potential insights into mental retardation.	[Ramiro-Cortes, Yazmin; Israely, Inbal] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, Oeiras, Portugal; [Ramiro-Cortes, Yazmin; Israely, Inbal] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud; Fundacao Champalimaud	Israely, I (corresponding author), Gulbenkian Inst Sci, Champalimaud Neurosci Programme, Oeiras, Portugal.	inbal.israely@neuro.fchampalimaud.org		CORTES, YAZMIN/0000-0003-4460-4175; Israely, Inbal/0000-0001-7234-6359	Champalimaud Foundation; Gulbenkian Foundation; Bial Foundation; Fundacao para Ciencia e Tecnologia; CONACyT	Champalimaud Foundation; Gulbenkian Foundation; Bial Foundation(Bial Foundation); Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Champalimaud Foundation, Gulbenkian Foundation, Bial Foundation, Fundacao para Ciencia e Tecnologia, and CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen CC, 2012, NEUROSCI LETT, V524, P65, DOI 10.1016/j.neulet.2012.07.014; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kato HK, 2012, J PHYSIOL-LONDON, V590, P3019, DOI 10.1113/jphysiol.2012.232942; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayford M, 2012, COLD SPRING HARB PER, V4; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Oh WC, 2012, P NATL ACAD SCI US; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Shinoda Y, 2005, BRAIN RES, V1042, P99, DOI 10.1016/j.brainres.2005.02.028; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71155	10.1371/journal.pone.0071155	http://dx.doi.org/10.1371/journal.pone.0071155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951097	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200032
J	von Bomhard, A; Veit, J; Bermueller, C; Rotter, N; Staudenmaier, R; Storck, K; The, HN				von Bomhard, Achim; Veit, Johannes; Bermueller, Christian; Rotter, Nicole; Staudenmaier, Rainer; Storck, Katharina; Hoang Nguyen The			Prefabrication of 3D Cartilage Contructs: Towards a Tissue Engineered Auricle - A Model Tested in Rabbits	PLOS ONE			English	Article							IN-VITRO; FLAP PREFABRICATION; HUMAN EAR; NEOVASCULARIZATION; TRANSPLANTATION	The reconstruction of an auricle for congenital deformity or following trauma remains one of the greatest challenges in reconstructive surgery. Tissue-engineered (TE) three-dimensional (3D) cartilage constructs have proven to be a promising option, but problems remain with regard to cell vitality in large cell constructs. The supply of nutrients and oxygen is limited because cultured cartilage is not vascular integrated due to missing perichondrium. The consequence is necrosis and thus a loss of form stability. The micro-surgical implantation of an arteriovenous loop represents a reliable technology for neovascularization, and thus vascular integration, of three-dimensional (3D) cultivated cell constructs. Auricular cartilage biopsies were obtained from 15 rabbits and seeded in 3D scaffolds made from polycaprolactone-based polyurethane in the shape and size of a human auricle. These cartilage cell constructs were implanted subcutaneously into a skin flap (1568 cm) and neovascularized by means of vascular loops implanted micro-surgically. They were then totally enhanced as 3D tissue and freely re-implanted in-situ through microsurgery. Neovascularization in the prefabricated flap and cultured cartilage construct was analyzed by microangiography. After explantation, the specimens were examined by histological and immunohistochemical methods. Cultivated 3D cartilage cell constructs with implanted vascular pedicle promoted the formation of engineered cartilaginous tissue within the scaffold in vivo. The auricles contained cartilage-specific extracellular matrix (ECM) components, such as GAGs and collagen even in the center oft the constructs. In contrast, in cultivated 3D cartilage cell constructs without vascular pedicle, ECM distribution was only detectable on the surface compared to constructs with vascular pedicle. We demonstrated, that the 3D flaps could be freely transplanted. On a microangiographic level it was evident that all the skin flaps and the implanted cultivated constructs were well neovascularized. The presented method is suggested as a promising alternative towards clinical application of engineered cartilaginous tissue for plastic and reconstructive surgery.	[von Bomhard, Achim] Tech Univ Munich, Dept Maxillofacial Surg, D-80290 Munich, Germany; [Veit, Johannes; Bermueller, Christian; Rotter, Nicole] Univ Ulm, Med Ctr, Dept Otorhinolaryngol, D-89069 Ulm, Germany; [Staudenmaier, Rainer] HNO Praxis Zentrum ENT & Plast Surg, Munich, Germany; [Storck, Katharina] Tech Univ Munich, Dept Otorhinolaryngol, D-80290 Munich, Germany; [Hoang Nguyen The] Mil Hosp 108, Dept Hand & Microsurg, Hanoi, Vietnam	Technical University of Munich; Ulm University; Technical University of Munich	von Bomhard, A (corresponding author), Tech Univ Munich, Dept Maxillofacial Surg, D-80290 Munich, Germany.	achimvonbomhard@gmail.com		Rotter, Nicole/0000-0003-1537-8340	Bayerische Forschungsstiftung (FORTEPRO) [Az. 442/01]	Bayerische Forschungsstiftung (FORTEPRO)	Grant sponsor: Bayerische Forschungsstiftung (FORTEPRO); Grant number: Az. 442/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTEKAR RG, 1974, CLIN ORTHOP RELAT R, P231; Bouwer AL, 2010, J IMMUNOL METHODS, V352, P178, DOI 10.1016/j.jim.2009.11.001; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Eyrich D, 2007, TISSUE ENG, V13, P2207, DOI 10.1089/ten.2006.0358; GAYOU RM, 1979, PLAST RECONSTR SURG, V63, P700, DOI 10.1097/00006534-197905000-00015; Green W T Jr, 1972, Surg Forum, V23, P453; Hadjipanayi E, 2010, J CONTROL RELEASE, V146, P309, DOI 10.1016/j.jconrel.2010.05.037; HIRASE Y, 1988, ANN PLAS SURG, V21, P342, DOI 10.1097/00000637-198810000-00008; Hoang NT, 2009, MICROSURG, V29, P52, DOI 10.1002/micr.20565; Hoang NT, 2005, MICROSURG, V25, P220, DOI 10.1002/micr.20099; IMBER G, 1974, PLAST RECONSTR SURG, V54, P183, DOI 10.1097/00006534-197408000-00010; Karatas O, 2000, ANN PLAS SURG, V44, P44, DOI 10.1097/00000637-200044010-00008; Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490; Martin I, 2006, Praxis (Bern 1994), V95, P841; MORRISON WA, 1990, BRIT J PLAST SURG, V43, P645, DOI 10.1016/0007-1226(90)90184-2; Neumeister MW, 2006, PLAST RECONSTR SURG, V117, P116, DOI 10.1097/01.prs.0000195071.01699.ce; Nguyen The H, 2004, Handchir Mikrochir Plast Chir, V36, P212, DOI 10.1055/s-2004-815747; Pribaz JJ, 1999, PLAST RECONSTR SURG, V103, P808, DOI 10.1097/00006534-199903000-00006; Rotter N, 1997, LARYNGO RHINO OTOL, V76, P241, DOI 10.1055/s-2007-997419; Song YS, 2009, ANAL BIOANAL CHEM, V395, P185, DOI 10.1007/s00216-009-2935-1; Staudenmaier R, 2004, J RECONSTR MICROSURG, V20, P555, DOI 10.1055/s-2004-836127; VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001; Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.1111/j.1582-4934.2006.tb00421.x; WALTON RL, 1993, ANN PLAS SURG, V30, P105, DOI 10.1097/00000637-199302000-00002; Wiese HDP, 2008, OPEN PORED POLYURETH	25	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71667	10.1371/journal.pone.0071667	http://dx.doi.org/10.1371/journal.pone.0071667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951215	Green Submitted, gold, Green Published			2022-12-27	WOS:000326473200066
J	Grossi, C; Rigacci, S; Ambrosini, S; Dami, TE; Luccarini, I; Traini, C; Failli, P; Berti, A; Casamenti, F; Stefani, M				Grossi, Cristina; Rigacci, Stefania; Ambrosini, Stefano; Dami, Teresa Ed; Luccarini, Ilaria; Traini, Chiara; Failli, Paola; Berti, Andrea; Casamenti, Fiorella; Stefani, Massimo			The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against A beta Plaque Pathology	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; VIRGIN OLIVE OIL; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; AMYLOID DEPOSITION; COGNITIVE FUNCTION; AUTOPHAGY; MEMORY; BRAIN; DYSFUNCTION	The claimed beneficial effects of the Mediterranean diet include prevention of several age-related dysfunctions including neurodegenerative diseases and Alzheimer-like pathology. These effects have been related to the protection against cognitive decline associated with aging and disease by a number of polyphenols found in red wine and extra virgin olive oil. The double transgenic TgCRND8 mice (overexpressing the Swedish and Indiana mutations in the human amyloid precursor protein), aged 1.5 and 4, and age-matched wild type control mice were used to examine in vivo the effects of 8 weeks dietary supplementation of oleuropein aglycone (50 mg/kg of diet), the main polyphenol found in extra virgin olive oil. We report here that dietary supplementation of oleuropein aglycone strongly improves the cognitive performance of young/middle-aged TgCRND8 mice, a model of amyloid-beta deposition, respect to age-matched littermates with un-supplemented diet. Immunofluorescence analysis of cerebral tissue in oleuropein aglycone-fed transgenic mice showed remarkably reduced beta-amyloid levels and plaque deposits, which appeared less compact and "fluffy"; moreover, microglia migration to the plaques for phagocytosis and a remarkable reduction of the astrocyte reaction were evident. Finally, oleuropein aglycone-fed mice brain displayed an astonishingly intense autophagic reaction, as shown by the increase of autophagic markers expression and of lysosomal activity. Data obtained with cultured cells confirmed the latter evidence, suggesting mTOR regulation by oleuropein aglycone. Our results support, and provide mechanistic insights into, the beneficial effects against Alzheimer-associated neurodegeneration of a polyphenol enriched in the extra virgin olive oil, a major component of the Mediterranean diet.	[Grossi, Cristina; Ambrosini, Stefano; Dami, Teresa Ed; Luccarini, Ilaria; Traini, Chiara; Failli, Paola; Casamenti, Fiorella] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Div Pharmacol & Toxicol, Florence, Italy; [Rigacci, Stefania; Berti, Andrea; Stefani, Massimo] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Berti, Andrea; Casamenti, Fiorella; Stefani, Massimo] Univ Florence, Res Ctr Mol Basis Neurodegenerat, Florence, Italy	University of Florence; University of Florence; University of Florence	Casamenti, F (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Div Pharmacol & Toxicol, Florence, Italy.	fiorella.casamenti@unifi.it		Failli, Paola/0000-0003-3879-9068; STEFANI, MASSIMO/0000-0002-4490-1922	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute"; ECRF	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute"(Regione Toscana); ECRF	This work was supported by the Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute 2009", PRIN2008, project R25HBW and by the ECRF 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini L, 1996, PHARMACOL BIOCHEM BE, V53, P277, DOI 10.1016/0091-3057(95)02021-7; Bellucci A, 2007, NEUROBIOL DIS, V27, P328, DOI 10.1016/j.nbd.2007.06.008; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Berr C, 2009, DEMENT GERIATR COGN, V28, P357, DOI 10.1159/000253483; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Daccache A, 2011, NEUROCHEM INT, V58, P700, DOI 10.1016/j.neuint.2011.02.010; Diomede L, 2013, PLOS ONE, V8; Dorostkar MM, 2012, NAT NEUROSCI, V15, P1323, DOI 10.1038/nn.3226; Farr SA, 2012, J ALZHEIMERS DIS, V28, P81, DOI 10.3233/JAD-2011-110662; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Grienberger C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1783; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; La Motta C, 2007, J MED CHEM, V50, P4917, DOI 10.1021/jm070398a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monti MC, 2012, J NAT PROD, V75, P1584, DOI 10.1021/np300384h; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Pallauf K, 2013, AGEING RES REV, V12, P237, DOI 10.1016/j.arr.2012.03.008; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pitozzi V, 2010, BRIT J NUTR, V103, P1674, DOI 10.1017/S0007114509993655; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Rigacci S, 2010, J NUTR BIOCHEM, V21, P726, DOI 10.1016/j.jnutbio.2009.04.010; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rudinskiy N, 2012, NAT NEUROSCI, V15, P1422, DOI 10.1038/nn.3199; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serra A, 2012, MOL NUTR FOOD RES, V56, P486, DOI 10.1002/mnfr.201100436; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Valls-Pedret C, 2012, J ALZHEIMERS DIS, V29, P773, DOI 10.3233/JAD-2012-111799; Vissers MN, 2002, J NUTR, V132, P409, DOI 10.1093/jn/132.3.409; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341	49	170	171	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71702	10.1371/journal.pone.0071702	http://dx.doi.org/10.1371/journal.pone.0071702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951225	gold, Green Published			2022-12-27	WOS:000323124000071
J	Poluektov, YO; Kim, A; Hartman, IZ; Sadegh-Nasseri, S				Poluektov, Yuri O.; Kim, AeRyon; Hartman, Isamu Z.; Sadegh-Nasseri, Scheherazade			HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DR MOLECULES; B-CELLS; INTRACELLULAR-TRANSPORT; PEPTIDE EXCHANGE; DENDRITIC CELLS; T-CELLS; LYSOSOMAL PH; DM; H2-O	Processing of antigens for presentation to helper T cells by MHC class II involves HLA-DM (DM) and HLA-DO (DO) accessory molecules. A mechanistic understanding of DO in this process has been missing. The leading model on its function proposes that DO inhibits the effects of DM. To directly study DO functions, we designed a recombinant soluble DO and expressed it in insect cells. The kinetics of binding and dissociation of several peptides to HLA-DR1 (DR1) molecules in the presence of DM and DO were measured. We found that DO reduced binding of DR1 to some peptides, and enhanced the binding of some other peptides to DR1. Interestingly, these enhancing and reducing effects were observed in the presence, or absence, of DM. We found that peptides that were negatively affected by DO were DM-sensitive, whereas peptides that were enhanced by DO were DM-resistant. The positive and negative effects of DO could only be measured on binding kinetics as peptide dissociation kinetics were not affected by DO. Using Surface Plasmon Resonance, we demonstrate direct binding of DO to a peptide-receptive, but not a closed conformation of DR1. We propose that DO imposes another layer of control on epitope selection during antigen processing.	[Poluektov, Yuri O.; Hartman, Isamu Z.; Sadegh-Nasseri, Scheherazade] Johns Hopkins Sch Med, Grad Program Immunol, Baltimore, MD USA; [Kim, AeRyon; Sadegh-Nasseri, Scheherazade] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Sadegh-Nasseri, S (corresponding author), Johns Hopkins Sch Med, Grad Program Immunol, Baltimore, MD USA.	ssadegh@jhmi.edu		Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720	National Institutes of Health [1R01AI63764, R21AI101987, 1R56AI091923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R56AI091923, R01AI063764, R21AI101987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health grants 1R01AI63764, R21AI101987 and 1R56AI091923 (to SS-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso C, 2003, J IMMUNOL, V171, P2331, DOI 10.4049/jimmunol.171.5.2331; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Brocke P, 2003, EUR J IMMUNOL, V33, P411, DOI 10.1002/immu.200310015; Castellino F, 1997, HUM IMMUNOL, V54, P159, DOI 10.1016/S0198-8859(97)00078-5; Chen XJ, 2006, J IMMUNOL, V176, P3548, DOI 10.4049/jimmunol.176.6.3548; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dalai S.K., 2011, IMMUNOL CELL BIOL; Dalai SK, 2008, J IMMUNOL, V181, P3221, DOI 10.4049/jimmunol.181.5.3221; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Deshaies F, 2005, P NATL ACAD SCI USA, V102, P6443, DOI 10.1073/pnas.0500853102; Deshaies F, 2009, IMMUNOLOGY, V127, P408, DOI 10.1111/j.1365-2567.2008.02984.x; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Draghi NA, 2010, P NATL ACAD SCI USA, V107, P16607, DOI 10.1073/pnas.1004664107; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Fallas JL, 2007, J IMMUNOL, V178, P1488, DOI 10.4049/jimmunol.178.3.1488; Fallas JL, 2004, J IMMUNOL, V173, P1549, DOI 10.4049/jimmunol.173.3.1549; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GREEN JM, 1995, J IMMUNOL, V155, P3759; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; Guce AI, 2012, NATURE STRUCTURAL MO; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Hornell TMC, 2006, J IMMUNOL, V176, P3536, DOI 10.4049/jimmunol.176.6.3536; Jensen PE, 1998, CURR BIOL, V8, pR128, DOI 10.1016/S0960-9822(98)70988-1; Kim A, 2013, ANTIGEN PROCESSING M, P447; Kremer AN, 2012, BLOOD, V120, P3246, DOI 10.1182/blood-2011-12-399311; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1998, EMBO J, V17, P2971, DOI 10.1093/emboj/17.11.2971; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Narayan K, 2009, MOL IMMUNOL, V46, P3157, DOI 10.1016/j.molimm.2009.07.001; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Perraudeau M, 2000, EUR J IMMUNOL, V30, P2871, DOI 10.1002/1521-4141(200010)30:10<2871::AID-IMMU2871>3.0.CO;2-B; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Reynolds RJ, 2010, GENES IMMUN, V11, P94, DOI 10.1038/gene.2009.69; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Sadegh-Nasseri S, 1994, ANTIGEN PROCESSING P, P170; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SADEGHNASSERI S, 1992, IMMUNOL TODAY, V13, P43, DOI 10.1016/0167-5699(92)90131-P; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Soll SJ, 2005, TISSUE ANTIGENS, V65, P283, DOI 10.1111/j.1399-0039.2005.00371.x; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; van Ham M, 2000, IMMUNOGENETICS, V51, P765, DOI 10.1007/s002510000208; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Vogt AB, 1997, IMMUNOL LETT, V57, P209, DOI 10.1016/S0165-2478(97)00061-8; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220; Yoon T, 2012, P NATL ACAD SCI USA, V109, P11276, DOI 10.1073/pnas.1113966109	70	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71228	10.1371/journal.pone.0071228	http://dx.doi.org/10.1371/journal.pone.0071228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951115	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000044
J	Zhu, RZ; Zeng, GF; Chen, YQ; Zhang, QY; Liu, B; Liu, J; Chen, HG; Li, MY				Zhu, Runzhi; Zeng, Guofang; Chen, Yinqin; Zhang, Qingyu; Liu, Bin; Liu, Jie; Chen, Hege; Li, Mingyi			Oroxylin A Accelerates Liver Regeneration in CCI4-Induced Acute Liver Injury Mice	PLOS ONE			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; CARBON-TETRACHLORIDE; INTERLEUKIN-6-DEFICIENT MICE; HEPATOCYTE PROLIFERATION; OXIDATIVE STRESS; NITRIC-OXIDE; IN-VITRO; KAPPA-B; APOPTOSIS; CIRRHOSIS	Introduction: Based on the previous research that oroxylin A can suppress inflammation, we investigated the hepatoprotective role of oroxylin A against CCl4-induced liver damage in mice and then studied the possible alteration of the activities of cytokine signaling participating in liver regeneration. Wild type (WT) mice were orally administrated with oroxylin A (60 mg/kg) for 4 days after CCl4 injection, the anti-inflammatory effects of oroxylin A were assessed directly by hepatic histology and indirectly by measuring serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and Albumin. Proliferating cell nuclear antigen (PCNA) staining was performed to evaluate the role of oroxylin A in promoting hepatocyte proliferation. Serum IL-1 beta, TNF-alpha, IL-6 and IL-1Ra levels were measured by enzyme-linked immunosorbent assay (ELISA) and liver HGF, EGF, TNF-alpha, IL-6, IL-1Ra and IL-1 beta gene expression was determined by quantitative real-time PCR. The data indicated that the IL-6 and TNF-alpha mRNA of oroxylin A administered group significantly increased higher than the control within 12 hours after CCl4 treatment. Meanwhile, oroxylin A significantly enhanced the expression of IL-1Ra at the early phase, which indicated that oroxylin A could facilitate the initiating events in liver regeneration by increasing IL-1Ra which acts as an Acute-Phase Protein (APP). In addition, a lethal CCl4-induced acute liver failure model offers a survival benefit in oroxylin A treated WT mice. However, oroxylin A could not significantly improve the percent survival of IL-1RI(-/-) mice with a lethal CCl4-induced acute liver failure. Conclusions: Our study confirmed that oroxylin A could strongly promote liver structural remodeling and functional recovery through IL-1Ra/IL-1RI signaling pathway. All these results support the possibility of oroxylin A being a therapeutic candidate for acute liver injury.	[Zhu, Runzhi; Zeng, Guofang; Chen, Yinqin; Zhang, Qingyu; Liu, Bin; Liu, Jie; Li, Mingyi] Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Lab Regenerat Med, Zhanjiang, Peoples R China; [Chen, Hege] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Guangdong Medical University; University System of Maryland; University of Maryland Baltimore	Chen, HG (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.	chenhege@hotmail.com; hepatolab2012@yahoo.cn	chen, hege/GYV-5810-2022		National Natural Science Funds [81041099]; Guangdong Province Natural Science Funds [S2011010003750]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds	This study was supported by grants from The National Natural Science Funds (81041099; http://www.nsfc.gov.cn/Portal0/default152.htm) and Guangdong Province Natural Science Funds (S2011010003750; http://gdsf.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2011, OXID STRESS APPL BAS, P467, DOI 10.1007/978-1-60761-956-7_21; Burr AW, 1998, J PATHOL, V185, P298; Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619; Campbell JS, 2001, J CLIN INVEST, V107, P1285, DOI 10.1172/JCI11867; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Davis JM, 2010, J IMMUNOL, V184, P7297, DOI 10.4049/jimmunol.0904180; Debonera F, 2001, J SURG RES, V96, P289, DOI 10.1006/jsre.2001.6086; Diao Y, 2011, WORLD J GASTROENTERO, V17, P111, DOI 10.3748/wjg.v17.i1.111; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gao Y, 2010, J CANCER RES CLIN, V136, P667, DOI 10.1007/s00432-009-0705-2; Heemann U, 2002, HEPATOLOGY, V36, P949, DOI 10.1053/jhep.2002.36130; Higgins GMA, 1931, ARCH PATHOL, P186; Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005; Li HN, 2009, TOXICOLOGY, V257, P80, DOI 10.1016/j.tox.2008.12.011; Masuda Y, 2006, YAKUGAKU ZASSHI, V126, P885, DOI 10.1248/yakushi.126.885; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Morio LA, 2001, TOXICOL APPL PHARM, V172, P44, DOI 10.1006/taap.2000.9133; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Ogiso T, 2007, J HEPATOL, V47, P816, DOI 10.1016/j.jhep.2007.06.017; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Sun Y, 2009, EUR J PHARMACOL, V603, P22, DOI 10.1016/j.ejphar.2008.12.008; Taniguchi M, 2004, LIFE SCI, V75, P1539, DOI 10.1016/j.lfs.2004.02.030; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Wang ZQ, 1998, HEPATOLOGY, V28, P430, DOI 10.1002/hep.510280221; Wu YL, 2010, CHEM-BIOL INTERACT, V188, P526, DOI 10.1016/j.cbi.2010.09.008; Wustefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604; Yang JY, 2010, J AGR FOOD CHEM, V58, P6525, DOI 10.1021/jf903070a; Yoneyama H, 2007, MED MOL MORPHOL, V40, P191, DOI 10.1007/s00795-007-0371-x; Zhu RZ, 2010, WORLD J GASTROENTERO, V16, P2771, DOI 10.3748/wjg.v16.i22.2771	39	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71612	10.1371/journal.pone.0071612	http://dx.doi.org/10.1371/journal.pone.0071612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951204	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000069
J	Bronckaers, A; Hilkens, P; Fanton, Y; Struys, T; Gervois, P; Politis, C; Martens, W; Lambrichts, I				Bronckaers, Annelies; Hilkens, Petra; Fanton, Yanick; Struys, Tom; Gervois, Pascal; Politis, Constantinus; Martens, Wendy; Lambrichts, Ivo			Angiogenic Properties of Human Dental Pulp Stem Cells	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; STROMAL CELLS; DIFFERENTIATION; REGENERATION; EXPRESSION; PROLIFERATION; OSTEOBLASTS; ACTIVATION; MECHANISMS; PHENOTYPE	Angiogenesis, the formation of capillaries from pre-existing blood vessels, is a key process in tissue engineering. If blood supply cannot be established rapidly, there is insufficient oxygen and nutrient transport and necrosis of the implanted tissue will occur. Recent studies indicate that the human dental pulp contains precursor cells, named dental pulp stem cells (hDPSC) that show self-renewal and multilineage differentiation capacity. Since these cells can be easily isolated, cultured and cryopreserved, they represent an attractive stem cell source for tissue engineering. Until now, only little is known about the angiogenic abilities and mechanisms of the hDPSC. In this study, the angiogenic profile of both cell lysates and conditioned medium of hDPSC was determined by means of an antibody array. Numerous pro-and anti-angiogenic factors such as vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), plasminogen activator inhibitor-1 (PAI-1) and endostatin were found both at the mRNA and protein level. hDPSC had no influence on the proliferation of the human microvascular endothelial cells (HMEC-1), but were able to significantly induce HMEC-1 migration in vitro. Addition of the PI3K-inhibitor LY294002 and the MEK-inhibitor U0126 to the HMEC-1 inhibited this effect, suggesting that both Akt and ERK pathways are involved in hDPSC-mediated HMEC-1 migration. Antibodies against VEGF also abolished the chemotactic actions of hDPSC. Furthermore, in the chicken chorioallantoic membrane (CAM) assay, hDPSC were able to significantly induce blood vessel formation. In conclusion, hDPSC have the ability to induce angiogenesis, meaning that this stem cell population has a great clinical potential, not only for tissue engineering but also for the treatment of chronic wounds, stroke and myocardial infarctions.	[Bronckaers, Annelies; Hilkens, Petra; Fanton, Yanick; Struys, Tom; Gervois, Pascal; Politis, Constantinus; Martens, Wendy; Lambrichts, Ivo] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium	Hasselt University	Bronckaers, A (corresponding author), Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium.	annelies.bronckaers@uhasselt.be	Gervois, Pascal/AAC-4624-2022; Politis, Constantinus/A-5472-2016; Lambrichts, Ivo/CAJ-1727-2022; Hilkens, Petra/ABE-4972-2020	Lambrichts, Ivo/0000-0001-7520-0021; Gervois, Pascal/0000-0002-8320-1320; Politis, Constantinus/0000-0003-4772-9897; Bronckaers, Annelies/0000-0001-8969-873X	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen- FWO') [1.5.060.13N]; FWO	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen- FWO')(FWO); FWO(FWO)	This research was supported by grants to A. B. from the Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen- FWO', grant Nr. 1.5.060.13N). P. H. benefits from a PhD scholarship of the FWO and A. B. is a postdoctoral fellow of the FWO. The funder (FWO) has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653; Bastaki M, 1997, ARTERIOSCL THROM VAS, V17, P454, DOI 10.1161/01.ATV.17.3.454; Bhadada SV, 2011, FUND CLIN PHARMACOL, V25, P29, DOI 10.1111/j.1472-8206.2010.00814.x; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Choi M, 2013, INT J BIOCHEM CELL B, V45, P560, DOI 10.1016/j.biocel.2012.12.001; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; Distler JHW, 2003, Q J NUCL MED, V47, P149; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Folkman J, 2007, J PEDIATR SURG, V42, P1, DOI 10.1016/j.jpedsurg.2006.09.048; Gamie Z, 2012, EXPERT OPIN BIOL TH, V12, P713, DOI 10.1517/14712598.2012.679652; Gandia C, 2008, STEM CELLS, V26, P638, DOI 10.1634/stemcells.2007-0484; Gotz W, 2006, ARCH ORAL BIOL, V51, P387, DOI 10.1016/j.archoralbio.2005.10.005; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Ishizaka R, 2013, BIOMATERIALS, V34, P1888, DOI 10.1016/j.biomaterials.2012.10.045; Ishkitiev N, 2012, J ENDODONT, V38, P475, DOI 10.1016/j.joen.2011.12.011; Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9; Karaoz E, 2011, HISTOCHEM CELL BIOL, V136, P455, DOI 10.1007/s00418-011-0858-3; Karbanova J, 2011, CELLS TISSUES ORGANS, V193, P344, DOI 10.1159/000321160; Kim SW, 2012, INT J CARDIOL; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kiraly M, 2009, NEUROCHEM INT, V55, P323, DOI 10.1016/j.neuint.2009.03.017; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lee MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006913; Liekens S, 2012, MOL CANCER THER, V11, P817, DOI 10.1158/1535-7163.MCT-11-0738; Marchionni C, 2009, INT J IMMUNOPATH PH, V22, P699, DOI 10.1177/039463200902200315; Martens W, 2012, CELLS TISSUES ORGANS, V196, P490, DOI 10.1159/000338654; Matsushita K, 2000, J DENT RES, V79, P1596, DOI 10.1177/00220345000790081201; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667; Park SH, 2004, INT ENDOD J, V37, P185, DOI 10.1111/j.0143-2885.2004.00782.x; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Sieveking DP, 2009, VASC MED, V14, P153, DOI 10.1177/1358863X08098698; Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036; Struys T, 2011, CELLS TISSUES ORGANS, V193, P366, DOI 10.1159/000321400; Struys T, 2012, CELL TRANSPLANT; Talavera-Adame D, 2009, TISSUE ENG PT A, V15, P3193, DOI [10.1089/ten.tea.2009.0024, 10.1089/ten.TEA.2009.0024]; Tran-Hung L, 2008, ARCH ORAL BIOL, V53, P9, DOI 10.1016/j.archoralbio.2007.07.001; Tran-Hung L, 2006, J DENT RES, V85, P819, DOI 10.1177/154405910608500908; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	58	145	149	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71104	10.1371/journal.pone.0071104	http://dx.doi.org/10.1371/journal.pone.0071104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951091	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700076
J	Chang, TS; Hou, SJ; Su, YC; Chen, LF; Ho, HC; Lee, MS; Lin, CH; Chou, P; Lee, CC				Chang, Ting-Shou; Hou, Szu-Jen; Su, Yu-Chieh; Chen, Li-Fu; Ho, Hsu-Chieh; Lee, Moon-Sing; Lin, Chun-Hsuan; Chou, Pesus; Lee, Ching-Chih			Disparities in Oral Cancer Survival among Mentally Ill Patients	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; PSYCHIATRIC-PATIENTS; NECK-CANCER; MORTALITY; DISORDERS; RATES; HEAD; APPENDICITIS; COMORBIDITY; IMPACT	Background: Many studies have reported excess cancer mortality in patients with mental illness. However, scant studies evaluated the differences in cancer treatment and its impact on survival rates among mentally ill patients. Oral cancer is one of the ten most common cancers in the world. We investigated differences in treatment type and survival rates between oral cancer patients with mental illness and without mental illness. Methods: Using the National Health Insurance (NHI) database, we compared the type of treatment and survival rates in 16687 oral cancer patients from 2002 to 2006. The utilization rate of surgery for oral cancer was compared between patients with mental illness and without mental illness using logistic regression. The Cox proportional hazards model was used for survival analysis. Results: Oral cancer patients with mental disorder conferred a grave prognosis, compared with patients without mental illness (hazard ratios [HR] = 1.58; 95% confidence interval [CI] = 1.30-1.93; P < 0.001). After adjusting for patients' characteristics and hospital characteristics, patients with mental illness were less likely to receive surgery with or without adjuvant therapy (odds ratio [OR] = 0.47; 95% CI = 0.34-0.65; P < 0.001). In multivariate analysis, oral cancer patients with mental illness carried a 1.58-times risk of death (95% CI = 1.30-1.93; P < 0.001). Conclusions: Oral cancer patients with mental illness were less likely to undergo surgery with or without adjuvant therapy than those without mental illness. Patients with mental illness have a poor prognosis compared to those without mental illness. To reduce disparities in physical health, public health strategies and welfare policies must continue to focus on this vulnerable group.	[Chang, Ting-Shou] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Hou, Szu-Jen; Ho, Hsu-Chieh; Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Su, Yu-Chieh; Ho, Hsu-Chieh; Lee, Moon-Sing; Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lee, Moon-Sing] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Div Hematol Oncol, Dept Internal Med, Chiayi, Taiwan; [Su, Yu-Chieh; Ho, Hsu-Chieh; Lee, Moon-Sing; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Chun-Hsuan] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency, Taipei, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017				Agerbo E, 2004, ARCH GEN PSYCHIAT, V61, P28, DOI 10.1001/archpsyc.61.1.28; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chong LM, 2001, HEAD NECK RAD ONCOLO, P395; Cooke BK, 2007, AM J SURG, V193, P41, DOI 10.1016/j.amjsurg.2006.06.034; Copeland LA, 2008, ANN SURG, V248, P31, DOI 10.1097/SLA.0b013e3181724f25; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Druss BG, 1998, AM J PSYCHIAT, V155, P1775, DOI 10.1176/ajp.155.12.1775; Hinshaw SP, 2008, ANNU REV CLIN PSYCHO, V4, P367, DOI 10.1146/annurev.clinpsy.4.022007.141245; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; Kisely S, 2008, CAN J PSYCHIAT, V53, P753, DOI 10.1177/070674370805301107; Kubicek GJ, 2011, AM J CLIN ONCOL-CANC, V34, P380, DOI 10.1097/COC.0b013e3181e9c0a2; Kudoh A, 2004, EUR J ANAESTH, V21, P414, DOI 10.1017/S026502150422511X; Kudoh A, 2003, J CLIN ANESTH, V15, P455, DOI 10.1016/j.jclinane.2003.03.008; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Lang K, 2004, ARCH OTOLARYNGOL, V130, P1269, DOI 10.1001/archotol.130.11.1269; Lawrence D, 2000, ACTA PSYCHIAT SCAND, V101, P382, DOI 10.1034/j.1600-0447.2000.101005382.x; Lee Jennifer M, 2004, Eur J Health Econ, V5, P70, DOI 10.1007/s10198-003-0204-3; Lin CC, 2008, SURGERY, V143, P343, DOI 10.1016/j.surg.2007.09.033; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Penn DL, 1998, PSYCHIAT QUART, V69, P235, DOI 10.1023/A:1022153327316; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Siahpush M, 2006, J EPIDEMIOL COMMUN H, V60, P1077, DOI 10.1136/jech.2005.042572; Tran E, 2009, CANCER-AM CANCER SOC, V115, P3555, DOI 10.1002/cncr.24383; Tsay JH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-331; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x	31	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70883	10.1371/journal.pone.0070883	http://dx.doi.org/10.1371/journal.pone.0070883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951029	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700059
J	Smith, DL; Perkins, TA; Tusting, LS; Scott, TW; Lindsay, SW				Smith, David L.; Perkins, T. Alex; Tusting, Lucy S.; Scott, Thomas W.; Lindsay, Steven W.			Mosquito Population Regulation and Larval Source Management in Heterogeneous Environments	PLOS ONE			English	Article							DAR-ES-SALAAM; AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; MALARIA TRANSMISSION; VECTOR CONTROL; CULEX-TRITAENIORHYNCHUS; ANOPHELES-STEPHENSI; SIMULATION-MODEL; ESSENTIAL OILS; LARGE-SCALE	An important question for mosquito population dynamics, mosquito-borne pathogen transmission and vector control is how mosquito populations are regulated. Here we develop simple models with heterogeneity in egg laying patterns and in the responses of larval populations to crowding in aquatic habitats. We use the models to evaluate how such heterogeneity affects mosquito population regulation and the effects of larval source management (LSM). We revisit the notion of a carrying capacity and show how heterogeneity changes our understanding of density dependence and the outcome of LSM. Crowding in and productivity of aquatic habitats is highly uneven unless egg-laying distributions are fine-tuned to match the distribution of habitats' carrying capacities. LSM reduces mosquito population density linearly with coverage if adult mosquitoes avoid laying eggs in treated habitats, but quadratically if eggs are laid in treated habitats and the effort is therefore wasted (i.e., treating 50% of habitat reduces mosquito density by approximately 75%). Unsurprisingly, targeting (i.e. treating a subset of the most productive pools) gives much larger reductions for similar coverage, but with poor targeting, increasing coverage could increase adult mosquito population densities if eggs are laid in higher capacity habitats. Our analysis suggests that, in some contexts, LSM models that accounts for heterogeneity in production of adult mosquitoes provide theoretical support for pursuing mosquito-borne disease prevention through strategic and repeated application of modern larvicides.	[Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA; [Smith, David L.; Perkins, T. Alex; Scott, Thomas W.; Lindsay, Steven W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Perkins, T. Alex; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Tusting, Lucy S.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Lindsay, Steven W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Davis; University of London; London School of Hygiene & Tropical Medicine; Durham University	Smith, DL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	dlsmith@jhsph.edu	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Perkins, Alex/0000-0002-7518-4014; Lindsay, Steve/0000-0002-3461-9050; Tusting, Lucy/0000-0002-6897-8625	Bloomberg Family Foundation; National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19AI089674]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	Bloomberg Family Foundation; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DLS acknowledges funding from the Bloomberg Family Foundation. DLS and SWL acknowledge funding from National Institutes of Health/National Institute of Allergy and Infectious Diseases (U19AI089674). DLS, TAP, SWL, and TWS acknowledge funding from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health.	[Anonymous], 2004, COCHRANE DB SYST REV; Ansari M. A., 2005, Journal of Vector Borne Diseases, V42, P95; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Carroll JF, 2011, J VECTOR ECOL, V36, P258, DOI 10.1111/j.1948-7134.2011.00166.x; Castro MC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-57; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Karunamoorthi K, 2008, PARASITOL RES, V103, P545, DOI 10.1007/s00436-008-1005-5; Kumar S. V., 2011, International Journal of Pharmacy and Technology, V3, P3143; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P369; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Pandey SK, 2009, PARASITOL RES, V105, P507, DOI 10.1007/s00436-009-1429-6; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rajkumar S, 2009, PARASITOL RES, V104, P337, DOI 10.1007/s00436-008-1197-8; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Ross R, 1907, LANCET, V2, P879; SCOTT T. W., 2008, VECTOR BORNE DIS UND, P132; Sharma SK, 2008, ACTA TROP, V107, P174, DOI 10.1016/j.actatropica.2008.05.014; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2012, ROL LARV MAL CONTR S; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Xue RD, 2003, J AM MOSQUITO CONTR, V19, P397; Xue RD, 2007, J AM MOSQUITO CONTR, V23, P283, DOI 10.2987/8756-971X(2007)23[283:ODALAO]2.0.CO;2; Yakob L, 2010, T ROY SOC TROP MED H, V104, P669, DOI 10.1016/j.trstmh.2010.07.014; Yapabandara AMGM, 2004, J AM MOSQUITO CONTR, V20, P395; Yapabandara AMGM, 2001, ACTA TROP, V80, P265, DOI 10.1016/S0001-706X(01)00178-4	51	29	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71247	10.1371/journal.pone.0071247	http://dx.doi.org/10.1371/journal.pone.0071247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951118	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700089
J	Rejiba, S; Bigand, C; Parmentier, C; Masmoudi, A; Hajri, A				Rejiba, Soukaina; Bigand, Christelle; Parmentier, Celine; Masmoudi, Ahmed; Hajri, Amor			Oncosuppressive Suicide Gene Virotherapy "PVH1-yCD/5-FC'' for Pancreatic Peritoneal Carcinomatosis Treatment: NF kappa B and Akt/PI3K Involvement	PLOS ONE			English	Article							PARVOVIRUS MINUTE VIRUS; AUTONOMOUS PARVOVIRUS; SELECTIVE REPLICATION; TUMOR-CELLS; WILD-TYPE; CANCER; MICE; H-1; INHIBITION; 5-FLUOROURACIL	Peritoneal carcinomatosis is common in advanced pancreatic cancer. Despite current standard treatment, patients with this disease until recently were considered incurable. Cancer gene therapy using oncolytic viruses have generated much interest over the past few years. Here, we investigated a new gene directed enzyme prodrug therapy (GDEPT) approach for an oncosuppressive virotherapy strategy using parvovirus H1 (PV-H1) which preferentially replicates and kills malignant cells. Although, PV-H1 is not potent enough to destroy tumors, it represents an attractive vector for cancer gene therapy. We therefore sought to determine whether the suicide gene/prodrug system, yCD/5-FC could be rationally combined to PV-H1 augmenting its intrinsic oncolytic activity for pancreatic cancer prevention and treatment. We showed that the engineered recombinant parvovirus rPVH1-yCD with 5-FC treatment increased significantly the intrinsic cytotoxic effect and resulted in potent induction of apoptosis and tumor growth inhibition in chemosensitive and chemoresistant cells. Additionally, the suicide gene-expressing PV-H1 infection reduced significantly the constitutive activities of NF kappa B and Akt/PI3K. Combination of their pharmacological inhibitors (MG132 and LY294002) with rPVH1-yCD/5-FC resulted in substantial increase of antitumor activity. In vivo, high and sustained expression of NS1 and yCD was observed in the disseminated tumor nodules and absent in normal tissues. Treatment of mice bearing intraperitoneal pancreatic carcinomatosis with rPVH1-yCD/5-FC resulted in a drastic inhibition of tumor cell spreading and subsequent increase in long-term survival. Together, the presented data show the improved oncolytic activity of wPV-H1 by yCD/5-FC and thus provides valuable effective and promising virotherapy strategy for prevention of tumor recurrence and treatment. In the light of this study, the suicide gene parvovirotherapy approach represents a new weapon in the war against pancreatic cancer. Moreover, these preliminary accomplishments are opening new field for future development of new combined targeted therapies to have a meaningful impact on advanced cancer.	[Rejiba, Soukaina; Bigand, Christelle; Parmentier, Celine] Univ Strasbourg, Strasbourg, France; [Masmoudi, Ahmed] Inst Super Biotechnol Sidi Thabet, Tunis, Tunisia; [Hajri, Amor] Univ Freiburg, FRIAS, Dept Bio3, D-79106 Freiburg, Germany	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Freiburg	Hajri, A (corresponding author), Univ Freiburg, FRIAS, Dept Bio3, Hugstetter Str 55, D-79106 Freiburg, Germany.	amor.hajri@biologie.uni-freiburg.de		Masmoudi, Ahmed/0000-0002-6418-705X; Masmoudi, Ahmed/0000-0003-4890-7173	club francais du pancreas; association pour la recherche contre le cancer	club francais du pancreas; association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer)	This study was supported by grants to SR from club francais du pancreas and association pour la recherche contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren JD, 1996, SEMIN ONCOL, V23, P241; Anderson KE PJ, 1996, CANC EPIDEMIOLOGY PR, P725; ANDERSON MJ, 1984, ARCH VIROL, V82, P137, DOI 10.1007/BF01311158; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Beger HG, 2002, CAN J GASTROENTEROL, V16, P117, DOI 10.1155/2002/174320; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; CORNELIS JJ, 1988, J VIROL, V62, P3438, DOI 10.1128/JVI.62.9.3438-3444.1988; Deleu L, 1999, J VIROL, V73, P3877, DOI 10.1128/JVI.73.5.3877-3885.1999; DUPRESSOIR T, 1989, CANCER RES, V49, P3203; Faisst S, 1998, INT J CANCER, V75, P584, DOI 10.1002/(SICI)1097-0215(19980209)75:4<584::AID-IJC15>3.0.CO;2-9; FAISST SR, 1993, VIROLOGY, V197, P770, DOI 10.1006/viro.1993.1654; Giese NA, 2002, CANCER GENE THER, V9, P432, DOI 10.1038/sj.cgt.7700457; Guo ZS, 2008, BBA-REV CANCER, V1785, P217, DOI 10.1016/j.bbcan.2008.02.001; Haag A, 2000, HUM GENE THER, V11, P597, DOI 10.1089/10430340050015789; Hajri A, 2004, CANCER GENE THER, V11, P16, DOI 10.1038/sj.cgt.7700628; Hernandez-Alcoceba R, 2002, HUM GENE THER, V13, P1737, DOI 10.1089/104303402760293574; Hristov G, 2010, J VIROL, V84, P5909, DOI 10.1128/JVI.01797-09; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Huang TG, 2003, GENE THER, V10, P1241, DOI 10.1038/sj.gt.3301987; HUBER BE, 1994, P NATL ACAD SCI USA, V91, P8302, DOI 10.1073/pnas.91.17.8302; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kestler J, 1999, HUM GENE THER, V10, P1619, DOI 10.1089/10430349950017626; Le Cesne A., 1993, PROC AM SOC CLIN ONC, V12, P297; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; MAXWELL IH, 1994, BIOTECHNIQUES, V16, P876; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Mueller A, 2012, CANCER CHEMOTH PHARM, V69, P1601, DOI 10.1007/s00280-012-1869-z; Nassim MA, 2002, INT J MOL MED, V10, P513; Nemunaitis J, 2000, CANCER RES, V60, P6359; Nyati MK, 2002, GENE THER, V9, P844, DOI 10.1038/sj.gt.3301706; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rayet B, 1998, J VIROL, V72, P8893, DOI 10.1128/JVI.72.11.8893-8903.1998; Regiba S, 2009, NEOPLASIA, V11, P637, DOI 10.1593/neo.81686; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Siegl G., 1983, PARVOVIRUSES, P297; TAKAHASHI T, 1990, BLOOD, V75, P603; TOOLAN HW, 1965, P SOC EXP BIOL MED, V119, P711, DOI 10.3181/00379727-119-30278; Vollmer CM, 1999, CANCER RES, V59, P4369	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70594	10.1371/journal.pone.0070594	http://dx.doi.org/10.1371/journal.pone.0070594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967078	Green Submitted, Green Published, gold			2022-12-27	WOS:000323221500018
J	Pouchieu, C; Levy, R; Faure, C; Andreeva, VA; Galan, P; Hercberg, S; Touvier, M				Pouchieu, Camille; Levy, Rachel; Faure, Celine; Andreeva, Valentina A.; Galan, Pilar; Hercberg, Serge; Touvier, Mathilde			Socioeconomic, Lifestyle and Dietary Factors Associated with Dietary Supplement Use during Pregnancy	PLOS ONE			English	Article							FOLIC-ACID; FOLATE STATUS; WOMEN; DETERMINANTS; IRON; PRODUCTS; DEFECTS; MOTHER; RISK	Background: Information on dietary supplement (DS) use during pregnancy is largely lacking. Besides, little is known about the share of DS use as self-medication versus such use following a physician's advice/prescription. Our aim was to evaluate DS use and its socioeconomic, lifestyle and dietary correlates among pregnant women participating in the French NutriNet-Sante cohort study. Method: Data were collected by self-administered web-based questionnaires. Food intake was assessed by repeated 24 h dietary records. 903 pregnant women provided data on their DS use (both "regular" DS and medication containing mainly vitamins/minerals). Supplement users were compared to non-users by unconditional logistic regression. Results: DS use-in general and as regards folic acid in particular-was positively correlated with age, being primiparous, having higher income and belonging to a higher socioprofessional category. DS users had significantly higher dietary intakes of most vitamins and minerals. The proportion of DS users (e.g., those reporting use at least three days a week) increased significantly with the trimester of pregnancy (58.0%, 62.2% and 74.5%, respectively). 50.2% of women in their 1st trimester used folic acid. The proportion of iron users tripled from the 1st to the 3rd trimester (18.5 to 63.9%). DS use was prescribed or recommended by a physician in 86.7% of the cases. Conclusion: This study provided new and detailed information on DS use and its correlates during pregnancy. Even in this relatively well-educated population, folic acid supplementation at the beginning of pregnancy was inadequate and was associated with socioeconomic and demographic disparities.	[Pouchieu, Camille; Levy, Rachel; Faure, Celine; Andreeva, Valentina A.; Galan, Pilar; Hercberg, Serge; Touvier, Mathilde] Univ Paris 13, SMBH Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr,Inra,Cnam,Inserm U557, Bobigny, France; [Levy, Rachel; Faure, Celine] Jean Verdier Hosp, Reprod Biol Unit CECOS, Bondy, France; [Hercberg, Serge] Avicenne Hosp, Dept Publ Hlth, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Pouchieu, C (corresponding author), Univ Paris 13, SMBH Paris 13, Nutr Epidemiol Res Team, Sorbonne Paris Cite Res Ctr,Inra,Cnam,Inserm U557, Bobigny, France.	c.pouchieu@uren.smbh.univ-paris13.fr	HERCBERG, Serge/B-4429-2008; Serge, Hercberg/F-3038-2017; Pilar, Galan/F-2908-2017; Andreeva, Valentina/F-2680-2017; Touvier, Mathilde/E-8817-2017	HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Pilar, Galan/0000-0003-1706-3107; Andreeva, Valentina/0000-0001-9480-5210; Touvier, Mathilde/0000-0002-8322-8857	Ministere de la Sante; Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Paris 13 University	Ministere de la Sante; Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Paris 13 University	The NutriNet-Sante cohort study is funded by the following public institutions: Ministere de la Sante, Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut National de la Sante et de la Recherche Medicale, Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFSSA, 2003, ENR FAR VIT B FRANC; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; Arkkola T, 2006, BRIT J NUTR, V96, P913, DOI 10.1017/BJN20061929; Barbour RS, 2012, J HUM NUTR DIET, V25, P140, DOI 10.1111/j.1365-277X.2011.01216.x; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Boon Heather, 2009, Int J Pharm Pract, V17, P31; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Buehler BA, 2003, BIRTH DEFECTS RES B, V68, P494, DOI 10.1002/bdrb.10049; Candito M, 2008, AM J MED GENET A, V146A, P1128, DOI 10.1002/ajmg.a.32199; Castillo-Lancellotti C, 2012, PUBLIC HEALTH NUTR, V16, P901, DOI DOI 10.1017/S1368980012003576; European Food Safety Authority, 2006, TOL UPP INT LEV VIT; European Surveillance of Congenital Anomalies (EUROCAT), 2012, PREV TABL; Forster DA, 2009, MIDWIFERY, V25, P134, DOI 10.1016/j.midw.2007.01.019; Hanson MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1025; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Haute Autorite de Sante, 2006, REC PROF COMM MIEUX; Hercberg S, 2002, SUVIMAX PORTIONS ALI, P132; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P767, DOI 10.1007/s10654-008-9304-9; Jensen CB, 2012, NUTRIENTS, V4, P259, DOI 10.3390/nu4040259; Knudsen VK, 2007, PUBLIC HEALTH NUTR, V10, P1104, DOI [10.1017/S136898000769956X, 10.1017/S136898000769956x]; Lassi ZS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006896.pub2; Li WY, 2011, CAN J PUBLIC HEALTH, V102, P308, DOI 10.1007/BF03404056; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Martin A, 2001, REPROD NUTR DEV, V41, P119, DOI 10.1051/rnd:2001100; McNally S, 2012, Ir Med J, V105, P236; Milman N, 2011, ANN NUTR METAB, V59, P50, DOI 10.1159/000332129; Ministere de l'Emploi du Travail et de la Sante INSERM, 2011, ENQ NAT PER 2010 NAI; Nilsen RM, 2006, AM J CLIN NUTR, V84, P1134, DOI 10.1093/ajcn/84.5.1134; Picciano MF, 2009, AM J CLIN NUTR, V89, p663S, DOI 10.3945/ajcn.2008.26811B; Pouchieu C, 2013, BRIT J NUTR, V110, P1480, DOI 10.1017/S0007114513000615; Roy A, 2012, CHRON DIS INJ CAN, V32, P76; Schlienger JL, 2011, MED MALADIES METABOL, V5, P521; Schnorr CE, 2011, FOOD CHEM TOXICOL, V49, P2645, DOI 10.1016/j.fct.2011.07.010; Smedts HPM, 2009, BJOG-INT J OBSTET GY, V116, P416, DOI 10.1111/j.1471-0528.2008.01957.x; Stagnaro-Green A, 2012, JAMA-J AM MED ASSOC, V308, P2463, DOI 10.1001/jama.2012.45423; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P384, DOI 10.1177/003335490912400307; Tarrant R C, 2011, Ir Med J, V104, P173; Timmermans S, 2008, PREV MED, V47, P427, DOI 10.1016/j.ypmed.2008.06.014; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; Tsui B, 2001, AM J OBSTET GYNECOL, V185, P433, DOI 10.1067/mob.2001.116688; Vandevijvere S, 2012, EUR J CLIN NUTR, V66, P1172, DOI 10.1038/ejcn.2012.111; Vergnaud AC, 2011, INT J PUBLIC HEALTH, V56, P407, DOI 10.1007/s00038-011-0257-5; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Vujkovic M, 2009, BJOG-INT J OBSTET GY, V116, P408, DOI 10.1111/j.1471-0528.2008.01963.x; WHO/ UNICEF (World Health Organization/ United Nations Children's Fund), 2007, REACH OPT IOD NUTR P; Zetstra-van der Woude PA, 2012, BIRTH DEFECTS RES A, V94, P96, DOI 10.1002/bdra.22882	52	36	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70733	10.1371/journal.pone.0070733	http://dx.doi.org/10.1371/journal.pone.0070733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967094	Green Submitted, gold, Green Published			2022-12-27	WOS:000323115800017
J	Chisti, MJ; Salam, MA; Ashraf, H; Faruque, ASG; Bardhan, PK; Das, SK; Shahunja, KM; Shahid, ASMSB; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Das, Sumon Kumar; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Ahmed, Tahmeed			Clinical Signs of Radiologic Pneumonia in Under-Five Hypokalemic Diarrheal Children Admitted to an Urban Hospital in Bangladesh	PLOS ONE			English	Article							PREDICTORS; MORTALITY; INFANTS; DHAKA	Background: Clinical signs of pneumonia are often veiled in under-five diarrheal children presenting with hypokalemia, making clinical diagnosis of pneumonia very difficult in such population. However, there is no published report that describes the influences of hypokalemia on the clinical signs of pneumonia in diarrheal children. Our objective was to assess the influences of hypokalemia, and their outcome in such children. Methods: We prospectively enrolled all under-five diarrheal children (n = 180) admitted to the Special Care Ward of the Dhaka Hospital of icddr,b from September-December 2007 with radiological pneumonia who also had their serum potassium estimated. We compared the clinical features and outcome of the diarrheal children having pneumonia with (cases = 55) and without hypokalemia (controls = 125). Results: The case-fatality among the cases was 2 times higher compared to the controls, but the difference was not statistically significant (p = 0.202). In logistic regression analysis, after adjusting for potential confounders such as age of the patient, clinical dehydration, severe wasting, abnormally sleepy, lower chest wall in-drawing, nasal flaring and inability to drink on admission, under-five diarrheal children with pneumonia who presented with nutritional edema had 3 times more risk to have hypokalemia compared to those without nutritional edema (OR = 2.76, 95% CI = 1.01-7.51) and these hypokalemic children were 64% less likely to present with fast breathing (OR = 0.36, 95% CI = 0.17-0.74). Conclusion and significance: The results of our analysis are simple but may have great public health implications and underscore the importance of diligent assessment for pneumonia in under-five diarrheal children having risk of hypokalemia as in children with nutritional edema even in absence of fast breathing, a useful sign of pneumonia. This may help for early initiation of first dose of parental antibiotics along with potassium supplementation before referral to tertiary hospitals by health workers to combat probability of deaths in such population especially in resource limited settings.	[Chisti, Mohammod Jobayer; Ashraf, Hasan; Faruque, Abu S. G.; Bardhan, Pradip Kumar; Das, Sumon Kumar; Shahunja, K. M.; Shahid, Abu S. M. S. B.; Ahmed, Tahmeed] Int Ctr Diarhoeal Dis Res, CNFS, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Ashraf, Hasan; Bardhan, Pradip Kumar] ICDDR B, CS, Dhaka, Bangladesh; [Salam, Mohammed Abdus] ICDDR B, RA, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Int Ctr Diarhoeal Dis Res, CNFS, Dhaka, Bangladesh.	chisti@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Shahunja, K M/AAR-6229-2020; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018	Shahunja, K M/0000-0002-9345-206X; 	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat SK, 1999, POSTGRAD MED J, V75, P193, DOI 10.1136/pgmj.75.882.193; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brody Tom, 1998, NUTR BIOCH; Chhabra A, 1995, Indian Pediatr, V32, P409; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025817; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051376; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti Mohammod Jobayer, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P719; Liu L, 2012, LANCET; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Odey F A, 2010, Niger Postgrad Med J, V17, P19; RAIZADA N, 1992, Indian Pediatrics, V29, P461; Shah G S, 2007, Kathmandu Univ Med J (KUMJ), V5, P60; STEDWELL RE, 1992, AM J EMERG MED, V10, P143, DOI 10.1016/0735-6757(92)90048-3; Suskind DMK, 1990, MALNOURISHED CHILD; Suskind RM, 1990, MALNOURISHED CHILD, P1; Talbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038321; WHO, 2012, POCK BOOK HOSP CAR C; World Health Organization, 1999, MAN SEV MALN MAN PHY	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71911	10.1371/journal.pone.0071911	http://dx.doi.org/10.1371/journal.pone.0071911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951267	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300171
J	Dobson-Stone, C; Polly, P; Korgaonkar, MS; Williams, LM; Gordon, E; Schofield, PR; Mather, K; Armstrong, NJ; Wen, W; Sachdev, PS; Kwok, JBJ				Dobson-Stone, Carol; Polly, Patsie; Korgaonkar, Mayuresh S.; Williams, Leanne M.; Gordon, Evian; Schofield, Peter R.; Mather, Karen; Armstrong, Nicola J.; Wen, Wei; Sachdev, Perminder S.; Kwok, John B. J.			GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; HAPLOTYPE-SPECIFIC EXPRESSION; TAU GENES INTERACT; LINKAGE DISEQUILIBRIUM; ALZHEIMERS-DISEASE; PARKINSONS; DEMENTIA; PROTEIN; TRANSCRIPTION; GENOTYPE	The microtubule-associated protein tau gene (MAPT) codes for a protein that plays an integral role in stabilisation of microtubules and axonal transport in neurons. As well as its role in susceptibility to neurodegeneration, previous studies have found an association between the MAPT haplotype and intracranial volume and regional grey matter volumes in healthy adults. The glycogen synthase kinase-3 beta gene (GSK3B) codes for a serine/threonine kinase that phosphorylates various proteins, including tau, and has also been associated with risk for neurodegenerative disorders and schizophrenia. We examined the effects of MAPT and two functional promoter polymorphisms in GSK3B (rs3755557 and rs334558) on total grey matter and intracranial volume in three independent cohorts totaling 776 neurologically healthy individuals. In vitro analyses revealed a significant effect of rs3755557 on gene expression, and altered binding of at least two transcription factors, Octamer transcription factor 1 (Oct-1) and Pre-B-cell leukemia transcription factor 1 (Pbx-1), to the GSK3B promoter. Meta-analysis across the three cohorts revealed a significant effect of rs3755557 on total grey matter volume (summary B = 0.082, 95% confidence interval = 0.037-0.128) and intracranial volume (summary B = 0.113, 95% confidence interval = 0.082-0.144). No significant effect was observed for MAPT H1/H2 diplotype or GSK3B rs334558 on total grey matter or intracranial volume. Our genetic and biochemical analyses have identified a role for GSK3B in brain development, which could have important aetiological implications for neurodegenerative and neurodevelopmental disorders.	[Dobson-Stone, Carol; Schofield, Peter R.; Kwok, John B. J.] Neurosci Res Australia, Randwick, NSW, Australia; [Dobson-Stone, Carol; Polly, Patsie; Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Sch Med, Dept Pathol, Kensington, NSW 2033, Australia; [Dobson-Stone, Carol; Polly, Patsie; Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Sch Med, Inflammat & Infect Res Ctr, Kensington, NSW 2033, Australia; [Korgaonkar, Mayuresh S.; Williams, Leanne M.] Univ Sydney, Sch Med, Brain Dynam Ctr, Westmead, NSW 2145, Australia; [Korgaonkar, Mayuresh S.; Williams, Leanne M.] Westmead Millennium Inst, Westmead, NSW, Australia; [Williams, Leanne M.; Gordon, Evian] Brain Resource Ltd, Brain Resource Int Database, Sydney, NSW, Australia; [Williams, Leanne M.; Gordon, Evian] Brain Resource Ltd, Brain Resource Int Database, San Francisco, CA USA; [Mather, Karen; Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Euroa Ctr, Randwick, NSW 2031, Australia; [Armstrong, Nicola J.] Garvan Inst Med Res, Canc Program, Sydney, NSW, Australia; [Armstrong, Nicola J.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Armstrong, Nicola J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Wen, Wei; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Total Brain; Total Brain; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Kwok, JBJ (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	j.kwok@neura.edu.au	Korgaonkar, Mayuresh/K-7447-2014; Armstrong, Nicola J./AAF-3045-2021; Williams, Leanne/GLU-4975-2022; Karen, Mather A/O-9795-2016; Williams, Leanne M/B-4095-2012; Sachdev, Perminder/ABC-1137-2020; Schofield, Peter/C-9669-2011	Korgaonkar, Mayuresh/0000-0002-1339-2221; Armstrong, Nicola J./0000-0002-4477-293X; Williams, Leanne/0000-0001-9987-7360; Karen, Mather A/0000-0003-4143-8941; Sachdev, Perminder/0000-0002-9595-3220; Dobson-Stone, Carol/0000-0002-2211-0257; Schofield, Peter/0000-0003-2967-9662; Wen, Wei/0000-0003-2753-3870; Kwok, John/0000-0001-9574-6195	National Health and Medical Research Council of Australia [NHMRC 630428, 510218]; NHMRC Enabling Grant [401184]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Enabling Grant(National Health and Medical Research Council (NHMRC) of Australia)	Carol Dobson-Stone and John Kwok received grant funding from the National Health and Medical Research Council of Australia (NHMRC 630428 and 510218 respectively). Sydney MAS DNA was extracted by Genetic Repositories Australia, which is funded by NHMRC Enabling Grant 401184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Batouli SAH, 2012, NEUROIMAGE, V62, P281, DOI 10.1016/j.neuroimage.2012.04.043; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Caffrey TM, 2008, NEUROBIOL AGING, V29, P1923, DOI 10.1016/j.neurobiolaging.2007.05.002; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Canu E, 2009, EUR J HUM GENET, V17, P287, DOI 10.1038/ejhg.2008.185; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Cohn-Hokke PE, 2012, AM J MED GENET B, V159B, P628, DOI 10.1002/ajmg.b.32080; Dobson-Stone C, 2007, NEUROIMAGE, V37, P394, DOI 10.1016/j.neuroimage.2007.05.011; Garcia-Gorostiaga I, 2009, ANN NEUROL, V65, P759, DOI 10.1002/ana.21687; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Haijma S.V., 2012, SCHIZOPHR B; Healy DG, 2004, J NEUROL NEUROSUR PS, V75, P962, DOI 10.1136/jnnp.2003.026203; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Kaat LD, 2011, CURR ALZHEIMER RES, V8, P295; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Kwok JBJ, 2005, ANN NEUROL, V58, P829, DOI 10.1002/ana.20691; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Kwok JBJ, 2008, ANN NEUROL, V64, P446, DOI 10.1002/ana.21476; Li M, 2011, SCHIZOPHR RES, V133, P165, DOI 10.1016/j.schres.2011.09.013; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schaffer BAJ, 2008, ARCH NEUROL-CHICAGO, V65, P1368, DOI 10.1001/archneur.65.10.1368; Sgado P, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-24; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Vandrovcova J, 2010, CURR ALZHEIMER RES, V7, P726, DOI 10.2174/156720510793611619; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhang N, 2011, BRAIN RES, V1391, P147, DOI 10.1016/j.brainres.2011.03.052	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71750	10.1371/journal.pone.0071750	http://dx.doi.org/10.1371/journal.pone.0071750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951236	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300153
J	Hendriks, RJJ; Carvalheiro, LG; Kleukers, RMJC; Biesmeijer, JC				Hendriks, Rob J. J.; Carvalheiro, Luisa G.; Kleukers, Roy M. J. C.; Biesmeijer, Jacobus C.			Temporal-Spatial Dynamics in Orthoptera in Relation to Nutrient Availability and Plant Species Richness	PLOS ONE			English	Article							VEGETATION STRUCTURE; NETHERLANDS; SEEDLINGS; SAVANNA; HERBIVORY; NITROGEN; INSECT	Nutrient availability in ecosystems has increased dramatically over the last century. Excess reactive nitrogen deposition is known to negatively impact plant communities, e. g. by changing species composition, biomass and vegetation structure. In contrast, little is known on how such impacts propagate to higher trophic levels. To evaluate how nitrogen deposition affects plants and herbivore communities through time, we used extensive databases of spatially explicit historical records of Dutch plant species and Orthoptera (grasshoppers and crickets), a group of animals that are particularly susceptible to changes in the C:N ratio of their resources. We use robust methods that deal with the unstandardized nature of historical databases to test whether nitrogen deposition levels and plant richness changes influence the patterns of richness change of Orthoptera, taking into account Orthoptera species functional traits. Our findings show that effects indeed also propagate to higher trophic levels. Differences in functional traits affected the temporal-spatial dynamics of assemblages of Orthoptera. While nitrogen deposition affected plant diversity, contrary to our expectations, we could not find a strong significant effect of food related traits. However we found that species with low habitat specificity, limited dispersal capacity and egg deposition in the soil were more negativly affected by nitrogen deposition levels. Despite the lack of significant effect of plant richness or food related traits on Orthoptera, the negative effects of nitrogen detected within certain trait groups (e. g. groups with limited disperse ability) could be related to subtle changes in plant abundance and plant quality. Our results, however, suggest that the changes in soil conditions (where many Orthoptera species lay their eggs) or other habitat changes driven by nitrogen have a stronger influence than food related traits. To fully evaluate the negative effects of nitrogen deposition on higher trophic levels it is essential to take into account species life-history traits.	[Hendriks, Rob J. J.] Radboud Univ Nijmegen, Dept Ecol, NL-6525 ED Nijmegen, Netherlands; [Carvalheiro, Luisa G.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Kleukers, Roy M. J. C.] European Invertebrate Survey Netherlands, Leiden, Netherlands; [Carvalheiro, Luisa G.; Kleukers, Roy M. J. C.; Biesmeijer, Jacobus C.] Naturalis Biodivers Ctr, Leiden, Netherlands	Radboud University Nijmegen; University of Leeds; Naturalis Biodiversity Center	Hendriks, RJJ (corresponding author), Radboud Univ Nijmegen, Dept Ecol, NL-6525 ED Nijmegen, Netherlands.	robh@science.ru.nl	Carvalheiro, Luisa/D-9414-2012	Carvalheiro, Luisa/0000-0001-7655-979X; Biesmeijer, Koos/0000-0003-0328-0573				Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 2009, LANG ENV STAT COMP; ATHEY LA, 1989, OECOLOGIA, V79, P390, DOI 10.1007/BF00384319; Augustine DJ, 2003, J APPL ECOL, V40, P137, DOI 10.1046/j.1365-2664.2003.00778.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bobbink R., 2011, REV REVISION EMPIRIC; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Cassey P, 2006, OIKOS, V115, P207, DOI 10.1111/j.2006.0030-1299.15223.x; COHN EJ, 1989, AM MIDL NAT, V121, P265, DOI 10.2307/2426030; Debain S, 2005, ECOSCIENCE, V12, P192, DOI 10.2980/i1195-6860-12-2-192.1; Grutters Mark, 2010, Nederlandse Faunistische Mededelingen, V34, P1; Hartung J., 2008, STAT METAANALYSIS AP; Hendriks RJJ, 2009, ENTOMOL EXP APPL, V131, P233, DOI 10.1111/j.1570-7458.2009.00852.x; Hochkirch A, 2009, BIOL J LINN SOC, V97, P118, DOI 10.1111/j.1095-8312.2008.01199.x; Keil P, 2011, ECOGRAPHY, V34, P392, DOI 10.1111/j.1600-0587.2010.06554.x; KLEUKERS RMJ, 2004, SPRINKHANEN KREKELS; Kleukers Roy, 2002, Nederlandse Faunistische Mededelingen, V17, P87; Noordijk H, 2007, AMM C; Pinheiro J, 2001, MIXED EFFECTS MODELS; Schaminee Joop H. J., 2012, Biodiversity Ecol, V4, P201, DOI 10.7809/b-e.00077; Schouten MA, 2007, J BIOGEOGR, V34, P1938, DOI 10.1111/j.1365-2699.2007.01742.x; SMIKA D. E., 1965, AGRON J, V57, P483; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; Takafumi H, 2010, ECOL ENTOMOL, V35, P576, DOI 10.1111/j.1365-2311.2010.01216.x; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; VANWINGERDEN WKRE, 1991, OECOLOGIA, V87, P417, DOI 10.1007/BF00634600; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walker BH, 1997, J BIOGEOGR, V24, P813, DOI 10.1046/j.1365-2699.1997.00123.x; Walters RJ, 2006, P ROY SOC B-BIOL SCI, V273, P2017, DOI 10.1098/rspb.2006.3542; Zuur AF, 2009, STAT BIOL HLTH, P269	32	10	10	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71736	10.1371/journal.pone.0071736	http://dx.doi.org/10.1371/journal.pone.0071736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951232	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300149
J	Kersting, DK; Bensoussan, N; Linares, C				Kersting, Diego K.; Bensoussan, Nathaniel; Linares, Cristina			Long-Term Responses of the Endemic Reef-Builder Cladocora caespitosa to Mediterranean Warming	PLOS ONE			English	Article							MASS MORTALITY EVENTS; OCULINA-PATAGONICA; CORAL-REEFS; EUNICELLA-SINGULARIS; ENVIRONMENTAL-STRESS; BENTHIC COMMUNITIES; SOLAR-RADIATION; CLIMATE-CHANGE; TEMPERATURE; SEA	Recurrent climate-induced mass-mortalities have been recorded in the Mediterranean Sea over the past 15 years. Cladocora caespitosa, the sole zooxanthellate scleractinian reef-builder in the Mediterranean, is among the organisms affected by these episodes. Extensive bioconstructions of this endemic coral are very rare at the present time and are threatened by several stressors. In this study, we assessed the long-term response of this temperate coral to warming sea-water in the Columbretes Islands (NW Mediterranean) and described, for the first time, the relationship between recurrent mortality events and local sea surface temperature (SST) regimes in the Mediterranean Sea. A water temperature series spanning more than 20 years showed a summer warming trend of 0.06 degrees C per year and an increased frequency of positive thermal anomalies. Mortality resulted from tissue necrosis without massive zooxanthellae loss and during the 11-year study, necrosis was recorded during nine summers separated into two mortality periods (2003-2006 and 2008-2012). The highest necrosis rates were registered during the first mortality period, after the exceptionally hot summer of 2003. Although necrosis and temperature were significantly associated, the variability in necrosis rates during summers with similar thermal anomalies pointed to other acting factors. In this sense, our results showed that these differences were more closely related to the interannual temperature context and delayed thermal stress after extreme summers, rather than to acclimatisation and adaption processes.	[Kersting, Diego K.; Linares, Cristina] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Bensoussan, Nathaniel] SCOPArl, IPSO FACTO, Marseille, France	University of Barcelona	Kersting, DK (corresponding author), Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain.	diegokersting@gmail.com	Linares, Cristina/A-5244-2018	Linares, Cristina/0000-0003-3855-2743; Kersting, Diego-Kurt/0000-0002-2049-7849	Spanish MICINN [CGL2012-32194, CTM2009-08045]; MINECO; Catalan Government [2009SGR-174]; Consolidated Research Groups; Ramo'n y Cajal [RYC-2011-08134]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); Catalan Government; Consolidated Research Groups; Ramo'n y Cajal(Spanish Government)	Financial support was provided by the projects BioRocK (CTM2009-08045) and SMART (CGL2012-32194) from the Spanish MICINN and MINECO and the Catalan Government grant (2009SGR-174) for Consolidated Research Groups. C. L. was supported by a "Ramo'n y Cajal" research contract (RYC-2011-08134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bianchi C. N., 1994, MEMORIE DESCRITTIVE, V52, P59; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Crisci C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023814; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Dunne RP, 2008, ECOL MODEL, V218, P188, DOI 10.1016/j.ecolmodel.2008.04.004; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; Dunne RP, 2001, CORAL REEFS, V20, P201; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Glynn PW, 2001, B MAR SCI, V69, P79; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 2002, NATURE, V415, P601, DOI 10.1038/415601a; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kersting D. K., 2009, ASLO AQ SCI M NIC FR, V133; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kersting DK, 2012, MAR ECOL-EVOL PERSP, V33, P427, DOI 10.1111/j.1439-0485.2011.00508.x; Kruzic P, 2008, MAR ECOL-EVOL PERSP, V29, P125, DOI 10.1111/j.1439-0485.2008.00220.x; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Metalpa RR, 2000, CORAL REEFS, V19, P24, DOI 10.1007/s003380050221; Oreskes N, 2005, SCIENCE, V307, P355; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; Romano JC, 2007, CR GEOSCI, V339, P57, DOI 10.1016/j.crte.2006.10.003; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Toren A, 1998, APPL ENVIRON MICROB, V64, P1379; Vacelet J., 1994, STRUGGLE EPIDEMIC WH; Vargas-Yanez M, 2008, GLOBAL PLANET CHANGE, V63, P177, DOI 10.1016/j.gloplacha.2007.09.001; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Visram S, 2006, J MAR BIOL ASSOC UK, V86, P1281, DOI 10.1017/S0025315406014299	56	61	62	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70820	10.1371/journal.pone.0070820	http://dx.doi.org/10.1371/journal.pone.0070820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951016	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300055
J	Krause, MP; Al-Sajee, D; D'Souza, DM; Rebalka, IA; Moradi, J; Riddell, MC; Hawke, TJ				Krause, Matthew P.; Al-Sajee, Dhuha; D'Souza, Donna M.; Rebalka, Irena A.; Moradi, Jasmin; Riddell, Michael C.; Hawke, Thomas J.			Impaired Macrophage and Satellite Cell Infiltration Occurs in a Muscle-Specific Fashion Following Injury in Diabetic Skeletal Muscle	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HISTOCHEMICAL PROPERTIES; MESSENGER-RNAS; WHOLE-BODY; REGENERATION; CONTRACTILE; EXPRESSION; MICE; PROTEIN; PAI-1	Background: Systemic elevations in PAI-1 suppress the fibrinolytic pathway leading to poor collagen remodelling and delayed regeneration of tibialis anterior (TA) muscles in type-1 diabetic Akita mice. However, how impaired collagen remodelling was specifically attenuating regeneration in Akita mice remained unknown. Furthermore, given intrinsic differences between muscle groups, it was unclear if the reparative responses between muscle groups were different. Principal Findings: Here we reveal that diabetic Akita muscles display differential regenerative responses with the TA and gastrocnemius muscles exhibiting reduced regenerating myofiber area compared to wild-type mice, while soleus muscles displayed no difference between animal groups following injury. Collagen levels in TA and gastrocnemius, but not soleus, were significantly increased post-injury versus controls. At 5 days post-injury, when degenerating/ necrotic regions were present in both animal groups, Akita TA and gastrocnemius muscles displayed reduced macrophage and satellite cell infiltration and poor myofiber formation. By 10 days post-injury, necrotic regions were absent in wild-type TA but persisted in Akita TA. In contrast, Akita soleus exhibited no impairment in any of these measures compared to wild-type soleus. In an effort to define how impaired collagen turnover was attenuating regeneration in Akita TA, a PAI-1 inhibitor (PAI-039) was orally administered to Akita mice following cardiotoxin injury. PAI-039 administration promoted macrophage and satellite cell infiltration into necrotic areas of the TA and gastrocnemius. Importantly, soleus muscles exhibit the highest inducible expression of MMP-9 following injury, providing a mechanism for normative collagen degradation and injury recovery in this muscle despite systemically elevated PAI-1. Conclusions: Our findings suggest the mechanism underlying how impaired collagen remodelling in type-1 diabetes results in delayed regeneration is an impairment in macrophage infiltration and satellite cell recruitment to degenerating areas; a phenomena that occurs differentially between muscle groups.	[Krause, Matthew P.; Al-Sajee, Dhuha; D'Souza, Donna M.; Rebalka, Irena A.; Moradi, Jasmin; Hawke, Thomas J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Riddell, Michael C.; Hawke, Thomas J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada	McMaster University; York University - Canada	Hawke, TJ (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	hawke@mcmaster.ca		Hawke, Thomas/0000-0003-4974-4820; Rebalka, Irena A./0000-0002-4732-5473	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarship Program; Canadian Institutes of Health Research Banting and Best Doctoral Fellowship Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Canadian Institutes of Health Research Banting and Best Doctoral Fellowship Program(Canadian Institutes of Health Research (CIHR))	The authors would like to thank: the Natural Sciences and Engineering Research Council of Canada (NSERC) for their financial support (T.J.H.), the Ontario Graduate Scholarship Program (to M.P.K.) and the Canadian Institutes of Health Research Banting and Best Doctoral Fellowship Program (to D.M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1975, CELL TISSUE RES, V162, P387; BARLOVATZMEIMON G, 1990, EUR J CELL BIOL, V52, P157; BENNET WM, 1990, DIABETOLOGIA, V33, P43, DOI 10.1007/BF00586460; Bryer SC, 2008, J IMMUNOL, V180, P1179, DOI 10.4049/jimmunol.180.2.1179; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; COTTER M, 1989, Q J EXP PHYSIOL CMS, V74, P65, DOI 10.1113/expphysiol.1989.sp003240; COTTER MA, 1993, EXP PHYSIOL, V78, P139, DOI 10.1113/expphysiol.1993.sp003675; Crandall DL, 2004, J THROMB HAEMOST, V2, P1422, DOI 10.1111/j.1538-7836.2004.00829.x; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; DiPasquale DM, 2007, AM J PHYSIOL-CELL PH, V293, pC1278, DOI 10.1152/ajpcell.00201.2007; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Fibbi G, 2001, LAB INVEST, V81, P27, DOI 10.1038/labinvest.3780209; Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181; Gordon CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014032; GULATI AK, 1991, ANAT RECORD, V229, P298, DOI 10.1002/ar.1092290303; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; JAKOBSEN J, 1986, CLIN NEUROPATHOL, V5, P73; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Koskinen SOA, 2001, AM J PHYSIOL-REG I, V280, pR1292, DOI 10.1152/ajpregu.2001.280.5.R1292; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Krause MP, 2011, DIABETES, V60, P1964, DOI 10.2337/db11-0007; Krause MP, 2011, PEDIATR DIABETES, V12, P345, DOI 10.1111/j.1399-5448.2010.00699.x; Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Lewis MP, 2000, J MUSCLE RES CELL M, V21, P223, DOI 10.1023/A:1005670507906; MEDINASANCHEZ M, 1991, AM J ANAT, V191, P48, DOI 10.1002/aja.1001910105; Mehan RS, 2011, CELLS TISSUES ORGANS, V194, P510, DOI 10.1159/000323654; Michelin AC, 2009, ANAT REC, V292, P387, DOI 10.1002/ar.20863; Naderi J, 2009, AM J PATHOL, V175, P763, DOI 10.2353/ajpath.2009.081009; NAIR KS, 1995, J CLIN INVEST, V95, P2926, DOI 10.1172/JCI118000; Nishimura T, 2008, J MUSCLE RES CELL M, V29, P37, DOI 10.1007/s10974-008-9140-2; Novak ML, 2011, J IMMUNOL, V187, P1448, DOI 10.4049/jimmunol.1004091; Oishi K, 2006, J THROMB HAEMOST, V4, P1566, DOI 10.1111/j.1538-7836.2006.01980.x; Oishi K, 2004, THROMB RES, V114, P129, DOI 10.1016/j.thromres.2004.05.011; Rosenfalck AM, 2002, DIABETIC MED, V19, P417, DOI 10.1046/j.1464-5491.2002.00702.x; Sanchez OA, 2005, J APPL PHYSIOL, V99, P472, DOI 10.1152/japplphysiol.01233.2004; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212; Snow LM, 2006, PATHOBIOLOGY, V73, P244, DOI 10.1159/000098210; Snow LM, 2005, ACTA HISTOCHEM, V107, P221, DOI 10.1016/j.acthis.2005.06.003; STANDL E, 1980, DIABETOLOGIA, V18, P463; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vignaud A, 2007, PATHOBIOLOGY, V74, P291, DOI 10.1159/000105812; Zaman AKMT, 2009, EXP BIOL MED, V234, P246, DOI 10.3181/0811-RM-321; Zeitler P, 2001, EXP CLIN ENDOCR DIAB, V109, P146, DOI 10.1055/s-2001-14837; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	51	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70971	10.1371/journal.pone.0070971	http://dx.doi.org/10.1371/journal.pone.0070971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951058	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300069
J	Liu, MM; Davey, JW; Banerjee, R; Han, J; Yang, F; Aboobaker, A; Blaxter, ML; Davison, A				Liu, Mengning Maureen; Davey, John W.; Banerjee, Ruby; Han, Jie; Yang, Fengtang; Aboobaker, Aziz; Blaxter, Mark L.; Davison, Angus			Fine Mapping of the Pond Snail Left-Right Asymmetry (Chirality) Locus Using RAD-Seq and Fibre-FISH	PLOS ONE			English	Article							LYMNAEA-STAGNALIS; BIOMPHALARIA-GLABRATA; GENOME; INHERITANCE; EVOLUTION; SINISTRALITY; HANDEDNESS; DISCOVERY; CELLS; SNP	The left-right asymmetry of snails, including the direction of shell coiling, is determined by the delayed effect of a maternal gene on the chiral twist that takes place during early embryonic cell divisions. Yet, despite being a well-established classical problem, the identity of the gene and the means by which left-right asymmetry is established in snails remain unknown. We here demonstrate the power of new genomic approaches for identification of the chirality gene, "D". First, heterozygous (Dd) pond snails Lymnaea stagnalis were self-fertilised or backcrossed, and the genotype of more than six thousand offspring inferred, either dextral (DD/Dd) or sinistral (dd). Then, twenty of the offspring were used for Restriction-site-Associated DNA Sequencing (RAD-Seq) to identify anonymous molecular markers that are linked to the chirality locus. A local genetic map was constructed by genotyping three flanking markers in over three thousand snails. The three markers lie either side of the chirality locus, with one very tightly linked (<0.1 cM). Finally, bacterial artificial chromosomes (BACs) were isolated that contained the three loci. Fluorescent in situ hybridization (FISH) of pachytene cells showed that the three BACs tightly cluster on the same bivalent chromosome. Fibre-FISH identified a region of greater that similar to 0.4 Mb between two BAC clone markers that must contain D. This work therefore establishes the resources for molecular identification of the chirality gene and the variation that underpins sinistral and dextral coiling. More generally, the results also show that combining genomic technologies, such as RAD-Seq and high resolution FISH, is a robust approach for mapping key loci in non-model systems.	[Liu, Mengning Maureen; Han, Jie; Aboobaker, Aziz; Davison, Angus] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Liu, Mengning Maureen] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Davey, John W.; Blaxter, Mark L.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Davey, John W.] Univ Cambridge, Dept Zool, Cambridge, England; [Banerjee, Ruby; Yang, Fengtang] Wellcome Trust Sanger Inst, Cambridge, England; [Han, Jie] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Aboobaker, Aziz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Blaxter, Mark L.] Univ Edinburgh, Sch Biol Sci, GenePool Genom Facil, Edinburgh, Midlothian, Scotland	University of Nottingham; University of Cambridge; University of Edinburgh; University of Cambridge; Wellcome Trust Sanger Institute; Beijing Normal University; University of Oxford; University of Edinburgh	Davison, A (corresponding author), Univ Nottingham, Sch Biol, Univ Pk, Nottingham NG7 2RD, England.	angus.davison@nottingham.ac.uk	Davison, Angus/C-3156-2009; Blaxter, Mark/O-2535-2019; GenePool, The/D-8812-2012	Davison, Angus/0000-0003-2554-8585; Davey, John/0000-0002-1017-9775; Aboobaker, Aziz/0000-0003-4902-5797	Biotechnology and Biological Sciences Research Council [BB/F018940/1, G00661X, F021135]; University of Edinburgh; University of Nottingham; Wellcome Trust Sanger Institute [WT098051]; Medical Research Council [G0900740]; Natural Environmental Research Council [R8/H10/56]; Biotechnology and Biological Sciences Research Council [BB/F021135/1] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish; BBSRC [BB/F018940/1, BB/F021135/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh; University of Nottingham; Wellcome Trust Sanger Institute(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was principally funded by Biotechnology and Biological Sciences Research Council grant BB/F018940/1 to AD and MLB with additional funding provided by the Universities of Edinburgh and Nottingham, the Wellcome Trust Sanger Institute (WT098051), Biotechnology and Biological Sciences Research Council grants G00661X and F021135; Medical Research Council grant (G0900740) and Natural Environmental Research Council grant (R8/H10/56) to MLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Asami T, 2008, J HERED, V99, P552, DOI 10.1093/jhered/esn032; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; Boycott AE, 1931, PHILOS T R SOC LON B, V219, P51, DOI 10.1098/rstb.1931.0002; BROWN NA, 1990, DEVELOPMENT, V109, P1; Crampton H. E., 1894, Annals of the New York Academy of Sciences, Vviii, P167; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Davison A, 2005, PARASITOLOGY, V130, P539, DOI 10.1017/S0031182004006791; Davison A, 2009, J EVOLUTION BIOL, V22, P1624, DOI 10.1111/j.1420-9101.2009.01770.x; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Etter PD, 2012, MOL METHODS EVOLUTIO; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gilbert SF, 2006, DEV BIOL; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Gurdon JB, 2005, CELL, V123, P751, DOI 10.1016/j.cell.2005.11.015; Knight M, 2011, INT J PARASITOL, V41, P61, DOI 10.1016/j.ijpara.2010.07.015; Kuroda R, 2009, NATURE, V462, P790, DOI 10.1038/nature08597; Odoemelam EC, 2010, METHODS MOL BIOL, V659, P379, DOI 10.1007/978-1-60761-789-1_29; Rozen S, 2000, Methods Mol Biol, V132, P365; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Utsuno H, 2011, EVOLUTION, V65, P2399, DOI 10.1111/j.1558-5646.2011.01293.x; Vandenberg LN, 2010, DEV DYNAM, V239, P3131, DOI 10.1002/dvdy.22450; Vinogradov AE, 1998, HEREDITAS, V128, P59, DOI 10.1111/j.1601-5223.1998.00059.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	37	30	31	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71067	10.1371/journal.pone.0071067	http://dx.doi.org/10.1371/journal.pone.0071067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951082	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323097300083
J	McLaughlin, MM; Chow, EPF; Wang, C; Yang, LG; Yang, B; Huang, JZ; Wang, YJ; Zhang, L; Tucker, JD				McLaughlin, Megan M.; Chow, Eric P. F.; Wang, Cheng; Yang, Li-Gang; Yang, Bin; Huang, Jennifer Z.; Wang, Yanjie; Zhang, Lei; Tucker, Joseph D.			Sexually Transmitted Infections among Heterosexual Male Clients of Female Sex Workers in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							YUNNAN PROVINCE; RISK-FACTORS; COMMERCIAL SEX; CONDOM USE; HIV; SYPHILIS; PREVALENCE; DISEASES; MEN; INCARCERATION	Background: Female sex workers have been the target of numerous sexually transmitted infection (STI) prevention strategies in China, but their male clients have attracted considerably less public health attention and resources. We sought to systematically assess the prevalence of HIV, syphilis, gonorrhea, and chlamydia among heterosexual male clients of female sex workers in China. Methods/Principal Findings: Original research manuscripts were identified by searching Chinese and English language databases, and 37 studies analyzing 26,552 male clients were included in the review. Client STI prevalence across studies was heterogeneous. Pooled prevalence estimates and 95% confidence intervals were 0.68% (0.36-1.28%) for HIV, 2.91% (2.17-3.89%) for syphilis, 2.16% (1.46-3.17%) for gonorrhea, and 8.01% (4.94-12.72%) for chlamydia. Conclusions/Significance: The pooled prevalence estimates of HIV, syphilis, gonorrhea, and chlamydia among clients in this review exceed the prevalences previously reported among population-representative samples and low-risk groups in China. However, heterogeneity across studies and sampling limitations prevent definitive conclusions about how the prevalence of STIs in this population compares to the general population. These findings suggest a need for greater attention to clients' sexual risk and disease prevalence in China's STI research agenda in order to inform effective prevention policies.	[McLaughlin, Megan M.; Tucker, Joseph D.] UNC Project China, Guangzhou, Guangdong, Peoples R China; [Chow, Eric P. F.; Wang, Yanjie; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Wang, Cheng; Yang, Li-Gang; Yang, Bin; Tucker, Joseph D.] Guangdong Prov Ctr STI & Skin Dis Control, Guangzhou, Guangdong, Peoples R China; [Huang, Jennifer Z.] Georgetown Univ, Dept Int Hlth, Sch Nursing & Hlth Studies, Washington, DC USA	University of New South Wales Sydney; Kirby Institute; Georgetown University	McLaughlin, MM (corresponding author), UNC Project China, Guangzhou, Guangdong, Peoples R China.	mclaughlin.megan@gmail.com; lzhang@kirby.unsw.edu.au	Chow, Eric P.F./W-6684-2019; Chow, Eric Pui Fung/H-3196-2013; Zhang, Lei/D-4039-2011	Chow, Eric P.F./0000-0003-1766-0657; Chow, Eric Pui Fung/0000-0003-1766-0657; Zhang, Lei/0000-0003-2343-084X; Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health (NIH) Fogarty K01 Award [US NIH 1K01TW008200-270 01A1]; UNC Fogarty AIDS International Research and Training Program [NIH FIC D43 TW01039]; UNC Social Science Research on HIV/AIDS in China [NIH NICHD R24 HD056670-01]; UNC Center for AIDS Research; Harvard Institute for Global Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056670] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039, K01TW008200] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fogarty K01 Award; UNC Fogarty AIDS International Research and Training Program; UNC Social Science Research on HIV/AIDS in China; UNC Center for AIDS Research; Harvard Institute for Global Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support for this research came from an National Institutes of Health (NIH) Fogarty K01 Award (US NIH 1K01TW008200-270 01A1), the UNC Fogarty AIDS International Research and Training Program (NIH FIC D43 TW01039), the UNC Social Science Research on HIV/AIDS in China (NIH NICHD R24 HD056670-01), the UNC Center for AIDS Research, and the Harvard Institute for Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton MJ, 2010, J HEALTH CARE POOR U, V21, P1194, DOI 10.1353/hpu.2010.0938; Cai Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-377; Chen XS, 2007, J INFECT DIS, V196, P1654, DOI 10.1086/522008; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen XS, 2012, BMC INFECT DIS, P1284; Chen Z, 2012, ZHONGGUO AI ZI BING, V18, P492; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; Chinese National Centers for Disease Control and Prevention, 2006, OP STAND LAB TEST ME; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; Dong XY, 2009, HUA NAN YU FANG YI X, P240; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng L, 2010, YU FANG YI XUE QING, V26; Flanigan TP, 2011, J INFECT DIS, V203, P1201, DOI 10.1093/infdis/jir034; Gao JM, 2008, ZHI YE YU JIAN KANG, V24, P1415; Hammett TM, 2009, CURR OPIN INFECT DIS, V22, P77, DOI 10.1097/QCO.0b013e328320a85d; Hesketh T, 2005, INT J STD AIDS, V16, P262, DOI 10.1258/0956462053420257; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong QY, 2010, ZHONGGUO WEI SHENG J, V20, P3064; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Hu XM, 2002, ZHONGGUO WEI SHENG G, P2115; Hua YZ, 2006, JIANGSU WEI SHENG BA, V8, P12; Huang YY, 2012, GLOB PUBLIC HEALTH, V7, P509, DOI 10.1080/17441692.2012.657663; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jiang WY, 2000, JI BING JIAN CE, V15, P221; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; Khan MR, 2011, AM J PUBLIC HEALTH, V101, P1110, DOI 10.2105/AJPH.2009.184721; Lau JTF, 2002, AIDS CARE, V14, P55, DOI 10.1080/09540120220097937; Lei SC, 2011, ZHONGGUO PI FU XING, V25, P450; Li DL, 2006, ZHONGGUO AI ZI BING, P4344; Li GY, 2010, ZHONG GUO AI ZI BING, P3251; Lin C, 2002, TERRITORIES PEOPLES; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; Liu J, 2012, ZHONG HUA JI BING KO, V16, P1060; Liu Q, 2012, REN KOU YAN JIU, V36, P60; Liu YQ, 2007, ZHI YE YU JIAN KANG, V23, P1430; Lu JC, 2008, LING NAN PI FU XING, V15, P178; Ma WJ, 2010, BIOMED ENVIRON SCI, V23, P287, DOI 10.1016/S0895-3988(10)60065-7; Mertz KJ, 2000, SEX TRANSM DIS, V27, P201, DOI 10.1097/00007435-200004000-00004; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Moher D., 2009, BMJ, V7, P889; Morris CN, 2007, SEX TRANSM INFECT, V83, P242, DOI 10.1136/sti.2006.024117; Nguyen NT, 2009, AIDS BEHAV, V13, P881, DOI 10.1007/s10461-008-9463-4; Ni CM, 2011, ZHONGGUO WEI SHENG J, V21, P2269; Pan SM, 2011, J INFECT DIS, V204, pS1211, DOI 10.1093/infdis/jir537; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Qiu XM, 2011, JI BING JIAN CE, V26, P295; Reilly KH, 2012, SEX TRANSM DIS, V39, P750, DOI 10.1097/OLQ.0b013e31825f7af7; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Sabido M, 2011, SEX TRANSM DIS, V38, P735, DOI 10.1097/OLQ.0b013e31821596b5; Sosman J, 2011, SEX TRANSM DIS, V38, P634, DOI 10.1097/OLQ.0b013e31820bc86c; Thomas JC, 2008, J URBAN HEALTH, V85, P90, DOI 10.1007/s11524-007-9231-1; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; Tucker J, 2010, SOC SCI MED, V70, P121, DOI 10.1016/j.socscimed.2009.10.010; Tunthanathip P, 2009, SEX TRANSM INFECT, V85, P36, DOI 10.1136/sti.2008.032532; Uretsky E, 2008, CULT HEALTH SEX, V10, P801, DOI 10.1080/13691050802380966; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang L, 2010, ZHONGGUO AI ZI BING, V16, P364; Wang XX, 2008, JI BING JIAN CE, V23, P490; Wang Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS93, DOI 10.1097/QAI.0b013e3181c7de7b; Willers DM, 2008, SEX TRANSM DIS, V35, P68, DOI 10.1097/OLQ.0b013e318154bdb2; Wong SPY, 2007, SEX TRANSM INFECT, V83, P351, DOI 10.1136/sti.2007.025015; Wu RH, 2012, ZHONGGUO AI ZI BING, V18, P325; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Xi XW, 2012, ZHI YE YU JIAN KANG, V28, P2514; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang C, 2010, SOC SCI MED, V71, P832, DOI 10.1016/j.socscimed.2010.04.039; Yang C, 2010, J URBAN HEALTH, V87, P292, DOI 10.1007/s11524-009-9431-y; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang YL, 2011, GONG GONG WEI SHENG, V22, P51; Yao Y, 2008, ZHONG HUA LIU XING B, V29, P651; Zeng YB, 2009, ZHONGGUO PI FU XING, V23, P228; Zhang CJ, 2001, HE NAN YU FANG YI XU, V12, P347; Zhang G, 2004, JI BING KONG ZHI ZA, V8; Zhang GL, 2010, JAIDS-J ACQ IMM DEF, V53, pS54, DOI 10.1097/QAI.0b013e3181c7d8d2; Zhang Heng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P534; Zhang Y, 2007, JIAN YAN YI XUE, V22; Zhang ZH, 2006, YI XUE XIN XI, V19, P169; Zhao R, 2008, AIDS CARE, V20, P782, DOI 10.1080/09540120701694030; Zhao YR, 2003, ZHONGGUO AI ZI BING, V9, P310; Zhu JC, 2006, ZHONGGUO XING KE XUE, V15, P46; Zhu LD, 2007, ZHONGGUO RE DAI YI X, V7	91	25	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71394	10.1371/journal.pone.0071394	http://dx.doi.org/10.1371/journal.pone.0071394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951153	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300112
J	Nakaoka, H; Nakagawa-Toyama, Y; Nishida, M; Okada, T; Kawase, R; Yamashita, T; Yuasa-Kawase, M; Nakatani, K; Masuda, D; Ohama, T; Sonobe, T; Shirai, M; Komuro, I; Yamashita, S				Nakaoka, Hajime; Nakagawa-Toyama, Yumiko; Nishida, Makoto; Okada, Takeshi; Kawase, Ryota; Yamashita, Taiji; Yuasa-Kawase, Miyako; Nakatani, Kazuhiro; Masuda, Daisaku; Ohama, Tohru; Sonobe, Takashi; Shirai, Mikiyasu; Komuro, Issei; Yamashita, Shizuya			Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions	PLOS ONE			English	Article							E-DEFICIENT MICE; DIET-INDUCED ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-E; CARDIAC DYSFUNCTION; PREMATURE DEATH; ARTERY-DISEASE; HEART-FAILURE; MOUSE; GENE	Objectives: Atherosclerotic lesions of the coronary arteries are the pathological basis for myocardial infarction and ischemic cardiomyopathy. Progression of heart failure after myocardial infarction is associated with cardiac remodeling, which has been studied by means of coronary ligation in mice. However, this ligation model requires excellent techniques. Recently, a new murine model, HypoE mouse was reported to exhibit atherogenic Paigen diet-induced coronary atherosclerosis and myocardial infarction; however, the HypoE mice died too early to make possible investigation of cardiac remodeling. Therefore, we aimed to modify the HypoE mouse model to establish a novel model for ischemic cardiomyopathy caused by atherosclerotic lesions, which the ligation model does not exhibit. Methods and Results: In our study, the sustained Paigen diet for the HypoE mice was shortened to 7 or 10 days, allowing the mice to survive longer. The 7-day Paigen diet intervention starting when the mice were 8 weeks old was adequate to permit the mice to survive myocardial infarction. Our murine model, called the "modified HypoE mouse", was maintained until 8 weeks, with a median survival period of 36 days, after the dietary intervention (male, n = 222). Echocardiography demonstrated that the fractional shortening 2 weeks after the Paigen diet (n = 14) significantly decreased compared with that just before the Paigen diet (n = 6) (31.4 +/- 11.9% vs. 54.4 +/- 2.6%, respectively, P<0.01). Coronary angiography revealed multiple diffuse lesions. Cardiac remodeling and fibrosis were identified by serial analyses of cardiac morphological features and mRNA expression levels in tissue factors such as MMP-2, MMP-9, TIMP-1, collagen-1, and TGF-beta. Conclusion: Modified HypoE mice are a suitable model for ischemic cardiomyopathy with multiple diffuse lesions and may be considered as a novel and convenient model for investigations of cardiac remodeling on a highly atherogenic background.	[Nakaoka, Hajime; Okada, Takeshi; Kawase, Ryota; Yamashita, Taiji; Yuasa-Kawase, Miyako; Nakatani, Kazuhiro; Masuda, Daisaku; Komuro, Issei; Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nakagawa-Toyama, Yumiko; Nishida, Makoto; Ohama, Tohru] Osaka Univ, Hlth Care Ctr, Toyonaka, Osaka 560, Japan; [Sonobe, Takashi; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan; [Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Community Med, Suita, Osaka, Japan	Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University	Yamashita, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan.	shizu@cardiology.med.osaka-u.ac.jp	Sonobe, Takashi/Q-6600-2016	Sonobe, Takashi/0000-0003-3589-0405; Nisihida, Makoto/0000-0002-0309-7106; Masuda, Daisaku/0000-0002-0954-4042; Okada, Takeshi/0000-0001-9097-3831				Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0; Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693; Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Davies JR, 2006, J AM COLL CARDIOL, V47, pC57, DOI 10.1016/j.jacc.2005.11.049; De Celle T, 2005, EXP PHYSIOL, V90, P593, DOI 10.1113/expphysiol.2005.030296; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Duprez DA, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_G.8; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Gao E, 2010, CIRC RES; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; ISHIDA BY, 1991, J LIPID RES, V32, P559; Klocke R, 2007, CARDIOVASC RES, V74, P29, DOI 10.1016/j.cardiores.2006.11.026; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346; Nakagawa-Toyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047965; Nakamura T, 1997, INT J OBESITY, V21, P580, DOI 10.1038/sj.ijo.0800445; NISHINA PM, 1990, J LIPID RES, V31, P859; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitman WA, 1998, ARTERIOSCL THROM VAS, V18, P615, DOI 10.1161/01.ATV.18.4.615; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosano GMC, 2006, AM J CARDIOL, V98, p14J, DOI 10.1016/j.amjcard.2006.07.004; Samokhin AO, 2010, ARTERIOSCL THROM VAS, V30, P1166, DOI 10.1161/ATVBAHA.110.203976; Shirai M, 2013, CIRC RES, V112, P209, DOI 10.1161/CIRCRESAHA.111.300096; STJOHNSUTTON MG, 1980, BRIT HEART J, V44, P433; Suehiro K, 2001, JPN CIRC J, V65, P979, DOI 10.1253/jcj.65.979; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tsubakio-Yamamoto K, 2012, METABOLISM, V61, P1763, DOI 10.1016/j.metabol.2012.05.011; Usui S, 2000, CLIN CHEM, V46, P63; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Ytrehus K, 2000, PHARMACOL RES, V42, P193, DOI 10.1006/phrs.2000.0669; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70755	10.1371/journal.pone.0070755	http://dx.doi.org/10.1371/journal.pone.0070755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950999	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300048
J	Sagaki, P; Thanachartwet, V; Desakorn, V; Sahassananda, D; Chamnanchanunt, S; Chierakul, W; Pitisuttithum, P; Ruangkanchanasetr, P				Sagaki, Patrick; Thanachartwet, Vipa; Desakorn, Varunee; Sahassananda, Duangjai; Chamnanchanunt, Supat; Chierakul, Wirongrong; Pitisuttithum, Punnee; Ruangkanchanasetr, Prajej			Clinical Factors for Severity of Plasmodium falciparum Malaria in Hospitalized Adults in Thailand	PLOS ONE			English	Article							RISK-FACTORS; INTENSIVE-CARE; SEVERE DISEASE	Plasmodium falciparum is a major cause of severe malaria in Southeast Asia, however, there is limited information regarding clinical factors associated with the severity of falciparum malaria from this region. We performed a retrospective case-control study to compare clinical factors and outcomes between patients with severe and non-severe malaria, and to identify clinical factors associated with the requirement for intensive care unit (ICU) admission of patients with severe falciparum malaria among hospitalized adults in Southeast Asia. A total of 255 patients with falciparum malaria in the Hospital for Tropical Diseases in Bangkok, Thailand between 2006 and 2012 were included. We identified 104 patients with severe malaria (cases) and 151 patients with non-severe malaria (controls). Patients with falciparum malaria with following clinical and laboratory characteristics on admission (1) referrals, (2) no prior history of malaria, (3) body temperature of >38.5 degrees C, (4) white blood cell counts >10x10(9)/mu L, (5) presence of schizonts in peripheral blood smears, and (6) albumin concentrations of <3.5 g/dL, were more likely to develop severe malaria (P<0.05). Among patients with severe malaria, patients who met >= 3 of the 2010 WHO criteria had sensitivity of 79.2% and specificity of 81.8% for requiring ICU admission. Multivariate analysis identified the following as independent associated factors for severe malaria requiring ICU admission; (1) ethnicity of Thai [odds ratio (OR) = 3.601, 95% confidence interval (CI) = 1.011-12.822] or Myanmar [OR = 3.610, 95% CI = 1.138-11.445]; (2) referrals [OR = 3.571, 95% CI = 1.306-9.762]; (3) no prior history of malaria [OR = 5.887, 95% CI = 1.354-25.594]; and (4) albumin concentrations of <3.5 g/dL [OR = 7.200, 95% CI = 1.802-28.759]. Our findings are important for the clinical management of patients with malaria because it can help early identification of patients that could develop severe malaria and require ICU admission. Early identification and the timely initiation of appropriate treatments may well improve the outcomes and reduce the mortality of these patients.	[Sagaki, Patrick; Thanachartwet, Vipa; Desakorn, Varunee; Chamnanchanunt, Supat; Chierakul, Wirongrong; Pitisuttithum, Punnee] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Sahassananda, Duangjai] Mahidol Univ, Fac Trop Med, Informat Technol Unit, Bangkok, Thailand; [Sagaki, Patrick] Amudat Hosp, Amudat, Uganda; [Ruangkanchanasetr, Prajej] Phramongkutklao Hosp, Dept Med, Bangkok, Thailand; [Ruangkanchanasetr, Prajej] Coll Med, Bangkok, Thailand	Mahidol University; Mahidol University; Phramongkutklao Hospital	Thanachartwet, V (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	vipa.tha@mahidol.ac.th	Chierakul, Wirongrong/AAC-3226-2020; chamnanchanunt, supat/K-2348-2019; chamnanchanunt, supat/R-4382-2019	Chierakul, Wirongrong/0000-0003-2103-9425; chamnanchanunt, supat/0000-0001-9916-327X; , Supat/0000-0003-1956-1097	Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abdagalil M. A., 2009, African Journal of Biochemistry Research, V3, P349; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Clark IA, 2000, PARASITOL TODAY, V16, P451, DOI 10.1016/S0169-4758(00)01757-9; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Faiz MA, 2005, LANCET, V366, P717; Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118; Parker D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-290; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; Roe JK, 2009, QJM-INT J MED, V102, P685, DOI 10.1093/qjmed/hcp087; Rosenthal PJ, 2008, NEW ENGL J MED, V358, P1829, DOI 10.1056/NEJMct0709050; Safeukui-Noubissi I, 2004, MICROBES INFECT, V6, P572, DOI 10.1016/j.micinf.2004.02.007; Saliba G, 2011, PATHOL BIOL, V59, P230, DOI 10.1016/j.patbio.2010.02.002; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Santos-Ciminera PD, 2007, EMERG INFECT DIS, V13, P1597, DOI 10.3201/eid1310.070052; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; WHO, 2010, GUID TREATM MAL, V2nd; Wilairatana P, 1999, AM J TROP MED HYG, V60, P233, DOI 10.4269/ajtmh.1999.60.233	19	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71503	10.1371/journal.pone.0071503	http://dx.doi.org/10.1371/journal.pone.0071503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951178	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300124
J	Sainz-Jaspeado, M; Huertas-Martinez, J; Lagares-Tena, L; Liberal, JM; Mateo-Lozano, S; de Alava, E; de Torres, C; Mora, J; del Muro, XG; Tirado, OM				Sainz-Jaspeado, Miguel; Huertas-Martinez, Juan; Lagares-Tena, Laura; Liberal, Juan Martin; Mateo-Lozano, Silvia; de Alava, Enrique; de Torres, Carmen; Mora, Jaume; del Muro, Xavier Garcia; Tirado, Oscar M.			EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1	PLOS ONE			English	Article							EPHA2 RECEPTOR; TYROSINE KINASE; TUMOR; EXPRESSION; EPHRINS; ACTIVATION; EWS/FLI-1; INVASION; FAMILY; TARGET	Angiogenesis is the result of the combined activity of the tumor microenvironment and signaling molecules. The angiogenic switch is represented as an imbalance between pro-and anti-angiogenic factors and is a rate-limiting step in the development of tumors. Eph receptor tyrosine kinases and their membrane-anchored ligands, known as ephrins, constitute the largest receptor tyrosine kinase (RTK) subfamily and are considered a major family of pro-angiogenic RTKs. Ewing sarcoma (EWS) is a highly aggressive bone and soft tissue tumor affecting children and young adults. As other solid tumors, EWS are reliant on a functional vascular network for the delivery of nutrients and oxygen and for the removal of waste. Based on the biological roles of EphA2 in promoting angiogenesis, we explored the functional role of this receptor and its relationship with caveolin-1 (CAV1) in EWS angiogenesis. We demonstrated that lack of CAV1 results in a significant reduction in micro vascular density (MVD) on 3 different in vivo models. In vitro, this phenomenon correlated with inactivation of EphA2 receptor, lack of AKT response and downregulation of bFGF. We also demonstrated that secreted bFGF from EWS cells acted as chemoattractant for endothelial cells. Furthermore, interaction between EphA2 and CAV1 was necessary for the right localization and signaling of the receptor to produce bFGF through AKT and promote migration of endothelial cells. Finally, introduction of a dominant-negative form of EphA2 into EWS cells mostly reproduced the effects occurred by CAV1 silencing, strongly suggesting that the axis EphA2-CAV1 participates in the promotion of endothelial cell migration toward the tumors favoring EWS angiogenesis.	[Sainz-Jaspeado, Miguel; Huertas-Martinez, Juan; Lagares-Tena, Laura; Liberal, Juan Martin; del Muro, Xavier Garcia; Tirado, Oscar M.] Hosp Llobregat, Inst Invest Biomed Bellvitge IDIBELL, Sarcoma Res Grp, Lab Oncol Mol, Barcelona, Spain; [Mateo-Lozano, Silvia] Vall Hebron Hosp, Res Inst, CIBBIM Nanomed, Nanomed Res Program,Mol Biol & Biochem Res Ctr, Barcelona, Spain; [de Alava, Enrique] Univ Salamanca CSIC, Ctr Invest Canc IBMCC, Salamanca, Spain; [de Torres, Carmen; Mora, Jaume] Hosp San Juan Dios, Dev Tumor Biol Lab, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Barcelona	Tirado, OM (corresponding author), Hosp Llobregat, Inst Invest Biomed Bellvitge IDIBELL, Sarcoma Res Grp, Lab Oncol Mol, Barcelona, Spain.	omartinez@idibell.cat	IBIS, SARCOMAS/O-1893-2015; Tirado, Oscar Martínez/R-9604-2019; de Alava, Enrique/GOH-0368-2022	Tirado, Oscar Martínez/0000-0002-4666-2822; de Alava, Enrique/0000-0001-8400-046X; Mora, Jaume/0000-0002-9386-5980; Mateo, Silvia/0000-0002-2365-1573; Lagares-Tena, Laura/0000-0002-5290-3346	Fondo de Investigaciones Sanitarias-ISCIII-FEDER [CP06/00151, PI080259, PI110038, PI110018, RD09/0076/00028, RD06/0020/0059, RD06/0020/1038]; Comissionat per a Universitats i Recerca (CUR) from Departament d'Innovacio, Universitats i Empresa (DIUE) de la Generalitat de Catalunya i del Fons Social Europeu	Fondo de Investigaciones Sanitarias-ISCIII-FEDER; Comissionat per a Universitats i Recerca (CUR) from Departament d'Innovacio, Universitats i Empresa (DIUE) de la Generalitat de Catalunya i del Fons Social Europeu	This work was funded by the Fondo de Investigaciones Sanitarias-ISCIII-FEDER (CP06/00151; PI080259; PI110038; PI110018; RD09/0076/00028; RD06/0020/0059; RD06/0020/1038). LLT is funded by the Comissionat per a Universitats i Recerca (CUR) from Departament d'Innovacio, Universitats i Empresa (DIUE) de la Generalitat de Catalunya i del Fons Social Europeu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Costa C, 2004, XENOTRANSPLANTATION, V11, P491, DOI 10.1111/j.1399-3089.2004.00169.x; Drake JM, 2012, P NATL ACAD SCI USA, V109, P1643, DOI 10.1073/pnas.1120985109; DuBois SG, 2010, CANCER-AM CANCER SOC, V116, P749, DOI 10.1002/cncr.24844; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kuo MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029000; Lee TH, 2006, INT J CANCER, V119, P839, DOI 10.1002/ijc.21916; Linkous AG, 2012, ANTICANCER RES, V32, P1; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nagano A, 2010, INT J CANCER, V126, P2790, DOI 10.1002/ijc.24781; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Sainz-Jaspeado M, 2010, MOL CANCER RES, V8, P1489, DOI 10.1158/1541-7786.MCR-10-0060; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Shi CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021482; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Stewart Keri S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/165837; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Wang S, 2012, BIOCHEM BIOPH RES CO, V421, P567, DOI 10.1016/j.bbrc.2012.04.046; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yang G, 2007, HUM PATHOL, V38, P1688, DOI 10.1016/j.humpath.2007.03.024; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7	47	31	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71449	10.1371/journal.pone.0071449	http://dx.doi.org/10.1371/journal.pone.0071449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951165	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300118
J	Zhang, HY; Liu, YR; Ji, C; Li, W; Dou, SX; Xie, P; Wang, WC; Zhang, LY; Wang, PY				Zhang, Hong-Yan; Liu, Yu-Ru; Ji, Chao; Li, Wei; Dou, Shuo-Xing; Xie, Ping; Wang, Wei-Chi; Zhang, Ling-Yun; Wang, Peng-Ye			Oxaliplatin and Its Enantiomer Induce Different Condensation Dynamics of Single DNA Molecules	PLOS ONE			English	Article							INTRASTRAND CROSS-LINK; PLATINUM(II) COMPLEXES; ANTITUMOR-ACTIVITY; (1,2-CYCLOHEXANEDIAMINE)PLATINUM(II) ISOMERS; DODECAMER DUPLEX; CARRIER LIGAND; CELL-LINES; 1,2-DIAMINOCYCLOHEXANE; ADDUCTS; BINDING	The interactions of DNA with oxaliplatin (Pt(R, R-DACH)) or its enantiomer (Pt(S, S-DACH)) were investigated using magnetic tweezers and atomic force microscope. In the process of DNA condensation induced by Pt-DACH, only diadducts and micro-loops are formed at low Pt-DACH concentrations, while at high Pt-DACH concentrations, besides the diadducts and micro-loops, long-range cross-links are also formed. The diadduct formation rate of Pt(R, R-DACH) is higher than that of Pt(S, SDACH). However, the proportions of micro-loops and long-range cross-links for Pt(S, S-DACH) are higher than those for Pt(R, R-DACH). We propose a model to explain these differences between the effect of Pt(R, R-DACH) and that of Pt(S, SDACH) on DNA condensation. The study has strong implications for the understanding of the effect of chirality on the interaction between Pt-DACH and DNA and the kinetics of DNA condensation induced by platinum complexes.	[Zhang, Hong-Yan; Liu, Yu-Ru; Ji, Chao; Li, Wei; Dou, Shuo-Xing; Xie, Ping; Wang, Wei-Chi; Zhang, Ling-Yun; Wang, Peng-Ye] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Key Lab Soft Matter Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS	Wang, PY (corresponding author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Key Lab Soft Matter Phys, POB 603, Beijing 100080, Peoples R China.	pywang@aphy.iphy.ac.cn		Dou, Shuo-Xing/0000-0002-7201-2081; Wang, Peng-Ye/0000-0002-9765-0610	National Natural Science Foundation of China [11274374]; National Basic Research Program of China (973 Program) [2009CB930704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant 11274374) and the National Basic Research Program of China (973 Program) (Grant 2009CB930704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BMJ, 2001, P NATL ACAD SCI USA, V98, P10658, DOI 10.1073/pnas.181029198; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BOUDNY V, 1992, NUCLEIC ACIDS RES, V20, P267, DOI 10.1093/nar/20.2.267; BRABEC V, 1994, BIOCHEMISTRY-US, V33, P1316, DOI 10.1021/bi00172a005; BRABEC V, 1992, BIOCHEMISTRY-US, V31, P12397, DOI 10.1021/bi00164a014; Brabec V, 2002, PROG NUCLEIC ACID RE, V71, P1, DOI 10.1016/S0079-6603(02)71040-4; BRABEC V, 2005, METAL COMPOUNDS CANC, P187; BURCHENAL JH, 1978, BIOCHIMIE, V60, P961, DOI 10.1016/S0300-9084(78)80582-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Culy CR, 2000, DRUGS, V60, P895, DOI 10.2165/00003495-200060040-00005; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; FANIZZI FP, 1987, INORG CHIM A-BIOINOR, V137, P45, DOI 10.1016/S0020-1693(00)87114-5; Hou XM, 2009, NUCLEIC ACIDS RES, V37, P1400, DOI 10.1093/nar/gkn933; INAGAKI K, 1990, INORG CHEM, V29, P4496, DOI 10.1021/ic00347a032; INAGAKI K, 1986, INORG CHEM, V25, P1, DOI 10.1021/ic00221a001; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; JENNERWEIN MM, 1989, CHEM-BIOL INTERACT, V70, P39, DOI 10.1016/0009-2797(89)90061-6; Ji C, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/6/068702; KIDANI Y, 1976, GANN, V67, P921; Krautbauer R, 2000, ANGEW CHEM INT EDIT, V39, P3912, DOI 10.1002/1521-3773(20001103)39:21<3912::AID-ANIE3912>3.0.CO;2-5; Lee NK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248101; Lehner R, 2005, CONFOCAL MICROSCOPY; LEOPOLD WR, 1981, CANCER RES, V41, P4368; Li W, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021918; Lionnet T, 2011, MAGNETIC TRAP CONSTR, P133; Liu ZG, 2010, MICRON, V41, P833, DOI 10.1016/j.micron.2010.05.001; Malina J, 2007, BIOPHYS J, V93, P3950, DOI 10.1529/biophysj.107.116996; Mani S, 2002, CANCER INVEST, V20, P246, DOI 10.1081/CNV-120001152; Marko JF, 2003, PHYS WORLD, V16, P37; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MAULDIN SK, 1988, CANCER RES, V48, P5136; Onoa GB, 1998, NUCLEIC ACIDS RES, V26, P1473, DOI 10.1093/nar/26.6.1473; PAGE JD, 1990, BIOCHEMISTRY-US, V29, P1016, DOI 10.1021/bi00456a026; PENDYALA L, 1995, CANCER LETT, V97, P177, DOI 10.1016/0304-3835(95)03974-2; PENDYALA L, 1993, CANCER RES, V53, P5970; Raymond E, 1998, CLIN CANCER RES, V4, P1021; REEDIJK J, 1992, INORG CHIM ACTA, V198, P873, DOI 10.1016/S0020-1693(00)92433-2; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Riccardi A, 1999, EUR J CANCER, V35, P86, DOI 10.1016/S0959-8049(98)00342-6; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Salerno D, 2010, NUCLEIC ACIDS RES, V38, P7089, DOI 10.1093/nar/gkq597; Saris CP, 1996, CARCINOGENESIS, V17, P2763, DOI 10.1093/carcin/17.12.2763; SIDDIK ZH, 1994, J CANCER RES CLIN, V120, P409, DOI 10.1007/BF01240140; SIDDIK ZH, 1993, J CANCER RES CLIN, V120, P12, DOI 10.1007/BF01200718; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Tyagi P, 2008, POLYHEDRON, V27, P3567, DOI 10.1016/j.poly.2008.08.025; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Verstraete S, 2001, J INORG BIOCHEM, V84, P129, DOI 10.1016/S0162-0134(00)00208-7; VOLLANO JF, 1987, J MED CHEM, V30, P716, DOI 10.1021/jm00387a023; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Woynarowski JM, 1998, MOL PHARMACOL, V54, P770, DOI 10.1124/mol.54.5.770; Wu YB, 2004, J MOL BIOL, V341, P1251, DOI 10.1016/j.jmb.2004.06.066; Yamada K, 2005, ANAL BIOANAL CHEM, V382, P1702, DOI 10.1007/s00216-005-3339-5; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905; Yoshikawa Y, 2011, INORG CHEM, V50, P11729, DOI 10.1021/ic2017165	57	15	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71556	10.1371/journal.pone.0071556	http://dx.doi.org/10.1371/journal.pone.0071556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951187	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300127
J	Yang, LL; Engeland, CG; Cheng, B				Yang, Linglan; Engeland, Christopher G.; Cheng, Bin			Social Isolation Impairs Oral Palatal Wound Healing in Sprague-Dawley Rats: A Role for miR-29 and miR-203 via VEGF Suppression	PLOS ONE			English	Article							CUTANEOUS WOUNDS; DISTINCT PATTERNS; SKIN; EXPRESSION; MICRORNAS; MUCOSAL; TRANSCRIPTOME; ANGIOGENESIS; FIBROSIS; IMMUNITY	Objective: To investigate the effects of social isolation on oral mucosal healing in rats, and to determine if wound-associated genes and microRNAs (miRNAs) may contribute to this response. Methods: Rats were group housed or socially isolated for 4 weeks before a 3.5 mm wound was placed on the hard oral palate. Wound closure was assessed daily and tissues were collected for determination of gene expression levels and miRNAs (i.e., miR-29a, b, c and miR-203). The predicted target of these microRNAs (i. e., vascular endothelial growth factor A, VEGFA) was functionally validated. Results: Social isolation stress delayed the healing process of oral palatal mucosal wounds in rats. Lower mRNA levels of interleukin-1 beta (IL1 beta), macrophage inflammatory protein-1 alpha (MIP1 alpha), fibroblast growth factor 7 (FGF7), and VEGFA were found in the biopsied tissues of isolated animals on days 1 and/or 3 post-wounding. Intriguingly, the isolated rats persistently exhibited higher levels of miR-29 family members and miR-203. Our results confirmed that VEGFA is a direct target of these miRNAs, as both miR-29a, c and miR-203 strongly and specifically suppressed endogenous VEGFA expression in vitro. Conclusions: This study in rats demonstrates for the first time that social isolation delays oral mucosal healing, and suggests a potential role for healing-associated gene and miRNA interactions during this process via modulation of VEGF expression.	[Yang, Linglan; Cheng, Bin] Sun Yat Sen Univ, Dept Oral Med, Affiliated Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Linglan; Cheng, Bin] Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China; [Engeland, Christopher G.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA; [Engeland, Christopher G.] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL USA; [Engeland, Christopher G.] Univ Illinois, Dept Women, Chicago, IL USA	Sun Yat Sen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cheng, B (corresponding author), Sun Yat Sen Univ, Dept Oral Med, Affiliated Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	chengbin@mail.sysu.edu.cn			National Natural Science Foundation of China [91029712, 81172567]; Program for New Century Excellent Talents in University [NCET-11-0535]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation Grant of China (91029712, 81172567) and Program for New Century Excellent Talents in University (NCET-11-0535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 2007, PSYCHOSOM MED, V69, P597, DOI 10.1097/PSY.0B013E318148C682; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Chen W, 2007, WOUND REPAIR REGEN, V15, P147, DOI 10.1111/j.1524-475X.2006.00195.x; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Eming SA, 2006, J INVEST DERM SYMP P, V11, P79, DOI 10.1038/sj.jidsymp.5650016; Glasper ER, 2005, BRAIN BEHAV IMMUN, V19, P61, DOI 10.1016/j.bbi.2004.03.002; Grippo AJ, 2011, PSYCHOSOM MED, V73, P59, DOI 10.1097/PSY.0b013e31820019e4; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Koschwanez HE, 2011, BRIT J HEALTH PSYCH, V16, P1, DOI 10.1348/135910710X524633; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Levine JB, 2008, NEUROSCIENCE, V151, P589, DOI 10.1016/j.neuroscience.2007.10.014; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Peng C, 2011, J INT MED RES, V39, P416, DOI 10.1177/147323001103900209; Primo MN, 2012, CYTOKINE, V60, P741, DOI 10.1016/j.cyto.2012.07.031; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rojas IG, 2002, BRAIN BEHAV IMMUN, V16, P74, DOI 10.1006/brbi.2000.0619; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Roy S, 2008, PHYSIOL GENOMICS, V34, P162, DOI 10.1152/physiolgenomics.00045.2008; Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Szpaderska AM, 2005, J DENT RES, V84, P309, DOI 10.1177/154405910508400403; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vitalo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005523; Viticchie G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.174; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	41	21	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72359	10.1371/journal.pone.0072359	http://dx.doi.org/10.1371/journal.pone.0072359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951316	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200081
J	Honorat, JA; Kinoshita, M; Okuno, T; Takata, K; Koda, T; Tada, S; Shirakura, T; Fujimura, H; Mochizuki, H; Sakoda, S; Nakatsuji, Y				Honorat, Josephe Archie; Kinoshita, Makoto; Okuno, Tatsusada; Takata, Kazushiro; Koda, Toru; Tada, Satoru; Shirakura, Takashi; Fujimura, Harutoshi; Mochizuki, Hideki; Sakoda, Saburo; Nakatsuji, Yuji			Xanthine Oxidase Mediates Axonal and Myelin Loss in a Murine Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NADPH OXIDASE; NITRIC-OXIDE; OXIDATIVE STRESS; WHITE-MATTER; SUSCEPTIBILITY; DEHYDROGENASE; PATHOGENESIS; PEROXYNITRITE	Objectives: Oxidative stress plays an important role in the pathogenesis of multiple sclerosis (MS). Though reactive oxygen species (ROS) are produced by various mechanisms, xanthine oxidase (XO) is a major enzyme generating ROS in the context of inflammation. The objectives of this study were to investigate the involvement of XO in the pathogenesis of MS and to develop a potent new therapy for MS based on the inhibition of ROS. Methods: XO were assessed in a model of MS: experimental autoimmune encephalomyelitis (EAE). The contribution of XO-generated ROS to the pathogenesis of EAE was assessed by treating EAE mice with a novel XO inhibitor, febuxostat. The efficacy of febuxostat was also examined in in vitro studies. Results: We showed for the first time that the expression and the activity of XO were increased dramatically within the central nervous system of EAE mice as compared to naive mice. Furthermore, prophylactic administration of febuxostat, a XO inhibitor, markedly reduced the clinical signs of EAE. Both in vivo and in vitro studies showed infiltrating macrophages and microglia as the major sources of excess XO production, and febuxostat significantly suppressed ROS generation from these cells. Inflammatory cellular infiltration and glial activation in the spinal cord of EAE mice were inhibited by the treatment with febuxostat. Importantly, therapeutic efficacy was observed not only in mice with relapsing-remitting EAE but also in mice with secondary progressive EAE by preventing axonal loss and demyelination. Conclusion: These results highlight the implication of XO in EAE pathogenesis and suggest XO as a target for MS treatment and febuxostat as a promising therapeutic option for MS neuropathology.	[Honorat, Josephe Archie; Kinoshita, Makoto; Okuno, Tatsusada; Takata, Kazushiro; Koda, Toru; Tada, Satoru; Mochizuki, Hideki; Nakatsuji, Yuji] Osaka Univ, Dept Neurol, Grad Sch Med, Suita, Osaka, Japan; [Kinoshita, Makoto] Osaka Univ, Dept Immune Regulat, Grad Sch Med, Suita, Osaka, Japan; [Fujimura, Harutoshi; Sakoda, Saburo] Natl Hosp Org, Dept Neurol, Toneyama Natl Hosp, Toyonaka, Osaka, Japan; [Shirakura, Takashi] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Tokyo, Japan	Osaka University; Osaka University; Teijin Pharma Limited	Nakatsuji, Y (corresponding author), Osaka Univ, Dept Neurol, Grad Sch Med, Suita, Osaka, Japan.	yuji@neurol.med.osaka-u.ac.jp		Tada, Satoru/0000-0002-0323-5644	Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [017]; Japan Society for the Promotion of Science [22590931]; Ministry of Education, Culture, Sports, Science and Technology [24111531]	Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (No. 017 to Y.N.), by a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (No. 22590931 to Y.N.) and by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (24111531 to H. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; CUNHA FQ, 1993, IMMUNOLOGY, V79, P408; DUPONT GP, 1992, J CLIN INVEST, V89, P197, DOI 10.1172/JCI115563; Ernst ME, 2009, CLIN THER, V31, P2503, DOI 10.1016/j.clinthera.2009.11.033; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Ferretti G, 2011, J NEUROL SCI, V311, P92, DOI 10.1016/j.jns.2011.09.004; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gray E, 2008, NEUROSCI LETT, V444, P195, DOI 10.1016/j.neulet.2008.08.035; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kanzawa T, 2000, J NEUROSCI RES, V62, P383, DOI 10.1002/1097-4547(20001101)62:3<383::AID-JNR8>3.0.CO;2-6; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; LEVINE SM, 1992, MED HYPOTHESES, V39, P271, DOI 10.1016/0306-9877(92)90121-R; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; Morini M, 2004, J NEUROIMMUNOL, V148, P146, DOI 10.1016/j.jneuroim.2003.11.021; Moriya M, 2005, J NEUROIMMUNOL, V170, P11, DOI 10.1016/j.jneuroim.2005.08.001; Moriya M, 2008, NEUROSCI LETT, V440, P323, DOI 10.1016/j.neulet.2008.05.110; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Okuda Y, 2002, IMMUNOL LETT, V81, P25, DOI 10.1016/S0165-2478(01)00339-X; Ono T, 2009, BRAIN RES, V1305, P158, DOI 10.1016/j.brainres.2009.09.061; Parkinson JF, 1997, J MOL MED, V75, P174, DOI 10.1007/s001090050102; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011	42	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71329	10.1371/journal.pone.0071329	http://dx.doi.org/10.1371/journal.pone.0071329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951137	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000050
J	Le, TP; Sun, M; Luo, X; Kraus, WL; Greene, GL				Le, Thien P.; Sun, Miao; Luo, Xin; Kraus, W. Lee; Greene, Geoffrey L.			Mapping ER beta Genomic Binding Sites Reveals Unique Genomic Features and Identifies EBF1 as an ER beta Interactor	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; GENE-EXPRESSION; BONE-MARROW; ENHANCES OSTEOGENESIS; WIDE ANALYSIS; TARGET GENES; CELL-LINES; CHIP-SEQ; ALPHA; ADIPOGENESIS	Considerable effort by numerous laboratories has resulted in an improved understanding of estrogen and SERM action mediated by the two estrogen receptors, ER alpha and ER beta. However, many of the targets for ER beta in cell physiology remain elusive. Here, the C4-12/Flag.ER beta cell line which stably expressed Flag. ER beta is used to study ER beta genomic functions without ER alpha interference. Mapping ER beta binding sites in these cells reveals ER beta unique distribution and motif enrichment patterns. Accompanying our mapping results, nascent RNA profiling is performed on cells at the same treatment time. The combined results allow the identification of ER beta target genes. Gene ontology analysis reveals that ER beta targets are enriched in differentiation, development and apoptosis. Concurrently, E2 treatment suppresses proliferation in these cells. Within ER beta binding sites, while the most prevalent binding motif is the canonical ERE, motifs of known ER interactors are also enriched in ER beta binding sites. Moreover, among enriched binding motifs are those of GFI, REST and EBF1, which are unique to ER beta binding sites in these cells. Further characterization confirms the association between EBF1 and the estrogen receptors, which favors the N-terminal region of the receptor. Furthermore, EBF1 negatively regulates ERs at the protein level. In summary, by studying ER beta genomic functions in our cell model, we confirm the anti-proliferative role of ER beta and discover the novel cross talk of ER beta with EBF1 which has various implications in normal physiology.	[Le, Thien P.; Greene, Geoffrey L.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sun, Miao; Luo, Xin; Kraus, W. Lee] Univ Texas Southwestern, Green Ctr Reprod Biol Sci, Dallas, TX USA	University of Chicago; University of Texas System; University of Texas Southwestern Medical Center Dallas	Greene, GL (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	ggreene@uchicago.edu			Virginia and D. K. Ludwig Fund; NCI [CA089489]; DOD PCRP [W81XWH-09-1-0297]; NIH/NIDDK [R01 DK058110]; University of Chicago Cancer Center Support Grant [CA 014599]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA089489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD PCRP; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Chicago Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Virginia and D. K. Ludwig Fund (GG), NCI CA089489 (GG), DOD PCRP W81XWH-09-1-0297 (TL), NIH/NIDDK R01 DK058110 (WLK) and the University of Chicago Cancer Center Support Grant CA 014599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblad P, 2005, PHYSIOL GENOMICS, V23, P206, DOI 10.1152/physiolgenomics.00015.2005; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; Bianco NR, 2003, MOL ENDOCRINOL, V17, P1344, DOI 10.1210/me.2002-0382; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Deroo BJ, 2010, MOL ENDOCRINOL, V24, P1703, DOI 10.1210/me.2009-0288; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gimble JM, 1998, CRIT REV EUKAR GENE, V8, P141, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.30; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hill L, 2011, MOL MED, V17, P211, DOI 10.2119/molmed.2010.00172; Hurtado A, 2008, CELL ONCOL, V30, P349, DOI 10.3233/CLO-2008-0430; Islander U, 2003, IMMUNOLOGY, V110, P149, DOI 10.1046/j.1365-2567.2003.01704.x; Jeong S, 2011, ACTA PHARMACOL SIN, V32, P230, DOI 10.1038/aps.2010.198; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Liao DQ, 2009, MOL CANCER RES, V7, P1893, DOI 10.1158/1541-7786.MCR-09-0229; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; MASOOD S, 1992, DIAGN CYTOPATHOL, V8, P475, DOI 10.1002/dc.2840080508; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; McInerney EM, 1998, ENDOCRINOLOGY, V139, P4513, DOI 10.1210/en.139.11.4513; Medina KL, 2000, BLOOD, V95, P2059, DOI 10.1182/blood.V95.6.2059; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Murphy LC, 2012, SEMIN REPROD MED, V30, P5, DOI 10.1055/s-0031-1299592; Oesterreich S, 2001, CANCER RES, V61, P5771; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; SMITHSON G, 1994, J EXP MED, V180, P717, DOI 10.1084/jem.180.2.717; Snyder MA, 2010, J NEUROSCI METH, V188, P226, DOI 10.1016/j.jneumeth.2010.02.012; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Walker MP, 2011, ONCOGENE, P1; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang M, 2009, PHYTOTHER RES, V23, P713, DOI 10.1002/ptr.2724; Zhao LY, 2006, CANCER RES, V66, P9445, DOI 10.1158/0008-5472.CAN-06-1713	58	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71355	10.1371/journal.pone.0071355	http://dx.doi.org/10.1371/journal.pone.0071355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951143	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000053
J	Rong, GH; Kang, H; Wang, YJ; Hai, T; Sun, HC				Rong, Guohua; Kang, Hua; Wang, Yajun; Hai, Tao; Sun, Haichen			Candidate Markers That Associate with Chemotherapy Resistance in Breast Cancer through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs)	PLOS ONE			English	Article							STROMAL FIBROBLASTS; PREDICTS RESISTANCE; SYSTEMIC THERAPY; STEM-CELLS; GROWTH; PROGRESSION; INTERLEUKIN-8; INVASION; MODEL; CXCR2	Recently, emerging evidence has suggested that carcinoma-associated fibroblasts (CAFs) could contribute to chemotherapy resistances in breast cancer treatment. The aim of this study is to compare the gene expression profiling of CAFs before and after chemotherapy and pick up candidate genes that might associate with chemotherapy resistance and could be used as predictors of treatment response. CAFs were cultured from surgically resected primary breast cancers and identified with immunohistochemistry (IHC) and Flow cytometry (FCM). MDA-MB-231 cells were cultured as the breast cancer cell line. Cell adhesion assay, invasion assay, and proliferation assay (MTT) were performed to compare the function of MDA-MB-231 cells co-cultured with CAFs and MDA-MB-231 cells without co-culture, after chemotherapy. Totally 6 pairs of CAFs were prepared for microarray analysis. Each pair of CAFs were obtained from the same patient and classified into two groups. One group was treated with Taxotere (regarded as after chemotherapy) while the other group was not processed with Taxotere (regarded as before chemotherapy). According to our study, the primary-cultured CAFs exhibited characteristic phenotype. After chemotherapy, MDA-MB-231 cells co-cultured with CAFs displayed increasing adhesion, invasiveness and proliferation abilities, compared with MDA-MB-231 cells without CAFs. Moreover, 35 differentially expressed genes (absolute fold change >2) were identified between CAFs after chemotherapy and before chemotherapy, including 17 up-regulated genes and 18 down-regulated genes. CXCL2, MMP1, IL8, RARRES1, FGF1, and CXCR7 were picked up as the candidate markers, of which the differential expression in CAFs before and after chemotherapy was confirmed. The results indicate the changes of gene expression in CAFs induced by Taxotere treatment and propose the candidate markers that possibly associate with chemotherapy resistance in breast cancer.	[Rong, Guohua; Kang, Hua; Wang, Yajun; Hai, Tao] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China; [Sun, Haichen] Capital Med Univ, Xuanwu Hosp, Surg Lab, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Kang, H (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China.	kanghua@xwh.ccmu.edu.cn			National Natural Science Fund [81172517]; Specialized Research Fund for the Doctoral Program of Higher Education from China [20111107110001]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education from China	The work was supported by National Natural Science Fund, No. 81172517 and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20111107110001) from China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Artacho-Cordon A, 2012, CANCER BIOL THER, V13, P14, DOI 10.4161/cbt.13.1.18869; Burgess M, 2010, LEUKEMIA LYMPHOMA, V29, P285; Burgess M, 2012, LEUKEMIA LYMPHOMA, V53, P1988, DOI 10.3109/10428194.2012.672735; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Han W, 2011, EXP THER MED, V2, P799, DOI 10.3892/etm.2011.299; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Hilton J, 2012, ONCOL LETT, V4, P141, DOI 10.3892/ol.2012.697; Hu C, 2013, GENE, V1119, P1644; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Jotzu C, 2010, ANAL CELL PATHOL, V33, P61, DOI [10.1155/2010/695162, 10.3233/ACP-CLO-2010-0535]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Korantzis I, 2012, ANTICANCER RES, V32, P4569; Kwok WK, 2009, CANCER GENET CYTOGEN, V194, P58, DOI 10.1016/j.cancergencyto.2009.06.005; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Li XL, 2012, CURR CANCER DRUG TAR, V12, P703, DOI 10.2174/156800912801784884; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marcinkowska E, 2006, ONCOL RES, V16, P27, DOI 10.3727/000000006783981242; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Netti PA, 2000, CANCER RES, V60, P2497; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Roberti MP, 2012, CANCER BIOL THER, V13, P1123, DOI 10.4161/cbt.21187; Perez EA, 2009, BREAST CANCER RES TR, V114, P195, DOI 10.1007/s10549-008-0005-6; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; RONNOVJESSEN L, 1992, J HISTOCHEM CYTOCHEM, V40, P475, DOI 10.1177/40.4.1552184; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snoussi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-283; Sonnenberg M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-364; Szlachcic A, 2012, INT J NANOMED, V7, P5915, DOI 10.2147/IJN.S36575; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trimis G, 2008, HUM MOL GENET, V17, P3596, DOI 10.1093/hmg/ddn252; Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101; Untch M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2227; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Wolff AC, 2008, J CLIN ONCOL, V26, P806, DOI 10.1200/JCO.2007.15.2983; Wu CC, 2006, EUR J CANCER, V42, P557, DOI 10.1016/j.ejca.2005.11.015	45	28	31	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70960	10.1371/journal.pone.0070960	http://dx.doi.org/10.1371/journal.pone.0070960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951052	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000034
J	Zhu, H; Xiao, SY; Liang, HJ				Zhu, Hong; Xiao, Shiyan; Liang, Haojun			Structural Dynamics of Human Telomeric G-Quadruplex Loops Studied by Molecular Dynamics Simulations	PLOS ONE			English	Article							NUCLEIC-ACID STRUCTURES; MICROSECOND TIME-SCALE; AMBER FORCE-FIELD; THROMBIN-BINDING; DNA QUADRUPLEX; STABILITY; GUANINE; GEOMETRY; CRYSTAL; SOLVENT	Loops which are linkers connecting G-strands and supporting the G-tetrad core in G-quadruplex are important for biological roles of G-quadruplexes. TTA loop is a common sequence which mainly resides in human telomeric DNA (hTel) G-quadruplex. A series of molecular dynamics (MD) simulations were carried out to investigate the structural dynamics of TTA loops. We found that (1) the TA base pair formed in TTA loops are very stable, the occupied of all hydrogen bonds are more than 0.95. (2) The TA base pair makes the adjacent G-quartet more stable than others. (3) For the edgewise loop and the diagonal loop, most loop bases are stacking with others, only few bases have considerable freedom. (4) The stabilities of these stacking structures are distinct. Part of the loops, especially TA base pairs, and bases stacking with the G-quartet, maintain certain stable conformations in the simulation, but other parts, like TT and TA stacking structures, are not stable enough. For the first time, spontaneous conformational switches of TTA edgewise loops were observed in our long time MD simulations. (5) For double chain reversal loop, it is really hard to maintain a stable conformation in the long time simulation under present force fields (parm99 and parmbsc0), as it has multiple conformations with similar free energies.	[Zhu, Hong; Xiao, Shiyan; Liang, Haojun] Univ Sci & Technol China, CAS Key Lab Soft Matter Chem, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China; [Liang, Haojun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liang, HJ (corresponding author), Univ Sci & Technol China, CAS Key Lab Soft Matter Chem, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China.	hjliang@ustc.edu.cn	Liang, Haojun/F-5960-2010	Xiao, Shiyan/0000-0003-1159-1224	National Natural Science Foundation of China (NNSFC) [20934004, 91127046]; National Basic Research Program of China (NBRPC) [2012CB821500, 2010CB934500]	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (NBRPC)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NNSFC) (Grant Nos. 20934004 and 91127046) (http://www.nsfc.gov.cn/), the National Basic Research Program of China (NBRPC) (Grant Nos. 2012CB821500 and 2010CB934500) (http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbieri CM, 2007, NUCLEIC ACIDS RES, V35, P3272, DOI 10.1093/nar/gkm188; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cang XH, 2011, J AM CHEM SOC, V133, P14270, DOI 10.1021/ja107805r; Cang XH, 2011, NUCLEIC ACIDS RES, V39, P4499, DOI 10.1093/nar/gkr031; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; Fadrna E, 2004, BIOPHYS J, V87, P227, DOI 10.1529/biophysj.103.034751; Fadrna E, 2009, J CHEM THEORY COMPUT, V5, P2514, DOI 10.1021/ct900200k; Gu JD, 2000, J PHYS CHEM A, V104, P6308, DOI 10.1021/jp000591f; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hazel P, 2006, NUCLEIC ACIDS RES, V34, P2117, DOI 10.1093/nar/gkl182; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Islam B, 2013, NUCLEIC ACIDS RES, V41, P2723, DOI 10.1093/nar/gks1331; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koirala D, 2012, CHEM COMMUN, V48, P2006, DOI 10.1039/c2cc16752b; Krepl M, 2012, J CHEM THEORY COMPUT, V8, P2506, DOI 10.1021/ct300275s; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Limongelli V, 2013, ANGEW CHEM INT EDIT, V52, P2269, DOI 10.1002/anie.201206522; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lu XJ, 1997, J MOL BIOL, V273, P668, DOI 10.1006/jmbi.1997.1346; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Mashimo T, 2010, J AM CHEM SOC, V132, P14910, DOI 10.1021/ja105806u; Meyer M, 2001, J COMPUT CHEM, V22, P109, DOI 10.1002/1096-987X(20010115)22:1<109::AID-JCC11>3.0.CO;2-5; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nagatoishi S, 2011, BIOCHIMIE, V93, P1231, DOI 10.1016/j.biochi.2011.03.013; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Olsen CM, 2009, J PHYS CHEM B, V113, P2587, DOI 10.1021/jp806853n; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Petraccone L, 2011, J AM CHEM SOC, V133, P20951, DOI 10.1021/ja209192a; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Reshetnikov R, 2010, J CHEM THEORY COMPUT, V6, P3003, DOI 10.1021/ct100253m; Risitano A, 2003, BIOCHEMISTRY-US, V42, P6507, DOI 10.1021/bi026997v; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sousa da Silva AW, 2012, BMC RES NOTES, V5, P367; Sponer J, 2007, METHODS, V43, P278, DOI 10.1016/j.ymeth.2007.02.004; Sponer J, 2012, METHODS, V57, P25, DOI 10.1016/j.ymeth.2012.04.005; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9	45	27	27	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71380	10.1371/journal.pone.0071380	http://dx.doi.org/10.1371/journal.pone.0071380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951152	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000055
J	Chao, TF; Lu, TM; Lin, YJ; Tsao, HM; Chang, SL; Lo, LW; Hu, YF; Tuan, TC; Hsieh, MH; Chen, SA				Chao, Tze-Fan; Lu, Tse-Min; Lin, Yenn-Jiang; Tsao, Hsuan-Ming; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Hsieh, Ming-Hsiung; Chen, Shih-Ann			Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; CARDIOVASCULAR EVENTS; STROKE; ADMA; OUTCOMES; LEVEL; DYSFUNCTION; MANAGEMENT; MORTALITY; PATHWAY	Objectives: Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases. This study aimed to investigate whether ADMA was a predictor of clinical outcomes in atrial fibrillation (AF). Methods and Results: From 2006-2009, 990 individuals were referred to our institution for coronary angiography. Among these patients, 141 subjects with a diagnosis of AF, including 52 paroxysmal AF (PAF) and 89 non-paroxysmal AF (non-PAF) patients, were identified as the study population. Plasma ADMA levels were measured. An adverse event was defined as the occurrence of ischemic stroke or cardiovascular death. The ADMA levels were higher in AF than non-AF patients (0.50 +/- 0.13 versus 0.45 +/- 0.07 mu mol/L; p<0.001). Besides, non-PAF patients had higher ADMA levels than PAF patients (0.52 +/- 0.15 versus 0.48 +/- 0.08 mu mol/L; p<0.001). During the follow-up of 30.7 +/- 14.4 months, 21 patients (14.9%) experienced adverse events, including cardiovascular death in 7 patients and ischemic stroke in 14. ADMA level, CHA(2)DS(2)-VASc score, and left atrial diameter were independent predictors of adverse events in the multivariate analysis. At a cutoff-value of 0.55 mu mol/L, the Kaplan-Meier survival analysis showed that patients with a high ADMA level had a higher event rate during the follow-up period. Conclusions: A higher level of ADMA was a risk factor of adverse events in AF patients, which was independent from the CHA(2)DS(2)-VASc score. It deserves to further study whether ADMA could potentially refine the clinical risk stratification in AF.	[Chao, Tze-Fan; Lu, Tse-Min; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Chao, Tze-Fan; Lu, Tse-Min; Lin, Yenn-Jiang; Tsao, Hsuan-Ming; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chao, Tze-Fan; Lu, Tse-Min; Lin, Yenn-Jiang; Tsao, Hsuan-Ming; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Tsao, Hsuan-Ming] Natl Yang Ming Univ Hosp, Div Cardiol, Ilan, Taiwan; [Hsieh, Ming-Hsiung] Taipei Med Univ, Wan Fang Hosp, Div Cardiol, Dept Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Municipal WanFang Hospital	Lu, TM (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.	tmlu@kimo.com; td7279@ms25.hinet.net	Chang, Shih-Lin/AGT-1191-2022		Taipei Veterans General Hospital, Taiwan [V99C1-120, V100C-109, V101C-060]; National Science Council, Taiwan [NSC98-2314-B-010-031-MY3, NSC 99-2911-I-008-100, NSC99-2628-B-075-007-MY3, NSC100-2314-B-010-033-MY3]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V99C1-120, V100C-109 and V101C-060) from Taipei Veterans General Hospital, Taiwan, and grants (NSC98-2314-B-010-031-MY3, NSC 99-2911-I-008-100, NSC99-2628-B-075-007-MY3, NSC100-2314-B-010-033-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cengel A, 2008, ACTA CARDIOL, V63, P33, DOI 10.2143/AC.63.1.2025329; Chan PS, 2011, AM J CARDIOL, V108, P1136, DOI 10.1016/j.amjcard.2011.06.017; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 2012, INT J CARDIOL, V154, P141, DOI 10.1016/j.ijcard.2010.09.004; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Li Y, 2011, J INTERV CARD ELECTR, V32, P147, DOI 10.1007/s10840-011-9588-7; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Liu HY, 2008, BIOCHEM BIOPH RES CO, V377, P884, DOI 10.1016/j.bbrc.2008.10.080; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Lu TM, 2011, CLIN J AM SOC NEPHRO, V6, P1566, DOI 10.2215/CJN.08490910; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Potpara TS, 2011, INT J CLIN PRACT, V65, P446, DOI 10.1111/j.1742-1241.2010.02618.x; Roldan V, 2012, J THROMB HAEMOST, V10, P1500, DOI 10.1111/j.1538-7836.2012.04812.x; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Wanby P, 2006, ATHEROSCLEROSIS, V185, P271, DOI 10.1016/j.atherosclerosis.2005.06.033; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xia W, 2008, PACE, V31, P1036, DOI 10.1111/j.1540-8159.2008.01131.x; Xia W, 2009, PACE, V32, P1562, DOI 10.1111/j.1540-8159.2009.02554.x	35	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71675	10.1371/journal.pone.0071675	http://dx.doi.org/10.1371/journal.pone.0071675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951217	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700112
J	Chen, SY; Sun, HX; Lei, YN; Gao, D; Wang, Y; Wang, YL; Zhou, Y; Wang, AX; Wang, WZ; Zhao, XQ				Chen, Shengyun; Sun, Haixin; Lei, Yanni; Gao, Ding; Wang, Yan; Wang, Yilong; Zhou, Yong; Wang, Anxin; Wang, Wenzhi; Zhao, Xingquan			Validation of the Los Angeles Pre-Hospital Stroke Screen (LAPSS) in a Chinese Urban Emergency Medical Service Population	PLOS ONE			English	Article							IDENTIFICATION; IMPACT; CARE	Background and purpose: Early and accurate diagnosis of stroke by emergency medical service (EMS) paramedics is critical for reducing pre-hospital delays. The Los Angeles pre-hospital stroke screen (LAPSS) has been widely used as a validated screening tool for early identifying stroke patients by EMS paramedics. However, validation of LAPSS has never been performed in Chinese stroke population. This study is aimed to verify the LAPSS for early identifying stroke patients in a Chinese urban EMS. Methods: 76 paramedics of five urban first aid stations attached to Beijing 120 EMS were involved. The paramedics were trained by professionals to quickly screen patients based on LAPSS. Potential "target stroke" individuals who met the base LAPSS screen criteria were identified. Sensitivity and specificity analyses of the LAPSS were calculated. Results: From June 10, 2009 to June 10, 2010, paramedics transported a total of 50,220 patients. 1550 patients who met the baseline screen criteria were identified as the potential "target stroke" population. 1130 patients had the completed LAPSS information datasheet and 997 patients were clinically diagnosed with stroke. The average time of completing the LAPSS was 4.3 +/- 3.0 minutes (median, 5 minutes). The sensitivity and specificity of the LAPSS in this study was 78.44% and 90.22%, respectively. After adjusting for age factor by excluding patients of >45 years old, the sensitivity was significantly increased to 82.95% with specificity unchanged. Conclusion: The paramedics of Beijing 120 EMS could efficiently use LAPSS as a screening tool for early identifying stroke patients. While the sensitivity of LAPSS in Chinese urban patient population was lower than those reported in previous LAPSS validation studies, the specificity was consistent with these studies. After excluded the item of "Age >45 years", the sensitivity was improved.	[Chen, Shengyun; Wang, Yan; Wang, Yilong; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Sun, Haixin; Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China; [Sun, Haixin; Wang, Wenzhi] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Lei, Yanni; Gao, Ding] Beijing Emergency Med Ctr, Beijing, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University	Wang, WZ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China.	qgnfbwwz@163.com; zxq@vip.163.com	Sun, HX/G-4628-2010		Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2007BAI24B03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (Grant No. 2007BAI24B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Bergs J, 2010, EUR J EMERG MED, V17, P2, DOI 10.1097/MEJ.0b013e32831040ec; Brainin M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074816; Bray JE, 2010, STROKE, V41, P1363, DOI 10.1161/STROKEAHA.109.571836; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Chen Z., 2008, 3 NATL SURVEY CAUSE, V1, P14; Frendl DM, 2009, STROKE, V40, P754, DOI 10.1161/STROKEAHA.108.531285; Jauch EC, 2010, CIRCULATION, V122, pS818, DOI 10.1161/CIRCULATIONAHA.110.971044; Kidwell C S, 1998, Prehosp Emerg Care, V2, P267, DOI 10.1080/10903129808958878; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Marini C, 1999, STROKE, V30, P2320, DOI 10.1161/01.STR.30.11.2320; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mosley I, 2007, STROKE, V38, P2765, DOI 10.1161/STROKEAHA.107.483446; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Sun HX, 2011, NEUROL RES, V33, P536, DOI 10.1179/016164111X13007856084368; Suyama J, 2002, EMERG MED CLIN N AM, V20, P537, DOI 10.1016/S0733-8627(02)00011-1; Wang YL, 2007, INT J STROKE, V2, P211, DOI 10.1111/j.1747-4949.2007.00142.x	18	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70742	10.1371/journal.pone.0070742	http://dx.doi.org/10.1371/journal.pone.0070742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950994	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700051
J	Gallo, SA; Carpenter, AS; Glisson, SR				Gallo, Stephen A.; Carpenter, Afton S.; Glisson, Scott R.			Teleconference versus Face-to-Face Scientific Peer Review of Grant Application: Effects on Review Outcomes	PLOS ONE			English	Review							RELIABILITY; PERFORMANCE	Teleconferencing as a setting for scientific peer review is an attractive option for funding agencies, given the substantial environmental and cost savings. Despite this, there is a paucity of published data validating teleconference-based peer review compared to the face-to-face process. Our aim was to conduct a retrospective analysis of scientific peer review data to investigate whether review setting has an effect on review process and outcome measures. We analyzed reviewer scoring data from a research program that had recently modified the review setting from face-to-face to a teleconference format with minimal changes to the overall review procedures. This analysis included approximately 1600 applications over a 4-year period: two years of face-to-face panel meetings compared to two years of teleconference meetings. The average overall scientific merit scores, score distribution, standard deviations and reviewer inter-rater reliability statistics were measured, as well as reviewer demographics and length of time discussing applications. The data indicate that few differences are evident between face-to-face and teleconference settings with regard to average overall scientific merit score, scoring distribution, standard deviation, reviewer demographics or inter-rater reliability. However, some difference was found in the discussion time. These findings suggest that most review outcome measures are unaffected by review setting, which would support the trend of using teleconference reviews rather than face-to-face meetings. However, further studies are needed to assess any correlations among discussion time, application funding and the productivity of funded research projects.	[Gallo, Stephen A.; Carpenter, Afton S.; Glisson, Scott R.] American Inst Biol Sci, Sci Peer Advisory & Review Serv SPARS Div, Reston, VA USA		Gallo, SA (corresponding author), American Inst Biol Sci, Sci Peer Advisory & Review Serv SPARS Div, Reston, VA USA.	sgallo@aibs.org		Gallo, Stephen/0000-0001-6043-2153				Alberts B, 2008, SCIENCE, V321, P15, DOI 10.1126/science.1162115; Bohannon J, 2011, SCIENCE, V331, P27, DOI 10.1126/science.331.6013.27; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; DiSilvestro RL, 1997, BIOSCIENCE, V47, P643, DOI 10.1093/bioscience/47.10.643; Driskell JE, 2003, GROUP DYN-THEOR RES, V7, P297, DOI 10.1037/1089-2699.7.4.297; Egido C, 1990, INTELLECTUAL TEAMWOR, P351; Fogelholm M, 2012, J CLIN EPIDEMIOL, V65, P47, DOI 10.1016/j.jclinepi.2011.05.001; Graetz KA, 1998, SMALL GR RES, V29, P714, DOI 10.1177/1046496498296003; HARGENS LL, 1990, SCIENTOMETRICS, V19, P91, DOI 10.1007/BF02130467; HARMON J, 1995, ORGAN BEHAV HUM DEC, V61, P138, DOI 10.1006/obhd.1995.1011; Ip EH, 2011, CONTEMP CLIN TRIALS, V32, P225, DOI 10.1016/j.cct.2010.11.001; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Martin MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013526; National Institutes of Health, 1996, REP COMM RAT GRANT A; Obrecht M, 2007, RES EVALUAT, V16, P79; Overbeke J, 2003, PEER REV HLTH SCI, P45; Rogelberg SG, 2002, J APPL PSYCHOL, V87, P994, DOI 10.1037//0021-9010.87.5.994; SCHWARTZ SM, 1995, BIOSCIENCE, V45, P558, DOI 10.1093/bioscience/45.8.558; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; Wood F., 2003, PEER REV HLTH SCI, V2nd ed., P14	23	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71693	10.1371/journal.pone.0071693	http://dx.doi.org/10.1371/journal.pone.0071693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951223	gold, Green Submitted, Green Published			2022-12-27	WOS:000323109700113
J	Nieminen, JK; Niemi, M; Sipponen, T; Salo, HM; Klemetti, P; Farkkila, M; Vakkila, J; Vaarala, O				Nieminen, Janne K.; Niemi, Mirja; Sipponen, Taina; Salo, Harri M.; Klemetti, Paula; Farkkila, Martti; Vakkila, Jukka; Vaarala, Outi			Dendritic Cells from Crohn's Disease Patients Show Aberrant STAT1 and STAT3 Signaling	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CD8(+) T-CELLS; REGULATORY-CELLS; ACTIVATION; BLOOD; EXPRESSION; INDUCTION; TOLERANCE; CD4(+); INTERLEUKIN-6	Abnormalities of dendritic cells (DCs) and STAT proteins have been reported in Crohn's disease (CD). Studies on JAK/STAT signaling in DCs are, however, lacking in CD. We applied a flowcytometric single-cell-based phosphoepitope assay to evaluate STAT1 and STAT3 pathways in DC subsets from CD patients. In addition, circulating DC counts were determined, together with the activation-related immunophenotype. We found that IL-6- and IFN-alpha-induced STAT3 phosphorylation and IFN-alpha-induced STAT1 phosphorylation were impaired in plasmacytoid DCs (pDCs) from CD patients (P = 0.005, P = 0.013, and P = 0.006, respectively). In myeloid DCs (mDCs), IFN-alpha-induced STAT1 and STAT3 phosphorylation were attenuated (P < 0.001 and P = 0.048, respectively), but IL-10-induced STAT3 phosphorylation was enhanced (P = 0.026). IFN-gamma-induced STAT1 signaling was intact in both DC subtypes. Elevated plasma IL-6 levels were detected in CD (P = 0.004), which strongly correlated with disease activity (rho = 0.690, P < 0.001) but not with IL-6-induced STAT3 phosphorylation. The numbers of pDCs and BDCA3+ mDCs were decreased, and CD40 expression on CD1c+ mDCs was increased in CD. When elucidating the effect of IL-6 signaling on pDC function, we observed that IL-6 treatment of healthy donor pDCs affected the maturation of and modified the T-cell priming by pDCs, favoring Th2 over Th1 type of response and the expression of IL-10 in T cells. Our results implicate DC signaling in human CD. Reduced IL-6 responsiveness in pDCs, together with the attenuated IFN-alpha-induced signaling in both DC subtypes, may contribute to the immunological dysregulation in CD patients.	[Nieminen, Janne K.; Niemi, Mirja; Salo, Harri M.; Klemetti, Paula; Vaarala, Outi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Immune Response Unit, Helsinki, Finland; [Sipponen, Taina; Farkkila, Martti] Univ Helsinki, Cent Hosp, Div Gastroenterol, Dept Med, Helsinki, Finland; [Vakkila, Jukka] Univ Helsinki, Hematol Res Unit, Helsinki, Finland; [Vakkila, Jukka] Univ Helsinki, Cent Hosp, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Nieminen, JK (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Immune Response Unit, Helsinki, Finland.	janne.nieminen@thl.fi	Färkkilä, Martti/AAG-6970-2021	Färkkilä, Martti/0000-0002-0250-8559; Sipponen, Taina/0000-0002-8069-5273; Nieminen, Janne/0000-0003-4089-163X	Finska Lakaresallskapet; Sigrid Juselius Foundation	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	JKN and OV were supported in part by grants from Finska Lakaresallskapet and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2011, CLIN EXP IMMUNOL, V166, P46, DOI 10.1111/j.1365-2249.2011.04439.x; Baumgart DC, 2009, CLIN EXP IMMUNOL, V157, P423, DOI 10.1111/j.1365-2249.2009.03981.x; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Jongbloed SL, 2009, J IMMUNOL, V182, P963, DOI 10.4049/jimmunol.182.2.963; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kato A, 2009, REGUL TOXICOL PHARM, V53, P46, DOI 10.1016/j.yrtph.2008.10.007; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kurche JS, 2012, J IMMUNOL, V188, P585, DOI 10.4049/jimmunol.1102550; Kuwana M, 2001, EUR J IMMUNOL, V31, P2547, DOI 10.1002/1521-4141(200109)31:9<2547::AID-IMMU2547>3.0.CO;2-J; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; MAHIDA YR, 1991, GUT, V32, P1531, DOI 10.1136/gut.32.12.1531; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Musso A, 2005, INFLAMM BOWEL DIS, V11, P91, DOI 10.1097/00054725-200502000-00001; Nancey S, 2008, DIGEST DIS SCI, V53, P242, DOI 10.1007/s10620-007-9849-6; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Sakuraba A, 2009, GASTROENTEROLOGY, V137, P1736, DOI 10.1053/j.gastro.2009.07.049; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Silva MA, 2004, INFLAMM BOWEL DIS, V10, P504, DOI 10.1097/00054725-200409000-00003; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Velde AAT, 2003, EUR J IMMUNOL, V33, P143, DOI 10.1002/immu.200390017; Willson TA, 2013, INFLAMM BOWEL DIS, V19, P512, DOI 10.1097/MIB.0b013e31828028ad; Willson TA, 2012, J PEDIATR GASTR NUTR, V55, P32, DOI 10.1097/MPG.0b013e318246be78; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110	50	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70738	10.1371/journal.pone.0070738	http://dx.doi.org/10.1371/journal.pone.0070738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950992	gold, Green Submitted, Green Published			2022-12-27	WOS:000323109700050
J	Daley, MA; Bramble, DM; Carrier, DR				Daley, Monica A.; Bramble, Dennis M.; Carrier, David R.			Impact Loading and Locomotor-Respiratory Coordination Significantly Influence Breathing Dynamics in Running Humans	PLOS ONE			English	Article							MUSCLE FATIGUE; HUMAN WALKING; DIAPHRAGMATIC FATIGUE; METABOLIC COST; LUNG-FUNCTION; NEONATAL-RAT; EXERCISE; PERFORMANCE; ENTRAINMENT; VENTILATION	Locomotor-respiratory coupling (LRC), phase-locking between breathing and stepping rhythms, occurs in many vertebrates. When quadrupedal mammals gallop, 1: 1 stride per breath coupling is necessitated by pronounced mechanical interactions between locomotion and ventilation. Humans show more flexibility in breathing patterns during locomotion, using LRC ratios of 2: 1, 2.5:1, 3: 1, or 4: 1 and sometimes no coupling. Previous studies provide conflicting evidence on the mechanical significance of LRC in running humans. Some studies suggest LRC improves breathing efficiency, but others suggest LRC is mechanically insignificant because 'step-driven flows' (ventilatory flows attributable to step-induced forces) contribute a negligible fraction of tidal volume. Yet, although step-driven flows are brief, they cause large fluctuations in ventilatory flow. Here we test the hypothesis that running humans use LRC to minimize antagonistic effects of step-driven flows on breathing. We measured locomotor-ventilatory dynamics in 14 subjects running at a self-selected speed (2.6 +/- 0.1 ms(-1)) and compared breathing dynamics in their naturally 'preferred' and 'avoided' entrainment patterns. Step-driven flows occurred at 1-2X step frequency with peak magnitudes of 0.97 +/- 0.45 Ls(-1) (mean +/- S.D). Step-driven flows varied depending on ventilatory state (high versus low lung volume), suggesting state-dependent changes in compliance and damping of thoraco-abdominal tissues. Subjects naturally preferred LRC patterns that minimized antagonistic interactions and aligned ventilatory transitions with assistive phases of the step. Ventilatory transitions initiated in 'preferred' phases within the step cycle occurred 2x faster than those in 'avoided' phases. We hypothesize that humans coordinate breathing and locomotion to minimize antagonistic loading of respiratory muscles, reduce work of breathing and minimize rate of fatigue. Future work could address the potential consequences of locomotor-ventilatory interactions for elite endurance athletes and individuals who are overweight or obese, populations in which respiratory muscle fatigue can be limiting.	[Daley, Monica A.] Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England; [Bramble, Dennis M.; Carrier, David R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of London; University of London Royal Veterinary College; Utah System of Higher Education; University of Utah	Daley, MA (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield, Herts, England.	mdaley@rvc.ac.uk	Daley, Monica A/AAE-5079-2019	Daley, Monica A/0000-0001-8584-2052				AARON EA, 1992, J APPL PHYSIOL, V72, P1818, DOI 10.1152/jappl.1992.72.5.1818; ALEXANDER RM, 1989, J ZOOL, V218, P69, DOI 10.1111/j.1469-7998.1989.tb02526.x; Babcock MA, 1996, J APPL PHYSIOL, V81, P2156, DOI 10.1152/jappl.1996.81.5.2156; Babcock MA, 2002, J APPL PHYSIOL, V93, P201, DOI 10.1152/japplphysiol.00612.2001; BANZETT RB, 1992, J APPL PHYSIOL, V72, P1922, DOI 10.1152/jappl.1992.72.5.1922; BAUDINETTE RV, 1987, J EXP BIOL, V129, P251; BERNASCONI P, 1995, EUR J APPL PHYSIOL O, V70, P387, DOI 10.1007/BF00618488; BERNASCONI P, 1993, J PHYSIOL-LONDON, V471, P693, DOI 10.1113/jphysiol.1993.sp019923; Boggs DF, 2002, COMP BIOCHEM PHYS A, V133, P269, DOI 10.1016/S1095-6433(02)00160-5; Bonsignore MR, 1998, MED SCI SPORT EXER, V30, P239, DOI 10.1097/00005768-199802000-00011; BRAMBLE DM, 1983, SCIENCE, V219, P251, DOI 10.1126/science.6849136; BRAMBLE DM, 1993, SCIENCE, V262, P235, DOI 10.1126/science.8211141; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BRAMBLE DM, 1989, AM ZOOL, V29, P171; Browning RC, 2009, J BIOMECH, V42, P2273, DOI 10.1016/j.jbiomech.2009.06.046; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; CARRIER DR, 1991, AM ZOOL, V31, P644; Carrier DR, 1996, J EXP BIOL, V199, P1455; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; Daley MA, 2010, BIOL LETTERS, V6, P418, DOI 10.1098/rsbl.2010.0175; Deban SM, 2002, J EXP BIOL, V205, P1953; DEMPSEY JA, 1996, HDB PHYSIOL 12, P448; DeTroyer A, 1991, LUNG SCI F, P869; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Dominelli PB, 2012, RESP PHYSIOL NEUROBI, V180, P147, DOI 10.1016/j.resp.2011.10.005; Dreher M, 2012, RESPIROLOGY, V17, P899, DOI 10.1111/j.1440-1843.2012.02151.x; Ebert D, 2000, EUR J APPL PHYSIOL, V81, P288, DOI 10.1007/s004210050045; Fabre N, 2007, RESP PHYSIOL NEUROBI, V155, P128, DOI 10.1016/j.resp.2006.04.015; Funk GD, 1997, J EXP BIOL, V200, P915; FUNK GD, 1993, J EXP BIOL, V175, P317; Giraudin A, 2008, J NEUROPHYSIOL, V99, P2626, DOI 10.1152/jn.01298.2007; Giraudin A, 2012, J NEUROSCI, V32, P11841, DOI 10.1523/JNEUROSCI.0360-12.2012; Giuliodori MJ, 2009, ADV PHYSIOL EDUC, V33, P315, DOI 10.1152/advan.00057.2009; Hodges PW, 2000, J APPL PHYSIOL, V89, P967, DOI 10.1152/jappl.2000.89.3.967; Johnson BD, 1996, MED SCI SPORT EXER, V28, P1129, DOI 10.1097/00005768-199609000-00008; JOHNSON BD, 1993, J PHYSIOL-LONDON, V460, P385, DOI 10.1113/jphysiol.1993.sp019477; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; LOKE J, 1982, J APPL PHYSIOL, V52, P821, DOI 10.1152/jappl.1982.52.4.821; Loring S.H., 1985, THORAX A, P327; LORING SH, 1992, J APPL PHYSIOL, V72, P1461, DOI 10.1152/jappl.1992.72.4.1461; MADOR MJ, 1993, AM REV RESPIR DIS, V148, P1571, DOI 10.1164/ajrccm/148.6_Pt_1.1571; MAHLER DA, 1981, AM REV RESPIR DIS, V124, P154; McDermott WJ, 2003, EUR J APPL PHYSIOL, V89, P435, DOI 10.1007/s00421-003-0831-5; Nassar PN, 2001, J EXP BIOL, V204, P1641; O'Halloran J, 2012, EUR J APPL PHYSIOL, V112, P929, DOI 10.1007/s00421-011-2040-y; PERSEGOL L, 1991, J PHYSIOL-PARIS, V85, P38; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; Pontzer H, 2009, J EXP BIOL, V212, P523, DOI 10.1242/jeb.024927; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Raichlen DA, 2011, J HUM EVOL, V60, P299, DOI 10.1016/j.jhevol.2010.11.002; Rassler B, 1996, J MOTOR BEHAV, V28, P48; Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007; Romer LM, 2002, MED SCI SPORT EXER, V34, P785, DOI 10.1097/00005768-200205000-00010; Saunders SW, 2004, GAIT POSTURE, V20, P280, DOI 10.1016/j.gaitpost.2003.10.003; Simons RS, 1996, J MORPHOL, V230, P299; Simons RS, 1999, J EXP BIOL, V202, P563; Soo CH, 2010, J EXP BIOL, V213, P4265, DOI 10.1242/jeb.044214; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Villiot-Danger JC, 2011, INT J OBESITY, V35, P692, DOI 10.1038/ijo.2010.191; WARREN GL, 1989, RESP PHYSIOL, V78, P253, DOI 10.1016/0034-5687(89)90057-1; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	65	35	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70752	10.1371/journal.pone.0070752	http://dx.doi.org/10.1371/journal.pone.0070752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950997	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300046
J	Machado, N; Loyola, RD				Machado, Nathalia; Loyola, Rafael Dias			A Comprehensive Quantitative Assessment of Bird Extinction Risk in Brazil	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; GAP ANALYSIS; RANGE SIZE; DEFORESTATION; POPULATION; PRIORITIES; DIVERSITY; PATTERNS; DECLINE	In an effort to avoid species loss, scientists have focused their efforts on the mechanisms making some species more prone to extinction than others. However, species show different responses to threats given their evolutionary history, behavior, and intrinsic biological features. We used bird biological features and external threats to (1) understand the multiple pathways driving Brazilian bird species to extinction, (2) to investigate if and how extinction risk is geographically structured, and (3) to quantify how much diversity is currently represented inside protected areas. We modeled the extinction risk of 1557 birds using classification trees and evaluated the relative contribution of each biological feature and external threat in predicting extinction risk. We also quantified the proportion of species and their geographic range currently protected by the network of Brazilian protected areas. The optimal classification tree showed different pathways to bird extinction. Habitat conversion was the most important predictor driving extinction risk though other variables, such as geographic range size, type of habitat, hunting or trapping and trophic guild, were also relevant in our models. Species under higher extinction risk were concentrated mainly in the Cerrado Biodiversity Hotspot and were not quite represented inside protected areas, neither in richness nor range. Predictive models could assist conservation actions, and this study could contribute by highlighting the importance of natural history and ecology in these actions.	[Machado, Nathalia; Loyola, Rafael Dias] Univ Fed Goias, Dept Ecol, Conservat Biogeog Lab, Goiania, Go, Brazil; [Machado, Nathalia] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Loyola, RD (corresponding author), Univ Fed Goias, Dept Ecol, Conservat Biogeog Lab, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735	CAPES; CNPq [304703/2011-7]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	NM received a PhD scholarship from CAPES. RDL received a productivity research grant from CNPq (grant # 304703/2011-7). Research in the Conservation Biogeography Lab has been continuously supported by CNPq, CAPES, and Conservation International Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anciaes M, 2006, CONDOR, V108, P778, DOI 10.1650/0010-5422(2006)108[778:CCEONM]2.0.CO;2; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2008, BIODIVERS CONSERV, V17, P2297, DOI 10.1007/s10531-007-9298-8; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Birdlife International, 2008, STAT WORLDS BIRDS IN; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Boyer AG, 2010, CONSERV BIOL, V24, P511, DOI 10.1111/j.1523-1739.2009.01341.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Collen B, 2006, BIODIVERS CONSERV, V15, P1859, DOI 10.1007/s10531-005-4303-6; DAFONSECA GAB, 1985, BIOL CONSERV, V34, P17, DOI 10.1016/0006-3207(85)90055-2; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10. 1016/j. brat. 2007. 10. 010, DOI 10.1016/J.BRAT.2007.10.010]; Gamer M, 2010, PACKAGE IRR, P31; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Harris GM, 2005, CONSERV BIOL, V19, P1957, DOI 10.1111/j.1523-1739.2005.00307.x; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN UNEP, 2010, WORLD DAT PROT AR WD, P1; Jenkins CN, 2011, NAT CONSERVACAO, V9, P152, DOI 10.4322/natcon.2011.021; Jenkins CN, 2006, BIOL CONSERVACAO ESS, P41; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jones H, 2008, POETRY WALES, V43, P22; Jones MJ, 2006, BIODIVERS CONSERV, V15, P1993, DOI 10.1007/s10531-005-4316-1; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Loiselle BA, 2010, J BIOGEOGR, V37, P1288, DOI 10.1111/j.1365-2699.2010.02285.x; Lopes LE, 2010, BIRD CONSERV INT, V20, P84, DOI 10.1017/S0959270909990190; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Murray S., 2000, PILOT ANAL GLOBAL EC; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Development Core Team, 2012, R LANG ENV STAT COMP; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Roff DA, 2003, EVOL ECOL RES, V5, P759; Rylands AB, 2005, CONSERV BIOL, V19, P612, DOI 10.1111/j.1523-1739.2005.00711.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Trindade J, 2012, BIOL CONSERV, V146, P155, DOI 10.1016/j.biocon.2011.12.004; Vale MM, 2008, CONSERV BIOL, V22, P1006, DOI 10.1111/j.1523-1739.2008.00939.x; Walk JW, 1999, AM MIDL NAT, V141, P339, DOI 10.1674/0003-0031(1999)141[0339:EOHAOT]2.0.CO;2	66	14	15	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72283	10.1371/journal.pone.0072283	http://dx.doi.org/10.1371/journal.pone.0072283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951302	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300185
J	Moss, AJ; Gaughran, FP; Karasu, A; Gilbert, AS; Mann, AJ; Gelder, CM; Oxford, JS; Stephens, HA; Lambkin-Williams, R				Moss, Alastair J.; Gaughran, Fiona P.; Karasu, Aliyye; Gilbert, Anthony S.; Mann, Alex J.; Gelder, Colin M.; Oxford, John S.; Stephens, Henry A.; Lambkin-Williams, Rob			Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination	PLOS ONE			English	Article							T-CELL RESPONSES; PROTECTION	Influenza is a major cause of morbidity and mortality. Despite vaccination, many elderly recipients do not develop a protective antibody response. To determine whether Human Leukocyte Antigen (HLA) alleles modulate seroprotection to influenza, a cohort of HLA class II-typed high-risk vaccine recipients was investigated. Haemagglutinin inhibition (HAI) titres were measured 14-40 days post-subunit vaccination. Seroprotection was defined as HAI titres reaching 40 or greater for all three vaccine strains. HLA-DRB1*04:01 and HLA-DPB1*04:01 alleles were detected at higher frequencies in seroprotected compared with non-seroprotected individuals. Thus, the presence of certain HLA class II alleles may determine the magnitude of antibody responses to influenza vaccination.	[Moss, Alastair J.] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England; [Gaughran, Fiona P.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Karasu, Aliyye; Stephens, Henry A.] Royal Free London NHS Fdn Trust, Anthony Nolan Labs, London, England; [Karasu, Aliyye; Stephens, Henry A.] Royal Free London NHS Fdn Trust, UCL Ctr Nephrol, London, England; [Gilbert, Anthony S.; Mann, Alex J.; Lambkin-Williams, Rob] Queen Mary BioEnterprises Innovat Ctr, Retroscreen Virol PLC, London, England; [Gelder, Colin M.; Oxford, John S.] Univ London, Queen Mary Sch Med & Dent, St Bartholomews & Royal London, London, England	University of Southampton; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; Queen Mary University London	Moss, AJ (corresponding author), Southampton Gen Hosp, Southampton SO9 4XY, Hants, England.	alastairmoss@gmail.com	Gaughran, Fiona/AAC-7160-2019; Lambkin-Williams, Rob/L-2397-2019; Gaughran, Fiona/H-5495-2011	Lambkin-Williams, Rob/0000-0003-2107-0174; Gaughran, Fiona/0000-0001-7414-5569; Gilbert, Anthony Saul/0000-0002-6582-3820; Moss, Alastair/0000-0003-4123-2070	UK National Health Service	UK National Health Service	This study was funded by the UK National Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges C B, 2001, MMWR Recomm Rep, V50, P1; Danke NA, 2003, J IMMUNOL, V171, P3163, DOI 10.4049/jimmunol.171.6.3163; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207; Desombere I, 1998, TISSUE ANTIGENS, V51, P593, DOI 10.1111/j.1399-0039.1998.tb03001.x; Gaughran F, 2007, J AM GERIATR SOC, V55, P1912, DOI 10.1111/j.1532-5415.2007.01471.x; Gebe JA, 2001, J IMMUNOL, V167, P3250, DOI 10.4049/jimmunol.167.6.3250; Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014; Gerolami K LM, 2001, HUMAN IMMUNOLOGY, V62; Iovannisci DM, 2006, GENET TEST, V10, P44, DOI 10.1089/gte.2006.10.44; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Schuenke KW, 1998, HUM IMMUNOL, V59, P783, DOI 10.1016/S0198-8859(98)00072-X; Whelan PJ, 2012, J MED ETHICS, P1; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yang JB, 2009, VACCINE, V27, P3862, DOI 10.1016/j.vaccine.2009.04.019	18	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71376	10.1371/journal.pone.0071376	http://dx.doi.org/10.1371/journal.pone.0071376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951151	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200044
J	Tripathi, N; Sekher, TV				Tripathi, Niharika; Sekher, T. V.			Youth in India Ready for Sex Education? Emerging Evidence from National Surveys	PLOS ONE			English	Article							FAMILY-LIFE EDUCATION; ADOLESCENTS; ATTITUDES; SEXUALITY; PROGRAMS; NEED	Context: Sex education/family life education (FLE) has been one of the highly controversial issues in Indian society. Due to increasing incidences of HIV/AIDS, RTIs/STIs and teenage pregnancies, there is a rising need to impart sex education. However, introducing sex education at school level always received mixed response from various segments of Indian society. Data and Methods: We attempt to understand the expectations and experiences of youth regarding family life education in India by analysing the data from District Level Household and Facility Survey (DLHS-3: 2007-08) and Youth Study in India (2006-07). We used descriptive methods to analyse the extent of access to FLE and socio demographic patterning among Indian youth. Results and Discussions: We found substantial gap between the proportion of youth who perceived sex education to be important and those who actually received it, revealing considerable unmet need for FLE. Youth who received FLE were relatively more aware about reproductive health issues than their counterparts. Majority among Indian youth, irrespective of their age and sex, favoured introduction of FLE at school level, preferably from standard 8th onwards. The challenge now is to develop a culturally-sensitive FLE curriculum acceptable to all sections of society.	[Tripathi, Niharika] Int Inst Populat Sci, Bombay, Maharashtra, India; [Sekher, T. V.] Int Inst Populat Sci, Dept Populat Policies & Programmes, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Tripathi, N (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	niharika.t2010@gmail.com	Sekher, T.V./ABD-4471-2020	Sekher, T.V./0000-0001-9725-002X; Tripathi, Niharika/0000-0002-7502-132X				ALEXANDER SJ, 1984, FAM RELAT, V33, P251, DOI 10.2307/583791; Anandhi S., 2007, ECON POLIT WEEKLY, V42, P3367; AVERY CE, 1964, FAM LIFE COODINATOR, V13, P27, DOI 10.2307/581561; Bhasin Sanjiv Kumar, 1999, Indian Journal of Pediatrics, V66, P527; D'Souza AA, 1979, SEX ED PERSONALITY D; DEVI G, 1988, J FAM WELFARE, V35, P55; Editorial EPW, 2007, ECON POLIT WEEKLY, V42, P3188; Gentleman A, 2007, NY TIMES; Government of India (GOI), 2000, NAT POP POL; Government of India Ministry of Women and Child Development, 2007, STUD CHILD AB IND; Henry Jane A, 2010, Indian J Community Med, V35, P373, DOI 10.4103/0970-0218.69246; Holzner BM, 2004, REPROD HEALTH MATTER, V12, P40, DOI 10.1016/S0968-8080(04)23122-6; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Institute for Population Sciences & Population Council, 2010, YOUTH IND SIT NEEDS; Israel S, 1967, J FAMILY WELFARE, V13; Jejeebhoy SJ, 1998, SOC SCI MED, V46, P1275, DOI 10.1016/S0277-9536(97)10056-9; Kafewo SA, 2008, REPROD HEALTH MATTER, V16, P202, DOI 10.1016/S0968-8080(08)31356-1; Lule E, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1109; MARSMAN JC, 1986, FAM RELAT, V35, P357, DOI 10.2307/584361; MASLINOFF L, 1973, FAM COORD, V22, P405, DOI 10.2307/583311; McElderry Darby H, 2003, Int J Adolesc Med Health, V15, P3; MOSES S, 1983, J FAM WELFARE, V30, P34; Motihar R., 2008, TRADITION MODERNITY; Munoz M, 2001, REPROD HEALTH MATTER, V9, P146, DOI 10.1016/S0968-8080(01)90018-7; Rajya Sabha, 2013, 145 RAJY SECR; RAO MP, 1988, J FAM WELFARE, V35, P42; Santhya K. G., 2003, Economic and Political Weekly, V38, P4370; Sengupta A., 2009, GUARDIAN; Strasburger VC, 2000, MED CLIN N AM, V84, P787, DOI 10.1016/S0025-7125(05)70261-3; Thakor Hitendra G., 2000, Indian Journal of Pediatrics, V67, P551, DOI 10.1007/BF02758475; UNFPA, 2011, AD REPR SEX HLTH; UNICEF, 2011, STAT WORLDS CHILDR A; Unni JC, 2010, INDIAN PEDIATR, V47, P176, DOI 10.1007/s13312-010-0029-y; Vishnoi A, 2009, INDIAN EXPRESS; World Health Organization, 2003, WHO INF SER SCH HLTH; Yashwantha CP, 2010, HINDU	37	33	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71584	10.1371/journal.pone.0071584	http://dx.doi.org/10.1371/journal.pone.0071584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23951197	Green Published, gold			2022-12-27	WOS:000326473200058
J	Segura-Cabrera, A; Garcia-Perez, CA; Guo, XW; Rodriguez-Perez, MA				Segura-Cabrera, Aldo; Garcia-Perez, Carlos A.; Guo, Xianwu; Rodriguez-Perez, Mario A.			A Viral-Human Interactome Based on Structural Motif-Domain Interactions Captures the Human Infectome	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NUCLEAR-LOCALIZATION SIGNAL; DENGUE VIRUS; PROTEIN INTERACTIONS; CORE PROTEIN; NS5 PROTEIN; HIV-1; IMPORT; NETWORKS; SYSTEMS	Protein interactions between a pathogen and its host are fundamental in the establishment of the pathogen and underline the infection mechanism. In the present work, we developed a single predictive model for building a host-viral interactome based on the identification of structural descriptors from motif-domain interactions of protein complexes deposited in the Protein Data Bank (PDB). The structural descriptors were used for searching, in a database of protein sequences of human and five clinically important viruses; therefore, viral and human proteins sharing a descriptor were predicted as interacting proteins. The analysis of the host-viral interactome allowed to identify a set of new interactions that further explain molecular mechanism associated with viral infections and showed that it was able to capture human proteins already associated to viral infections (human infectome) and non-infectious diseases (human diseasome). The analysis of human proteins targeted by viral proteins in the context of a human interactome showed that their neighbors are enriched in proteins reported with differential expression under infection and disease conditions. It is expected that the findings of this work will contribute to the development of systems biology for infectious diseases, and help guide the rational identification and prioritization of novel drug targets.	[Segura-Cabrera, Aldo; Garcia-Perez, Carlos A.] Inst Politecn Nacl, Ctr Biotechnol Genom, Lab Bioinformat, Reynosa, Mexico; [Guo, Xianwu; Rodriguez-Perez, Mario A.] Inst Politecn Nacl, Ctr Biotechnol Genom, Lab Biomed Mol, Reynosa, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Segura-Cabrera, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	asegurac@ipn.mx	Guo, Xianwu/D-6709-2018; Rodriguez-Perez, Mario A./P-8814-2014; Perez, Mario A. Rodriguez/AAH-3572-2020	Rodriguez-Perez, Mario A./0000-0002-0905-6073; Perez, Mario A. Rodriguez/0000-0002-0905-6073; Segura-Cabrera, Aldo/0000-0003-3044-8028	Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacioanl [20130929]; Comision de Operacion y Fomento de Actividades Academicas (COFAA/IPN)	Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacioanl; Comision de Operacion y Fomento de Actividades Academicas (COFAA/IPN)	This work was supported by Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacioanl (http://www.sip.ipn.mx/) (Grant number: 20130929). Article processing fees were funded by Comision de Operacion y Fomento de Actividades Academicas (COFAA/IPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2011, J VIROL, V85, P8208, DOI 10.1128/JVI.00114-11; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Cha HJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001379; Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dampier W, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-47; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Doolittle JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-82; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Franzosa EA, 2011, P NATL ACAD SCI USA, V108, P10538, DOI 10.1073/pnas.1101440108; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Keskin O, 2000, ANTI-CANCER DRUG DES, V15, P79; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Kim B, 2010, PATHOLOGY, V42, P58, DOI 10.3109/00313020903356392; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Liu J, 2011, ARCH VIROL, V156, P1013, DOI 10.1007/s00705-011-0943-x; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meyniel-Schicklin L, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014738; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Nicolaides L, 2011, VIROLOGY, V414, P137, DOI 10.1016/j.virol.2011.03.017; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Team RDC, 2019, R LANG ENV STAT COMP; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vazquez-Ortiz G, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-68; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Webb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003254; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102; Zhang Y., 2012, HEPATOLOGY; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	86	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71526	10.1371/journal.pone.0071526	http://dx.doi.org/10.1371/journal.pone.0071526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951184	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000065
J	Cashman, DJ; Ortega, DR; Zhulin, IB; Baudry, J				Cashman, Derek J.; Ortega, Davi R.; Zhulin, Igor B.; Baudry, Jerome			Homology Modeling of the CheW Coupling Protein of the Chemotaxis Signaling Complex	PLOS ONE			English	Article							CHEMORECEPTOR ARRAYS; INTERACTION SURFACES; COMPUTER-SIMULATION; MOLECULAR-DYNAMICS; BINDING; SEQUENCE; FLUCTUATIONS; ARCHITECTURE; MECHANISM; KINASE	Homology models of the E. coli and T. maritima chemotaxis protein CheW were constructed to assess the quality of structural predictions and their applicability in chemotaxis research: i) a model of E. coli CheW was constructed using the T. maritima CheW NMR structure as a template, and ii) a model of T. maritima CheW was constructed using the E. coli CheW NMR structure as a template. The conformational space accessible to the homology models and to the NMR structures was investigated using molecular dynamics and Monte Carlo simulations. The results show that even though static homology models of CheW may be partially structurally different from their corresponding experimentally determined structures, the conformational space they can access through their dynamic variations can be similar, for specific regions of the protein, to that of the experimental NMR structures. When CheW homology models are allowed to explore their local accessible conformational space, modeling can provide a rational path to predicting CheW interactions with the MCP and CheA proteins of the chemotaxis complex. Homology models of CheW (and potentially, of other chemotaxis proteins) should be seen as snapshots of an otherwise larger ensemble of accessible conformational space.	[Cashman, Derek J.; Baudry, Jerome] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Cashman, Derek J.; Baudry, Jerome] Univ Tennessee, UT ORNL Ctr Mol Biophys, Knoxville, TN USA; [Ortega, Davi R.] Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA; [Ortega, Davi R.; Zhulin, Igor B.] Oak Ridge Natl Lab, Joint Inst Computat Sci, Oak Ridge, TN USA; [Zhulin, Igor B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Baudry, J (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	jbaudry@utk.edu	Zhulin, Igor/T-3509-2019; Zhulin, Igor B/A-2308-2012	Zhulin, Igor/0000-0002-6708-5323; Zhulin, Igor B/0000-0002-6708-5323; Cashman, Derek/0000-0002-6041-8922	National Institutes of Health [GM072285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM072285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre G, 2003, J BACTERIOL, V185, P544, DOI 10.1128/JB.185.2.544-552.2003; Vu A, 2012, J MOL BIOL, V415, P759, DOI 10.1016/j.jmb.2011.11.043; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boukhvalova M, 2002, J BIOL CHEM, V277, P23596, DOI 10.1074/jbc.M202288200; Boukhvalova MS, 2002, J BIOL CHEM, V277, P22251, DOI 10.1074/jbc.M110908200; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; CAPUTO A, 1994, NAT STRUCT BIOL, V1, P364, DOI 10.1038/nsb0694-364; CARSON M, 1994, ACTA CRYSTALLOGR D, V50, P889, DOI 10.1107/S0907444994004907; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; DROUPADI PR, 1994, MOL IMMUNOL, V31, P537, DOI 10.1016/0161-5890(94)90041-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Li Y, 2007, BIOCHEM BIOPH RES CO, V360, P863, DOI 10.1016/j.bbrc.2007.06.146; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mamonov AB, 2009, J PHYS CHEM B, V113, P10891, DOI 10.1021/jp901322v; Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; RING CS, 1993, P NATL ACAD SCI USA, V90, P3583, DOI 10.1073/pnas.90.8.3583; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; SALI A, 1993, J BIOL CHEM, V268, P9023; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; SUTCLIFFE MJ, 1992, BIOCHEMISTRY-US, V31, P2962, DOI 10.1021/bi00126a017; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; UEDA Y, 1978, BIOPOLYMERS, V17, P1531, DOI 10.1002/bip.1978.360170612; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Underbakke ES, 2011, J MOL BIOL, V409, P483, DOI 10.1016/j.jmb.2011.03.040; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Zhang K, 2012, MOL MICROBIOL, V85, P782, DOI 10.1111/j.1365-2958.2012.08139.x	48	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70705	10.1371/journal.pone.0070705	http://dx.doi.org/10.1371/journal.pone.0070705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950985	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700046
J	Chen, F; Shi, J; Luo, YQ; Sun, SY; Pu, M				Chen, Fang; Shi, Juan; Luo, You-qing; Sun, Shuang-yan; Pu, Min			Genetic Characterization of the Gypsy Moth from China (Lepidoptera, Lymantriidae) Using Inter Simple Sequence Repeats Markers	PLOS ONE			English	Article							DISPAR LEPIDOPTERA; DNA VARIATION; ISSR MARKERS; POPULATIONS; DIVERSITY	This study provides the first genetic characterization of the gypsy moth from China (Lymantria dispar), one of the most recognized pests of forests and ornamental trees in the world. We assessed genetic diversity and structure in eight geographic populations of gypsy moths from China using five polymorphic Inter simple sequence repeat markers, which produced reproducible banding patterns. We observed 102 polymorphic loci across the 176 individuals sampled. Overall genetic diversity (Nei's, H) was 0.2357, while the mean genetic diversity within geographic populations was 0.1845 +/- 0.0150. The observed genetic distance among the eight populations ranged from 0.0432 to 0.1034. Clustering analysis (using an unweighted pair-group method with arithmetic mean and multidimensional scaling), revealed strong concordance between the strength of genetic relationships among populations and their geographic proximity. Analysis of molecular variance demonstrated that 25.43% of the total variability (F-ST = 0.2543, P < 0.001) was attributable to variation among geographic populations. The results of our analyses investigating the degree of polymorphism, genetic diversity (Nei's and Shannon) and genetic structure, suggest that individuals from Hebei may be better able to adapt to different environments and to disperse to new habitats. This study provides crucial genetic information needed to assess the distribution and population dynamics of this important pest species of global concern.	[Chen, Fang; Shi, Juan; Luo, You-qing] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Sun, Shuang-yan; Pu, Min] Stand & Regulat Res Ctr AQSIQ, Beijing, Peoples R China	Beijing Forestry University	Shi, J (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	shi_juan@263.net; youqingluo@126.com			National Natural Science Foundation of China [31170613]; Fundamental Research Funds for the Central Universities [BLYJ201306]; Program for New Century Excellent Talents in University [NCET-10-0232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (31170613), the Fundamental Research Funds for the Central Universities (BLYJ201306), and Program for New Century Excellent Talents in University (NCET-10-0232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranchikov Y. N., 1989, ECOLOGICAL BASIS EVO; Bogdanowicz SM, 1997, ANN ENTOMOL SOC AM, V90, P768, DOI 10.1093/aesa/90.6.768; Bogdanowicz SM, 2000, MOL PHYLOGENET EVOL, V15, P487, DOI 10.1006/mpev.1999.0744; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Essadki M, 2006, GENET RESOUR CROP EV, V53, P475, DOI 10.1007/s10722-004-1931-8; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forbush E. H., 1896, GYPSY MOTH PORTHETRI, P495; Grativol C, 2011, MOL BIOL REP, V38, P4245, DOI 10.1007/s11033-010-0547-7; Gui FR, 2006, THESIS CHINESE ACAD, P1; Gupta S, 2010, AFR J BIOTECHNOL, V7; He L, 2007, FORENSIC SCI INT, V168, P148, DOI 10.1016/j.forsciint.2006.07.006; Keena MA, 2008, ENVIRON ENTOMOL, V37, P636, DOI 10.1603/0046-225X(2008)37[636:WDOFFA]2.0.CO;2; Keena MA, 1996, ANN ENTOMOL SOC AM, V89, P564, DOI 10.1093/aesa/89.4.564; Lewontin R. C., 1972, EVOL BIOL, V6, P1; Lin WH, 2006, J GUANGXI NORMAL U N, V24, P86; Liu JN, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5201; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pannacciulli FG, 2009, MAR BIOL, V156, P2441, DOI 10.1007/s00227-009-1269-z; PFEIFER TA, 1995, CAN ENTOMOL, V127, P49, DOI 10.4039/Ent12749-1; QIAN TR, 2000, PLANTS QUARANTINE, V14, P317; Reineke A, 1999, B ENTOMOL RES, V89, P79, DOI 10.1017/S0007485399000103; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vasconcelos S, MOL MARKERS ACCESS G; Fernandez MV, 2011, CR BIOL, V334, P705, DOI 10.1016/j.crvi.2011.07.005; Vijayan K, 2006, J INSECT SCI, V6, DOI 10.1673/2006_6_30.1; Wang LZ, 2006, FOREST PESTS DIS CHI, V25, P21; Yan MM, 2008, J ANHUI AGR SCI, V9, P39; Yeh F. C., 2000, POPGENE32 MICROSOFT; Zhang ZZ, 1988, GYPSY MOTH RES INTEG; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	34	28	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e73017	10.1371/journal.pone.0073017	http://dx.doi.org/10.1371/journal.pone.0073017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951339	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700139
J	Hu, YF; Lee, KT; Wang, HH; Ueng, KC; Yeh, HI; Chao, TF; Liao, JN; Lin, YJ; Chang, SL; Lo, LW; Tuan, TC; Li, CH; Chung, FP; Hsu, CP; Chang, HH; Huang, CH; Chen, SA				Hu, Yu-Feng; Lee, Kun-Tai; Wang, Hsueh-Hsiao; Ueng, Kwo-Chang; Yeh, Hung-I; Chao, Tze-Fan; Liao, Jo-Nan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Tuan, Ta-Chuan; Li, Cheng-Hung; Chung, Fa-Po; Hsu, Chiao-Po; Chang, Hsiao-Huang; Huang, Cheng-Hsiung; Chen, Shih-Ann			The Association between Heme Oxygenase-1 Gene Promoter Polymorphism and the Outcomes of Catheter Ablation of Atrial Fibrillation	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MICROSATELLITE POLYMORPHISM; BALLOON ANGIOPLASTY; DIABETIC-PATIENTS; SUSCEPTIBILITY; CELLS; HEMOXYGENASE-1; RECURRENCE; EXPRESSION; RESTENOSIS	A length polymorphism of GT repeats in the promoter region of the human heme oxygenase-1 (HO-1) gene modulates its gene transcription to protect against myocardial injury. The present study investigated the association between HO-1 promoter polymorphisms and the outcomes of catheter ablation of atrial fibrillation (AF). The allelic frequencies of GT repeats in the HO-1 gene promoter were screened in 205 random individuals who underwent catheter ablation for drug refractory AF. In the patients who received catheter ablation, those with AF recurrence had fewer GT repeats (53.4+/-7.1 vs. 56.1+/-6.5, p = 0.004), a lower incidence of hyperlipidemia, more non-paroxysmal AF, and a larger left atrial diameter. After conducting a multivariate logistic analysis, the number of GT repeats (Odds ratio: 0.94, 95% CI 0.90-0.99, p = 0.01) and the diameter of the left atrium (Odds ratio: 1.08, 95% CI 1.02-1.15, p = 0.01) remained independent predictors. The carriers of GT repeats, which were <29 in both alleles, were associated with a lower sinus maintenance rate after catheter ablation (38.5% vs. 60.1%, p = 0.003). The patients were divided into paroxysmal and non-paroxysmal AF groups; the number of GT repeats was associated with AF recurrence only in the patients with paroxysmal AF. The number of GT repeats, combined with LAD, was significant for predicting AF recurrence after catheter ablation (p = 0.01). The number of GT repeats was not found to be associated with differences in the left atrial diameter, the biatrial voltage, or the levels of bilirubin, ferritin, iron, C-reactive protein, or von-Willibrand factor. In conclusions, HO-1 gene promoter polymorphisms were associated with AF recurrence after catheter ablation.	[Hu, Yu-Feng; Chao, Tze-Fan; Liao, Jo-Nan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Tuan, Ta-Chuan; Li, Cheng-Hung; Chung, Fa-Po; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Hu, Yu-Feng; Chao, Tze-Fan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Tuan, Ta-Chuan; Li, Cheng-Hung; Chung, Fa-Po; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hu, Yu-Feng; Chao, Tze-Fan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Tuan, Ta-Chuan; Li, Cheng-Hung; Chung, Fa-Po; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Inst, Taipei 112, Taiwan; [Lee, Kun-Tai] Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Hsueh-Hsiao; Yeh, Hung-I] Mackay Mem Hosp, Mackay Med Coll, Dept Internal Med, Taipei, Taiwan; [Wang, Hsueh-Hsiao; Yeh, Hung-I] Mackay Mem Hosp, Mackay Med Coll, Dept Med Res, Taipei, Taiwan; [Ueng, Kwo-Chang] Chung Shan Med Univ, Sch Med, Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan; [Hsu, Chiao-Po; Chang, Hsiao-Huang; Huang, Cheng-Hsiung] Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Hsu, Chiao-Po; Chang, Hsiao-Huang; Huang, Cheng-Hsiung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Mackay Medical College; Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, SA (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	epsachen@ms41.hinet.net	Passos-Bueno, Maria Rita/I-6796-2016; Chang, Shih-Lin/AGT-1191-2022; Hu, Yu-Feng/V-1401-2019; Tiziani, Valdenize/F-9848-2012	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Hu, Yu-Feng/0000-0001-5715-2070; Tiziani, Valdenize/0000-0001-6783-9212; de Almeida, Salome/0000-0001-9447-1820	Taipei Veterans General Hospital [V98C1-037, V99C1-120, V101B-005, V101C-060]; National Scientific Council [NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3, NSC 99-2911-I-008-100, NSC 100-2314-B-075-051, NSC 101-2321-B-075-004]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Scientific Council	This work was supported by research grants from the Taipei Veterans General Hospital (V98C1-037, V99C1-120, V101B-005, V101C-060) and the National Scientific Council (NSC97-2314-B-010-037-MY3, NSC97-2314-B-010-038, NSC98-2314-B-010-031-MY3, NSC 99-2911-I-008-100, NSC 100-2314-B-075-051, NSC 101-2321-B-075-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; BALLA G, 1992, J BIOL CHEM, V267, P18148; Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen YH, 2004, EUR HEART J, V25, P39, DOI 10.1016/j.ehj.2003.10.009; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; EWING JF, 1994, J PHARMACOL EXP THER, V271, P408; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Hu YF, 2012, CIRC-ARRHYTHMIA ELEC, V5, P334, DOI 10.1161/CIRCEP.111.965996; Hu YF, 2011, HEART RHYTHM, V8, P650, DOI 10.1016/j.hrthm.2010.12.036; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Lin YJ, 2009, J CARDIOVASC ELECTR, V20, P607, DOI 10.1111/j.1540-8167.2008.01393.x; Liu J, 2011, PACE, V34, P398, DOI 10.1111/j.1540-8159.2010.02978.x; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morita T, 2005, CURR NEUROVASC RES, V2, P113, DOI 10.2174/1567202053586848; Nakazawa Y, 2009, HEART RHYTHM, V6, P725, DOI 10.1016/j.hrthm.2009.02.027; Ono K, 2003, J HYPERTENS, V21, P1497, DOI 10.1097/00004872-200308000-00013; Richter B, 2012, CLIN RES CARDIOL, V101, P217, DOI 10.1007/s00392-011-0383-3; Schillinger M, 2004, J AM COLL CARDIOL, V43, P950, DOI 10.1016/j.jacc.2003.09.058; Schillinger M, 2002, THROMB RES, V106, P131, DOI 10.1016/S0049-3848(02)00100-7; Schillinger M, 2002, J ENDOVASC THER, V9, P385, DOI 10.1583/1545-1550(2002)009<0385:HOGIAV>2.0.CO;2; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Vulapalli SR, 2002, AM J PHYSIOL-HEART C, V283, pH688, DOI 10.1152/ajpheart.00133.2002; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	33	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56440	10.1371/journal.pone.0056440	http://dx.doi.org/10.1371/journal.pone.0056440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23951358	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200074
J	Lo, WY; Chang, NW				Lo, Wan-Yu; Chang, Nai-Wen			An Indirubin Derivative, Indirubin-3 '-Monoxime Suppresses Oral Cancer Tumorigenesis through the Downregulation of Survivin	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INDUCE APOPTOSIS; TUMOR-GROWTH; NECK-CANCER; KINASE; HEAD; INHIBITION; INVASION; SERUM; CYCLOOXYGENASE-2	Oral cancer is the fourth most common cause of death from cancer in Taiwanese men. Indirubin-3'-monoxime (I3M), a potent cyclin-dependent kinase inhibitor, has therapeutic effects in other cancer cells. In this study, we carried out in vitro assays to test cell viability, cell cycle progression, apoptosis, cell migration and invasion in this cancer type. In addition, using an oral tumorigenic animal model, we examined target gene and protein expression using real time qPCR, immunoblotting and immunohistochemical staining. Our results demonstrate that I3M has an anti-proliferative effect in both Cal-27 and HSC-3 oral cancer cell lines and that treatment of Cal-27 and HSC-3 cells with I3M results in apoptosis through the activation of cytochrome c. In addition, I3M interrupts the cell cycle in Cal-27 cells in a dose-dependent manner by arresting cells in the G2/M phase. We also found that I3M suppresses migration and invasion in Cal-27 cells by inhibiting the expression of focal adhesion kinase, urokinase-type plasminogen inhibitor, and matrix metalloproteinase 9. Moreover, we identified survivin as a target protein in I3M-treated oral cancer cells. Using an oral cancer mouse model, we demonstrate that topical application of an adhesive gel composed of I3M and poly(vinyl alcohol) (I3M/PVA) has dose-dependent anti-tumorigenic effects. Following treatment, the expression of survivin protein and mRNA was downregulated in cancerous tissues. Furthermore, plasma survivin levels were also reduced in the I3M-treated mice. These results suggest that topical application of I3M, a drug synthesized from indirubin, which is found in Qing-Dai - has therapeutic potential for treating oral cancer.	[Lo, Wan-Yu] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Lo, Wan-Yu] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lo, Wan-Yu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chang, Nai-Wen] China Med Univ, Coll Med, Dept Biochem, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan	Lo, WY (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.	wylo@mail.cmu.edu.tw			National Science Council [NSC96-2320-B-039-024, NSC 97-2320-B-039-016-MY3]; Taiwan Department of Health; China Medical University Hospital Cancer Research Center of Excellence [DOH102-TD-C-111-005]; China Medical University Hospital [DMR-96-043]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health; China Medical University Hospital Cancer Research Center of Excellence; China Medical University Hospital	The authors would also like to thank The National Science Council (NSC96-2320-B-039-024, NSC 97-2320-B-039-016-MY3), The Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence (DOH102-TD-C-111-005) and China Medical University Hospital (DMR-96-043) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Chang NW, 2010, CHEM-BIOL INTERACT, V183, P231, DOI 10.1016/j.cbi.2009.10.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eisenbrand G, 2004, J CANCER RES CLIN, V130, P627, DOI 10.1007/s00432-004-0579-2; Fan MJ, 2011, IN VIVO, V25, P355; Guney N, 2006, MED ONCOL, V23, P335, DOI 10.1385/MO:23:3:335; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Huang S, 2000, J BIOL CHEM, V275, P12266, DOI 10.1074/jbc.275.16.12266; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kehinde EO, 2008, CAN J UROL, V15, P3967; Kim SA, 2011, CANCER LETT, V306, P197, DOI 10.1016/j.canlet.2011.03.006; Kim YH, 2010, J ORAL PATHOL MED, V39, P368, DOI 10.1111/j.1600-0714.2009.00844.x; Kinugasa Y, 2004, CLIN EXP METASTAS, V21, P737, DOI 10.1007/s10585-005-1190-x; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liao XM, 2013, ONCOL REP, V29, P371, DOI 10.3892/or.2012.2094; Lin CY, 2005, ORAL ONCOL, V41, P645, DOI 10.1016/j.oraloncology.2005.02.009; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Marioni G, 2010, ACTA OTO-LARYNGOL, V130, P4, DOI 10.3109/00016480902856588; Marko D, 2001, BRIT J CANCER, V84, P283, DOI 10.1054/bjoc.2000.1546; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Mehrotra S, 2006, CANCER CELL, V17, P53; Miyazaki A, 2011, CANCER SCI, V102, P324, DOI 10.1111/j.1349-7006.2010.01789.x; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; No JH, 2011, GYNECOL OBSTET INVES, V71, P136, DOI 10.1159/000316049; Provenzano PP, 2009, CELL ADHES MIGR, V3, P347, DOI 10.4161/cam.3.4.9458; Ribeiro DA, 2007, EXP MOL PATHOL, V83, P131, DOI 10.1016/j.yexmp.2007.02.006; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schwaiberger AV, 2010, ARTERIOSCL THROM VAS, V30, P2475, DOI 10.1161/ATVBAHA.110.212654; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Shi J, 2008, BIOCHEM PHARMACOL, V75, P1729, DOI 10.1016/j.bcp.2008.01.021; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Smith J, 2009, ORAL ONCOL, V45, P647, DOI 10.1016/j.oraloncology.2009.02.006; Smolewski P, 2008, IDRUGS, V11, P204; Su LP, 2010, ORAL SURG ORAL MED O, V110, P484, DOI 10.1016/j.tripleo.2010.04.009; Wang HJ, 2010, BIOCHEM BIOPH RES CO, V391, P716, DOI 10.1016/j.bbrc.2009.11.126; Xiao ZJ, 2002, LEUKEMIA LYMPHOMA, V43, P1763, DOI 10.1080/1042819021000006295; Yamamoto H, 2008, CANCER SCI, V99, P1709, DOI 10.1111/j.1349-7006.2008.00870.x; Yu FS, 2011, J DENT RES, V90, P168, DOI 10.1177/0022034510384619; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909; Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473	47	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70198	10.1371/journal.pone.0070198	http://dx.doi.org/10.1371/journal.pone.0070198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967071	Green Published, Green Submitted, gold			2022-12-27	WOS:000323115800005
J	Shikiya, Y; Tomita, S; Arakawa, T; Shiraki, K				Shikiya, Yui; Tomita, Shunsuke; Arakawa, Tsutomu; Shiraki, Kentaro			Arginine Inhibits Adsorption of Proteins on Polystyrene Surface	PLOS ONE			English	Article								Nonspecific adsorption of protein on solid surfaces causes a reduction of concentration as well as enzyme inactivation during purification and storage. However, there are no versatile inhibitors of the adsorption between proteins and solid surfaces at low concentrations. Therefore, we examined additives for the prevention of protein adsorption on polystyrene particles (PS particles) as a commonly-used material for vessels such as disposable test tubes and microtubes. A protein solution was mixed with PS particles, and then adsorption of protein was monitored by the concentration and activity of protein in the supernatant after centrifugation. Five different proteins bound to PS particles through electrostatic, hydrophobic, and aromatic interactions, causing a decrease in protein concentration and loss of enzyme activity in the supernatant. Among the additives, including arginine hydrochloride (Arg), lysine hydrochloride, guanidine hydrochloride, NaCl, glycine, and glucose, Arg was most effective in preventing the binding of proteins to PS particles as well as activity loss. Moreover, even after the mixing of protein and PS particles, the addition of Arg caused desorption of the bound protein from PS particles. This study demonstrated a new function of Arg, which expands the potential for application of Arg to proteins.	[Shikiya, Yui; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Tomita, Shunsuke] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Arakawa, Tsutomu] Alliance Prot Labs, San Diego, CA USA	University of Tsukuba; University of Tokyo	Shiraki, K (corresponding author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan.	shiraki@bk.tsukuba.ac.jp	Tomita, Shunsuke/I-1464-2015	Tomita, Shunsuke/0000-0002-0586-6976	JSPS KAKENHI [23246063, 23550189]; Grants-in-Aid for Scientific Research [12J08921] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 23246063, 23550189 (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; Arakawa T, 2004, PROTEIN EXPRES PURIF, V36, P244, DOI 10.1016/j.pep.2004.04.009; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Arakawa T, 2008, INT J PHARM, V355, P220, DOI 10.1016/j.ijpharm.2007.12.009; Arakawa T, 2007, PROTEIN EXPRES PURIF, V54, P110, DOI 10.1016/j.pep.2007.02.010; Arakawa T, 2007, PROTEIN EXPRES PURIF, V52, P410, DOI 10.1016/j.pep.2006.10.005; Arakawa T, 2007, J BIOCHEM BIOPH METH, V70, P493, DOI 10.1016/j.jbbm.2006.12.001; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arakawa T, 2010, PROTEIN EXPRES PURIF, V71, P168, DOI 10.1016/j.pep.2009.11.004; Arakawa T, 2009, PROTEIN EXPRES PURIF, V63, P158, DOI 10.1016/j.pep.2008.09.011; Ariki R, 2012, J BIOCHEM, V151, P27, DOI 10.1093/jb/mvr117; Ariki R, 2011, J BIOCHEM, V149, P389, DOI 10.1093/jb/mvr004; Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Bee JS, 2010, BIOTECHNOL BIOENG, V105, P121, DOI 10.1002/bit.22525; BRESLOW R, 1990, P NATL ACAD SCI USA, V87, P167, DOI 10.1073/pnas.87.1.167; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Ejima D, 2005, J CHROMATOGR A, V1094, P49, DOI 10.1016/j.chroma.2005.07.086; Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004; Evers F, 2011, LANGMUIR, V27, P6995, DOI 10.1021/la2010908; Evers F, 2009, J PHYS CHEM B, V113, P8462, DOI 10.1021/jp904065w; Fujimoto A, 2010, PROTEIN J, V29, P161, DOI 10.1007/s10930-010-9235-7; Hirano A, 2008, J BIOCHEM, V144, P363, DOI 10.1093/jb/mvn078; Hirano A, 2010, J PHYS CHEM B, V114, P13455, DOI 10.1021/jp101909a; Husecken AK, 2010, LANGMUIR, V26, P13429, DOI 10.1021/la102222z; Ito L, 2011, PROTEIN ENG DES SEL, V24, P269, DOI 10.1093/protein/gzq101; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; KITA Y, 1994, BIOCHEMISTRY-US, V33, P15178, DOI 10.1021/bi00254a029; Koo J, 2008, J PHYS CHEM B, V112, P6292, DOI 10.1021/jp801981t; Lange C, 2009, CURR PHARM BIOTECHNO, V10, P408, DOI 10.2174/138920109788488851; LIN WJ, 1993, PROTEIN EXPRES PURIF, V4, P256, DOI 10.1006/prep.1993.1033; Matsuoka T, 2009, BIOTECHNOL PROGR, V25, P1515, DOI 10.1002/btpr.245; Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; STOYAN T, 1993, EUR J BIOCHEM, V216, P239, DOI 10.1111/j.1432-1033.1993.tb18138.x; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tsumoto K, 2007, J PHARM SCI-US, V96, P1677, DOI 10.1002/jps.20821; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Vermeer AWP, 2000, J COLLOID INTERF SCI, V225, P394, DOI 10.1006/jcis.2000.6769; Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200	41	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70762	10.1371/journal.pone.0070762	http://dx.doi.org/10.1371/journal.pone.0070762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967100	gold, Green Published, Green Submitted			2022-12-27	WOS:000323115800020
J	Yasuda, K; Torigoe, T; Morita, R; Kuroda, T; Takahashi, A; Matsuzaki, J; Kochin, V; Asanuma, H; Hasegawa, T; Saito, T; Hirohashi, Y; Sato, N				Yasuda, Kazuyo; Torigoe, Toshihiko; Morita, Rena; Kuroda, Takahumi; Takahashi, Akari; Matsuzaki, Junichi; Kochin, Vitaly; Asanuma, Hiroko; Hasegawa, Tadashi; Saito, Tsuyoshi; Hirohashi, Yoshihiko; Sato, Noriyuki			Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; ACUTE MYELOID-LEUKEMIA; DRUG-RESISTANCE; IN-VIVO; IDENTIFICATION; EXPRESSION; TUMORIGENICITY; ANTIGEN; MARKER; ALDH1	Cancer stem-like cells (CSCs)/cancer-initiaiting cells (CICs) are defined as a small population of cancer cells that have self-renewal capacity, differentiation potential and high tumor-initiating ability. CSCs/CICs of ovarian cancer have been isolated by side population (SP) analysis, ALDEFLUOR assay and using cell surface markers. However, these approaches are not definitive markers for CSCs/CICs, and it is necessary to refine recent methods for identifying more highly purified CSCs/CICs. In this study, we analyzed SP cells and aldehyde dehydrogenese bright (ALDH(Br)) cells from ovarian cancer cells. Both SP cells and ALDH(Br) cells exhibited higher tumor-initiating ability and higher expression level of a stem cell marker, sex determining region Y-box 2 (SOX2), than those of main population (MP) cells and ALDH(Low) cells, respectively. We analyzed an SP and ALDH(Br) overlapping population (SP/ALDH(Br)), and the SP/ALDH(Br) population exhibited higher tumor-initiating ability than that of SP cells or ALDH(Br) cells, enabling initiation of tumor with as few as 10(2) cells. Furthermore, SP/ADLH(Br) population showed higher sphere-forming ability, cisplatin resistance, adipocyte differentiation ability and expression of SOX2 than those of SP/ALDH(Low), MP/ALDH(Br) and MP/ALDH(Low) cells. Gene knockdown of SOX2 suppressed the tumor-initiation of ovarian cancer cells. An SP/ALDH(Br) population was detected in several gynecological cancer cells with ratios of 0.1% for HEC-1 endometrioid adenocarcinoma cells to 1% for MCAS ovary mucinous adenocarcinoma cells. Taken together, use of the SP and ALDH(Br) overlapping population is a promising approach to isolate highly purified CSCs/CICs and SOX2 might be a novel functional marker for ovarian CSCs/CICs.	[Yasuda, Kazuyo; Torigoe, Toshihiko; Morita, Rena; Kuroda, Takahumi; Takahashi, Akari; Matsuzaki, Junichi; Kochin, Vitaly; Hirohashi, Yoshihiko; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Torigoe, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan.	torigoe@sapmed.ac.jp; hirohash@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan for Practical Application Research from the Japan Science and Technology Agency [16209013, 17016061, 15659097]; Ministry of Education, Culture, Sports, Science and Technology of Japan for Cancer Research from the Ministry of Health, Labor and Welfare of Japan [15-17, 19-14]; Ono Cancer Research Fund; Takeda Science Foundation; National Cancer Center Research and Development Fund [23-A-44]; Grants-in-Aid for Scientific Research [24659165] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan for Practical Application Research from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan for Cancer Research from the Ministry of Health, Labor and Welfare of Japan; Ono Cancer Research Fund(Ono Cancer Research Fund); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant Nos. 16209013, 17016061 and 15659097) for Practical Application Research from the Japan Science and Technology Agency, and for Cancer Research (15-17 and 19-14) from the Ministry of Health, Labor and Welfare of Japan, Ono Cancer Research Fund (to NS) and Takeda Science Foundation (to YH). This work was supported in part by the National Cancer Center Research and Development Fund (23-A-44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; Ghaffari Saghi, 2011, F1000 Med Rep, V3, P23, DOI 10.3410/M3-23; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hirohashi Y, 2012, ONCOIMMUNOLOGY, V1, P124, DOI 10.4161/onci.1.1.18075; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI 10.2217/IMT.10.10; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Michifuri Y, 2012, PATHOL INT, V62, P684, DOI 10.1111/j.1440-1827.2012.02851.x; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2009, CANCER SCI, V100, P1485, DOI 10.1111/j.1349-7006.2009.01187.x; Pecorelliai S, 2003, INT J GYNECOL OBSTET, V82, P369, DOI 10.1016/S0020-7292(03)00225-X; Pierre-Louis O, 2009, STEM CELLS, V27, P2552, DOI 10.1002/stem.186; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Varghese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052825; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	38	62	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e68187	10.1371/journal.pone.0068187	http://dx.doi.org/10.1371/journal.pone.0068187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967051	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800001
J	Cheng, W; Li, Q; Jiang, YL; Zhou, CZ; Chen, YX				Cheng, Wang; Li, Qiong; Jiang, Yong-Liang; Zhou, Cong-Zhao; Chen, Yuxing			Structures of Streptococcus pneumoniae PiaA and Its Complex with Ferrichrome Reveal Insights into the Substrate Binding and Release of High Affinity Iron Transporters	PLOS ONE			English	Article							HYDROXAMATE TRANSPORT; PROTEIN; SYSTEM; SIDEROPHORES; MEMBRANE; FHUD; SYNTHETASES; SPECIFICITY; ALBOMYCIN; SEQUENCE	Iron scarcity is one of the nutrition limitations that the Gram-positive infectious pathogens Streptococcus pneumoniae encounter in the human host. To guarantee sufficient iron supply, the ATP binding cassette (ABC) transporter Pia is employed to uptake iron chelated by hydroxamate siderophore, via the membrane-anchored substrate-binding protein PiaA. The high affinity towards ferrichrome enables PiaA to capture iron at a very low concentration in the host. We presented here the crystal structures of PiaA in both apo and ferrichrome-complexed forms at 2.7 and 2.1 angstrom resolution, respectively. Similar to other class III substrate binding proteins, PiaA is composed of an N-terminal and a C-terminal domain bridged by an alpha-helix. At the inter-domain cleft, a molecule of ferrichrome is stabilized by a number of highly conserved residues. Upon ferrichrome binding, two highly flexible segments at the entrance of the cleft undergo significant conformational changes, indicating their contribution to the binding and/or release of ferrichrome. Superposition to the structure of Escherichia coli ABC transporter BtuF enabled us to define two conserved residues: Glu119 and Glu262, which were proposed to form salt bridges with two arginines of the permease subunits. Further structure-based sequence alignment revealed that the ferrichrome binding pattern is highly conserved in a series of PiaA homologs encoded by both Gram-positive and negative bacteria, which were predicted to be sensitive to albomycin, a sideromycin antibiotic derived from ferrichrome.	[Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, YX (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	cyxing@ustc.edu.cn	Johnson, Michael D. L./B-4352-2012; Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2009CB918800]; National Natural Science Foundation of China [31270781]; Research Fund for the Doctoral Program of Higher Education of China [20123402110004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Ministry of Science and Technology of China (Grant No. 2009CB918800, http://www.most.gov.cn/eng/), the National Natural Science Foundation of China (Grant No. 31270781, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and Research Fund for the Doctoral Program of Higher Education of China (Grand No. 20123402110004, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Boukhalfa H, 2002, BIOMETALS, V15, P325, DOI 10.1023/A:1020218608266; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W.L, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Killmann H, 2002, ANAL BIOCHEM, V310, P55, DOI 10.1016/S0003-2697(02)00285-3; KOSTER W, 1991, BIOL MET, V4, P23, DOI 10.1007/BF01135553; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU J, 1993, P NATL ACAD SCI USA, V90, P10653, DOI 10.1073/pnas.90.22.10653; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peuckert F, 2011, CHEM BIOL, V18, P907, DOI 10.1016/j.chembiol.2011.05.006; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Pramanik A, 2007, INT J MED MICROBIOL, V297, P459, DOI 10.1016/j.ijmm.2007.03.002; Pramanik A, 2006, J BACTERIOL, V188, P3878, DOI 10.1128/JB.00205-06; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Roosenberg JM, 2000, CURR MED CHEM, V7, P159, DOI 10.2174/0929867003375353; Schwecke T, 2006, CHEMBIOCHEM, V7, P612, DOI 10.1002/cbic.200500301; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Tai SS, 2003, FEMS MICROBIOL LETT, V220, P303, DOI 10.1016/S0378-1097(03)00135-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Whalan RH, 2006, J BACTERIOL, V188, P1031, DOI 10.1128/JB.188.3.1031-1038.2006; Zwart PH, 2005, CCP4 NEWSLETTER, V42	42	23	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71451	10.1371/journal.pone.0071451	http://dx.doi.org/10.1371/journal.pone.0071451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951167	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300119
J	Goren, A; Liu, XC; Gupta, S; Simon, TA; Phatak, H				Goren, Amir; Liu, Xianchen; Gupta, Shaloo; Simon, Teresa A.; Phatak, Hemant			Quality of Life, Activity Impairment, and Healthcare Resource Utilization Associated with Atrial Fibrillation in the US National Health and Wellness Survey	PLOS ONE			English	Article							WORK PRODUCTIVITY; INSOMNIA; DEPRESSION; POPULATION; STROKE; COSTS; MANAGEMENT; REGISTRY; ANXIETY; BURDEN	Objectives: This study builds upon current studies of atrial fibrillation (AF) and health outcomes by examining more comprehensively the humanistic burden of illness (quality of life, activity impairment, and healthcare resource utilization) among adult patients with AF, using a large, nationally representative sample and matched controls. Methods: Data were analyzed from the Internet-based 2009 US National Health and Wellness Survey. Outcomes were Mental and Physical Component Summary (MCS and PCS) and health utility scores from the SF-12, activity impairment, hospitalizations, and healthcare provider and emergency room (ER) visits. Patients with self-reported diagnosis of AF were matched randomly on age and gender with an equal number of respondents without AF. Generalized linear models examined outcomes as a function of AF vs. non-AF status, controlling for CHADS(2) score, comorbidity counts, demographics, and clinical variables. Exploratory structural equation modeling assessed the above in an integrated model of humanistic burden. Results: Mean age of AF patients (1,296 from a total sample of 75,000) was 64.9 years and 65.1% were male. Adjusting for covariates, compared with non-AF patients, AF patients had lower MCS, PCS, and utility scores, greater activity impairment (rate ratio = 1.26), more traditional provider visits (rate ratio = 1.43), and increased odds of ER visits (OR = 2.53) and hospitalizations (OR = 2.71). Exploratory structural equation modeling analyses revealed that persons with AF experienced a significantly higher overall humanistic burden. Conclusions: This study highlights and clarifies the substantial burden of AF and its implications for preparing efficacious AF management plans to address the imminent rise in prevalence.	[Goren, Amir] Kantar Hlth, Hlth Outcomes Practice, New York, NY USA; [Liu, Xianchen] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; [Liu, Xianchen] Pfizer Inc, Pfizer Primary Care BU, New York, NY USA; [Gupta, Shaloo] Kantar Hlth, Hlth Outcomes Practice, Princeton, NJ USA; [Simon, Teresa A.] Bristol Myers Squibb, Global Pharmacovigilence & Epidemiol, Pennington, NJ USA; [Phatak, Hemant] Bristol Myers Squibb, Global Hlth Econ & Outcomes Res, Pennington, NJ USA	Indiana University System; Indiana University-Purdue University Indianapolis; Pfizer; Bristol-Myers Squibb; Bristol-Myers Squibb	Goren, A (corresponding author), Kantar Hlth, Hlth Outcomes Practice, New York, NY USA.	Amir.Goren@kantarhealth.com			Bristol-Myers Squibb; Pfizer, Inc.	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer, Inc.(Pfizer)	The authors would like to acknowledge the financial support from Bristol-Myers Squibb and Pfizer, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2010, ATR FIBR; Bohnen M, 2011, PACE, V34, P804, DOI 10.1111/j.1540-8159.2011.03111.x; Bolge SC, 2009, QUAL LIFE RES, V18, P415, DOI 10.1007/s11136-009-9462-6; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen Q, 2011, J AM GERIATR SOC, V59, P1385, DOI 10.1111/j.1532-5415.2011.03544.x; Dabrowski R, 2010, KARDIOL POL, V68, P1133; DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Dorian P, 2002, AM HEART J, V143, P984, DOI 10.1067/mhj.2002.122518; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hu L., 1996, STRUCTURAL EQUATION, V6, P1, DOI DOI 10.1080/10705519909540118; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Humes KR, 2011, OVERVIEW RACE HISPAN; Kang Younhee, 2004, Eur J Cardiovasc Nurs, V3, P71, DOI 10.1016/j.ejcnurse.2003.12.002; Kang Y, 2006, HEART LUNG, V35, P170, DOI 10.1016/j.hrtlng.2006.01.002; Kaplan D., 2009, STRUCTURAL EQUATION, V2; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Kirchhof P, 2007, EUROPACE, V9, P1006, DOI 10.1093/europace/eum191; Kline R. B., 2005, PRINCIPALS PRACTICE; Lakkireddy D, 2013, J AM COLL CARDIOL, V61, P1177, DOI 10.1016/j.jacc.2012.11.060; LaMori Joyce C, 2012, Crit Pathw Cardiol, V11, P14, DOI 10.1097/HPC.0b013e318246fae8; Lane DA, 2009, J INTERV CARD ELECTR, V25, P37, DOI 10.1007/s10840-008-9318-y; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; McDonald M, 2011, J OCCUP ENVIRON MED, V53, P765, DOI 10.1097/JOM.0b013e318222af81; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Peinado R, 2010, REV ESP CARDIOL, V63, P1402, DOI 10.1016/S0300-8932(10)70266-9; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Reynolds MR, 2006, AM HEART J, V152, P1097, DOI 10.1016/j.ahj.2006.08.011; Rohrbacker NJ, 2010, J OCCUP ENVIRON MED, V52, P383, DOI 10.1097/JOM.0b013e3181d967bc; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Thrall G, 2007, CHEST, V132, P1259, DOI 10.1378/chest.07-0036; Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03; Ullman S., 2001, USING MULTIVARIATE S, P653; van den Berg MP, 2001, EUR HEART J, V22, P247, DOI 10.1053/euhj.2001.2180; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware JE, 2001, USERS MANUAL SF 12V2; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	46	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71264	10.1371/journal.pone.0071264	http://dx.doi.org/10.1371/journal.pone.0071264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951122	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300105
J	Itoh, S; Hattori, T; Tomita, N; Aoyama, E; Yutani, Y; Yamashiro, T; Takigawa, M				Itoh, Shinsuke; Hattori, Takako; Tomita, Nao; Aoyama, Eriko; Yutani, Yasutaka; Yamashiro, Takashi; Takigawa, Masaharu			CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes	PLOS ONE			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; X COLLAGEN; JOINT DISEASE; STIMULATES PROLIFERATION; EXPRESSION; DIFFERENTIATION; KNEE; BONE; MATRIX; MOUSE	To examine the role of connective tissue growth factor CCN2/CTGF (CCN2) in the maintenance of the articular cartilaginous phenotype, we analyzed knee joints from aging transgenic mice (TG) overexpressing CCN2 driven by the Col2a1 promoter. Knee joints from 3-, 14-, 40-, and 60-day-old and 5-, 12-, 18-, 21-, and 24-month-old littermates were analyzed. Ccn2-LacZ transgene expression in articular cartilage was followed by X-gal staining until 5 months of age. Overexpression of CCN2 protein was confirmed through all ages in TG articular cartilage and in growth plates. Radiographic analysis of knee joints showed a narrowing joint space and other features of osteoarthritis in 50% of WT, but not in any of the TG mice. Transgenic articular cartilage showed enhanced toluidine blue and safranin-O staining as well as chondrocyte proliferation but reduced staining for type X and I collagen and MMP-13 as compared with those parameters for WT cartilage. Staining for aggrecan neoepitope, a marker of aggrecan degradation in WT articular cartilage, increased at 5 and 12 months, but disappeared at 24 months due to loss of cartilage; whereas it was reduced in TG articular cartilage after 12 months. Expression of cartilage genes and MMPs under cyclic tension stress (CTS) was measured by using primary cultures of chondrocytes obtained from wild-type (WT) rib cartilage and TG or WT epiphyseal cartilage. CTS applied to primary cultures of mock-transfected rib chondrocytes from WT cartilage and WT epiphyseal cartilage induced expression of Col1a1, ColXa1, Mmp-13, and Mmp-9 mRNAs; however, their levels were not affected in CCN2-overexpressing chondrocytes and TG epiphyseal cartilage. In conclusion, cartilage-specific overexpression of CCN2 during the developmental and growth periods reduced age-related changes in articular cartilage. Thus CCN2 may play a role as an anti-aging factor by stabilizing articular cartilage.	[Itoh, Shinsuke; Hattori, Takako; Tomita, Nao; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan; [Itoh, Shinsuke; Tomita, Nao; Yamashiro, Takashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, Okayama, Japan; [Aoyama, Eriko] Okayama Univ, Sch Dent, Biodental Res Ctr, Okayama 700, Japan; [Yutani, Yasutaka] Yutani Orthopaed Clin, Kobe, Hyogo, Japan	Okayama University; Okayama University; Okayama University	Hattori, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan.	hattorit@md.okayama-u.ac.jp; Takigawa@md.okayama-u.ac.jp	Yamashiro, Takashi/Y-6411-2019; Yamashiro, Takashi/S-6010-2019	Yamashiro, Takashi/0000-0002-4419-9643	Japan Society for the Promotion of Science [21592359, 25462888, 19109008, 24390415]; Okayama University; Senri Life Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okayama University; Senri Life Science Foundation	Supported by the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (C; 21592359, 25462888) [to T. H.] and Scientific Research (S; 19109008) [to M. T.] and (B; 24390415) [to M. T.] and Exploratory Research [to M. T.], by internal grants from Okayama University (to T. H.), and by a grant from Senri Life Science Foundation (to T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER T, 1992, VIRCHOWS ARCH B, V62, P337, DOI 10.1007/BF02899701; AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; AIGNER T, 1993, VIRCHOWS ARCH B, V63, P205, DOI 10.1007/BF02899263; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Ding L, 2010, OSTEOARTHR CARTILAGE, V18, P1509, DOI 10.1016/j.joca.2010.08.014; Eerola I, 1998, ARTHRITIS RHEUM-US, V41, P1287, DOI 10.1002/1529-0131(199807)41:7<1287::AID-ART20>3.0.CO;2-D; Evans R G, 1994, Osteoarthritis Cartilage, V2, P103, DOI 10.1016/S1063-4584(05)80060-3; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Fujisawa T, 2008, OSTEOARTHR CARTILAGE, V16, P787, DOI 10.1016/j.joca.2007.11.001; Fukuda K, 1997, J LAB CLIN MED, V130, P209, DOI 10.1016/S0022-2143(97)90098-6; GAY S, 1976, KLIN WOCHENSCHR, V54, P969, DOI 10.1007/BF01468947; Girkontaite I, 1996, MATRIX BIOL, V15, P231, DOI 10.1016/S0945-053X(96)90114-6; GOLDWASSER M, 1982, CLIN ORTHOP RELAT R, P296; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 2006, ANN NY ACAD SCI, V1068, P498, DOI 10.1196/annals.1346.011; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Hiraki Y, 1999, EUR J BIOCHEM, V260, P869, DOI 10.1046/j.1432-1327.1999.00227.x; HOLMDAHL R, 1986, SCAND J IMMUNOL, V24, P197, DOI 10.1111/j.1365-3083.1986.tb02086.x; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Huang J, 2007, GENE, V404, P101, DOI 10.1016/j.gene.2007.09.007; Huebner JL, 1998, ARTHRITIS RHEUM-US, V41, P877, DOI 10.1002/1529-0131(199805)41:5<877::AID-ART16>3.0.CO;2-#; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kawaguchi H, 2009, J BONE MINER RES, V24, P8, DOI 10.1359/JBMR.081115; Krzeski P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2315; Kubota S, 2011, J CELL COMMUN SIGNAL, V5, P209, DOI 10.1007/s12079-011-0123-5; Lammi P, 1998, MATRIX BIOL, V17, P449, DOI 10.1016/S0945-053X(98)90104-4; Li NG, 2011, CURR MED CHEM, V18, P977, DOI 10.2174/092986711794940905; Loeser RF, 2011, CURR OPIN RHEUMATOL, V23, P492, DOI 10.1097/BOR.0b013e3283494005; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Martel-Pelletier J, 1998, OSTEOARTHR CARTILAGE, V6, P374, DOI 10.1053/joca.1998.0140; Miosge N, 2004, HISTOCHEM CELL BIOL, V122, P229, DOI 10.1007/s00418-004-0697-6; MUNASINGHE JP, 1995, MAGN RESON IMAGING, V13, P421, DOI 10.1016/0730-725X(94)00123-K; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; OHBA Y, 1995, BBA-GEN SUBJECTS, V1245, P1, DOI 10.1016/0304-4165(95)00065-J; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Pullig O, 2000, MATRIX BIOL, V19, P245, DOI 10.1016/S0945-053X(00)00068-8; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Rogers J, 2004, ARTHRITIS RHEUM-US, V50, P452, DOI 10.1002/art.20136; Rucklidge GJ, 1996, BIOCHEM BIOPH RES CO, V224, P297, DOI 10.1006/bbrc.1996.1024; Sarukawa J, 2010, ARTHRITIS RHEUM-US, V62, P463, DOI 10.1002/art.27202; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Shlopov BV, 2000, ARTHRITIS RHEUM-US, V43, P195, DOI 10.1002/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G; Silberberg M, 1941, AM J ANAT, V68, P69, DOI 10.1002/aja.1000680104; SOKOLOFF L, 1956, ARCH PATHOL, V62, P118; STRAUSS PG, 1990, J CELL BIOL, V110, P1369, DOI 10.1083/jcb.110.4.1369; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Takigawa M, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P19, DOI 10.1142/9781860946899_0002; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; van den Berg WB, 2001, CURR OPIN RHEUMATOL, V13, P452, DOI 10.1097/00002281-200109000-00019; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; WALTON M, 1977, J PATHOL, V123, P97, DOI 10.1002/path.1711230206; Wang D, 2011, OSTEOARTHR CARTILAGE, V19, P213, DOI 10.1016/j.joca.2010.11.003	59	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71156	10.1371/journal.pone.0071156	http://dx.doi.org/10.1371/journal.pone.0071156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951098	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300092
J	Schmitt, L; Regnard, J; Desmarets, M; Mauny, F; Mourot, L; Fouillot, JP; Coulmy, N; Millet, G				Schmitt, Laurent; Regnard, Jacques; Desmarets, Maxime; Mauny, Frederic; Mourot, Laurent; Fouillot, Jean-Pierre; Coulmy, Nicolas; Millet, Gregoire			Fatigue Shifts and Scatters Heart Rate Variability in Elite Endurance Athletes	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; BAROREFLEX SENSITIVITY; PERFORMANCE; RESPONSES; POWER; MODULATION; TONE	Purpose: This longitudinal study aimed at comparing heart rate variability (HRV) in elite athletes identified either in 'fatigue' or in 'no-fatigue' state in 'real life' conditions. Methods: 57 elite Nordic-skiers were surveyed over 4 years. R-R intervals were recorded supine (SU) and standing (ST). A fatigue state was quoted with a validated questionnaire. A multilevel linear regression model was used to analyze relationships between heart rate (HR) and HRV descriptors [total spectral power (TP), power in low (LF) and high frequency (HF) ranges expressed in ms(2) and normalized units (nu)] and the status without and with fatigue. The variables not distributed normally were transformed by taking their common logarithm (log(10)). Results: 172 trials were identified as in a 'fatigue' and 891 as in 'no-fatigue' state. All supine HR and HRV parameters (Beta +/- SE) were significantly different (P < 0.0001) between 'fatigue' and 'no-fatigue': HRSU (+6.27 +/- 0.61 bpm), logTP(SU) (-0.36 +/- 0.04), logLF(SU) (-0.27 +/- 0.04), logHF(SU) (-0.46 +/- 0.05), logLF/HFSU (+0.19 +/- 0.03), HFSU(nu) (-9.55 +/- 1.33). Differences were also significant (P < 0.0001) in standing: HRST (+8.83 +/- 0.89), logTP(ST) (-0.28 +/- 0.03), logLF(ST) (-0.29 +/- 0.03), logHF(ST) (-0.32 +/- 0.04). Also, intra-individual variance of HRV parameters was larger (P < 0.05) in the 'fatigue' state (logTP(SU): 0.26 vs. 0.07, logLF(SU): 0.28 vs. 0.11, logHF(SU): 0.32 vs. 0.08, logTP(ST): 0.13 vs. 0.07, logLF(ST): 0.16 vs. 0.07, logHF(ST): 0.25 vs. 0.14). Conclusion: HRV was significantly lower in ' fatigue' vs. ' no-fatigue' but accompanied with larger intra-individual variance of HRV parameters in ' fatigue'. The broader intra-individual variance of HRV parameters might encompass different changes from no-fatigue state, possibly reflecting different fatigue-induced alterations of HRV pattern.	[Schmitt, Laurent] Natl Ski Nord Ctr, Natl Sch Mt Sports, Premanon, Les Rousses, France; [Regnard, Jacques] Univ Franche Comte, Prognost Markers & Control Factors Cardiovasc Pat, Univ Hosp Besancon, Res Unit EA3920, F-25030 Besancon, France; [Desmarets, Maxime; Mauny, Frederic] Univ Hosp Besancon, Clin Res Methods Ctr, Besancon, France; [Mauny, Frederic] Univ Franche Comte, Univ Hosp Besancon, Res Unit UMR Chronoenvironm 6249, F-25030 Besancon, France; [Mourot, Laurent] Univ Franche Comte, Res Unit Culture Sport Hlth Soc & Exercise Perfor, F-25030 Besancon, France; [Fouillot, Jean-Pierre] Univ Paris 13, ARPE, Res Unit EA2363, Bobigny, France; [Coulmy, Nicolas] French Ski Federat, Annecy, France; [Millet, Gregoire] Univ Lausanne, Fac Biol & Med, Dept Physiol, Inst Sport Sci, Lausanne, Switzerland	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite Paris 13; University of Lausanne	Schmitt, L (corresponding author), Natl Ski Nord Ctr, Natl Sch Mt Sports, Premanon, Les Rousses, France.	laurent.schmitt@ensm.sports.gouv.fr	Mourot, Laurent/ABE-1867-2021; Millet, Gregoire P/F-4104-2012; Mourot, Laurent/M-2114-2019; Desmarets, Maxime/AAB-9897-2022; Millet, Grégoire/M-3220-2019; Mauny, Fred/G-2469-2018	Millet, Gregoire P/0000-0001-8081-4423; Mourot, Laurent/0000-0001-9486-3090; Desmarets, Maxime/0000-0002-3801-5297; Millet, Grégoire/0000-0001-8081-4423; coulmy, Nicolas/0000-0003-3400-4619; Mauny, Fred/0000-0002-8512-2693				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Barantke M, 2008, J CARDIOVASC ELECTR, V19, P1296, DOI 10.1111/j.1540-8167.2008.01257.x; Baumert M, 2006, CLIN J SPORT MED, V16, P412, DOI 10.1097/01.jsm.0000244610.34594.07; Benhaddad AA, 1999, CLIN HEMORHEOL MICRO, V20, P117; Camm AJ, 1996, CIRCULATION, V93, P1043; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; Fry R.W., 1993, CLIN J SPORT MED, V3, P6; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gratze G, 2005, J APPL PHYSIOL, V99, P1728, DOI 10.1152/japplphysiol.00487.2005; Halson SL, 2003, MED SCI SPORT EXER, V35, P854, DOI 10.1249/01.MSS.0000064964.80040.E9; Hansson-Sandsten M, 2007, IEEE T BIO-MED ENG, V54, P1770, DOI 10.1109/TBME.2007.904527; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Hedelin R, 2000, MED SCI SPORT EXER, V32, P1480, DOI 10.1097/00005768-200008000-00017; Iellamo F, 2002, CIRCULATION, V105, P2719, DOI 10.1161/01.CIR.0000018124.01299.AE; JOST J, 1989, EUR J APPL PHYSIOL O, V58, P596, DOI 10.1007/BF00418505; Joyner MJ, 2011, MED SCI SPORT EXER, V43, P655, DOI 10.1249/MSS.0b013e3181fe605a; KLEIGER RE, 1991, AM J CARDIOL, V68, P626, DOI 10.1016/0002-9149(91)90355-O; Lee CM, 2003, MED SCI SPORT EXER, V35, P961, DOI 10.1249/01.MSS.0000069410.56710.DA; Maso F, 2004, BRIT J SPORT MED, V38, P260, DOI 10.1136/bjsm.2002.000254; Matos NF, 2001, MED SCI SPORTS EXERC, V43, P1287; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Mourot L, 2004, CLIN PHYSIOL FUNCT I, V24, P10, DOI 10.1046/j.1475-0961.2003.00523.x; Mourot L, 2008, AVIAT SPACE ENVIR MD, V79, P14, DOI 10.3357/ASEM.2147.2008; NORITAKE M, 1992, INTERNAL MED, V31, P453, DOI 10.2169/internalmedicine.31.453; Pichot V, 2002, MED SCI SPORT EXER, V34, P1660, DOI 10.1097/00005768-200210000-00019; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Rasbash J, 2011, USERS GUIDE MLWIN; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Schmitt L, 2008, INT J SPORTS MED, V29, P300, DOI 10.1055/s-2007-965355; Singh JP, 1999, CIRCULATION, V99, P2251, DOI 10.1161/01.CIR.99.17.2251; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Uusitalo AIT, 1998, INT J SPORTS MED, V19, P532, DOI 10.1055/s-2007-971956; Uusitalo ALT, 2000, INT J SPORTS MED, V21, P45; Uusitalo ALT, 1998, CLIN PHYSIOL, V18, P510; Varlet-Marie E, 2004, CLIN HEMORHEOL MICRO, V30, P211; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9	39	63	63	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71588	10.1371/journal.pone.0071588	http://dx.doi.org/10.1371/journal.pone.0071588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951198	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300133
J	Wheaton, BJ; Noor, NM; Whish, SC; Truettner, JS; Dietrich, WD; Zhang, M; Crack, PJ; Dziegielewska, KM; Saunders, NR				Wheaton, Benjamin J.; Noor, Natassya M.; Whish, Sophie C.; Truettner, Jessie S.; Dietrich, W. Dalton; Zhang, Moses; Crack, Peter J.; Dziegielewska, Katarzyna M.; Saunders, Norman R.			Weight-Bearing Locomotion in the Developing Opossum, Monodelphis domestica following Spinal Transection: Remodeling of Neuronal Circuits Caudal to Lesion	PLOS ONE			English	Article							SHORT-TAILED OPOSSUM; CORD-INJURY; FUNCTIONAL RECOVERY; NEONATAL OPOSSUM; BRAIN-STEM; EPIDURAL STIMULATION; SUPRASPINAL AXONS; EXPRESSION; RATS; MODULATION	Complete spinal transection in the mature nervous system is typically followed by minimal axonal repair, extensive motor paralysis and loss of sensory functions caudal to the injury. In contrast, the immature nervous system has greater capacity for repair, a phenomenon sometimes called the infant lesion effect. This study investigates spinal injuries early in development using the marsupial opossum Monodelphis domestica whose young are born very immature, allowing access to developmental stages only accessible in utero in eutherian mammals. Spinal cords of Monodelphis pups were completely transected in the lower thoracic region, T10, on postnatal-day (P) 7 or P28 and the animals grew to adulthood. In P7-injured animals regrown supraspinal and propriospinal axons through the injury site were demonstrated using retrograde axonal labelling. These animals recovered near-normal coordinated overground locomotion, but with altered gait characteristics including foot placement phase lags. In P28-injured animals no axonal regrowth through the injury site could be demonstrated yet they were able to perform weight-supporting hindlimb stepping overground and on the treadmill. When placed in an environment of reduced sensory feedback (swimming) P7-injured animals swam using their hindlimbs, suggesting that the axons that grew across the lesion made functional connections; P28-injured animals swam using their forelimbs only, suggesting that their overground hindlimb movements were reflex-dependent and thus likely to be generated locally in the lumbar spinal cord. Modifications to propriospinal circuitry in P7- and P28-injured opossums were demonstrated by changes in the number of fluorescently labelled neurons detected in the lumbar cord following tracer studies and changes in the balance of excitatory, inhibitory and neuromodulatory neurotransmitter receptors' gene expression shown by qRT-PCR. These results are discussed in the context of studies indicating that although following injury the isolated segment of the spinal cord retains some capability of rhythmic movement the mechanisms involved in weight-bearing locomotion are distinct.	[Wheaton, Benjamin J.; Noor, Natassya M.; Whish, Sophie C.; Zhang, Moses; Crack, Peter J.; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia; [Truettner, Jessie S.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	University of Melbourne; University of Miami	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Crack, Peter/ABE-2065-2020; Wheaton, Ben/AAC-7037-2021	Crack, Peter/0000-0002-5030-0330; Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777	Victorian Neurotrauma Initiative [DP049]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative (Grant #DP049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Antri M, 2005, NEUROSCI LETT, V384, P162, DOI 10.1016/j.neulet.2005.04.062; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Chen XW, 2012, SPINAL CORD, V50, P467, DOI 10.1038/sc.2011.138; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu GKT, 2007, NEUROSCIENCE, V148, P668, DOI 10.1016/j.neuroscience.2007.05.028; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; de Leon RD, 2002, PROG BRAIN RES, V137, P141; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; DOUGLAS JR, 1993, J NEUROSCI, V13, P990; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; EDGERTON VR, 1992, J NEUROTRAUM, V9, pS119; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; FADEM BH, 1982, LAB ANIM SCI, V32, P405; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Geiman EJ, 2002, J COMP NEUROL, V444, P275, DOI 10.1002/cne.10148; Gerard RW, 1931, ARCH NEURO PSYCHIATR, V26, P469, DOI 10.1001/archneurpsyc.1931.02230090002001; Giroux N, 1999, J COMP NEUROL, V406, P402; Giszter SF, 2010, ANN NY ACAD SCI, V1198, P279, DOI 10.1111/j.1749-6632.2010.05534.x; GRILLNER S, 1973, ACTA PHYSIOL SCAND, V87, P320, DOI 10.1111/j.1748-1716.1973.tb05396.x; Grillner S, 2002, PROG BRAIN RES, V137, P97; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ito Z, 2010, J NEUROSCI, V30, P5937, DOI 10.1523/JNEUROSCI.2570-09.2010; Kao T, 2006, BRAIN RES, V1112, P159, DOI 10.1016/j.brainres.2006.07.020; Khristy W, 2009, BRAIN RES, V1273, P9, DOI 10.1016/j.brainres.2009.03.060; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kostyk SK, 2008, NEUROSCIENCE, V156, P498, DOI 10.1016/j.neuroscience.2008.08.013; Kuerzi J, 2010, EXP NEUROL, V224, P178, DOI 10.1016/j.expneurol.2010.03.008; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; LOVELY RG, 1990, BRAIN RES, V514, P206, DOI 10.1016/0006-8993(90)91417-F; Migliavacca A, 1930, ARCH ITAL BIOL, V83, P109; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Nooijen CFJ, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-36; Pearson KG, 2000, PROG BRAIN RES, V128, P61; QIN YQ, 1993, DEV BRAIN RES, V75, P75, DOI 10.1016/0165-3806(93)90067-K; ROBINSON GA, 1986, EXP BRAIN RES, V62, P387, DOI 10.1007/BF00238858; Rossignol S, 2004, PROG BRAIN RES, V143, P163, DOI 10.1016/S0079-6123(03)43016-1; Rossignol S, 1998, ANN NY ACAD SCI, V860, P346, DOI 10.1111/j.1749-6632.1998.tb09061.x; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Ryge J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-365; Ryge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003415; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; STELZNER DJ, 1975, EXP NEUROL, V46, P156, DOI 10.1016/0014-4886(75)90039-4; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Swinnen E, 2010, J REHABIL MED, V42, P520, DOI 10.2340/16501977-0538; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.3.CO;2-6; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; VANDEBERG JL, 1999, UFAW HDB CARE MANAGE, P193; VARGA ZM, 1995, EUR J NEUROSCI, V7, P2119, DOI 10.1111/j.1460-9568.1995.tb00634.x; Varga ZM, 1996, J COMP NEUROL, V366, P600; VARGA ZM, 1995, P NATL ACAD SCI USA, V92, P10959, DOI 10.1073/pnas.92.24.10959; Wang XM, 1998, J COMP NEUROL, V398, P83; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Wienecke J, 2010, J NEUROPHYSIOL, V103, P761, DOI 10.1152/jn.00609.2009	78	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71181	10.1371/journal.pone.0071181	http://dx.doi.org/10.1371/journal.pone.0071181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951105	Green Published, gold			2022-12-27	WOS:000323097300095
J	Zhang, ZQ; Deng, J; He, LP; Ling, WH; Su, YX; Chen, YM				Zhang, Zhe-qing; Deng, Juan; He, Li-ping; Ling, Wen-hua; Su, Yi-xiang; Chen, Yu-ming			Comparison of Various Anthropometric and Body Fat Indices in Identifying Cardiometabolic Disturbances in Chinese Men and Women	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BIOELECTRICAL-IMPEDANCE ANALYSIS; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; BLOOD-PRESSURE; MASS INDEX; ABDOMINAL OBESITY; HIP CIRCUMFERENCE; SCREENING TOOL	Background: Although many adiposity indices may be used to predict obesity-related health risks, uncertainty remains over which of them performs best. Objective: This study compared the predictive capability of direct and indirect adiposity measures in identifying people at higher risk of metabolic abnormalities. Methods: This population-based cross-sectional study recruited 2780 women and 1160 men. Body weight and height, waist circumference (WC), and hip circumference (HC) were measured and body mass index (BMI), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) were calculated. Body fat (and percentage of fat) over the whole body and the trunk were determined by bioelectrical impedance analysis (BIA). Blood pressure, fasting lipid profiles, and glucose and urine acid levels were assessed. Results: In women, the ROC and the multivariate logistic regression analyses both showed that WHtR consistently had the best performance in identifying hypertension, dyslipidemia, hyperuricemia, diabetes/IFG, and metabolic syndrome (MetS). In men, the ROC analysis showed that WHtR was the best predictor of hypertension, WHtR and WC were equally good predictors of dyslipidemia and MetS, and WHtR was the second-best predictor of hyperuricemia and diabetes/IFG. The multivariate logistic regression also found WHtR to be superior in discriminating between MetS, diabetes/IFG, and dyslipidemia while BMI performed better in predicting hypertension and hyperuricemia in men. The BIA-derived indices were the second-worst predictors for all of the endpoints, and HC was the worst. Conclusion: WHtR was the best predictor of various metabolic abnormalities. BMI may be used as an alternative measure of obesity for identifying hypertension in both sexes.	[Zhang, Zhe-qing; Deng, Juan; He, Li-ping; Ling, Wen-hua; Su, Yi-xiang; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Health, Guangzhou, Peoples R China; [He, Li-ping] Guangzhou Panyu Cent Hosp, Guangzhou, Peoples R China	Sun Yat Sen University	Su, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Health, Guangzhou, Peoples R China.	suyx@mail.sysu.edu.cn; chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China [2007032]; State Key Program of National Natural Science of China [81130052]	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032) and the State Key Program of National Natural Science of China (No. 81130052). Tanita Corporation (China) provided the BIA system (TBF-418B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2006, INT J OBESITY, V30, P1782, DOI 10.1038/sj.ijo.0803346; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Al-Odat AZ, 2012, DIABETES METAB SYND, V6, P15, DOI 10.1016/j.dsx.2012.05.012; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2009, OBESITY FACTS, V2, P97, DOI 10.1159/000203363; Beydoun MA, 2011, PUBLIC HEALTH NUTR, V14, P77, DOI 10.1017/S1368980010002648; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; CAAN B, 1994, INT J OBESITY, V18, P397; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; De Lorenzo F, 1998, THROMB HAEMOSTASIS, V80, P603; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Esmaillzadeh A, 2006, INT J CARDIOL, V108, P338, DOI 10.1016/j.ijcard.2005.05.019; Esmaillzadeh A, 2004, INT J OBESITY, V28, P1325, DOI 10.1038/sj.ijo.0802757; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043275; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504; Ho SC, 2001, INT J OBESITY, V25, P1689, DOI 10.1038/sj.ijo.0801784; Ho SY, 2003, ANN EPIDEMIOL, V13, P683, DOI 10.1016/S1047-2797(03)00067-X; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Hyun YJ, 2008, CIRC J, V72, P1308, DOI 10.1253/circj.72.1308; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Kobayashi J, 2006, J ATHEROSCLER THROMB, V13, P221, DOI 10.5551/jat.13.221; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Menke A, 2007, OBESITY, V15, P785, DOI 10.1038/oby.2007.593; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Nagaya T, 1999, INT J OBESITY, V23, P771, DOI 10.1038/sj.ijo.0800961; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Shao J, 2010, J NUTR HEALTH AGING, V14, P782, DOI 10.1007/s12603-010-0106-x; Sironi AM, 2004, HYPERTENSION, V44, P127, DOI 10.1161/01.HYP.0000137982.10191.0a; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Takami R, 2001, DIABETES CARE, V24, P1248, DOI 10.2337/diacare.24.7.1248; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Xu L, 2011, J CLIN DENSITOM, V14, P458, DOI 10.1016/j.jocd.2011.04.001; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005; Zhou Beifan, 2002, Obes Rev, V3, P147, DOI 10.1046/j.1467-789X.2002.00068.x; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	55	71	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70893	10.1371/journal.pone.0070893	http://dx.doi.org/10.1371/journal.pone.0070893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951031	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300063
J	Sanada, S; Futami, K; Terada, A; Yonemoto, K; Ogasawara, S; Akiba, J; Yasumoto, M; Sumi, A; Ushijima, K; Kamura, T; Furuichi, Y; Yano, H				Sanada, Sakiko; Futami, Kazunobu; Terada, Atsumu; Yonemoto, Koji; Ogasawara, Sachiko; Akiba, Jun; Yasumoto, Makiko; Sumi, Akiko; Ushijima, Kimio; Kamura, Toshiharu; Furuichi, Yasuhiro; Yano, Hirohisa			RECQL1 DNA Repair Helicase: A Potential Therapeutic Target and a Proliferative Marker against Ovarian Cancer	PLOS ONE			English	Article							PHASE-II TRIAL; MITOTIC CATASTROPHE; FAMILY HELICASES; CELL CARCINOMA; ADENOCARCINOMA; EXPRESSION; SIRNA; GENE	Objective: This study analyzed the clinicopathological correlation between ovarian cancer (OC) and RECQL1 DNA helicase to assess its therapeutic potential. Methods: Surgically resected OC from 118 retrospective cases, for which paraffin blocks and all clinical data were complete, were used in this study. RECQL1 and Ki-67 immunostaining were performed on sections to correlate RECQL1 staining with subtype and patient survival. Ten OC and two normal cell lines were then examined for RECQL1 expression and were treated with siRNA against RECQL1 to assess its effect on cell proliferation. Results: Of the 118 cases of adenocarcinoma (50, serous; 26, endometrioid; 21, clear cell; 15, mucinous; 6, other histology), 104 (90%) showed varying levels of RECQL1 expression in the nuclei of OC cells. The Cox hazards model confirmed that diffuse and strong staining of RECQL1 was correlated with histological type. However, RECQL1 expression did not correlate with overall patient survival or FIGO stage. In vitro, RECQL1 expression was exceptionally high in rapidly growing OC cell lines, as compared with normal cells. Using a time-course analysis of RECQL1-siRNA transfection, we observed a significant inhibition in cell proliferation. Conclusions: RECQL1 DNA helicase is a marker of highly proliferative cells. RECQL1-siRNA may offer a new therapeutic strategy against various subtypes of OC, including platinum-resistant cancers, or in recurrent cancers that gain platinum resistance.	[Sanada, Sakiko; Ogasawara, Sachiko; Akiba, Jun; Yasumoto, Makiko; Sumi, Akiko; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan; [Futami, Kazunobu; Furuichi, Yasuhiro] Gene Care Res Inst Co Ltd, Kamakura, Kanagawa, Japan; [Terada, Atsumu; Ushijima, Kimio; Kamura, Toshiharu] Kurume Univ, Sch Med, Dept Obstet & Gynecol, Fukuoka, Japan; [Yonemoto, Koji] Kurume Univ, Sch Med, Biostat Unit, Fukuoka, Japan	Kurume University; Kurume University; Kurume University	Sanada, S (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan.	jiro0720@med.kurume-u.ac.jp						Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Arai A, 2011, CANCER RES, V71, P4598, DOI 10.1158/0008-5472.CAN-11-0320; CANNISTRA SA, 1993, NEW ENGL J MED, V329, P1550, DOI 10.1056/NEJM199311183292108; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Furuichi Y, 2001, ANN NY ACAD SCI, V928, P121; Futami K, 2008, CANCER SCI, V99, P1227, DOI 10.1111/j.1349-7006.2008.00794.x; Futami K, 2008, CANCER SCI, V99, P71, DOI 10.1111/j.1349-7006.2007.00647.x; Futami K, 2007, BIOL PHARM BULL, V30, P1958, DOI 10.1248/bpb.30.1958; Futami K, 2010, INT J MOL MED, V25, P537, DOI 10.3892/ijmm_00000375; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; Mendoza-Maldonado R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-83; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Prat J, 2004, PATHOLOGY OVARY, P47; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Raspollini MR, 2005, INT J SURG PATHOL, V13, P135, DOI 10.1177/106689690501300202; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Shimamoto Akira, 2004, Int J Clin Oncol, V9, P288, DOI 10.1007/s10147-004-0426-0; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Takakura S, 2010, INT J GYNECOL CANCER, V20, P240, DOI 10.1111/IGC.0b013e3181cafb47; Tomioka Y., 1998, J KURUME MED ASS, V61, P323; Yonesaka K, 2006, INT J CANCER, V118, P812, DOI 10.1002/ijc.21350; Yoshino K, 2013, INT J CLIN ONCOL, V18, P148, DOI 10.1007/s10147-011-0357-5	29	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72820	10.1371/journal.pone.0072820	http://dx.doi.org/10.1371/journal.pone.0072820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951333	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200085
J	Grillon, C; Franco-Chaves, JA; Mateus, CF; Ionescu, DF; Zarate, CA				Grillon, Christian; Franco-Chaves, Jose A.; Mateus, Camilo F.; Ionescu, Dawn F.; Zarate, Carlos A.			Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; PANIC DISORDER PATIENTS; POSTTRAUMATIC-STRESS-DISORDER; UNIPOLAR DEPRESSION; LEARNED HELPLESSNESS; INCREASED AMYGDALA; MODULATED STARTLE; VIETNAM VETERANS; ACOUSTIC STARTLE; CONTEXTUAL FEAR	According to the emotion-context insensitivity (ECI) hypothesis, major depressive disorder (MDD) is associated with a diminished ability to react emotionally to positive stimuli and with blunting of defensive responses to threat. That defensive responses are blunted in MDD seems inconsistent with the conceptualization and diagnostic nosology of MDD. The present study tested the ECI hypothesis in MDD using a threat of shock paradigm. Twenty-eight patients with MDD (35.5+/-10.4 years) were compared with 28 controls (35.1+/-7.4 years). Participants were exposed to three conditions: no shock, predictable shock, and unpredictable shock. Startle magnitude was used to assess defensive responses. Inconsistent with the ECI hypothesis, startle potentiation to predictable and unpredictable shock was not reduced in the MDD group. Rather, MDD patients showed elevated startle throughout testing as well as increased contextual anxiety during the placement of the shock electrodes and in the predictable condition. A regression analysis indicated that illness duration and Beck depression inventory scores explained 37% (p<.005) of the variance in patients' startle reactivity. MDD is not associated with emotional blunting but rather enhanced defensive reactivity during anticipation of harm. These results do not support a strong version of the ECI hypothesis. Understanding the nature of stimuli or situations that lead to blunted or enhanced defensive reactivity will provide better insight into dysfunctional emotional experience in MDD.	[Grillon, Christian] NIMH, Sect Neurobiol Fear & Anxiety, NIH, Bethesda, MD 20892 USA; [Franco-Chaves, Jose A.; Mateus, Camilo F.; Ionescu, Dawn F.; Zarate, Carlos A.] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Grillon, C (corresponding author), NIMH, Sect Neurobiol Fear & Anxiety, NIH, Bethesda, MD 20892 USA.	Christian.grillon@nih.gov	Zarate, Carlos/ABD-6843-2021; Ionescu, Dawn F./K-5675-2015		Intramural Research Program of the National Institutes of Mental Health [MH002798]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002798] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support of this study was provided by the Intramural Research Program of the National Institutes of Mental Health (MH002798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NB, 1999, BIOL PSYCHIAT, V46, P542, DOI 10.1016/S0006-3223(99)00025-6; Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; Amrhein C, 2005, J ANXIETY DISORD, V19, P177, DOI 10.1016/j.janxdis.2004.01.004; Beck A, 1987, BDI BECK DEPRESSION; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; DEPUE RA, 1989, ANNU REV PSYCHOL, V40, P457, DOI 10.1146/annurev.ps.40.020189.002325; Dichter GS, 2008, J ABNORM PSYCHOL, V117, P1, DOI 10.1037/0021-843X.117.1.1; Dichter GS, 2004, PSYCHOPHYSIOLOGY, V41, P433, DOI 10.1111/j.1469-8986.00162.x; Elliott R, 2011, NEUROPSYCHOPHARMACOL, V36, P153, DOI 10.1038/npp.2010.77; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Favaron E, 2010, PSYCHIAT RES, V176, P254, DOI 10.1016/j.psychres.2009.04.020; First M.B., 2016, STRUCTURED CLIN INTE; Forbes EE, 2005, PSYCHIAT RES, V134, P11, DOI 10.1016/j.psychres.2005.01.001; GOTLIB IH, 1984, J ABNORM PSYCHOL, V93, P19, DOI 10.1037/0021-843X.93.1.19; GRILLON C, 1994, BIOL PSYCHIAT, V35, P431, DOI 10.1016/0006-3223(94)90040-X; Grillon C, 2005, BIOL PSYCHIAT, V57, P953, DOI 10.1016/j.biopsych.2005.01.045; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; Grillon C, 1998, INT J PSYCHOPHYSIOL, V28, P223, DOI 10.1016/S0167-8760(97)00072-X; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P451, DOI 10.1111/j.1469-8986.1997.tb02389.x; Grillon C, 1998, BIOL PSYCHIAT, V44, P1027, DOI 10.1016/S0006-3223(98)00034-1; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Grillon C, 1996, BIOL PSYCHIAT, V39, P555; Grillon C, 2008, AM J PSYCHIAT, V165, P898, DOI 10.1176/appi.ajp.2007.07101581; Grillon C, 2007, NEUROPSYCHOPHARMACOL, V32, P225, DOI 10.1038/sj.npp.1301204; Grillon C, 2006, BIOL PSYCHIAT, V60, P760, DOI 10.1016/j.biopsych.2005.11.027; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Holsboer F, 2008, EUR J PHARMACOL, V583, P350, DOI 10.1016/j.ejphar.2007.12.032; Insel TR, 2009, BIOL PSYCHIAT, V66, P988, DOI 10.1016/j.biopsych.2009.10.008; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; Kling MA, 2009, DEPRESS ANXIETY, V26, P641, DOI 10.1002/da.20546; Lang P.J., 1988, INT AFFECTIVE PICTUR; Lissek S, 2007, BIOL PSYCHOL, V76, P124, DOI 10.1016/j.biopsycho.2007.07.002; Ludewig S, 2002, DEPRESS ANXIETY, V15, P55, DOI 10.1002/da.10026; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Melzig CA, 2007, PSYCHOPHYSIOLOGY, V44, P846, DOI 10.1111/j.1469-8986.2007.00560.x; Mneimne M, 2008, EMOTION, V8, P552, DOI 10.1037/a0012827; Nesse RM, 2000, ARCH GEN PSYCHIAT, V57, P14, DOI 10.1001/archpsyc.57.1.14; Nissen C, 2010, BIOL PSYCHIAT, V68, P544, DOI 10.1016/j.biopsych.2010.05.026; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Shankman SA, J ABN PSYCH IN PRESS; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Sloan DM, 2010, BIOL PSYCHOL, V84, P368, DOI 10.1016/j.biopsycho.2010.04.004; Sloan DM, 1997, J AFFECT DISORDERS, V46, P135, DOI 10.1016/S0165-0327(97)00097-9; Soares VD, 2011, BEHAV BRAIN RES, V225, P590, DOI 10.1016/j.bbr.2011.08.032; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Strekalova T, 2005, BEHAV PHARMACOL, V16, P171, DOI 10.1097/00008877-200505000-00006; Taylor-Clift A, 2011, PSYCHOL MED, V41, P129, DOI 10.1017/S003329171000036X; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wood GE, 2008, BEHAV NEUROSCI, V122, P282, DOI 10.1037/0735-7044.122.2.282; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	61	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70969	10.1371/journal.pone.0070969	http://dx.doi.org/10.1371/journal.pone.0070969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23951057	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000036
J	Hamilton, PT; Jansen, MS; Ganesan, S; Benson, RE; Hyde-DeRuyscher, R; Beyer, WF; Gile, JC; Nair, SA; Hodges, JA; Gron, H				Hamilton, Paul T.; Jansen, Michelle S.; Ganesan, Sathya; Benson, R. Edward; Hyde-DeRuyscher, Robin; Beyer, Wayne F.; Gile, Joseph C.; Nair, Shrikumar A.; Hodges, Jonathan A.; Gron, Hanne			Improved Bone Morphogenetic Protein-2 Retention in an Injectable Collagen Matrix Using Bifunctional Peptides	PLOS ONE			English	Article							OSTEOGENIC FACTORS; DELIVERY; REGENERATION; FRACTURES; LIBRARIES; REPAIR	To promote healing of many orthopedic injuries, tissue engineering approaches are being developed that combine growth factors such as Bone Morphogenetic Proteins (BMP) with biomaterial carriers. Although these technologies have shown great promise, they still face limitations. We describe a generalized approach to create target-specific modular peptides that bind growth factors to implantable biomaterials. These bifunctional peptide coatings provide a novel way to modulate biology on the surface of an implant. Using phage display techniques, we have identified peptides that bind with high affinity to BMP-2. The peptides that bind to BMP-2 fall into two different sequence clusters. The first cluster of peptide sequences contains the motif W-X-X-F-X-X-L (where X can be any amino acid) and the second cluster contains the motif F-P-L-K-G. We have synthesized bifunctional peptide linkers that contain BMP-2 and collagen-binding domains. Using a rat ectopic bone formation model, we have injected rhBMP-2 into a collagen matrix with or without a bifunctional BMP-2: collagen peptide (BC-1). The presence of BC-1 significantly increased osteogenic cellular activity, the area of bone formed, and bone maturity at the site of injection. Our results suggest that bifunctional peptides that can simultaneously bind to a growth factor and an implantable biomaterial can be used to control the delivery and release of growth factors at the site of implantation.	[Hamilton, Paul T.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA; [Jansen, Michelle S.; Ganesan, Sathya; Nair, Shrikumar A.; Hodges, Jonathan A.] Affinergy LLC, Res Triangle Pk, NC USA; [Benson, R. Edward] GlaxoSmithKline, Platform Technol & Sci, Res Triangle Pk, NC USA; [Hyde-DeRuyscher, Robin] Biogen Idec Inc, Mfg Sci, Res Triangle Pk, NC USA; [Beyer, Wayne F.] QNS Grp LLC, Durham, NC USA; [Gile, Joseph C.] Gile Surg Support, Bangor, ME USA; [Gron, Hanne] Novo Nordisk, Haemophilia Biochem, Malov, Denmark	University of North Carolina; North Carolina State University; GlaxoSmithKline; Biogen; Novo Nordisk	Hodges, JA (corresponding author), Affinergy LLC, Res Triangle Pk, NC USA.	jhodges@affinergy.com	Hamilton, Paul/H-6267-2019	Hamilton, Paul/0000-0003-4028-424X	National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH) [R43AR053387, R43AR051264, R44GM077753, R44DE018071]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR051264, R43AR053387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R44DE018071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM077753] Funding Source: NIH RePORTER	National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Arthritis and Musculoskeletal and Skin Disease, General Medicine, and Dental and Craniofacial Research of the National Institutes of Health (NIH) under award numbers R43AR053387, R43AR051264, R44GM077753 and R44DE018071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Andrade FK, 2010, J BIOMED MATER RES A, V92A, P9, DOI 10.1002/jbm.a.32284; [Anonymous], 2000, MUSC INJ REP INC RIS; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010; Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Gron H, 2008, METHODS COMPOSITIONS; Hyde-DeRuyscher R, 2000, CHEM BIOL, V7, P17, DOI 10.1016/S1074-5521(00)00062-4; Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007; Lee J. S., 2009, ANGEW CHEM, V121, P6384; Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003; Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016; Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/00007632-200208151-00005; Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; Sparks Andrew B., 1996, P227, DOI 10.1016/B978-012402380-2/50015-0	24	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70715	10.1371/journal.pone.0070715	http://dx.doi.org/10.1371/journal.pone.0070715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950987	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000025
J	Cook, R; Farinas-Franco, JM; Gell, FR; Holt, RHF; Holt, T; Lindenbaum, C; Porter, JS; Seed, R; Skates, LR; Stringell, TB; Sanderson, WG				Cook, Robert; Farinas-Franco, Jose M.; Gell, Fiona R.; Holt, Rohan H. F.; Holt, Terry; Lindenbaum, Charles; Porter, Joanne S.; Seed, Ray; Skates, Lucie R.; Stringell, Thomas B.; Sanderson, William G.			The Substantial First Impact of Bottom Fishing on Rare Biodiversity Hotspots: A Dilemma for Evidence-Based Conservation	PLOS ONE			English	Article							SMALL-SCALE VARIATION; MODIOLUS-MODIOLUS MOLLUSCA; LONG-TERM IMPACTS; IRISH SEA; BIVALVIA REEF; FOVEAUX STRAIT; DISTURBANCE; COMMUNITIES; BAY; FISHERIES	This study describes the impact of the first passage of two types of bottom-towed fishing gear on rare protected shellfish-reefs formed by the horse mussel Modiolus modiolus (L.). One of the study sites was trawled and the other was scallop-dredged. Divers collected HD video imagery of epifauna from quadrats at the two study sites and directed infaunal samples from one site. The total number of epifaunal organisms was significantly reduced following a single pass of a trawl (90%) or scallop dredge (59%), as was the diversity of the associated community and the total number of M. modiolus at the trawled site. At both sites declines in anthozoans, hydrozoans, bivalves, echinoderms and ascidians accounted for most of the change. A year later, no recovery was evident at the trawled site and significantly fewer infaunal taxa (polychaetes, malacostracans, bivalves and ophuroids) were recorded in the trawl track. The severity of the two types of impact reflected the undisturbed status of the habitats compared to previous studies. As a 'priority habitat' the nature of the impacts described on M. modiolus communities are important to the development of conservation management policy and indicators of condition in Marine Protected Areas (EU Habitats Directive) as well as indicators of 'Good Environmental Status' under the European Union Marine Strategy Framework Directive. Conservation managers are under pressure to support decisions with good quality evidence. Elsewhere, indirect studies have shown declines of M. modiolus biogenic communities in fishing grounds. However, given the protected status of the rare habitat, premeditated demonstration of direct impact is unethical or illegal in Marine Protected Areas. This study therefore provides a unique opportunity to investigate the impact from fishing gear whilst at the same time reflecting on the dilemma of evidence-based conservation management.	[Cook, Robert; Seed, Ray] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Gell, Fiona R.] Isle Of Man Govt, Fisheries Directorate, Dept Environm Food & Agr, St Johns, Man, England; [Holt, Rohan H. F.; Lindenbaum, Charles; Skates, Lucie R.; Stringell, Thomas B.; Sanderson, William G.] Nat Resources Wales, Bangor, Gwynedd, Wales; [Holt, Terry] Ctr Marine & Coastal Studies Ltd CMACS, Port Erin, Man, England; [Cook, Robert; Farinas-Franco, Jose M.; Porter, Joanne S.; Sanderson, William G.] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland	Bangor University; Heriot Watt University	Sanderson, WG (corresponding author), Nat Resources Wales, Bangor, Gwynedd, Wales.	w.g.sanderson@hw.ac.uk	Stringell, Thomas/AAY-1667-2020; Porter, Joanne S/B-8060-2011; Fariñas-Franco, Jose M./C-7803-2009	Porter, Joanne S/0000-0002-5878-3912; Fariñas-Franco, Jose M./0000-0002-1308-9003; Sanderson, William/0000-0003-1686-0585	Joint Nature Conservation Committee (JNCC) [C12-0233-0583]	Joint Nature Conservation Committee (JNCC)	This project was resourced under a reciprocal agreement between the Countryside Council for Wales and the Isle of Man Government. Additional work was completed under the Joint Nature Conservation Committee (JNCC) contract C12-0233-0583 awarded to Heriot Watt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2000, B MAR SCI, V66, P875; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANWAR NA, 1990, J MAR BIOL ASSOC UK, V70, P441, DOI 10.1017/S0025315400035529; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beck M. W., 2009, SHELLFISH REEFS RISK; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BERR, 2008, ATL UK MAR REN EN RE; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradshaw C, 2001, HYDROBIOLOGIA, V465, P129, DOI 10.1023/A:1014573731609; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Cook CN, 2012, J ENVIRON MANAGE, V113, P341, DOI 10.1016/j.jenvman.2012.09.002; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Cranfield HJ, 2003, CONT SHELF RES, V23, P1337, DOI 10.1016/S0278-4343(03)00122-5; DSCC, 2005, DEB CLAIMS SUST HIGH; European Commission DG Environment Nature and Biodiversity, 2007, 27 EUR EUR COMM DG E; Farinas-Franco JM, 2013, J SEA RES, V78, P59, DOI 10.1016/j.seares.2012.10.008; Garcia EG, 2006, ICES J MAR SCI, V63, P434, DOI 10.1016/j.icesjms.2005.08.013; Gorley C.K., 2006, GETTING STARTED PRIM; Gray JS, 2006, MAR POLLUT BULL, V52, P840, DOI 10.1016/j.marpolbul.2006.07.003; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; Hinz H, 2012, MAR ENVIRON RES, V73, P85, DOI 10.1016/j.marenvres.2011.11.009; Hirst N., 2012, 500 SCOTT NAT HER; Holt TJ, 1997, PRE POSTDRILLI UNPUB; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoydal K, 2005, NATURE, V433, P105, DOI 10.1038/433105b; Hydrographic Office, 1992, CARD BAY NO PART ADM; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kaiser MJ, 1996, J ANIM ECOL, V65, P348, DOI 10.2307/5881; Kenchington EL, 2007, J SEA RES, V58, P220, DOI 10.1016/j.seares.2007.04.001; Kenchington ELR, 2006, J SEA RES, V56, P249, DOI 10.1016/j.seares.2006.03.010; Lambert GI, 2011, MAR ECOL PROG SER, V430, P71, DOI 10.3354/meps09112; Lambert GI, 2012, ICES J MAR SCI, V69, P682, DOI 10.1093/icesjms/fss018; Lindenbaum C, 2008, J MAR BIOL ASSOC UK, V88, P133, DOI 10.1017/S0025315408000374; Lokkeberg S., 2005, 472 FAO; Magorrian BH, 1998, MAR POLLUT BULL, V36, P354, DOI 10.1016/S0025-326X(97)00192-6; Moffat C., 2011, ADVICE UK BIODIVERSI; Naumov AD, 2006, P ZOOL I RUSS AC SCI; OSPAR, 2005, MOD MOD HORS MUSS BE; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; R Development Core Team, 2012, R LANG ENV STAT COMP; Ragnarsson SA, 2012, J SEA RES, V72, P55, DOI 10.1016/j.seares.2012.05.011; Ramos-Espla, 1997, PUBLICACIONES ESPECI, V23, P243; Ramsay K, 1998, J SEA RES, V39, P299, DOI 10.1016/S1385-1101(98)00005-7; Rees EIS, 2008, J MAR BIOL ASSOC UK, V88, P151, DOI 10.1017/S0025315408000052; Rees E.I.S., 2009, OSPAR COMMISSION BIO; Roberts D, 2011, MODIOLUS RESTORATION; Robinson KA, 2012, ELSEV INSIGHT, P523, DOI 10.1016/B978-0-12-385140-6.00037-2; Rogers SI, 2005, MAR POLLUT BULL, V50, P9, DOI 10.1016/j.marpolbul.2004.10.028; Royal Commission on Environmental Pollution, 2004, TURN TID ADDR IMP FI; Sanderson WG, 2008, J MAR BIOL ASSOC UK, V88, P143, DOI 10.1017/S0025315408000040; Service M, 1997, J MAR BIOL ASSOC UK, V77, P1151, DOI 10.1017/S0025315400038686; Solyanko K, 2011, MAR ECOL-EVOL PERSP, V32, P36, DOI 10.1111/j.1439-0485.2011.00438.x; SOMERFIELD PJ, 1995, MAR ECOL PROG SER, V127, P113, DOI 10.3354/meps127113; Strain EMA, 2012, J SEA RES, V67, P58, DOI 10.1016/j.seares.2011.10.001; Stringell TB, 2013, ECOL EVOL, V3, P1667, DOI 10.1002/ece3.585; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Venables WN., 2002, MODERN APPL STAT S 4; WAG, 2010, WELSH ASS GOV SCALL; Wiborg K., 1946, NORW FISHERY MAR INV, VVIII, P85; Wildish DJ, 1998, CONT SHELF RES, V18, P105, DOI 10.1016/S0278-4343(98)80002-2	63	59	61	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69904	10.1371/journal.pone.0069904	http://dx.doi.org/10.1371/journal.pone.0069904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967063	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500009
J	Edgett, BA; Foster, WS; Hankinson, PB; Simpson, CA; Little, JP; Graham, RB; Gurd, BJ				Edgett, Brittany A.; Foster, William S.; Hankinson, Paul B.; Simpson, Craig A.; Little, Jonathan P.; Graham, Ryan B.; Gurd, Brendon J.			Dissociation of Increases in PGC-1 alpha and Its Regulators from Exercise Intensity and Muscle Activation Following Acute Exercise	PLOS ONE			English	Article							MOTOR UNIT RECRUITMENT; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; MESSENGER-RNA; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; DEPENDENT ACTIVATION; SPECTRAL PROPERTIES; ENDURANCE EXERCISE; PROTEIN-KINASE	Muscle activation as well as changes in peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) following high-intensity interval exercise (HIIE) were examined in young healthy men (n = 8; age, 21.9 +/- 2.2 yrs; VO(2)peak, 53.1 +/- 6.4 ml/min/kg; peak work rate, 317 +/- 23.5 watts). On each of 3 visits HIIE was performed on a cycle ergometer at a target intensity of 73, 100, or 133% of peak work rate. Muscle biopsies were taken at rest and three hours after each exercise condition. Total work was not different between conditions (similar to 730 kJ) while average power output (73%, 237 +/- 21; 100%, 323 +/- 26; 133%, 384 +/- 35 watts) and EMG derived muscle activation (73%, 1262 +/- 605; 100%, 2089 +/- 737; 133%, 3029 +/- 1206 total integrated EMG per interval) increased in an intensity dependent fashion. PGC-1 alpha mRNA was elevated after all three conditions (p < 0.05), with a greater increase observed following the 100% condition (similar to 9 fold, p < 0.05) compared to both the 73 and 133% conditions (similar to 4 fold). When expressed relative to muscle activation, the increase in PGC-1 alpha mRNA for the 133% condition was less than that for the 73 and 100% conditions (p < 0.05). SIRT1 mRNA was also elevated after all three conditions (similar to 1.4 fold, p < 0.05), with no difference between conditions. These findings suggest that intensity-dependent increases in PGC-1 alpha mRNA following submaximal exercise are largely due to increases in muscle recruitment. As well, the blunted response of PGC-1 alpha mRNA expression following supramaximal exercise may indicate that signalling mediated activation of PGC-1 alpha may also be blunted. We also indentify that increases in PDK4, SIRT1, and RIP140 mRNA following acute exercise are dissociated from exercise intensity and muscle activation, while increases in EGR1 are augmented with supramaximal HIIE (p < 0.05).	[Edgett, Brittany A.; Foster, William S.; Hankinson, Paul B.; Graham, Ryan B.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Simpson, Craig A.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Graham, Ryan B.] Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada	Queens University - Canada; Queens University - Canada; University of British Columbia; University of British Columbia Okanagan; Nipissing University	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca	Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008; Edgett, Brittany/0000-0002-8232-0432	NSERC [402635-2011]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC (402635-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSHAKRA SR, 1993, MOL BRAIN RES, V18, P216, DOI 10.1016/0169-328X(93)90192-R; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Coyle EF, 2005, J APPL PHYSIOL, V98, P1983, DOI 10.1152/japplphysiol.00215.2005; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Dumke CL, 2009, EUR J APPL PHYSIOL, V107, P419, DOI 10.1007/s00421-009-1143-1; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2010, OBESITY, V18, P79, DOI 10.1038/oby.2009.204; Farina D, 2008, J APPL PHYSIOL, V105, P1673, DOI 10.1152/japplphysiol.90598.2008a; Frier BC, 2011, J APPL PHYSIOL, V111, P688, DOI 10.1152/japplphysiol.00279.2011; Gaesser GA, 2011, J APPL PHYSIOL, V111, P1540, DOI 10.1152/japplphysiol.01237.2011; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Godin R, 2010, J PHYSIOL-LONDON, V588, P4073, DOI 10.1113/jphysiol.2010.195925; Graham RB, 2012, J BIOMECH, V45, P1593, DOI 10.1016/j.jbiomech.2012.04.007; Graham RB, 2009, APPL ERGON, V40, P936, DOI 10.1016/j.apergo.2009.01.006; Gurd BJ, 2012, J APPL PHYSIOL, V112, P926, DOI 10.1152/japplphysiol.01262.2011; Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Jensen TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031054; Jozsi AC, 2000, MECH AGEING DEV, V120, P45, DOI 10.1016/S0047-6374(00)00178-0; Kamen G, 2010, ESSENTIALS ELECTROMY; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marfe Gabriella, 2010, BMC Physiology, V10, P7, DOI 10.1186/1472-6793-10-7; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nordsborg NB, 2010, MED SCI SPORT EXER, V42, P1477, DOI 10.1249/MSS.0b013e3181d2d21c; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; SALE DG, 1987, EXERCISE SPORT SCI R, V15, P95; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shiose K., 2012, OPEN J MOL INTEGRATI, V2, P119, DOI [10.4236/ojmip.2012.24017, DOI 10.4236/OJMIP.2012.24017]; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stepto NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053080; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; von Tscharner V, 2008, J APPL PHYSIOL, V105, P1671, DOI 10.1152/japplphysiol.90598.2008; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x	63	66	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71623	10.1371/journal.pone.0071623	http://dx.doi.org/10.1371/journal.pone.0071623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951207	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300137
J	Filiano, AN; Millender-Swain, T; Johnson, R; Young, ME; Gamble, KL; Bailey, SM				Filiano, Ashley N.; Millender-Swain, Telisha; Johnson, Russell, Jr.; Young, Martin E.; Gamble, Karen L.; Bailey, Shannon M.			Chronic Ethanol Consumption Disrupts the Core Molecular Clock and Diurnal Rhythms of Metabolic Genes in the Liver without Affecting the Suprachiasmatic Nucleus	PLOS ONE			English	Article							CIRCADIAN CLOCK; MAMMALIAN CLOCK; PHASE-SHIFTS; ALCOHOL; EXPRESSION; TOLERANCE; PERIOD; ORGANIZATION; OSCILLATIONS; PACEMAKER	Chronic ethanol consumption disrupts several metabolic pathways including beta-oxidation and lipid biosynthesis, facilitating the development of alcoholic fatty liver disease. Many of these same metabolic pathways are directly regulated by cell autonomous circadian clocks, and recent studies suggest that disruption of daily rhythms in metabolism contributes to multiple common cardiometabolic diseases (including non-alcoholic fatty liver disease). However, it is not known whether ethanol disrupts the core molecular clock in the liver, nor whether this, in turn, alters rhythms in lipid metabolism. Herein, we tested the hypothesis that chronic ethanol consumption disrupts the molecular circadian clock in the liver and potentially changes the diurnal expression patterns of lipid metabolism genes. Consistent with previous studies, male C57BL/6J mice fed an ethanol-containing diet exhibited higher levels of liver triglycerides compared to control mice, indicating hepatic steatosis. Further, the diurnal oscillations of core clock genes (Bmal1, Clock, Cry1, Cry2, Per1, and Per2) and clock-controlled genes (Dbp, Hlf, Nocturnin, Npas2, Rev-erba, and Tef) were altered in livers from ethanol-fed mice. In contrast, ethanol had only minor effects on the expression of core clock genes in the suprachiasmatic nucleus (SCN). These results were confirmed in Per2(Luciferase) knock-in mice, in which ethanol induced a phase advance in PER2::LUC bioluminescence oscillations in liver, but not SCN. Further, there was greater variability in the phase of PER2::LUC oscillations in livers from ethanol-fed mice. Ethanol consumption also affected the diurnal oscillations of metabolic genes, including Adh1, Cpt1a, Cyp2e1, Pck1, Pdk4, Ppargc1a, Ppargc1b and Srebp1c, in the livers of C57BL/6J mice. In summary, chronic ethanol consumption alters the function of the circadian clock in liver. Importantly, these results suggest that chronic ethanol consumption, at levels sufficient to cause steatosis, disrupts the core hepatic clock as well as the diurnal rhythms of key lipid metabolism genes.	[Filiano, Ashley N.; Millender-Swain, Telisha; Bailey, Shannon M.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Johnson, Russell, Jr.; Gamble, Karen L.] Univ Alabama Birmingham, Dept Psychiat, Div Behav Neurobiol, Birmingham, AL 35294 USA; [Young, Martin E.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bailey, SM (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.	sbailey@uab.edu		Bailey, Shannon/0000-0003-0002-3424; Gamble, Karen/0000-0003-3813-8577	National Institutes of Health [AA018841, AA020199]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020199, R01AA018841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants (www.nih.gov/) AA018841 (SMB) and AA020199 (SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2009, BIOCHEM BIOPH RES CO, V380, P684, DOI 10.1016/j.bbrc.2009.01.150; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bailey SM, 1999, ALCOHOL CLIN EXP RES, V23, P1210, DOI 10.1111/j.1530-0277.1999.tb04280.x; Besing RC, 2012, CHRONOBIOL INT, V29, P91, DOI 10.3109/07420528.2011.649382; Brager AJ, 2011, ALCOHOL CLIN EXP RES, V35, P1467, DOI 10.1111/j.1530-0277.2011.01483.x; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Chen CP, 2004, J NEUROCHEM, V88, P1547, DOI 10.1046/j.1471-4159.2003.02300.x; Cho H, 2012, NATURE; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; El-Guindy NBD, 2010, ALCOHOL CLIN EXP RES, V34, P1489, DOI 10.1111/j.1530-0277.2010.01234.x; Farnell YZ, 2008, ALCOHOL CLIN EXP RES, V32, P544, DOI 10.1111/j.1530-0277.2007.00598.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Huang MC, 2010, ALCOHOL CLIN EXP RES, V34, P1899, DOI 10.1111/j.1530-0277.2010.01278.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Matson L, 2013, ALCOHOL CLIN EXP RES, V37, P194, DOI 10.1111/j.1530-0277.2012.01873.x; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; McElroy B, 2009, NEUROSCIENCE, V164, P842, DOI 10.1016/j.neuroscience.2009.08.020; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Prosser RA, 2008, NEUROSCIENCE, V152, P837, DOI 10.1016/j.neuroscience.2007.12.049; Prosser RA, 2009, ALCOHOL CLIN EXP RES, V33, P2088, DOI 10.1111/j.1530-0277.2009.01048.x; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Rosenwasser AM, 2005, CHRONOBIOL INT, V22, P227, DOI 10.1081/CBI-200053496; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Seggio JA, 2009, J BIOL RHYTHM, V24, P304, DOI 10.1177/0748730409338449; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Tsuchiya M, 2012, HEPATOLOGY, V56, P130, DOI 10.1002/hep.25641; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yang XX, 2009, J BIOCHEM, V145, P609, DOI 10.1093/jb/mvp018; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	55	62	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71684	10.1371/journal.pone.0071684	http://dx.doi.org/10.1371/journal.pone.0071684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951220	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300142
J	Kelble, CR; Loomis, DK; Lovelace, S; Nuttle, WK; Ortner, PB; Fletcher, P; Cook, GS; Lorenz, JJ; Boyer, JN				Kelble, Christopher R.; Loomis, Dave K.; Lovelace, Susan; Nuttle, William K.; Ortner, Peter B.; Fletcher, Pamela; Cook, Geoffrey S.; Lorenz, Jerry J.; Boyer, Joseph N.			The EBM-DPSER Conceptual Model: Integrating Ecosystem Services into the DPSIR Framework	PLOS ONE			English	Article							SOUTH FLORIDA; MANAGEMENT; INDICATORS; BIODIVERSITY; RESTORATION; VALUATION; SEAGRASS; ECOLOGY; SCIENCE; POLICY	There is a pressing need to integrate biophysical and human dimensions science to better inform holistic ecosystem management supporting the transition from single species or single-sector management to multi-sector ecosystem-based management. Ecosystem-based management should focus upon ecosystem services, since they reflect societal goals, values, desires, and benefits. The inclusion of ecosystem services into holistic management strategies improves management by better capturing the diversity of positive and negative human-natural interactions and making explicit the benefits to society. To facilitate this inclusion, we propose a conceptual model that merges the broadly applied Driver, Pressure, State, Impact, and Response (DPSIR) conceptual model with ecosystem services yielding a Driver, Pressure, State, Ecosystem service, and Response (EBM-DPSER) conceptual model. The impact module in traditional DPSIR models focuses attention upon negative anthropomorphic impacts on the ecosystem; by replacing impacts with ecosystem services the EBM-DPSER model incorporates not only negative, but also positive changes in the ecosystem. Responses occur as a result of changes in ecosystem services and include inter alia management actions directed at proactively altering human population or individual behavior and infrastructure to meet societal goals. The EBM-DPSER conceptual model was applied to the Florida Keys and Dry Tortugas marine ecosystem as a case study to illustrate how it can inform management decisions. This case study captures our system-level understanding and results in a more holistic representation of ecosystem and human society interactions, thus improving our ability to identify trade-offs. The EBM-DPSER model should be a useful operational tool for implementing EBM, in that it fully integrates our knowledge of all ecosystem components while focusing management attention upon those aspects of the ecosystem most important to human society and does so within a framework already familiar to resource managers.	[Kelble, Christopher R.; Cook, Geoffrey S.] NOAA, Ocean Chem Div, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Loomis, Dave K.] E Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC USA; [Lovelace, Susan] NOAA, JHT Inc, Hollings Marine Lab, Natl Ctr Coastal Ocean Sci, Charleston, SC USA; [Nuttle, William K.] Ecohydrology, Ottawa, ON, Canada; [Ortner, Peter B.; Cook, Geoffrey S.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA; [Fletcher, Pamela] Univ Florida Sea Grant, Gainesville, FL USA; [Lorenz, Jerry J.] Audubon Florida, Tavernier Sci Ctr, Tavernier, FL USA; [Boyer, Joseph N.] Plymouth State Univ, Ctr Environm, Plymouth, NH USA	National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of North Carolina; East Carolina University; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); University of Miami; State University System of Florida; University of Florida; University System Of New Hampshire; Plymouth State University	Kelble, CR (corresponding author), NOAA, Ocean Chem Div, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA.	chris.kelble@noaa.gov	Cook, Geoffrey/A-7469-2014; Kelble, Christopher R/A-8511-2008; Fletcher, Pamela/F-7296-2015	Kelble, Christopher R/0000-0003-0914-4134; 	National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research (Coastal Ocean Program) [NA08OAR4320889, NA09NOS4780224, NA09NOS4780225, NA09NOS4780226, NA09NOS4780227, NA09NOS4780228]	National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research (Coastal Ocean Program)	This paper is a result of research under the Marine and Estuarine Goal Setting (MARES) for South Florida Project funded by the National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research (Coastal Ocean Program), under award NA08OAR4320889 to the University of Miami, NA09NOS4780224 to Nova Southeastern University, NA09NOS4780225 to the University of Massachusetts Amherst, NA09NOS4780226 to the National Audubon Society, NA09NOS4780227 to Florida Gulf Coast University, NA09NOS4780228 to Florida International University, and to the NOAA Atlantic Oceanographic and Meteorological Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman I, 2011, FRONT ECOL ENVIRON, V9, P183, DOI 10.1890/080186; Anderson LE, 2012, NORMATIVE STANDARDS; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Borja A, 2006, ESTUAR COAST SHELF S, V66, P84, DOI 10.1016/j.ecss.2005.07.021; Bowen RE, 2003, OCEAN COAST MANAGE, V46, P299, DOI 10.1016/S0964-5691(03)00008-5; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Burkhard B, 2010, ECOL COMPLEX, V7, P257, DOI 10.1016/j.ecocom.2010.07.001; Carr ER, 2007, INT J SUST DEV WORLD, V14, P543, DOI 10.1080/13504500709469753; Cheong SM, 2008, MAR POLICY, V32, P1090, DOI 10.1016/j.marpol.2008.03.004; Collado-Vides L, 2007, ESTUAR COAST SHELF S, V73, P680, DOI 10.1016/j.ecss.2007.03.009; Collins SL, 2011, FRONT ECOL ENVIRON, V9, P351, DOI 10.1890/100068; Cook GS, 2005, NAT AREA J, V25, P390; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 1997, NATURES SERVICES SOC, P47; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Curtice C, 2012, BIOSCIENCE, V62, P508, DOI 10.1525/bio.2012.62.5.13; de Jonge VN, 2012, OCEAN COAST MANAGE, V68, P169, DOI 10.1016/j.ocecoaman.2012.05.017; DEUTSCH M, 1975, J SOC ISSUES, V31, P137, DOI 10.1111/j.1540-4560.1975.tb01000.x; Doren RF, 2009, ECOL INDIC, V9, pS2, DOI 10.1016/j.ecolind.2008.08.009; Elliott M, 2011, MAR POLLUT BULL, V62, P651, DOI 10.1016/j.marpolbul.2010.11.033; Farber S, 2006, BIOSCIENCE, V56, P121, DOI 10.1641/0006-3568(2006)056[0121:LEAEFE]2.0.CO;2; Fassio A, 2005, J HYDROL, V304, P462, DOI 10.1016/j.jhydrol.2004.07.048; Feld CK, 2010, BIODIVERS CONSERV, V19, P2895, DOI 10.1007/s10531-010-9875-0; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Gentile JH, 2001, SCI TOTAL ENVIRON, V274, P231, DOI 10.1016/S0048-9697(01)00746-X; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Kelble CR, 2005, ESTUARIES, V28, P560, DOI 10.1007/BF02696067; Kerenyi A, 2011, PUBLIC FINANC Q-HUNG, V56, P518; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kohsaka R, 2010, ECOL RES, V25, P925, DOI 10.1007/s11284-010-0746-7; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V308, P23, DOI 10.1016/j.jembe.2004.01.019; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Leeworthy V. R., 2004, IMPORTANCE SATISFACT; Levin P, 2008, INTEGRATED ECOSYSTEM; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LOOMIS DK, 1993, FISHERIES, V18, P14, DOI 10.1577/1548-8446(1993)018<0014:DJIFM>2.0.CO;2; Loomis J, 2000, ECOL ECON, V33, P103, DOI 10.1016/S0921-8009(99)00131-7; Lovelace S, 2012, PRIORITIZING COUNTY; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Lubchenco J., 2009, NOAA ANN GUIDANCE ME, P14; Lubchenco J, 2010, SCIENCE, V328, P1485, DOI 10.1126/science.1190041; Mangi SC, 2007, OCEAN COAST MANAGE, V50, P463, DOI 10.1016/j.ocecoaman.2006.10.003; McLeod K., 2005, COMMUNICATION PARTNE; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Mee LD, 2008, MAR POLLUT BULL, V56, P187, DOI 10.1016/j.marpolbul.2007.09.038; Muller F, 2012, ECOSYST SERV, V1, P26, DOI 10.1016/j.ecoser.2012.06.001; Niemeijer David, 2008, Environment Development and Sustainability, V10, P89, DOI 10.1007/s10668-006-9040-9; Nuttle WK, 2013, INTEGRATED CONCEPTUA; Ogden JC, 2005, WETLANDS, V25, P795, DOI 10.1672/0277-5212(2005)025[0795:TUOCEM]2.0.CO;2; Ogden JC, 2005, WETLANDS, V25, P810, DOI 10.1672/0277-5212(2005)025[0810:ERASCE]2.0.CO;2; PCAST, 2011, SUST ENV CAP PROT SO, P125; Pimm SL, 1997, NATURE, V387, P231, DOI 10.1038/387231a0; Rehr AP, 2012, ENVIRON MANAGE, V50, P1204, DOI 10.1007/s00267-012-9941-3; Rosenberg AA, 2005, MAR ECOL PROG SER, V300, P270; Rounsevell MDA, 2010, BIODIVERS CONSERV, V19, P2823, DOI 10.1007/s10531-010-9838-5; Sekovski I, 2012, ESTUAR COAST SHELF S, V96, P48, DOI 10.1016/j.ecss.2011.07.011; Sherrouse BC, 2011, APPL GEOGR, V31, P748, DOI 10.1016/j.apgeog.2010.08.002; SLOCOMBE DS, 1993, BIOSCIENCE, V43, P612, DOI 10.2307/1312148; Smeets E., 1999, ENV INDICATORS TYPOL; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Svarstad H, 2008, LAND USE POLICY, V25, P116, DOI 10.1016/j.landusepol.2007.03.005; Tscherning K, 2012, LAND USE POLICY, V29, P102, DOI 10.1016/j.landusepol.2011.05.009; Turner RK, 2000, J MARINE SYST, V25, P447, DOI 10.1016/S0924-7963(00)00033-6; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; Turner RK, 1998, GEOGR J, V164, P269, DOI 10.2307/3060616; Visser L., 1999, J COAST CONSERV, V5, P145, DOI [10.1007/BF02802751, DOI 10.1007/BF02802751]; Wegner G, 2011, GLOBAL ENVIRON CHANG, V21, P492, DOI 10.1016/j.gloenvcha.2010.12.008; Weinstein MP, 2009, ESTUAR COAST, V32, P1044, DOI 10.1007/s12237-009-9221-5; Wellbeing CIo, 2012, AR CAN REALL DOING 2	74	150	161	7	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70766	10.1371/journal.pone.0070766	http://dx.doi.org/10.1371/journal.pone.0070766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951002	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000323097300049
J	Liao, M; Yang, F; Zhang, Y; He, Z; Song, M; Jiang, TZ; Li, ZX; Lu, SJ; Wu, WW; Su, LY; Li, LJ				Liao, Mei; Yang, Fan; Zhang, Yan; He, Zhong; Song, Ming; Jiang, Tianzi; Li, Zexuan; Lu, Shaojia; Wu, Weiwei; Su, Linyan; Li, Lingjiang			Childhood Maltreatment Is Associated with Larger Left Thalamic Gray Matter Volume in Adolescents with Generalized Anxiety Disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; POSTTRAUMATIC-STRESS-DISORDER; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; AMYGDALA VOLUMES; BRAIN STRUCTURE; BASAL GANGLIA; HIPPOCAMPAL; ADULTS; PILOT	Background: Generalized anxiety disorder (GAD) is a common anxiety disorder that usually begins in adolescence. Childhood maltreatment is highly prevalent and increases the possibility for developing a variety of mental disorders including anxiety disorders. An earlier age at onset of GAD is significantly related to maltreatment in childhood. Exploring the underpinnings of the relationship between childhood maltreatment and adolescent onset GAD would be helpful in identifying the potential risk markers of this condition. Methods: Twenty-six adolescents with GAD and 25 healthy controls participated in this study. A childhood trauma questionnaire (CTQ) was introduced to assess childhood maltreatment. All subjects underwent high-resolution structural magnetic resonance scans. Voxel-based morphometry (VBM) was used to investigate gray matter alterations. Results: Significantly larger gray matter volumes of the right putamen were observed in GAD patients compared to healthy controls. In addition, a significant diagnosis-by-maltreatment interaction effect for the left thalamic gray matter volume was revealed, as shown by larger volumes of the left thalamic gray matter in GAD patients with childhood maltreatment compared with GAD patients without childhood maltreatment as well as with healthy controls with/without childhood maltreatment. A significant positive association between childhood maltreatment and left thalamic gray matter volume was only seen in GAD patients. Conclusions: These findings revealed an increased volume in the subcortical regions in adolescent GAD, and the alterations in the left thalamus might be involved in the association between childhood maltreatment and the occurrence of GAD.	[Liao, Mei; Yang, Fan; Zhang, Yan; Li, Zexuan; Lu, Shaojia; Wu, Weiwei; Su, Linyan; Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China; [He, Zhong] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Song, Ming; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Central South University; Central South University; Chinese Academy of Sciences; Institute of Automation, CAS	Su, LY (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China.	childpsy8@yahoo.com.cn; llj2920@163.com	Jiang, Tianzi/I-4256-2012; Lu, Dali/GSE-4800-2022	Jiang, Tianzi/0000-0001-9531-291X; Lu, Shaojia/0000-0001-6121-7754	National Natural Science Foundation of China [30830046, 81171286, 91232714, 81171291, 81101004]; National 973 Program of China [2009CB918303]; Chinese Ministry of Education [20090162110011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (30830046 & 81171286 & 91232714 to Lingjiang Li, 81171291 to Linyan Su, 81101004 to Yan Zhang), the National 973 Program of China (2009CB918303 to Lingjiang Li) and Program of Chinese Ministry of Education (20090162110011 to Lingjiang Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barbas H, 2011, BIOL PSYCHIAT, V69, P1133, DOI 10.1016/j.biopsych.2010.08.008; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2000, BIOL PSYCHIAT, V48, P51, DOI 10.1016/S0006-3223(00)00835-0; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Dugas MJ, 2010, J ANXIETY DISORD, V24, P780, DOI 10.1016/j.janxdis.2010.05.012; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fisher AJ, 2010, BIOL PSYCHOL, V83, P191, DOI 10.1016/j.biopsycho.2009.12.007; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Goncalves DC, 2012, DEPRESS ANXIETY, V29, P39, DOI 10.1002/da.20881; Guyer AE, 2012, AM J PSYCHIAT, V169, P205, DOI 10.1176/appi.ajp.2011.11010006; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Isovich E, 2000, EUR J NEUROSCI, V12, P1071, DOI 10.1046/j.1460-9568.2000.00969.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kessler RC, 2008, PSYCHOL MED, V38, P365, DOI 10.1017/S0033291707002012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Majer M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-61; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Milham MP, 2005, BIOL PSYCHIAT, V57, P961, DOI 10.1016/j.biopsych.2005.01.038; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Parr LA, 2012, DEV COGN NEUROS-NETH, V2, P181, DOI 10.1016/j.dcn.2011.09.003; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Scher CD, 2004, CHILD ABUSE NEGLECT, V28, P167, DOI 10.1016/j.chiabu.2003.09.012; Schienle A, 2011, EUR ARCH PSY CLIN N, V261, P303, DOI 10.1007/s00406-010-0147-5; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Su LY, 2008, J ANXIETY DISORD, V22, P612, DOI 10.1016/j.janxdis.2007.05.011; Sugama S, 2007, NEUROSCIENCE, V146, P1388, DOI 10.1016/j.neuroscience.2007.02.043; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Weintraub D, 2005, J NUCL MED, V46, P227; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Yoo HK, 2005, EUR J NEUROSCI, V22, P2089, DOI 10.1111/j.1460-9568.2005.04394.x; Yoo SY, 2008, J KOREAN MED SCI, V23, P24, DOI 10.3346/jkms.2008.23.1.24	64	39	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71898	10.1371/journal.pone.0071898	http://dx.doi.org/10.1371/journal.pone.0071898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951265	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300169
J	Nugue, G; Bidart, M; Arlotto, M; Mousseau, M; Berger, F; Pelletier, L				Nugue, Guillaume; Bidart, Marie; Arlotto, Marie; Mousseau, Mireille; Berger, Francois; Pelletier, Laurent			Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab	PLOS ONE			English	Article							DRUG DEVELOPMENT; GROWTH-FACTOR; PHARMACOKINETICS; CANCER; PHARMACODYNAMICS; IRINOTECAN	Developing therapeutic monoclonal antibodies paves the way for new strategies in oncology using targeted therapy which should improve specificity. However, due to a lack of biomarkers, a personalized therapy scheme cannot always be applied with monoclonal antibodies. As a consequence, the efficacy or side effects associated with this type of treatment often appear to be sporadic. Bevacizumab is a therapeutic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF). It is used to limit tumor vascularization. No prognosis or response biomarker is associated with this antibody, we therefore assessed whether the administration protocol could be a possible cause of heterogeneous responses (or variable efficacy). To do this, we developed a bevacizumab assay with a broad sensitivity range to measure blood bevacizumab concentrations. We then analyzed bevacizumab concentrations in 17 patients throughout the first quarter of treatment. In line with previously published data, average blood concentrations were 88+/227 mg/L following the first dose administered, and 213+/2105 mg/L after the last (6th) dose administered. However, the individual values were scattered, with a mean 4-fold difference between the lowest and the highest concentration for each dose administered. We demonstrated that the bevacizumab administration schedule results in a high inter-individual variability in terms of blood concentrations. Comparison of assay data with clinical data indicates that blood concentrations above the median are associated with side effects, whereas values below the median favor inefficacy. In conclusion, bevacizumab-based therapy could benefit from a personalized administration schedule including follow-up and adjustment of circulating bevacizumab concentrations.	[Nugue, Guillaume; Bidart, Marie; Arlotto, Marie; Mousseau, Mireille; Berger, Francois; Pelletier, Laurent] Grenoble Inst Neurosci, Grenoble, France; [Bidart, Marie; Mousseau, Mireille; Berger, Francois; Pelletier, Laurent] CHU Grenoble, F-38043 Grenoble, France; [Nugue, Guillaume; Bidart, Marie; Arlotto, Marie; Mousseau, Mireille; Berger, Francois; Pelletier, Laurent] Univ Grenoble 1, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pelletier, L (corresponding author), Grenoble Inst Neurosci, Grenoble, France.	laurent.pelletier@ujf-grenoble.fr	Mousseau, Mireille/M-5942-2014	ARLOTTO, Marie/0000-0001-5079-5962				Cohen MH, 2009, ONCOLOGIST, V14, P1131, DOI 10.1634/theoncologist.2009-0121; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Houser B, 2012, ARCH PHYSIOL BIOCHEM, V118, P192, DOI 10.3109/13813455.2012.705301; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lu JF, 2008, CANCER CHEMOTH PHARM, V62, P779, DOI 10.1007/s00280-007-0664-8; Margolin K, 2001, J CLIN ONCOL, V19, P851, DOI 10.1200/JCO.2001.19.3.851; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Mould DR, 2007, CURR OPIN DRUG DISC, V10, P84; Mould DR, 2010, BIODRUGS, V24, P23, DOI 10.2165/11530560-000000000-00000; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Reardon DA, 2012, J NEURO-ONCOL, V107, P155, DOI 10.1007/s11060-011-0722-2; Ternant D, 2010, THER DRUG MONIT, V32, P647, DOI 10.1097/FTD.0b013e3181ef582a; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424	17	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72021	10.1371/journal.pone.0072021	http://dx.doi.org/10.1371/journal.pone.0072021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951280	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300174
J	Pelkmans, L; Kelchtermans, H; de Groot, PG; Zuily, S; Regnault, V; Wahl, D; Pengo, V; de Laat, B				Pelkmans, Leonie; Kelchtermans, Hilde; de Groot, Philip G.; Zuily, Stephane; Regnault, Veronique; Wahl, Denis; Pengo, Vittorio; de Laat, Bas			Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs	PLOS ONE			English	Article							BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID ANTIBODIES; CRYSTAL-STRUCTURE; STANDARDIZATION; BINDING; AUTOANTIBODIES; THROMBOSIS	Background: A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between commercial anti-beta(2)glycoprotein I (beta(2)GPI) assays. Predominantly antibodies reactive against cryptic epitope Glycine40-Arginine43 (G40-R43) in domain I are associated with an increased risk for thrombosis. Upon interaction with anionic surfaces beta(2)GPI opens up, thereby exposing G40-R43. Objectives: To examine whether suboptimal exposure of epitope G40-R43 explains the variations in results observed between commercial assays. Methods: Two patient-derived monoclonal antibodies were tested on neutral versus anionic plates. Antibody P1-117 reacts with G40-R43 in the open conformation while P2-6 recognizes beta(2)GPI irrespective of its conformation. These antibodies were tested in commercial anti-beta(2)GPI assays (A-E). Results: In assay A, both antibodies showed equal reactivity towards beta(2)GPI, indicating that all the beta(2)GPI exposes G40-R43. In other assays P1-117 displayed lower reactivity than P2-6, demonstrating reduced G40-R43 availability. To exclude influences of other assay features, reactivity was re-examined on plates of assay A and B using the protocol/reagents from each assay. In all combinations, reactivity of both antibodies on a plate was comparable to results obtained with its own protocol/reagents, suggesting that the coating, rather than other assay components, accounts for the observed differences. In two patient cohorts we demonstrated that a number of domain I-reactive samples are missed in assays characterized by a decreased exposure of epitope G40-R43. Conclusions: Exposure of epitope G40-R43 on beta(2)GPI is highly variable between commercial anti-beta(2)GPI assays. As a consequence, patients can be falsely assigned negative in assays characterized by a reduced exposure of G40-R43.	[Pelkmans, Leonie; Kelchtermans, Hilde; de Laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Pelkmans, Leonie; Kelchtermans, Hilde; de Laat, Bas] Synapse BV, Maastricht, Netherlands; [de Groot, Philip G.; de Laat, Bas] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Zuily, Stephane; Wahl, Denis] CHU Nancy, Reg Competence Ctr Rare Vasc Dis, Vasc Med Div, Nancy, France; [Zuily, Stephane; Regnault, Veronique; Wahl, Denis] Univ Lorraine, INSERM U1116, Nancy, France; [Pengo, Vittorio] Univ Padua, Thrombosis Ctr, Dept Cardiothorac & Vasc Sci, Padua, Italy; [de Laat, Bas] Sanquin Res, Amsterdam, Netherlands	Maastricht University; Utrecht University; Utrecht University Medical Center; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Padua	Kelchtermans, H (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	H.Kelchtermans@thrombin.com	Pengo, Vittorio/AAV-9491-2020; Pengo, Vittorio/GSE-5972-2022; Regnault, Veronique/H-9138-2016; REGNAULT, Veronique/AAY-1711-2020	Pengo, Vittorio/0000-0003-2064-6071; Pengo, Vittorio/0000-0003-2064-6071; REGNAULT, Veronique/0000-0001-6418-5022; Kelchtermans, Hilde/0000-0002-2724-3438	Dutch Heart Foundation [NHS2006T053, NHS2006T5301]; Ministere Francais de la Sante et des Sports (Programme Hospitalier de Recherche Clinique); Fondation de France	Dutch Heart Foundation(Netherlands Heart Foundation); Ministere Francais de la Sante et des Sports (Programme Hospitalier de Recherche Clinique); Fondation de France(Fondation de France)	BDL, LP and HK were supported in part by the Dutch Heart Foundation (NHS2006T053;NHS2006T5301). DW, VR and SZ were supported by grants from the Ministere Francais de la Sante et des Sports (Programme Hospitalier de Recherche Clinique) and the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; De Laat B, 2009, J THROMB HAEMOST, V7, P1767, DOI 10.1111/j.1538-7836.2009.03588.x; Devreese KMJ, 2012, LUPUS, V21, P718, DOI 10.1177/0961203312439335; Dienava-Verdoold I, 2011, J THROMB HAEMOST, V9, P738, DOI 10.1111/j.1538-7836.2011.04212.x; Hammel M, 2002, J MOL BIOL, V321, P85, DOI 10.1016/S0022-2836(02)00621-6; Ioannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002/art.22306; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Iverson GM, 2002, J AUTOIMMUN, V18, P289, DOI 10.1006/jaut.2002.0590; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Reber G, 2012, LUPUS, V21, P722, DOI 10.1177/0961203312446389; Reber G, 2002, THROMB HAEMOSTASIS, V88, P66; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Tincani A, 2009, LUPUS, V18, P913, DOI 10.1177/0961203309106919; Tsutsumi A, 2000, J RHEUMATOL, V27, P391; Urbanus RT, 2011, BLOOD REV, V25, P97, DOI 10.1016/j.blre.2010.12.001; Willis R, 2012, SEMIN THROMB HEMOST, V38, P360, DOI 10.1055/s-0032-1313564	20	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71402	10.1371/journal.pone.0071402	http://dx.doi.org/10.1371/journal.pone.0071402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951154	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300113
J	Qu, QM; Sanchez, S; Blom, H; Tafforeau, P; Ahlberg, PE				Qu, Qingming; Sanchez, Sophie; Blom, Henning; Tafforeau, Paul; Ahlberg, Per Erik			Scales and Tooth Whorls of Ancient Fishes Challenge Distinction between External and Oral 'Teeth'	PLOS ONE			English	Article							FOSSIL ACTINOPTERYGIAN FISHES; VERTEBRATE DENTITION; DERMAL SKELETON; EVOLUTIONARY ORIGINS; PHARYNGEAL DENTICLES; JAWED VERTEBRATES; DENTAL LAMINA; MICROSTRUCTURE; GROWTH; GNATHOSTOMES	The debate about the origin of the vertebrate dentition has been given fresh fuel by new fossil discoveries and developmental studies of extant animals. Odontodes (teeth or tooth-like structures) can be found in two distinct regions, the 'internal' oropharyngeal cavity and the 'external' skin. A recent hypothesis argues that regularly patterned odontodes is a specific oropharyngeal feature, whereas odontodes in the external skeleton lack this organization. However, this argument relies on the skeletal system of modern chondrichthyans (sharks and their relatives), which differ from other gnathostome (jawed vertebrate) groups in not having dermal bones associated with the odontodes. Their external skeleton is also composed of monoodontode 'placoid scales', whereas the scales of most early fossil gnathostomes are polyodontode, i.e. constructed from several odontodes on a shared bony base. Propagation phase contrast X-ray Synchrotron microtomography (PPC-SRmCT) is used to study the polyodontode scales of the early bony fish Andreolepis hedei. The odontodes constructing a single scale are reconstructed in 3D, and a linear and regular growth mechanism similar to that in a gnathostome dentition is confirmed, together with a second, gap-filling growth mechanism. Acanthodian tooth whorls are described, which show that ossification of the whorl base preceded and probably patterned the development of the dental lamina, in contrast to the condition in sharks where the dental lamina develops early and patterns the dentition. The new findings reveal, for the first time, how polyodontode scales grow in 3D in an extinct bony fish. They show that dentition-like odontode patterning occurs on scales and that the primary patterning unit of a tooth whorl may be the bony base rather than the odontodes it carries. These results contradict the hypothesis that oropharyngeal and external odontode skeletons are fundamentally separate and suggest that the importance of dermal bone interactions to odontode patterning has been underestimated.	[Qu, Qingming; Sanchez, Sophie; Blom, Henning; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Uppsala University; European Synchrotron Radiation Facility (ESRF)	Qu, QM (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden.	quqingming@hotmail.com; per.ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Qu, Qingming/R-7194-2016	Qu, Qingming/0000-0002-8291-8493; Ahlberg, Per/0000-0001-9054-2900; Sanchez, Sophie/0000-0002-3611-6836; Tafforeau, Paul/0000-0002-5962-1683	ERC [233111]; Knut & Alice Wallenberg Foundation; ESRF [ec688]	ERC(European Research Council (ERC)European Commission); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ESRF	Funding was provided by ERC Advanced Investigator Grant 233111 and a Wallenberg Scholarship from the Knut & Alice Wallenberg Foundation (both to Per E. Ahlberg), and by ESRF proposal ec688 (to Sophie Sanchez, Henning Blom, Per E. Ahlberg and colleagues). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais SA, 2011, J VERTEBR PALEONTOL, V31, P1189, DOI 10.1080/02724634.2011.607992; Botella H, 2006, J VERTEBR PALEONTOL, V26, P1002, DOI 10.1671/0272-4634(2006)26[1002:TOFEOA]2.0.CO;2; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2012, PALAEONTOLOGY, V55, P355, DOI 10.1111/j.1475-4983.2012.01130.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 1999, J VERTEBR PALEONTOL, V19, P204, DOI 10.1080/02724634.1999.10011135; Chen DK, 2012, ATMOS OCEAN, V50, P1, DOI 10.1080/07055900.2012.741787; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean B, 1909, MEMOIRS AM MUSEUM NA, V9, P212; Denison, 1979, ACANTHODII; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Fraser GJ, 2011, J EXP ZOOL PART B, V316B, P99, DOI 10.1002/jez.b.21387; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gross W., 1973, Palaeontographica Abt A, V142, P51; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Gross W., 1938, Senckenbergiana Frankfurt a M, V20, P123; Gross W., 1971, Palaeontographica A, V136, P1; Gross W., 1967, ZOOLOGICAL J LINNEAN, V47, P121; GROSS WALTER, 1953, PAL AONT ZEITS [STUTTGART], V27, P85; Huysseune A, 2010, J APPL ICHTHYOL, V26, P152, DOI 10.1111/j.1439-0426.2010.01395.x; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Janvier P., 1996, EARLY VERTEBRATES; Jeppsson L, 1999, J PALEONTOL, V73, P964, DOI 10.1017/S0022336000040798; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Johanson Z, 2003, J MORPHOL, V257, P289, DOI 10.1002/jmor.10124; Karatajute-Talimaa Valentina, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P21; Karatajute-Talimaa Valentina, 1995, Geobios Memoire Special (Villeurbanne), V19, P35; KARATAYUTETALIMAA VN, 1990, PALEONTOL ZH, P76; Marss T., 1986, Fossilia Baltica, V1, P1; Martin T, 2009, IEEE T NUCL SCI, V56, P1412, DOI 10.1109/TNS.2009.2015878; Nelson G. J., 1970, Am. Mus. Novit., VNo. 2415, P1; ORVIG T, 1978, ZOOL SCR, V7, P33, DOI 10.1111/j.1463-6409.1978.tb00587.x; Orvig T., 1973, Palaeontographica Abt A, V143, P119; ORVIG T, 1978, ZOOL SCR, V7, P297, DOI 10.1111/j.1463-6409.1978.tb00613.x; ORVIG T, 1978, ZOOL SCR, V7, P125, DOI 10.1111/j.1463-6409.1978.tb00596.x; Orvig T, 1968, CURRENT PROBLEMS LOW, V4, P373; Orvig T., 1967, STRUCTURAL CHEM ORG, P45; REIF WE, 1982, EVOL BIOL, V15, P287; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Rothova M, 2012, DEV DYNAM, V241, P1183, DOI 10.1002/dvdy.23804; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Smith M.M., 2000, P133, DOI 10.1017/CBO9780511542626.010; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 1998, EUR J ORAL SCI, V106, P482, DOI 10.1111/j.1600-0722.1998.tb02212.x; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Witzmann F, 2011, ACTA ZOOL-STOCKHOLM, V92, P281, DOI 10.1111/j.1463-6395.2010.00460.x; Woodward AS, 1938, ANN MAGAZINE NATURAL, V11, P367; Young GC, 2003, J VERTEBR PALEONTOL, V23, P987, DOI 10.1671/31; Zangerl R, 1968, CURRENT PROBLEMS LOW, P399	54	22	22	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71890	10.1371/journal.pone.0071890	http://dx.doi.org/10.1371/journal.pone.0071890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951264	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300168
J	van Wilgenburg, B; Browne, C; Vowles, J; Cowley, SA				van Wilgenburg, Bonnie; Browne, Cathy; Vowles, Jane; Cowley, Sally A.			Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ANTIINFLAMMATORY TYPE-2 MACROPHAGES; LENTIVIRAL VECTOR; HUMAN BLASTOCYSTS; GENE-EXPRESSION; MYELOID CELLS; IN-VITRO; M-CSF; ACTIVATION; DIFFERENTIATION	Human macrophages are specialised hosts for HIV-1, dengue virus, Leishmania and Mycobacterium tuberculosis. Yet macrophage research is hampered by lack of appropriate cell models for modelling infection by these human pathogens, because available myeloid cell lines are, by definition, not terminally differentiated like tissue macrophages. We describe here a method for deriving monocytes and macrophages from human Pluripotent Stem Cells which improves on previously published protocols in that it uses entirely defined, feeder-and serum-free culture conditions and produces very consistent, pure, high yields across both human Embryonic Stem Cell (hESC) and multiple human induced Pluripotent Stem Cell (hiPSC) lines over time periods of up to one year. Cumulatively, up to similar to 3x10(7) monocytes can be harvested per 6-well plate. The monocytes produced are most closely similar to the major blood monocyte (CD14(+), CD16(low), CD163(+)). Differentiation with M-CSF produces macrophages that are highly phagocytic, HIV-1-infectable, and upon activation produce a pro-inflammatory cytokine profile similar to blood monocyte-derived macrophages. Macrophages are notoriously hard to genetically manipulate, as they recognise foreign nucleic acids; the lentivector system described here overcomes this, as pluripotent stem cells can be relatively simply genetically manipulated for efficient transgene expression in the differentiated cells, surmounting issues of transgene silencing. Overall, the method we describe here is an efficient, effective, scalable system for the reproducible production and genetic modification of human macrophages, facilitating the interrogation of human macrophage biology.	[van Wilgenburg, Bonnie; Browne, Cathy; Vowles, Jane; Cowley, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cowley, SA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	sally.cowley@path.ox.ac.uk	james, william/H-4289-2013	james, william/0000-0002-2506-1198; Cowley, Sally/0000-0003-0297-6675	Wellcome Trust [WT082260, 090532/Z/09/Z]; Medical Research Council; Edward Penley Abraham Research Fund; Parkinson's UK; MRC Hub grant [G0900747 91070]; Parkinson&quot;s UK [J-0901] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edward Penley Abraham Research Fund; Parkinson's UK(Parkinson's UK); MRC Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&quot;s UK(Parkinson&apos;s UK)	The work was supported by the Wellcome Trust (Career Re-entry Fellowship WT082260 to SC); the Medical Research Council and Edward Penley Abraham Research Fund (BvW D.Phil studentship). The Oxford Martin School provides core support to the James Martin Stem Cell Facility within the Sir William Dunn School of Pathology (LC0910-004). The iPS lines used in this study were derived as part of the Oxford Monument Trust Discovery Award from Parkinson's UK. The High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (generation of Illumina genotyping and transcriptome data) is funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2010, FRONT BIOSCI-LANDMRK, V15, P854, DOI 10.2741/3650; Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; Anderson JS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-24; Bakri Y, 2001, BIOMED PHARMACOTHER, V55, P32, DOI 10.1016/S0753-3322(00)00015-9; Baranov P, 2012, TISSUE ENG C; Bhattacharya B, 2012, CURRENT STEM CELL RE, P98; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cowley SA, 2012, MACROPHAGES LIFE CYC; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Di Marzio P, 1998, AIDS RES HUM RETROV, V14, P129, DOI 10.1089/aid.1998.14.129; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jiang Y, 2012, STEM CELLS, V30, P599, DOI 10.1002/stem.1053; Kambal A, 2011, MOL THER, V19, P584, DOI 10.1038/mt.2010.269; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Murphy FJ, 1996, IMMUNOLOGY, V89, P587, DOI 10.1046/j.1365-2567.1996.d01-788.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Salez L, 2000, J LEUKOCYTE BIOL, V67, P545, DOI 10.1002/jlb.67.4.545; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Senju S, 2011, GENE THER; Smith W, 1998, EUR J IMMUNOL, V28, P2498, DOI 10.1002/(SICI)1521-4141(199808)28:08<2498::AID-IMMU2498>3.0.CO;2-Q; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Subramanian Aparna, 2009, J Stem Cells, V4, P29, DOI jsc.2009.4.1.29; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; YOUNG DA, 1990, J IMMUNOL, V145, P607; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	44	143	151	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71098	10.1371/journal.pone.0071098	http://dx.doi.org/10.1371/journal.pone.0071098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951090	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300089
J	Wei, R; Yang, J; Hou, WF; Liu, GQ; Gao, MJ; Zhang, L; Wang, HN; Mao, GH; Gao, HW; Chen, GA; Hong, TP				Wei, Rui; Yang, Jin; Hou, Wenfang; Liu, Guoqiang; Gao, Meijuan; Zhang, Lin; Wang, Haining; Mao, Genhong; Gao, Hongwei; Chen, Guian; Hong, Tianpei			Insulin-Producing Cells Derived from Human Embryonic Stem Cells: Comparison of Definitive Endoderm- and Nestin-Positive Progenitor-Based Differentiation Strategies	PLOS ONE			English	Article							PANCREATIC-ISLETS; BETA-CELLS; DIABETIC MICE; IN-VITRO; EXPRESSION; MOUSE; MICRORNAS; LINES; VIVO; ENDOCRINE	Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differentiation into highly specialized cells including pancreatic islet cells. Thus, they represent a novel alternative source for targeted therapies and regenerative medicine for diabetes. Significant progress has been made in differentiating hESCs toward pancreatic lineages. One approach is based on the similarities of pancreatic beta cell and neuroepithelial development. Nestin-positive cells are selected as pancreatic beta cell precursors and further differentiated to secrete insulin. The other approach is based on our knowledge of developmental biology in which the differentiation protocol sequentially reproduces the individual steps that are known in normal beta cell ontogenesis during fetal pancreatic development. In the present study, the hESC cell line PKU1.1 was induced to differentiate into insulin-producing cells (IPCs) using both protocols. The differentiation process was dynamically investigated and the similarities and differences between both strategies were explored. Our results show that IPCs can be successfully induced with both differentiation strategies. The resulting IPCs from both protocols shared many similar features with pancreatic islet cells, but not mature, functional beta cells. However, these differently-derived IPC cell types displayed specific morphologies and different expression levels of pancreatic islet development-related markers. These data not only broaden our outlook on hESC differentiation into IPCs, but also extend the full potential of these processes for regenerative medicine in diabetes.	[Wei, Rui; Yang, Jin; Hou, Wenfang; Liu, Guoqiang; Gao, Meijuan; Zhang, Lin; Wang, Haining; Gao, Hongwei; Hong, Tianpei] Peking Univ, Hosp 3, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Mao, Genhong; Chen, Guian] Peking Univ, Hosp 3, Reprod Med Ctr, Beijing 100871, Peoples R China; [Wei, Rui; Yang, Jin; Hou, Wenfang; Liu, Guoqiang; Gao, Meijuan; Zhang, Lin; Wang, Haining; Mao, Genhong; Gao, Hongwei; Chen, Guian; Hong, Tianpei] Peking Univ, Hosp 3, Clin Stem Cell Res Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Hong, TP (corresponding author), Peking Univ, Hosp 3, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	tpho66@bjmu.edu.cn		Hong, Tianpei/0000-0002-5744-5129; Wei, Rui/0000-0002-8838-703X	Chinese National 973 Program [2012CB517502]; Chinese National 863 Program [2006AA02A112]; National Natural Sciences Foundation of China [30771032, 30700879, 81070701, 81000315, 81270858]; Specialized Research Fund for the Doctoral Program of Higher Education [20100001110083]	Chinese National 973 Program(National Basic Research Program of China); Chinese National 863 Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Chinese National 973 Program (2012CB517502), web site: http://www.most.gov.cn; the Chinese National 863 Program (2006AA02A112), web site: http://www.most.gov.cn; the National Natural Sciences Foundation of China (30771032, 30700879, 81070701, 81000315 and 81270858), web site: http://www.nsfc.gov.cn; and the Specialized Research Fund for the Doctoral Program of Higher Education (20100001110083), web site: http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Bramblett DE, 2000, ADV PHARMACOL, V47, P255; Cai Han-Qing, 2009, Zhonghua Yi Xue Za Zhi, V89, P836; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DELTOUR L, 1991, DEVELOPMENT, V112, P1115; Do Kwon Y, 2005, MOL THER, V12, P28, DOI 10.1016/y.ymthe.2005.03.01; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Peng HM, 2006, HUM REPROD, V21, P217, DOI 10.1093/humrep/dei275; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Rojas A, 2010, ADV EXP MED BIOL, V654, P59, DOI 10.1007/978-90-481-3271-3_4; Rolletschek A, 2006, DIABETOLOGIA, V49, P2541, DOI 10.1007/s00125-006-0441-y; Scharfmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003559; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang H, 2011, ISLETS, V3, P58, DOI 10.4161/isl.3.2.15036; Wei R, 2013, GENE, V518, P246, DOI 10.1016/j.gene.2013.01.038; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	38	25	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72513	10.1371/journal.pone.0072513	http://dx.doi.org/10.1371/journal.pone.0072513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951327	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300199
J	Yan, XR; Ray, P; Paulmurugan, R; Tong, R; Gong, YQ; Sathirachinda, A; Wu, JC; Gambhir, SS				Yan, Xinrui; Ray, Pritha; Paulmurugan, Ramasamy; Tong, Ricky; Gong, Yongquan; Sathirachinda, Ataya; Wu, Joseph C.; Gambhir, Sanjiv S.			A Transgenic Tri-Modality Reporter Mouse	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MESENCHYMAL STEM-CELLS; TYPE-1 THYMIDINE KINASE; GENE-EXPRESSION; LIVING SUBJECTS; IN-VIVO; OPTICAL BIOLUMINESCENCE; MYOCARDIAL-INFARCTION; MICE; DIFFERENTIATION	Transgenic mouse with a stably integrated reporter gene(s) can be a valuable resource for obtaining uniformly labeled stem cells, tissues, and organs for various applications. We have generated a transgenic mouse model that ubiquitously expresses a tri-fusion reporter gene (fluc2-tdTomato-ttk) driven by a constitutive chicken beta-actin promoter. This "Tri-Modality Reporter Mouse" system allows one to isolate most cells from this donor mouse and image them for bioluminescent (fluc2), fluorescent (tdTomato), and positron emission tomography (PET) (ttk) modalities. Transgenic colonies with different levels of tri-fusion reporter gene expression showed a linear correlation between all three-reporter proteins (R-2=0.89 for TdTomato vs Fluc, R-2=0.94 for Fluc vs TTK, R-2=0.89 for TdTomato vs TTK) in vitro from tissue lysates and in vivo by optical and PET imaging. Mesenchymal stem cells (MSCs) isolated from this transgenics showed high level of reporter gene expression, which linearly correlated with the cell numbers (R-2=0.99 for bioluminescence imaging (BLI)). Both BLI (R-2=0.93) and micro-PET (R-2=0.94) imaging of the subcutaneous implants of Tri-Modality Reporter Mouse derived MSCs in nude mice showed linear correlation with the cell numbers and across different imaging modalities (R-2=0.97). Serial imaging of MSCs transplanted to mice with acute myocardial infarction (MI) by intramyocardial injection exhibited significantly higher signals in MI heart at days 2, 3, 4, and 7 (p<0.01). MSCs transplanted to the ischemic hindlimb of nude mice showed significantly higher BLI and PET signals in the first 2 weeks that dropped by 4th week due to poor cell survival. However, laser Doppler perfusion imaging revealed that blood circulation in the ischemic limb was significantly improved in the MSCs transplantation group compared with the control group. In summary, this mouse can be used as a source of donor cells and organs in various research areas such as stem cell research, tissue engineering research, and organ transplantation.	[Yan, Xinrui; Paulmurugan, Ramasamy; Tong, Ricky; Gong, Yongquan; Sathirachinda, Ataya; Wu, Joseph C.; Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, MIPS & Biox, Stanford, CA 94305 USA; [Ray, Pritha] Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India; [Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Stanford University; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, MIPS & Biox, Stanford, CA 94305 USA.	sgambhir@stanford.edu	; Wu, Joseph/H-1067-2013	Paulmurugan, Ramasamy/0000-0001-7155-4738; Wu, Joseph/0000-0002-6068-8041	NIBIB [R01 EB009689]; NHLBI [R01 HL093172]; NCI ICMIC [P50CA114747]; NCI [RO1 CA082214, RO1 CA135486]; Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael foundation; NATIONAL CANCER INSTITUTE [P50CA114747, R01CA082214, R01CA135486] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009689] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI ICMIC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was funded by the following: NIBIB R01 EB009689 (JCW), http://www.nibib.nih.gov/FundingMain; NHLBI R01 HL093172 (JCW), http://www.nhlbi.nih.gov/funding/inits/; NCI ICMIC P50CA114747 (SSG), http://imaging.cancer.gov/programsandresources/specializedinitiatives/icmics; NCI RO1 CA082214 (SSG), http://grants.nih.gov/grants/oer.htm; NCI RO1 CA135486 (SSG), http://grants.nih.gov/grants/oer.htm; the Canary Foundation, http://www.canaryfoundation.org/; Ben & Catherine Ivy Foundation (SSG), http://www.ivyfoundation.org/; and the Sir Peter Michael foundation (SSG), http:// www.petermichaelfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAWI R, 1991, MOL CELL BIOL, V11, P4207, DOI 10.1128/MCB.11.8.4207; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cohen J, 1998, NATION, V266, P7; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Curtis A, 2011, MOL IMAGING BIOL, V13, P1114, DOI 10.1007/s11307-010-0440-8; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Degreve B, 1998, J VIROL, V72, P9535; Deuse T, 2011, CELL TRANSPLANT, V20, P655, DOI 10.3727/096368910X536473; FRIDENSHTEIN AY, 1982, ARK PATOL, V44, P3; Gaikwad SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055971; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Moriya Y, 1990, Nichidai Koko Kagaku, V16, P347; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ray P, 2003, CANCER RES, V63, P1160; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Swijnenburg RJ, 2010, CIRC-CARDIOVASC IMAG, V3, P77, DOI 10.1161/CIRCIMAGING.109.872085; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Wu JC, 2004, J NUCL CARDIOL, V11, P491, DOI 10.1016/j.nuclcard.2004.04.004; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Yaghoubi SS, 2006, NAT PROTOC, V1, P2137, DOI 10.1038/nprot.2006.334; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yamada S, 2005, CELL TRANSPLANT, V14, P647, DOI 10.3727/000000005783982738	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73580	10.1371/journal.pone.0073580	http://dx.doi.org/10.1371/journal.pone.0073580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951359	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200094
J	Li, X; Ishihara, S; Yasuda, M; Nishioka, T; Mizutani, T; Ishikawa, M; Kawabata, K; Shirato, H; Haga, H				Li, Xue; Ishihara, Seiichiro; Yasuda, Motoaki; Nishioka, Takeshi; Mizutani, Takeomi; Ishikawa, Masayori; Kawabata, Kazushige; Shirato, Hiroki; Haga, Hisashi			Lung Cancer Cells That Survive Ionizing Radiation Show Increased Integrin alpha 2 beta 1-and EGFR-Dependent Invasiveness	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; 3-DIMENSIONAL COLLAGEN LATTICES; GLIOMA-CELLS; IN-VITRO; ACTIVATION; INHIBITION; INVASION; PROMOTES; PATHWAYS; RADIOSENSITIVITY	Ionizing radiation (IR)-enhanced tumor invasiveness is emerging as a contributor to the limited benefit of radiotherapy; however, its mechanism is still unclear. We previously showed that subcloned lung adenocarcinoma A549 cells (P cells), which survived 10 Gy IR (IR cells), acquired high invasiveness in vitro. Here, we tried to identify the mechanism by which IR cells increase their invasiveness by examining altered gene expression and signaling pathways in IR cells compared with those in P cells. To simulate the microenvironment in vivo, cells were embedded in a three-dimensional (3D) collagen type I gel, in which the IR cells were elongated, while the P cells were spherical. The integrin expression pattern was surveyed, and expression levels of the integrin alpha 2 and beta 1 subunits were significantly elevated in IR cells. Knockdown of alpha 2 expression or functional blockade of integrin alpha 2 beta 1 resulted in a round morphology of IR cells, and abrogated their invasion in the collagen matrix, suggesting the molecule's essential role in cell spread and invasion in 3D collagen. Epidermal growth factor receptor (EGFR) also presented enhanced expression and activation in IR cells. Treatment with EGFR tyrosine kinase inhibitor, PD168393, decreased the ratio of elongated cells and cell invasiveness. Signaling molecules, including extracellular signal-regulated kinase-1/2 (Erk1/2) and Akt, exhibited higher activation in IR cells. Inhibition of Akt activation by treating with phosphoinositide 3-kinase (PI3K) inhibitor LY294002 decreased IR cell invasion, whereas inhibition of Erk1/2 activation by mitogen-activated protein kinase kinase (MEK) inhibitor U0126 did not. Our results show that integrin alpha 2 beta 1 and EGFR cooperatively promote higher invasiveness of IR-survived lung cancer cells, mediated in part by the PI3K/Akt signaling pathway, and might serve as alternative targets in combination with radiotherapy.	[Li, Xue; Ishihara, Seiichiro; Mizutani, Takeomi; Kawabata, Kazushige; Haga, Hisashi] Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan; [Yasuda, Motoaki] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Sapporo, Hokkaido, Japan; [Nishioka, Takeshi] Hokkaido Univ, Fac Hlth Sci, Dept Biomed Sci & Engn, Sapporo, Hokkaido, Japan; [Ishikawa, Masayori] Hokkaido Univ, Grad Sch Med, Dept Med Phys, Sapporo, Hokkaido, Japan; [Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Haga, H (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan.	haga@sci.hokudai.ac.jp	Shirato, Hiroki/A-7068-2010; Haga, Hisashi/E-6931-2010; Ishikawa, Masayori/D-9878-2012	Haga, Hisashi/0000-0001-9464-6723; Ishikawa, Masayori/0000-0003-0317-0200	Ministry of Education, Culture, Sports, Science and Technology, Japan [11J06280, 21249065, 24390285, 24106502, 23651099]; Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science"; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25287106, 24106502, 23770167] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science"; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for JSPS Fellows (11J06280) to S. I., Scientific Research (A) (21249065) to H. S. and H. H., Scientific Research (B) (24390285) to M.Y., T.N. and H. H., Scientific Research on Innovative Areas (24106502) to T. M., and Exploratory Research (23651099) to K. K. from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also partially supported by Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science" to M. I., H. S. and H. H. funded from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Carter S, 1998, ONCOGENE, V16, P2787, DOI 10.1038/sj.onc.1201802; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; CHEN FA, 1991, J EXP MED, V173, P1111, DOI 10.1084/jem.173.5.1111; Chu SH, 2007, SURG NEUROL, V68, P610, DOI [10.1016/j.sumeu.2006.12.050, 10.1016/j.surneu.2006.12.050]; Cordes N, 2004, CANCER RES, V64, P5683, DOI 10.1158/0008-5472.CAN-04-1056; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gandara D, 2005, CLIN CANCER RES, V11, p5057S, DOI 10.1158/1078-0432.CCR-05-9012; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; Gogineni VR, 2011, INT J ONCOL, V38, P1615, DOI 10.3892/ijo.2011.987; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hu CQ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-16; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Ishihara S, 2010, BIOCHEM BIOPH RES CO, V396, P651, DOI 10.1016/j.bbrc.2010.04.150; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Krensel K, 1999, INT J CANCER, V80, P546, DOI 10.1002/(SICI)1097-0215(19990209)80:4<546::AID-IJC11>3.0.CO;2-9; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Liang K, 2003, INT J RADIAT ONCOL, V57, P246, DOI 10.1016/S0360-3016(03)00511-X; Ling C, 2012, CANCER GENE THER, V19, P697, DOI 10.1038/cgt.2012.50; Marampon F, 2011, MOL CANCER THER, V10, P159, DOI 10.1158/1535-7163.MCT-10-0631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Ramis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038770; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sawhney RS, 2003, J BIOL CHEM, V278, P19861, DOI 10.1074/jbc.M213162200; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Thariat J, 2007, INT J RADIAT ONCOL, V69, P974, DOI 10.1016/j.ijrobp.2007.06.076; Van Slambrouck S, 2009, INT J ONCOL, V34, P1717, DOI 10.3892/ijo_00000302; VONESSEN CF, 1991, CLIN EXP METASTAS, V9, P77, DOI 10.1007/BF01756381; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang M, 2011, CANCER RES, V71, P6261, DOI 10.1158/0008-5472.CAN-11-0213; Wild-Bode C, 2001, CANCER RES, V61, P2744; Yao HR, 2011, TRANSL ONCOL, V4, P282, DOI 10.1593/tlo.11133; Yu X, 2000, J CELL SCI, V113, P2139; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4	54	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70905	10.1371/journal.pone.0070905	http://dx.doi.org/10.1371/journal.pone.0070905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951036	Green Published, gold			2022-12-27	WOS:000323124000031
J	Vinson, A; Mitchell, AD; Toffey, D; Silver, J; Raboin, MJ				Vinson, Amanda; Mitchell, Asia D.; Toffey, David; Silver, Jacob; Raboin, Michael J.			Sex-Specific Heritability of Spontaneous Lipid Levels in an Extended Pedigree of Indian-Origin Rhesus Macaques (Macaca mulatta)	PLOS ONE			English	Article							LDL-CHOLESTEROL CONCENTRATION; ATHEROSCLEROSIS RISK; PLASMA-CHOLESTEROL; LP-PLA(2) ACTIVITY; NONHUMAN-PRIMATES; HDL-CHOLESTEROL; MONKEYS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; INFLAMMATION	The rhesus macaque is an important model for human atherosclerosis but genetic determinants of relevant phenotypes have not yet been investigated in this species. Because lipid levels are well-established and heritable risk factors for human atherosclerosis, our goal was to assess the heritability of lipoprotein cholesterol and triglyceride levels in a single, extended pedigree of 1,289 Indian-origin rhesus macaques. Additionally, because increasing evidence supports sex differences in the genetic architecture of lipid levels and lipid metabolism in humans and macaques, we also explored sex-specific heritability for all lipid measures investigated in this study. Using standard methods, we measured lipoprotein cholesterol and triglyceride levels from fasted plasma in a sample of 193 pedigreed rhesus macaques selected for membership in large, paternal half-sib cohorts, and maintained on a low-fat, low cholesterol chow diet. Employing a variance components approach, we found moderate heritability for total cholesterol (h(2)=0.257, P=0.032), LDL cholesterol (h(2)=0.252, P=0.030), and triglyceride levels (h(2)=0.197, P=0.034) in the full sample. However, stratification by sex (N=68 males, N=125 females) revealed substantial sex-specific heritability for total cholesterol (0.644, P=0.004, females only), HDL cholesterol (0.843, P=0.0008, females only), VLDL cholesterol (0.482, P=0.018, males only), and triglyceride levels (0.705, P=0.001, males only) that was obscured or absent when sexes were combined in the full sample. We conclude that genes contribute to spontaneous variation in circulating lipid levels in the Indian-origin rhesus macaque in a sex-specific manner, and that the rhesus macaque is likely to be a valuable model for sex-specific genetic effects on lipid risk factors for human atherosclerosis. These findings are a first-ever report of heritability for cholesterol levels in this species, and support the need for expanded analysis of these traits in this population.	[Vinson, Amanda; Toffey, David; Raboin, Michael J.] Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Vinson, Amanda; Mitchell, Asia D.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Silver, Jacob] Oregon Natl Primate Res Ctr, Summer Undergrad Fellowship Program, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Vinson, A (corresponding author), Oregon Natl Primate Res Ctr, Beaverton, OR USA.	vinsona@ohsu.edu		Mitchell, Asia/0000-0003-0969-1680	NIH Office of Research Infrastructure Programs (ORIP) [P51OD011092]; Human Genetics Initiative at the Oregon Health & Science University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs (ORIP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Genetics Initiative at the Oregon Health & Science University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was made possible by a base grant from the NIH Office of Research Infrastructure Programs (ORIP) to the Oregon National Primate Research Center (P51OD011092), and by funds provided to A.V. from the Human Genetics Initiative at the Oregon Health & Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ALMASY L, 2010, COLD SPRING HARBOR P, P39422; Almasy L, 2008, ADV GENET, V60, P175, DOI 10.1016/S0065-2660(07)00408-7; Armstrong M L, 1976, Primates Med, V9, P16; BHATTACHARYYA AK, 1987, ATHEROSCLEROSIS, V67, P33, DOI 10.1016/0021-9150(87)90262-0; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; BOEHNKE M, 1987, AM J EPIDEMIOL, V125, P679, DOI 10.1093/oxfordjournals.aje.a114581; BOND MG, 1980, AM J PATHOL, V101, P675; DAVIS HR, 1984, ATHEROSCLEROSIS, V50, P241, DOI 10.1016/0021-9150(84)90072-8; Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015; Edwards KL, 1999, ARTERIOSCL THROM VAS, V19, P2456, DOI 10.1161/01.ATV.19.10.2456; Goldschmidt-Clermont PJ, 2012, CURR ATHEROSCLER REP, V14, P201, DOI 10.1007/s11883-012-0244-1; GRESHAM GA, 1976, MONOGRAPHS ATHEROSCL, P24; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HUMMEL M, 1990, P NATL ACAD SCI USA, V87, P3122, DOI 10.1073/pnas.87.8.3122; Isaacs A, 2007, EUR J EPIDEMIOL, V22, P99, DOI 10.1007/s10654-006-9103-0; Kassim SH, 2011, PHYSIOL GENOMICS, V43, P911, DOI 10.1152/physiolgenomics.00006.2011; KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5; KUSUMI Y, 1993, ATHEROSCLEROSIS, V99, P165, DOI 10.1016/0021-9150(93)90019-Q; Lutsey PL, 2012, CIRC-CARDIOVASC GENE, V5, P73, DOI 10.1161/CIRCGENETICS.111.959619; National Cholesterol Education Program, 2001, NIH PUBLICATION; NEWMAN WP, 1974, ATHEROSCLEROSIS, V19, P75, DOI 10.1016/0021-9150(74)90045-8; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; PRONCZUK A, 1991, LIPIDS, V26, P213, DOI 10.1007/BF02543974; Puig O, 2011, CIRC-CARDIOVASC GENE, V4, P595, DOI 10.1161/CIRCGENETICS.111.960773; Rudel LL, 1997, J AM COLL NUTR, V16, P306, DOI 10.1080/07315724.1997.10718691; Shamekh R, 2011, METABOLISM, V60, P1165, DOI 10.1016/j.metabol.2010.12.012; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Tan YY, 2010, MATURITAS, V65, P149, DOI 10.1016/j.maturitas.2009.09.023; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Villard EF, 2013, ARTERIOSCL THROM VAS, V33, P822, DOI 10.1161/ATVBAHA.112.300979; Vinson A, 2008, ATHEROSCLEROSIS, V196, P667, DOI 10.1016/j.atherosclerosis.2007.07.014; VINSON A, I LAB ANIM IN PRESS; Vinson A, 2008, J LIPID RES, V49, P1295, DOI 10.1194/jlr.M800020-JLR200; WARNICK GR, 1990, CLIN CHEM, V36, P15; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; WILLIAMS JK, 1991, ARCH PATHOL LAB MED, V115, P784; Zhang YB, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062118	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72241	10.1371/journal.pone.0072241	http://dx.doi.org/10.1371/journal.pone.0072241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951301	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000084
J	Wang, H; Rascoe, AM; Holley, DC; Gouaux, E; Kavanaugh, MP				Wang, Hui; Rascoe, Avi M.; Holley, David C.; Gouaux, Eric; Kavanaugh, Michael P.			Novel Dicarboxylate Selectivity in an Insect Glutamate Transporter Homolog	PLOS ONE			English	Article							SUBSTRATE INTERACTIONS; BINDING; FAMILY; IDENTIFICATION	Mammals express seven transporters from the SLC1 (solute carrier 1) gene family, including five acidic amino acid transporters (EAAT1-5) and two neutral amino acid transporters (ASCT1-2). In contrast, insects of the order Diptera possess only two SLC1 genes. In this work we show that in the mosquito Culex quinquefasciatus, a carrier of West Nile virus, one of its two SLC1 EAAT-like genes encodes a transporter that displays an unusual selectivity for dicarboxylic acids over acidic amino acids. In eukaryotes, dicarboxylic acid uptake has been previously thought to be mediated exclusively by transporters outside the SLC1 family. The dicarboxylate selectivity was found to be associated with two residues in transmembrane domain 8, near the presumed substrate binding site. These residues appear to be conserved in all eukaryotic SLC1 transporters (Asp444 and Thr448, human EAAT3 numbering) with the exception of this novel C. quinquefasciatus transporter and an ortholog from the yellow fever mosquito Aedes aegypti, in which they are changed to Asn and Ala. In the prokaryotic EAAT-like SLC1 transporter DctA, a dicarboxylate transporter which was lost in the lineage leading to eukaryotes, the corresponding TMD8 residues are Ser and Ala. Functional analysis of engineered mutant mosquito and human transporters expressed in Xenopus laevis oocytes provide support for a model defining interactions of charged and polar transporter residues in TMD8 with a-amino acids and ions. Together with the phylogenetic evidence, the functional data suggest that a novel route of dicarboxylic acid uptake evolved in these mosquitos by mutations in an ancestral glutamate transporter gene.	[Wang, Hui; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Rascoe, Avi M.; Holley, David C.; Kavanaugh, Michael P.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; University of Montana System; University of Montana; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	gouauxe@ohsu.edu; michael.kavanaugh@mso.umt.edu	Wang, Hui/C-4051-2012; Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institutes of Health [R15 GM088799, PG20GM103546]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546, R15GM110690, R15GM088799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grants R15 GM088799, PG20GM103546, and Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Besson MT, 2005, J BIOL CHEM, V280, P6621, DOI 10.1074/jbc.M412440200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Broer S, 2002, PFLUG ARCH EUR J PHY, V444, P457, DOI 10.1007/s00424-002-0840-y; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; ENGELKE T, 1989, J BACTERIOL, V171, P5551, DOI 10.1128/jb.171.10.5551-5560.1989; Gesemann M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-117; Groeneveld M, 2010, J BACTERIOL, V192, P2900, DOI 10.1128/JB.00136-10; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Inoue K, 2002, BIOCHEM J, V367, P313, DOI 10.1042/BJ20021132; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jiang J, 2011, NEUROPHARMACOLOGY, V60, P172, DOI 10.1016/j.neuropharm.2010.07.019; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; Scopelliti AJ, 2013, J BIOL CHEM, V288, P8250, DOI 10.1074/jbc.M112.441022; Seal RP, 1998, RECEPTOR CHANNEL, V6, P51; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Umesh A, 2003, J EXP BIOL, V206, P2241, DOI 10.1242/jeb.00430; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70947	10.1371/journal.pone.0070947	http://dx.doi.org/10.1371/journal.pone.0070947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951049	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700067
J	Zhang, XL; Rogers, M; Bierschenk, D; Bonten, MJM; Willems, RJL; van Schaik, W				Zhang, Xinglin; Rogers, Malbert; Bierschenk, Damien; Bonten, Marc J. M.; Willems, Rob J. L.; van Schaik, Willem			A LacI-Family Regulator Activates Maltodextrin Metabolism of Enterococcus faecium	PLOS ONE			English	Article							ESCHERICHIA-COLI; SYSTEM; DIGESTION; MALTOSE; IDENTIFICATION; EXPRESSION; TRANSPORT; COMMENSAL	Enterococcus faecium is a gut commensal of humans and animals. In the intestinal tract, E. faecium will have access to a wide variety of carbohydrates, including maltodextrins and maltose, which are the sugars that result from the enzymatic digestion of starch by host-derived and microbial amylases. In this study, we identified the genetic determinants for maltodextrin utilization of E. faecium E1162. We generated a deletion mutant of the mdxABCD-pulA gene cluster that is homologous to maltodextrin uptake genes in other Gram-positive bacteria, and a deletion mutant of the mdxR gene, which is predicted to encode a LacI family regulator of mdxABCD-pulA. Both mutations impaired growth on maltodextrins but had no effect on the growth on maltose and glucose. Comparative transcriptome analysis showed that eight genes (including mdxABCD-pulA) were expressed at significantly lower levels in the isogenic.mdxR mutant strain compared to the parental strain when grown on maltose. Quantitative real-time RTPCR confirmed the results of transcriptome analysis and showed that the transcription of a putative maltose utilization gene cluster is induced in a semi-defined medium supplemented with maltose but is not regulated by MdxR. Understanding the maltodextrin metabolism of E. faecium could yield novel insights into the underlying mechanisms that contribute to the gut commensal lifestyle of E. faecium.	[Zhang, Xinglin; Rogers, Malbert; Bierschenk, Damien; Bonten, Marc J. M.; Willems, Rob J. L.; van Schaik, Willem] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Zhang, XL (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	x.zhang@umcutrecht.nl	Willems, Rob JL/E-3681-2010; Bierschenk, Damien/C-7987-2017	Willems, Rob JL/0000-0002-7370-0812; Bierschenk, Damien/0000-0003-1647-8837; van Schaik, Willem/0000-0001-5832-0988	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI] [916.86.044]; European Union [282004]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI]; European Union(European Commission)	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI grant 916.86.044] and the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) Evolution and Transfer of Antibiotic Resistance (EvoTAR) [grant agreement number 282004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; COTTA MA, 1992, APPL ENVIRON MICROB, V58, P48, DOI 10.1128/AEM.58.1.48-54.1992; DEIBEL RH, 1963, J BACTERIOL, V86, P1275, DOI 10.1128/JB.86.6.1275-1282.1963; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423; ENGLYST HN, 1986, AM J CLIN NUTR, V44, P42, DOI 10.1093/ajcn/44.1.42; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; GRAY GM, 1992, J NUTR, V122, P172, DOI 10.1093/jn/122.1.172; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Huycke MM, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P133; Kamionka A, 2001, FEMS MICROBIOL LETT, V204, P55, DOI 10.1111/j.1574-6968.2001.tb10862.x; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; Lebreton F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002834; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Mokhtari A, 2013, MOL MICROBIOL, V88, P234, DOI 10.1111/mmi.12183; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2007, J BACTERIOL, V189, P2610, DOI 10.1128/JB.01539-06; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789; Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x; Top J, 2011, J BACTERIOL, V193, P1003, DOI 10.1128/JB.00952-10; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Wang X, 1999, APPL ENVIRON MICROB, V65, P4848; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zhang XL, 2013, J INFECT DIS, V207, P1780, DOI 10.1093/infdis/jit076; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhang XL, 2011, ENVIRON MICROBIOL, V13, P518, DOI 10.1111/j.1462-2920.2010.02355.x	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72285	10.1371/journal.pone.0072285	http://dx.doi.org/10.1371/journal.pone.0072285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951303	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700132
J	Flink, IJE; Prins, RG; Mackenbach, JJP; Jaddoe, VW; Hofman, A; Verhulst, FC; Tiemeier, H; Raat, H				Flink, Ilse J. E.; Prins, Rick G.; Mackenbach, Johan J. P.; Jaddoe, Vincent W.; Hofman, Albert; Verhulst, Frank C.; Tiemeier, Henning; Raat, Hein			Neighborhood Ethnic Diversity and Behavioral and Emotional Problems in 3 Year Olds: Results from the Generation R Study	PLOS ONE			English	Article							DENSITY; CONTEXT; FAMILY; CHILD; PERCEPTIONS; AMERICAN; OUTCOMES; HEALTH; US	Background: Studies suggest that neighborhood ethnic diversity may be important when it comes to understanding ethnic inequalities in mental health. The primary aim of this study was to investigate whether neighborhood ethnic diversity moderated the association between the ethnic minority status and child behavioral and emotional problems. Methods: We included 3076 preschoolers participating in the Generation R Study, a birth cohort study in Rotterdam, the Netherlands. At child age 3-years, parents completed the Child Behavior Checklist (CBCL/1,5-5). Individual-level data, assessed with questionnaires, was combined with neighborhood-level data. Multi-level logistic regression models predicted the Odds Ratios for the CBCL total problems score as a function of maternal ethnic background and neighborhood ethnic diversity, computed with the Racial Diversity Index and categorized into tertiles. Interaction on the additive scale was assessed using Relative Access Risk due to Interaction. Results: Being from an ethnic minority was associated with child behavioral and emotional problems in unadjusted (OR 2.76, 95% CI 1.88-4.04) and adjusted models (OR 2.64, 95% CI 1.79-3.92). Residing in a high diversity neighborhood was associated with child behavioral and emotional problems in unadjusted (OR 2.03, 95% CI 1.13-3.64) but not in adjusted models (OR 0.89, 95% CI 0.51-1.57). When stratifying by the three levels of neighborhood ethnic diversity, ethnic inequalities in behavioral and emotional problems were greatest in low diversity neighborhoods (OR 5.24, 95% CI 2.47-11.14), smaller in high diversity neighborhoods (OR 3.15, 95% CI 1.66-5.99) and smallest in medium diversity neighborhoods (OR 1.59, 95% CI 0.90-2.82). Tests for interaction (when comparing medium to low diversity neighborhoods) trended towards negative on both the additive and multiplicative scale for the maternal-report (RERI: -3.22, 95% CI -0.70-0.59; Ratio of ORs: 0.30, 95% CI 0.12-0.76). Conclusion: This study suggests that ethnic inequalities in child behavioral and emotional problems may be greatest in ethnically homogeneous neighborhoods.	[Flink, Ilse J. E.; Jaddoe, Vincent W.] Erasmus Univ, Med Ctr, Generat Study Grp R, Rotterdam, Netherlands; [Flink, Ilse J. E.; Prins, Rick G.; Mackenbach, Johan J. P.; Raat, Hein] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Jaddoe, Vincent W.; Hofman, Albert; Verhulst, Frank C.; Tiemeier, Henning] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W.] Erasmus Univ, Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Flink, IJE (corresponding author), Erasmus Univ, Med Ctr, Generat Study Grp R, Rotterdam, Netherlands.	i.flink@erasmusmc.nl	Tiemeier, Henning/H-6534-2019	Tiemeier, Henning/0000-0002-4395-1397; Prins, Richard/0000-0003-1573-8318	Erasmus University Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Netherlands Organization for Health Research and Development [80-82465-98-055]	Erasmus University Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The Generation R Study is made possible by financial support from: Erasmus University Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw: www.zonmw.nl). The present study was supported by an additional grant from the Netherlands Organization for Health Research and Development (grant No. 80-82465-98-055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Budescu DV, 2012, PSYCHOL METHODS, V17, P215, DOI 10.1037/a0027129; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Flink IJE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1092; Gieling M, 2010, SOC PSYCH PSYCH EPID, V45, P639, DOI 10.1007/s00127-009-0105-6; Gottfredson NC, 2008, J DIVERS HIGH EDUC, V1, P80, DOI 10.1037/1938-8926.1.2.80; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hurtado S, 2005, J SOC ISSUES, V61, P595, DOI 10.1111/j.1540-4560.2005.00422.x; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jansen PW, 2010, J ABNORM CHILD PSYCH, V38, P1151, DOI 10.1007/s10802-010-9424-z; Juvonen J, 2006, PSYCHOL SCI, V17, P393, DOI 10.1111/j.1467-9280.2006.01718.x; Kirkbride JB, 2008, PSYCHOL MED, V38, P1083, DOI 10.1017/S0033291707002085; Kirkbride JB, 2007, PSYCHOL MED, V37, P1413, DOI 10.1017/S0033291707000499; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Molnar Beth E, 2003, Child Maltreat, V8, P84, DOI 10.1177/1077559502250822; Parke RD, 2004, CHILD DEV, V75, P1632, DOI 10.1111/j.1467-8624.2004.00807.x; Phares V, 1997, J ABNORM CHILD PSYCH, V25, P165, DOI 10.1023/A:1025787613984; Pickett KE, 2008, ETHNIC HEALTH, V13, P321, DOI 10.1080/13557850701882928; Pickett KE, 2009, SOC SCI MED, V69, P1476, DOI 10.1016/j.socscimed.2009.08.031; Reldpath DD, 2003, SOC SCI MED, V57, P253, DOI 10.1016/S0277-9536(02)00344-1; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rowe DC, 1997, J ABNORM CHILD PSYCH, V25, P265, DOI 10.1023/A:1025756201689; Seaton EK, 2009, J YOUTH ADOLESCENCE, V38, P153, DOI 10.1007/s10964-008-9356-x; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Shaw RJ, 2013, AM J PUBLIC HEALTH, V103, P1052, DOI 10.2105/AJPH.2012.300985; Shaw RJ, 2010, AM J PUBLIC HEALTH, V100, P707, DOI 10.2105/AJPH.2009.167114; Statistics Netherlands, 2008, KERNC WIJK BUURT 200; Statistics Netherlands, 2012, BEGR ALL; Statistics Rotterdam, 2012, BEV 2005 2011 AANT P; Stelter RL, 2011, INFANT CHILD DEV, V20, P272, DOI 10.1002/icd.693; Sussner KM, 2009, J AM DIET ASSOC, V109, P218, DOI 10.1016/j.jada.2008.10.056; Tick NT, 2007, J AM ACAD CHILD PSY, V46, P1333, DOI 10.1097/chi.0b013e3181337532; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Walsh JA, 2007, J RES CRIME DELINQ, V44, P64, DOI 10.1177/0022427806295552	37	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70070	10.1371/journal.pone.0070070	http://dx.doi.org/10.1371/journal.pone.0070070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967068	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500013
J	Kross, E; Verduyn, P; Demiralp, E; Park, J; Lee, DS; Lin, N; Shablack, H; Jonides, J; Ybarra, O				Kross, Ethan; Verduyn, Philippe; Demiralp, Emre; Park, Jiyoung; Lee, David Seungjae; Lin, Natalie; Shablack, Holly; Jonides, John; Ybarra, Oscar			Facebook Use Predicts Declines in Subjective Well-Being in Young Adults	PLOS ONE			English	Article							INTERNET USE; LIFE; HEALTH; SATISFACTION; LONELINESS; EXPERIENCE; SCALE	Over 500 million people interact daily with Facebook. Yet, whether Facebook use influences subjective well-being over time is unknown. We addressed this issue using experience-sampling, the most reliable method for measuring in-vivo behavior and psychological experience. We text-messaged people five times per day for two-weeks to examine how Facebook use influences the two components of subjective well-being: how people feel moment-to-moment and how satisfied they are with their lives. Our results indicate that Facebook use predicts negative shifts on both of these variables over time. The more people used Facebook at one time point, the worse they felt the next time we text-messaged them; the more they used Facebook over two-weeks, the more their life satisfaction levels declined over time. Interacting with other people "directly'' did not predict these negative outcomes. They were also not moderated by the size of people's Facebook networks, their perceived supportiveness, motivation for using Facebook, gender, loneliness, self-esteem, or depression. On the surface, Facebook provides an invaluable resource for fulfilling the basic human need for social connection. Rather than enhancing well-being, however, these findings suggest that Facebook may undermine it.	[Kross, Ethan; Demiralp, Emre; Park, Jiyoung; Lee, David Seungjae; Lin, Natalie; Shablack, Holly; Jonides, John; Ybarra, Oscar] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Verduyn, Philippe] Univ Louvain, Dept Psychol, Louvain, Belgium	University of Michigan System; University of Michigan	Kross, E (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	ekross@umich.edu		, Ethan/0000-0002-8664-2711; Lee, Seungjae/0000-0001-9081-2835; Verduyn, Philippe/0000-0001-8266-2216				Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; [Anonymous], 2012, FAC INF; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beck A., 1996, PEARSON; Bessiere Katherine, 2008, Information Communication & Society, V11, P47, DOI 10.1080/13691180701858851; Boehm JK, 2011, HEALTH PSYCHOL, V30, P259, DOI 10.1037/a0023124; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Chou HTG, 2012, CYBERPSYCH BEH SOC N, V15, P117, DOI 10.1089/cyber.2011.0324; CUTRONA CE, 1989, J PERS SOC PSYCHOL, V57, P723, DOI 10.1037/0022-3514.57.4.723; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Forest AL, 2012, PSYCHOL SCI, V23, P295, DOI 10.1177/0956797611429709; Haferkamp N, 2011, CYBERPSYCH BEH SOC N, V14, P309, DOI 10.1089/cyber.2010.0120; Hofmann W, 2012, PSYCHOL SCI; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huang C, 2010, CYBERPSYCH BEH SOC N, V13, P241, DOI 10.1089/cyber.2009.0217; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kim J, 2009, CYBERPSYCHOL BEHAV, V12, P451, DOI 10.1089/cpb.2008.0327; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Manago AM, 2012, DEV PSYCHOL, V48, P369, DOI 10.1037/a0026338; Moberly NJ, 2008, BEHAV RES THER, V46, P1034, DOI 10.1016/j.brat.2008.06.004; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Steptoe A, 2011, P NATL ACAD SCI USA, V108, P18244, DOI 10.1073/pnas.1110892108; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Ybarra O, 2008, PERS SOC PSYCHOL B, V34, P248, DOI 10.1177/0146167207310454	34	680	694	22	491	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69841	10.1371/journal.pone.0069841	http://dx.doi.org/10.1371/journal.pone.0069841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967061	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500007
J	Nielsen, JR; Lundgren, B; Kristensen, K; Bastardie, F				Nielsen, J. Rasmus; Lundgren, Bo; Kristensen, Kasper; Bastardie, Francois			Localisation of Nursery Areas Based on Comparative Analyses of the Horizontal and Vertical Distribution Patterns of Juvenile Baltic Cod (Gadus morhua)	PLOS ONE			English	Article							TARGET STRENGTH; ATLANTIC COD; RECRUITMENT SUCCESS; FEEDING PATTERNS; BORNHOLM BASIN; SEDIMENT TYPE; NORWAY POUT; NORTH-SEA; SINGLE; VARIABILITY	Knowledge of the spatial distribution of juvenile cod is essential for obtaining precise recruitment data to conduct sustainable management of the eastern and western Baltic cod stocks. In this study, the horizontal and vertical distribution and density patterns of settled juvenile 0- and 1-group Baltic cod are determined, and their nursery areas are localised according to the environmental factors affecting them. Comparative statistical analyses of biological, hydrographic and hydroacoustic data are carried out based on standard ICES demersal trawl surveys and special integrated trawl and acoustic research surveys. Horizontal distribution maps for the 2001-2010 cohorts of juvenile cod are further generated by applying a statistical log-Gaussian Cox process model to the standard trawl survey data. The analyses indicate size-dependent horizontal and distinct vertical and diurnal distribution patterns related to the seabed topography, water layer depth, and the presence of hydrographic frontal zones (pycnoclines) as well as intraspecific patterns in relation to the presence of adult cod. The extent of the nursery areas also depends on the cod year class strength. Juvenile cod (>= 3 cm) are present in all areas of the central Baltic Sea (CBS), showing broad dispersal. However, their highest density in the Baltic Basins is found at localities with a 40-70 m bottom depth in waters with oxygen concentrations above 2 ml O-2.l(-1) and temperatures above 5 degrees C. The smallest juveniles are also found in deep sea localities down to a 100 m depth and at oxygen concentrations between 2-4 ml O-2.l(-1). The vertical, diurnally stratified and repeated trawling and hydroacoustic target strength-depth distributions obtained from the special surveys show juvenile cod concentrations in frontal zone water layers (pycnocline). However, the analyses indicate that in the CBS, juvenile cod of all sizes do not appear to aggregate in dense schooling patterns, which differs from what has been reported from the North Sea.	[Nielsen, J. Rasmus; Kristensen, Kasper; Bastardie, Francois] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Lundgren, Bo] Tech Univ Denmark, Natl Inst Aquat Resources, Hirtshals, Denmark	Technical University of Denmark; Technical University of Denmark	Nielsen, JR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	rn@aqua.dtu.dk	Nielsen, J. Rasmus/AAG-2647-2021	Nielsen, J. Rasmus/0000-0002-2833-3873; Lundgren, Bo/0000-0003-2038-8973; Bastardie, Francois/0000-0002-2669-6179; Kristensen, Kasper/0000-0003-3425-3762	European Union [AIR2-94-1226]; DTU Aqua internal resources; International Femern Belt Science Provision Project; Danish Strategic Research Council Project IMAGE (MAFIA); EU FP7 SOCIOEC Project	European Union(European Commission); DTU Aqua internal resources; International Femern Belt Science Provision Project; Danish Strategic Research Council Project IMAGE (MAFIA); EU FP7 SOCIOEC Project	This study was funded in part by the European Union (AIR2-94-1226), DTU Aqua internal resources, and the International Femern Belt Science Provision Project (Femern Baelt A/S, DK). Smaller parts of the study have been supported by the Danish Strategic Research Council Project IMAGE (MAFIA) and the EU FP7 SOCIOEC Project.	BAILEY RS, 1975, J MAR BIOL ASSOC UK, V55, P133, DOI 10.1017/S0025315400015794; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Bastardie F, 2010, ICES J MAR SCI, V67, P71, DOI 10.1093/icesjms/fsp228; Bleil M, 2009, J APPL ICHTHYOL, V25, P10, DOI 10.1111/j.1439-0426.2008.01172.x; Bromley PJ, 1997, ICES J MAR SCI, V54, P846, DOI 10.1006/jmsc.1996.0211; Bromley PJ, 1995, 1995G27 ICES CM; Chabot D, 1999, J FISH BIOL, V55, P472, DOI 10.1111/j.1095-8649.1999.tb00693.x; D'Amours Denis, 1993, Fisheries Oceanography, V2, P24, DOI 10.1111/j.1365-2419.1993.tb00009.x; DEGNBOL P, 1985, DANA-J FISH MAR RES, V5, P45; Degnbol P, 1988, 1988B8 ICES CM; Degnbol P, 1990, 1990B10 ICES CM; DEMER DA, 1995, J ACOUST SOC AM, V98, P1111, DOI 10.1121/1.413609; Eero M, 2012, CONSERV LETT, P1; Eero M, 2012, ECOL INDIC, V15, P248, DOI 10.1016/j.ecolind.2011.09.035; Eero M, 2011, ECOL APPL, V21, P214, DOI 10.1890/09-1879.1; ENGAS A, 1989, J CONSEIL, V45, P269; Feistel R, 2003, OCEANOLOGIA, V45, P623; FOOTE KG, 1986, J ACOUST SOC AM, V80, P612, DOI 10.1121/1.394056; Gislason H, 1999, ICES J MAR SCI, V56, P571, DOI 10.1006/jmsc.1999.0492; Hansen P. M., 1949, Rapport Conseil Exploration Mer Copenhague, V123, P1; Hinrichsen HH, 2007, MAR ECOL PROG SER, V345, P245, DOI 10.3354/meps06989; Hinrichsen HH, 2012, ICES J MAR SCI, V69, P1744, DOI 10.1093/icesjms/fss137; Hinrichsen HH, 2009, ICES J MAR SCI, V66, P101, DOI 10.1093/icesjms/fsn207; Hinrichsen HH, 2003, J SEA RES, V49, P187, DOI 10.1016/S1385-1101(03)00006-6; Hussy K, 1997, MAR ECOL PROG SER, V155, P199, DOI 10.3354/meps155199; Hussy K, 2011, ICES J MAR SCI, V68, P1459, DOI 10.1093/icesjms/fsr088; ICES, 2012, 2012ICESCM2012ACOM10; ICES, 2012, REP BALT INT FISH SU; Jansen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038758; JONES FRH, 1985, J COMP PHYSIOL B, V155, P319; Koster F, 1999, 1999Y26 ICES CM; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Koster FW, 2001, CAN J FISH AQUAT SCI, V58, P1516, DOI 10.1139/cjfas-58-8-1516; Kristensen K, 2009, THESIS U COPENHAGN; Kristensen K, 2006, CAN J FISH AQUAT SCI, V63, P2531, DOI 10.1139/F06-135; Laurel BJ, 2003, MAR ECOL PROG SER, V262, P241, DOI 10.3354/meps262241; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Lewy P, 2004, CAN J FISH AQUAT SCI, V61, P636, DOI 10.1139/F04-034; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Lough RG, 2010, FISH OCEANOGR, V19, P159, DOI 10.1111/j.1365-2419.2010.00535.x; LOUGH RG, 1989, MAR ECOL PROG SER, V56, P1, DOI 10.3354/meps056001; Lundgren B, 2008, ICES J MAR SCI, V65, P581, DOI 10.1093/icesjms/fsn031; McCullagh P, 1989, GEN LINEAR MODELS; METHVEN DA, 1994, CAN J FISH AQUAT SCI, V51, P78, DOI 10.1139/f94-010; Methven DA, 1998, CAN J FISH AQUAT SCI, V55, P1430, DOI 10.1139/cjfas-55-6-1430; Methven DA, 2003, ICES J MAR SCI, V60, P38, DOI 10.1006/jmsc.2002.1315; MUNK P, 1995, MAR ECOL PROG SER, V125, P21, DOI 10.3354/meps125021; Munk P, 1993, 1993G40 ICES CM; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; NAKKEN O, 1977, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V170, P52; Nausch G, 2012, LEIBNIZ I OSTSEEFORS; Neuenfeldt S, 2009, J FISH BIOL, V75, P290, DOI 10.1111/j.1095-8649.2009.02281.x; Neuenfeldt S, 2000, ICES J MAR SCI, V57, P300, DOI 10.1006/jmsc.2000.0647; Nielsen J. R., 1997, 1997S19 ICES CM; Nielsen J. Rasmus, 2001, Journal of Northwest Atlantic Fishery Science, V29, P1; Nielsen JR, 2012, ICES J MAR SCI, V69, P197, DOI 10.1093/icesjms/fss001; Nielsen JR, 1999, ICES J MAR SCI, V56, P627, DOI 10.1006/jmsc.1999.0515; Nielsen JR, 2001, FISH RES, V50, P235; Nielsen JR, 2001, A4JF2001 DG FISH EUR; Nilsson LAF, 2003, AQUAT LIV RES, V16; Ona E, 1994, 1994B30 ICES CM; Ona E, 1999, J ACOUST SOC AM, V105, P1049; Patokina FA, 1997, 1997GG06 ICES CM; Piechura J, 2004, OCEANOLOGIA, V46, P113; Plante S, 1998, J FISH BIOL, V53, P1342, DOI 10.1006/jfbi.1998.0798; Pohl C., 2008, STATE EVOLUTION BALT, P367; RUDSTAM LG, 1989, MAR BIOL, V101, P43, DOI 10.1007/BF00393476; SAS, 1996, SAS STAT SOFTW CHANG; SAS Institute, 2008, SAS STAT SOFTW; Schaber M, 2009, MAR ECOL PROG SER, V377, P239, DOI 10.3354/meps07822; Shvetsova G, 1992, 1992L29 ICES CM; Simmonds, 2011, REP SUBGR IMP ASS BA; Simmonds, 2012, MULT MAN PLANS BALT; SIMRAD, 1996, SIMRAD EY500 PORT SC; Soule M, 1997, ICES J MAR SCI, V54, P934, DOI 10.1006/jmsc.1997.0270; Soule M, 1996, ICES J MAR SCI, V53, P237, DOI 10.1006/jmsc.1996.0028; SOULE M, 1995, ICES J MAR SCI, V52, P139, DOI 10.1016/1054-3139(95)80022-0; Sparholt Henrik, 1994, Dana, V10, P131; Tomkiewicz J, 1998, FISH OCEANOGR, V7, P48, DOI 10.1046/j.1365-2419.1998.00051.x; Tomkiewicz J, 2003, J FISH BIOL, V62, P253, DOI 10.1046/j.1095-8649.2003.00001.x; Uzars D, 2000, ICES J MAR SCI, V57, P324, DOI 10.1006/jmsc.1999.0527	82	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70668	10.1371/journal.pone.0070668	http://dx.doi.org/10.1371/journal.pone.0070668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967084	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500022
J	Fitzgerald, P; Leonard, H; Pikora, TJ; Bourke, J; Hammond, G				Fitzgerald, Patrick; Leonard, Helen; Pikora, Terri J.; Bourke, Jenny; Hammond, Geoffrey			Hospital Admissions in Children with Down Syndrome: Experience of a Population-Based Cohort Followed from Birth	PLOS ONE			English	Article								Objective: Children with Down syndrome, the most common genetic cause of intellectual disability, are prone to multiple and varied health-related problems. This study describes patterns of hospitalisations for children and young people with Down syndrome in Western Australia. Methods: Birth records were linked to the Western Australian population-based Intellectual Disability database to identify all children born with Down syndrome in Western Australia between 1 January, 1983 and 31 December, 1999. These records were linked to the Hospital Morbidity Data System to provide information on all hospitalisations up to 31 December, 2004. Hospitalisation data, coded using ICD-9CM or ICD-10 (v0.5) were grouped into clinically relevant categories using the primary diagnosis. Rates of hospital admission for all and specific diagnoses were expressed in 1000-person-years at-risk and median age at first admission and length of stay were calculated. Results: Of the 405 children, 395 had one or more hospital admissions, totalling 3786 admissions for all children and an estimated 39.5 person-years in hospital. On average, children were admitted 9.7 times, with an estimated rate of 757.2 admissions per 1000pyr (95% CI: 680, 843). A quarter of all admissions occurred in the first year of life. The average hospital length of stay was 3.8 days (95% CI: 3.7, 4.1). Upper respiratory tract conditions affected the most children (58.5%) and accounted for 12.1% of all admissions. Other disorders which affected a high percentage of children were ear/hearing conditions (50.6%), disorders of the oral cavity (38.0%) and lower respiratory tract conditions (37.5%). Overall, children with Down syndrome were hospitalised at a rate five times (95% CI = 4.3-6.2) that of the general population. Conclusion: Children with Down syndrome are at increased risk of morbidity for varied causes underlining the importance of comprehensive and targeted primary care for this group.	[Fitzgerald, Patrick; Leonard, Helen; Pikora, Terri J.; Bourke, Jenny; Hammond, Geoffrey] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Crawley, WA, Australia	Telethon Kids Institute; University of Western Australia	Leonard, H (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Crawley, WA, Australia.	hleonard@ichr.uwa.edu.au	Pikora, Terri/AAB-1759-2019; Leonard, Helen/A-1010-2013	Pikora, Terri/0000-0002-9099-1607; Leonard, Helen/0000-0001-6405-5834	Australian National Health and Medical Research Council (NHMRC) [572742]; NHMRC [572568]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Australian National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au/) Program Grants 572742, NHMRC Research Fellowship (572568) (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Bergholdt R, 2006, DIABETOLOGIA, V49, P1179, DOI 10.1007/s00125-006-0231-6; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Bower C, 2011, W AUSTR REGISTER DEV; Cleves MA, 2007, BIRTH DEFECTS RES A, V79, P657, DOI 10.1002/bdra.20393; Colvin L, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-32; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; Driscoll Carlie, 2003, Australian and New Zealand Journal of Audiology, V25, P85, DOI 10.1375/audi.25.2.85.31120; Foley KR, CHILD CARE HLTH DEV; Frid C, 2002, J INTELL DISABIL RES, V46, P310, DOI 10.1046/j.1365-2788.2002.00392.x; Geelhoed EA, 2011, J PEDIATR-US, V159, P541, DOI 10.1016/j.jpeds.2011.06.007; Goldacre MJ, 2004, ARCH DIS CHILD, V89, P1014, DOI 10.1136/adc.2003.046219; Guazzarotti L, 2009, AJIDD-AM J INTELLECT, V114, P100, DOI 10.1352/2009.114.100-109; Hill DA, 2003, ARCH INTERN MED, V163, P705, DOI 10.1001/archinte.163.6.705; Hilton JM, 1999, J PAEDIATR CHILD H, V35, P383, DOI 10.1046/j.1440-1754.1999.00386.x; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Irving CA, 2012, ARCH DIS CHILD, V97, P326, DOI 10.1136/adc.2010.210534; Joyce A, 2009, 27 ANN REPORT W AUST; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kruger E, 2006, AUST DENT J, V51, P231, DOI 10.1111/j.1834-7819.2006.tb00434.x; Kupferman JC, 2009, PEDIATRICS, V124, pE615, DOI 10.1542/peds.2009-0181; Leonard S, 1999, DEV MED CHILD NEUROL, V41, P683, DOI 10.1017/S0012162299001401; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Maatta Tuomo, 2006, Downs Syndr Res Pract, V11, P78, DOI 10.3104/reports.317; MARCELL MM, 1995, J INTELL DISABIL RES, V39, P215, DOI 10.1111/j.1365-2788.1995.tb00504.x; Microsoft Corporation, 2010, EXC 2010 VERS 14; Milne E, 2008, INT J CANCER, V122, P1130, DOI 10.1002/ijc.23226; National Coding Centre, 1996, AUSTR VERS INT CLASS; O'Leary P, 2006, AUST NZ J OBSTET GYN, V46, P427, DOI 10.1111/j.1479-828X.2006.00629.x; OLeary P, 1996, AUST NZ J OBSTET GYN, V36, P385, DOI 10.1111/j.1479-828X.1996.tb02176.x; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Schieve LA, 2009, PEDIATRICS, V123, pE253, DOI 10.1542/peds.2008-1440; Shott SR, 2006, AM J MED GENET C, V142C, P131, DOI 10.1002/ajmg.c.30095; Silva D, 1999, SPECIFIC CHILD ADOLE; Silva D, 1999, CHILD ADOLESCENT HLT; Slack-Smith L, 2009, ARCH DIS CHILD, V94, P517, DOI 10.1136/adc.2008.145672; So SA, 2007, J INTELL DISABIL RES, V51, P1030, DOI 10.1111/j.1365-2788.2007.01013.x; StataCorp, 2021, STATA STAT SOFTWARE; Sullivan SG, 2007, J INTELL DISABIL RES, V51, P228, DOI 10.1111/j.1365-2788.2006.00862.x; Thomas K, 2011, J PEDIATR-US, V158, P194, DOI 10.1016/j.jpeds.2010.08.045; Thomas K, 2010, INT REV RES MENT RET, V39, P67, DOI 10.1016/S0074-7750(10)39003-3; Van Cleve Susan N, 2006, J Pediatr Health Care, V20, P47, DOI 10.1016/j.pedhc.2005.10.004; van Trotsenburg ASP, 2006, PEDIATRICS, V118, P1633, DOI 10.1542/peds.2006-1136; Venail F, 2004, CLIN PEDIATR, V43, P783, DOI 10.1177/000992280404300902; Williams K, 2005, ARCH DIS CHILD, V90, P1243, DOI 10.1136/adc.2004.062422; Zachariah P, 2012, J PEDIATR-US, V160, P827, DOI 10.1016/j.jpeds.2011.11.004; Zeller B, 2005, BRIT J HAEMATOL, V128, P797, DOI 10.1111/j.1365-2141.2005.05398.x	50	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70401	10.1371/journal.pone.0070401	http://dx.doi.org/10.1371/journal.pone.0070401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967074	Green Submitted, Green Published, gold			2022-12-27	WOS:000323115800006
J	Borel, AL; Monneret, D; Tamisier, R; Baguet, JP; Faure, P; Levy, P; Halimi, S; Pepin, JL				Borel, Anne-Laure; Monneret, Denis; Tamisier, Renaud; Baguet, Jean-Philippe; Faure, Patrice; Levy, Patrick; Halimi, Serge; Pepin, Jean-Louis			The Severity of Nocturnal Hypoxia but Not Abdominal Adiposity Is Associated with Insulin Resistance in Non-Obese Men with Sleep Apnea	PLOS ONE			English	Article							STYLE INTERVENTION PROGRAM; POSITIVE AIRWAY PRESSURE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; GLUCOSE-TOLERANCE; SERUM LEPTIN; RISK-FACTORS; OBESITY; TISSUE	Background: Beyond obesity, sleep apnea syndrome is frequently associated with excess abdominal adiposity that could contribute to the deteriorated cardiometabolic risk profile of apneic patients. Methods: The present study addressed the respective contribution of the severity of sleep apnea syndrome and excess abdominal adiposity to the cardiometabolic risk profile of 38 non obese men with polysomnography-diagnosed sleep apnea syndrome (apnea-hypopnea index > 15 events/hour). These otherwise healthy men performed a 75g-oral glucose tolerance test (OGTT) with plasma lipid/inflammatory and redox profiles. Twenty-one apneic men with high-waist circumference (>94 cm) were compared to 17 apneic men with low-waist circumference. Results: Apneic men with high-waist circumference had higher AUC glucose and AUC insulin than apneic men with low-waist circumference. Accordingly, apneic men with high-waist circumference had higher hepatic insulin resistance as reflected by higher HOMA-resistance index, and lower global insulin sensitivity as reflected by lower insulin sensitivity index of Matsuda (derived from OGTT). The sleep structure and the apnea-hypopnea index were not different between the two groups. However, apneic men with high-waist circumference presented with lower mean nocturnal oxyhemoglobin (SpO(2)). In the 38 men, waist circumference and mean nocturnal SpO(2) were inversely correlated (r = -20.43, p = 0.011) and were both associated with plasma glucose/insulin homeostasis indices: the higher the waist circumference, the lower the mean nocturnal SpO(2), the lower the insulin-sensitivity. Finally, in multivariable regression model, mean nocturnal SpO(2) and not waist circumference was associated with insulin-resistance. Conclusion: Thus, excess abdominal adiposity in non obese apneic men was associated with a deteriorated insulin-sensitivity that could be driven by a more severe nocturnal hypoxemia.	[Borel, Anne-Laure; Halimi, Serge] Univ Hosp, Dept Endocrinol, Grenoble, France; [Borel, Anne-Laure; Monneret, Denis; Tamisier, Renaud; Levy, Patrick; Pepin, Jean-Louis] INSERM, U1042, Grenoble, France; [Borel, Anne-Laure; Monneret, Denis; Tamisier, Renaud; Levy, Patrick; Pepin, Jean-Louis] Univ Grenoble Alpes, HP2 Lab, Grenoble, France; [Monneret, Denis] La Pitie Salpetriere Hosp, Dept Metab Biochem, Paris, France; [Tamisier, Renaud; Levy, Patrick; Pepin, Jean-Louis] Univ Hosp, Sleep Exercise & Physiol Dept, Grenoble, France; [Baguet, Jean-Philippe] Univ Hosp, Dept Cardiol, Grenoble, France; [Faure, Patrice] Univ Hosp, Dept Biol, Grenoble, France	CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Grenoble Alpes; CHU Grenoble Alpes; CHU Grenoble Alpes	Borel, AL (corresponding author), Univ Hosp, Dept Endocrinol, Grenoble, France.	alborel@chu-grenoble.fr	Baguet, Jean-Philippe/M-5536-2014; Tamisier, Renaud/M-6858-2014; Lévy, Patrick/M-6903-2014; PEPIN, Jean-Louis/M-6549-2014; Borel, Anne-Laure/M-7117-2014; LEVY, Patrick/AAX-2802-2020	Tamisier, Renaud/0000-0003-1128-6529; Lévy, Patrick/0000-0003-3632-1327; LEVY, Patrick/0000-0003-3174-7935; Pepin, Jean Louis/0000-0003-3832-2358; Borel, Anne-Laure/0000-0002-7368-172X	Direction de la Recherche Clinique; University Hospital of Grenoble, France; scientific council of`"Agiradom'', Meylan, France	Direction de la Recherche Clinique; University Hospital of Grenoble, France; scientific council of`"Agiradom'', Meylan, France	The present study was supported by a grant from the "Direction de la Recherche Clinique'', University Hospital of Grenoble, France (www.chugrenoble.fr) and by a grant from the scientific council of "Agiradom'', Meylan, France (www.agiradom.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Baguet JP, 2012, NAT REV CARDIOL; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Borel AL, 2012, THORAX, V67, P735, DOI 10.1136/thoraxjnl-2011-201001; Borel AL, 2012, METABOLISM, V61, P262, DOI 10.1016/j.metabol.2011.06.024; Chin KZ, 1999, CIRCULATION, V100, P706, DOI 10.1161/01.CIR.100.7.706; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Pamidi S, 2012, DIABETES CARE; Pamidi Sushmita, 2012, Front Neurol, V3, P126; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Schafer H, 2002, CHEST, V122, P829, DOI 10.1378/chest.122.3.829; Seidell JC, 2010, EUR J CLIN NUTR, V64, P35, DOI 10.1038/ejcn.2009.71; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; Vgontzas Alexandros N., 2008, Archives of Physiology and Biochemistry, V114, P211, DOI [10.1080/13813450802364627, 10.1080/13813450802364627 ]; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Zavorsky GS, 2008, OBES REV, V9, P326, DOI 10.1111/j.1467-789X.2008.00471.x	35	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71000	10.1371/journal.pone.0071000	http://dx.doi.org/10.1371/journal.pone.0071000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951064	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300070
J	Franko, E; Joly, O				Franko, Edit; Joly, Olivier		Alzheimer's Dis Neuroimaging Initi	Evaluating Alzheimer's Disease Progression Using Rate of Regional Hippocampal Atrophy	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AUTOMATED SEGMENTATION; BRAIN ATROPHY; VOLUME; MRI; DEMENTIA; SHAPE; CLASSIFICATION; CONVERSION; DIAGNOSIS	Alzheimer's disease (AD) is characterized by neurofibrillary tangle and neuropil thread deposition, which ultimately results in neuronal loss. A large number of magnetic resonance imaging studies have reported a smaller hippocampus in AD patients as compared to healthy elderlies. Even though this difference is often interpreted as atrophy, it is only an indirect measurement. A more direct way of measuring the atrophy is to use repeated MRIs within the same individual. Even though several groups have used this appropriate approach, the pattern of hippocampal atrophy still remains unclear and difficult to relate to underlying pathophysiology. Here, in this longitudinal study, we aimed to map hippocampal atrophy rates in patients with AD, mild cognitive impairment (MCI) and elderly controls. Data consisted of two MRI scans for each subject. The symmetric deformation field between the first and the second MRI was computed and mapped onto the three-dimensional hippocampal surface. The pattern of atrophy rate was similar in all three groups, but the rate was significantly higher in patients with AD than in control subjects. We also found higher atrophy rates in progressive MCI patients as compared to stable MCI, particularly in the antero-lateral portion of the right hippocampus. Importantly, the regions showing the highest atrophy rate correspond to those that were described to have the highest burden of tau deposition. Our results show that local hippocampal atrophy rate is a reliable biomarker of disease stage and progression and could also be considered as a method to objectively evaluate treatment effects.	[Franko, Edit] Univ Caen Basse Normandie, INSERM, U1075, Caen, France; [Franko, Edit] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England; [Franko, Edit] UCL, Inst Neurol, Natl Prion Clin, London, England; [Joly, Olivier] NeuroSpin, Gif Sur Yvette, France; [Joly, Olivier] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; University of London; University College London; University of London; University College London; Newcastle University - UK	Franko, E (corresponding author), Univ Caen Basse Normandie, INSERM, U1075, Caen, France.	e.franko@ucl.ac.uk		Joly, Olivier/0000-0002-5818-6552	University of Caen; INSERM; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; GlaxoSmithKilne; Innogenetics; Johnson and Johnson; Eli Lilly and Co.; Medpace, Inc.; Merck and Co., Inc.; Novartis AD; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	University of Caen; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); GlaxoSmithKilne; Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co.(Eli Lilly); Medpace, Inc.; Merck and Co., Inc.(Merck & Company); Novartis AD; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors of this study have only been funded by the University of Caen and INSERM. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI was funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKilne, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AD, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2010, NEUROBIOL AGING, V31, P1077, DOI 10.1016/j.neurobiolaging.2008.08.008; Bobinski M, 1996, NEUROBIOL AGING, V17, P909, DOI 10.1016/S0197-4580(97)85095-6; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Cummings Jeffrey L, 2004, Rev Neurol Dis, V1, P60; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Franko E, 2010, 2010 NEUR M PLANN SA; Franko E, 2014, HUM BRAIN MAPP, V35, P248, DOI 10.1002/hbm.22170; Frisoni GB, 2006, NEUROIMAGE, V32, P104, DOI 10.1016/j.neuroimage.2006.03.015; Frisoni GB, 2008, BRAIN, V131, P3266, DOI 10.1093/brain/awn280; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Gutman B, 2009, HIPPOCAMPUS, V19, P572, DOI 10.1002/hipo.20627; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Insausti R., 2004, HUMAN NERVOUS SYSTEM, P871, DOI [10.1016/B978-012547626-3/50024-7, DOI 10.1016/B978-012547626-3/50024-7]; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Juottonen K, 1998, NEUROBIOL AGING, V19, P15, DOI 10.1016/S0197-4580(98)00007-4; Konrad C, 2009, NEUROIMAGE, V47, P1185, DOI 10.1016/j.neuroimage.2009.05.019; Laakso MP, 2000, BIOL PSYCHIAT, V47, P557, DOI 10.1016/S0006-3223(99)00167-5; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lorenzi M., 2013, NEUROIMAGE; Macdonald KE, 2012, ALZHEIMER DIS ASS DI; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Pluta J, 2012, J ALZHEIMERS DIS, V31, P85, DOI 10.3233/JAD-2012-111931; Pluta J, 2009, HIPPOCAMPUS, V19, P565, DOI 10.1002/hipo.20619; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; van de Pol LA, 2007, NEUROIMAGE, V34, P1036, DOI 10.1016/j.neuroimage.2006.10.033; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wang L, 2006, NEUROIMAGE, V30, P52, DOI 10.1016/j.neuroimage.2005.09.017; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Wang L, 2010, ARCH NEUROL-CHICAGO, V67, P99, DOI 10.1001/archneurol.2009.292; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042	52	68	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71354	10.1371/journal.pone.0071354	http://dx.doi.org/10.1371/journal.pone.0071354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951142	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300107
J	Hirvenkari, L; Ruusuvuori, J; Saarinen, VM; Kivioja, M; Perakyla, A; Hari, R				Hirvenkari, Lotta; Ruusuvuori, Johanna; Saarinen, Veli-Matti; Kivioja, Maari; Perakyla, Anssi; Hari, Riitta			Influence of Turn-Taking in a Two-Person Conversation on the Gaze of a Viewer	PLOS ONE			English	Article							EYE-MOVEMENTS; RESPONSES	In natural conversation, the minimal gaps and overlaps of the turns at talk indicate an accurate regulation of the timings of the turn-taking system. Here we studied how the turn-taking affects the gaze of a non-involved viewer of a two-person conversation. The subjects were presented with a video of a conversation while their eye gaze was tracked with an infrared camera. As a control, the video was presented without sound and the sound with still image of the speakers. Turns at talk directed the gaze behaviour of the viewers; the gaze followed, rather than predicted, the speakership change around the turn transition. Both visual and auditory cues presented alone also induced gaze shifts towards the speaking person, although significantly less and later than when the cues of both modalities were available. These results show that the organization of turn-taking has a strong influence on the gaze patterns of even non-involved viewers of the conversation, and that visual and auditory cues are in part redundant in guiding the viewers' gaze.	[Hirvenkari, Lotta; Saarinen, Veli-Matti; Hari, Riitta] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Ruusuvuori, Johanna] Univ Tampere, Sch Social Sci & Humanities, FIN-33101 Tampere, Finland; [Kivioja, Maari; Perakyla, Anssi] Univ Helsinki, Dept Social Res, Helsinki, Finland	Aalto University; Tampere University; University of Helsinki	Hirvenkari, L (corresponding author), Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland.	lotta.hirvenkari@aalto.fi	Hari, Riitta K/J-1880-2012	Hari, Riitta K/0000-0002-3142-2703	Academy of Finland (National Centers of Excellence Programme); European Union (NEST Programme PERCEPT, Perceptual Consciousness - Explication and Testing) [043261]; UI-ART project of the TKK MIDE research programme (Finland); Jenny and Antti Wihuri Foundation; ERC [232946]	Academy of Finland (National Centers of Excellence Programme)(Academy of Finland); European Union (NEST Programme PERCEPT, Perceptual Consciousness - Explication and Testing); UI-ART project of the TKK MIDE research programme (Finland); Jenny and Antti Wihuri Foundation; ERC(European Research Council (ERC)European Commission)	This study was financially supported by the Academy of Finland (National Centers of Excellence Programme 2006-2011), European Union (NEST Programme PERCEPT, Perceptual Consciousness - Explication and Testing, 043261), UI-ART project of the TKK MIDE research programme (Finland), Jenny and Antti Wihuri Foundation and the ERC Advanced Grant (#232946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyle M, 1972, SEMIOTICA, V6, P32, DOI DOI 10.1515/SEMI.1972.6.1.32; Argyle M, 1974, GAZE MUTUAL GAZE; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Carpenter RHS, 1988, MOVEMENTS EYES, P69; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Di Paolo E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00163; Ford Cecilia E., 1996, INTERACTION GRAMMAR, P135; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; LEVINE MH, 1973, DEV PSYCHOL, V9, P400, DOI 10.1037/h0034929; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Novick DG, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1888, DOI 10.1109/ICSLP.1996.608001; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Rossano F, 2012, GAZE BEHAV FACE TO F; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; WILSON TP, 1986, DISCOURSE PROCESS, V9, P375, DOI 10.1080/01638538609544649; ZAMBARBIERI D, 1982, EXP BRAIN RES, V47, P417	23	23	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71569	10.1371/journal.pone.0071569	http://dx.doi.org/10.1371/journal.pone.0071569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951192	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323097300130
J	Lepage, E; Zampini, E; Boyle, B; Brisson, N				Lepage, Etienne; Zampini, Eric; Boyle, Brian; Brisson, Normand			Time- and Cost-Efficient Identification of T-DNA Insertion Sites through Targeted Genomic Sequencing	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MUTAGENESIS; REVERSE	Forward genetic screens enable the unbiased identification of genes involved in biological processes. In Arabidopsis, several mutant collections are publicly available, which greatly facilitates such practice. Most of these collections were generated by agrotransformation of a T-DNA at random sites in the plant genome. However, precise mapping of T-DNA insertion sites in mutants isolated from such screens is a laborious and time-consuming task. Here we report a simple, low-cost and time efficient approach to precisely map T-DNA insertions simultaneously in many different mutants. By combining sequence capture, next-generation sequencing and 2D-PCR pooling, we developed a new method that allowed the rapid localization of T-DNA insertion sites in 55 out of 64 mutant plants isolated in a screen for gyrase inhibition hypersensitivity.	[Lepage, Etienne; Zampini, Eric; Brisson, Normand] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Boyle, Brian] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada	Universite de Montreal; Laval University	Brisson, N (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	normand.brisson@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC) to NB, EZ and EL were funded by scholarships from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso JM, 2006, NAT REV GENET, V7, P524, DOI 10.1038/nrg1893; BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; Cappadocia L, 2010, PLANT CELL, V22, P1849, DOI 10.1105/tpc.109.071399; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Ji JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010577; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Nacry P, 1998, GENETICS, V149, P641; OCHMAN H, 1988, GENETICS, V120, P621; Ostergaard L, 2004, PLANT J, V39, P682, DOI 10.1111/j.1365-313X.2004.02149.x; Parent JS, 2011, PLANT PHYSIOL, V156, P254, DOI 10.1104/pp.111.173849; Polko JK, 2012, MOL PLANT, V5, P948, DOI 10.1093/mp/sss022; Raherison E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-434; Robinson SJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-101; Rowan BA, 2010, J EXP BOT, V61, P2575, DOI 10.1093/jxb/erq088; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Urbanski DF, 2012, PLANT J, V69, P731, DOI 10.1111/j.1365-313X.2011.04827.x; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; Weigel D., 2002, ARABIDOPSIS LAB MANU; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x	20	24	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70912	10.1371/journal.pone.0070912	http://dx.doi.org/10.1371/journal.pone.0070912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951038	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300066
J	Nadhanan, RR; Skinner, J; Chung, R; Su, YW; Howe, PR; Xian, CJ				Nadhanan, Rethi Raghu; Skinner, Jayne; Chung, Rosa; Su, Yu-Wen; Howe, Peter R.; Xian, Cory J.			Supplementation with Fish Oil and Genistein, Individually or in Combination, Protects Bone against the Adverse Effects of Methotrexate Chemotherapy in Rats	PLOS ONE			English	Article							N-3 FATTY-ACIDS; LOW-DOSE METHOTREXATE; OSTEOCLAST DIFFERENTIATION; ADIPOGENIC DIFFERENTIATION; CELL-DIFFERENTIATION; PHYTO-ESTROGENS; GROWTH-PLATE; YOUNG-RATS; MARROW; FRACTURES	Cancer chemotherapy has been shown to induce long-term skeletal side effects such as osteoporosis and fractures; however, there are no preventative treatments. This study investigated the damaging effects of anti-metabolite methotrexate (MTX) subcutaneous injections (0.75 mg/kg BW) for five days and the potential protective benefits of daily oral gavage of fish oil at 0.5 mL/100 g BW (containing 375 mg of n-3 PUFA/100 g BW), genistein (2 mg/100 g BW), or their combination in young adult rats. MTX treatment alone significantly reduced primary spongiosa height and secondary spongiosa trabecular bone volume. Bone marrow stromal cells from the treated rats showed a significant reduction in osteogenic differentiation but an increase in adipogenesis ex vivo. Consistently, stromal cells had significantly higher mRNA levels of adipogenesis-related proliferator activator activated receptor-gamma (PPAR-gamma) and fatty acid binding protein (FABP4). MTX significantly increased the numbers of bone-resorbing osteoclasts and marrow osteoclast precursor cell pool while significantly enhancing the mRNA expression of receptor activator for nuclear factor kappa B ligand (RANKL), the RANKL/osteoprotegerin (OPG) ratio, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in the bone. Supplementary treatment with fish oil and/or genistein significantly preserved trabecular bone volume and osteogenesis but suppressed MTX-induced adipogenesis and increases in osteoclast numbers and pro-osteoclastogenic cytokine expression. Thus, Fish oil and/or genistein supplementation during MTX treatment enabled not only preservation of osteogenic differentiation, osteoblast number and bone volume, but also prevention of MTX treatment-induced increases in bone marrow adiposity, osteoclastogenic cytokine expression and osteoclast formation, and thus bone loss.	[Nadhanan, Rethi Raghu; Skinner, Jayne; Chung, Rosa; Su, Yu-Wen; Xian, Cory J.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Howe, Peter R.] Univ Newcastle, Clin Nutr Res Ctr, Callaghan, NSW 2308, Australia	University of South Australia; University of Newcastle	Xian, CJ (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	Cory.Xian@unisa.edu.au	Howe, Peter/AAM-4972-2021; Su, Yu-Wen/V-4948-2018; Howe, Peter/A-5006-2008; Xian, Cory/D-2646-2009	Howe, Peter/0000-0001-6546-7742; Su, Yu-Wen/0000-0002-2067-5270; Howe, Peter/0000-0001-6546-7742; Xian, Cory/0000-0002-8467-2845	Channel-7 Children's Research Foundation of South Australia; National Health and Medical Research Council (NHMRC) Australia; University of South Australia	Channel-7 Children's Research Foundation of South Australia; National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This project was funded in part by project grants from Channel-7 Children's Research Foundation of South Australia and National Health and Medical Research Council (NHMRC) Australia. RRN is a recipient of University of South Australia PhD scholarship. CJX is a senior fellow of NHMRC Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; ATKINSON SA, 1989, J PEDIATR-US, V114, P793, DOI 10.1016/S0022-3476(89)80138-6; Atkinson TG, 1997, LIPIDS, V32, P293, DOI 10.1007/s11745-997-0036-x; Belur LR, 2005, J PHARMACOL EXP THER, V314, P668, DOI 10.1124/jpet.104.082982; Bhattacharya A, 2005, J AM COLL NUTR, V24, P200, DOI 10.1080/07315724.2005.10719466; Bitto A, 2009, BRIT J PHARMACOL, V156, P1287, DOI 10.1111/j.1476-5381.2008.00100.x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Branca F, 2003, P NUTR SOC, V62, P877, DOI 10.1079/PNS2003309; Chen X., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P352; Chen XW, 2002, BIOCHEM BIOPH RES CO, V295, P417, DOI 10.1016/S0006-291X(02)00667-8; Coleman RE, 2008, BRIT J CANCER, V98, P1736, DOI 10.1038/sj.bjc.6604382; Darst M, 2004, J IMMUNOL, V172, P6330, DOI 10.4049/jimmunol.172.10.6330; Delclos KB, 2001, REPROD TOXICOL, V15, P647, DOI 10.1016/S0890-6238(01)00177-0; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Ecklund K, 1997, RADIOLOGY, V202, P543, DOI 10.1148/radiology.202.2.9015088; Fan CM, 2009, BONE, V44, P61, DOI 10.1016/j.bone.2008.09.014; Ferguson SA, 2002, NEUROTOXICOL TERATOL, V24, P37, DOI 10.1016/S0892-0362(01)00193-3; Fernandes G, 2003, PROSTAG LEUKOTR ESS, V68, P361, DOI 10.1016/S0952-3278(03)00060-7; Georgiou KR, 2012, BONE, V50, P1223, DOI 10.1016/j.bone.2012.03.027; Georgiou KR, 2012, J CELL PHYSIOL, V227, P909, DOI 10.1002/jcp.22807; Griel AE, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-2; Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Herrera BS, 2008, BRIT J PHARMACOL, V155, P1214, DOI 10.1038/bjp.2008.367; Hogler W, 2007, PEDIATR BLOOD CANCER, V48, P21, DOI 10.1002/pbc.20701; Huang Chang-xin, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P661; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; ISLAM A, 1987, J MED, V18, P108; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; JOLIVET J, 1983, NEW ENGL J MED, V309, P1094, DOI 10.1056/NEJM198311033091805; Karieb S, 2011, J CELL BIOCHEM, V112, P476, DOI 10.1002/jcb.22935; King TJ, 2012, AM J PATHOL, V181, P121, DOI 10.1016/j.ajpath.2012.03.037; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kolahi S, 2010, CLIN BIOCHEM, V43, P576, DOI 10.1016/j.clinbiochem.2009.12.011; Kruger MC, 1998, AGING-CLIN EXP RES, V10, P385, DOI 10.1007/BF03339885; Li BB, 2003, BIOL PHARM BULL, V26, P780, DOI 10.1248/bpb.26.780; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Li XH, 2005, ACTA PHARMACOL SIN, V26, P1081, DOI 10.1111/j.1745-7254.2005.00161.x; Ma HP ML, 2010, J CELL BIOCHEM, P916; MAY KP, 1994, ARTHRITIS RHEUM, V37, P201, DOI 10.1002/art.1780370208; McCarty RC, 2009, J CELL PHYSIOL, V219, P324, DOI 10.1002/jcp.21670; Ming LG, 2012, J CELL PHYSL, DOI [10.1002/jcp.24158, DOI 10.1002/JCP.24158.[]; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; NESBIT M, 1976, CANCER-AM CANCER SOC, V37, P1048, DOI 10.1002/1097-0142(197602)37:2+<1048::AID-CNCR2820370811>3.0.CO;2-V; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; OREGAN S, 1973, AM J DIS CHILD, V126, P489, DOI 10.1001/archpedi.1973.02110190403008; Papaconstantinou HT, 2001, SURGERY, V130, P859, DOI 10.1067/msy.2001.117376; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; Poulsen RC, 2008, AM J HEMATOL, V83, P437, DOI 10.1002/ajh.21170; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RAGAB AH, 1970, CANCER, V25, P580, DOI 10.1002/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M; Sasaki H, 2004, J PERIODONTAL RES, V39, P432, DOI 10.1111/j.1600-0765.2004.00760.x; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S; Sirtori CR, 2001, DRUG SAFETY, V24, P665, DOI 10.2165/00002018-200124090-00003; Sliwinski L, 2005, PHARMACOL REP, V57, P352; STANISAVLJEVIC S, 1977, CLIN ORTHOP RELAT R, P139; Sudo A, 2003, J Orthop Surg (Hong Kong), V11, P6; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Terano T, 2001, WORLD REV NUTR DIET, V88, P141; Uchida R, 2011, J BONE MINER METAB, V29, P404, DOI 10.1007/s00774-010-0234-8; Ullmann U, 2005, J Physiol Pharmacol, V56 Suppl 1, P79; Vanek C, 2007, AM J CLIN NUTR, V85, P647, DOI 10.1093/ajcn/85.3.647; Villani F, 2002, ANTICANCER RES, V22, P2403; Watkins BA, 2005, J NUTR BIOCHEM, V16, P479, DOI 10.1016/j.jnutbio.2005.01.019; Watkins BA, 2000, J AM COLL NUTR, V19, p478S, DOI 10.1080/07315724.2000.10718951; Watkins BA, 2003, PROSTAG LEUKOTR ESS, V68, P387, DOI 10.1016/S0952-3278(03)00063-2; WHEELER DL, 1995, BONE, V16, P215, DOI 10.1016/8756-3282(94)00032-U; Xian CJ, 2008, J CELL PHYSIOL, V214, P777, DOI 10.1002/jcp.21274; Xian CJ, 2007, BONE, V41, P842, DOI 10.1016/j.bone.2007.07.021; Xian CJ, 2007, CANCER BIOL THER, V6, P170, DOI 10.4161/cbt.6.2.3576; Xian CJ, 2006, J CELL BIOCHEM, V99, P1688, DOI 10.1002/jcb.20889; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhou FH, 2004, BONE, V35, P1307, DOI 10.1016/j.bone.2004.09.014	77	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71592	10.1371/journal.pone.0071592	http://dx.doi.org/10.1371/journal.pone.0071592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951199	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000323097300134
J	Taylor, A; Sheng, KC; Herrero, LJ; Chen, WQ; Rulli, NE; Mahalingam, S				Taylor, Adam; Sheng, Kuo-Ching; Herrero, Lara J.; Chen, Weiqiang; Rulli, Nestor E.; Mahalingam, Suresh			Methotrexate Treatment Causes Early Onset of Disease in a Mouse Model of Ross River Virus-Induced Inflammatory Disease through Increased Monocyte Production	PLOS ONE			English	Article							LOW-DOSE METHOTREXATE; RHEUMATOID-ARTHRITIS; INFECTION; MYOSITIS; POLYGLUTAMATES; ALPHAVIRUS; INHIBITOR; BINDARIT; SITES; RISK	Part of the Togaviridae family, alphaviruses, including chikungunya virus (CHIKV), Sindbis virus (SINV) and Ross River virus (RRV), are able to cause significant inflammatory pathologies ranging from arthritis to encephalitis. Following symptomatic infection with arthritis-associated alphaviruses, patients often experience severe joint pain, affecting distal and small joints, which can last six months or longer. Recently, methotrexate (MTX), a disease modifying anti-rheumatic drug (DMARD), was used to treat patients experiencing chronic rheumatic symptoms following infection with CHIKV. Here, the effect of MTX on Ross River virus disease (RRVD) in mice was examined to better understand its therapeutic potential for alphaviral-induced musculoskeletal disease and to further our knowledge of the development of alphaviral pathologies. Using a mouse model, we analyzed the effect of MTX on RRVD. RRV disease pathogenesis in response to MTX treatment was determined by measuring levels of proinflammatory factors, cellular infiltrates, viral titer and histological analysis of infected tissues. RRV-infected mice receiving MTX treatment rapidly developed musculoskeletal disease, which correlated with a significant influx of inflammatory cell infiltrates into the skeletal muscle tissue. Although no difference was observed in the level of proinflammatory cytokines and chemokines, the viral load increased at early time points post infection in the serum and quadriceps of MTX treated mice, possibly contributing to disease pathogenesis. Results suggest that MTX treatment of acute RRVD in mice provides no therapeutic benefit and underline the importance of inflammatory monocytes in alphaviral induced arthritides.	[Taylor, Adam; Sheng, Kuo-Ching; Herrero, Lara J.; Chen, Weiqiang; Rulli, Nestor E.; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Nathan, Qld 4111, Australia	Griffith University	Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Nathan, Qld 4111, Australia.	s.mahalingam@griffith.edu.au	Herrero, Lara/A-4628-2015; Taylor, Adam/C-2981-2017	Herrero, Lara/0000-0002-5661-9828; Taylor, Adam/0000-0002-7159-3961; Tripp, Ralph/0000-0002-2924-9956; Mahalingam, Suresh/0000-0003-3141-8410; Chen, Weiqiang/0000-0002-8840-1823	Australian National Health and Medical Research Council [2148600]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Australian National Health and Medical Research Council to SM (grant 2148600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1157, DOI 10.1093/rheumatology/kem076; BOERBOOMS AMT, 1995, SEMIN ARTHRITIS RHEU, V24, P411, DOI 10.1016/S0049-0172(95)80009-3; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; FREEMANNARROD M, 1977, J NATL CANCER I, V58, P735; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Government WA, 2012, ROSS RIV VIR NOT W A; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Johnston A, 2005, CLIN IMMUNOL, V114, P154, DOI 10.1016/j.clim.2004.09.001; Kimura E, 2004, INT J BIOCHEM CELL B, V36, P814, DOI 10.1016/j.biocel.2003.09.002; Kline K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001755; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P832, DOI 10.1002/art.1780290703; KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X; LEMENSE GP, 1994, AM J RESP CRIT CARE, V150, P258, DOI 10.1164/ajrccm.150.1.8025760; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; McLean-Tooke A, 2009, RHEUMATOLOGY, V48, P867, DOI 10.1093/rheumatology/kep101; Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006; Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470; Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682; Seitz M, 1998, ARTHRITIS RHEUM-US, V41, P2032, DOI 10.1002/1529-0131(199811)41:11<2032::AID-ART19>3.3.CO;2-A; Sloan-Gardner T, 2011, COMMUN DIS INTELL, V35, P61; Smitten AL, 2008, J RHEUMATOL, V35, P387; Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E; Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; WEINBLATT ME, 1992, ARTHRITIS RHEUM, V35, P129, DOI 10.1002/art.1780350202; Zaid A, 2011, ARTHRITIS RHEUM-US, V63, P488, DOI 10.1002/art.30112	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71146	10.1371/journal.pone.0071146	http://dx.doi.org/10.1371/journal.pone.0071146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951095	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300090
J	Tjomsland, V; Bojmar, L; Sandstrom, P; Bratthall, C; Messmer, D; Spangeus, A; Larsson, M				Tjomsland, Vegard; Bojmar, Linda; Sandstrom, Per; Bratthall, Charlotte; Messmer, Davorka; Spangeus, Anna; Larsson, Marie			IL-1 alpha Expression in Pancreatic Ductal Adenocarcinoma Affects the Tumor Cell Migration and Is Regulated by the p38MAPK Signaling Pathway	PLOS ONE			English	Article							CANCER CELLS; MAP KINASE; P38 MAPK; K-RAS; INTERLEUKIN-1; ACTIVATION; MICROENVIRONMENT; MUTATIONS; PHENOTYPE; CYTOKINES	The interplay between the tumor cells and the surrounding stroma creates inflammation, which promotes tumor growth and spread. The inflammation is a hallmark for pancreatic adenocarcinoma (PDAC) and is to high extent driven by IL-1 alpha. IL1-alpha is expressed and secreted by the tumor cells and exerting its effect on the stroma, i.e. cancer associated fibroblasts (CAF), which in turn produce massive amount of inflammatory and immune regulatory factors. IL-1 induces activation of transcription factors such as nuclear factor-kappa b (NF-kappa b), but also activator protein 1 (AP-1) via the small G-protein Ras. Dysregulation of Ras pathways are common in cancer as this oncogene is the most frequently mutated in many cancers. In contrast, the signaling events leading up to the expression of IL-1 alpha by tumor cells are not well elucidated. Our aim was to examine the signaling cascade involved in the induction of IL-1 alpha expression in PDAC. We found p38MAPK, activated by the kappa-Ras signaling pathway, to be involved in the expression of IL-1 alpha by PDAC as blocking this pathway decreased both the gene and protein expression of IL-1 alpha. Blockage of the P38MAPK signaling in PDAC also dampened the ability of the tumor cell to induce inflammation in CAFs. In addition, the IL-1 alpha autocrine signaling regulated the migratory capacity of PDAC cells. Taken together, the blockage of signaling pathways leading to IL-1 alpha expression and/or neutralization of IL-1 alpha in the PDAC microenvironment should be taken into consideration as possible treatment or complement to existing treatment of this cancer.	[Tjomsland, Vegard; Larsson, Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Bojmar, Linda; Sandstrom, Per] Linkoping Univ, Dept Clin & Expt Med, Div Surg, Linkoping, Sweden; [Bratthall, Charlotte] Kalmar Hosp, Div Oncol, Kalmar, Sweden; [Messmer, Davorka] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Spangeus, Anna] Linkoping Univ, Div Internal Med, Dept Med & Hlth Sci, Linkoping, Sweden; [Spangeus, Anna] Linkoping Univ, Dept Endocrinol, Dept Med & Hlth Sci, Linkoping, Sweden	Linkoping University; Linkoping University; University of California System; University of California San Diego; Linkoping University; Linkoping University	Larsson, M (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	marie.larsson@liu.se	SandstrÃm, Per/AAF-1841-2019	Larsson, Marie/0000-0002-4524-0177	Swedish Research Council [AI52731]; VINNMER (Vinnova); Medical Research Council of Southeast Sweden; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNMER (Vinnova)(Vinnova); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society of Medicine	This work has been supported by grants from: The Swedish Research Council (AI52731), VINNMER (Vinnova), the Medical Research Council of Southeast Sweden, and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner TB, 2005, CANCER RES, V65, P8433, DOI 10.1158/0008-5472.CAN-05-0158; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHIRIVI RGS, 1993, CANCER RES, V53, P5051; Dong Z, 2001, INT J CANCER, V93, P507, DOI 10.1002/ijc.1358; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Kim ST, 2011, MOL CANCER THER, V10, P1993, DOI 10.1158/1535-7163.MCT-11-0269; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manes T, 2003, J CELL BIOL, V161, P817, DOI 10.1083/jcb.200212172; Masui T, 2004, BIOCHEM BIOPH RES CO, V315, P85, DOI 10.1016/j.bbrc.2004.01.021; Matsuo Y, 2009, J SURG RES, V153, P274, DOI 10.1016/j.jss.2008.04.040; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Melisi D, 2009, MOL CANCER RES, V7, P624, DOI 10.1158/1541-7786.MCR-08-0201; Mu DQ, 2004, WORLD J GASTROENTERO, V10, P471, DOI 10.3748/wjg.v10.i4.471; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Saad S, 2002, CANCER RES, V62, P283; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Slebos RJC, 2000, CANCER EPIDEM BIOMAR, V9, P1223; Somasundaram R, 2009, SEMIN CANCER BIOL, V19, P92, DOI 10.1016/j.semcancer.2008.11.002; TABATA T, 1993, INT J PANCREATOL, V14, P237; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Tjomsland V, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/212810; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.11332; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694	34	27	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70874	10.1371/journal.pone.0070874	http://dx.doi.org/10.1371/journal.pone.0070874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951028	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300061
J	Karnas, D; Hicks, D; Mordel, J; Pevet, P; Meissl, H				Karnas, Diana; Hicks, David; Mordel, Jerome; Pevet, Paul; Meissl, Hilmar			Intrinsic Photosensitive Retinal Ganglion Cells in the Diurnal Rodent, Arvicanthis ansorgei	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; DIFFERENTIAL EXPRESSION; NEURONAL-ACTIVITY; LIGHT RESPONSES; CLOCK GENES; MELANOPSIN; MOUSE; PROTEIN; PHOTOENTRAINMENT; ORGANIZATION	Intrinsically photosensitive retinal ganglion cells (ipRGCs) represent a new class of photoreceptors which support a variety of non-image forming physiological functions, such as circadian photoentrainment, pupillary light reflex and masking responses to light. In view of the recently proposed role of retinal inputs for the regulation of diurnal and nocturnal behavior, we performed the first deep analysis of the ipRGC system in a diurnal rodent model, Arvicanthis ansorgei, and compared the anatomical and physiological properties of ipRGCs with those of nocturnal mice. Based on somata location, stratification pattern and melanopsin expression, we identified two main ipRGC types in the retina of Arvicanthis: M1, constituting 74% of all ipRGCs and non-M1 (consisting mainly of the M2 type) constituting the following 25%. The displaced ipRGCs were rarely encountered. Phenotypical staining patterns of ganglion cell markers showed a preferential expression of Brn3 and neurofilaments in non-M1 ipRGCs. In general, the anatomical properties and molecular phenotyping of ipRGCs in Arvicanthis resemble ipRGCs of the mouse retina, however the percentage of M1 cells is considerably higher in the diurnal animal. Multi-electrode array recordings (MEA) identified in newborn retinas of Arvicanthis three response types of ipRGCs (type I, II and III) which are distinguished by their light sensitivity, response strength, latency and duration. Type I ipRGCs exhibited a high sensitivity to short light flashes and showed, contrary to mouse type I ipRGCs, robust light responses to 10 ms flashes. The morphological, molecular and physiological analysis reveals very few differences between mouse and Arvicanthis ipRGCs. These data imply that the influence of retinal inputs in defining the temporal niche could be related to a stronger cone input into ipRGCs in the cone-rich Arvicanthis retina, and to the higher sensitivity of type I ipRGCs and elevated proportion of M1 cells.	[Karnas, Diana; Mordel, Jerome; Meissl, Hilmar] Max Planck Inst Brain Res, Neuroanat Dept, Frankfurt, Germany; [Karnas, Diana; Hicks, David; Mordel, Jerome; Pevet, Paul] Strasbourg Univ, Inst Cellular & Integrat Neurosci, CNRS, UPR 3212, Strasbourg, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hicks, D (corresponding author), Strasbourg Univ, Inst Cellular & Integrat Neurosci, CNRS, UPR 3212, Strasbourg, France.	photoreceptor67@hotmail.com; hilmar.meissl@brain.mpg.de			Max Planck Society, Munchen [367]; CNRS, Paris	Max Planck Society, Munchen(Max Planck Society); CNRS, Paris(Centre National de la Recherche Scientifique (CNRS))	Research was carried out within the scope of the Associated European Laboratory "European Laboratory for Circadian Research", LEA CNRS-UdS-MPG (LEA No. 367) funded by the Max Planck Society, Munchen, and CNRS, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Challet E, 2002, J BIOL RHYTHM, V17, P52, DOI 10.1177/074873002129002339; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Doyle SE, 2008, P NATL ACAD SCI USA, V105, P13133, DOI 10.1073/pnas.0801728105; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; DRAGER UC, 1984, J NEUROSCI, V4, P2025; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hut RA, 2012, PROG BRAIN RES, V199, P281, DOI 10.1016/B978-0-444-59427-3.00017-4; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Katona C, 1997, PHYSIOL BEHAV, V61, P365, DOI 10.1016/S0031-9384(96)00407-6; Klisch C, 2009, EUR J NEUROSCI, V30, P65, DOI 10.1111/j.1460-9568.2009.06794.x; KURUMIYA S, 1988, J COMP PHYSIOL A, V162, P301, DOI 10.1007/BF00606118; Mahoney MM, 2009, EUR J NEUROSCI, V30, P1537, DOI 10.1111/j.1460-9568.2009.06936.x; McNeill DS, 2008, P NATL ACAD SCI USA, V105, P12645, DOI 10.1073/pnas.0806878105; Mordel J, 2011, J PHYSIOL-LONDON, V589, P2287, DOI 10.1113/jphysiol.2010.204693; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; OKABE S, 1989, BRAIN RES, V483, P335, DOI 10.1016/0006-8993(89)90178-9; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P4202; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Ramanathan C, 2009, NEUROSCIENCE, V161, P960, DOI 10.1016/j.neuroscience.2009.04.040; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sernagor E, 2005, CURR BIOL, V15, pR556, DOI 10.1016/j.cub.2005.07.004; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Surgucheva I, 2008, MOL VIS, V14, P1540; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Todd WD, 2012, J COMP NEUROL, V520, P3277, DOI 10.1002/cne.23098; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7	63	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73343	10.1371/journal.pone.0073343	http://dx.doi.org/10.1371/journal.pone.0073343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951350	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200088
J	Tamborindeguy, C; Bereman, MS; DeBlasio, S; Igwe, D; Smith, DM; White, F; MacCoss, MJ; Gray, SM; Cilia, M				Tamborindeguy, Cecilia; Bereman, Michael S.; DeBlasio, Stacy; Igwe, David; Smith, Dawn M.; White, Frank; MacCoss, Michael J.; Gray, Stewart M.; Cilia, Michelle			Genomic and Proteomic Analysis of Schizaphis graminum Reveals Cyclophilin Proteins Are Involved in the Transmission of Cereal Yellow Dwarf Virus	PLOS ONE			English	Article							POTATO LEAFROLL-VIRUS; LUTEOVIRUS TRANSMISSION; APHID TRANSMISSION; GREENBUG HOMOPTERA; COUPLING GENETICS; COAT PROTEIN; IDENTIFICATION; ISOMERASE; BINDING; VECTOR	Yellow dwarf viruses cause the most economically important virus diseases of cereal crops worldwide and are transmitted by aphid vectors. The identification of aphid genes and proteins mediating virus transmission is critical to develop agriculturally sustainable virus management practices and to understand viral strategies for circulative movement in all insect vectors. Two cyclophilin B proteins, S28 and S29, were identified previously in populations of Schizaphis graminum that differed in their ability to transmit the RPV strain of Cereal yellow dwarf virus (CYDV-RPV). The presence of S29 was correlated with F2 genotypes that were efficient virus transmitters. The present study revealed the two proteins were isoforms, and a single amino acid change distinguished S28 and S29. The distribution of the two alleles was determined in 12 F2 genotypes segregating for CYDV-RPV transmission capacity and in 11 genetically independent, field-collected S. graminum biotypes. Transmission efficiency for CYDV-RPV was determined in all genotypes and biotypes. The S29 isoform was present in all genotypes or biotypes that efficiently transmit CYDV-RPV and more specifically in genotypes that efficiently transport virus across the hindgut. We confirmed a direct interaction between CYDV-RPV and both S28 and S29 using purified virus and bacterially expressed, his-tagged S28 and S29 proteins. Importantly, S29 failed to interact with a closely related virus that is transported across the aphid midgut. We tested for in vivo interactions using an aphid-virus co-immunoprecipitation strategy coupled with a bottom-up LC-MS/MS analysis using a Q Exactive mass spectrometer. This analysis enabled us to identify a third cyclophilin protein, cyclophilin A, interacting directly or in complex with purified CYDV-RPV. Taken together, these data provide evidence that both cyclophilin A and B interact with CYDV-RPV, and these interactions may be important but not sufficient to mediate virus transport from the hindgut lumen into the hemocoel.	[Tamborindeguy, Cecilia; DeBlasio, Stacy; Smith, Dawn M.; Gray, Stewart M.; Cilia, Michelle] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Bereman, Michael S.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Igwe, David] Int Inst Trop Agr, Virol & Mol Diagnost Unit, Ibadan, Nigeria; [White, Frank] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Cornell University; United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle; CGIAR; International Institute of Tropical Agriculture (IITA); Kansas State University	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@ag.tamu.edu; mlc68@cornell.edu			United States Department of Agriculture [1907-22000-018-13, 2005-35604-15446]; NSF-BREAD grant [1109989]; Kansas State University Arthropod Genomics Center Seed Grant; National Institutes of Health [2R01GM086688-03, 5R01RR023334-04, 7S10RR025107]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023334, S10RR025107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086688] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1109989] Funding Source: National Science Foundation	United States Department of Agriculture(United States Department of Agriculture (USDA)); NSF-BREAD grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kansas State University Arthropod Genomics Center Seed Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was graciously funded by United States Department of Agriculture grants 1907-22000-018-13, 2005-35604-15446, NSF-BREAD grant 1109989, a Kansas State University Arthropod Genomics Center Seed Grant, and National Institutes of Health grants 2R01GM086688-03, 5R01RR023334-04, and 7S10RR025107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bose S, 2003, J GEN VIROL, V84, P1687, DOI 10.1099/vir.0.19074-0; Brault W, 2005, J VIROL, V79, P9685, DOI 10.1128/JVI.79.15.9685-9693.2005; Burd JD, 2006, J ECON ENTOMOL, V99, P959, DOI 10.1603/0022-0493-99.3.959; Burrows ME, 2007, HEREDITY, V98, P106, DOI 10.1038/sj.hdy.6800909; Burrows ME, 2006, PHYTOPATHOLOGY, V96, P828, DOI 10.1094/PHYTO-96-0828; Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chavez JD, 2012, J PROTEOME RES, V11, P2968, DOI 10.1021/pr300041t; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Cilia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048177; Cilia M, 2011, PROTEOMICS, V11, P2440, DOI 10.1002/pmic.201000519; Cristea I.M., 2011, COLD SPRING HARB PRO, V2011; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; GARRET A, 1993, ARCH VIROL, V131, P377, DOI 10.1007/BF01378639; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gildow F.E., 1999, LUTEOVIRIDAE, P88; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P270, DOI 10.1094/Phyto-83-270; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 2002, PHYTOPATHOLOGY, V92, P970, DOI 10.1094/PHYTO.2002.92.9.970; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; Herrbach E., 1999, LUTEOVIRIDAE, P85; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Katsar C, 1999, MAINTENANCE OF HUMAN, ANIMAL, AND PLANT PATHOGEN VECTORS, P181; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lee L, 2005, J VIROL, V79, P1207, DOI 10.1128/JVI.79.2.1207-1214.2005; Li CY, 2001, VIROLOGY, V286, P125, DOI 10.1006/viro.2001.0929; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Miller W.A., 1999, ENCY VIROLOGY, P901; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Porter DR, 1997, J ECON ENTOMOL, V90, P1055, DOI 10.1093/jee/90.5.1055; Power Alison G., 1995, P259; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; ROBINSON AB, 1974, P NATL ACAD SCI USA, V71, P885, DOI 10.1073/pnas.71.3.885; SCHILLING B, 2012, MOL CELL PROTEOMICS; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Shufran KA, 2000, INSECT MOL BIOL, V9, P179, DOI 10.1046/j.1365-2583.2000.00177.x; Simon JC, 2011, J HERED, V102, P512, DOI 10.1093/jhered/esr020; SMITH HG, 1999, LUTEOVIRIDAE, P297; Srinivasan DG, 2012, GENET RES INT, V2012, DOI 10.1155/2012/431531; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TAKEMURA T, 2013, J VIROL; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; VANDENHEUVEL JFJM, 1993, PHYTOPATHOLOGY, V83, P1125, DOI 10.1094/Phyto-83-1125; Wang XF, 2003, CHINESE SCI BULL, V48, P2083, DOI 10.1360/03wc0153; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07	55	32	32	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71620	10.1371/journal.pone.0071620	http://dx.doi.org/10.1371/journal.pone.0071620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951206	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200060
J	Wu, J; Xue, K; Li, HY; Sun, JY; Liu, K				Wu, Jun; Xue, Ke; Li, Haiyan; Sun, Junying; Liu, Kai			Improvement of PHBV Scaffolds with Bioglass for Cartilage Tissue Engineering	PLOS ONE			English	Article							MACROPOROUS POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) MATRICES; IN-VITRO; COMPOSITE SCAFFOLDS; CHONDROCYTES; BONE; CELLS; SURFACES; POLYMER; CULTURE; GROWTH	Polymer scaffold systems consisting of poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) have proven to be possible matrices for the three-dimensional growth of chondrocyte cultures. However, the engineered cartilage grown on these PHBV scaffolds is currently unsatisfactory for clinical applications due to PHBV's poor hydrophilicity, resulting in inadequate thickness and poor biomechanical properties of the engineered cartilage. It has been reported that the incorporation of Bioglass (BG) into PHBV can improve the hydrophilicity of the composites. In this study, we compared the effects of PHBV scaffolds and PHBV/BG composite scaffolds on the properties of engineered cartilage in vivo. Rabbit articular chondrocytes were seeded into PHBV scaffolds and PHBV/BG scaffolds. Short-term in vitro culture followed by long-term in vivo transplantation was performed to evaluate the difference in cartilage regeneration between the cartilage layers grown on PHBV and PHBV/BG scaffolds. The results show that the incorporation of BG into PHBV efficiently improved both the hydrophilicity of the composites and the percentage of adhered cells and promoted cell migration into the inner part the constructs. With prolonged incubation time in vivo, the chondrocyte-scaffold constructs in the PHBV/BG group formed thicker cartilage-like tissue with better biomechanical properties and a higher cartilage matrix content than the constructs in the PHBV/BG group. These results indicate that PHBV/BG scaffolds can be used to prepare better engineered cartilage than pure PHBV.	[Wu, Jun; Sun, Junying] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China; [Wu, Jun] First Peoples Hosp Changzhou, Dept Orthoped, Changzhou, Jiangsu, Peoples R China; [Xue, Ke; Liu, Kai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Li, Haiyan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Med X Res Inst, Shanghai 200030, Peoples R China	Soochow University - China; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, JY (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.	sun_junying@hotmail.com; drkailiu@126.com	Xue, Ke/GRX-6020-2022	xue, ke/0000-0001-5347-2712; Li, Haiyan/0000-0002-7423-2715	Changzhou Health Bureau [ZD201008]; National Natural Science Foundation of China [81272128]	Changzhou Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the research grant of the Changzhou Health Bureau (ZD201008) and the National Natural Science Foundation of China (81272128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.3.CO;2-W; Bal BS, 2010, J BIOMED MATER RES B, V93B, P164, DOI 10.1002/jbm.b.31571; Bastiaansen-Jenniskens YM, 2008, OSTEOARTHR CARTILAGE, V16, P359, DOI 10.1016/j.joca.2007.07.003; BJORNSSON S, 1993, ANAL BIOCHEM, V210, P282, DOI 10.1006/abio.1993.1197; Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9; Carey J, 2000, J BIOMED MATER RES, V51, P711, DOI 10.1002/1097-4636(20000915)51:4<711::AID-JBM20>3.0.CO;2-Z; Chu CR, 1997, CLIN ORTHOP RELAT R, P220; Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104; Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010; Gugala Z, 2004, BIOMATERIALS, V25, P2299, DOI 10.1016/j.biomaterials.2003.09.009; GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901; HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411; Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8; KATO Y, 1984, J CELL PHYSIOL, V120, P354, DOI 10.1002/jcp.1041200314; Ke Y, 2010, ACTA BIOMATER, V6, P1329, DOI 10.1016/j.actbio.2009.10.026; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037; Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4; Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0; Li HY, 2008, J MATER SCI-MATER M, V19, P67, DOI 10.1007/s10856-007-3170-y; Li HY, 2005, J BIOMATER APPL, V20, P137, DOI 10.1177/0885328205049472; Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052; Liang HJ, 1999, LIFE SCI, V65, P1163, DOI 10.1016/S0024-3205(99)00350-1; Liu JO, 2010, J BIOMED MATER RES A, V94A, P603, DOI 10.1002/jbm.a.32730; LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0; Mikic B, 2004, ANN BIOMED ENG, V32, P18, DOI 10.1023/B:ABME.0000007787.39262.a7; Moroni L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003032; Nehrer S, 1997, J BIOMED MATER RES, V38, P95; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K; Sun JY, 2005, EUR POLYM J, V41, P2443, DOI 10.1016/j.eurpolymj.2005.04.039; Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.3.CO;2-1; Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8; VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; Wang AH, 2012, J BIOMED MATER RES A, V100A, P1505, DOI 10.1002/jbm.a.34034; Wang YJ, 2006, J BIOMED MATER RES A, V76A, P589, DOI 10.1002/jbm.a.30575; Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	41	39	42	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71563	10.1371/journal.pone.0071563	http://dx.doi.org/10.1371/journal.pone.0071563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951190	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200055
J	Zaidi, N; Ajmal, MR; Rabbani, G; Ahmad, E; Khan, RH				Zaidi, Nida; Ajmal, Mohammad Rehan; Rabbani, Gulam; Ahmad, Ejaz; Khan, Rizwan Hasan			A Comprehensive Insight into Binding of Hippuric Acid to Human Serum Albumin: A Study to Uncover Its Impaired Elimination through Hemodialysis	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; INDOXYL SULFATE; CRYSTAL-STRUCTURE; UREMIC TOXINS; CALORIMETRY; SPECTROSCOPY; STABILITY; PROTEINS; BOVINE; SYSTEM	Binding of hippuric acid (HA), a uremic toxin, with human serum albumin (HSA) has been examined by isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), molecular docking, circular dichroism (CD) and fluorescence spectroscopy to understand the reason that govern its impaired elimination through hemodialysis. ITC results shows that the HA binds with HSA at high (K-b similar to 10(4)) and low affinity (K-b similar to 10(3)) sites whereas spectroscopic results predict binding at a single site (K-b similar to 10(3)). The HA form complex with HSA that involves electrostatic, hydrogen and hydrophobic binding forces as illustrated by calculated thermodynamic parameters. Molecular docking and displacement studies collectively revealed that HA bound to both site I and site II; however, relatively strongly to the later. Esterase-like activity of HSA confirms the involvement of Arg410 and Tyr411 of Sudlow site II in binding of HA. CD results show slight conformational changes occurs in the protein upon ligation that may be responsible for the discrepancy in van't Hoff and calorimetric enthalpy change. Furthermore, an increase in T-m(1) and T-m(2) is observed from DSC results that indicate increase in stability of HSA upon binding to HA. The combined results provide that HA binds to HSA and thus its elimination is hindered.	[Zaidi, Nida; Ajmal, Mohammad Rehan; Rabbani, Gulam; Ahmad, Ejaz; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Ahmad, Ejaz/L-1506-2013; Khan, Rehan/AAR-4803-2020; Rabbani, Gulam/AAE-5629-2022; Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014	Ahmad, Ejaz/0000-0002-5713-6713; Khan, Rehan/0000-0001-8724-5788; Rabbani, Gulam/0000-0002-5293-8231; Khan, Rizwan Hasan/0000-0002-9965-8982; Zaidi, Dr Nida/0000-0003-2579-2190; khan, mohammad rehan ajmal/0000-0002-2480-9379	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to NZ in the form of a Senior Research Fellowship was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2012, DISC STUD MOD ENV RE; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Anand U, 2010, J PHYS CHEM B, V114, P15839, DOI 10.1021/jp106703h; BOUMENDILPODEVIN EF, 1975, J CLIN INVEST, V55, P1142, DOI 10.1172/JCI108031; Celej MS, 2006, ANAL BIOCHEM, V350, P277, DOI 10.1016/j.ab.2005.12.029; Celej MS, 2006, BIOCHIM BIOPHYS ACTA, V1750, P122; Chi ZX, 2011, BIOMACROMOLECULES, V12, P203, DOI 10.1021/bm1011568; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Dzurik R, 2001, KIDNEY INT, V59, pS278; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hu YJ, 2009, BIOMACROMOLECULES, V10, P517, DOI 10.1021/bm801120k; Hung HC, 2001, BIOPHYS J, V81, P3456, DOI 10.1016/S0006-3495(01)75977-2; Keswani N, 2010, J BIOCHEM, V148, P71, DOI 10.1093/jb/mvq035; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P277, DOI DOI 10.1007/978-1-4757-3061-6; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P282; Miyamoto Y, 2010, FEBS LETT, V584, P2816, DOI 10.1016/j.febslet.2010.04.046; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Neelam S, 2010, J PHYS CHEM B, V114, P3005, DOI 10.1021/jp910156k; Niwa T, 1996, SEMIN NEPHROL, V16, P167; Ohtsuki S, 2002, J NEUROCHEM, V83, P57, DOI 10.1046/j.1471-4159.2002.01108.x; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Rezaei-Tavirani M, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI 10.5483/BMBRep.2006.39.5.530; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sharma R, 2012, EUR J PHARM SCI, V46, P435, DOI 10.1016/j.ejps.2012.03.007; SPUSTOVA V, 1991, PHYSIOL RES, V40, P599; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Thoppil AA, 2008, BIOPOLYMERS, V89, P831, DOI 10.1002/bip.21021; Tian JN, 2004, BIOMACROMOLECULES, V5, P1956, DOI 10.1021/bm049668m; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uversky VN, 1997, BIOCHEMISTRY-US, V36, P13638, DOI 10.1021/bi970332p; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; VANHOLDER RC, 1992, CLIN CHEM, V38, P1429; Varshney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017230; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Zaidi N, 2013, J PHYS CHEM B, V117, P2595, DOI 10.1021/jp3069877; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	42	110	114	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71422	10.1371/journal.pone.0071422	http://dx.doi.org/10.1371/journal.pone.0071422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951159	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200046
J	Megevand, P; Molholm, S; Nayak, A; Foxe, JJ				Megevand, Pierre; Molholm, Sophie; Nayak, Ashabari; Foxe, John J.			Recalibration of the Multisensory Temporal Window of Integration Results from Changing Task Demands	PLOS ONE			English	Article							RACE MODEL INEQUALITY; ORDER JUDGMENTS; REACTION-TIME; AUDIOVISUAL SYNCHRONY; STIMULUS ONSET; PERCEPTION; SIMULTANEITY; ATTENTION; SPEECH; HUMANS	The notion of the temporal window of integration, when applied in a multisensory context, refers to the breadth of the interval across which the brain perceives two stimuli from different sensory modalities as synchronous. It maintains a unitary perception of multisensory events despite physical and biophysical timing differences between the senses. The boundaries of the window can be influenced by attention and past sensory experience. Here we examined whether task demands could also influence the multisensory temporal window of integration. We varied the stimulus onset asynchrony between simple, short-lasting auditory and visual stimuli while participants performed two tasks in separate blocks: a temporal order judgment task that required the discrimination of subtle auditory-visual asynchronies, and a reaction time task to the first incoming stimulus irrespective of its sensory modality. We defined the temporal window of integration as the range of stimulus onset asynchronies where performance was below 75% in the temporal order judgment task, as well as the range of stimulus onset asynchronies where responses showed multisensory facilitation (race model violation) in the reaction time task. In 5 of 11 participants, we observed audio-visual stimulus onset asynchronies where reaction time was significantly accelerated (indicating successful integration in this task) while performance was accurate in the temporal order judgment task (indicating successful segregation in that task). This dissociation suggests that in some participants, the boundaries of the temporal window of integration can adaptively recalibrate in order to optimize performance according to specific task demands.	[Foxe, John J.] Albert Einstein Coll Med, Dept Pediat, Childrens Evaluat & Rehabil Ctr, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, Bronx, NY USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Foxe, JJ (corresponding author), Albert Einstein Coll Med, Dept Pediat, Childrens Evaluat & Rehabil Ctr, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, Bronx, NY USA.	john.foxe@einstein.yu.edu	Mégevand, Pierre/I-3829-2019	Mégevand, Pierre/0000-0002-0427-547X; Molholm, Sophie/0000-0002-0094-4015; Foxe, John/0000-0002-4300-3098	U.S. National Institute of Mental Health (NIMH) [RO1 - MH085322]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD P30 HD071593]; Swiss National Science Foundation [PBGEP3_139829]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085322] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by a grant from the U.S. National Institute of Mental Health (NIMH) to JJF and SM (RO1 - MH085322). Recruitment of participants was conducted through the Human Clinical Phenotyping Core at Einstein, a facility of the RFK-IDDRC which is funded through a center grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD P30 HD071593). PM was supported by grant PBGEP3_139829 from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett DJK, 2012, EXP BRAIN RES, V222, P11, DOI 10.1007/s00221-012-3191-8; Boenke LT, 2009, EXP BRAIN RES, V198, P233, DOI 10.1007/s00221-009-1917-z; Bonath B, 2013, NEUROIMAGE, V66, P110, DOI 10.1016/j.neuroimage.2012.10.018; Brandwein AB, 2012, CEREBRAL CORTEX; Brandwein AB, 2011, CEREB CORTEX, V21, P1042, DOI 10.1093/cercor/bhq170; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cardoso-Leite P, 2007, J VISION, V7, DOI 10.1167/7.6.11; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2009, PROG BRAIN RES, V174, P119, DOI 10.1016/S0079-6123(09)01311-9; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; ERIKSEN CW, 1988, PERCEPT PSYCHOPHYS, V44, P191, DOI 10.3758/BF03208712; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gondan M, 2008, J MATH PSYCHOL, V52, P324, DOI 10.1016/j.jmp.2008.08.002; Gondan M, 2010, BEHAV RES METHODS, V42, P23, DOI 10.3758/BRM.42.1.23; Gondan M, 2009, J EXP PSYCHOL HUMAN, V35, P575, DOI 10.1037/a0013620; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Hodges DA, 2005, ANN NY ACAD SCI, V1060, P175, DOI 10.1196/annals.1360.012; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Jaskowski P, 1996, PERCEPT MOTOR SKILL, V82, P707; Kiesel A, 2007, BEHAV RES METHODS, V39, P539, DOI 10.3758/BF03193024; Kuss M, 2005, J VISION, V5, P478, DOI 10.1167/5.5.8; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Li RJ, 2010, J VISION, V10, DOI 10.1167/10.14.33; Miller J, 2006, J EXP PSYCHOL HUMAN, V32, P394, DOI 10.1037/0096-1523.32.2.394; Miller J, 2004, COGNITIVE PSYCHOL, V49, P118, DOI 10.1016/j.cogpsych.2003.12.003; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; MILLER J, 1991, PERCEPT PSYCHOPHYS, V50, P584, DOI 10.3758/BF03207544; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Moran RJ, 2008, EUR J NEUROSCI, V27, P2303, DOI 10.1111/j.1460-9568.2008.06187.x; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Neal RM, 2003, ANN STAT, V31, P705, DOI 10.1214/aos/1056562461; Neumann O, 2004, SCI PSYCH S, P245; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Noesselt T, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00064; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Rach S, 2010, ATTEN PERCEPT PSYCHO, V72, P839, DOI 10.3758/APP.72.3.839; RUTSCHMANN JACQUES, 1964, PERCEPT MOT SKILLS, V18, P345; Schwarz W, 2006, J EXP PSYCHOL HUMAN, V32, P558, DOI 10.1037/0096-1523.32.3.558; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Stevenson R. A., 2012, J EXP PSYCHOL HUM PE; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	73	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71608	10.1371/journal.pone.0071608	http://dx.doi.org/10.1371/journal.pone.0071608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23951203	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000068
J	Liu, KJ; Liu, QH; Chen, W; Liang, MJ; Luo, W; Wu, XF; Ruan, YP; Wang, J; Xu, RC; Zhan, XJ; Yu, JW; Tan, JQ; Dong, XQ; Zhang, JC; Yu, XQ				Liu, Kejin; Liu, Qinghua; Chen, Wei; Liang, Mengjun; Luo, Wei; Wu, Xianfeng; Ruan, Yiping; Wang, Jie; Xu, Ricong; Zhan, Xiaojiang; Yu, Jianwen; Tan, Jiaqing; Dong, Xiuqing; Zhang, Jincai; Yu, Xueqing			Prevalence and Risk Factors of CKD in Chinese Patients with Periodontal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; POPULATION; INFECTIONS; PREDICT; UPDATE; HEALTH	Background: Periodontal disease is common among adults and is associated with an increasing risk of chronic kidney disease (CKD). We aimed to investigate the prevalence and risk factors of CKD in patients with periodontal disease in China. Methods: In the current cross-sectional study, patients with periodontal disease were included from Guangdong Provincial Stomatological Hospital between March 2011 and August 2011. CKD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2), the presence of albuminuria, or hematuria. All patients with periodontal disease underwent a periodontal examination, including periodontal probing pocket depth, gingival recession, and clinical attachment level by Florida Probe. They completed a questionnaire and had blood and urine samples taken. The adjusted prevalence of indicators of kidney damage was calculated and risk factors associated with CKD were analyzed. Results: A total of 1392 patients with periodontal disease were invited to participate this study and 1268 completed the survey and examination. After adjusting for age and sex, the prevalence of reduced eGFR, albuminuria, and hematuria was 2.7% (95% CI 1.7-3.7), 6.7% (95% CI 5.5-8.1) and 10.9% (95% CI 9.2-12.5), respectively. The adjusted prevalence of CKD was 18.2% (95% CI 16.2-20.3). Age, male, diabetes, hypertension, history of CKD, hyperuricemia, and interleukin-6 levels (>= 7.54 ng/L) were independent risk factors for reduced eGFR. Female, diabetes, hypertension, history of CKD, hyperuricemia, high level of cholesterol, and high sensitivity C-reactive protein (hsCRP) (>= 1.03 mg/L) and TNF-alpha levels (>= 1.12 ng/L) were independently associated with an increased risk of albuminuria. Female, lower education (<high school), and history of CKD were independent risk factors for hematuria. Conclusions: 18.2% of Chinese patients with periodontal disease have proteinuria, hematuria, or reduced eGFR, indicating the presence of kidney damage. Whether prevention or treatment of periodontal disease can reduce the high prevalence of CKD, however, remains to be further investigated.	[Liu, Qinghua; Chen, Wei; Liang, Mengjun; Wu, Xianfeng; Ruan, Yiping; Wang, Jie; Xu, Ricong; Zhan, Xiaojiang; Yu, Jianwen; Tan, Jiaqing; Dong, Xiuqing; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Minist Hlth, Dept Nephrol,Key Lab Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Kejin; Luo, Wei; Zhang, Jincai] Southern Med Univ, Guangdong Prov Stomatol Hosp, Dept Periodontol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Liu, QH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Minist Hlth, Dept Nephrol,Key Lab Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	fylqh1234@126.com		, xianfeng/0000-0001-7447-5189	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B05]; Guangzhou Committee of Science and Technology, China [2010U1-E00831]; 5010 clinical Program of Sun Yat-sen University [2007007]; Scientific and Technologic Committee of Guangdong province [2010B031600117, 2011B080701088]; Medical Scientific Research Foundation of Guangdong Province [B2011035]; Doctoral Program of Higher Education of China [20100171120067]; Natural Science Foundation of Guangdong Province [10451008901005957]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Guangzhou Committee of Science and Technology, China; 5010 clinical Program of Sun Yat-sen University; Scientific and Technologic Committee of Guangdong province; Medical Scientific Research Foundation of Guangdong Province; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2011BAI10B05); Guangzhou Committee of Science and Technology, China (Grant No 2010U1-E00831), and 5010 clinical Program of Sun Yat-sen University (Grant No 2007007) to Xueqing Yu. Jincai Zhang was supported by grants from the Scientific and Technologic Committee of Guangdong province (No. 2010B031600117). Kejin Liu was supported by grants from the Scientific and Technologic Committee of Guangdong province (No. 2011B080701088) and Medical Scientific Research Foundation of Guangdong Province (B2011035). Qinghua Liu was supported by grants from Doctoral Program of Higher Education of China (20100171120067) and Natural Science Foundation of Guangdong Province (10451008901005957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baboolal K, 1998, AM J KIDNEY DIS, V31, P971, DOI 10.1053/ajkd.1998.v31.pm9631841; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Beck JD, 1999, AM HEART J, V138, pS528, DOI 10.1016/S0002-8703(99)70293-0; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Caps MT, 1998, KIDNEY INT, V53, P735, DOI 10.1046/j.1523-1755.1998.00805.x; Chambrone L, 2013, J CLIN PERIODONTOL, V40, P443, DOI 10.1111/jcpe.12067; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Deepa R, 2012, J Indian Soc Periodontol, V16, P74, DOI 10.4103/0972-124X.94609; Ebersole JL, 2000, PERIODONTOL 2000, V23, P19, DOI 10.1034/j.1600-0757.2000.2230103.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fisher MA, 2008, AM J KIDNEY DIS, V51, P45, DOI 10.1053/j.ajkd.2007.09.018; Forman JP, 2008, J AM SOC NEPHROL, V19, P1983, DOI 10.1681/ASN.2008010038; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hu DY, 2011, INT J ORAL SCI, V3, P7, DOI 10.4248/IJOS11006; Kshirsagar AV, 2005, AM J KIDNEY DIS, V45, P650, DOI 10.1053/j.ajkd.2004.12.009; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MAILLOUX LU, 1994, AM J KIDNEY DIS, V24, P622, DOI 10.1016/S0272-6386(12)80223-X; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Slots J, 2003, INT DENT J, V53, P200, DOI 10.1111/j.1875-595X.2003.tb00771.x; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang WR, 2012, HYPERTENSION, V59, P136, DOI 10.1161/HYPERTENSIONAHA.111.173328	27	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70767	10.1371/journal.pone.0070767	http://dx.doi.org/10.1371/journal.pone.0070767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951003	gold, Green Submitted, Green Published			2022-12-27	WOS:000323109700053
J	Walker, EJ; Younessi, P; Fulcher, AJ; McCuaig, R; Thomas, BJ; Bardin, PG; Jans, DA; Ghildyal, R				Walker, Erin J.; Younessi, Parisa; Fulcher, Alex J.; McCuaig, Robert; Thomas, Belinda J.; Bardin, Philip G.; Jans, David A.; Ghildyal, Reena			Rhinovirus 3C Protease Facilitates Specific Nucleoporin Cleavage and Mislocalisation of Nuclear Proteins in Infected Host Cells	PLOS ONE			English	Article							PORE COMPLEX PROTEINS; VIRUS MATRIX PROTEIN; NUCLEOCYTOPLASMIC TRAFFICKING; CYTOPLASMIC RELOCALIZATION; POLIOVIRUS INFECTION; IMPORT; LOCALIZATION; PERMEABILITY; INHIBITION; NUCLEOLIN	Human Rhinovirus (HRV) infection results in shut down of essential cellular processes, in part through disruption of nucleocytoplasmic transport by cleavage of the nucleoporin proteins (Nups) that make up the host cell nuclear pore. Although the HRV genome encodes two proteases (2A and 3C) able to cleave host proteins such as Nup62, little is known regarding the specific contribution of each. Here we use transfected as well as HRV-infected cells to establish for the first time that 3C protease is most likely the mediator of cleavage of Nup153 during HRV infection, while Nup62 and Nup98 are likely to be targets of HRV2A protease. HRV16 3C protease was also able to elicit changes in the appearance and distribution of the nuclear speckle protein SC35 in transfected cells, implicating it as a key mediator of the mislocalisation of SC35 in HRV16-infected cells. In addition, 3C protease activity led to the redistribution of the nucleolin protein out of the nucleolus, but did not affect nuclear localisation of hnRNP proteins, implying that complete disruption of nucleocytoplasmic transport leading to relocalisation of hnRNP proteins from the nucleus to the cytoplasm in HRV-infected cells almost certainly requires 2A in addition to 3C protease. Thus, a specific role for HRV 3C protease in cleavage and mislocalisation of host cell nuclear proteins, in concert with 2A, is implicated for the first time in HRV pathogenesis.	[Walker, Erin J.; Younessi, Parisa; McCuaig, Robert; Ghildyal, Reena] Univ Canberra, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia; [Fulcher, Alex J.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Thomas, Belinda J.; Bardin, Philip G.] Monash Med Ctr, Monash Inst Med Res & Monash Lung & Sleep, Clayton, Vic 3168, Australia	University of Canberra; Monash University; Monash University	Ghildyal, R (corresponding author), Univ Canberra, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia.	Reena.Ghildyal@canberra.edu.au	Walker, Erin J/H-5302-2013	Walker, Erin J/0000-0001-8476-7302; McCuaig, Robert D./0000-0003-0124-4173; Ghildyal, Reena/0000-0002-3147-4976; Jans, David/0000-0001-5115-4745	National Health and Medical Research Council (Australia) [APP545844, APP1027312, APP1002486]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by National Health and Medical Research Council (Australia) project (APP545844 and APP1027312) grants and SPRF1 fellowship (to DAJ; APP1002486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvisi G, 2008, BBA-PROTEINS PROTEOM, V1784, P213, DOI 10.1016/j.bbapap.2007.08.021; Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Binford SL, 2005, ANTIMICROB AGENTS CH, V49, P619, DOI 10.1128/AAC.49.2.619-626.2005; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Cancio-Lonches C, 2011, J VIROL, V85, P8056, DOI 10.1128/JVI.01878-10; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fridell RA, 1997, J CELL SCI, V110, P1325; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2005, J MED VIROL, V75, P608, DOI 10.1002/jmv.20315; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hames B.D., 1998, GEL ELECTROPHORESIS, V4th ed.; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kaur B, 1998, BRIT MED J, V316, P118; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lidsky PV, 2006, J VIROL, V80, P2705, DOI 10.1128/JVI.80.6.2705-2717.2006; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Mahy B.W., 1996, VIROLOGY METHODS MAN, P25; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nagy PD, 2011, VIROLOGY, V411, P374, DOI 10.1016/j.virol.2010.12.061; Niepmann M, 2010, BIOCH BIOPHYS ACTA G, V1789, P529; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; See H, 2008, PAEDIATR RESPIR REV, V9, P243, DOI 10.1016/j.prrv.2008.04.001; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003	42	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71316	10.1371/journal.pone.0071316	http://dx.doi.org/10.1371/journal.pone.0071316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951130	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700094
J	Guerif, F; McKeegan, P; Leese, HJ; Sturmey, RG				Guerif, Fabrice; McKeegan, Paul; Leese, Henry J.; Sturmey, Roger G.			A Simple Approach for COnsumption and RElease (CORE) Analysis of Metabolic Activity in Single Mammalian Embryos	PLOS ONE			English	Article							AMINO-ACID TURNOVER; PREIMPLANTATION MOUSE EMBRYOS; NEAR-INFRARED SPECTROSCOPY; NONINVASIVE MEASUREMENT; PYRUVATE UPTAKE; GLUCOSE-UPTAKE; ENERGY-METABOLISM; BOVINE EMBRYOS; VIABILITY; BLASTOCYST	Non-invasive assay of the consumption and release of metabolites by individual human embryos could allow selection at the cleavage stage of development and facilitate Single Embryo Transfer in clinical IVF but will require simple, high throughput, sensitive methods applicable to small volume samples. A rapid, simple, non-invasive method has therefore been devised using a standard fluorescence plate reader, and used to measure the consumption of pyruvate and glucose, and release of lactate by single bovine embryos at all stages of preimplantation development in culture; amino acid profiles have been determined using HPLC. Early embryos with an 'intermediate' level (6.14 +/- 0.27 pmol/embryo/h) of pyruvate uptake were associated with the highest rate (68.3%) of blastocyst development indicating that a mid "optimum" range of pyruvate consumption correlates with high viability in this bovine model.	[Guerif, Fabrice; McKeegan, Paul; Leese, Henry J.; Sturmey, Roger G.] Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Guerif, Fabrice] CHRU Tours, Serv Med & Biol Reprod, Tours, France; [Guerif, Fabrice] Univ Tours, Tours, France; [Guerif, Fabrice] INRA, PRC UMR85, F-37380 Nouzilly, France	University of Hull; University of York - UK; CHU Tours; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Sturmey, RG (corresponding author), Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England.	Roger.Sturmey@hyms.ac.uk	McKeegan, Paul/O-7160-2019	McKeegan, Paul/0000-0002-5318-2317; Sturmey, Roger/0000-0003-4423-5058	Hull York Medical School; Hospital of Tours, France; Medical Research Council [G0802556] Funding Source: researchfish; MRC [G0802556] Funding Source: UKRI	Hull York Medical School; Hospital of Tours, France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge the Hull York Medical School and The Hospital of Tours, France, for funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1969, EXP CELL RES, V54, P205, DOI 10.1016/0014-4827(69)90234-1; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Butcher L, 1998, BIOL REPROD, V58, P1054, DOI 10.1095/biolreprod58.4.1054; CONAGHAN J, 1993, J ASSIST REPROD GEN, V10, P21, DOI 10.1007/BF01204436; Fernandez-Gonzalez R, 2007, MOL REPROD DEV, V74, P1149, DOI 10.1002/mrd.20746; Gardner DK, 2011, HUM REPROD, V26, P1981, DOI 10.1093/humrep/der143; GARDNER DK, 1987, J EXP ZOOL, V242, P103, DOI 10.1002/jez.1402420115; GARDNER DK, 1986, HUM REPROD, V1, P25, DOI 10.1093/oxfordjournals.humrep.a136336; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; GOTT AL, 1990, HUM REPROD, V5, P104, DOI 10.1093/oxfordjournals.humrep.a137028; Guerif F, 2009, HUM REPROD, V24, P1051, DOI 10.1093/humrep/dep018; Hardarson T, 2012, HUM REPROD, V27, P89, DOI 10.1093/humrep/der373; HARDY K, 1989, HUM REPROD, V4, P188, DOI 10.1093/oxfordjournals.humrep.a136869; Harper J, 2012, HUM REPROD, V27, P303, DOI 10.1093/humrep/der414; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Krisher RL, 2012, MOL REPROD DEV, V79, P311, DOI 10.1002/mrd.22037; Leary C., 2012, PRACTICAL MANUAL VIT, P431, DOI [10.1007/978-1-4419-1780-5_47, DOI 10.1007/978-1-4419-1780-5_47]; Leese HJ, 2007, HUM REPROD, V22, P3047, DOI 10.1093/humrep/dem253; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; LEESE HJ, 1987, HUM REPROD, V2, P435, DOI 10.1093/oxfordjournals.humrep.a136564; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Leese HJ, 1989, MONOGRAPH BLASTOCYST; Leese HJ, 1989, EARLY EMBRYO DEV PAR; Lonergan P, 2003, Reprod Biomed Online, V7, P657; Lopes AS, 2005, REPRODUCTION, V130, P669, DOI 10.1530/rep.1.00703; LU KH, 1987, VET REC, V121, P259, DOI 10.1136/vr.121.11.259; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; Orsi NM, 2004, THERIOGENOLOGY, V61, P561, DOI 10.1016/S0093-691X(03)00206-1; ROGERS PAW, 1983, INT J MICROCIRC, V2, P241; Seli E, 2007, FERTIL STERIL, V88, P1350, DOI 10.1016/j.fertnstert.2007.07.1390; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Sturmey RG, 2008, REPROD BIOMED ONLINE, V17, P486, DOI 10.1016/S1472-6483(10)60234-9; Thompson JG, 2002, HUM REPROD, V17, P2783, DOI 10.1093/humrep/17.11.2783; Thompson JG, 1996, J REPROD FERTIL, V106, P299, DOI 10.1530/jrf.0.1060299; Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866; TURNER K, 1994, HUM REPROD, V9, P2362, DOI 10.1093/oxfordjournals.humrep.a138453; Vergouw CG, 2008, HUM REPROD, V23, P1499, DOI 10.1093/humrep/den111	43	45	45	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e67834	10.1371/journal.pone.0067834	http://dx.doi.org/10.1371/journal.pone.0067834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967049	gold, Green Published, Green Submitted			2022-12-27	WOS:000323378000002
J	Rohlfs, RV; Murphy, E; Song, YS; Slatkin, M				Rohlfs, Rori V.; Murphy, Erin; Song, Yun S.; Slatkin, Montgomery			The Influence of Relatives on the Efficiency and Error Rate of Familial Searching	PLOS ONE			English	Article							GENETIC RESEARCH; DNA; ISSUES	We investigate the consequences of adopting the criteria used by the state of California, as described by Myers et al. (2011), for conducting familial searches. We carried out a simulation study of randomly generated profiles of related and unrelated individuals with 13-locus CODIS genotypes and YFiler (R) Y-chromosome haplotypes, on which the Myers protocol for relative identification was carried out. For Y-chromosome sharing first degree relatives, the Myers protocol has a high probability (80 similar to 99%) of identifying their relationship. For unrelated individuals, there is a low probability that an unrelated person in the database will be identified as a first-degree relative. For more distant Y-haplotype sharing relatives (half-siblings, first cousins, half-first cousins or second cousins) there is a substantial probability that the more distant relative will be incorrectly identified as a first-degree relative. For example, there is a 3 similar to 18% probability that a first cousin will be identified as a full sibling, with the probability depending on the population background. Although the California familial search policy is likely to identify a first degree relative if his profile is in the database, and it poses little risk of falsely identifying an unrelated individual in a database as a first-degree relative, there is a substantial risk of falsely identifying a more distant Y-haplotype sharing relative in the database as a first-degree relative, with the consequence that their immediate family may become the target for further investigation. This risk falls disproportionately on those ethnic groups that are currently overrepresented in state and federal databases.	[Rohlfs, Rori V.; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Murphy, Erin] NYU, Sch Law, New York, NY 10003 USA; [Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Song, Yun S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; New York University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rohlfs, RV (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rrohlfs@berkeley.edu		Rohlfs, Rori/0000-0002-2625-192X	National Institutes of Health [R01-GM40282]; National Science Foundation [1103767]; CAREER [DBI-0846015]; Packard Fellowship for Science and Engineering; Filomen D'Agostino; Max E. Greenberg Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CAREER(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; Filomen D'Agostino; Max E. Greenberg Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant R01-GM40282, National Science Foundation award 1103767 and CAREER Grant DBI-0846015, a Packard Fellowship for Science and Engineering, and the Filomen D'Agostino and Max E. Greenberg Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2009, INT J CULT PROP, V16, P213, DOI 10.1017/S094073910909016X; [Anonymous], 2006, INTERIM PLAN RELEASE; [Anonymous], 2007, NOT SO PERFECT MATCH; Applied Biosystems, YFILER HAPL DAT; Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; Asociacion ANDES, 2011, GEN PROJ HUNTS LAST; Balding DJ, 2013, FORENSIC SCI INT-GEN, V7, P52, DOI 10.1016/j.fsigen.2012.06.001; Bieber FR, 2006, SCIENCE, V312, P1315, DOI 10.1126/science.1122655; Buckleton J., 2005, FORENSIC DNA EVIDENC; Budowle B, 1998, 9 INT S HUM ID, V1, P64; Butler JM, 2012, ADVANCED TOPICS IN FORENSIC DNA TYPING: METHODOLOGY, P1; California Department of Corrections and Rehabilitation, 2008, TOT I POP OFF ETHN G; California Department of Justice Division of Law Enforcement, 2008, INFORM B; Curran JM, 2008, SCI JUSTICE, V48, P164, DOI 10.1016/j.scijus.2008.04.004; Dalton R, 2002, NATURE, V420, P111, DOI 10.1038/420111a; FBI, 2012, CODIS NDIS STAT; Garrison N, 2013, NATURE REV GENETICS, V14; Gershaw CJ, 2011, FORENSIC SCI INT-GEN, V5, P16, DOI 10.1016/j.fsigen.2010.07.005; Global Privacy and Information Quality Working Group (QPIQWG), 2011, INTR FAM DNA SEARCH; Goering S, 2008, HASTINGS CENT REP, V38, P43, DOI 10.1353/hcr.2008.0027; Greely HT, 2006, J LAW MED ETHICS, V34, P248, DOI 10.1111/j.1748-720X.2006.00031.x; Grimm DJ, 2007, COLUMBIA LAW REV, V107, P1164; Hicks T, 2010, FORENSIC SCI INT-GEN, V4, P316, DOI 10.1016/j.fsigen.2009.11.006; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Konzak K, 2011, 22 INT S HUM ID FAM; Krane DE, 2009, SCIENCE, V326, P1631, DOI 10.1126/science.326.5960.1631; McInnes RR, 2011, AM J HUM GENET, V88, P254, DOI 10.1016/j.ajhg.2011.02.014; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Murphy E, 2010, MICH LAW REV, V109, P291; Myers SP, 2011, FORENSIC SCI INT-GEN, V5, P493, DOI 10.1016/j.fsigen.2010.10.010; Nakashima E., 2008, WASHINGTON POST; *NAT RES COUNC, 1996, EV FOR DNA EV; Netherlands Ministry of Security and Justice, 2011, SEN AGR DNA REL TEST; O'Connor K, 2010, 21 INT S HUM ID FAM; O'Connor K, 2011, INTRO FAMILIAM SEARC; Ram N, 2011, STANFORD LAW REV, V63, P751; Reid TM, 2008, FORENSIC SCI INT-GEN, V2, P340, DOI 10.1016/j.fsigen.2008.04.008; Rohlfs RV, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002469; Rosen J, 2009, GENETIC SURVEILLANCE; Rushton S., 2010, FAMILIAL SEARCHING P; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2009, FORENSIC SCI COMMUNI, V11, P1; Slooten K, 2012, ARXIV12014261V3; Steinberger E, 2009, PROSECUTORS BRIEF, V31, P28; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; West H, 2008, 3 BUR JUST STAT; Williams R, 2005, J LAW MED ETHICS, V33, P545, DOI 10.1111/j.1748-720X.2005.tb00517.x; Wiwchar D, 2004, HA SHILTH SA    1216	47	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70495	10.1371/journal.pone.0070495	http://dx.doi.org/10.1371/journal.pone.0070495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967076	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500017
J	Cornelisse, TM; Bennett, MK; Letourneau, DK				Cornelisse, Tara M.; Bennett, Michelle K.; Letourneau, Deborah K.			The Implications of Habitat Management on the Population Viability of the Endangered Ohlone Tiger Beetle (Cicindela ohlone) Metapopulation	PLOS ONE			English	Article							QUALITY; CONSERVATION; DISTURBANCES; BUTTERFLIES; COLEOPTERA; RESPONSES; SURVIVAL; DENSITY; PATCHES; AREA	Despite their role in providing ecosystem services, insects remain overlooked in conservation planning, and insect management approaches often lack a rigorous scientific basis. The endangered Ohlone tiger beetle (Cicindela ohlone) occurs in a 24-km(2) area in Santa Cruz County, California. The once larger metapopulation now consists of subpopulations inhabiting five patches of coastal prairie where it depends on bare ground for mating, foraging, and oviposition. Human activities have eliminated natural disturbances and spread invasive grasses, reducing C. ohlone's bare-ground habitat. Management actions to restore critical beetle habitat consist of cattle and horse grazing, maintaining slow bicycle speeds on occupied public trails, and artificial creation of bare-ground plots. Recreational biking trails help maintain bare ground, but can cause beetle mortality if left unregulated. We tracked C. ohlone survivorship and estimated fecundity for three years. We then constructed a stage-structured population projection matrix model to estimate population viability among the five patches, and to evaluate the success of management interventions. We demonstrate that habitat creation, regulation of bicycle speed, and migration between patches increase C. ohlone survival and population viability. Our results can be directly applied to management actions for conservation outcomes that will reduce species extinction risk and promote recolonization of extirpated patches.	[Cornelisse, Tara M.; Bennett, Michelle K.; Letourneau, Deborah K.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Cornelisse, TM (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	tara.cornelisse@gmail.com			University of California Santa Cruz Open Access Fund; Robert and Patricia Switzer Foundation;  [DGE-0947923];  [NSFGK-12]	University of California Santa Cruz Open Access Fund; Robert and Patricia Switzer Foundation; ; 	Full funding for Open Access was provided by the University of California Santa Cruz Open Access Fund. TMC was supported by The Robert and Patricia Switzer Foundation (http://switzernetwork.org/) and NSFGK-12 DGE-0947923 (to G. Gilbert, I. Parker, D. Ash) (http://scwibles.ucsc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK., 2007, CALIFORNIA GRASSLAND, P57; Beyer LJ, 2010, BIOL CONSERV, V143, P862, DOI 10.1016/j.biocon.2009.12.031; Bonnot TW, 2011, BIOL CONSERV, V144, P2041, DOI 10.1016/j.biocon.2011.04.026; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Collinge SK, 2003, CONSERV BIOL, V17, P178, DOI 10.1046/j.1523-1739.2003.01315.x; Cooper D, 2009, OHLONE TIGER BEETLE; Cornelisse TM, 2013, J INSECT CONSERV, V17, P17, DOI 10.1007/s10841-012-9482-3; D'Antonio C., 2007, CALIFORNIA GRASSLAND, P67; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Hanski I., 1999, METAPOPULATION ECOLO; Hayes GF, 2003, APPL VEG SCI, V6, P235, DOI 10.1111/j.1654-109X.2003.tb00584.x; Heisswolf A, 2009, J INSECT CONSERV, V13, P165, DOI 10.1007/s10841-008-9139-4; Hoback WW, 2000, ECOL ENTOMOL, V25, P180, DOI 10.1046/j.1365-2311.2000.00256.x; Hodgson JA, 2009, ECOLOGY, V90, P1608, DOI 10.1890/08-1227.1; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Knisley C. B., 1997, BIOL TIGER BEETLES G; Knisley C. B., 2004, BIOL CONSERATION OHL, P34; Knisley C. Barry, 2011, Terrestrial Arthropod Reviews, V4, P41, DOI 10.1163/187498311X555706; KNISLEY CB, 1988, ECOLOGY, V69, P1983, DOI 10.2307/1941176; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; LAWTON JH, 1994, PHILOS T ROY SOC B, V344, P61, DOI 10.1098/rstb.1994.0052; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Morris W., 1999, PRACTICAL HDB POPULA; Morris W. F., 2002, QUANTITATIVE CONSERV; Pearson D. L., 2001, TIGER BEETLES; PEARSON DL, 1985, OIKOS, V45, P161, DOI 10.2307/3565701; Pearson DL, 2006, FIELD GUIDE TIGER BE; Poyry J, 2009, OECOLOGIA, V160, P577, DOI 10.1007/s00442-009-1328-7; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Schultz CB, 2003, CONSERV BIOL, V17, P1372, DOI 10.1046/j.1523-1739.2003.02141.x; SHIVASHANKAR T, 1994, BIOTROPICA, V26, P436, DOI 10.2307/2389238; Simberloff D, 1994, ACTA PALAENTOL POL, V38, P159; Sodhi NS, 2010, CONSERVATION BIOLOGY FOR ALL, P1; Takeuchi Y, 2007, POPUL ECOL, V49, P305, DOI 10.1007/s10144-007-0047-3; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tigreros Natasha, 2008, Boletin del Museo de Entomologia de la Universidad del Valle, V9, P22; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; TULJAPURKAR SD, 1982, THEOR POPUL BIOL, V21, P141, DOI 10.1016/0040-5809(82)90010-7; Wigand PE., 2007, CALIFORNIA GRASSLAND, P37	41	6	7	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71005	10.1371/journal.pone.0071005	http://dx.doi.org/10.1371/journal.pone.0071005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951067	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300072
J	Garcia-Hidalgo, J; Hormigo, D; Arroyo, M; de la Mata, I				Garcia-Hidalgo, Javier; Hormigo, Daniel; Arroyo, Miguel; de la Mata, Isabel			Novel Extracellular PHB Depolymerase from Streptomyces ascomycinicus: PHB Copolymers Degradation in Acidic Conditions	PLOS ONE			English	Article							POLY(3-HYDROXYBUTYRATE) DEPOLYMERASE; MICROBIAL-DEGRADATION; ESCHERICHIA-COLI; PENICILLIUM-SP; PURIFICATION; PROTEIN; BINDING; GENE; POLYHYDROXYALKANOATES; IDENTIFICATION	The ascomycin-producer strain Streptomyces ascomycinicus has been proven to be an extracellular poly(R)-3-hydroxybutyrate (PHB) degrader. The fkbU gene, encoding a PHB depolymerase (PhaZ(Sa)), has been cloned in E. coli and Rhodococcus sp. T104 strains for gene expression. Gram-positive host Rhodococcus sp. T104 was able to produce and secrete to the extracellular medium an active protein form. PhaZ(Sa) was purified by two hydrophobic interaction chromatographic steps, and afterwards was biochemically as well as structurally characterized. The enzyme was found to be a monomer with a molecular mass of 48.4 kDa, and displayed highest activity at 45 degrees C and pH 6, thus being the first PHB depolymerase from a gram-positive bacterium presenting an acidic pH optimum. The PHB depolymerase activity of PhaZ(Sa) was increased in the presence of divalent cations due to non-essential activation, and also in the presence of methyl-beta-cyclodextrin and PEG 3350. Protein structure was analyzed, revealing a globular shape with an alpha-beta hydrolase fold. The amino acids comprising the catalytic triad, Ser(131)-Asp(209)-His(269), were identified by multiple sequence alignment, chemical modification of amino acids and site-directed mutagenesis. These structural results supported the proposal of a three-dimensional model for this depolymerase. PhaZ(Sa) was able to degrade PHB, but also demonstrated its ability to degrade films made of PHB, PHBV copolymers and a blend of PHB and starch (7:3 proportion wt/wt). The features shown by PhaZ(Sa) make it an interesting candidate for industrial applications involving PHB degradation.	[Garcia-Hidalgo, Javier; Hormigo, Daniel; Arroyo, Miguel; de la Mata, Isabel] Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol 1, Madrid, Spain	Complutense University of Madrid	de la Mata, I (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol 1, Madrid, Spain.	isabel@bbm1.ucm.es	DE LA MATA, Isabel/I-4327-2016; García-Hidalgo, Javier/S-4356-2017; Arroyo, Miguel/C-8868-2009; Hidalgo, Javier García/I-4772-2019	DE LA MATA, Isabel/0000-0002-6637-2451; García-Hidalgo, Javier/0000-0002-1909-847X; Arroyo, Miguel/0000-0002-1593-9817; Hormigo, Daniel/0000-0003-4734-4233	European Commission [BIOPRODUCTION/NMP-2-CT- 2007-026515]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was carried out in the framework of the IP-Project "Sustainable Microbial and Biocatalytic Production of Advanced Functional Materials" (BIOPRODUCTION/NMP-2-CT- 2007-026515) funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunegg G, 1998, J BIOTECHNOL, V65, P127, DOI 10.1016/S0168-1656(98)00126-6; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; BRUCATO CL, 1991, ARCH BIOCHEM BIOPHYS, V290, P497, DOI 10.1016/0003-9861(91)90572-Z; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chen HJ, 2009, APPL ENVIRON MICROB, V75, P5290, DOI 10.1128/AEM.00621-09; Chiba K, 2007, JPN J INFECT DIS, V60, P45; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gangoiti J, 2012, APPL ENVIRON MICROB, V78, P7229, DOI 10.1128/AEM.01707-12; Garcia-Hidalgo J, 2012, APPL MICROBIOL BIOT, V93, P1975, DOI 10.1007/s00253-011-3527-5; Gebauer B, 2006, APPL ENVIRON MICROB, V72, P6094, DOI 10.1128/AEM.01184-06; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Godbole S, 2003, BIORESOURCE TECHNOL, V86, P33, DOI 10.1016/S0960-8524(02)00110-4; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hermawan S, 2010, POLYM DEGRAD STABIL, V95, P1429, DOI 10.1016/j.polymdegradstab.2010.01.002; Hernandez BS, 1997, BIODEGRADATION, V8, P153, DOI 10.1023/A:1008255218432; Hiraishi T, 2006, APPL ENVIRON MICROB, V72, P7331, DOI 10.1128/AEM.01187-06; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jendrossek D, 2007, APPL MICROBIOL BIOT, V74, P1186, DOI 10.1007/s00253-007-0860-9; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim DY, 2002, J MICROBIOL, V40, P129; Klingbeil B, 1996, FEMS MICROBIOL LETT, V142, P215; Knoll M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-89; Kumar Y, 2010, INT J SYST EVOL MICR, V60, P769, DOI 10.1099/ijs.0.012161-0; KURUSU Y, 1994, STUD POLYM SCI, V12, P357; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HY, 2006, J POLYM ENVIRON, V14, P419, DOI 10.1007/s10924-006-0031-6; LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MERGAERT J, 1993, APPL ENVIRON MICROB, V59, P3233, DOI 10.1128/AEM.59.10.3233-3238.1993; Miyazaki S, 2000, J POLYM ENVIRON, V8, P175, DOI 10.1023/A:1015245710406; NAKAYAMA K, 1985, BIOCHIM BIOPHYS ACTA, V827, P63, DOI 10.1016/0167-4838(85)90101-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oda Y, 1997, CURR MICROBIOL, V34, P230, DOI 10.1007/s002849900174; Papaneophytou CP, 2009, APPL MICROBIOL BIOT, V83, P659, DOI 10.1007/s00253-008-1842-2; Park SJ, 2012, BIOTECHNOL ADV, V30, P1196, DOI 10.1016/j.biotechadv.2011.11.007; PRIDHAM TG, 1948, J BACTERIOL, V56, P107, DOI 10.1128/JB.56.1.107-114.1948; Quiros LM, 1998, MOL MICROBIOL, V28, P1177, DOI 10.1046/j.1365-2958.1998.00880.x; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIRAKURA Y, 1983, BIOCHIM BIOPHYS ACTA, V748, P331, DOI 10.1016/0167-4838(83)90310-2; Sznajder A, 2011, APPL MICROBIOL BIOT, V89, P1487, DOI 10.1007/s00253-011-3096-7; Takeda M, 1998, J FERMENT BIOENG, V85, P375, DOI 10.1016/S0922-338X(98)80080-9; Tokiwa Y, 2007, J BIOTECHNOL, V132, P264, DOI 10.1016/j.jbiotec.2007.03.015; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Zhou HL, 2009, POLYM-PLAST TECHNOL, V48, P58, DOI 10.1080/03602550802539627	56	19	20	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71699	10.1371/journal.pone.0071699	http://dx.doi.org/10.1371/journal.pone.0071699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951224	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300144
J	Liu, X; Guo, JP; Jia, Y; Zhao, Y; Liu, X; Cheng, F; Li, XX; Zheng, Y; Shi, XH; Li, HY; Huang, CB; Cheng, YJ; Lai, B; Huang, YH; Wang, T; Ding, B; Li, ZG				Liu, Xu; Guo, Jianping; Jia, Yuan; Zhao, Yi; Liu, Xia; Cheng, Feng; Li, Xiaoxia; Zheng, Yi; Shi, Xuhua; Li, Haiyun; Huang, Cibo; Cheng, Yongjing; Lai, Bei; Huang, Yanhong; Wang, Tian; Ding, Bo; Li, ZhangGuo			HLA-DRB1 Shared Epitope-Dependent DR-DQ Haplotypes Are Associated with Both Anti-CCP-Positive and -Negative Rheumatoid Arthritis in Chinese Han	PLOS ONE			English	Article							HLA; SUSCEPTIBILITY; PREDISPOSITION; DISEASE; GENE; PROTECTION; ALLELES; PTPN22	The association between Human Leukocyte Antigen (HLA) class II and rheumatoid arthritis (RA) has been extensively studied, but few reported DR-DQ haplotype. Here we investigated the association of HLA-DRB1, DQA1, DQB1, and DR-DQ haplotypes with RA susceptibility and with anti-CCP antibodies in 281 RA patients and 297 control in Han population. High-resolution genotyping were performed. The HLA-DRB1 shared epitope (SE)-encoding allele *0405 displayed the most significant RA association (P = 1.35x10(-6)). The grouped DRB1 SE alleles showed great association with RA (P = 3.88x10(-13)). The DRB1 DRRAA alleles displayed significant protective effects (P = 0.021). The SE-dependent DR-DQ haplotype SE-DQ3/4/5 remained strong association with both anti-CCP -positive (P = 3.71x10(-13)) and -negative RA (P = 3.89x10(-5)). Our study revealed that SE alleles and its haplotypes SE-DQ3/4/5 were highly associated with RA susceptibility in Han population. The SE-DQ3/4/5 haplotypes were associated with both anti-CCP positive RA and -negative RA.	[Liu, Xu; Guo, Jianping; Jia, Yuan; Li, ZhangGuo] Peking Univ, Dept Rheumatol & Immunol, Peoples Hosp, Beijing 100871, Peoples R China; [Zhao, Yi; Li, Xiaoxia] Xuanwu Hosp Capital Med Univ, Dept Rheumatol, Beijing, Peoples R China; [Liu, Xia] China Japan Friendship Hosp, Dept Rheumatol, Beijing, Peoples R China; [Cheng, Feng] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Zheng, Yi; Shi, Xuhua; Li, Haiyun] Chao Yang Hosp, Dept Rheumatol, Beijing, Peoples R China; [Huang, Cibo; Cheng, Yongjing; Lai, Bei] Beijing Hosp, Dept Rheumatol, Minist Hlth, Beijing, Peoples R China; [Huang, Yanhong] Beijing Jishuitan Hosp, Dept Rheumatol, Beijing, Peoples R China; [Wang, Tian] Capital Med Univ, Beijing Anzhen Hosp, Dept Internal Med, Beijing, Peoples R China; [Ding, Bo] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Peking University; Capital Medical University; China-Japan Friendship Hospital; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Beijing Hospital; Capital Medical University; Karolinska Institutet	Li, ZG (corresponding author), Peking Univ, Dept Rheumatol & Immunol, Peoples Hosp, Beijing 100871, Peoples R China.	liuxu0201@gmail.com	Cheng, Feng/P-3233-2015; huang, yan/GWM-4747-2022	Cheng, Feng/0000-0003-2982-9675; Wang, Tian/0000-0001-6136-9117	National Basic Research Program of China (973 Program) [2010CB529105]; General Program of the National Natural Science Foundation of China [30901319]; Program of International Science & Technology Cooperation from MOST [2010DFB34000]; Major International Joint Research Project from Natural Science Foundation of China [81120108020]; Doctoral Fund of Ministry of Education of China [20110001110045]; Beijing Natural Science Foundation [7122196]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International Science & Technology Cooperation from MOST; Major International Joint Research Project from Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was financially supported by National Basic Research Program of China (973 Program) (No. 2010CB529105), General Program of the National Natural Science Foundation of China (No. 30901319), Program of International Science & Technology Cooperation from MOST (No: 2010DFB34000), Major International Joint Research Project from Natural Science Foundation of China (No: 81120108020), Doctoral Fund of Ministry of Education of China (No: 20110001110045) and Beijing Natural Science Foundation(No: 7122196). The funders of the manuscript had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2008, HUM MOL GENET, V17, P2274, DOI 10.1093/hmg/ddn128; Bettencourt BF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-68; Carrier N, 2009, ARTHRITIS RHEUM-US, V60, P698, DOI 10.1002/art.24353; Chun-Lai T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021069; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Jun KR, 2007, J KOREAN MED SCI, V22, P973, DOI 10.3346/jkms.2007.22.6.973; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Laivoranta-Nyman S, 2004, ANN RHEUM DIS, V63, P1406, DOI 10.1136/ard.2003.009969; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Mackie SL, 2012, GENES IMMUN, V13, P120, DOI 10.1038/gene.2011.60; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Shadick NA, 2007, ANN RHEUM DIS, V66, P1497, DOI 10.1136/ard.2006.067603; Sjoroos M, 1998, DIS MARKERS, V14, P9; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; Voorter CEM, 2005, TISSUE ANTIGENS, V65, P56, DOI 10.1111/j.1399-0039.2005.00344.x; Vos K, 2001, HUM IMMUNOL, V62, P1217, DOI 10.1016/S0198-8859(01)00315-9; Wakitani S, 1998, SCAND J RHEUMATOL, V27, P381; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P151; Zanelli E, 1996, P NATL ACAD SCI USA, V93, P1814, DOI 10.1073/pnas.93.5.1814; Zanelli E, 1997, J IMMUNOL, V158, P3545; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3	24	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71373	10.1371/journal.pone.0071373	http://dx.doi.org/10.1371/journal.pone.0071373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951149	gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300111
J	Qu, MB; Liu, T; Chen, P; Yang, Q				Qu, Mingbo; Liu, Tian; Chen, Peng; Yang, Qing			A Sperm-Plasma beta-N-Acetyl-D-Hexosaminidase Interacting with a Chitinolytic beta-N-Acetyl-D-Hexosaminidase in Insect Molting Fluid	PLOS ONE			English	Article							OSTRINIA-FURNACALIS; TOBACCO HORNWORM; EXPRESSION; PURIFICATION; ACETYLGLUCOSAMINIDASE; SEQUENCE; CLONING; BIOCHEMISTRY; SILKWORM; SYNTHASE	Insects require molting fluids to shed the old cuticle during molting. beta-N-acetyl-D-hexosaminidase, known as Hex1, together with various chitinases, is responsible for degrading the chitin component of the old cuticle. This study showed that another beta-N-acetyl-D-hexosaminidase, termed Of Hex3, interacted with Hex1 and functioned in the molting fluid, although the homolog of Of Hex3 was known as a sperm-plasma enzyme functioning in egg-sperm recognition. Of Hex3 is an enzyme cloned from the insect Asian corn borer, Ostrinia furnacalis, which is one of the most destructive pests of maize. The enzymatic activity analysis indicated that Of Hex3 was able to degrade chitooligosaccharides, but at a lower rate than that of Of Hex1. Because Of Hex3 did not have substrate inhibition, we deduced that the presence of Of Hex3 might help Of Hex1 relieve substrate inhibition during chitin degradation during molting. The expression patterns of Of Hex3 during O. furnacalis development were studied by real-time PCR as well as western blot. The results showed that both gene transcription and protein translation levels of Of Hex3 were up-regulated during larval-larval molting. The tissue-specific expression pattern analysis indicated that Of Hex3 was mostly localized in the fat body and testis. All these data further supported that Hex3 was involved in molting as well as in fertilization. This study may help to understand the complexity of cuticle degradation during insect molting, and may provide a possible target for pest control.	[Qu, Mingbo; Liu, Tian; Chen, Peng; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Dalian University of Technology	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	qingyang@dlut.edu.cn	Liu, Tian/E-2481-2012; Yang, Qing/GZK-2526-2022; Qu, Mingbo/F-5037-2014; Qu, Mingbo/L-6231-2016	Liu, Tian/0000-0001-9768-5496; Yang, Qing/0000-0001-8623-7532; Qu, Mingbo/0000-0003-0397-1630; Qu, Mingbo/0000-0003-0397-1630	National Key Project for Basic Research [2010CB126100]; National Natural Science Foundation [31070715, 31101671]; National High Technology Research and Development Program of China [2011AA10A204]; National Key Technology RD Program [2011BAE06B05]; Fundamental Research Funds for the Central Universities of China [DUT11RC(3)73]; China Postdoctoral Science Foundation [2013M530122]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors acknowledge the financial support provided by the National Key Project for Basic Research (2010CB126100), the National Natural Science Foundation (31070715, 31101671), the National High Technology Research and Development Program of China (2011AA10A204), the National Key Technology R&D Program (2011BAE06B05), the Fundamental Research Funds for the Central Universities (DUT11RC(3)73) of China, and China Postdoctoral Science Foundation (2013M530122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cattaneo F, 2002, INSECT BIOCHEM MOLEC, V32, P929, DOI 10.1016/S0965-1748(02)00031-0; DZIADIKTURNER C, 1981, ARCH BIOCHEM BIOPHYS, V212, P546, DOI 10.1016/0003-9861(81)90398-2; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Hamamura Y., 1940, J AGR CHEM SOC JPN, V16, P907; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Intra J, 2011, INSECT BIOCHEM MOLEC, V41, P90, DOI 10.1016/j.ibmb.2010.10.004; Intra J, 2009, MOL REPROD DEV, V76, P85, DOI 10.1002/mrd.20932; KOGA D, 1986, AGR BIOL CHEM TOKYO, V50, P2357, DOI 10.1080/00021369.1986.10867738; KOGA D, 1983, COMP BIOCHEM PHYS B, V74, P515, DOI 10.1016/0305-0491(83)90220-1; KRAMER KJ, 1986, INSECT BIOCHEM, V16, P851, DOI 10.1016/0020-1790(86)90059-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu FY, 2012, INT J BIOL SCI, V8, P1085, DOI 10.7150/ijbs.4406; Liu T, 2013, PROCESS BIOCHEM, V48, P103, DOI 10.1016/j.procbio.2012.11.018; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; NAGAMATSU Y, 1995, BIOSCI BIOTECH BIOCH, V59, P219, DOI 10.1271/bbb.59.219; Okada T, 2007, BIOSCI BIOTECH BIOCH, V71, P1626, DOI 10.1271/bbb.60705; Pasini ME, 2011, GENE, V473, P44, DOI 10.1016/j.gene.2010.11.003; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perotti ME, 2006, GLYCOBIOLOGY, V16, P786; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qu M, 2012, INSECT MOL BIOL, V21, P395, DOI 10.1111/j.1365-2583.2012.01145.x; Qu MB, 2011, INSECT BIOCHEM MOLEC, V41, P923, DOI 10.1016/j.ibmb.2011.09.001; Qu MB, 2011, BIOCHEM BIOPH RES CO, V404, P302, DOI 10.1016/j.bbrc.2010.11.111; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; Zen KC, 1996, INSECT BIOCHEM MOLEC, V26, P435, DOI 10.1016/0965-1748(95)00111-5; Zheng YP, 2008, ARCH INSECT BIOCHEM, V68, P49, DOI 10.1002/arch.20235	34	12	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71738	10.1371/journal.pone.0071738	http://dx.doi.org/10.1371/journal.pone.0071738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951233	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300150
J	Schmahl, C; Arvastson, L; Tamm, JA; Bohus, M; Abdourahman, A; Antonijevic, I				Schmahl, Christian; Arvastson, Lars; Tamm, Joseph A.; Bohus, Martin; Abdourahman, Aicha; Antonijevic, Irina			Gene Expression Profiles in Relation to Tension and Dissociation in Borderline Personality Disorder	PLOS ONE			English	Article							CHILDHOOD ABUSE; DEXAMETHASONE-SUPPRESSION; MAP KINASE; ATYPICAL DEPRESSION; POSTMORTEM BRAIN; FEMALE-PATIENTS; EXPERIENCES; STRESS; BLOOD; DYSREGULATION	The biological underpinnings of borderline personality disorder (BPD) and its psychopathology including states of aversive tension and dissociation is poorly understood. Our goal was to examine transcriptional changes associated with states of tension or dissociation within individual patients in a pilot study. Dissociation is not only a critical symptom of BPD but has also been associated with higher risk for self-mutilation and depression. We conducted a whole blood gene expression profile analysis using quantitative PCR in 31 female inpatients with BPD. For each individual, two samples were drawn during a state of high tension and dissociation, while two samples were drawn at non-tension states. There was no association between gene expression and tension states. However, we could show that Interleukin-6 was positively correlated to dissociation scores, whereas Guanine nucleotide-binding protein G(s) subunit alpha isoforms, Mitogenactivated protein kinase 3 and 8, Guanine nucleotide-binding protein G(i) subunit alpha-2, Beta-arrestin-1 and 2, and Cyclic AMP-responsive element-binding protein were negatively correlated to dissociation. Our data point to a potential association of dissociation levels with the expression of genes involved in immune system regulation as well as cellular signalling/second-messenger systems. Major limitations of the study are the the possibly heterogeneous cell proportions in whole blood and the heterogeneous medication.	[Schmahl, Christian; Bohus, Martin] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychosomat Med & Psychotherapy, Mannheim, Germany; [Arvastson, Lars] H Lundbeck & Co AS, Valby, Denmark; [Tamm, Joseph A.; Abdourahman, Aicha; Antonijevic, Irina] Lundbeck Res USA, Paramus, NJ USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Lundbeck Corporation	Schmahl, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychosomat Med & Psychotherapy, Mannheim, Germany.	christian.schmahl@zi-mannheim.de	Schmahl, Christian/E-8760-2012	Schmahl, Christian/0000-0003-0141-0821	Lundbeck Research USA, Inc.	Lundbeck Research USA, Inc.	C.S. received payment for this study from Lundbeck Research USA, Inc., the employer of Joseph A. Tamm, Aicha Abdourahman and Irina Antonijevic. Lars Arvastson is employed by H. Lundbeck A/S. I.A. and J.A.T. are authors on a pending patent application describing the use of transcription profiles in blood to diagnose affective disorder (Title: System and methods for measuring biomarker profiles. Reference number 71021-WO-PCT). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Avissar S, 2004, AM J PSYCHIAT, V161, P2066, DOI 10.1176/appi.ajp.161.11.2066; Becker-Blease KA, 2004, J CHILD PSYCHOL PSYC, V45, P522, DOI 10.1111/j.1469-7610.2004.00242.x; Belzeaux R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.112; Belzeaux R, 2010, J PSYCHIATR RES, V44, P1205, DOI 10.1016/j.jpsychires.2010.04.011; Black DW, 2004, J PERS DISORD, V18, P226, DOI 10.1521/pedi.18.3.226.35445; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Bohus M, 1996, PSYCHIAT RES, V65, P45, DOI 10.1016/0165-1781(96)02913-7; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; BRODSKY BS, 1995, AM J PSYCHIAT, V152, P1788; Collins LJ, 2009, TRENDS GENET, V25, P120, DOI 10.1016/j.tig.2008.12.003; Dammann G, 2011, EPIGENETICS-US, V6, P1454, DOI 10.4161/epi.6.12.18363; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DelaFuente JM, 1996, BIOL PSYCHIAT, V40, P412, DOI 10.1016/0006-3223(95)00394-0; Dwivedi Y, 2006, MOL PSYCHIATR, V11, P86, DOI 10.1038/sj.mp.4001744; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Ebner-Priemer UW, 2005, J PSYCHIATR RES, V39, P85, DOI 10.1016/j.jpsychires.2004.05.001; First M.B., 2016, STRUCTURED CLIN INTE; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gold PW, 2002, ENDOCRIN METAB CLIN, V31, P37, DOI 10.1016/S0889-8529(01)00022-6; Gouin JP, 2012, ANN BEHAV MED, V44, P287, DOI 10.1007/s12160-012-9386-1; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Higuchi F, 2011, J PSYCHIATR RES, V45, P1295, DOI 10.1016/j.jpsychires.2011.04.008; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Iga J, 2006, NEUROSCI LETT, V400, P203, DOI 10.1016/j.neulet.2006.02.044; Jang KL, 1998, J NERV MENT DIS, V186, P345, DOI 10.1097/00005053-199806000-00004; Kahl KG, 2006, BIOL PSYCHIAT, V59, P667, DOI 10.1016/j.biopsych.2005.08.001; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; KORZEKWA M, 1991, CAN J PSYCHIAT, V36, P26, DOI 10.1177/070674379103600106; Krause-Utz A, 2012, PSYCHOL MED, P1; LAHMEYER HW, 1988, PSYCHIAT RES, V25, P19, DOI 10.1016/0165-1781(88)90154-0; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lieb K, 2004, J PSYCHIATR RES, V38, P559, DOI 10.1016/j.jpsychires.2004.04.002; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Lochner C, 2007, NEUROPSYCHOBIOLOGY, V56, P6, DOI 10.1159/000109971; Loranger A. W, 1999, INT PERSONALITY DISO; Ludascher P, 2007, PSYCHIAT RES, V149, P291, DOI 10.1016/j.psychres.2005.04.009; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Martini C, 2011, WORLD J BIOL PSYCHIA; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Munkholm K, 2012, BIPOLAR DISORD, V14, P684, DOI 10.1111/bdi.12005; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1565, DOI 10.1016/j.psyneuen.2010.06.002; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Pajer K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.26; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Savitz JB, 2008, INT J NEUROPSYCHOPH, V11, P149, DOI 10.1017/S1461145707007900; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Stiglmayr CE, 2008, ACTA PSYCHIAT SCAND, V117, P139, DOI 10.1111/j.1600-0447.2007.01126.x; Stiglmayr CE, 2003, PSYCHOTHER PSYCH MED, V53, P287; Stiglmayr CE, 2001, J PSYCHIAT RES, V35, P111, DOI 10.1016/S0022-3956(01)00012-7; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Trollope AF, 2012, EXP NEUROL, V233, P3, DOI 10.1016/j.expneurol.2011.03.022; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; Vollmayr B, 1995, PROG NEURO-PSYCHOPH, V19, P1263, DOI 10.1016/0278-5846(95)00265-0; Westling S, 2011, ACTA PSYCHIAT SCAND, V124, P301, DOI 10.1111/j.1600-0447.2011.01734.x; Zanarini MC, 2000, PSYCHIAT CLIN N AM, V23, P89, DOI 10.1016/S0193-953X(05)70145-3; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zanarini MC, 2000, COMPR PSYCHIAT, V41, P223, DOI 10.1016/S0010-440X(00)90051-8	63	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70787	10.1371/journal.pone.0070787	http://dx.doi.org/10.1371/journal.pone.0070787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951008	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300051
J	Spuhler, IA; Hauri, A				Spuehler, Isabelle Ayumi; Hauri, Andreas			Decoding the Dopamine Signal in Macaque Prefrontal Cortex: A Simulation Study Using the Cx3Dp Simulator	PLOS ONE			English	Article							MONKEY CEREBRAL-CORTEX; RECEPTOR ACTIVATION; NMDA RECEPTOR; QUANTITATIVE-ANALYSIS; BEHAVIORAL REACTIONS; DENDRITIC SPINES; WORKING-MEMORY; RHESUS-MONKEY; D1 RECEPTOR; NEURONS	Dopamine transmission in the prefrontal cortex plays an important role in reward based learning, working memory and attention. Dopamine is thought to be released non-synaptically into the extracellular space and to reach distant receptors through diffusion. This simulation study examines how the dopamine signal might be decoded by the recipient neuron. The simulation was based on parameters from the literature and on our own quantified, structural data from macaque prefrontal area 10. The change in extracellular dopamine concentration was estimated at different distances from release sites and related to the affinity of the dopamine receptors. Due to the sparse and random distribution of release sites, a transient heterogeneous pattern of dopamine concentration emerges. Our simulation predicts, however, that at any point in the simulation volume there is sufficient dopamine to bind and activate high-affinity dopamine receptors. We propose that dopamine is broadcast to its distant receptors and any change from the local baseline concentration might be decoded by a transient change in the binding probability of dopamine receptors. Dopamine could thus provide a graduated 'teaching' signal to reinforce concurrently active synapses and cell assemblies. In conditions of highly reduced or highly elevated dopamine levels the simulations predict that relative changes in the dopamine signal can no longer be decoded, which might explain why cognitive deficits are observed in patients with Parkinson's disease, or induced through drugs blocking dopamine reuptake.	[Spuehler, Isabelle Ayumi] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; ETH, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Spuhler, IA (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	ayumi@ini.phys.ethz.ch			European Union SECO Project [FP7-216593]; HSFP grant	European Union SECO Project; HSFP grant	This work was supported by the European Union SECO Project Grant FP7-216593 to Kevan A. C. Martin and Rodney J. Douglas and an HSFP grant to Kevan A. C. Martin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Cumming P, 2011, SYNAPSE, V65, P892, DOI 10.1002/syn.20916; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Jan C, 2003, EUR J NEUROSCI, V18, P2082, DOI 10.1046/j.1460-9568.2003.02946.x; Kang UG, 2012, PROG NEURO-PSYCHOPH, V36, P117, DOI 10.1016/j.pnpbp.2011.08.009; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Martin KAC, 2013, EUR J NEUROSCI, V37, P1061, DOI 10.1111/ejn.12124; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; Negyessy L, 2005, J COMP NEUROL, V488, P464, DOI 10.1002/cne.20601; NICHOLSON C, 1995, BIOPHYS J, V68, P1699, DOI 10.1016/S0006-3495(95)80348-6; NICHOLSON C, 1992, CAN J PHYSIOL PHARM, V70, pS314, DOI 10.1139/y92-278; Nirenberg MJ, 1997, J NEUROSCI, V17, P4037; Pan PY, 2012, NAT NEUROSCI; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Pothos EN, 1998, J NEUROSCI, V18, P4106; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; SAWAGUCHI T, 1986, BRAIN RES, V371, P404, DOI 10.1016/0006-8993(86)90385-9; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Scott L, 2009, NEUROSCIENCE, V158, P62, DOI 10.1016/j.neuroscience.2008.10.020; Sesack SR, 1998, J NEUROSCI, V18, P2697; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Zhang XZ, 2007, RAPID COMMUN MASS SP, V21, P3621, DOI 10.1002/rcm.3251; Zubler F, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.025.2009	43	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71615	10.1371/journal.pone.0071615	http://dx.doi.org/10.1371/journal.pone.0071615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951205	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000323097300136
J	Suresh, BV; Muthamilarasan, M; Misra, G; Prasad, M				Suresh, Venkata B.; Muthamilarasan, Mehanathan; Misra, Gopal; Prasad, Manoj			FmMDb: A Versatile Database of Foxtail Millet Markers for Millets and Bioenergy Grasses Research	PLOS ONE			English	Article							SETARIA-ITALICA; MICROSATELLITE MARKERS; GENOME SEQUENCE; STRESS; GENE; MAPS	The prominent attributes of foxtail millet (Setaria italica L.) including its small genome size, short life cycle, inbreeding nature, and phylogenetic proximity to various biofuel crops have made this crop an excellent model system to investigate various aspects of architectural, evolutionary and physiological significances in Panicoid bioenergy grasses. After release of its whole genome sequence, large-scale genomic resources in terms of molecular markers were generated for the improvement of both foxtail millet and its related species. Hence it is now essential to congregate, curate and make available these genomic resources for the benefit of researchers and breeders working towards crop improvement. In view of this, we have constructed the Foxtail millet Marker Database (FmMDb; http://www.nipgr.res.in/foxtail.html), a comprehensive online database for information retrieval, visualization and management of large-scale marker datasets with unrestricted public access. FmMDb is the first database which provides complete marker information to the plant science community attempting to produce elite cultivars of millet and bioenergy grass species, thus addressing global food insecurity.	[Suresh, Venkata B.; Muthamilarasan, Mehanathan; Misra, Gopal; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017; Bonthala, Venkata Suresh/G-9852-2013	Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Bonthala, Venkata Suresh/0000-0001-6550-1648	National Institute of Plant Genome Research (NIPGR), New Delhi, India	National Institute of Plant Genome Research (NIPGR), New Delhi, India	This work was financially supported by the core grant of National Institute of Plant Genome Research (NIPGR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Cao HC, 2013, MOL BREEDING, V31, P655, DOI 10.1007/s11032-012-9823-7; Chen X, 2011, USDA DOE PLANT FEEDS; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Du FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061337; Fang FQ, 2008, EUPHYTICA, V163, P103; Garg B, 2012, MOL BIOL REP, V39, P10865, DOI 10.1007/s11033-012-1983-3; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Gupta S, 2013, PLANT BREEDING, V132, P367, DOI 10.1111/pbr.12070; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2011, GENOME, V54, P586, DOI [10.1139/G11-020, 10.1139/g11-020]; Jayaraman A, 2008, MOL BIOTECHNOL, V40, P241, DOI 10.1007/s12033-008-9081-4; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2014, J PLANT BIOCHEM BIOT, V23, P119, DOI 10.1007/s13562-013-0193-y; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lata C, 2011, PROTOPLASMA, V248, P817, DOI 10.1007/s00709-010-0257-y; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Liu YingHui, 2005, Journal of Agricultural Biotechnology, V13, P32; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Puranik S, 2011, J PLANT PHYSIOL, V168, P280, DOI 10.1016/j.jplph.2010.07.005; Rudd S, 2005, NUCLEIC ACIDS RES, V33, pD628, DOI 10.1093/nar/gki074; Shen D, 2013, PLANT CELL PHYSIOL, V54, pE3, DOI 10.1093/pcp/pcs176; Wang MZ, 2011, AFR J BIOTECHNOL, V10, P16466, DOI 10.5897/AJB10.2330; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	34	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71418	10.1371/journal.pone.0071418	http://dx.doi.org/10.1371/journal.pone.0071418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951158	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300115
J	Ungerer, M; Li, ZM; Baumgartner, C; Goebel, S; Vogelmann, J; Holthoff, HP; Gawaz, M; Munch, G				Ungerer, Martin; Li, Zhongmin; Baumgartner, Christine; Goebel, Silvia; Vogelmann, Jasmin; Holthoff, Hans-Peter; Gawaz, Meinrad; Muench, Goetz			The GPVI - Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times	PLOS ONE			English	Article							GLYCOPROTEIN-VI; PLATELET-ADHESION; AGGREGATION; MODEL	Aims: Glycoprotein VI (GPVI) is a key platelet receptor which mediates plaque-induced platelet activation and consecutive atherothrombosis, but GPVI is also involved in platelet-mediated atheroprogression. Therefore, interference in GPVI-mediated platelet activation has the potential to combine short-term and long-term beneficial effects, specificity and safety especially regarding bleeding complications. Methods and Results: We investigated the effects of the soluble dimeric GPVI receptor fusion protein, Revacept, an antagonist of collagen-mediated platelet activation, in an animal model of atherosclerosis: twenty week old rabbits, which had been fed on a cholesterol-rich diet for 8 weeks, received Revacept (8 mg/kg) or control twice weekly for 4 weeks. Pharmacokinetics indicated a slight accumulation of the drug in the serum after repeated dosing of Revacept for 3 weeks. A significant improvement of endothelial dysfunction after 0.06 and 0.6 mu g/min acetylcholine and a significant decrease of vessel wall thickening were found after Revacept treatment. Accordingly, aortic vessel weight was reduced, and plaque sizes, macrophage and T-cell invasion tended to be reduced in histological evaluations. Bleeding time was determined after tail clipping in mice. Revacept alone or in combination with widely used anti-platelet drugs revealed a high safety margin with no prolongation of bleeding times. Conclusion: Repeated doses of Revacept led to a significant improvement of endothelial dysfunction and vascular morphology in atherosclerotic rabbits. Furthermore, no influence of Revacept on bleeding time alone or in combinations with various anti-platelet drugs was found in mice. Thus, the inhibition of collagen-mediated platelet interaction with the atherosclerotic endothelium by Revacept exerts beneficial effects on morphology and vascular function in vivo and seems to have a wide therapeutic window without influencing the bleeding time.	[Ungerer, Martin; Li, Zhongmin; Baumgartner, Christine; Goebel, Silvia; Vogelmann, Jasmin; Holthoff, Hans-Peter; Muench, Goetz] AdvanceCOR GmbH, Procorde GmbH, Martinsried, Germany; [Gawaz, Meinrad] Univ Tubingen, Med Klin 3, Tubingen, Germany	Eberhard Karls University of Tubingen	Gawaz, M (corresponding author), Univ Tubingen, Med Klin 3, Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de; muench@advanceCOR.com			Lilly; Bristol-Myers Squibb; Bayer-Schering	Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer-Schering(Bayer AG)	Authors MU, ZL, SG, JV, HPH and GM are employed by, or hold shares of the biotech company advanceCOR GmbH - this company funded this study. MG is a co-founder of AdvanceCOR, owns shares of AdvanceCOR and is Professor at the Cardiology Department of the University of Tubingen. He further received honoraria payments from Lilly, Bristol-Myers Squibb and Bayer-Schering and is also consultant for Bayer-Schering. CB was an employee of the predecessor company, ProCorde GmbH, at the time of the study. Advancecor holds patents on and develops GPVI-Fc as a product for the treatment of patients with vascular diseases. There are no marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bultmann A, 2006, THROMB HAEMOSTASIS, V95, P763, DOI 10.1160/TH05-11-0731; Bultmann A, 2010, J MOL CELL CARDIOL, V49, P532, DOI 10.1016/j.yjmcc.2010.04.009; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Makkar RR, 1998, EUR HEART J, V19, P1538, DOI 10.1053/euhj.1998.1042; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; Massberg S, 2003, THROMB RES, V110, P187, DOI 10.1016/S0049-3848(03)00342-6; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Reininger AJ, 2010, J AM COLL CARDIOL, V55, P1147, DOI 10.1016/j.jacc.2009.11.051; Schonberger T, 2008, CARDIOVASC RES, V80, P131, DOI 10.1093/cvr/cvn169; Schulz C, 2008, BASIC RES CARDIOL, V103, P356, DOI 10.1007/s00395-008-0722-3; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Ungerer M, 2011, CIRCULATION, V123, P1891, DOI 10.1161/CIRCULATIONAHA.110.980623; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009	18	52	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71193	10.1371/journal.pone.0071193	http://dx.doi.org/10.1371/journal.pone.0071193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951109	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300098
J	Nghiem, LTP; Soliman, T; Yeo, DCJ; Tan, HTW; Evans, TA; Mumford, JD; Keller, RP; Baker, RHA; Corlett, RT; Carrasco, LR				Nghiem, Le T. P.; Soliman, Tarek; Yeo, Darren C. J.; Tan, Hugh T. W.; Evans, Theodore A.; Mumford, John D.; Keller, Reuben P.; Baker, Richard H. A.; Corlett, Richard T.; Carrasco, Luis R.			Economic and Environmental Impacts of Harmful Non-Indigenous Species in Southeast Asia	PLOS ONE			English	Article							GOLDEN APPLE SNAIL; BIOLOGICAL INVASIONS; COSTS; DISEASE	Harmful non-indigenous species (NIS) impose great economic and environmental impacts globally, but little is known about their impacts in Southeast Asia. Lack of knowledge of the magnitude of the problem hinders the allocation of appropriate resources for NIS prevention and management. We used benefit-cost analysis embedded in a Monte-Carlo simulation model and analysed economic and environmental impacts of NIS in the region to estimate the total burden of NIS in Southeast Asia. The total annual loss caused by NIS to agriculture, human health and the environment in Southeast Asia is estimated to be US$33.5 billion (5th and 95th percentile US$25.8-39.8 billion). Losses and costs to the agricultural sector are estimated to be nearly 90% of the total (US$23.4-33.9 billion), while the annual costs associated with human health and the environment are US$1.85 billion (US$1.4-2.5 billion) and US$2.1 billion (US$0.9-3.3 billion), respectively, although these estimates are based on conservative assumptions. We demonstrate that the economic and environmental impacts of NIS in low and middle-income regions can be considerable and that further measures, such as the adoption of regional risk assessment protocols to inform decisions on prevention and control of NIS in Southeast Asia, could be beneficial.	[Nghiem, Le T. P.; Soliman, Tarek; Yeo, Darren C. J.; Tan, Hugh T. W.; Evans, Theodore A.; Carrasco, Luis R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Mumford, John D.] Univ London Imperial Coll Sci Technol & Med, Ctr Environm Policy, London, England; [Keller, Reuben P.] Loyola Univ, Inst Environm Sustainabil, Chicago, IL 60611 USA; [Baker, Richard H. A.] Food & Environm Res Agcy, Dept Environm Food & Rural Affairs, York, England; [Corlett, Richard T.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China	National University of Singapore; Imperial College London; Loyola University Chicago; Food & Environment Research Agency; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsctlr@nus.edu.sg	Corlett, Richard T./S-2899-2019; Tan, Hugh Tiang Wah/H-9802-2012; Yeo, Darren CJ/H-9790-2012; Evans, Theodore A/A-6020-2008; Nghiem, Long D/E-4847-2011; Carrasco, Luis R/H-8017-2012	Corlett, Richard T./0000-0002-2508-9465; Evans, Theodore A/0000-0002-0558-3036; Nghiem, Long D/0000-0002-9039-5792; Carrasco, Luis R/0000-0002-2894-1473; Mumford, John/0000-0001-8964-1784; Tan, Hugh Tiang Wah/0000-0002-3056-4945	NUS [R-154-000-556-112]; National University of Singapore [R-154-000-465-133]	NUS(National University of Singapore); National University of Singapore(National University of Singapore)	LTPN, TS, and LRC acknowledge support by the NUS grant "Prevention, detection and control of invasive alien species in Southeast Asia" (WBS No. R-154-000-556-112). DCJY acknowledges support from National University of Singapore grant R-154-000-465-133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alowe S., 2004, 100 WORLDS WORST INV; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; ASEAN Secretariat, 2010, PREVENTION CONTROL E; Baguinon NT, 2003, COUNTRY REPORT FORES, P173; Bonnaud E, 2011, BIOL INVASIONS, V13, P581, DOI 10.1007/s10530-010-9851-3; Briggs M, 2005, FAO FISHERIES TECHNI; Brooks-Moizer F, 2009, ECOL SOC, V14; CABI, 2012, INVASIVE SPECIES COM; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Carrasco L, 2011, PLOS NEGLECT TROP D, V5, P1; Carrasco LR, 2011, J R SOC INTERFACE, V8, P1307, DOI 10.1098/rsif.2010.0715; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CountrySTAT Philippines, 2013, PEST DEAL; Denslow J.S., 2008, TROPICAL FOREST COMM, P409; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Duong VC, 2009, MIMOSA PIGRA L DANGE; FAO, 2011, FISHSTATJ UNIVERSAL; FAO, 2019, US; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Fuentes RU, 2009, REGIONAL MANAGEMENT, V8, P5; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garsetiasih R, 2003, INVASION ACACIA NILO, P173; Ismail AA, 1988, METHODS WATER HYACIN, P100; ISSG, 2012, GLOBAL INVASIVE SPEC; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; Kim C. S., 2006, Agricultural and Resource Economics Review, V35, P29; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Kongsin S., 2010, Dengue Bulletin, V34, P77; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Leach AW, 2008, ENVIRON POLLUT, V151, P139, DOI 10.1016/j.envpol.2007.02.019; Lee SHJ, 2006, WILDLIFE TRADE SINGA; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKinnon JR, 2002, ASEAN REV BIODIVERS, P9; Matthews S, 2004, TROPICAL ASIA INVADE, V65; Melifonwu A. A., 1994, African Crop Science Journal, V2, P519; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nang K., 2003, RAP PUBLICATION, V2005/18, P78; Nash SV, 1993, SOLD SONG TRADE SE A; Naylor R, 1996, AMBIO, V25, P443; Noor Hasyierah Mohd S, 2012, DISTRIBUTION MANAGEM, V2; Oerke E.C., 1994, CROP PRODUCTION CROP; Othman MH, 2003, INVASIVE ALIEN SPECI, P111; Palisade, 2012, RISK EXC 6 0 0; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Perry BD, 1999, REV SCI TECH OIE, V18, P478, DOI 10.20506/rst.18.2.1163; Pham QT, 2003, FOREST INVASIVE SPEC, P173; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; PINGALI PL, 1994, AM J AGR ECON, V76, P587, DOI 10.2307/1243669; Poulos C, 2012, EPIDEMIOL INFECT, V140, P500, DOI 10.1017/S0950268811000513; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Qiang S, 2012, PLANT THREATS PACIFI; Robson T. O., 1976, Aquatic weeds in S.E. Asia. Proceedings of a Regional Seminar on Noxious Aquatic Vegetation, New Delhi, 1973., P25; Samouth C, 2002, MIMOSA PIGRA INFESTA, P173; Sanchez-Martinez JG, 2007, AQUAC RES, V38, P1339, DOI 10.1111/j.1365-2109.2007.01827.x; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Singleton GR., 2003, IRRI DISCUSSION PAPE, V45, P30; Singleton GR, 1994, REV BIOL MANAGEMENT; Sinohin VO, 2003, INVASIVE ALIEN SPECI; Sodhi N.S., 2006, WINGED INVADERS PEST; Suharto H., 2002, GOLDEN APPLE SNAIL P, P69; Thamasara S, 1985, P 10 C AS PAC WEEDS, P7; Thiem VD, 2011, J HLTH POPULATION NU, V21, P304; U.S Congress, 1993, HARMF NON SPEC US OT; UNAIDS, 2012, AIDSINFO; United Nations Statistics Division, 2012, PURCH POW PAR PPP CO; van Aarde RJ, 1977, J ANTARCTIC RES, V9, P14; Vitousek PM, 1996, AM SCI, V84, P468; VOSE Software, 2007, PERT DISTRIBUTION; Waterhouse DF, 1993, MAJOR ANTHROPOD PEST; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2012, CHOLERA, P289; WHO, 2012, DIS INJURY REGIONAL; WHO, 2013, CUMULATIVE NUMBER CO; Williams F., 2010, VM10066 CABI; Yap Charlotte A. M., 2004, Ornithological Science, V3, P57, DOI 10.2326/osj.3.57; YEO D. C. J., 2010, COSMOS, V6, P23, DOI DOI 10.1142/S0219607710000486	85	77	79	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71255	10.1371/journal.pone.0071255	http://dx.doi.org/10.1371/journal.pone.0071255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23951120	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200035
J	Venkata, BP; Lauter, N; Li, X; Chapple, C; Krupke, C; Johal, G; Moose, S				Venkata, Bala Puchakayala; Lauter, Nick; Li, Xu; Chapple, Clint; Krupke, Christian; Johal, Gurmukh; Moose, Stephen			crw1 - A Novel Maize Mutant Highly Susceptible to Foliar Damage by the Western Corn Rootworm Beetle	PLOS ONE			English	Article							VEGETATIVE PHASE-TRANSITION; CHRYSOMELIDAE LARVAL INJURY; CELL DIVISIONS; NORTHERN CORN; COLEOPTERA; RESISTANCE; HYBRIDS; LIGNIN; LEAF; CORNGRASS1	Western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte (Coleoptera: Chrysomelidae), is the most destructive insect pest of corn (Zea mays L.) in the United States. The adult WCR beetles derive their nourishment from multiple sources including corn pollen and silks as well as the pollen of alternate hosts. Conversely, the corn foliage is largely neglected as a food source by WCR beetles, leading to a perception of a passive interaction between the two. We report here a novel recessive mutation of corn that was identified and named after its foliar susceptibility to corn rootworm beetles (crw1). The crw1 mutant under field conditions was exceptionally susceptible to foliar damage by WCR beetles in an age-specific manner. It exhibits pleiotropic defects on cell wall biochemistry, morphology of leaf epidermal cells and lower structural integrity via differential accumulation of cell wall bound phenolic acids. These findings indicate that crw1 is perturbed in a pathway that was not previously ascribed to WCR susceptibility, as well as implying the presence of an active mechanism(s) deterring WCR beetles from devouring corn foliage. The discovery and characterization of this mutant provides a unique opportunity for genetic analysis of interactions between maize and adult WCR beetles and identify new strategies to control the spread and invasion of this destructive pest.	[Venkata, Bala Puchakayala; Johal, Gurmukh] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Lauter, Nick] Iowa State Univ, USDA, ARS, Ames, IA USA; [Li, Xu] N Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA; [Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Krupke, Christian] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Moose, Stephen] Univ Illinois, Dept Crop Sci, Champaign, IL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign	Moose, S (corresponding author), Univ Illinois, Dept Crop Sci, Champaign, IL USA.	smoose@illinois.edu	Chapple, Clint CS/Q-5456-2017; Johal, Guri/F-5056-2017	Chapple, Clint CS/0000-0002-5195-562X; Johal, Guri/0000-0001-8101-8410; Li, Xu/0000-0002-4640-2529	Illinois Agricultural Experiment Station [ILLU-15-0359]; USDA [2001-34346-10586, 2003-35304-13239]; Purdue University	Illinois Agricultural Experiment Station; USDA(United States Department of Agriculture (USDA)); Purdue University	Identification and characterization of the crw1-4 mutation identified at the University of Illinois was supported by a grant to SPM from the Illinois Agricultural Experiment Station (ILLU-15-0359), USDA grant Award to SPM (Award number 2001-34346-10586), and USDA postdoctoral training award to NL (Award number 2003-35304-13239). The work at Purdue University was supported by startup funds to Guri Johal from Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon BG, 1996, J HERED, V87, P219, DOI 10.1093/oxfordjournals.jhered.a022988; Ahern KR, 2009, PLANT CELL, V22, P1667; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Bai F, 2012, P NATL ACAD SCI USA, V109, P12225, DOI 10.1073/pnas.1202439109; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; BRANSON TF, 1967, J ECON ENTOMOL, V60, P201, DOI 10.1093/jee/60.1.201; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; CHYB S, 1995, J CHEM ECOL, V21, P313, DOI 10.1007/BF02036720; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; FISHER JR, 1986, ENVIRON ENTOMOL, V15, P626, DOI 10.1093/ee/15.3.626; Flint-Garcia SA, 2009, J ECON ENTOMOL, V102, P1317, DOI 10.1603/029.102.0359; Frank MJ, 2003, DEVELOPMENT, V130, P753, DOI 10.1242/dev.00290; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; FUKUSHIMA RS, 1991, J ANIM SCI, V69, P295; Gallagher K, 1999, DEVELOPMENT, V126, P4623; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gillette CP, 1912, J ECON ENTOMOL, V5, P364, DOI 10.1093/jee/5.4.364a; Grabber JH, 2007, PLANTA, V226, P741, DOI 10.1007/s00425-007-0521-3; Gray ME, 2007, J APPL ENTOMOL, V131, P386, DOI 10.1111/j.1439-0418.2007.01171.x; Gray ME, 1998, J ECON ENTOMOL, V91, P723, DOI 10.1093/jee/91.3.723; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Harbor AL, 2002, THESIS PURDUE U; Hibbard BE, 2008, ENVIRON ENTOMOL, V37, P1558, DOI 10.1603/0046-225X-37.6.1558; Hibbard BE, 2009, ILL CORN BREED SCH P, P157; KAHLER AL, 1985, AGRON J, V77, P769, DOI 10.2134/agronj1985.00021962007700050023x; Kessler S, 2002, DEVELOPMENT, V129, P1859; Levine E, 1996, J ECON ENTOMOL, V89, P1010, DOI 10.1093/jee/89.4.1010; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; Meicenheimer RD, 2008, AM J BOT, V95, P1191, DOI 10.3732/ajb.0800127; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Metcalf Robert L., 1994, Series Entomologica (Dordrecht), V50, P153; Meyer K, 1996, P NATL ACAD SCI USA, V93, P6869, DOI 10.1073/pnas.93.14.6869; Moeser J, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P41, DOI 10.1079/9780851998176.0041; MOESER J, 2003, THESIS; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Moose SP, 1995, THESIS N CAROLINA ST; NARANJO SE, 1988, ENVIRON ENTOMOL, V17, P508, DOI 10.1093/ee/17.3.508; O'Neal ME, 2002, ENVIRON ENTOMOL, V31, P285, DOI 10.1603/0046-225X-31.2.285; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Oyediran IO, 2004, ENVIRON ENTOMOL, V33, P1497, DOI 10.1603/0046-225X-33.5.1497; PALMER LT, 1969, PHYTOPATHOLOGY, V59, P1613; Peeters PJ, 2002, BIOL J LINN SOC, V77, P43, DOI 10.1046/j.1095-8312.2002.00091.x; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Revilla P, 2005, J ECON ENTOMOL, V98, P982, DOI 10.1603/0022-0493-98.3.982; Revilla P, 2005, J AM SOC HORTIC SCI, V130, P64, DOI 10.21273/JASHS.130.1.64; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Santiago LS, 2005, TREES-STRUCT FUNCT, V19, P349, DOI 10.1007/s00468-004-0389-9; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Sindhu A, 2007, PLANT PHYSIOL, V145, P1444, DOI 10.1104/pp.107.102582; Suguiyama LF, 1985, USDA AGR INFORM B, V487; Sylvester AW, 2009, HDB MAIZE ITS BIOL; TIMMINS WA, 1988, PHYSIOL ENTOMOL, V13, P303, DOI 10.1111/j.1365-3032.1988.tb00482.x; Vermerris W, 2001, J AGR FOOD CHEM, V49, P721, DOI 10.1021/jf000740r	59	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71296	10.1371/journal.pone.0071296	http://dx.doi.org/10.1371/journal.pone.0071296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951124	Green Submitted, gold, Green Published			2022-12-27	WOS:000326473200036
J	Chu, J; Li, JG; Pratico, D				Chu, Jin; Li, Jin-Guo; Pratico, Domenico			Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer's Disease with Plaques and Tangles	PLOS ONE			English	Article							5-LIPOXYGENASE; EXPRESSION; PHENOTYPE; BRAIN	The 5-lipoxygenase (5LO) enzyme is widely distributed within the central nervous system. Previous works showed that this protein is up-regulated in Alzheimer's disease (AD), and plays an active role in the development of brain amyloidosis in the APP transgenic mice. In the present paper, we studied the effect of its pharmacological inhibition on the entire AD-like phenotype of a mouse model with plaques and tangles, the 3xTg mice. Compared with mice receiving placebo, the group treated with zileuton, a specific 5LO inhibitor, manifested a significant improvement of their memory impairments. The same animals had a significant reduction in A beta levels and deposition, which was secondary to a down-regulation of the gamma-secretase pathway. Additionally, while total tau levels were unchanged for both groups, zileuton-treated mice had a significant reduction in its phosphorylation state and insoluble forms, secondary to a decreased activation of the cdk5 kinase. These data establish a functional role for 5LO in the pathogenesis of the full spectrum of the AD-like phenotype and represent the successful completion of the initial step for the preclinical development of 5LO inhibitors as viable therapeutic agents for AD.	[Chu, Jin; Li, Jin-Guo; Pratico, Domenico] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pratico, D (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	praticod@temple.edu	Pratico, Domenico/ABA-9590-2020		US National Institute of Health (NIH) [AG33568]; NATIONAL INSTITUTE ON AGING [R01AG033568] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by a grant from the US National Institute of Health (NIH)(AG33568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Chu J, 2012, ANN NEUROL, V72, P442, DOI 10.1002/ana.23642; Chu J, 2011, ANN NEUROL, V69, P34, DOI 10.1002/ana.22234; Chu J, 2011, AM J PATHOL, V178, P1762, DOI 10.1016/j.ajpath.2010.12.032; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Giannopoulos PF, 2013, MOL PSYCH       0312; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Humbert S, 2000, J CELL SCI, V113, P975; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; Kubavat AH, 2013, AM J THER, V20, P154, DOI 10.1097/MJT.0b013e318254259b; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Qu TY, 2001, J NEUROPSYCH CLIN N, V13, P304, DOI 10.1176/appi.neuropsych.13.2.304; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Riccioni G, 2004, ANN CLIN LAB SCI, V34, P379; Yang HX, 2010, BIOL PSYCHIAT, V68, P922, DOI 10.1016/j.biopsych.2010.04.010; Yoshi BY, 2012, J ALZHEIMERS DIS, V31, P167	19	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70991	10.1371/journal.pone.0070991	http://dx.doi.org/10.1371/journal.pone.0070991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951061	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700071
J	Li, HX; Chen, XB; Pang, LJ; Shi, WS				Li, Huixian; Chen, Xubao; Pang, Liaojun; Shi, Weisong			Quantum Attack-Resistant Certificateless Multi-Receiver Signcryption Scheme	PLOS ONE			English	Article								The existing certificateless signcryption schemes were designed mainly based on the traditional public key cryptography, whose security relies on the hard problems, such as factor decomposition, and discrete logarithm. However, these problems will be easily solved by the quantum computing. So the existing certificateless signcryption schemes are vulnerable to quantum attacks. Multivariate public key cryptography (MPKC), which can resist the quantum attack, is one of the alternatives to guarantee the security of communication in the post-quantum age. Motivated by these concerns, we proposed a new construction of the certificateless multi-receiver signcryption scheme (CLMSC) based on MPKC. The new scheme inherits the security of MPKC, that is, it can withdraw quantum attacks. Multivariate quadratic polynomial operations, which need lower computation than pairing operations, are employed in signcrypting a message for any number of receivers in our scheme. We proved its semantic security under the hardness of Multivariate Quadratic (MQ) problem and its unforgeability under the Isomorphism of Polynomials (IP) assumption in the random oracle model, respectively. The results of analyses show that our scheme also has the security properties of non-repudiation, perfect forward secrecy, perfect backward secrecy and publicly verifiability. Compared with the existing schemes in terms of the computational complexity and the ciphertext size, our scheme is more efficient, and thus it is suitable for terminals with lower computation capacity like smart cards.	[Li, Huixian; Chen, Xubao] Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Peoples R China; [Li, Huixian; Shi, Weisong] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Pang, Liaojun] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China	Northwestern Polytechnical University; Wayne State University; Xidian University	Li, HX (corresponding author), Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Peoples R China.	lihuixian@nwpu.edu.cn			Higher Education of China [20096102120045]	Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Higher Education of China under Grant No. 20096102120045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Riyami SS, 2003, LECT NOTES COMPUT SC, V2894, P452; Barbosa M., 2008, P 2008 ACM S INFORM, P369, DOI DOI 10.1145/1368310.1368364; Barreto PSLM, 2008, EFFICIENT CERTIFICAT; Billet O, 2007, LECT NOTES COMPUT SC, V4586, P82; Dubois V, 2007, LECT NOTES COMPUT SC, V4622, P1; Kim IT, P 12 IEEE INT C REH, P1; Li FG, 2009, LECT NOTES COMPUT SC, V5451, P112; Li P., 2010, J COMPUTATIONAL INFO, V11, P3643; Luo M, 2008, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, P17, DOI 10.1109/ICCSIT.2008.14; Pang L, 2012, IET COMMUN, V6, P1126, DOI 10.1049/iet-com.2010.0954; Patarin J., 1997, Information and Communications Security. First International Conference, ICIS '97. Proceedings, P356, DOI 10.1007/BFb0028491; Patarin J, 1996, LECT NOTES COMPUT SC, V1070, P33; Selvi SSD, 2008, LECT NOTES COMPUT SC, V5324, P52; Selvi SSD, 2009, NOTE CERTIFICATELESS, P308; Selvi SSD, 2009, INT C INFORM SECURIT, P75; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Songqin Miao, 2010, Proceedings 2010 Second International Conference on Multimedia Information Networking and Security (MINES 2010), P593, DOI 10.1109/MINES.2010.130; Wang LC, 2006, LECT NOTES COMPUT SC, V3860, P132; Xiaofei Jing, 2011, 2011 International Conference on Electronic & Mechanical Engineering and Information Technology (EMEIT 2011), P4753, DOI 10.1109/EMEIT.2011.6024098; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	20	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e49141	10.1371/journal.pone.0049141	http://dx.doi.org/10.1371/journal.pone.0049141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23967037	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400001
J	Konstandi, M; Shah, YM; Matsubara, T; Gonzalez, FJ				Konstandi, Maria; Shah, Yatrik M.; Matsubara, Tsutomu; Gonzalez, Frank J.			Role of PPAR alpha and HNF4 alpha in Stress-Mediated Alterations in Lipid Homeostasis	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; TARGETED DISRUPTION; METABOLIC SYNDROME; TRIGLYCERIDE; CHOLESTEROL; RECEPTORS; OBESITY; GENE; SECRETION; ACID	Stress is a risk factor for several cardiovascular pathologies. PPAR alpha holds a fundamental role in control of lipid homeostasis by directly regulating genes involved in fatty acid transport and oxidation. Importantly, PPAR alpha agonists are effective in raising HDL-cholesterol and lowering triglycerides, properties that reduce the risk for cardiovascular diseases. This study investigated the role of stress and adrenergic receptor (AR)-related pathways in PPAR alpha and HNF4 alpha regulation and signaling in mice following repeated restraint stress or treatment with AR-antagonists administered prior to stress to block AR-linked pathways. Repeated restraint stress up-regulated Ppar alpha and its target genes in the liver, including Acox, Acot1, Acot4, Cyp4a10, Cyp4a14 and Lipin2, an effect that was highly correlated with Hnf4 alpha. In vitro studies using primary hepatocyte cultures treated with epinephrine or AR-agonists confirmed that hepatic AR/cAMP/PKA/CREB- and JNK-linked pathways are involved in PPAR alpha and HNF4 alpha regulation. Notably, restraint stress, independent of PPAR alpha, suppressed plasma triglyceride levels. This stress-induced effect could be attributed in part to hormone sensitive lipase activation in the white adipose tissue, which was not prevented by the increased levels of perilipin. Overall, this study identifies a mechanistic basis for the modification of lipid homeostasis following stress and potentially indicates novel roles for PPAR alpha and HNF4 alpha in stress-induced lipid metabolism.	[Konstandi, Maria; Shah, Yatrik M.; Matsubara, Tsutomu; Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Konstandi, Maria] Univ Ioannina, Sch Med, Dept Pharmacol, GR-45110 Ioannina, Greece; [Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Ioannina; University of Michigan System; University of Michigan	Konstandi, M (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	mkonstan@cc.uoi.gr			National Cancer Institute Intramural Research Program; Molecular Life Science, University of Oslo; Norwegian Cancer Society [PR-2006-0442, PR-2007-0166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Life Science, University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Cancer Institute Intramural Research Program. ML is supported as a PhD student by Molecular Life Science, University of Oslo and the study is supported by the Norwegian Cancer Society (PR-2006-0442, RAL; PR-2007-0166, RIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Akiyama TE, 2001, J BIOL CHEM, V276, P39088, DOI 10.1074/jbc.M107073200; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Aschbacher K, 2013, PSYCHONEUROENDOCRINO; Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chamouton J, 2012, CURR DRUG METAB, V13, P1436, DOI 10.2174/138920012803762738; Chan LSA, 2009, PPAR RES, V2009, DOI 10.1155/2009/925309; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Chrousos GP, 1998, J CLIN ENDOCR METAB, V83, P1842, DOI 10.1210/jc.83.6.1842; CRUISE JL, 1987, HEPATOLOGY, V7, P1189, DOI 10.1002/hep.1840070604; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flierl MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004414; Friedman TC, 1996, ENDOCR J, V43, P645, DOI 10.1507/endocrj.43.645; Fruchart JC, 2006, DRUGS TODAY, V42, P39, DOI 10.1358/dot.2006.42.1.963528; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021; Graham A, 1996, ATHEROSCLEROSIS, V120, P135, DOI 10.1016/0021-9150(95)05695-5; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guyre P M, 1984, Prog Clin Biol Res, V142, P181; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hansen MK, 2008, CURR OPIN INVEST DR, V9, P247; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Karavanaki K, 2008, J ENDOCRINOL INVEST, V31, P406, DOI 10.1007/BF03346384; Koch FS, 2008, J PEDIATR-US, V153, P839, DOI 10.1016/j.jpeds.2008.06.016; Konstandi M, 2004, CHEM-BIOL INTERACT, V147, P65, DOI 10.1016/j.cbi.2003.10.007; Kuusisto Johanna, 2007, Curr Atheroscler Rep, V9, P274, DOI 10.1007/s11883-007-0033-4; Lalchandani SG, 2004, BIOCHEM PHARMACOL, V67, P87, DOI 10.1016/j.bcp.2003.08.043; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Le Bourg E, 2010, DOSE-RESPONSE, V8, P64, DOI 10.2203/dose-response.09-042.LeBourg; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; MINNEMAN KP, 1994, ANNU REV PHARMACOL, V34, P117; MORROW LA, 1991, J GERONTOL, V46, pM108, DOI 10.1093/geronj/46.4.M108; Pardon MC, 2009, NEUROBIOL AGING, V30, P1099, DOI 10.1016/j.neurobiolaging.2007.10.002; Park SH, 2006, BIOCHEM J, V397, P159, DOI 10.1042/BJ20060332; Rampler H, 2003, MOL GENET METAB, V80, P398, DOI 10.1016/j.ymgme.2003.09.002; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Robillard R, 2005, HANDB EXP PHARM, V170, P389; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Saha SA, 2011, CURR OPIN LIPIDOL, V22, P270, DOI 10.1097/MOL.0b013e32834701c3; Sanderson LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001681; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tolwani RJ, 1996, GENE, V170, P165, DOI 10.1016/0378-1119(95)00882-9; Tsigos C, 1996, ANNU REV MED, V47, P443; TUOMISTO J, 1985, PHARMACOL REV, V37, P249; VIRTANEN R, 1989, ACTA VET SCAND, P29; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wang YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-4; Ware WR, 2008, MED HYPOTHESES, V70, P543, DOI 10.1016/j.mehy.2007.06.031; YATES JC, 1980, BRIT J EXP PATHOL, V61, P242; Yumuk VD, 2006, ANN NY ACAD SCI, V1083, P306, DOI 10.1196/annals.1367.019; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	71	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70675	10.1371/journal.pone.0070675	http://dx.doi.org/10.1371/journal.pone.0070675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967086	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500023
J	Skripchenko, A; Awatefe, H; Thompson-Montgomery, D; Myrup, A; Turgeon, A; Wagner, SJ				Skripchenko, Andrey; Awatefe, Helen; Thompson-Montgomery, Dedeene; Myrup, Andrew; Turgeon, Annette; Wagner, Stephen J.			An Inhibition of p38 Mitogen Activated Protein Kinase Delays the Platelet Storage Lesion	PLOS ONE			English	Article								Background and Objectives: Platelets during storage undergo diverse alterations collectively known as the platelet storage lesion, including metabolic, morphological, functional and structural changes. Some changes correlate with activation of p38 mitogen activated protein kinase (p38 MAPK). Another MAPK, extracellular signal-related kinase (ERK), is involved in PLT activation. The aim of this study was to compare the properties of platelets stored in plasma in the presence or absence of p38 and ERK MAPK inhibitors. Materials and Methods: A single Trima apheresis platelet unit (n = 12) was aliquoted into five CLX storage bags. Two aliquots were continuously agitated with or without MAPK inhibitors. Two aliquots were subjected to 48 hours of interruption of agitation with or without MAPK inhibitors. One aliquot contained the same amount of solvent vehicle used to deliver the inhibitor. Platelets were stored at 20-24 degrees C for 7 days and sampled on Days 1, 4, and 7 for 18 in vitro parameters. Results: Inhibition of p38 MAPK by VX-702 leads to better maintenance of all platelet in vitro storage parameters including platelet mitochondrial function. Accelerated by interruption of agitation, the platelet storage lesion of units stored with VX-702 was diminished to that of platelets stored with continuous agitation. Inhibition of ERK MAPK did not ameliorate decrements in any in vitro platelet properties. Conclusion: Signaling through p38 MAPK, but not ERK, is associated with platelet deterioration during storage.	[Skripchenko, Andrey; Awatefe, Helen; Thompson-Montgomery, Dedeene; Myrup, Andrew; Turgeon, Annette; Wagner, Stephen J.] Amer Red Cross Biomed Serv, Holland Lab, Rockville, MD USA	American Red Cross	Skripchenko, A (corresponding author), Amer Red Cross Biomed Serv, Holland Lab, Rockville, MD USA.	Andrey.Skripchenko@redcross.org						Bazuine M, 2005, ENDOCRINOLOGY, V146, P1818, DOI 10.1210/en.2004-1347; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706; Cardigan R, 2003, TRANSFUSION MED, V13, P173, DOI 10.1046/j.1365-3148.2003.00449.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cauwenberghs S, 2007, TRANSFUS MED REV, V21, P287, DOI 10.1016/j.tmrv.2007.05.004; Chambers MA, 2009, J PHYSIOL-LONDON, V587, P3363, DOI 10.1113/jphysiol.2008.165639; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dumont LJ, 2010, TRANSFUSION, V50, P589, DOI 10.1111/j.1537-2995.2009.02460.x; Gordi T, 2004, CLIN THER, V26, P780, DOI 10.1016/S0149-2918(04)90078-1; Holme S, 1998, TRANSFUSION, V38, P31, DOI 10.1046/j.1537-2995.1998.38198141495.x; HOLME S, 1978, BLOOD, V52, P425; HOLME S, 1978, J LAB CLIN MED, V92, P53; Jaswal JS, 2007, AM J PHYSIOL-HEART C, V292, pH1978, DOI 10.1152/ajpheart.01121.2006; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Leaver HA, 2006, PLATELETS, V17, P368, DOI 10.1080/09537100600757216; Lee MR, 2005, CURR MED CHEM, V12, P2979, DOI 10.2174/092986705774462914; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Ohto H, 2011, TRANSFUS APHER SCI, V44, P321, DOI 10.1016/j.transci.2011.03.008; Okada T, 2005, AM J PHYSIOL-HEART C, V289, pH2310, DOI 10.1152/ajpheart.00462.2005; Paliga AJM, 2005, BIOL CELL, V97, P629, DOI 10.1042/BC20040146; Perrotta PL, 2003, TRANSFUSION, V43, P526, DOI 10.1046/j.1537-2995.2003.00349.x; Picker SM, 2009, VOX SANG, V97, P26, DOI 10.1111/j.1423-0410.2009.01176.x; RINDER HM, 1991, TRANSFUSION, V31, P409, DOI 10.1046/j.1537-2995.1991.31591263195.x; Saeed SA, 2007, PHARMACOL REP, V59, P238; Schubert P, 2010, TRANSFUSION, V50, p62A; Schubert P, 2009, TRANSFUSION, V49, P1944, DOI 10.1111/j.1537-2995.2009.02224.x; Shah VP, 2012, THROMB RES, V129, P36, DOI 10.1016/j.thromres.2011.08.010; SHIMIZU T, 1988, TOHOKU J EXP MED, V156, P91, DOI 10.1620/tjem.156.91; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Skripchenko A, 2010, TRANSFUSION, V50, P390, DOI 10.1111/j.1537-2995.2009.02450.x; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; van der Meer PF, 2011, TRANSFUS APHER SCI, V44, P297, DOI 10.1016/j.transci.2011.03.005; Wagner SJ, 2008, TRANSFUSION, V48, P1072, DOI 10.1111/j.1537-2995.2008.01690.x	39	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70732	10.1371/journal.pone.0070732	http://dx.doi.org/10.1371/journal.pone.0070732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967093	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800016
J	Abizari, AR; Pilime, N; Armar-Klemesu, M; Brouwer, ID				Abizari, Abdul-Razak; Pilime, Nerisa; Armar-Klemesu, Margaret; Brouwer, Inge D.			Cowpeas in Northern Ghana and the Factors that Predict Caregivers' Intention to Give Them to Schoolchildren	PLOS ONE			English	Article							HEALTH BELIEF MODEL; PLANNED BEHAVIOR; PHYTIC ACID; VIGNA-UNGUICULATA; CONSUMER PREFERENCES; IRON BIOAVAILABILITY; TEMPORAL STABILITY; YOUNG-WOMEN; MOLAR RATIO; CONSUMPTION	Background: Cowpeas are important staple legumes among the rural poor in northern Ghana. Our objectives were to assess the iron and zinc content of cowpea landraces and identify factors that predict the intention of mothers/caregivers to give cowpeas to their schoolchildren. Methods and Findings: We performed biochemical analysis on 14 landraces of cowpeas and assessed the opinion of 120 caregiver-child pairs on constructs based on the combined model of the Theory of Planned Behaviour and Health Belief Model. We used correlations and multiple regressions to measure simple associations between constructs and identify predictive constructs. Cowpea landraces contained iron and zinc in the range of 4.9-8.2 mg/100 gd.w and 2.7-4.1 mg/100 gd.w respectively. The landraces also contained high amounts of phytate (477-1110 mg/100 gd.w) and polyphenol (327-1055 mg/100 gd.w). Intention of mothers was strongly associated (r(s) = 0.72, P<0.001) with and predicted (beta = 0.63, P<0.001) behaviour. The constructs, barriers (beta = -0.42, P = 0.001) and attitudes towards behaviour (beta = 0.25, P<0.028), significantly predicted intention albeit the predictive ability of the model was weak. Conclusions: We conclude that some cowpea landraces from northern Ghana have appreciable amounts of iron and zinc but probably with poor bioavailability. Attitudes towards giving cowpeas and perception of barriers are important predictors of caregivers' intention to give cowpeas to their schoolchildren. Finally our results suggest that increasing knowledge on nutritional benefits of cowpeas may increase health values caregivers hold for their children in support of giving cowpeas to schoolchildren.	[Abizari, Abdul-Razak; Pilime, Nerisa; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Abizari, Abdul-Razak] Univ Dev Studies, Sch Med & Hlth Sci, Dept Community Nutr, Tamale, Ghana; [Armar-Klemesu, Margaret] Univ Ghana, Noguchi Mem Inst Med Res, Dept Nutr, Legon, Ghana	Wageningen University & Research; University for Development Studies; University of Ghana	Abizari, AR (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	abizaria@yahoo.com	Brouwer, Inge D/K-8455-2013	Brouwer, Inge/0000-0002-2554-7227	Interdisciplinary Research and Education Fund (INREF) of Wageningen University	Interdisciplinary Research and Education Fund (INREF) of Wageningen University	Research was supported by the Interdisciplinary Research and Education Fund (INREF) of Wageningen University through the TELFUN (Tailoring food sciences to Endogenous patterns of Local food supply for FUture Nutrition) Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2012, J NUTR, V142, P1950, DOI 10.3945/jn.112.164095; Abizari AR, 2012, J NUTR, V142, P1836, DOI 10.3945/jn.112.165753; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; AKINYELE IO, 1987, BRIT J NUTR, V58, P31, DOI 10.1079/BJN19870066; Allen L, 2006, GUIDELINES FOOD FORT; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Aykroyd W, 1982, LEGUMES HUMAN NUTR; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Conner M, 2000, BRIT J SOC PSYCHOL, V39, P469, DOI 10.1348/014466600164598; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dovlo F. E., 1976, COWPEAS HOME PREPARA; Fanou-Fogny N, 2011, J NUTR EDUC BEHAV, V43, P219, DOI 10.1016/j.jneb.2010.03.008; Field A, 2013, DISCOVERING STAT USI; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Giami SY, 2005, J FOOD COMPOS ANAL, V18, P665, DOI 10.1016/j.jfca.2004.06.007; Gibson Rosalind S., 1994, Nutrition Research Reviews, V7, P151, DOI 10.1079/NRR19940010; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137; Kim KW, 2003, J NUTR EDUC BEHAV, V35, P294, DOI 10.1016/S1499-4046(06)60343-6; Kraemer K, 2007, NUTR ANEMIA; Langyintuo AS, 2004, AGR ECON-BLACKWELL, V30, P203, DOI [10.1111/j.1574-0862.2004.tb00189.x, 10.1016/j.agecon.2002.12.001]; Lynch SR, 2005, BEST PRACT RES CL HA, V18, P333, DOI 10.1016/j.beha.2004.09.003; Macharia-Mutie CW, 2011, ECOL FOOD NUTR, V50, P375, DOI 10.1080/03670244.2011.604584; Madode YE, 2012, INT J FOOD SCI TECH, V47, P2636, DOI 10.1111/j.1365-2621.2012.03146.x; MAKOWER RU, 1970, CEREAL CHEM, V47, P288; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; Mills C. F., 1996, TRAC EL HUM NUTR HLT; Mishili FJ, 2009, AGRIBUSINESS, V25, P16, DOI 10.1002/agr.20184; MORRIS ER, 1989, BIOL TRACE ELEM RES, V19, P107, DOI 10.1007/BF02925452; Murdock LL, 2003, FIELD CROP RES, V82, P169, DOI 10.1016/S0378-4290(03)00036-4; NDUBUAKU VO, 1989, APPETITE, V13, P171, DOI 10.1016/0195-6663(89)90010-X; Osteras N, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-14; Petry N, 2010, J NUTR, V140, P1977, DOI 10.3945/jn.110.125369; Phillips RD, 2003, FIELD CROP RES, V82, P193, DOI 10.1016/S0378-4290(03)00038-8; Poss J E, 2001, ANS Adv Nurs Sci, V23, P1; Quaye W, 2009, AFR J AGR RES, V4, P311; Rah JH, 2004, J NUTR EDUC BEHAV, V36, P238, DOI 10.1016/S1499-4046(06)60386-2; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Samuel Folake Olukemi, 2002, Food and Nutrition Bulletin, V23, P248; Sheeran P, 1999, PERS SOC PSYCHOL B, V25, P721; Sheeran P, 1999, EUR J SOC PSYCHOL, V29, P403, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<403::AID-EJSP942>3.0.CO;2-A; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Sun XY, 2006, J NUTR EDUC BEHAV, V38, P276, DOI [10.1016/j.jneb.2006.04.144, 10.1016/J.JNEB.2006.04.144]; TKDA, 2012, TOL KUMB DISTR PROF; TURNLUND JR, 1984, AM J CLIN NUTR, V40, P1071, DOI 10.1093/ajcn/40.5.1071; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; World Health Organization, 2001, IR DEF AN ASS PREV C; [No title captured]	51	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72087	10.1371/journal.pone.0072087	http://dx.doi.org/10.1371/journal.pone.0072087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951289	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300178
J	Julian, MW; Shao, GH; VanGundy, ZC; Papenfuss, TL; Crouser, ED				Julian, Mark W.; Shao, Guohong; VanGundy, Zachary C.; Papenfuss, Tracey L.; Crouser, Elliott D.			Mitochondrial Transcription Factor A, an Endogenous Danger Signal, Promotes TNF alpha Release via RAGE- and TLR9-Responsive Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							NECROTIC CELLS; I IFN; RECEPTOR; HMGB1; ACTIVATION; BINDING; INFLAMMATION; TRAFFICKING; AMPHOTERIN; INHIBITOR	Objective: Mitochondrial transcription factor A (TFAM) is normally bound to and remains associated with mitochondrial DNA (mtDNA) when released from damaged cells. We hypothesized that TFAM, bound to mtDNA (or equivalent CpG-enriched DNA), amplifies TNF alpha release from TLR9-expressing plasmacytoid dendritic cells (pDCs) by engaging RAGE. Materials and Methods: Murine Flt3 ligand-expanded splenocytes obtained from C57BL/6 mice were treated with recombinant human TFAM, alone or in combination with CpG-enriched DNA with subsequent TNF alpha release measured by ELISA. The role of RAGE was determined by pre-treatment with soluble RAGE or heparin or by employing matching RAGE (-/-) splenocytes. TLR9 signaling was evaluated using a specific TLR9-blocking oligonucleotide and by inhibiting endosomal processing, PI3K and NF-kappa B. Additional studies examined whether heparin sulfate moieties or endothelin converting enzyme-1 (ECE-1)-dependent recycling of endosomal receptors were required for TFAM and CpG DNA recognition. Main Results: TFAM augmented splenocyte TNF alpha release in response to CpGA DNA, which was strongly dependent upon pDCs and regulated by RAGE and TLR9 receptors. Putative TLR9 signaling pathways, including endosomal acidification and signaling through PI3K and NF-kappa B, were essential for splenocyte TNF alpha release in response to TFAM+CpGA DNA. Interestingly, TNF alpha release depended upon endothelin converting enzyme (ECE)-1, which cleaves and presumably activates TLR9 within endosomes. Recognition of the TFAM-CpGA DNA complex was dependent upon heparin sulfate moieties, and recombinant TFAM Box 1 and Box 2 proteins were equivalent in terms of augmenting TNF alpha release. Conclusions: TFAM promoted TNF alpha release in a splenocyte culture model representing complex cell-cell interactions in vivo with pDCs playing a critical role. To our knowledge, this study is the first to incriminate ECE-1-dependent endosomal cleavage of TLR9 as a critical step in the signaling pathway leading to TNF alpha release. These findings, and others reported herein, significantly advance our understanding of sterile immune responses triggered by mitochondrial danger signals.	[Julian, Mark W.; Shao, Guohong; Crouser, Elliott D.] Ohio State Univ, Wexner Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [VanGundy, Zachary C.; Papenfuss, Tracey L.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Crouser, ED (corresponding author), Ohio State Univ, Wexner Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Elliott.Crouser@osumc.edu	Crouser, Elliott/E-2933-2011; Crouser, Elliott/ABC-2602-2021		NIH [R21-AI083912, RO3-AI62740]; DHLRI Davis Developmental Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083912, R03AI062740] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHLRI Davis Developmental Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding sources for this study are: NIH grants R21-AI083912 and RO3-AI62740 (EDC), and the DHLRI Davis Developmental Grant (EDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Bauer S, 2013, IMMUNOL LETT, V149, P85, DOI 10.1016/j.imlet.2012.11.003; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; Christie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028268; Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae; Duan XB, 2008, J LEUKOCYTE BIOL, V83, P305, DOI 10.1189/jlb.0407228; ENGEL A, 2010, SCI SIGNAL, V150, pE45; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gottmann U, 2007, TRANSPL INT, V20, P542, DOI 10.1111/j.1432-2277.2007.00471.x; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hoene V, 2006, J LEUKOCYTE BIOL, V80, P1328, DOI 10.1189/jlb.0106011; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Huttunen HJ, 2002, CANCER RES, V62, P4805; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kajino K, 2007, IMMUNOLOGY, V120, P28, DOI 10.1111/j.1365-2567.2006.02474.x; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; LI Y, 2011, EMBO J, V31, P919, DOI DOI 10.1038/EMB0J.2011.441.PUBMED:22258621; Mach N, 2000, CANCER RES, V60, P3239; Matsumura Y, 2000, JPN J PHARMACOL, V84, P16, DOI 10.1254/jjp.84.16; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nair JR, 2005, BBA-MOL CELL RES, V1746, P38, DOI 10.1016/j.bbamcr.2005.08.004; Noel G, 2007, SHOCK, V27, P312, DOI 10.1097/01.shk.0000239753.75088.5e; Papenfuss TL, 2007, J LEUKOCYTE BIOL, V82, P1510, DOI 10.1189/jlb.0406257; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Umekawa K, 2000, JPN J PHARMACOL, V84, P7, DOI 10.1254/jjp.84.7; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Xu D, 2011, J BIOL CHEM, V286, P41736, DOI 10.1074/jbc.M111.299685; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	52	55	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72354	10.1371/journal.pone.0072354	http://dx.doi.org/10.1371/journal.pone.0072354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951313	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300191
J	Adler, PH; Huang, YT; Reeves, WK; Kim, SK; Otsuka, Y; Takaoka, H				Adler, Peter H.; Huang, Yao-Te; Reeves, Will K.; Kim, Sam Kyu; Otsuka, Yasushi; Takaoka, Hiroyuki			Macrogenomic Evidence for the Origin of the Black Fly Simulium suzukii (Diptera: Simuliidae) on Okinawa Island, Japan	PLOS ONE			English	Article							RYUKYU ARCHIPELAGO; PALEOGEOGRAPHIC IMPLICATIONS; POPULATION-GENETICS; FLIES; COLONIZATION; CYTOGENETICS; COLEOPTERA; EVOLUTION; INTRODUCTIONS; EPIDEMIOLOGY	To determine the geographic origin of the black fly Simulium suzukii on Okinawa Island, Japan, macrogenomic profiles derived from its polytene chromosomes were compared with those of mainland and other insular populations of S. suzukii and of the isomorphic Simulium tani species complex. The Okinawan population is a chromosomally unique cytoform, designated 'D,' which is essentially monomorphic and differs by about 27 fixed rearrangements from the chromosomal standard sequence for the subgenus Simulium and by two fixed differences from its nearest known relative, representing the type of S. suzukii, on the main islands of Japan. Chromosomal band sequences revealed two additional, sympatric cytoforms of S. suzukii, designated 'A' and 'B,' each with species status, in Korea, and a third cytoform, designated 'C,' on Hokkaido, Japan. A new cytoform, 'K,' of S. tani from Malaysia, representing the type of S. tani, is more closely related to cytoforms in Thailand, as are populations from Taiwan previously treated as S. suzukii but more closely aligned with S. tani and newly recognized as cytoform 'L' of the latter nominal species. Rooting of chromosomal band sequences by outgroup comparisons allowed directionality of chromosomal rearrangements to be established, enabling phylogenetic inference of cytoforms. Of 41 macrogenomic rearrangements discovered in the five new cytoforms, four provide evidence for a stepwise origin of the Okinawan population from populations characteristic of the main islands of Japan. The macrogenomic approach applied to black flies on Okinawa Island illustrates its potential utility in defining source areas for other species of flies including those that might pose medical and veterinary risks.	[Adler, Peter H.; Huang, Yao-Te] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC 29631 USA; [Huang, Yao-Te] Natl Chiayi Univ, Dept Plant Med, Chiayi, Taiwan; [Reeves, Will K.] US Air Force Sch Aerosp Med, Wright Patterson AFB, OH USA; [Kim, Sam Kyu] Kangwon Natl Univ, Dept Appl Biol, Chunchon, South Korea; [Otsuka, Yasushi] Oita Univ, Dept Infect Dis Control, Oita 87011, Japan; [Takaoka, Hiroyuki] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	Clemson University; National Chiayi University; Kangwon National University; Oita University; Universiti Malaya	Adler, PH (corresponding author), Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC 29631 USA.	padler@clemson.edu	Takaoka, Hiroyuki/G-6120-2010		National Science Foundation [DEB-0841636, DEB-0933218]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700433]; Malaysian government Fundamental Research Grant Scheme [FP016-2012A]; University of Malaya [RP003A-13SUS]; Direct For Biological Sciences [0933218, 0841636] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Malaysian government Fundamental Research Grant Scheme; University of Malaya(Universiti Malaya); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded, in part, by National Science Foundation grants DEB-0841636 (under the American Recovery and Reinvestment Act of 2009) and DEB-0933218 (http://www.nsf.gov/). This is Technical Contribution No. 6103 of the Clemson University Experiment Station based on work supported in part by the Cooperative State Research, Education, and Extension Service/United States Department of Agriculture (Project No. SC-1700433). We also acknowledge support from the Malaysian government Fundamental Research Grant Scheme (Project No. FP016-2012A) and University of Malaya (RP003A-13SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedraabo Sandra, 1993, Bulletin de la Societe Entomologique de France, V98, P108; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2005, J BIOGEOGR, V32, P211, DOI 10.1111/j.1365-2699.2004.01156.x; Adler PH, 2001, CAN J ZOOL, V79, P1972, DOI 10.1139/cjz-79-11-1972; Adler PH, 2013, WORLD BLACKFLIES DIP; Adler PH, 2004, BLACK FLIES SIMULIID; ANDERSON JR, 1987, CAN ENTOMOL, V119, P29, DOI 10.4039/Ent11929-1; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; BEDO DG, 1975, CAN J ZOOL, V53, P1147, DOI 10.1139/z75-134; BEDO DG, 1989, GENOME, V32, P570, DOI 10.1139/g89-484; BEDO DG, 1979, EVOLUTION, V33, P309, DOI [10.1111/j.1558-5646.1979.tb04684.x, 10.2307/2407621]; BROCKHOUSE C, 1985, CAN J ZOOL, V63, P2145, DOI 10.1139/z85-316; COLBO MH, 1980, CAN J ZOOL, V58, P1483, DOI 10.1139/z80-204; Crosskey R.W., 1990, NATURAL HIST BLACKFL; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Giannoulis T, 2012, B ENTOMOL RES, V102, P325, DOI 10.1017/S0007485311000733; Hadi Upik Kesumawati, 1995, Japanese Journal of Sanitary Zoology, V46, P235; Huang Yao-Te, 2011, Medical Entomology and Zoology, V62, P23; Ito N, 2010, ZOOL SCI, V27, P313, DOI 10.2108/zsj.27.313; Kimura M., 2000, TROPICS, V10, P5, DOI [10.3759/tropics.10.5, DOI 10.3759/TROPICS.10.5]; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Matsui M, 2005, MOL PHYLOGENET EVOL, V37, P733, DOI 10.1016/j.ympev.2005.04.030; Ogata K., 1966, Kontyu, V34, P123; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Pramual P, 2008, CYTOLOGIA, V73, P293, DOI 10.1508/cytologia.73.293; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; Reeves WK, 2011, P ENTOMOL SOC WASH, V113, P371, DOI 10.4289/0013-8797.113.3.371; Ribera I, 2003, MOL ECOL, V12, P153, DOI 10.1046/j.1365-294X.2003.01711.x; Richardson JE, 2003, EVOLUTION, V57, P816; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K. H., 1956, JOUR HEREDITY, V47, P113; ROTHFELS KH, 1979, ANNU REV ENTOMOL, V24, P507, DOI 10.1146/annurev.en.24.010179.002451; Sert H, 2009, MAMM BIOL, V74, P286, DOI 10.1016/j.mambio.2008.05.008; Takahashi A, 2008, PAC SCI, V62, P395, DOI 10.2984/1534-6188(2008)62[395:SROLPT]2.0.CO;2; TAKAOKA H, 1979, PAC INSECTS, V20, P365; Takaoka H, 1977, Japanese Journal of Sanitary Zoology, V28, P193; Takaoka H., 1976, Japanese J Sanit Zool, V27, P385; Takaoka H., 1976, Japanese J Sanit Zool, V27, P163; Takaoka H., 1977, Japanese Journal of Sanitary Zoology, V28, P219; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Thornton I, 2007, ECOL REV, P1, DOI 10.1017/CBO9780511618710; Van der Geer A., 2010, EVOLUTION ISLAND MAM	44	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70765	10.1371/journal.pone.0070765	http://dx.doi.org/10.1371/journal.pone.0070765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951001	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200017
J	Santulli, P; Borghese, B; Lemarechal, H; Leconte, M; Millischer, AE; Batteux, F; Chapron, C; Borderie, D				Santulli, Pietro; Borghese, Bruno; Lemarechal, Herve; Leconte, Mahaut; Millischer, Anne-Elodie; Batteux, Frederic; Chapron, Charles; Borderie, Didier			Increased Serum Oxidative Stress Markers in Women with Uterine Leiomyoma	PLOS ONE			English	Article							INFILTRATING ENDOMETRIOSIS; LIPID-PEROXIDATION; PROTEIN OXIDATION; GROWTH-FACTORS; CELLS; FIBROIDS; HYSTERECTOMY; PATHOGENESIS; FIBROCYTES; MEDIATORS	Background: Uterine leiomyomas (fibroids) are the most common gynaecological benign tumors in premenopausal women. Evidences support the role of oxidative stress in the development of uterine leiomyoma. We have analysed oxidative stress markers (thiols, advanced oxidized protein products (AOPP), protein carbonyls and nitrates/nitrites) in preoperative sera from women with histologically proven uterine leiomyoma. Methodology/Principal Findings: We conducted a laboratory study in a tertiary-care university hospital. Fifty-nine women with histologically proven uterine leiomyoma and ninety-two leiomyoma-free control women have been enrolled in this study. Complete surgical exploration of the abdominopelvic cavity was performed in each patient. Preoperative serum samples were obtained from all study participants to assay serum thiols, AOPP, protein carbonyls and nitrates/nitrites. Concentrations of serum protein carbonyl groups and AOPP were higher in leiomyoma patients than in the control group (p=0.005 and p<0.001, respectively). By contrast, serum thiol levels were lower in leiomyoma patients (p<0.001). We found positive correlations between serum AOPP concentrations and total fibroids weight (r=0.339; p=0.028), serum AOPP and serum protein carbonyls with duration of infertility (r=0.762; p=0.006 and r=0.683; p=0.021, respectively). Conclusions/Significance: This study, for the first time, reveals a significant increase of protein oxidative stress status and reduced antioxidant capacity in sera from women with uterine leiomyoma.	[Santulli, Pietro; Borghese, Bruno; Millischer, Anne-Elodie; Chapron, Charles] Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Fac Med,Dept Gynecol Obstet &, F-75679 Paris, France; [Santulli, Pietro; Leconte, Mahaut; Batteux, Frederic; Chapron, Charles] Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Fac Med,Lab Immunol,EA 1833, F-75679 Paris, France; [Santulli, Pietro; Borghese, Bruno; Chapron, Charles] Univ Paris 05, Sorbonne Paris Cite, Unite Rech U1016, Fac Med,INSERM,Inst Cochin,CNRS,UMR 8104, F-75679 Paris, France; [Lemarechal, Herve; Borderie, Didier] Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Fac Med,Lab Biochem, F-75679 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Santulli, P (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Fac Med,Dept Gynecol Obstet &, F-75679 Paris, France.	pietro.santulli@cch.aphp.fr	Batteux, Frederic/O-7889-2017; Santulli, Pietro/T-5201-2019; Santulli, Pi/O-8756-2017; Chapron, Charles/O-8567-2017	Batteux, Frederic/0000-0002-1265-7996; Borghese, Bruno/0000-0002-6385-5829				Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alexandre J, 2006, J NATL CANCER I, V98, P236, DOI 10.1093/jnci/djj049; Allanore Y, 2004, AM J MED, V116, P595, DOI 10.1016/j.amjmed.2003.11.022; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Benaglia L, 2011, FERTIL STERIL, V95, P2489, DOI 10.1016/j.fertnstert.2010.12.051; Bolton JL, 2002, TOXICOLOGY, V177, P55, DOI 10.1016/S0300-483X(02)00195-6; Borghese B, 2010, J GYNECOL OBST BIO R, V39, P196, DOI 10.1016/j.jgyn.2010.03.006; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Casini ML, 2006, GYNECOL ENDOCRINOL, V22, P106, DOI 10.1080/09513590600604673; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2010, FERTIL STERIL, V94, P2353, DOI 10.1016/j.fertnstert.2010.04.020; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; Chegini N, 2010, SEMIN REPROD MED, V28, P179, DOI 10.1055/s-0030-1251476; Chiou JF, 1999, CLIN BIOCHEM, V32, P189, DOI 10.1016/S0009-9120(98)00110-6; Ciarmela P, 2011, HUM REPROD UPDATE, V17, P772, DOI 10.1093/humupd/dmr031; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2228, DOI 10.1002/art.23645; Dousset B, 2010, ANN SURG, V251, P887, DOI 10.1097/SLA.0b013e3181d9722d; Dubuisson JB, 2001, HUM REPROD, V16, P1726, DOI 10.1093/humrep/16.8.1726; Eude I, 2001, EUR J ENDOCRINOL, V144, P543, DOI 10.1530/eje.0.1440543; Fauconnier A, 2002, FERTIL STERIL, V78, P719, DOI 10.1016/S0015-0282(02)03331-9; Foksinski M, 2000, FREE RADICAL BIO MED, V29, P597, DOI 10.1016/S0891-5849(00)00358-0; Grudzien MM, 2010, FERTIL STERIL, V93, P1290, DOI 10.1016/j.fertnstert.2008.11.018; Hartmann KE, 2006, OBSTET GYNECOL, V108, P930, DOI 10.1097/01.AOG.0000234651.41000.58; Hsieh YY, 2007, FERTIL STERIL, V87, P886, DOI 10.1016/j.fertnstert.2006.07.1541; HU ML, 1993, J LAB CLIN MED, V121, P257; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kavian N, 2012, ARTHRITIS RHEUM-US, V64, P3430, DOI 10.1002/art.34534; Keeley EC, 2009, THROMB HAEMOSTASIS, V101, P613, DOI 10.1160/TH08-11-0726; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Laurent A, 2005, CANCER RES, V65, P948; Leconte M, 2011, AM J PATHOL, V179, P880, DOI 10.1016/j.ajpath.2011.04.020; Lemarechal H, 2006, CLIN CHIM ACTA, V372, P147, DOI 10.1016/j.cca.2006.04.002; Lemarechal H, 2007, FREE RADICAL RES, V41, P688, DOI 10.1080/10715760701294468; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Pejic S, 2006, BIOL RES, V39, P619, DOI 10.4067/S0716-97602006000500005; Piketty M, 2009, HUM REPROD, V24, P602, DOI 10.1093/humrep/den405; Pillet MCL, 2012, HUM REPROD, V27, P265, DOI 10.1093/humrep/der346; Pillet MCL, 2009, HUM REPROD, V24, P842, DOI 10.1093/humrep/den467; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Salama SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007356; Sastry KVH, 2002, ANAL BIOCHEM, V306, P79, DOI 10.1006/abio.2002.5676; Somigliana E, 2011, HUM REPROD, V26, P834, DOI 10.1093/humrep/der015; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Sugino N, 2007, PLACENTA, V28, pS133, DOI 10.1016/j.placenta.2006.12.002; Vural M, 2012, J OBSTET GYNAECOL, V32, P68, DOI 10.3109/01443615.2011.633718; Wegienka G, 2012, MED HYPOTHESES, V79, P226, DOI 10.1016/j.mehy.2012.04.046; WILCOX LS, 1994, OBSTET GYNECOL, V83, P549, DOI 10.1097/00006250-199404000-00011; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Yuge A, 2007, HUM REPROD, V22, P938, DOI 10.1093/humrep/del485	56	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72069	10.1371/journal.pone.0072069	http://dx.doi.org/10.1371/journal.pone.0072069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951284	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200077
J	Flores-Moreno, H; Moles, AT				Flores-Moreno, Habacuc; Moles, Angela T.			A Comparison of the Recruitment Success of Introduced and Native Species Under Natural Conditions	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; PHYLOGENETICALLY INDEPENDENT CONTRASTS; BIOLOGICAL INVASIONS; COMPARATIVE DEMOGRAPHY; PHENOTYPIC PLASTICITY; SEEDLING GROWTH; PLANT INVASIONS; INVADED RANGES; NEW-ZEALAND; ALIEN	It is commonly accepted that introduced species have recruitment advantages over native species. However, this idea has not been widely tested, and those studies that have compared survival of introduced and native species have produced mixed results. We compiled data from the literature on survival through germination (seed to seedling survival), early seedling survival (survival through one week from seedling emergence) and survival to adulthood (survival from germination to first reproduction) under natural conditions for 285 native and 63 introduced species. Contrary to expectations, we found that introduced and native species do not significantly differ in survival through germination, early seedling survival, or survival from germination to first reproduction. These comparisons remained non-significant after accounting for seed mass, longevity and when including a random effect for site. Results remained consistent after excluding naturalized species from the introduced species data set, after performing phylogenetic independent contrasts, and after accounting for the effect of life form (woody/non-woody). Although introduced species sometimes do have advantages over native species (for example, through enemy release, or greater phenotypic plasticity), our findings suggest that the overall advantage conferred by these factors is either counterbalanced by advantages of native species (such as superior adaptation to local conditions) or is simply too small to be detected at a broad scale.	[Flores-Moreno, Habacuc; Moles, Angela T.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Flores-Moreno, H (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	h.floresmoreno@unsw.edu.au	Moles, Angela T/C-3083-2008	Moles, Angela T/0000-0003-2041-7762	Evolution & Ecology Research Centre at UNSW; Australian Research Council [DP 0984222]	Evolution & Ecology Research Centre at UNSW; Australian Research Council(Australian Research Council)	H.F.M. was supported by a scholarship from the Evolution & Ecology Research Centre at UNSW. A.T.M. was supported by funding from the Australian Research Council (DP 0984222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RB, 1991, NEW ZEAL J BOT, V29, P353, DOI 10.1080/0028825X.1991.10415488; Bellingham PJ, 2004, OIKOS, V106, P308, DOI 10.1111/j.0030-1299.2004.13171.x; BIERZYCHUDEK P, 1981, AM NAT, V117, P838, DOI 10.1086/283773; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Botanical Gardens Royal Kew, 2008, SEED INF DAT SID VER; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Cervera JC, 2009, PLANT ECOL, V205, P285, DOI 10.1007/s11258-009-9617-0; CAVERS PB, 1983, CAN J BOT, V61, P3578, DOI 10.1139/b83-407; Chrobock T, 2011, BASIC APPL ECOL, V12, P244, DOI 10.1016/j.baae.2011.03.001; Chun YJ, 2010, ECOL LETT, V13, P937, DOI 10.1111/j.1461-0248.2010.01498.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Corbin JD, 2010, PLANT ECOL, V209, P71, DOI 10.1007/s11258-010-9722-0; Core R Team, 2012, R LANG ENV STAT COMP; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2012, NEW PHYTOL, V194, P602, DOI 10.1111/j.1469-8137.2012.04141.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis NE, 2010, BIOL INVASIONS, V12, P1079, DOI 10.1007/s10530-009-9525-1; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; Flores-Moreno H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068541; Flory SL, 2009, BIOL CONSERV, V142, P2531, DOI 10.1016/j.biocon.2009.05.024; FRENOT Y, 1994, POLAR BIOL, V14, P473; Garcia-Serrano H, 2004, CAN J BOT, V82, P1346, DOI [10.1139/B04-097, 10.1139/b04-097]; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Grigulis K, 2001, J APPL ECOL, V38, P281, DOI 10.1046/j.1365-2664.2001.00587.x; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; HONIG MA, 1992, AUST J ECOL, V17, P305, DOI 10.1111/j.1442-9993.1992.tb00812.x; Horton JL, 2001, FOREST ECOL MANAG, V140, P239, DOI 10.1016/S0378-1127(00)00314-5; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Klink CA, 1996, J TROP ECOL, V12, P139, DOI 10.1017/S0266467400009354; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Mandak B, 2003, FLORA, V198, P45, DOI 10.1078/0367-2530-00075; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; McAlpine KG, 2008, PLANT ECOL, V197, P119, DOI 10.1007/s11258-007-9365-y; Moles AT, 2011, NEW PHYTOL, V191, P777, DOI 10.1111/j.1469-8137.2011.03732.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Morrison JA, 2007, J ECOL, V95, P1036, DOI 10.1111/j.1365-2745.2007.01270.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Pysek Petr, 2007, V193, P97; Radford IJ, 2000, OECOLOGIA, V125, P531, DOI 10.1007/s004420000474; Ramula S, 2008, J APPL ECOL, V45, P1124, DOI 10.1111/j.1365-2664.2008.01502.x; Randall RP, 2007, LOBAL COMPEDIUM WEED, P906; Rees M, 1997, J APPL ECOL, V34, P1203, DOI 10.2307/2405232; Rejmanek M, 1996, ECOLOGY, V78, P171; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanford NL, 2003, FOREST ECOL MANAG, V183, P377, DOI 10.1016/S0378-1127(03)00141-5; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Schumacher E, 2009, BIOL INVASIONS, V11, P1941, DOI 10.1007/s10530-008-9371-6; Sher AA, 2003, AM J BOT, V90, P413, DOI 10.3732/ajb.90.3.413; Sher AA, 2002, ECOL APPL, V12, P760, DOI 10.2307/3060987; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Smith MA, 1999, AUST J ECOL, V24, P35, DOI 10.1046/j.1442-9993.1999.00944.x; Sokal R. H., 1995, BIOMETRY PRINCIPLES; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Thebaud C, 1996, ECOLOGY, V77, P791, DOI 10.2307/2265502; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Van Clef M, 2001, NORTHEAST NAT, V8, P301, DOI 10.2307/3858486; Van Kleunen M, 2007, J ECOL, V95, P674, DOI 10.1111/j.1365-2745.2007.01250.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 1998, ECOLOGY, V79, P1053, DOI 10.1890/0012-9658(1998)079[1053:FCASDO]2.0.CO;2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yamashita N, 2003, J VEG SCI, V14, P15, DOI 10.1111/j.1654-1103.2003.tb02123.x	76	12	12	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72509	10.1371/journal.pone.0072509	http://dx.doi.org/10.1371/journal.pone.0072509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951326	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000086
J	Kovanen, L; Kaunisto, M; Donner, K; Saarikoski, ST; Partonen, T				Kovanen, Leena; Kaunisto, Mari; Donner, Kati; Saarikoski, Sirkku T.; Partonen, Timo			CRY2 Genetic Variants Associate with Dysthymia	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; MOOD DISORDERS; SUPRACHIASMATIC NUCLEUS; LARGE-SCALE; DEPRESSION; GENOME; IDENTIFICATION; CRYPTOCHROMES; POPULATION; EXPRESSION	People with mood disorders often have disruptions in their circadian rhythms. Recent molecular genetics has linked circadian clock genes to mood disorders. Our objective was to study two core circadian clock genes, CRY1 and CRY2 as well as TTC1 that interacts with CRY2, in relation to depressive and anxiety disorders. Of these three genes, 48 single-nucleotide polymorphisms (SNPs) whose selection was based on the linkage disequilibrium and potential functionality were genotyped in 5910 individuals from a nationwide population-based sample. The diagnoses of major depressive disorder, dysthymia and anxiety disorders were assessed with a structured interview (M-CIDI). In addition, the participants filled in self-report questionnaires on depressive and anxiety symptoms. Logistic and linear regression models were used to analyze the associations of the SNPs with the phenotypes. Four CRY2 genetic variants (rs10838524, rs7121611, rs7945565, rs1401419) associated significantly with dysthymia (false discovery rate q<0.05). This finding together with earlier CRY2 associations with winter depression and with bipolar type 1 disorder supports the view that CRY2 gene has a role in mood disorders.	[Kovanen, Leena; Partonen, Timo] Natl Inst Hlth & Welf THL, Dept Mental Hlth, Helsinki, Finland; [Kovanen, Leena; Partonen, Timo] Natl Inst Hlth & Welf THL, Subst Abuse Serv, Helsinki, Finland; [Kaunisto, Mari; Donner, Kati] Univ Helsinki, FIMM, Helsinki, Finland; [Kaunisto, Mari] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Saarikoski, Sirkku T.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Saarikoski, Sirkku T.] Minist Social Affairs & Hlth, Dept Occupat Safety & Hlth, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki	Kovanen, L (corresponding author), Natl Inst Hlth & Welf THL, Dept Mental Hlth, Helsinki, Finland.	leena.kovanen@thl.fi	Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Kovanen, Leena/0000-0002-3552-124X; Kaunisto, Mari/0000-0002-6946-9195; Donner, Kati/0000-0001-9190-4336				Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BUNNEY BG, 2012, BIOL PSYCHIAT; Cheng YC, 2012, NUCLEIC ACIDS RES, V40, pW76, DOI 10.1093/nar/gks397; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Coogan AN, 2011, WORLD J BIOL PSYCHIA, V12, P40, DOI 10.3109/15622975.2011.598389; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; DRENNAN MD, 1991, J AFFECT DISORDERS, V23, P93, DOI 10.1016/0165-0327(91)90096-B; Fiedorowicz JG, 2012, PSYCHIAT GENET, V22, P305, DOI 10.1097/YPG.0b013e3283539594; Gaspar-Barba E, 2009, J AFFECT DISORDERS, V119, P100, DOI 10.1016/j.jad.2009.02.021; Goldberg D, 1978, MANUAL GEN HLTH QUES; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Hidalgo MP, 2009, PSYCHIAT CLIN NEUROS, V63, P283, DOI 10.1111/j.1440-1819.2009.01965.x; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kitamura S, 2010, CHRONOBIOL INT, V27, P1797, DOI 10.3109/07420528.2010.516705; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lahermo P, 2006, HUM MUTAT, V27, P711, DOI 10.1002/humu.20346; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Li JZ, 2013, P NATL ACAD SCI US; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Ono D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2670; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Partonen T, 2012, J NEURAL TRANSM, V119, P1133, DOI 10.1007/s00702-012-0810-2; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raitasalo R, 2007, SOSIAALI JA TERVEYST; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Schaufeli W.B., 1996, MASLACH BURNOUT INVE; Sjoholm LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012632; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Utge SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009259; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wehr T., 1984, SEASONAL PATTERN ASS; Wisor JP, 2008, J NEUROSCI, V28, P7193, DOI 10.1523/JNEUROSCI.1150-08.2008; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x	51	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71450	10.1371/journal.pone.0071450	http://dx.doi.org/10.1371/journal.pone.0071450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951166	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000059
J	Marin, C; Ingresa-Capaccioni, S; Gonzalez-Bodi, S; Marco-Jimenez, F; Vega, S				Marin, Clara; Ingresa-Capaccioni, Sofia; Gonzalez-Bodi, Sara; Marco-Jimenez, Francisco; Vega, Santiago			Free-Living Turtles Are a Reservoir for Salmonella but Not for Campylobacter	PLOS ONE			English	Article							RISK-FACTORS; MUCOSAL SAMPLES; DISEASE BURDEN; PREVALENCE; INFECTION; ENTERICA; REPTILES; WILD; NETHERLANDS; JEJUNI	Different studies have reported the prevalence of Salmonella in turtles and its role in reptile-associated salmonellosis in humans, but there is a lack of scientific literature related with the epidemiology of Campylobacter in turtles. The aim of this study was to evaluate the prevalence of Campylobacter and Salmonella in free-living native (Emys orbicularis, n=83) and exotic (Trachemys scripta elegans, n= 117) turtles from 11 natural ponds in Eastern Spain. In addition, different types of samples (cloacal swabs, intestinal content and water from Turtle containers) were compared. Regardless of the turtle species, natural ponds where individuals were captured and the type of sample taken, Campylobacter was not detected. Salmonella was isolated in similar proportions in native (8.0+/-3.1%) and exotic (15.0+/-3.3%) turtles (p=0.189). The prevalence of Salmonella positive turtles was associated with the natural ponds where animals were captured. Captured turtles from 8 of the 11 natural ponds were positive, ranged between 3.0+/-3.1% and 60.0+/-11.0%. Serotyping revealed 8 different serovars among four Salmonella enterica subspecies: S. enterica subsp. enterica (n = 21), S. enterica subsp. salamae (n = 2), S. enterica subsp. diarizonae (n = 3), and S. enterica subsp. houtenae (n = 1). Two serovars were predominant: S. Thompson (n= 16) and S. typhimurium (n= 3). In addition, there was an effect of sample type on Salmonella detection. The highest isolation of Salmonella was obtained from intestinal content samples (12.0+/-3.0%), while lower percentages were found for water from the containers and cloacal swabs (8.0+/-2.5% and 3.0+/-1.5%, respectively). Our results imply that free-living turtles are a risk factor for Salmonella transmission, but do not seem to be a reservoir for Campylobacter. We therefore rule out turtles as a risk factor for human campylobacteriosis. Nevertheless, further studies should be undertaken in other countries to confirm these results.	[Marin, Clara; Ingresa-Capaccioni, Sofia; Gonzalez-Bodi, Sara; Vega, Santiago] Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Dept Prod Anim, Fac Vet, Valencia, Spain; [Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain	Universidad CEU Cardenal Herrera; Universitat Politecnica de Valencia	Marin, C (corresponding author), Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Dept Prod Anim, Fac Vet, Valencia, Spain.	clara.marin@uch.ceu.es	Jiménez, Francisco Marco/I-7126-2012; Vega, Santiago/AAI-3813-2021; Vega, Santiago/K-8172-2019; Marin, Clara/S-1396-2016	Jiménez, Francisco Marco/0000-0002-5226-4118; Vega, Santiago/0000-0002-4220-6029; Marin, Clara/0000-0001-6152-3778; Ingresa Capaccioni, Sofia/0000-0002-7228-8432	Conselleria de Infraestructura, Territorio y Medio Ambiente [Life09-Trachemys, Resolution 28/02/12 CITMA]	Conselleria de Infraestructura, Territorio y Medio Ambiente	This work was supported by the Conselleria de Infraestructura, Territorio y Medio Ambiente for their assistance and financial support (Life09-Trachemys, Resolution 28/02/12 CITMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; ALLOS BM, 1995, CLIN INFECT DIS, V20, P1092, DOI 10.1093/clinids/20.5.1092; Andreacchio A, 2000, ORTHOPEDICS, V23, P1201; [Anonymous], TECHN M SALM CAMP CH; Bergmire-Sweat D., 2008, Morbidity and Mortality Weekly Report, V57, P69; Brenner D, 2002, J ZOO WILDLIFE MED, V33, P311, DOI 10.1638/1042-7260(2002)033[0311:HSOWAC]2.0.CO;2; Briones V, 2004, ENVIRON MICROBIOL, V6, P868, DOI 10.1111/j.1462-2920.2004.00631.x; Burke C., 2010, Morbidity and Mortality Weekly Report, V59, P191; Carrique-Mas JJ, 2008, REV SCI TECH OIE, V27, P657, DOI 10.20506/rst.27.3.1825; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1206; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P347; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1009; Chambers DL, 2006, APPL ENVIRON MICROB, V72, P3771, DOI 10.1128/AEM.72.5.3771-3773.2006; Chatfield D., 2007, Morbidity and Mortality Weekly Report, V56, P649; Cyriac J, 2000, Commun Dis Public Health, V3, P66; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; DUPONTE MW, 1978, AM J VET RES, V39, P529; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FEELEY JC, 1969, PUBLIC HEALTH REP, V84, P156, DOI 10.2307/4593527; Franco A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023147; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gaertner JP, 2008, J HERPETOL, V42, P223, DOI 10.1670/07-1731.1; Geue L, 2002, VET MICROBIOL, V84, P79, DOI 10.1016/S0378-1135(01)00437-0; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; HARVEY S, 1985, J CLIN MICROBIOL, V21, P260, DOI 10.1128/JCM.21.2.260-261.1985; Harwood WJ, 1999, APPL ENVIRON MICROB, V65, P865; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Hernandez E, 2012, EURO SURVEILL, V17; Hersey EF, 1963, SALMONELLA HARTFORD, P22; Hidalgo-Vila J, 2008, RES VET SCI, V85, P449, DOI 10.1016/j.rvsc.2008.01.011; Hidalgo-Vila J, 2007, VET MICROBIOL, V119, P311, DOI 10.1016/j.vetmic.2006.08.012; Jeffrey JS, 2001, POULTRY SCI, V80, P1390, DOI 10.1093/ps/80.9.1390; Jong BC, 2005, EMERG INFECT DIS, V11, P398, DOI 10.3201/eid1103.040694; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Lafuente S, 2013, ENFERM INFEC MICR CL, V31, P32, DOI 10.1016/j.eimc.2012.05.013; Lopez B, 2012, 22 EUR C CLIN MICR I, P1578; Lynch M, 1999, J INFECTION, V38, P182, DOI 10.1016/S0163-4453(99)90248-7; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Sanchez-Jimenez MM, 2011, J INFECT DEV COUNTR, V5, P361, DOI 10.3855/jidc.1126; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Mermin J, 1997, PEDIATRICS, V99, P399, DOI 10.1542/peds.99.3.399; MITCHELL J C, 1990, Virginia Journal of Science, V41, P233; Nakadai A, 2005, J VET MED SCI, V67, P97, DOI 10.1292/jvms.67.97; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Perko-Makela P, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-18; Readel AM, 2010, HERPETOL CONSERV BIO, V5, P207; Readel Anne M., 2008, Herpetological Review, V39, P427; Richards JM, 2004, J ZOO WILDLIFE MED, V35, P562, DOI 10.1638/03-070; Rodgers GL, 2002, J PEDIAT HEMATOL ONC, V24, P75, DOI 10.1097/00043426-200201000-00020; Saelinger CA, 2006, JAVMA-J AM VET MED A, V229, P266, DOI 10.2460/javma.229.2.266; Salna B., 2005, Morbidity and Mortality Weekly Report, V54, P223; Scheelings TF, 2011, J WILDLIFE DIS, V47, P1, DOI 10.7589/0090-3558-47.1.1; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Strohl P, 2004, VET REC, V154, P56, DOI 10.1136/vr.154.2.56; Studahl A, 2000, EPIDEMIOL INFECT, V125, P269, DOI 10.1017/S0950268899004562; Thompson SA, 2000, CAMPYLOBACTER, P321; Torfoss D, 2000, Tidsskr Nor Laegeforen, V120, P3670; Tu ZC, 2004, J CLIN MICROBIOL, V42, P4405, DOI 10.1128/JCM.42.9.4405-4407.2004; Ugarte-Ruiz M, 2012, J APPL MICROBIOL, V113, P200, DOI 10.1111/j.1365-2672.2012.05323.x; Van Meervenne E, 2009, J MED MICROBIOL, V58, P1379, DOI 10.1099/jmm.0.012146-0; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Wang SC, 2008, J MICROBIOL IMMUNOL, V41, P408; WILLIAMS LP, 1965, J AMER MED ASSOC, V192, P347, DOI 10.1001/jama.1965.03080180005001; Woodward DL, 1997, J CLIN MICROBIOL, V35, P2786, DOI 10.1128/JCM.35.11.2786-2790.1997; Wybo I, 2004, ACTA CLIN BELG, V59, P232; Xia XD, 2009, INT J FOOD MICROBIOL, V129, P93, DOI 10.1016/j.ijfoodmicro.2008.11.007	70	26	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72350	10.1371/journal.pone.0072350	http://dx.doi.org/10.1371/journal.pone.0072350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951312	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700135
J	Miranda, ER; Zhuchenko, O; Toplak, M; Santhanam, B; Zupan, B; Kuspa, A; Shaulsky, G				Miranda, Edward Roshan; Zhuchenko, Olga; Toplak, Marko; Santhanam, Balaji; Zupan, Blaz; Kuspa, Adam; Shaulsky, Gad			ABC Transporters in Dictyostelium discoideum Development	PLOS ONE			English	Article							SERINE PROTEASE/ABC TRANSPORTER; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTOR; PROTEIN-KINASE; GENE; EXPRESSION; IDENTIFICATION; MORPHOGENESIS; GENERATION; TISSUE	ATP-binding cassette (ABC) transporters can translocate a broad spectrum of molecules across the cell membrane including physiological cargo and toxins. ABC transporters are known for the role they play in resistance towards anticancer agents in chemotherapy of cancer patients. There are 68 ABC transporters annotated in the genome of the social amoeba Dictyostelium discoideum. We have characterized more than half of these ABC transporters through a systematic study of mutations in their genes. We have analyzed morphological and transcriptional phenotypes for these mutants during growth and development and found that most of the mutants exhibited rather subtle phenotypes. A few of the genes may share physiological functions, as reflected in their transcriptional phenotypes. Since most of the abc-transporter mutants showed subtle morphological phenotypes, we utilized these transcriptional phenotypes to identify genes that are important for development by looking for transcripts whose abundance was unperturbed in most of the mutants. We found a set of 668 genes that includes many validated D. discoideum developmental genes. We have also found that abcG6 and abcG18 may have potential roles in intercellular signaling during terminal differentiation of spores and stalks.	[Miranda, Edward Roshan; Santhanam, Balaji; Zupan, Blaz; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Miranda, Edward Roshan; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Zhuchenko, Olga; Kuspa, Adam] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Toplak, Marko; Zupan, Blaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Santhanam, Balaji; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Ljubljana; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	gadi@bcm.edu	Zupan, Blaz/L-1595-2019	Toplak, Marko/0000-0003-4413-1603; Zupan, Blaz/0000-0002-5864-7056; Kuspa, Adam/0000-0002-9156-149X; Shaulsky, Gad/0000-0002-0532-0551	Dictyostelium Functional Genomics Program Project Grant from the National institutes of Health [P01 HD39691]; Slovenian Research Agency; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER	Dictyostelium Functional Genomics Program Project Grant from the National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian Research Agency(Slovenian Research Agency - Slovenia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Dictyostelium Functional Genomics Program Project Grant from the National institutes of Health (P01 HD39691) by grants from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABC, TRANSP GEN; Abe T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng095; Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEVELOPMENT, V125, P4067; Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Anjard C, 2008, DEVELOPMENT, V135, P819, DOI 10.1242/dev.018051; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Anjard C, 2011, EUKARYOT CELL, V10, P956, DOI 10.1128/EC.05053-11; Booth EO, 2005, BIOINFORMATICS, V21, P4371, DOI 10.1093/bioinformatics/bti726; Brazill DT, 2001, J CELL SCI, V114, P3923; Cabral M, 2006, EUKARYOT CELL, V5, P2024, DOI 10.1128/EC.00287-05; Campanale JP, 2012, DEVELOPMENT, V139, P783, DOI 10.1242/dev.076752; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; EARLY AE, 1988, MOL CELL BIOL, V8, P3458, DOI 10.1128/MCB.8.8.3458; FIRTEL RA, 1990, GENE DEV, V4, P18, DOI 10.1101/gad.4.1.18; FOSNAUGH KL, 1993, DEV BIOL, V157, P38, DOI 10.1006/dbio.1993.1110; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; Han Z, 1998, DEVELOPMENT, V125, P313; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Katayama T, 2008, DEV GROWTH DIFFER, V50, P645, DOI 10.1111/j.1440-169X.2008.01062.x; KAY RR, 1983, EUR J BIOCHEM, V136, P51, DOI 10.1111/j.1432-1033.1983.tb07703.x; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Khare A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000854; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KONIJN TM, 1969, J BACTERIOL, V99, P510, DOI 10.1128/JB.99.2.510-512.1969; Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Loomis WF., 1975, DICTYOSTELIUM DISCOI; Miranda Edward Roshan, 2013, Methods Mol Biol, V983, P139, DOI 10.1007/978-1-62703-302-2_8; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mu XQ, 2001, DEVELOPMENT, V128, P2569; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; SCHNITZLER GR, 1994, GENE DEV, V8, P502, DOI 10.1101/gad.8.4.502; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Uchida N, 2002, EXP HEMATOL, V30, P862, DOI 10.1016/S0301-472X(02)00879-2; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Wang B, 2002, EUKARYOT CELL, V1, P126, DOI 10.1128/EC.1.1.126-136.2002; Zhou S, 2003, BIOTECHNIQUES, V35, P1248, DOI 10.2144/03356ss04; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	50	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70040	10.1371/journal.pone.0070040	http://dx.doi.org/10.1371/journal.pone.0070040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967067	Green Submitted, Green Published, gold			2022-12-27	WOS:000323221500012
J	Fuchs, S; Zuhlke, D; Pane-Farre, J; Kusch, H; Wolf, C; Reiss, S; Binh, LTN; Albrecht, D; Riedel, K; Hecker, M; Engelmann, S				Fuchs, Stephan; Zuehlke, Daniela; Pane-Farre, Jan; Kusch, Harald; Wolf, Carmen; Reiss, Swantje; Le Thi Nguyen Binh; Albrecht, Dirk; Riedel, Katharina; Hecker, Michael; Engelmann, Susanne			Aureolib - A Proteome Signature Library: Towards an Understanding of Staphylococcus aureus Pathophysiology	PLOS ONE			English	Article							ANAEROBIC GENE-EXPRESSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STATIONARY-PHASE; SIGMA(B) REGULON; VIRULENCE; STRESS; THIOL; REGULATOR; RESPONSES	Gel-based proteomics is a powerful approach to study the physiology of Staphylococcus aureus under various growth restricting conditions. We analyzed 679 protein spots from a reference 2-dimensional gel of cytosolic proteins of S. aureus COL by mass spectrometry resulting in 521 different proteins. 4,692 time dependent protein synthesis profiles were generated by exposing S. aureus to nine infection-related stress and starvation stimuli (H2O2, diamide, paraquat, NO, fermentation, nitrate respiration, heat shock, puromycin, mupirocin). These expression profiles are stored in an online resource called Aureolib (http://www.aureolib.de). Moreover, information on target genes of 75 regulators and regulatory elements were included in the database. Cross-comparisons of this extensive data collection of protein synthesis profiles using the tools implemented in Aureolib lead to the identification of stress and starvation specific marker proteins. Altogether, 226 protein synthesis profiles showed induction ratios of 2.5-fold or higher under at least one of the tested conditions with 157 protein synthesis profiles specifically induced in response to a single stimulus. The respective proteins might serve as marker proteins for the corresponding stimulus. By contrast, proteins whose synthesis was increased or repressed in response to more than four stimuli are rather exceptional. The only protein that was induced by six stimuli is the universal stress protein SACOL1759. Most strikingly, cluster analyses of synthesis profiles of proteins differentially synthesized under at least one condition revealed only in rare cases a grouping that correlated with known regulon structures. The most prominent examples are the GapR, Rex, and CtsR regulon. In contrast, protein synthesis profiles of proteins belonging to the CodY and sigma(B) regulon are widely distributed. In summary, Aureolib is by far the most comprehensive protein expression database for S. aureus and provides an essential tool to decipher more complex adaptation processes in S. aureus during host pathogen interaction.	[Fuchs, Stephan; Zuehlke, Daniela; Pane-Farre, Jan; Kusch, Harald; Wolf, Carmen; Reiss, Swantje; Le Thi Nguyen Binh; Albrecht, Dirk; Riedel, Katharina; Hecker, Michael; Engelmann, Susanne] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Engelmann, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany.	Susanne.Engelmann@uni-greifswald.de	Kusch, Harald/I-5912-2015; Riedel, Katharina/B-6091-2015	Kusch, Harald/0000-0002-9895-2469; Riedel, Katharina/0000-0002-4629-3019; Fuchs, Stephan/0000-0002-1338-2699	Deutsche Forschungsgemeinschaft [SFB-TRR 34, FOR 585, GRK 840]; Bundesministerium fur Bildung und Forschung [031U107A/-207A, 031U213B]; EU [LSHM-CT-2006-019064]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	The study was supported by research grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) [SFB-TRR 34, FOR 585, GRK 840], Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/)(GenomikPlus) [031U107A/-207A, 031U213B] and EU (http://cordis.europa.eu/projects/home_de.html)(StaphDynamics) [LSHM-CT-2006-019064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Bichara M, 2007, MOL MICROBIOL, V65, P218, DOI 10.1111/j.1365-2958.2007.05790.x; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Chastanet A, 2003, MOL MICROBIOL, V47, P1061, DOI 10.1046/j.1365-2958.2003.03355.x; Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Engelmann Susanne, 2008, V431, P25; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Francois P, 2010, J PROTEOMICS, V73, P701, DOI 10.1016/j.jprot.2009.10.007; Frees D, 2005, ARCH MICROBIOL, V183, P286, DOI 10.1007/s00203-005-0773-x; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Fuchs S, 2010, PROTEOMICS, V10, P2982, DOI 10.1002/pmic.200900388; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gertz S, 2000, J BACTERIOL, V182, P6983, DOI 10.1128/JB.182.24.6983-6991.2000; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hecker M, 2010, INT J MED MICROBIOL, V300, P76, DOI 10.1016/j.ijmm.2009.10.006; Hecker M, 2008, PROTEOMICS, V8, P4958, DOI 10.1002/pmic.200800278; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; HUGHES J, 1980, BIOCHEM J, V191, P209, DOI 10.1042/bj1910209; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Maass S, 2011, ANAL CHEM, V83, P2677, DOI 10.1021/ac1031836; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; Novichkov PS, 2012, NUCLEIC ACIDS RES, V40, pW604, DOI 10.1093/nar/gks562; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Plikat U, 2007, PROTEOMICS, V7, P992, DOI 10.1002/pmic.200600925; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Ravcheev DA, 2011, J BACTERIOL, V193, P3228, DOI 10.1128/JB.00350-11; Reiss S, 2012, ANTIMICROB AGENTS CH, V56, P787, DOI 10.1128/AAC.05363-11; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanchez B, 2010, INT J FOOD MICROBIOL, V144, P160, DOI 10.1016/j.ijfoodmicro.2010.09.015; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schlag S, 2008, J BACTERIOL, V190, P7847, DOI 10.1128/JB.00905-08; Schmidt F, 2010, PROTEOMICS, V10, P2801, DOI 10.1002/pmic.201000045; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x; VanBogelen RA, 1999, ELECTROPHORESIS, V20, P2149, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2149::AID-ELPS2149>3.3.CO;2-E; Vinella D, 1996, J BACTERIOL, V178, P3818, DOI 10.1128/jb.178.13.3818-3828.1996; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wang W, 2006, ANTIMICROB AGENTS CH, V50, P1656, DOI 10.1128/AAC.50.5.1656-1663.2006; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Wenzel M, 2011, PROTEOMICS, V11, P3256, DOI 10.1002/pmic.201100046; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	72	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70669	10.1371/journal.pone.0070669	http://dx.doi.org/10.1371/journal.pone.0070669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967085	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800011
J	Westram, AM; Jokela, J; Keller, I				Westram, Anja Marie; Jokela, Jukka; Keller, Irene			Hidden Biodiversity in an Ecologically Important Freshwater Amphipod: Differences in Genetic Structure between Two Cryptic Species	PLOS ONE			English	Article							GAMMARUS SPP. CRUSTACEA; MICROSATELLITE MARKERS; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; COMPUTER-PROGRAM; DIVERSITY; DIFFERENTIATION; FOSSARUM; DNA; DISPERSAL	Cryptic species, i.e. species that are morphologically hard to distinguish, have been detected repeatedly in various taxa and ecosystems. In order to evaluate the importance of this finding, we have to know in how far cryptic species differ in various aspects of their biology. The amphipod Gammarus fossarum is a key invertebrate in freshwater streams and contains several cryptic species. We examined the population genetic structure, genetic diversity and demographic history of two of them (type A and type B) using microsatellite markers and asked whether they show significant differences. We present results of population genetic analyses based on a total of 37 populations from the headwaters of two major European drainages, Rhine and Rhone. We found that, in both species, genetic diversity was geographically structured among and within drainages. For type A in the Rhine and type B in the Rhone, we detected significant patterns of isolation by distance. The increase of genetic differentiation with geographical distance, however, was much higher in type A than in type B. This result indicates substantial interspecific differences in population history and/or the extent of current gene flow between populations. In the Rhine, type B does not show evidence of isolation by distance, and population differentiation is relatively low across hundreds of kilometres. The majority of these populations also show signatures of recent bottlenecks. These patterns are consistent with a recent expansion of type B into the Rhine drainage. In summary, our results suggest considerable and previously unrecognized interspecific differences in the genetic structure of these cryptic keystone species.	[Westram, Anja Marie] Univ Sheffield, Sheffield, S Yorkshire, England; [Westram, Anja Marie; Jokela, Jukka] ETH, Dept Biol, Zurich, Switzerland; [Jokela, Jukka] Eawag Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Keller, Irene] Eawag Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland; [Keller, Irene] Univ Bern, Dept Aquat Ecol & Macroevolut, Bern, Switzerland	University of Sheffield; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern	Westram, AM (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.	a.westram@sheffield.ac.uk	Keller, Irene/F-6043-2012	Jokela, Jukka/0000-0002-1731-727X; Westram, Anja Marie/0000-0003-1050-4969	Competence Center Environment and Sustainability of the ETH Domain BioChange project; Eawag discretionary funding (project AquaDiverse)	Competence Center Environment and Sustainability of the ETH Domain BioChange project; Eawag discretionary funding (project AquaDiverse)	This work was funded by the Competence Center Environment and Sustainability of the ETH Domain BioChange project and Eawag discretionary funding (project AquaDiverse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp M, 2012, FRESHWATER BIOL, V57, P969, DOI 10.1111/j.1365-2427.2012.02758.x; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Durand JD, 2002, MOL ECOL, V8, P989; Egge JJD, 2006, ZOOL SCR, V35, P581, DOI 10.1111/j.1463-6409.2006.00247.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Feulner PGD, 2006, MOL PHYLOGENET EVOL, V39, P198, DOI 10.1016/j.ympev.2005.09.008; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GEE JHR, 1988, FRESHWATER BIOL, V19, P333, DOI 10.1111/j.1365-2427.1988.tb00355.x; Gomez-Uchida D, 2009, MOL ECOL, V18, P4854, DOI 10.1111/j.1365-294X.2009.04409.x; Hanski I, 1999, METAPOPULATION ECOLO; HARGRAVE BT, 1970, J FISH RES BOARD CAN, V27, P685, DOI 10.1139/f70-073; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Huey JA, 2008, FRESHWATER BIOL, V53, P1393, DOI 10.1111/j.1365-2427.2008.01971.x; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Jazdzewski K, 2002, INVASIVE PONTO CASPI; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Marchetto F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-111; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; McGovern TM, 2003, MOL ECOL, V12, P1207, DOI 10.1046/j.1365-294X.2003.01758.x; MEIJERING MPD, 1991, HYDROBIOLOGIA, V223, P159, DOI 10.1007/BF00047637; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Muller J, 1998, J EVOLUTION BIOL, V11, P79, DOI 10.1046/j.1420-9101.1998.11010079.x; Muller J, 2000, BIOL J LINN SOC, V69, P41, DOI 10.1111/j.1095-8312.2000.tb01668.x; Muller J, 2000, MOL PHYLOGENET EVOL, V15, P260, DOI 10.1006/mpev.1999.0740; Muller J, 1998, P 4 INT CRUST C, P279; Nesbo CL, 2002, MOL ECOL, V8, P1387; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Peeters ETHM, 1998, FRESHWATER BIOL, V39, P605, DOI 10.1046/j.1365-2427.1998.00304.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Pritchard JK, 2000, GENETICS, V155, P945; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Robinson CT, 2003, AQUAT SCI, V65, P210, DOI 10.1007/s00027-003-0663-8; Rousset F, 1997, GENETICS, V145, P1219; SCHEEPMAKER M, 1989, BIJDR DIERKD, V59, P127, DOI 10.1163/26660644-05903001; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; SIEGISMUND HR, 1988, HEREDITAS, V109, P269, DOI 10.1111/j.1601-5223.1988.tb00364.x; SIEGISMUND HR, 1991, HEREDITY, V66, P419, DOI 10.1038/hdy.1991.52; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sonstebo JH, 2007, CONSERV GENET, V8, P33, DOI 10.1007/s10592-006-9145-6; SWANSON GA, 1984, J WILDLIFE MANAGE, V48, P988, DOI 10.2307/3801453; TAYLOR DJ, 1992, LIMNOL OCEANOGR, V37, P658, DOI 10.4319/lo.1992.37.3.0658; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Westram AM, 2010, CONSERV GENET RESOUR, V2, P401, DOI 10.1007/s12686-010-9287-1; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Williams HC, 2006, MOL PHYLOGENET EVOL, V40, P370, DOI 10.1016/j.ympev.2006.03.004; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x	70	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e69576	10.1371/journal.pone.0069576	http://dx.doi.org/10.1371/journal.pone.0069576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967060	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000323115800004
J	Ismail, I; Bulgiba, A				Ismail, Ismawati; Bulgiba, Awang			Predictors of Death during Tuberculosis Treatment in TB/HIV Co-Infected Patients in Malaysia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; HIV-INFECTION; TB TREATMENT; SURVIVAL; MORTALITY; COHORT; IMPACT; ADULTS	Background: Mortality among TB/HIV co-infected patients is still high particularly in developing countries. This study aimed to determine the predictors of death in TB/HIV co-infected patients during TB treatment. Methods: We reviewed medical records at the time of TB diagnosis and subsequent follow-up of all newly registered TB patients with HIV co-infection at TB clinics in the Institute of Respiratory Medicine and three public hospitals in the Klang Valley between January 2010 and September 2010. We reviewed these medical records again twelve months after their initial diagnosis to determine treatment outcomes and survival. We analysed using Kaplan-Meier and conducted multivariate Cox proportional hazards analysis to identify predictors of death during TB treatment in TB/HIV co-infected patients. Results: Of the 227 patients studied, 53 (23.3%) had died at the end of the study with 40% of deaths within two months of TB diagnosis. Survival at 2, 6 and 12 months after initiating TB treatment were 90.7%, 82.8% and 78.8% respectively. After adjusting for other factors, death in TB/HIV co-infected patients was associated with being Malay (aHR 4.48; 95% CI 1.73-11.64), CD4 T-lymphocytes count <200 cells/mu l (aHR 3.89; 95% CI 1.20-12.63), three or more opportunistic infections (aHR 3.61; 95% CI 1.04-12.55), not receiving antiretroviral therapy (aHR 3.21; 95% CI 1.76-5.85) and increase per 103 total white blood cell count per microliter (aHR 1.12; 95% CI 1.05-1.20) Conclusion: TB/HIV co-infected patients had a high case fatality rate during TB treatment. Initiation of antiretroviral therapy in these patients can improve survival by restoring immune function and preventing opportunistic infections.	[Ismail, Ismawati; Bulgiba, Awang] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Ismail, Ismawati] Minist Hlth, Putrajaya, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia	Ismail, I (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	drismawati@gmail.com	Bulgiba, Awang/B-8271-2010; Ismail, Issham/Q-9075-2017	Bulgiba, Awang/0000-0002-5313-0445; Ismail, Issham/0000-0003-0134-1870	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; University of Malaya Research Grant [PS230/2010A]	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; University of Malaya Research Grant	This work is part of the STeMM Programme supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001) and the University of Malaya Research Grant (PS230/2010A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert PL, 1997, CLIN INFECT DIS, V24, P661, DOI 10.1093/clind/24.4.661; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Catala L, 2011, INT J TUBERC LUNG D, V15, P263; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; Gadkowski LB, 2009, AIDS PATIENT CARE ST, V23, P845, DOI 10.1089/apc.2009.0030; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Girardi E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/931325; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Ministry of Health Malaysia, 2012, TB CONTR PROGR MAL A; Ministry of Health Malaysia, 2002, PRACT GUID CONTR MAN, P51; Ministry of Health Malaysia, 2011, ATL STRAT PLAN TB CO; Mohammad Zahiruddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P140; MORRIS CDW, 1989, Q J MED, V73, P1151; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Nanteza MW, 2011, J INFECT DIS, V204, P884, DOI 10.1093/infdis/jir503; Nissapatorn V., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P946; Palmieri F, 1999, INFECTION, V27, P331, DOI 10.1007/s150100050038; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Porter JDH, 1996, J ANTIMICROB CHEMOTH, V37, P113, DOI 10.1093/jac/37.suppl_B.113; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Shafer RW, 1996, AIDS, V10, P269, DOI 10.1097/00002030-199603000-00005; Sungkanuparph S, 2007, INT J TUBERC LUNG D, V11, P325; Thuy TT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000507; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Veenstra H, 2006, CLIN EXP IMMUNOL, V145, P252, DOI 10.1111/j.1365-2249.2006.03144.x; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; Whalen C, 1997, AIDS, V11, P455, DOI 10.1097/00002030-199704000-00008; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2011, GLOB TUB CONTR WHO; World Health Organization, 2004, TB HIV CLIN MAN, V2nd	41	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73250	10.1371/journal.pone.0073250	http://dx.doi.org/10.1371/journal.pone.0073250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951346	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300204
J	Li, JH; Han, YY; Zhao, QZ; Li, CH; Xie, Q; Chong, K; Xu, YY				Li, Junhua; Han, Yingying; Zhao, Qingzhen; Li, Chunhua; Xie, Qi; Chong, Kang; Xu, Yunyuan			The E3 Ligase AtRDUF1 Positively Regulates Salt Stress Responses in Arabidopsis thaliana	PLOS ONE			English	Article							ABSCISIC-ACID; UBIQUITIN-LIGASE; BETA-GLUCURONIDASE; ROOT DEVELOPMENT; OSMOTIC-STRESS; GLYCEROL; PROTEIN; SEED; GROWTH; ACCUMULATION	Ubiquitination is an important post-translational protein modification that is known to play critical roles in diverse biological processes in eukaryotes. The RING E3 ligases function in ubiquitination pathways, and are involved in a large diversity of physiological processes in higher plants. The RING domain-containing E3 ligase AtRDUF1 was previously identified as a positive regulator of ABA-mediated dehydration stress response in Arabidopsis. In this study, we report that AtRDUF1 is involved in plant responses to salt stress. AtRDUF1 expression is upregulated by salt treatment. Overexpression of AtRDUF1 in Arabidopsis results in an insensitivity to salt and osmotic stresses during germination and seedling growth. A double knock-out mutant of AtRDUF1 and its close homolog AtRDUF2 (atrduf1atrduf2) was hypersensitive to salt treatment. The expression levels of the stress-response genes RD29B, RD22, and KIN1 are more sensitive to salt treatment in AtRDUF1 overexpression plants. In summary, our data show that AtRDUF1 positively regulates responses to salt stress in Arabidopsis.	[Li, Junhua; Han, Yingying; Li, Chunhua; Chong, Kang; Xu, Yunyuan] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Li, Junhua] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Zhao, Qingzhen; Xie, Qi] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Han, Yingying] Heilongjiang Univ, Coll Life Sci, Key Lab Mol Biol, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Henan Normal University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Heilongjiang University	Xu, YY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	xuyy@ibcas.ac.cn	Xie, Qi/P-1464-2016	Xie, Qi/0000-0002-8262-9093	Chinese Ministry of Agriculture [2011ZX0 8009-003-002]; Natural Science Foundation of China [31121065]; Innovation Grant of CAS [KSCX2-EW-N-07-3]	Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Grant of CAS	This work was supported by the Program from the Chinese Ministry of Agriculture (2011ZX0 8009-003-002), the Natural Science Foundation of China for the innovation team (31121065) and the Innovation Grant of CAS (KSCX2-EW-N-07-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Block M, 1998, METH MOL B, V82, P397; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eastmond PJ, 2004, PLANT J, V37, P617, DOI 10.1111/j.1365-313X.2003.01989.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; Hare PD, 2003, CURR OPIN PLANT BIOL, V6, P453, DOI 10.1016/S1369-5266(03)00080-3; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hozain M, J PLANT PHYSL, V169, P1261; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang JF, 2007, PLANT CELL ENVIRON, V30, P690, DOI 10.1111/j.1365-3040.2007.01663.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kang M, PLANT MOL BIOL, V75, P451; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V420, P141, DOI 10.1016/j.bbrc.2012.02.131; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee R.E. Jr, 1991, P17; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lu CF, 2002, PLANT PHYSIOL, V129, P1352, DOI 10.1104/pp.006122; Managbanag JR, 2002, MYCOLOGIA, V94, P384, DOI 10.2307/3761772; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Redkar RJ, 1995, EXP MYCOL, V19, P241, DOI 10.1006/emyc.1995.1030; Salinas-Mondragon Raul E., 2000, Plant Molecular Biology, V40, P579; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; Ward JM, 2003, TRENDS PLANT SCI, V8, P200, DOI 10.1016/S1360-1385(03)00059-1; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xu RQ, 2003, PLANT MOL BIOL, V53, P37, DOI 10.1023/B:PLAN.0000009256.01620.a6; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Yanagawa Y, 2005, PLANT CELL PHYSIOL, V46, pS242; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhou J, 2009, J PLANT PHYSIOL, V166, P1296, DOI 10.1016/j.jplph.2009.02.007; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	56	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71078	10.1371/journal.pone.0071078	http://dx.doi.org/10.1371/journal.pone.0071078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951086	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300086
J	Su, HX; Zhang, YH; Xu, DZ; Wang, B; Zhang, L; Li, D; Xiao, D; Li, F; Zhang, JX; Yan, YP				Su, Haixia; Zhang, Yuhai; Xu, Dezhong; Wang, Bo; Zhang, Lei; Li, Duan; Xiao, Dan; Li, Fan; Zhang, Jingxia; Yan, Yongping			Occult Hepatitis B Virus Infection in Anti-HBs-Positive Infants Born to HBsAg-Positive Mothers in China	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CHILDREN; VACCINATION; PREVALENCE; TRANSMISSION; MUTATIONS; DISEASE; ADULTS; GENOME; AREA	Objective: To investigate the prevalence of occult HBV infection (OBI) among children and to characterize virology of occult HBV, we conducted an epidemiological survey. Methods: 186 HB-vaccinated infants born to HBsAg-positive mothers were included in the study. Serological tests for HBV markers were performed using commercial ELISA kits. Real-time quantitative PCR and nested PCR were used to detect HBV DNA. PCR products of the C and pre-S/S regions were sequenced and analyzed. Results: 1.61% (3/186) infants were HBsAg positive, and 4.92% (9/183) infants were considered as occult infection. The viral load of mothers was associated with occult infection (P = 0.020). Incomplete three-dose injections of HB vaccine was associated with HBV infection (P = 0.022). Six OBI infants were positive for anti-HBs, but their titers were not greater than 100 mIU/mL. Seven isolated HBV pre-S/S sequences were obtained from nine OBI infants. Three of the sequences were genotype C, and four of the sequences were genotype C/D. Escape mutation S143L was found in the four sequences of genotype C/D. All seven sequences lacked G145R and other escape mutation in S region. Conclusions: Occult HBV infection was detected in anti-HBs positive infants born to HBsAg-positive mothers in China. Occult infection was associated with absent anti-HBs or with low anti-HBs level, high maternal viral loads and escape mutations in the S gene.	[Su, Haixia; Xu, Dezhong; Wang, Bo; Zhang, Lei; Li, Duan; Xiao, Dan; Li, Fan; Zhang, Jingxia; Yan, Yongping] Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Yuhai] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China; [Zhang, Yuhai] Fourth Mil Med Univ, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi, Peoples R China.	yanyping@fmmu.edu.cn	Yan, Yongping/K-9634-2019	Su, Haixia/0000-0002-1154-8077	National Natural Science Foundation of China [81001269]; China Special Grant for the Prevention and Control of Infectious Diseases [2012ZX10004907]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Special Grant for the Prevention and Control of Infectious Diseases	This work was supported by grants from the National Natural Science Foundation of China (No. 81001269) and partially by the China Special Grant for the Prevention and Control of Infectious Diseases (2012ZX10004907): Infectious disease prevention and control in demonstration areas and the field epidemiological study of viral hepatitis B in Wuwei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2006, J HEPATOL, V44, P617, DOI 10.1016/j.jhep.2005.12.003; Blackberg J, 2000, J HEPATOL, V33, P992, DOI 10.1016/S0168-8278(00)80134-8; Bzowej Natalie H, 2010, Curr Hepat Rep, V9, P197, DOI 10.1007/s11901-010-0059-x; Chakvetadze C, 2011, VACCINE, V29, P2846, DOI 10.1016/j.vaccine.2011.01.101; Chang MH, 2005, CLIN CANCER RES, V11, P7953, DOI 10.1158/1078-0432.CCR-05-1095; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Chen SJ, 2012, VIRUS RES, V163, P197, DOI 10.1016/j.virusres.2011.09.029; Datta S, 2006, J MED VIROL, V78, P53, DOI 10.1002/jmv.20503; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Hamkar R, 2010, DIAGN MICR INFEC DIS, V66, P285, DOI 10.1016/j.diagmicrobio.2009.10.006; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Levicnik-Stezinar S, 2008, J HEPATOL, V48, P1022, DOI 10.1016/j.jhep.2008.02.016; Li F, 2012, VACCINE, V30, P7118, DOI 10.1016/j.vaccine.2012.09.031; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Ni YH, 2010, PATHOL BIOL, V58, P296, DOI 10.1016/j.patbio.2009.11.002; Paganelli M, 2012, J HEPATOL, V57, P885, DOI 10.1016/j.jhep.2012.03.036; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Reesink HW, 2008, VOX SANG, V94, P153, DOI 10.1111/j.1423-0410.2008.01017.x; Shahmoradi S, 2012, J HEPATOL, V57, P515, DOI 10.1016/j.jhep.2012.04.021; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Su HX, 2005, J MED VIROL, V77, P180, DOI 10.1002/jmv.20454; Svicher V, 2012, ANTIVIR RES, V93, P86, DOI 10.1016/j.antiviral.2011.10.022; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; van Hemert FJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-146; Walz A, 2009, J INFECT DIS, V200, P1227, DOI 10.1086/605698; Xu LB, 2010, VACCINE, V28, P5986, DOI 10.1016/j.vaccine.2010.06.106; Yuen MF, 2010, GUT, V59, P1389, DOI 10.1136/gut.2010.209148; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x; Zhang Li, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P305; Zhou YH, 2008, CHIN MED J, V121, P98	35	30	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70768	10.1371/journal.pone.0070768	http://dx.doi.org/10.1371/journal.pone.0070768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951004	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300050
J	Vanderperre, B; Lucier, JF; Bissonnette, C; Motard, J; Tremblay, G; Vanderperre, S; Wisztorski, M; Salzet, M; Boisvert, FM; Roucou, X				Vanderperre, Benoit; Lucier, Jean-Francois; Bissonnette, Cyntia; Motard, Julie; Tremblay, Guillaume; Vanderperre, Solene; Wisztorski, Maxence; Salzet, Michel; Boisvert, Francois-Michel; Roucou, Xavier			Direct Detection of Alternative Open Reading Frames Translation Products in Human Significantly Expands the Proteome	PLOS ONE			English	Article							GENE; IDENTIFICATION; PROTEINS; EPITOPES; CONSEQUENCES; LYMPHOCYTES; BIOMARKERS; DISCOVERY; REVEALS; SEARCH	A fully mature mRNA is usually associated to a reference open reading frame encoding a single protein. Yet, mature mRNAs contain unconventional alternative open reading frames (AltORFs) located in untranslated regions (UTRs) or overlapping the reference ORFs (RefORFs) in non-canonical +2 and +3 reading frames. Although recent ribosome profiling and footprinting approaches have suggested the significant use of unconventional translation initiation sites in mammals, direct evidence of large-scale alternative protein expression at the proteome level is still lacking. To determine the contribution of alternative proteins to the human proteome, we generated a database of predicted human AltORFs revealing a new proteome mainly composed of small proteins with a median length of 57 amino acids, compared to 344 amino acids for the reference proteome. We experimentally detected a total of 1,259 alternative proteins by mass spectrometry analyses of human cell lines, tissues and fluids. In plasma and serum, alternative proteins represent up to 55% of the proteome and may be a potential unsuspected new source for biomarkers. We observed constitutive co-expression of RefORFs and AltORFs from endogenous genes and from transfected cDNAs, including tumor suppressor p53, and provide evidence that out-of-frame clones representing AltORFs are mistakenly rejected as false positive in cDNAs screening assays. Functional importance of alternative proteins is strongly supported by significant evolutionary conservation in vertebrates, invertebrates, and yeast. Our results imply that coding of multiple proteins in a single gene by the use of AltORFs may be a common feature in eukaryotes, and confirm that translation of unconventional ORFs generates an as yet unexplored proteome.	[Vanderperre, Benoit; Bissonnette, Cyntia; Motard, Julie; Tremblay, Guillaume; Vanderperre, Solene; Roucou, Xavier] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Quebec City, PQ, Canada; [Lucier, Jean-Francois] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol, Quebec City, PQ, Canada; [Wisztorski, Maxence; Salzet, Michel] Univ Lille 1, PRISM, Lab Prote, EA 4550,SN3, F-59655 Villeneuve Dascq, France; [Boisvert, Francois-Michel] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Quebec City, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Lille - ISITE; Universite de Lille; University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Quebec City, PQ, Canada.	xavier.roucou@usherbrooke.ca	Salzet, Michel/A-7675-2011; Wisztorski, Maxence/F-4380-2010	Salzet, Michel/0000-0003-4318-0817; Wisztorski, Maxence/0000-0003-1320-075X; Vanderperre, Benoit/0000-0002-2111-1071	Canadian Institutes for Health Research [MOP-89881, MOP-123469]; Fonds de Recherche Nature et Technologies du Quebec; National Sciences and Engineering Research Council of Canada; Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche; PRISM Laboratory; Thermofisher	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Nature et Technologies du Quebec; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR)); PRISM Laboratory; Thermofisher	Most of this work was supported by an operating grant from the Canadian Institutes for Health Research MOP-89881 to XR. BV was supported in part by a scholarship from the Fonds de Recherche Nature et Technologies du Quebec and CB by a scholarship from the National Sciences and Engineering Research Council of Canada. Work in Francois-Michel Boisvert was supported by an operating grant from the Canadian Institutes for Health Research (MOP-123469). Work in Michel Salzet's laboratory was supported by the Ministere de L'Education Nationale de l'Enseignement Superieur et de la Recherche (to MS), Agence Nationale de la Recherche, and a collaboration between PRISM Laboratory and Thermofisher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m; Akimoto C, 2012, BIOCH BIOPHYS ACTA; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anikin M, 2010, NUCLEIC ACIDS MOL BI, V24, P409, DOI 10.1007/978-0-387-89382-2_19; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Bonnel D, 2011, ANAL BIOANAL CHEM, V401, P149, DOI 10.1007/s00216-011-5020-5; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Franck J, 2009, ANAL CHEM, V81, P8193, DOI 10.1021/ac901328p; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kochetov AV, 2013, J BIOMOL STRUCT DYN, V31, P103, DOI 10.1080/07391102.2012.691367; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Lemaire R, 2007, J PROTEOME RES, V6, P1295, DOI 10.1021/pr060549i; Lemaire R, 2007, J PROTEOME RES, V6, P4127, DOI 10.1021/pr0702722; Li CW, 2009, P NATL ACAD SCI USA, V106, P10770, DOI 10.1073/pnas.0902269106; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr600; Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Michel AM, 2012, GENOME RES; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pendleton LC, 2005, J BIOL CHEM, V280, P24252, DOI 10.1074/jbc.M500106200; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Ronsin C, 1999, J IMMUNOL, V163, P483; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Vanderperre B, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas025; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wills NM, 2006, RNA, V12, P1149, DOI 10.1261/rna.84406	58	127	133	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70698	10.1371/journal.pone.0070698	http://dx.doi.org/10.1371/journal.pone.0070698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950983	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300040
J	Heublein, S; Mayr, D; Vrekoussis, T; Friese, K; Hofmann, SS; Jeschke, U; Lenhard, M				Heublein, Sabine; Mayr, Doris; Vrekoussis, Thomas; Friese, Klaus; Hofmann, Simone S.; Jeschke, Udo; Lenhard, Miriam			The G-Protein Coupled Estrogen Receptor (GPER/GPR30) Is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; PHASE-II TRIAL; SURFACE EPITHELIAL-CELLS; BREAST-CANCER; GENE-EXPRESSION; LUTEINIZING-HORMONE; GROWTH PROMOTION; SURVIVAL; TAMOXIFEN; GOSERELIN	Follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHCGR) were demonstrated to impact upon survival of patients suffering from epithelial ovarian cancer (EOC). Though structure wise the G-protein coupled estrogen receptor (GPER/GPR30) is related to FSHR/LHCGR, its prognostic impact in EOC remains controversial. We recently found that FSHR negative patients represent a specific EOC subgroup that may behave differently in respect to both treatment response and prognosis. Hence, the current study aimed to analyze how GPER may interact with the FSHR/LHCGR system in EOC and whether the prognostic significance of GPER in EOC cases (n = 151) may be dependent on the FSHR/LHCGR immunophenotype of the tumor. Ovarian cancer cell lines were used to study how FSH and LH regulate GPER and whether GPER activation differentially affects in vitro cell proliferation in presence/absence of activated FSHR/LHCGR. In EOC tissue, GPER correlated with FSHR/LHCGR and was related to prolonged overall survival only in FSHR/LHCGR negative patients. Although GPER was found to be specifically induced by LH/FSH, GPER agonists (4-Hydroxy-Tamoxifen, G1) reduced EOC cell proliferation only in case of LH/FSH unstimulated pathways. To the same direction, only patients characterized as LHCGR/FSHR negative seem to gain from GPER in terms of survival. Our combined tissue and in vitro results support thus the hypothesis that GPER activation could be of therapeutic benefit in LHCGR/FSHR negative EOC patients. Further studies are needed to evaluate the impact of GPER activation on a clinical scheme.	[Heublein, Sabine; Vrekoussis, Thomas; Friese, Klaus; Hofmann, Simone S.; Jeschke, Udo] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Mayr, Doris; Friese, Klaus] Univ Munich, Dept Pathol, Munich, Germany; [Lenhard, Miriam] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany	University of Munich; University of Munich; University of Munich	Jeschke, U (corresponding author), Univ Munich, Dept Obstet & Gynaecol, Campus Innenstadt, Munich, Germany.	udo.jeschke@med.uni-muenchen.de	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235	Medical Faculty of the Ludwig Maximilians University of Munich	Medical Faculty of the Ludwig Maximilians University of Munich	This work was supported by the Medical Faculty of the Ludwig Maximilians University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almey A, 2012, ENDOCRINOLOGY, V153, P5373, DOI 10.1210/en.2012-1458; Argenta PA, 2009, GYNECOL ONCOL, V113, P205, DOI 10.1016/j.ygyno.2009.01.012; Arias-Pulido H, 2009, GYNECOL ONCOL, V114, P480, DOI 10.1016/j.ygyno.2009.05.045; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Bartsch R, 2012, EUR J CANCER, V48, P1932, DOI 10.1016/j.ejca.2012.03.002; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bowman A, 2002, CLIN CANCER RES, V8, P2233; Cheng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045529; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Choi JH, 2006, ENDOCR-RELAT CANCER, V13, P641, DOI 10.1677/erc.1.01057; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Du GQ, 2012, BIOCHEM BIOPH RES CO, V420, P343; FISHER B, 1981, NEW ENGL J MED, V305, P1, DOI 10.1056/NEJM198107023050101; Fujiwara S, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-35; Hasan J, 2005, BRIT J CANCER, V93, P647, DOI 10.1038/sj.bjc.6602752; Heublein S, 2013, J REPROD IMMUNOL, V97, P95, DOI 10.1016/j.jri.2012.10.013; Heublein S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-6; Heublein S, 2012, REPROD SCI, V19, P1197, DOI 10.1177/1933719112446085; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Jala VR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-624; Ji Q, 2004, INT J CANCER, V112, P803, DOI 10.1002/ijc.20478; Karagol H, 2007, MED ONCOL, V24, P39, DOI 10.1007/BF02685901; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kolkova Z, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-9; Kostenis E, 2002, J RECEPT SIGNAL TR R, V22, P267, DOI 10.1081/RRS-120014601; Lenhard M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-553; Lenhard M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-2; Levine D, 2007, CANCER, V110, P2448, DOI 10.1002/cncr.23072; Li Y, 2007, MOL CELL ENDOCRINOL, V267, P26, DOI 10.1016/j.mce.2006.11.010; Lu JJ, 2000, GYNECOL ONCOL, V79, P158, DOI 10.1006/gyno.2000.5928; Ng Y, 2009, MOL CELL ENDOCRINOL, V303, P25, DOI 10.1016/j.mce.2009.01.016; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Pavlik R, 2011, HISTOCHEM CELL BIOL, V136, P289, DOI 10.1007/s00418-011-0846-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REMMELE W, 1987, PATHOLOGE, V8, P138; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Wagner U, 2007, GYNECOL ONCOL, V105, P132, DOI 10.1016/j.ygyno.2006.10.053; Williams C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001034.pub2; Zheng WX, 2000, GYNECOL ONCOL, V76, P80, DOI 10.1006/gyno.1999.5628	41	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71791	10.1371/journal.pone.0071791	http://dx.doi.org/10.1371/journal.pone.0071791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951246	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200073
J	Spears, M; McSharry, C; Chaudhuri, R; Weir, CJ; de Wet, C; Thomson, NC				Spears, Mark; McSharry, Charles; Chaudhuri, Rekha; Weir, Christopher J.; de Wet, Carl; Thomson, Neil C.			Smoking in Asthma Is Associated with Elevated Levels of Corticosteroid Resistant Sputum Cytokines-An Exploratory Study	PLOS ONE			English	Article							AIRWAY INFLAMMATION; CIGARETTE-SMOKING; LUNG-FUNCTION; SMOKERS; COMBINATION; IMPROVEMENT; EOSINOPHIL; PROTEIN	Background: Current cigarette smoking is associated with reduced acute responses to corticosteroids and worse clinical outcomes in stable chronic asthma. The mechanism by which current smoking promotes this altered behavior is currently unclear. Whilst cytokines can induce corticosteroid insensitivity in-vitro, how current and former smoking affects airway cytokine concentrations and their responses to oral corticosteroids in stable chronic asthma is unclear. Objectives: To examine blood and sputum cytokine concentrations in never, ex and current smokers with asthma before and after oral corticosteroids. Methods: Exploratory study utilizing two weeks of oral dexamethasone (equivalent to 40 mg/day prednisolone) in 22 current, 21 never and 10 ex-smokers with asthma. Induced sputum supernatant and plasma was obtained before and after oral dexamethasone. 25 cytokines were measured by multiplex microbead system (Invitrogen, UK) on a Luminex platform. Results: Smokers with asthma had elevated sputum cytokine interleukin (IL) -6, -7, and -12 concentrations compared to never smokers with asthma. Few sputum cytokine concentrations changed in response to dexamethasone IL-17 and IFN alpha increased in smokers, CCL4 increased in never smokers and CCL5 and CXCL10 reduced in ex-smokers with asthma. Ex-smokers with asthma appeared to have evidence of an ongoing corticosteroid resistant elevation of cytokines despite smoking cessation. Several plasma cytokines were lower in smokers with asthma compared to never smokers with asthma. Conclusion: Cigarette smoking in asthma is associated with a corticosteroid insensitive increase in multiple airway cytokines. Distinct airway cytokine profiles are present in current smokers and never smokers with asthma and could provide an explanatory mechanism for the altered clinical behavior observed in smokers with asthma.	[Spears, Mark; McSharry, Charles; Chaudhuri, Rekha; Thomson, Neil C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Weir, Christopher J.] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Weir, Christopher J.] Univ Edinburgh, Edinburgh Med Res Council Clin Trials Methodol Hu, Edinburgh, Midlothian, Scotland; [de Wet, Carl] NHS Educ Scotland, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Edinburgh; NHS Education for Scotland	Spears, M (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	mark.spears@glasgow.ac.uk		Spears, Mark/0000-0003-4381-5819; Weir, Christopher/0000-0002-6494-4903; Thomson, Neil/0000-0003-1632-6630; McSharry, Charles/0000-0003-4758-9038	Chief Scientist's Office, Scotland [CAF/06/07]; Chief Scientist Office [CAF/06/07] Funding Source: researchfish	Chief Scientist's Office, Scotland; Chief Scientist Office	This study was supported through the award of an academic training fellowship to Dr. Mark Spears by the Chief Scientist's Office, Scotland. Grant number; CAF/06/07, http://www.scotland.gov.uk/Publications/2007/10/25102837/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 1999, J ASTHMA, V36, P257, DOI 10.3109/02770909909075409; Broekema M, 2009, AM J RESP CRIT CARE, V180, P1170, DOI 10.1164/rccm.200906-0828OC; Chalmers GW, 2002, THORAX, V57, P226, DOI 10.1136/thorax.57.3.226; Chalmers GW, 2001, CHEST, V120, P1917, DOI 10.1378/chest.120.6.1917; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Chaudhuri R, 2008, ALLERGY, V63, P132, DOI 10.1111/j.1398-9995.2007.01538.x; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Edwards MR, 2007, J BIOL CHEM, V282, P15366, DOI 10.1074/jbc.M701325200; Goleva E, 2009, AM J RESP CELL MOL, V40, P223, DOI 10.1165/rcmb.2007-0327OC; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; KAM JC, 1993, J IMMUNOL, V151, P3460; KERSTJENS HAM, 1993, EUR RESPIR J, V6, P868; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Livingston E, 2007, EUR RESPIR J, V29, P64, DOI 10.1183/09031936.06.00120505; McKay A, 2004, CLIN EXP ALLERGY, V34, P904, DOI 10.1111/j.1365-2222.2004.01973.x; Meijer RJ, 2002, CLIN EXP ALLERGY, V32, P1096, DOI 10.1046/j.1365-2222.2002.01412.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Pedersen B, 1996, AM J RESP CRIT CARE, V153, P1519, DOI 10.1164/ajrccm.153.5.8630596; Pedersen SE, 2007, J ALLERGY CLIN IMMUN, V120, P1036, DOI 10.1016/j.jaci.2007.07.016; Qiu Z, 2004, CLIN EXP ALLERGY, V34, P1321, DOI 10.1111/j.1365-2222.2004.02013.x; SHER ER, 1994, J CLIN INVEST, V93, P33, DOI 10.1172/JCI116963; Spears M, 2009, EUR RESPIR J, V33, P1010, DOI 10.1183/09031936.00158208; St-Laurent J, 2008, CLIN EXP ALLERGY, V38, P1582, DOI 10.1111/j.1365-2222.2008.03032.x; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	33	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71460	10.1371/journal.pone.0071460	http://dx.doi.org/10.1371/journal.pone.0071460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951170	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000326473200049
J	Jiang, B; Xie, DS; Liu, WR; Peng, QW; He, XM				Jiang, Biao; Xie, Dasen; Liu, Wenrui; Peng, Qingwu; He, Xiaoming			De Novo Assembly and Characterization of the Transcriptome, and Development of SSR Markers in Wax Gourd (Benicasa hispida)	PLOS ONE			English	Article							BENINCASA-HISPIDA; GENETIC DIVERSITY; ANNOTATION; GENERATION; CUCUMBER; UTILITY; GENOME; RAPD	Background: Wax gourd is a widely used vegetable of Cucuribtaceae, and also has important medicinal and health values. However, the genomic resources of wax gourd were scarcity, and only a few nucleotide sequences could be obtained in public databases. Methodology/Principal Findings: In this study, we examined transcriptome in wax gourd. More than 44 million of high quality reads were generated from five different tissues of wax gourd using Illumina paired-end sequencing technology. Approximately 4 Gbp data were generated, and de novo assembled into 65,059 unigenes, with an N50 of 1,132 bp. Based on sequence similarity search with known protein database, 36,070 (55.4%) showed significant similarity to known proteins in Nr database, and 24,969 (38.4%) had BLAST hits in Swiss-Prot database. Among the annotated unigenes, 14,994 of wax gourd unigenes were assigned to GO term annotation, and 23,977 were found to have COG classifications. In addition, a total of 18,713 unigenes were assigned to 281 KEGG pathways. Furthermore, 6,242 microsatellites (simple sequence repeats) were detected as potential molecular markers in wax gourd. Two hundred primer pairs for SSRs were designed for validation of the amplification and polymorphism. The result showed that 170 of the 200 primer pairs were successfully amplified and 49 (28.8%) of them exhibited polymorphisms. Conclusion/Significance: Our study enriches the genomic resources of wax gourd and provides powerful information for future studies. The availability of this ample amount of information about the transcriptome and SSRs in wax gourd could serve as valuable basis for studies on the physiology, biochemistry, molecular genetics and molecular breeding of this important vegetable crop.	[Jiang, Biao; Xie, Dasen; Liu, Wenrui; Peng, Qingwu; He, Xiaoming] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China; [Jiang, Biao; Xie, Dasen; Liu, Wenrui; He, Xiaoming] Guangdong Prov Key Lab New Technol Res Vegetables, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Xie, DS (corresponding author), Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China.	xiedasen@126.com			presidential foundation of Guangdong academy of agricultural sciences [201204]	presidential foundation of Guangdong academy of agricultural sciences	This work was financially supported by the presidential foundation of Guangdong academy of agricultural sciences (201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-518; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bushman BS, 2011, THEOR APPL GENET, V123, P119, DOI 10.1007/s00122-011-1571-2; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chopra R.N., 1956, GLOSSARY INDIAN MED, P35; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Gao XG, 2012, COMP BIOCHEM PHYS D, V7, P277, DOI 10.1016/j.cbd.2012.05.001; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grover JK, 2000, FITOTERAPIA, V71, P707, DOI 10.1016/S0367-326X(00)00227-6; Grover JK, 2001, J ETHNOPHARMACOL, V78, P159, DOI 10.1016/S0378-8741(01)00334-8; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang QS, 2012, AQUAT TOXICOL, V120, P54, DOI 10.1016/j.aquatox.2012.04.013; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morton JF, 1971, WAX GOURD YEAR ROUND, P104; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; Pandey S, 2008, SCI HORTIC-AMSTERDAM, V118, P80, DOI 10.1016/j.scienta.2008.05.031; Senior ML, 1998, CROP SCI, V38, P1088, DOI 10.2135/cropsci1998.0011183X003800040034x; Sharma LK, 1984, PRACTICAL NATURE CUR, P169; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Verma VK, 2007, SCI HORTIC-AMSTERDAM, V113, P231, DOI 10.1016/j.scienta.2007.03.019; Wang Y, 2002, GENOME, V45, P319, DOI 10.1139/G01-153; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Warier PK, 1994, INDIAN MED PLANTS, P261; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	38	39	51	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71054	10.1371/journal.pone.0071054	http://dx.doi.org/10.1371/journal.pone.0071054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951078	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000038
J	Vieira, AB; Coelho, LP; Insuela, DBR; Carvalho, VF; dos Santos, MH; Silva, PMR; Martins, MA				Vieira, Aline B.; Coelho, Luciana P.; Insuela, Daniella B. R.; Carvalho, Vinicius F.; dos Santos, Marcelo H.; Silva, Patricia M. R.; Martins, Marco A.			Mangiferin Prevents Guinea Pig Tracheal Contraction via Activation of the Nitric Oxide-Cyclic GMP Pathway	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; L. EXTRACT VIMANG; INDICA STEM BARK; ANTIOXIDANT ACTIVITY; IN-VITRO; RELAXATION; CELLS; MODULATION; EPITHELIUM; SYNTHASE	Previous studies have described the antispasmodic effect of mangiferin, a natural glucoside xanthone (2-C-beta-Dglucopyranosyl-1,3,6,7-tetrahydroxyxanthone) that is present in mango trees and other plants, but its mechanism of action remains unknown. The aim of this study was to examine the potential contribution of the nitric oxide-cyclic GMP pathway to the antispasmodic effect of mangiferin on isolated tracheal rings preparations. The functional effect of mangiferin on allergic and non-allergic contraction of guinea pig tracheal rings was assessed in conventional organ baths. Cultured tracheal rings were exposed to mangiferin or vehicle, and nitric oxide synthase (NOS) 3 and cyclic GMP (cGMP) levels were quantified using western blotting and enzyme immunoassays, respectively. Mangiferin (0.1-10 mu M) inhibited tracheal contractions induced by distinct stimuli, such as allergen, histamine, 5-hydroxytryptamine or carbachol, in a concentration-dependent manner. Mangiferin also caused marked relaxation of tracheal rings that were precontracted by carbachol, suggesting that it has both anti-contraction and relaxant properties that are prevented by removing the epithelium. The effect of mangiferin was inhibited by the nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME) (100 mu M), and the soluble guanylate cyclase inhibitor, 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 mu M), but not the adenylate cyclase inhibitor, 9-(tetrahydro-2-furyl)adenine (SQ22536) (100 mu M). The antispasmodic effect of mangiferin was also sensitive to K+ channel blockers, such as tetraethylammonium (TEA), glibenclamide and apamin. Furthermore, mangiferin inhibited Ca2+-induced contractions in K+ (60 mM)-depolarised tracheal rings preparations. In addition, mangiferin increased NOS3 protein levels and cGMP intracellular levels in cultured tracheal rings. Finally, mangiferin-induced increase in cGMP levels was abrogated by co-incubation with either ODQ or L-NAME. These data suggest that the antispasmodic effect of mangiferin is mediated by epithelium-nitric oxide- and cGMP-dependent mechanisms.	[Vieira, Aline B.; Coelho, Luciana P.; Insuela, Daniella B. R.; Carvalho, Vinicius F.; Silva, Patricia M. R.; Martins, Marco A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inflammat, Rio De Janeiro, RJ, Brazil; [dos Santos, Marcelo H.] Univ Fed Alfenas, Dept Pharm, Lab Phytochem & Med & Chem, Alfenas, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Alfenas	Martins, MA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inflammat, Rio De Janeiro, RJ, Brazil.	mmartins@ioc.fiocruz.br	Dos Santos, M.H./D-1748-2017; Carvalho, Vinicius F/M-4762-2016; SILVA, PATRICIA MACHADO RODRIGUES E/AAS-4906-2020	Dos Santos, M.H./0000-0003-1440-4340; Bianchi Reis Insuela, Daniella/0000-0003-2523-2484	European Community [HEALTH-F4-2011-281608]; National Institute of Science and Technology-INOFAR [573.564/2008-6]	European Community(European Commission); National Institute of Science and Technology-INOFAR	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7-2007-2013) under grant agreement no. HEALTH-F4-2011-281608, and from National Institute of Science and Technology-INOFAR under grant agreement no. 573.564/2008-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmane A, 1998, AM J RESP CELL MOL, V19, P485, DOI 10.1165/ajrcmb.19.3.2996; Agbonon A, 2005, PHARM BIOL, V43, P475, DOI 10.1080/13880200590963943; Agbonon A, 2002, FITOTERAPIA, V73, P619, DOI 10.1016/S0367-326X(02)00230-7; Alvarez A, 2009, B LATINOAM CARIBE PL, V8, P63; Beltran AE, 2004, EUR J PHARMACOL, V499, P297, DOI 10.1016/j.ejphar.2004.07.073; Bock C, 2008, NUTR RES, V28, P879, DOI 10.1016/j.nutres.2008.08.001; BOWEN IH, 1985, PLANTA MED, V51, P483, DOI 10.1055/s-2007-969569; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Coelho LP, 2008, J PHARMACOL EXP THER, V327, P206, DOI 10.1124/jpet.108.138032; De A, 2009, IMMUNOBIOLOGY, V214, P367, DOI 10.1016/j.imbio.2008.10.001; FELBEL J, 1988, J BIOL CHEM, V263, P16764; Ferrari J, 2000, PHYTOCHEMISTRY, V54, P883, DOI 10.1016/S0031-9422(00)00046-7; Folkerts G, 1998, TRENDS PHARMACOL SCI, V19, P334, DOI 10.1016/S0165-6147(98)01232-2; Forstermann U, 1998, FASEB J, V12, P773; Garcia D, 2002, INT IMMUNOPHARMACOL, V2, P797, DOI 10.1016/S1567-5769(02)00018-8; Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Garrido-Suarez BB, 2010, MOLECULES, V15, P9035, DOI 10.3390/molecules15129035; HISADA T, 1990, PFLUG ARCH EUR J PHY, V416, P151, DOI 10.1007/BF00370237; Hudecova A, 2012, FOOD CHEM TOXICOL, V50, P3352, DOI 10.1016/j.fct.2012.06.017; Joubert E, 2010, J AGR FOOD CHEM, V58, P338, DOI 10.1021/jf902754b; KATSUKI S, 1977, MOL PHARMACOL, V13, P330; KNOX AJ, 1995, THORAX, V50, P894, DOI 10.1136/thx.50.8.894; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; Lee B, 2009, PLANTA MED, V75, P1415, DOI 10.1055/s-0029-1185773; Li J, 2009, J CHROMATOGR A, V1216, P2071, DOI 10.1016/j.chroma.2008.05.082; Li YH, 2008, LIFE SCI, V82, P1045, DOI 10.1016/j.lfs.2008.03.005; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Marquez L, 2012, EUR J NUTR, V51, P729, DOI 10.1007/s00394-011-0252-x; MARTHAN R, 1989, J APPL PHYSIOL, V66, P1706, DOI 10.1152/jappl.1989.66.4.1706; MCGROGAN I, 1995, AM J PHYSIOL-LUNG C, V268, pL407, DOI 10.1152/ajplung.1995.268.3.L407; Menkovic N, 2000, PLANTA MED, V66, P96, DOI 10.1055/s-0029-1243123; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nunez-Selles AJ, 2007, PHARMACOL RES, V55, P351, DOI 10.1016/j.phrs.2007.01.004; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Sa-Nunes A, 2006, INT IMMUNOPHARMACOL, V6, P1515, DOI 10.1016/j.intimp.2006.04.008; da Costa JCS, 2007, J ALLERGY CLIN IMMUN, V119, P219, DOI 10.1016/j.jaci.2006.08.037; SATO T, 1992, CHEM PHARM BULL, V40, P721, DOI 10.1248/cpb.40.721; Selles AJN, 2002, J AGR FOOD CHEM, V50, P762, DOI 10.1021/jf011064b; SHAUL PW, 1994, J CLIN INVEST, V94, P2231, DOI 10.1172/JCI117585; Singh S. K., 2009, Herba Polonica, V55, P126; Sissing L, 2011, NUTR CANCER, V63, P600, DOI 10.1080/01635581.2011.539313; STRETTON D, 1991, CLIN EXP PHARMACOL P, V18, P675, DOI 10.1111/j.1440-1681.1991.tb01380.x; SUZUKI K, 1986, CLIN EXP PHARMACOL P, V13, P39, DOI 10.1111/j.1440-1681.1986.tb00313.x; van der Merwe JD, 2012, FOOD CHEM TOXICOL, V50, P808, DOI 10.1016/j.fct.2011.11.018; Viswanadh EK, 2010, HUM EXP TOXICOL, V29, P409, DOI 10.1177/0960327110361752; Vyas A, 2012, MINI-REV MED CHEM, V12, P412, DOI 10.2174/138955712800493870; Wei Zhiquan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1798; Wu BN, 2004, BRIT J PHARMACOL, V142, P1105, DOI 10.1038/sj.bjp.0705791; Zheng BJ, 2010, J NEUROL SCI, V295, P97, DOI 10.1016/j.jns.2010.04.012	50	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71759	10.1371/journal.pone.0071759	http://dx.doi.org/10.1371/journal.pone.0071759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951240	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000072
J	Fessler, DMT; Holbrook, C				Fessler, Daniel M. T.; Holbrook, Colin			Bound to Lose: Physical Incapacitation Increases the Conceptualized Size of an Antagonist in Men	PLOS ONE			English	Article							FORMIDABILITY; DOMINANCE; EVOLUTION; STRENGTH; CUES	Because decision-making in situations of potential conflict hinges on assessing many features of the self and the foe, this process can be facilitated by summarizing diverse attributes in a single heuristic representation. Physical size and strength are evolutionarily ancient determinants of victory in conflict, and their relevance is reinforced during development. Accordingly, size and muscularity constitute ready dimensions for a summary representation of relative formidability, a perspective paralleled by the notion that social power is represented using envisioned relative size. Physical incapacitation constitutes a significant tactical disadvantage, hence temporary incapacitation should increase the envisioned size and strength of an antagonist. In Study 1, being bound to a chair increased men's estimates of the size of an angry man and decreased estimates of their own height. Study 2 conceptually replicated these effects: among men for whom standing on a balance board was challenging, the attendant experience of postural instability increased estimates of an angry man's size and muscularity, with similar patterns occurring at a reduced level among all but those whose equilibrium was apparently unaffected by this task.	[Fessler, Daniel M. T.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fessler, DMT (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	dfessler@anthro.ucla.edu			U.S. Air Force Office of Scientific Research [FA9550-10-1-0511]	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by the U.S. Air Force Office of Scientific Research under Award #FA9550-10-1-0511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Munoz-Reyes JA, 2012, AM J HUM BIOL, V24, P611, DOI 10.1002/ajhb.22281; Archer J, 2009, EVOL HUM BEHAV, V30, P315, DOI 10.1016/j.evolhumbehav.2009.03.003; Barkow J. H., 1989, DARWIN SEX STATUS BI, DOI 10.1002/AJPA.1330840213; Clark JA, 2010, EMOT REV, V2, P397, DOI 10.1177/1754073910374663; *CRIM RED CTR, 2000, BRIT FEAR LOC CRIM S; DALY M, 1988, HOMICIDE, V12; Duguid MM, 2012, PSYCHOL SCI, V23, P36, DOI 10.1177/0956797611422915; Fessler D.M.T., 1999, UNDERSTANDING UNIVER, P75; Fessler DMT, 2013, PSYCHOL SCI, V24, P797, DOI 10.1177/0956797612461508; Fessler DMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032751; FESSLER DMT, MENS PHYS STRE UNPUB; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; FREDERICK DA, 2007, 8 ANN M SOC PERS SOC; Gribble PA, 2004, J ATHL TRAINING, V39, P321; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hess N, 2010, HUM NATURE-INT BIOS, V21, P330, DOI 10.1007/s12110-010-9094-0; HOLBROOK C, 2013, EMOTION IN PRESS; Holbrook C, 2013, COGNITION, V127, P46, DOI 10.1016/j.cognition.2012.12.002; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; SCHWARTZ B, 1982, SOC PSYCHOL QUART, V45, P114, DOI 10.2307/3033934; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Snyder JK, 2011, EVOL HUM BEHAV, V32, P127, DOI 10.1016/j.evolhumbehav.2010.08.007; Watkins CD, 2012, BEHAV ECOL, V23, P539, DOI 10.1093/beheco/arr221; Watkins CD, 2010, BEHAV ECOL, V21, P943, DOI 10.1093/beheco/arq091; YAP AJ, J EXPT SOCI IN PRESS	29	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71306	10.1371/journal.pone.0071306	http://dx.doi.org/10.1371/journal.pone.0071306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951126	gold, Green Published			2022-12-27	WOS:000323109700092
J	Fukuzaki, Y; Sugawara, H; Yamanoha, B; Kogure, S				Fukuzaki, Yumi; Sugawara, Haruna; Yamanoha, Banri; Kogure, Shinichi			532 nm Low-Power Laser Irradiation Recovers gamma-Secretase Inhibitor-Mediated Cell Growth Suppression and Promotes Cell Proliferation via Akt Signaling	PLOS ONE			English	Article							NOTCH; BETA	Background and Objective: The gamma-secretase inhibitor (GSI) has been shown to inhibit expression of amyloid beta (A beta), but GSI also has a side effect of reducing cell survival. Since low-power laser irradiation (LLI) has been known to promote cell survival, we examined whether 532 nm LLI can rescue the GSI side effect or not. Study Design/Materials and Methods: The human-derived glioblastoma cells (A-172) were cultured in 35 mm culture dishes or 96-well plate. The center of dish or selected wells was irradiated with 532 nm laser (Nd:YVO4, CW, 60 mW) for 20, 40 and 60 min, respectively. The irradiated cells were photographed at immediately after, 24 and 48 h later and counted. GSI was supplemented in medium 3 h before LLI. The MTT assay was also used to estimate viable cells at 48 h after irradiation. The expression of phosphorylated Akt (p-Akt) or phosphorylated PTEN (p-PTEN) was examined by immunofluorescent staining and measured by fluorescence intensity using the software (BZ-9000, KEYENCE, Japan). Results: GSI application depressed cell proliferation as well as cell survival compared to control. GSI down-regulated A beta but up-regulated p-PTEN and suppressed p-Akt. Application of 532 nm LLI in the presence of GSI significantly recovered the GSI-mediated effects, i.e., LLI could decrease elevated p-PTEN, while increased p-Akt expression with keeping A beta suppression. The LLI effects had a dose-dependency. Conclusion: We confirmed that GSI potently suppressed intracellular A beta and decreased cell survival. We conclude that a combination of GSI application and 532 nm LLI can increase cell proliferation via Akt activation while keeping PTEN and A beta suppressed.	[Fukuzaki, Yumi; Sugawara, Haruna; Kogure, Shinichi] Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan; [Yamanoha, Banri] Soka Univ, Fac Engn, Dept Environm Engn Symbiosis, Hachioji, Tokyo, Japan	Soka University; Soka University	Kogure, S (corresponding author), Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan.	kogure@soka.ac.jp			Faculty Research Fees from Soka University; Sasakawa Scientific Research Grant of The Japan Science Society	Faculty Research Fees from Soka University; Sasakawa Scientific Research Grant of The Japan Science Society	The authors have received Faculty Research Fees (total: 1,200,000 Yen) from Soka University in 2011 and 2012. Yumi Fukuzaki received 600,000 Yen from the Sasakawa Scientific Research Grant of The Japan Science Society in 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang FY, 2012, LASER MED SCI, V27, P935, DOI 10.1007/s10103-011-1009-8; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Azevedo LH, 2006, LASER MED SCI, V21, P86, DOI 10.1007/s10103-006-0379-9; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; Cavett W, 1997, Biomed Sci Instrum, V33, P155; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; CONLON RA, 1995, DEVELOPMENT, V121, P1533; da Silva JP, 2010, PHOTOMED LASER SURG, V28, P17, DOI 10.1089/pho.2008.2372; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Gresner P, 2005, J PHOTOCH PHOTOBIO B, V79, P43, DOI 10.1016/j.jphotobiol.2004.11.018; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu T, 2003, BIOMEDICAL PHOTONICS, V48; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kassak P, 2005, GEN PHYSIOL BIOPHYS, V24, P209; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MESTER E, 1968, ACTA CHIR HUNG, V9, P349; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Murayama H, 2012, LASER MED SCI, V27, P87, DOI 10.1007/s10103-011-0924-z; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Panza F, 2009, DRUG AGING, V26, P537, DOI 10.2165/11315770-000000000-00000; Prince M, 2009, ALZHEIMERS DIS INT W; Shefer G, 2002, J CELL SCI, V115, P1461; Shefer G, 2001, J CELL PHYSIOL, V187, P73, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Su CC, 2012, AM J PHYSIOL-HEART C, V302, pH716, DOI 10.1152/ajpheart.00455.2011; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Zhang JT, 2008, J CELL PHYSIOL, V217, P518, DOI 10.1002/jcp.21529; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697; Zhao H, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-15	41	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70737	10.1371/journal.pone.0070737	http://dx.doi.org/10.1371/journal.pone.0070737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950991	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700049
J	Henostroza, G; Topp, SM; Hatwiinda, S; Maggard, KR; Phiri, W; Harris, JB; Kruuner, A; Kapata, N; Ayles, H; Chileshe, C; Reid, SE				Henostroza, German; Topp, Stephanie M.; Hatwiinda, Sisa; Maggard, Katie R.; Phiri, Winifreda; Harris, Jennifer B.; Krueuener, Annika; Kapata, Nathan; Ayles, Helen; Chileshe, Chisela; Reid, Stewart E.			The High Burden of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) in a Large Zambian Prison: A Public Health Alert	PLOS ONE			English	Article							INMATES; PREVALENCE; POPULATION; RESISTANCE; MALAWI; STATE	Background: Tuberculosis (TB) and human immunodeficiency virus (HIV) represent two of the greatest health threats in African prisons. In 2010, collaboration between the Centre for Infectious Disease Research in Zambia, the Zambia Prisons Service, and the National TB Program established a TB and HIV screening program in six Zambian prisons. We report data on the prevalence of TB and HIV in one of the largest facilities: Lusaka Central Prison. Methods: Between November 2010 and April 2011, we assessed the prevalence of TB and HIV amongst inmates entering, residing, and exiting the prison, as well as in the surrounding community. The screening protocol included complete history and physical exam, digital radiography, opt-out HIV counseling and testing, sputum smear and culture. A TB case was defined as either bacteriologically confirmed or clinically diagnosed. Results: A total of 2323 participants completed screening. A majority (88%) were male, median age 31 years and body mass index 21.9. TB symptoms were found in 1430 (62%). TB was diagnosed in 176 (7.6%) individuals and 52 people were already on TB treatment at time of screening. TB was bacteriologically confirmed in 88 cases (3.8%) and clinically diagnosed in 88 cases (3.8%). Confirmed TB at entry and exit interventions were 4.6% and 5.3% respectively. Smear was positive in only 25% (n = 22) of bacteriologically confirmed cases. HIV prevalence among inmates currently residing in prison was 27.4%. Conclusion: Ineffective TB and HIV screening programs deter successful disease control strategies in prison facilities and their surrounding communities. We found rates of TB and HIV in Lusaka Central Prison that are substantially higher than the Zambian average, with a trend towards concentration and potential transmission of both diseases within the facility and to the general population. Investment in institutional and criminal justice reform as well as prison-specific health systems is urgently required.	[Henostroza, German; Topp, Stephanie M.; Harris, Jennifer B.; Krueuener, Annika] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Henostroza, German; Topp, Stephanie M.; Hatwiinda, Sisa; Maggard, Katie R.; Phiri, Winifreda; Harris, Jennifer B.; Krueuener, Annika; Reid, Stewart E.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Maggard, Katie R.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Kapata, Nathan] Minist Hlth, Natl TB Program, Lusaka, Zambia; [Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, Lusaka, Zambia; [Ayles, Helen] Zambia AIDS Related TB Project, Lusaka, Zambia; [Chileshe, Chisela] Minist Home Affairs, Prisons Hlth Serv, Lusaka, Zambia; [Reid, Stewart E.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Henostroza, G (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	germanh@uab.edu	Topp, Stephanie M/H-3923-2019; Kapata, Nathan/AAW-2469-2020	Topp, Stephanie M/0000-0002-3448-7983; Kapata, Nathan/0000-0002-3877-8809; Ayles, Helen/0000-0003-4108-2842; Reid, Stewart/0000-0001-7779-4820	TB REACH Initiative of the Stop TB Partnership [T9-370-114ZAM]; U.S. Centers for Disease Control and Prevention (CDC) through the President's Emergency Fund for AIDS Relief (PEPFAR); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)	TB REACH Initiative of the Stop TB Partnership; U.S. Centers for Disease Control and Prevention (CDC) through the President's Emergency Fund for AIDS Relief (PEPFAR); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)	Funding for program implementation and evaluation was provided by the TB REACH Initiative of the Stop TB Partnership (T9-370-114ZAM). Funding for renovation of the tuberculosis isolation facility at Lusaka Central Prison was provided by the U.S. Centers for Disease Control and Prevention (CDC) through the President's Emergency Fund for AIDS Relief (PEPFAR) and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33; Adoga MP, 2009, J INFECT DEV COUNTR, V3, P539, DOI 10.3855/jidc.472; AIDS & Rights Alliance for Southern Africa Prisons Care & Counseling Association Human Rights Watch, 2010, UNJ UNH HIV TB AB ZA; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P250; Chimphambano C, 2007, TROP DOCT, V37, P226, DOI 10.1258/004947507782333189; CONINX R, 1995, LANCET, V346, P1238, DOI 10.1016/S0140-6736(95)92952-5; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Dada M O, 2006, Niger Postgrad Med J, V13, P6; Derlega VJ, 2008, INT J STD AIDS, V19, P259, DOI 10.1258/ijsa.2007.007141; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Hellard M E, 2004, Sex Health, V1, P107, DOI 10.1071/SH03018; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; MacNeil JR, 2005, AM J PUBLIC HEALTH, V95, P1800, DOI 10.2105/AJPH.2004.055442; Maher D, 2009, GUIDELINES CONTROL T; Noeske J, 2006, East Afr Med J, V83, P25; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; Reid SE, 2012, J INFECT DIS; Rutta E, 2001, INT J TUBERC LUNG D, V5, P703; Simooya OO, 2001, AIDS, V15, P1741, DOI 10.1097/00002030-200109070-00023; Stop TB partnership, 2010, GLOB PLAN STOP TB 20; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2001, TUB CONTR PRIS MAN P	27	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e67338	10.1371/journal.pone.0067338	http://dx.doi.org/10.1371/journal.pone.0067338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967048	Green Published, gold, Green Accepted			2022-12-27	WOS:000323221500002
J	Dean, AS; Bonfoh, B; Kulo, AE; Boukaya, GA; Amidou, M; Hattendorf, J; Pilo, P; Schelling, E				Dean, Anna S.; Bonfoh, Bassirou; Kulo, Abalo E.; Boukaya, G. Aboudou; Amidou, Moussa; Hattendorf, Jan; Pilo, Paola; Schelling, Esther			Epidemiology of Brucellosis and Q Fever in Linked Human and Animal Populations in Northern Togo	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; COXIELLA-BURNETII; HEALTH; MILK; MLVA; SEROPREVALENCE; VACCINATION; DIAGNOSIS; LIVESTOCK; ABORTUS	Background: Although brucellosis (Brucella spp.) and Q Fever (Coxiella burnetii) are zoonoses of global importance, very little high quality data are available from West Africa. Methods/Principal Findings: A serosurvey was conducted in Togo's main livestock-raising zone in 2011 in 25 randomly selected villages, including 683 people, 596 cattle, 465 sheep and 221 goats. Additionally, 464 transhumant cattle from Burkina Faso were sampled in 2012. The serological analyses performed were the Rose Bengal Test and ELISA for brucellosis and ELISA and the immunofluorescence assay (IFA) for Q Fever Brucellosis did not appear to pose a major human health problem in the study zone, with only 7 seropositive participants. B. abortus was isolated from 3 bovine hygroma samples, and is likely to be the predominant circulating strain. This may explain the observed seropositivity amongst village cattle (9.2%, 95% CI: 4.3-18.6%) and transhumant cattle (7.3%, 95% CI: 3.5-14.7%), with an absence of seropositive small ruminants. Exposure of livestock and people to C. burnetii was common, potentially influenced by cultural factors. People of Fulani ethnicity had greater livestock contact and a significantly higher seroprevalence than other ethnic groups (Fulani: 45.5%, 95% CI: 37.7-53.6%; non-Fulani: 27.1%, 95% CI: 20.6-34.7%). Appropriate diagnostic test cut-off values in endemic settings requires further investigation. Both brucellosis and Q Fever appeared to impact on livestock production. Seropositive cows were more likely to have aborted a foetus during the previous year than seronegative cows, when adjusted for age. This odds was 3.8 times higher (95% CI: 1.2-12.1) for brucellosis and 6.7 times higher (95% CI: 1.3-34.8) for Q Fever. Conclusions: This is the first epidemiological study of zoonoses in Togo in linked human and animal populations, providing much needed data for West Africa. Exposure to Brucella and C. burnetii is common but further research is needed into the clinical and economic impact.	[Dean, Anna S.; Hattendorf, Jan; Schelling, Esther] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Dean, Anna S.; Hattendorf, Jan; Schelling, Esther] Univ Basel, Basel, Switzerland; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Kulo, Abalo E.] Univ Lome, Ecole Super Agron, Lome, Togo; [Boukaya, G. Aboudou] Minist Agr Elevage & Peche, Direct Elevage, Lome, Togo; [Amidou, Moussa] Direct Reg Sante Savanes, Lome, Togo; [Pilo, Paola] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern	Schelling, E (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	esther.schelling@unibas.ch	Hattendorf, Jan/F-5371-2010; Schelling, Esther/K-7990-2015	Hattendorf, Jan/0000-0002-1176-401X; Schelling, Esther/0000-0001-6444-0898; Dean, Anna/0000-0002-9539-7164	National Center of Competence in Research North-South (NCCR North-South) in Switzerland; EU [FP7-221948 ICONZ]	National Center of Competence in Research North-South (NCCR North-South) in Switzerland; EU(European Commission)	This study was funded by the National Center of Competence in Research North-South (NCCR North-South) in Switzerland. JH received financial support from EU grant FP7-221948 ICONZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Bankole AA, 2010, VET REC, V166, P753, DOI 10.1136/vr.b4862; Bassett TJ, 2007, HUM ECOL, V35, P33, DOI 10.1007/s10745-006-9067-4; Bennett S, 1991, RAPPORT TRIMESTRIEL, P98; BENSON WW, 1963, PUBLIC HEALTH REP, V78, P707, DOI 10.2307/4591908; Blaauw GJ, 2012, EPIDEMIOL INFECT, V140, P36, DOI 10.1017/S0950268811000021; Bonfoh B, 2006, FOOD CONTROL, V17, P153, DOI 10.1016/j.foodcont.2004.09.015; Cerf O, 2006, EPIDEMIOL INFECT, V134, P946, DOI 10.1017/S0950268806005978; Corbel M.J, 2006, BRUC HUM AN; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; de Rooij MMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032108; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Diaz R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000950; Domingo AM, 2000, ACTA TROP, V76, P65, DOI 10.1016/S0001-706X(00)00092-9; Forland F, 2012, EUROSURVEILLANCE, V17, P5; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5094, DOI 10.1128/JCM.41.11.5094-5098.2003; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; IIED and SOS Sahel UK, 2010, MOD MOB FUT LIV PROD; Kponmassi T, 1991, THESIS ECOLE INTERET; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Mangen M.J., 2002, 8 FAO UN; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McGiven JA, 2003, J IMMUNOL METHODS, V278, P171, DOI 10.1016/S0022-1759(03)00201-1; Newcombe RG, 2001, AM STAT, V55, P200, DOI 10.1198/000313001317098167; OIE, 2012, CAPR OV BRUC MAN DIA; OIE, 2009, BOV BRUC MAN DIAGN T; Oppong YPA, 2002, WHO ARE WE CROSSING, P1; Otte MJ, 1997, PREV VET MED, V31, P147, DOI 10.1016/S0167-5877(96)01108-7; Porter SR., 2011, INT J MICROBIOL, DOI 10.1155/2011/248418; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Schelling E, 2005, BMJ-BRIT MED J, V331, P1264, DOI 10.1136/bmj.331.7527.1264; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Schelling E, 2007, EMERG INFECT DIS, V13, P373, DOI 10.3201/eid1303.060391; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Thys E., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P205; TOUNKARA K, 1994, REV SCI TECH OIE, V13, P777, DOI 10.20506/rst.13.3.795; TURKSON PK, 1992, ACTA TROP, V52, P39, DOI 10.1016/0001-706X(92)90005-I; VERGER JM, 1982, ANN RECH VET, V13, P177; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8; Zinsstag J, 2007, EMERGING INFECT DIS, V13; Zinsstag J, 2009, VET ITAL, V45, P121	47	54	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71501	10.1371/journal.pone.0071501	http://dx.doi.org/10.1371/journal.pone.0071501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951177	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323097300123
J	Lemos, JRD; Rodrigues, WF; Miguel, CB; Parreira, RC; Miguel, RB; Rogerio, AD; Oliveira, CJF; Chica, JEL				Dias Lemos, Juliana Regina; Rodrigues, Wellington Francisco; Miguel, Camila Botelho; Parreira, Ricardo Cambraia; Miguel, Renata Botelho; Rogerio, Alexandre de Paula; Freire Oliveira, Carlo Jose; Lazo Chica, Javier Emilio			Influence of Parasite Load on Renal Function in Mice Acutely Infected with Trypanosoma cruzi	PLOS ONE			English	Article							CHAGAS-DISEASE; IMMUNE-SYSTEM; NITRIC-OXIDE; ACUTE-PHASE; IFN-GAMMA; TNF-ALPHA; MYOCARDITIS; SUSCEPTIBILITY; PATHOGENESIS; ACTIVATION	Background: Chagas disease is a neglected tropical disease caused by Trypanosoma cruzi. Despite the vast number of studies evaluating the pathophysiological mechanisms of the disease, the influence of parasite burden on kidney lesions remains unclear. Thus, the main goal of this work was to evaluate the effect of T. cruzi infection on renal function and determine whether there was a correlation between parasite load and renal injury using an acute experimental model of the disease. Methodology/Principal Findings: Low, medium and high parasite loads were generated by infecting C57BL/6 mice with 300 (low), 3,000 (medium) or 30,000 (high) numbers of "Y" strain trypomastigotes. We found that mice infected with T. cruzi trypomastigotes show increased renal injury. The infection resulted in reduced urinary excretion and creatinine clearance. We also observed a marked elevation in the ratio of urine volume to kidney and body weight, blood urea nitrogen, chloride ion, nitric oxide, pro-and anti-inflammatory cytokines and the number of leukocytes in the blood and/or renal tissues of infected mice. Additionally, we observed the presence of the parasite in the cortical/medullary and peri-renal region, an increase of inflammatory infiltrate and of vascular permeability of the kidney. Overall, most renal changes occurred mainly in animals infected with high parasitic loads. Conclusions/Significance: These data demonstrate that T. cruzi impairs kidney function, and this impairment is more evident in mice infected with high parasitic loads. Moreover, these data suggest that, in addition to the extensively studied cardiovascular effects, renal injury should be regarded as an important indicator for better understanding the pan-infectivity of the parasite and consequently for understanding the disease in experimental models.	[Dias Lemos, Juliana Regina; Rodrigues, Wellington Francisco; Miguel, Camila Botelho; Lazo Chica, Javier Emilio] Univ Fed Triangulo Mineiro, Postgrad Course Pathol, Uberaba, MG, Brazil; [Parreira, Ricardo Cambraia; Freire Oliveira, Carlo Jose; Lazo Chica, Javier Emilio] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Uberaba, MG, Brazil; [Miguel, Renata Botelho] Portuguese Beneficent Hosp Uberaba, Dept Nutr & Dietet, Uberaba, MG, Brazil; [Rogerio, Alexandre de Paula] Univ Fed Triangulo Mineiro, Lab Expt Immunopharmacol, Uberaba, MG, Brazil; [Rogerio, Alexandre de Paula; Freire Oliveira, Carlo Jose] Univ Fed Triangulo Mineiro, Postgrad Course Trop Med, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Chica, JEL (corresponding author), Univ Fed Triangulo Mineiro, Postgrad Course Pathol, Uberaba, MG, Brazil.	jlazo@dcb.uftm.edu.br	Parreira, Ricardo C/I-4878-2013; Rodrigues, Wellington/AEW-3823-2022; Oliveira, Carlo Jose Freire/AAY-8751-2020; de Paula Rogerio, Alexandre/K-8866-2013; Botelho Miguel, Camila/GNP-5269-2022	Parreira, Ricardo C/0000-0002-2769-7958; Rodrigues, Wellington/0000-0002-3426-2186; de Paula Rogerio, Alexandre/0000-0001-5913-3703; Lazo Chica, Javier Emilio/0000-0003-1950-1895	Foundation for Support of Research in Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Program of Restructuring and Expansion of the Brazilian Federal Universities	Foundation for Support of Research in Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Program of Restructuring and Expansion of the Brazilian Federal Universities	This work was supported by the Foundation for Support of Research in Minas Gerais, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and the Program of Restructuring and Expansion of the Brazilian Federal Universities. The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Albuquerque B. C. N. C. de, 2008, Revista Brasileira de Ciencia Veterinaria, V15, P3; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; APERIA A, 1977, ANN RADIOL, V20, P141; Arango HG., 2001, BIOESTATISTICA TEORI; Araujo-Jorge TC, 2000, REV I MED TROP SAO P; Arias LF, 2006, TRANSPLANT P, V38, P885, DOI 10.1016/j.transproceed.2006.02.033; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Carvalho Maria Fernanda C., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P223, DOI 10.1590/S0036-46651997000400008; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Costa JAC, 2003, S URGENCIAS EMERGENC, V36, P307; COSTA RS, 1991, CLIN IMMUNOL IMMUNOP, V58, P102, DOI 10.1016/0090-1229(91)90152-Z; de Oliveira GM, 2009, MEM I OSWALDO CRUZ, V104, P1063, DOI 10.1590/S0074-02762009000800002; de Oliveira GM, 2009, PARASITOL RES, V106, P111, DOI 10.1007/s00436-009-1637-0; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1157/13100280; Gurjar M, 2011, TROP DOCT, V41, P175, DOI 10.1258/td.2011.110082; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; GYRDHANSEN N, 1968, ACTA VET SCAND, V9, P183; HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S; Holscher C, 1998, INFECT IMMUN, V66, P1208; Howard CV, 2005, UNBIASED STEREOLOGY; JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348; Kute VB, 2012, PARASITOL RES, V110, P2573, DOI 10.1007/s00436-011-2776-7; Lages-Silva E, 2001, AM J TROP MED HYG, V65, P435, DOI 10.4269/ajtmh.2001.65.435; Lannes-Vieira J, 2011, ADV EXP MED BIOL, V691, P221, DOI 10.1007/978-1-4419-6612-4_23; Leon JS, 2003, CIRCULATION, V107, P2264, DOI 10.1161/01.CIR.0000062690.79456.D0; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999; Martins GA, 1998, IMMUNOL LETT, V63, P113, DOI 10.1016/S0165-2478(98)00066-2; Mathew AJ, 2011, ANN SAUDI MED, V31, P451, DOI 10.4103/0256-4947.84620; Moreno E., 1999, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V39, P1; NIETO CG, 1992, VET PARASITOL, V45, P33, DOI 10.1016/0304-4017(92)90025-5; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; Oliveira GM, 2011, PARASITOL RES, V109, P483; Pereira-da Silva L. H., 1953, Folia Clinica et Biologica Sao Paulo, V20, P191; PINTO FH, 1986, REV SAUDE PUBL, V20, P133, DOI 10.1590/S0034-89101986000200004; Prata A, 1990, Rev Soc Bras Med Trop, V23, P109, DOI 10.1590/S0037-86821990000200008; Prianti MG, 2007, BRAZ J MED BIOL RES, V40, P819, DOI 10.1590/S0100-879X2007000600011; REED SG, 1988, J IMMUNOL, V140, P4342; Riarte A, 1999, CLIN INFECT DIS, V29, P561, DOI 10.1086/598634; Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; SCHNERMANN J, 1984, KIDNEY INT, V25, P53, DOI 10.1038/ki.1984.8; SHINABERGER JH, 1967, J PHARMACOL EXP THER, V158, P460; Siegel S, 1977, NONPARAMETRIC STAT B, P52; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; STAROBINAS N, 1991, RES IMMUNOL, V142, P117, DOI 10.1016/0923-2494(91)90019-F; SUAREZ CA, 1968, AM J VET RES, V29, P995; TAFURI WL, 1989, REV I MED TROP, V31, P139, DOI 10.1590/S0036-46651989000300002; TARLETON RL, 1988, CLIN EXP IMMUNOL, V73, P186; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; WESTGARD JO, 1981, CLIN CHEM, V27, P493; White LE, 2012, INT J NEPHROL, V2012, DOI 10.4061/2012/505197; Ysebaert DK, 2004, KIDNEY INT, V66, P491, DOI 10.1111/j.1523-1755.2004.761_4.x	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71772	10.1371/journal.pone.0071772	http://dx.doi.org/10.1371/journal.pone.0071772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951243	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300156
J	Lemmens, P; Mergeay, J; De Bie, T; Van Wichelen, J; De Meester, L; Declerck, SAJ				Lemmens, Pieter; Mergeay, Joachim; De Bie, Tom; Van Wichelen, Jeroen; De Meester, Luc; Declerck, Steven A. J.			How to Maximally Support Local and Regional Biodiversity in Applied Conservation? Insights from Pond Management	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; SHALLOW LAKES; LAND-USE; AGRICULTURAL LANDSCAPES; PARTITIONING DIVERSITY; MACROPHYTE COMMUNITIES; SEDIMENT RESUSPENSION; PHYTOPLANKTON BIOMASS; ZOOPLANKTON; RESTORATION	Biodiversity and nature values in anthropogenic landscapes often depend on land use practices and management. Evaluations of the association between management and biodiversity remain, however, comparatively scarce, especially in aquatic systems. Furthermore, studies also tend to focus on a limited set of organism groups at the local scale, whereas a multi-group approach at the landscape scale is to be preferred. This study aims to investigate the effect of pond management on the diversity of multiple aquatic organism groups (e.g. phytoplankton, zooplankton, several groups of macro-invertebrates, submerged and emergent macrophytes) at local and regional spatial scales. For this purpose, we performed a field study of 39 shallow man-made ponds representing five different management types. Our results indicate that fish stock management and periodic pond drainage are crucial drivers of pond biodiversity. Furthermore, this study provides insight in how the management of eutrophied ponds can contribute to aquatic biodiversity. A combination of regular draining of ponds with efforts to keep ponds free of fish seems to be highly beneficial for the biodiversity of many groups of aquatic organisms at local and regional scales. Regular draining combined with a stocking of fish at low biomass is also preferable to infrequent draining and lack of fish stock control. These insights are essential for the development of conservation programs that aim long-term maintenance of regional biodiversity in pond areas across Europe.	[Lemmens, Pieter; Mergeay, Joachim; De Bie, Tom; De Meester, Luc; Declerck, Steven A. J.] Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Geraardsbergen, Belgium; [Van Wichelen, Jeroen] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Declerck, Steven A. J.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Research Institute for Nature & Forest; Ghent University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Lemmens, P (corresponding author), Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium.	pieter.lemmens@bio.kuleuven.be	Van+Wichelen, Jeroen/AAP-6900-2021; De Meester, Luc/F-3832-2015; Declerck, Steven/E-4338-2010; Mergeay, Joachim/E-7670-2011; KNAW, NIOO-KNAW/A-4320-2012	Van+Wichelen, Jeroen/0000-0002-0255-9591; De Meester, Luc/0000-0001-5433-6843; Declerck, Steven/0000-0001-6179-667X; Mergeay, Joachim/0000-0002-6504-0551; KNAW, NIOO-KNAW/0000-0002-3835-159X; Lemmens, Pieter/0000-0002-3135-9724	Agency for Nature and Forests via a national TWOL project [LIM/AMINAL/AN/LIM/2004/10]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Agency for Nature and Forests via a national TWOL project; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was funded by the Agency for Nature and Forests via a national TWOL project (LIM/AMINAL/AN/LIM/2004/10). PL was financially supported by a grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ATLAS FLORA VLAANDER; Arts GHP, 2002, AQUAT BOT, V73, P373, DOI 10.1016/S0304-3770(02)00031-1; ARTS GHP, 1990, FRESHWATER BIOL, V24, P287, DOI 10.1111/j.1365-2427.1990.tb00709.x; Bignal Eric M., 2000, Environmental Reviews, V8, P149, DOI 10.1139/a00-009; Bonte D, 2001, EEN GEDOCUMENTEERDE; BREUKELAAR AW, 1994, FRESHWATER BIOL, V32, P113, DOI 10.1111/j.1365-2427.1994.tb00871.x; Burks RL, 2001, LIMNOL OCEANOGR, V46, P230, DOI 10.4319/lo.2001.46.2.0230; Burny J, 1999, BIJDRAGE TOT HIST EC; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Clarke K.R., 2001, PRIMERV5 USER MANUAL; Davies B, 2008, AGR ECOSYST ENVIRON, V125, P1, DOI 10.1016/j.agee.2007.10.006; De Bie T, 2010, POND CONSERVATION EU, P19; de Pauw N., 1991, MACROINVERTEBRATEN W; Declerck SAJ, 2011, BASIC APPL ECOL, V12, P466, DOI 10.1016/j.baae.2011.05.001; Dolman PM, 2012, J APPL ECOL, V49, P986, DOI 10.1111/j.1365-2664.2012.02174.x; Fattorini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040018; Flossner D, 2000, HAPLOPODA CLADOCERA; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; HAVENS KE, 1991, J PLANKTON RES, V13, P1163, DOI 10.1093/plankt/13.6.1163; Heino J, 2003, J ANIM ECOL, V72, P425, DOI 10.1046/j.1365-2656.2003.00711.x; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; HOUGH RA, 1991, AQUAT BOT, V41, P299, DOI 10.1016/0304-3770(91)90049-B; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jeppesen E, 1999, HYDROBIOLOGIA, V408, P217, DOI 10.1023/A:1017071600486; Jeppesen E., 1998, STRUCTURING ROLE SUB; John DM., 2002, FRESHWATER ALGAL FLO; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Koroleff F, 1970, DETERMINATION TOTAL; Leps J, 2003, MULTIVARIATE ANAL EC; Liasko R, 2011, HYDROBIOLOGIA, V658, P317, DOI 10.1007/s10750-010-0502-6; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; Louette G, 2007, BELG J ZOOL, V137, P117; Louette G, 2009, RESTOR ECOL, V17, P629, DOI 10.1111/j.1526-100X.2008.00409.x; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Moranz RA, 2012, BIODIVERS CONSERV, V21, P2719, DOI 10.1007/s10531-012-0330-2; Nicolet P, 2004, BIOL CONSERV, V120, P261, DOI 10.1016/j.biocon.2004.03.010; Oertli B, 2005, AQUAT CONSERV, V15, P535, DOI 10.1002/aqc.752; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Oertli S, 2005, BIOL CONSERV, V126, P195, DOI 10.1016/j.biocon.2005.05.014; Padial AA, 2012, FRESHWATER BIOL, V57, P2411, DOI 10.1111/fwb.12008; Pechar L, 2000, FISHERIES MANAG ECOL, V7, P23, DOI 10.1046/j.1365-2400.2000.00193.x; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Regan HM, 2008, DIVERS DISTRIB, V14, P462, DOI 10.1111/j.1472-4642.2007.00447.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Roozen FCJM, 2007, FRESHWATER BIOL, V52, P977, DOI 10.1111/j.1365-2427.2007.01729.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SONDERGAARD M, 1992, HYDROBIOLOGIA, V228, P91, DOI 10.1007/BF00006480; Talling JF, 1963, S PRIMARY PRODUCTIVI, P142; Team RDC, 2019, R LANG ENV STAT COMP; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thiere G, 2009, BIOL CONSERV, V142, P964, DOI 10.1016/j.biocon.2009.01.006; Van Wichelen J, 2007, HYDROBIOLOGIA, V584, P291, DOI 10.1007/s10750-007-0611-z; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Woltemade CJ, 1997, J AM WATER RESOUR AS, V33, P443, DOI 10.1111/j.1752-1688.1997.tb03523.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Zambrano L, 2001, OIKOS, V94, P344, DOI 10.1034/j.1600-0706.2001.940215.x	66	45	49	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72538	10.1371/journal.pone.0072538	http://dx.doi.org/10.1371/journal.pone.0072538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951328	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300200
J	Moreno-Navarrete, JM; Ortega, F; Gomez-Serrano, M; Garcia-Santos, E; Ricart, W; Tinahones, F; Mingrone, G; Peral, B; Fernandez-Real, JM				Maria Moreno-Navarrete, Jose; Ortega, Francisco; Gomez-Serrano, Maria; Garcia-Santos, Eva; Ricart, Wifredo; Tinahones, Francisco; Mingrone, Geltrude; Peral, Belen; Manuel Fernandez-Real, Jose			The MRC1/CD68 Ratio Is Positively Associated with Adipose Tissue Lipogenesis and with Muscle Mitochondrial Gene Expression in Humans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; WEIGHT-LOSS; OBESITY; MACROPHAGES; ADIPONECTIN; FAT; SENSITIVITY; EXERCISE	Background: Alternative macrophages (M2) express the cluster differentiation (CD) 206 (MCR1) at high levels. Decreased M2 in adipose tissue is known to be associated with obesity and inflammation-related metabolic disturbances. Here we aimed to investigate MCR1 relative to CD68 (total macrophages) gene expression in association with adipogenic and mitochondrial genes, which were measured in human visceral [VWAT, n = 147] and subcutaneous adipose tissue [SWAT, n = 76] and in rectus abdominis muscle (n = 23). The effects of surgery-induced weight loss were also longitudinally evaluated (n = 6). Results: MCR1 and CD68 gene expression levels were similar in VWAT and SWAT. A higher proportion of CD206 relative to total CD68 was present in subjects with less body fat and lower fasting glucose concentrations. The ratio MCR1/CD68was positively associated with IRS1gene expression and with the expression of lipogenic genes such as ACACA, FASN and THRSP, even after adjusting for BMI. The ratio MCR1/CD68 in SWAT increased significantly after the surgery-induced weight loss (+ 44.7%; p = 0.005) in parallel to the expression of adipogenic genes. In addition, SWAT MCR1/CD68ratio was significantly associated with muscle mitochondrial gene expression (PPARGC1A, TFAM and MT-CO3). AT CD206 was confirmed by immunohistochemistry to be specific of macrophages, especially abundant in crown-like structures. Conclusion: A decreased ratio MCR1/CD68 is linked to adipose tissue and muscle mitochondrial dysfunction at least at the level of expression of adipogenic and mitochondrial genes.	[Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Invest Biomed Girona IdIBGi, CIBEROBN CB06 03 010, Serv Diabet Endocrinol & Nutr, Girona, Spain; [Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Girona, Spain; [Gomez-Serrano, Maria; Garcia-Santos, Eva; Peral, Belen] CSIC, Inst Invest Biomed Alberto Sols IIB, Madrid, Spain; [Gomez-Serrano, Maria; Garcia-Santos, Eva; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Tinahones, Francisco] Inst Salud Carlos III, CIBEROBN Fisiopatol Obesidad & Nutr CB06 03 018, Hosp Virgen Victoria Malaga, Dept Endocrinol & Nutr, Malaga, Spain; [Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Inst Internal Med, Rome, Italy	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Fernandez-Real, JM (corresponding author), Inst Invest Biomed Girona IdIBGi, CIBEROBN CB06 03 010, Serv Diabet Endocrinol & Nutr, Girona, Spain.	jmfreal@idibgi.org	Gómez-Serrano, María/AAZ-3953-2021; Mingrone, Geltrude/AAB-9681-2019; Tinahones, Francisco José/AAB-2882-2020; Moreno-Navarrete, José María/ABG-5548-2021; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Peral, Belén/F-4562-2015	Gómez-Serrano, María/0000-0002-9669-091X; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Peral, Belén/0000-0003-4984-4020; Ricart, Wifredo/0000-0002-3452-9098; Tinahones, Francisco J/0000-0001-6871-4403; Mingrone, Geltrude/0000-0003-2021-528X	Ministerio de Economia y Competitividad, Spain [SAF-2009-10461, PI11-00214]	Ministerio de Economia y Competitividad, Spain	This work was supported by grant SAF-2009-10461 and grant PI11-00214 from the Ministerio de Economia y Competitividad, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chung NN, 2012, CAN J PHYSIOL PHARM, V90, P1634, DOI 10.1139/y2012-144; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gastaldi G, 2007, DIABETOLOGIA, V50, P2348, DOI 10.1007/s00125-007-0782-1; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Hutchison SK, 2012, DIABETOLOGIA, V55, P1424, DOI 10.1007/s00125-011-2442-8; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Masgrau A, 2012, J PHYSIOL-LONDON, V590, P5199, DOI 10.1113/jphysiol.2012.238576; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qiao LP, 2012, DIABETES, V61, P1463, DOI 10.2337/db11-1475; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Veilleux A, 2009, METABOLISM, V58, P624, DOI 10.1016/j.metabol.2008.12.007; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	41	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70810	10.1371/journal.pone.0070810	http://dx.doi.org/10.1371/journal.pone.0070810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951013	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300053
J	Tan, JF; Wang, MJ; Tu, LL; Nie, YC; Lin, YJ; Zhang, XL				Tan, Jiafu; Wang, Maojun; Tu, Lili; Nie, Yichun; Lin, Yongjun; Zhang, Xianlong			The Flavonoid Pathway Regulates the Petal Colors of Cotton Flower	PLOS ONE			English	Article							ARMIGERA HUBNER LEPIDOPTERA; ARABIDOPSIS SEEDLINGS; ANTHOCYANIN BIOSYNTHESIS; CHALCONE SYNTHASE; PETUNIA-HYBRIDA; EXPRESSION; GENES; NOCTUIDAE; EVOLUTION; PIGMENTATION	Although biochemists and geneticists have studied the cotton flower for more than one century, little is known about the molecular mechanisms underlying the dramatic color change that occurs during its short developmental life following blooming. Through the analysis of world cotton germplasms, we found that all of the flowers underwent color changes post-anthesis, but there is a diverse array of petal colors among cotton species, with cream, yellow and red colors dominating the color scheme. Genetic and biochemical analyses indicated that both the original cream and red colors and the color changes post-anthesis were related to flavonoid content. The anthocyanin content and the expression of biosynthesis genes were both increased from blooming to one day post-anthesis (DPA) when the flower was withering and undergoing abscission. Our results indicated that the color changes and flavonoid biosynthesis of cotton flowers were precisely controlled and genetically regulated. In addition, flavonol synthase (FLS) genes involved in flavonol biosynthesis showed specific expression at 11 am when the flowers were fully opened. The anthocyanidin reductase (ANR) genes, which are responsible for proanthocyanidins biosynthesis, showed the highest expression at 6 pm on 0 DPA, when the flowers were withered. Light showed primary, moderate and little effects on flavonol, anthocyanin and proanthocyanidin biosynthesis, respectively. Flavonol biosynthesis was in response to light exposure, while anthocyanin biosynthesis was involved in flower color changes. Further expression analysis of flavonoid genes in flowers of wild type and a flavanone 3-hydroxylase (F3H) silenced line showed that the development of cotton flower color was controlled by a complex interaction between genes and light. These results present novel information regarding flavonoids metabolism and flower development.	[Tan, Jiafu; Wang, Maojun; Tu, Lili; Nie, Yichun; Lin, Yongjun; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Tu, LL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	lilitu@mail.hzau.edu.cn	Wang, Maojun/M-2587-2019; Tan, Jiafu/A-9980-2016; Tan, Jiafu/J-2422-2013	Wang, Maojun/0000-0002-4791-3742; Tan, Jiafu/0000-0002-6498-7495	National High Technology Research and Development Program of China (863 Program) [2012AA101108]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program, grant number 2012AA101108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; ASEN S, 1975, PHYTOCHEMISTRY, V14, P2677, DOI 10.1016/0031-9422(75)85249-6; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Casimero V, 2000, APPL ENTOMOL ZOOL, V35, P69, DOI 10.1303/aez.2000.69; Chhabra N, 1978, FACTORS AFFECTING AN, P136; DELPH LF, 1989, EVOLUTION, V43, P1252, DOI [10.1111/j.1558-5646.1989.tb02572.x, 10.2307/2409360]; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Farzad M, 2002, PLANT SCI, V162, P225, DOI 10.1016/S0168-9452(01)00557-X; Fryxell P.A., 1992, RHEEDEA, V2, P108; Fryxell PA, 1971, EVOLUTION, P554; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; GRIESBACH RJ, 1992, HORTSCIENCE, V27, P817, DOI 10.21273/HORTSCI.27.7.817; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HEDIN PA, 1983, EXPERIENTIA, V39, P799, DOI 10.1007/BF01990335; Ida TY, 2003, AM J BOT, V90, P1751, DOI 10.3732/ajb.90.12.1751; Irani NG, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-7; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Kubasek WL, 1998, PLANT MOL BIOL, V37, P217, DOI 10.1023/A:1005977103116; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liang ZL, 1997, SCI CHINA SER C, V40, P284, DOI 10.1007/BF02879089; MAEKAWA S, 1983, PLANT CELL PHYSIOL, V24, P759, DOI 10.1093/oxfordjournals.pcp.a076573; MANCINELLI AL, 1984, PLANT CELL PHYSIOL, V25, P93; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; MARTIN C, 1993, PLANT CELL, V5, P1253, DOI 10.1105/tpc.5.10.1253; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Neelakantam K, 1935, P INDIAN ACAD SCI A, V1, P887; Neelakantam K., 1937, P INDIAN ACAD SCI, V5, P357, DOI [10.1007/BF03051222, DOI 10.1007/BF03051222]; NEEMAN G, 1995, ISRAEL J PLANT SCI, V43, P135, DOI 10.1080/07929978.1995.10676599; Niesenbaum RA, 1999, AM MIDL NAT, V141, P59, DOI 10.1674/0003-0031(1999)141[0059:DFCCIA]2.0.CO;2; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Parks C, 1972, AM J BOT, P158; Parks C, 1975, B TORREY BOT CLUB, P350; Parks CR, 1965, AM J BOT, P849; Parks CR, 1965, AM J BOT, P309; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; STEPHENS SG, 1954, GENETICS, V39, P712; STEPHENS SG, 1948, GENETICS, V33, P191; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tan JF, 2012, J PLANT GROWTH REGUL, V31, P599, DOI 10.1007/s00344-012-9260-1; THOMPSON WR, 1972, SCIENCE, V177, P528, DOI 10.1126/science.177.4048.528; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; VANTUNEN AJ, 1988, EMBO J, V7, P1257, DOI 10.1002/j.1460-2075.1988.tb02939.x; Vlaming P, 1983, THEOR APPL GENET, V66, P271; Vogt T, 1999, PHYTOCHEMISTRY, V52, P583, DOI 10.1016/S0031-9422(99)00151-X; WAAGE SK, 1984, PHYTOCHEMISTRY, V23, P2509, DOI 10.1016/S0031-9422(00)84086-8; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Weiss D, 2000, PHYSIOL PLANTARUM, V110, P152, DOI 10.1034/j.1399-3054.2000.110202.x; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Yang YZ, 2008, AUST J ENTOMOL, V47, P137, DOI 10.1111/j.1440-6055.2008.00640.x	54	31	35	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72364	10.1371/journal.pone.0072364	http://dx.doi.org/10.1371/journal.pone.0072364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951318	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300195
J	Zitterbart, DP; Kindermann, L; Burkhardt, E; Boebel, O				Zitterbart, Daniel P.; Kindermann, Lars; Burkhardt, Elke; Boebel, Olaf			Automatic Round-the-Clock Detection of Whales for Mitigation from Underwater Noise Impacts	PLOS ONE			English	Article							AIRGUNS	Loud hydroacoustic sources, such as naval mid-frequency sonars or airguns for marine geophysical prospecting, have been increasingly criticized for their possible negative effects on marine mammals and were implicated in several whale stranding events. Competent authorities now regularly request the implementation of mitigation measures, including the shut-down of acoustic sources when marine mammals are sighted within a predefined exclusion zone. Commonly, ship-based marine mammal observers (MMOs) are employed to visually monitor this zone. This approach is personnel-intensive and not applicable during night time, even though most hydroacoustic activities run day and night. This study describes and evaluates an automatic, ship-based, thermographic whale detection system that continuously scans the ship's environs for whale blows. Its performance is independent of daylight and exhibits an almost uniform, omnidirectional detection probability within a radius of 5 km. It outperforms alerted observers in terms of number of detected blows and ship-whale encounters. Our results demonstrate that thermal imaging can be used for reliable and continuous marine mammal protection.	[Zitterbart, Daniel P.; Kindermann, Lars; Burkhardt, Elke; Boebel, Olaf] Helmholtz Zentrum Polar Meeresforsch, Alfred Wegener Inst, Ocean Acoust Lab, Bremerhaven, Germany; [Zitterbart, Daniel P.] Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Erlangen Nuremberg	Zitterbart, DP (corresponding author), Helmholtz Zentrum Polar Meeresforsch, Alfred Wegener Inst, Ocean Acoust Lab, Bremerhaven, Germany.	daniel.zitterbart@awi.de	Zitterbart, Daniel/N-7489-2013	Zitterbart, Daniel/0000-0001-9429-4350	German Federal Ministry of Education and Research [BMBF 03F0479I]; Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [BMU 370891101-01]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federal Ministry for the Environment, Nature Conservation and Nuclear Safety	This project was funded by the German Federal Ministry of Education and Research (grant number BMBF 03F0479I) and the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (grant number BMU 370891101-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P239; Boebel O, 2011, REPORTS POLAR MARINE, V102; Burkhardt E, 2012, REPORTS POLAR MARINE, V59; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; COPPENS F, 1985, GEOPHYS PROSPECT, V33, P1212, DOI 10.1111/j.1365-2478.1985.tb01360.x; CUYLER LC, 1992, MAR MAMMAL SCI, V8, P120, DOI 10.1111/j.1748-7692.1992.tb00371.x; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Felzenszwalb P, 2008, PROC CVPR IEEE, P1984; Greene CR, 1987, INFRARED DETECTION W; Hoag H, 2010, NATURE, DOI [10.1038/news.2010.403, DOI 10.1038/NEWS.2010.403]; Jackson E, 2012, TORONTO STAR; Lerczak JA, 1998, MAR MAMMAL SCI, V14, P590, DOI 10.1111/j.1748-7692.1998.tb00745.x; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; Perryman WL, 1999, MAR MAMMAL SCI, V15, P426, DOI 10.1111/j.1748-7692.1999.tb00811.x; Piotr D, 2006, PIOTRS IMAGE VIDEO M; Richter S, 2012, REPORTS POLAR MARINE, V56; Rowley H. A., 1995, CITESEER; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Stone Carolyn J., 2006, Journal of Cetacean Research and Management, V8, P255; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wartzok D, 2012, ADV EXP MED BIOL, V730, P551, DOI 10.1007/978-1-4419-7311-5_125	23	17	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71217	10.1371/journal.pone.0071217	http://dx.doi.org/10.1371/journal.pone.0071217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951113	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300102
J	Irie, T; Yoshida, A; Sakaguchi, T				Irie, Takashi; Yoshida, Asuka; Sakaguchi, Takemasa			Clustered Basic Amino Acids of the Small Sendai Virus C Protein Y1 Are Critical to Its Ran GTPase-Mediated Nuclear Localization	PLOS ONE			English	Article							VIRAL-RNA SYNTHESIS; ANTIVIRAL ACTION; PLASMA-MEMBRANE; V-PROTEIN; INTERFERON; ACTIVATION; STAT1; PROMOTER; INHIBIT; GENOME	The Sendai virus (SeV) C proteins are shown to exert multiple functions during the course of infection. Perhaps reflecting their many functions, they occur at multiple sites of the cell. In this study, we focused on the nuclear-localizing ability of the smaller C protein, Y1, and found that this translocation is mediated by Ran GTPase but not by passive diffusion, and that basic residues within the 149-157 amino acid region are critical for that. The mechanism of inhibition of interferon (IFN)-signaling seemed to differ between the C and Y1 proteins, since deletion of 12 C-terminal amino acids resulted in a loss of the function for the C but not for the Y1 protein. The ability of Y1 mutants to inhibit IFN-alpha-induced, ISRE-driven expression of a reporter gene almost paralleled with that to localize in the nucleus. These results suggest that nuclear localization of the Y1 protein might be important for the inhibitory effect on type-I IFN-stimulated gene expression.	[Irie, Takashi; Yoshida, Asuka; Sakaguchi, Takemasa] Hiroshima Univ, Dept Virol, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Irie, T (corresponding author), Hiroshima Univ, Dept Virol, Inst Biomed & Hlth Sci, Hiroshima, Japan.	tirie@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	JSPS KAKENHI [23790505]; Grants-in-Aid for Scientific Research [25460569] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23790505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Cadd T, 1996, J VIROL, V70, P5067, DOI 10.1128/JVI.70.8.5067-5074.1996; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; Garcin D, 2003, J VIROL, V77, P2321, DOI 10.1128/JVI.77.4.2321-2329.2003; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Gotoh G, 2003, VIROLOGY, V316, P29, DOI 10.1016/S0042-6822(03)00590-7; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Irie T, 2012, J VIROL, V86, P7136, DOI 10.1128/JVI.06705-11; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010719; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; Kato A, 2001, J VIROL, V75, P3802, DOI 10.1128/JVI.75.8.3802-3810.2001; Kiyotani K, 2007, VIROLOGY, V359, P82, DOI 10.1016/j.virol.2006.08.053; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Komatsu T, 2007, MICROBES INFECT, V9, P954, DOI 10.1016/j.micinf.2007.03.014; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; Koyama AH, 2003, MICROBES INFECT, V5, P373, DOI 10.1016/S1286-4579(03)00043-1; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; PORTNER A, 1986, VIRUS RES, V6, P109, DOI 10.1016/0168-1702(86)90043-2; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Sakaguchi T, 2011, NEUROSCI LETT, V505, P279, DOI 10.1016/j.neulet.2011.10.040; Sakaguchi T, 2011, MICROBIOL IMMUNOL, V55, P760, DOI 10.1111/j.1348-0421.2011.00379.x; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997; YAMADA H, 1990, ARCH VIROL, V113, P245, DOI 10.1007/BF01316677; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoshida A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049968	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73740	10.1371/journal.pone.0073740	http://dx.doi.org/10.1371/journal.pone.0073740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951363	gold, Green Submitted, Green Published			2022-12-27	WOS:000326473200097
J	Vohra, S; Biggin, PC				Vohra, Shabana; Biggin, Philip C.			Mutationmapper: A Tool to Aid the Mapping of Protein Mutation Data	PLOS ONE			English	Article							EXTRACTION; RECEPTOR; CHALLENGES; VARIANTS; SEQUENCE	There has been a rapid increase in the amount of mutational data due to, amongst other things, an increase in single nucleotide polymorphism (SNP) data and the use of site-directed mutagenesis as a tool to help dissect out functional properties of proteins. Many manually curated databases have been developed to index point mutations but they are not sustainable with the ever-increasing volume of scientific literature. There have been considerable efforts in the automatic extraction of mutation specific information from raw text involving use of various text-mining approaches. However, one of the key problems is to link these mutations with its associated protein and to present this data in such a way that researchers can immediately contextualize it within a structurally related family of proteins. To aid this process, we have developed an application called MutationMapper. Point mutations are extracted from abstracts and are validated against protein sequences in Uniprot as far as possible. Our methodology differs in a fundamental way from the usual text-mining approach. Rather than start with abstracts, we start with protein sequences, which facilitates greatly the process of validating a potential point mutation identified in an abstract. The results are displayed as mutations mapped on to the protein sequence or a multiple sequence alignment. The latter enables one to readily pick up mutations performed at equivalent positions in related proteins. We demonstrate the use of MutationMapper against several examples including a single sequence and multiple sequence alignments. The application is available as a web-service at http://mutationmapper.bioch.ox.ac.uk.	[Vohra, Shabana; Biggin, Philip C.] Univ Oxford, Oxford, England; [Vohra, Shabana; Biggin, Philip C.] Oxford Ctr Integrat Syst Biol, Dept Biochem, Oxford, England	University of Oxford; University of Oxford	Biggin, PC (corresponding author), Univ Oxford, Oxford, England.	philip.biggin@bioch.ox.ac.uk		Biggin, Philip/0000-0001-5100-8836	Oxford Centre for Integrative Systems Biology (BBSRC)	Oxford Centre for Integrative Systems Biology (BBSRC)	This work was supported by the Oxford Centre for Integrative Systems Biology (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CJO, 2006, INFORM SYST FRONT, V8, P47, DOI 10.1007/s10796-006-6103-2; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; BOYD A, 1981, CELL, V26, P333, DOI 10.1016/0092-8674(81)90202-6; Caporaso JG, 2007, BIOINFORMATICS, V23, P1862, DOI 10.1093/bioinformatics/btm235; Cohen KB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-492; Fukuda K, 1998, INFORM EXTRACTION ID, P707; Gyimesi G, 2012, HUM MUTAT, V33, P1547, DOI 10.1002/humu.22138; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553; Horn F, 2004, BIOINFORMATICS, V20, P557, DOI 10.1093/bioinformatics/btg449; Humphreys K, 2000, 2 APPL INFORM EXTRAC, P505; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kuipers R, 2010, HUM MUTAT, V31, P1026, DOI 10.1002/humu.21317; Lee LC, 2007, PLOS COMPUT BIOL, V3, P184, DOI 10.1371/journal.pcbi.0030016; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; McIntosh T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-311; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; Murthy SE, 2012, J GEN PHYSIOL, V140, P267, DOI 10.1085/jgp.201210786; Ogren PV, 2006, KNOWTATOR PROTEGE PL, P273; Placzek AN, 2004, MOL PHARMACOL, V66, P169, DOI 10.1124/mol.66.1.169; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Salgado D, 2012, BIOINFORMATICS, V28, P2285, DOI 10.1093/bioinformatics/bts435; Stenetorp P., 2012, BRAT RAPID ANNOTATIO; Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124; TOMITA M, 1978, BIOCHEMISTRY-US, V17, P4756, DOI 10.1021/bi00615a025; Unezaki S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-59; Wei C. H., 2012, P BIOCREATIVE 2012 W, P145; Wei CH, 2013, BIOINFORMATICS, V29, P1433, DOI 10.1093/bioinformatics/btt156; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671; Yip Yum Lina, 2007, J Bioinform Comput Biol, V5, P1215, DOI 10.1142/S021972000700320X	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71711	10.1371/journal.pone.0071711	http://dx.doi.org/10.1371/journal.pone.0071711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951226	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200068
J	Barros, A; Alvarez, D; Velando, A				Barros, Alvaro; Alvarez, David; Velando, Alberto			Climate Influences Fledgling Sex Ratio and Sex-Specific Dispersal in a Seabird	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; PRESTIGE OIL-SPILL; NATAL DISPERSAL; EUROPEAN SHAGS; STICTOCARBO-ARISTOTELIS; INBREEDING AVOIDANCE; POPULATION-DYNAMICS; FORAGING BEHAVIOR; LAYING DATE; ATLANTIC	Climate influences the dynamics of natural populations by direct effects over habitat quality but also modulating the phenotypic responses of organisms' life-history traits. These responses may be different in males and females, particularly in dimorphic species, due to sex-specific requirements or constraints. Here, in a coastal seabird, the European shag (Phalacrocorax aristotelis), we studied the influence of climate (North Atlantic Oscillation, NAO; Sea Surface Temperature, SST) on two sex-related population parameters: fledgling sex ratio and sex-specific dispersal. We found that fledgling sex ratio was female skewed in NAO-positive years and male skewed in NAO-negative years. Accordingly, females dispersed a longer distance in NAO-positive years when females were overproduced, and on the contrary, males dispersed more in NAO-negative years. Overall, our findings provide rare evidence on vertebrates with genetic sex determination that climate conditions may govern population dynamics by affecting sex-specific density and dispersal.	[Barros, Alvaro; Alvarez, David; Velando, Alberto] Univ Vigo, Dept Ecoloxia & Biol Anim, Pontevedra, Spain	Universidade de Vigo	Barros, A (corresponding author), Univ Vigo, Dept Ecoloxia & Biol Anim, Pontevedra, Spain.	alvaro.barros@uvigo.es	Velando, Alberto/B-1701-2009; Alvarez, David/B-7472-2012	Velando, Alberto/0000-0001-8909-0724; Alvarez, David/0000-0002-2190-7950	Spanish Ministerio de Medio Ambiente (Organismo Autonomo Parques Nacionales) [48/2005, 275/2011]; Spanish Ministerio de Ciencia e Innovacion [CGL2012-40229-C02-02]	Spanish Ministerio de Medio Ambiente (Organismo Autonomo Parques Nacionales); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Finance was provided by the Spanish Ministerio de Medio Ambiente (Organismo Autonomo Parques Nacionales, 48/2005; 275/2011) and the Spanish Ministerio de Ciencia e Innovacion (CGL2012-40229-C02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1995, IBIS, V137, P11, DOI 10.1111/j.1474-919X.1995.tb03214.x; AEBISCHER NJ, 1986, J ANIM ECOL, V55, P613, DOI 10.2307/4743; AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Albon S.D., 1988, Special Publication of the British Ecological Society, V7, P93; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Alvarez D, 2007, CORMORAN MONUDO ESPA; Alvarez D, 2011, ARDEOLA, V58, P239, DOI 10.13157/arla.58.2.2011.239; Barbraud C, 2003, J ANIM ECOL, V72, P246, DOI 10.1046/j.1365-2656.2003.00695.x; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Benard MF, 2008, AM NAT, V171, P553, DOI 10.1086/587072; Bonte D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-16; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P1, DOI 10.1093/acprof:osobl/9780199602568.001.0001; Noguera JC, 2012, BIOL LETTERS, V8, P61, DOI 10.1098/rsbl.2011.0756; Castro-Diez Y, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014042; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2002, NATURE, V415, P633, DOI 10.1038/415633a; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; COULSON JC, 1986, BIRD STUDY, V33, P55, DOI 10.1080/00063658609476893; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; DOBSON FS, 1985, AM NAT, V126, P855, DOI 10.1086/284457; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Gjerdrum C, 2003, P NATL ACAD SCI USA, V100, P9377, DOI 10.1073/pnas.1133383100; Goth A, 2005, BIOL LETTERS, V1, P31, DOI 10.1098/rsbl.2004.0247; Greatbatch RJ, 2000, STOCH ENV RES RISK A, V14, P213, DOI 10.1007/s004770000047; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guisande C, 2004, FISH OCEANOGR, V13, P91, DOI 10.1046/j.1365-2419.2003.00276.x; Guisande C, 2001, MAR ECOL PROG SER, V223, P243, DOI 10.3354/meps223243; Hanski Ilkka, 2001, P283; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurrell JW, 2001, SCIENCE, V291, P603, DOI 10.1126/science.1058761; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Jenouvrier S, 2003, J ANIM ECOL, V72, P576, DOI 10.1046/j.1365-2656.2003.00727.x; Jenouvrier S, 2010, AM NAT, V175, P739, DOI 10.1086/652436; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Kokko H, 2004, J ANIM ECOL, V73, P367, DOI 10.1111/j.0021-8790.2004.00813.x; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; LAMBIN X, 1994, ECOLOGY, V75, P224, DOI 10.2307/1939396; LAWRENCE WS, 1986, BEHAV ECOL SOCIOBIOL, V18, P289, DOI 10.1007/BF00300006; LAWRENCE WS, 1987, BEHAV ECOL SOCIOBIOL, V21, P367, DOI 10.1007/BF00299931; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LENS L, 1994, IBIS, V136, P147, DOI 10.1111/j.1474-919X.1994.tb01078.x; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Little RC, 2006, SAS MIXED MODELS; Martinez-Abrain A, 2006, MAR ECOL PROG SER, V318, P271, DOI 10.3354/meps318271; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; Meylan S, 2002, HORM BEHAV, V42, P319, DOI 10.1006/hbeh.2002.1827; Meylan S, 2004, ECOSCIENCE, V11, P123, DOI 10.1080/11956860.2004.11682816; Moller AP, 2006, J ANIM ECOL, V75, P657, DOI 10.1111/j.1365-2656.2006.01086.x; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parn H, 2012, P ROY SOC B-BIOL SCI, V279, P144, DOI 10.1098/rspb.2011.0673; Perez C, 2006, J ORNITHOL, V147, P513, DOI 10.1007/s10336-006-0074-4; POTTS GR, 1969, J ANIM ECOL, V38, P53, DOI 10.2307/2740; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Sandvik H, 2008, GLOBAL CHANGE BIOL, V14, P703, DOI 10.1111/j.1365-2486.2007.01533.x; Sandvik H, 2008, ECOGRAPHY, V31, P73, DOI 10.1111/j.2007.0906-7590.05090.x; Signa G, 2008, CONT SHELF RES, V28, P2659, DOI 10.1016/j.csr.2008.08.008; SNOW BARBARA, 1960, IBIS, V102, P554, DOI 10.1111/j.1474-919X.1960.tb07132.x; Spear LB, 1998, J ANIM ECOL, V67, P165, DOI 10.1046/j.1365-2656.1998.00190.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Torres R, 1999, OECOLOGIA, V118, P16, DOI 10.1007/s004420050698; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Velando A, 1999, ARDEA, V87, P51; Velando A, 2000, ANIM BEHAV, V60, P181, DOI 10.1006/anbe.2000.1445; Velando A, 2000, ARDEA, V88, P127; Velando A, 2005, MAR ECOL PROG SER, V302, P263, DOI 10.3354/meps302263; Velando A, 2005, J ORNITHOL, V146, P116, DOI 10.1007/s10336-004-0068-z; Velando A, 2002, BIOL CONSERV, V107, P59, DOI 10.1016/S0006-3207(02)00044-7; Velando A, 2001, J ETHOL, V19, P121, DOI 10.1007/s101640170008; Velando A, 1997, THESIS U VIGO SPAIN; Velando A, 2004, LIBRO ROJO AVES ESPA, P60; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Walls SS, 2005, J ANIM ECOL, V74, P190, DOI 10.1111/j.1365-2656.2005.00914.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; WASER PM, 1989, ANIM BEHAV, V37, P987, DOI 10.1016/0003-3472(89)90142-5; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	100	13	14	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71358	10.1371/journal.pone.0071358	http://dx.doi.org/10.1371/journal.pone.0071358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951144	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000054
J	Della Beffa, C; Slansky, E; Pommerenke, C; Klawonn, F; Li, JL; Dai, L; Schumacher, HR; Pessler, F				Della Beffa, Cristina; Slansky, Elisabeth; Pommerenke, Claudia; Klawonn, Frank; Li, Jialiang; Dai, Lie; Schumacher, H. Ralph, Jr.; Pessler, Frank			The Relative Composition of the Inflammatory Infiltrate as an Additional Tool for Synovial Tissue Classification	PLOS ONE			English	Article							WAR-VETERANS-ILLNESS; JOINT PAIN; ARTHRITIS; ARTHROPATHIES; BIOMARKER; SCORE	Objectives: Traditionally, differences in absolute numbers of cells expressing a certain marker (e. g., positive staining cells per mm(2)) have been used in immunohistological synovial tissue classification. We have begun to evaluate the relative composition of the inflammatory infiltrates, i.e. percentages of inflammatory cell types in inflammatory infiltrates, as an alternate classification tool that may potentially improve tissue diagnostics, subgrouping in clinical trials, and understanding of pathogenesis of inflammatory and noninflammatory arthropathies. Methods: Synovial tissue specimens (normal synovium, n=15; orthopedic arthropathies, n=6; osteoarthritis, n=26; early undifferentiated arthritis, n=10; rheumatoid arthritis, n=26; chronic septic arthritis, n=11) were stained for CD15, CD68, CD3, CD20, and CD38. Densities of cells expressing a given marker were determined in the superficial subintima. Binary and multicategory receiver operating characteristic (ROC) analysis and naive Bayes classifier were used to compare the abilities of (1) the absolute densities of cells expressing a given marker (absolute method) with (2) the percentages of these cells in the inflammatory cell population (relative method) to differentiate among the six tissue classes. Results: The inflammatory infiltrates in normal synovium and the orthopedic arthropathies consisted almost exclusively of CD68+ and CD3+ cells. Notable fractions of CD20+ and CD38+ cells appeared in a subset of osteoarthritis samples, and increased further in early, rheumatoid and chronic septic arthritis. ROC analyses and naive Bayes classifier ranked the absolute method above the relative method in terms of overall discriminatory ability. The relative method became slightly superior when the samples were also stratified according to the total number of inflammatory cells/mm(2). Conclusions: This exploratory investigation featuring a variety of joint disorders revealed that measuring the relative proportions of inflammatory cell types may aid in synovial tissue classification if the samples are also stratified according to the intensity of inflammation.	[Della Beffa, Cristina; Klawonn, Frank] Helmholtz Ctr Infect Res, Dept Cellular Prote, Braunschweig, Germany; [Pommerenke, Claudia] Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany; [Klawonn, Frank] Ostfalia Univ Appl Sci, Dept Comp Sci, Wolfenbuttel, Germany; [Slansky, Elisabeth; Li, Jialiang] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Dai, Lie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Schumacher, H. Ralph, Jr.] Philadelphia Vet Affairs Med Ctr, Div Rheumatol, Philadelphia, PA USA; [Pessler, Frank] TWINCORE Ctr Expt & Clin Infect Res, Res Grp Biomarkers Infect Dis, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; National University of Singapore; Sun Yat Sen University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Helmholtz Association; Helmholtz-Center for Infection Research	Pessler, F (corresponding author), TWINCORE Ctr Expt & Clin Infect Res, Res Grp Biomarkers Infect Dis, Hannover, Germany.	frank.pessler@twincore.de	Klawonn, Frank/HFH-5887-2022; Li, Jialiang/B-9132-2014; Stangel, Martin/AAH-5345-2020; Li, Jialiang/N-8529-2019	Klawonn, Frank/0000-0001-9613-182X; Li, Jialiang/0000-0002-9704-4135; Li, Jialiang/0000-0002-9704-4135	International Collaboration Seed from the German Federal Ministry for Education and Science (International Office) [SGP 08/A01, SGP 09/1AP]	International Collaboration Seed from the German Federal Ministry for Education and Science (International Office)	Support is gratefully acknowledged from International Collaboration Seed Grant SGP 08/A01 and grant SGP 09/1AP "German-Singaporean Network for Rheumatology Research" from the German Federal Ministry for Education and Science (International Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresnihan B, 2007, ANN RHEUM DIS, V66, P1656, DOI 10.1136/ard.2006.061143; Diaz-Torne C, 2007, ARTHRIT RHEUM-ARTHR, V57, P1316, DOI 10.1002/art.23006; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Jahangier ZN, 2006, ANN RHEUM DIS, V65, P1286, DOI 10.1136/ard.2005.042333; Kraan MC, 1999, RHEUMATOLOGY, V38, P1074, DOI 10.1093/rheumatology/38.11.1074; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261; Li JL, 2008, BIOSTATISTICS, V9, P566, DOI 10.1093/biostatistics/kxm050; Morawietz L, 2009, HISTOPATHOLOGY, V54, P847, DOI 10.1111/j.1365-2559.2009.03313.x; Oehler S, 2002, CLIN EXP RHEUMATOL, V20, P633; Ogdie A, 2010, BIOMARKERS, V15, P183, DOI 10.3109/13547500903411095; Pessler F, 2008, ARTHRIT RHEUM-ARTHR, V59, P1137, DOI 10.1002/art.23915; Pessler F, 2008, CLIN RHEUMATOL, V27, P1127, DOI 10.1007/s10067-008-0878-0; Pessler F, 2008, ANN RHEUM DIS, V67, P1184, DOI 10.1136/ard.2008.087775; Pessler F, 2008, ANN RHEUM DIS, V67, P162, DOI 10.1136/ard.2007.071670; Slansky E, 2010, HISTOPATHOLOGY, V57, P436, DOI 10.1111/j.1365-2559.2010.03641.x; van der Hall Pascal O., 2007, V135, P121	18	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72494	10.1371/journal.pone.0072494	http://dx.doi.org/10.1371/journal.pone.0072494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951325	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000085
J	Gerber, PA; Thalhammer, C; Schmied, C; Spring, S; Amann-Vesti, B; Spinas, GA; Berneis, K				Gerber, Philipp A.; Thalhammer, Christoph; Schmied, Christian; Spring, Silviana; Amann-Vesti, Beatrice; Spinas, Giatgen A.; Berneis, Kaspar			Small, Dense LDL Particles Predict Changes in Intima Media Thickness and Insulin Resistance in Men with Type 2 Diabetes and Prediabetes - A Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK; PLASMA; LIPOPROTEINS; TRIGLYCERIDE; CHOLESTEROL; MORTALITY; MARKERS; SIZE; ATHEROSCLEROSIS	The association of small, dense low-density lipoprotein (sdLDL) particles with an increased cardiovascular risk is well established. However, its predictive value with regard to glucose metabolism and arterial disease in patients with type 2 diabetes has not been thoroughly investigated. We conducted a prospective longitudinal cohort study in patients with (pre)diabetes who were seen at baseline and after two years. sdLDL particles were determined by gradient gel electrophoresis. Insulin resistance was estimated by using the homeostatic model assessment 2 (HOMA2). Intima media thickness (IMT) and flow-mediated dilation (FMD) were assessed by ultrasound measurements. Fifty-nine patients (mean age 63.0 +/- 12.2 years) were enrolled and 39 were seen at follow-up. IMT increased in the whole cohort during follow-up. The change in IMT was predicted by the proportion of sdLDL particles at baseline (p=0.03), and the change in FMD was predicted by LDL-cholesterol levels at baseline (p=0.049). HOMA2 and changes in HOMA2 correlated with the proportion of sdLDL particles and changes in this proportion, respectively (p<0.05 for both). Serum resistin levels increased in parallel with the increasing sdLDL particle number, while serum adiponectin increased only in patients with unaltered sdLDL particle number at follow-up (p<0.01 for both). In conclusion, the proportion of small, dense LDL particles and changes in this proportion are predictive of changes in intima media thickness and insulin resistance, and are closely associated with other determinants of an adverse metabolic status. Thus, this parameter extends the individual risk assessment beyond the limitations of traditional risk markers in patients with dysglycemia.	[Gerber, Philipp A.; Spinas, Giatgen A.; Berneis, Kaspar] Univ Zurich Hosp, Div Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland; [Thalhammer, Christoph; Spring, Silviana; Amann-Vesti, Beatrice] Univ Zurich Hosp, Div Angiol, CH-8091 Zurich, Switzerland; [Schmied, Christian] Univ Zurich Hosp, Div Cardiol, CH-8091 Zurich, Switzerland; [Gerber, Philipp A.; Spinas, Giatgen A.] Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Berneis, Kaspar] Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Gerber, PA (corresponding author), Univ Zurich Hosp, Div Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland.	philipp.gerber@usz.ch	Gerber, Philipp/C-2145-2015	Gerber, Philipp/0000-0002-2476-7076	Swiss National Science Foundation [32003B-105258]; AstraZeneca, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AstraZeneca, Switzerland(AstraZeneca)	This study was supported in part by the Swiss National Science Foundation (grant no 32003B-105258 to KB) and an unrestricted grant from AstraZeneca, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; Avena R, 1998, J VASC SURG, V28, P1024, DOI 10.1016/S0741-5214(98)70028-X; Berneis K, 2005, METABOLISM, V54, P227, DOI 10.1016/j.metabol.2004.08.017; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CORESH J, 1993, J LIPID RES, V34, P1687; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; FEINGOLD KR, 1992, ARTERIOSCLER THROMB, V12, P1496, DOI 10.1161/01.ATV.12.12.1496; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HARRIS LM, 1995, AM J CARDIOL, V76, P207, DOI 10.1016/S0002-9149(99)80066-6; Hayashi Y, 2007, METABOLISM, V56, P608, DOI 10.1016/j.metabol.2007.01.001; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Krauss RM, 2005, ARTERIOSCL THROM VAS, V25, P2265, DOI 10.1161/01.ATV.0000186365.73973.f0; KRAUSS RM, 1982, J LIPID RES, V23, P97; Krauss RM, 2004, DIABETES CARE, V27, P1496, DOI 10.2337/diacare.27.6.1496; Krayenbuehl PA, 2008, SWISS MED WKLY, V138, P275, DOI 2008/19/smw-12124; LAWS A, 1992, J INTERN MED, V231, P25, DOI 10.1111/j.1365-2796.1992.tb00494.x; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Malo E, 2011, METAB SYNDR RELAT D, V9, P203, DOI 10.1089/met.2010.0106; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Norata GD, 2007, EUR J ENDOCRINOL, V156, P279, DOI 10.1530/eje.1.02338; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pellme F, 2003, DIABETES, V52, P1182, DOI 10.2337/diabetes.52.5.1182; Rizzo M, 2009, CLIN ENDOCRINOL, V70, P870, DOI 10.1111/j.1365-2265.2008.03407.x; Sampson UK, 2012, CURR ATHEROSCLER REP, V14, P1, DOI 10.1007/s11883-011-0219-7; Thalhammer C, 1999, ARTERIOSCL THROM VAS, V19, P1173, DOI 10.1161/01.ATV.19.5.1173; Younis N, 2009, ATHEROSCLEROSIS, V202, P162, DOI 10.1016/j.atherosclerosis.2008.04.036	32	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72763	10.1371/journal.pone.0072763	http://dx.doi.org/10.1371/journal.pone.0072763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951331	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323124000088
J	Khor, EC; Abel, T; Tickner, J; Chim, SM; Wang, C; Cheng, T; Ng, B; Ng, PY; Teguh, DA; Kenny, J; Yang, XH; Chen, HH; Nakayama, KI; Nakayama, K; Pavlos, N; Zheng, MH; Xu, JK				Khor, Ee Cheng; Abel, Tamara; Tickner, Jennifer; Chim, Shek Man; Wang, Cathy; Cheng, Taksum; Benjamin Ng; Pei Ying Ng; Teguh, Dian Astari; Kenny, Jacob; Yang, Xiaohong; Chen, Honghui; Nakayama, Keiichi I.; Nakayama, Keiko; Pavlos, Nathan; Zheng, Ming H.; Xu, Jiake			Loss of Protein Kinase C-delta Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption	PLOS ONE			English	Article							NF-KAPPA-B; TYROSINE-PHOSPHATASE; SRC KINASE; RECEPTOR ACTIVATOR; GENE-EXPRESSION; INHIBITS OSTEOCLASTOGENESIS; ALPHA(V)BETA(3) INTEGRIN; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; TARGETED DISRUPTION	Bone remodeling is intrinsically regulated by cell signaling molecules. The Protein Kinase C (PKC) family of serine/threonine kinases is involved in multiple signaling pathways including cell proliferation, differentiation, apoptosis and osteoclast biology. However, the precise involvement of individual PKC isoforms in the regulation of osteoclast formation and bone homeostasis remains unclear. Here, we identify PKC-delta as the major PKC isoform expressed among all PKCs in osteoclasts; including classical PKCs (-alpha, -beta and -gamma), novel PKCs (-delta, -epsilon, -eta and -theta) and atypical PKCs (-iota/lambda and -lambda). Interestingly, pharmacological inhibition and genetic ablation of PKC-delta impairs osteoclastic bone resorption in vitro. Moreover, disruption of PKC-delta activity protects against LPS-induced osteolysis in mice, with osteoclasts accumulating on the bone surface failing to resorb bone. Treatment with the PKC-delta inhibitor Rottlerin, blocks LPS-induced bone resorption in mice. Consistently, PKC-delta deficient mice exhibit increased trabeculae bone containing residual cartilage matrix, indicative of an osteoclast-rich osteopetrosis phenotype. Cultured ex vivo osteoclasts derived from PKC-delta null mice exhibit decreased CTX-1 levels and MARKS phosphorylation, with enhanced formation rates. This is accompanied by elevated gene expression levels of cathepsin K and PKC -alpha, -gamma, -epsilon, as well as altered signaling of pERK and pcSrc416/527 upon RANKL-induction, possibly to compensate for the defects in bone resorption. Collectively, our data indicate that PKC-delta is an intrinsic regulator of osteoclast formation and bone resorption and thus is a potential therapeutic target for pathological osteolysis.	[Khor, Ee Cheng; Wang, Cathy; Cheng, Taksum; Pei Ying Ng; Pavlos, Nathan; Zheng, Ming H.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia; [Khor, Ee Cheng; Tickner, Jennifer; Chim, Shek Man; Benjamin Ng; Teguh, Dian Astari; Kenny, Jacob; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Abel, Tamara] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Nedlands, WA 6009, Australia; [Yang, Xiaohong; Chen, Honghui] Jinan Univ, Affiliated Hosp 4, Coll Med, Guangzhou Inst Traumat Surg, Guangzhou, Guangdong, Peoples R China; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [Nakayama, Keiko] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan	University of Western Australia; University of Western Australia; University of Western Australia; Jinan University; Kyushu University; Kyushu University	Zheng, MH (corresponding author), Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia.	minghao.zheng@uwa.edu.au; jiake.xu@uwa.edu.au	Tickner, Jennifer/H-5965-2014; Chim, Shek Man/AAK-6809-2020	Tickner, Jennifer/0000-0002-5020-0671; Chim, Shek Man/0000-0002-5116-8394; Zheng, Minghao/0000-0003-1185-4768; Pavlos, Nathan/0000-0001-7003-188X; Xu, Jiake/0000-0003-2021-8309; /0000-0002-2151-3433; Kenny, Jacob/0000-0001-8169-9842	National Health and Medical Research Council [5138323]; National Natural Science Foundation of China (NSFC) [81228013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was funded in part by grants from the National Health and Medical Research Council (number 5138323). This study was also supported by a grant from the National Natural Science Foundation of China (NSFC) (number 81228013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Bakker A, 2003, METH MOLEC MED, V80, P19; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Buitrago C, 2011, MOL CELL ENDOCRINOL, V339, P81, DOI 10.1016/j.mce.2011.03.022; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Cremasco V, 2012, J BONE MINER RES, V27, P2452, DOI 10.1002/jbmr.1701; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Ha J, 2011, CYTOKINE, V55, P48, DOI 10.1016/j.cyto.2011.03.026; HELFRICH MH, 1991, BONE, V12, P411, DOI 10.1016/8756-3282(91)90030-M; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kozuka Y, 2006, CALCIFIED TISSUE INT, V78, P125, DOI 10.1007/s00223-005-0149-x; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lampasso JD, 2002, J BONE MINER RES, V17, P1968, DOI 10.1359/jbmr.2002.17.11.1968; Lee SW, 2003, BONE, V32, P217, DOI 10.1016/S8756-3282(02)00976-6; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Lima F, 2009, MOL BIOL CELL, V20, P2697, DOI 10.1091/mbc.E08-10-1079; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Margolis D, 2008, CALCIFIED TISSUE INT, V82, P66276; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Moonga BS, 1996, CALCIFIED TISSUE INT, V59, P105, DOI 10.1007/s002239900095; Moonga BS, 1998, EXP PHYSIOL, V83, P717, DOI 10.1113/expphysiol.1998.sp004153; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ozaki Y, 2009, BONE, V44, P1169, DOI 10.1016/j.bone.2009.01.375; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Shinohara M, 2012, J BONE MINER RES, V27, P2464, DOI 10.1002/jbmr.1703; SISMEYDURRANT HJ, 1991, ORAL MICROBIOL IMMUN, V6, P378, DOI 10.1111/j.1399-302X.1991.tb00510.x; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sorensen MG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-250; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SU YJ, 1992, ENDOCRINOLOGY, V131, P1497, DOI 10.1210/en.131.3.1497; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; WALKER DG, 1973, SCIENCE, V180, P875, DOI 10.1126/science.180.4088.875; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200; Zhuang L, 2007, LARYNGOSCOPE, V117, P841, DOI 10.1097/MLG.0b013e318033783a; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	68	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70815	10.1371/journal.pone.0070815	http://dx.doi.org/10.1371/journal.pone.0070815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951014	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000028
J	Markiewicz, A; Welnicka-Jaskiewicz, M; Skokowski, J; Jaskiewicz, J; Szade, J; Jassem, J; Zaczek, AJ				Markiewicz, Aleksandra; Welnicka-Jaskiewicz, Marzena; Skokowski, Jaroslaw; Jaskiewicz, Janusz; Szade, Jolanta; Jassem, Jacek; Zaczek, Anna J.			Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients	PLOS ONE			English	Article							ESTROGEN-RECEPTOR GENE; POSTMENOPAUSAL PATIENTS; CLINICAL-SIGNIFICANCE; ADJUVANT TAMOXIFEN; ALPHA GENE; METABOLISM; EXPRESSION; RESISTANCE; SURVIVAL; THERAPY	Introduction: Amplification of the ESR1 gene, coding for estrogen receptor alpha, was shown to predict responsiveness to tamoxifen, however its prognostic impact in breast cancer patients has not been thoroughly investigated. Other factors that could contribute to responsiveness to tamoxifen treatment are polymorphisms in ESR1 gene and genes involved in tamoxifen metabolism. The aim of this study was to assess the prognostic role of ESR1 gene dosage in a consecutive group of breast cancer patients and to correlate this feature with clinico-pathological factors. Additionally, ESR1 PvuII, CYP2C19*2 and UGT2B15*2 polymorphisms were analyzed in the tamoxifen-treated subgroup of patients. Materials and Methods: Primary tumor samples from 281 stage I-III consecutive breast cancer patients were analyzed for ESR1 gene dosage using real-time PCR with locked nucleic acids hydrolysis probes. In the tamoxifen-treated subgroup of patients, ESR1 PvuII, CYP2C19*2 and UGT2B15*2 polymorphism in leukocytes genomic DNA were analyzed. Results were correlated with clinico-pathological factors and with disease-free survival (DFS) and overall survival (OS). Results: ESR1 amplification (with a cut-off level of 2.0) was found in 12% of the entire group of breast cancer patients, and in 18% of the ER-negative subgroup. This feature was associated with decreased DFS both in the entire group (P=0.007) and in the ER-negative subgroup (P=0.03), but not in the tamoxifen-treated patients. Patients with ESR1 PvuII wt/wt genotype and at least one UGT2B15 wt allele had a worse DFS (P=0.03) and showed a trend towards decreased Os (P=0.08) in comparison to patients with ESR1 PvuII wt/vt or vt/vt genotype and UGT2B15 *2/*2 genotype. Conclusions: ESR1 amplification can occur in ER-negative tumors and may carry poor prognosis. In the tamoxifen-treated subgroup, poor prognosis was related to the combined presence of ESR1 PvuII wt/wt and UGT2B15wt/wt or wt/*2 genotype.	[Markiewicz, Aleksandra; Zaczek, Anna J.] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland; [Markiewicz, Aleksandra; Zaczek, Anna J.] Med Univ Gdansk, Gdansk, Poland; [Markiewicz, Aleksandra] Med Univ Warsaw, PostgraduateSch Mol Med, Warsaw, Poland; [Welnicka-Jaskiewicz, Marzena; Jassem, Jacek] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Med Lab Diagnost, Bank Frozen Tissues & Genet Specimens, Gdansk, Poland; [Skokowski, Jaroslaw; Jaskiewicz, Janusz] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Szade, Jolanta] Med Univ Gdansk, Dept Pathol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zaczek, AJ (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland.	azaczek@gumed.edu.pl	; Markiewicz, Aleksandra/C-1493-2013	Jassem, Jacek/0000-0002-8875-6747; Markiewicz, Aleksandra/0000-0003-4590-4698; Skokowski, Jaroslaw/0000-0002-3079-3502; Zaczek, Anna J/0000-0003-1482-6068; Welnicka-Jaskiewicz, Marzena/0000-0003-4578-6302; Szade, Jolanta/0000-0003-0429-0677	National Science Centre [N N402 686240]; University of Gdansk [538-M000-1294-12]	National Science Centre(National Science Centre, Poland); University of Gdansk	This research was supported by a grant from the National Science Centre N N402 686240 and a grant from the University of Gdansk 538-M000-1294-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albertson DG, 2012, J PATHOL, V227, P1, DOI 10.1002/path.3999; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Brown LA, 2008, NAT GENET, V40, P806, DOI 10.1038/ng0708-806; Cai QY, 2003, CANCER EPIDEM BIOMAR, V12, P853; Crewe HK, 2002, DRUG METAB DISPOS, V30, P869, DOI 10.1124/dmd.30.8.869; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dezentje VO, 2010, 2010 ASCO ANN M; Ebeshi BU, 2011, INT J MED MED SCI, V3, P193; Ejlertsen B, 2012, ANN ONCOL, V23, P1138, DOI 10.1093/annonc/mdr438; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HILL SM, 1989, CANCER RES, V49, P145; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Horlings HM, 2008, NAT GENET, V40, P807, DOI 10.1038/ng0708-807; Levesque E, 1997, PHARMACOGENETICS, V7, P317, DOI 10.1097/00008571-199708000-00007; Lin CH, 2013, J CLIN PATHOL, V66, P140, DOI [10.1136/jdinpath-2012-200929, 10.1136/jclinpath-2012-200929]; Markiewicz A, 2010, ANN ONCOL, V21, P57; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Moelans CB, 2010, ANAL CELL PATHOL, V33, P13, DOI [10.1155/2010/619180, 10.3233/ACP-CLO-2010-0527]; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nielsen KV, 2011, BREAST CANCER RES TR, V127, P345, DOI 10.1007/s10549-010-0984-y; Nishiyama T, 2002, BIOCHEM PHARMACOL, V63, P1817, DOI 10.1016/S0006-2952(02)00994-2; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Okishiro M, 2009, CANCER-AM CANCER SOC, V115, P952, DOI 10.1002/cncr.24111; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Reis-Filho JS, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809b; Reynisson E, 2006, J MICROBIOL METH, V66, P206, DOI 10.1016/j.mimet.2005.11.006; Ruiter R, 2010, PHARMACOGENOMICS, V11, P1367, DOI 10.2217/PGS.10.112; Ryan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034112; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; YAICH L, 1992, CANCER RES, V52, P77; Yoshidome K, 2000, CANCER RES, V60, P6901	37	18	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72219	10.1371/journal.pone.0072219	http://dx.doi.org/10.1371/journal.pone.0072219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951298	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000083
J	Yu, SW; Chen, CM; Chen, YC; Chang, CW; Chang, HS; Lyu, RK; Ro, LS; Wu, YR				Yu, Shao-wen; Chen, Chiung-Mei; Chen, Yi-Chun; Chang, Chia Wen; Chang, Hong-Shiu; Lyu, Rong-Kuo; Ro, Long-Sun; Wu, Yih-Ru			SLC1A2 Variant Is Associated with Essential Tremor in Taiwanese Population	PLOS ONE			English	Article							FAMILIAL ESSENTIAL TREMOR; LINGO1; GENE; DISEASE; TWINS; RISK; AGE	Essential tremor (ET), which is one of the most common movement disorders, may lead to severe interference in quality of life. The first genome-wide association study (GWAS) has identified an association of the LINGO1 variant (rs9652490) with ET in Americans and Europeans. Recently, a second GWAS that was performed in a European population has discovered a new variant (rs3794087) of the main glial glutamate transporter (SLC1A2) that increases the risk of ET with an odds ratio of about 1.4. SLC1A2 encodes for the major glial high-affinity glutamate reuptake transporter in the brain and is a potential ET susceptibility gene. Because replication in a different ethnic population is important for validating a finding, we conducted a case-control study to investigate the SLC1A2 variant in an Asian cohort with ET in Taiwan. A total of 542 subjects (273 ET patients and 269 controls) were included. The results showed that rs3794087 was associated with ET among the Taiwanese. The odds ratio was 1.37. Our results were similar to those of the second GWAS of ET in Europeans, and this confirms that SLC1A2 may be a good functional candidate gene for ET. A replication study in another independent population is of importance to validate this association.	[Yu, Shao-wen; Chen, Chiung-Mei; Chen, Yi-Chun; Chang, Chia Wen; Chang, Hong-Shiu; Lyu, Rong-Kuo; Ro, Long-Sun; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Wu, YR (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan.	yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3A0132, CMRPG331182]; National Science Council, Executive Yuan, Taiwan [NSC101-2314-B-182A-065]	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG3A0132; CMRPG331182), and National Science Council, Executive Yuan, Taiwan (NSC101-2314-B-182A-065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridon P, 2008, PARKINSONISM RELAT D, V14, P15, DOI 10.1016/j.parkreldis.2007.05.002; Deng H, 2012, ACTA NEUROL SCAND, V125, P1, DOI 10.1111/j.1600-0404.2011.01516.x; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Deuschl G, 2002, MOVEMENT DISORD, V17, pS41, DOI 10.1002/mds.10141; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Elble RJ, 2009, CURR NEUROL NEUROSCI, V9, P273, DOI 10.1007/s11910-009-0041-6; Gulcher JR, 1997, NAT GENET, V17, P84, DOI 10.1038/ng0997-84; Higgins JJ, 1997, MOVEMENT DISORD, V12, P859, DOI 10.1002/mds.870120605; Jimenez-Jimenez FJ, 2012, J NEUROL SCI, V317, P52, DOI 10.1016/j.jns.2012.02.030; Lorenz D, 2004, NEUROLOGY, V62, P208, DOI 10.1212/01.WNL.0000103236.26934.41; Louis ED, 2005, LANCET NEUROL, V4, P100, DOI 10.1016/S1474-4422(05)00991-9; Louis ED, 2006, MOVEMENT DISORD, V21, P1980, DOI 10.1002/mds.21102; Rowland Lewis P, 2010, MERRITTS NEUROLOGY; Shatunov A, 2006, BRAIN, V129, P2318, DOI 10.1093/brain/awl120; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Tan EK, 2008, EUR J NEUROL, V15, P889, DOI 10.1111/j.1468-1331.2008.02226.x; Tan EK, 2013, NEUROLOGY, V80, P1618, DOI 10.1212/WNL.0b013e31828f1903; Tanner CM, 2001, NEUROLOGY, V57, P1389, DOI 10.1212/WNL.57.8.1389; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Thier S, 2010, MOVEMENT DISORD, V25, P717, DOI 10.1002/mds.22887	20	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71919	10.1371/journal.pone.0071919	http://dx.doi.org/10.1371/journal.pone.0071919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951268	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000074
J	Bitu, CC; Kauppila, JH; Bufalino, A; Nurmenniemi, S; Teppo, S; Keinanen, M; Vilen, ST; Lehenkari, P; Nyberg, P; Coletta, RD; Salo, T				Bitu, Carolina C.; Kauppila, Joonas H.; Bufalino, Andreia; Nurmenniemi, Sini; Teppo, Susanna; Keinanen, Meeri; Vilen, Suvi-Tuuli; Lehenkari, Petri; Nyberg, Pia; Coletta, Ricardo D.; Salo, Tuula			Cathepsin K Is Present in Invasive Oral Tongue Squamous Cell Carcinoma In Vivo and In Vitro	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; SKIN FIBROBLASTS; PROSTATE-CANCER; PROTEASES; EXPRESSION; PROGRESSION; DEGRADATION; MATRIX; INHIBITOR; TURNOVER	Objectives: Cathepsin K, a lysosomal cysteine protease, is expressed in the tumor microenvironment (TME) of skin carcinoma, but nothing is known about cathepsin K in oral tongue squamous cell carcinoma (OTSCC). Our aim was to describe the expression of cathepsin K in invasive OTSCC in vitro and in a series of clinical cancer specimens. Materials and Methods: OTSCC invasion in vitro was studied using invasive HSC-3 tongue carcinoma cells in 3D organotypic models. In total, 121 mobile tongue OTSCCs and 10 lymph node metastases were analyzed for cathepsin K expression. The association between cathepsin K expression and clinicopathological factors was evaluated. Results: Cysteine protease inhibitor E64 and cathepsin K silencing significantly (p < 0.0001) reduced HSC-3 cell invasion in the 3D models. Cathepsin K was expressed in a majority of carcinoma and metastatic cells, but the expression pattern in carcinoma cells did not correlate with clinical parameters. Instead, the weak expression of cathepsin K in the invasive TME front correlated with increased overall recurrence (p < 0.05), and in early-stage tumors this pattern predicted both cancer recurrence and cancer-specific mortality (p < 0.05 and p < 0.005, respectively). Conclusions: Cathepsin K is expressed in OTSCC tissue in both carcinoma and TME cells. Although the diminished activity and expression in aggressive tongue HSC-3 cells reduced 3D invasion in vitro, the amount of cathepsin K in carcinoma cells was not associated with the outcome of cancer patients. Instead, cathepsin K in the invasive TME front seems to have a protective role in the complex progression of tongue cancer.	[Bitu, Carolina C.; Nurmenniemi, Sini; Teppo, Susanna; Vilen, Suvi-Tuuli; Nyberg, Pia; Salo, Tuula] Univ Oulu, Dept Diagnost & Oral Med, Inst Dent, Oulu, Finland; [Kauppila, Joonas H.] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Kauppila, Joonas H.] Univ Oulu, Dept Surg, Inst Clin Med, Oulu, Finland; [Vilen, Suvi-Tuuli; Salo, Tuula] Univ Helsinki, Biomedicum Helsinki Fac Med, Inst Dent, Dept Cell Biol Oral Dis, Helsinki, Finland; [Keinanen, Meeri; Lehenkari, Petri] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Kauppila, Joonas H.; Lehenkari, Petri; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Bufalino, Andreia; Coletta, Ricardo D.] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Piracicaba, SP, Brazil	University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Oulu; University of Oulu; Universidade Estadual de Campinas	Salo, T (corresponding author), Univ Oulu, Dept Diagnost & Oral Med, Inst Dent, Oulu, Finland.	tuula.salo@oulu.fi	Bufalino, Andreia/H-7047-2014; Lehenkari, Petri/O-3009-2016; , tuula/ABG-2051-2021; Coletta, Ricardo D./B-4909-2015; Kauppila, Joonas/P-1363-2015	Bufalino, Andreia/0000-0002-6714-6253; Lehenkari, Petri/0000-0002-0055-5183; Coletta, Ricardo D./0000-0001-5285-3046; Kauppila, Joonas/0000-0001-6740-3726; Salo, Tuula/0000-0001-6039-0088	Emil Aaltonen Foundation; Cancer Foundation of Northern Ostrobotnia; Oulu University Research Foundation; Georg C. and Mary Ehrnrooth Foundation; Finnish Medical Foundation; Academy of Finland; Sigrid Juselius Foundation; Kevo grants	Emil Aaltonen Foundation; Cancer Foundation of Northern Ostrobotnia; Oulu University Research Foundation; Georg C. and Mary Ehrnrooth Foundation; Finnish Medical Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kevo grants	This work was supported with grants from the following foundations: Emil Aaltonen Foundation, Cancer Foundation of Northern Ostrobotnia, Oulu University Research Foundation, Georg C. and Mary Ehrnrooth Foundation, the Finnish Medical Foundation, Academy of Finland, Sigrid Juselius Foundation and Kevo grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamahi A, 2009, IDRUGS, V12, P799; Aoki T, 2008, STROKE, V39, P2603, DOI 10.1161/STROKEAHA.107.513648; Bello IO, 2008, HUM PATHOL, V39, P1212, DOI 10.1016/j.humpath.2007.12.015; Bone HG, 2010, J BONE MINER RES, V25, P937, DOI 10.1359/jbmr.091035; Brubaker KD, 2003, J BONE MINER RES, V18, P222, DOI 10.1359/jbmr.2003.18.2.222; Codriansky KA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1356, DOI 10.1111/j.1751-1097.2009.00592.x; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; CURRY T E JR, 1989, Steroids, V54, P501, DOI 10.1016/0039-128X(89)90044-5; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Erdem NF, 2007, J ORAL MAXIL SURG, V65, P1725, DOI 10.1016/j.joms.2006.11.034; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Le Gall C, 2007, CANCER RES, V67, P9894, DOI 10.1158/0008-5472.CAN-06-3940; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; Novinec M, 2013, BIOL CHEM B IN PRESS; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Podgorski I, 2007, BIOCHEM SOC T, V35, P701, DOI 10.1042/BST0350701; Quintanilla-Dieck MJ, 2008, J INVEST DERMATOL, V128, P2281, DOI 10.1038/jid.2008.63; Quintanilla-Dieck MJ, 2009, EXP DERMATOL, V18, P596, DOI 10.1111/j.1600-0625.2009.00855.x; Runger TM, 2007, J INVEST DERMATOL, V127, P293, DOI 10.1038/sj.jid.5700535; Samokhin AO, 2008, ATHEROSCLEROSIS, V200, P58, DOI 10.1016/j.atherosclerosis.2007.12.047; Suojanen J, 2009, ORAL DIS, V15, P170, DOI 10.1111/j.1601-0825.2008.01507.x; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; Xie LN, 2011, J DERMATOL SCI, V61, P45, DOI 10.1016/j.jdermsci.2010.09.005; Yan X, 2011, J EUR ACAD DERMATOL, V25, P362, DOI 10.1111/j.1468-3083.2010.03743.x; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-72; Zimmerman S, 2009, J REPROD IMMUNOL, V83, P19, DOI 10.1016/j.jri.2009.07.006	40	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70925	10.1371/journal.pone.0070925	http://dx.doi.org/10.1371/journal.pone.0070925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951042	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700064
J	Greenaway, KH; Louis, WR; Hornsey, MJ				Greenaway, Katharine H.; Louis, Winnifred R.; Hornsey, Matthew J.			Loss of Control Increases Belief in Precognition and Belief in Precognition Increases Control	PLOS ONE			English	Article							COMPENSATORY CONTROL; SUPERSTITION; DEPRIVATION; UNCERTAINTY; MOTIVATION; GOVERNMENT; SUPPORT; ORDER; GOD	Every year thousands of dollars are spent on psychics who claim to "know" the future. The present research questions why, despite no evidence that humans are able to psychically predict the future, do people persist in holding irrational beliefs about precognition? We argue that believing the future is predictable increases one's own perceived ability to exert control over future events. As a result, belief in precognition should be particularly strong when people most desire control-that is, when they lack it. In Experiment 1(N = 87), people who were experimentally induced to feel low in control reported greater belief in precognition than people who felt high in control. Experiment 2 (N = 53) investigated whether belief in precognition increases perceived control. Consistent with this notion, providing scientific evidence that precognition is possible increased feelings of control relative to providing scientific evidence that precognition was not possible. Experiment 3 (N = 132) revealed that when control is low, believing in precognition helps people to feel in control once more. Prediction therefore acts as a compensatory mechanism in times of low control. The present research provides new insights into the psychological functions of seemingly irrational beliefs, like belief in psychic abilities.	[Greenaway, Katharine H.; Louis, Winnifred R.; Hornsey, Matthew J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Greenaway, KH (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	k.greenaway@psy.uq.edu.au	Louis, Winnifred/A-1968-2008; Greenaway, Katharine/A-9269-2015	Louis, Winnifred/0000-0003-2996-982X; Greenaway, Katharine/0000-0002-0271-5312; Hornsey, Matthew/0000-0003-1275-3977				AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Bem DJ, 2011, J PERS SOC PSYCHOL, V100, P407, DOI 10.1037/a0021524; Berlin L, 2011, DAILY FINANCE   0921; BLACKMORE S, 1985, BRIT J PSYCHOL, V76, P459, DOI 10.1111/j.2044-8295.1985.tb01969.x; Blackmore SJ, 1991, SKEPTICAL INQUIRER, V11, P244; Bleak J. L., 1998, Journal of Sport Behavior, V21, P1; BURGER JM, 1987, J EXP SOC PSYCHOL, V23, P350, DOI 10.1016/0022-1031(87)90046-1; Caner GC, 1940, ARCH NEUROL PSYCHIAT, V90, P782; Case TI, 2004, J APPL SOC PSYCHOL, V34, P848, DOI 10.1111/j.1559-1816.2004.tb02574.x; Ciborowski T, 1997, SPORT PSYCHOL, V11, P305, DOI 10.1123/tsp.11.3.305; Damisch L, 2010, PSYCHOL SCI, V21, P1014, DOI 10.1177/0956797610372631; DAVIES MF, 1985, PERS INDIV DIFFER, V6, P661, DOI 10.1016/0191-8869(85)90021-2; Eakin Emily, 2001, NY TIMES; Fritsche I, 2008, J PERS SOC PSYCHOL, V95, P524, DOI 10.1037/a0012666; Fritsche I, 2013, J EXP SOC PSYCHOL, V49, P19, DOI 10.1016/j.jesp.2012.07.014; HECKHAUSEN J, 1995, PSYCHOL REV, V102, P284, DOI 10.1037/0033-295X.102.2.284; Hyman R, 2007, CRITICAL THINKING IN PSYCHOLOGY, P216; Irwin, 2003, J SOC PSYCHICAL RES, V67, P200; Irwin H.J., 2000, EUR J PARAPSYCHOL, V15, P68; Irwin HJ, 2005, PSYCHOL PARANORMAL B; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kay AC, 2010, J PERS SOC PSYCHOL, V99, P725, DOI 10.1037/a0021140; Kay AC, 2010, PERS SOC PSYCHOL REV, V14, P37, DOI 10.1177/1088868309353750; Kay AC, 2009, CURR DIR PSYCHOL SCI, V18, P264, DOI 10.1111/j.1467-8721.2009.01649.x; Keinan G, 2002, PERS SOC PSYCHOL B, V28, P102, DOI 10.1177/0146167202281009; Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Norton MI, 2014, J EXP PSYCHOL GEN, V143, P266, DOI 10.1037/a0031772; PADGETT VR, 1982, PERS SOC PSYCHOL B, V8, P736, DOI 10.1177/0146167282084021; Pittman T. S., 1998, HDB SOCIAL PSYCHOL, P549; PITTMAN TS, 1989, J EXP SOC PSYCHOL, V25, P465, DOI 10.1016/0022-1031(89)90001-2; PITTMAN TS, 1980, J PERS SOC PSYCHOL, V39, P377, DOI 10.1037/0022-3514.39.3.377; Pittman TS, 1985, ATTRIBUTION BASIC IS, P117; RODIN J, 1977, J PERS SOC PSYCHOL, V35, P897, DOI 10.1037/0022-3514.35.12.897; Romans C, 2009, CNN LIVING      0205; ROTHBAUM F, 1982, J PERS SOC PSYCHOL, V42, P5, DOI 10.1037/0022-3514.42.1.5; Rudski J, 2003, CURR PSYCHOL, V22, P306; Rutjens BT, 2013, J EXP PSYCHOL GEN, V142, P313, DOI 10.1037/a0028716; Rutjens BT, 2010, SOC PSYCHOL PERS SCI, V1, P246, DOI 10.1177/1948550610361782; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Shepherd S, 2011, J EXP SOC PSYCHOL, V47, P949, DOI 10.1016/j.jesp.2011.03.026; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; TOBACYK J, 1983, J PERS SOC PSYCHOL, V44, P1029, DOI 10.1037/0022-3514.44.5.1029; Tobacyk Jerome., 2004, INT J TRANSPERSONAL, V23, P94, DOI [DOI 10.24972/IJTS.2004.23.1.94, DOI 10.1037/T14015-000]; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Watt C, 2007, PERS INDIV DIFFER, V42, P335, DOI 10.1016/j.paid.2006.07.015; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845	48	37	40	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71327	10.1371/journal.pone.0071327	http://dx.doi.org/10.1371/journal.pone.0071327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951136	Green Published, gold			2022-12-27	WOS:000323109700095
J	Hanami, T; Delobel, D; Kanamori, H; Tanaka, Y; Kimura, Y; Nakasone, A; Soma, T; Hayashizaki, Y; Usui, K; Harbers, M				Hanami, Takeshi; Delobel, Diane; Kanamori, Hajime; Tanaka, Yuki; Kimura, Yasumasa; Nakasone, Ayako; Soma, Takahiro; Hayashizaki, Yoshihide; Usui, Kengo; Harbers, Matthias			Eprobe Mediated Real-Time PCR Monitoring and Melting Curve Analysis	PLOS ONE			English	Article							DNA-POLYMERASE; LUNG-CANCER; PROBES; HYBRIDIZATION; MUTATIONS; AMPLIFICATION; FLUORESCENCE; QUANTIFICATION	Real-time monitoring of PCR is one of the most important methods for DNA and RNA detection widely used in research and medical diagnostics. Here we describe a new approach for combined real-time PCR monitoring and melting curve analysis using a 39 end-blocked Exciton-Controlled Hybridization-sensitive fluorescent Oligonucleotide (ECHO) called Eprobe. Eprobes contain two dye moieties attached to the same nucleotide and their fluorescent signal is strongly suppressed as single-stranded oligonucleotides by an excitonic interaction between the dyes. Upon hybridization to a complementary DNA strand, the dyes are separated and intercalate into the double-strand leading to strong fluorescence signals. Intercalation of dyes can further stabilize the DNA/DNA hybrid and increase the melting temperature compared to standard DNA oligonucleotides. Eprobes allow for specific real-time monitoring of amplification reactions by hybridizing to the amplicon in a sequence-dependent manner. Similarly, Eprobes allow for analysis of reaction products by melting curve analysis. The function of different Eprobes was studied using the L858R mutation in the human epidermal growth factor receptor (EGFR) gene, and multiplex detection was demonstrated for the human EGFR and KRAS genes using Eprobes with two different dyes. Combining amplification and melting curve analysis in a single-tube reaction provides powerful means for new mutation detection assays. Functioning as "sequence-specific dyes", Eprobes hold great promises for future applications not only in PCR but also as hybridization probes in other applications.	[Hanami, Takeshi; Delobel, Diane; Tanaka, Yuki; Kimura, Yasumasa; Soma, Takahiro; Usui, Kengo; Harbers, Matthias] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Kanamori, Hajime; Nakasone, Ayako; Harbers, Matthias] KK DNAFORM, Yokohama, Kanagawa, Japan; [Hayashizaki, Yoshihide; Usui, Kengo] RIKEN, Prevent Med & Diag Innovat Program, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Usui, K (corresponding author), RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	kusui@gsc.riken.jp; matthias.harbers@riken.jp	Hanami, Takeshi/C-3653-2017; Kimura, Yasumasa/M-9720-2013; Usui, Kengo/A-7203-2016; Hayashizaki, Yoshihide/N-6590-2015; Delobel, Diane/C-4152-2017; TANAKA, Yuki/AAE-4497-2019	Hanami, Takeshi/0000-0003-1868-1409; Delobel, Diane/0000-0002-1644-1228; Harbers, Matthias/0000-0002-5613-7220	RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by (1) research grants for RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to YH, (2) a research grant from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program to YH, and (3) a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gasparic MB, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-26; Henriques A., 2012, BIOTECHNIQUES; Hoshi K, 2007, CLIN CANCER RES, V13, P4974, DOI 10.1158/1078-0432.CCR-07-0509; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019206; Ikeda S, 2008, CHEM-ASIAN J, V3, P958, DOI 10.1002/asia.200800014; Ikeda Shuji, 2009, Nucleic Acids Symp Ser (Oxf), P155, DOI 10.1093/nass/nrp078; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Juskowiak B, 2011, ANAL BIOANAL CHEM, V399, P3157, DOI 10.1007/s00216-010-4304-5; Kawai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030236; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Kubota T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013003; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Lezhava A, 2010, HUM MUTAT, V31, P208, DOI 10.1002/humu.21177; Lu S, 2010, MOL CELL PROBE, V24, P315, DOI 10.1016/j.mcp.2010.04.002; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Mackay IM, 2005, METHOD MICROBIOL, V34, P255, DOI 10.1016/S0580-9517(04)34010-9; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nazarenko IA, 1997, NUCLEIC ACIDS RES, V25, P2516, DOI 10.1093/nar/25.12.2516; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Okamoto Akimitsu, 2009, Nucleic Acids Symp Ser (Oxf), P49, DOI 10.1093/nass/nrp025; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Szilvasi A, 2005, CLIN BIOCHEM, V38, P727, DOI 10.1016/j.clinbiochem.2005.04.015; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Tyagi Sanjay, 2012, F1000 Med Rep, V4, P10, DOI 10.3410/M4-10; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang DO, 2012, J PHOTOCH PHOTOBIO C, V13, P112, DOI 10.1016/j.jphotochemrev.2012.03.001; Wang DO, 2012, RNA, V18, P166, DOI 10.1261/rna.028431.111; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Wilhelm J, 2001, BIOTECHNIQUES, V30, P1052, DOI 10.2144/01305rr04; Yu D, 1997, BIOTECHNIQUES, V23, P714, DOI 10.2144/97234st06; [No title captured]	38	15	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70942	10.1371/journal.pone.0070942	http://dx.doi.org/10.1371/journal.pone.0070942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951046	Green Published, gold			2022-12-27	WOS:000323109700065
J	Assis, J; Coelho, NC; Alberto, F; Valero, M; Raimondi, P; Reed, D; Serrao, EA				Assis, Jorge; Coelho, Nelson Castilho; Alberto, Filipe; Valero, Myriam; Raimondi, Pete; Reed, Dan; Serrao, Ester Alvares			High and Distinct Range-Edge Genetic Diversity despite Local Bottlenecks	PLOS ONE			English	Article							CLIMATE-CHANGE; SACCORHIZA-POLYSCHIDES; LAMINARIA-OCHROLEUCA; GEOGRAPHICAL RANGES; SPECIES RANGE; F-STATISTICS; KELP; POPULATIONS; PATTERNS; DIFFERENTIATION	The genetic consequences of living on the edge of distributional ranges have been the subject of a largely unresolved debate. Populations occurring along persistent low latitude ranges (rear-edge) are expected to retain high and unique genetic diversity. In contrast, currently less favourable environmental conditions limiting population size at such range-edges may have caused genetic erosion that prevails over past historical effects, with potential consequences on reducing future adaptive capacity. The present study provides an empirical test of whether population declines towards a peripheral range might be reflected on decreasing diversity and increasing population isolation and differentiation. We compare population genetic differentiation and diversity with trends in abundance along a latitudinal gradient towards the peripheral distribution range of Saccorhiza polyschides, a large brown seaweed that is the main structural species of kelp forests in SW Europe. Signatures of recent bottleneck events were also evaluated to determine whether the recently recorded distributional shifts had a negative influence on effective population size. Our findings show decreasing population density and increasing spatial fragmentation and local extinctions towards the southern edge. Genetic data revealed two well supported groups with a central contact zone. As predicted, higher differentiation and signs of bottlenecks were found at the southern edge region. However, a decrease in genetic diversity associated with this pattern was not verified. Surprisingly, genetic diversity increased towards the edge despite bottlenecks and much lower densities, suggesting that extinctions and recolonizations have not strongly reduced diversity or that diversity might have been even higher there in the past, a process of shifting genetic baselines.	[Assis, Jorge; Coelho, Nelson Castilho; Alberto, Filipe; Serrao, Ester Alvares] Univ Algarve, Ctr Ciencias Mar Algarve, CIMAR Lab Associado, Faro, Portugal; [Alberto, Filipe] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Valero, Myriam] Univ Paris 06, CNRS, UMR CNRS, UPMC 7144, Roscoff, France; [Raimondi, Pete] Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Universidade do Algarve; University of Wisconsin System; University of Wisconsin Milwaukee; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Assis, J (corresponding author), Univ Algarve, Ctr Ciencias Mar Algarve, CIMAR Lab Associado, Campus Gambelas, Faro, Portugal.	jorgemfa@gmail.com	Serrao, Ester A/C-6686-2012; Valero, Myriam/C-7550-2011; Valero, Myriam/M-6052-2019; Assis, Jorge/AAC-6524-2019; Assis, Jorge/G-9688-2012	Serrao, Ester A/0000-0003-1316-658X; Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; Assis, Jorge/0000-0002-6624-4820; Assis, Jorge/0000-0002-6624-4820; Coelho, Nelson/0000-0002-8331-5889; Alberto, Filipe/0000-0003-0593-3240	FCT - Portuguese Science Foundation [PTDC/AAC-CLI/109108/2008, EXCL/AAG-GLO/0661/2012, SFRH / BD / 65702 / 2009]; Directorate For Geosciences [1232779] Funding Source: National Science Foundation	FCT - Portuguese Science Foundation(Portuguese Foundation for Science and Technology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the FCT - Portuguese Science Foundation (project PTDC/AAC-CLI/109108/2008 (EDGES), project EXCL/AAG-GLO/0661/2012 (EXTANT) and PhD fellowship ref. SFRH / BD / 65702 / 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2006, MAR ECOL PROG SER, V309, P117, DOI 10.3354/meps309117; Alberto F, 2010, ECOLOGY, V91, P49, DOI 10.1890/09-0050.1; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; [Anonymous], MARINE METAPOPULATIO; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Assis J, 2009, J COASTAL RES, P1469; Barradas A, 2011, CAH BIOL MAR, V52, P435; BELKHIR K, 2004, GENETIX POPULATIONS; Billingham MR, 2003, MAR ECOL PROG SER, V265, P77, DOI 10.3354/meps265077; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Boaventura D, 2002, MAR ECOL-P S Z N I, V23, P69, DOI 10.1046/j.1439-0485.2002.02758.x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Carney LT, 2011, J PHYCOL, V47, P244, DOI 10.1111/j.1529-8817.2011.00957.x; Carney LT, 2010, J PHYCOL, V46, P987, DOI 10.1111/j.1529-8817.2010.00882.x; CARVALHO D, 1992, CARTA GEOLOGICA PORT; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Coleman FC, 2002, TRENDS ECOL EVOL, V17, P40, DOI 10.1016/S0169-5347(01)02330-8; Cornuet JM, 1996, GENETICS, V144, P2001; Coyer JA, 2011, MAR GENOM, V4, P41, DOI 10.1016/j.margen.2010.12.003; Coyer JA, 2003, MOL ECOL, V12, P1817, DOI 10.1046/j.1365-294X.2003.01850.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Engel CR, 2008, MOL ECOL RESOUR, V8, P406, DOI 10.1111/j.1471-8286.2007.01972.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Fraser CI, 2009, J PHYCOL, V45, P436, DOI 10.1111/j.1529-8817.2009.00658.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GARZA JC, 2006, CRITICAL M; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; *GONC, 2004, ARCH FISH MAR RES, V51, P233; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hoarau G, 2007, MOL ECOL NOTES, V7, P191, DOI 10.1111/j.1471-8286.2006.01587.x; Hock Z, 2008, AM J BOT, V95, P542, DOI 10.3732/ajb.2007283; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; HOFFMANN AJ, 1991, MAR ECOL PROG SER, V79, P185, DOI 10.3354/meps079185; Jump AS, 2003, NEW PHYTOL, V160, P349, DOI 10.1046/j.1469-8137.2003.00873.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Langella O., 1999, POPULATIONS 1 2 30 P; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mandak B, 2005, PLANT SYST EVOL, V253, P219, DOI 10.1007/s00606-005-0316-6; MANTEL N, 1967, CANCER RES, V27, P209; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Muth AF, 2012, J PHYCOL, V48, P1374, DOI 10.1111/j.1529-8817.2012.01211.x; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; Neiva J, 2012, J BIOGEOGR, V39, P1167, DOI 10.1111/j.1365-2699.2011.02670.x; Neiva J, 2010, MOL ECOL, V19, P4812, DOI 10.1111/j.1365-294X.2010.04853.x; Neushul M, 1983, EFFECTS WASTE DISPOS, P282; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; NORTON TA, 1977, NEW PHYTOL, V78, P625, DOI 10.1111/j.1469-8137.1977.tb02167.x; Oliveira PB, 2009, CONT SHELF RES, V29, P759, DOI 10.1016/j.csr.2008.08.004; Palmer MA, 1997, J N AM BENTHOL SOC, V16, P189, DOI 10.2307/1468251; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; Pereira SG, 2006, HYDROBIOLOGIA, V555, P185, DOI 10.1007/s10750-005-1115-3; Pereira TR, 2011, CAH BIOL MAR, V52, P395; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pujol B, 2008, SCIENCE, V321, P96, DOI 10.1126/science.1157570; *R DEV COR TEAM, 2005, R DEV COR TEAM R LAN; REED DC, 1990, ECOLOGY, V71, P776, DOI 10.2307/1940329; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rogell B, 2010, CONSERV GENET, V11, P489, DOI 10.1007/s10592-009-0039-2; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; SANTOS R, 1993, MAR ECOL PROG SER, V94, P181, DOI 10.3354/meps094181; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Sorte CJB, 2004, MAR ECOL PROG SER, V274, P263, DOI 10.3354/meps274263; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Valero M, 2011, CAH BIOL MAR, V52, P467; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Walser B, 2012, MOL ECOL, V21, P851, DOI 10.1111/j.1365-294X.2011.05416.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Yakimowski SB, 2008, NEW PHYTOL, V180, P534, DOI 10.1111/j.1469-8137.2008.02582.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zuur Alain F., 2009, P1	96	71	71	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68646	10.1371/journal.pone.0068646	http://dx.doi.org/10.1371/journal.pone.0068646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182SU	23967038	Green Published, Green Submitted, gold			2022-12-27	WOS:000321765300059
J	De Marchis, GM; Pugin, D; Lantigua, H; Zammit, C; Tadi, P; Schmidt, JM; Falo, MC; Agarwal, S; Mayer, SA; Claassen, J				De Marchis, Gian Marco; Pugin, Deborah; Lantigua, Hector; Zammit, Christopher; Tadi, Prasanna; Schmidt, J. Michael; Falo, M. Cristina; Agarwal, Sachin; Mayer, Stephan A.; Claassen, Jan			Tonic-Clonic Activity at Subarachnoid Hemorrhage Onset: Impact on Complications and Outcome	PLOS ONE			English	Article							SEIZURES; VASOSPASM; BLOOD; ANEURYSMS; ISCHEMIA; EPILEPSY; RISK	Objective: Tonic-clonic activity (TCA) at onset complicates 3% to 21% of cases of subarachnoid hemorrhage (SAH). The impact of onset TCA on in-hospital complications, including seizures, remains unclear. One study associated onset TCA with poor clinical outcome at 6 weeks after SAH, but to our knowledge no other studies have confirmed this relationship. This study aims to assess the impact of onset TCA on in-hospital complications, poor functional outcome, mortality, and epilepsy at 3 months. Methods: Analysis of a prospective study cohort of 1479 SAH patients admitted to Columbia University Medical Center between 1996 and 2012. TCA within 6 hours of hemorrhage onset was identified based on accounts of emergency care providers or family witnesses. Results: TCA at onset was described in 170 patients (11%). Patients with onset TCA were younger (P = 0.002), presented more often with poor clinical grade (55% vs. 26%, P<0.001) and had larger amounts of cisternal, intraventricular, and intracerebral blood than those without onset TCA (all, P<0.001). After adjusting for known confounders, onset TCA was significantly associated with in-hospital seizures (OR 3.80, 95%-CI: 2.43-5.96, P<0.001), in-hospital pneumonia (OR 1.56, 95%-CI: 1.06-2.31, p = 0.02), and delayed cerebral ischemia (OR 1.77, 95%-CI: 1.21-2.58, P = 0.003). At 3 months, however, onset TCA was not associated with poor functional outcome, mortality, and epilepsy after adjusting for age, admission clinical grade, and cisternal blood volume. Conclusions: Onset TCA is not a rare event as it complicates 11% of cases of SAH. New and clinically relevant findings are the association of onset TCA with in-hospital seizures, pneumonia and delayed cerebral ischemia. Despite the increased risk of in-hospital complications, onset TCA is not associated with disability, mortality, and epilepsy at 3 months.	[Claassen, Jan] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA; Columbia Univ, Dept Neurosurg, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University	Claassen, J (corresponding author), Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA.	jc1439@mail.cumc.columbia.edu	Claassen, Jan/AAA-5451-2020; De Marchis, Gian Marco/J-5414-2019; Tadi, Prasanna/AAP-9026-2020	De Marchis, Gian Marco/0000-0002-0342-9780; Tadi, Prasanna/0000-0003-3782-6722; Schmidt, J. Michael/0000-0001-8141-2944	Career Development Grant [PBBEP3_139388]; Swiss National Science Foundation; Swisslife Jubilaumsstiftung for Medical Research; Swiss Neurological Society; Fondazione Dr. Ettore Balli; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1 TR000040]; National Center for Research Resources [UL1 RR024156]	Career Development Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung for Medical Research; Swiss Neurological Society; Fondazione Dr. Ettore Balli; National Center for Advancing Translational Sciences, National Institutes of Health (NIH); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	GMDM is supported in the frame of a Career Development Grant for junior investigators (PBBEP3_139388) funded by the Swiss National Science Foundation; by a Grant from the Swisslife Jubilaumsstiftung for Medical Research; by a Grant of Swiss Neurological Society; by a Grant of the Fondazione Dr. Ettore Balli. JC was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLER J, 1987, NEUROSURGERY, V21, P664, DOI 10.1227/00006123-198711000-00011; BROUWERS PJAM, 1993, STROKE, V24, P809, DOI 10.1161/01.STR.24.6.809; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Byrne JV, 2003, NEUROSURGERY, V52, P545, DOI 10.1227/01.NEU.0000047672.25068.4A; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; de Rooij NK, 2012, STROKE, DOI [10.1161/STRO-KEAHA.112.674291, DOI 10.1161/STR0-KEAHA.112.674291]; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; HASAN D, 1993, ANN NEUROL, V33, P286; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lord AS, 2012, NEUROLOGY, V78, P31, DOI 10.1212/WNL.0b013e31823ed0a4; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; Moshe SL, 2000, NEUROLOGY, V55, pS15; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35	23	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71405	10.1371/journal.pone.0071405	http://dx.doi.org/10.1371/journal.pone.0071405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951155	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300114
J	Gnatenko, DV; Xu, X; Zhu, W; Schmidt, VA				Gnatenko, Dmitri V.; Xu, Xiao; Zhu, Wei; Schmidt, Valentina A.			Transcript Profiling Identifies Iqgap2(-/-) Mouse as a Model for Advanced Human Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-II; COMPARATIVE FUNCTIONAL GENOMICS; FATTY LIVER-DISEASE; TARGET GENES; CELL-GROWTH; EXPRESSION; PATHWAYS; MICE; IQGAP1; CANCER	It is broadly accepted that genetically engineered animal models do not always recapitulate human pathobiology. Therefore identifying best-fit mouse models of human cancers that truly reflect the corresponding human disease is of vital importance in elucidating molecular mechanisms of tumorigenesis and developing preventive and therapeutic approaches. A new hepatocellular carcinoma (HCC) mouse model lacking a novel putative tumor suppressor IQGAP2 has been generated by our laboratory. The aim of this study was to obtain the molecular signature of Iqgap2(-/-) HCC tumors and establish the relevance of this model to human disease. Here we report a comprehensive transcriptome analysis of Iqgap2(-/-) livers and a cross-species comparison of human and Iqgap2(-/-) HCC tumors using Significance Analysis of Microarray (SAM) and unsupervised hierarchical clustering analysis. We identified the Wnt/beta-catenin signaling pathway as the top canonical pathway dysregulated in Iqgap2(-/-) livers. We also demonstrated that Iqgap2(-/-) hepatic tumors shared genetic signatures with HCC tumors from patients with advanced disease as evidenced by a 78% mouse-to-human microarray data set concordance rate with 117 out of 151 identified ortholog genes having similar expression profiles across the two species. Collectively, these results indicate that the Iqgap2 knockout mouse model closely recapitulates human HCC at the molecular level and supports its further application for the study of this disease.	[Gnatenko, Dmitri V.; Schmidt, Valentina A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Xu, Xiao; Zhu, Wei] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Xu, Xiao] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schmidt, VA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	Valentina.Schmidt@stonybrookmedicine.edu			American Cancer Society [RSG-09-033-01-CSM]	American Cancer Society(American Cancer Society)	This research was supported by the Research Scholar Grant (RSG-09-033-01-CSM) from the American Cancer Society to VAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Behari J, 2010, EXPERT REV GASTROENT, V4, P745, DOI [10.1586/egh.10.74, 10.1586/EGH.10.74]; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CARIANI E, 1991, HEPATOLOGY, V13, P644, DOI 10.1002/hep.1840130406; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Chiariello CS, 2012, REGUL PEPTIDES, V173, P36, DOI 10.1016/j.regpep.2011.09.003; Deng YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014662; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong YW, 2000, MOL CELL BIOCHEM, V207, P101, DOI 10.1023/A:1007010818094; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovska I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024582; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lambert CB, 2009, TOXICOL APPL PHARM, V234, P345, DOI 10.1016/j.taap.2008.11.008; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lee JS, 2005, CARCINOGENESIS, V26, P1013, DOI 10.1093/carcin/bgi030; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li N, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-122; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Marquardt JU, 2013, HEPATOLOGY; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Midorikawa Y, 2010, HEPATOL RES, V40, P49, DOI 10.1111/j.1872-034X.2009.00583.x; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Scharf JG, 2001, J CLIN PATHOL-MOL PA, V54, P138, DOI 10.1136/mp.54.3.138; SCHIRMACHER P, 1992, CANCER RES, V52, P2549; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schmidt VA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/958673; Schroder PC, 2011, FUNCT INTEGR GENOMIC, V11, P419, DOI 10.1007/s10142-011-0230-7; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Tarocchi M, 2011, HEPATOLOGY, V54, P522, DOI 10.1002/hep.24413; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Woo HG, 2011, MOL CARCINOGEN, V50, P235, DOI 10.1002/mc.20691; Yamada T, 1997, P NATL ACAD SCI USA, V94, P10351, DOI 10.1073/pnas.94.19.10351	49	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71826	10.1371/journal.pone.0071826	http://dx.doi.org/10.1371/journal.pone.0071826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951254	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300162
J	Gupta, RK; Johansson, S				Gupta, Rajesh Kumar; Johansson, Staffan			Fibronectin Assembly in the Crypts of Cytokinesis-Blocked Multilobular Cells Promotes Anchorage-Independent Growth	PLOS ONE			English	Article							CYCLE PROGRESSION; FACTOR-BETA; MATRIX; POLYMERIZATION; ADHESION; TUMORIGENICITY; ACTIVATION; EXPRESSION; DETACHMENT; FIBRILS	Anchorage-independent growth is a characteristic feature of cancer cells. However, it is unclear whether it represents a cause or a consequence of tumorigenesis. For normal cells, integrin-mediated adhesion is required for completion of the G1 and cytokinesis stages of the cell cycle. This study identified a mechanism that can drive anchorage-independent growth if the G1 checkpoint is suppressed. Cells with defective G1 checkpoint progressed through several rounds of the cell cycle in suspension in spite of uncompleted cytokinesis, thereby forming bi- and multilobular cells. Aurora B and CEP55 were localized to midbodies between the lobes, suggesting that the cytokinesis process reached close to abscission. Integrin-mediated re-attachment of such cells induced cytokinesis completion uncoupled from karyokinesis in most cells. However, a portion of the cells instead lost the constriction and became binucleated. Also, long-term suspension culture in soft agar produced colonies where the cytokinesis block was overcome. This process was fibronectin-dependent since fibronectin-deficient cells did not form colonies unless fibronectin was expressed or exogenously added. While fibronectin normally is not deposited on non-adherent single cells, bi/multilobular cells accumulated fibronectin in the intussusceptions. Based on our data we conclude: 1) Suppression of the G1 checkpoint allows multiple rounds of the cell cycle in detached cells and thereby enables matrix formation on their surface. 2) Uncompleted cytokinesis due to cell detachment resumes if integrin interactions are re-formed, allowing colony formation in soft agar 3) Such delayed cell division can generate binucleated cells, a feature known to cause chromosomal instability.	[Gupta, Rajesh Kumar; Johansson, Staffan] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Johansson, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	staffan.johansson@imbim.uu.se			Swedish Cancer Foundation; Swedish Research Council; Agnes och Mac Rudberg stiftelse	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Agnes och Mac Rudberg stiftelse	Economic support was obtained from the Swedish Cancer Foundation, the Swedish Research Council and Agnes och Mac Rudberg stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; COLBURN NH, 1978, CANCER RES, V38, P624; Cremona CA, 2009, J CELL SCI, V122, P3272, DOI 10.1242/jcs.047126; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gupta RK, 2008, CANCER BIOL THER, V7, P1473, DOI 10.4161/cbt.7.9.6428; Gupta RK, 2012, HISTOCHEM CELL BIOL, V138, P881, DOI 10.1007/s00418-012-1003-7; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; JOHANSSON S, 1984, J CELL BIOL, V98, P810, DOI 10.1083/jcb.98.3.810; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; ORLY J, 1979, CELL, V17, P295, DOI 10.1016/0092-8674(79)90155-7; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; RIZZINO A, 1986, CANCER RES, V46, P2816; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Saulnier R, 1996, EXP CELL RES, V222, P360, DOI 10.1006/excr.1996.0045; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SMILENOV L, 1992, FEBS LETT, V302, P227, DOI 10.1016/0014-5793(92)80447-O; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; STANBRIDGE EJ, 1978, P NATL ACAD SCI USA, V75, P1466, DOI 10.1073/pnas.75.3.1466; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thullberg M, 2008, CELL CYCLE, V7, P984, DOI 10.4161/cc.7.8.5674; Thullberg M, 2007, P NATL ACAD SCI USA, V104, P20338, DOI 10.1073/pnas.0706609105; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; VANZOELEN EJJ, 1986, J BIOL CHEM, V261, P5003; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Velling T, 2008, EXP CELL RES, V314, P309, DOI 10.1016/j.yexcr.2007.08.018; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Yoshikawa Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2481, DOI 10.1271/bbb.80362; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhang QH, 1999, BLOOD, V93, P2984; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	50	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72933	10.1371/journal.pone.0072933	http://dx.doi.org/10.1371/journal.pone.0072933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951336	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300201
J	Jadasz, JJ; Kremer, D; Gottle, P; Tzekova, N; Domke, J; Rivera, FJ; Adjaye, J; Hartung, HP; Aigner, L; Kury, P				Jadasz, Janusz Joachim; Kremer, David; Goettle, Peter; Tzekova, Nevena; Domke, Julia; Rivera, Francisco J.; Adjaye, James; Hartung, Hans-Peter; Aigner, Ludwig; Kuery, Patrick			Mesenchymal Stem Cell Conditioning Promotes Rat Oligodendroglial Cell Maturation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADULT NEURAL PROGENITORS; MULTIPLE-SCLEROSIS; FATE DECISION; SPINAL-CORD; IN-VITRO; DIFFERENTIATION; PROTEIN; NEUROPROTECTION; PROLIFERATION	Oligodendroglial progenitor/precursor cells (OPCs) represent the main cellular source for the generation of new myelinating oligodendrocytes in the adult central nervous system (CNS). In demyelinating diseases such as multiple sclerosis (MS) myelin repair activities based on recruitment, activation and differentiation of resident OPCs can be observed. However, the overall degree of successful remyelination is limited and the existence of an MS-derived anti-oligodendrogenic milieu prevents OPCs from contributing to myelin repair. It is therefore of considerable interest to understand oligodendroglial homeostasis and maturation processes in order to enable the development of remyelination therapies. Mesenchymal stem cells (MSC) have been shown to exert positive immunomodulatory effects, reduce demyelination, increase neuroprotection and to promote adult neural stem cell differentiation towards the oligodendroglial lineage. We here addressed whether MSC secreted factors can boost the OPC's oligodendrogenic capacity in a myelin non-permissive environment. To this end, we analyzed cellular morphologies, expression and regulation of key factors involved in oligodendroglial fate and maturation of primary rat cells upon incubation with MSC-conditioned medium. This demonstrated that MSC-derived soluble factors promote and accelerate oligodendroglial differentiation, even under astrocytic endorsing conditions. Accelerated maturation resulted in elevated levels of myelin expression, reduced glial fibrillary acidic protein expression and was accompanied by downregulation of prominent inhibitory differentiation factors such as Id2 and Id4. We thus conclude that apart from their suggested application as potential anti-inflammatory and immunomodulatory MS treatment, these cells might also be exploited to support endogenous myelin repair activities.	[Jadasz, Janusz Joachim; Kremer, David; Goettle, Peter; Tzekova, Nevena; Domke, Julia; Hartung, Hans-Peter; Kuery, Patrick] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Rivera, Francisco J.; Aigner, Ludwig] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Rivera, Francisco J.] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge, England; [Rivera, Francisco J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Rivera, Francisco J.; Aigner, Ludwig] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Adjaye, James] Univ Dusseldorf, Fac Med, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Paracelsus Private Medical University; University of Cambridge; University of Cambridge; Paracelsus Private Medical University; Heinrich Heine University Dusseldorf	Kury, P (corresponding author), Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany.	kuery@uni-duesseldorf.de	Rivera, Francisco J./D-7398-2015	Rivera, Francisco J./0000-0001-7895-6318; Gottle, Peter/0000-0001-6830-0956; Aigner, Ludwig/0000-0002-1653-8046; Jadasz, Janusz J./0000-0002-5505-4570; Kury, Patrick/0000-0002-2654-1126	Christiane and Claudia Hempel Foundation; James and Elisabeth Cloppenburg Stiftung; Peek & Cloppenburg Dusseldorf Stiftung; Research Commission of the Medical Faculty of Heinrich-Heine-University; Walter-and-Ilse Rose Stiftung	Christiane and Claudia Hempel Foundation; James and Elisabeth Cloppenburg Stiftung; Peek & Cloppenburg Dusseldorf Stiftung; Research Commission of the Medical Faculty of Heinrich-Heine-University; Walter-and-Ilse Rose Stiftung	This work was supported by the Christiane and Claudia Hempel Foundation as well as in part by the James and Elisabeth Cloppenburg, Peek & Cloppenburg Dusseldorf Stiftung and the Research Commission of the Medical Faculty of Heinrich-Heine-University. The MS Center at the Department of Neurology is supported in part by the Walter-and-Ilse Rose Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aktas O, 2010, TRENDS NEUROSCI, V33, P140, DOI 10.1016/j.tins.2009.12.002; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; GARD AL, 1995, DEV BIOL, V167, P596, DOI 10.1006/dbio.1995.1051; Gottle P, 2010, ANN NEUROL, V68, P915, DOI 10.1002/ana.22214; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Jadasz JJ, 2012, DEVELOPMENT, V139, P3306, DOI 10.1242/dev.074518; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kremer D, 2009, P NATL ACAD SCI USA, V106, P9087, DOI 10.1073/pnas.0900204106; Lindsay SL, 2013, GLIA, V61, P368, DOI 10.1002/glia.22440; Mabie PC, 1997, J NEUROSCI, V17, P4112; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P885, DOI 10.1038/nrd3610; Ohya W, 2007, BRAIN RES, V1147, P51, DOI 10.1016/j.brainres.2007.02.045; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rivera FJ, 2008, J NEUROCHEM, V107, P832, DOI 10.1111/j.1471-4159.2008.05674.x; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	28	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71814	10.1371/journal.pone.0071814	http://dx.doi.org/10.1371/journal.pone.0071814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951248	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300158
J	Lahaye, SEP; Eens, M; Darras, VM; Pinxten, R				Lahaye, Stefanie E. P.; Eens, Marcel; Darras, Veerle M.; Pinxten, Rianne			Hot or Not: The Effects of Exogenous Testosterone on Female Attractiveness to Male Conspecifics in the Budgerigar	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; JUNCOS JUNCO-HYEMALIS; MALE MATE CHOICE; SEXUAL SELECTION; ELEVATED TESTOSTERONE; REPRODUCTIVE SUCCESS; MELOPSITTACUS-UNDULATUS; MUTUAL ORNAMENTATION; PARENTAL INVESTMENT; PLASMA TESTOSTERONE	An increasing number of studies indicate that not only females but also males can be selective when choosing a mate. In species exhibiting male or mutual mate choice, females may benefit from being attractive. While male attractiveness is often positively influenced by higher plasma levels of the androgenic hormone testosterone, it has been shown that testosterone can masculinise female behavior and morphology in several bird species, potentially rendering them less attractive. In this study, we investigated whether female budgerigars, Melopsittacus undulatus, suffer from increased plasma testosterone levels through a negative effect on their attractiveness to males. We experimentally increased plasma testosterone levels in testosterone-treated females (T-females) compared to controls (C-females) and allowed males to choose between a T-and a C-female in a two-way choice situation. Although testosterone treatment significantly affected female behavioral and morphological characteristics, males did not show a significant difference in preference between T-and C-females. These results suggest that experimentally increasing testosterone levels in females does not appear to influence male preference during initial mate choice. Our findings indicate that selection for higher levels of testosterone in male budgerigars is probably not constrained by a correlated response to selection causing negative effects on female attractiveness during initial mate choice. Evaluating whether or not a potential constraint may arise from negative testosterone-induced effects on other fitness related traits in females requires further work.	[Lahaye, Stefanie E. P.; Eens, Marcel; Pinxten, Rianne] Univ Antwerp, Res Grp Ethol, B-2020 Antwerp, Belgium; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Louvain, Belgium	University of Antwerp; KU Leuven	Lahaye, SEP (corresponding author), Univ Antwerp, Res Grp Ethol, B-2020 Antwerp, Belgium.	Stefanie.lahaye@ua.ac.be	Eens, Marcel/AAC-8466-2020		FWO-Flanders; University of Antwerp	FWO-Flanders(FWO); University of Antwerp	Stefanie E. P. Lahaye was funded by a PhD grant of FWO-Flanders. Marcel Eens and Rianne Pinxten were funded by the University of Antwerp and supported by FWO-Flanders (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi P, 2012, BEHAV ECOL, V23, P775, DOI 10.1093/beheco/ars030; Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 1997, P ROY SOC B-BIOL SCI, V264, P1579, DOI 10.1098/rspb.1997.0220; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; Baltz AP, 1996, ETHOLOGY, V102, P109; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Brockway B. F., 1964, Behaviour, V22, P193, DOI 10.1163/156853964X00021; Brockway B. F., 1964, Behaviour, V23, P294, DOI 10.1163/156853964X00193; BROCKWAY BF, 1974, BEHAVIOUR, V51, P1, DOI 10.1163/156853974X00110; BROCKWAY BF, 1968, ANIM BEHAV, V16, P5, DOI 10.1016/0003-3472(68)90099-7; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1977, P NATL ACAD SCI USA, V74, P3476, DOI 10.1073/pnas.74.8.3476; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Day LB, 2007, HORM BEHAV, V51, P69, DOI 10.1016/j.yhbeh.2006.08.006; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Doutrelant C, 2008, J EVOLUTION BIOL, V21, P226, DOI 10.1111/j.1420-9101.2007.01451.x; Eda-Fujiwara H, 2003, J ETHOL, V21, P23, DOI 10.1007/s10164-002-0075-6; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Enstrom DA, 1997, ANIM BEHAV, V54, P1135, DOI 10.1006/anbe.1997.0555; FITZPATRICK S, 1995, BIOL J LINN SOC, V55, P251, DOI 10.1111/j.1095-8312.1995.tb01063.x; Flores DL, 1995, HORM BEHAV, V29, P458, DOI 10.1006/hbeh.1995.1277; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Fusani L, 2008, HORM BEHAV, V54, P227, DOI 10.1016/j.yhbeh.2008.04.004; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; Garcia-Vigon E, 2008, ANIM BEHAV, V76, P345, DOI 10.1016/j.anbehav.2008.01.019; Gerlach NM, 2013, HORM BEHAV, V63, P782, DOI 10.1016/j.yhbeh.2013.03.005; Giraudeau M, 2010, P ROY SOC LOND B BIO, V278, P781; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2010, BEHAV PROCESS, V84, P739, DOI 10.1016/j.beproc.2010.05.003; Griggio M, 2010, J ETHOL, V28, P455, DOI 10.1007/s10164-010-0205-5; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Hill Geoffrey E., 2006, P137; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Juniper T, 1998, PARROTS GUIDE PARROT; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Kraaijeveld K, 2004, BEHAV ECOL, V15, P380, DOI 10.1093/beheco/arh023; Lack D., 1968, pvii; Lahaye SEP, 2012, GEN COMP ENDOCR, V178, P82, DOI 10.1016/j.ygcen.2012.04.021; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lank DB, 1999, P ROY SOC B-BIOL SCI, V266, P2323, DOI 10.1098/rspb.1999.0926; Linville SU, 1998, ANIM BEHAV, V55, P119, DOI 10.1006/anbe.1997.0595; Littell R. C, 1996, SAS SYSTEM MIXED MOD; Lopez-Rull I, 2009, BEHAV PROCESS, V82, P312, DOI 10.1016/j.beproc.2009.07.012; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Mahr K, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-14; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; Massa R, 1996, ITAL J ZOOL, V63, P243, DOI 10.1080/11250009609356140; McGlothlin JW, 2004, P ROY SOC B-BIOL SCI, V271, P1377, DOI 10.1098/rspb.2004.2741; McGraw KJ, 2006, PHYSIOL BEHAV, V88, P347, DOI 10.1016/j.physbeh.2006.04.003; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Montgomerie Robert, 2006, P90; Morales J, 2012, BEHAV ECOL SOCIOBIOL, V66, P135, DOI 10.1007/s00265-011-1261-8; Moravec ML, 2006, ETHOLOGY, V112, P1108, DOI 10.1111/j.1439-0310.2006.01267.x; Moravec ML, 2010, ETHOLOGY, V116, P961, DOI 10.1111/j.1439-0310.2010.01809.x; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Mountjoy DJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P65, DOI 10.1007/s002650050218; Nespor AA, 1996, HORM BEHAV, V30, P162, DOI 10.1006/hbeh.1996.0020; Nordeide JT, 2013, J ANIM ECOL, V82, P26, DOI 10.1111/1365-2656.12021; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P315, DOI 10.1098/rspb.1996.0048; Pearn SM, 2001, P ROY SOC B-BIOL SCI, V268, P2273, DOI 10.1098/rspb.2001.1813; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Remes V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-14; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rosvall KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054120; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Ruscio MG, 2003, ANIM BEHAV, V65, P397, DOI 10.1006/anbe.2003.2055; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; SEARCY WA, 1988, ECOLOGY, V69, P85, DOI 10.2307/1943163; Torres R, 2005, ANIM BEHAV, V69, P59, DOI 10.1016/j.anbehav.2004.03.008; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; van der Jeugd HP, 2001, ANIM BEHAV, V62, P1075, DOI 10.1006/anbe.2001.1857; Van Hout AJM, 2010, GEN COMP ENDOCR, V168, P505, DOI 10.1016/j.ygcen.2010.06.012; Veiga JP, 2008, AM NAT, V172, P42, DOI 10.1086/587850; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Von Engelhardt N, 2004, PROXIMATE CONTROL AV, P31; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Whitaker B, 1990, THESIS STATE U NEW J; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339, DOI 10.1080/08927014.2004.9522625; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	98	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e74005	10.1371/journal.pone.0074005	http://dx.doi.org/10.1371/journal.pone.0074005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951365	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300210
J	Tappeiner, C; Balmer, J; Iglicki, M; Schuerch, K; Jazwinska, A; Enzmann, V; Tschopp, M				Tappeiner, Christoph; Balmer, Jasmin; Iglicki, Matias; Schuerch, Kaspar; Jazwinska, Anna; Enzmann, Volker; Tschopp, Markus			Characteristics of Rod Regeneration in a Novel Zebrafish Retinal Degeneration Model Using N-Methyl-N-Nitrosourea (MNU)	PLOS ONE			English	Article							MULLER GLIA; CONE SURVIVAL; PHOTORECEPTOR DEGENERATION; RETINITIS-PIGMENTOSA; CELL-PROLIFERATION; MOUSE MODEL; DEATH; NEUROGENESIS; PROTEIN; SYSTEM	Primary loss of photoreceptors caused by diseases such as retinitis pigmentosa is one of the main causes of blindness worldwide. To study such diseases, rodent models of N-methyl-N-nitrosourea (MNU)-induced retinal degeneration are widely used. As zebrafish (Danio rerio) are a popular model system for visual research that offers persistent retinal neurogenesis throughout the lifetime and retinal regeneration after severe damage, we have established a novel MNU-induced model in this species. Histology with staining for apoptosis (TUNEL), proliferation (PCNA), activated Muller glial cells (GFAP), rods (rhodopsin) and cones (zpr-1) were performed. A characteristic sequence of retinal changes was found. First, apoptosis of rod photoreceptors occurred 3 days after MNU treatment and resulted in a loss of rod cells. Consequently, proliferation started in the inner nuclear layer (INL) with a maximum at day 8, whereas in the outer nuclear layer (ONL) a maximum was observed at day 15. The proliferation in the ONL persisted to the end of the follow-up (3 months), interestingly, without ongoing rod cell death. We demonstrate that rod degeneration is a sufficient trigger for the induction of Muller glial cell activation, even if only a minimal number of rod cells undergo cell death. In conclusion, the use of MNU is a simple and feasible model for rod photoreceptor degeneration in the zebrafish that offers new insights into rod regeneration.	[Tappeiner, Christoph; Balmer, Jasmin; Iglicki, Matias; Schuerch, Kaspar; Enzmann, Volker; Tschopp, Markus] Univ Bern, Dept Ophthalmol, Bern, Switzerland; [Iglicki, Matias] Univ Buenos Aires, Hosp Clin, Dept Ophthalmol, Buenos Aires, DF, Argentina; [Jazwinska, Anna] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Tschopp, Markus] Univ Basel Hosp, Dept Ophthalmol, CH-4031 Basel, Switzerland	University of Bern; University of Buenos Aires; University of Fribourg; University of Basel	Tschopp, M (corresponding author), Univ Bern, Dept Ophthalmol, Bern, Switzerland.	markus.tschopp@windowslive.com	Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284; Tschopp, Markus/0000-0001-6684-7325; Enzmann, Volker/0000-0003-4384-4855	Berne University Research Foundation; Peter Mayor Gedenkstiftung	Berne University Research Foundation; Peter Mayor Gedenkstiftung	This research was supported by an unrestricted grant from the Berne University Research Foundation and the Peter Mayor Gedenkstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Battista AG, 2009, J NEUROCHEM, V111, P600, DOI 10.1111/j.1471-4159.2009.06352.x; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Bilotta J, 2001, INT J DEV NEUROSCI, V19, P621, DOI 10.1016/S0736-5748(01)00050-8; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Boudard DL, 2011, INVEST OPHTH VIS SCI, V52, P8686, DOI 10.1167/iovs.11-8162; Brand Michael, 2002, P7; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Cunningham LL, 2000, INVEST OPHTH VIS SCI, V41, P3590; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; FERNALD RD, 1990, J EXP ZOOL, P167; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Goel M, 2012, NEUROSCIENCE, V225, P152, DOI 10.1016/j.neuroscience.2012.08.066; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hicks D, 1999, INVEST OPHTH VIS SCI, V40, P3071; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035256; Huang YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006550; Johns P, 1977, J COMP NEUROL; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V2, P178; Julian D, 1998, J COMP NEUROL, V394, P271; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liu Q, 2007, EXP EYE RES, V84, P163, DOI 10.1016/j.exer.2006.09.011; Machida K, 2008, J TOXICOL SCI, V33, P493, DOI 10.2131/jts.33.493; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; Miller J A, 1994, Adv Pharmacol, V27, P1, DOI 10.1016/S1054-3589(08)61027-3; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morris AC, 2005, INVEST OPHTH VIS SCI, V46, P4762, DOI 10.1167/iovs.05-0797; Morris AC, 2008, DEV NEUROBIOL, V68, P605, DOI 10.1002/dneu.20610; Morton D, 2008, TOXICOL PATHOL, V36, P926, DOI 10.1177/0192623308324959; Nelson CM, 2012, ADV EXP MED BIOL, V723, P425, DOI 10.1007/978-1-4614-0631-0_54; OGINO H, 1993, TOXICOL PATHOL, V21, P21, DOI 10.1177/019262339302100103; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Qin Z, 2011, EXP EYE RES, V93, P726, DOI 10.1016/j.exer.2011.09.003; RAYMOND PA, 1988, J COMP NEUROL, V276, P231, DOI 10.1002/cne.902760207; RAYMOND PA, 1987, DEV BIOL, V122, P120, DOI 10.1016/0012-1606(87)90338-1; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Tappeiner C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-10; TERRACINI B, 1970, BRIT J CANCER, V24, P588, DOI 10.1038/bjc.1970.71; Thomas JL, 2012, EXP EYE RES, V97, P105, DOI 10.1016/j.exer.2012.02.004; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tsubura A, 2010, HISTOL HISTOPATHOL, V25, P933, DOI 10.14670/HH-25.933; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P3259, DOI 10.1167/iovs.08-1785; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yurco P, 2005, VISION RES, V45, P991, DOI 10.1016/j.visres.2004.10.022; Zulliger R, 2011, GRAEF ARCH CLIN EXP, V249, P859, DOI 10.1007/s00417-010-1584-6	57	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71064	10.1371/journal.pone.0071064	http://dx.doi.org/10.1371/journal.pone.0071064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951079	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300081
J	Wang, YF; Zhang, YH; Qian, H; Lu, J; Zhang, ZF; Min, XW; Lang, MJ; Yang, HD; Wang, NP; Zhang, P				Wang, Yinfang; Zhang, Yahui; Qian, Hang; Lu, Juan; Zhang, Zhifeng; Min, Xinwen; Lang, Mingjian; Yang, Handong; Wang, Nanping; Zhang, Peng			The G0/G1 Switch Gene 2 Is an Important Regulator of Hepatic Triglyceride Metabolism	PLOS ONE			English	Article							INSULIN-RESISTANCE; LIPID-METABOLISM; FATTY LIVER; PPAR-ALPHA; STEATOSIS; EXPRESSION; ACTIVATION; PROTEIN; MICE; ATHEROSCLEROSIS	Nonalcoholic fatty liver disease is associated with obesity and insulin resistance. Factors that regulate the disposal of hepatic triglycerides contribute to the development of hepatic steatosis. G(0)/G(1) switch gene 2 (G0S2) is a target of peroxisome proliferator-activated receptors and plays an important role in regulating lipolysis in adipocytes. Therefore, we investigated whether G0S2 plays a role in hepatic lipid metabolism. Adenovirus-mediated expression of G0S2 (Ad-G0S2) potently induced fatty liver in mice. The liver mass of Ad-G0S2-infected mice was markedly increased with excess triglyceride content compared to the control mice. G0S2 did not change cellular cholesterol levels in hepatocytes. G0S2 was found to be co-localized with adipose triglyceride lipase at the surface of lipid droplets. Hepatic G0S2 overexpression resulted in an increase in plasma Low-density lipoprotein (LDL)/Very-Low-density (VLDL) lipoprotein cholesterol level. Plasma High-density lipoprotein (HDL) cholesterol and ketone body levels were slightly decreased in Ad-G0S2 injected mice. G0S2 also increased the accumulation of neutral lipids in cultured HepG2 and L02 cells. However, G0S2 overexpression in the liver significantly improved glucose tolerance in mice. Livers expressing G0S2 exhibited increased 6-(N-(7-nitrobenz-2-oxa-1-3-diazol-4-yl) amino)-6-deoxyglucose uptake compared with livers transfected with control adenovirus. Taken together, our results provide evidence supporting an important role for G0S2 as a regulator of triglyceride content in the liver and suggest that G0S2 may be a molecular target for the treatment of insulin resistance and other obesity-related metabolic disorders.	[Wang, Yinfang; Qian, Hang; Lu, Juan; Zhang, Zhifeng; Min, Xinwen; Lang, Mingjian; Yang, Handong; Zhang, Peng] Hubei Univ Med, Cardiovasc Res Ctr, Wuchang, Hubei, Peoples R China; [Wang, Yinfang; Lu, Juan; Zhang, Zhifeng; Zhang, Peng] Hubei Univ Med, Dept Physiol, Wuchang, Hubei, Peoples R China; [Zhang, Yahui] Hubei Univ Med, Dept Pathophysiol, Wuchang, Hubei, Peoples R China; [Wang, Nanping] Xi An Jiao Tong Univ, Sch Med, Cardiovasc Res Ctr, Xian 710049, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; Xi'an Jiaotong University	Zhang, P (corresponding author), Hubei Univ Med, Cardiovasc Res Ctr, Wuchang, Hubei, Peoples R China.	zhangnep@yahoo.cn	Wang, Nanping/G-1818-2011	Min, Xinwen/0000-0002-8429-6560; Qian, Hang/0000-0001-9171-0232; Wang, Nanping/0000-0002-8528-8132	National Natural Science Foundation of China [30900631, 30890041]; Education Department of Hubei Province, China [T201212, Q20122401]; Ministry of Science and Technology of China (973 program) [2010CB912502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Hubei Province, China; Ministry of Science and Technology of China (973 program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China)	This work is supported by the grants from the National Natural Science Foundation of China (#30900631, #30890041); Education Department of Hubei Province, China (#T201212, #Q20122401) and the grants from the Ministry of Science and Technology of China (973 program, 2010CB912502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner D, 1998, DEV DYNAM, V213, P398; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Huang XS, 2009, BRIT J PHARMACOL, V158, P706, DOI 10.1111/j.1476-5381.2009.00350.x; Kitareewan S, 2008, INT J ONCOL, V33, P397, DOI 10.3892/ijo_00000021; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Latruffe N, 2000, CELL BIOCHEM BIOPHYS, V32, P213, DOI 10.1385/CBB:32:1-3:213; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Ljung B, 2002, J LIPID RES, V43, P1855, DOI 10.1194/jlr.M200127-JLR200; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pan SY, 2006, EUR J PHARMACOL, V552, P170, DOI 10.1016/j.ejphar.2006.09.011; Richard J, 2011, EXPERT REV CARDIOVAS, V9, P321, DOI [10.1586/ERC.11.15, 10.1586/erc.11.15]; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Santos RD, 2007, ATHEROSCLEROSIS, V194, P517, DOI 10.1016/j.atherosclerosis.2007.01.026; Srivastava RAK, 2009, EUR J PHARMACOL, V607, P258, DOI 10.1016/j.ejphar.2009.02.024; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Targher G, 2004, DIABETES CARE, V27, P2498, DOI 10.2337/diacare.27.10.2498; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Waterman IJ, 2002, DIABETES, V51, P1708, DOI 10.2337/diabetes.51.6.1708; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	38	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72315	10.1371/journal.pone.0072315	http://dx.doi.org/10.1371/journal.pone.0072315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951308	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300189
J	Chun, K; Miller, LA; Schelegle, ES; Hyde, DM; Capitanio, JP				Chun, Katie; Miller, Lisa A.; Schelegle, Edward S.; Hyde, Dallas M.; Capitanio, John P.			Behavioral Inhibition in Rhesus Monkeys (Macaca mulatta) Is Related to the Airways Response, but Not Immune Measures, Commonly Associated with Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; PRENATAL STRESS; ANXIETY; MODEL; RISK; CHILDHOOD; METHACHOLINE; EOSINOPHILIA; TEMPERAMENT; POPULATION	Behavioral inhibition reflects a disposition to react warily to novel situations, and has been associated with atopic diseases such as asthma. Retrospective work established the relationship between behavioral inhibition in rhesus monkeys (Macaca mulatta) and airway hyperresponsiveness, but not atopy, and the suggestion was made that behavioral inhibition might index components of asthma that are not immune-related. In the present study, we prospectively examined the relationship between behavioral inhibition and airway hyperresponsiveness, and whether hormonal and immune measures often associated with asthma were associated with behavioral inhibition and/or airway hyperresponsiveness. In a sample of 49 yearling rhesus monkeys (mean = 1.25 years, n = 24 behaviorally inhibited animals), we measured in vitro cytokine levels (IL-4, IL-10, IL-12, IFN-gamma) in response to stimulation, as well as peripheral blood cell percentages, cortisol levels, and percentage of regulatory T-cells (CD3+CD4+CD25+FOXP3+). Airway reactivity was assessed using an inhaled methacholine challenge. Bronchoalveolar lavage was performed and the proportion of immune cells was determined. Behaviorally inhibited monkeys had airway hyperresponsiveness as indicated by the methacholine challenge (p = 0.031), confirming our earlier retrospective result. Airway hyperresponsiveness was also associated with lower lymphocyte percentages in lavage fluid and marginally lower plasma cortisol concentrations. However, none of the tested measures was significantly related to both behavioral inhibition and airway hyperresponsiveness, and so could not mediate their relationship. Airway hyperresponsiveness is common to atopic and non-atopic asthma and behavioral inhibition has been related to altered autonomic activity in other studies. Our results suggest that behavioral inhibition might index an autonomically mediated reactive airway phenotype, and that a variety of stimuli (including inflammation within lung tissue that is not specifically associated with behavioral inhibition) may trigger the airways response.	[Chun, Katie; Miller, Lisa A.; Schelegle, Edward S.; Hyde, Dallas M.; Capitanio, John P.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Chun, Katie; Capitanio, John P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Miller, Lisa A.; Schelegle, Edward S.; Hyde, Dallas M.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chun, K (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	kchun@ucdavis.edu		Chun, Katie/0000-0002-2906-7108	National Center for Research Resources [R24RR019970, P51RR000169]; Office of Research Infrastructure Programs/OD [R24OD010962, P51OD011157]; National Heart, Lung, Blood Institute, National Institutes of Health [R21HL089148]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR019970, P51RR000169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011157, R24OD010962] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; National Heart, Lung, Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the National Center for Research Resources (R24RR019970, P51RR000169) and is currently supported by the Office of Research Infrastructure Programs/OD (R24OD010962 and P51OD011157, respectively). Support was also obtained from the National Heart, Lung, Blood Institute, National Institutes of Health (R21HL089148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2011, AM J PATHOL, V179, P1667, DOI 10.1016/j.ajpath.2011.06.009; Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blackford JU, 2012, SOC COGN AFFECT NEUR; Blanco C, 2012, INT J NEUROPSYCHOPH, P1; BOLIG R, 1992, INT J PRIMATOL, V13, P287, DOI 10.1007/BF02547817; Boyce WT, 1998, HEALTH PSYCHOL, V17, P285, DOI 10.1037/0278-6133.17.3.285; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Capitanio J.P., 2006, NURSERY REARING NONH, P191, DOI [10.1007/978-0-387-25640-5_11, DOI 10.1007/978-0-387-25640-5_11]; Capitanio JP, 2011, PSYCHOSOM MED, V73, P288, DOI 10.1097/PSY.0b013e3182155c83; Capitanio JP, 1998, AM J PRIMATOL, V44, P29, DOI 10.1002/(SICI)1098-2345(1998)44:1<29::AID-AJP3>3.0.CO;2-Z; CASPI A, 1989, J PERS, V57, P375, DOI 10.1111/j.1467-6494.1989.tb00487.x; Coe CL, 1999, BIOL NEONATE, V76, P301, DOI 10.1159/000014172; Coe CL, 2002, J CLIN ENDOCR METAB, V87, P675, DOI 10.1210/jc.87.2.675; Coffman RL, 2005, J EXP MED, V201, P1875, DOI 10.1084/jem.20050901; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; Gest SD, 1997, J PERS SOC PSYCHOL, V72, P467, DOI 10.1037/0022-3514.72.2.467; Gladstone GL, 2006, J AFFECT DISORDERS, V95, P85, DOI 10.1016/j.jad.2006.04.015; GOLDSTEIN MF, 1994, CHEST, V105, P1082, DOI 10.1378/chest.105.4.1082; Golub MS, 2009, DEV PSYCHOBIOL, V51, P47, DOI 10.1002/dev.20345; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HIRSHFELD DR, 1992, J AM ACAD CHILD PSY, V31, P103, DOI 10.1097/00004583-199201000-00016; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; KAGAN J, 1989, CHILD DEV, V60, P838, DOI 10.2307/1131025; KIM SP, 1980, J PEDIATR-US, V97, P483, DOI 10.1016/S0022-3476(80)80214-9; LAUDENSLAGER M, 1985, AM J PSYCHIAT, V142, P862; LECHIN F, 1994, J MED, V25, P181; Lechin F, 1998, CLIN PHARMACOL THER, V64, P223, DOI 10.1016/S0009-9236(98)90156-4; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Loerbroks A, 2010, PSYCHOSOM MED, V72, P309, DOI 10.1097/PSY.0b013e3181d2f0f1; Miller BD, 1997, J AM ACAD CHILD PSY, V36, P669, DOI 10.1097/00004583-199705000-00018; Miller LA, 1998, AM J RESP CELL MOL, V19, P892, DOI 10.1165/ajrcmb.19.6.3245mrev; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; Molzon ES, 2011, J ASTHMA ALLERGY ED, V2, P288, DOI DOI 10.1177/2150129711416501; Moore BD, 2012, RESPIRATION, V83, P529, DOI 10.1159/000336835; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Priftis KN, 2009, ALLERGY, V64, P18, DOI 10.1111/j.1398-9995.2008.01948.x; Rapee RM, 2002, BIOL PSYCHIAT, V52, P947, DOI 10.1016/S0006-3223(02)01572-X; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Schelegle ES, 2001, AM J PATHOL, V158, P333, DOI 10.1016/S0002-9440(10)63973-9; Schwartz CE, 1999, J AM ACAD CHILD PSY, V38, P1008, DOI 10.1097/00004583-199908000-00017; Shirtcliff EA, 2012, DEV PSYCHOBIOL, V54, P493, DOI 10.1002/dev.20607; Suomi S.J., 1999, CHILD PSYCHOL HDB CO, P510; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; WALKER C, 1991, J IMMUNOL, V146, P1829; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Weil CM, 1999, PEDIATRICS, V104, P1274, DOI 10.1542/peds.104.6.1274; Wenzel SE, 1996, J ALLERGY CLIN IMMUN, V98, pS17, DOI 10.1016/S0091-6749(96)80124-2; Wright RJ, 1998, THORAX, V53, P1066, DOI 10.1136/thx.53.12.1066; Yasue M, 1998, INT ARCH ALLERGY IMM, V115, P303, DOI 10.1159/000069461	57	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71575	10.1371/journal.pone.0071575	http://dx.doi.org/10.1371/journal.pone.0071575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951195	gold, Green Published			2022-12-27	WOS:000326473200057
J	Lippai, D; Bala, S; Csak, T; Kurt-Jones, EA; Szabo, G				Lippai, Dora; Bala, Shashi; Csak, Timea; Kurt-Jones, Evelyn A.; Szabo, Gyongyi			Chronic Alcohol-Induced microRNA-155 Contributes to Neuroinflammation in a TLR4-Dependent Manner in Mice	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; DENDRITIC CELLS; RECEPTOR; ACTIVATION; MIR-155; NEURODEGENERATION; INFLAMMATION; MECHANISMS; MONOCYTES	Introduction: Alcohol-induced neuroinflammation is mediated by pro-inflammatory cytokines and chemokines including tumor necrosis factor-alpha (TNF alpha), monocyte chemotactic protein-1 (MCP1) and interleukin-1-beta (IL-1 beta). Toll-like receptor-4 (TLR4) pathway induced nuclear factor-kappa B (NF-kappa B) activation is involved in the pathogenesis of alcohol-induced neuroinflammation. Inflammation is a highly regulated process. Recent studies suggest that microRNAs (miRNAs) play crucial role in fine tuning gene expression and miR-155 is a major regulator of inflammation in immune cells after TLR stimulation. Aim: To evaluate the role of miR-155 in the pathogenesis of alcohol-induced neuroinflammation. Methods: Wild type (WT), miR-155- and TLR4-knockout (KO) mice received 5% ethanol-containing or isocaloric control diet for 5 weeks. Microglia markers were measured by q-RTPCR; inflammasome activation was measured by enzyme activity; TNF alpha, MCP1, IL-1 beta mRNA and protein were measured by q-RTPCR and ELISA; phospho-p65 protein and NF-kappa B were measured by Western-blotting and EMSA; miRNAs were measured by q-PCR in the cerebellum. MiR-155 was measured in immortalized and primary mouse microglia after lipopolysaccharide and ethanol stimulation. Results: Chronic ethanol feeding up-regulated miR-155 and miR-132 expression in mouse cerebellum. Deficiency in miR-155 protected mice from alcohol-induced increase in inflammatory cytokines; TNF alpha, MCP1 protein and TNF alpha, MCP1, pro-IL-1 beta and pro-caspase-1 mRNA levels were reduced in miR-155 KO alcohol-fed mice. NF-kappa B was activated in WT but not in miR-155 KO alcohol-fed mice. However increases in cerebellar caspase-1 activity and IL-1 beta levels were similar in alcohol-fed miR-155-KO and WT mice. Alcohol-fed TLR4-KO mice were protected from the induction of miR-155. NF-kappa B activation measured by phosphorylation of p65 and neuroinflammation were reduced in alcohol-fed TLR4-KO compared to control mice. TLR4 stimulation with lipopolysaccharide in primary or immortalized mouse microglia resulted in increased miR-155. Conclusion: Chronic alcohol induces miR-155 in the cerebellum in a TLR4-dependent manner. Alcohol-induced miR-155 regulates TNF alpha and MCP1 expression but not caspase-dependent IL-1 beta increase in neuroinflammation.	[Lippai, Dora; Bala, Shashi; Csak, Timea; Kurt-Jones, Evelyn A.; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu			NIH/NIAAA [5R01AA011576, 1R01AA020744]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020744] Funding Source: NIH RePORTER	NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant support provided by NIH/NIAAA 5R01AA011576, Alcohol and Monocyte Signaling and NIH/NIAAA 1R01AA020744 Micro RNA's in Alcohol Liver Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Clare S, 2013, INFECT IMMUN, V81, P723, DOI 10.1128/IAI.00969-12; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Fitzpatrick LE, 2012, ALCOHOL CLIN EXP RES, V36, P1942, DOI 10.1111/j.1530-0277.2012.01821.x; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Hunsberger JG, 2012, AM J TRANSL RES, V4, P316; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1872, DOI 10.1097/01.ALC.0000042220.48841.9E; Mankan AK, 2012, CLIN EXP IMMUNOL, V167, P369, DOI 10.1111/j.1365-2249.2011.04534.x; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Oak S, 2006, J IMMUNOL, V176, P7628, DOI 10.4049/jimmunol.176.12.7628; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Thounaojam MC, 2013, MOL NEUROBIOL, V47, P1034, DOI 10.1007/s12035-013-8400-3; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhou S, 2008, J NEUROIMMUNOL, V194, P70, DOI 10.1016/j.jneuroim.2007.11.018	34	97	101	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70945	10.1371/journal.pone.0070945	http://dx.doi.org/10.1371/journal.pone.0070945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951048	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200024
J	Lockhart, JS; DeVeaux, LC				Lockhart, J. Scott; DeVeaux, Linda C.			The Essential Role of the Deinococcus radiodurans ssb Gene in Cell Survival and Radiation Tolerance	PLOS ONE			English	Article							DNA-BINDING PROTEIN; IONIZING-RADIATION; DDRB; QUANTIFICATION; IDENTIFICATION; DESICCATION; REVEALS; COMPLEX; RECA	Recent evidence has implicated single-stranded DNA-binding protein (SSB) expression level as an important factor in microbial radiation resistance. The genome of the extremely radiation resistant bacterium Deinococcus radiodurans contains genes for two SSB homologs: the homodimeric, canonical Ssb, encoded by the gene ssb, and a novel pentameric protein encoded by the gene ddrB. ddrB is highly induced upon exposure to radiation, and deletions result in decreased radiation-resistance, suggesting an integral role of the protein in the extreme resistance exhibited by this organism. Although expression of ssb is also induced after irradiation, Ssb is thought to be involved primarily in replication. In this study, we demonstrate that Ssb in D. radiodurans is essential for cell survival. The lethality of an ssb deletion cannot be complemented by providing ddrB in trans. In addition, the radiation-sensitive phenotype conferred by a ddrB deletion is not alleviated by providing ssb in trans. By altering expression of the ssb gene, we also show that lower levels of transcription are required for optimal growth than are necessary for high radiation resistance. When expression is reduced to that of E. coli, ionizing radiation resistance is similarly reduced. UV resistance is also decreased under low ssb transcript levels where growth is unimpaired. These results indicate that the expression of ssb is a key component of both normal cellular metabolism as well as pathways responsible for the high radiation tolerance of D. radiodurans.	[Lockhart, J. Scott; DeVeaux, Linda C.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA	Idaho; Idaho State University	DeVeaux, LC (corresponding author), South Dakota Sch Mines & Technol, Dept Chem & Appl Biol Sci, Rapid City, SD USA.	Linda.deveaux@sdsmt.edu			Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [HU0001-09-1-0002]	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	This work was supported by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Award HU0001-09-1-0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 2011, ASBIO COLLECTION STA; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Breljak D, 2005, FOOD TECHNOL BIOTECH, V43, P379; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Cavero S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001138; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; DeVeaux LC, 2007, RADIAT RES, V168, P507, DOI 10.1667/RR0935.1; DeVeaux LC, 2006, NUCL INSTRUM METH A, V562, P981, DOI 10.1016/j.nima.2006.02.119; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Gygli PE, 2011, DNA REPAIR; Hall E, 2000, RADIOBIOLOGY RADIOLO; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Liu YQ, 2004, ANTIMICROB AGENTS CH, V48, P3884, DOI 10.1128/AAC.48.10.3884-3891.2004; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mestari MA, 2009, AIP CONF PROC, V1099, P3, DOI 10.1063/1.3120062; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Robbins JB, 2005, J BIOL CHEM, V280, P15325, DOI 10.1074/jbc.M412870200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Skowyra A, 2012, NUCLEIC ACIDS RES, V40, P1077, DOI 10.1093/nar/gkr838; Stroud A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00224; Sugiman-Marangos S, 2012, ACTA CRYSTALLOGR F, V68, P1534, DOI 10.1107/S1744309112044041; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Ujaoney AK, 2010, J BACTERIOL, V192, P5637, DOI 10.1128/JB.00752-10; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	39	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71651	10.1371/journal.pone.0071651	http://dx.doi.org/10.1371/journal.pone.0071651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951213	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200065
J	Marwarha, G; Raza, S; Prasanthi, JRP; Ghribi, O				Marwarha, Gurdeep; Raza, Shaneabbas; Prasanthi, Jaya R. P.; Ghribi, Othman			Gadd153 and NF-kappa B Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and beta-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; PRECURSOR PROTEIN; A-BETA; SECRETASE; EXPRESSION; TRANSCRIPTION; PLAQUES; NEURONS; ALPHA	beta-amyloid (A beta) peptide, accumulation of which is a culprit for Alzheimer's disease (AD), is derived from the initial cleavage of amyloid precursor protein by the aspartyl protease BACE1. Identification of cellular mechanisms that regulate BACE1 production is of high relevance to the search for potential disease-modifying therapies that inhibit BACE1 to reduce A beta accumulation and AD progression. In the present study, we show that the cholesterol oxidation product 27-hydroxycholesterol (27-OHC) increases BACE1 and A beta levels in human neuroblastoma SH-SY5Y cells. This increase in BACE1 involves a crosstalk between the two transcription factors NF-kappa B and the endoplasmic reticulum stress marker, the growth arrest and DNA damage induced gene-153 (gadd153, also called CHOP). We specifically show that 27-OHC induces a substantial increase in NF-kappa B binding to the BACE1 promoter and subsequent increase in BACE1 transcription and A beta production. The NF-kappa B inhibitor, sc514, significantly attenuated the 27-OHC-induced increase in NF-kappa B-mediated BACE1 expression and A beta genesis. We further show that the 27-OHC-induced NF-kappa B activation and increased NF-kappa B-mediated BACE1 expression is contingent on the increased activation of gadd153. Silencing gadd153 expression with siRNA alleviated the 27-OHC-induced increase in NF-kappa B activation, NF-kappa B binding to the BACE1 promoter, and subsequent increase in BACE1 transcription and Ab production. We also show that increased levels of BACE1 in the triple transgenic mouse model for AD is preceded by gadd153 and NF-kappa B activation. In summary, our study demonstrates that gadd153 and NF-kappa B work in concert to regulate BACE1 expression. Agents that inhibit gadd153 activation and subsequent interaction with NF-kappa B might be promising targets to reduce BACE1 and A beta overproduction and may ultimately serve as disease-modifying treatments for AD.	[Marwarha, Gurdeep; Raza, Shaneabbas; Prasanthi, Jaya R. P.; Ghribi, Othman] Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Ghribi, O (corresponding author), Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	othman.ghribi@med.und.edu		MARWARHA, GURDEEP/0000-0001-5556-0003	National Institutes of Health (NIH) [RO1ES014826]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014826] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Institutes of Health (NIH) (RO1ES014826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baxter A, 2004, BIOORG MED CHEM LETT, V14, P2817, DOI 10.1016/j.bmcl.2004.03.058; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bories C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046111; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chadwick W, 2012, CURR ALZHEIMER RES, V9, P110, DOI 10.2174/156720512799015055; Chen CH, 2011, INT J NEUROPSYCHOPH, V18, P1, DOI DOI 10.1017/S1461145711000149; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Dasari B, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-22; Ferrer I, 1998, NEUROPATH APPL NEURO, V24, P271; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghribi O, 2006, CURR MOL MED, V6, P119, DOI 10.2174/156652406775574514; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hamilton LK, 2010, EUR J NEUROSCI, V32, P905, DOI 10.1111/j.1460-9568.2010.07379.x; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Leuba G, 2005, DEMENT GERIATR COGN, V19, P171, DOI 10.1159/000083496; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mielke MM, 2010, ALZHEIMERS DEMENT, V6, P378, DOI 10.1016/j.jalz.2010.03.014; Milhavet O, 2002, J NEUROCHEM, V83, P673, DOI 10.1046/j.1471-4159.2002.01165.x; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Prasanthi RPJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026420; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Shafaati M, 2011, J LIPID RES, V52, P1004, DOI 10.1194/jlr.M014548; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Sun AY, 2002, EXP NEUROL, V175, P10, DOI 10.1006/exnr.2002.7875; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Terai K, 1996, BRAIN RES, V735, P159; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	58	56	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70773	10.1371/journal.pone.0070773	http://dx.doi.org/10.1371/journal.pone.0070773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951005	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200018
J	Tsai, HF; Huang, CW; Chang, HF; Chen, JJW; Lee, CH; Cheng, JY				Tsai, Hsieh-Fu; Huang, Ching-Wen; Chang, Hui-Fang; Chen, Jeremy J. W.; Lee, Chau-Hwang; Cheng, Ji-Yen			Evaluation of EGFR and RTK Signaling in the Electrotaxis of Lung Adenocarcinoma Cells under Direct-Current Electric Field Stimulation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; FACTOR RECEPTORS; MIGRATION; ACTIVATION; MOTILITY; PHOSPHORYLATION; ELECTROPHORESIS	Physiological electric field (EF) plays a pivotal role in tissue development and regeneration. In vitro, cells under direct-current electric field (dcEF) stimulation may demonstrate directional migration (electrotaxis) and long axis reorientation (electro-alignment). Although the biophysical models and biochemical signaling pathways behind cell electrotaxis have been investigated in numerous normal cells and cancer cells, the molecular signaling mechanisms in CL1 lung adenocarcinoma cells have not been identified. Two subclones of CL1 cells, the low invasive CL1-0 cells and the highly invasive CL 1-5 cells, were investigated in the present study. CL1-0 cells are non-electrotactic while the CL 1-5 cells are anodally electrotactic and have high expression level of epidermal growth factor receptor (EGFR), in this study, we investigated the generally accepted hypothesis of receptor tyrosine kinase (RTK) activation in the two cell lines under dcEF stimulation. Erbitux, a therapeutic drug containing an anti-EGFR monoclonal antibody, cetuximab, was used to investigate the EGFR signaling in the electrotaxis of CL 1-5 cells. To investigate RTK phosphorylation and intracellular signaling in the CL1 cells, large amount of cellular proteins were collected in an airtight dcEF stimulation device, which has advantages of large culture area, uniform EF distribution, easy operation, easy cell collection, no contamination, and no medium evaporation. Commercial antibody arrays and Western blotting were used to study the phosphorylation profiles of major proteins in CL1 cells under dcEF stimulation. We found that electrotaxis of CL 1-5 cells is serum independent and EGFR independent. Moreover, the phosphorylation of Akt and S6 ribosomal protein (rpS6) in dcEF-stimulated CL1 cells are different from that in EGF-stimulated cells. This result suggests that CL1 cells' response to dcEF stimulation is not through EGFR-triggered pathways. The new large-scale dcEF stimulation device developed in the present work will aid the sample preparation for protein-based experiments.	[Tsai, Hsieh-Fu; Lee, Chau-Hwang; Cheng, Ji-Yen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Tsai, Hsieh-Fu; Huang, Ching-Wen; Chang, Hui-Fang; Lee, Chau-Hwang; Cheng, Ji-Yen] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Tsai, Hsieh-Fu; Lee, Chau-Hwang; Cheng, Ji-Yen] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Cheng, Ji-Yen] Natl Taiwan Ocean Univ, Dept Mech & Mechatron Engn, Keelung, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Chung Hsing University; National Taiwan Ocean University	Cheng, JY (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	jycheng@gate.sinica.edu.tw	Cheng, Ji-Yen/D-7272-2011; Tsai, Hsieh-Fu/F-2427-2011; Lee, Chau-Hwang/B-2204-2008	Cheng, Ji-Yen/0000-0001-7623-7555; Tsai, Hsieh-Fu/0000-0002-8652-4643; Lee, Chau-Hwang/0000-0001-5013-7062; Chen, Jeremy J.W./0000-0003-1049-3825; Huang, Ching-Wen/0000-0001-9233-3002	National Science Council Taiwan [100-2113-M-001-014-MY3]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work is financially supported by National Science Council Taiwan (Contract no. 100-2113-M-001-014-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; Bai H, 2011, CYTOKINE, V55, P110, DOI 10.1016/j.cyto.2011.03.003; Carillio G, 2012, EXPERT REV ANTICANC, V12, P163, DOI [10.1586/era.11.178, 10.1586/ERA.11.178]; Carpentier G., 2010, IMAGEJ USER DEVELOPE; Chen JJW, 2001, CANCER RES, V61, P5223; Cheng JY, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2952290; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dittmar T, 2002, FASEB J, V16, P1823, DOI 10.1096/fj.02-0096fje; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; Fang KS, 1998, J INVEST DERMATOL, V111, P751, DOI 10.1046/j.1523-1747.1998.00366.x; FUHR G, 1995, J MICROMECH MICROENG, V5, P77, DOI 10.1088/0960-1317/5/2/006; GIUGNI TD, 1987, J CELL BIOL, V104, P1291, DOI 10.1083/jcb.104.5.1291; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Huang CW, 2009, BIOSENS BIOELECTRON, V24, P3510, DOI 10.1016/j.bios.2009.05.001; JAFFE LF, 1977, NATURE, V265, P600, DOI 10.1038/265600a0; Kemkemer Ralf, 1999, Cell Biochemistry and Biophysics, V30, P167, DOI 10.1007/BF02738066; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Marotta M, 2004, BIOTECHNIQUES, V36, P68, DOI 10.2144/04361ST01; Martin-Granados C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040769; McBain VA, 2003, INVEST OPHTH VIS SCI, V44, P540, DOI 10.1167/iovs.02-0570; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G; MCCAIG CD, 1986, J EMBRYOL EXP MORPH, V94, P245; MCCAIG CD, 1989, BIOL BULL, V176, P136, DOI 10.2307/1541663; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; MCLAUGHLIN S, 1981, BIOPHYS J, V34, P85, DOI 10.1016/S0006-3495(81)84838-2; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Messerli MA, 2011, BIOL BULL-US, V221, P79, DOI 10.1086/BBLv221n1p79; METCALF MEM, 1994, J EXP ZOOL, V268, P323, DOI 10.1002/jez.1402680408; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; POO MM, 1977, NATURE, V265, P602, DOI 10.1038/265602a0; POO MM, 1981, ANNU REV BIOPHYS BIO, V10, P245, DOI 10.1146/annurev.bb.10.060181.001333; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Pullar CE, 2001, CELL MOTIL CYTOSKEL, V50, P207, DOI 10.1002/cm.10009; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Sakata S, 2011, J PHYSIOL-LONDON, V589, P2687, DOI 10.1113/jphysiol.2011.208165; Sato J D, 1983, Mol Biol Med, V1, P511; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Shatos MA, 2008, INVEST OPHTH VIS SCI, V49, P3351, DOI 10.1167/iovs.08-1677; STOLLBERG J, 1990, J NEUROSCI, V10, P247; Sun YS, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3671399; SUZUKI M, 1986, BIOCHIM BIOPHYS ACTA, V889, P149, DOI 10.1016/0167-4889(86)90098-4; Tai GP, 2009, METHODS MOL BIOL, V571, P77, DOI 10.1007/978-1-60761-198-1_5; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; TEISSIE J, 1988, BIOELECTROCH BIOENER, V20, P133, DOI 10.1016/S0302-4598(98)80011-1; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Tsai HF, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4749826; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Wang ET, 2003, INVEST OPHTH VIS SCI, V44, P244, DOI 10.1167/iovs.02-0456; Yan XL, 2009, BIOELECTROMAGNETICS, V30, P29, DOI 10.1002/bem.20436; Zengel P, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-21; Zhang HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026805; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	80	25	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73418	10.1371/journal.pone.0073418	http://dx.doi.org/10.1371/journal.pone.0073418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951353	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200091
J	Weschke, S; Niedeggen, M				Weschke, Sarah; Niedeggen, Michael			The Effect of the Physical Presence of Co-Players on Perceived Ostracism and Event-Related Brain Potentials in the Cyberball Paradigm	PLOS ONE			English	Article							SOCIAL-PARTICIPATION; EXCLUSION; IMPACT; P300; P3A; CYBEROSTRACISM; MOTIVATION; RELEVANCE; ATTITUDES; COMPUTER	The affective and cognitive mechanisms elicited by the experience of social exclusion-or ostracism-have recently been explored using behavioral and neurocognitive methods. Most of the studies took advantage of the Cyberball paradigm, a virtual ball tossing game with presumed co-players connected via the internet. Consistent behavioral findings indicate that exclusion obviously threatens fundamental social needs (belonging, self-esteem, meaningful existence, and control) and lowers mood. In this study, we followed the question whether the credibility of the setting affects the processing of social exclusion. In contrast to a control group (standard Cyberball setup), co-players were physically present in an experimental group. Although the credibility of the virtual ball tossing game was significantly enhanced in the experimental group, self-reported negative mood and need threat were not enhanced compared to the control group. Event-related brain potentials (ERPs), however, indicated a differential processing of social exclusion. The N2 amplitude triggered by occasional ball receptions was significantly reduced in the experimental group. This effect was restricted for an early time range (130-210 ms), and did not extend to the following P3 components. The ERP effect in the N2 time range can be related to a differential social reward processing in ostracism if co-players are physically present. The lack of a corresponding correlate in the behavioral data indicates that some facets of ostracism processing are not covered by questionnaire data.	[Weschke, Sarah; Niedeggen, Michael] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany	Free University of Berlin	Niedeggen, M (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	niedegg@zedat.fu-berlin.de		Weschke, Sarah/0000-0003-2069-9245				ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Castelli L, 2008, J EXP SOC PSYCHOL, V44, P679, DOI 10.1016/j.jesp.2007.04.006; Crowley MJ, 2010, SOC NEUROSCI-UK, V5, P483, DOI 10.1080/17470919.2010.500169; Crowley MJ, 2009, NEUROREPORT, V20, P1518, DOI 10.1097/WNR.0b013e328330377a; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Gutz L, 2011, NEUROREPORT, V22, P453, DOI 10.1097/WNR.0b013e3283476b67; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Holroyd CB, 2011, NEUROREPORT, V22, P249, DOI 10.1097/WNR.0b013e328345441d; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; Kiesler S, 1996, J PERS SOC PSYCHOL, V70, P47, DOI 10.1037/0022-3514.70.1.47; Mardaga S, 2009, NEUROPHYSIOL CLIN, V39, P41, DOI 10.1016/j.neucli.2008.12.005; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Miwa K, 2012, COMPUT HUM BEHAV, V28, P1286, DOI 10.1016/j.chb.2012.02.012; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Potts GF, 2004, INT J PSYCHOPHYSIOL, V52, P197, DOI 10.1016/j.ijpsycho.2003.10.005; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Renneberg B, 2012, CLIN PSYCHOL PSYCHOT, V19, P473, DOI 10.1002/cpp.772; RITTLE RH, 1977, PERS SOC PSYCHOL B, V3, P127; Romero-Canyas R, 2010, J PERS, V78, P119, DOI 10.1111/j.1467-6494.2009.00611.x; Sinclair S, 2005, J PERS SOC PSYCHOL, V89, P583, DOI 10.1037/0022-3514.89.4.583; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Staebler K, 2011, PSYCHOL MED, V41, P1929, DOI 10.1017/S0033291711000080; Stanford MS, 2001, PSYCHIAT RES, V102, P125, DOI 10.1016/S0165-1781(01)00236-0; Sundar SS, 2000, COMMUN RES, V27, P683, DOI 10.1177/009365000027006001; Themanson JR, 2012, SOC COGN AFFECT NEUR; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; WIJERS AA, 1987, BIOL PSYCHOL, V25, P33, DOI 10.1016/0301-0511(87)90066-4; Williams K. J., 2001, IEE 29th Annual Weekend Meeting - History of Electrical Engineering (Ref. No.01/162), p2/1; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2002, GROUP DYN-THEOR RES, V6, P65, DOI 10.1037//1089-2699.6.1.65; Williams KD, 2005, SYDNEY S SOCIAL PSYC, P19; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	48	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71928	10.1371/journal.pone.0071928	http://dx.doi.org/10.1371/journal.pone.0071928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23951269	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200076
J	Zanotti, I; Greco, D; Lusardi, G; Zimetti, F; Poti, F; Arnaboldi, L; Corsini, A; Bernini, F				Zanotti, Ilaria; Greco, Daniela; Lusardi, Giulia; Zimetti, Francesca; Poti, Francesco; Arnaboldi, Lorenzo; Corsini, Alberto; Bernini, Franco			Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; HMG-COA REDUCTASE; IMMUNOSUPPRESSIVE AGENTS; APOLIPOPROTEIN-E; GENE-EXPRESSION; IN-VIVO; EFFLUX; ATHEROSCLEROSIS; ABCA1; INFLAMMATION	Despite the efficacy in reducing acute rejection events in organ transplanted subjects, long term therapy with cyclosporine A is associated with increased atherosclerotic cardiovascular morbidity. We studied whether this drug affects the antiatherogenic process of the reverse cholesterol transport from macrophages in vivo. Cyclosporine A 50 mg/kg/d was administered to C57BL/6 mice by subcutaneous injection for 14 days. Macrophage reverse cholesterol transport was assessed by following [H-3]-cholesterol mobilization from pre-labeled intraperitoneally injected macrophages, expressing or not apolipoprotein E, to plasma, liver and feces. The pharmacological treatment significantly reduced the amount of radioactive sterols in the feces, independently on the expression of apolipoprotein E in the macrophages injected into recipient mice and in absence of changes of plasma levels of high density lipoprotein-cholesterol. Gene expression analysis revealed that cyclosporine A inhibited the hepatic levels of cholesterol 7-alpha-hydroxylase, concomitantly with the increase in hepatic and intestinal expression of ATP Binding Cassette G5. However, the in vivo relevance of the last observation was challenged by the demonstration that mice treated or not with cyclosporine A showed the same levels of circulating beta-sitosterol. These results indicate that treatment of mice with cyclosporine A impaired the macrophage reverse cholesterol transport by reducing fecal sterol excretion, possibly through the inhibition of cholesterol 7-alpha-hydroxylase expression. The current observation may provide a potential mechanism for the high incidence of atherosclerotic coronary artery disease following the immunosuppressant therapy in organ transplanted recipients.	[Zanotti, Ilaria; Greco, Daniela; Lusardi, Giulia; Zimetti, Francesca; Bernini, Franco] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Poti, Francesco] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy; [Arnaboldi, Lorenzo; Corsini, Alberto] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Parma; Universita di Modena e Reggio Emilia; University of Milan	Zanotti, I (corresponding author), Univ Parma, Dipartimento Farm, I-43100 Parma, Italy.	ilaria.zanotti@unipr.it	Bernini, Franco/B-6740-2011; Poti, Francesco/O-6600-2016	Zimetti, Francesca/0000-0002-6665-263X; Poti, Francesco/0000-0002-1708-0719; Arnaboldi, Lorenzo/0000-0002-4017-7631; Zanotti, Ilaria/0000-0003-2701-6021	Istituto per le Ricerche Cardiovascolari (INRC); Consortium Tefarco Innova	Istituto per le Ricerche Cardiovascolari (INRC); Consortium Tefarco Innova	This work was supported by Istituto per le Ricerche Cardiovascolari (INRC) and Consortium Tefarco Innova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Batta AK, 1999, J LIPID RES, V40, P1148; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; EMESON EE, 1993, AM J PATHOL, V142, P1906; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gueguen Y, 2007, BASIC CLIN PHARMACOL, V100, P392, DOI 10.1111/j.1742-7843.2007.00066.x; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Nishimoto T, 2009, ARTERIOSCL THROM VAS, V29, P1502, DOI 10.1161/ATVBAHA.109.187252; Oram JF, 2002, CURR OPIN LIPIDOL, V13, P373, DOI 10.1097/00041433-200208000-00004; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Tachibana S, 2007, BIOSCI BIOTECH BIOCH, V71, P1886, DOI 10.1271/bbb.70109; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Vaziri ND, 2000, J PHARMACOL EXP THER, V294, P778; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Ye D, 2008, ATHEROSCLEROSIS, V196, P650, DOI 10.1016/j.atherosclerosis.2007.07.021; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zanotti I, 2011, BRIT J PHARMACOL, V164, P1642, DOI 10.1111/j.1476-5381.2011.01376.x; Zanotti I, 2012, CURR PHARM BIOTECHNO, V13, P292, DOI 10.2174/138920112799095383; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zheng XL, 2006, J MOL ENDOCRINOL, V37, P367, DOI 10.1677/jme.1.02052	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71572	10.1371/journal.pone.0071572	http://dx.doi.org/10.1371/journal.pone.0071572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951193	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200056
J	Ng, SH; Lin, CY; Chan, SC; Yen, TC; Liao, CT; Chang, JTC; Ko, SF; Wang, HM; Huang, SF; Lin, YC; Wang, JJ				Ng, Shu-Hang; Lin, Chien-Yu; Chan, Sheng-Chieh; Yen, Tzu-Chen; Liao, Chun-Ta; Chang, Joseph Tung-Chieh; Ko, Sheung-Fat; Wang, Hung-Ming; Huang, Shiang-Fu; Lin, Yu-Chun; Wang, Jiun-Jie			Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; APPARENT DIFFUSION-COEFFICIENT; DEFINITIVE RADIOTHERAPY; HUMAN-PAPILLOMAVIRUS; ORGAN PRESERVATION; CLINICAL-OUTCOMES; ADVANCED HEAD; CANCER; SURVIVAL; THERAPY	The role of pretreatment dynamic contrast-enhanced perfusion MR imaging (DCE-PWI) and diffusion-weighted MR imaging (DWI) in predicting the treatment response of oropharyngeal or hypopharyngeal squamous cell carcinoma (OHSCC) to chemoradiation remains unclear. We prospectively investigated the ability of pharmacokinetic parameters derived from pretreatment DCE-PWI and DWI to predict the local control of OHSCC patients treated with chemoradiation. Between August, 2010 and March, 2012, patients with untreated OHSCC scheduled for chemoradiation were eligible for this prospective study. DCE-PWI and DWI were performed in addition to conventional MRI. The relationship of local control with the following clinical and imaging variables was analyzed: the hemoglobin level, T-stage, tumor location, gross tumor volume, maximum standardized uptake value, metabolic tumor volume and total lesion glycolysis on FDG PET/CT, transfer constant (K-trans), volume of blood plasma and volume of extracellular extravascular space on DCE-PWI, and apparent diffusion coefficient on DWI of the primary tumor. The patients were also divided into a local control group and a local failure group, and their clinical and imaging parameters were compared. There were 58 patients (29 with oropharynx squamous cell carcinoma [SCC] and 29 with hypopharynx SCC) with successful pretreatment DCE-PWI and DWI available for analysis. After a median follow-up of 18.2 months, 17 (29.3%) participants had local failure, whereas the remaining 41 patients achieved local control. Univariate analysis revealed that only the K-trans value was significantly associated with local control (P = 0.03). When the local control and local failure groups were compared, significant differences were observed in K-trans and the tumor location (P = 0.01 and P = 0.04, respectively). In the multivariable analysis, only K-trans was statistically significant (P = 0.04). Our results suggest that pretreatment K-trans may help predict the local control in OHSCC patients treated with chemoradiation.	[Ng, Shu-Hang; Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan; [Ng, Shu-Hang; Ko, Sheung-Fat; Lin, Yu-Chun] Chang Gung Univ, Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Ng, Shu-Hang; Lin, Yu-Chun; Wang, Jiun-Jie] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Lin, Chien-Yu; Chang, Joseph Tung-Chieh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Liao, Chun-Ta; Huang, Shiang-Fu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wang, JJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.	jwang@mail.cgu.edu.tw	Chan, Sheng Chieh/AAF-9127-2019	Chan, Sheng Chieh/0000-0003-3236-395X; Wang, Jiun-Jie/0000-0002-2422-9059	National Science Council-Taiwan [99-2314-B-182A-095-MY3]	National Science Council-Taiwan(Ministry of Science and Technology, Taiwan)	we received grants from the National Science Council-Taiwan (99-2314-B-182A-095-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Allal AS, 2002, J CLIN ONCOL, V20, P1398, DOI 10.1200/JCO.20.5.1398; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chen SW, 2009, HEAD NECK-J SCI SPEC, V31, P709, DOI 10.1002/hed.21011; Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Grant DG, 1999, J LARYNGOL OTOL, V113, P829, DOI 10.1017/S0022215100145323; Greven KM, 2001, HEAD NECK-J SCI SPEC, V23, P942, DOI 10.1002/hed.1136; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; Hatakenaka M, 2011, INT J RADIAT ONCOL, V81, P339, DOI 10.1016/j.ijrobp.2010.05.051; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Kamijo T, 2000, CLIN CANCER RES, V6, P3159; Kato H, 2009, EUR RADIOL, V19, P103, DOI 10.1007/s00330-008-1108-5; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; King AD, 2010, EUR RADIOL, V20, P2213, DOI 10.1007/s00330-010-1769-8; La TH, 2009, INT J RADIAT ONCOL, V74, P1335, DOI 10.1016/j.ijrobp.2008.10.060; Lee WR, 1998, INT J RADIAT ONCOL, V42, P1069, DOI 10.1016/S0360-3016(98)00348-4; Lim R, 2012, J NUCL MED, V53, P1506, DOI 10.2967/jnumed.111.101402; Lin YC, 2012, MAGN RESON MED, V68, P1439, DOI 10.1002/mrm.24144; Mendenhall WM, 2003, HEAD NECK-J SCI SPEC, V25, P535, DOI 10.1002/hed.10253; Nathu RM, 2000, HEAD NECK-J SCI SPEC, V22, P1, DOI 10.1002/(SICI)1097-0347(200001)22:1<1::AID-HED1>3.0.CO;2-6; Ohnishi K, 2011, J RADIAT RES, V52, P522, DOI 10.1269/jrr.10178; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Strongin A, 2012, INT J RADIAT ONCOL, V82, P1823, DOI 10.1016/j.ijrobp.2010.10.053; Studer G, 2007, ACTA ONCOL, V46, P386, DOI 10.1080/02841860600815407; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Torizuka T, 2009, AM J ROENTGENOL, V192, pW156, DOI 10.2214/AJR.08.1429; Urba SG, 2005, J CLIN ONCOL, V23, P88, DOI 10.1200/JCO.2005.04.017; van Laarhoven HWM, 2007, NMR BIOMED, V20, P128, DOI 10.1002/nbm.1098; Vernon MR, 2008, INT J RADIAT ONCOL, V70, P678, DOI 10.1016/j.ijrobp.2007.10.044; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Yamashita Y, 2000, RADIOLOGY, V216, P803, DOI 10.1148/radiology.216.3.r00se07803	41	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72230	10.1371/journal.pone.0072230	http://dx.doi.org/10.1371/journal.pone.0072230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951300	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700131
J	Romero, T; Konno, A; Hasegawa, T				Romero, Teresa; Konno, Akitsugu; Hasegawa, Toshikazu			Familiarity Bias and Physiological Responses in Contagious Yawning by Dogs Support Link to Empathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CANIS-FAMILIARIS; STRANGE SITUATION; VALIDATION; ATTACHMENT; IMITATION; PRIMATES; BEHAVIOR; ANIMALS; MONITOR	In humans, the susceptibility to yawn contagion has been theoretically and empirically related to our capacity for empathy. Because of its relevance to evolutionary biology, this phenomenon has been the focus of recent investigations in non-human species. In line with the empathic hypothesis, contagious yawning has been shown to correlate with the level of social attachment in several primate species. Domestic dogs (Canis familiaris) have also shown the ability to yawn contagiously. To date, however, the social modulation of dog contagious yawning has received contradictory support and alternative explanations (i.e., yawn as a mild distress response) could explain positive evidence. The present study aims to replicate contagious yawning in dogs and to discriminate between the two possible mediating mechanisms (i.e., empathic vs. distress related response). Twenty-five dogs observed familiar (dog's owner) and unfamiliar human models (experimenter) acting out a yawn or control mouth movements. Concurrent physiological measures (heart rate) were additionally monitored for twenty-one of the subjects. The occurrence of yawn contagion was significantly higher during the yawning condition than during the control mouth movements. Furthermore, the dogs yawned more frequently when watching the familiar model than the unfamiliar one demonstrating that the contagiousness of yawning in dogs correlated with the level of emotional proximity. Moreover, subjects' heart rate did not differ among conditions suggesting that the phenomenon of contagious yawning in dogs is unrelated to stressful events. Our findings are consistent with the view that contagious yawning is modulated by affective components of the behavior and may indicate that rudimentary forms of empathy could be present in domesticated dogs.	[Romero, Teresa; Konno, Akitsugu; Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Romero, Teresa; Konno, Akitsugu] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Romero, T (corresponding author), Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	tromero@darwin.c.u-tokyo.ac.jp		Konno, Akitsugu/0000-0003-2517-7761	Challenging Exploratory Research Grant from JSPS [23650132]; Japan Society for the Promotion of Sciences (JSPS); Grants-in-Aid for Scientific Research [25118003] Funding Source: KAKEN	Challenging Exploratory Research Grant from JSPS; Japan Society for the Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by the Challenging Exploratory Research Grant from JSPS (No. 23650132) to T. Hasegawa, and by Japan Society for the Promotion of Sciences (JSPS) research fellowships to T. Romero and A. Konno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2010, FRONT NEUROL NEUROSC, V28, P63, DOI 10.1159/000307082; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; BEKOFF M, 1972, Q REV BIOL, V47, P412, DOI 10.1086/407400; Bradshaw John W. S., 1995, P115; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2010, FRONT NEUROL NEUROSC, V28, P120, DOI 10.1159/000307090; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; Fallani G, 2007, PHYSIOL BEHAV, V90, P648, DOI 10.1016/j.physbeh.2006.12.001; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; HOPSTER H, 1994, CAN J ANIM SCI, V74, P465, DOI 10.4141/cjas94-066; Horowitz A, 2009, ANIM COGN, V12, P107, DOI 10.1007/s10071-008-0175-y; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Jonckheer-Sheehy VSM, 2012, J VET BEHAV, V7, P205, DOI 10.1016/j.jveb.2011.10.006; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Madsen EA, 2013, ANIM COGN, V16, P233, DOI 10.1007/s10071-012-0568-9; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Marchant-Forde RM, 2004, PHYSIOL BEHAV, V80, P449, DOI 10.1016/j.physbeh.2003.09.007; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miller ML, 2012, BEHAV PROCESS, V89, P264, DOI 10.1016/j.beproc.2011.12.012; Nagasawa M, 2009, JPN PSYCHOL RES, V51, P209, DOI 10.1111/j.1468-5884.2009.00402.x; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Palestrini C, 2005, APPL ANIM BEHAV SCI, V94, P75, DOI 10.1016/j.applanim.2005.02.005; Parker M, 2009, COMP EXERC PHYSIOL, V6, P137, DOI 10.1017/S1755254010000024; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Platek SM, 2010, FRONT NEUROL NEUROSC, V28, P107, DOI 10.1159/000307086; Pongracz P, 2003, ETHOLOGY, V109, P809, DOI 10.1046/j.0179-1613.2003.00923.x; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; PROVINE RR, 1989, B PSYCHONOMIC SOC, V27, P211, DOI 10.3758/BF03334587; R Core Team, 2018, R LANG ENV STAT COMP; Range F, 2009, APPL ANIM BEHAV SCI, V120, P170, DOI 10.1016/j.applanim.2009.05.012; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Senju A, 2010, FRONT NEUROL NEUROSC, V28, P113, DOI 10.1159/000307088; Senju A, 2009, J AUTISM DEV DISORD, V39, P1598, DOI 10.1007/s10803-009-0785-5; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Slabbert JM, 1997, APPL ANIM BEHAV SCI, V53, P309, DOI 10.1016/S0168-1591(96)01163-X; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; Zentall TR, 2001, CYBERNET SYST, V32, P53, DOI 10.1080/019697201300001812	58	79	79	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71365	10.1371/journal.pone.0071365	http://dx.doi.org/10.1371/journal.pone.0071365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951146	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323109700096
J	Gaveau, DLA; Kshatriya, M; Sheil, D; Sloan, S; Molidena, E; Wijaya, A; Wich, S; Ancrenaz, M; Hansen, M; Broich, M; Guariguata, MR; Pacheco, P; Potapov, P; Turubanova, S; Meijaard, E				Gaveau, David L. A.; Kshatriya, Mrigesh; Sheil, Douglas; Sloan, Sean; Molidena, Elis; Wijaya, Arief; Wich, Serge; Ancrenaz, Marc; Hansen, Matthew; Broich, Mark; Guariguata, Manuel R.; Pacheco, Pablo; Potapov, Peter; Turubanova, Svetlana; Meijaard, Erik			Reconciling Forest Conservation and Logging in Indonesian Borneo	PLOS ONE			English	Article							PROTECTED AREAS; TROPICAL FORESTS; BRAZILIAN AMAZON; SOUTHEAST-ASIA; RAIN-FORESTS; COVER LOSS; EL-NINO; BIODIVERSITY; DEFORESTATION; ROADS	Combining protected areas with natural forest timber concessions may sustain larger forest landscapes than is possible via protected areas alone. However, the role of timber concessions in maintaining natural forest remains poorly characterized. An estimated 57% (303,525 km(2)) of Kalimantan's land area (532,100 km(2)) was covered by natural forest in 2000. About 14,212 km(2) (4.7%) had been cleared by 2010. Forests in oil palm concessions had been reduced by 5,600 km(2) (14.1%), while the figures for timber concessions are 1,336 km(2) (1.5%), and for protected forests are 1,122 km(2) (1.2%). These deforestation rates explain little about the relative performance of the different land use categories under equivalent conversion risks due to the confounding effects of location. An estimated 25% of lands allocated for timber harvesting in 2000 had their status changed to industrial plantation concessions in 2010. Based on a sample of 3,391 forest plots (161 km; 100 ha), and matching statistical analyses, 2000-2010 deforestation was on average 17.6 ha lower (95% C. I.: -22.3 ha--212.9 ha) in timber concession plots than in oil palm concession plots. When location effects were accounted for, deforestation rates in timber concessions and protected areas were not significantly different (Mean difference: 0.35 ha; 95% C. I.: -0.002 ha-0.7 ha). Natural forest timber concessions in Kalimantan had similar ability as protected areas to maintain forest cover during 2000-2010, provided the former were not reclassified to industrial plantation concessions. Our study indicates the desirability of the Government of Indonesia designating its natural forest timber concessions as protected areas under the IUCN Protected Area Category VI to protect them from reclassification.	[Gaveau, David L. A.; Kshatriya, Mrigesh; Sheil, Douglas; Molidena, Elis; Wijaya, Arief; Guariguata, Manuel R.; Pacheco, Pablo; Meijaard, Erik] Ctr Int Forestry Res, Bogor, Indonesia; [Sheil, Douglas] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Sheil, Douglas] MUST, ITFC, Kabale, Uganda; [Sloan, Sean] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Wich, Serge] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Ancrenaz, Marc] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] HUTAN, Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu, Sa, Malaysia; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Hansen, Matthew] Univ Maryland, Dept Geog Sci, College Pk, MD USA; [Broich, Mark] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Project, Jakarta, Indonesia; [Meijaard, Erik] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	CGIAR; Center for International Forestry Research (CIFOR); Southern Cross University; James Cook University; Liverpool John Moores University; University System of Maryland; University of Maryland College Park; University of Technology Sydney; People & Nature Consulting International; University of Queensland	Gaveau, DLA (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	d.gaveau@cgiar.org	potapov, peter/AAE-7388-2019; Sheil, Douglas/N-3291-2019; Pacheco, Pablo/D-9851-2013; Sheil, Douglas/A-3867-2015; Wijaya, Arief/L-8405-2015; Pacheco, Pablo/I-7090-2019; Meijaard, Erik/A-2687-2016; Sloan, Sean/A-8630-2012; Hansen, Matthew C/ABE-7226-2020	Pacheco, Pablo/0000-0001-7192-6861; Sheil, Douglas/0000-0002-1166-6591; Wijaya, Arief/0000-0001-6165-0144; Pacheco, Pablo/0000-0001-7192-6861; Meijaard, Erik/0000-0001-8685-3685; Sloan, Sean/0000-0002-7834-0203; Potapov, Peter/0000-0003-3977-0021; Wich, Serge/0000-0003-3954-5174	Arcus foundation; CGIAR Research Program on Forests, Trees and Agroforestry	Arcus foundation; CGIAR Research Program on Forests, Trees and Agroforestry	This work was funded by the Arcus foundation and the CGIAR Research Program on Forests, Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Billand A., 2008, GESTION CONCERTEE RE, P201; Brandon K., 1998, PARKS PERIL PEOPLE P; Broich M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014010; Broich M, 2011, INT J APPL EARTH OBS, V13, P277, DOI 10.1016/j.jag.2010.11.004; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; CASSON A, 2000, 29 CIFOR; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dickinson M, 1996, COMMONWEALTH FORESTR, V75; Edwards DP, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-b; Emerton L, 2001, ECOFORUM, V24, P7; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Gaveau DLA, 2009, BIOL CONSERV, V142, P597, DOI 10.1016/j.biocon.2008.11.024; Giam X, 2011, BIOL CONSERV, V144, P3149, DOI 10.1016/j.biocon.2011.10.001; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; KAIMOWITZ D., 1998, EC MODELS TROPICAL D; Kartodiharjo H, 2000, 26E CIFOR; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Laurance WF, 2013, TRENDS ECOL EVOL, V28, P261, DOI 10.1016/j.tree.2013.01.017; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; MacKinnon Kathy, 1994, Oryx, V28, P191, DOI 10.1017/S0030605300028556; McKinnon K, 1996, ECOLOGY KALIMANTAN; McQuistan C. I., 2006, PROT AR FUND IND STU; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard E, PLOS ONE IN PRESS; Meijaard E, 2007, NATURE, V446, P974, DOI 10.1038/446974a; Ministry of Forestry, 2011, FOR STAT IND 2011; Ministry of Forestry, 2013, NAT FOR MON SYST; Ministry of Forestry, 2008, GUID CONC LIC MAN EC; Naughton-Treves L, 2006, SUSTAINABILITY SCI P, V2, P1; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Padmanaba M, 2007, BIODIVERS CONSERV, V16, P137, DOI 10.1007/s10531-006-9009-x; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Revkin A. C., 2012, NY TIMES; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sheil D, 2006, ENVIRON MANAGE, V38, P126, DOI 10.1007/s00267-005-0092-7; Sheil D, 2006, AMBIO, V35, P17, DOI 10.1579/0044-7447-35.1.17; Sheil D, 2003, TROPICAL FOREST; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Sist P, 1998, FOREST ECOL MANAG, V108, P251, DOI 10.1016/S0378-1127(98)00228-X; Sist P., 1998, REDUCED IMPACT LOGGI; Sloan S, 2012, CONSERV LETT, V5, P222, DOI 10.1111/j.1755-263X.2012.00233.x; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sodhi NS, 2006, CONSERV BIOL, V20, P1811, DOI 10.1111/j.1523-1739.2006.00541.x; van Schaik CP, 1997, LAST STAND PROTECTED; Vanclay JK, 2012, CAN FOREST CONSERVAT; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Whitten T, 2004, HOTSPOTS REVISITED A; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wilson K, 2005, BIOL CONSERV, V122, P9, DOI 10.1016/j.biocon.2004.06.015; Wilson K, 2010, MEANJIN, V69, P20; Wooster MJ, 2012, BIOGEOSCIENCES, V9, P317, DOI 10.5194/bg-9-317-2012; World Wildlife Fund, 2007, TRACK PROGR MAN PROT	77	102	103	0	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69887	10.1371/journal.pone.0069887	http://dx.doi.org/10.1371/journal.pone.0069887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967062	Green Published, gold, Green Accepted			2022-12-27	WOS:000323221500008
J	Kuo, KL; Lin, WC; Ho, IL; Chang, HC; Lee, PY; Chung, YT; Hsieh, JT; Pu, YS; Shi, CS; Huang, KH				Kuo, Kuan-Lin; Lin, Wei-Chou; Ho, I-Lin; Chang, Hong-Chiang; Lee, Ping-Yi; Chung, Yuan-Ting; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Shi, Chung-Sheng; Huang, Kuo-How			2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells	PLOS ONE			English	Article							CANCER; INDUCTION; PHOSPHORYLATION; COMBINATION; REQUIRES; GROWTH; DRUGS	2-Methoxyestradiol (2-ME), an endogenous derivative of 17 beta-estradiol, has been reported to elicit antiproliferative responses in various tumors. In this study, we investigated the effects of 2-ME on cell viability, proliferation, cell cycle, and apoptosis in human urothelial carcinoma (UC) cell lines. We used two high-grade human bladder UC cell lines (NTUB1 and T24). After treatment with 2-ME, the cell viability and apoptosis were measured by MTT assay and flow cytometry (fluorescence-activated cell sorting), with annexin V-FITC staining and propidium iodide (PI) labeling. DNA fragmentation was analyzed by agarose gel electrophoresis. Flow cytometry with PI labeling was used for the cell cycle analyses. The protein levels of caspase activations, poly (ADP-ribose) polymerase (PARP) cleavage, phospho-histone H2A.X, phospho-Bad, and cell cycle regulatory molecules were measured by Western blot. The effects of the drug combinations were analyzed using the computer software, CalcuSyn. We demonstrated that 2-ME effectively induces dose-dependent cytotoxicity and apoptosis in human UC cells after 24 h exposure. DNA fragmentation, PARP cleavage, and caspase-3, 7, 8, 9 activations can be observed with 2-ME-induced apoptosis. The decreased phospho-Bad (Ser136 and Ser155) and mitotic arrest of the cell cycle in the process of apoptosis after 2-ME treatment was remarkable. In response to mitotic arrest, the mitotic forms of cdc25C, phospho-cdc2, cyclin B1, and phospho-histone H3 (Ser10) were activated. In combination with arsenic trioxide (As2O3), 2-ME elicited synergistic cytotoxicity (combination index <1) in UC cells. We concluded that 2-ME significantly induces apoptosis through decreased phospho-Bad and arrests bladder UC cells at the mitotic phase. The synergistic antitumor effect with As2O3 provides a novel implication in clinical treatment of UC.	[Kuo, Kuan-Lin; Ho, I-Lin; Chang, Hong-Chiang; Lee, Ping-Yi; Chung, Yuan-Ting; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Huang, Kuo-How] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei 10764, Taiwan; [Lin, Wei-Chou] Natl Taiwan Univ, Coll Med, Dept Pathol, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Shi, Chung-Sheng] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Shi, Chung-Sheng] Chang Gung Mem Hosp, Dept Med Res, Chiayi, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, KH (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei 10764, Taiwan.	khhuang123@ntu.edu.tw		Huang, Kuo-How/0000-0002-0989-0578; Ho, I-Lin/0000-0002-8914-710X; LIN, WEI-CHOU/0000-0003-2857-3479; CHANG, HONG-CHIANG/0000-0001-5411-6680; Shi, Chung-Sheng/0000-0002-5548-7675; HSIEH, JU-TON/0000-0001-7545-8487; Kuo, Kuan-Lin/0000-0001-7204-3032; PU, YEONG-SHIAU/0000-0002-2859-3966	Taiwan National Science Council [NSC 98-2314-B-002-056, 99-2314-B-002-067-MY3]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Taiwan National Science Council (NSC 98-2314-B-002-056 and 99-2314-B-002-067-MY3). The authors also acknowledge help from the Second and Sixth core laboratories of National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2002, CELL DEATH DIFFER, V9, P1240, DOI 10.1038/sj.cdd.4401097; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Carothers AM, 2002, CANCER LETT, V187, P77, DOI 10.1016/S0304-3835(02)00409-3; Chen CH, 2009, EUR J GYNAECOL ONCOL, V30, P275; Choi HJ, 2012, BBA-MOL CELL RES, V1823, P1306, DOI 10.1016/j.bbamcr.2012.05.003; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cohen MH, 2001, J CLIN ONCOL, V19, P1229, DOI 10.1200/JCO.2001.19.4.1229; Davoodpour P, 2005, J BIOL CHEM, V280, P14773, DOI 10.1074/jbc.M414470200; Hou YQ, 2009, J ORG CHEM, V74, P6362, DOI 10.1021/jo901086s; Hour TC, 2006, ANTICANCER RES, V26, P375; Huang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033615; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kumar AP, 2003, CARCINOGENESIS, V24, P209, DOI 10.1093/carcin/24.2.209; Lakhani NJ, 2003, PHARMACOTHERAPY, V23, P165, DOI 10.1592/phco.23.2.165.32088; Latini DM, 2010, UROLOGY, V75, P334, DOI 10.1016/j.urology.2009.09.051; Lee YM, 2008, CANCER LETT, V268, P295, DOI 10.1016/j.canlet.2008.04.010; Li Dong-Liang, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P335; Li L, 2004, ANTICANCER RES, V24, P873; Lin HL, 2001, CANCER, V92, P500, DOI 10.1002/1097-0142(20010801)92:3<500::AID-CNCR1348>3.0.CO;2-4; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Pu YS, 2002, UROLOGY, V60, P346, DOI 10.1016/S0090-4295(02)01699-0; Sanchez Y, 2010, J PHARMACOL EXP THER, V335, P114, DOI 10.1124/jpet.110.168344; Stander BA, 2010, J STEROID BIOCHEM, V119, P149, DOI 10.1016/j.jsbmb.2010.02.019; Takahashi S, 2010, ANTI-CANCER AGENT ME, V10, P504, DOI 10.2174/1871520611009060504; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; Zoubine MN, 1999, INT J ONCOL, V15, P639	36	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e68703	10.1371/journal.pone.0068703	http://dx.doi.org/10.1371/journal.pone.0068703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967052	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800002
J	Staubach, F; Baines, JF; Kunzel, S; Bik, EM; Petrov, DA				Staubach, Fabian; Baines, John F.; Kuenzel, Sven; Bik, Elisabeth M.; Petrov, Dmitri A.			Host Species and Environmental Effects on Bacterial Communities Associated with Drosophila in the Laboratory and in the Natural Environment	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT; MELANOGASTER; HOMEOSTASIS; SYMBIONTS; COLONIZATION; PROVIDENCIA; RESISTANCE; DIVERSITY; EVOLUTION	The fruit fly Drosophila is a classic model organism to study adaptation as well as the relationship between genetic variation and phenotypes. Although associated bacterial communities might be important for many aspects of Drosophila biology, knowledge about their diversity, composition, and factors shaping them is limited. We used 454-based sequencing of a variable region of the bacterial 16S ribosomal RNA gene to characterize the bacterial communities associated with wild and laboratory Drosophila isolates. In order to specifically investigate effects of food source and host species on bacterial communities, we analyzed samples from wild Drosophila melanogaster and D. simulans collected from a variety of natural substrates, as well as from adults and larvae of nine laboratory-reared Drosophila species. We find no evidence for host species effects in lab-reared flies; instead, lab of origin and stochastic effects, which could influence studies of Drosophila phenotypes, are pronounced. In contrast, the natural Drosophila-associated microbiota appears to be predominantly shaped by food substrate with an additional but smaller effect of host species identity. We identify a core member of this natural microbiota that belongs to the genus Gluconobacter and is common to all wild-caught flies in this study, but absent from the laboratory. This makes it a strong candidate for being part of what could be a natural D. melanogaster and D. simulans core microbiome. Furthermore, we were able to identify candidate pathogens in natural fly isolates.	[Staubach, Fabian; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Baines, John F.; Kuenzel, Sven] Max Planck Inst Evolutionary Biol, Plon, Germany; [Bik, Elisabeth M.] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; Max Planck Society; Stanford University	Staubach, F (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	fabians@stanford.edu	Bik, Elisabeth M/A-1204-2007; Baines, John F/B-3580-2010	Bik, Elisabeth M/0000-0001-5477-0324; Baines, John F/0000-0002-8132-4909; Petrov, Dmitri/0000-0002-3664-9130	DFG Forschungsstipedium [STA 1154/1-1]; NIH [RO1GM100366, RO1GM097415]; Excellence Cluster Inflammation at Interfaces; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100366, R01GM097415] Funding Source: NIH RePORTER	DFG Forschungsstipedium(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster Inflammation at Interfaces; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a DFG Forschungsstipedium to FS (STA 1154/1-1). NIH grants RO1GM100366 and RO1GM097415 to DAP; and the Excellence Cluster Inflammation at Interfaces(JFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Auld RR, 2013, J MICROBIOL METH, V93, P108, DOI 10.1016/j.mimet.2013.01.023; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; DABBAH R, 1970, APPL MICROBIOL, V19, P27, DOI 10.1128/AEM.19.1.27-31.1970; Deppenmeier U, 2002, APPL MICROBIOL BIOT, V60, P233, DOI 10.1007/s00253-002-1114-5; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fraune S, 2009, ENVIRON MICROBIOL, V11, P2361, DOI 10.1111/j.1462-2920.2009.01963.x; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Hubbell Stephen P., 2001, V32, pi; Hurst GDD, 2000, GENETICS, V156, P699; Juneja P, 2009, INT J SYST EVOL MICR, V59, P1108, DOI 10.1099/ijs.0.000117-0; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Linderman JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041907; McFall-Ngai M, 2012, SEMIN IMMUNOL, V24, P3, DOI 10.1016/j.smim.2011.11.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nunney L, 1996, OECOLOGIA, V108, P552, DOI 10.1007/BF00333733; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; Ravussin Y, 2011, OBESITY SILVER SPRIN, V20, P738, DOI 10.1038/oby.2011.111; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; TSIROPOULOS GJ, 1983, Z ANGEW ENTOMOL, V96, P337; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Vos P., 2009, BERGEYS MANUAL SYSTE; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]	59	145	154	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70749	10.1371/journal.pone.0070749	http://dx.doi.org/10.1371/journal.pone.0070749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967097	Green Submitted, gold, Green Published			2022-12-27	WOS:000323115800019
J	Gillman, A; Muradrasoli, S; Soderstrom, H; Nordh, J; Brojer, C; Lindberg, RH; Latorre-Margalef, N; Waldenstrom, J; Olsen, B; Jarhult, JD				Gillman, Anna; Muradrasoli, Shaman; Soderstrom, Hanna; Nordh, Johan; Brojer, Caroline; Lindberg, Richard H.; Latorre-Margalef, Neus; Waldenstrom, Jonas; Olsen, Bjorn; Jarhult, Josef D.			Resistance Mutation R292K Is Induced in Influenza A(H6N2) Virus by Exposure of Infected Mallards to Low Levels of Oseltamivir	PLOS ONE			English	Article							NEURAMINIDASE ACTIVE-SITE; PANDEMIC INFLUENZA; IN-VITRO; STRUCTURAL BASIS; ANTIVIRAL DRUGS; A VIRUSES; INHIBITORS; FERRETS; TRANSMISSION; EMERGENCE	Resistance to neuraminidase inhibitors (NAIs) is problematic as these drugs constitute the major treatment option for severe influenza. Extensive use of the NAI oseltamivir (Tamiflu(R)) results in up to 865 ng/L of its active metabolite oseltamivir carboxylate (OC) in river water. There one of the natural reservoirs of influenza A, dabbling ducks, can be exposed. We previously demonstrated that an influenza A(H1N1) virus in mallards (Anas platyrhynchos) exposed to 1 mu g/L of OC developed oseltamivir resistance through the mutation H274Y (N2-numbering). In this study, we assessed the resistance development in an A(H6N2) virus, which belongs to the phylogenetic N2 group of neuraminidases with distinct functional and resistance characteristics. Mallards were infected with A(H6N2) while exposed to 120 ng/L, 1.2 mu g/L or 12 mu g/L of OC in their sole water source. After 4 days with 12 mu g/L of OC exposure, the resistance mutation R292K emerged and then persisted. Drug sensitivity was decreased approximate to 13,000-fold for OC and approximate to 7.8-fold for zanamivir. Viral shedding was similar when comparing R292K and wild-type virus indicating sustained replication and transmission. Reduced neuraminidase activity and decrease in recovered virus after propagation in embryonated hen eggs was observed in R292K viruses. The initial, but not the later R292K isolates reverted to wild-type during egg-propagation, suggesting a stabilization of the mutation, possibly through additional mutations in the neuraminidase (D113N or D141N) or hemagglutinin (E216K). Our results indicate a risk for OC resistance development also in a N2 group influenza virus and that exposure to one NAI can result in a decreased sensitivity to other NAIs as well. If established in influenza viruses circulating among wild birds, the resistance could spread to humans via re-assortment or direct transmission. This could potentially cause an oseltamivir-resistant pandemic; a serious health concern as preparedness plans rely heavily on oseltamivir before vaccines can be mass-produced.	[Gillman, Anna; Nordh, Johan; Olsen, Bjorn; Jarhult, Josef D.] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Muradrasoli, Shaman] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Bacteriol & Food Safety, Uppsala, Sweden; [Soderstrom, Hanna; Lindberg, Richard H.] Umea Univ, Dept Chem, Umea, Sweden; [Brojer, Caroline] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Pathol Pharmacol & Toxicol, Uppsala, Sweden; [Latorre-Margalef, Neus; Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Umea University; Swedish University of Agricultural Sciences; Linnaeus University	Jarhult, JD (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	josef.jarhult@medsci.uu.se	Jarhult, Josef D./ABE-8149-2020; Lindberg, Richard/C-8882-2013; Waldenström, Jonas/E-4460-2013	Jarhult, Josef D./0000-0002-7075-1059; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X; Soderstrom, Hanna/0000-0003-1341-7879	Family Olinder-Nielsen's Foundation; Swedish Research Council; Swedish Research Council (FORMAS)	Family Olinder-Nielsen's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas)	The Family Olinder-Nielsen's Foundation, the Swedish Research Council and the Swedish Research Council (FORMAS) provided financial support. F. Hoffman-La Roche Ltd. donated OC and deuterium labeled OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Abelin A, 2011, VACCINE, V29, P1135, DOI 10.1016/j.vaccine.2010.11.042; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Brockwell-Staats C, 2009, INFLUENZA OTHER RESP, V3, P207, DOI 10.1111/j.1750-2659.2009.00096.x; Brojer C, 2009, J VET DIAGN INVEST, P587; Brojer C, 2013, J WILDLIFE DIS, V49, P103, DOI 10.7589/2011-11-335; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cohen-Daniel L, 2009, J CLIN VIROL, V44, P138, DOI 10.1016/j.jcv.2008.11.014; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Doshi S, 2011, J INFECT DIS, V204, P1848, DOI 10.1093/infdis/jir648; Eshaghi A, 2009, J CLIN VIROL, V45, P142, DOI 10.1016/j.jcv.2009.04.010; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Fields B. N., 2007, FIELDS VIROLOGY; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jarhult JD, PLOS ONE, V6; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Leknes H, 2012, SCI TOTAL ENVIRON, V414, P632, DOI 10.1016/j.scitotenv.2011.11.004; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Partridge J, 2010, VACCINE, V28, P4709, DOI 10.1016/j.vaccine.2010.04.083; Patel A, 2009, CLIN PHARMACOL THER, V86, P241, DOI 10.1038/clpt.2009.142; Petersen E, 2011, SCAND J INFECT DIS, V43, P495, DOI 10.3109/00365548.2011.556144; Po ALW, 2009, EMERG INFECT DIS, V15, P1686, DOI 10.3201/eid1510.090844; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Takanami R, 2012, J WATER ENV TECHNOLO, V2012, P57; Takanami R, 2010, J WATER ENV TECHNOLO, V2010, P363; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; Watanabe T, 2011, J VIROL, V85, P13195, DOI 10.1128/JVI.00859-11; WHO, 2005, WHO MAN AN INFL DIAG; WHO, 2012, WKLY EPIDEMIOL REC, V87, P369; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018177; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Zaraket H, 2010, J CLIN MICROBIOL, V48, P1085, DOI 10.1128/JCM.01532-09; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	59	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71230	10.1371/journal.pone.0071230	http://dx.doi.org/10.1371/journal.pone.0071230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951116	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300103
J	Pang, WJ; Wang, Y; Wei, N; Xu, RX; Xiong, Y; Wang, P; Shen, QW; Yang, GS				Pang, Weijun; Wang, Yu; Wei, Ning; Xu, Ruxiang; Xiong, Yan; Wang, Ping; Shen, Qingwu; Yang, Gongshe			Sirt1 Inhibits Akt2-Mediated Porcine Adipogenesis Potentially by Direct Protein-Protein Interaction	PLOS ONE			English	Article							KINASE-B; PHOSPHOINOSITIDE 3-KINASE; MICE LACKING; INSULIN-RESISTANCE; DIABETES-MELLITUS; PKB/AKT ISOFORMS; ADIPOSE-TISSUE; GROWTH; DIFFERENTIATION; ADIPOCYTES	Compared with the rodent, the domestic pig is a much better animal model for studying adipogenesis and obesity-related diseases. Currently, the role of Akt2 and Sirt1 in porcine adipogenesis remains elusive. In this study, we defined the effect of Akt2 and Sirt1 on porcine preadipocyte lipogenesis and the regulatory mechanism. First, we found that Akt2 was widely expressed in porcine various tissues and at high level in adipose tissue. Further analysis showed that the expression level of Akt2 was much higher in adipose tissue and adipocytes of the Bamei pig breed (a Chinese indigenous fatty pig) than in that of the Large White pig breed (a Lean type pig), whereas the level of Sirt1 expression was opposite. The expression levels of Sirt1 and Akt2 gradually increased during adipogenic differentiation. Adipogenesis was robustly inhibited in Akt2 deficient fat cells, whereas it was promoted in Sirt1 deficient cells using the lentiviral-mediated shRNA approach. Interestingly, adipogenesis returned to normal in Akt2 and Sirt1 dual-deficient cells, showing that the pro-and anti-adipogenic effects were balanced. Sirt1 inhibited transcriptional activity of Akt2 in a dose-dependent way. Interaction of endogenous Akt2 and Sirt1 was gradually enhanced before day 6 of differentiation, and then attenuated. Akt2 and Sirt1 also interacted with C/EBP alpha in adipocytes. Moreover, knockdown of Akt2 or/and Sirt1 affected pro-lipogenesis of insulin-stimulated by PI3K/Akt pathway. We further found that Sirt1 respectively interacted with PI3K and GSK3 beta which were key upstream and downstream components of PI3K/Akt pathway. Based on the above findings, we concluded that the crosstalk between C/EBP alpha and PI3K/Akt signaling pathways is implicated in Akt2 and Sirt1 regulation of adipogenesis.	[Pang, Weijun; Wang, Yu; Wei, Ning; Xu, Ruxiang; Xiong, Yan; Wang, Ping; Shen, Qingwu; Yang, Gongshe] Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Peoples R China	Northwest A&F University - China	Pang, WJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Peoples R China.	pwj1226@nwsuaf.edu.cn	卫, 宁/I-7531-2017	Wei, Ning/0000-0002-7790-7335; Yang, Gongshe/0000-0003-2003-979X	National Key Basic Research Program of China [2012CB124705]; National Natural Science Foundation of China [30600437]; Chinese Universities Scientific Fund [QN2009021]; National Swine Industry Technology System Foundation [CARS-36]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; National Swine Industry Technology System Foundation	This work was supported by the grants from the National Key Basic Research Program of China (No. 2012CB124705), the Program of the National Natural Science Foundation of China (No. 30600437), the Chinese Universities Scientific Fund (No. QN2009021), and the National Swine Industry Technology System Foundation (No. CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Brambilla Gianfranco, 2004, Ann Ist Super Sanita, V40, P241; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen D, 2004, MOL CELL BIOL, V24, P320, DOI 10.1128/MCB.24.1.320-329.2004; Chen SF, 2012, J NUTR BIOCHEM, V23, P1100, DOI 10.1016/j.jnutbio.2011.06.003; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi Y, 2012, INT J OBES IN PRESS; Christoffersen CT, 1998, BIOCHEM BIOPH RES CO, V246, P426, DOI 10.1006/bbrc.1998.8637; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gardner S, 2012, AM J PHYSL IN PRESS; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hasegawa M, 2002, DIABETES RES CLIN PR, V58, P79, DOI 10.1016/S0168-8227(02)00132-8; Holst LS, 1998, BIOCHEM BIOPH RES CO, V250, P181, DOI 10.1006/bbrc.1998.9166; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Kadowaki T, 2012, CELL, V148, P624, DOI 10.1016/j.cell.2012.01.034; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Nakajima I, 2003, BIOCHEM BIOPH RES CO, V309, P702, DOI 10.1016/j.bbrc.2003.08.057; Pang WJ, 2013, EXP CELL RES, V319, P670, DOI 10.1016/j.yexcr.2012.12.025; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wang Y, 2012, AM J PHYSIOL-GASTR L, V302, pG207, DOI 10.1152/ajpgi.00302.2011; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xu F, 2012, ENDOCRINOLOGY, V153, P1706, DOI 10.1210/en.2011-1667; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034	53	31	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71576	10.1371/journal.pone.0071576	http://dx.doi.org/10.1371/journal.pone.0071576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951196	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300132
J	Roquilly, A; Braudeau, C; Cinotti, R; Dumonte, E; Motreul, R; Josien, R; Asehnoune, K				Roquilly, Antoine; Braudeau, Cecile; Cinotti, Raphael; Dumonte, Erwan; Motreul, Remi; Josien, Regis; Asehnoune, Karim			Impaired Blood Dendritic Cell Numbers and Functions after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MONONUCLEAR-CELLS; KAPPA-B; EXPRESSION; ANTIGEN; SEPSIS; INJURY; IMMUNOSUPPRESSION; MICROORGANISMS; ACTIVATION	Previous Presentation: Portions of this study were presented at the Annual Congress of Societe Francaise d'Anesthesie et de Reanimation in Paris, September 2012. Background: Toll-like receptor (TLR) agonists are promising therapy for the prevention of nosocomial infections in critical ill patients. We aimed to analyze the TLR-reactivity of circulating dendritic cells (DC) as assessed by cytokine production after an ex vivo challenge with TLR agonists in aneurysmal subarachnoid hemorrhage (SAH) patients. Methods and Findings: A single-center prospective observational study took place in one intensive care unit of a teaching hospital. Blood samples were harvested on days 2, 5 and 10 in 21 severe SAH patients requiring mechanical ventilation and 17 healthy controls. DC production of cytokines (Tumour Necrosis Factor, TNF-alpha; Interleukin, IL-12; and Interferon, IFN-alpha) was assessed by intracellular immunostaining on TLR-3, 4, 7/8 and 9 stimulations. SAH patients had decreased numbers of blood myeloid (mDCs) and plasmacytoid DCs (pDCs) on days 2, 5 and 10. Compared with the healthy controls, the frequency of mDCs producing TNF-alpha after TLR-3 stimulation was decreased in the SAH patients. The frequency of myeloid DCs producing IL-12 after TLR-3 and 4 stimulations was also decreased in the SAH patients. In contrast, the mDCs response to TLR-7/8 was not impaired in the SAH patients. The frequency of pDCs producing TNF-alpha(+) and IFN-alpha(+) on TLR-7/8 stimulation were reduced at all of the tested times in the SAH patients, whereas reactivity to TLR-9 was preserved. On day 2, the pDCs from non-survivor patients (n = 8) had a decreased ability to produce IFN-alpha on TLR-9 stimulation compared with the survivors. Conclusions: These data suggest functional abnormalities of circulating pDCs and mDCs that could be important for immunomodulation after SAH.	[Roquilly, Antoine; Cinotti, Raphael; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Roquilly, Antoine; Asehnoune, Karim] Ctr Hosp Univ, Hotel Dieu, Serv Anesthesie Reanimat Chirurg, Nantes, France; [Braudeau, Cecile; Josien, Regis] Ctr Rech Transplantat & Immunol, INSERM, UMR 1064, Nantes, France; [Braudeau, Cecile; Josien, Regis] CHU Nantes, Inst Transplantat Urol Nephrol, F-44035 Nantes 01, France; [Braudeau, Cecile; Dumonte, Erwan; Josien, Regis] CHU Nantes, Immunol Lab, Ctr Immunomonitorage Nantes Atlantique, F-44035 Nantes 01, France; [Cinotti, Raphael; Motreul, Remi] CHU Nantes, Hop Guillaume & Rene Laennec, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France	Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Asehnoune, K (corresponding author), Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France.	karim.asehnoune@chu-nantes.fr	Roquilly, Antoine/P-9826-2017; Josien, Regis/L-7468-2015; Josien, Regis/U-4405-2019	Josien, Regis/0000-0001-7900-7413; 	Societe Francaise d'Anesthesie Reanimation, la fondation des "Gueules Cassees"	Societe Francaise d'Anesthesie Reanimation, la fondation des "Gueules Cassees"	This work was supported by institutional funds. A. Roquilly was a recipient of funding from the Societe Francaise d'Anesthesie Reanimation, la fondation des "Gueules Cassees". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30; Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Deknuydt F, 2013, CRIT CARE MED, V41, P245, DOI 10.1097/CCM.0b013e3182676052; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Grimaldi D, 2011, INTENS CARE MED, V37, P1438, DOI 10.1007/s00134-011-2306-1; Hedayat M, 2011, LANCET INFECT DIS, V11, P702, DOI 10.1016/S1473-3099(11)70099-8; Hemont C, 2013, J LEUKOCYTE BIOL, V93, P599, DOI 10.1189/jlb.0912452; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Markey KA, 2012, BLOOD, V119, P5918, DOI 10.1182/blood-2011-12-398164; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; MILLER C H, 1991, Neurological Research, V13, P117; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pene F, 2008, J IMMUNOL, V181, P8513, DOI 10.4049/jimmunol.181.12.8513; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rimbert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018734; Rondeau N, 2012, NEUROCRIT CARE, V17, P183, DOI 10.1007/s12028-012-9732-y; Roquilly A, 2013, EUR RESPIR J, V42, P1365, DOI 10.1183/09031936.00152612; Roquilly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013228; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Schindler D, 2012, AM J PATHOL, V181, P1327, DOI 10.1016/j.ajpath.2012.06.039; Stasiolek M, 2006, BRAIN, V129, P1293, DOI 10.1093/brain/awl043; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706	43	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71639	10.1371/journal.pone.0071639	http://dx.doi.org/10.1371/journal.pone.0071639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951210	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200063
J	Bouyioukos, C; Moscou, MJ; Champouret, N; Hernandez-Pinzon, I; Ward, ER; Wulff, BBH				Bouyioukos, Costas; Moscou, Matthew J.; Champouret, Nicolas; Hernandez-Pinzon, Inmaculada; Ward, Eric R.; Wulff, Brande B. H.			Characterisation and Analysis of the Aegilops sharonensis Transcriptome, a Wild Relative of Wheat in the Sitopsis Section	PLOS ONE			English	Article							GENOME EVOLUTION; DRAFT GENOME; A-GENOME; RESISTANCE; DIVERSITY; SEQUENCE; POLYMORPHISM; CHROMOSOMES; POPULATION; ANNOTATION	Aegilops sharonensis Eig (Sharon goatgrass) is a wild diploid relative of wheat within the Sitopsis section of Aegilops. This species represents an untapped reservoir of genetic diversity for traits of agronomic importance, especially as a source of novel disease resistance. To gain a foothold in this genetic resource, we sequenced the cDNA from leaf tissue of two geographically distinct Ae. sharonensis accessions (1644 and 2232) using the 454 Life Sciences platform. We compared the results of two different assembly programs using different parameter sets to generate 13 distinct assemblies in an attempt to maximize representation of the gene space in de novo transcriptome assembly. The most sensitive assembly (71,029 contigs; N50 674 nts) retrieved 18,684 unique best reciprocal BLAST hits (BRBH) against six previously characterised grass proteomes while the most specific assembly (30,609 contigs; N50 815 nts) retrieved 15,687 BRBH. We combined these two assemblies into a set of 62,243 non-redundant sequences and identified 139 belonging to plant disease resistance genes of the nucleotide binding leucine-rich repeat class. Based on the non-redundant sequences, we predicted 37,743 single nucleotide polymorphisms (SNP), equivalent to one per 1,142 bp. We estimated the level of heterozygosity as 1.6% in accession 1644 and 30.1% in 2232. The Ae. sharonensis leaf transcriptome provides a rich source of sequence and SNPs for this wild wheat relative. These sequences can be used with existing monocot genome sequences and EST sequence collections (e.g. barley, Brachypodium, wheat, rice, maize and Sorghum) to assist with genetic and physical mapping and candidate gene identification in Ae. sharonensis. These resources provide an initial framework to further build on and characterise the genetic and genomic structure of Ae. sharonensis.	[Bouyioukos, Costas; Moscou, Matthew J.; Champouret, Nicolas; Hernandez-Pinzon, Inmaculada; Ward, Eric R.; Wulff, Brande B. H.] Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wulff, BBH (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	brande.wulff@sainsbury-laboratory.ac.uk	Wulff, Brande BH/C-7465-2013; Wulff, Brande B/N-4273-2013; Moscou, Matthew/D-5266-2011	Wulff, Brande BH/0000-0003-4044-4346; Moscou, Matthew/0000-0003-2098-6818; Bouyioukos, Costas/0000-0002-7443-3736	Gatsby Charitable Foundation; UK Biotechnology and Biological Sciences Research Council [BB/J003166/1]; Human Frontier Science Program [LT000218/2011-L]; Biotechnology and Biological Sciences Research Council [BB/J003166/1, BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193, BB/J003166/1] Funding Source: UKRI	Gatsby Charitable Foundation; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Program(Human Frontier Science Program); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Gatsby Charitable Foundation and UK Biotechnology and Biological Sciences Research Council Grant BB/J003166/1. MJM was supported by a fellowship from the Human Frontier Science Program (LT000218/2011-L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able JA, 2007, TRENDS PLANT SCI, V12, P71, DOI 10.1016/j.tplants.2006.12.002; Ayliffe M, 2008, CURR OPIN PLANT BIOL, V11, P187, DOI 10.1016/j.pbi.2008.02.001; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dvorak J, 1998, GENETICS, V148, P423; Eddy Sean R, 2009, Genome Inform, V23, P205; EIG A, 1929, REPERT SPEC NOV RE S, V55, P1; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; ENDO TR, 1990, JPN J GENET, V65, P135, DOI 10.1266/jjg.65.135; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Food and Agriculture Organization of the United Nations (FAO), 2006, FAO STAT YB 2005 200; FURUTA Y, 1986, JPN J GENET, V61, P97, DOI 10.1266/jjg.61.97; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Olivera PD, 2007, PLANT DIS, V91, P942, DOI 10.1094/PDIS-91-8-0942; Olivera PD, 2010, CROP SCI, V50, P636, DOI 10.2135/cropsci2009.04.0192; Olivera PD, 2009, BOTANY, V87, P740, DOI 10.1139/B09-040; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Royal Society, 2009, REAP BEN SCI SUST IN; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Steffenson BJ, 2007, AUST J AGR RES, V58, P532, DOI 10.1071/AR07123; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524	48	8	8	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72782	10.1371/journal.pone.0072782	http://dx.doi.org/10.1371/journal.pone.0072782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951332	Green Published, gold			2022-12-27	WOS:000323124000089
J	Eyford, BA; Ahmad, R; Enyaru, JC; Carr, SA; Pearson, TW				Eyford, Brett A.; Ahmad, Rushdy; Enyaru, John C.; Carr, Steven A.; Pearson, Terry W.			Identification of Trypanosome Proteins in Plasma from African Sleeping Sickness Patients Infected with T-b. rhodesiense	PLOS ONE			English	Article							DETECTION ENZYME-IMMUNOASSAY; FIELD DIAGNOSIS; BRUCEI-RHODESIENSE; ANTIBODIES; ANTIGENS; GAMBIENSE; CATTLE; ELISA; CULTIVATION; CONGOLENSE	Control of human African sleeping sickness, caused by subspecies of the protozoan parasite Trypanosoma brucei, is based on preventing transmission by elimination of the tsetse vector and by active diagnostic screening and treatment of infected patients. To identify trypanosome proteins that have potential as biomarkers for detection and monitoring of African sleeping sickness, we have used a 'deep-mining'' proteomics approach to identify trypanosome proteins in human plasma. Abundant human plasma proteins were removed by immunodepletion. Depleted plasma samples were then digested to peptides with trypsin, fractionated by basic reversed phase and each fraction analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). This sample processing and analysis method enabled identification of low levels of trypanosome proteins in pooled plasma from late stage sleeping sickness patients infected with Trypanosoma brucei rhodesiense. A total of 254 trypanosome proteins were confidently identified. Many of the parasite proteins identified were of unknown function, although metabolic enzymes, chaperones, proteases and ubiquitin-related/acting proteins were found. This approach to the identification of conserved, soluble trypanosome proteins in human plasma offers a possible route to improved disease diagnosis and monitoring, since these molecules are potential biomarkers for the development of a new generation of antigen-detection assays. The combined immuno-depletion/mass spectrometric approach can be applied to a variety of infectious diseases for unbiased biomarker identification.	[Eyford, Brett A.; Pearson, Terry W.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Ahmad, Rushdy; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Enyaru, John C.] Makerere Univ, Dept Biochem, Kampala, Uganda	University of Victoria; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Makerere University	Pearson, TW (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	parasite@uvic.ca	Carr, Steven A./AAH-8366-2019		Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to Terry W. Pearson. Brett Eyford was supported by an NSERC postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2005, TRENDS PARASITOL, V21, P154, DOI 10.1016/j.pt.2005.02.003; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; ANDERSON NL, 1985, MOL BIOCHEM PARASIT, V16, P299, DOI 10.1016/0166-6851(85)90072-6; [Anonymous], 2007, TSETS TRYP INF B 2, V30; AUTHIE E, 1994, PARASITOL TODAY, V10, P360, DOI 10.1016/0169-4758(94)90252-6; BRUN R, 1979, ACTA TROP, V36, P289; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Eyford BA, 2011, MOL BIOCHEM PARASIT, V177, P116, DOI 10.1016/j.molbiopara.2011.02.009; FISH WR, 1989, BIOCHEMISTRY-US, V28, P5415, DOI 10.1021/bi00439a015; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Huang HL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-178; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; KASHIWAZAKI Y, 1994, VET PARASITOL, V55, P57, DOI 10.1016/0304-4017(94)90055-8; Kuepfer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000968; Lejon V, 1998, ACTA TROP, V69, P151, DOI 10.1016/S0001-706X(97)00137-X; LIU MK, 1989, ACTA TROP, V46, P257, DOI 10.1016/0001-706X(89)90026-0; LIU MK, 1987, PARASITOLOGY, V95, P277, DOI 10.1017/S0031182000057735; LIU MK, 1988, ACTA TROP, V45, P321; Liu MK, 1989, THESIS U VICTORIA W; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Manful T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009630; MASAKE RA, 1991, J PARASITOL, V77, P231, DOI 10.2307/3283087; Murray Clinton K, 2009, Interdiscip Perspect Infect Dis, V2009, P415953, DOI 10.1155/2009/415953; NANTULYA VM, 1992, ANN TROP MED PARASIT, V86, P225, DOI 10.1080/00034983.1992.11812658; NANTULYA VM, 1989, PARASITE IMMUNOL, V11, P69, DOI 10.1111/j.1365-3024.1989.tb00649.x; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Njiru ZK, 2011, J CLIN MICROBIOL, V49, P1530, DOI 10.1128/JCM.01817-10; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Patel BB, 2012, J PROTEOME RES, V11, P5947, DOI 10.1021/pr300686k; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; Woo P. T. K., 1970, Acta trop., V27, P384	37	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71463	10.1371/journal.pone.0071463	http://dx.doi.org/10.1371/journal.pone.0071463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951171	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000060
J	Klein, E; Mann, A; Huber, S; Bloechle, J; Willmes, K; Karim, AA; Nuerk, HC; Moeller, K				Klein, Elise; Mann, Anne; Huber, Stefan; Bloechle, Johannes; Willmes, Klaus; Karim, Ahmed A.; Nuerk, Hans-Christoph; Moeller, Korbinian			Bilateral Bi-Cephalic Tdcs with Two Active Electrodes of the Same Polarity Modulates Bilateral Cognitive Processes Differentially	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; INTRAPARIETAL SULCUS; NUMBER; CORTEX; LANGUAGE; MEMORY; FMRI; REPRESENTATIONS; APPROXIMATE	Transcranial direct current stimulation (tDCS) is an innovative method to explore the causal structure-function relationship of brain areas. We investigated the specificity of bilateral bi-cephalic tDCS with two active electrodes of the same polarity (e.g., cathodal on both hemispheres) applied to intraparietal cortices bilaterally using a combined between-and within-task approach. Regarding between-task specificity, we observed that bilateral bi-cephalic tDCS affected a numerical (mental addition) but not a control task (colour word Stroop), indicating a specific influence of tDCS on numerical but not on domain general cognitive processes associated with the bilateral IPS. In particular, the numerical effect of distractor distance was more pronounced under cathodal than under anodal stimulation. Moreover, with respect to within-task specificity we only found the numerical distractor distance effect in mental addition to be modulated by direct current stimulation, whereas the effect of target identity was not affected. This implies a differential influence of bilateral bi-cephalic tDCS on the recruitment of different processing components within the same task (number magnitude processing vs. recognition of familiarity). In sum, this first successful application of bilateral bi-cephalic tDCS with two active electrodes of the same polarity in numerical cognition research corroborates the specific proposition of the Triple Code Model that number magnitude information is represented bilaterally in the intraparietal cortices.	[Klein, Elise; Huber, Stefan; Nuerk, Hans-Christoph; Moeller, Korbinian] Knowledge Media Res Ctr, Neurocognit Lab, Tubingen, Germany; [Klein, Elise; Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurol, Sect Neuropsychol, Aachen, Germany; [Klein, Elise; Willmes, Klaus] Rhein Westfal TH Aachen, Fac Med, Brain Imaging Facil, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Klein, Elise; Mann, Anne; Huber, Stefan; Bloechle, Johannes; Nuerk, Hans-Christoph; Moeller, Korbinian] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Karim, Ahmed A.] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Klein, E (corresponding author), Knowledge Media Res Ctr, Neurocognit Lab, Tubingen, Germany.	e.klein@iwm-kmrc.de	Karim, Ahmed A/D-2503-2009; Willmes, Klaus F/A-1268-2014; Huber, Stefan/D-7724-2015; Moeller, Korbinian/AAC-6387-2020	Willmes, Klaus F/0000-0002-9012-0553; Huber, Stefan/0000-0002-5842-5859; Karim, Ahmed A./0000-0003-1763-1565	"Projektforderung fur NachwuchswissenschaftlerInnen" of the Eberhard Karls University Tuebingen [Az: 7532.22]; Ministry of Science, Research and Arts of Baden-Wurttemberg [Az: 35-7532.20/739]; Volkswagen; BIAL Foundation	"Projektforderung fur NachwuchswissenschaftlerInnen" of the Eberhard Karls University Tuebingen; Ministry of Science, Research and Arts of Baden-Wurttemberg; Volkswagen(Volkswagen); BIAL Foundation(Bial Foundation)	This work was supported by grants from the "Projektforderung fur NachwuchswissenschaftlerInnen 2011" of the Eberhard Karls University Tuebingen (Az: 7532.22) to Elise Klein as well as from the Ministry of Science, Research and Arts of Baden-Wurttemberg (Az: 35-7532.20/739) within the "Exzellenzinitiative Research Seed Capital Program (RiSC)" to Elise Klein. Ahmed A. Karim was supported by the Volkswagen and the BIAL Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Andres M, 2011, NEUROIMAGE, V54, P3048, DOI 10.1016/j.neuroimage.2010.11.009; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; Cheng GLF, 2013, BRAIN STIMUL, V6, P160, DOI 10.1016/j.brs.2012.04.005; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Cohen L, 2000, COGN NEUROPSYCHOL, V17, P563, DOI 10.1080/02643290050110656; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; Delazer M, 2006, NEUROPSYCHOLOGIA, V44, P1909, DOI 10.1016/j.neuropsychologia.2006.02.007; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Driver J, 2010, EXP BRAIN RES, V206, P153, DOI 10.1007/s00221-010-2205-7; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fusco A, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/837595; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; Kadosh RC, 2012, CURR BIOL, V22, pR108, DOI 10.1016/j.cub.2012.01.013; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Klein E, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-15; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-70; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-42; Klein E, 2009, BRAIN COGNITION, V69, P369, DOI 10.1016/j.bandc.2008.08.031; Knops A, 2006, NEUROIMAGE, V29, P1, DOI 10.1016/j.neuroimage.2005.07.009; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Ladeira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025399; Lapenta OM, 2012, NEUROSCI LETT, V527, P105, DOI 10.1016/j.neulet.2012.08.076; Lemer C, 2003, NEUROPSYCHOLOGIA, V41, P1942, DOI 10.1016/S0028-3932(03)00123-4; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mameli F, 2010, BEHAV BRAIN RES, V211, P164, DOI 10.1016/j.bbr.2010.03.024; Mattai A, 2011, BRAIN STIMUL, V4, P275, DOI 10.1016/j.brs.2011.01.001; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Paulus W, 2003, P 2 INT TRANSCR MAGN; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Sandrini M, 2004, NEUROPSYCHOLOGIA, V42, P1902, DOI 10.1016/j.neuropsychologia.2004.05.005; Schlaug G, 2008, EXPERT REV MED DEVIC, V5, P759, DOI 10.1586/17434440.5.6.759; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Willmes Klaus, 2008, Handb Clin Neurol, V88, P339, DOI 10.1016/S0072-9752(07)88017-1; Wood G, 2008, BRAIN RES, V1187, P154, DOI 10.1016/j.brainres.2007.09.094	64	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71607	10.1371/journal.pone.0071607	http://dx.doi.org/10.1371/journal.pone.0071607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951202	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000067
J	Masson, E; Chen, JM; Audrezet, MP; Cooper, DN; Ferec, C				Masson, Emmanuelle; Chen, Jian-Min; Audrezet, Marie-Pierre; Cooper, David N.; Ferec, Claude			A Conservative Assessment of the Major Genetic Causes of Idiopathic Chronic Pancreatitis: Data from a Comprehensive Analysis of PRSS1, SPINK1, CTRC and CFTR Genes in 253 Young French Patients	PLOS ONE			English	Article							CATIONIC TRYPSINOGEN GENE; CYSTIC-FIBROSIS GENE; INHIBITOR PSTI GENE; HEREDITARY PANCREATITIS; MISSENSE MUTATIONS; 5T ALLELE; CONDUCTANCE; VARIANTS; IDENTIFICATION; PATHOGENESIS	Idiopathic chronic pancreatitis (ICP) has traditionally been defined as chronic pancreatitis in the absence of any obvious precipitating factors (e.g. alcohol abuse) and family history of the disease. Studies over the past 15 years have revealed that ICP has a highly complex genetic architecture involving multiple gene loci. Here, we have attempted to provide a conservative assessment of the major genetic causes of ICP in a sample of 253 young French ICP patients. For the first time, conventional types of mutation (comprising coding sequence variants and variants at intron/exon boundaries) and gross genomic rearrangements were screened for in all four major pancreatitis genes, PRSS1, SPINK1, CTRC and CFTR. For the purposes of the study, synonymous, intronic and 5'- or 3'-untranslated region variants were excluded from the analysis except where there was persuasive evidence of functional consequences. The remaining sequence variants/genotypes were classified into causative, contributory or neutral categories by consideration of (i) their allele frequencies in patient and normal control populations, (ii) their presumed or experimentally confirmed functional effects, (iii) the relative importance of their associated genes in the pathogenesis of chronic pancreatitis and (iv) gene-gene interactions wherever applicable. Adoption of this strategy allowed us to assess the pathogenic relevance of specific variants/genotypes to their respective carriers to an unprecedented degree. The genetic cause of ICP could be assigned in 23.7% of individuals in the study group. A strong genetic susceptibility factor was also present in an additional 24.5% of cases. Taken together, up to 48.2% of the studied ICP patients were found to display evidence of a genetic basis for their pancreatitis. Whereas these particular proportions may not be extrapolable to all ICP patients, the approach employed should serve as a useful framework for acquiring a better understanding of the role of genetic factors in causing this oligogenic disease.	[Masson, Emmanuelle; Chen, Jian-Min; Audrezet, Marie-Pierre; Ferec, Claude] INSERM, U1078, Brest, France; [Masson, Emmanuelle; Audrezet, Marie-Pierre; Ferec, Claude] Hop Morvan, Ctr Hosp Reg Univ Brest, Lab Genet Mol & Histocompatibil, Brest, France; [Chen, Jian-Min; Ferec, Claude] Etab Francais Sang Bretagne, Brest, France; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales; [Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Cardiff University; Universite de Bretagne Occidentale	Chen, JM (corresponding author), INSERM, U1078, Brest, France.	Jian-Min.Chen@univ-brest.fr; claude.ferec@univ-brest.fr	Cooper, David N/H-4384-2011; Ferec, Claude/ABG-9699-2020	Cooper, David N/0000-0002-8943-8484; Ferec, Claude/0000-0002-2325-0710; Chen, Jian-Min/0000-0002-2424-3969; MASSON, Emmanuelle/0000-0001-9777-523X	Institut National de la Sante et de la Recherche Medicale (INSERM); Association des Pancreatites Chroniques Hereditaires (APCH), France	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association des Pancreatites Chroniques Hereditaires (APCH), France	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association des Pancreatites Chroniques Hereditaires (APCH), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002003; Audrezet M, 2004, HUM MUTAT, V23, P343, DOI 10.1002/humu.20009; Audrezet MP, 2008, J MOL DIAGN, V10, P424, DOI 10.2353/jmoldx.2008.080056; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; Bernardino Andrea L Ferreira, 2003, JOP, V4, P169; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Boulling A., 2012, WEBMEDCENTRAL GENE, V3; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Chen JM, 2012, CLIN RES HEPATOL GAS, V36, P334, DOI 10.1016/j.clinre.2012.05.003; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Chen JM, 2001, GASTROENTEROLOGY, V120, P1061, DOI 10.1053/gast.2001.23094; Chen JM, 2001, CLIN GENET, V59, P189, DOI 10.1034/j.1399-0004.2001.590308.x; Chen JM, 2000, J MED GENET, V37, P67, DOI 10.1136/jmg.37.1.67; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Creighton J, 1999, LANCET, V354, P42, DOI 10.1016/S0140-6736(99)01814-0; Friedman KJ, 1997, HUM MUTAT, V10, P108, DOI 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.3.CO;2-3; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Keiles S, 2006, PANCREAS, V33, P221, DOI 10.1097/01.mpa.0000232014.94974.75; Kereszturi E, 2009, GUT, V58, P545, DOI 10.1136/gut.2008.164947; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Le Marechal C, 2004, Hum Mutat, V23, P205, DOI 10.1002/humu.9212; Le Marechal C, 2001, MOL GENET METAB, V74, P342, DOI 10.1006/mgme.2001.3246; Le Marechal C, 2001, HUM GENET, V108, P290, DOI 10.1007/s004390100490; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Mantovani V, 2007, CLIN CHEM, V53, P531, DOI 10.1373/clinchem.2006.074807; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Masson E, 2007, MOL GENET METAB, V92, P168, DOI 10.1016/j.ymgme.2007.06.006; Masson E, 2013, MOL GENET METAB, V109, P296, DOI 10.1016/j.ymgme.2013.04.022; Park HW, 2010, GASTROENTEROLOGY, V139, P620, DOI 10.1053/j.gastro.2010.04.004; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Rebours V, 2009, GUT, V58, P97, DOI 10.1136/gut.2008.149179; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Schnur A, 2014, GUT, V63, P337, DOI 10.1136/gutjnl-2012-304331; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Spanier BWM, 2008, BEST PRACT RES CL GA, V22, P45, DOI 10.1016/j.bpg.2007.10.007; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 2004, HUM MUTAT, V23, P22, DOI 10.1002/humu.10285; Whitcomb DC, 2010, ANNU REV MED, V61, P413, DOI 10.1146/annurev.med.041608.121416; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001	46	70	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e73522	10.1371/journal.pone.0073522	http://dx.doi.org/10.1371/journal.pone.0073522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951356	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000096
J	Wright, E; Rahgozar, K; Hallworth, N; Lanker, S; Carrithers, MD				Wright, Erik; Rahgozar, Kusha; Hallworth, Nicholas; Lanker, Stefan; Carrithers, Michael D.			Epithelial V-Like Antigen Mediates Efficacy of Anti-Alpha(4) Integrin Treatment in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							ADHESION MOLECULE; IMMUNE SURVEILLANCE; DISEASE-ACTIVITY; POTENTIAL ROLE; B-CELLS; NATALIZUMAB; EXPRESSION; MEMORY; B-1A; CD5	Natalizumab inhibits the transmigration of activated T lymphocytes into the brain and is highly efficacious in multiple sclerosis (MS). However, from a pharmacogenomic perspective, its efficacy and safety in specific patients remain unclear. Here our goal was to analyze the effects of epithelial V-like antigen (EVA) on anti-alpha4 integrin (VLA4) efficacy in a mouse model of MS, experimental autoimmune encephalomyelitis (EAE). EVA has been previously characterized in human CD4 T lymphocytes, mouse thymic development, and choroid plexus epithelial cells. Further analysis here demonstrated expression in B lymphocytes and an increase in EVA(+) lymphocytes following immunization. Following active induction of EAE using the MOG(35-55) active immunization model, EVA deficient mice developed more severe EAE and white matter tissue injury as compared to wild type controls. This severe EAE phenotype did not respond to anti-VLA4 treatment. In both the control antibody and anti-VLA4 conditions, these mice demonstrated persistent CNS invasion of mature B lymphocyte (CD19(+), CD21(+), sIgG(+)), increased serum autoantibody levels, and extensive complement and IgG deposition within lesions containing CD5(+)IgG(+) cells. Wild type mice treated with control antibody also demonstrated the presence of CD19(+), CD21(+), sIgG(+) cells within the CNS during peak EAE disease severity and detectable serum autoantibody. In contrast, wild type mice treated with anti-VLA4 demonstrated reduced serum autoantibody levels as compared to wild type controls and EVA-knockout mice. As expected, anti-VLA4 treatment in wild type mice reduced the total numbers of all CNS mononuclear cells and markedly decreased CD4 T lymphocyte invasion. Treatment also reduced the frequency of CD19(+), CD21(+), sIgG(+) cells in the CNS. These results suggest that anti-VLA4 treatment may reduce B lymphocyte associated autoimmunity in some individuals and that EVA expression is necessary for an optimal therapeutic response. We postulate that these findings could optimize the selection of treatment responders.	[Wright, Erik; Rahgozar, Kusha; Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA; [Carrithers, Michael D.] William Middleton VA, Neurol Serv, Madison, WI USA; [Hallworth, Nicholas; Lanker, Stefan] Biogen Idec Inc, Cambridge, MA USA	University of Wisconsin System; University of Wisconsin Madison; Biogen	Carrithers, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA.	carrithers@neurology.wisc.edu			Biogen-Idec	Biogen-Idec(Biogen)	This work was supported by Biogen-Idec as an investigator-initiated study to Dr. MDC. Drs. NH and SL are employees of Biogen-Idec and assisted with study design and review of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD WJ, 1992, VIROLOGY, V190, P716, DOI 10.1016/0042-6822(92)90909-9; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Carrithers MD, 2002, J NEUROIMMUNOL, V129, P51, DOI 10.1016/S0165-5728(02)00172-8; Carrithers MD, 2012, CURR PHARM BIOTECHNO, V13, P1409; Chatterjee G, 2008, BIOCHEM BIOPH RES CO, V372, P412, DOI 10.1016/j.bbrc.2008.05.053; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Finn WG, 2001, HUM PATHOL, V32, P66, DOI 10.1053/hupa.2001.20891; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Guttinger M, 1998, J CELL BIOL, V141, P1061, DOI 10.1083/jcb.141.4.1061; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; MIX E, 1990, CLIN EXP IMMUNOL, V79, P21; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prosperini L, 2012, J NEUROL SCI, V323, P104, DOI 10.1016/j.jns.2012.08.027; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Seidi OA, 2002, J NEUROIMMUNOL, V133, P205, DOI 10.1016/S0165-5728(02)00360-0; Sindhava VJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00372; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Wojcik E, 2011, NEUROSCI LETT, V495, P115, DOI 10.1016/j.neulet.2011.03.051; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	24	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70954	10.1371/journal.pone.0070954	http://dx.doi.org/10.1371/journal.pone.0070954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951051	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000033
J	Graf, EH; Pace, MJ; Peterson, BA; Lynch, LJ; Chukwulebe, SB; Mexas, AM; Shaheen, F; Martin, JN; Deeks, SG; Connors, M; Migueles, SA; O'Doherty, U				Graf, Erin H.; Pace, Matthew J.; Peterson, Bennett A.; Lynch, Lindsay J.; Chukwulebe, Steve B.; Mexas, Angela M.; Shaheen, Farida; Martin, Jeffrey N.; Deeks, Steven G.; Connors, Mark; Migueles, Stephen A.; O'Doherty, Una			Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; ANTIRETROVIRAL THERAPY; ELITE CONTROLLERS; PERIPHERAL-BLOOD; LATENT INFECTION; PLASMA VIREMIA; IMMUNE CONTROL; EX-VIVO; REPLICATION	Resting CD4+T cells infected with HIV persist in the presence of suppressive anti-viral therapy (ART) and are barriers to a cure. One potential curative approach, therapeutic vaccination, is fueled by recognition of the ability of a subset of elite controllers (EC) to control virus without therapy due to robust anti-HIV immune responses. Controllers have low levels of integrated HIV DNA and low levels of replication competent virus, suggesting a small reservoir. As our recent data indicates some reservoir cells can produce HIV proteins (termed GPR cells for Gag-positive reservoir cells), we hypothesized that a fraction of HIV-expressing resting CD4+T cells could be efficiently targeted and cleared in individuals who control HIV via anti-HIV cytotoxic T lymphocytes (CTL). To test this we examined if superinfected resting CD4+T cells from EC express HIV Gag without producing infectious virus and the susceptibility of these cells to CTL. We found that resting CD4+T cells expressed HIV Gag and were cleared by autologous CD8+T cells from EC. Importantly, we found the extent of CTL clearance in our in vitro assay correlates with in vivo reservoir size and that a population of Gag expressing resting CD4+T cells exists in vivo in patients well controlled on therapy.	[Graf, Erin H.; Pace, Matthew J.; Lynch, Lindsay J.; Chukwulebe, Steve B.; Mexas, Angela M.; O'Doherty, Una] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Peterson, Bennett A.; Connors, Mark; Migueles, Stephen A.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Shaheen, Farida] Univ Penn, Ctr AIDS Res, Philadelphia, PA 19104 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Doherty, U (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	unao@mail.med.upenn.edu		Pace, Matthew/0000-0002-5703-3984	National Institutes of Health (NIH) [AI087461]; NIH T32 training grant [AI00762]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000762, R21AI087461, ZIAAI000855, P30AI027763, T32AI007632] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work presented was funded by the National Institutes of Health (NIH) grant AI087461, the NIH T32 training grant AI00762, and Merck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto LM, 2009, J VIROL; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fischer M, 2002, ANTIVIR THER, V7, P91; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Lefrere JJ, 1999, J INFECT DIS, V180, P526, DOI 10.1086/314906; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Persaud D, 2011, AIDS, V25, P2227, DOI 10.1097/QAD.0b013e32834cdaba; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; SAKAI H, 1993, J VIROL, V67, P1169, DOI 10.1128/JVI.67.3.1169-1174.1993; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10	45	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71879	10.1371/journal.pone.0071879	http://dx.doi.org/10.1371/journal.pone.0071879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951263	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700122
J	Nishijima, T; Gatanaga, H; Komatsu, H; Takano, M; Ogane, M; Ikeda, K; Oka, S				Nishijima, Takeshi; Gatanaga, Hiroyuki; Komatsu, Hirokazu; Takano, Misao; Ogane, Miwa; Ikeda, Kazuko; Oka, Shinichi			Illicit Drug Use Is a Significant Risk Factor for Loss to Follow Up in Patients with HIV-1 Infection at a Large Urban HIV Clinic in Tokyo	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; SURVIVAL; MEN; INJECTION; THERAPY; METHAMPHETAMINE; DETERMINANTS; INITIATION; RETENTION; MORTALITY	Background: Loss to follow up (LTFU) is an important prognostic factor in patients with HIV-1 infection. The impact of illicit drug use on LTFU of patients with HIV-1 infection is unknown in Japan. Methods: A single center observational study was conducted to elucidate the impact of illicit drug use on LTFU at a large HIV clinic in Tokyo. LTFU was defined as those who discontinued their visits to the clinic for at least 12 months and were not known to be under the care of other facilities or have died within 12 months of their last visit. Patients who first visited the clinic between January 2005 and August 2010 were enrolled. Information on illicit drug use was collected in a structured interview and medical charts. Comparison of the effects of illicit drug use and no use on LTFU was conducted by uni- and multi-variate Cox hazards models as the primary exposure. Results: The study subjects were 1,208 patients, mostly Japanese men, of relatively young age, and infected through homosexual contact. A total of 111 patients (9.2%) were LTFU (incidence: 24.9 per 1,000 person-years). Among illicit drug users and non users, 55 (13.3%) and 56 (7.1%) patients, respectively, were LTFU, with incidence of 35.7 and 19.2 per 1,000 person-years, respectively. Uni- and multi-variate analyses showed that illicit drug use was a significant risk for LTFU (HR= 1.860; 95% CI, 1.282-2.699; p= 0.001) (adjusted HR= 1.544; 95% CI, 1.028-2.318; p= 0.036). Multivariate analysis also identified young age, high CD4 count, no antiretroviral therapy, and no health insurance as risk factors for LTFU. Conclusions: The incidence of LTFU among illicit drug users was almost twice higher than that among non users. Effective intervention for illicit drug use in this population is warranted to ensure proper treatment and prevent the spread of HIV.	[Nishijima, Takeshi; Gatanaga, Hiroyuki; Takano, Misao; Ogane, Miwa; Ikeda, Kazuko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]; Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001), and the Global Center of Excellence Program (Global Education and Research Center Aiming at the Control of AIDS) from the Japanese Ministry of Education, Science, Sports and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano Thomas P, 2011, Top Antivir Med, V19, P12; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Halkitis PN, 2005, J URBAN HEALTH, V82, pI18, DOI 10.1093/jurban/jti020; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Kurtz SP, 2005, AIDS BEHAV, V9, P63, DOI 10.1007/s10461-005-1682-3; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Mansergh G, 2006, SEX TRANSM INFECT, V82, P131, DOI 10.1136/sti.2005.017129; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Pollini RA, 2011, SUBST ABUSE REHABIL, V2, P173, DOI 10.2147/SAR.S24800; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Qian HZ, 2011, J SUBST ABUSE TREAT, V41, P14, DOI 10.1016/j.jsat.2011.01.007; Rice BD, 2011, SEX TRANSM DIS, V38, P685, DOI 10.1097/OLQ.0b013e318214b92e; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tominaga M, 2009, SOC PSYCH PSYCH EPID, V44, P777, DOI 10.1007/s00127-009-0499-1; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wada K, 1999, ADDICTION, V94, P1063, DOI 10.1046/j.1360-0443.1999.947106311.x; Wada K, 2011, ANN NY ACAD SCI, V1216, P62, DOI 10.1111/j.1749-6632.2010.05914.x; Wada Kiyoshi, 2010, Nihon Rinsho, V68, P1437; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703	38	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e72310	10.1371/journal.pone.0072310	http://dx.doi.org/10.1371/journal.pone.0072310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951307	Green Submitted, Green Published, gold			2022-12-27	WOS:000323109700133
J	Chen-Hussey, V; Carneiro, I; Keomanila, H; Gray, R; Bannavong, S; Phanalasy, S; Lindsay, SW				Chen-Hussey, Vanessa; Carneiro, Ilona; Keomanila, Hongkham; Gray, Rob; Bannavong, Sihamano; Phanalasy, Saysana; Lindsay, Steven W.			Can Topical Insect Repellents Reduce Malaria? A Cluster-Randomised Controlled Trial of the Insect Repellent N,N-diethyl-m-toluamide (DEET) in Lao PDR	PLOS ONE			English	Article							PROVIDES PERSONAL PROTECTION; DOMINANT ANOPHELES VECTORS; TREATED BED NETS; MOSQUITO REPELLENT; DISTRIBUTION MAPS; ATTAPEU PROVINCE; CULICIDAE; EFFICACY; DISEASE; DIPTERA	Background: Mosquito vectors of malaria in Southeast Asia readily feed outdoors making malaria control through indoor insecticides such as long-lasting insecticidal nets (LLINs) and indoor residual spraying more difficult. Topical insect repellents may be able to protect users from outdoor biting, thereby providing additional protection above the current best practice of LLINs. Methods and Findings: A double blind, household randomised, placebo-controlled trial of insect repellent to reduce malaria was carried out in southern Lao PDR to determine whether the use of repellent and long-lasting insecticidal nets (LLINs) could reduce malaria more than LLINs alone. A total of 1,597 households, including 7,979 participants, were recruited in June 2009 and April 2010. Equal group allocation, stratified by village, was used to randomise 795 households to a 15% DEET lotion and the remainder were given a placebo lotion. Participants, field staff and data analysts were blinded to the group assignment until data analysis had been completed. All households received new LLINs. Participants were asked to apply their lotion to exposed skin every evening and sleep under the LLINs each night. Plasmodium falciparum and P. vivax cases were actively identified by monthly rapid diagnostic tests. Intention to treat analysis found no effect from the use of repellent on malaria incidence (hazard ratio: 1.00, 95% CI: 0.99-1.01, p = 0.868). A higher socio-economic score was found to significantly decrease malaria risk (hazard ratio: 0.72, 95% CI: 0.58-0.90, p = 0.004). Women were also found to have a reduced risk of infection (hazard ratio: 0.59, 95% CI: 0.37-0.92, p = 0.020). According to protocol analysis which excluded participants using the lotions less than 90% of the time found similar results with no effect from the use of repellent. Conclusions: This randomised controlled trial suggests that topical repellents are not a suitable intervention in addition to LLINs against malaria amongst agricultural populations in southern Lao PDR. These results are also likely to be applicable to much of the Greater Mekong Sub-region.	[Chen-Hussey, Vanessa; Carneiro, Ilona; Lindsay, Steven W.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Keomanila, Hongkham] Minist Hlth, Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Gray, Rob; Bannavong, Sihamano; Phanalasy, Saysana] Populat Serv Int Laos, Viangchan, Laos; [Lindsay, Steven W.] Univ Durham, Sch Biol & Biomed Studies, Durham, England	University of London; London School of Hygiene & Tropical Medicine; Durham University	Chen-Hussey, V (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Vanessa.Chen-Hussey@lshtm.ac.uk		Lindsay, Steve/0000-0002-3461-9050	Research and Policy for Infectious Disease Dynamics Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Research and Policy for Infectious Disease Dynamics Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	SWL is supported by the Research and Policy for Infectious Disease Dynamics Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIMAI V, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P151; Barnard DR, 1998, J MED ENTOMOL, V35, P340, DOI 10.1093/jmedent/35.3.340; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Chen-Hussey V, 2012, THESIS SCH HYGIENE T; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; Kroeger A, 1997, AM J TROP MED HYG, V56, P580, DOI 10.4269/ajtmh.1997.56.580; Lindsay SW, 1998, MED VET ENTOMOL, V12, P295, DOI 10.1046/j.1365-2915.1998.00115.x; McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3; Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Phetsouvanh R., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P547; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Shirayama Y, 2008, T ROY SOC TROP MED H, V102, P743, DOI 10.1016/j.trstmh.2008.05.014; Sidavong B., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P309; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Socheat Doung, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P1; Socheath S, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P106; TAYLOR B, 1975, T ROY ENT SOC LONDON, V127, P277; Toma Takako, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P532; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; TunLin W, 1995, J AM MOSQUITO CONTR, V11, P401; United Nations Development Programme (UNDP), 2001, NAT HUM DEV REP LAO; Vythilingam I, 2006, J AM MOSQUITO CONTR, V22, P140, DOI 10.2987/8756-971X(2006)22[140:SCOMOA]2.0.CO;2; Vythilingam I, 2005, T ROY SOC TROP MED H, V99, P833, DOI 10.1016/j.trstmh.2005.06.012; Vythilingam I, 2003, TROP MED INT HEALTH, V8, P525, DOI 10.1046/j.1365-3156.2003.01052.x; Vythilingam Indra, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P83; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2008, COUNTR HLTH INF PROF; WHO Mekong Malaria Programme, 2010, MAL GREAT MEK SUBR R; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; Yap HH, 2000, J AM MOSQUITO CONTR, V16, P241; YAP HH, 1986, J AM MOSQUITO CONTR, V2, P63	41	25	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70664	10.1371/journal.pone.0070664	http://dx.doi.org/10.1371/journal.pone.0070664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967083	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000323221500020
J	Sugimoto, A; Nomura, S; Tsubokura, M; Matsumura, T; Muto, K; Sato, M; Gilmour, S				Sugimoto, Amina; Nomura, Shuhei; Tsubokura, Masaharu; Matsumura, Tomoko; Muto, Kaori; Sato, Mikiko; Gilmour, Stuart			The Relationship between Media Consumption and Health-Related Anxieties after the Fukushima Daiichi Nuclear Disaster	PLOS ONE			English	Article							RADIATION; CHERNOBYL	Background: The Fukushima Daiichi nuclear disaster caused a global panic by a release of harmful radionuclides. In a disaster setting, misusage of contemporary media sources available today can lead to disseminated incorrect information and panic. The study aims to build a scale which examines associations between media and individual anxieties, and to propose effective media usages for future disaster management. Methods: The University of Tokyo collaborated with the Fukushima local government to conduct a radiation-health-seminar for a total of 1560 residents, at 12 different locations in Fukushima. A 13 item questionnaire collected once before and after a radiation-seminar was used on factor analysis to develop sub-scales for multiple regression models, to determine relationships between the sub-scales and media type consumed. A paired t-test was used to examine any changes in sub-scale of pre- and post-seminar scores. Results: Three sub-scales were revealed and were associated with different media types: was with rumors, while concern for the future was positively associated with regional-newspapers and negatively with national-newspapers. Anxiety about social-disruption was associated with radio. The seminar had a significant effect on anxiety reduction for all the three sub-scales. Conclusion: Different media types were associated with various heightened concerns, and that a radiation seminar was helpful to reduce anxieties in the post-disaster setting. By tailoring post-disaster messages via specific media types, i.e., radio, it may be possible to effectively convey important information, as well as to calm fears about particular elements of post-disaster recovery and to combat rumors.	[Sugimoto, Amina; Nomura, Shuhei; Gilmour, Stuart] Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Tsubokura, Masaharu; Matsumura, Tomoko] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Muto, Kaori; Sato, Mikiko] Univ Tokyo, Inst Med Sci, Dept Publ Policy, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sugimoto, A (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	amigon0918@m.u-tokyo.ac.jp	Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021; Nomura, Shuhei/HCH-5356-2022	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X; Nomura, Shuhei/0000-0002-2963-7297	Toyota Foundation Great East Japan Special Policy Development Grant program [D12-EA-0078]	Toyota Foundation Great East Japan Special Policy Development Grant program	This work was supported by The Toyota Foundation Great East Japan Special Policy Development Grant program (grant number D12-EA-0078). No additional external funding received for this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Red Cross, 2011, SOC MED DIS EM AM RE; Barnes MD, 2008, AM J PUBLIC HEALTH, V98, P604, DOI 10.2105/AJPH.2007.112235; BREWIN TB, 1994, BRIT MED J, V309, P208, DOI 10.1136/bmj.309.6948.208; Bromet EJ, 2011, WORLD PSYCHIATRY, V10, P83; DROTTZSJOBERG BM, 1993, HEALTH PHYS, V64, P223, DOI 10.1097/00004032-199303000-00001; FRIEDMAN SM, 1987, J COMMUN, V37, P58, DOI 10.1111/j.1460-2466.1987.tb00994.x; Hosaka T, 2011, TOHOKU DISASTER SPAR; Kanayama T, 2007, COMMUNITY TIES REVIT; Raphael B, 2011, MOL PSYCHIATR, V16, P247, DOI 10.1038/mp.2010.68; Shklovski I, 2008, FINDING COMMUNITY IN; Slovic P, 1996, RADIAT PROT DOSIM, V68, P165, DOI 10.1093/oxfordjournals.rpd.a031860; Smith J, 2011, NATURE, V472, P7, DOI 10.1038/472007a; Taira T, 2011, NATURE, V480, P313, DOI 10.1038/480313a; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010	14	65	66	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e65331	10.1371/journal.pone.0065331	http://dx.doi.org/10.1371/journal.pone.0065331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967046	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500001
J	Forrest, MD				Forrest, Michael D.			Mathematical Model of Bursting in Dissociated Purkinje Neurons	PLOS ONE			English	Article								In vitro, Purkinje cell behaviour is sometimes studied in a dissociated soma preparation in which the dendritic projection has been cleaved. A fraction of these dissociated somas spontaneously burst. The mechanism of this bursting is incompletely understood. We have constructed a biophysical Purkinje soma model, guided and constrained by experimental reports in the literature, that can replicate the somatically driven bursting pattern and which hypothesises Persistent Na+ current (I-NaP) to be its burst initiator and SK K+ current (I-SK) to be its burst terminator.	Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Forrest, MD (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	mikeforrest@hotmail.com		Forrest, Michael/0000-0002-0648-7468	Medical Research Council (MRC) of the UK	Medical Research Council (MRC) of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The author conducted this work in 2007 and was funded at the time by the Medical Research Council (MRC) of the UK, http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was reviewed by the author, and written up for journal publication, in 2012 (with no funding appropriated for this task).	Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Alroy G, 1999, J PHYSIOL-LONDON, V518, P71, DOI 10.1111/j.1469-7793.1999.0071r.x; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; DEMIERA EVS, 1997, P NATL ACAD SCI USA, V94, P7059; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Forrest MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051169; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; Hammarstrom AKM, 1999, J PHYSIOL-LONDON, V520, P451, DOI 10.1111/j.1469-7793.1999.t01-1-00451.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Kay AR, 1998, J NEUROPHYSIOL, V80, P1167, DOI 10.1152/jn.1998.80.3.1167; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Miyasho T, 2001, BRAIN RES, V891, P106, DOI 10.1016/S0006-8993(00)03206-6; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Prinz A., 2006, SCHOLARPEDIA, V2, P1903, DOI [10.4249/scholarpedia.l903, DOI 10.4249/SCHOLARPEDIA.1903]; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; Swensen AM, 2003, J NEUROSCI, V23, P9650; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e68765	10.1371/journal.pone.0068765	http://dx.doi.org/10.1371/journal.pone.0068765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967054	Green Published, gold, Green Submitted			2022-12-27	WOS:000323115800003
J	Genovart, M; Thibault, JC; Igual, JM; Bauza-Ribot, MD; Rabouam, C; Bretagnolle, V				Genovart, Meritxell; Thibault, Jean-Claude; Manuel Igual, Jose; del Mar Bauza-Ribot, Maria; Rabouam, Corinne; Bretagnolle, Vincent			Population Structure and Dispersal Patterns within and between Atlantic and Mediterranean Populations of a Large-Range Pelagic Seabird	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; ENDANGERED BALEARIC SHEARWATER; MAXIMUM-LIKELIHOOD-ESTIMATION; CORYS SHEARWATER; GENE FLOW; AVIAN PHYLOGEOGRAPHY; WANDERING ALBATROSS; COALESCENT APPROACH; MITOCHONDRIAL-DNA; MIGRATION RATES	Dispersal is critically linked to the demographic and evolutionary trajectories of populations, but in most seabird species it may be difficult to estimate. Using molecular tools, we explored population structure and the spatial dispersal pattern of a highly pelagic but philopatric seabird, the Cory's shearwater Calonectris diomedea. Microsatellite fragments were analysed from samples collected across almost the entire breeding range of the species. To help disentangle the taxonomic status of the two subspecies described, the Atlantic form C. d. borealis and the Mediterranean form C. d. diomedea, we analysed genetic divergence between subspecies and quantified both historical and recent migration rates between the Mediterranean and Atlantic basins. We also searched for evidence of isolation by distance (IBD) and addressed spatial patterns of gene flow. We found a low genetic structure in the Mediterranean basin. Conversely, strong genetic differentiation appeared in the Atlantic basin. Even if the species was mostly philopatric (97%), results suggest recent dispersal between basins, especially from the Atlantic to the Mediterranean (aprox. 10% of migrants/generation across the last two generations). Long-term gene flow analyses also suggested an historical exchange between basins (about 70 breeders/generation). Spatial analysis of genetic variation indicates that distance is not the main factor in shaping genetic structure in this species. Given our results we recommend gathering more data before concluded whether these taxa should be treated as two species or subspecies.	[Genovart, Meritxell; Manuel Igual, Jose; del Mar Bauza-Ribot, Maria] Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Populat Ecol Grp, Esporles, Mallorca, Spain; [Thibault, Jean-Claude] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Origine Struct & Evolut Biodiversite 7205, F-75231 Paris, France; [Rabouam, Corinne; Bretagnolle, Vincent] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Genovart, M (corresponding author), Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Populat Ecol Grp, Esporles, Mallorca, Spain.	m.genovart@uib.es	Igual, Jose/N-3975-2014; Genovart, Meritxell/L-4873-2014	Igual, Jose/0000-0002-8369-3150; Genovart, Meritxell/0000-0003-2919-1288	Spanish Ministry of Education and Science; Spanish Ministry of Science and Innovation [CGL2009-08298]; Consell Insular de Menorca [645/541A]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consell Insular de Menorca	MG was partially funded by an I3P postdoctoral fellowship from the Spanish Ministry of Education and Science. This work received partial financial support from the project CGL2009-08298 from the Spanish Ministry of Science and Innovation and 645/541A from the Consell Insular de Menorca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balloux F, 2002, MOL ECOL, V11, P771, DOI 10.1046/j.1365-294X.2002.01474.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; Belkhir K, 2001, GENETIX 4 05 LOGICIE; Benjamini Y, 2001, ANN STAT, V29, P1165; Bicknell AWJ, 2012, MOL ECOL, V21, P2863, DOI 10.1111/j.1365-294X.2012.05558.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; BRETAGNOLLE V, 1990, ETHOLOGY, V85, P313; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Brooke M, 2004, ALBATROSSES PETRELS; Cachia-Zammit R, 1986, IL MERILL, V24, P1; Cagnon C, 2004, MAR BIOL, V145, P1257, DOI 10.1007/s00227-004-1407-6; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Congdon BC, 2000, EVOLUTION, V54, P974; Cure C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1823, DOI 10.1007/s00265-010-0994-0; Cure C, 2009, BIOL J LINN SOC, V96, P115, DOI 10.1111/j.1095-8312.2008.01104.x; da Silva MC, 1999, CONDOR, V101, P174, DOI 10.2307/1370461; de Juana A. Eduardo, 1994, Ardeola, V41, P91; Dearborn DC, 2003, MOL ECOL, V12, P2835, DOI 10.1046/j.1365-294X.2003.01931.x; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gauthier G, 2010, J ANIM ECOL, V79, P879, DOI 10.1111/j.1365-2656.2010.01683.x; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Genovart M, 2013, J ANIM ECOL, V82, P121, DOI 10.1111/j.1365-2656.2012.02015.x; Genovart M, 2012, J HERED, V103, P330, DOI 10.1093/jhered/ess010; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez EG, 2009, MOL ECOL RESOUR, V9, P1044, DOI 10.1111/j.1755-0998.2009.02563.x; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granadeiro JP, 1991, SEABIRD, V13, P30; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; Hazevoet CJ, 1995, BIRDS CAPE VERDE ISL, V13; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Juliano MF, 2007, J PHYS OCEANOGR, V37, P2573, DOI 10.1175/2007JPO3150.1; lo Valvo M., 1988, Bocagiana (Funchal), P1; Manel S, 2003, TRENDS ECOL EVOL, V15, P290; Martinez-Abrain A, 2002, WATERBIRDS, V25, P221, DOI 10.1675/1524-4695(2002)025[0221:ACSBIA]2.0.CO;2; Massa B., 1986, NATO ASI Series Series G Ecological Sciences, V12, P293; Mays Gilles, 2006, Ornithos, V13, P316; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Molina B, 2005, ARDEOLA, V52, P423; Mougin J.L., 1987, Gerfaut, V77, P353; Munilla I, 2008, PLAN INTEGRAL RECUPE; NEI M, 1978, GENETICS, V89, P583; Nichols J., 2001, DISPERSAL; ODEN NL, 1986, SYST ZOOL, V35, P608, DOI 10.2307/2413120; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Pons JM, 2004, J ZOOL SYST EVOL RES, V42, P245, DOI 10.1111/j.1439-0469.2004.00255.x; Pritchard JK, 2000, GENETICS, V155, P945; Rabouam C, 1998, AUK, V115, P483; Rabouam C, 2000, AUK, V117, P651, DOI 10.1642/0004-8038(2000)117[0651:GROCSS]2.0.CO;2; Rabouam C, 1997, THESIS U F RABELAIS; RANDI E, 1989, AUK, V106, P411; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes-Gonzalez JM, 2012, ENCICLOPEDIA VIRTUAL; RISTOW D, 1990, Vogelwelt, V111, P172; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Sanz-Aguilar A, 2011, ECOL APPL, V21, P555, DOI 10.1890/09-2339.1; Schneider S, 2000, ARLEQUIN V 2 0 SOFRW; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; STAMPS JA, 1987, AM NAT, V129, P629, DOI 10.1086/284663; Thibault J-C, 1997, BIRDS W PALEARCTIC U, V1, P75; Thibault JC, 1998, IBIS, V140, P523, DOI 10.1111/j.1474-919X.1998.tb04615.x; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson GA, 2003, GENETICS, V163, P1177; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zotier R, 1999, J BIOGEOGR, V26, P297, DOI 10.1046/j.1365-2699.1999.00260.x	88	26	27	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70711	10.1371/journal.pone.0070711	http://dx.doi.org/10.1371/journal.pone.0070711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950986	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300042
J	Haflidadottir, BS; Larne, O; Martin, M; Persson, M; Edsjo, A; Bjartell, A; Ceder, Y				Haflidadottir, Benedikta S.; Larne, Olivia; Martin, Myriam; Persson, Margareta; Edsjo, Anders; Bjartell, Anders; Ceder, Yvonne			Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; FORKHEAD TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR; EXPRESSION; MICRORNAS; INHIBITION; PROTEINS; THERAPY; MIR-182; PTEN	Aberrant expression of miR-96 in prostate cancer has previously been reported. However, the role and mechanism of action of miR-96 in prostate cancer has not been determined. In this study, the diagnostic and prognostic properties of miR-96 expression levels were investigated by qRT-PCR in two well documented prostate cancer cohorts. The miR-96 expression was found to be significantly higher in prostate cancer patients and correlate with WHO grade, and decreased overall survival time; patients with low levels of miR-96 lived 1.5 years longer than patients with high miR-96 levels. The therapeutic potential was further investigated in vitro, showing that ectopic levels of miR-96 enhances growth and cellular proliferation in prostate cancer cells, implying that miR-96 has oncogenic properties in this setting. We demonstrate that miR-96 expression decreases the transcript and protein levels of FOXO1 by binding to one of two predicted binding sites in the FOXO1 3'UTR sequence. Blocking this binding site completely inhibited the growth enhancement conveyed by miR-96. This finding was corroborated in a large external prostate cancer patient cohort where miR-96 expression inversely correlated to FOXO1 expression. Taken together these findings indicate that miR-96 plays a key role in prostate cancer cellular proliferation and can enhance prostate cancer progression. This knowledge might be utilized for the development of novel therapeutic tools for prostate cancer.	[Haflidadottir, Benedikta S.; Larne, Olivia; Persson, Margareta; Ceder, Yvonne] Lund Univ, Dept Lab Med, Div Clin Chem, Malmo, Sweden; [Martin, Myriam] Lund Univ, Dept Lab Med, Div Med Prot Chem, Malmo, Sweden; [Edsjo, Anders] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Bjartell, Anders] Lund Univ, Dept Clin Sci, Div Urol Canc, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University	Ceder, Y (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem, Malmo, Sweden.	Yvonne.Ceder@med.lu.se	Edsjö, Anders/AAC-8658-2019	Ceder, Yvonne/0000-0002-8705-8293; Martin, Myriam/0000-0003-1526-8678	European Union [201438]; Swedish Research council; Gunnar Nilssons Cancer foundation; Jeanssons foundation; Gyllenstiernska Krapperups foundation	European Union(European Commission); Swedish Research council(Swedish Research CouncilEuropean Commission); Gunnar Nilssons Cancer foundation; Jeanssons foundation; Gyllenstiernska Krapperups foundation	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no201438, the Swedish Research council, Gunnar Nilssons Cancer foundation, Jeanssons foundation and Gyllenstiernska Krapperups foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bohrer LR, 2013, PROSTATE, V73, P1017, DOI 10.1002/pros.22649; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Ferlay J, 2010, IARC CANCERBASE; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hagman Z, 2013, BRIT J CANCER, V108, P1668, DOI 10.1038/bjc.2013.131; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Jalvy-Delvaille S, 2012, NUCLEIC ACIDS RES, V40, P1356, DOI 10.1093/nar/gkr843; Klein EA, 2009, UROL ONCOL-SEMIN ORI, V27, P67, DOI 10.1016/j.urolonc.2008.04.001; Larne O, 2013, INT J CANCER, V132, P2867, DOI 10.1002/ijc.27973; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Lundwall A, 2002, MOL HUM REPROD, V8, P805, DOI 10.1093/molehr/8.9.805; Ma QP, 2009, MOL ENDOCRINOL, V23, P213, DOI 10.1210/me.2008-0147; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Whittington R, 1999, INT J RADIAT ONCOL, V44, P1107, DOI 10.1016/S0360-3016(99)00119-4; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	37	73	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72400	10.1371/journal.pone.0072400	http://dx.doi.org/10.1371/journal.pone.0072400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951320	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300197
J	Hooper, SB; Fouras, A; Siew, ML; Wallace, MJ; Kitchen, MJ; te Pas, AB; Klingenberg, C; Lewis, RA; Davis, PG; Morley, CJ; Schmolzer, GM				Hooper, Stuart B.; Fouras, Andreas; Siew, Melissa L.; Wallace, Megan J.; Kitchen, Marcus J.; te Pas, Arjan B.; Klingenberg, Claus; Lewis, Robert A.; Davis, Peter G.; Morley, Colin J.; Schmoelzer, Georg M.			Expired CO2 Levels Indicate Degree of Lung Aeration at Birth	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY; END-EXPIRATORY PRESSURE; TIDAL CARBON-DIOXIDE; INTENSIVE-CARE-UNIT; NEONATAL RESUSCITATION; LIQUID CLEARANCE; SUSTAINED INFLATION; PRETERM RABBITS; VENTILATION; DELIVERY	As neonatal resuscitation critically depends upon lung aeration at birth, knowledge of the progression of this process is required to guide ongoing care. We investigated whether expired CO2 (ECO2) levels indicate the degree of lung aeration immediately after birth in two animal models and in preterm infants. Lambs were delivered by caesarean section and ventilated from birth. In lambs, ECO2 levels were significantly (p<0.0001) related to tidal volumes and CO2 clearance/ breath increased exponentially when tidal volumes were greater than 6 mL/kg. Preterm (28 days of gestation; term = 32 days) rabbits were also delivered by caesarean section and lung aeration was measured using phase contrast X-ray imaging. In rabbit kittens, ECO2 levels were closely related (p<0.001) to lung volumes at end-inflation and were first detected when,7% of the distal lung regions were aerated. ECO2 levels in preterm infants at birth also correlated with tidal volumes. In each infant, ECO2 levels increased to >10 mmHg 28 (median) (21-36) seconds before the heart rate increased above 100 beats per minute. These data demonstrate that ECO2 levels can indicate the relative degree of lung aeration after birth and can be used to clinically assess ventilation in the immediate newborn period.	[Hooper, Stuart B.; Siew, Melissa L.; Wallace, Megan J.; te Pas, Arjan B.; Schmoelzer, Georg M.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Fouras, Andreas] Monash Univ, Div Biol Engn, Melbourne, Vic 3004, Australia; [Kitchen, Marcus J.] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia; [te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Klingenberg, Claus] Univ Hosp North Norway, Dept Paediat, Tromso, Norway; [Klingenberg, Claus] Univ Tromso, Fac Hlth Sci, Paediat Res Grp, Tromso, Norway; [Lewis, Robert A.] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic, Australia; [Lewis, Robert A.] Univ Saskatchewan, Saskatoon, SK, Canada; [Lewis, Robert A.] Monash Univ, Dept Radiol & Biomed Imaging, Melbourne, Vic 3004, Australia; [Davis, Peter G.; Morley, Colin J.; Schmoelzer, Georg M.] Royal Hosp Women, Dept Newborn Res, Melbourne, Vic, Australia; [Schmoelzer, Georg M.] Med Univ, Dept Pediat, Div Neonatol, Graz, Austria	Monash University; Monash University; Monash University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Monash University; University of Saskatchewan; Monash University; Medical University of Graz	Hooper, SB (corresponding author), Monash Univ, Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia.	Stuart.hooper@monash.edu	Klingenberg, Claus/AAH-4467-2019; Schmölzer, Georg M/E-7883-2010; pas, arjan te/AAA-9019-2020; Fouras, Andreas/A-9410-2008; Kitchen, Marcus/A-1355-2008	Schmölzer, Georg M/0000-0001-9798-2415; pas, arjan te/0000-0001-7831-8797; Fouras, Andreas/0000-0002-8933-1759; Kitchen, Marcus/0000-0002-0029-6660; Wallace, Megan/0000-0001-5785-5120; Siew, Melissa/0000-0003-3014-2379; Morley, Colin/0000-0001-5388-0214; Hooper, Stuart/0000-0003-1676-4825	Australian Research Council (ARC); Australian National Health and Medical Research Council (NHMRC) [491103]; Victorian Government's Operational Infrastructure Support Program; International Synchrotron Access Program (ISAP); Australian Government; SPring-8 Program Review Committee [2010B0022]; Laerdal Foundation for Acute Medicine; Australian NHMRC Postgraduate Scholarship; ARC Australian Research Fellowship; Australia NHMRC Research Fellowships; Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw); Innovational Research Incentives Scheme Veni-Vidi-Vici [91612027]	Australian Research Council (ARC)(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; International Synchrotron Access Program (ISAP); Australian Government(Australian GovernmentCGIAR); SPring-8 Program Review Committee; Laerdal Foundation for Acute Medicine; Australian NHMRC Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); ARC Australian Research Fellowship(Australian Research Council); Australia NHMRC Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw); Innovational Research Incentives Scheme Veni-Vidi-Vici	This research is supported by Australian Research Council (ARC), Australian National Health and Medical Research Council (NHMRC #491103) and the Victorian Government's Operational Infrastructure Support Program. Authors acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and funded by the Australian Government. The authors also gratefully acknowledge support provided by the SPring-8 synchrotron facility (Japan), granted by the SPring-8 Program Review Committee (proposal nos. 2010B0022). GMS acknowledges funds by the Laerdal Foundation for Acute Medicine. MLS was a recipient of an Australian NHMRC Postgraduate Scholarship, MJK was a recipient of an ARC Australian Research Fellowship and PGD and SBH are recipients of Australia NHMRC Research Fellowships. ABtP was a recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici (project nos. 91612027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dawson JA, 2010, ARCH DIS CHILD-FETAL, V95, pF177, DOI 10.1136/adc.2009.169102; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Finer NN, 2004, CURR OPIN PEDIATR, V16, P157, DOI 10.1097/00008480-200404000-00007; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; IWAMOTO HS, 1993, PEDIATR RES, V33, P639, DOI 10.1203/00006450-199306000-00021; IWAMOTO HS, 1987, PEDIATR RES, V22, P634, DOI 10.1203/00006450-198712000-00004; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Kitchen MJ, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/02/T02002; Perlman JM, 2010, PEDIATRICS, V126, pE1319, DOI 10.1542/peds.2010-2972B; Schmalisch G, 2012, PHYSIOL MEAS, V33, P1631, DOI 10.1088/0967-3334/33/10/1631; Schmolzer GM, 2012, J PEDIATR-US, V160, P377, DOI 10.1016/j.jpeds.2011.09.017; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF295, DOI 10.1136/adc.2009.165878; Siew ML, 2011, PEDIATR RES, V70, P50, DOI 10.1203/PDR.0b013e31821be094; Siew ML, 2009, J APPL PHYSIOL, V106, P1888, DOI 10.1152/japplphysiol.91526.2008; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; Te Pas AB, 2008, J PEDIATR-US, V152, P607, DOI 10.1016/j.jpeds.2007.10.041; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; TEITEL DF, 1990, PEDIATR RES, V27, P372, DOI 10.1203/00006450-199004000-00010; Tingay DG, 2005, ARCH DIS CHILD-FETAL, V90, pF523, DOI 10.1136/adc.2004.064717; Tracy M, 2004, ARCH DIS CHILD-FETAL, V89, pF84, DOI 10.1136/fn.89.1.F84; TRILLO G, 1994, RESUSCITATION, V27, P1, DOI 10.1016/0300-9572(94)90014-0; Wu CH, 2003, PEDIATR PULM, V35, P292, DOI 10.1002/ppul.10260	25	66	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70895	10.1371/journal.pone.0070895	http://dx.doi.org/10.1371/journal.pone.0070895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951032	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300064
J	Hu, Y; Chen, IP; de Almeida, S; Tiziani, V; Do Amaral, CMR; Gowrishankar, K; Passos-Bueno, MR; Reichenberger, EJ				Hu, Ying; Chen, I-Ping; de Almeida, Salome; Tiziani, Valdenize; Raposo Do Amaral, Cassio M.; Gowrishankar, Kalpana; Passos-Bueno, Maria Rita; Reichenberger, Ernst J.			A Novel Autosomal Recessive GJA1 Missense Mutation Linked to Craniometaphyseal Dysplasia	PLOS ONE			English	Article							FORAMEN MAGNUM DECOMPRESSION; GAP-JUNCTION PROTEIN; OCULODENTODIGITAL DYSPLASIA; PHE377DEL MUTATION; MOUSE MODEL; TGF-BETA; OSTEOBLAST; DIFFERENTIATION; GENE; ANKH	Craniometaphyseal dysplasia (CMD) is a rare sclerosing skeletal disorder with progressive hyperostosis of craniofacial bones. CMD can be inherited in an autosomal dominant (AD) trait or occur after de novo mutations in the pyrophosphate transporter ANKH. Although the autosomal recessive (AR) form of CMD had been mapped to 6q21-22 the mutation has been elusive. In this study, we performed whole-exome sequencing for one subject with AR CMD and identified a novel missense mutation (c.716G>A, p.Arg239Gln) in the C-terminus of the gap junction protein alpha-1 (GJA1) coding for connexin 43 (Cx43). We confirmed this mutation in 6 individuals from 3 additional families. The homozygous mutation cosegregated only with affected family members. Connexin 43 is a major component of gap junctions in osteoblasts, osteocytes, osteoclasts and chondrocytes. Gap junctions are responsible for the diffusion of low molecular weight molecules between cells. Mutations in Cx43 cause several dominant and recessive disorders involving developmental abnormalities of bone such as dominant and recessive oculodentodigital dysplasia (ODDD; MIM #164200, 257850) and isolated syndactyly type III (MIM #186100), the characteristic digital anomaly in ODDD. However, characteristic ocular and dental features of ODDD as well as syndactyly are absent in patients with the recessive Arg239Gln Cx43 mutation. Bone remodeling mechanisms disrupted by this novel Cx43 mutation remain to be elucidated.	[Hu, Ying; Reichenberger, Ernst J.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Dev Biol, Farmington, CT 06032 USA; [Chen, I-Ping] Univ Connecticut, Ctr Hlth, Dept Oral Hlth & Diagnost Sci, Farmington, CT USA; [de Almeida, Salome] Ctr Hosp Lisboa, Med Genet Serv, Central, Portugal; [Raposo Do Amaral, Cassio M.] Inst Cirurg Plast Craniofacial SOBRAPAR, Campinas, SP, Brazil; [Gowrishankar, Kalpana] Kanchi Kamakoti Childs Trust Hosp, Dept Med Genet, Madras, Tamil Nadu, India; [Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil	University of Connecticut; University of Connecticut; Universidade de Lisboa; Universidade de Sao Paulo	Reichenberger, EJ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Dev Biol, Farmington, CT 06032 USA.	reichenberger@uchc.edu	Passos-Bueno, Maria Rita/I-6796-2016; Chang, Shih-Lin/AGT-1191-2022; Hu, Yu-Feng/V-1401-2019; Tiziani, Valdenize/F-9848-2012	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Hu, Yu-Feng/0000-0001-5715-2070; Tiziani, Valdenize/0000-0001-6783-9212; de Almeida, Salome/0000-0001-9447-1820	National Institutes of Health [M01RR006192]; University of Connecticut Health Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Health Center	Funding provided by National Institutes of Health support #M01RR006192 and University of Connecticut Health Center institutional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIGHTON P, 1995, J MED GENET, V32, P370, DOI 10.1136/jmg.32.5.370; Bivi N, 2012, CALCIFIED TISSUE INT, V91, P215, DOI 10.1007/s00223-012-9628-z; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Chaible LM, 2011, TOXICOL PATHOL, V39, P1046, DOI 10.1177/0192623311422075; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen IP, 2011, HUM MOL GENET, V20, P948, DOI 10.1093/hmg/ddq541; Chen IP, 2009, J BONE MINER RES, V24, P1206, DOI [10.1359/JBMR.090218, 10.1359/jbmr.090218]; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; Day RAA, 1997, NEUROSURGERY, V41, P960, DOI 10.1097/00006123-199710000-00039; Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315, DOI 10.1152/ajpcell.2000.278.2.C315; Dutra EH, 2012, CLIN GENET, V81, P93, DOI 10.1111/j.1399-0004.2011.01700.x; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; GORLIN RJ, 1994, PEDIATR RADIOL, V24, P392, DOI 10.1007/BF02011904; Hayashibara T, 2000, J ORAL PATHOL MED, V29, P460, DOI 10.1034/j.1600-0714.2000.290907.x; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Huang T, 2013, J CELL SCI, V126, P2857, DOI 10.1242/jcs.123315; Iughetti P, 2000, AM J MED GENET, V95, P482, DOI 10.1002/1096-8628(20001218)95:5<482::AID-AJMG14>3.0.CO;2-X; Juergens P, 2011, J NEUROSURG, V115, P528, DOI 10.3171/2011.3.JNS101517; Jung YJ, 2003, J BIOL CHEM, V278, P7445, DOI 10.1074/jbc.M209804200; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Kornak U, 2010, AM J MED GENET A, V152A, P870, DOI 10.1002/ajmg.a.33301; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6; Loddenkemper T, 2002, J NEUROL, V249, P584, DOI 10.1007/s004150200068; Loiselle AE, 2013, J ORTHOP RES, V31, P147, DOI 10.1002/jor.22178; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; MILLARD DR, 1967, AM J SURG, V113, P615, DOI 10.1016/0002-9610(67)90307-8; Mintz S, 2004, DENTOMAXILLOFAC RAD, V33, P262, DOI 10.1259/dmfr/17660567; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; PENCHASZADEH VB, 1980, AM J MED GENET, V5, P43, DOI 10.1002/ajmg.1320050107; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Prontera P, 2011, AM J MED GENET A, V155A, P1106, DOI 10.1002/ajmg.a.33826; Reichenberger E, 2001, AM J HUM GENET, V68, P1321, DOI 10.1086/320612; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Sewell MD, 2008, BRIT J NEUROSURG, V22, P83, DOI 10.1080/02688690701658737; Shao Q, 2012, MOL BIOL CELL, V23, P3312, DOI 10.1091/mbc.E12-02-0128; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Tinschert S, 1998, AM J MED GENET, V77, P175, DOI 10.1002/(SICI)1096-8628(19980518)77:3<175::AID-AJMG1>3.0.CO;2-P; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Zajac A, 2010, AM J MED GENET A, V152A, P770, DOI 10.1002/ajmg.a.33317; Zhang H, 2007, PEDIATR DENT, V29, P415; Zhang Y, 2011, PPAR RES, V2011, DOI 10.1155/2011/164925; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08	51	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e73576	10.1371/journal.pone.0073576	http://dx.doi.org/10.1371/journal.pone.0073576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951358	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300207
J	Ramachandran, S; Basha, HI; Sarma, NJ; Lin, Y; Crippin, JS; Chapman, WC; Mohanakumar, T				Ramachandran, Sabarinathan; Basha, Haseeb Ilias; Sarma, Nayan J.; Lin, Yiing; Crippin, Jeffrey S.; Chapman, William C.; Mohanakumar, Thalachallour			Hepatitis C Virus Induced miR200c Down Modulates FAP-1, a Negative Regulator of Src Signaling and Promotes Hepatic Fibrosis	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL GENE-REGULATION; LIVER FIBROSIS; TGF-BETA; MICRORNA EXPRESSION; REPRESSORS ZEB1; GROWTH-FACTOR; PROGRESSION; KINASE; HCV; CIRRHOSIS	Hepatitis C virus (HCV) induced liver disease is the leading indication for liver transplantation (LTx). Reinfection and accelerated development of fibrosis is a universal phenomenon following LTx. The molecular events that lead to fibrosis following HCV infection still remains poorly defined. In this study, we determined microRNA (miRNA) and mRNA expression profiles in livers from chronic HCV patients and normals using microarrays. Using Genego software and pathway finder we performed an interactive analysis to identify target genes that are modulated by miRNAs. 22 miRNAs were up regulated (>2 fold) and 35 miRNAs were down regulated (>2fold) compared to controls. Liver from HCV patients demonstrated increased expression of 306 genes (>3 fold) and reduced expression of 133 genes (>3 fold). Combinatorial analysis of the networks modulated by the miRNAs identified regulation of the phospholipase C pathway (miR200c, miR20b, and miR31through cellular proto-oncogene tyrosine-protein kinase Src (cSrc)), response to growth factors and hormones (miR141, miR107 and miR200c through peroxisome proliferator-activated receptor alpha and extracellular-signal-regulated kinases, and regulation of cellular proliferation (miR20b, miR10b, and miR141 through cyclin-dependent kinase inhibitor 1 or CDK-interacting protein 1 p21). Real time PCR (RT-PCR) validation of the miRNA in HCV infected livers demonstrated a 3.3 +/- 0.9 fold increase in miR200c. In vitro transfection of fibroblasts with miR200c resulted in a 2.2 fold reduction in expression of tyrosine-protein phosphatase non-receptor type 13 or FAS associated phosphatase 1 (FAP-1) and 2.3 fold increase in expression of cSrc. miR200c transfection resulted in significant increases in expression of collagen and fibroblast growth factor (2.8 and 3.4 fold, p<0.05). Therefore, we propose that HCV induced increased expression of miR200c can down modulate the expression of FAP1, a critical regulator of Src and MAP kinase pathway that play an important role in the production of fibrogenic growth factors and development of fibrosis.	[Ramachandran, Sabarinathan; Basha, Haseeb Ilias; Sarma, Nayan J.; Lin, Yiing; Chapman, William C.; Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Crippin, Jeffrey S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mohanakumar, T (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	kumart@wustl.edu		Lin, Yiing/0000-0002-0317-7608; Ramachandran, Sabarinathan/0000-0003-2239-8083	National Insitutes of Health/National Institute of Diabetes and Digestive and Kidney [DK065982]; Barnes-Jewish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065982] Funding Source: NIH RePORTER	National Insitutes of Health/National Institute of Diabetes and Digestive and Kidney; Barnes-Jewish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Insitutes of Health/National Institute of Diabetes and Digestive and Kidney DK065982 and the Barnes-Jewish Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boivin-Angele S, 2000, J HEPATOL, V33, P290, DOI 10.1016/S0168-8278(00)80370-0; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Chinnadurai R, 2012, AM J TRANSPLANT, V12, P298, DOI 10.1111/j.1600-6143.2011.03812.x; Costantini S, 2010, EUR CYTOKINE NETW, V21, P251, DOI 10.1684/ecn.2010.0214; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang XX, 2007, LIVER INT, V27, P960, DOI 10.1111/j.1478-3231.2007.01542.x; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035; Luedde Tom, 2008, Hepatology, V47, P1089, DOI 10.1002/hep.22232; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Murillo MM, 2005, ONCOGENE, V24, P4580, DOI 10.1038/sj.onc.1208664; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Neuman MG, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/231210; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Peters L, 2010, CURR OPIN HIV AIDS, V5, P517, DOI 10.1097/COH.0b013e32833e3ee6; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Talaat RM, 2010, VIRAL IMMUNOL, V23, P151, DOI 10.1089/vim.2009.0089; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Watt K, 2009, AM J TRANSPLANT, V9, P1707, DOI 10.1111/j.1600-6143.2009.02702.x; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	38	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70744	10.1371/journal.pone.0070744	http://dx.doi.org/10.1371/journal.pone.0070744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950995	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300044
J	Rodriguez-Girones, MA; Trillo, A; Corcobado, G				Rodriguez-Girones, Miguel A.; Trillo, Alejandro; Corcobado, Guadalupe			Long Term Effects of Aversive Reinforcement on Colour Discrimination Learning in Free-Flying Bumblebees	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; CHROMATIC PROPERTIES; BOMBUS-TERRESTRIS; FORAGING SPEED; OPTIC LOBES; HONEYBEES; BEES; PSYCHOPHYSICS; INTERNEURONS; PERCEPTION	The results of behavioural experiments provide important information about the structure and information-processing abilities of the visual system. Nevertheless, if we want to infer from behavioural data how the visual system operates, it is important to know how different learning protocols affect performance and to devise protocols that minimise noise in the response of experimental subjects. The purpose of this work was to investigate how reinforcement schedule and individual variability affect the learning process in a colour discrimination task. Free-flying bumblebees were trained to discriminate between two perceptually similar colours. The target colour was associated with sucrose solution, and the distractor could be associated with water or quinine solution throughout the experiment, or with one substance during the first half of the experiment and the other during the second half. Both acquisition and final performance of the discrimination task (measured as proportion of correct choices) were determined by the choice of reinforcer during the first half of the experiment: regardless of whether bees were trained with water or quinine during the second half of the experiment, bees trained with quinine during the first half learned the task faster and performed better during the whole experiment. Our results confirm that the choice of stimuli used during training affects the rate at which colour discrimination tasks are acquired and show that early contact with a strongly aversive stimulus can be sufficient to maintain high levels of attention during several hours. On the other hand, bees which took more time to decide on which flower to alight were more likely to make correct choices than bees which made fast decisions. This result supports the existence of a trade-off between foraging speed and accuracy, and highlights the importance of measuring choice latencies during behavioural experiments focusing on cognitive abilities.	[Rodriguez-Girones, Miguel A.; Trillo, Alejandro; Corcobado, Guadalupe] CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Rodriguez-Girones, MA (corresponding author), CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain.	rgirones@eeza.csic.es	Rodriguez-Girones, Miguel A/H-1859-2015	Rodriguez-Girones, Miguel A/0000-0002-5619-9819; Trillo, Alejandro/0000-0002-6944-0923	Spanish Ministerio de Ciencia e Innovacion/FEDER [CGL2010-16795]	Spanish Ministerio de Ciencia e Innovacion/FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion/FEDER (project CGL2010-16795 to MARG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2012, P NATL ACAD SCI USA, V109, P7481, DOI 10.1073/pnas.1202576109; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; Ayestaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015000; BACKHAUS W, 1987, BIOL CYBERN, V56, P293, DOI 10.1007/BF00319510; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Brandt R, 1997, VISION RES, V37, P425, DOI 10.1016/S0042-6989(96)00195-2; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Chiappe D, 2005, J GEN PSYCHOL, V132, P5, DOI 10.3200/GENP.132.1.5-40; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2012, J EXP BIOL, V215, P387, DOI 10.1242/jeb.038190; Dyer AG, 2005, J COMP PHYSIOL A, V191, P547, DOI 10.1007/s00359-005-0622-z; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; HERTEL H, 1980, J COMP PHYSIOL, V137, P215, DOI 10.1007/BF00657117; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; KAISER W, 1974, J COMP PHYSIOL, V90, P405, DOI 10.1007/BF00694179; KIEN J, 1977, J COMP PHYSIOL, V113, P35, DOI 10.1007/BF00610452; Mazur JE, 2005, LEARNING BEHAV; Muller H, 2008, CURR BIOL, V18, pR961, DOI 10.1016/j.cub.2008.09.001; Muller H, 2012, ENTOMOL GEN, V34, P1; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; Reser DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048577; Rodriguez-Girones MA, 2001, Q J EXP PSYCHOL-A, V54, P527, DOI 10.1080/02724980042000264; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1	40	10	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71551	10.1371/journal.pone.0071551	http://dx.doi.org/10.1371/journal.pone.0071551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951186	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300126
J	Wei, BJ; Chen, YJ; Yu, L; Wu, B				Wei, Ben-Juan; Chen, Yi-Jun; Yu, Li; Wu, Bin			Periodontal Disease and Risk of Preeclampsia: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							MATERNAL PERIODONTITIS; ORAL-HEALTH; PREGNANCY; ASSOCIATION; WOMEN	Background: Many epidemiological studies have found a positive association between periodontal disease (PD) and the risk of preeclampsia, but the magnitude of this association varies and independent studies have reported conflicting findings. We performed a meta-analysis to ascertain the relationship between PD and preeclampsia. Methods: The PubMed database was searched up to January 12, 2013, for relevant observational studies on an association between PD and the risk of preeclampsia. Data were extracted and analyzed independently by two authors. The meta-analysis was performed using comprehensive meta-analysis software. Results: Thirteen observational case-control studies and two cohort studies, involving 1089 preeclampsia patients, were identified. Based on a random-effects meta-analysis, a significant association between PD and preeclampsia was identified (odds ratio = 2.79, 95% confidence interval CI, 2.01-3.01, P<0.0001). Conclusions: Although the causality remains unclear, the association between PD and preeclampsia may reflect the induction of PD by the preeclamptic state, or it may be part of an overall exaggerated inflammatory response to pregnancy. Larger randomized controlled trials with preeclampsia as the primary outcome and pathophysiological studies are required to explore causality and to dissect the biological mechanisms involved.	[Wei, Ben-Juan; Chen, Yi-Jun; Yu, Li] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Stomatol, Shanghai 200030, Peoples R China; [Wu, Bin] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, B (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Pharm, Shanghai 200030, Peoples R China.	wbwithtg@hotmail.com			School of Medicine, Shanghai Jiaotong University [12XJ10053]	School of Medicine, Shanghai Jiaotong University	This work was supported by a grant from the School of Medicine, Shanghai Jiaotong University (NO. 12XJ10053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Canakci V, 2004, AUST NZ J OBSTET GYN, V44, P568, DOI 10.1111/j.1479-828X.2004.00323.x; Canakci V, 2007, J CLIN PERIODONTOL, V34, P639, DOI 10.1111/j.1600-051X.2007.01105.x; Castaldi JL, 2006, REV PANAM SALUD PUBL, V19, P253, DOI 10.1590/S1020-49892006000400005; Contreras A, 2006, J PERIODONTOL, V77, P182, DOI 10.1902/jop.2006.050020; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; da Silva GM, 2012, J PERIODONTOL, V83, P1388, DOI 10.1902/jop.2012.110256; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ha JE, 2011, J PERIODONTOL, V82, P1685, DOI 10.1902/jop.2011.110035; Herrera JA, 2007, J HYPERTENS, V25, P1459, DOI 10.1097/HJH.0b013e3281139ea9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kunnen A, 2007, J CLIN PERIODONTOL, V34, P202, DOI 10.1111/j.1600-051X.2006.01036.x; Lohsoonthorn V, 2009, AM J HYPERTENS, V22, P457, DOI 10.1038/ajh.2008.365; Lopez-Jaramillo P, 2011, J HYPERTENS, V29, P1020, DOI 10.1097/HJH.0b013e328344b6e8; Megson E, 2010, INT J EVID-BASED HEA, V8, P129, DOI 10.1111/j.1744-1609.2010.00171.x; Meurman JH, 2006, CLIN ORAL INVEST, V10, P96, DOI 10.1007/s00784-006-0037-4; Cota LOM, 2006, J PERIODONTOL, V77, P2063, DOI 10.1902/jop.2006.060061; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Politano GT, 2011, J PERIODONTAL RES, V46, P505, DOI 10.1111/j.1600-0765.2011.01368.x; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Sargent IL, 2006, REPROD BIOMED ONLINE, V13, P680, DOI 10.1016/S1472-6483(10)60659-1; Sayar F, 2011, IRAN J PUBLIC HEALTH, V40, P122; Shetty M, 2010, ACTA OBSTET GYN SCAN, V89, P718, DOI 10.3109/00016341003623738; Siqueira FM, 2008, J PERIODONTOL, V79, P207, DOI [10.1902/jop.2008.070174, 10.1902/jop.2008.070174 ]; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; Taghzouti N, 2012, J PERIODONTOL, V83, P871, DOI 10.1902/jop.2011.110342; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Xiong X, 2007, OBSTET GYNECOL SURV, V62, P605, DOI 10.1097/01.ogx.0000279292.63435.40	37	27	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70901	10.1371/journal.pone.0070901	http://dx.doi.org/10.1371/journal.pone.0070901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951033	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300065
J	Zhao, Y; Chen, ZX; Rewuti, A; Ma, YS; Wang, XF; Xia, Q; Fu, D; Han, YS				Zhao, Yuan; Chen, Zi-Xian; Rewuti, Abudouaini; Ma, Yu-Shui; Wang, Xiao-Feng; Xia, Qing; Fu, Da; Han, Yu-Song			Quantitative Assessment of the Influence of Cytochrome P450 1A2 Gene Polymorphism and Colorectal Cancer Risk	PLOS ONE			English	Article							CYP1A2 GENE; HETEROCYCLIC AMINES; CIGARETTE-SMOKING; MEAT CONSUMPTION; RED MEAT; CHEMICAL CARCINOGENESIS; FUNCTIONAL-SIGNIFICANCE; CLOZAPINE CLEARANCE; 5'-FLANKING REGION; METAANALYSIS	Cytochrome P450 1A2 (CYP1A2) encodes a member of the cytochrome P450 superfamily of enzymes, which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of colorectal cancer (CRC). The CYP1A2*C (rs2069514) and CYP1A2*F (rs762551) polymorphism are two of the most commonly studied polymorphisms of the gene for their association with risk of CRC, but the results are conflicting. To derive a more precise estimation of the relationship between CYP1A2 and genetic risk of CRC, we performed a comprehensive meta-analysis which included 7088 cases and 7568 controls from 12 published case-control studies. In a combined analysis, the summary per-allele odds ratio for CRC was 0.91 (95% CI: 0.83-1.00, P = 0.04), and 0.91 (95% CI: 0.68-1.22, P = 0.53), for CYP1A2*F and *C allele, respectively. In the subgroup analysis by ethnicity, significant associations were found in Asians for CYP1A2*F and CYP1A2*C, while no significant associations were detected among Caucasian populations. Similar results were also observed using dominant genetic model. Potential sources of heterogeneity were explored by subgroup analysis and meta-regression. No significant heterogeneity was detected in most of comparisons. This meta-analysis suggests that the CYP1A2*F and *C polymorphism is a protective factor against CRC among Asians.	[Zhao, Yuan; Fu, Da] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Chen, Zi-Xian; Rewuti, Abudouaini; Ma, Yu-Shui; Wang, Xiao-Feng; Xia, Qing; Fu, Da] Fudan Univ, Zhongshan Hosp, Dept Orthoped Surg, Shanghai 200433, Peoples R China; [Han, Yu-Song] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Fu, D (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	superdafu@hotmail.com; han_yusong001@163.com	Fu, Da/GXF-2656-2022; ma, yushui/HGC-6206-2022		National Natural Science Foundation of China [81201535]; Shanghai Natural Science Foundation [12ZR1436000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by National Natural Science Foundation of China (81201535), and Shanghai Natural Science Foundation (12ZR1436000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison KJ, 2000, PHARMACOGENETICS, V10, P695, DOI 10.1097/00008571-200011000-00004; Almendingen K, 2000, EUR J CANCER PREV, V9, P193, DOI 10.1097/00008469-200006000-00008; Bae SY, 2006, CANCER SCI, V97, P774, DOI 10.1111/j.1349-7006.2006.00241.x; Bond J H, 2000, Semin Gastrointest Dis, V11, P176; BOOBIS AR, 1994, CANCER RES, V54, P89; Butler LM, 2003, AM J EPIDEMIOL, V157, P434, DOI 10.1093/aje/kwf221; Chen Kun, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P659; Chen XP, 2005, CLIN PHARMACOL THER, V78, P249, DOI 10.1016/j.clpt.2005.05.012; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EATON DL, 1995, PHARMACOGENETICS, V5, P259, DOI 10.1097/00008571-199510000-00001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Heavey PM, 2004, NUTR CANCER, V48, P124, DOI 10.1207/s15327914nc4802_2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Kootstra-Ros JE, 2005, ANN CLIN BIOCHEM, V42, P216, DOI 10.1258/0004563053857798; KUNE GA, 1992, INT J CANCER, V50, P369, DOI 10.1002/ijc.2910500307; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MacLeod S, 1997, MUTAT RES-FUND MOL M, V376, P135, DOI 10.1016/S0027-5107(97)00036-5; MANABE S, 1991, CARCINOGENESIS, V12, P1945, DOI 10.1093/carcin/12.10.1945; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moonen HJJ, 2004, FOOD CHEM TOXICOL, V42, P869, DOI 10.1016/j.fct.2004.01.010; Morgan TM, 2003, CLIN GENET, V64, P7, DOI 10.1034/j.1399-0004.2003.00088.x; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Nordmark A, 2002, BRIT J CLIN PHARMACO, V54, P504, DOI 10.1046/j.1365-2125.2002.01673.x; Pavanello S, 2005, MUTAT RES-GEN TOX EN, V587, P59, DOI 10.1016/j.mrgentox.2005.08.008; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sachse C, 2003, BRIT J CLIN PHARMACO, V55, P68, DOI 10.1046/j.1365-2125.2003.01733.x; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Saebo M, 2008, ANTICANCER RES, V28, P2289; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; SUGIMURA T, 1985, MUTAT RES, V150, P33, DOI 10.1016/0027-5107(85)90098-3; Takata K, 2006, EUR J CLIN PHARMACOL, V62, P23, DOI 10.1007/s00228-005-0057-z; van der Weide J, 2003, PHARMACOGENETICS, V13, P169, DOI 10.1097/00008571-200303000-00006; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang HS, 2011, CARCINOGENESIS, V32, P203, DOI 10.1093/carcin/bgq237; Wang HG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-528; Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yeh CC, 2009, DIS COLON RECTUM, V52, P104, DOI 10.1007/DCR.0b013e31819734d7; Yoshida K, 2007, ASIAN PAC J CANCER P, V8, P438	49	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71481	10.1371/journal.pone.0071481	http://dx.doi.org/10.1371/journal.pone.0071481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951174	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300121
J	Arora, T; Broglia, E; Pushpakumar, D; Lodhi, T; Taheri, S				Arora, Teresa; Broglia, Emma; Pushpakumar, Dunstan; Lodhi, Taha; Taheri, Shahrad			An Investigation into the Strength of the Association and Agreement Levels between Subjective and Objective Sleep Duration in Adolescents	PLOS ONE			English	Article							OVERWEIGHT; PATTERNS; OBESITY; DIARY	Study Objectives: The majority of adolescent sleep research has utilized self-reported sleep duration and some have based information on a solitary question. Whilst some have claimed to have validated sleep survey data with objective actigraphy measures in adolescents, the statistical approach applied only demonstrates the strength of the association between subjective and objective sleep duration data and does not reflect if these different methods actually agree. Methods: Data were collected as part of the Midlands Adolescents Schools Sleep Education Study (MASSES). Adolescents (n=225) aged 11-13 years provided estimates for weekday, weekend and combined sleep duration based on self-reported survey data, a 7-day sleep diary, and wrist-worn actigraphy. Results: We assessed the strength of the relationship as well as agreement levels between subjective and objectively determined sleep duration (weekday, weekend and combined). Subjective diary sleep duration was significantly correlated with actigraphy estimates for weekday and weekend sleep duration r=0.30, p <= 0.001 and r=0.31, p <= 0.001 respectively. Pitman's test demonstrated no significant difference in the variance between weekend sleep duration (r=0.09, p=0.16) and combined sleep duration (r=0.12, p=0.08) indicating acceptable agreement between actigraphy and sleep diary sleep duration only. Self-reported sleep duration estimates (weekday, weekend and combined) did not agree with actigraphy determined sleep duration. Conclusions: Sleep diaries are a cost-effective alternative to survey/questionnaire data. Self-reported measures of sleep duration in adolescents do not agree with actigraphy measures and should be avoided where possible. Previous adolescent sleep studies that have utilized self-reported survey data may not provide a complete representation of sleep on the outcome measure of interest.	[Arora, Teresa; Taheri, Shahrad] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Arora, Teresa; Broglia, Emma; Taheri, Shahrad] Univ Birmingham, Birmingham & Black Country Natl Inst Hlth Res Col, Birmingham, W Midlands, England; [Broglia, Emma; Pushpakumar, Dunstan; Taheri, Shahrad] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Lodhi, Taha] Univ Manchester, Sch Med, Manchester, Lancs, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Manchester	Taheri, S (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	staheri@me.com	Taheri, Shahrad/O-9721-2016; Broglia, Emma/T-7359-2019	Taheri, Shahrad/0000-0001-8314-1500; Broglia, Emma/0000-0003-2137-8187; Arora, Teresa/0000-0001-8360-7358	children's charity Action Medical Research; National Institute for Health Research (NIHR)	children's charity Action Medical Research; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	Dr. Arora is funded by the children's charity Action Medical Research. Dr. Taheri received funding from the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Arora T, 2012, OBESITY, V20, P1122; Arora T, 2013, INT J OBES LOND; Calamaro CJ, 2010, J SLEEP RES, V19, P559, DOI 10.1111/j.1365-2869.2010.00840.x; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Foundation NS, 2006, TEENS SLEEP SLEEP AM; Gupta NK, 2002, AM J HUM BIOL, V14, P762, DOI 10.1002/ajhb.10093; Kim SJ, 2011, ARCH PEDIAT ADOL MED, V165, P806, DOI 10.1001/archpediatrics.2011.128; Knutson KL, 2005, J PEDIATR-US, V147, P830, DOI 10.1016/j.jpeds.2005.07.019; Knutson KL, 2007, PEDIATRICS, V119, pE1056, DOI 10.1542/peds.2006-2597; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Mori K, 2011, WORLD SLEEP M 2011 J; Pasch KE, 2010, AM J HEALTH BEHAV, V34, P237; Seicean A, 2007, SLEEP BREATH, V11, P285, DOI 10.1007/s11325-007-0108-z; Short MA, 2012, SLEEP MED, V13, P378, DOI 10.1016/j.sleep.2011.11.005; Sun YC, 2009, J EPIDEMIOL, V19, P303, DOI 10.2188/jea.JE20080095; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	24	99	99	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72406	10.1371/journal.pone.0072406	http://dx.doi.org/10.1371/journal.pone.0072406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951321	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200082
J	Fernandez-Perianez, R; Molina-Privado, I; Rojo, F; Guijarro-Munoz, I; Alonso-Camino, V; Zazo, S; Compte, M; Alvarez-Cienfuegos, A; Cuesta, AM; Sanchez-Martin, D; Alvarez-Mendez, AM; Sanz, L; Alvarez-Vallina, L				Fernandez-Perianez, Rodrigo; Molina-Privado, Irene; Rojo, Federico; Guijarro-Munoz, Irene; Alonso-Camino, Vanesa; Zazo, Sandra; Compte, Marta; Alvarez-Cienfuegos, Ana; Cuesta, Angel M.; Sanchez-Martin, David; Alvarez-Mendez, Ana M.; Sanz, Laura; Alvarez-Vallina, Luis			Basement Membrane-Rich Organoids with Functional Human Blood Vessels Are Permissive Niches for Human Breast Cancer Metastasis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VIVO; PROGENITOR CELLS; VASCULAR NETWORKS; LUNG METASTASIS; MOUSE MODELS; GROWTH; BONE; PROGRESSION; XENOGRAFTS	Metastasic breast cancer is the leading cause of death by malignancy in women worldwide. Tumor metastasis is a multistep process encompassing local invasion of cancer cells at primary tumor site, intravasation into the blood vessel, survival in systemic circulation, and extravasation across the endothelium to metastasize at a secondary site. However, only a small percentage of circulating cancer cells initiate metastatic colonies. This fact, together with the inaccessibility and structural complexity of target tissues has hampered the study of the later steps in cancer metastasis. In addition, most data are derived from in vivo models where critical steps such as intravasation/extravasation of human cancer cells are mediated by murine endothelial cells. Here, we developed a new mouse model to study the molecular and cellular mechanisms underlying late steps of the metastatic cascade. We have shown that a network of functional human blood vessels can be formed by co-implantation of human endothelial cells and mesenchymal cells, embedded within a reconstituted basement membrane-like matrix and inoculated subcutaneously into immunodeficient mice. The ability of circulating cancer cells to colonize these human vascularized organoids was next assessed in an orthotopic model of human breast cancer by bioluminescent imaging, molecular techniques and immunohistological analysis. We demonstrate that disseminated human breast cancer cells efficiently colonize organoids containing a functional microvessel network composed of human endothelial cells, connected to the mouse circulatory system. Human breast cancer cells could be clearly detected at different stages of the metastatic process: initial arrest in the human microvasculature, extravasation, and growth into avascular micrometastases. This new mouse model may help us to map the extravasation process with unprecedented detail, opening the way for the identification of relevant targets for therapeutic intervention.	[Fernandez-Perianez, Rodrigo; Molina-Privado, Irene; Guijarro-Munoz, Irene; Alonso-Camino, Vanesa; Compte, Marta; Alvarez-Cienfuegos, Ana; Cuesta, Angel M.; Sanchez-Martin, David; Sanz, Laura; Alvarez-Vallina, Luis] Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain; [Rojo, Federico; Zazo, Sandra] IIS Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Alvarez-Mendez, Ana M.] Univ Complutense Madrid, FEBIO Res Grp, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Fundacion Jimenez Diaz; Complutense University of Madrid	Alvarez-Vallina, L (corresponding author), Hosp Univ Puerta de Hierro, Mol Immunol Unit, Madrid, Spain.	lalvarezv.hpth@salud.madrid.org	Sánchez-Martín, David/C-9927-2013; Sanz, Laura/F-8542-2010; Alvarez-Vallina, Luis/ABD-2431-2020; Cuesta, Angel/F-1668-2011; AM, Cuesta/AAA-9356-2020; Rojo, Federico/S-6551-2016	Sánchez-Martín, David/0000-0002-2712-4762; Sanz, Laura/0000-0002-3119-3218; Alvarez-Vallina, Luis/0000-0003-3053-6757; Cuesta, Angel/0000-0002-6596-9600; AM, Cuesta/0000-0002-6596-9600; Compte Grau, Marta/0000-0002-7138-9266; Rojo, Federico/0000-0001-9989-0290	Ministerio de Ciencia e Innovacion [BIO2008-03233]; Ministerio de Economia y Competitividad [BIO2011-22738, BES-2009-027649]; Comunidad de Madrid [S2010/BMD-2312]; European Union [IMMUNONETSOE1/P1/E014]; Fondo de Investigacion Sanitaria [PS09/00227, PS09/01296, RD09/0076/00101, RD06/0020/0109]; Fundacion Mutua Madrileia [AP86442011]; Gobierno Vasco [BFI07.132]; Fundacion Investigacion Biomedica Hospital Universitario Puerta de Hierro; Comunidad de Madrid/Fondo Social Europeo Training Grant [FPI-000531]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Mutua Madrileia; Gobierno Vasco(Basque Government); Fundacion Investigacion Biomedica Hospital Universitario Puerta de Hierro; Comunidad de Madrid/Fondo Social Europeo Training Grant(Comunidad de Madrid)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (BIO2008-03233), Ministerio de Economia y Competitividad (BIO2011-22738), the Comunidad de Madrid (S2010/BMD-2312) and the European Union [SUDOE-FEDER (IMMUNONETSOE1/P1/E014)] to LAV; by grant PS09/00227 from the Fondo de Investigacion Sanitaria to L. S; by grants PS09/01296, RD09/0076/00101 and RD06/0020/0109 from the Fondo de Investigacion Sanitaria to FR and by grant AP86442011 from Fundacion Mutua Madrileia to FR. RFP was supported by a predoctoral fellowship from the Ministerio de Economia y Competitividad (BES-2009-027649), VAC by a predoctoral fellowship from the Gobierno Vasco (BFI07.132), PSV by a predoctoral fellowship from the Fundacion Investigacion Biomedica Hospital Universitario Puerta de Hierro, and DSM by a Comunidad de Madrid/Fondo Social Europeo Training Grant (FPI-000531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Alonso-Camino V, 2011, MICROVASC RES, V81, P18, DOI 10.1016/j.mvr.2010.10.002; Arnaoutova I, 2012, STEM CELL REV REP, V8, P163, DOI 10.1007/s12015-011-9278-y; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Compte M, 2007, CANCER GENE THER, V14, P380, DOI 10.1038/sj.cgt.7701021; Compte M, 2010, GENE THER, V17, P745, DOI 10.1038/gt.2010.33; DeLisser H, 2010, P NATL ACAD SCI USA, V107, P18616, DOI 10.1073/pnas.1004654107; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hughes CS, 2011, PROTEOMICS, V11, P675, DOI 10.1002/pmic.201000407; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mantovani A, 2008, ADV EXP MED BIOL, V610, P112; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oskarsson T, 2012, EMBO J, V31, P254, DOI 10.1038/emboj.2011.469; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sanz L, 2008, MICROVASC RES, V75, P308, DOI 10.1016/j.mvr.2007.11.007; Sanz L, 2009, LAB INVEST, V89, P91, DOI 10.1038/labinvest.2008.108; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Whittaker David R, 2006, Vasc Endovascular Surg, V40, P85, DOI 10.1177/153857440604000201	39	13	13	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72957	10.1371/journal.pone.0072957	http://dx.doi.org/10.1371/journal.pone.0072957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951338	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000092
J	Gryganskyi, AP; Humber, RA; Stajich, JE; Mullens, B; Anishchenko, IM; Vilgalys, R				Gryganskyi, Andrii P.; Humber, Richard A.; Stajich, Jason E.; Mullens, Bradley; Anishchenko, Iryna M.; Vilgalys, Rytas			Sequential Utilization of Hosts from Different Fly Families by Genetically Distinct, Sympatric Populations within the Entomophthora muscae Species Complex	PLOS ONE			English	Article							GENUS ENTOMOPHTHORA; FUNGAL PATHOGEN; DELIA-ANTIQUA; DIPTERA; PRIMERS; TEMPERATURE; SPECIFICITY; INFERENCE; COHN; PCR	The fungus Entomophthora muscae (Entomophthoromycota, Entomophthorales, Entomophthoraceae) is a widespread insect pathogen responsible for fatal epizootic events in many dipteran fly hosts. During epizootics in 2011 and 2012 in Durham, North Carolina, we observed a transition of fungal infections from one host, the plant-feeding fly Delia radicum, to a second host, the predatory fly Coenosia tigrina. Infections first appeared on Delia in the middle of March, but by the end of May, Coenosia comprised 100% of infected hosts. Multilocus sequence typing revealed that E. muscae in Durham comprises two distinct subpopulations (clades) with several haplotypes in each. Fungi from either clade are able to infect both fly species, but vary in their infection phenologies and host-specificities. Individuals of the more phylogenetically diverse clade I predominated during the beginning of the spring epizootic, infecting mostly phytophagous Delia flies. Clade II dominated in late April and May and affected mostly predatory Coenosia flies. Analysis of population structure revealed two subpopulations within E. muscae with limited gene exchange. This study provides the first evidence of recombination and population structure within the E. muscae species complex, and illustrates the complexity of insect-fungus relationships that should be considered for development of biological control methods.	[Gryganskyi, Andrii P.; Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Humber, Richard A.] USDA ARS BioIPM Res, RW Holley Ctr Agr & Hlth, Ithaca, NY USA; [Stajich, Jason E.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Mullens, Bradley] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Anishchenko, Iryna M.] Natl Acad Sci Ukraine, M Kholodny Inst Bot, Kiev, Ukraine	Duke University; University of California System; University of California Riverside; University of California System; University of California Riverside; National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine	Gryganskyi, AP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	apg10@duke.edu	M., Anishchenko Iryna/AAC-2366-2020; Stajich, Jason Eric/C-7297-2008	Stajich, Jason Eric/0000-0002-7591-0020; Gryganskyi, Andrii/0000-0002-6037-0092; Vilgalys, Rytas/0000-0001-8299-3605	AFToL-2 (National Science Foundation) [0228668]	AFToL-2 (National Science Foundation)	The authors are very thankful to AFToL-2 (National Science Foundation grant 0228668; aftol.org) for partial financing of the project, namely processing and analysis of the data. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript besides the above mentioned AFToL grant.	Balazy S, 1993, ENTOMOPHTHORALES; BELLINI R, 1992, ENTOMOPHAGA, V37, P11, DOI 10.1007/BF02372969; BROBYN PJ, 1983, T BRIT MYCOL SOC, V80, P1, DOI 10.1016/S0007-1536(83)80157-0; CARRUTHERS RI, 1985, J INVERTEBR PATHOL, V45, P81, DOI 10.1016/0022-2011(85)90053-9; CARRUTHERS RI, 1986, ENVIRON ENTOMOL, V15, P1154, DOI 10.1093/ee/15.6.1154; Collier R.H., 1988, P27; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gilioli G, 2005, J ECON ENTOMOL, V98, P1524, DOI 10.1603/0022-0493-98.5.1524; Gryganskyi AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015273; Hajek AE, 1999, MICROBIOL MOL BIOL R, V63, P814, DOI 10.1128/MMBR.63.4.814-835.1999; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HUMBER RA, 1989, MYCOTAXON, V34, P441; Humber RA, 2012, MYCOTAXON, V120, P477, DOI 10.5248/120.477; Jensen AB, 2001, J INVERTEBR PATHOL, V78, P251, DOI 10.1006/jipa.2002.5079; Jensen AB, 2001, MYCOL RES, V105, P307, DOI 10.1017/S0953756201003434; Jensen AB, 2006, MYCOL RES, V110, P941, DOI 10.1016/j.mycres.2006.06.003; Jensen AB, 2009, FEMS MICROBIOL LETT, V300, P180, DOI 10.1111/j.1574-6968.2009.01778.x; Keller S, 2002, SYDOWIA, V54, P157; Keller S, 1999, SYDOWIA, V51, P197; Keller S, 1984, SYDOWIA, V40, P122; Keller S, 1987, MITTEILUNGEN SCHWEIZ, V57, P131; Koval E.Z., 2007, ZYGOMYCETES ENTOMOPH; Lutzoni FM, 2005, F LUTZONIS LAB; MACLEOD DM, 1976, MYCOLOGIA, V68, P1, DOI 10.2307/3758894; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; McAlpine JF., 1987, MANUAL NEARCTIC DIPT; McGary MJ, 2001, BULBS N AM N AM ROCK, P28; Molitoris P.H., 1996, P COLLECTION SCI ART, P316; MULLENS BA, 1987, HILGARDIA, V55, P1; MULLENS BA, 1989, J INVERTEBR PATHOL, V53, P272, DOI 10.1016/0022-2011(89)90018-9; Papierok Bernard, 1997, P187, DOI 10.1016/B978-012432555-5/50012-9; Pritchard JK, 2000, GENETICS, V155, P945; Sabouraud R., 1896, TRICHOPHYTIES HUMAIN, P49; Shewell G.W., 1981, MANUAL NEARCTIC DIPT; SPATAFORA J, 2003, ASSEMBLING FUNGAL TR; STEINKRAUS DC, 1988, MYCOTAXON, V32, P105; STEINKRAUS DC, 1987, MYCOPATHOLOGIA, V100, P55, DOI 10.1007/BF00769569; Thomsen L, 2000, J INVERTEBR PATHOL, V76, P127, DOI 10.1006/jipa.2000.4961; TU CM, 1988, AGR ECOSYST ENVIRON, V20, P143, DOI 10.1016/0167-8809(88)90154-5; Valentini M, 2009, NUOVE TECNICHE ALLEV; WATERHOUSE G M, 1982, Bulletin of the British Mycological Society, V16, P113; Waterhouse GM., 1973, FUNGI ADV TREATISE B, VIVB, P219; Weather Underground I, 2012, HIST RAL DURH AIRP	47	8	8	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71168	10.1371/journal.pone.0071168	http://dx.doi.org/10.1371/journal.pone.0071168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951101	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000041
J	Chin, K; Pearson, D; Ekdale, AA				Chin, Karen; Pearson, Dean; Ekdale, A. A.			Fossil Worm Burrows Reveal Very Early Terrestrial Animal Activity and Shed Light on Trophic Resources after the End-Cretaceous Mass Extinction	PLOS ONE			English	Article							TERTIARY BOUNDARY; APORRECTODEA-NOCTURNA; PALEOGENE; IMPACT; EVENT; BASIN; PLANT; ICHNOFOSSILS; DISRUPTION; PALEOSOLS	The widespread mass extinctions at the end of the Cretaceous caused world-wide disruption of ecosystems, and faunal responses to the one-two punch of severe environmental perturbation and ecosystem collapse are still unclear. Here we report the discovery of in situ terrestrial fossil burrows from just above the impact-defined Cretaceous-Paleogene (K/Pg) boundary in southwestern North Dakota. The crisscrossing networks of horizontal burrows occur at the interface of a lignitic coal and silty sandstone, and reveal intense faunal activity within centimeters of the boundary clay. Estimated rates of sedimentation and coal formation suggest that the burrows were made less than ten thousand years after the end-Cretaceous impact. The burrow characteristics are most consistent with burrows of extant earthworms. Moreover, the burrowing and detritivorous habits of these annelids fit models that predict the trophic and sheltering lifestyles of terrestrial animals that survived the K/Pg extinction event. In turn, such detritus-eaters would have played a critical role in supporting secondary consumers. Thus, some of the carnivorous vertebrates that radiated after the K/Pg extinction may owe their evolutionary success to thriving populations of earthworms.	[Chin, Karen] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Chin, Karen] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Pearson, Dean] Pioneer Trails Reg Museum, Dept Paleontol, Bowman, ND USA; [Ekdale, A. A.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Utah System of Higher Education; University of Utah	Chin, K (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	Karen.Chin@colorado.edu	Chin, Karen/AAD-8555-2019	Chin, Karen/0000-0003-4925-248X				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Ausden M, 2001, J APPL ECOL, V38, P320, DOI 10.1046/j.1365-2664.2001.00600.x; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Barclay R. S., 2003, ROCKY MT GEOL, V38, P45, DOI DOI 10.2113/GSR0CKY.38.1.45; Bedatou E, 2009, SEDIMENT GEOL, V218, P74, DOI 10.1016/j.sedgeo.2009.04.005; Bercovici A, 2009, CRETACEOUS RES, V30, P632, DOI 10.1016/j.cretres.2008.12.007; BOHOR BF, 1984, SCIENCE, V224, P867, DOI 10.1126/science.224.4651.867; BOWN TM, 1983, PALAEOGEOGR PALAEOCL, V43, P95, DOI 10.1016/0031-0182(83)90050-0; Capowiez Y, 2000, BIOL FERT SOILS, V30, P341, DOI 10.1007/s003740050013; Capowiez Y, 2001, APPL SOIL ECOL, V16, P109, DOI 10.1016/S0929-1393(00)00110-4; Craft B.C., 2001, WETLAND SOILS GENESI, P107; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Darwin C, 1881, DARWIN HUMUS EARTHWO; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; EKDALE AA, 1984, J SEDIMENT PETROL, V54, P681; Hazen B. M., 1937, Journal of Paleontology Menasha, V11, P250; Hembree DI, 2007, PALAIOS, V22, P123, DOI 10.2110/palo.2005.p05-119r; Hicks J. F., 2003, ROCKY MOUNTAIN GEOLO, V38, P1, DOI DOI 10.2113/GSR0CKY.38.1.1; Hildebrand AR, 1988, LUNAR PLANETARY I CO, V673, P78; Rodriguez-Tovar FJ, 2008, GEOBIOS-LYON, V41, P661, DOI 10.1016/j.geobios.2008.01.003; Jegou D, 1998, BIOL FERT SOILS, V26, P116; Johnson KR, 2002, GEOL S AM S, P329; JOHNSON KR, 1990, GEOLOGICAL SOC AM SP, V247, P433, DOI DOI 10.1130/SPE247-P433; Keighley Dave G., 1995, Ichnos, V3, P301; Kretzschmar Andre, 2004, P201; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; McCabe PJ., 1984, SEDIMENTOLOGY COAL C, P13; Mcilroy D, 2003, J GEOL SOC LONDON, V160, P489, DOI 10.1144/0016-764902-141; McIver EE, 1999, CAN J EARTH SCI, V36, P775, DOI 10.1139/e97-112; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Molina E, 2006, EPISODES, V29, P263, DOI 10.18814/epiiugs/2006/v29i4/004; MORRIS SC, 1982, CAN J EARTH SCI, V19, P2150, DOI 10.1139/e82-189; Needham SJ, 2004, BIOGEOSCIENCES, V1, P113, DOI 10.5194/bg-1-113-2004; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; Nichols DJ, 2002, GEOL S AM S, P95; NICHOLS DJ, 1992, CRETACEOUS RES, V13, P3, DOI 10.1016/0195-6671(92)90026-M; NICHOLS DJ, 2000, GEOLOGICAL SOC AM AB, V32, P130; Novo M, 2011, MOL PHYLOGENET EVOL, V61, P125, DOI 10.1016/j.ympev.2011.05.018; Peppe DJ, 2009, GEOL SOC AM BULL, V121, P65, DOI 10.1130/B26353.1; Retallack GJ, 1976, J GEOL SOC AUSTR, V23, P383, DOI DOI 10.1080/00167617608728953; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Rodriguez-Tovar FJ, 2005, GEOLOGY, V33, P585, DOI 10.1130/G21527.1; RYER TA, 1980, J SEDIMENT PETROL, V50, P987; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sheehan Peter M., 1996, Geological Society of America Special Paper, V307, P477; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; SWEET AR, 1992, CRETACEOUS RES, V13, P31, DOI 10.1016/0195-6671(92)90027-N; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; Vajda V, 2007, REV PALAEOBOT PALYNO, V144, P99, DOI 10.1016/j.revpalbo.2005.09.007; Verde M, 2007, PALAEOGEOGR PALAEOCL, V243, P339, DOI 10.1016/j.palaeo.2006.08.005; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569	53	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70920	10.1371/journal.pone.0070920	http://dx.doi.org/10.1371/journal.pone.0070920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951041	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700063
J	Kakumoto, T; Nakata, T				Kakumoto, Toshiyuki; Nakata, Takao			Optogenetic Control of PIP3: PIP3 Is Sufficient to Induce the Actin-Based Active Part of Growth Cones and Is Regulated via Endocytosis	PLOS ONE			English	Article							NEURONAL POLARITY; MEDIATED ENDOCYTOSIS; HIPPOCAMPAL AXONS; KINESIN-1 MOTOR; POLARIZATION; MICROTUBULES; PROTEINS; PI3K; ORGANIZATION; ACTIVATION	Phosphatidylinositol-3,4,5-trisphosphate (PIP3) is highly regulated in a spatiotemporal manner and plays multiple roles in individual cells. However, the local dynamics and primary functions of PIP3 in developing neurons remain unclear because of a lack of techniques for manipulating PIP3 spatiotemporally. We addressed this issue by combining optogenetic control and observation of endogenous PIP3 signaling. Endogenous PIP3 was abundant in actin-rich structures such as growth cones and "waves", and PIP3-rich plasma membranes moved actively within growth cones. To study the role of PIP3 in developing neurons, we developed a PI3K photoswitch that can induce production of PIP3 at specific locations upon blue light exposure. We succeeded in producing PIP3 locally in mouse hippocampal neurons. Local PIP3 elevation at neurite tips did not induce neurite elongation, but it was sufficient to induce the formation of filopodia and lamellipodia. Interestingly, ectopic PIP3 elevation alone activated membranes to form actin-based structures whose behavior was similar to that of growth-cone-like "waves". We also found that endocytosis regulates effective PIP3 concentration at plasma membranes. These results revealed the local dynamics and primary functions of PIP3, providing fundamental information about PIP3 signaling in neurons.	[Kakumoto, Toshiyuki; Nakata, Takao] Tokyo Med & Dent Univ, Dept Cell Biol, Tokyo, Japan; [Kakumoto, Toshiyuki; Nakata, Takao] Tokyo Med & Dent Univ, CBIR, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nakata, T (corresponding author), Tokyo Med & Dent Univ, Dept Cell Biol, Tokyo, Japan.	nakata.cbio@tmd.ac.jp		Kakumoto, Toshiyuki/0000-0002-1147-9454; Nakata, Takao/0000-0002-0629-0518	Japan Society for the Promotion of Science Fellowship for Young Scientists; Research Foundation for Opto-Science and Technology; Yamada Science Foundation; Uehara Memorial Foundation; Brain Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293042]; Grants-in-Aid for Scientific Research [25293042] Funding Source: KAKEN	Japan Society for the Promotion of Science Fellowship for Young Scientists; Research Foundation for Opto-Science and Technology; Yamada Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Brain Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	T.K. is supported by a Japan Society for the Promotion of Science Fellowship for Young Scientists. This work was supported by a grant from the Research Foundation for Opto-Science and Technology to T.N., a grant from the Yamada Science Foundation to T.N., a grant from The Uehara Memorial Foundation to T.N., a grant from the Brain Science Foundation to T.N., and the Ministry of Education, Culture, Sports, Science and Technology, Japan under a Grant in Aid for Scientific Research B (No. 25293042) to T.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CUPERS P, 1994, J CELL BIOL, V127, P725, DOI 10.1083/jcb.127.3.725; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Fields IC, 2010, MOL BIOL CELL; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Ruthel G, 1998, CELL MOTIL CYTOSKEL, V40, P160, DOI 10.1002/(SICI)1097-0169(1998)40:2<160::AID-CM5>3.0.CO;2-J; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	51	57	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70861	10.1371/journal.pone.0070861	http://dx.doi.org/10.1371/journal.pone.0070861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951027	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700058
J	Meier, ER; Byrnes, C; Lee, YT; Wright, EC; Schechter, AN; Luban, NLC; Miller, JL				Meier, Emily Riehm; Byrnes, Colleen; Lee, Y. Terry; Wright, Elizabeth C.; Schechter, Alan N.; Luban, Naomi L. C.; Miller, Jeffery L.			Increased Reticulocytosis during Infancy Is Associated with Increased Hospitalizations in Sickle Cell Anemia Patients during the First Three Years of Life	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; ADVERSE OUTCOMES; DISEASE; CHILDREN; COHORT; PREDICTION; SEVERITY; TRIAL	Objective: Among older children with sickle cell anemia, leukocyte counts, hemoglobin, and reticulocytosis have previously been suggested as disease severity markers. Here we explored whether these blood parameters may be useful to predict early childhood disease severity when tested in early infancy, defined as postnatal ages 60-180 days. Study Design: Data from fifty-nine subjects who were followed at Children's National Medical Center's Sickle Cell Program for at least three years was retrospectively analyzed. Comparisons were made between white blood cell counts, hemoglobin and reticulocyte levels measured at ages 60-180 days and the clinical course of sickle cell anemia during infancy and childhood. Results: A majority of subjects had demonstrable anemia with increased reticulocytosis. Only increased absolute reticulocyte levels during early infancy were associated with a significant increase in hospitalization during the first three years of life. Higher absolute reticulocyte counts were also associated with a markedly shorter time to first hospitalizations and a four-fold higher cumulative frequency of clinical manifestations over the first three years of life. No significant increase in white blood cell counts was identified among the infant subjects. Conclusions: These data suggest that during early infancy, increased reticulocytosis among asymptomatic SCA subjects is associated with increased severity of disease in childhood.	[Meier, Emily Riehm; Byrnes, Colleen; Lee, Y. Terry; Schechter, Alan N.; Miller, Jeffery L.] NIDDK, Mol Med Branch, NIH, Bethesda, MD USA; [Meier, Emily Riehm; Luban, Naomi L. C.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Wright, Elizabeth C.] NIDDK, Off Director, NIH, Bethesda, MD USA; [Meier, Emily Riehm; Luban, Naomi L. C.] George Washington Univ, Med Ctr, Dept Pediat, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); George Washington University	Miller, JL (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD USA.	jm7f@nih.gov		Schechter, Alan N/0000-0002-5235-9408	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Marshall B. Coyne Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025094, ZIADK025016, ZIADK025098] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Marshall B. Coyne Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work. Emily R. Meier is also supported by funds from the Marshall B. Coyne Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Battersby AJ, 2010, PEDIATR BLOOD CANCER, V55, P401, DOI 10.1002/pbc.22461; BRAY GL, 1994, AM J PEDIAT HEMATOL, V16, P50; Browne PV, 1996, J LAB CLIN MED, V127, P340, DOI 10.1016/S0022-2143(96)90181-X; Brugnara C., 2003, HEMATOLOGY INFANCY C, P1835; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Josephson CD, 2007, TRANSFUS MED REV, V21, P118, DOI 10.1016/j.tmrv.2006.11.003; McGann PT, 2012, BLOOD, V120; Meier ER, 2011, PEDIATR BLOOD CANCER, V56, P103, DOI 10.1002/pbc.22643; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; OBRIEN RT, 1971, J PEDIATR-US, V79, P132, DOI 10.1016/S0022-3476(71)80076-8; Oneal PA, 2006, BLOOD, V108, P2081, DOI 10.1182/blood-2006-04-015859; PEARSON HA, 1969, NEW ENGL J MED, V281, P923, DOI 10.1056/NEJM196910232811703; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Quinn CT, 2008, BLOOD, V111, P544, DOI 10.1182/blood-2007-07-100719; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Sebastiani P, 2010, AM J HEMATOL, V85, P29, DOI 10.1002/ajh.21572; SERJEANT GR, 1981, BRIT J HAEMATOL, V48, P533, DOI 10.1111/j.1365-2141.1981.tb02750.x; Serjeant GR, 2001, SICKLE CELL DIS; Silva CM, 2011, PEDIATR BLOOD CANCER, V56, P116, DOI 10.1002/pbc.22680; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704	28	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70794	10.1371/journal.pone.0070794	http://dx.doi.org/10.1371/journal.pone.0070794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951011	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700054
J	Kwong, RWM; Kumai, Y; Perry, SF				Kwong, Raymond W. M.; Kumai, Yusuke; Perry, Steve F.			The Role of Aquaporin and Tight Junction Proteins in the Regulation of Water Movement in Larval Zebrafish (Danio rerio)	PLOS ONE			English	Article							EEL ANGUILLA-ANGUILLA; EUROPEAN EEL; MOLECULAR CHARACTERIZATION; EPITHELIAL PERMEABILITY; SEAWATER ACCLIMATION; GLUCOSE TRANSPORTERS; EXPRESSION; CORTISOL; CHANNEL; INTESTINE	Teleost fish living in freshwater are challenged by passive water influx; however the molecular mechanisms regulating water influx in fish are not well understood. The potential involvement of aquaporins (AQP) and epithelial tight junction proteins in the regulation of transcellular and paracellular water movement was investigated in larval zebrafish (Danio rerio). We observed that the half-time for saturation of water influx (K-u) was 4.3 +/- 0.9 min, and reached equilibrium at approximately 30 min. These findings suggest a high turnover rate of water between the fish and the environment. Water influx was reduced by the putative AQP inhibitor phloretin (100 or 500 mu M). Immunohistochemistry and confocal microscopy revealed that AQP1a1 protein was expressed in cells on the yolk sac epithelium. A substantial number of these AQP1a1-positive cells were identified as ionocytes, either H+-ATPase-rich cells or Na+/K+-ATPase-rich cells. AQP1a1 appeared to be expressed predominantly on the basolateral membranes of ionocytes, suggesting its potential involvement in regulating ionocyte volume and/or water flux into the circulation. Additionally, translational gene knockdown of AQP1a1 protein reduced water influx by approximately 30%, further indicating a role for AQP1a1 in facilitating transcellular water uptake. On the other hand, incubation with the Ca2+-chelator EDTA or knockdown of the epithelial tight junction protein claudin-b significantly increased water influx. These findings indicate that the epithelial tight junctions normally act to restrict paracellular water influx. Together, the results of the present study provide direct in vivo evidence that water movement can occur through transcellular routes (via AQP); the paracellular routes may become significant when the paracellular permeability is increased.	[Kwong, Raymond W. M.; Kumai, Yusuke; Perry, Steve F.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Kwong, RWM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	wkwong@uottawa.ca	Kwong, Raymond/AAC-3368-2020	Kwong, Raymond/0000-0002-0784-9651	Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council (NSERC) Discovery and NSERC Research Tools and Instrumentation Grants to SFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1996, PFLUG ARCH EUR J PHY, V431, P408, DOI 10.1007/BF02207279; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chen LM, 2010, AM J PHYSIOL-REG I, V299, pR1163, DOI 10.1152/ajpregu.00319.2010; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Contreras RG, 1991, CALCIUM TIGHT JUNCTI; Cutler CP, 2002, J EXP BIOL, V205, P2643; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Engelund MB, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00051; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; FISCHBARG J, 1990, P NATL ACAD SCI USA, V87, P3244, DOI 10.1073/pnas.87.8.3244; Fischbarg J, 2010, PHYSIOL REV, V90, P1271, DOI 10.1152/physrev.00025.2009; Gao JW, 2006, ANAL BIOCHEM, V350, P165, DOI 10.1016/j.ab.2006.01.003; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; ISAIA J, 1984, FISH PHYSIOL, V10, P1; Kawedia JD, 2008, J PHARMACOL EXP THER, V326, P829, DOI 10.1124/jpet.107.135798; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; KNEPPER MA, 1989, AM J PHYSIOL, V256, pF610, DOI 10.1152/ajprenal.1989.256.4.F610; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kwong RWM, 2013, J ENDOCRINOL, V217, P253, DOI 10.1530/JOE-12-0574; Kwong RWM, 2013, AM J PHYSIOL-REG I, V304, pR504, DOI 10.1152/ajpregu.00385.2012; Kwong RWM, 2013, J COMP PHYSIOL B, V183, P203, DOI 10.1007/s00360-012-0700-9; Lin LY, 2000, PHYSIOL BIOCHEM ZOOL, V73, P283, DOI 10.1086/316747; LOESCHKE K, 1994, AM J PHYSIOL, V266, pG722, DOI 10.1152/ajpgi.1994.266.4.G722; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Madsen SS, 2011, FRONTIER PHYSL, V2; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P99, DOI 10.1007/BF02183004; Martial S, 1996, AM J PHYSIOL-RENAL, V271, pF1264, DOI 10.1152/ajprenal.1996.271.6.F1264; Martinez AS, 2005, BIOL CELL, V97, P615, DOI 10.1042/BC20040111; Martinez AS, 2005, AM J PHYSIOL-REG I, V288, pR1733, DOI 10.1152/ajpregu.00747.2004; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rehn K, 2011, INT J DEV BIOL, V55, P613, DOI 10.1387/ijdb.103249kp; Rombough P, 2002, J EXP BIOL, V205, P1787; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tseng YC, 2009, AM J PHYSIOL-REG I, V297, pR275, DOI 10.1152/ajpregu.00180.2009; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Vallon V, 2000, AM J PHYSIOL-RENAL, V278, pF1030, DOI 10.1152/ajprenal.2000.278.6.F1030; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Watanabe S, 2005, J EXP BIOL, V208, P2673, DOI 10.1242/jeb.01684; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wood CM, 2012, J EXP BIOL, V215, P508, DOI 10.1242/jeb.060004; Yang BX, 1998, J BIOL CHEM, V273, P9369, DOI 10.1074/jbc.273.16.9369; Zeuthen T, 2007, J PHYSIOL-LONDON, V579, P345, DOI 10.1113/jphysiol.2006.123380	56	19	19	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70764	10.1371/journal.pone.0070764	http://dx.doi.org/10.1371/journal.pone.0070764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967101	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500027
J	Nakajima, NI; Brunton, H; Watanabe, R; Shrikhande, A; Hirayama, R; Matsufuji, N; Fujimori, A; Murakami, T; Okayasu, R; Jeggo, P; Shibata, A				Nakajima, Nakako Izumi; Brunton, Holly; Watanabe, Ritsuko; Shrikhande, Amruta; Hirayama, Ryoichi; Matsufuji, Naruhiro; Fujimori, Akira; Murakami, Takeshi; Okayasu, Ryuichi; Jeggo, Penny; Shibata, Atsushi			Visualisation of gamma H2AX Foci Caused by Heavy Ion Particle Traversal; Distinction between Core Track versus Non-Track Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; HIGH-LET; RADIAL-DISTRIBUTION; DNA; REPAIR; ATM; CELLS; HETEROCHROMATIN; IRRADIATION	Heavy particle irradiation produces complex DNA double strand breaks (DSBs) which can arise from primary ionisation events within the particle trajectory. Additionally, secondary electrons, termed delta-electrons, which have a range of distributions can create low linear energy transfer (LET) damage within but also distant from the track. DNA damage by delta-electrons distant from the track has not previously been carefully characterised. Using imaging with deconvolution, we show that at 8 hours after exposure to Fe (similar to 200 keV/mu m) ions, gamma H2AX foci forming at DSBs within the particle track are large and encompass multiple smaller and closely localised foci, which we designate as clustered gamma H2AX foci. These foci are repaired with slow kinetics by DNA non-homologous end-joining (NHEJ) in G1 phase with the magnitude of complexity diminishing with time. These clustered foci (containing 10 or more individual foci) represent a signature of DSBs caused by high LET heavy particle radiation. We also identified simple gamma H2AX foci distant from the track, which resemble those arising after X-ray exposure, which we attribute to low LET delta-electron induced DSBs. They are rapidly repaired by NHEJ. Clustered gamma H2AX foci induced by heavy particle radiation cause prolonged checkpoint arrest compared to simple gamma H2AX foci following X-irradiation. However, mitotic entry was observed when similar to 10 clustered foci remain. Thus, cells can progress into mitosis with multiple clusters of DSBs following the traversal of a heavy particle.	[Nakajima, Nakako Izumi; Hirayama, Ryoichi; Matsufuji, Naruhiro; Fujimori, Akira; Murakami, Takeshi; Okayasu, Ryuichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Nakajima, Nakako Izumi; Hirayama, Ryoichi; Matsufuji, Naruhiro; Fujimori, Akira; Murakami, Takeshi; Okayasu, Ryuichi] Natl Inst Radiol Sci, Int Open Lab, Chiba 260, Japan; [Brunton, Holly; Shrikhande, Amruta; Jeggo, Penny; Shibata, Atsushi] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Watanabe, Ritsuko] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; University of Sussex; Japan Atomic Energy Agency	Jeggo, P (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	p.a.jeggo@sussex.ac.uk; as303@sussex.ac.uk	Okayasu, Ryuichi/F-2071-2013; Shibata, Atsushi/AAX-1283-2021	Okayasu, Ryuichi/0000-0001-5091-7210; Shibata, Atsushi/0000-0001-8912-6977; Brunton, Holly/0000-0001-6753-9623	Chang Yung-Fa fund; JSPS [A24249067, B23390301]; MEXT [19-9, H23-A-43]; Medical Research Council; Association for International Cancer Research, Department of Health; Wellcome Research Trust; MRC [G1000050] Funding Source: UKRI; Medical Research Council [G1000050, G0801130B] Funding Source: researchfish	Chang Yung-Fa fund; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research, Department of Health; Wellcome Research Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Chang Yung-Fa fund; JSPS grants A24249067 and B23390301 (RO); and Grant-in-Aid for Cancer Research (19-9, H23-A-43) from MEXT (RO). This work is a component of the Research Project with Heavy Ions at NIRS-HIMAC. The PAJ laboratory is supported by the Medical Research Council, the Association for International Cancer Research, Department of Health and the Wellcome Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2007, DNA REPAIR, V6, P190, DOI 10.1016/j.dnarep.2006.09.010; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bekker-Jensen S, 2010, DNA REPAIR AMST; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Brunton H, 2011, MOL CELL BIOL, V31, P4022, DOI 10.1128/MCB.05289-11; CHATTERJEE A, 1976, RADIAT ENVIRON BIOPH, V13, P215, DOI 10.1007/BF01330766; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 1998, RADIAT ENVIRON BIOPH, V37, P259, DOI 10.1007/s004110050127; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Deckbar D, 2010, CANCER RES, V70, P4412, DOI 10.1158/0008-5472.CAN-09-3198; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; Fernet M, 2009, DNA REPAIR AMST; Genet SC, 2012, ONCOL REP, V28, P1591, DOI 10.3892/or.2012.1982; Hirayama R, 2009, RADIAT RES, V171, P212, DOI 10.1667/RR1490.1; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kase Y, 2006, PHYS MED BIOL, V51, pN467, DOI 10.1088/0031-9155/51/24/N03; KATZ R, 1971, RADIAT RES, V47, P402, DOI 10.2307/3573247; Kegel P, 2007, DNA REPAIR, V6, P1692, DOI 10.1016/j.dnarep.2007.05.013; KIEFER J, 1986, PHYS MED BIOL, V31, P1201, DOI 10.1088/0031-9155/31/11/002; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; KRAMER M, 1994, RADIAT ENVIRON BIOPH, V33, P91, DOI 10.1007/BF01219334; Krempler A, 2007, CELL CYCLE, V6, P1682, DOI 10.4161/cc.6.14.4480; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Maalouf M, 2011, J RADIAT RES, V52, P126, DOI 10.1269/jrr.10128; Minohara S, 2010, J RADIAT RES, V51, P385, DOI 10.1269/jrr.10028; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sekine E, 2008, MUTAT RES-GEN TOX EN, V652, P95, DOI 10.1016/j.mrgentox.2008.01.003; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Watanabe R, 2011, RADIAT PROT DOSIM, V143, P186, DOI 10.1093/rpd/ncq539	40	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70107	10.1371/journal.pone.0070107	http://dx.doi.org/10.1371/journal.pone.0070107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967070	Green Submitted, gold, Green Published			2022-12-27	WOS:000323221500015
J	Ramachandran, G; Kumar, M; Rani, DS; Annanthapur, V; Calambur, N; Nallari, P; Kaur, P				Ramachandran, Gayatri; Kumar, Manoj; Rani, Deepa Selvi; Annanthapur, Venkateshwari; Calambur, Narasimhan; Nallari, Pratibha; Kaur, Punit			An In Silico Analysis of Troponin I Mutations in Hypertrophic Cardiomyopathy of Indian Origin	PLOS ONE			English	Article								Hypertrophic Cardiomyopathy (HCM) is an autosomal dominant disorder of the myocardium which is hypertrophied resulting in arrhythmias and heart failure leading to sudden cardiac death (SCD). Several sarcomeric proteins and modifier genes have been implicated in this disease. Troponin I, being a part of the Troponin complex (troponin I, troponin C, troponin T), is an important gene for sarcomeric function. Four mutations (1 novel) were identified in Indian HCM cases, namely, Pro82Ser, Arg98Gln, Arg141Gln and Arg162Gln in Troponin I protein, which are in functionally significant domains. In order to analyse the effect of the mutations on protein stability and protein-protein interactions within the Troponin complex, an in silico study was carried out. The freely available X-ray crystal structure (PDB ID: 1JIE) was used as the template to model the protein followed by loop generation and development of troponin complex for both the troponin I wild type and four mutants (NCBI ID: PRJNA194382). The structural study was carried out to determine the effect of mutation on the structural stability and protein-protein interactions between three subunits in the complex. These mutations, especially the arginine to glutamine substitutions were found to result in local perturbations within the troponin complex by creating/removing inter/intra molecular hydrogen bonds with troponin T and troponin C. This has led to a decrease in the protein stability and loss of important interactions between the three subunits. It could have a significant impact on the disease progression when coupled with allelic heterogeneity which was observed in the cases carrying these mutations. However, this can be further confirmed by functional studies on protein levels in the identified cases.	[Ramachandran, Gayatri; Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Rani, Deepa Selvi] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Annanthapur, Venkateshwari] Inst Genet & Hosp Genet Dis, Hyderabad, Andhra Pradesh, India; [Calambur, Narasimhan] CARE Hosp, Dept Cardiol, Hyderabad, Andhra Pradesh, India; [Kumar, Manoj; Kaur, Punit] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	Osmania University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); All India Institute of Medical Sciences (AIIMS) New Delhi	Nallari, P (corresponding author), Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India.	prathinallari@yahoo.com	KUMAR, MANOJ/HHC-0782-2022		CSIR, New Delhi, India; OU-DST-PURSE, New Delhi, India; DST, New Delhi, India; ICMR, New Delhi, India; UGC-CAS II Program, New Delhi, India	CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); OU-DST-PURSE, New Delhi, India; DST, New Delhi, India(Department of Science & Technology (India)); ICMR, New Delhi, India(Indian Council of Medical Research (ICMR)); UGC-CAS II Program, New Delhi, India	This study is supported by CSIR, New Delhi, India; OU-DST-PURSE, New Delhi, India; DST, New Delhi, India; ICMR, New Delhi, India; and UGC-CAS II Program, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MJ, 2003, AMINO ACID PROPERTIE, V4, P289; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; D'Onofrio G, 2002, GENE, V300, P155, DOI 10.1016/S0378-1119(02)01048-X; Day A, 1996, SOURCE STABILITY PRO; Deepa SR, 2012, BMC MED GEN, V13, P1; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Discovery Studio 2.0, 2007, MOL MODELING PROGRAM; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; GRAND RJA, 1982, BIOCHEM J, V203, P61, DOI 10.1042/bj2030061; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Gu WJ, 2004, BIOSYSTEMS, V73, P89, DOI 10.1016/j.biosystems.2003.10.001; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim DS, 2001, J AM COLL CARDIOL, V38, P1175, DOI 10.1016/S0735-1097(01)01509-1; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Spassov VZ, 2007, PROTEIN SCI, V16, P494, DOI 10.1110/ps.062447107; Summers KM, 1996, HUM MUTAT, V7, P283; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Ushasree B, 2009, J GEN, V88, P3; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Wei Z, 1997, J OPTIMIZ THEORY APP, V95, P177, DOI 10.1023/A:1022691513687; Westfall MV, 2001, NEWS PHYSL SCI, V16	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70704	10.1371/journal.pone.0070704	http://dx.doi.org/10.1371/journal.pone.0070704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967088	Green Published, Green Submitted, gold			2022-12-27	WOS:000323115800013
J	Ali, A; Scior, K; Ratti, V; Strydom, A; King, M; Hassiotis, A				Ali, Afia; Scior, Katrina; Ratti, Victoria; Strydom, Andre; King, Michael; Hassiotis, Angela			Discrimination and Other Barriers to Accessing Health Care: Perspectives of Patients with Mild and Moderate Intellectual Disability and Their Carers	PLOS ONE			English	Article							HOSPITAL EXPERIENCES; LEARNING-DISABILITY; PEOPLE; ADULTS; COMMUNICATION; ADOLESCENTS; OUTCOMES; CHILDREN; QUALITY; PARENTS	Background: People with intellectual disability have a higher prevalence of physical health problems but often experience disparities in accessing health care. In England, a number of legislative changes, policies and recommendations have been introduced to improve health care access for this population. The aim of this qualitative study was to examine the extent to which patients with intellectual disability and their carers experience discrimination or other barriers in accessing health services, and whether health care experiences have improved over the last decade years. Method and Main Findings: Twenty nine participants (14 patient and carer dyads, and one carer) took part in semi-structured interviews. The interviews were audio-taped and transcribed and analysed using thematic analysis. Eight themes were identified. Half the participants thought that the patient had been treated unfairly or had been discriminated against by health services. There were accounts of negative staff attitudes and behaviour, and failure of services to make reasonable adjustments. Other barriers included problems with communication, and accessing services because of lack of knowledge of local services and service eligibility issues; lack of support and involvement of carers; and language problems in participants from minority ethnic groups. Most participants were able to report at least one example of good practice in health care provision. Suggestions for improving services are presented. Conclusion: Despite some improvements to services as a result of health policies and recommendations, more progress is required to ensure that health services make reasonable adjustments to reduce both direct and indirect discrimination of people with intellectual disability.	[Ali, Afia; Ratti, Victoria; Strydom, Andre; King, Michael; Hassiotis, Angela] UCL, Mental Hlth Sci Unit, London, England; [Scior, Katrina] UCL, Div Psychol & Language Sci, London, England	University of London; University College London; University of London; University College London	Ali, A (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	afia.ali@ucl.ac.uk		Strydom, Andre/0000-0002-2502-6704; Scior, Katrina/0000-0002-4679-0090; Hassiotis, Angela/0000-0002-9800-3909; Ali, Afia/0000-0002-0104-9370	Medical Research Council (UK); MRC [G0901946] Funding Source: UKRI; Medical Research Council [G0901946] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10210] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	A Ali has received funding from the Medical Research Council (UK) to complete this study as part of a three year MRC clinical training fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD W, 1996, RACE COMMUNITY CARE; Ali A, 2008, BMJ-BRIT MED J, V336, P570, DOI 10.1136/bmj.39490.543137.80; Azmi S, 1997, J APPL RES INTELLECT, V10, P250, DOI 10.1111/j.1468-3148.1997.tb00020.x; Baxter C, 1998, ASSESSING HLTH NEEDS, P231; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Broughton S, 2000, J ADV NURS, V32, P905, DOI 10.1046/j.1365-2648.2000.01555.x; Butt J., 1996, SOCIAL CARE BLACK CO; Dinsmore AP, 2012, BRIT J LEARN DISABIL, V40, P201, DOI 10.1111/j.1468-3156.2011.00694.x; Disability Rights Commission, 2006, EQ TREATM CLOS GAP F; Donner B, 2010, J APPL RES INTELLECT, V23, P214, DOI 10.1111/j.1468-3148.2009.00527.x; Eisikovits Z, 2010, QUAL HEALTH RES, V20, P1642, DOI 10.1177/1049732310376520; Emerson E, 2011, PEOPLE LEARNING DISA; Emerson E., 2002, FUTURE DEMAND SERVIC; Emerson E, 2010, HLTH INEQUALITIES PE; Fazil Q, 2002, DISABIL SOC, V17, P237, DOI 10.1080/09687590220139838; Fisher K, 2005, APPL NURS RES, V18, P155, DOI 10.1016/j.apnr.2004.08.006; Fox D, 1999, J CLIN NURS, V8, P610, DOI 10.1046/j.1365-2702.1999.00324.x; Gibbs SM, 2008, J INTELL DISABIL RES, V52, P1061, DOI 10.1111/j.1365-2788.2008.01057.x; Glover G, 2010, LEARN DISABIL OBSERV, P1; Hatton C, 1998, BRIT J SOC WORK, V28, P821; Hatton C., 1997, MENTAL HLTH CARE, V1, P91; Hoghton M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7589; Iacono T, 2003, RES DEV DISABIL, V24, P247, DOI 10.1016/S0891-4222(03)00041-6; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; LANGAN J, 1994, HEALTH SOC CARE COMM, V2, P357; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McGrother CW, 1996, J INTELL DISABIL RES, V40, P183, DOI 10.1111/j.1365-2788.1996.tb00621.x; MENCAP, 2007, DEATH IND; Michael J, 2008, HEALTHCARE ALL REPOR; Minnes P, 2009, CHILD CARE HLTH DEV, V35, P250, DOI 10.1111/j.1365-2214.2008.00931.x; Mir G., 2001, LEARNING DIFFICULTIE; OHara J., 2003, ADV PSYCHIAT TREATME, V9, P166, DOI [10.1192/apt.9.3.166, DOI 10.1192/APT.9.3.166]; Robertson J., 2010, HLTH CHECKS PEOPLE L; Ward RL, 2010, HEALTH SOC WORK, V35, P280, DOI 10.1093/hsw/35.4.280; Webber R, 2010, J INTELLECT DEV DIS, V35, P155, DOI 10.3109/13668250.2010.491071; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wullink M, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-82; Ziviani J, 2004, J INTELLECT DEV DIS, V29, P211, DOI 10.1080/13668250412331285163	38	128	128	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70855	10.1371/journal.pone.0070855	http://dx.doi.org/10.1371/journal.pone.0070855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951026	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300060
J	Antaloae, AV; Montigny, C; le Maire, M; Watson, KA; Sorensen, TLM				Antaloae, Ana V.; Montigny, Cedric; le Maire, Marc; Watson, Kimberly A.; Sorensen, Thomas L. -M.			Optimisation of Recombinant Production of Active Human Cardiac SERCA2a ATPase	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; EUKARYOTIC MEMBRANE-PROTEINS; AFFINITY-CHROMATOGRAPHY; STRUCTURAL BASIS; PICHIA-PASTORIS; GENE-EXPRESSION; 3 ISOFORMS; CA2+ PUMP; PURIFICATION; HEART	Methods for recombinant production of eukaryotic membrane proteins, yielding sufficient quantity and quality of protein for structural biology, remain a challenge. We describe here, expression and purification optimisation of the human SERCA2a cardiac isoform of Ca2+ translocating ATPase, using Saccharomyces cerevisiae as the heterologous expression system of choice. Two different expression vectors were utilised, allowing expression of C-terminal fusion proteins with a biotinylation domain or a GFP-His(8) tag. Solubilised membrane fractions containing the protein of interest were purified onto Streptavidin-Sepharose, Ni-NTA or Talon resin, depending on the fusion tag present. Biotinylated protein was detected using specific antibody directed against SERCA2 and, advantageously, GFP-His(8) fusion protein was easily traced during the purification steps using in-gel fluorescence. Importantly, talon resin affinity purification proved more specific than Ni-NTA resin for the GFP-His(8) tagged protein, providing better separation of oligomers present, during size exclusion chromatography. The optimised method for expression and purification of human cardiac SERCA2a reported herein, yields purified protein (> 90%) that displays a calcium-dependent thapsigargin-sensitive activity and is suitable for further biophysical, structural and physiological studies. This work provides support for the use of Saccharomyces cerevisiae as a suitable expression system for recombinant production of multi-domain eukaryotic membrane proteins.	[Antaloae, Ana V.; Watson, Kimberly A.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Montigny, Cedric; le Maire, Marc] Univ Paris 11, UMR 8221, CNRS, CEA,iBiTec S, Saclay, France; [Sorensen, Thomas L. -M.] Diamond Light Source Ltd, Didcot, Oxon, England	University of Reading; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Diamond Light Source	Watson, KA (corresponding author), Univ Reading, Sch Biol Sci, Whiteknights Campus, Reading, Berks, England.	k.a.watson@reading.ac.uk; thomas.sorensen@diamond.ac.uk	Watson, Kimberly/AAL-7548-2020; MONTIGNY, Cédric/AAH-4216-2021; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Watson, Kimberly/0000-0002-9987-8539; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499	University of Reading Endowment Trust Faculty Studentship (MRC DTG); Diamond Light Source	University of Reading Endowment Trust Faculty Studentship (MRC DTG); Diamond Light Source	This work was supported by the University of Reading Endowment Trust Faculty Studentship (MRC DTG) and Diamond Light Source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Bobe R, 2004, J BIOL CHEM, V279, P24297, DOI 10.1074/jbc.M314286200; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; BURGE SM, 1992, J AM ACAD DERMATOL, V27, P40, DOI 10.1016/0190-9622(92)70154-8; Cardi D, 2010, METHODS MOL BIOL, V601, P247, DOI 10.1007/978-1-60761-344-2_15; Chaga G, 1999, BIOTECHNOL APPL BIOC, V29, P19; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Dally S, 2009, CELL CALCIUM, V45, P144, DOI 10.1016/j.ceca.2008.08.002; Dalton KA, 1999, BIOCHEM J, V342, P431, DOI 10.1042/0264-6021:3420431; DEFORESTA B, 1992, EUR J BIOCHEM, V209, P1023, DOI 10.1111/j.1432-1033.1992.tb17378.x; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dode L, 1998, J BIOL CHEM, V273, P13982, DOI 10.1074/jbc.273.22.13982; Donald M, 2010, METHOD CELL BIOL, V99, P1; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; ENOUF J, 1992, BIOCHEM J, V286, P135, DOI 10.1042/bj2860135; Gelebart P, 2003, BIOCHEM BIOPH RES CO, V303, P676, DOI 10.1016/S0006-291X(03)00405-4; Girish V, 2004, Indian J Cancer, V41, P47; Hovnanian A., 2007, V45, P337; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lee AG, 1998, BIOCHEM SOC T, V26, P359, DOI 10.1042/bst0260359; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; LOMPRE AM, 1989, FEBS LETT, V249, P35, DOI 10.1016/0014-5793(89)80010-9; LUND S, 1989, J BIOL CHEM, V264, P4907; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Magro M, 2012, LANGMUIR, V28, P15392, DOI 10.1021/la303148u; Maire M L, 1978, J Biol Chem, V253, P7051; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Menguy T, 1998, ANAL BIOCHEM, V264, P141, DOI 10.1006/abio.1998.2854; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Miras R, 2001, PROTEIN EXPRES PURIF, V22, P299, DOI 10.1006/prep.2001.1436; Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032; Misquitta CM, 1999, BIOCHEM J, V338, P167, DOI 10.1042/0264-6021:3380167; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Stolz J, 1995, FEBS LETT, V377, P167, DOI 10.1016/0014-5793(95)01333-4; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Tavadia S, 2004, BRIT J DERMATOL, V151, P440, DOI 10.1111/j.1365-2133.2004.06130.x; Tepsic V, 1998, PHYSIOL RES, V47, P413; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vandecaetsbeek I, 2011, BBA-MOL CELL RES, V1813, P1118, DOI 10.1016/j.bbamcr.2010.12.020; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; VILSEN B, 1992, FEBS LETT, V306, P213, DOI 10.1016/0014-5793(92)81003-5; WAKU K, 1971, J BIOCHEM-TOKYO, V69, P483; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	70	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71842	10.1371/journal.pone.0071842	http://dx.doi.org/10.1371/journal.pone.0071842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951256	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323097300163
J	Asaoka, R				Asaoka, Ryo			Measuring Visual Field Progression in the Central 10 Degrees Using Additional Information from Central 24 Degrees Visual Fields and 'Lasso Regression'	PLOS ONE			English	Article							AUTOMATIC PERIMETRY; GLAUCOMA; PERFORMANCE; RISK	Purpose: To measure progression of the visual field (VF) mean deviation (MD) index in longitudinal 10-2 VFs more accurately, by adding information from 24-2 VFs using Lasso regression. Methods: A training dataset consisted of 138 eyes from 97 patients with glaucoma or ocular hypertension and a testing dataset consisted of 40 eyes from 34 patients with glaucoma or ocular hypertension. The Lasso method was used to predict total deviation (TD) values in training patients' 10-2 VFs based on information from their 24-2 VFs (52 TD values, foveal sensitivity and mean deviation MD). Then, the MD of each patient's 10-2 VF was estimated as the average of these Lassopredicted TD values (10-2 VF 'Lasso MD'; LMD). Finally, linear regression was applied to each testing patient's series of longitudinal 10-2 VF MDs with and without additional Lasso-derived LMDs in order to predict future MDs not included in the regression analysis. Absolute prediction errors were compared when only actual 10-2 MDs were regressed against when a combination of actual 10-2 MDs and LMDs were regressed. Results: The average absolute prediction error was significantly smaller for the novel method incorporating LMDs (range: 1.6 to 1.8 dB) compared with the standard approach (range: 1.7 to 3.4 dB) (p<0.05, ANOVA test). Conclusions: Deriving 10-2 VF MD values from 24-2 VFs improves the prediction accuracy of progression. This approach will help clinicians to predict patients' visual function in the parafoveal area.	Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp						ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363; AULHORN E., 1967, P151; Aulhorn E., 1977, DOC OPHTHALMOL PROC, V14, P75; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; BIRCH MK, 1995, PERIMETRY UPDATE 1994/1995, P31; Blumenthal EZ, 2003, OPHTHALMOLOGY, V110, P1895, DOI 10.1016/S0161-6420(03)00541-4; CHAUHAN BC, 1990, INVEST OPHTH VIS SCI, V31, P512; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Fung SS, 2013, BR J OPHTHALMOL; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Heijl A, 1991, EXTENDED EMPIRICAL S; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; Jansonius NM, 2010, BRIT J OPHTHALMOL, V94, P1404, DOI 10.1136/bjo.2009.164897; Japkowicz N., 2011, EVALUATING LEARNING, DOI 10.1017/CBO9780511921803; Klein BEK, 1998, OPHTHALMOLOGY, V105, P160, DOI 10.1016/S0161-6420(98)91911-X; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Langerhorst CC, 1997, PERIMETRY UPDATE 199; MCNAUGHT AI, 1995, GRAEF ARCH CLIN EXP, V233, P750, DOI 10.1007/BF00184085; NouriMahdavi K, 1997, OPHTHALMOLOGY, V104, P1228, DOI 10.1016/S0161-6420(97)30153-5; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Su D, 2012, OPHTHALMOLOGY; Sumi I, 2003, OPHTHALMOLOGY, V110, P332, DOI 10.1016/S0161-6420(02)01742-6; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Viswanathan AC, 1997, BRIT J OPHTHALMOL, V81, P1037, DOI 10.1136/bjo.81.12.1037; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; WEBER J, 1989, INT OPHTHALMOL, V13, P47, DOI 10.1007/BF02028637; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wirght DB, 2009, MODERN REGRESSION TE; ZALTA AH, 1991, BRIT J OPHTHALMOL, V75, P151, DOI 10.1136/bjo.75.3.151; Zhu HG, 2010, INVEST OPHTH VIS SCI, V51, P5657, DOI 10.1167/iovs.10-5239	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72199	10.1371/journal.pone.0072199	http://dx.doi.org/10.1371/journal.pone.0072199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951295	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300181
J	Combs, PA; Eisen, MB				Combs, Peter A.; Eisen, Michael B.			Sequencing mRNA from Cryo-Sliced Drosophila Embryos to Determine Genome-Wide Spatial Patterns of Gene Expression	PLOS ONE			English	Article							GLOBAL ANALYSIS; ALIGNMENT	Complex spatial and temporal patterns of gene expression underlie embryo differentiation, yet methods do not yet exist for the efficient genome-wide determination of spatial expression patterns during development. In situ imaging of transcripts and proteins is the gold-standard, but it is difficult and time consuming to apply to an entire genome, even when highly automated. Sequencing, in contrast, is fast and genome-wide, but is generally applied to homogenized tissues, thereby discarding spatial information. To take advantage of the efficiency and comprehensiveness of sequencing while retaining spatial information, we cryosectioned individual blastoderm stage Drosophila melanogaster embryos along the anterior-posterior axis and developed methods to reliably sequence the mRNA isolated from each 25 mu m slice. The spatial patterns of gene expression we infer closely match patterns previously determined by in situ hybridization and microscopy. We applied this method to generate a genome-wide timecourse of spatial gene expression from shortly after fertilization through gastrulation. We identified numerous genes with spatial patterns that have not yet been described in the several ongoing systematic in situ based projects. This simple experiment demonstrates the potential for combining careful anatomical dissection with high-throughput sequencing to obtain spatially resolved gene expression on a genome-wide scale.	[Combs, Peter A.] Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Combs, PA (corresponding author), Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA.	peter.combs@berkeley.edu		Combs, Peter/0000-0003-2835-5623; Eisen, Michael/0000-0002-7528-738X	Howard Hughes Medical Institute; National Institutes of Health [T32 HG 00047]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by a Howard Hughes Medical Institute investigator award to MBE, and National Institutes of Health training grant #T32 HG 00047 to PAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ding DL, 1993, ZYGOTE, V1, P257, DOI 10.1017/S0967199400001544; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones E., 2001, SCIPY OPEN SOURCE SC; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Perez F, 2007, COMPUTING SCI ENG; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	17	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71820	10.1371/journal.pone.0071820	http://dx.doi.org/10.1371/journal.pone.0071820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951250	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300160
J	Grava, T; Fairhurst, GD; Avey, MT; Grava, A; Bradley, J; Avis, JL; Bortolotti, GR; Sturdy, CB; Otter, KA				Grava, Thibault; Fairhurst, Graham D.; Avey, Marc T.; Grava, Angelique; Bradley, James; Avis, Jillian L.; Bortolotti, Gary R.; Sturdy, Christopher B.; Otter, Ken A.			Habitat Quality Affects Early Physiology and Subsequent Neuromotor Development of Juvenile Black-Capped Chickadees	PLOS ONE			English	Article							STRESS-RESPONSE; ADRENOCORTICAL-RESPONSE; POECILE-ATRICAPILLUS; NEURAL MECHANISMS; SOCIAL-DOMINANCE; NESTLING GROWTH; SONG COMPLEXITY; HONEST SIGNAL; DAWN CHORUS; CORTICOSTERONE	In songbirds, the ability to learn and render the species-specific song is influenced by the development of both the song nuclei in the brain and the syrinx (bird's vocal apparatus) early in the bird's life. In black-capped chickadees (Poecille atricapillus), habitat quality is known to affect song structure, with birds in high-quality habitat (mature forest) having a higher song consistency than birds in low-quality habitat (young forest). Although this difference is suspected to stem from differences in development, the developmental status of juvenile birds in either habitat remains unexplored. In this study, we used ptilochronology and feather corticosterone to compare the conditional state of juvenile chickadees in young and mature forest during two distinct periods of song learning - the sensory phase, which occurs prior to settlement, and the sensorimotor phase, which occurs post-settlement. A sample of juvenile males was captured and euthanized several weeks prior to their first breeding season to compare the development of song center nuclei and syrinx in both habitats. The corticosterone levels of natally-grown feathers were greater among birds that settled in mature than young forests - as these feathers were grown pre-settlement, they reflect differences in physiology during the sensory phase. This difference in conditional state is reflected by differences in syrinx and song center nuclei development later during the sensorimotor phase - birds in young forest have smaller syrinx, and moderately-larger RA, than birds in mature forest. Those differences could be responsible for the difference in consistency in song structure observed across habitats. The difference in physiological state across habitats, combined with potential compounding effect of differences in winter resources between habitats, could influence the difference in syrinx and neural development seen in juvenile males during the early spring, and influence the male's ability to learn and render their species-specific song.	[Grava, Thibault; Grava, Angelique; Bradley, James; Otter, Ken A.] Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada; [Fairhurst, Graham D.; Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Avey, Marc T.; Avis, Jillian L.; Sturdy, Christopher B.] Univ Edmonton, Dept Psychol, Edmonton, AB, Canada	University of Northern British Columbia; University of Saskatchewan	Grava, T (corresponding author), Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada.	thibault.grava@gmail.com	Fairhurst, Graham/ABB-1218-2020; Sturdy, Christopher B/A-4407-2009; Fairhurst, Graham/E-1639-2011	Avey, Marc/0000-0002-8696-3232; Fairhurst, Graham/0000-0001-8731-1298; Sturdy, Christopher/0000-0003-2721-3770	Natural Sciences and Engineering Research Council of Canada; University of Northern British Columbia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Northern British Columbia	This work by funded by Natural Sciences and Engineering Research Council of Canada and University of Northern British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 2007, P ROY SOC B-BIOL SCI, V274, P2563, DOI 10.1098/rspb.2007.0687; Baker Myron C., 2003, Bioacoustics, V13, P265; Bauer CM, 2011, COMP BIOCHEM PHYS A, V160, P390, DOI 10.1016/j.cbpa.2011.07.009; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2010, ECOL APPL, V20, P1766, DOI 10.1890/09-1473.1; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Buchanan KL, 2004, P ROY SOC B-BIOL SCI, V271, P2381, DOI 10.1098/rspb.2004.2874; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P203, DOI 10.1017/CBO9780511754791.009; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Cohen J., 1988, STAT POWER ANAL BEHA, P590; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doutrelant C, 2000, J AVIAN BIOL, V31, P360, DOI 10.1034/j.1600-048X.2000.310312.x; Fairhurst GD, 2012, CAN J ZOOL, V90, P1422, DOI 10.1139/cjz-2012-0096; Fairhurst GD, 2012, P ROY SOC B-BIOL SCI, V279, P177, DOI 10.1098/rspb.2011.0884; Fairhurst GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017663; Foote J. R., 2010, BIRDS N AM ONLINE; Fort KT, 2004, AUK, V121, P1070, DOI 10.1642/0004-8038(2004)121[1070:EOHDOR]2.0.CO;2; Fort KT, 2004, ANIM BEHAV, V68, P407, DOI 10.1016/j.anbehav.2003.08.023; Godfrey J.D., 2003, Science for Conservation (Wellington), V214, P11; Gosler A, 1999, J AVIAN BIOL, V30, P447, DOI 10.2307/3677017; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Grava T, 2012, THESIS U NO BRIT COL; Grava T, 2012, BEHAVIOUR, V149, P35, DOI 10.1163/156853912X625854; Grava T, 2009, CONDOR, V111, P560, DOI 10.1525/cond.2009.080061; Grubb Jr TC, 2006, PTILOCHRONOLOGY FEAT, P192; GRUBB TC, 1989, AUK, V106, P314; GRUBB TC, 1994, AUK, V111, P756; Hultsch Henrike, 2004, P80, DOI 10.1016/B978-012473070-0/50006-2; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; Kitaysky AS, 1999, J COMP PHYSIOL B, V169, P303, DOI 10.1007/s003600050225; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; MEIGS JB, 1983, J FIELD ORNITHOL, V54, P283; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Nowicki S, 2000, P ROY SOC B-BIOL SCI, V267, P2419, DOI 10.1098/rspb.2000.1300; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Otter Ken A., 2007, P277; Otter KA, 2007, ANIM BEHAV, V74, P847, DOI 10.1016/j.anbehav.2007.01.016; Phillmore LS, 2006, J NEUROBIOL, V66, P1002, DOI 10.1002/neu.20282; Pravosudov VV, 2006, GEN COMP ENDOCR, V145, P25, DOI 10.1016/j.ygcen.2005.06.011; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Saino N, 2003, BEHAV ECOL, V14, P318, DOI 10.1093/beheco/14.3.318; Schmidt KL, 2012, J EXP BIOL, V215, P3207, DOI 10.1242/jeb.068965; SHACKLETON SA, 1993, WILSON BULL, V105, P637; Smith SM, 1991, BLACK CAPPED CHICKAD, P362; Smulders TV, 2006, J NEUROBIOL, V66, P991, DOI 10.1002/neu.20281; Solis MM, 2000, NEURON, V25, P109, DOI 10.1016/S0896-6273(00)80875-2; Spencer KA, 2005, P ROY SOC B-BIOL SCI, V272, P2037, DOI 10.1098/rspb.2005.3188; Spencer KA, 2004, P ROY SOC B-BIOL SCI, V271, pS121, DOI 10.1098/rsbl.2003.0122; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Suorsa P, 2003, P ROY SOC B-BIOL SCI, V270, P963, DOI 10.1098/rspb.2002.2326; van Oort H, 2005, CAN J ZOOL, V83, P1495, DOI [10.1139/Z05-147, 10.1139/z05-147]; van Oort H, 2007, CONDOR, V109, P88, DOI 10.1650/0010-5422(2007)109[88:HDATPQ]2.0.CO;2; van Oort H, 2006, ETHOLOGY, V112, P772, DOI 10.1111/j.1439-0310.2006.01228.x; Wayland M, 2002, ENVIRON RES, V90, P47, DOI 10.1006/enrs.2002.4384; Zann R, 2008, BEHAV ECOL SOCIOBIOL, V62, P391, DOI 10.1007/s00265-007-0467-2	64	15	15	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71852	10.1371/journal.pone.0071852	http://dx.doi.org/10.1371/journal.pone.0071852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951257	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300164
J	Heller, A; Witt-Geiges, T				Heller, Annerose; Witt-Geiges, Tanja			Oxalic Acid Has an Additional, Detoxifying Function in Sclerotinia sclerotiorum Pathogenesis	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; PROGRAMMED CELL-DEATH; POLYGALACTURONASE ISOENZYMES; OXALATE PRODUCTION; BOTRYTIS-CINEREA; CALCIUM-OXALATE; MYCELIAL GROWTH; ENDOPOLYGALACTURONASE; PATHOGENICITY; VIRULENCE	The mechanism of the diseases caused by the necrotroph plant pathogen Sclerotinia sclerotiorum is not well understood. To investigate the role of oxalic acid during infection high resolution, light-, scanning-, transmission electron microscopy and various histochemical staining methods were used. Our inoculation method allowed us to follow degradation of host plant tissue around single hyphae and to observe the reaction of host cells in direct contact with single invading hyphae. After penetration the outer epidermal cell wall matrix appeared degraded around subcuticular hyphae (12-24 hpi). Calcium oxalate crystals were detected in advanced (36-48 hpi) and late (72 hpi) infection stages, but not in early stages. In early infection stages, surprisingly, no toxic effect of oxalic acid eventually secreted by S. sclerotiorum was observed. As oxalic acid is a common metabolite in plants, we propose that attacked host cells are able to metabolize oxalic acid in the early infection stage and translocate it to their vacuoles where it is stored as calcium oxalate. The effects, observed on healthy tissue upon external application of oxalic acid to noninfected, living tissue and cell wall degradation of dead host cells starting at the inner side of the walls support this idea. The results indicate that oxalic acid concentrations in the early stage of infection stay below the toxic level. In plant and fungi oxalic acid/calcium oxalate plays an important role in calcium regulation. Oxalic acid likely could quench calcium ions released during cell wall breakdown to protect growing hyphae from toxic calcium concentrations in the infection area. As calcium antimonate-precipitates were found in vesicles of young hyphae, we propose that calcium is translocated to the older parts of hyphae and detoxified by building non-toxic, stable oxalate crystals. We propose an infection model where oxalic acid plays a detoxifying role in late infection stages.	[Heller, Annerose; Witt-Geiges, Tanja] Univ Hohenheim, Inst Bot 210, Stuttgart, Germany	University Hohenheim	Heller, A (corresponding author), Univ Hohenheim, Inst Bot 210, Stuttgart, Germany.	Anne.Heller@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [HE 2230/1-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was partly supported by the Deutsche Forschungsgemeinschaft, HE 2230/1-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arnott H.J., 1995, CALCIUM OXALATE BIOL, P73; BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Billon-Grand G, 2012, MOL PLANT PATHOL, V13, P568, DOI 10.1111/j.1364-3703.2011.00772.x; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; CALLAHAN FE, 1991, PHYTOPATHOLOGY, V81, P1546, DOI 10.1094/Phyto-81-1546; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Cober ER, 2003, CROP SCI, V43, P92, DOI 10.2135/cropsci2003.0092; Cunha WG, 2010, PLANT PATHOL, V59, P654, DOI 10.1111/j.1365-3059.2010.02279.x; DEBARY A, 1886, SCLEROTINIEN SCLEROT, V44, P341; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; FAVALI MA, 1986, CYTOBIOS, V48, P133; FAVARON F, 1988, PHYSIOL MOL PLANT P, V33, P385, DOI 10.1016/0885-5765(88)90005-7; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1989, PROTOPLASMA, V148, P130, DOI 10.1007/BF02079332; Franceschi VR, 1995, CALCIUM OXALATE BIOL, P113; Garg H, 2010, ANN BOT-LONDON, V106, P897, DOI 10.1093/aob/mcq196; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; HAYAT MA, 1975, POSITIVE STAINING EL, P80; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Horner H.T., 1995, CALCIUM OXALATE BIOL, P53; Kasza Z, 2004, CURR MICROBIOL, V48, P208, DOI 10.1007/s00284-003-4166-6; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Li GQ, 2003, MYCOL RES, V107, P1350, DOI 10.1017/S0953756203008591; LI GQ, 2001, P INT S RAP SCI, P261; LIBERT MA, 1837, IANTE CRYTOGAMICAE A; LUMSDEN RD, 1973, PHYTOPATHOLOGY, V63, P708, DOI 10.1094/Phyto-63-708; LUMSDEN RD, 1976, CAN J BOT, V54, P2630, DOI 10.1139/b76-283; MAGRO P, 1984, FEMS MICROBIOL LETT, V24, P9, DOI 10.1111/j.1574-6968.1984.tb01234.x; MARCIANO P, 1982, PHYSIOL PLANT PATHOL, V20, P201, DOI 10.1016/0048-4059(82)90085-6; MARCIANO P, 1983, PHYSIOL PLANT PATHOL, V22, P339; MAXWELL DP, 1970, PHYTOPATHOLOGY, V60, P1395, DOI 10.1094/Phyto-60-1395; NOYES RD, 1981, PHYSIOL PLANT PATHOL, V18, P123; PUNJA ZK, 1985, CAN J PLANT PATHOL, V7, P109, DOI 10.1080/07060668509501485; ROBSON GD, 1991, EXP MYCOL, V15, P263, DOI 10.1016/0147-5975(91)90028-C; Sexton AC, 2006, FEMS MICROBIOL LETT, V258, P150, DOI 10.1111/j.1574-6968.2006.00212.x; Ten Have A, 2002, MYCOTA, V11, P341; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; WOLF G, 1981, PHYTOPATHOLOGY, V71, P596, DOI 10.1094/Phyto-71-596; YASUE T, 1969, Acta Histochemica et Cytochemica, V2, P83; Zhou T, 1999, CAN J PLANT PATHOL, V21, P93, DOI 10.1080/07060661.1999.10600090; Zuppini A, 2005, MOL PLANT MICROBE IN, V18, P849, DOI 10.1094/MPMI-18-0849	48	43	48	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72292	10.1371/journal.pone.0072292	http://dx.doi.org/10.1371/journal.pone.0072292			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951305	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300187
J	Othman, S; Roe, AJ; Parton, R; Coote, JG				Othman, Sarah; Roe, Andrew J.; Parton, Roger; Coote, John G.			Use of a Dual Reporter Plasmid to Demonstrate Bactofection with an Attenuated AroA(-) Derivative of Pasteurella multocida B:2	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; HEMORRHAGIC SEPTICEMIA; LISTERIA-MONOCYTOGENES; PROTECTIVE IMMUNITY; MAMMALIAN-CELLS; GENE-TRANSFER; DNA VACCINES; VACCINATION; DELIVERY; B-2	A reporter plasmid pSRG has been developed which expresses red fluorescent protein (RFP) from a constitutive prokaryotic promoter within Pasteurella multocida B: 2 and green fluorescent protein (GFP) from a constitutive eukaryotic promoter within mammalian cells. This construct has been used to determine the location and viability of the bacteria when moving from the extracellular environment into the intracellular compartment of mammalian cells. Invasion assays with embryonic bovine lung (EBL) cells and an attenuated AroA(-) derivative of Pasteurella multocida B: 2 (strain JRMT12), harbouring the plasmid pSRG, showed that RFP-expressing bacteria could be detected intracellularly at 3 h post-invasion. At this stage, some EBL cells harbouring RFP-expressing bacteria were observed to express GFP simultaneously, indicating release of the plasmid into the intracellular environment. At 5 h post-invasion, more EBL cells were expressing GFP, while still harbouring RFP-expressing bacteria. Concurrently, some EBL cells were shown to express only GFP, indicating loss of viable bacteria within these cells. These experiments proved the functionality of the pSRG dual reporter system and the potential of P. multocida B: 2 JRMT12 for bactofection and delivery of a DNA vaccine.	[Othman, Sarah; Roe, Andrew J.; Parton, Roger; Coote, John G.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Othman, S (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang 43400, Selangor, Malaysia.	sarahothman@upm.edu.my	Othman, Sarah/N-1262-2017	Othman, Sarah/0000-0001-5802-6359; roe, andrew/0000-0003-3698-6134	Universiti Putra Malaysia; Ministry of Higher Education, Malaysia	Universiti Putra Malaysia; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	SO is funded by Universiti Putra Malaysia (http://www.upm.edu.my/) and Ministry of Higher Education, Malaysia (http://www.mohe.gov.my/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2000, VACCINE, V18, P2193, DOI 10.1016/S0264-410X(00)00025-6; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; Carter G.R., 1989, PASTEURELLA PASTEURE, P131; Dagleish MP, 2007, INFECT IMMUN, V75, P5837, DOI 10.1128/IAI.00834-07; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Darji A, 2000, FEMS IMMUNOL MED MIC, V27, P341; De Alwis MC, 1999, ACIAR P, V57, P99; De Alwis MCL, 1992, ACIAR P, V43, P11; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; Fennelly GJ, 1999, J IMMUNOL, V162, P1603; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Hense M, 2001, CELL MICROBIOL, V3, P599, DOI 10.1046/j.1462-5822.2001.00138.x; Hodgson JC, 2005, INFECT IMMUN, V73, P1475, DOI 10.1128/IAI.73.3.1475-1481.2005; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Othman S, 2012, MICROB PATHOGENESIS, V52, P353, DOI 10.1016/j.micpath.2012.03.005; Paglia P, 1998, J LEUKOCYTE BIOL, P92; Sambrook J., 2002, MOL CLONING LAB MANU; Tabatabaei M, 2002, INFECT IMMUN, V70, P3355, DOI 10.1128/IAI.70.7.3355-3362.2002	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71524	10.1371/journal.pone.0071524	http://dx.doi.org/10.1371/journal.pone.0071524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951183	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000323097300125
J	Palmer, RK; Long, D; Brennan, F; Buber, T; Bryant, R; Salemme, FR				Palmer, R. Kyle; Long, Daniel; Brennan, Francis; Buber, Tulu; Bryant, Robert; Salemme, F. Raymond			A High Throughput In Vivo Assay for Taste Quality and Palatability	PLOS ONE			English	Article							MONOSODIUM GLUTAMATE; SWEET TASTE; LICKING RESPONSES; FOOD-DEPRIVATION; UMAMI TASTE; SUCROSE; DISCRIMINATION; RATS; PREFERENCE; AVERSION	Taste quality and palatability are two of the most important properties measured in the evaluation of taste stimuli. Human panels can report both aspects, but are of limited experimental flexibility and throughput capacity. Relatively efficient animal models for taste evaluation have been developed, but each of them is designed to measure either taste quality or palatability as independent experimental endpoints. We present here a new apparatus and method for high throughput quantification of both taste quality and palatability using rats in an operant taste discrimination paradigm. Cohorts of four rats were trained in a modified operant chamber to sample taste stimuli by licking solutions from a 96-well plate that moved in a randomized pattern beneath the chamber floor. As a rat's tongue entered the well it disrupted a laser beam projecting across the top of the 96-well plate, consequently producing two retractable levers that operated a pellet dispenser. The taste of sucrose was associated with food reinforcement by presses on a sucrose-designated lever, whereas the taste of water and other basic tastes were associated with the alternative lever. Each disruption of the laser was counted as a lick. Using this procedure, rats were trained to discriminate 100 mM sucrose from water, quinine, citric acid, and NaCl with 90-100% accuracy. Palatability was determined by the number of licks per trial and, due to intermediate rates of licking for water, was quantifiable along the entire spectrum of appetitiveness to aversiveness. All 96 samples were evaluated within 90 minute test sessions with no evidence of desensitization or fatigue. The technology is capable of generating multiple concentration-response functions within a single session, is suitable for in vivo primary screening of tastant libraries, and potentially can be used to evaluate stimuli for any taste system.	[Palmer, R. Kyle; Long, Daniel; Buber, Tulu] Opertech Bio Inc, Philadelphia, PA USA; [Brennan, Francis] Genomind LLC, Chalfont, PA USA; [Bryant, Robert] Asheville Flavor Innovat LLC, Asheville, NC USA; [Salemme, F. Raymond] Imiplex LLC, Bristol, PA USA		Palmer, RK (corresponding author), Opertech Bio Inc, Philadelphia, PA USA.	kpalmer@opertechbio.com			Opertech Bio	Opertech Bio	RKP and DL currently, and TB formerly are employed by Opertech Bio, whose company funded this study and which uses the technology described in the manuscript for commercial purposes. RKP and FRS are named as inventors on a patent application for the described technology (US Application No.: 11/275,059 HIGH-THROUGHPUT OPERANT SENSORY DISCRIMINATION APPARATUS AND METHOD). FB is an employee of Genomind LLC. RB is an employee of Bryant Scientific Consulting LLC. FRS is an employee of Imiplex LLC. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Breslin PAS, 2008, CURR BIOL, V18, pR148, DOI 10.1016/j.cub.2007.12.017; Colpaert FC, 1999, PHARMACOL BIOCHEM BE, V64, P337, DOI 10.1016/S0091-3057(99)00047-7; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; DAVIS JD, 1993, AM J PHYSIOL, V264, pR97, DOI 10.1152/ajpregu.1993.264.1.R97; Delay ER, 2007, NEUROSCIENCE, V148, P266, DOI 10.1016/j.neuroscience.2007.05.045; Delay ER, 2004, CHEM SENSES, V29, P291, DOI 10.1093/chemse/bjh031; Devantier HR, 2008, BEHAV PHARMACOL, V19, P673, DOI 10.1097/FBP.0b013e3283123cd6; Dietz DM, 2006, CHEM SENSES, V31, P33, DOI 10.1093/chemse/bjj003; Dotson CD, 2007, J NEUROSCI, V27, P11242, DOI 10.1523/JNEUROSCI.1227-07.2007; Eddy MC, 2012, CHEM SENSES, V37, P391, DOI 10.1093/chemse/bjr093; Gautam SH, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00019; Geran LC, 2000, BEHAV NEUROSCI, V114, P623, DOI 10.1037/0735-7044.114.3.623; Glendinning JI, 2005, CHEM SENSES, V30, P299, DOI 10.1093/chemse/bji025; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Grobe CL, 2008, PHYSIOL BEHAV, V95, P413, DOI 10.1016/j.physbeh.2008.07.007; Halpern B.P., 1977, DRINK BEHAV, P1, DOI [10.1007/978-1-4684-2319-8_1, DOI 10.1007/978-1-4684-2319-8_1]; Heyer BR, 2003, CHEM SENSES, V28, P631, DOI 10.1093/chemse/bjg056; IWASAKI K, 1986, CHEM SENSES, V11, P79, DOI 10.1093/chemse/11.1.79; Keast RSJ, 2004, CHEM SENSES, V29, P513, DOI 10.1093/chemse/bjh053; Kurihara K, 2009, AM J CLIN NUTR, V90, p719S, DOI 10.3945/ajcn.2009.27462D; Loney GC, 2012, CHEM SENSES, V37, P445, DOI 10.1093/chemse/bjr126; Loney GC, 2011, CHEM SENSES, V36, P733, DOI 10.1093/chemse/bjr048; Long DJ, 2010, J PHARMACOL EXP THER, V332, P525, DOI 10.1124/jpet.109.155416; Manita S, 2006, CHEM SENSES, V31, P785, DOI 10.1093/chemse/bjl020; Mathes CM, 2012, AM J PHYSIOL-REG I, V302, pR751, DOI 10.1152/ajpregu.00214.2011; MORRISON GR, 1969, J COMP PHYSIOL PSYCH, V68, P45, DOI 10.1037/h0027686; MORRISON GR, 1966, CAN J PSYCHOLOGY, V20, P208, DOI 10.1037/h0082938; Murata Y, 2003, CHEM SENSES, V28, P237, DOI 10.1093/chemse/28.3.237; *NAT RES COUNC, 1995, NUTR REQ LAB AN, P15; Palmer RK, 2007, MOL INTERV, V7, P87, DOI 10.1124/mi.7.2.9; SCHIFFMAN SS, 1993, NEUROSCI BIOBEHAV R, V17, P313, DOI 10.1016/S0149-7634(05)80015-6; SCHIFFMAN SS, 1979, PHYSIOL BEHAV, V23, P1, DOI 10.1016/0031-9384(79)90113-6; SCLAFANI A, 1986, PHYSIOL BEHAV, V37, P253, DOI 10.1016/0031-9384(86)90228-3; Servant G, 2010, P NATL ACAD SCI USA, V107, P4746, DOI 10.1073/pnas.0911670107; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Smith JC, 2001, APPETITE, V36, P93, DOI 10.1006/appe.2000.0372; Snyder DJ, 2006, ADV OTO-RHINO-LARYNG, V63, P221, DOI 10.1159/000093762; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Spector AC, 1996, J NEUROSCI, V16, P8115; Spector AC, 2009, CURR OPIN NEUROBIOL, V19, P370, DOI 10.1016/j.conb.2009.07.014; Stapleton JR, 2002, CHEM SENSES, V27, P375, DOI 10.1093/chemse/27.4.375; TAKAHASHI LK, 1980, BEHAV NEURAL BIOL, V29, P527, DOI 10.1016/S0163-1047(80)92863-0; Treesukosol Y, 2012, AM J PHYSL REGUL INT; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Young R, 2009, FRONT NEUROSCI, P39; ZAWALICH WS, 1973, COMP BIOCHEM PHYSIOL, V44, P903, DOI 10.1016/0300-9629(73)90154-0; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	51	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72391	10.1371/journal.pone.0072391	http://dx.doi.org/10.1371/journal.pone.0072391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951319	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300196
J	Schroder, R; Prasse, R				Schroeder, Roland; Prasse, Ruediger			Do Cultivated Varieties of Native Plants Have the Ability to Outperform Their Wild Relatives?	PLOS ONE			English	Article							ASYMMETRIC COMPETITION; GRASSLAND; GRASSES; ESTABLISHMENT; RESTORATION; POPULATIONS; ADAPTATION; STRATEGIES; COMMON; ALIEN	Vast amounts of cultivars of native plants are annually introduced into the semi-natural range of their wild relatives for revegetation and restoration. As cultivars are often selected towards enhanced biomass production and might transfer these traits into wild relatives by hybridization, it is suggested that cultivars and the wild x cultivar hybrids are competitively superior to their wild relatives. The release of such varieties may therefore result in unintended changes in native vegetation. In this study we examined for two species frequently used in re-vegetation (Plantago lanceolata and Lotus corniculatus) whether cultivars and artificially generated intra-specific wild x cultivar hybrids may produce a higher vegetative and generative biomass than their wilds. For that purpose a competition experiment was conducted for two growing seasons in a common garden. Every plant type was growing (a.) alone, (b.) in pairwise combination with a similar plant type and (c.) in pairwise interaction with a different plant type. When competing with wilds cultivars of both species showed larger biomass production than their wilds in the first year only and hybrids showed larger biomass production than their wild relatives in both study years. As biomass production is an important factor determining fitness and competitive ability, we conclude that cultivars and hybrids are competitively superior their wild relatives. However, cultivars of both species experienced large fitness reductions (nearly complete mortality in L. corniculatus) due to local climatic conditions. We conclude that cultivars are good competitors only as long as they are not subjected to stressful environmental factors. As hybrids seemed to inherit both the ability to cope with the local climatic conditions from their wild parents as well as the enhanced competitive strength from their cultivars, we regard them as strong competitors and assume that they are able to outperform their wilds at least over the short-term.	[Schroeder, Roland; Prasse, Ruediger] Leibniz Univ Hannover, Inst Environm Planning, Hannover, Germany	Leibniz University Hannover	Schroder, R (corresponding author), Leibniz Univ Hannover, Inst Environm Planning, Hannover, Germany.	schroeder@umwelt.uni-hannover.de		Schroder, Roland/0000-0002-3067-6517	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Leibniz Universitat Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Leibniz Universitat Hannover	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boller B, 2009, EUPHYTICA, V170, P53, DOI 10.1007/s10681-009-9963-y; Byrne M, 2011, J APPL ECOL, V48, P1365, DOI 10.1111/j.1365-2664.2011.02045.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CAVERS PB, 1980, CAN J PLANT SCI, V60, P1269, DOI 10.4141/cjps80-180; Connolly J, 1996, OECOLOGIA, V108, P311, DOI 10.1007/BF00334656; Dawson W, 2012, ECOL LETT, V15, P873, DOI 10.1111/j.1461-0248.2012.01811.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2012, DATA ANAL USING REGR; GOLDBERG DE, 1987, ECOLOGY, V68, P1211, DOI 10.2307/1939205; GOLDBERG DE, 1987, J ECOL, V75, P1131, DOI 10.2307/2260318; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Hauser TP, 2002, CONSERV GENET, V3, P75; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; JONES DA, 1986, J ECOL, V74, P1185, DOI 10.2307/2260243; KEDDY PA, 1989, OIKOS, V54, P234, DOI 10.2307/3565272; Kitajima K, 2006, BIOL INVASIONS, V8, P1471, DOI 10.1007/s10530-005-5839-9; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert AM, 2011, RESTOR ECOL, V19, P43, DOI 10.1111/j.1526-100X.2010.00673.x; Levin DA, 2001, SYST BOT, V26, P197; Lumaret R., 1990, BIOL INVASIONS EUROP, P392; Peter-Schmid MKI, 2008, EUPHYTICA, V164, P239, DOI 10.1007/s10681-008-9719-0; Prasse R, 2010, AZ23931 UNV ABSCHL D; R Development Core Team, 2012, R LANG ENV STAT COMP; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Schroder R, 2013, RESTOR ECOL, V21, P793, DOI 10.1111/rec.12018; Stevens JM, 2011, RESTOR ECOL, V19, P399, DOI 10.1111/j.1526-100X.2009.00565.x; Van Gaal TM, 1998, SCI HORTIC-AMSTERDAM, V76, P73, DOI 10.1016/S0304-4238(98)00119-8; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Vergeer P, 2004, CONSERV BIOL, V18, P812, DOI 10.1111/j.1523-1739.2004.00562.x; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Warren J, 2002, OECOLOGIA, V132, P125, DOI 10.1007/s00442-002-0935-3; Warren JM, 1998, HEREDITY, V81, P556, DOI 10.1046/j.1365-2540.1998.00426.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Zuur Alain F., 2009, P1	41	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71066	10.1371/journal.pone.0071066	http://dx.doi.org/10.1371/journal.pone.0071066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951081	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300082
J	Wang, SW; Wang, JS; Lin, PL; Li, ZB; Yao, C; Chang, GQ; Li, XX; Wang, SM				Wang, Siwen; Wang, Jinsong; Lin, Peiliang; Li, Zhibin; Yao, Chen; Chang, Guangqi; Li, Xiaoxi; Wang, Shenming			Short-Term Curative Effect of Endovascular Stent-Graft Treatment for Aortic Diseases in China: A Systematic Review	PLOS ONE			English	Article							DISSECTION; REPAIR; ANEURYSMS; PLACEMENT; EXPERIENCE; TRIAL; METAANALYSIS; EUROSTAR	Introduction: We analyzed the short-term efficacy of endovascular treatment for aortic diseases by summarizing all available published data on endovascular stent-graft treatment for abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), type A aortic dissection (type A AD) and type B aortic dissection (type B AD) in China. Methods: We performed a systematic analysis of 935 published series on retrograde endovascular treatment for aortic diseases in China from January 1996 to November 2010. Based on the inclusion criteria, 159 studies, involving a total of 5531 patients, were included. Results: There were no significant differences in procedural success among the studies (P>0.05). The rates of overall neurologic complications and stroke were significantly different in all two-group comparisons (P<0.01). The type A AD patients had the highest rates of neurologic complications (both 6.67 +/- 0.00%), and the AAA patients had the lowest rates (0.31 +/- 0.04% and 0.11 +/- 0.02%). Significant differences were noted in the rates of cardiac, renal, pulmonary and visceral complications, which were all higher in the type A AD patients than in the other three groups (P<0.01). The endoleak rate was highest in the TAA patients (19.27 +/- 5.74%) and was similar in the type A AD patients (P>0.05). A significant difference was noted between the 30-day mortality rate of the type A AD patients and the AAA or type B AD patients (P>0.05). Conclusion: Endovascular stent-graft is a feasible and safe treatment for aortic diseases, with high procedural success and low incidences of post-procedural complications and short-term mortality. Endovascular treatment for AAA and type B AD is more efficient than for type A AD and TAA.	[Wang, Siwen; Wang, Jinsong; Lin, Peiliang; Yao, Chen; Chang, Guangqi; Li, Xiaoxi; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc & Thyroid Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhibin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, SM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc & Thyroid Surg, Guangzhou 510275, Guangdong, Peoples R China.	shenming_wang@126.com						Corbillon E, 2008, J VASC SURG, V47, P1099, DOI 10.1016/j.jvs.2007.11.021; Cronenwett JL, 2005, RUTHERFORD VASCULAR; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; Eggebrecht H, 2006, EUR HEART J, V27, P489, DOI 10.1093/eurheartj/ehi493; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Ius F, 2010, ANN THORAC SURG, V90, P1450, DOI 10.1016/j.athoracsur.2010.06.087; Jing Z, 1998, Zhonghua Wai Ke Za Zhi, V36, P212; Jing Z, 1999, ACAD J SEC MIL MED U, V20, P828; Kato M, 2002, J THORAC CARDIOV SUR, V124, P531, DOI 10.1067/mtc.2002.124388; Katzen BT, 2005, CIRCULATION, V112, P1663, DOI 10.1161/CIRCULATIONAHA.105.541284; Leurs LJ, 2004, J VASC SURG, V40, P670, DOI 10.1016/j.jvs.2004.07.008; Lovegrove RE, 2008, BRIT J SURG, V95, P677, DOI 10.1002/bjs.6240; Makaroun MS, 2011, J VASC SURG, V54, P601, DOI 10.1016/j.jvs.2011.03.002; Marin ML, 2003, ANN SURG, V238, P586, DOI 10.1097/01.sla.0000090473.63393.e9; Mizuno T, 2002, EUR J CARDIO-THORAC, V22, P504, DOI 10.1016/S1010-7940(02)00429-3; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Ohki T, 2001, ANN SURG, V234, P323, DOI 10.1097/00000658-200109000-00006; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Sueda T, 1999, Ann Thorac Cardiovasc Surg, V5, P206; Sun LZ, 2002, ZHONGHUA WAI KE ZA Z, V42, P812; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823; Wang ZG, 1999, ZHONGGUO PU TONG WAI, V8, P403; Zipfel B, 2011, J ENDOVASC THER, V18, P131, DOI 10.1583/10-3233MR.1	25	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71012	10.1371/journal.pone.0071012	http://dx.doi.org/10.1371/journal.pone.0071012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951070	Green Submitted, gold, Green Published			2022-12-27	WOS:000323097300075
J	Chen, JX; Yuan, T; Liu, MG; Chen, P				Chen, Jingxiang; Yuan, Tao; Liu, Menggang; Chen, Ping			Association between TCF7L2 Gene Polymorphism and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; ATHEROSCLEROSIS RISK; COLORECTAL-CANCER; COLON-CANCER; VARIANTS; COMMUNITIES; POPULATION; CONSORTIUM; BIAS	Objective: The transcription factor 7-like 2 (TCF7L2) gene has been suggested to play an important role in the pathogenesis of cancer. However, the results have been inconsistent. In this study, we performed a meta-analysis to clarify the associations between TCF7L2 polymorphism and cancer risk. Methods: Published literature from PubMed and EMBASE were retrieved. Pooled odds ratios (ORs) with 95% confidence interval (CIs) were calculated using fixed-or random-effects model. Results: A total of 19 studies (14,814 cases and 33,856 controls) were identified for the analysis of the association between TCF7L2 polymorphism and cancer risk. The results showed that TCF7L2 polymorphism was associated with breast cancer (Homogeneous model: OR = 1.17, 95%CI = 1.02-1.35, I-2 = 21.8%, p for heterogeneity = 0.276; Heterogeneous model: OR = 1.11, 95%CI = 1.03-1.20, I-2 = 0.0%, p for heterogeneity = 0.543), prostate cancer (Homogeneous model: OR = 0.89, 95%CI = 0.84-0.96, I-2 = 0.0%, p for heterogeneity = 0.640; Heterogeneous model: OR = 0.89, 95%CI = 0.84-0.95, I-2 = 0.0%, p for heterogeneity = 0.871), and colon cancer (Heterogeneous model: OR = 1.15, 95%CI = 1.01-1.31, I-2 = 0.0%, p for heterogeneity = 0.658), but not with colorectal cancer, lung cancer, and ovarian cancer. Conclusions: The present meta-analysis indicated that there were significantly associations between the TCF7L2 rs7903146 polymorphism and risk of breast, prostate and colon cancers, rather than colorectal cancer, lung cancer, and ovarian cancer.	[Chen, Jingxiang; Yuan, Tao; Liu, Menggang; Chen, Ping] Third Mil Med Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Chen, Jingxiang] Jiangjin Cent Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University	Chen, P (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Chongqing, Peoples R China.	pingchen1956@163.com						Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Connor AE, 2012, BREAST CANCER RES TR, V136, P593, DOI 10.1007/s10549-012-2299-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Domenyuk V. P., 2007, Experimental Oncology, V29, P152; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Goode EL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-312; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Machiela MJ, 2012, AM J EPIDEMIOL, V176, P1121, DOI 10.1093/aje/kws191; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Naidu R, 2012, MED ONCOL, V29, P411, DOI 10.1007/s12032-011-9837-8; Peng SH, 2013, MUTAGENESIS, V28, P25, DOI 10.1093/mutage/ges048; Sainz J, 2012, J CLIN ENDOCR METAB, V97, pE845, DOI 10.1210/jc.2011-2565; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Slattery ML, 2008, CANCER EPIDEM BIOMAR, V17, P978, DOI 10.1158/1055-9965.EPI-07-2687; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933	23	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71730	10.1371/journal.pone.0071730	http://dx.doi.org/10.1371/journal.pone.0071730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951231	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200069
J	Liu, ZJ; Zheng, H; Gottschalk, M; Bai, XM; Lan, RT; Ji, SB; Liu, HC; Xu, JG				Liu, Zhijie; Zheng, Han; Gottschalk, Marcelo; Bai, Xuemei; Lan, Ruiting; Ji, Shaobo; Liu, Haican; Xu, Jianguo			Development of Multiplex PCR Assays for the Identification of the 33 Serotypes of Streptococcus suis	PLOS ONE			English	Article							DISEASED PIGS; CPS LOCUS; GENETIC-ANALYSIS; CAPSULAR TYPES; YOUNG-PIGS; SEQUENCE; MENINGITIS; INFECTION; RELATEDNESS; PNEUMONIAE	Streptococcus suis is an important zoonotic agent causing severe diseases in pigs and humans. To date, 33 serotypes of S. suis have been identified based on antigenic differences in the capsular polysaccharide. The capsular polysaccharide synthesis (cps) locus encodes proteins/enzymes that are responsible for capsular production and variation in the capsule structures are the basis of S. suis serotyping. Multiplex and/or simplex PCR assays have been developed for 15 serotypes based on serotype-specific genes in the cps gene cluster. In this study, we developed a set of multiplex PCR (mPCR) assays to identify the 33 currently known S. suis serotypes. To identify serotype-specific genes for mPCR, the entire genomes of reference strains for the 33 serotypes were sequenced using whole genome high-throughput sequencing, and the cps gene clusters from these strains were identified and compared. We developed a set of 4 mPCR assays based on the polysaccharide polymerase gene wzy, one of the serotype-specific genes. The assays can identify all serotypes except for two pairs of serotypes: 1 and 14, and 2 and 1/2, which have no serotype-specific genes between them. The first assay identifies 12 serotypes (serotypes 1 to 10, 1/2, and 14) that are the most frequently isolated from diseased pigs and patients; the second identifies 10 serotypes (serotypes 11 to 21 except 14); the third identifies the remaining 11 serotypes (serotypes 22 to 31, and 33); and the fourth identifies a new cps cluster of S. suis discovered in this study in 16 isolates that agglutinated with antisera for serotypes 29 and 21. The multiplex PCR assays developed in this study provide a rapid and specific method for molecular serotyping of S. suis.	[Liu, Zhijie; Zheng, Han; Bai, Xuemei; Ji, Shaobo; Liu, Haican; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Liu, Zhijie] Huaihua Med Coll, Dept Lab Med, Huaihua, Hunan, Peoples R China; [Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Grp Rech Malad Infect Du Porc, Quebec City, PQ, Canada; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Universite de Montreal; University of New South Wales Sydney	Xu, JG (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	xujianguo@icdc.cn	Gottschalk, Marcelo/I-8116-2012; Zheng, Han/AAH-6977-2019	Lan, Ruiting/0000-0001-9834-5258	 [2013ZX10004221];  [2013ZX10004216-001-002];  [812111251]	; ; 	This study was supported by grant (2013ZX10004221, 2013ZX10004216-001-002 and 812111251) from Minister of Science and Technology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1998, VET MICROBIOL, V60, P59, DOI 10.1016/S0378-1135(98)00147-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Boyle B, 2012, J BACTERIOL, V194, P6343, DOI 10.1128/JB.01559-12; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Demoor CE, 1963, DESIGNATED R S T A V, V29, P272, DOI [10.1007/BF02046069, DOI 10.1007/BF02046069]; ELLIOTT SD, 1966, J HYG-CAMB, V64, P205, DOI 10.1017/S0022172400040468; Gottschalk M., 2012, DIS SWINE, P841; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2013, VET MICROBIOL, V162, P819, DOI 10.1016/j.vetmic.2012.10.028; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HAREL J, 1994, CAN J VET RES, V58, P259; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Hill JE, 2005, VET MICROBIOL, V107, P63, DOI 10.1016/j.vetmic.2005.01.003; Huang Yu-Tsung, 2005, Journal of Microbiology Immunology and Infection, V38, P306; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; KATAOKA Y, 1993, J VET MED SCI, V55, P623, DOI 10.1292/jvms.55.623; KAY R, 1995, QJM-INT J MED, V88, P39; Kerdsin A, 2012, J MED MICROBIOL, V61, P1669, DOI 10.1099/jmm.0.048587-0; Kerdsin A, 2011, LANCET, V378, P960, DOI 10.1016/S0140-6736(11)60923-9; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; Kim D, 2010, CAN J VET RES, V74, P314; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Le HTT, 2013, VET MICROBIOL, V162, P842, DOI 10.1016/j.vetmic.2012.11.001; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Messier S, 2008, CAN VET J, V49, P461; Mural R J, 2000, Brief Bioinform, V1, P199, DOI 10.1093/bib/1.2.199; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okura M, 2013, APPL ENVIRON MICROB, V79, P2796, DOI 10.1128/AEM.03742-12; Prosdocimi F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000900014; Schultsz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033854; Smith HE, 1999, J CLIN MICROBIOL, V37, P3146, DOI 10.1128/JCM.37.10.3146-3152.1999; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 1999, FEMS MICROBIOL LETT, V178, P265, DOI 10.1111/j.1574-6968.1999.tb08686.x; Takeuchi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031265; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilaichone Ratha-Korn, 2002, Journal of the Medical Association of Thailand, V85, pS109; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002; Wang KC, 2012, J CLIN MICROBIOL, V50, P3329, DOI 10.1128/JCM.01584-12; Wang KC, 2011, FEMS MICROBIOL LETT, V324, P117, DOI 10.1111/j.1574-6968.2011.02394.x; Wang KC, 2011, VET MICROBIOL, V153, P403, DOI 10.1016/j.vetmic.2011.05.050; Wei ZG, 2009, VET MICROBIOL, V137, P196, DOI 10.1016/j.vetmic.2008.12.015; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; WINDSOR RS, 1975, J HYG-CAMBRIDGE, V75, P69, DOI 10.1017/S0022172400047070; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Wisselink HJ, 2002, J CLIN MICROBIOL, V40, P2922, DOI 10.1128/JCM.40.8.2922-2929.2002; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yu Hong-jie, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P636; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	59	54	65	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72070	10.1371/journal.pone.0072070	http://dx.doi.org/10.1371/journal.pone.0072070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951285	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200078
J	Lu, JC; Chang, YT; Wang, CT; Lin, YC; Lin, CK; Wu, ZS				Lu, Juu-Chin; Chang, Yu-Tzu; Wang, Chih-Tien; Lin, Yu-Chun; Lin, Chun-Ken; Wu, Zhong-Sheng			Trichostatin A Modulates Thiazolidinedione-Mediated Suppression of Tumor Necrosis Factor alpha-Induced Lipolysis in 3T3-L1 Adipocytes	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; ADIPOSE TRIGLYCERIDE LIPASE; PRIMARY RAT ADIPOCYTES; SIGNAL-RELATED KINASE; GAMMA PPAR-GAMMA; INSULIN-RESISTANCE; GENE-EXPRESSION; VALPROIC ACID; MOLECULAR-MECHANISMS; MAPK PHOSPHATASE-1	In obesity, high levels of tumor necrosis factor a (TNF alpha) stimulate lipolysis in adipocytes, leading to hyperlipidemia and insulin resistance. Thiazolidinediones (TZDs), the insulin-sensitizing drugs, antagonize TNF alpha-induced lipolysis in adipocytes, thereby increasing insulin sensitivity in diabetes patients. The cellular target of TZDs is peroxisome proliferator-activated receptor gamma (PPAR gamma), a nuclear receptor that controls many adipocyte functions. As a transcription factor, PPAR gamma is closely modulated by coregulators, which include coactivators and corepressors. Previous studies have revealed that in macrophages, the insulin-sensitizing effect of PPAR gamma may involve suppression of proinflammatory gene expression by recruiting the corepressor complex that contains corepressors and histone deacetylases (HDACs). Therefore, we investigated whether the corepressor complex is involved in TZD-mediated suppression of TNF alpha-induced lipolysis in 3T3-L1 adipocytes. Trichostatin A (TSA), a pan HDAC inhibitor (HDACI) that inhibits class I and II HDACs, was used to examine the involvement of HDACs in the actions of TZDs. TSA alone increased basal lipolysis and attenuated TZD-mediated suppression of TNF alpha-induced lipolysis. Increased basal lipolysis may in part result from class I HDAC inhibition because selective class I HDACI treatment had similar results. However, attenuation of TZD-mediated TNF alpha antagonism may be specific to TSA and related hydroxamate-based HDACI rather than to HDAC inhibition. Consistently, corepressor depletion did not affect TZD-mediated suppression. Interestingly, TSA treatment greatly reduced PPAR gamma levels in differentiated adipocytes. Finally, extracellular signal-related kinase 1/2 (ERK1/2) mediated TNF alpha-induced lipolysis, and TZDs suppressed TNF alpha-induced ERK phosphorylation. We determined that TSA increased basal ERK phosphorylation, and attenuated TZD-mediated suppression of TNF alpha-induced ERK phosphorylation, consistent with TSA's effects on lipolysis. These studies suggest that TSA, through down-regulating PPAR gamma, attenuates TZD-mediated suppression of TNF alpha-induced ERK phosphorylation and lipolysis in adipocytes.	[Lu, Juu-Chin; Chang, Yu-Tzu; Lin, Yu-Chun] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Lu, Juu-Chin; Lin, Yu-Chun; Lin, Chun-Ken] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Zhong-Sheng] Chang Gung Univ, Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; National Taiwan University	Lu, JC (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.	juuchin@mail.cgu.edu.tw	Wang, Chih-Tien/GRE-8232-2022; Lu, Juu-Chin/ABB-3198-2020	Wang, Chih-Tien/0000-0001-7639-7508; Lu, Juu-Chin/0000-0001-8523-6992	National Science Council [NSC99-2320-B-N-182-020-MY2, NSC101-2320-B-182-007, NSC100-2321-B-002-001]; Chang Gung Medical Research Project [CMRPD180511, CMRPD180512, CMRPD180513]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Project	This study was supported by the National Science Council Grant NSC99-2320-B-N-182-020-MY2, NSC101-2320-B-182-007 (to JCL), NSC100-2321-B-002-001 (to CTW), and Chang Gung Medical Research Project CMRPD180511, CMRPD180512, CMRPD180513 (to JCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Catalioto RM, 2009, EXP CELL RES, V315, P3267, DOI 10.1016/j.yexcr.2009.09.012; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hamed SA, 2007, EPILEPSY RES, V75, P1, DOI 10.1016/j.eplepsyres.2007.04.001; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Jallon P, 2001, DRUG SAFETY, V24, P969, DOI 10.2165/00002018-200124130-00004; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim SN, 2009, ARCH PHARM RES, V32, P535, DOI 10.1007/s12272-009-1409-5; Lagace DC, 2004, ENDOCRINOLOGY, V145, P5493, DOI 10.1210/en.2004-0877; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Landstrom TR, 2000, BIOCHEM J, V346, P337, DOI 10.1042/bj3460337; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Lu JC, 2005, J BIOL CHEM, V280, P33909, DOI 10.1074/jbc.M508118200; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Rapold RA, 2013, J LIPID RES, V54, P63, DOI 10.1194/jlr.M028035; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosenbaum SE, 1998, MOL ENDOCRINOL, V12, P1150, DOI 10.1210/me.12.8.1150; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Wardell SE, 2009, MOL ENDOCRINOL, V23, P388, DOI 10.1210/me.2008-0179; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yang YQ, 2010, BIOCHEM CELL BIOL, V88, P853, DOI [10.1139/O10-116, 10.1139/o10-116]; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	54	16	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71517	10.1371/journal.pone.0071517	http://dx.doi.org/10.1371/journal.pone.0071517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951179	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200052
J	Sturnieks, DL; Menant, J; Delbaere, K; Vanrenterghem, J; Rogers, MW; Fitzpatrick, RC; Lord, SR				Sturnieks, Daina L.; Menant, Jasmine; Delbaere, Kim; Vanrenterghem, Jos; Rogers, Mark W.; Fitzpatrick, Richard C.; Lord, Stephen R.			Force-Controlled Balance Perturbations Associated with Falls in Older People: A Prospective Cohort Study	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; STEPPING RESPONSES; OUTDOOR FALLS; RECOVERY; INDOOR; YOUNG; STABILITY; ADULTS; RISK	Balance recovery from an unpredictable postural perturbation can be a challenging task for many older people and poor recovery could contribute to their risk of falls. This study examined associations between responses to unpredictable perturbations and fall risk in older people. 242 older adults (80.0+/-4.4 years) underwent assessments of stepping responses to multi-directional force-controlled waist-pull perturbations. Participants returned monthly falls calendars for the subsequent 12 months. Future falls were associated with lower force thresholds for stepping in the posterior and lateral but not anterior directions. Those with lower posterior force thresholds for stepping were 68% more likely to fall at home than those with higher force thresholds for stepping. These results suggest that amount of force that can be withstood following an unpredictable balance perturbation predicts future falls in community-dwelling older adults. Perturbations in the posterior direction best discriminated between future fallers and non-fallers.	[Sturnieks, Daina L.; Menant, Jasmine; Delbaere, Kim; Fitzpatrick, Richard C.; Lord, Stephen R.] Neurosci Res Australia, Sydney, NSW, Australia; [Sturnieks, Daina L.; Menant, Jasmine; Delbaere, Kim; Fitzpatrick, Richard C.; Lord, Stephen R.] Univ New S Wales, Sydney, NSW, Australia; [Vanrenterghem, Jos] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Rogers, Mark W.] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	Neuroscience Research Australia; University of New South Wales Sydney; Liverpool John Moores University; University System of Maryland; University of Maryland Baltimore	Sturnieks, DL (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	d.sturnieks@neura.edu.au	Menant, Jasmine C/A-7457-2015; Sturnieks, Daina L/D-5379-2011; Lord, Stephen R/C-9612-2011; Delbaere, Kim/D-6370-2011	Menant, Jasmine C/0000-0001-8686-0500; Delbaere, Kim/0000-0002-5655-0234; Lord, Stephen R/0000-0002-7111-8802; Vanrenterghem, Jos/0000-0002-1682-8430; Sturnieks, Daina/0000-0002-4602-7685	National Health and Medical Research Council of Australia [510110, 350833]; NATIONAL INSTITUTE ON AGING [P30AG028747] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), Project Grant 510110 and Program Grant 350833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Bhatt T, 2012, ARCH PHYS MED REHAB, V93, P557, DOI 10.1016/j.apmr.2011.10.027; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Hall CD, 2002, J AM GERIATR SOC, V50, P1782, DOI 10.1046/j.1532-5415.2002.50505.x; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Hsiao-Wecksler ET, 2008, J ELECTROMYOGR KINES, V18, P179, DOI 10.1016/j.jelekin.2007.06.007; Kelsey JL, 2010, J AM GERIATR SOC, V58, P2135, DOI 10.1111/j.1532-5415.2010.03062.x; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; LORD SR, 1994, MED J AUSTRALIA, V160, P684, DOI 10.5694/j.1326-5377.1994.tb125905.x; LUCHIES CW, 1994, J AM GERIATR SOC, V42, P506, DOI 10.1111/j.1532-5415.1994.tb04972.x; Maki B, 2001, CONTROL POSTURE GAIT, P126; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Manty M, 2009, AGE AGEING, V38, P757, DOI 10.1093/ageing/afp178; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; MCILROY WE, 1993, BRAIN RES, V616, P30, DOI 10.1016/0006-8993(93)90188-S; Mille ML, 2005, CLIN BIOMECH, V20, P607, DOI 10.1016/j.clinbiomech.2005.03.004; Mille ML, 2003, J NEUROPHYSIOL, V90, P666, DOI 10.1152/jn.00974.2002; Mille ML, 2013, J J GERON A IN PRESS; Pai YC, 1998, J BIOMECH, V31, P1111, DOI 10.1016/S0021-9290(98)00124-9; Pavol MJ, 2001, J GERONTOL A-BIOL, V56, pM428, DOI 10.1093/gerona/56.7.M428; Pijnappels M, 2005, GAIT POSTURE, V21, P388, DOI 10.1016/j.gaitpost.2004.04.009; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schulz BW, 2005, GAIT POSTURE, V22, P198, DOI 10.1016/j.gaitpost.2004.09.004; Sturnieks DL, 2012, GAIT POSTURE, V36, P356, DOI 10.1016/j.gaitpost.2012.03.007; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Yungher DA, 2012, CLIN BIOMECH, V27, P151, DOI 10.1016/j.clinbiomech.2011.09.003	32	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70981	10.1371/journal.pone.0070981	http://dx.doi.org/10.1371/journal.pone.0070981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23951059	Green Published, gold			2022-12-27	WOS:000326473200027
J	Teixeira, AL; Gomes, M; Nogueira, A; Azevedo, AS; Assis, J; Dias, F; Santos, JI; Lobo, F; Morais, A; Mauricio, J; Medeiros, R				Teixeira, Ana L.; Gomes, Monica; Nogueira, Augusto; Azevedo, Andreia S.; Assis, Joana; Dias, Francisca; Santos, Juliana I.; Lobo, Francisco; Morais, Antonio; Mauricio, Joaquina; Medeiros, Rui			Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGF beta 1 Signaling Pathway Modulation	PLOS ONE			English	Article							GASTRIC-CANCER; BREAST-CANCER; BETA; POLYMORPHISMS; TGFBR2; RISK; EXPRESSION; CARCINOMA; TRANSFORMING-GROWTH-FACTOR-BETA-1; INACTIVATION	Prostate cancer (PC) is the most frequently diagnosed cancer in men. The acquisition of castration-resistant (CR) phenotype is associated with the activation of signaling pathways mediated by growth factors. The TGF beta 1 and its receptors have an important role in tumor progression, being the pro-apoptotic function modulated by the expression of TGFBR2. A single nucleotide polymorphism -875 G > A in TGFBR2 gene has been described, which may influence the expression levels of the receptor. Our purpose was to investigate the potential role of TGFBR2-875G>A in PC risk and in the response to androgen deprivation therapy (ADT). TGFBR2-875G>A polymorphism was studied by allelic discrimination using real-time polymerase chain reaction (PCR) in 891 patients with PC and 874 controls. A follow-up study was undertaken to evaluate response to ADT. The TGFBR2 and SMAD7 mRNA expression were analyzed by a quantitative real-time PCR. We found that TGFBR2-875GG homozygous patients present lower expression levels of TGFBR2 mRNA (AA/AG: 2(Delta Delta CT) = 1.5, P=0.016). GG genotype was also associated with higher Gleason grade (OR=1.51, P=0.019) and increased risk of an early relapse after ADT (HR=1.47, P=0.024). The concordance (c) index analysis showed that the definition of profiles that contains information regarding tumor characteristics associated with genetic information present an increased capacity to predict the risk for CR development (c-index model 1:0.683 vs model 2:0.736 vs model 3:0.746 vs model 4:0.759). The TGFBR2-875G>A contribution to an early relapse in ADT patients, due to changes in mRNA expression, supports the involvement of TGF beta 1 pathway in CRPC. Furthermore, according to our results, we hypothesize the potential benefits of the association of genetic information in predictive models of CR development.	[Teixeira, Ana L.; Gomes, Monica; Nogueira, Augusto; Azevedo, Andreia S.; Assis, Joana; Dias, Francisca; Santos, Juliana I.; Medeiros, Rui] Portuguese Inst Oncol Porto, Mol Oncol Grp, Porto, Portugal; [Teixeira, Ana L.; Gomes, Monica; Dias, Francisca; Santos, Juliana I.; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci, P-4100 Porto, Portugal; [Lobo, Francisco; Morais, Antonio] Portuguese Inst Oncol Porto, Dept Urol, Porto, Portugal; [Mauricio, Joaquina] Portuguese Inst Oncol Porto, Dept Oncol, Porto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, Fac Hlth Sci, Porto, Portugal; [Medeiros, Rui] Portuguese League Canc NRNorte, Res Dept, Porto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Universidade Fernando Pessoa	Medeiros, R (corresponding author), Portuguese Inst Oncol Porto, Mol Oncol Grp, Porto, Portugal.	ruimedei@ipoporto.min-saude.pt	Dias, Francisca/P-1272-2018; Dias, Francisca/AAH-4148-2021; Medeiros, Rui/C-7938-2009; Teixeira, Ana Luísa/ABB-3437-2020	Dias, Francisca/0000-0002-4993-4467; Dias, Francisca/0000-0002-4993-4467; Medeiros, Rui/0000-0003-3010-8373; Azevedo, Andreia Sofia/0000-0002-0521-2841; Santos, Juliana Ines/0000-0001-8613-6942; Gomes, Monica/0000-0001-9947-5775; Teixeira, Ana L/0000-0002-7489-2211; Nogueira, Augusto/0000-0002-5447-0791	FCT [PTDC/SAU-FCF/71552/2006, SFRH/BD/47381/2008]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors would like to thank the Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer) and Fundacao para a Ciencia e Tecnologia (FCT), this project was partially sponsored by an unrestricted educational grant for basic research in molecular oncology from FCT (PTDC/SAU-FCF/71552/2006). ALT is a Doctoral degree grant holder from FCT (SFRH/BD/47381/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, ONCOLOGIST, V16, P264, DOI 10.1634/theoncologist.2010-0216; Aschelter AM, 2012, FRONT ENDOCRINOL, V3, P1; Aschelter Anna M, 2012, Front Endocrinol (Lausanne), V3, P128, DOI 10.3389/fendo.2012.00128; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Bruckheimer EM, 2001, ENDOCRINOLOGY, V142, P2419, DOI 10.1210/en.142.6.2419; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chen LQ, 2011, CLIN CANCER RES, V17, P6218, DOI 10.1158/1078-0432.CCR-11-1548; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Choe BK, 2012, MOL CELL TOXICOL, V8, P1, DOI 10.1007/s13273-012-0001-0; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grady WM, 2006, INT J CANCER, V118, P600, DOI 10.1002/ijc.21399; Guo W, 2012, MOL BIOL REP, V39, P4301, DOI 10.1007/s11033-011-1217-0; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hou XY, 2012, ADV UROL, V2012, DOI 10.1155/2012/978531; Jin GF, 2008, J CANCER RES CLIN, V134, P345, DOI 10.1007/s00432-007-0290-1; Jin GF, 2007, INT J CANCER, V120, P1330, DOI 10.1002/ijc.22443; Jin QR, 2004, INT J CANCER, V112, P94, DOI 10.1002/ijc.20370; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Li ZH, 2004, CARCINOGENESIS, V25, P237, DOI 10.1093/carcin/bgg197; Lu Bin, 2009, Ai Zheng, V28, P538; Mottet N, 2011, EUR UROL, V59, P572, DOI 10.1016/j.eururo.2011.01.025; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Seijo ER, 2001, MUTAT RES-FUND MOL M, V483, P19, DOI 10.1016/S0027-5107(01)00217-2; Teixeira AL, 2009, PHARMACOGENOMICS J, V9, P341, DOI 10.1038/tpj.2009.20; Teixeira AL, 2008, CLIN CANCER RES, V14, P3367, DOI 10.1158/1078-0432.CCR-07-5119; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wikstrom P, 2001, MICROSC RES TECHNIQ, V52, P411, DOI 10.1002/1097-0029(20010215)52:4<411::AID-JEMT1026>3.0.CO;2-8; Xu LX, 2011, ONCOL LETT, V2, P371, DOI 10.3892/ol.2011.249; Zhang M, 2011, ONCOL LETT, V2, P653, DOI 10.3892/ol.2011.312	34	23	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e72419	10.1371/journal.pone.0072419	http://dx.doi.org/10.1371/journal.pone.0072419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951322	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200083
J	Zhang, J; Wang, B; Zhang, W; Wei, Y; Bian, Z; Zhang, CY; Li, LM; Zen, K				Zhang, Jing; Wang, Bing; Zhang, Wen; Wei, Yao; Bian, Zhen; Zhang, Chen-Yu; Li, Limin; Zen, Ke			Protein Tyrosine Phosphatase 1B Deficiency Ameliorates Murine Experimental Colitis via the Expansion of Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							CHRONIC INFLAMMATION; IMMUNE-RESPONSES; T-CELLS; PTP1B; OBESITY; ROLES; ACCUMULATION; DISRUPTION; RECEPTORS; DYNAMICS	Protein tyrosine phosphatase 1B (PTP1B) is a key molecule in modulating low-degree inflammatory conditions such as diabetes. The role of PTP1B in other chronic inflammations, however, remains unknown. Here, we report that PTP1B deficiency ameliorates Dextran Sulfate Sodium (DSS)-induced murine experimental colitis via expanding CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs). Employing DSS-induced murine experimental colitis as inflammatory animal model, we found that, compared with wild-type littermates, PTP1B-null mice demonstrated greater resistance to DSS-induced colitis, as reflected by slower weight-loss, greater survival rates and decreased PMN and macrophage infiltration into the colon. The evidence collectively also demonstrated that the resistance of PTP1B-null mice to DSS-induced colitis is based on the expansion of MDSCs. First, PTP1B-null mice exhibited a greater frequency of MDSCs in the bone marrow (BM), peripheral blood and spleen when compared with wild-type littermates. Second, PTP1B levels in BM leukocytes were significantly decreased after cells were induced into MDSCs by IL-6 and GM-CSF, and the MDSC induction occurred more rapidly in PTP1B-null mice than in wild-type littermates, suggesting PTP1B as a negative regulator of MDSCs. Third, the adoptive transfer of MDSCs into mice with DSS-colitis significantly attenuated colitis, which accompanies with a decreased serum IL-17 level. Finally, PTP1B deficiency increased the frequency of MDSCs from BM cells likely through enhancing the activities of signal transducer and activator of transcription 3 (STAT3) and Janus kinase 2 (JAK2). In conclusion, our study provides the first evidences that PTP1B deficiency ameliorates murine experimental colitis via expanding MDSCs.	[Zhang, Jing; Zhang, Wen; Wei, Yao; Bian, Zhen; Zhang, Chen-Yu; Li, Limin; Zen, Ke] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Bing] Peoples Liberat Army 404 Hosp, Weihai, Shandong, Peoples R China	Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; bixuehan2005@163.com; kzen@nju.edu.cn			National Basic Research Program of China (973 Program) [2012CB517603, 2011CB504803]; National Natural Science Foundation of China [30988003, 30225037, 30471991, 30570731]; Natural Science Foundation of Jiangsu Province [BK2011013]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Basic Research Program of China (973 Program, 2012CB517603 and 2011CB504803), the National Natural Science Foundation of China (Nos. 30988003, 30225037, 30471991, 30570731) and the Natural Science Foundation of Jiangsu Province (No. BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Berdnikovs S, 2013, AM J PHYSIOL-LUNG C, V304, pL240, DOI 10.1152/ajplung.00375.2012; Bian Z, 2012, J IMMUNOL, V188, P844, DOI 10.4049/jimmunol.1101736; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Monteleone I, 2012, CURR MOL MED, V12, P592, DOI 10.2174/156652412800620066; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Singh UP, 2012, BRAIN BEHAV IMMUN, V26, P72, DOI 10.1016/j.bbi.2011.07.236; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Xia LJ, 2010, METHOD ENZYMOL, V479, P123, DOI 10.1016/S0076-6879(10)79007-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhao HW, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-57	43	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70828	10.1371/journal.pone.0070828	http://dx.doi.org/10.1371/journal.pone.0070828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951017	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200021
J	Foth, C; Rauhut, OWM				Foth, Christian; Rauhut, Oliver W. M.			The Good, the Bad, and the Ugly: The Influence of Skull Reconstructions and Intraspecific Variability in Studies of Cranial Morphometrics in Theropods and Basal Saurischians	PLOS ONE			English	Article							TYRANNOSAURIDAE DINOSAURIA; EARLY EVOLUTION; DISPARITY; SPHENODON; PATTERNS; TAXONOMY; DIAPSIDA; INSIGHTS; TOOTH; SHAPE	Several studies investigating macroevolutionary skull shape variation in fossil reptiles were published recently, often using skull reconstructions taken from the scientific literature. However, this approach could be potentially problematic, because skull reconstructions might differ notably due to incompleteness and/or deformation of the material. Furthermore, the influence of intraspecific variation has usually not been explored in these studies. Both points could influence the results of morphometric analyses by affecting the relative position of species to each other within the morphospace. The aim of the current study is to investigate the variation in morphometric data between skull reconstructions based on the same specimen, and to compare the results to shape variation occurring in skull reconstructions based on different specimens of the same species (intraspecific variation) and skulls of closely related species (intraspecific variation). Based on the current results, shape variation of different skull reconstructions based on the same specimen seems to have generally little influence on the results of a geometric morphometric analysis, although it cannot be excluded that some erroneous reconstructions of poorly preserved specimens might cause problems occasionally. In contrast, for different specimens of the same species the variation is generally higher than between different reconstructions based on the same specimen. For closely related species, at least with similar ecological preferences in respect to the dietary spectrum, the degree of interspecific variation can overlap with that of intraspecific variation, most probably due to similar biomechanical constraints.	[Foth, Christian; Rauhut, Oliver W. M.] Bayer Staatssammlung Palaontol & Geol, SNSB, Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Rauhut, Oliver W. M.] Univ Munich, GeoBioCtr, Munich, Germany	University of Munich; University of Munich	Foth, C (corresponding author), Bayer Staatssammlung Palaontol & Geol, SNSB, Richard Wagner Str 10, Munich, Germany.	christian.foth@gmx.net	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X	Deutsche Forschungsgemeinschaft [RA1012/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft (http://www.dfg.de) grant number: RA1012/12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PM, 2010, EARTH ENV SCI T R SO, V101, P383, DOI 10.1017/S1755691011020111; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Braun W. J., 2008, 1 COURSE STAT PROGRA; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; Brusatte SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1815; Brusatte SL, 2010, ZOOL J LINN SOC-LOND, V158, P573, DOI 10.1111/j.1096-3642.2009.00563.x; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carpenter K., 1990, P141, DOI 10.1017/CBO9780511608377.013; Carpenter K, 2010, PALEONTOL RES, V14, P250, DOI 10.2517/1342-8144-14.4.250; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chapman R.E., 1990, P21, DOI 10.1017/CBO9780511608377.005; CHURE DJ, 2000, NEW SPECIES ALLOSAUR; CZECHURA G V, 1982, Memoirs of the Queensland Museum, V20, P639; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; FOOTE M, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P101; Foth C, 2012, J EVOLUTION BIOL, V25, P904, DOI 10.1111/j.1420-9101.2012.02479.x; Foth C, 2013, ACTA PALAEONTOL POL, V58, P1, DOI 10.4202/app.2011.0145; Galton P.M., 1984, Geologica et Palaeontologica, V18, P139; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2001, Revue de Paleobiologie, V20, P435; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; GOW C E, 1990, Palaeontologia Africana, V27, P45; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henderson D.M., 2000, GAIA, V15, P219; Henderson DM, 2002, J VERTEBR PALEONTOL, V22, P766, DOI 10.1671/0272-4634(2002)022[0766:TEHITS]2.0.CO;2; Hinic S, 2002, CRANIAL OSTEOLOGY MA; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; LANGER MC, 2009, BIOL REV, V84, P1, DOI DOI 10.1111/J.1469-185X.2008.00058.X; Larson P., 2008, TYRANNOSAURUS REX TY, P103; Lockwood CA, 2005, T R SOC SA, V60, P1, DOI [10.1080/00359190509519178, DOI 10.1080/00359190509519178]; Loewen MA, 2009, VARIATION LATE JURAS, P1; Maleev E.A., 1974, P132; Mallon JC, 2011, J VERTEBR PALEONTOL, V31, P1047, DOI 10.1080/02724634.2011.601484; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meloro C, 2012, J EVOLUTION BIOL, V25, P2194, DOI 10.1111/j.1420-9101.2012.02595.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Molnar R.E., 1990, P71, DOI 10.1017/CBO9780511608377.008; Molnar RE, 2005, LIFE O PAST, P284; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Prentice KC, 2011, J SYST PALAEONTOL, V9, P337, DOI 10.1080/14772019.2011.565081; Prieto-Marquez A, 2011, AM MUS NOVIT, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauhut Oliver W.M., 2011, P119; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Sakamoto M, 2010, P ROY SOC B-BIOL SCI, V277, P3327, DOI 10.1098/rspb.2010.0794; Singleton M, 2002, J HUM EVOL, V42, P547, DOI 10.1006/jhev.2001.0539; Smith DK, 1998, J VERTEBR PALEONTOL, V18, P126, DOI 10.1080/02724634.1998.10011039; Weishampel D.B., 1990, P43, DOI 10.1017/CBO9780511608377.006; Wills MA, 1998, BIOL J LINN SOC, V65, P455, DOI 10.1111/j.1095-8312.1998.tb01149.x; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; ZHAO XJ, 1993, CAN J EARTH SCI, V30, P2027, DOI 10.1139/e93-178	62	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72007	10.1371/journal.pone.0072007	http://dx.doi.org/10.1371/journal.pone.0072007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951279	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000076
J	Lee, K; Huang, XQ; Yang, CC; Lee, D; Ho, V; Nobuta, K; Fan, JB; Wang, K				Lee, Keunsub; Huang, Xiaoqiu; Yang, Chichun; Lee, Danny; Ho, Vincent; Nobuta, Kan; Fan, Jian-Bing; Wang, Kan			A Genome-Wide Survey of Highly Expressed Non-Coding RNAs and Biological Validation of Selected Candidates in Agrobacterium tumefaciens	PLOS ONE			English	Article							COLE1 PLASMID REPLICATION; ANTISENSE RNA; MESSENGER-RNA; PLANT PATHOGEN; RIBOSOMAL-RNA; SOLUBLE-RNAS; DIFFERENTIAL EXPRESSION; REGULATES EXPRESSION; GENE-EXPRESSION; DUAL-FUNCTION	Agrobacterium tumefaciens is a plant pathogen that has the natural ability of delivering and integrating a piece of its own DNA into plant genome. Although bacterial non-coding RNAs (ncRNAs) have been shown to regulate various biological processes including virulence, we have limited knowledge of how Agrobacterium ncRNAs regulate this unique inter-Kingdom gene transfer. Using whole transcriptome sequencing and an ncRNA search algorithm developed for this work, we identified 475 highly expressed candidate ncRNAs from A. tumefaciens C58, including 101 trans-encoded small RNAs (sRNAs), 354 antisense RNAs (asRNAs), 20 5' untranslated region (UTR) leaders including a RNA thermosensor and 6 riboswitches. Moreover, transcription start site (TSS) mapping analysis revealed that about 51% of the mapped mRNAs have 5' UTRs longer than 60 nt, suggesting that numerous cis-acting regulatory elements might be encoded in the A. tumefaciens genome. Eighteen asRNAs were found on the complementary strands of virA, virB, virC, virD, and virE operons. Fifteen ncRNAs were induced and 7 were suppressed by the Agrobacterium virulence (vir) gene inducer acetosyringone (AS), a phenolic compound secreted by the plants. Interestingly, fourteen of the AS-induced ncRNAs have putative vir box sequences in the upstream regions. We experimentally validated expression of 36 ncRNAs using Northern blot and Rapid Amplification of cDNA Ends analyses. We show functional relevance of two 5' UTR elements: a RNA thermonsensor (C1_109596F) that may regulate translation of the major cold shock protein cspA, and a thi-box riboswitch (C1_2541934R) that may transcriptionally regulate a thiamine biosynthesis operon, thiCOGG. Further studies on ncRNAs functions in this bacterium may provide insights and strategies that can be used to better manage pathogenic bacteria for plants and to improve Agrobacterum-mediated plant transformation.	[Lee, Keunsub; Yang, Chichun; Wang, Kan] Iowa State Univ, Inst Plant Sci, Ctr Plant Transformat, Ames, IA 50011 USA; [Lee, Keunsub; Yang, Chichun; Wang, Kan] Iowa State Univ, Dept Agron, Ames, IA USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Lee, Danny; Ho, Vincent; Nobuta, Kan; Fan, Jian-Bing] Illumina Inc, Sci Res, San Diego, CA USA	Iowa State University; Iowa State University; Iowa State University; Illumina	Wang, K (corresponding author), Iowa State Univ, Inst Plant Sci, Ctr Plant Transformat, Ames, IA 50011 USA.	kanwang@iastate.edu	Wang, Kan/X-2324-2019; Lee, Keunsub/AAI-3673-2020	Lee, Keunsub/0000-0002-3174-2475	Iowa State University Plant Sciences Institute	Iowa State University Plant Sciences Institute	This work was supported by Iowa State University Plant Sciences Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2006, J COMPUT BIOL, V13, P267, DOI 10.1089/cmb.2006.13.267; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BANTA LM, 1994, J BACTERIOL, V176, P3242, DOI 10.1128/jb.176.11.3242-3249.1994; BELASCO JG, 1988, GENE, V72, P15, DOI 10.1016/0378-1119(88)90123-0; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chai YR, 2005, MOL MICROBIOL, V56, P1574, DOI 10.1111/j.1365-2958.2005.04636.x; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Clemente T, 2006, METH MOL B, V343, P143; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dorazi R, 2003, J THEOR BIOL, V225, P383, DOI 10.1016/S0022-5193(03)00268-6; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Evguenieva-Hackenberg E, 2005, MOL MICROBIOL, V57, P318, DOI 10.1111/j.1365-2958.2005.04662.x; Farran I, 2008, PLANT BIOTECHNOL J, V6, P516, DOI 10.1111/j.1467-7652.2008.00334.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Frame BR, 2006, METH MOL B, V343, P185; Gelvin SB, 2006, METH MOL B, V343, P77; Gelvin SB, 2006, METH MOL B, V343, P105; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gerhart E, 2005, APPROACHES IDENTIFY; Gimpel M, 2010, MOL MICROBIOL, V76, P990, DOI 10.1111/j.1365-2958.2010.07158.x; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; GOTTESMAN S, 2010, COLD SPRING HARB PER; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Gullerova M, 2010, COLD SH Q B, V75, P299, DOI 10.1101/sqb.2010.75.048; Gustafson AM, 2002, CAN J MICROBIOL, V48, P821, DOI [10.1139/w02-078, 10.1139/W02-078]; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2010, FEBS LETT, V584, P4325, DOI 10.1016/j.febslet.2010.09.024; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Malmgren C, 1997, J BIOL CHEM, V272, P12508, DOI 10.1074/jbc.272.19.12508; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Matthysse AG, 2000, BBA-GENE STRUCT EXPR, V1490, P208, DOI 10.1016/S0167-4781(99)00250-X; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Naville M, 2010, BRIEF FUNCT GENOMICS, V9, P178, DOI 10.1093/bfgp/elq008; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; PAZOUR GJ, 1990, NUCLEIC ACIDS RES, V18, P6909, DOI 10.1093/nar/18.23.6909; PAZOUR GJ, 1991, NUCLEIC ACIDS RES, V19, P1358, DOI 10.1093/nar/19.6.1358-a; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Saad NY, 2012, J BIOL CHEM; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; Tzfira T, 2008, AGROBACTERIUM BIOL B, P735; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Venkova-Canova T, 2003, J BACTERIOL, V185, P2402, DOI 10.1128/JB.185.8.2402-2409.2003; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilms I, 2012, J BACTERIOL, V194, P5209, DOI 10.1128/JB.00510-12; Wilms I, 2012, RNA BIOL, V9, P446, DOI 10.4161/rna.17212; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; WINANS SC, 1988, J BACTERIOL, V170, P4047, DOI 10.1128/jb.170.9.4047-4054.1988; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	91	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70720	10.1371/journal.pone.0070720	http://dx.doi.org/10.1371/journal.pone.0070720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23950988	gold, Green Submitted, Green Published			2022-12-27	WOS:000323124000026
J	Tiwari, G; Mohanty, D				Tiwari, Garima; Mohanty, Debasisa			An In Silico Analysis of the Binding Modes and Binding Affinities of Small Molecule Modulators of PDZ-Peptide Interactions	PLOS ONE			English	Article							DOMAIN PROTEINS; CHEMICAL LIBRARY; RATIONAL DESIGN; RECOGNITION; ANTAGONISTS; INHIBITORS; REGULATOR; MECHANICS; DISCOVERY; KINASE	Inhibitors of PDZ-peptide interactions have important implications in a variety of biological processes including treatment of cancer and Parkinson's disease. Even though experimental studies have reported characterization of peptidomimetic inhibitors of PDZ-peptide interactions, the binding modes for most of them have not been characterized by structural studies. In this study we have attempted to understand the structural basis of the small molecule-PDZ interactions by in silico analysis of the binding modes and binding affinities of a set of 38 small molecules with known K-i or K-d values for PDZ2 and PDZ3 domains of PSD-95 protein. These two PDZ domains show differential selectivity for these compounds despite having a high degree of sequence similarity and almost identical peptide binding pockets. Optimum binding modes for these ligands for PDZ2 and PDZ3 domains were identified by using a novel combination of semi-flexible docking and explicit solvent molecular dynamics (MD) simulations. Analysis of the binding modes revealed most of the peptidomimectic ligands which had high K-i or K-d moved away from the peptide binding pocket, while ligands with high binding affinities remained in the peptide binding pocket. The differential specificities of the PDZ2 and PDZ3 domains primarily arise from differences in the conformation of the loop connecting beta B and beta C strands, because this loop interacts with the N-terminal chemical moieties of the ligands. We have also computed the MM/PBSA binding free energy values for these 38 compounds with both the PDZ domains from multiple 5 ns MD trajectories on each complex i.e. a total of 228 MD trajectories of 5 ns length each. Interestingly, computational binding free energies show good agreement with experimental binding free energies with a correlation coefficient of approximately 0.6. Thus our study demonstrates that combined use of docking and MD simulations can help in identification of potent inhibitors of PDZ-peptide complexes.	[Tiwari, Garima; Mohanty, Debasisa] Natl Inst Immunol, Bioinformat Ctr, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mohanty, D (corresponding author), Natl Inst Immunol, Bioinformat Ctr, Aruna Asaf Ali Marg, New Delhi 110067, India.	deb@nii.res.in	Mohanty, Debasisa/A-1428-2009	MOHANTY, DEBASISA/0000-0002-3374-0588	Department of Biotechnology, Government of India; DBT, India under BTIS project; National Bioscience Career Development award	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DBT, India under BTIS project; National Bioscience Career Development award	This work was supported by the Department of Biotechnology, Government of India grant to National Institute of Immunology, New Delhi. DM also acknowledges financial support from DBT, India under BTIS project and National Bioscience Career Development award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2011, J MED CHEM, V54, P1333, DOI 10.1021/jm1013924; Bach A, 2010, ORG BIOMOL CHEM, V8, P4281, DOI 10.1039/c0ob00025f; Bossard F, 2007, AM J PHYSIOL-LUNG C, V292, pL1085, DOI 10.1152/ajplung.00445.2005; Boucherle B, 2011, BIOORGAN MED CHEM, V19, P4346, DOI 10.1016/j.bmc.2011.05.036; Case D, 2006, AMBER 9; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fujii N, 2007, BIOORG MED CHEM LETT, V17, P549, DOI 10.1016/j.bmcl.2006.10.006; Fujii N, 2007, BIOORG MED CHEM LETT, V17, P546, DOI 10.1016/j.bmcl.2006.10.027; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Hammond MC, 2006, CHEM BIOL, V13, P1247, DOI 10.1016/j.chembiol.2006.11.010; Jeong KW, 2007, ONCOGENE, V26, P487, DOI 10.1038/sj.onc.1209837; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LeBlanc BW, 2010, NEUROSCIENCE, V167, P490, DOI 10.1016/j.neuroscience.2010.02.031; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Mayasundari A, 2008, BIOORG MED CHEM LETT, V18, P942, DOI 10.1016/j.bmcl.2007.12.038; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Pichon X, 2010, MOL THER, V18, P1462, DOI 10.1038/mt.2010.101; Saupe J, 2011, CHEMMEDCHEM, V6, P1411, DOI 10.1002/cmdc.201100094; Shan JF, 2009, J COMPUT AID MOL DES, V23, P37, DOI 10.1007/s10822-008-9236-1; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Udugamasooriya DG, 2008, CHEMBIOCHEM, V9, P1587, DOI 10.1002/cbic.200800126; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; Vogrig A, 2011, BIOORG MED CHEM LETT, V21, P3349, DOI 10.1016/j.bmcl.2011.04.011; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wen WY, 2006, CURR TOP MED CHEM, V6, P711, DOI 10.2174/156802606776894474; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; You L, 2008, MOL CANCER THER, V7, P1633, DOI 10.1158/1535-7163.MCT-08-0155	46	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71340	10.1371/journal.pone.0071340	http://dx.doi.org/10.1371/journal.pone.0071340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951139	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000051
J	Visweswaran, GRR; Steen, A; Leenhouts, K; Szeliga, M; Ruban, B; Hesseling-Meinders, A; Dijkstra, BW; Kuipers, OP; Kok, J; Buist, G				Visweswaran, Ganesh Ram R.; Steen, Anton; Leenhouts, Kees; Szeliga, Monika; Ruban, Beata; Hesseling-Meinders, Anne; Dijkstra, Bauke W.; Kuipers, Oscar P.; Kok, Jan; Buist, Girbe			AcmD, a Homolog of the Major Autolysin AcmA of Lactococcus lactis, Binds to the Cell Wall and Contributes to Cell Separation and Autolysis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; N-ACETYLGLUCOSAMINIDASE; ESCHERICHIA-COLI; ACID BACTERIUM; PEPTIDOGLYCAN HYDROLASE; LYSM DOMAINS; EXPRESSION; PLASMID; SYSTEM; PROTEINS	Lactococcus lactis expresses the homologous glucosaminidases AcmB, AcmC, AcmA and AcmD. The latter two have three C-terminal LysM repeats for peptidoglycan binding. AcmD has much shorter intervening sequences separating the LysM repeats and a lower iso-electric point (4.3) than AcmA (10.3). Under standard laboratory conditions AcmD was mainly secreted into the culture supernatant. An L. lactis acmAacmD double mutant formed longer chains than the acmA single mutant, indicating that AcmD contributes to cell separation. This phenotype could be complemented by plasmid-encoded expression of AcmD in the double mutant. No clear difference in cellular lysis and protein secretion was observed between both mutants. Nevertheless, overexpression of AcmD resulted in increased autolysis when AcmA was present (as in the wild type strain) or when AcmA was added to the culture medium of an AcmA-minus strain. Possibly, AcmD is mainly active within the cell wall, at places where proper conditions are present for its binding and catalytic activity. Various fusion proteins carrying either the three LysM repeats of AcmA or AcmD were used to study and compare their cell wall binding characteristics. Whereas binding of the LysM domain of AcmA took place at pHs ranging from 4 to 8, LysM domain of AcmD seems to bind strongest at pH 4.	[Visweswaran, Ganesh Ram R.; Steen, Anton; Szeliga, Monika; Ruban, Beata; Hesseling-Meinders, Anne; Kuipers, Oscar P.; Kok, Jan; Buist, Girbe] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [Buist, Girbe] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Visweswaran, Ganesh Ram R.; Dijkstra, Bauke W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Groningen, Netherlands; [Leenhouts, Kees] Mucosis BV, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Kok, J (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands.	jan.kok@rug.nl	Kuipers, Oscar/B-6752-2009; Visweswaran, Ganesh Ram R/H-7888-2013; Dijkstra, Bauke W./H-4308-2019; Kok, Jan/C-9972-2012	Kuipers, Oscar/0000-0001-5596-7735; Dijkstra, Bauke W./0000-0001-9731-6586; 	Ubbo-Emmius scholarship from the University of Groningen	Ubbo-Emmius scholarship from the University of Groningen	Ganesh Ram R. Visweswaran is funded by the Ubbo-Emmius scholarship from the University of Groningen (www.rug.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00119-12; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bolotin A, 2012, J BACTERIOL, V194, P1241, DOI 10.1128/JB.06629-11; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Buist G, 1997, APPL ENVIRON MICROB, V63, P2722, DOI 10.1128/AEM.63.7.2722-2728.1997; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Buist G, 1998, J BACTERIOL, V180, P5947, DOI 10.1128/JB.180.22.5947-5953.1998; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Gao Y, 2011, J BACTERIOL, V193, P2886, DOI 10.1128/JB.00358-11; GASSON MJ, 1983, J BACTERIOL, V154, P1; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Huard C, 2004, APPL ENVIRON MICROB, V70, P3493, DOI 10.1128/AEM.70.6.3493-3499.2004; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Inagaki N, 2009, GENE, V447, P61, DOI 10.1016/j.gene.2009.08.004; Kato H, 2012, J BACTERIOL, V194, P2102, DOI 10.1128/JB.00074-12; KEMPER MA, 1993, J BACTERIOL, V175, P5690, DOI 10.1128/JB.175.17.5690-5696.1993; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Leenhouts K, 1998, APPL MICROBIOL BIOT, V49, P417, DOI 10.1007/s002530051192; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Leenhouts K, 1999, ANTON LEEUW INT J G, V76, P367, DOI 10.1023/A:1002095802571; Leenhouts K, 1993, PLASMIDS PRACTICAL A, P65; Lortal S, 2005, INT DAIRY J, V15, P857, DOI 10.1016/j.idairyj.2004.08.024; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Quenee P, 2005, FEMS MICROBIOL LETT, V248, P101, DOI 10.1016/j.femsle.2005.05.026; Ramasamy R, 1999, PARASITE IMMUNOL, V21, P397, DOI 10.1046/j.1365-3024.1999.00239.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEEGERS JFML, 1994, MICROBIOL-UK, V140, P1291, DOI 10.1099/00221287-140-6-1291; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Steen A, 2008, APPL ENVIRON MICROB, V74, P4671, DOI 10.1128/AEM.00103-08; Steen A, 2007, INT DAIRY J, V17, P926, DOI 10.1016/j.idairyj.2006.12.007; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDIE IM, 1983, J GEN MICROBIOL, V129, P663; Visweswaran GRR, 2012, APPL MICROBIOL BIOT, V96, P729, DOI 10.1007/s00253-012-3871-0; Visweswaran GRR, 2011, APPL MICROBIOL BIOT, V92, P921, DOI 10.1007/s00253-011-3637-0; Visweswaran GRR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021582; Visweswaran GRR, 2010, ARCHAEA, V2010, DOI 10.1155/2010/480492; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; ZABAROVSKY ER, 1990, NUCLEIC ACIDS RES, V18, P5912	51	33	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72167	10.1371/journal.pone.0072167	http://dx.doi.org/10.1371/journal.pone.0072167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951292	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000080
J	Ceballos, I; Ruiz, M; Fernandez, C; Pena, R; Rodriguez, A; Sanders, IR				Ceballos, Isabel; Ruiz, Michael; Fernandez, Cristhian; Pena, Ricardo; Rodriguez, Alia; Sanders, Ian R.			The In Vitro Mass-Produced Model Mycorrhizal Fungus, Rhizophagus irregularis, Significantly Increases Yields of the Globally Important Food Security Crop Cassava	PLOS ONE			English	Article							GLOMUS-INTRARADICES; ARBUSCULAR MYCORRHIZA; GENETIC DIVERSITY; CHALLENGE; EXCHANGE; GROWTH	The arbuscular mycorrhizal symbiosis is formed between arbuscular mycorrhizal fungi (AMF) and plant roots. The fungi provide the plant with inorganic phosphate (P). The symbiosis can result in increased plant growth. Although most global food crops naturally form this symbiosis, very few studies have shown that their practical application can lead to large-scale increases in food production. Application of AMF to crops in the tropics is potentially effective for improving yields. However, a main problem of using AMF on a large-scale is producing cheap inoculum in a clean sterile carrier and sufficiently concentrated to cheaply transport. Recently, mass-produced in vitro inoculum of the model mycorrhizal fungus Rhizophagus irregularis became available, potentially making its use viable in tropical agriculture. One of the most globally important food plants in the tropics is cassava. We evaluated the effect of in vitro mass-produced R. irregularis inoculum on the yield of cassava crops at two locations in Colombia. A significant effect of R. irregularis inoculation on yield occurred at both sites. At one site, yield increases were observed irrespective of P fertilization. At the other site, inoculation with AMF and 50% of the normally applied P gave the highest yield. Despite that AMF inoculation resulted in greater food production, economic analyses revealed that AMF inoculation did not give greater return on investment than with conventional cultivation. However, the amount of AMF inoculum used was double the recommended dose and was calculated with European, not Colombian, inoculum prices. R. irregularis can also be manipulated genetically in vitro, leading to improved plant growth. We conclude that application of in vitro R. irregularis is currently a way of increasing cassava yields, that there is a strong potential for it to be economically profitable and that there is enormous potential to improve this efficiency further in the future.	[Ceballos, Isabel; Ruiz, Michael; Rodriguez, Alia] Univ Nacl Colombia, Bogota, Colombia; [Fernandez, Cristhian; Pena, Ricardo] La Salle Univ, Yopal, Colombia; [Sanders, Ian R.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Universidad Nacional de Colombia; Universidad de La Salle; University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	ian.sanders@unil.ch	Sanders, Ian R/T-9988-2017	Sanders, Ian R/0000-0002-9591-8214; Ceballos R, Isabel C/0000-0002-0368-6349; Fernandez Lizarazo, John Cristhian/0000-0001-9015-7404; Pena Venegas, Ricardo Alexander/0000-0002-4204-9043	Swiss National Science Foundation [IZ70Z0-131311/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank the Swiss National Science Foundation (http://www.snf.ch) for funding this study with a Joint Research Project awarded to AR and IRS (project number: IZ70Z0-131311/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Colard A, 2011, APPL ENVIRON MICROB, V77, P6510, DOI 10.1128/AEM.05696-11; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; Croll D, 2008, NEW PHYTOL, V178, P672, DOI 10.1111/j.1469-8137.2008.02381.x; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; F.A.O, 2005, P VAL FOR GLOB CASS; FAO, 2013, FAOSTAT; Foresight, 2011, MIGR GLOB ENV CHANG; Friesen DK, 1997, PLANT SOIL, V196, P289, DOI 10.1023/A:1004226708485; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gross M, 2010, CURR BIOL, V20, pR386, DOI 10.1016/j.cub.2010.04.031; HOWELER RH, 1983, PLANT SOIL, V75, P245, DOI 10.1007/BF02375570; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Martin F, 2008, NEW PHYTOL, V180, P747, DOI 10.1111/j.1469-8137.2008.02671.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; Schwartz MW, 2006, ECOL LETT, V9, P501, DOI 10.1111/j.1461-0248.2006.00910.x; SIEVERDING E, 1985, PLANT SOIL, V88, P213, DOI 10.1007/BF02182447; Sieverding E., 1991, SCHRIFTENREIHE GTZ G; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x	29	90	95	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70633	10.1371/journal.pone.0070633	http://dx.doi.org/10.1371/journal.pone.0070633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23950975	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700045
J	Chen, CW; Chen, TC; Huang, KY; Chou, P; Chen, PF; Lee, CC				Chen, Chih-Wei; Chen, Ting-Chang; Huang, Kuang-Yung; Chou, Pesus; Chen, Pin-Fan; Lee, Ching-Chih			Differential Impact of Statin on New-Onset Diabetes in Different Age Groups: A Population-Based Case-Control Study in Women from an Asian Country	PLOS ONE			English	Article							RETROSPECTIVE LONGITUDINAL COHORT; METABOLIC SYNDROME; RANDOMIZED-TRIALS; RISK; MELLITUS; METAANALYSIS; CHOLESTEROL; PRAVASTATIN; PARTICIPANTS; ATORVASTATIN	Background: Statins reduce cardiovascular risks but increase the risk of new-onset diabetes (NOD). The aim of this study is to determine what effect, if any, statins have on the risk of NOD events in a population-based case-control study. An evaluation of the relationship between age and statin-exposure on NOD risks was further examined in a female Asian population. Method: In a nationwide case-controlled study, the authors assessed 1065 female NOD patients and 10650 controls with matching ages, genders and physician visit dates. The impact of statin-exposure on NOD was examined through multiple logistic regression models. Subgroup analysis for exploring the risk of NOD and statin-exposure in different age groups was performed. Results: Statin-exposure was statistically significantly associated with increased new-onset diabetes risks using multivariate analysis. Interaction effect between age and statin-exposure on NOD risk was noted. For atorvastatin, the risk of cDDDs>60 was highest among the 55-64 year-olds (adjusted odds ratio [OR], 8.0; 95% confidence interval [CI], 2.57-24.90). For rosuvastatin, the risk of cDDDs>60 was highest among the 40-54 year-olds (adjusted OR, 14.8; 95% CI, 2.27-96.15). For simvastatin, the risk of cDDDs>60 was highest among the 55-64 year-olds (adjusted OR, 15.8; 95% CI, 5.77-43.26). For pravastatin, the risk of cDDDs>60 was highest among the 55-64 year-olds (adjusted OR, 14.0; 95% CI, 1.56-125.18). Conclusions: This population-based study found that statin use is associated with an increased risk of NOD in women. The risk of statin-related NOD was more evident for women aged 40-64 years compared to women aged 65 or more, and was cumulative-dose dependent. The use of statins should always be determined by weighing the clinical benefits and potential risks for NOD, and the patients should be continuously monitored for adverse effects.	[Chen, Chih-Wei] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan; [Chen, Ting-Chang; Chen, Pin-Fan] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Chen, Chih-Wei; Chen, Ting-Chang; Huang, Kuang-Yung; Chen, Pin-Fan; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Chen, PF (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan.	hematcd2@hotmail.com; hematcd@hotmail.com			Buddhist Dalin Tzu Chi General Hospital [DTCRD 101(1)-I-15]	Buddhist Dalin Tzu Chi General Hospital	This study was funded in part by the Buddhist Dalin Tzu Chi General Hospital ((DTCRD 101(1)-I-15). No additional external funding was received for this study. The funding resource had no role in the design, analysis of the data or in the decision to submit the manuscript for publication.	Abbas A, 2012, CLIN MED INSIGHTS-EN, V5, P13, DOI 10.4137/CMED.S7591; Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Athyros VG, 2012, ANGIOLOGY, V63, P358, DOI 10.1177/0003319711421341; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baker WL, 2010, DIABETES RES CLIN PR, V87, P98, DOI 10.1016/j.diabres.2009.10.008; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Freeman DJ, 2001, CIRCULATION, V103, P357; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; Koh KK, 2009, ATHEROSCLEROSIS, V204, P483, DOI 10.1016/j.atherosclerosis.2008.09.021; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Ma TC, 2012, CLIN THER, V34, P1977, DOI 10.1016/j.clinthera.2012.08.004; Ma TC, 2012, DRUG AGING, V29, P45, DOI 10.2165/11597250-000000000-00000; Ma Yunsheng, 2013, Ther Adv Cardiovasc Dis, V7, P41, DOI 10.1177/1753944712468499; Mita T, 2007, ENDOCR J, V54, P441, DOI 10.1507/endocrj.K06-198; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shah RV, 2012, CIRCULATION, V126, pE282, DOI 10.1161/CIRCULATIONAHA.112.122135; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243; Wang KL, 2012, J AM COLL CARDIOL, V60, P1231, DOI 10.1016/j.jacc.2012.05.019; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Weng CY, 2012, INT J MED SCI, V9, P730, DOI 10.7150/ijms.4752; Xia FZ, 2008, ENDOCRINOLOGY, V149, P5136, DOI 10.1210/en.2008-0161	28	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71817	10.1371/journal.pone.0071817	http://dx.doi.org/10.1371/journal.pone.0071817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951249	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300159
J	Miron, RJ; Caluseru, OM; Guillemette, V; Zhang, Y; Gemperli, AC; Chandad, F; Sculean, A				Miron, Richard J.; Caluseru, Oana M.; Guillemette, Vincent; Zhang, Yufeng; Gemperli, Anja C.; Chandad, Fatiha; Sculean, Anton			Influence of Enamel Matrix Derivative on Cells at Different Maturation Stages of Differentiation	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; PERIODONTAL-LIGAMENT CELLS; PRIMARY HUMAN OSTEOBLASTS; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; GENE SPLICE PRODUCTS; IN-VITRO; AMELOGENIN GENE; OSTEOGENIC DIFFERENTIATION; STIMULATES PROLIFERATION	Enamel matrix derivative (EMD), a porcine extract harvested from developing porcine teeth, has been shown to promote formation of new cementum, periodontal ligament and alveolar bone. Despite its widespread use, an incredibly large variability among in vitro studies has been observed. The aim of the present study was to determine the influence of EMD on cells at different maturation stages of osteoblast differentiation by testing 6 cell types to determine if cell phenotype plays a role in cell behaviour following treatment with EMD. Six cell types including MC3T3-E1 pre-osteoblasts, rat calvarial osteoblasts, human periodontal ligament (PDL) cells, ROS cells, MG63 cells and human alveolar osteoblasts were cultured in the presence or absence of EMD and proliferation rates were quantified by an MTS assay. Gene expression of collagen1(COL1), alkaline phosphate(ALP) and osteocalcin(OC) were investigated by real-time PCR. While EMD significantly increased cell proliferation of all cell types, its effect on osteoblast differentiation was more variable. EMD significantly up-regulated gene expression of COL1, ALP and OC in cells early in their differentiation process when compared to osteoblasts at later stages of maturation. Furthermore, the effect of cell passaging of primary human PDL cells (passage 2 to 15) was tested in response to treatment with EMD. EMD significantly increased cell proliferation and differentiation of cells at passages 2-5 however had completely lost their ability to respond to EMD by passages 10+. The results from the present study suggest that cell stimulation with EMD has a more pronounced effect on cells earlier in their differentiation process and may partially explain why treatment with EMD primarily favors regeneration of periodontal defects (where the periodontal ligament contains a higher number of undifferentiated progenitor cells) over regeneration of pure alveolar bone defects containing no periodontal ligament and a more limited number of osteoprogenitor cells.	[Miron, Richard J.; Caluseru, Oana M.; Guillemette, Vincent; Chandad, Fatiha] Univ Laval, Fac Med Dent, Quebec City, PQ, Canada; [Miron, Richard J.; Sculean, Anton] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Zhang, Yufeng] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland	Laval University; University of Bern; Wuhan University; Wuhan University; Institut Straumann AG	Miron, RJ (corresponding author), Univ Laval, Fac Med Dent, Pavillon Med Dent,Rue Terrasse, Quebec City, PQ, Canada.	richard.miron.1@ulaval.ca	Miron, Richard/J-4995-2012		Department of Periodontology at the University of Bern; Institut Straumann AG (Basel, Switzerland)	Department of Periodontology at the University of Bern; Institut Straumann AG (Basel, Switzerland)	This work was funded by the Department of Periodontology at the University of Bern, and Institut Straumann AG (Basel, Switzerland). www.straumann.com. The funder had no role in the study design or data collection but assisted with the preparation of the manuscript.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Amin HD, 2012, ACTA BIOMATER; Bartlett JD, 2006, CURR TOP DEV BIOL, V74, P57, DOI 10.1016/S0070-2153(06)74003-0; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9; Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x; Cattaneo V, 2003, J PERIODONTAL RES, V38, P568, DOI 10.1034/j.1600-0765.2003.00690.x; Fong CD, 1998, EUR J ORAL SCI, V106, P324, DOI 10.1111/j.1600-0722.1998.tb02193.x; Galli C, 2006, J PERIODONTOL, V77, P1223, DOI 10.1902/jop.2006.050304; Gerber I., 2002, European Cells & Materials, V3, P19; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x; Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605; Guida L, 2007, J PERIODONTOL, V78, P2190, DOI 10.1902/jop.2007.070185; Hakki SS, 2001, J PERIODONTOL, V72, P679, DOI 10.1902/jop.2001.72.5.679; Hama H, 2008, J PERIODONTAL RES, V43, P179, DOI 10.1111/j.1600-0765.2007.01010.x; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; He JN, 2004, ORAL SURG ORAL MED O, V97, P239, DOI 10.1016/j.tripleo.2003.10.005; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang J, 2006, ORAL SURG ORAL MED O, V102, P698, DOI 10.1016/j.tripleo.2006.02.011; Jue SS, 2010, CLIN ORAL IMPLAN RES, V21, P741, DOI 10.1111/j.1600-0501.2009.01901.x; Kemoun P, 2011, BIOMATERIALS, V32, P7375, DOI 10.1016/j.biomaterials.2011.06.043; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x; MacDougall M, 2000, EUR J ORAL SCI, V108, P303, DOI 10.1034/j.1600-0722.2000.108004303.x; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Miron RJ, 2013, CLIN ORAL INVEST, V17, P405, DOI 10.1007/s00784-012-0742-0; Miron RJ, 2012, J PERIODONTOL, V83, P936, DOI 10.1902/jop.2011.110480; Miron RJ, 2012, J PERIODONTOL, V83, P885, DOI 10.1902/jop.2011.110404; Miron RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023375; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Miron RJ, 2012, CLIN IMPLANT DENT RE; Miron RJ, 2013, CLIN ORAL INVESTIG; Miron RJ, 2013, J PERIODONTOL; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Nokhbehsaim M, 2011, J CLIN PERIODONTOL, V38, P479, DOI 10.1111/j.1600-051X.2010.01696.x; Ohyama M, 2002, J PERIODONTOL, V73, P543, DOI 10.1902/jop.2002.73.5.543; Oida S, 2002, J DENT RES, V81, P103, DOI 10.1177/154405910208100204; Okubo K, 2003, J PERIODONTAL RES, V38, P1, DOI 10.1034/j.1600-0765.2003.01607.x; Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; Schwartz Z, 2000, J PERIODONTOL, V71, P1287, DOI 10.1902/jop.2000.71.8.1287; Sculean A, 2011, CLIN ADV PERIODONTIC, V1, P101, DOI 10.1902/cap.2011.110047; Siggelkow H, 1998, EXP CLIN ENDOCR DIAB, V106, P217, DOI 10.1055/s-0029-1211979; Tokiyasu Y, 2000, J PERIODONTOL, V71, P1829, DOI 10.1902/jop.2000.71.12.1829; Tompkins K, 2005, J BONE MINER RES, V20, P341, DOI 10.1359/JBMR.041107; Tompkins K, 2002, CONNECT TISSUE RES, V43, P224, DOI 10.1080/03008200290001096; van den Dolder J, 2006, J PERIODONTAL RES, V41, P471, DOI 10.1111/j.1600-0765.2006.00894.x; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Wada Y, 2008, J PERIODONTOL, V79, P341, DOI [10.1902/jop.2008.070197, 10.1902/jop.2008.070197 ]; Wada Y, 2012, INT J ORAL MAX IMPL, V27, P849; Wang HL, 2005, J PERIODONTOL, V76, P1601; Weishaupt P, 2008, ORAL SURG ORAL MED O, V106, P304, DOI 10.1016/j.tripleo.2008.02.033; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x; Zhang Feng-qiu, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P6	61	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71008	10.1371/journal.pone.0071008	http://dx.doi.org/10.1371/journal.pone.0071008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951068	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300073
J	Byrne, JH; Voogt, M; Turner, KM; Eyles, DW; McGrath, JJ; Burne, THJ				Byrne, Jacqueline H.; Voogt, Meggie; Turner, Karly M.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.			The Impact of Adult Vitamin D Deficiency on Behaviour and Brain Function in Male Sprague-Dawley Rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ANIMAL-MODEL; SUBSTANTIA-NIGRA; BALB/C MICE; SCHIZOPHRENIA; ALTERS; HYPERLOCOMOTION; METAANALYSIS; STRIATUM; ANXIETY	Background: Vitamin D deficiency is common in the adult population, and this has been linked to depression and cognitive outcomes in clinical populations. The aim of this study was to investigate the effects of adult vitamin D (AVD) deficiency on behavioural tasks of relevance to neuropsychiatric disorders in male Sprague-Dawley rats. Methods: Ten-week old male Sprague-Dawley rats were fed a control or vitamin D deficient diet for 6 weeks prior to, and during behavioural testing. We first examined a range of behavioural domains including locomotion, exploration, anxiety, social behaviour, learned helplessness, sensorimotor gating, and nociception. We then assessed locomotor response to the psychomimetic drugs, amphetamine and MK-801. Attention and vigilance were assessed using the 5 choice serial reaction time task (5C-SRT) and the 5 choice continuous performance task (5C-CPT) and, in a separate cohort, working memory was assessed using the delay match to sample (DMTS) task. We also examined excitatory and inhibitory neurotransmitters in prefrontal cortex and striatum. Results: AVD-deficient rats were deficient in vitamin D-3 (<10 nM) and had normal calcium and phosphate levels after 8-10 weeks on the diet. Overall, AVD deficiency was not associated with an altered phenotype across the range of behavioural domains tested. On the 5C-SRT AVD-deficient rats made more premature responses and more head entries during longer inter-trial intervals (ITI) than control rats. On the 5C-CPT AVD-deficient rats took longer to make false alarm (FA) responses than control rats. AVD-deficient rats had increases in baseline GABA levels and the ratio of DOPAC/HVA within the striatum. Conclusions: AVD-deficient rats exhibited no major impairments in any of the behavioural domains tested. Impairments in premature responses in AVD-deficient rats may indicate that these animals have specific alterations in striatal systems governing compulsive or reward-seeking behaviour.	[Byrne, Jacqueline H.; Voogt, Meggie; Turner, Karly M.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [McGrath, John J.] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Burne, THJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Turner, Karly/F-4607-2012; Burne, Thomas H/C-5656-2009; Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010	Turner, Karly/0000-0003-3714-5118; Burne, Thomas H/0000-0003-3502-9789; Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068; Byrne, Jacqueline/0000-0003-2697-2409	National Health and Medical Research Council of Australia [511066]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 511066 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEMUS KL, 1987, PHYSIOL BEHAV, V39, P435, DOI 10.1016/0031-9384(87)90369-6; Anderson PH, 2007, J STEROID BIOCHEM, V103, P592, DOI 10.1016/j.jsbmb.2006.12.086; Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Baarendse PJJ, 2012, PSYCHOPHARMACOLOGY, V219, P313, DOI 10.1007/s00213-011-2576-x; Balden R, 2012, ENDOCRINOLOGY, V153, P2420, DOI 10.1210/en.2011-1783; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Buccafusco JJ, 2000, J PHARMACOL EXP THER, V295, P438; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Burne THJ, 2004, PHYSIOL BEHAV, V81, P651, DOI 10.1016/j.physbeh.2004.03.004; Burne THJ, 2006, BEHAV BRAIN RES, V174, P119, DOI 10.1016/j.bbr.2006.07.015; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Cui XY, 2013, AM J CLIN NUTR, V97, P907, DOI 10.3945/ajcn.113.061176; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Silva DMD, 2009, J NEUROSCI METH, V177, P289, DOI 10.1016/j.jneumeth.2008.10.011; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; FASMER OB, 1985, NEUROPHARMACOLOGY, V24, P729, DOI 10.1016/0028-3908(85)90006-1; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Hampson RE, 1999, LIFE SCI, V65, P715, DOI 10.1016/S0024-3205(99)00294-5; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Higashi T, 2001, BIOL PHARM BULL, V24, P738, DOI 10.1248/bpb.24.738; HOLICK MF, 1979, BIOCHEMISTRY-US, V18, P1003, DOI 10.1021/bi00573a011; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Hymoller L, 2010, J DAIRY SCI, V93, P2025, DOI 10.3168/jds.2009-2991; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; Kesby JP, 2009, NEUROSCI LETT, V461, P155, DOI 10.1016/j.neulet.2009.05.070; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lalonde R, 2010, FUND CLIN PHARMACOL, V24, P365, DOI 10.1111/j.1472-8206.2009.00772.x; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; OLTON DS, 1968, J COMP PHYSIOL PSYCH, V65, P535, DOI 10.1037/h0025830; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Peinado V, 2004, TOXICOLOGY, V204, P155, DOI 10.1016/j.tox.2004.06.021; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Sams-Dodd F, 1999, REV NEUROSCIENCE, V10, P59; Sanchez B, 2009, J NEUROSCI RES, V87, P723, DOI 10.1002/jnr.21878; Suzuki M, 2013, AM J CLIN NUTR, V97, P1004, DOI 10.3945/ajcn.112.051664; Tekes K, 2009, HORM METAB RES, V41, P277, DOI 10.1055/s-0028-1103287; TENENHOUSE A, 1991, NEUROCHEM INT, V18, P249, DOI 10.1016/0197-0186(91)90192-G; TJOLSEN A, 1991, J PHARMACOL METHOD, V25, P241, DOI 10.1016/0160-5402(91)90014-V; Trang HM, 1998, AM J CLIN NUTR, V68, P854, DOI 10.1093/ajcn/68.4.854; Turner KM, 2013, BEHAV BRAIN RES, V242, P47, DOI 10.1016/j.bbr.2012.12.029; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Zhu Y, 2012, HIPPOCAMPUS, V22, P421, DOI 10.1002/hipo.20908	57	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71593	10.1371/journal.pone.0071593	http://dx.doi.org/10.1371/journal.pone.0071593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951200	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200059
J	Mansouri, L; Paulsson, JM; Moshfegh, A; Jacobson, SH; Lundahl, J				Mansouri, Ladan; Paulsson, Josefin M.; Moshfegh, Ali; Jacobson, Stefan H.; Lundahl, Joachim			Leukocyte Proliferation and Immune Modulator Production in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; WHOLE-BLOOD; T-CELLS; HEMODIALYSIS; RESPONSES; UREMIA; MONOCYTE; ASSAY; RECEPTORS; SECRETION	Introduction: In Chronic Kidney Disease (CKD), immune cells are affected by uremic retention toxins. Given this effect, we analyzed lymphocyte proliferative response and immune modulators production following in vitro stimulation. Methods: Whole blood was drawn from healthy controls, patients with eGFR <20 ml/min/1.73 m(2) (Pre-dialysis, CKD stages 4 and 5) and hemodialysis patients (stage 5D). Peripheral cells were incubated for six days with pokeweed mitogen, concanavalin A, Staphylococcus enterotoxin A or influenza A vaccine. Peripheral lymphocyte proliferation was then analyzed by the "Flow-cytometric Assay of Specific Cell-mediated Immune response in Activated whole blood" (FASCIA) method, and cytokine profile in the cell supernatants was analyzed by the Milliplex multi-array method. Results: The absolute number of lymphoblasts in response to mitogenic stimulation and the number of cells in each CD4+ and CD8+ subpopulation were similar comparing the three groups, except for a single decline in number of lymphoblasts after stimulation with Staphylococcus enterotoxin A, comparing dialysis patients with healthy controls. Levels of interleukin (IL)-2 (p=0.026), -10 (p=0.019) and -15 (p=0.027) in the Staphylococcus enterotoxin A-stimulated supernatant were lower in hemodialysis patients compared to healthy controls. Levels of IL-15 (p=0.017) from pre-dialysis patients and levels of IL-5 (p=0.019) from hemodialysis patients in influenza A vaccine-stimulated supernatants were also lower compared to controls. In pokeweed mitogen-stimulated supernatant, IL-2 levels (p=0.013) were lower in hemodialysis patients compared to pre-dialysis patients. TNF-alpha, IL-10, IL-12, IL-15, IL-8, MCP-1, IP-10, IFN-alpha 2, IL-1 alpha and eotaxin levels were all significantly higher in plasma obtained from CKD patients. Conclusion: Our results suggest that T-cells from CKD patients have similar proliferative response to stimulation compared with healthy individuals. Moreover, however the immune cells show inability to produce selected cytokines, most likely due to the uremic milieu or dialysis procedure.	[Mansouri, Ladan; Paulsson, Josefin M.; Lundahl, Joachim] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Unit Clin Immunol & Allergy, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Stockholm, Sweden; [Jacobson, Stefan H.] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Mansouri, L (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Unit Clin Immunol & Allergy, Stockholm, Sweden.	ladan.mansouri@ki.se			Karolinska Institutet, Stockholm, Sweden; Amgen	Karolinska Institutet, Stockholm, Sweden; Amgen(Amgen)	This study was supported by grants from Karolinska Institutet, Stockholm, Sweden and by Amgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud S, 2010, CLIN VACCINE IMMUNOL, V17, P1124, DOI 10.1128/CVI.00008-10; Ahmed T, 2009, VACCINE, V28, P422, DOI 10.1016/j.vaccine.2009.10.032; Ando M, 2005, NEPHROL DIAL TRANSPL, V20, P2497, DOI 10.1093/ndt/gfi048; Ankersmit HJ, 2001, CLIN EXP IMMUNOL, V125, P142, DOI 10.1046/j.1365-2249.2001.01590.x; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671; Banche G, 2006, NEPHROL DIAL TRANSPL, V21, P3532, DOI 10.1093/ndt/gfl415; Borgstrom E, 2011, J IMMUNOL METHODS, V370, P55, DOI 10.1016/j.jim.2011.05.008; Brunet P, 1998, NEPHROL DIAL TRANSPL, V13, P1745, DOI 10.1093/ndt/13.7.1745; Deenadayalan Anbarasu, 2013, BMC Res Notes, V6, P120, DOI 10.1186/1756-0500-6-120; Fernandez-Fresnedo G, 2000, NEPHROL DIAL TRANSPL, V15, P502, DOI 10.1093/ndt/15.4.502; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Gaines H, 1996, J IMMUNOL METHODS, V195, P63, DOI 10.1016/0022-1759(96)00085-3; Jacobson SH, 2000, NEPHROL DIAL TRANSPL, V15, P1414, DOI 10.1093/ndt/15.9.1414; Jimenez R, 2005, KIDNEY INT, V68, P11; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; KIMMEL PL, 1990, KIDNEY INT, V38, P129, DOI 10.1038/ki.1990.177; Ledebo I, 2007, NEPHROL DIAL TRANSPL, V22, P20, DOI 10.1093/ndt/gfl574; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim WH, 2007, KIDNEY INT, V72, P1138, DOI 10.1038/sj.ki.5002425; Lisowska KA, 2012, J CLIN IMMUNOL, V32, P189, DOI 10.1007/s10875-011-9603-x; Lisowska KA, 2010, ARTIF ORGANS, V34, pE77, DOI 10.1111/j.1525-1594.2009.00942.x; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; MOOKERJEE BK, 1976, TRANSPLANTATION, V22, P101, DOI 10.1097/00007890-197608000-00004; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Rysz J, 2006, CELL MOL IMMUNOL, V3, P151; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; STACHOWSKI J, 1993, NEPHRON, V64, P369, DOI 10.1159/000187356; Svahn A, 2003, J IMMUNOL METHODS, V277, P17, DOI 10.1016/S0022-1759(03)00111-X; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van Riemsdijk IC, 2003, BLOOD PURIFICAT, V21, P158, DOI 10.1159/000069154; van Riemsdijk IC, 2001, KIDNEY INT, V59, P883, DOI 10.1046/j.1523-1755.2001.059003883.x; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Weil AA, 2009, INFECT IMMUN, V77, P5090, DOI 10.1128/IAI.00793-09; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0	37	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73141	10.1371/journal.pone.0073141	http://dx.doi.org/10.1371/journal.pone.0073141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951343	Green Submitted, Green Published, gold			2022-12-27	WOS:000326473200087
J	Qviller, L; Risnes-Olsen, N; Baerum, KM; Meisingset, EL; Loe, LE; Ytrehus, B; Viljugrein, H; Mysterud, A				Qviller, Lars; Risnes-Olsen, Nina; Baerum, Kim Magnus; Meisingset, Erling L.; Loe, Leif Egil; Ytrehus, Bjornar; Viljugrein, Hildegunn; Mysterud, Atle			Landscape Level Variation in Tick Abundance Relative to Seasonal Migration in Red Deer	PLOS ONE			English	Article							IXODES-RICINUS; ANAPLASMA-PHAGOCYTOPHILUM; VERTICAL-DISTRIBUTION; SATURATION DEFICIT; DENSITY; INFECTION; DISEASE; POPULATIONS; PHENOLOGY; GRADIENT	Partial migration is common among northern ungulates, typically involving an altitudinal movement for seasonally migratory individuals. The main driving force behind migration is the benefit of an extended period of access to newly emerged, high quality forage along the green up gradient with increasing altitude; termed the forage maturation hypothesis. Any other limiting factor spatially correlated with this gradient may provide extra benefits or costs to migration, without necessarily being the cause of it. A common ectoparasite on cervids in Europe is the sheep tick (Ixodes ricinus), but it has not been tested whether migration may lead to the spatial separation from these parasites and thus potentially provide an additional benefit to migration. Further, if there is questing of ticks in winter ranges in May before spring migration, deer migration may also play a role for the distribution of ticks. We quantified the abundance of questing sheep tick within winter and summer home ranges of migratory (n = 42) and resident red deer (Cervus elaphus) individuals (n = 32) in two populations in May and August 2009-2012. Consistent with predictions, there was markedly lower abundance of questing ticks in the summer areas of migrating red deer (0.6/20 m(2)), both when compared to the annual home range of resident deer (4.9/20 m(2)) and the winter home ranges of migrants (5.8/20 m(2)). The reduced abundances within summer home ranges of migrants were explained by lower abundance of ticks with increasing altitude and distance from the coast. The lower abundance of ticks in summer home ranges of migratory deer does not imply that ticks are the main driver of migration (being most likely the benefits expected from forage maturation), but it suggests that ticks may add to the value of migration in some ecosystems and that it may act to spread ticks long distances in the landscape.	[Qviller, Lars; Risnes-Olsen, Nina; Baerum, Kim Magnus; Viljugrein, Hildegunn; Mysterud, Atle] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Meisingset, Erling L.] Norwegian Inst Agr & Environm Res, Organ Food & Farming Div, Tingvoll, Norway; [Loe, Leif Egil] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Ytrehus, Bjornar; Viljugrein, Hildegunn] Norwegian Vet Inst, Oslo, Norway	University of Oslo; Bioforsk; Norwegian University of Life Sciences; Norwegian Veterinary Institute	Mysterud, A (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	atle.mysterud@ibv.uio.no	Mysterud, Atle/AAQ-2864-2020; Loe, Leif Egil/M-5798-2016; Viljugrein, Hildegunn/N-6657-2015	Mysterud, Atle/0000-0001-8993-7382; Loe, Leif Egil/0000-0003-4804-2253; Viljugrein, Hildegunn/0000-0002-3798-5267; Meisingset, Erling/0000-0001-9145-2480; Ytrehus, Bjornar/0000-0002-2511-865X	Research Council of Norway; Directorate for nature management (TickDeer project) [203786/E40]	Research Council of Norway(Research Council of Norway); Directorate for nature management (TickDeer project)	This work was supported by the Research Council of Norway and the Directorate for nature management (TickDeer project; 203786/E40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen J, 1977, NORD UTREDN B, V34, P1; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Austrheim G, 2011, WILDLIFE BIOL, V17, P286, DOI 10.2981/10-038; Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; BERGERUD AT, 1990, ANIM BEHAV, V39, P360, DOI 10.1016/S0003-3472(05)80882-6; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bolger DT, 2008, ECOL LETT, V11, P63; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Chapman BB, 2011, OIKOS, V120, P1761, DOI 10.1111/j.1600-0706.2011.20070.x; Chemini C., 1997, Parassitologia (Rome), V39, P59; DANIEL M, 1977, Folia Parasitologica (Ceske Budejovice), V24, P149; DANIEL M, 1993, ACAROLOGIA, V34, P105; Dobson ADM, 2011, TICKS TICK-BORNE DIS, V2, P67, DOI 10.1016/j.ttbdis.2011.03.002; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gilbert L, 2012, ECOL APPL, V22, P658, DOI 10.1890/11-0458.1; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Grova L, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-30; Hagemoen RIM, 2002, J ANIM ECOL, V71, P883, DOI 10.1046/j.1365-2656.2002.00654.x; HART BL, 1994, PARASITOLOGY, V109, pS139, DOI 10.1017/S0031182000085140; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; HEWETSON RW, 1968, AUST J AGR RES, V19, P323, DOI 10.1071/AR9680323; Hjeljord O, 2001, ALCES-N AM MOOSE CON, V37, P353; Hutchings MR, 2001, ANIM BEHAV, V62, P955, DOI 10.1006/anbe.2001.1837; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; Jouda F, 2004, J MED ENTOMOL, V41, P162, DOI 10.1603/0022-2585-41.2.162; Kiffner C, 2010, EXP APPL ACAROL, V52, P73, DOI 10.1007/s10493-010-9341-4; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; LITTLE D. A., 1963, AUSTRALIAN VET JOUR, V39, P6, DOI 10.1111/j.1751-0813.1963.tb04168.x; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Materna J, 2008, INT J MED MICROBIOL, V298, P25, DOI 10.1016/j.ijmm.2008.05.004; MEHL R, 1983, Fauna Norvegica Series B, V30, P46; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Mooring MS, 1997, ANIM BEHAV, V53, P925, DOI 10.1006/anbe.1996.0341; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2002, J ANIM ECOL, V71, P569, DOI 10.1046/j.1365-2656.2002.00622.x; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Perret JL, 2003, J EXP BIOL, V206, P1809, DOI 10.1242/jeb.00345; Petrovec M, 2002, WIEN KLIN WOCHENSCHR, V114, P641; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randolph S.E., 2002, P119; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Rodven R, 2009, J ANIM ECOL, V78, P600, DOI 10.1111/j.1365-2656.2008.01515.x; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Skaug H., 2011, GLMMADMB GEN LINEAR; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Stuen S, 2006, J WILDLIFE DIS, V42, P170, DOI 10.7589/0090-3558-42.1.170; Stuen S, 2002, EXP APPL ACAROL, V28, P209, DOI 10.1023/A:1025350517733; SUTHERST RW, 1986, EXPERIENTIA, V42, P194, DOI 10.1007/BF01952465; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Tambs-Lyche H., 1943, Norsk Veterinaertidsskrift, V55, P337; Tambs-Lyche H, 1943, NOR VETERINAERTIDSSK, V55, P449; Tambs-Lyche H, 1943, NORSK VET TIDSSKRIFT, V55, P401; Vassallo M, 2000, J MED ENTOMOL, V37, P335, DOI 10.1603/0022-2585(2000)037[0335:MFSQNO]2.0.CO;2; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	65	48	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71299	10.1371/journal.pone.0071299	http://dx.doi.org/10.1371/journal.pone.0071299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951125	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200037
J	Vangestel, C; Callens, T; Vandomme, V; Lens, L				Vangestel, Carl; Callens, Tom; Vandomme, Viki; Lens, Luc			Sex-Biased Dispersal at Different Geographical Scales in a Cooperative Breeder from Fragmented Rainforest	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; GENETIC-STRUCTURE; BIODIVERSITY HOTSPOTS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; CONSERVATION; EXTINCTION; PHILOPATRY; FLOW; CONNECTIVITY	Dispersal affects both social behavior and population structure and is therefore a key determinant of long-term population persistence. However, dispersal strategies and responses to spatial habitat alteration may differ between sexes. Here we analyzed spatial and temporal variation in ten polymorphic microsatellite DNA loci of male and female Cabanis's greenbuls (Phyllastrephus cabanisi), a cooperative breeder of Afrotropical rainforest, to quantify rates of gene flow and fine-grained genetic structuring within and among fragmented populations. We found genetic evidence for female-biased dispersal at small spatial scales, but not at the landscape level. Local autocorrelation analysis provided evidence of positive genetic structure within 300 m distance ranges, which is consistent with behavioral observations of short-distance natal dispersal. At a landscape scale, individual-based autocorrelation values decreased over time while levels of admixture increased, possibly indicating increased gene flow over the past decade.	[Vangestel, Carl; Callens, Tom; Vandomme, Viki; Lens, Luc] Univ Ghent, Terr Ecol Unit, B-9000 Ghent, Belgium	Ghent University	Vangestel, C (corresponding author), Univ Ghent, Terr Ecol Unit, B-9000 Ghent, Belgium.	Carl.Vangestel@UGent.be		Lens, Luc/0000-0002-0241-2215; vangestel, carl/0000-0003-1024-8213	Research Foundation Flanders (FWO) [G.0055.08, G0258.01, G.0149.09]; Flemish Interuniversity Council [02/6/7-338-607, WO.037.10N]; Leopold III Foundation; Foundation for Scientific Research in Africa; Flemish Agency for Innovation by Science and Technology	Research Foundation Flanders (FWO)(FWO); Flemish Interuniversity Council; Leopold III Foundation; Foundation for Scientific Research in Africa; Flemish Agency for Innovation by Science and Technology	Fieldwork and genetic analyses were funded by research grants G.0055.08, G0258.01 and G.0149.09 of Research Foundation Flanders (FWO), by Flemish Interuniversity Council project 02/6/7-338-607, through contacts facilitated by FWO research community WO.037.10N, and by small grants of the Leopold III Foundation and the Foundation for Scientific Research in Africa. TC was supported by a doctoral grant from the Flemish Agency for Innovation by Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2006, J ORNITHOL, V147, P125; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Beentje HJ, 1987, UTAFITI, V1, P23; Bennun LA, 1999, IMPORTANT BIRD AREAS; Bennun Leon, 1998, Journal of East African Natural History, V85, P23, DOI 10.2982/0012-8317(1996)85[23:TFBOKA]2.0.CO;2; Blackmore CJ, 2011, J ANIM ECOL, V80, P69, DOI 10.1111/j.1365-2656.2010.01761.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Callens T, 2012, THESIS GHENT U BELGI; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Jackson C., 2005, AFRING NEWS, V34, P60; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Keith S., 1992, BIRDS AFRICA, V4; Lachish S, 2011, HEREDITY, V106, P172, DOI 10.1038/hdy.2010.17; Laurance WF, 1999, BIOL CONSERV, V91, P101, DOI 10.1016/S0006-3207(99)00087-7; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mank JE, 2004, GENET RES, V84, P135, DOI 10.1017/S0016672304007190; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmark WD., 1998, J E AFR NAT HIST, V87, P29, DOI [10.2982/0012-8317(1998)87[29:FAFALI]2.0.CO;2, DOI 10.2982/0012-8317(1998)87[29:FAFALI]2.0.CO;2]; Nichols J., 2001, DISPERSAL; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pellikka PKE, 2009, INT J APPL EARTH OBS, V11, P221, DOI 10.1016/j.jag.2009.02.002; Perrin Nicolas, 2001, P123; Pierson JC, 2010, EVOL APPL, V3, P263, DOI 10.1111/j.1752-4571.2009.00111.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Schmuki C, 2006, MOL ECOL, V15, P1481, DOI 10.1111/j.1365-294X.2006.02849.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sodhi NS, 2007, J ORNITHOL, V148, pS305, DOI 10.1007/s10336-007-0180-y; Sodhi NS, 2006, CONSERV BIOL, V20, P772, DOI 10.1111/j.1523-1739.2006.00363.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Van Treuren R, 1999, MOL ECOL, V8, P181, DOI 10.1046/j.1365-294X.1999.00548.x; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047683; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson AG, 2011, CONSERV GENET, V12, P213, DOI 10.1007/s10592-010-0134-4; Wright S, 1931, GENETICS, V16, P0097; Yannic G, 2012, EVOLUTION, V66, P1737, DOI 10.1111/j.1558-5646.2011.01554.x	68	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71624	10.1371/journal.pone.0071624	http://dx.doi.org/10.1371/journal.pone.0071624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951208	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200061
J	Yang, I; Eibach, D; Kops, F; Brenneke, B; Woltemate, S; Schulze, J; Bleich, A; Gruber, AD; Muthupalani, S; Fox, JG; Josenhans, C; Suerbaum, S				Yang, Ines; Eibach, Daniel; Kops, Friederike; Brenneke, Birgit; Woltemate, Sabrina; Schulze, Jessika; Bleich, Andre; Gruber, Achim D.; Muthupalani, Sureshkumar; Fox, James G.; Josenhans, Christine; Suerbaum, Sebastian			Intestinal Microbiota Composition of Interleukin-10 Deficient C57BL/6J Mice and Susceptibility to Helicobacter hepaticus-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYTOLETHAL DISTENDING TOXIN; MULTIPLE SEQUENCE ALIGNMENT; ALTERED SCHAEDLER FLORA; SWISS WEBSTER MICE; GUT MICROBIOTA; BILOPHILA-WADSWORTHIA; BACTERIAL-INFECTION; IMMUNE-RESPONSES; EPITHELIAL-CELLS	The mouse pathobiont Helicobacter hepaticus can induce typhlocolitis in interleukin-10-deficient mice, and H. hepaticus infection of immunodeficient mice is widely used as a model to study the role of pathogens and commensal bacteria in the pathogenesis of inflammatory bowel disease. C57BL/6J Il10(-/-) mice kept under specific pathogen-free conditions in two different facilities (MHH and MIT), displayed strong differences with respect to their susceptibilities to H. hepaticus-induced intestinal pathology. Mice at MIT developed robust typhlocolitis after infection with H. hepaticus, while mice at MHH developed no significant pathology after infection with the same H. hepaticus strain. We hypothesized that the intestinal microbiota might be responsible for these differences and therefore performed high resolution analysis of the intestinal microbiota composition in uninfected mice from the two facilities by deep sequencing of partial 16S rRNA amplicons. The microbiota composition differed markedly between mice from both facilities. Significant differences were also detected between two groups of MHH mice born in different years. Of the 119 operational taxonomic units (OTUs) that occurred in at least half the cecum or colon samples of at least one mouse group, 24 were only found in MIT mice, and another 13 OTUs could only be found in MHH samples. While most of the MHH-specific OTUs could only be identified to class or family level, the MIT-specific set contained OTUs identified to genus or species level, including the opportunistic pathogen, Bilophila wadsworthia. The susceptibility to H. hepaticus-induced colitis differed considerably between Il10(-/-) mice originating from the two institutions. This was associated with significant differences in microbiota composition, highlighting the importance of characterizing the intestinal microbiome when studying murine models of IBD.	[Yang, Ines; Eibach, Daniel; Kops, Friederike; Brenneke, Birgit; Woltemate, Sabrina; Schulze, Jessika; Josenhans, Christine; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Yang, Ines; Eibach, Daniel; Kops, Friederike; Brenneke, Birgit; Woltemate, Sabrina; Schulze, Jessika; Josenhans, Christine; Suerbaum, Sebastian] DZIF German Ctr Infect Res, Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Muthupalani, Sureshkumar; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Hannover Medical School; German Center for Infection Research; Hannover Medical School; Free University of Berlin; Massachusetts Institute of Technology (MIT)	Suerbaum, S (corresponding author), Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany.	suerbaum.sebastian@mh-hannover.de	Yang, Ines/D-6904-2012; Muthupalani, Sureshkumar/C-7244-2015; Gruber, Achim D./ABA-4514-2021	Yang, Ines/0000-0002-3812-2690; 	German Research Foundation (DFG) [DFG SFB 621/B8, DFG SFB 900/Z1]; National Institutes of Health (NIH) [NIH P01-CA26731, NIH P30ES0026731, NIH R01-OD011141]; NATIONAL CANCER INSTITUTE [P01CA026731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, R21ES026731] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011141] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants DFG SFB 621/B8 and DFG SFB 900/Z1 from the German Research Foundation (DFG) to S. S., and National Institutes of Health (NIH) grants NIH P01-CA26731, NIH P30ES0026731 and NIH R01-OD011141 to J.G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo MSP, 2012, BENEF MICROBES, V3, P33, DOI 10.3920/BM2011.0041; BARON EJ, 1989, J GEN MICROBIOL, V135, P3405; Bartonickova L, 2013, CELL MICROBIOL, V15, P992, DOI 10.1111/cmi.12094; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Boutin SR, 2005, INFECT IMMUN, V73, P8449, DOI 10.1128/IAI.73.12.8449-8452.2005; Boutin SR, 2004, TOXICOL PATHOL, V32, P678, DOI 10.1080/01926230490524058; Buchler G, 2012, INFLAMM BOWEL DIS, V18, P943, DOI 10.1002/ibd.21895; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Ciszek-Lenda M, 2011, CENT EUR J IMMUNOL, V36, P121; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dieleman LA, 2000, INFECT IMMUN, V68, P5107, DOI 10.1128/IAI.68.9.5107-5113.2000; Drummond A, 2012, GENEIOUS; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; FINEGOLD S, 1992, EUR J CLIN MICROBIOL, V11, P1058, DOI 10.1007/BF01967799; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 1996, INFECT IMMUN, V64, P3673, DOI 10.1128/IAI.64.9.3673-3681.1996; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fred ALN, 2003, PROC CVPR IEEE, P128; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ge ZM, 2008, MICROBES INFECT, V10, P726, DOI 10.1016/j.micinf.2008.03.011; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Ge ZM, 2001, J CLIN MICROBIOL, V39, P2598, DOI 10.1128/JCM.39.7.2598-2602.2001; Giongo A, 2010, DIVERSITY-BASEL, V2, P1015, DOI DOI 10.3390/d2071015; Hoffmann M, 2008, J NUTR, V138, P1684, DOI 10.1093/jn/138.9.1684; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jia WJ, 2012, FEMS IMMUNOL MED MIC, V65, P55, DOI 10.1111/j.1574-695X.2012.00935.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kulagina EV, 2012, BIOSCI BIOTECH BIOCH, V76, P169, DOI 10.1271/bbb.110434; Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Nahid A, 2011, HEATMAP; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Pratt JS, 2006, INFECT IMMUN, V74, P4496, DOI 10.1128/IAI.00503-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2011, SILVA REFERENCE FILE; Schloss PD, 2011, SCHLOSS SOP MOTHUR; Schumacher Ulrike K., 1997, Clin Microbiol Infect, V3, P134; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sterzenbach T, 2008, J BACTERIOL, V190, P6398, DOI 10.1128/JB.00626-08; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaahtovuo J, 2001, ANTON LEEUW INT J G, V80, P35, DOI 10.1023/A:1012058107731; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Wedekind D, 2012, LABORATORY MOUSE, P621, DOI 10.1016/B978-0-12-382008-2.00026-X; Whary MT, 2011, IMMUNOLOGY, V133, P165, DOI 10.1111/j.1365-2567.2011.03423.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Young VB, 2004, INFECT IMMUN, V72, P2521, DOI 10.1128/IAI.72.5.2521-2527.2004; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	76	82	83	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e70783	10.1371/journal.pone.0070783	http://dx.doi.org/10.1371/journal.pone.0070783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951007	gold, Green Published, Green Submitted			2022-12-27	WOS:000326473200019
J	Randau, M; Carbone, C; Turvey, ST				Randau, Marcela; Carbone, Chris; Turvey, Samuel T.			Canine Evolution in Sabretoothed Carnivores: Natural Selection or Sexual Selection?	PLOS ONE			English	Article							POSITIVE ALLOMETRY; SIZE; DIMORPHISM; BEHAVIOR; CONSTRAINTS; MORPHOLOGY; ORNAMENTS; FELINE	The remarkable elongated upper canines of extinct sabretoothed carnivorous mammals have been the subject of considerable speculation on their adaptive function, but the absence of living analogues prevents any direct inference about their evolution. We analysed scaling relationships of the upper canines of 20 sabretoothed feliform carnivores (Nimravidae, Barbourofelidae, Machairodontinae), representing both dirk-toothed and scimitar-toothed sabretooth ecomorphs, and 33 non-sabretoothed felids in relation to body size in order to characterize and identify the evolutionary processes driving their development, using the scaling relationships of carnassial teeth in both groups as a control. Carnassials display isometric allometry in both sabretooths and non-sabretooths, supporting their close relationship with meat-slicing, whereas the upper canines of both groups display positive allometry with body size. Whereas there is no statistical difference in allometry of upper canine height between dirk-toothed and scimitar-toothed sabretooth ecomorphs, the significantly stronger positive allometry of upper canine height shown by sabretooths as a whole compared to non-sabretooths reveals that different processes drove canine evolution in these groups. Although sabretoothed canines must still have been effective for prey capture and processing by hypercarnivorous predators, canine morphology in these extinct carnivores was likely to have been driven to a greater extent by sexual selection than in non-sabretooths. Scaling relationships therefore indicate the probable importance of sexual selection in the evolution of the hypertrophied sabretooth anterior dentition.	[Randau, Marcela; Carbone, Chris; Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England	Zoological Society of London	Randau, M (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	marcela.randau@gmail.com						ALEXANDER RM, 1979, J ZOOL, V189, P305; Andersson K, 2004, ZOOL J LINN SOC-LOND, V142, P91, DOI 10.1111/j.1096-3642.2004.00129.x; Andersson K, 2003, P ROY SOC B-BIOL SCI, V270, pS163, DOI 10.1098/rsbl.2003.0070; Andersson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024971; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Chenoweth SF, 2008, AM NAT, V171, P22, DOI 10.1086/523946; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Cisneros JC, 2011, SCIENCE, V331, P1603, DOI 10.1126/science.1200305; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; DAYAN T, 1990, AM NAT, V136, P39, DOI 10.1086/285081; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; GOULD SJ, 1973, NATURE, V244, P375, DOI 10.1038/244375a0; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Kappeler PM, 2004, SEXUAL SELECTION PRI; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kraaijeveld K, 2004, BEHAV ECOL, V15, P380, DOI 10.1093/beheco/arh023; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Meehan TJ, 2003, NATURWISSENSCHAFTEN, V90, P131, DOI 10.1007/s00114-002-0392-1; Meiri S, 2005, FUNCT ECOL, V19, P337, DOI 10.1111/j.1365-2435.2005.00964.x; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; R Development Core Team, 2011, VERS 2 13 0; Silva M, 1998, J MAMMAL, V79, P20, DOI 10.2307/1382839; Simpson G. G., 1941, AM MUS NOVIT, V1120; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; THOMASON JJ, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P249; Tomkins JL, 2010, AM NAT, V176, P141, DOI 10.1086/653001; Turner A., 1997, BIG CATS THEIR FOSSI; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VEZINA AF, 1985, OECOLOGIA, V67, P555, DOI 10.1007/BF00790027; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	16	16	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72868	10.1371/journal.pone.0072868	http://dx.doi.org/10.1371/journal.pone.0072868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951334	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000090
J	Takahashi, M; Chiyo, T; Okada, T; Hohjoh, H				Takahashi, Masaki; Chiyo, Tomoko; Okada, Takashi; Hohjoh, Hirohiko			Specific Inhibition of Tumor Cells by Oncogenic EGFR Specific Silencing by RNA interference	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ZD1839 IRESSA; IN-VITRO; GENE; MUTATIONS; ADDICTION; DELIVERY	Anticancer agents that have minimal effects on normal cells and tissues are ideal cancer drugs. Here, we show specific inhibition of human cancer cells carrying oncogenic mutations in the epidermal growth factor receptor (EGFR) gene by means of oncogenic allele-specific RNA interference (RNAi), both in vivo and in vitro. The allele-specific RNAi (ASP-RNAi) treatment did not affect normal cells or tissues that had no target oncogenic allele, whereas the suppression of a normal EGFR allele by a conventional in vivo RNAi caused adverse effects, i.e., normal EGFR is vital. Taken together, our current findings suggest that specific inhibition of oncogenic EGFR alleles without affecting the normal EGFR allele may provide a safe treatment approach for cancer patients and that ASP-RNAi treatment may be capable of becoming a safe and effective, anticancer treatment method.	[Takahashi, Masaki; Hohjoh, Hirohiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 187, Japan; [Chiyo, Tomoko; Okada, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Hohjoh, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 187, Japan.	hohjohh@ncnp.go.jp		Takahashi, Masaki/0000-0003-1190-2213	Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan, and also by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Gridelli C, 2011, LUNG CANCER, V72, P3, DOI 10.1016/j.lungcan.2010.12.009; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hanai K, 2006, ANN NY ACAD SCI, V1082, P9, DOI 10.1196/annals.1348.010; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Hohjoh H, 2010, METHODS MOL BIOL, V623, P67, DOI 10.1007/978-1-60761-588-0_4; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Okada T, 1997, BIOCHEM BIOPH RES CO, V240, P203, DOI 10.1006/bbrc.1997.7563; Okada T, 2004, J GENE MED, V6, P288, DOI 10.1002/jgm.490; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Takahashi M, 2012, GENE THER, V19, P781, DOI 10.1038/gt.2011.193; Takahashi M, 2010, P NATL ACAD SCI USA, V107, P21731, DOI 10.1073/pnas.1012153107; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Uchibori R, 2009, J GENE MED, V11, P373, DOI 10.1002/jgm.1313; Wakeling AE, 2002, CANCER RES, V62, P5749	24	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e73214	10.1371/journal.pone.0073214	http://dx.doi.org/10.1371/journal.pone.0073214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951344	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000093
J	Gracey, E; Lin, A; Akram, A; Chiu, B; Inman, RD				Gracey, Eric; Lin, Aifeng; Akram, Ali; Chiu, Basil; Inman, Robert D.			Intracellular Survival and Persistence of Chlamydia muridarum Is Determined by Macrophage Polarization	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; IFN-GAMMA; PNEUMONIAE INFECTION; DEVELOPMENTAL CYCLE; TRACHOMATIS GENES; EXPRESSION; CELLS; SUSCEPTIBILITY; PROFILES; CLEARANCE	Macrophages can display a number of distinct phenotypes, known collectively as polarized macrophages. The best defined of these phenotypes are the classically-activated, interferon gamma (IFN gamma)/LPS induced (M1) and alternatively-activated, IL-4 induced (M2) macrophages. The goal of this study is to characterize macrophage-Chlamydia interactions in the context of macrophage polarization. Here we use Chlamydia muridarum and murine bone-marrow derived macrophages to show Chlamydia does not induce M2 polarization in macrophages as a survival strategy. Unexpectedly, the infection of macrophages was silent with no upregulation of M1 macrophage-associated genes. We further demonstrate that macrophages polarized prior to infection have a differential capacity to control Chlamydia. M1 macrophages harbor up to 40-fold lower inclusion forming units (IFU) than non-polarized or M2 polarized macrophages. Gene expression analysis showed an increase in 16sRNA in M2 macrophages with no change in M1 macrophages. Suppressed Chlamydia growth in M1 macrophages correlated with the induction of a bacterial gene expression profile typical of persistence as evident by increased Euo expression and decreased Omp1 and Tal expression. Observations of permissive Chlamydia growth in non-polarized and M2 macrophages and persistence in M1 macrophages were supported through electron microscopy. This work supports the importance of IFN gamma in the innate immune response to Chlamydia. However, demonstration that the M1 macrophages, despite an antimicrobial signature, fail to eliminate intracellular Chlamydia supports the notion that host-pathogen co-evolution has yielded a pathogen that can evade cellular defenses against this pathogen, and persist for prolonged periods of time in the host.	[Gracey, Eric; Inman, Robert D.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Gracey, Eric; Lin, Aifeng; Akram, Ali; Chiu, Basil; Inman, Robert D.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Health Network Toronto	Inman, RD (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	Robert.Inman@uhn.on.ca	Gracey, Eric/AAD-7560-2020	Gracey, Eric/0000-0003-0984-435X; Inman, Robert/0000-0002-4750-1422	Canadian Institutes for Health Research (CIHR) [68967]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes for Health Research (CIHR) under grant #68967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Airenne S, 1999, INFECT IMMUN, V67, P1445, DOI 10.1128/IAI.67.3.1445-1449.1999; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Chen BJ, 1996, FEMS IMMUNOL MED MIC, V14, P109, DOI 10.1016/0928-8244(96)00018-1; Coers J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000333; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Gerard HC, 1998, MED MICROBIOL IMMUN, V187, P115, DOI 10.1007/s004300050082; Gerard HC, 2004, MICROB PATHOGENESIS, V36, P35, DOI 10.1016/j.micpath.2003.08.005; Gerard HC, 2002, MICROBES INFECT, V4, P13, DOI 10.1016/S1286-4579(01)01504-0; Gerard HC, 2001, MOL MICROBIOL, V41, P731, DOI 10.1046/j.1365-2958.2001.02550.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Inman RD, 2006, ARTHRITIS RHEUM-US, V54, P499, DOI 10.1002/art.21643; Jiang XZ, 2010, IMMUNOLOGY, V129, P556, DOI 10.1111/j.1365-2567.2009.03157.x; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kokab A, 2010, MICROB PATHOGENESIS, V49, P217, DOI 10.1016/j.micpath.2010.06.002; Kuo CC, 2002, MICROB PATHOGENESIS, V32, P43, DOI 10.1006/mpat.2001.0479; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lewis PR, 1977, STAINING METHODS SEC, P49; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Mannonen L, 2004, MICROB PATHOGENESIS, V36, P41, DOI 10.1016/j.micpath.2003.09.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukhopadhyay S, 2004, J CLIN MICROBIOL, V42, P3288, DOI 10.1128/JCM.42.7.3288-3290.2004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nettelnbreker E, 1998, J MED MICROBIOL, V47, P141, DOI 10.1099/00222615-47-2-141; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sun HS, 2012, J LEUKOCYTE BIOL, V92, P815, DOI 10.1189/jlb.0711336; Weischenfeldt J, 2008, COLD SPRING HARB PRO; World Health Organization, 2020, ALL GLOB EL BLIND TR, P2003; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yin ZH, 1997, ARTHRITIS RHEUM, V40, P1788, DOI 10.1002/art.1780401010; Zhang L, 1998, INFECT IMMUN, V66, P1167, DOI 10.1128/IAI.66.3.1167-1173.1998	50	26	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69421	10.1371/journal.pone.0069421	http://dx.doi.org/10.1371/journal.pone.0069421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967058	Green Published, gold, Green Submitted			2022-12-27	WOS:000323221500005
J	Dominguez-Valentin, M; Therkildsen, C; Veerla, S; Jonsson, M; Bernstein, I; Borg, A; Nilbert, M				Dominguez-Valentin, Mev; Therkildsen, Christina; Veerla, Srinivas; Jonsson, Mats; Bernstein, Inge; Borg, Ake; Nilbert, Mef			Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; MISMATCH REPAIR; COLON-CANCER; CRITERIA; FEATURES; PROTEIN; HNPCC; MICROARRAYS; MANAGEMENT; PROFILES	Introduction: Heredity is estimated to cause at least 20% of colorectal cancer. The hereditary nonpolyposis colorectal cancer subset is divided into Lynch syndrome and familial colorectal cancer type X (FCCTX) based on presence of mismatch repair (MMR) gene defects. Purpose: We addressed the gene expression signatures in colorectal cancer linked to Lynch syndrome and FCCTX with the aim to identify candidate genes and to map signaling pathways relevant in hereditary colorectal carcinogenesis. Experimental design: The 18 k whole-genome c-DNA-mediated annealing, selection, extension, and ligation (WG-DASL) assay was applied to 123 colorectal cancers, including 39 Lynch syndrome tumors and 37 FCCTX tumors. Target genes were technically validated using real-time quantitative RT-PCR (qRT-PCR) and the expression signature was validated in independent datasets. Results: Colorectal cancers linked to Lynch syndrome and FCCTX showed distinct gene expression profiles, which by significance analysis of microarrays (SAM) differed by 2188 genes. Functional pathways involved were related to G-protein coupled receptor signaling, oxidative phosphorylation, and cell cycle function and mitosis. qRT-PCR verified altered expression of the selected genes NDUFA9, AXIN2, MYC, DNA2 and H2AFZ. Application of the 2188-gene signature to independent datasets showed strong correlation to MMR status. Conclusion: Distinct genetic profiles and deregulation of different canonical pathways apply to Lynch syndrome and FCCTX and key targets herein may be relevant to pursue for refined diagnostic and therapeutic strategies in hereditary colorectal cancer.	[Dominguez-Valentin, Mev; Veerla, Srinivas; Jonsson, Mats; Borg, Ake; Nilbert, Mef] Lund Univ, Inst Clin Sci, Dept Oncol, Lund, Sweden; [Therkildsen, Christina; Bernstein, Inge; Nilbert, Mef] Copenhagen Univ Hosp, Clin Res Ctr, Danish HNPCC Register, Hvidovre, Denmark; [Therkildsen, Christina; Bernstein, Inge; Nilbert, Mef] Copenhagen Univ Hosp, Dept Gastroenterol, Hvidovre, Denmark	Lund University; University of Copenhagen; University of Copenhagen	Dominguez-Valentin, M (corresponding author), Lund Univ, Inst Clin Sci, Dept Oncol, Lund, Sweden.	mev_dv@yahoo.com	Therkildsen, Christina/O-5913-2019; Bernstein, Inge/AAD-8159-2020	Therkildsen, Christina/0000-0002-2833-6986; Bernstein, Inge/0000-0003-4095-432X; Dominguez-Valentin, Mev/0000-0001-7856-0057; Veerla, Srinivas/0000-0001-7328-6239; Nilbert, Mef/0000-0003-2717-1937	Swedish Research Council; Lundbeck foundation; Nilsson Cancer Fund; Kamprad Cancer Fund; Hvidovre University Hospital, Denmark	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck foundation(Lundbeckfonden); Nilsson Cancer Fund; Kamprad Cancer Fund; Hvidovre University Hospital, Denmark	The Danish and the Swedish Cancer Funds, from the Swedish Research Council, the Lundbeck foundation, the Nilsson Cancer Fund, the Kamprad Cancer Fund and the Hvidovre University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2005, ONCOGENE, V24, P1542, DOI 10.1038/sj.onc.1208387; Balmana J, 2010, ANN ONCOL, V21, pv78, DOI 10.1093/annonc/mdq169; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Belt EJT, 2012, ANN SURG ONCOL, V19, pS682, DOI 10.1245/s10434-012-2216-7; Benatti P, 2001, INT J CANCER, V95, P323, DOI 10.1002/1097-0215(20010920)95:5<323::AID-IJC1056>3.0.CO;2-H; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Duldulao MP, 2012, J SURG RES, V174, P1, DOI 10.1016/j.jss.2011.06.016; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hu Y, 2005, CELL MOL LIFE SCI, V62, P1974, DOI 10.1007/s00018-005-5134-z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jardim MJ, 2009, MOL BIOL CELL, V20, P3801, DOI 10.1091/mbc.E09-04-0303; Jass Jeremy R., 2006, Critical Reviews in Oncogenesis, V12, P273; Jin YT, 2008, ONCOL RES, V17, P59, DOI 10.3727/096504008784523630; Kim H, 2004, ONCOGENE, V23, P6218, DOI 10.1038/sj.onc.1207853; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Klarskov L, 2012, J CLIN PATHOL, V65, P352, DOI 10.1136/jclinpath-2011-200535; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lee WS, 2008, J SURG RES, V144, P29, DOI 10.1016/j.jss.2007.02.005; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Llor X, 2005, CLIN CANCER RES, V11, P7304, DOI 10.1158/1078-0432.CCR-05-0965; Lynch HT, 2005, NEW ENGL J MED, V352, P1920, DOI 10.1056/NEJMe058058; Malbon Craig C, 2005, Sci STKE, V2005, ppe35, DOI 10.1126/stke.2922005pe35; Mecklin JP, 2005, FAM CANCER, V4, P267, DOI 10.1007/a10689-005-1475-x; Middeldorp A, 2012, INT J CANCER, V130, P837, DOI 10.1002/ijc.26093; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Pires IM, 2010, BRIT J PHARMACOL, V159, P1326, DOI 10.1111/j.1476-5381.2009.00607.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-de-Abajo A, 2007, CLIN CANCER RES, V13, P5729, DOI 10.1158/1078-0432.CCR-06-2996; Sinicrope FA, 1998, CLIN CANCER RES, V4, P1251; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Therkildsen C, 2013, EUR J CANCER, V49, P1226, DOI 10.1016/j.ejca.2012.11.011; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Watanabe K, 1999, CANCER RES, V59, P5093; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; WORKMAN C, 2002, GENOME BIOL, V0003; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yuan ZQ, 2003, ONCOGENE, V22, P6304, DOI 10.1038/sj.onc.1206609	45	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71755	10.1371/journal.pone.0071755	http://dx.doi.org/10.1371/journal.pone.0071755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951239	Green Published, gold			2022-12-27	WOS:000323097300154
J	Kessler, JP				Kessler, Jean-Pierre			Control of Cleft Glutamate Concentration and Glutamate Spill-Out by Perisynaptic Glia: Uptake and Diffusion Barriers	PLOS ONE			English	Article							SYNAPTICALLY RELEASED GLUTAMATE; HIPPOCAMPAL SYNAPSES; TRANSPORTERS; ACTIVATION; PLASTICITY; RECEPTORS; REVEALS; DOMAINS	Most glutamatergic synapses in the mammalian central nervous system are covered by thin astroglial processes that exert a dual action on synaptically released glutamate: they form physical barriers that oppose diffusion and they carry specific transporters that remove glutamate from the extracellular space. The present study was undertaken to investigate the dual action of glia by means of computer simulation. A realistic synapse model based on electron microscope data and Monte Carlo algorithms were used for this purpose. Results show (1) that physical obstacles formed by glial processes delay glutamate exit from the cleft and (2) that this effect is efficiently counteracted by glutamate uptake. Thus, depending on transporter densities, the presence of perisynaptic glia may result in increased or decreased glutamate transient in the synaptic cleft. Changes in temporal profiles of cleft glutamate concentration induced by glia differentially impact the response of the various synaptic and perisynaptic receptor subtypes. In particular, GluN2B- and GluN2C-NMDA receptor responses are strongly modified while GluN2A-NMDA receptor responses are almost unaffected. Thus, variations in glial transporter expression may allow differential tuning of NMDA receptors according to their subunit composition. In addition, simulation data suggest that the sink effect generated by transporters accumulation in the vicinity of the release site is the main mechanism limiting glutamate spill-out. Physical obstacles formed by glial processes play a comparatively minor role.	Aix Marseille Univ, CNRS, CRN2M UMR 7286, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Kessler, JP (corresponding author), Aix Marseille Univ, CNRS, CRN2M UMR 7286, Marseille, France.	jean-pierre.kessler@univ-amu.fr	Kessler, Jean-Pierre/F-5298-2012	Kessler, Jean-Pierre/0000-0002-5482-588X	Centre National de la Recherche Scientifique (CNRS); Aix-marseille Universite (AMU)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-marseille Universite (AMU)	Centre National de la Recherche Scientifique (CNRS) and Aix-marseille Universite (AMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bergles DE, 2002, J NEUROSCI, V22, P10153; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; Chounlamountry K, 2011, GLIA, V59, P655, DOI 10.1002/glia.21135; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Kohr G, 2003, J NEUROSCI, V23, P10791; Lachamp P, 2002, J NEUROBIOL, V52, P336, DOI 10.1002/neu.10091; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lozovaya NA, 1999, NEUROSCIENCE, V91, P1321, DOI 10.1016/S0306-4522(98)00638-1; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Marcaggi P, 2009, P NATL ACAD SCI USA, V106, P11388, DOI 10.1073/pnas.0901290106; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; RAMBOURG A, 1967, J CELL BIOL, V32, P27, DOI 10.1083/jcb.32.1.27; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zhao ST, 2012, J COMP NEUROL, V520, P2340, DOI 10.1002/cne.23040; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	31	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70791	10.1371/journal.pone.0070791	http://dx.doi.org/10.1371/journal.pone.0070791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951010	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300052
J	Li, R; Wang, SS; Zhu, L; Guo, J; Zeng, L; Gong, QY; He, L; Chen, HF				Li, Rong; Wang, Shanshan; Zhu, Ling; Guo, Jian; Zeng, Ling; Gong, Qiyong; He, Li; Chen, Huafu			Aberrant Functional Connectivity of Resting State Networks in Transient Ischemic Attack	PLOS ONE			English	Article							DEFAULT-MODE; COGNITIVE IMPAIRMENT; CAROTID-ARTERY; BRAIN ACTIVITY; ATTENTION; CORTEX; PERFORMANCE; ACTIVATION; RISK; PET	Background: Transient ischemic attack (TIA) is usually defined as a neurologic ischemic disorder without permanent cerebral infarction. Studies have showed that patients with TIA can have lasting cognitive functional impairment. Inherent brain activity in the resting state is spatially organized in a set of specific coherent patterns named resting state networks (RSNs), which epitomize the functional architecture of memory, language, attention, visual, auditory and somato-motor networks. Here, we aimed to detect differences in RSNs between TIA patients and healthy controls (HCs). Methods: Twenty one TIA patients suffered an ischemic event and 21 matched HCs were enrolled in the study. All subjects were investigated using cognitive tests, psychiatric tests and functional magnetic resonance imaging (fMRI). Independent component analysis (ICA) was adopted to acquire the eight brain RSNs. Then one-sample t-tests were calculated in each group to gather the spatial maps of each RSNs, followed by second level analysis to investigate statistical differences on RSNs between twenty one TIA patients and 21 controls. Furthermore, a correlation analysis was performed to explore the relationship between functional connectivity (FC) and cognitive and psychiatric scales in TIA group. Results: Compared with the controls, TIA patients exhibited both decreased and increased functional connectivity in default mode network (DMN) and self-referential network (SRN), and decreased functional connectivity in dorsal attention network (DAN), central-executive network (CEN), core network (CN), somato-motor network (SMN), visual network (VN) and auditory network (AN). There was no correlation between neuropsychological scores and functional connectivity in regions of RSNs. Conclusions: We observed selective impairments of RSN intrinsic FC in TIA patients, whose all eight RSNs had aberrant functional connectivity. These changes indicate that TIA is a disease with widely abnormal brain networks. Our results might put forward a novel way to look into neuro-pathophysiological mechanisms in TIA patients.	[Li, Rong; Wang, Shanshan; Zhu, Ling; Zeng, Ling; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Guo, Jian; He, Li] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Gong, Qiyong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610064, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; Sichuan University	He, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Peoples R China.	heli2003new@126.com; chenhf@uestc.edu.cn	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871	Natural Science Foundation of China [61035006, 61125304, 81171406]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Natural Science Foundation of China, Grant Nos. 61035006, 61125304, 81171406 and by the Specialized Research Fund for the Doctoral Program of Higher Education of China 20120185110028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Bakker FC, 2000, J NEUROL, V247, P669, DOI 10.1007/s004150070108; Bakker FC, 2003, J NEUROL, V250, P1340, DOI 10.1007/s00415-003-0222-1; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bejot Y, 2007, CEREBROVASC DIS, V23, P126, DOI 10.1159/000097049; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Charoenkitkarn V, 2009, PAC RIM INT J NURS R, V13, P199; Cloft HJ, 2011, CEREBROVASC DIS, V31, P588, DOI 10.1159/000324951; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crisostomo RA, 2003, STROKE, V34, P932, DOI 10.1161/01.STR.0000061496.00669.5E; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; den Heijer T, 2006, ARCH GEN PSYCHIAT, V63, P57, DOI 10.1001/archpsyc.63.1.57; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Georgiadis JR, 2009, HUM BRAIN MAPP, V30, P3089, DOI 10.1002/hbm.20733; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gur RC, 2007, HUM BRAIN MAPP, V28, P263, DOI 10.1002/hbm.20319; Hager F, 1998, EUR ARCH PSY CLIN N, V248, P161; Herath P, 2001, HUM BRAIN MAPP, V12, P110, DOI 10.1002/1097-0193(200102)12:2<110::AID-HBM1008>3.0.CO;2-0; Herholz K, 2001, NEUROPSYCHOLOGIA, V39, P643, DOI 10.1016/S0028-3932(00)00144-5; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Johnston SC, 2004, ANN INTERN MED, V140, P237, DOI 10.7326/0003-4819-140-4-200402170-00005; Kasner SE, 2004, BLUE BOOKS PRACTICAL, V29; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Leube DT, 2001, NEUROREPORT, V12, P2773, DOI 10.1097/00001756-200108280-00035; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Lu J., 2009, INT J PSYCHOL STUDIE, V1, P35; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marois R, 2004, J NEUROPHYSIOL, V92, P2985, DOI 10.1152/jn.01061.2003; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Pendlebury ST, 2012, CEREBROVASC DIS, V34, P48, DOI 10.1159/000338905; Posner M. I., 1998, EXECUTIVE ATTENTION; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Ushicla T, 2008, NEUROSCI LETT, V439, P7, DOI 10.1016/j.neulet.2008.04.085; Vorobyev VA, 2004, COGNITIVE BRAIN RES, V20, P309, DOI 10.1016/j.cogbrainres.2004.03.011; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	62	32	32	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71009	10.1371/journal.pone.0071009	http://dx.doi.org/10.1371/journal.pone.0071009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951069	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300074
J	Mourino-Perez, RR; Linacre-Rojas, LP; Roman-Gavilanes, AI; Lew, TK; Callejas-Negrete, OA; Roberson, RW; Freitag, M				Mourino-Perez, Rosa R.; Linacre-Rojas, Lorena P.; Roman-Gavilanes, Ariana I.; Lew, Thomas K.; Callejas-Negrete, Olga A.; Roberson, Robert W.; Freitag, Michael			MTB-3, a Microtubule Plus-End Tracking Protein ( plus TIP) of Neurospora crassa	PLOS ONE			English	Article							BINDING-PROTEIN; EB1; DYNAMICS; ORGANIZATION; GROWTH; LOCALIZATION; CYTOSKELETON; P150(GLUED); NUCLEATION; DYNACTIN	The microtubule (MT) "plus end" constitutes the platform for the accumulation of a structurally and functionally diverse group of proteins, collectively called "MT plus-end tracking proteins" (+TIPs). +TIPs control MT dynamics and link MTs to diverse sub-cellular structures. Neurospora crassa MicroTubule Binding protein-3 (MTB-3) is the homolog of yeast EB1, a highly conserved +TIP. To address the function of MTB-3, we examined strains with mtb-3 deletions, and we tagged MTB-3 with GFP to assess its dynamic behavior. MTB-3-GFP was present as comet-like structures distributed more or less homogeneously within the hyphal cytoplasm, and moving mainly towards the apex at speeds up to 4x faster than the normal hyphal elongation rates. MTB-3-GFP comets were present in all developmental stages, but were most abundant in mature hyphae. MTB-3-GFP comets were observed moving in anterograde and retrograde direction along the hypha. Retrograde movement was also observed as originating from the apical dome. The integrity of the microtubular cytoskeleton affects the presence and dynamics of MTB-3-GFP comets, while actin does not seem to play a role. The size of MTB-3-GFP comets is affected by the absence of dynactin and conventional kinesin. We detected no obvious morphological phenotypes in Delta mtb-3 mutants but there were fewer MTs in Delta mtb-3, MTs were less bundled and less organized. Compared to WT, both MT polymerization and depolymerization rates were significantly decreased in Delta mtb-3. In summary, the lack of MTB-3 affects overall growth and morphological phenotypes of N. crassa only slightly, but deletion of mtb-3 has strong effect on MT dynamics.	[Mourino-Perez, Rosa R.; Linacre-Rojas, Lorena P.; Roman-Gavilanes, Ariana I.; Callejas-Negrete, Olga A.] Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico; [Lew, Thomas K.; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Roberson, Robert W.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Oregon State University; Arizona State University; Arizona State University-Tempe	Mourino-Perez, RR (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico.	rmourino@cicese.mx	Mouriño-Pérez, Rosa Reyna Reyna/F-9192-2014; Linacre, Lorena/B-7815-2016	Mouriño-Pérez, Rosa Reyna Reyna/0000-0002-7958-2212; Linacre, Lorena/0000-0003-2650-6643; Callejas-Negrete, Olga Alicia/0000-0002-9285-7014	Consejo Nacional de Ciencia y Tecnologia Ciencia Basica [133518]; American Cancer Society [RSG-08-030-01-CCG]	Consejo Nacional de Ciencia y Tecnologia Ciencia Basica; American Cancer Society(American Cancer Society)	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia Ciencia Basica (133518) to RRMP and the American Cancer Society (RSG-08-030-01-CCG) to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2011, CURR BIOL, V21, pR283, DOI 10.1016/j.cub.2011.03.023; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Alberts B, 2009, ESSENTIAL CELL BIOL; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Chan J, 2005, PLANT CELL, V17, P1737, DOI 10.1105/tpc.105.032615; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Courtright JB, 1975, NEUROSPORA NEWSL, V22, P5; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Fink G, 2006, MOL BIOL CELL, V17, P3242, DOI 10.1091/mbc.E05-12-1118; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Seiler S, 1997, EMBO J, V16, P3025, DOI 10.1093/emboj/16.11.3025; Staudt MW, 2010, FUNGAL GENET BIOL, V47, P310, DOI 10.1016/j.fgb.2009.12.010; Stepanova T, 2003, J NEUROSCI, V23, P2655; Straube A, 2003, MOL BIOL CELL, V14, P642, DOI 10.1091/mbc.E02-08-0513; SU LK, 1995, CANCER RES, V55, P2972; Tinsley JH, 1996, MOL BIOL CELL, V7, P731, DOI 10.1091/mbc.7.5.731; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Uchida M, 2008, FUNGAL GENET BIOL, V45, P683, DOI 10.1016/j.fgb.2007.10.013; Uchida Maho, 2010, Fungal Biology Reviews, V24, P132, DOI 10.1016/j.fbr.2010.12.003; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Verdin J, 2008, 9 EUR C FUNG GEN ECF	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70655	10.1371/journal.pone.0070655	http://dx.doi.org/10.1371/journal.pone.0070655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23950979	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300039
J	Slater, H; Michael, E				Slater, Hannah; Michael, Edwin			Mapping, Bayesian Geostatistical Analysis and Spatial Prediction of Lymphatic Filariasis Prevalence in Africa	PLOS ONE			English	Article							CLIMATE-CHANGE; BANCROFTIAN FILARIASIS; GEOGRAPHIC-DISTRIBUTION; SCHISTOSOMIASIS CONTROL; INFORMATION-SYSTEMS; GLOBAL DISTRIBUTION; STATISTICAL-MODEL; RISK PREDICTION; DISEASE; MALARIA	There is increasing interest to control or eradicate the major neglected tropical diseases. Accurate modelling of the geographic distributions of parasitic infections will be crucial to this endeavour. We used 664 community level infection prevalence data collated from the published literature in conjunction with eight environmental variables, altitude and population density, and a multivariate Bayesian generalized linear spatial model that allows explicit accounting for spatial autocorrelation and incorporation of uncertainty in input data and model parameters, to construct the first spatially-explicit map describing LF prevalence distribution in Africa. We also ran the best-fit model against predictions made by the HADCM3 and CCCMA climate models for 2050 to predict the likely distributions of LF under future climate and population changes. We show that LF prevalence is strongly influenced by spatial autocorrelation between locations but is only weakly associated with environmental covariates. Infection prevalence, however, is found to be related to variations in population density. All associations with key environmental/demographic variables appear to be complex and non-linear. LF prevalence is predicted to be highly heterogenous across Africa, with high prevalences (>20%) estimated to occur primarily along coastal West and East Africa, and lowest prevalences predicted for the central part of the continent. Error maps, however, indicate a need for further surveys to overcome problems with data scarcity in the latter and other regions. Analysis of future changes in prevalence indicates that population growth rather than climate change per se will represent the dominant factor in the predicted increase/decrease and spread of LF on the continent. We indicate that these results could play an important role in aiding the development of strategies that are best able to achieve the goals of parasite elimination locally and globally in a manner that may also account for the effects of future climate change on parasitic infection.	[Slater, Hannah] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Michael, Edwin] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	Imperial College London; University of Notre Dame	Michael, E (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	emichael@nd.edu	Michael, Edwin/D-3388-2014	Slater, Hannah/0000-0003-4291-7899	Natural Environment Research Council (NERC), United Kingdom; Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, United States of America [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	Natural Environment Research Council (NERC), United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Natural Environment Research Council (NERC), United Kingdom, for a NERC/Economic and Social Research Council Interdisciplinary Research Studentship to HS. The authors also acknowledge the Grantham Institute for Climate Change at Imperial College London, and the National Institutes of Health, United States of America (under grant number RO1 AI069387-01A1), for partial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON R M, 1991; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Awerbuch T, 2002, ENV CHANGE CLIMATE H, P96; Beck-Worner C, 2007, AM J TROP MED HYG, V76, P956, DOI 10.4269/ajtmh.2007.76.956; Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001; Belitz C, 2009, BAYESX SOFTWARE BAYE; Beven K, 2007, HYDROL EARTH SYST SC, V11, P460, DOI 10.5194/hess-11-460-2007; Bosello F, 2006, ECOL ECON, V58, P579, DOI 10.1016/j.ecolecon.2005.07.032; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; BRINKMANN UK, 1976, TROPENMED PARASITOL, V27, P50; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Campbell-Lendrum D, 2006, ENVIRON HEALTH PERSP, V114, P1935, DOI 10.1289/ehp.8432; Christensen O.F., 2002, R NEWS, V2, P26; Clements ACA, 2008, INT J PARASITOL, V38, P401, DOI 10.1016/j.ijpara.2007.08.001; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; Clements ACA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000431; Craig MH, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-44; De Rochars MVEB, 2004, AM J TROP MED HYG, V71, P598, DOI 10.4269/ajtmh.2004.71.598; Diggle P.J., 2003, SPATIAL STAT COMPUTA, P43, DOI 10.1007/978-0-387-21811-3_2; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ellis BR, 2009, CAD SAUDE PUBLICA, V25, pS155, DOI 10.1590/S0102-311X2009001300015; Gambhir M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002874; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hassan Ali N., 1998, Journal of the Egyptian Society of Parasitology, V28, P119; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Juminer B, 1971, Archs Inst Pasteur Tunis, V48, P231; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kitron U, 2000, PARASITOL TODAY, V16, P324, DOI 10.1016/S0169-4758(00)01708-7; Kitron U, 1998, J MED ENTOMOL, V35, P435, DOI 10.1093/jmedent/35.4.435; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lamontellerie M, 1972, ANN PARASITOLOGIE HU, V47, P743; Lardeux F, 1997, PARASITOLOGY, V114, P123, DOI 10.1017/S0031182096008359; Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael AJ, 2003, INTERN MED J, V33, P554, DOI 10.1111/j.1445-5994.2003.00492.x; Meyrowitsch DW, 1998, ACTA TROP, V70, P335, DOI 10.1016/S0001-706X(98)00037-0; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4; Michael E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002936; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; MOTT KE, 1995, B WORLD HEALTH ORGAN, V73, P247; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2005, ECOSYSTEMS HUMAN WEL, P391; Raso G, 2005, PARASITOLOGY, V131, P97, DOI 10.1017/S0031182005007432; Ribeiro PJ, 2003, DSC 2003 WORKING PAP; Richards F O Jr, 1993, Bull Pan Am Health Organ, V27, P52; Robinson TP, 1998, PARASITOL TODAY, V14, P457, DOI 10.1016/S0169-4758(98)01336-2; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Sabesan S, 2000, ANN TROP MED PARASIT, V94, P591, DOI 10.1080/00034983.2000.11813582; Silue KD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-111; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowilem Mohamed M., 2006, Journal of the Egyptian Society of Parasitology, V36, P373; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter TD, 2007, WINBUGS USER MANUAL; Srividya A, 2002, AM J TROP MED HYG, V67, P480, DOI 10.4269/ajtmh.2002.67.480; Staubach C, 2002, PREV VET MED, V56, P75, DOI 10.1016/S0167-5877(02)00125-3; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Thompson DF, 1996, EMERG INFECT DIS, V2, P234, DOI 10.3201/eid0203.960313; Tol R. S., 2001, INTEGR ASSESS, V2, P173; Tol RSJ, 2007, ENVIRON DEV ECON, V12, P687, DOI 10.1017/S1355770X07003841; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; Wang XH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000250; Wardrop NA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000914; WHO, 2004, LYMPH FIL EL AFR REG; WHO, 1998, TDRTDFCOMDT982 WHO; WIJERS DJB, 1977, ANN TROP MED PARASIT, V71, P313, DOI 10.1080/00034983.1977.11687193; Zhang H, 2002, BIOMETRICS, V58, P129, DOI 10.1111/j.0006-341X.2002.00129.x; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	86	35	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71574	10.1371/journal.pone.0071574	http://dx.doi.org/10.1371/journal.pone.0071574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951194	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300131
J	Towner, AV; Underhill, LG; Jewell, OJD; Smale, MJ				Towner, Alison V.; Underhill, Les G.; Jewell, Oliver J. D.; Smale, Malcolm J.			Environmental Influences on the Abundance and Sexual Composition of White Sharks Carcharodon carcharias in Gansbaai, South Africa	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; NEPTUNE ISLANDS; MOVEMENTS; BEHAVIOR; MIGRATION; DYNAMICS; HABITAT; COAST; AGGREGATION; VARIABILITY	The seasonal occurrence of white sharks visiting Gansbaai, South Africa was investigated from 2007 to 2011 using sightings from white shark cage diving boats. Generalized linear models were used to investigate the number of great white sharks sighted per trip in relation to sex, month, sea surface temperature and Multivariate El Nino/Southern Oscillation (ENSO) Indices (MEI). Water conditions are more variable in summer than winter due to wind-driven cold water upwelling and thermocline displacement, culminating in colder water temperatures, and shark sightings of both sexes were higher during the autumn and winter months (March-August). MEI, an index to quantify the strength of Southern Oscillation, differed in its effect on the recorded numbers of male and female white sharks, with highly significant interannual trends. This data suggests that water temperature and climatic phenomena influence the abundance of white sharks at this coastal site. In this study, more females were seen in Gansbaai overall in warmer water/positive MEI years. Conversely, the opposite trend was observed for males. In cool water years (2010 to 2011) sightings of male sharks were significantly higher than in previous years. The influence of environmental factors on the physiology of sharks in terms of their size and sex is discussed. The findings of this study could contribute to bather safety programmes because the incorporation of environmental parameters into predictive models may help identify times and localities of higher risk to bathers and help mitigate human-white shark interactions.	[Towner, Alison V.; Jewell, Oliver J. D.] Dyer Isl Conservat Trust, Kleinbaai, South Africa; [Towner, Alison V.; Underhill, Les G.] Univ Cape Town, Dept Biol Sci, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Towner, Alison V.; Underhill, Les G.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa; [Jewell, Oliver J. D.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Smale, Malcolm J.] Port Elizabeth Museum Bayworld, Humewood, South Africa; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	University of Cape Town; University of Cape Town; University of Pretoria; Nelson Mandela University	Towner, AV (corresponding author), Dyer Isl Conservat Trust, Kleinbaai, South Africa.	alisontowner@gmail.com		Jewell, Oliver/0000-0001-7680-8960; Underhill, Les/0000-0002-8758-1527; Smale, Malcolm/0000-0002-1135-8687	Dyer Island Conservation Trust; University of Cape Town Research Committee; Oppenheimer Memorial Trust; Bayworld museum	Dyer Island Conservation Trust; University of Cape Town Research Committee; Oppenheimer Memorial Trust; Bayworld museum	AVT acknowledges support from the Dyer Island Conservation Trust. LGU acknowledges support from the University of Cape Town Research Committee and the Oppenheimer Memorial Trust. OJDJ was supported by the Dyer Island Conservation Trust. MJS was supported by Bayworld museum. The Marine Dynamics team and many volunteers assisted with data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, MARINE FISHERIES REV; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Bernal D, 2003, J EXP BIOL, V206, P2831, DOI 10.1242/jeb.00481; Bernal D, 2005, FISH LOCOMOTION ECOE, P437; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; BLOCK BA, 1985, J COMP PHYSIOL B, V156, P229, DOI 10.1007/BF00695777; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; BOYD AJ, 1994, S AFR J SCI, V90, P114; Bruce B., 2008, SHARKS OPEN OCEAN BI, P69, DOI DOI 10.1002/9781444302516; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce BD, 2013, MAR BIOL, V160, P889, DOI 10.1007/s00227-012-2142-z; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; CAREY FG, 1982, COPEIA, P254; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; Cliff G, 2000, S AFR J SCI, V96, P365; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; COMPAGNO LJV, 2001, SHARKS WORLD ANNOTAT, V2, P269; Compagno LJV, 1987, SHARKS ILLUSTRATED E, P134; Compagno LJV., 1984, FAO FISH SYNOP, P20; David J.H.M., 1986, P126; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dicken ML, 2008, MAR FRESHWATER RES, V59, P596, DOI 10.1071/MF07223; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier Michael L., 2012, P133; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley Sheldon F.J., 2012, P511; Duffy CAJ, 2012, GLOBAL PERSPECTIVES, P147; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Emery S.H., 1985, Memoirs of the Southern California Academy of Sciences, V9, P73; ENFIELD DB, 1980, J PHYS OCEANOGR, V10, P557, DOI 10.1175/1520-0485(1980)010<0557:OTSADO>2.0.CO;2; Ezcurra Juan M., 2012, P3; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Francis MP, 2012, GLOBAL PERSPECTIVES, P147; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Hammerschlag N, 2006, ENVIRON BIOL FISH, V76, P341, DOI 10.1007/s10641-006-9038-z; Hardman-Mountford NJ, 2003, PROG OCEANOGR, V59, P181, DOI 10.1016/j.pocean.2003.10.001; Hussey Nigel E., 2012, P27; Johnson R, 2008, J MICROMECH MICROENG, P1; Johnson RL, 2003, THESIS U PRETORIA PR; Jorgensen Salvador J., 2012, P159; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Jury MR., 1985, S AFRICAN OCEAN COLO, P29; Klimley AP, 1996, GREAT WHITE SHARKS, P175, DOI 10.1016/B978-012415031-7/50017-3; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Klimley AP, 1985, S CAL ACAD SCI MEM, V9, P15; Kock A.A., 2006, FINDING BALANCE WHIT, P1; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P51, DOI 10.2989/025776187784522621; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P737, DOI 10.1016/S0278-4343(99)00092-8; Malcolm H, 2001, REV BIOL STATUS WHIT, P81; Mazzarella A, 2010, THEOR APPL CLIMATOL, V100, P23, DOI 10.1007/s00704-009-0159-0; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; Norman J. R., 1937, GIANT FISHES WHALES; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; PHILANDER SGH, 1986, J GEOPHYS RES-OCEANS, V91, P14192, DOI 10.1029/JC091iC12p14192; Pyle P, 1996, GREAT WHITE SHARKS, P281, DOI 10.1016/B978-012415031-7/50027-6; Quinn WH, 1992, CLIMATE AD 1500, V1500, P623, DOI DOI 10.1002/JOC.3370130411; RAMAGE CS, 1987, J CLIM APPL METEOROL, V26, P525, DOI 10.1175/1520-0450(1987)026<0525:SCIRSW>2.0.CO;2; RAND RW, 1967, INVESTIGATIONAL REPO, V60, P139; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Robbins RL, 2007, J FISH BIOL, V70, P1350, DOI 10.1111/j.1095-8649.2007.01414.x; Robbins Rachel L., 2012, P287; Roberts MJ, 2005, ICES J MAR SCI, V62, P33, DOI 10.1016/j.icesjms.2004.10.002; Roberts MJ, 1998, FISHING IND HDB S AF, P233; Saidi B, 2005, CYBIUM, V29, P303; SCHUMANN EH, 1995, J MAR RES, V53, P231, DOI 10.1357/0022240953213205; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shaughnessy PD, 1982, FOOD AGR ORG FISHERI, V5, P163; Shillington F.A., 1998, SEA, V11, P583; Sims DW, 2001, MAR BIOL, V139, P1165; Skomal Gregory B., 2012, P405; STRONG WR, 1992, AUST J MAR FRESH RES, V43, P13; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066035; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Uchida S, 1996, GREAT WHITE SHARKS, P139, DOI 10.1016/B978-012415031-7/50015-X; Wcisel MA, 2013, THESIS U CAPE TOWN C; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; Wintner SP, 1999, FISH B-NOAA, V97, P153; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336	89	21	21	0	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71197	10.1371/journal.pone.0071197	http://dx.doi.org/10.1371/journal.pone.0071197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951111	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300100
J	Zhou, P; Zhang, SM; Wang, QL; Wu, Q; Chen, M; Pei, JM				Zhou, Peng; Zhang, Shu-Miao; Wang, Qiu-Lin; Wu, Qi; Chen, Mai; Pei, Jian-Ming			Anti-Arrhythmic Effect of Verapamil Is Accompanied by Preservation of Cx43 Protein in Rat Heart	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTOR; VENTRICULAR-ARRHYTHMIAS; BORDER ZONE; ISCHEMIA; CONNEXIN43; CA2+; HEMICHANNELS; DISPERSION; INFARCTS; PEPTIDE	The present study was to test the hypothesis that anti-arrhythmic properties of verapamil may be accompanied by preserving connexin43 (Cx43) protein via calcium influx inhibition. In an in vivo study, myocardial ischemic arrhythmia was induced by occlusion of the left anterior descending (LAD) coronary artery for 45 min in Sprague-Dawley rats. Verapamil, a calcium channel antagonist, was injected i.v. into a femoral vein prior to ischemia. Effects of verapamil on arrhythmias induced by Bay K8644 (a calcium channel agonist) were also determined. In an ex vivo study, the isolated heart underwent an initial 10 min of baseline normal perfusion and was subjected to high calcium perfusion in the absence or presence of verapamil. Cardiac arrhythmia was measured by electrocardiogram (ECG) and Cx43 protein was determined by immunohistochemistry and western blotting. Administration of verapamil prior to myocardial ischemia significantly reduced the incidence of ventricular arrhythmias and total arrhythmia scores, with the reductions in heat rate, mean arterial pressure and left ventricular systolic pressure. Verapamil also inhibited arrhythmias induced by Bay K8644 and high calcium perfusion. Effect of verapamil on ischemic arrhythmia scores was abolished by heptanol, a Cx43 protein uncoupler and Gap 26, a Cx43 channels inhibitor. Immunohistochemistry data showed that ischemia-induced redistribution and reduced immunostaining of Cx43 were prevented by verapamil. In addition, diminished expression of Cx43 protein determined by western blotting was observed following myocardial ischemia in vivo or following high calcium perfusion ex vivo and was preserved after verapamil administration. Our data suggest that verapamil may confer an anti-arrhythmic effect via calcium influx inhibition, inhibition of oxygen consumption and accompanied by preservation of Cx43 protein.	[Zhou, Peng; Wang, Qiu-Lin; Wu, Qi; Pei, Jian-Ming] Chengdu Med Coll, Dept Cardiol, Chengdu, Peoples R China; [Zhang, Shu-Miao; Pei, Jian-Ming] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Chen, Mai] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China	Chengdu Medical College; Air Force Military Medical University; Air Force Military Medical University	Chen, M (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China.	chenmai@fmmu.edu.cn; jmpei8@fmmu.edu.cn			National Natural Science Foundation of China [81270402, 31200875, 30971060, 30900535]; Shaanxi Province of China [2011JM4001, 2013K132-02-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province of China	This work was supported by research grants from the National Natural Science Foundation of China (Nos. 81270402, 31200875, 30971060, 30900535) and grants from Shaanxi Province of China (Nos. 2011JM4001, 2013K132-02-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2002, J CARDIOVASC ELECTR, V13, P195, DOI 10.1046/j.1540-8167.2002.00195.x; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; DEMELLO WC, 1986, BIOCHIM BIOPHYS ACTA, V888, P91, DOI 10.1016/0167-4889(86)90074-1; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; DHEIN S, 1994, N-S ARCH PHARMACOL, V350, P174; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; KANEKO S, 1994, NEUROREPORT, V5, P2506, DOI 10.1097/00001756-199412000-00025; Kurebayashi N, 2008, AM J PHYSIOL-CELL PH, V294, pC1419, DOI 10.1152/ajpcell.00413.2007; Lerner DL, 2000, CIRCULATION, V101, P547, DOI 10.1161/01.CIR.101.5.547; Liu JC, 2008, ARCH MED RES, V39, P483, DOI 10.1016/j.arcmed.2008.02.011; Oyamada M, 2001, CELL COMMUN ADHES, V8, P335, DOI 10.3109/15419060109080749; Pei JM, 2000, AM J PHYSIOL-CELL PH, V279, pC1455, DOI 10.1152/ajpcell.2000.279.5.C1455; Roberts-Thomson KC, 2011, NAT REV CARDIOL, V8, P311, DOI 10.1038/nrcardio.2011.15; Takanari H, 2011, J PHARMACOL SCI, V115, P15, DOI 10.1254/jphs.10233FP; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Tribulova N, 2001, PHYSIOL RES, V50, P247; TULLO NG, 1993, ACTA ANAESTH SCAND, V37, P43, DOI 10.1111/j.1399-6576.1993.tb03824.x; Wang GY, 2001, AM J PHYSIOL-HEART C, V280, pH384, DOI 10.1152/ajpheart.2001.280.1.H384; WILLIAMS EMV, 1984, J CLIN PHARMACOL, V24, P129, DOI 10.1002/j.1552-4604.1984.tb01822.x; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zhang QY, 2010, CRIT CARE MED, V38, P2365, DOI 10.1097/CCM.0b013e3181fa0437; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	24	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71567	10.1371/journal.pone.0071567	http://dx.doi.org/10.1371/journal.pone.0071567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951191	Green Submitted, Green Published, gold			2022-12-27	WOS:000323097300129
J	Steward, WT; Miege, P; Choi, KH				Steward, Wayne T.; Miege, Pierre; Choi, Kyung-Hee			Charting a Moral Life: The Influence of Stigma and Filial Duties on Marital Decisions among Chinese Men who Have Sex with Men	PLOS ONE			English	Article							SOCIAL DISCRIMINATION; HIV TRANSMISSION; BISEXUAL MEN; SHANGHAI; BRIDGE; RISK	Introduction: Stigma constitutes a critical challenge to the rising rates of HIV among Chinese men who have sex with men (MSM). It reduces willingness to disclose one's sexual orientation and can lead to concurrent sexual partnerships. Disclosure decisions are also affected by cultural norms that place pressures on sons to marry. In this manuscript, we characterize how stigma and cultural factors influenced Chinese MSM's decisions around disclosure and marriage. We seek to show that MSM's actions were motivated by moral considerations, even when those choices posed HIV transmission risks. Methods: We conducted qualitative interviews with 30 MSM in Beijing, China. Interviews were audio-recorded, transcribed, and translated into English for analysis. Transcripts were coded using a procedure that allowed for themes to emerge organically. Results: Participants struggled with feelings of shame and believed that others possessed stigmatizing attitudes about homosexuality. They had experienced relatively little discrimination because they infrequently disclosed their MSM status. In response to marital pressures, participant had to reconcile same-sex attractions with filial expectations. Their choices included: not being involved with women; putting on the appearance of a heterosexual relationship by marrying a lesbian; or fulfilling family expectations by marrying a heterosexual woman. Regardless of the decision, many rooted the justifications for their choices in the considerations they had given to others' needs. Conclusion: The growing epidemic among MSM in China requires action from the public health community. As programs are scaled up to serve these men, it is critical to remember that MSM, who often fear social sanction if they were to reveal their sexual orientation, continue to face the same pressures from culturally normative social duties as heterosexual men. Interventions must find ways to help men navigate a balance between their own needs and the responsibilities they feel toward their parents and others.	[Steward, Wayne T.; Choi, Kyung-Hee] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Miege, Pierre] Beijing Normal Univ, Inst Social Dev & Publ Policy, Beijing 100875, Peoples R China	University of California System; University of California San Francisco; Beijing Normal University	Steward, WT (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA.	wayne.steward@ucsf.edu		Miege, Pierre/0000-0003-1898-2578	United States National Institute of Mental Health [R01MH085581]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085581] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by a grant from the United States National Institute of Mental Health (R01MH085581). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034972; Brown J, 2010, AM J MENS HEALTH, V4, P267, DOI 10.1177/1557988309342002; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2008, AIDS BEHAV, V12, pS71, DOI 10.1007/s10461-008-9394-0; Chow EPF, 2012, INT J INFECT DIS, V16, pE312, DOI 10.1016/j.ijid.2012.01.012; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; He Q, 2009, SEX TRANSM INFECT, V85, P383, DOI 10.1136/sti.2009.035808; Herek GM, 2009, NEBR SYM MOTIV, V54, P65, DOI 10.1007/978-0-387-09556-1_4; Jones E. E., 1984, SOCIAL STIGMA PSYCHO; Leiber E, 2009, AIDS EDUC PREV, V21, P415, DOI 10.1521/aeap.2009.21.5.415; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Scambler G., 1989, EPILEPSY; Solomon Sunil S, 2010, J Int AIDS Soc, V13 Suppl 2, pS7, DOI 10.1186/1758-2652-13-S2-S7; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Steward WT, 2011, PSYCHOL HEALTH MED, V16, P74, DOI 10.1080/13548506.2010.521568; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Wang QQ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-955; Wu Z, 2013, CLIN INFECT DIS	30	60	62	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71778	10.1371/journal.pone.0071778	http://dx.doi.org/10.1371/journal.pone.0071778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245OM	23951245	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200072
J	Chae, H; Yook, SH; Kim, Y				Chae, Huiseung; Yook, Soon-Hyung; Kim, Yup			Phase Transitions in Paradigm Shift Models	PLOS ONE			English	Article							EVOLUTION	Two general models for paradigm shifts, deterministic propagation model (DM) and stochastic propagation model (SM), are proposed to describe paradigm shifts and the adoption of new technological levels. By defining the order parameter m based on the diversity of ideas, Delta, it is studied when and how the phase transition or the disappearance of a dominant paradigm occurs as a cost C in DM or an innovation probability alpha in SM increases. In addition, we also investigate how the propagation processes affect the transition nature. From analytical calculations and numerical simulations m is shown to satisfy the scaling relation m = 1 - f (C/N) for DM with the number of agents N. In contrast, m in SM scales as m = 1 - f (alpha N-a).	[Kim, Yup] Kyung Hee Univ, Dept Phys, Seoul, South Korea; Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kim, Y (corresponding author), Kyung Hee Univ, Dept Phys, Seoul, South Korea.	ykim@khu.ac.kr	Yook, Soon-Hyung/AAH-9157-2020		National Research Foundation of Korea (NRF); Korean Government (MEST) [2011-0015257]; Basic Science Research Program through the National Research Foundation of Korea(NRF); Ministry of Education, Science and Technology [2012R1A1A2007430]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (Grants No. 2011-0015257) and by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (No. 2012R1A1A2007430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PRINCIPLES CONDENSED; Arenas A, 2000, PHYS REV E, V61, P3466, DOI 10.1103/PhysRevE.61.3466; Bordogna CM, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/6/065144; Bornholdt S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058701; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Guardiola X, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026121; Khun TS, 1962, STRUCTURE SCI REVOLU; Kim Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046110; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Rosvall M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026111; Stauffer D, 2000, INT J MOD PHYS C, V11, P1239, DOI 10.1142/S012918310000105X; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936	13	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70928	10.1371/journal.pone.0070928	http://dx.doi.org/10.1371/journal.pone.0070928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951043	Green Published, Green Submitted, gold			2022-12-27	WOS:000323124000032
J	Chakraborti, S; Bhattacharya, S; Chowdhury, R; Chakrabarti, P				Chakraborti, Soumyananda; Bhattacharya, Saurabh; Chowdhury, Rukhsana; Chakrabarti, Pinak			The Molecular Basis of Inactivation of Metronidazole-Resistant Helicobacter pylori Using Polyethyleneimine Functionalized Zinc Oxide Nanoparticles	PLOS ONE			English	Article							ZNO NANOPARTICLES; SILVER NANOPARTICLES; ANTIBACTERIAL ACTIVITY; CANCER-CELLS; IN-VITRO; BACTERIA; MECHANISM; APOPTOSIS; TOXICITY; STRESS	In view of the world wide prevalence of Helicobacter pylori infection, its potentially serious consequences, and the increasing emergence of antibiotic resistant H. pylori strains there is an urgent need for the development of alternative strategies to combat the infection. In this study it has been demonstrated that polyethyleneimine (PEI) functionalized zinc oxide (ZnO) nanoparticles (NPs) inhibit the growth of a metronidazole-resistant strain of H. pylori and the molecular basis of the antibacterial activity of ZnO-PEI NP has been investigated. The ZnO-PEI NP was synthesized using a wet chemical method with a core size of approximately 3-7 nm. Internalization and distribution of ZnO-PEI NP without agglomeration was observed in H. pylori cytosol by electron microscopy. Several lines of evidence including scanning electron microscopy, propidium iodide uptake and ATP assay indicate severe membrane damage in ZnO-PEI NP treated H. pylori. Intracellular ROS generation increased rapidly following the treatment of H. pylori with ZnO-PEI NP and extensive degradation of 16S and 23S rRNA was observed by quantitative reverse-transcriptase PCR. Finally, considerable synergy between ZnO-PEI NP and antibiotics was observed and it has been demonstrated that the concentration of ZnO-PEI NP (20 mu g/ml) that is non-toxic to human cells could be used in combination with sub-inhibitory concentrations of antibiotics for the inhibition of H. pylori growth.	[Chakraborti, Soumyananda; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata, India; [Bhattacharya, Saurabh; Chowdhury, Rukhsana] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India	Department of Science & Technology (India); Bose Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chowdhury, R (corresponding author), CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India.	rukhsana@iicb.res.in; pinak@jcbose.ac.in		Chakraborti, Soumyananda/0000-0002-7384-690X	Department of Science and Technology, India; Council of Scientific and Industrial Research, India; JC Bose National Fellowship	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); JC Bose National Fellowship	This work was supported by Department of Science and Technology, India, and Council of Scientific and Industrial Research, India. PC is supported by the JC Bose National Fellowship. SC and SB are thankful to the Council of Scientific and Industrial Research, India for research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Beyerle A, 2011, MOL PHARMACEUT, V8, P976, DOI 10.1021/mp1004492; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Bhadra P, 2011, MAT SCI ENG C-MATER, V31, P929, DOI 10.1016/j.msec.2011.02.015; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Boussif O, 1996, GENE THER, V3, P1074; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Chakraborti S, 2012, LANGMUIR, V28, P11142, DOI 10.1021/la3007603; Clemens DL, 2012, ANTIMICROB AGENTS CH, V56, P2535, DOI 10.1128/AAC.06049-11; Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057; Helander IM, 1997, MICROBIOL-UK, V143, P3193, DOI 10.1099/00221287-143-10-3193; Jalal R, 2010, MATER CHEM PHYS, V121, P198, DOI 10.1016/j.matchemphys.2010.01.020; Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x; Joshi P, 2009, ADV SCI LETT, V2, P360, DOI 10.1166/asl.2009.1043; Joshi P, 2009, J NANOSCI NANOTECHNO, V9, P6427, DOI 10.1166/jnn.2009.1584; Kasemets K, 2009, TOXICOL IN VITRO, V23, P1116, DOI 10.1016/j.tiv.2009.05.015; Kuipers EJ, 1997, ALIMENT PHARM THER, V11, P71, DOI 10.1046/j.1365-2036.11.s1.5.x; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; Lee HJ, 2011, COLLOID SURFACE B, V88, P505, DOI 10.1016/j.colsurfb.2011.07.041; Luo J, 2010, INT J ANTIMICROB AG, V36, P549, DOI 10.1016/j.ijantimicag.2010.08.015; Meena R., 2012, ADV MAT LETT, V3, P459, DOI [10.5185/amlett.2012.icnano.157, DOI 10.5185/AMLETT.2012.ICNANO.157]; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Nagy A, 2011, INT J NANOMED, V6, P1833, DOI 10.2147/IJN.S24019; Espitia PJP, 2012, FOOD BIOPROCESS TECH, V5, P1447, DOI 10.1007/s11947-012-0797-6; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rainsford KD, 1997, PHARM SCI-IRAN, V3, P483; Rainsford KD, 1992, EXPT CLIN GASTROENTE, V1, P349; Vicentini DS, 2010, MAT SCI ENG C-MATER, V30, P503, DOI 10.1016/j.msec.2009.01.026; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu WM, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/723183; Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; Zhang LL, 2008, PROG NAT SCI-MATER, V18, P939, DOI 10.1016/j.pnsc.2008.01.026	36	31	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e70776	10.1371/journal.pone.0070776	http://dx.doi.org/10.1371/journal.pone.0070776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951006	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000027
J	Chaput, C; Spindler, E; Gill, RT; Zychlinsky, A				Chaput, Catherine; Spindler, Eileen; Gill, Ryan T.; Zychlinsky, Arturo			O-Antigen Protects Gram-Negative Bacteria from Histone Killing	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; KLEBSIELLA-PNEUMONIAE; SIDE-CHAIN; VIRULENCE; LIPOPOLYSACCHARIDE; POLYSACCHARIDE; RESISTANCE; DEFENSINS; MEMBRANE; PROTEINS	Beyond their traditional role of wrapping DNA, histones display antibacterial activity to Gram-negative and -positive bacteria. To identify bacterial components that allow survival to a histone challenge, we selected resistant bacteria from homologous Escherichia coli libraries that harbor plasmids carrying pieces of the chromosome in different sizes. We identified genes required for exopolysaccharide production and for the synthesis of the polysaccharide domain of the lipopolysaccharide, called O-antigen. Indeed, O-antigen and exopolysaccharide conferred further resistance to histones. Notably, O-antigen also conferred resistance to histones in the pathogens Shigella flexneri and Klebsiella pneumoniae.	[Chaput, Catherine; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Spindler, Eileen; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	Max Planck Society; University of Colorado System; University of Colorado Boulder	Chaput, C (corresponding author), Charite, Dept Infect Dis & Pulm Med, Berlin, Germany.	catherine.chaput@charite.de; zychlinsky@mpiib-berlin.mpg.de	Huber, Kelly/AAE-3449-2020					Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Edwards NJ, 2000, MOL MICROBIOL, V35, P1530, DOI 10.1046/j.1365-2958.2000.01823.x; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Fernandes JMO, 2004, DEV COMP IMMUNOL, V28, P127, DOI 10.1016/S0145-305X(03)00120-4; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Holzl MA, 2008, IMMUNOL LETT, V119, P4, DOI 10.1016/j.imlet.2008.05.003; Kim HS, 1996, BIOCHEM BIOPH RES CO, V229, P381, DOI 10.1006/bbrc.1996.1814; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Neidhardt F, 1996, ESCHERICHIA COLI SAM; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Park CB, 1996, BIOCHEM BIOPH RES CO, V218, P408, DOI 10.1006/bbrc.1996.0071; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914	37	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71097	10.1371/journal.pone.0071097	http://dx.doi.org/10.1371/journal.pone.0071097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951089	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000039
J	Panov, A; Orynbayeva, Z				Panov, Alexander; Orynbayeva, Zulfiya			Bioenergetic and Antiapoptotic Properties of Mitochondria from Cultured Human Prostate Cancer Cell Lines PC-3, DU145 and LNCaP	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERMEABILITY TRANSITION PORE; LIVER-MITOCHONDRIA; CALCIUM-IONS; FATTY-ACID; RAT-LIVER; BCL-XL; APOPTOSIS; METABOLISM; CARCINOMA	The purpose of this work was to reveal the metabolic features of mitochondria that might be essential for inhibition of apoptotic potential in prostate cancer cells. We studied mitochondria isolated from normal prostate epithelial cells (PrEC), metastatic prostate cancer cell lines LNCaP, PC-3, DU145; and non-prostate cancer cells - human fibrosarcoma HT1080 cells; and normal human lymphoblastoid cells. PrEC cells contained 2 to 4 times less mitochondria per gram of cells than the three PC cell lines. Respiratory activities of PrEC cell mitochondria were 5-20-fold lower than PC mitochondria, depending on substrates and the metabolic state, due to lower content and lower activity of the respiratory enzyme complexes. Mitochondria from the three metastatic prostate cancer cell lines revealed several features that are distinctive only to these cells: low affinity of Complex I for NADH, 20-30 mV higher electrical membrane potential (Delta psi). Unprotected with cyclosporine A (CsA) the PC-3 mitochondria required 4 times more Ca2+ to open the permeability transition pore (mPTP) when compared with the PrEC mitochondria, and they did not undergo swelling even in the presence of alamethicin, a large pore forming antibiotic. In the presence of CsA, the PC-3 mitochondria did not open spontaneously the mPTP. We conclude that the low apoptotic potential of the metastatic PC cells may arise from inhibition of the Ca2+-dependent permeability transition due to a very high.. and higher capacity to sequester Ca2+. We suggest that due to the high.., mitochondrial metabolism of the metastatic prostate cancer cells is predominantly based on utilization of glutamate and glutamine, which may promote development of cachexia.	[Panov, Alexander] Russian Acad Med Sci, Inst Mol Biol & Biophys, Siberian Div, Novosibirsk, Russia; [Orynbayeva, Zulfiya] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA	Russian Academy of Medical Sciences; Russian Academy of Sciences; Drexel University	Panov, A (corresponding author), Russian Acad Med Sci, Inst Mol Biol & Biophys, Siberian Div, Novosibirsk, Russia.	alexander.panov55@gmail.com			National Institutes of Health [CA69764]; Emory University Trust for Urologic Research; NATIONAL CANCER INSTITUTE [R21CA069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Trust for Urologic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant National Institutes of Health CA69764 (to J.A. Petros), Emory University Trust for Urologic Research. Cornelius F.J. Beukenkamp Endowment for Prostate Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; AVADHANI NG, 1972, BIOCHEM BIOPH RES CO, V46, P773, DOI 10.1016/S0006-291X(72)80207-9; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Bourdeau-Heller Jeanne, 2007, J Cell Physiol, V212, P744, DOI 10.1002/jcp.21069; Bruchovsky N, 1996, PROSTATE, P13; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Costello LC, 2000, PROSTATE, V42, P196; Costello LC, 1997, J BIOL CHEM, V272, P28875, DOI 10.1074/jbc.272.46.28875; COSTELLO LC, 1991, PROSTATE, V18, P25, DOI 10.1002/pros.2990180104; DAVEY PJ, 1970, ARCH BIOCHEM BIOPHYS, V136, P54, DOI 10.1016/0003-9861(70)90326-7; De Bari L, 2010, INT J ONCOL, V37, P1607, DOI 10.3892/ijo_00000815; Effert PJ, 1996, J UROLOGY, V155, P994, DOI 10.1016/S0022-5347(01)66366-3; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; FORD WCL, 1984, INT J ANDROL, V7, P198, DOI 10.1111/j.1365-2605.1984.tb00777.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hail N, 2009, APOPTOSIS, V14, P849, DOI 10.1007/s10495-009-0356-4; HASMANN M, 1989, BIOCHEM PHARMACOL, V38, P305, DOI 10.1016/0006-2952(89)90041-5; Herrmann JL, 1998, ONCOGENE, V17, P2889, DOI 10.1038/sj.onc.1202221; Higgins LH, 2009, BBA-BIOENERGETICS, V1787, P1433, DOI 10.1016/j.bbabio.2009.06.003; Hirst J, 2003, BIOCHIM BIOPHYS ACTA, V1604; Hochachka PW, 2002, BIOESSAYS, V24, P749, DOI 10.1002/bies.10131; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jorgensen LH, 2011, AM J PATHOL, V178, P273, DOI 10.1016/j.ajpath.2010.11.027; Joshi B, 1999, CANCER RES, V59, P4343; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang BH, 2010, CLIN CANCER RES, V16, P4779, DOI 10.1158/1078-0432.CCR-10-1818; Koivisto P, 1997, J PATHOL, V183, P51, DOI 10.1002/(SICI)1096-9896(199709)183:1<51::AID-PATH1092>3.0.CO;2-N; KRISHNAMOORTHY G, 1984, BIOCHEMISTRY-US, V23, P1640, DOI 10.1021/bi00303a009; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LANOUE KF, 1986, BIOCHEMISTRY-US, V25, P7667, DOI 10.1021/bi00371a058; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Lebedeva I, 2000, CANCER RES, V60, P6052; Liu YY, 2010, ANTICANCER RES, V30, P369; MAO P, 1966, CANCER RES, V26, P955; Marcelli M, 2000, PROSTATE, V42, P260, DOI 10.1002/(SICI)1097-0045(20000301)42:4<260::AID-PROS3>3.0.CO;2-0; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P4208, DOI 10.4161/cc.10.24.18487; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Palmberg C, 2000, ONCOL REP, V7, P1141; PANOV A, 1980, ARCH BIOCHEM BIOPHYS, V199, P420, DOI 10.1016/0003-9861(80)90298-2; Panov A, 2013, PRACTICAL MITOCHONDR, P2013; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9; Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013; Panov AV, 1996, AM J PHYSIOL-HEART C, V270, pH1398, DOI 10.1152/ajpheart.1996.270.4.H1398; Pantazis P, 1996, J Exp Ther Oncol, V1, P322; Parker SL, 1966, CA-CANCER J CLIN, V65, P5; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Rokhlin OW, 1997, CANCER RES, V57, P1758; ROTTENBERG H, 1984, J MEMBRANE BIOL, V81, P127, DOI 10.1007/BF01868977; Saeed B, 1997, PROSTATE, V31, P145; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; SHABALINA IG, 1991, BIOCHEMISTRY-MOSCOW+, V56, P282; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TORRONI A, 1990, J BIOL CHEM, V265, P20589; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Wallace DC, 1983, ENDOCYTOBIOLOGY, VII, P87; Wirmer J, 2006, METHOD ENZYMOL, V415, P180, DOI 10.1016/S0076-6879(06)15012-0; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; Zhang HC, 1996, PROSTATE, V29, P69	81	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72078	10.1371/journal.pone.0072078	http://dx.doi.org/10.1371/journal.pone.0072078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951286	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000077
J	Verdenius, I; Harper, DM; Harris, GD; Griffith, RS; Wall, J; Hempstead, LK; Malnar, GJ; Bekkers, RLM				Verdenius, Inge; Harper, Diane M.; Harris, George D.; Griffith, R. Stephen; Wall, Jeffrey; Hempstead, Laura K.; Malnar, Gerard J.; Bekkers, Ruud L. M.			Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; YOUNG-WOMEN; COMPLETION; ADOLESCENTS; HEALTH; SERIES; INITIATION; EFFICACY; CARE; IMMUNOGENICITY	Background: HPV4 is approved as a series of three timed doses expected to result in efficacy against specific HPV infections. Completion rates in the US are quite low at the same time the structure of health care delivery is changing. The aim of this study was to determine how the patient-, clinic-and systems-level characteristics facilitate or hinder the timely completion of three HPV4 doses in both adolescent and adult female populations in a high-risk safety net population. Methods: This is a retrospective study in which patient-, clinic-and systems-level data are abstracted from the electronic medical record (EMR) for all females 10-26 years of age receiving at least one dose of HPV4 between July 1, 2006 and October 1, 2009. Results: Adults were more likely to complete the three dose series if they had at least one health care visit in addition to their HPV4 visit, (aOR = 1.54 (95% CI: 1.10, 2.15). Adults were less likely to complete the three dose series if they received their second HPV4 dose at an acute health care, preventive care or postpartum visits compared to an HPV4-only visit (aOR = 0.31 (95% CI: 0.13, 0.72), 0.12 (0.04, 0.35), 0.30 (0.14, 0.62), respectively). Hispanic adults were less likely than whites to complete the series (aOR = 0.24 (95% CI: 0.10, 0.59). 39% of adolescents who completed two doses completed the series. Conclusions: HPV4 is more likely to be effectively administered to adults in a safety net population if multiple health care needs can be met within the health care system.	[Verdenius, Inge] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Harper, Diane M.] Univ Missouri Kansas City Sch Med, Ctr Excellence, Womens Hlth, Kansas City, MO USA; [Harper, Diane M.] Univ Missouri Kansas City Sch Med, Dept Biomed Informat, Kansas City, MO USA; [Harper, Diane M.] Univ Missouri Kansas City Sch Med, Dept Hlth Informat, Kansas City, MO USA; [Harper, Diane M.; Wall, Jeffrey; Malnar, Gerard J.] Univ Missouri Kansas City Sch Med, Dept Obstet & Gynecol, Kansas City, MO USA; [Harper, Diane M.; Harris, George D.; Griffith, R. Stephen; Hempstead, Laura K.] Univ Missouri Kansas City Sch Med, Dept Community & Family Med, Kansas City, MO USA; [Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen	Harper, DM (corresponding author), Univ Missouri Kansas City Sch Med, Ctr Excellence, Womens Hlth, Kansas City, MO USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014; Bekkers, Ruud/M-3866-2014; Bekkers, Ruud/AAU-5319-2020	Harper, Diane M./0000-0001-7648-883X; Bekkers, Ruud/0000-0002-4577-8495; 				ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Chao C, 2009, MAYO CLIN PROC, V84, P864, DOI 10.1016/S0025-6196(11)60503-X; Chou B, 2011, OBSTET GYNECOL, V118, P14, DOI 10.1097/AOG.0b013e318220ebf3; Cook RL, 2010, J ADOLESCENT HEALTH, V47, P596, DOI 10.1016/j.jadohealth.2010.09.015; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Dempsey A, 2010, VACCINE, V28, P989, DOI 10.1016/j.vaccine.2009.10.133; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Dorell CG, 2011, PEDIATRICS, V128, P830, DOI 10.1542/peds.2011-0950; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Falik M, 2001, MED CARE, V39, P551, DOI 10.1097/00005650-200106000-00004; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Freeman HP, 2005, NIH PUB; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Gold R, 2011, PREV MED, V52, P456, DOI 10.1016/j.ypmed.2011.04.010; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Harper D. M., 2010, J VACCINES VACCIN, V1, P107, DOI [10.4172/2157-7560.1000107, DOI 10.4172/2157-7560.1000107]; Heitmann ER, 2012, CURR OBSTET GYNECOL, V1, P95, DOI 10.1007/s13669-012-0017-4; Hirth JM, 2012, CANCER-AM CANCER SOC, V118, P5623, DOI 10.1002/cncr.27598; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Klein JD, 2008, PEDIATRICS, V121, P1263, DOI 10.1542/peds.2008-0694; LEWIN ME, 2000, AM HLTH CARE SAFETY, P1; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Neubrand TPL, 2009, CLIN PEDIATR, V48, P966, DOI 10.1177/0009922809337534; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Niccolai LM, 2011, AM J PREV MED, V41, P428, DOI 10.1016/j.amepre.2011.06.032; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Perkins RB, 2012, J WOMENS HEALTH, V21, P813, DOI 10.1089/jwh.2011.3364; Pinheiro RD, 2011, J ORAL PATHOL MED, V40, P121, DOI 10.1111/j.1600-0714.2010.00954.x; Rouzier R, 2010, J ADOLESCENT HEALTH, V47, P237, DOI 10.1016/j.jadohealth.2010.04.006; Rubin RF, 2012, J COMMUN HEALTH, V37, P1145, DOI 10.1007/s10900-012-9581-9; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schluterman NH, 2011, VACCINE, V29, P3767, DOI 10.1016/j.vaccine.2011.03.032; Smith LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-645; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; SOWARD JL, 1995, ILLUSTRATED ACCOUNT; *SPSS INC, 1999, PASW STAT 18 REL 18; Szilagyi PG, 2008, PEDIATRICS, V121, pS15, DOI 10.1542/peds.2007-1115C; Tan WY, 2011, VACCINE, V29, P2548, DOI 10.1016/j.vaccine.2011.01.066; Tiro JA, 2012, VACCINE, V30, P2368, DOI 10.1016/j.vaccine.2011.11.031; Unger ER, 2011, PEDIATRICS, V128, pE658, DOI 10.1542/peds.2010-2247; Weiss TW, 2010, J ADOLESCENT HEALTH, V47, P3, DOI 10.1016/j.jadohealth.2010.03.003; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Widdice LE, 2011, PEDIATRICS, V127, P77, DOI 10.1542/peds.2010-0812; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Zimmerman RK, 2010, J WOMENS HEALTH, V19, P1441, DOI 10.1089/jwh.2009.1753; [No title captured]	51	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71295	10.1371/journal.pone.0071295	http://dx.doi.org/10.1371/journal.pone.0071295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201ER	23951123	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000045
J	Abu Aboud, O; Wettersten, HI; Weiss, RH				Abu Aboud, Omran; Wettersten, Hiromi I.; Weiss, Robert H.			Inhibition of PPAR alpha Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; C-MYC; PEROXISOME PROLIFERATORS; CARCINOMA; METABOLISM; IDENTIFICATION; EPIDEMIOLOGY; PROGRESSION; MECHANISM; THERAPY	Renal cell carcinoma (RCC) is the sixth most common cancer in the US. While RCC is highly metastatic, there are few therapeutics options available for patients with metastatic RCC, and progression-free survival of patients even with the newest targeted therapeutics is only up to two years. Thus, novel therapeutic targets for this disease are desperately needed. Based on our previous metabolomics studies showing alteration of peroxisome proliferator-activated receptor alpha (PPAR alpha) related events in both RCC patient and xenograft mice materials, this pathway was further examined in the current study in the setting of RCC. PPAR alpha is a nuclear receptor protein that functions as a transcription factor for genes including those encoding enzymes involved in energy metabolism; while PPAR alpha has been reported to regulate tumor growth in several cancers, it has not been evaluated in RCC. A specific PPAR alpha antagonist, GW6471, induced both apoptosis and cell cycle arrest at G0/G1 in VHL(+) and VHL(-) RCC cell lines (786-O and Caki-1) associated with attenuation of the cell cycle regulatory proteins c-Myc, Cyclin D1, and CDK4; this data was confirmed as specific to PPAR alpha antagonism by siRNA methods. Interestingly, when glycolysis was blocked by several methods, the cytotoxicity of GW6471 was synergistically increased, suggesting a switch to fatty acid oxidation from glycolysis and providing an entirely novel therapeutic approach for RCC.	[Abu Aboud, Omran; Wettersten, Hiromi I.; Weiss, Robert H.] Univ Calif Davis, Div Nephrol, Dept Internal Med, Davis, CA 95616 USA; [Abu Aboud, Omran; Weiss, Robert H.] Univ Calif Davis, Comparat Pathol Grad Grp, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Weiss, RH (corresponding author), Univ Calif Davis, Div Nephrol, Dept Internal Med, Davis, CA 95616 USA.	rhweiss@ucdavis.edu			National Institutes of Health [1R01CA135401-01A1, 1R01DK082690-01A1]; Medical Service of the US Department of Veterans' Affairs; NATIONAL CANCER INSTITUTE [R01CA135401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Service of the US Department of Veterans' Affairs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 1R01CA135401-01A1 and 1R01DK082690-01A1 (to RHW) and the Medical Service of the US Department of Veterans' Affairs (to RHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; Belldegrun AS, 2008, CANCER-AM CANCER SOC, V113, P2457, DOI 10.1002/cncr.23851; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Ganti S, 2012, CANC RES; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Inoue H, 2011, CANC BIOL THERAPY, V12; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Krishnan B, 2002, HUM PATHOL, V33, P68, DOI 10.1053/hupa.2002.30210; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Liu DC, 2004, ACTA PHARMACOL SIN, V25, P1312; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lotz C, 2011, EXP BIOL MED, V236, P113, DOI 10.1258/ebm.2010.010210; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Neve BP, 2000, BIOCHEM PHARMACOL, V60, P1245, DOI 10.1016/S0006-2952(00)00430-5; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Perroud B, 2009, MOL CELL PROTEOMICS, V8, P971, DOI 10.1074/mcp.M800252-MCP200; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 1998, CARCINOGENESIS, V19, P1989, DOI 10.1093/carcin/19.11.1989; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Ribet C, 2010, ENDOCRINOLOGY, V151, P123, DOI 10.1210/en.2009-0726; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Ryan CW, 2010, AM SOC CLIN ONCOLOGY, V1092-9118, P1; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Suchanek KM, 2002, INT J BIOCHEM CELL B, V34, P1051, DOI 10.1016/S1357-2725(02)00025-0; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tachibana Keisuke, 2006, Nucleic Acids Symp Ser (Oxf), P257; Thoms HC, 2007, CELL CYCLE, V6, P1293, DOI 10.4161/cc.6.11.4312; Voss MH, 2011, HEMATOL ONCOL CLIN N, V25, P835, DOI 10.1016/j.hoc.2011.04.008; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Weiss RH, 2006, KIDNEY INT, V69, P224, DOI 10.1038/sj.ki.5000065; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	43	33	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71115	10.1371/journal.pone.0071115	http://dx.doi.org/10.1371/journal.pone.0071115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951092	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700079
J	Fitzer, SC; Caldwell, GS; Clare, AS; Upstill-Goddard, RC; Bentley, MG				Fitzer, Susan C.; Caldwell, Gary S.; Clare, Anthony S.; Upstill-Goddard, Robert C.; Bentley, Matthew G.			Response of Copepods to Elevated pCO(2) and Environmental Copper as Co-Stressors - A Multigenerational Study	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SEA-URCHIN; EMBRYONIC-DEVELOPMENT; MARINE-INVERTEBRATES; CLIMATE-CHANGE; LIFE STAGES; TOXICITY; CADMIUM; METALS; GROWTH	We examined the impacts of ocean acidification and copper as co-stressors on the reproduction and population level responses of the benthic copepod Tisbe battagliai across two generations. Naupliar production, growth, and cuticle elemental composition were determined for four pH values: 8.06 (control); 7.95; 7.82; 7.67, with copper addition to concentrations equivalent to those in benthic pore waters. An additive synergistic effect was observed; the decline in naupliar production was greater with added copper at decreasing pH than for decreasing pH alone. Naupliar production modelled for the two generations revealed a negative synergistic impact between ocean acidification and environmentally relevant copper concentrations. Conversely, copper addition enhanced copepod growth, with larger copepods produced at each pH compared to the impact of pH alone. Copepod digests revealed significantly reduced cuticle concentrations of sulphur, phosphorus and calcium under decreasing pH; further, copper uptake increased to toxic levels that lead to reduced naupliar production. These data suggest that ocean acidification will enhance copper bioavailability, resulting in larger, but less fecund individuals that may have an overall detrimental outcome for copepod populations.	[Fitzer, Susan C.; Caldwell, Gary S.; Clare, Anthony S.; Upstill-Goddard, Robert C.; Bentley, Matthew G.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fitzer, Susan C.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland	Newcastle University - UK; University of Glasgow	Fitzer, SC (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Susan.Fitzer@glasgow.ac.uk	Caldwell, Gary S./A-4364-2008; Fitzer, Susan/I-2418-2014	Caldwell, Gary S./0000-0001-5687-6894; Fitzer, Susan/0000-0003-3556-7624; Bentley, Matt/0000-0002-6494-2545; Clare, Anthony S./0000-0002-7692-9583; Upstill-Goddard, Robert/0000-0003-3396-284X	Natural Environmental Research Council (NERC) [NE/G523412/1]	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was fully sponsored by Natural Environmental Research Council (NERC) with grant number NE/G523412/1 as part of NERC funded PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Araujo CVM, 2010, ENVIRON TOXICOL CHEM, V29, P393, DOI 10.1002/etc.46; Barata C, 2002, MAR ECOL PROG SER, V230, P183, DOI 10.3354/meps230183; Barka S, 2001, COMP BIOCHEM PHYS C, V128, P479, DOI 10.1016/S1532-0456(00)00198-8; Bossuyt BTA, 2004, ENVIRON TOXICOL CHEM, V23, P2029, DOI 10.1897/03-377; Byrne M, 2012, MAR ENVIRON RES, V76, P3, DOI 10.1016/j.marenvres.2011.10.004; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Clapham ME, 2011, GEOLOGY, V39, P1059, DOI 10.1130/G32230.1; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Crawley M.J., 2007, R BOOK; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; DAVE G, 1984, COMP BIOCHEM PHYS C, V78, P439, DOI 10.1016/0742-8413(84)90112-9; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Diz FR, 2009, ECOTOX ENVIRON SAFE, V72, P1881, DOI 10.1016/j.ecoenv.2009.03.004; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DUCHART P, 1973, LIMNOL OCEANOGR, V18, P605, DOI 10.4319/lo.1973.18.4.0605; Dykstra MJ, 2002, TOXICOL PATHOL, V30, P735, DOI 10.1080/01926230290166823; Egilsdottir H, 2009, MAR POLLUT BULL, V58, P1187, DOI 10.1016/j.marpolbul.2009.03.017; Faraway JJ., 2005, EXTENDING LINEAR MOD; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Findlay HS, 2010, ESTUAR COAST SHELF S, V86, P675, DOI 10.1016/j.ecss.2009.11.036; Fitzer SC, 2012, J CRUSTACEAN BIOL, V32, P685, DOI 10.1163/193724012X639788; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Gutierrez MF, 2010, WATER AIR SOIL POLL, V213, P275, DOI 10.1007/s11270-010-0383-3; Frankignoulle M, 2001, AQUAT GEOCHEM, V7, P267, DOI 10.1023/A:1015251010481; Gao Y, 2009, MAR CHEM, V117, P88, DOI 10.1016/j.marchem.2009.05.002; Geffard O, 2005, ENVIRON TOXICOL, V20, P407, DOI 10.1002/tox.20126; Gelman A., 2007, DATA ANAL USING REGR; Gibbs SJ, 2010, EARTH PLANET SC LETT, V295, P583, DOI 10.1016/j.epsl.2010.04.044; GREEN AS, 1993, ENVIRON TOXICOL CHEM, V12, P1497, DOI 10.1002/etc.5620120817; Hagopian-Schlekat T, 2001, MAR ENVIRON RES, V51, P247, DOI 10.1016/S0141-1136(00)00102-1; Harish V, 2011, TOXICOL ENVIRON CHEM, V93, P1399, DOI 10.1080/02772248.2011.588393; Hopkin S. P., 1989, ECOPHYSIOLOGY METALS, P366; HUTCHINSON TH, 1994, MAR ENVIRON RES, V38, P275, DOI 10.1016/0141-1136(94)90028-0; IPCC, 2007, CLIM CHANG 2007; Kottelat R, 2010, CHEMOSPHERE, V81, P1407, DOI 10.1016/j.chemosphere.2010.09.024; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; LACOUELABARTHE T, 2009, BIOGEOSCIENCES DISCU, V6, P4865; Pinho GLL, 2007, AQUAT TOXICOL, V84, P62, DOI 10.1016/j.aquatox.2007.06.001; Lee KW, 2008, CHEMOSPHERE, V72, P1359, DOI 10.1016/j.chemosphere.2008.04.023; Lewis C, 2013, MAR BIOL, V160, P2089, DOI 10.1007/s00227-012-2081-8; Luckey TD, 1975, ENVIRON QUAL SAFETY, P81; Lundstrom E, 2010, AQUAT TOXICOL, V96, P298, DOI 10.1016/j.aquatox.2009.11.011; Mathis JT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048884; Matson PG, 2012, BIOL BULL-US, V223, P312, DOI 10.1086/BBLv223n3p312; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Meakin NG, 2011, ISME J, V5, P1397, DOI 10.1038/ismej.2011.18; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Millero FJ, 2010, J SOLUTION CHEM, V39, P543, DOI 10.1007/s10953-010-9523-z; Nikinmaa M, 2013, AQUAT TOXICOL, V126, P365, DOI 10.1016/j.aquatox.2012.09.006; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Ogden DE, 2012, P NATL ACAD SCI USA, V109, P59, DOI 10.1073/pnas.1118675109; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pascal PY, 2010, MAR POLLUT BULL, V60, P2201, DOI 10.1016/j.marpolbul.2010.08.018; Rainbow PS, 1997, J MAR BIOL ASSOC UK, V77, P195, DOI 10.1017/S0025315400033877; Richards R, 2011, ECOL MODEL, V222, P3559, DOI 10.1016/j.ecolmodel.2011.08.017; Riebesell U., 2010, GUIDE BEST PRACTICES, P1; Roberts DA, 2013, GLOBAL CHANGE BIOL, V19, P340, DOI 10.1111/gcb.12048; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Santos-Echeandia J, 2009, MAR CHEM, V117, P77, DOI 10.1016/j.marchem.2009.05.001; Schlegel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053118; STEBBING ARD, 1978, WATER RES, V12, P631, DOI 10.1016/0043-1354(78)90144-6; STEBBING ARD, 1981, AQUAT TOXICOL, V1, P227, DOI 10.1016/0166-445X(81)90017-5; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Taylor RL, 2005, AQUAT TOXICOL, V74, P20, DOI 10.1016/j.aquatox.2005.04.006; Thomas KV, 2003, CHEMOSPHERE, V53, P1105, DOI 10.1016/S0045-6535(03)00611-8; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Van Assche F, 1997, NATL ENV HLTH FORUM, P33; VAN DEN BERG CMG, 1979, J FISH RES BOARD CAN, V36, P901, DOI 10.1139/f79-128; VERRIOPOULOS G, 1982, MAR POLLUT BULL, V13, P123, DOI 10.1016/0025-326X(82)90368-X; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; Wang MH, 2010, ECOTOXICOLOGY, V19, P273, DOI 10.1007/s10646-009-0410-6; Winner RW, 1976, US EPA ECOLOGICAL RE	81	28	28	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71257	10.1371/journal.pone.0071257	http://dx.doi.org/10.1371/journal.pone.0071257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951121	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323109700090
J	Vieten, MM; Sehle, A; Jensen, RL				Vieten, Manfred M.; Sehle, Aida; Jensen, Randall L.			A Novel Approach to Quantify Time Series Differences of Gait Data Using Attractor Attributes	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; LYAPUNOV EXPONENTS; DUAL-TASK; RELIABILITY; VARIABILITY; WALKING; MOTOR	In this paper we introduce a new method to expressly use live/corporeal data in quantifying differences of time series data with an underlying limit cycle attractor; and apply it using an example of gait data. Our intention is to identify gait pattern differences between diverse situations and classify them on group and individual subject levels. First we approximated the limit cycle attractors, from which three measures were calculated: delta M amounts to the difference between two attractors (a measure for the differences of two movements), delta D computes the difference between the two associated deviations of the state vector away from the attractor (a measure for the change in movement variation), and delta F, a combination of the previous two, is an index of the change. As an application we quantified these measures for walking on a treadmill under three different conditions: normal walking, dual task walking, and walking with additional weights at the ankle. The new method was able to successfully differentiate between the three walking conditions. Day to day repeatability, studied with repeated trials approximately one week apart, indicated excellent reliability for delta M (ICCave > 0.73 with no differences across days; p > 0.05) and good reliability for delta D (ICCave = 0.414 to 0.610 with no differences across days; p > 0.05). Based on the ability to detect differences in varying gait conditions and the good repeatability of the measures across days, the new method is recommended as an alternative to expensive and time consuming techniques of gait classification assessment. In particular, the new method is an easy to use diagnostic tool to quantify clinical changes in neurological patients.	[Vieten, Manfred M.; Sehle, Aida; Jensen, Randall L.] Univ Konstanz, Dept Sport Sci, Constance, Germany; [Jensen, Randall L.] No Michigan Univ, Dept Hlth Phys Educ Recreat, Marquette, MI 49855 USA	University of Konstanz; Northern Michigan University	Vieten, MM (corresponding author), Univ Konstanz, Dept Sport Sci, Constance, Germany.	manfred.vieten@uni-konstanz.de	Vieten, Manfred/GMW-7459-2022	Vieten, Manfred/0000-0002-2745-2344	University of Konstanz [04/11]	University of Konstanz	This project was supported/funded by the University of Konstanz (project number 04/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alligood KT, 1997, CHAOS INTRO DYNAMICA, P231; Baetens T, 2013, ARCH PHYS MED REHAB, V94, P680, DOI 10.1016/j.apmr.2012.11.023; Bruijn SM, 2012, MED ENG PHYS, V34, P428, DOI 10.1016/j.medengphy.2011.07.024; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Cignetti F, 2012, ANN BIOMED ENG, V40, P1122, DOI 10.1007/s10439-011-0474-3; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, J BIOMECH, V33, P1269, DOI 10.1016/S0021-9290(00)00092-0; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Harris G.F., 1996, HUMAN MOTION ANAL CU; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kantz H., 2004, NONLINEAR TIME SERIE; Klausmeier CA, 2008, THEOR ECOL-NETH, V1, P153, DOI 10.1007/s12080-008-0016-2; Liu CS, 2001, INT J NONLINEAR MECH, V36, P1047, DOI 10.1016/S0020-7462(00)00069-X; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Schablowski-Trautmann M, 2006, BIOMED TECH, V51, P294, DOI 10.1515/BMT.2006.060; Sekine M, 2000, P ANN INT IEEE EMBS, V22, P1879, DOI 10.1109/IEMBS.2000.900456; Senden R, 2009, GAIT POSTURE, V30, P192, DOI 10.1016/j.gaitpost.2009.04.008; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Thickbroom GW, 2008, J NEUROL, V255, P1001, DOI 10.1007/s00415-008-0818-6; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Vieten MM, 2004, ISBS C P ARCH, P1; Williams GP, 1997, CHAOS THEORY TAMED, P370; Winter DA, 2009, BIOMECHANICS MOTOR C, P49; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yogev-Seligmann G, 2013, EXP BRAIN RES, V226, P81, DOI 10.1007/s00221-013-3412-9	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71824	10.1371/journal.pone.0071824	http://dx.doi.org/10.1371/journal.pone.0071824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951252	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700119
J	Funk, S; Bogich, TL; Jones, KE; Kilpatrick, AM; Daszak, P				Funk, Sebastian; Bogich, Tiffany L.; Jones, Kate E.; Kilpatrick, A. Marm; Daszak, Peter			Quantifying Trends in Disease Impact to Produce a Consistent and Reproducible Definition of an Emerging Infectious Disease	PLOS ONE			English	Article							EMERGENCE; PATHOGENS; EVOLUTION; ECOLOGY; HEALTH	The proper allocation of public health resources for research and control requires quantification of both a disease's current burden and the trend in its impact. Infectious diseases that have been labeled as "emerging infectious diseases'' (EIDs) have received heightened scientific and public attention and resources. However, the label 'emerging' is rarely backed by quantitative analysis and is often used subjectively. This can lead to over-allocation of resources to diseases that are incorrectly labelled "emerging,'' and insufficient allocation of resources to diseases for which evidence of an increasing or high sustained impact is strong. We suggest a simple quantitative approach, segmented regression, to characterize the trends and emergence of diseases. Segmented regression identifies one or more trends in a time series and determines the most statistically parsimonious split(s) (or joinpoints) in the time series. These joinpoints in the time series indicate time points when a change in trend occurred and may identify periods in which drivers of disease impact change. We illustrate the method by analyzing temporal patterns in incidence data for twelve diseases. This approach provides a way to classify a disease as currently emerging, re-emerging, receding, or stable based on temporal trends, as well as to pinpoint the time when the change in these trends happened. We argue that quantitative approaches to defining emergence based on the trend in impact of a disease can, with appropriate context, be used to prioritize resources for research and control. Implementing this more rigorous definition of an EID will require buy-in and enforcement from scientists, policy makers, peer reviewers and journal editors, but has the potential to improve resource allocation for global health.	[Funk, Sebastian; Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Funk, Sebastian; Bogich, Tiffany L.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Funk, Sebastian] London Sch Hyg & Trop Med, London WC1, England; [Bogich, Tiffany L.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Bogich, Tiffany L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Jones, Kate E.] UCL, Dept Genet Evolut & Environm, London, England; [Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Zoological Society of London; Princeton University; University of London; London School of Hygiene & Tropical Medicine; EcoHealth Alliance; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of London; University College London; University of California System; University of California Santa Cruz	Kilpatrick, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	akilpatr@ucsc.edu; daszak@ecohealthalliance.org	Jones, Kate/Y-3317-2019; Jones, Kate E/G-4768-2010; daszak, peter/U-4588-2017	Jones, Kate/0000-0001-5231-3293; Jones, Kate E/0000-0001-5231-3293; daszak, peter/0000-0002-2046-5695; Funk, Sebastian/0000-0002-2842-3406; Bogich, Tiffany/0000-0002-8143-5289	Fogarty International Center [2R01-TW005869]; NSF [EF-0914866, DEB -1115895]; National Institute of Health [1R01AI090159]; National Science Foundation Human and Social Dynamics 'Agents of Change' award [BCS-0826779]; Medical Research Council [MR/K021680/1] Funding Source: researchfish; Natural Environment Research Council [NE/J000507/2] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090159] Funding Source: NIH RePORTER; MRC [MR/K021680/1] Funding Source: UKRI; NERC [NE/J000507/2] Funding Source: UKRI	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Human and Social Dynamics 'Agents of Change' award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT; by three NIH/NSF "Ecology and Evolution of Infectious Diseases'' awards from the Fogarty International Center (2R01-TW005869) and NSF (EF-0914866 and DEB -1115895), a grant from the National Institute of Health (1R01AI090159), and by a National Science Foundation Human and Social Dynamics 'Agents of Change' award (BCS-0826779). TLB acknowledges the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U. S. Department of Homeland Security, and the Fogarty International Center, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EM PAND THREATS PROG; Cliff AD, 2009, INFECT DIS EMERGENCE; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de La Rocque S, 2011, ECOHEALTH, V7, pS10; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Formenty P, 2006, MED MALADIES INFECT, V36, P9, DOI 10.1016/j.medmal.2005.06.009; Garnett GP, 1996, BIOSCIENCE, V46, P127, DOI 10.2307/1312815; GIDEON online, 2012, GLOB INF DIS EP NETW; Joinpoint Regression Program, 2012, JOINP REGR PROGR; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; Kilbourne ED, 1996, MT SINAI J MED, V63, P159; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kim HJ, 2009, STAT SINICA, V19, P597; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lederberg J., 1992, I MED US COMMITTEE; LEVINS R, 1994, AM SCI, V82, P52; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse Stephen S., 1993, P10; OSTER M S, 1961, Med Bull US Army Eur, V18, P176; Petersen LR, 2000, EMERG INFECT DIS, V6, P576, DOI 10.3201/eid0606.000605; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Remme JHF, 2002, TRENDS PARASITOL, V18, P421, DOI 10.1016/S1471-4922(02)02387-5; Russell KL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S2; Sanchez JL, 2011, BMC PUBLIC HLTH, V11; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Stephens DS, 1998, AM J MED SCI, V315, P64, DOI 10.1097/00000441-199802000-00002; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERGING INFECT DIS, V11	34	14	14	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69951	10.1371/journal.pone.0069951	http://dx.doi.org/10.1371/journal.pone.0069951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967065	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500010
J	Berlow, EL; Knapp, RA; Ostoja, SM; Williams, RJ; McKenny, H; Matchett, JR; Guo, QH; Fellers, GM; Kleeman, P; Brooks, ML; Joppa, L				Berlow, Eric L.; Knapp, Roland A.; Ostoja, Steven M.; Williams, Richard J.; McKenny, Heather; Matchett, John R.; Guo, Qinghua; Fellers, Gary M.; Kleeman, Patrick; Brooks, Matthew L.; Joppa, Lucas			A Network Extension of Species Occupancy Models in a Patchy Environment Applied to the Yosemite Toad (Anaxyrus canorus)	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; ESTIMATING SITE OCCUPANCY; NATIONAL-PARK; NONNATIVE FISH; METAPOPULATION; LANDSCAPE; VIABILITY; FAUNA; CONSERVATION; PERSISTENCE	A central challenge of conservation biology is using limited data to predict rare species occurrence and identify conservation areas that play a disproportionate role in regional persistence. Where species occupy discrete patches in a landscape, such predictions require data about environmental quality of individual patches and the connectivity among high quality patches. We present a novel extension to species occupancy modeling that blends traditional predictions of individual patch environmental quality with network analysis to estimate connectivity characteristics using limited survey data. We demonstrate this approach using environmental and geospatial attributes to predict observed occupancy patterns of the Yosemite toad (Anaxyrus (= Bufo) canorus) across >2,500 meadows in Yosemite National Park (USA). A. canorus, a Federal Proposed Species, breeds in shallow water associated with meadows. Our generalized linear model (GLM) accurately predicted similar to 84% of true presence-absence data on a subset of data withheld for testing. The predicted environmental quality of each meadow was iteratively 'boosted' by the quality of neighbors within dispersal distance. We used this park-wide meadow connectivity network to estimate the relative influence of an individual Meadow's 'environmental quality' versus its 'network quality' to predict: a) clusters of high quality breeding meadows potentially linked by dispersal, b) breeding meadows with high environmental quality that are isolated from other such meadows, c) breeding meadows with lower environmental quality where long-term persistence may critically depend on the network neighborhood, and d) breeding meadows with the biggest impact on park-wide breeding patterns. Combined with targeted data on dispersal, genetics, disease, and other potential stressors, these results can guide designation of core conservation areas for A. canorus in Yosemite National Park.	[Berlow, Eric L.; Ostoja, Steven M.; Matchett, John R.; Brooks, Matthew L.] US Geol Survey, Western Ecol Res Ctr, Yosemite Field Stn, Oakhurst, CA USA; [Berlow, Eric L.] Vibrant Data Labs, Berkeley, CA USA; [Knapp, Roland A.] Univ Calif, Sierra Nevada Aquat Res Lab, Mammoth Lakes, CA USA; [Williams, Richard J.; Joppa, Lucas] Microsoft Res, Cambridge, England; [Williams, Richard J.] Quid Inc, San Francisco, CA USA; [McKenny, Heather] Natl Pk Serv, Yosemite, CA USA; [Guo, Qinghua] Univ Calif, Merced, CA USA; [Fellers, Gary M.; Kleeman, Patrick] US Geol Survey, Western Ecol Res Ctr, Pt Reyes Stn, Pt Reyes Station, CA USA	United States Department of the Interior; United States Geological Survey; Microsoft; QUID INC.; United States Department of the Interior; University of California System; University of California Merced; United States Department of the Interior; United States Geological Survey	Joppa, L (corresponding author), Microsoft Res, Cambridge, England.	lujoppa@microsoft.com	Guo, Qinghua/B-7731-2012; Williams, Richard J/B-8344-2011; Knapp, Roland/B-1337-2009	Guo, Qinghua/0000-0002-1065-0838; Williams, Richard J/0000-0001-8847-3213; Knapp, Roland/0000-0002-1954-2745; Kleeman, Patrick/0000-0001-6567-3239	U.S. Geological Survey Wildlife Terrestrial and Endangered Resources Program; U.S. Geological Survey Natural Resources Preservation Program; National Park Service; Yosemite Conservancy; Wilderness Society; Aspenwood Foundation	U.S. Geological Survey Wildlife Terrestrial and Endangered Resources Program; U.S. Geological Survey Natural Resources Preservation Program; National Park Service; Yosemite Conservancy; Wilderness Society; Aspenwood Foundation	Financial support was provided by the U.S. Geological Survey Wildlife Terrestrial and Endangered Resources Program, U.S. Geological Survey Natural Resources Preservation Program, the National Park Service, Yosemite Conservancy, Wilderness Society, and Aspenwood Foundation. The content is solely the responsibility of the authors and does not necessarily reflect the views of the organizations listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2004, CONSERV BIOL, V18, P526, DOI 10.1111/j.1523-1739.2004.00520.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Bollmann K, 2011, ECOGRAPHY, V34, P276, DOI 10.1111/j.1600-0587.2010.06314.x; Bradford DF, 2003, ECOLOGY, V84, P1012, DOI 10.1890/0012-9658(2003)084[1012:HPOBTB]2.0.CO;2; Brown C, 2012, HERPETOL CONSERV BIO, V7, P115; Burnham K, 2002, DR MODEL SELECTION M; California Department of Fish and Game (CDFG), 2004, CAL NAT DIV DAT SPEC; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Cumming GS, 2010, DIVERS DISTRIB, V16, P414, DOI 10.1111/j.1472-4642.2010.00651.x; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Dozier J, 2008, ADV WATER RESOUR, V31, P1515, DOI 10.1016/j.advwatres.2008.08.011; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Fellers G. M., 1995, NPSWRUCNRTR9501; Gaston KJ, 2002, J BIOSCIENCES, V27, P361, DOI 10.1007/BF02704966; Grasso RL, 2010, COPEIA, P457, DOI 10.1643/CH-09-033; Hanski I, 1996, CONSERV BIOL, V10, P578, DOI 10.1046/j.1523-1739.1996.10020578.x; Huang C, 2002, INT J REMOTE SENS, V23, P1741, DOI 10.1080/01431160110106113; Jimenez-Valverde A, 2009, COMMUNITY ECOL, V10, P196, DOI 10.1556/ComEc.10.2009.2.9; Kagarise-Sherman C, 1980, THESIS U MICHIGAN AN; KARLSTROM ERNEST L., 1962, UNIV CALIFORNIA PUBL ZOO1, V62, P1; Keeler-Wolf T, 2012, YOSEMITE NATL PARK V; Knapp RA, 2003, ECOL APPL, V13, P1069, DOI 10.1890/1051-0761(2003)13[1069:DPMTPA]2.0.CO;2; Knapp RA, 2001, ECOL MONOGR, V71, P401, DOI 10.1890/0012-9615(2001)071[0401:RAROAL]2.0.CO;2; Knapp RA, 2005, ECOL APPL, V15, P835, DOI 10.1890/04-0619; Knapp RA, 2005, BIOL CONSERV, V121, P265, DOI 10.1016/j.biocon.2004.05.003; Knapp RA, 2007, BIOL CONSERV, V135, P11, DOI 10.1016/j.biocon.2006.09.013; Langford WT, 2009, ECOL INFORM, V4, P123, DOI 10.1016/j.ecoinf.2009.04.002; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lenda M, 2010, ACTA OECOL, V36, P497, DOI 10.1016/j.actao.2010.07.002; Liang C.T., 2010, THESIS U CALIFORNIA; Liang CT, 2011, FRONT EARTH SCI-PRC, V5, P217, DOI 10.1007/s11707-011-0157-2; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindenmayer DB, 2001, J APPL ECOL, V38, P36, DOI 10.1046/j.1365-2664.2001.00558.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin DL, 2008, THESIS U CALIFORNIA; Moilanen A, 1998, AM NAT, V152, P530, DOI 10.1086/286188; Morton ML, 2010, HERPETOL CONSERV BIO, V5, P388; MULLALLY DP, 1953, COPEIA, P182, DOI 10.2307/1439932; Painter TH, 2009, REMOTE SENS ENVIRON, V113, P868, DOI 10.1016/j.rse.2009.01.001; Perlich C, 2004, J MACH LEARN RES, V4, P211, DOI 10.1162/153244304322972694; R Core Team, 2021, R LANGUAGE ENV STAT; Schtickzelle N, 2004, OIKOS, V104, P277, DOI 10.1111/j.0030-1299.2004.12825.x; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; SHERMAN CK, 1984, NAT HIST, V93, P72; Sjogren-Gulve Per, 1996, P111; THOMAS CD, 1993, J ANIM ECOL, V62, P472, DOI 10.2307/5196; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2002, FED REGISTER, V67, P75834; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2004, FED REGISTER, V69, P25876; U.S. Department of Interior Fish and Wildlife Service (USFWS), 2013, FED REGISTER, V78, P24472; Van Wagtendonk JW, 2003, INT J REMOTE SENS, V24, P1639, DOI 10.1080/01431160210144679; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101	52	12	12	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72200	10.1371/journal.pone.0072200	http://dx.doi.org/10.1371/journal.pone.0072200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951296	Green Published, gold			2022-12-27	WOS:000323097300182
J	De Brito, T; Aiello, VD; da Silva, LFF; da Silva, AMG; da Silva, WLF; Castelli, JB; Seguro, AC				De Brito, Thales; Aiello, Vera Demarchi; Ferraz da Silva, Luis Fernando; Goncalves da Silva, Ana Maria; Ferreira da Silva, Wellington Luiz; Castelli, Jussara Bianchi; Seguro, Antonio Carlos			Human Hemorrhagic Pulmonary Leptospirosis: Pathological Findings and Pathophysiological Correlations	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; SODIUM TRANSPORTERS; FLUID TRANSPORT; LUNG INJURY; GUINEA-PIG; I CELLS; KIDNEY; MODEL; ION; IMMUNOGLOBULIN	Background: Leptospirosis is a re-emerging zoonosis with protean clinical manifestations. Recently, the importance of pulmonary hemorrhage as a lethal complication of this disease has been recognized. In the present study, five human necropsies of leptospirosis (Weil's syndrome) with extensive pulmonary manifestations were analysed, and the antibodies expressed in blood vessels and cells involved in ion and water transport were used, seeking to better understand the pathophysiology of the lung injury associated with this disease. Principal Findings: Prominent vascular damage was present in the lung microcirculation, with decreased CD34 and preserved aquaporin 1 expression. At the periphery and even inside the extensive areas of edema and intraalveolar hemorrhage, enlarged, apparently hypertrophic type I pneumocytes (PI) were detected and interpreted as a non-specific attempt of clearence of the intraalveolar fluid, in which ionic transport, particularly of sodium, plays a predominant role, as suggested by the apparently increased ENaC and aquaporin 5 expression. Connexin 43 was present in most pneumocytes, and in the cytoplasm of the more preserved endothelial cells. The number of type II pneumocytes (PII) was slightly decreased when compared to normal lungs and those of patients with septicemia from other causes, a fact that may contribute to the progressively low PI count, resulting in deficient restoration after damage to the alveolar epithelial integrity and, consequently, a poor outcome of the pulmonary edema and hemorrhage. Conclusions: Pathogenesis of lung injury in human leptospirosis was discussed, and the possibility of primary non-inflammatory vascular damage was considered, so far of undefinite etiopathogenesis, as the initial pathological manifestation of the disease.	[De Brito, Thales; Goncalves da Silva, Ana Maria] Univ Sao Paulo, Sch Med, Inst Trop Med, Sao Paulo, Brazil; [De Brito, Thales; Ferraz da Silva, Luis Fernando; Ferreira da Silva, Wellington Luiz] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Aiello, Vera Demarchi; Castelli, Jussara Bianchi] Univ Sao Paulo, Sch Med, Heart Inst InCor, Pathol Lab, Sao Paulo, Brazil; [Seguro, Antonio Carlos] Univ Sao Paulo, Sch Med, Dept Nephrol, Lab Med Res, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	De Brito, T (corresponding author), Univ Sao Paulo, Sch Med, Inst Trop Med, Sao Paulo, Brazil.	thalesbr@usp.br	Castelli, Jussara B/I-4798-2013; Aiello, Vera/A-9495-2008; Silva, Luiz/D-2760-2012; De Brito, Thales/L-2865-2017; da Silva, Ana Maria Gonçalves/ABD-3920-2020	Castelli, Jussara B/0000-0002-8414-4161; Aiello, Vera/0000-0002-4185-9423; Silva, Luiz/0000-0002-0181-6357; De Brito, Thales/0000-0003-1106-7254; Silva, Ana Maria/0000-0001-7554-0894	LIM 06 and 12 (Laboratories of Investigation in Medicine 06 and 12); LIM 06 and 12 (Sao Paulo Medical School, University of Sao Paulo); LIM 06 and 12 ("Hospital das Clinicas," Sao Paulo, Brazil)	LIM 06 and 12 (Laboratories of Investigation in Medicine 06 and 12); LIM 06 and 12 (Sao Paulo Medical School, University of Sao Paulo); LIM 06 and 12 ("Hospital das Clinicas," Sao Paulo, Brazil)	Work supported by grants from LIM 06 and 12 (Laboratories of Investigation in Medicine 06 and 12, Sao Paulo Medical School, University of Sao Paulo and "Hospital das Clinicas," Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006; Araujo ER, 2010, VIRCHOWS ARCH, V456, P367, DOI 10.1007/s00428-010-0894-8; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Borok Z, 2002, AM J PHYSIOL-LUNG C, V282, pL599, DOI 10.1152/ajplung.00130.2000; Clerici C, 2011, AM J PHYSIOL-LUNG C, V301, pL20, DOI 10.1152/ajplung.00126.2011; Croda J, 2010, CLIN MICROBIOL INFEC, V16, P593, DOI 10.1111/j.1469-0691.2009.02916.x; De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z; DEBRITO T, 1979, J PATHOL, V128, P177, DOI 10.1002/path.1711280403; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; Droemann D, 2003, HISTOCHEM CELL BIOL, V119, P103, DOI 10.1007/s00418-003-0497-4; Garcia MAM, 2000, EUR J CLIN MICROBIOL, V19, P471, DOI 10.1007/s100960000294; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Luks AM, 2003, CHEST, V123, P639, DOI 10.1378/chest.123.2.639; Marchiori E, 2011, LUNG, V189, P1, DOI 10.1007/s00408-010-9273-0; Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V282, pL595, DOI 10.1152/ajplung.00473.2001; Matthay MA, 2007, NAT MED, V13, P780, DOI 10.1038/nm0707-780; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; MILLER NG, 1974, MED MICROBIOL IMMUN, V160, P269, DOI 10.1007/BF02121442; Minami M, 2012, PATHOL INT, V62, P99, DOI 10.1111/j.1440-1827.2011.02756.x; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P281, DOI 10.1097/PAP.0b013e3182691c2a; PARK SK, 1989, AM J TROP MED HYG, V41, P345, DOI 10.4269/ajtmh.1989.41.345; Rannels DE, 2001, AM J PHYSIOL-LUNG C, V280, pL1083, DOI 10.1152/ajplung.2001.280.6.L1083; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Szeredi L, 2006, VET PATHOL, V43, P755, DOI 10.1354/vp.43-5-755; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8	35	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71743	10.1371/journal.pone.0071743	http://dx.doi.org/10.1371/journal.pone.0071743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951234	Green Published, gold			2022-12-27	WOS:000323097300151
J	Ohniwa, RL; Muchaku, H; Saito, S; Wada, C; Morikawa, K				Ohniwa, Ryosuke L.; Muchaku, Hiroki; Saito, Shinji; Wada, Chieko; Morikawa, Kazuya			Atomic Force Microscopy Analysis of the Role of Major DNA-Binding Proteins in Organization of the Nucleoid in Escherichia coli	PLOS ONE			English	Article							H-NS PROTEIN; GROWTH; IHF; ARCHITECTURE; STRESS; GENES	Bacterial genomic DNA is packed within the nucleoid of the cell along with various proteins and RNAs. We previously showed that the nucleoid in log phase cells consist of fibrous structures with diameters ranging from 30 to 80 nm, and that these structures, upon RNase A treatment, are converted into homogeneous thinner fibers with diameter of 10 nm. In this study, we investigated the role of major DNA-binding proteins in nucleoid organization by analyzing the nucleoid of mutant Escherichia coli strains lacking HU, IHF, H-NS, StpA, Fis, or Hfq using atomic force microscopy. Deletion of particular DNA-binding protein genes altered the nucleoid structure in different ways, but did not release the naked DNA even after the treatment with RNase A. This suggests that major DNA-binding proteins are involved in the formation of higher order structure once 10-nm fiber structure is built up from naked DNA.	[Ohniwa, Ryosuke L.; Muchaku, Hiroki; Saito, Shinji; Morikawa, Kazuya] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan; [Wada, Chieko] Yoshida Biol Lab, Yamashina Ku, Kyoto, Japan	University of Tsukuba	Ohniwa, RL (corresponding author), Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan.	ohniwa@md.tsukuba.ac.jp		Morikawa, Kazuya/0000-0002-1503-7151	Japan Society for the Promotion of Science [19770145]; MEXT, Japan; Grants-in-Aid for Scientific Research [25840002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists of the Japan Society for the Promotion of Science (to R.L.O) (Grant Number: 19770145, http://www.jsps.go.jp/english/index.html), and by Program to Disseminate Tenure Tracking System, MEXT, Japan (to R.L.O., http://ttweb.sec.tsukuba.ac.jp/e_aisatsu.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL, P235; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; HUBNER P, 1989, EMBO J, V8, P577, DOI 10.1002/j.1460-2075.1989.tb03412.x; Ishihama A, 2009, ECOSAL ESCHERICHIA C, DOI [10.1128/ecosal.2.6, DOI 10.1128/EC0SAL.2.6]; KANO Y, 1990, GENE, V89, P133, DOI 10.1016/0378-1119(90)90216-E; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oberto J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004367; Ohniwa RL, 2007, MICROSC MICROANAL, V13, P3, DOI 10.1017/S1431927607070055; Ohniwa RL, 2006, EMBO J, V25, P5591, DOI 10.1038/sj.emboj.7601414; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Ohniwa RL, 2010, GEN-RES ISSUES, P91; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Skoko D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208101; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Sonnenfield JM, 2001, BIOCHIMIE, V83, P243, DOI 10.1016/S0300-9084(01)01232-9; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Takeyasu K, 2004, CYTOGENET GENOME RES, V107, P38, DOI 10.1159/000079570; Takeyasu K, 1996, FEBS LETT, V392, P110, DOI 10.1016/0014-5793(96)00796-X; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9	28	24	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72954	10.1371/journal.pone.0072954	http://dx.doi.org/10.1371/journal.pone.0072954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951337	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300202
J	Xue, XX; Yin, ZH; Lu, Y; Zhang, HB; Yan, Y; Zhao, YX; Li, XL; Cui, ZS; Yu, M; Yao, L; Zhou, BS				Xue, Xiaoxia; Yin, Zhihua; Lu, Yao; Zhang, Haibo; Yan, Ying; Zhao, Yuxia; Li, Xuelian; Cui, Zeshi; Yu, Miao; Yao, Lu; Zhou, Baosen			The Joint Effect of hOGG1, APE1, and ADPRT Polymorphisms and Cooking Oil Fumes on the Risk of Lung Adenocarcinoma in Chinese Non-Smoking Females	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; GENE-ENVIRONMENT INTERACTIONS; CANCER-RISK; DNA-REPAIR; SER326CYS POLYMORPHISM; OXIDATIVE DAMAGE; WOMEN NONSMOKERS; HUMAN-POPULATION; SMOKING HABIT; OGG1 GENE	Background: The human 8-oxoguanine DNA glycosylase 1 (hOGG1), apurinic/apyrimidinic endonuclease 1 (APE1), and adenosine diphosphate ribosyl transferase (ADPRT) genes play an important role in the DNA base excision repair pathway. Single nucleotide polymorphisms (SNPs) in critical genes are suspected to be associated with the risk of lung cancer. This study aimed to identify the association between the polymorphisms of hOGG1 Ser326Cys, APE1 Asp148Glu, and ADPRT Val762Ala, and the risk of lung adenocarcinoma in the non-smoking female population, and investigated the interaction between genetic polymorphisms and environmental exposure in lung adenocarcinoma. Methods: We performed a hospital-based case-control study, including 410 lung adenocarcinoma patients and 410 cancer-free hospital control subjects who were matched for age. Each case and control was interviewed to collect information by well-trained interviewers. A total of 10 ml of venous blood was collected for genotype testing. Three polymorphisms were analyzed by the polymerase chain reaction-restriction fragment length polymorphism technique. Results: We found that individuals who were homozygous for the variant hOGG1 326Cys/Cys showed a significantly increased risk of lung adenocarcinoma (OR = 1.54; 95% CI: 1.01-2.36; P = 0.045). When the combined effect of variant alleles was analyzed, we found an increased OR of 1.89 (95% CI: 1.24-2.88, P = 0.003) for lung adenocarcinoma individuals with more than one homozygous variant allele. In stratified analyses, we found that the OR for the gene-environment interaction between Ser/Cys and Cys/Cys genotypes of hOGG1 codon 326 and cooking oil fumes for the risk of lung adenocarcinoma was 1.37 (95% CI: 0.77-2.44; P = 0.279) and 2.79 (95% CI: 1.50-5.18; P = 0.001), respectively. Conclusions: The hOGG1 Ser326Cys polymorphism might be associated with the risk of lung adenocarcinoma in Chinese non-smoking females. Furthermore, there is a significant gene-environment association between cooking oil fumes and hOGG1 326 Cys/Cys genotype in lung adenocarcinoma among female non-smokers.	[Xue, Xiaoxia; Lu, Yao; Cui, Zeshi; Yu, Miao; Yao, Lu] China Med Univ, Ctr Lab Technol & Expt Med 3, Shenyang, Peoples R China; [Yin, Zhihua; Li, Xuelian; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China; [Zhang, Haibo; Yan, Ying] Shenyang Northern Hosp, Dept Radiotherapy, Shenyang, Peoples R China; [Zhao, Yuxia] China Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China.	bszhou@mail.cmu.edu.cn			National Natural Science Foundation of China [81102194, 81272293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81102194 and Grant No. 81272293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belani CP, 2007, LUNG CANCER, V55, P15, DOI 10.1016/j.lungcan.2006.09.008; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Chang CH, 2009, AM J EPIDEMIOL, V170, P695, DOI 10.1093/aje/kwp019; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Cheng YW, 2003, J ENVIRON SCI HEAL C, V21, P1, DOI 10.1081/GNC-120021371; Choi JE, 2003, CANCER EPIDEM BIOMAR, V12, P947; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gackowski D, 2003, CANCER RES, V63, P4899; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Gossage Lucy, 2012, Curr Mol Pharmacol, V5, P115; Guan P, 2011, ASIAN PAC J CANCER P, V12, P1067; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hung RJ, 2005, JNCI-J NATL CANCER I, V97, P567, DOI 10.1093/jnci/dji101; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Ito Hidemi, 2002, J Epidemiol, V12, P258; Kiyohara C, 2006, LUNG CANCER, V54, P267, DOI 10.1016/j.lungcan.2006.08.009; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Ko YC, 2000, AM J EPIDEMIOL, V151, P140, DOI 10.1093/oxfordjournals.aje.a010181; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kothandapani A, 2013, NUCLEIC ACIDS RES, V12, P1; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P409; Li HX, 2008, CANCER EPIDEM BIOMAR, V17, P1739, DOI 10.1158/1055-9965.EPI-08-0001; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Liu CJ, 2010, ANTICANCER RES, V30, P4141; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Misra RR, 2003, CANCER LETT, V191, P171, DOI 10.1016/S0304-3835(02)00638-9; Park J, 2004, PHARMACOGENETICS, V14, P103, DOI 10.1097/00008571-200402000-00004; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Shen M, 2005, ANTICANCER RES, V25, P537; Shinmura K, 2001, ANTIOXID REDOX SIGN, V3, P597, DOI 10.1089/15230860152542952; Simonelli V, 2012, MUTAT RES-FUND MOL M, V731, P1, DOI 10.1016/j.mrfmmm.2011.10.012; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Sugimura H, 1999, CANCER EPIDEM BIOMAR, V8, P669; Sunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730; Takezaki T, 2002, INT J CANCER, V99, P624, DOI 10.1002/ijc.10400; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu M, 2008, ENVIRON MOL MUTAGEN, V49, P265, DOI 10.1002/em.20381; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; [袭著革 Xi Zhuge], 2003, [环境与健康杂志, Journal of Environment and Health], V20, P259; Yin ZH, 2007, CHINESE J CANCER RES, V19, P184, DOI 10.1007/s11670-007-0184-4; Yin ZH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-153; Yoshida A, 2003, BIOCHEM BIOPH RES CO, V310, P522, DOI 10.1016/j.bbrc.2003.09.033; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zhang XM, 2005, CANCER RES, V65, P722; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	67	20	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71157	10.1371/journal.pone.0071157	http://dx.doi.org/10.1371/journal.pone.0071157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951099	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300093
J	Nallamshetty, S; Wang, H; Rhee, EJ; Kiefer, FW; Brown, JD; Lotinun, S; Le, P; Baron, R; Rosen, CJ; Plutzky, J				Nallamshetty, Shriram; Wang, Hong; Rhee, Eun-Jung; Kiefer, Florian W.; Brown, Jonathan D.; Lotinun, Sutada; Le, Phuong; Baron, Roland; Rosen, Clifford J.; Plutzky, Jorge			Deficiency of Retinaldehyde Dehydrogenase 1 Induces BMP2 and Increases Bone Mass In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; RETINOIC ACID; MINERAL DENSITY; ALDEHYDE DEHYDROGENASE; HYPERVITAMINOSIS-A; GENE-EXPRESSION; VITAMIN-A; MORPHOGENETIC PROTEINS; OSTEOBLASTIC CELLS	The effects of retinoids, the structural derivatives of vitamin A (retinol), on post-natal peak bone density acquisition and skeletal remodeling are complex and compartment specific. Emerging data indicates that retinoids, such as all trans retinoic acid (ATRA) and its precursor all trans retinaldehyde (Rald), exhibit distinct and divergent transcriptional effects in metabolism. Despite these observations, the role of enzymes that control retinoid metabolism in bone remains undefined. In this study, we examined the skeletal phenotype of mice deficient in retinaldehyde dehydrogenase 1 (Aldh1a1), the enzyme responsible for converting Rald to ATRA in adult animals. Bone densitometry and micro-computed tomography (mu CT) demonstrated that Aldh1a1-deficient (Aldh1a1(-/-)) female mice had higher trabecular and cortical bone mass compared to age and sex-matched control C57Bl/6 wild type (WT) mice at multiple time points. Histomorphometry confirmed increased cortical bone thickness and demonstrated significantly higher bone marrow adiposity in Aldh1a1(-/-) mice. In serum assays, Aldh1a1(-/-) mice also had higher serum IGF-1 levels. In vitro, primary Aldh1a1(-/-) mesenchymal stem cells (MSCs) expressed significantly higher levels of bone morphogenetic protein 2 (BMP2) and demonstrated enhanced osteoblastogenesis and adipogenesis versus WT MSCs. BMP2 was also expressed at higher levels in the femurs and tibias of Aldh1a1(-/-) mice with accompanying induction of BMP2-regulated responses, including expression of Runx2 and alkaline phosphatase, and Smad phosphorylation. In vitro, Rald, which accumulates in Aldh1a1(-/-) mice, potently induced BMP2 in WT MSCs in a retinoic acid receptor (RAR)-dependent manner, suggesting that Rald is involved in the BMP2 increases seen in Aldh1a1 deficiency in vivo. Collectively, these data implicate Aldh1a1 as a novel determinant of cortical bone density and marrow adiposity in the skeleton in vivo through modulation of BMP signaling.	[Nallamshetty, Shriram; Wang, Hong; Rhee, Eun-Jung; Kiefer, Florian W.; Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Nallamshetty, Shriram] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Lotinun, Sutada; Baron, Roland] Harvard Univ, Dept Oral Med Infect & Immun, Sch Dent Med, Boston, MA 02115 USA; [Le, Phuong; Rosen, Clifford J.] Maine Med Ctr Res Inst, Ctr Clin & Translat Res, Scarborough, ME USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine; Maine Medical Center	Plutzky, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Rhee, Eun-Jung/M-9294-2015; Plutzky, Jorge/V-3410-2019	Rhee, Eun-Jung/0000-0002-6108-7758; Kiefer, Florian/0000-0003-2191-025X	NIH PPG [5P01HL048743-20]; NIH [5T32HL007208-34]; Austrian Science Fund (FWF) [J3107-B19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105678, T32HL007208, P01HL048743] Funding Source: NIH RePORTER	NIH PPG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research supported by NIH PPG Grant 5P01HL048743-20. SN supported by NIH Training Grant 5T32HL007208-34. FWK supported by Austrian Science Fund (FWF): J3107-B19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; BARSHIRAMAYMON B, 1989, CALCIFIED TISSUE INT, V44, P99, DOI 10.1007/BF02556468; BARSHIRAMAYMON B, 1989, CALCIFIED TISSUE INT, V44, P36, DOI 10.1007/BF02556238; Bell KL, 1999, J BONE MINER RES, V14, P111, DOI 10.1359/jbmr.1999.14.1.111; Bouxsein ML, 2002, J BONE MINER RES, V17, P570, DOI 10.1359/jbmr.2002.17.4.570; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Colucci S, 1996, BIOCHEM BIOPH RES CO, V227, P47, DOI 10.1006/bbrc.1996.1465; Deitrich Richard A, 2007, Novartis Found Symp, V285, P23; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; DHEM A, 1984, FOOD CHEM TOXICOL, V22, P199, DOI 10.1016/0278-6915(84)90127-3; Dingwall M, 2011, DIFFERENTIATION, V82, P57, DOI 10.1016/j.diff.2011.05.003; Feik SA, 1997, J ANAT, V191, P407, DOI 10.1046/j.1469-7580.1997.19130407.x; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; FRANKEL TL, 1986, J NUTR, V116, P578, DOI 10.1093/jn/116.4.578; Gong YH, 2006, NUCLEIC ACIDS RES, V34, P6158, DOI 10.1093/nar/gkl834; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Hisada K, 2013, J BONE MINER METAB, V31, P53, DOI 10.1007/s00774-012-0385-x; HOUGH S, 1988, ENDOCRINOLOGY, V122, P2933, DOI 10.1210/endo-122-6-2933; Ishimi Y, 1999, ENDOCRINOLOGY, V140, P1893, DOI 10.1210/en.140.4.1893; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; KAJI H, 1995, LIFE SCI, V56, P1903, DOI 10.1016/0024-3205(95)00165-3; Kanayasu-Toyoda T, 2005, J STEROID BIOCHEM, V94, P303, DOI 10.1016/j.jsbmb.2004.11.007; Kiefer FW, 2012, ENDOCRINOLOGY, V153, P3089, DOI 10.1210/en.2011-2104; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Lim JS, 2011, BIOCHEM BIOPH RES CO, V412, P500, DOI 10.1016/j.bbrc.2011.07.130; Lorentzon M, 2005, J BONE MINER RES, V20, P1936, DOI 10.1359/JBMR.050709; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200; MOORE T, 1945, BIOCHEM J, V39, P222, DOI 10.1042/bj0390222; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; NAKAYAMA Y, 1990, FEBS LETT, V261, P93, DOI 10.1016/0014-5793(90)80644-X; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NAPOLI JL, 1996, CLIN IMMUNOL IMMUNOP, V80, P52; Obinata A, 2011, INT J DEV BIOL, V55, P933, DOI 10.1387/ijdb.113326ao; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park CK, 1997, J NUTR SCI VITAMINOL, V43, P281, DOI 10.3177/jnsv.43.281; Rauch F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P217; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; Schoenau E, 2002, BONE, V31, P110, DOI 10.1016/S8756-3282(02)00802-5; Silbermann M, 1987, Compr Gerontol A, V1, P45; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Suzawa M, 1999, ENDOCRINOLOGY, V140, P2125, DOI 10.1210/en.140.5.2125; SVANAS GW, 1985, ARCH BIOCHEM BIOPHYS, V236, P36, DOI 10.1016/0003-9861(85)90603-4; Taes YEC, 2009, J CLIN ENDOCR METAB, V94, P2325, DOI 10.1210/jc.2008-2501; Tsuchiya T, 2013, BONE, V53, P358, DOI 10.1016/j.bone.2012.12.049; Urs S, 2010, FASEB J, V24, P3264, DOI 10.1096/fj.10-155127; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]; Yakar S, 2009, FASEB J, V23, P709, DOI 10.1096/fj.08-118976; Yan T, 2001, GROWTH HORM IGF RES, V11, P368, DOI 10.1054/ghir.2001.0249; YOSHIDA A, 1992, ENZYME, V46, P239, DOI 10.1159/000468794; Yu ZL, 2008, J CELL BIOCHEM, V104, P2185, DOI 10.1002/jcb.21773; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	63	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71307	10.1371/journal.pone.0071307	http://dx.doi.org/10.1371/journal.pone.0071307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951127	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200038
J	Padilla-Parra, S; Marin, M; Gahlaut, N; Suter, R; Kondo, N; Melikyan, GB				Padilla-Parra, Sergi; Marin, Mariana; Gahlaut, Nivriti; Suter, Rolf; Kondo, Naoyuki; Melikyan, Gregory B.			Fusion of Mature HIV-1 Particles Leads to Complete Release of a Gag-GFP-Based Content Marker and Raises the Intraviral pH	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITION; TO-CELL TRANSFER; ENVELOPE GLYCOPROTEIN; FLUORESCENT PROTEINS; VIROLOGICAL SYNAPSES; VIRION MATURATION; RECEPTOR-BINDING; PLASMA-MEMBRANE; PORE FORMATION	By imaging the release of a GFP-based viral content marker produced upon virus maturation, we have previously found that HIV-1 fuses with endosomes. In contrast, fusion at the cell surface did not progress beyond a lipid mixing stage (hemifusion). However, recent evidence suggesting that free GFP can be trapped within the mature HIV-1 capsid raises concerns that this content marker may not be released immediately after the formation of a fusion pore. To determine whether a significant portion of GFP is trapped in the mature capsid, we first permeabilized the viral membrane with saponin. The overwhelming majority of pseudoviruses fully released GFP while the remaining particles exhibited partial loss or no loss of content. The extent of GFP release correlated with HIV-1 maturation, implying that incomplete Gag processing, but not GFP entrapment by mature capsids, causes partial content release. Next, we designed a complementary assay for visualizing pore formation by monitoring the intraviral pH with an additional pH-sensitive fluorescent marker. The loss of GFP through saponin-mediated pores was associated with a concomitant increase in the intraviral pH due to equilibration with the pH of an external buffer. We next imaged single HIV-cell fusion and found that these events were manifested in a highly correlated loss of content and increase in the intraviral pH, as it equilibrated with the cytosolic pH. Fused or saponin-permeabilized pseudoviruses that partially lost GFP did not release the remaining content marker under conditions expected to promote the capsid dissociation. We were thus unable to detect significant entrapment of GFP by the mature HIV-1 capsid. Together, our results validate the use of the GFP-based content marker for imaging single virus fusion and inferring the sites of HIV-1 entry.	[Padilla-Parra, Sergi; Marin, Mariana; Gahlaut, Nivriti; Suter, Rolf; Kondo, Naoyuki; Melikyan, Gregory B.] Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Kondo, Naoyuki/W-5845-2019; Padilla-Parra, Sergi/S-3017-2018; Padilla-Parra, Sergi/N-8725-2019	Kondo, Naoyuki/0000-0002-6624-5989; Padilla-Parra, Sergi/0000-0002-8010-9481	National Institutes of Health [AI053668, GM054787]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787, R29GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health AI053668 and GM054787 grants to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 2006, CURR OPIN HIV AIDS, V1, P194, DOI 10.1097/01.COH.0000221591.11294.c1; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bieniasz P. D., 1998, FRONT BIOSCI, V3, P44; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Checkley MA, 2010, VIROLOGY, V400, P137, DOI 10.1016/j.virol.2010.01.028; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Demirkhanyan LH, 2012, J BIOL CHEM; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 2012, VIRUS RES; Forshey BM, 2003, J VIROL, V77, P4409, DOI 10.1128/JVI.77.7.4409-4414.2003; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kaczmarczyk SJ, 2011, P NATL ACAD SCI USA, V108, P16998, DOI 10.1073/pnas.1101874108; Kadiu I, 2011, J NEUROIMMUNE PHARM, V6, P658, DOI 10.1007/s11481-011-9298-z; Kozak SL, 1997, J VIROL, V71, P873, DOI 10.1128/JVI.71.2.873-882.1997; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Matsuyama S, 2004, J VIROL, V78, P8201, DOI 10.1128/JVI.78.15.8201-8209.2004; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Permanyer M, 2012, J BIOL CHEM; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sloan RD, 2013, J VIROL; Smith JG, 2004, J VIROL, V78, P1403, DOI 10.1128/JVI.78.3.1403-1410.2004; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yu ZH, 2013, J MOL BIOL, V425, P112, DOI 10.1016/j.jmb.2012.10.006	62	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71002	10.1371/journal.pone.0071002	http://dx.doi.org/10.1371/journal.pone.0071002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951066	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200030
J	Wiens, KE; Swaminathan, H; Copin, R; Lun, DS; Ernst, JD				Wiens, Kirsten E.; Swaminathan, Harish; Copin, Richard; Lun, Desmond S.; Ernst, Joel D.			Equivalent T Cell Epitope Promiscuity in Ecologically Diverse Human Pathogens	PLOS ONE			English	Article							BINDING PREDICTION SERVERS; I ALLELE PROMISCUITY; MYCOBACTERIUM-TUBERCULOSIS; PEPTIDE BINDING; IDENTIFICATION; RECOGNITION; STRATEGIES; DRIFT; GAG	Background: The HLA (human leukocyte antigen) molecules that present pathogen-derived epitopes to T cells are highly diverse. Correspondingly, many pathogens such as HIV evolve epitope variants in order to evade immune recognition. In contrast, another persistent human pathogen, Mycobacterium tuberculosis, has highly conserved epitope sequences. This raises the question whether there is also a difference in the ability of these pathogens' epitopes to bind diverse HLA alleles, referred to as an epitope's binding promiscuity. To address this question, we compared the in silico HLA binding promiscuity of T cell epitopes from pathogens with distinct infection strategies and outcomes of human exposure. Methods: We used computer algorithms to predict the binding affinity of experimentally-verified microbial epitope peptides to diverse HLA-DR, HLA-A and HLA-B alleles. We then analyzed binding promiscuity of epitopes derived from HIV and M. tuberculosis. We also analyzed promiscuity of epitopes from Streptococcus pyogenes, which is known to exhibit epitope diversity, and epitopes of Bacillus anthracis and Clostridium tetani toxins, as these bacteria do not depend on human hosts for their survival or replication, and their toxin antigens are highly immunogenic human vaccines. Results: We found that B. anthracis and C. tetani epitopes were the most promiscuous of the group that we analyzed. However, there was no consistent difference or trend in promiscuity in epitopes contained in HIV, M. tuberculosis, and S. pyogenes. Conclusions: Our results show that human pathogens with distinct immune evasion strategies and epitope diversities exhibit equivalent levels of T cell epitope promiscuity. These results indicate that differences in epitope promiscuity do not account for the observed differences in epitope variation and conservation.	[Wiens, Kirsten E.; Copin, Richard; Ernst, Joel D.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Ernst, Joel D.] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Ernst, Joel D.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Swaminathan, Harish; Lun, Desmond S.] Rutgers State Univ, Dept Comp Sci, Camden, NJ 08102 USA; [Swaminathan, Harish; Lun, Desmond S.] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA	New York University; New York University; New York University; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick	Ernst, JD (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207; copin, richard/0000-0001-7717-2183; Wiens, Kirsten E./0000-0003-4093-4054	National Institutes of Health [R01 AI090928]; Belgian American Education Foundation; Potts Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian American Education Foundation; Potts Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant R01 AI090928 (JDE), the Belgian American Education Foundation (RC), and the Potts Memorial Foundation (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Axelsson-Robertson R, 2010, IMMUNOLOGY, V129, P496, DOI 10.1111/j.1365-2567.2009.03201.x; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Croft NP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003129; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Eisen HN, 2012, P NATL ACAD SCI USA, V109, P4580, DOI 10.1073/pnas.1201586109; FISCHETTI VA, 1988, REV INFECT DIS, V10, pS356; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; JONES MC, 1993, STAT COMPUT, V3, P135, DOI 10.1007/BF00147776; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005; Kubinak JL, 2012, P NATL ACAD SCI USA, V109, P3422, DOI 10.1073/pnas.1112633109; Lamonaca V, 1999, HEPATOLOGY, V30, P1088, DOI 10.1002/hep.510300435; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Masemola AM, 2004, J IMMUNOL, V173, P4607, DOI 10.4049/jimmunol.173.7.4607; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Nakagawa M, 2007, J VIROL, V81, P1412, DOI 10.1128/JVI.01768-06; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Sabbaj S, 2003, JAIDS-J ACQ IMM DEF, V33, P426, DOI 10.1097/00126334-200308010-00003; Sanjuan R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001523; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Tan PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008754; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73124	10.1371/journal.pone.0073124	http://dx.doi.org/10.1371/journal.pone.0073124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951341	Green Published, gold			2022-12-27	WOS:000326473200086
J	Xu, XH; Jiang, SY; Wang, TY; Bai, YT; Zhong, MH; Wang, AX; Lippmann, M; Chen, LC; Rajagopalan, S; Sun, QH				Xu, Xiaohua; Jiang, Silis Y.; Wang, Tse-Yao; Bai, Yuntao; Zhong, Mianhua; Wang, Aixia; Lippmann, Morton; Chen, Lung-Chi; Rajagopalan, Sanjay; Sun, Qinghua			Inflammatory Response to Fine Particulate Air Pollution Exposure: Neutrophil versus Monocyte	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; HEART-DISEASE; HOST RESPONSE; LUNG INJURY; MACROPHAGE; ACTIVATION; OBESITY; RECRUITMENT	Objectives: Studies have shown that chronic exposure to ambient fine particulate matter (less than 2.5 mu m in aerodynamic diameter, PM2.5) pollution induces insulin resistance through alterations in inflammatory pathways. It is critical to study how the immune system responds to this stimulant, which has been linked to cardiovascular and autoimmune diseases, but few studies have been focused on such involvement of both neutrophils and monocytes in a timely manner. We hypothesized that the neutrophil was involved in the inflammatory response to air pollution. Methods and Results: C57BL/6 mice were exposed to PM2.5 or filtered air (6 hours/day, 5 days/week) for 5, 14, and 21 days, respectively, in Columbus, OH. At the end of each of the exposure periods, we investigated the inflammatory response through flow cytometry, histology, intravital microscopy, and real-time PCR. PM2.5-exposed mice demonstrated a significant inflammatory response after 5 days of exposure. In the lung tissue and bronchoalveolar lavage fluid, monocytes/macrophages showed a transient response, while neutrophils showed a cumulative response. In addition, exposure to PM2.5 resulted in elevation of the monocyte chemoattractant protein 1 (MCP-1) cytokine, a monocyte/macrophage attractant in blood, at an early stage of exposure. Conclusions: These findings suggest that PM2.5 exposure induces the inflammatory responses from both macrophages and neutrophils involvement.	[Xu, Xiaohua; Bai, Yuntao; Wang, Aixia; Rajagopalan, Sanjay; Sun, Qinghua] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Jiang, Silis Y.; Wang, Tse-Yao; Sun, Qinghua] Ohio State Univ, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Zhong, Mianhua; Lippmann, Morton; Chen, Lung-Chi] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY USA; [Rajagopalan, Sanjay; Sun, Qinghua] Ohio State Univ, Coll Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; New York University; University System of Ohio; Ohio State University	Sun, QH (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	sun.224@osu.edu	Bai, Yuntao/S-8408-2016	Jiang, Silis/0000-0002-5140-182X; Chen, Lung Chi/0000-0003-1154-2107	National Institute of Health (NIH) [ES016588, ES017412, ES018900]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015146, R56ES018900, K01ES016588, R01ES018900, R21ES017412] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health (NIH) grants ES016588, ES017412, and ES018900 to Qinghua Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; Brown SB, 1999, J IMMUNOL, V162, P480; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dibazar F., 2008, Folia Morphologica, V67, P231; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Esteve E, 2007, DIABETES CARE, V30, P939, DOI 10.2337/dc06-1793; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haroon ZA, 1999, LAB INVEST, V79, P1679; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Petrofsky M, 1999, CLIN IMMUNOL, V91, P354, DOI 10.1006/clim.1999.4709; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	33	34	41	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71414	10.1371/journal.pone.0071414	http://dx.doi.org/10.1371/journal.pone.0071414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951156	gold, Green Published, Green Submitted			2022-12-27	WOS:000323124000056
J	Ahonen, SJ; Pietila, E; Mellersh, CS; Tiira, K; Hansen, L; Johnson, GS; Lohi, H				Ahonen, Saija J.; Pietila, Elina; Mellersh, Cathryn S.; Tiira, Katriina; Hansen, Liz; Johnson, Gary S.; Lohi, Hannes			Genome-Wide Association Study Identifies a Novel Canine Glaucoma Locus	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; SINGLE NUCLEOTIDE POLYMORPHISMS; PECTINATE LIGAMENT DYSPLASIA; MOLECULAR-GENETICS; CLOSURE GLAUCOMA; IRIDOCORNEAL ANGLE; SUSCEPTIBILITY LOCI; VISUAL IMPAIRMENT; POPULATION	Glaucoma is an optic neuropathy and one of the leading causes of blindness. Its hereditary forms are classified into primary closed-angle (PCAG), primary open-angle (POAG) and primary congenital glaucoma (PCG). Although many loci have been mapped in human, only a few genes have been identified that are associated with the development of glaucoma and the genetic basis of the disease remains poorly understood. Glaucoma has also been described in many dog breeds, including Dandie Dinmont Terriers (DDT) in which it is a late-onset (>7 years) disease. We designed clinical and genetic studies to better define the clinical features of glaucoma in the DDT and to identify the genetic cause. Clinical diagnosis was based on ophthalmic examinations of the affected dogs and 18 additionally investigated unaffected DDTs. We collected DNA from over 400 DTTs and a genome wide association study was performed in a cohort of 23 affected and 23 controls, followed by a fine mapping, a replication study and candidate gene sequencing. The clinical study suggested that ocular abnormalities including abnormal iridocorneal angles and pectinate ligament dysplasia are common (50% and 72%, respectively) in the breed and the disease resembles human PCAG. The genetic study identified a novel 9.5 Mb locus on canine chromosome 8 including the 1.6 Mb best associated region (p = 1.63x10(-10), OR = 32 for homozygosity). Mutation screening in five candidate genes did not reveal any causative variants. This study indicates that although ocular abnormalities are common in DDTs, the genetic risk for glaucoma is conferred by a novel locus on CFA8. The canine locus shares synteny to a region in human chromosome 14q, which harbors several loci associated with POAG and PCG. Our study reveals a new locus for canine glaucoma and ongoing molecular studies will likely help to understand the genetic etiology of the disease.	[Ahonen, Saija J.; Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Tiira, Katriina; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Pietila, Elina] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Mellersh, Cathryn S.] Canine Genet Anim Hlth Trust, Newmarket, Suffolk, England; [Hansen, Liz; Johnson, Gary S.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Helsinki; University of Helsinki; University of Helsinki; Animal Health Trust; University of Missouri System; University of Missouri Columbia	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Tiira, Katriina/U-4035-2018	Lohi, Hannes/0000-0003-1087-5532; Tiira, Katriina/0000-0002-2253-8755; Ahonen, Saija/0000-0003-3313-784X	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation	This study was supported partly by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation. SA is a student in Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; Aung T, 2008, MOL VIS, V14, P1313; Bjerkas E, 2002, VET OPHTHALMOL, V5, P49, DOI 10.1046/j.1463-5224.2002.00213.x; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Chen XL, 2011, FRONT BIOSCI-LANDMRK, V16, P2052, DOI 10.2741/3838; Cong YH, 2009, MOL VIS, V15, P1412; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; EKESTEN B, 1991, AM J VET RES, V52, P1875; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Firasat S, 2008, MOL VIS, V14, P1659; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; Gelatt KN, 2004, VET OPHTHALMOL, V7, P97, DOI 10.1111/j.1463-5224.2004.04006.x; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Kato K, 2006, VET OPHTHALMOL, V9, P71, DOI 10.1111/j.1463-5224.2006.00438.x; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Lowe R F, 1971, Trans Aust Coll Ophthalmol, V3, P11; Michael S, 2008, MOL VIS, V14, P661; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; MORRISON JC, 1982, INVEST OPHTH VIS SCI, V23, P726; Munoz B, 2002, BRIT J OPHTHALMOL, V86, P498, DOI 10.1136/bjo.86.5.498; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Ray K, 2003, MOL CELL BIOCHEM, V253, P223, DOI 10.1023/A:1026059800470; Raymond V, 1997, AM J HUM GENET, V60, P272; Read R. A., 1998, Veterinary Ophthalmology, V1, P85, DOI 10.1046/j.1463-5224.1998.00019.x; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Shastry BS, 2013, DISCOV MED, V15, P17; Shi YJ, 2000, INVEST OPHTH VIS SCI, V41, P1337; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; STOILOV IR, 2002, ARVO ANN M FORT LAUD, P5; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; VANDERLINDESIPMAN JS, 1987, VET PATHOL, V24, P201, DOI 10.1177/030098588702400301; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang IJ, 2006, MOL VIS, V12, P1223; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Wood J. L. N., 1998, Veterinary Ophthalmology, V1, P91, DOI 10.1046/j.1463-5224.1998.00020.x	45	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70903	10.1371/journal.pone.0070903	http://dx.doi.org/10.1371/journal.pone.0070903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951034	Green Published, Green Submitted, gold			2022-12-27	WOS:000323109700060
J	Hwang, TJ				Hwang, Thomas J.			Stock Market Returns and Clinical Trial Results of Investigational Compounds: An Event Study Analysis of Large Biopharmaceutical Companies	PLOS ONE			English	Article							PUBLIC ANNOUNCEMENTS; PRICE REACTION; WALL-STREET; NEWS; BUSINESS; BEHAVIOR; IMPACT; DRUGS; MEDIA	Background: For biopharmaceutical companies, investments in research and development are risky, and the results from clinical trials are key inflection points in the process. Few studies have explored how and to what extent the public equity market values clinical trial results. Methods: Our study dataset matched announcements of clinical trial results for investigational compounds from January 2011 to May 2013 with daily stock market returns of large United States-listed pharmaceutical and biotechnology companies. Event study methodology was used to examine the relationship between clinical research events and changes in stock returns. Results: We identified public announcements for clinical trials of 24 investigational compounds, including 16 (67%) positive and 8 (33%) negative events. The majority of announcements were for Phase 3 clinical trials (N = 13, 54%), and for oncologic (N = 7, 29%) and neurologic (N = 6, 24%) indications. The median cumulative abnormal returns on the day of the announcement were 0.8% (95% confidence interval [CI]: -2.3, 13.4%; P = 0.02) for positive events and -2.0% (95% CI: -9.1, 0.7%; P = 0.04) for negative events, with statistically significant differences from zero. In the day immediately following the announcement, firms with positive events were associated with stock price corrections, with median cumulative abnormal returns falling to 0.4% (95% CI: -3.8, 12.3%; P = 0.33). For firms with negative announcements, the median cumulative abnormal returns were -1.7% (95% CI: -9.5, 1.0%; P = 0.03), and remained significantly negative over the two day event window. The magnitude of abnormal returns did not differ statistically by indication, by trial phase, or between biotechnology and pharmaceutical firms. Conclusions: The release of clinical trial results is an economically significant event and has meaningful effects on market value for large biopharmaceutical companies. Stock return underperformance due to negative events is greater in magnitude and persists longer than abnormal returns due to positive events, suggesting asymmetric market reactions.	Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University	Hwang, TJ (corresponding author), Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA.	tjhwang@college.harvard.edu		Hwang, Thomas/0000-0003-0717-1497	Cordeiro Research Fellowship of the Interfaculty Initiative in Health Policy at Harvard University; Center for American Political Studies at Harvard University	Cordeiro Research Fellowship of the Interfaculty Initiative in Health Policy at Harvard University; Center for American Political Studies at Harvard University	TJH was supported by the Cordeiro Research Fellowship of the Interfaculty Initiative in Health Policy and a research grant from the Center for American Political Studies, both at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 2012, BLOOMBERG; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Bailey W, 2006, J FINANC ECON, V81, P175, DOI 10.1016/j.jfineco.2005.06.002; Barber BM, 2008, REV FINANC STUD, V21, P785, DOI 10.1093/rfs/hhm079; Benowitz S, 2002, J NATL CANCER I, V94, P1352; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; CAMPBELL CJ, 1993, J FINANC ECON, V33, P73, DOI 10.1016/0304-405X(93)90025-7; Campbell J., 1997, ECONOMETRICS FINANCI; Carpenter D, 2010, PRINC STUD AM POLIT, P1; CHAN SH, 1990, J FINANC ECON, V26, P255, DOI 10.1016/0304-405X(90)90005-K; Chan WS, 2003, J FINANC ECON, V70, P223, DOI 10.1016/S0304-405X(03)00146-6; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Dellavigna S, 2011, J FINANC, V64, P709; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DRANOVE D, 1994, J LAW ECON, V37, P323, DOI 10.1086/467316; Engelberg JE, 2011, J FINANC, V66, P67, DOI 10.1111/j.1540-6261.2010.01626.x; Ferguson JR, 1997, NEW ENGL J MED, V337, P631, DOI 10.1056/NEJM199708283370910; Fidrmuc JP, 2006, J FINANC, V61, P2931, DOI 10.1111/j.1540-6261.2006.01008.x; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Hisano R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064846; Joulin A, 2008, ARXIV08031769; Kolari JW, 2011, J EMPIR FINANC, V18, P953, DOI 10.1016/j.jempfin.2011.08.003; LANG LHP, 1992, J FINANC ECON, V32, P45, DOI 10.1016/0304-405X(92)90024-R; Lillo F, 2012, ARXIV12073300; MacKinlay AC, 1997, J ECON LIT, V35, P13; MCQUEEN G, 1993, REV FINANC STUD, V6, P683, DOI 10.1093/rfs/6.3.683; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Overgaard CB, 2000, J INVEST MED, V48, P118; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Panattoni LE, 2011, J HEALTH ECON, V30, P126, DOI 10.1016/j.jhealeco.2010.09.004; Perez-Rodriguez JV, 2012, GAC SANIT, V26, P352, DOI 10.1016/j.gaceta.2011.07.028; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Rang HP, 2006, DRUG DISCOVERY DEV T; Rothenstein JM, 2011, J NATL CANCER I, V103, P1507, DOI 10.1093/jnci/djr338; Rothfeld M, 2012, WALL STREET J; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Senard JM, 1996, LANCET, V347, P987, DOI 10.1016/S0140-6736(96)90141-5; Sharma A, 2004, J PROD INNOVAT MANAG, V21, P297, DOI 10.1111/j.0737-6782.2004.00084.x; Shortridge R.T., 2004, J BUS FINANCE ACCOUN, V31, P1301, DOI [DOI 10.1111/J.0306-686X.2004.00575.X, 10.1111/j.0306-686X.2004.00575.x]; Steinbrook R, 2005, NEW ENGL J MED, V353, P1091, DOI 10.1056/NEJMp058216; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Thomson Reuters, 2012, CMR INT PHARM R D FA; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P2654, DOI 10.1001/jama.293.21.2654; Vega C, 2006, J FINANC ECON, V82, P103, DOI 10.1016/j.jfineco.2005.07.011	47	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71966	10.1371/journal.pone.0071966	http://dx.doi.org/10.1371/journal.pone.0071966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951273	gold, Green Published, Green Submitted			2022-12-27	WOS:000323109700125
J	Papachristou, E; Ormel, J; Oldehinkel, AJ; Kyriakopoulos, M; Reinares, M; Reichenberg, A; Frangou, S				Papachristou, Efstathios; Ormel, Johan; Oldehinkel, Albertine J.; Kyriakopoulos, Marinos; Reinares, Maria; Reichenberg, Abraham; Frangou, Sophia			Child Behavior Checklist-Mania Scale (CBCL-MS): Development and Evaluation of a Population-Based Screening Scale for Bipolar Disorder	PLOS ONE			English	Article							EARLY INTERVENTION; SPECTRUM DISORDER; COMMUNITY SAMPLE; RATING-SCALE; EARLY-ONSET; VALIDITY; MOOD; SYMPTOMS; QUESTIONNAIRE; RELIABILITY	Context: Early identification of Bipolar Disorder (BD) remains poor despite the high levels of disability associated with the disorder. Objective: We developed and evaluated a new DSM orientated scale for the identification of young people at risk for BD based on the Child Behavior Checklist (CBCL) and compared its performance against the CBCL-Pediatric Bipolar Disorder (CBCL-PBD) and the CBCL-Externalizing Scale, the two most widely used scales. Methods: The new scale, CBCL-Mania Scale (CBCL-MS), comprises 19 CBCL items that directly correspond to operational criteria for mania. We tested the reliability, longitudinal stability and diagnostic accuracy of the CBCL-MS on data from the TRacking Adolescents' Individual Lives Survey (TRAILS), a prospective epidemiological cohort study of 2230 Dutch youths assessed with the CBCL at ages 11, 13 and 16. At age 19 lifetime psychiatric diagnoses were ascertained with the Composite International Diagnostic Interview. We compared the predictive ability of the CBCL-MS against the CBCL-Externalising Scale and the CBCL-PBD in the TRAILS sample. Results: The CBCL-MS had high internal consistency and satisfactory accuracy (area under the curve = 0.64) in this general population sample. Principal Component Analyses, followed by parallel analyses and confirmatory factor analyses, identified four factors corresponding to distractibility/disinhibition, psychosis, increased libido and disrupted sleep. This factor structure remained stable across all assessment ages. Logistic regression analyses showed that the CBCL-MS had significantly higher predictive ability than both the other scales. Conclusions: Our data demonstrate that the CBCL-MS is a promising screening instrument for BD. The factor structure of the CBCL-MS showed remarkable temporal stability between late childhood and early adulthood suggesting that it maps on to meaningful developmental dimensions of liability to BD.	[Papachristou, Efstathios; Kyriakopoulos, Marinos; Reinares, Maria] Kings Coll London, Inst Psychiat, Child Psychiat Dept, London, England; [Kyriakopoulos, Marinos] Maudsley Hosp & Inst Psychiat, Child & Adolescent Mental Hlth Serv, London SE5 8AZ, England; [Reichenberg, Abraham; Frangou, Sophia] Ichan Sch Med Mt Sinai, New York, NY USA; [Ormel, Johan; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychpathol & Emot Regulat, Groningen, Netherlands	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; Icahn School of Medicine at Mount Sinai; University of Groningen	Frangou, S (corresponding author), Ichan Sch Med Mt Sinai, New York, NY USA.	sophia.frangou@mssm.edu	Kyriakopoulos, Marinos/F-8310-2014; Reichenberg, Abraham/GQB-1227-2022; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013; Papachristou, Steven/GZK-4654-2022	Kyriakopoulos, Marinos/0000-0002-4594-2646; ormel, johan/0000-0002-5463-037X; Papachristou, Steven/0000-0001-5746-9561; Frangou, Sophia/0000-0002-3210-6470	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; ZonMW Brainpower grant [100-001-004]; ZonMw Risk Behavior and Dependence [60-60600-97-118]; ZonMw Culture and Health [261-98-710]; Social Sciences Council medium-sized investment [MaGW 480-01-006, GB-MaGW 480-07-001]; Social Sciences Council project [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; NWO large-sized investment [175.010.2003.005]; NWO Longitudinal Survey and Panel Funding [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS) [FP-006]; banking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); ZonMW Brainpower grant; ZonMw Risk Behavior and Dependence; ZonMw Culture and Health; Social Sciences Council medium-sized investment; Social Sciences Council project; NWO large-sized investment; NWO Longitudinal Survey and Panel Funding; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); banking and Biomolecular Resources Research Infrastructure BBMRI-NL	TRAILS has been supported by grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 1991, MANUAL TEACHER REPOR; Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Agrawal A, 2010, PSYCHOL MED, V40, P1549, DOI 10.1017/S0033291709992005; Althoff RR, 2010, J AM ACAD CHILD PSY, V49, P1105, DOI 10.1016/j.jaac.2010.08.006; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 1991, MANUAL CHILD BEHAV C; Berk M, 2007, J AFFECT DISORDERS, V103, P181, DOI 10.1016/j.jad.2007.01.027; Berk M, 2010, J MENT HEALTH, V19, P113, DOI 10.3109/09638230903469111; Biederman J, 2004, J AFFECT DISORDERS, V82, pS45, DOI 10.1016/j.jad.2004.05.021; BIEDERMAN J, 1995, J AM ACAD CHILD PSY, V34, P464, DOI 10.1097/00004583-199504000-00013; Biederman J, 2008, J DEV BEHAV PEDIATR, V29, P501, DOI 10.1097/DBP.0b013e318190b290; Brooks JO, 2011, J CLIN PSYCHIAT, V72, P240, DOI [10.4088/JCP.09m05214yel, 10.4088/JCP.9075tx1c]; Cassano GB, 2009, J AFFECT DISORDERS, V112, P59, DOI 10.1016/j.jad.2008.04.019; Cassidy F, 1998, ARCH GEN PSYCHIAT, V55, P27, DOI 10.1001/archpsyc.55.1.27; Coryell W, 2001, J AFFECT DISORDERS, V67, P79, DOI 10.1016/S0165-0327(99)00024-5; Danielson CK, 2003, J ABNORM CHILD PSYCH, V31, P29, DOI 10.1023/A:1021717231272; Diler RS, 2009, J CHILD ADOL PSYCHOP, V19, P23, DOI 10.1089/cap.2008.067; Dodd S, 2009, AUST NZ J PSYCHIAT, V43, P526, DOI 10.1080/00048670902873706; Duffy A, 2007, BIPOLAR DISORD, V9, P828, DOI 10.1111/j.1399-5618.2007.00421.x; Faraone SV, 2005, BIPOLAR DISORD, V7, P518, DOI 10.1111/j.1399-5618.2005.00271.x; Faraone SV, 1997, J AM ACAD CHILD PSY, V36, P1378, DOI 10.1097/00004583-199710000-00020; Geller B, 1998, J AFFECT DISORDERS, V51, P81, DOI 10.1016/S0165-0327(98)00175-X; Gracious BL, 2002, J AM ACAD CHILD PSY, V41, P1350, DOI 10.1097/00004583-200211000-00017; Grzybowski M, 1997, ACAD EMERG MED, V4, P818, DOI 10.1111/j.1553-2712.1997.tb03793.x; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hirschfeld RMA, 2003, AM J PSYCHIAT, V160, P178, DOI 10.1176/appi.ajp.160.1.178; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Inal-Emiroglu FN, 2008, WORLD PSYCHIATRY, V7, P110; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; Johns LC, 2002, BRIT J PSYCHIAT, V180, P174, DOI 10.1192/bjp.180.2.174; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Keck PE, 2008, J PSYCHIATR PRACT, V14, P31, DOI 10.1097/01.pra.0000320124.91799.2a; Keck PE, 2003, COMPR PSYCHIAT, V44, P263, DOI 10.1016/S0010-440X(03)00089-0; Kessler RC, 2006, J AFFECT DISORDERS, V96, P259, DOI 10.1016/j.jad.2006.08.018; Kim J, 2012, J CHILD PSYCHOL PSYC, V53, P918, DOI 10.1111/j.1469-7610.2012.02546.x; Leibenluft E, 2008, ANNU REV CLIN PSYCHO, V4, P163, DOI 10.1146/annurev.clinpsy.4.022007.141216; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Merikangas KR, 2012, ARCH GEN PSYCHIAT, V69, P943, DOI 10.1001/archgenpsychiatry.2012.38; Mick E, 2003, BIOL PSYCHIAT, V53, P1021, DOI 10.1016/S0006-3223(03)00234-8; Miklowitz DJ, 2013, J AM ACAD CHILD PSY, V52, P121, DOI 10.1016/j.jaac.2012.10.007; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Passarotti AM, 2010, J AM ACAD CHILD PSY, V49, P1064, DOI 10.1016/j.jaac.2010.07.009; Passarotti AM, 2010, PSYCHIAT RES-NEUROIM, V181, P36, DOI 10.1016/j.pscychresns.2009.07.002; Pavuluri MN, 2006, J AM ACAD CHILD PSY, V45, P550, DOI 10.1097/01.chi.0000205700.40700.50; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; Perugi G, 2000, COMPR PSYCHIAT, V41, P13, DOI 10.1016/S0010-440X(00)90125-1; Picardi A, 2008, J AFFECT DISORDERS, V108, P183, DOI 10.1016/j.jad.2007.09.010; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; ROBINS LN, 1985, ARCH GEN PSYCHIAT, V42, P918; Skirrow C, 2012, J AFFECT DISORDERS, V141, P143, DOI 10.1016/j.jad.2012.04.003; Topor DR, 2013, J AFFECT DISORDERS, V145, P409, DOI 10.1016/j.jad.2012.06.024; Volk HE, 2007, BIOL PSYCHIAT, V62, P115, DOI 10.1016/j.biopsych.2006.05.036; Wagner KD, 2006, J CLIN PSYCHIAT, V67, P827, DOI 10.4088/JCP.v67n0518; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; World Health Organization, 1990, COMP INT DIAGN INT C; Youngstrom EA, 2004, J AM ACAD CHILD PSY, V43, P847, DOI 10.1097/01.chi.0000125091.35109.1e; Youngstrom EA, 2001, PSYCHOL ASSESSMENT, V13, P267, DOI 10.1037/1040-3590.13.2.267; Zimmerman M, 2011, COMPR PSYCHIAT, V52, P600, DOI 10.1016/j.comppsych.2011.01.004; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	66	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e69459	10.1371/journal.pone.0069459	http://dx.doi.org/10.1371/journal.pone.0069459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967059	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500006
J	Wang, Y; Xiong, B; Liang, B; Zhao, H; Li, H; Qian, J; Liang, HM; Feng, GS; Zheng, CS				Wang, Yong; Xiong, Bin; Liang, Bin; Zhao, Hui; Li, Hui; Qian, Jun; Liang, Hui-Min; Feng, Gan-Sheng; Zheng, Chuan-Sheng			Hepatic Parenchymal Changes following Transcatheter Embolization and Chemoembolization in a Rabbit Tumor Model	PLOS ONE			English	Article							ARTERIAL EMBOLIZATION; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; STELLATE CELLS; THERAPY; DAMAGE; MALIGNANCY; CIRRHOSIS; INJURIES	Objective: To compare the effects of transcatheter arterial chemoembolization (TACE) with transcatheter arterial embolization (TAE) on liver function, hepatic damage, and hepatic fibrogenesis in a rabbit tumor model. Materials and Methods: Thirty-nine New Zealand white rabbits implanted with VX2 tumors in the left liver lobes were randomly divided into three groups: TAE, TACE, and control group. In the TAE group (n = 15), polyvinyl alcohol particles (PVAs) were used for left hepatic artery embolization. In the TACE group (n = 15), the tumors were treated with left hepatic arterial infusions of a suspension of 10-hydroxycamptothecin and lipiodol, followed by embolization with PVAs. In the control group (n = 9), the animals received sham treatment with distilled water. Serum and liver samples were collected at 6 hours, 3 days and 7 days after treatment. Liver damage was measured using a liver function test and histological analyses. Liver fibrogenesis and hepatic stellate cell (HSC) activation were evaluated using Sirius Red and anti-alpha-smooth muscle actin (alpha-SMA) immunohistochemical stains. Results: TACE caused liver injury with greater increases in serum alanine aminotransferase and aspartate aminotransferase levels on day 3 (P<0.05). Histological analyses revealed increased hepatic necrosis in adjacent non-tumorous liver tissue from day 3 compared to the TAE group (Suzuki score of 2.33 +/- 1.29 versus 1.13 +/- 1.18, P = 0.001). HSC activation and proliferation were significantly increased in the TACE group compared to the control group at 3 and 7 days after treatment (0.074 +/- 0.014 vs. 0.010 +/- 0.006, and 0.088 +/- 0.023 vs. 0.017 +/- 0.009, P<0.05). Sirius Red staining demonstrated a statistically significant increase in collagen deposition in the livers in the TACE group 7 days after embolization compared to the control group (0.118 +/- 0.012 vs. 0.060 +/- 0.017, P = 0.05). Conclusion: The results of this animal study revealed that TACE induced prominent hepatocellular damage and hepatic fibrogenesis, which compromised liver function and may be responsible for chronic liver decompensation.	[Wang, Yong; Xiong, Bin; Liang, Bin; Zhao, Hui; Li, Hui; Qian, Jun; Liang, Hui-Min; Feng, Gan-Sheng; Zheng, Chuan-Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zheng, CS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China.	hqzcsxh@sina.com	Wang, Yong/B-6207-2015; Xiong, Bin/AGX-8289-2022	Wang, Yong/0000-0003-4707-5280; 	National Natural Sciences Foundation of China [30970804]; Hubei Provincial Key Laboratory of Molecular Imaging [02.03.2011-78]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Key Laboratory of Molecular Imaging	This study was supported by grants (30970804) from National Natural Sciences Foundation of China and grants from Hubei Provincial Key Laboratory of Molecular Imaging (No. 02.03.2011-78). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinyan A, 2008, HPB, V10, P396, DOI 10.1080/13651820802356564; Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513; Caturelli E, 2000, RADIOLOGY, V215, P123, DOI 10.1148/radiology.215.1.r00ap21123; Chan AO, 2002, CANCER-AM CANCER SOC, V94, P1747, DOI 10.1002/cncr.10407; Chung J, 2010, BRIT J RADIOL, V83, P71, DOI 10.1259/bjr/82377365; Farinati F, 1996, DIGEST DIS SCI, V41, P2332, DOI 10.1007/BF02100123; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Itoh Y, 1999, LIVER, V19, P97, DOI 10.1111/j.1478-3231.1999.tb00017.x; KANEKO A, 1992, AM J GASTROENTEROL, V87, P1014; KHAN KN, 1991, CANCER RES, V51, P5667; KOBAYASHI S, 1994, J GASTROEN HEPATOL, V9, P45, DOI 10.1111/j.1440-1746.1994.tb01215.x; Kong J, 2002, SHI YONG FANG SHE XU, V18, P312; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; Liang B, 2010, CARDIOVASC INTER RAD, V33, P806, DOI 10.1007/s00270-009-9762-9; Morimoto K, 2008, CARDIOVASC INTER RAD, V31, P981, DOI 10.1007/s00270-008-9367-8; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; SUOU T, 1993, HEPATOLOGY, V18, P809, DOI 10.1002/hep.1840180410; Virmani S, 2008, J VASC INTERV RADIOL, V19, P1483, DOI 10.1016/j.jvir.2008.06.017; Wallace S, 2000, ACTA GASTRO-ENT BELG, V63, P169; Wang Y, 2011, J VASC INTERV RADIOL, V22, P1606, DOI 10.1016/j.jvir.2011.08.005; YAMASHITA Y, 1993, ABDOM IMAGING, V18, P352, DOI 10.1007/BF00201780; Yu JS, 2002, CARDIOVASC INTER RAD, V25, P270, DOI 10.1007/s00270-001-0049-z; Yu JS, 2001, RADIOLOGY, V221, P429, DOI 10.1148/radiol.2212010339; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491	24	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70757	10.1371/journal.pone.0070757	http://dx.doi.org/10.1371/journal.pone.0070757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967098	Green Published, Green Submitted, gold			2022-12-27	WOS:000323221500025
J	Leavitt, JC; Gogokhia, L; Gilcrease, EB; Bhardwaj, A; Cingolani, G; Casjens, SR				Leavitt, Justin C.; Gogokhia, Lasha; Gilcrease, Eddie B.; Bhardwaj, Anshul; Cingolani, Gino; Casjens, Sherwood R.			The Tip of the Tail Needle Affects the Rate of DNA Delivery by Bacteriophage P22	PLOS ONE			English	Article							PHAGE-P22 TAILSPIKE PROTEIN; ESCHERICHIA-COLI; SALMONELLA PHAGE-P22; NUCLEOTIDE-SEQUENCE; SUPERINFECTION EXCLUSION; SCAFFOLDING PROTEIN; CRYSTAL-STRUCTURE; GENOMIC ANALYSIS; VIRION PROTEIN; T7 VIRION	The P22-like bacteriophages have short tails. Their virions bind to their polysaccharide receptors through six trimeric tailspike proteins that surround the tail tip. These short tails also have a trimeric needle protein that extends beyond the tailspikes from the center of the tail tip, in a position that suggests that it should make first contact with the host's outer membrane during the infection process. The base of the needle serves as a plug that keeps the DNA in the virion, but role of the needle during adsorption and DNA injection is not well understood. Among the P22-like phages are needle types with two completely different C-terminal distal tip domains. In the phage Sf6-type needle, unlike the other P22-type needle, the distal tip folds into a "knob'' with a TNF-like fold, similar to the fiber knobs of bacteriophage PRD1 and Adenovirus. The phage HS1 knob is very similar to that of Sf6, and we report here its crystal structure which, like the Sf6 knob, contains three bound L-glutamate molecules. A chimeric P22 phage with a tail needle that contains the HS1 terminal knob efficiently infects the P22 host, Salmonella enterica, suggesting the knob does not confer host specificity. Likewise, mutations that should abrogate the binding of L-glutamate to the needle do not appear to affect virion function, but several different other genetic changes to the tip of the needle slow down potassium release from the host during infection. These findings suggest that the needle plays a role in phage P22 DNA delivery by controlling the kinetics of DNA ejection into the host.	[Leavitt, Justin C.; Casjens, Sherwood R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Gogokhia, Lasha; Gilcrease, Eddie B.; Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Jefferson University	Casjens, SR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	sherwood.casjens@path.utah.edu		Bhardwaj, Anshul/0000-0002-0897-979X; Leavitt, Justin/0000-0003-4544-0483	National Institutes of Health [RO1 AI074825, GM100888]; NCI Cancer Center Support Grant [P30 CA56036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1 AI074825 to SRC and GM100888 to GC. Research in this publication includes work carried out at the Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MB, 1985, J VIROL, V53, P180, DOI 10.1128/JVI.53.1.180-184.1985; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Andres D, 2010, BIOCHEM SOC T, V38, P1386, DOI 10.1042/BST0381386; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; BOTSTEIN D, 1970, Journal of Molecular Biology, V54, P417, DOI 10.1016/0022-2836(70)90119-1; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; BOULANGER P, 1992, J BIOL CHEM, V267, P3168; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; CHAN RK, 1972, VIROLOGY, V49, P257, DOI 10.1016/S0042-6822(72)80027-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; Cumby N, 2012, J BACTERIOL, V194, P5012, DOI 10.1128/JB.00843-12; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; HOFFMAN B, 1975, J VIROL, V16, P1536, DOI 10.1128/JVI.16.6.1536-1546.1975; HOFFMAN B, 1975, J VIROL, V16, P1547, DOI 10.1128/JVI.16.6.1547-1559.1975; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; ISRAEL V, 1967, VIROLOGY, V33, P317, DOI 10.1016/0042-6822(67)90150-X; ISRAEL V, 1972, J VIROL, V10, P1152, DOI 10.1128/JVI.10.6.1152-1158.1972; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Kemp P, 2004, MOL MICROBIOL, V53, P1251, DOI 10.1111/j.1365-2958.2004.04204.x; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; LENK E, 1975, VIROLOGY, V68, P182, DOI 10.1016/0042-6822(75)90160-9; Letellier L, 2004, FRONT BIOSCI-LANDMRK, V9, P1228, DOI 10.2741/1333; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; LEVINE MM, 1977, INFECT IMMUN, V17, P78, DOI 10.1128/IAI.17.1.78-82.1977; LEVINE MM, 1978, LANCET, V1, P1119; Liu J, 2011, VIROLOGY, V417, P304, DOI 10.1016/j.virol.2011.06.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Molineux IJ, 2006, VIROLOGY, V344, P221, DOI 10.1016/j.virol.2005.09.014; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla-Meier GP, 2012, J BIOL CHEM, V287, P33766, DOI 10.1074/jbc.M112.393132; Panja D, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045006; Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RHOADES M, 1968, J MOL BIOL, V37, P41, DOI 10.1016/0022-2836(68)90072-7; Serwer Philip, 2008, BMC Res Notes, V1, P36, DOI 10.1186/1756-0500-1-36; Sissoeff L, 2005, J GEN VIROL, V86, P2543, DOI 10.1099/vir.0.81063-0; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; Struthers-Schlinke JS, 2000, J MOL BIOL, V301, P35, DOI 10.1006/jmbi.2000.3940; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; SUSSKIND MM, 1974, VIROLOGY, V62, P350, DOI 10.1016/0042-6822(74)90398-5; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; TERNIKOGOSSIAN VA, 1991, BIOFIZIKA+, V36, P281; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Villafane R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-227; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WEAVER S, 1977, VIROLOGY, V76, P29, DOI 10.1016/0042-6822(77)90278-1; WEAVER S, 1977, VIROLOGY, V76, P19, DOI 10.1016/0042-6822(77)90277-X; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; YOUDERIAN P, 1983, CELL, V35, P777, DOI 10.1016/0092-8674(83)90110-1; YOUDERIAN P, 1982, J MOL BIOL, V154, P449, DOI 10.1016/S0022-2836(82)80006-5; YOUNG BG, 1964, VIROLOGY, V23, P279, DOI 10.1016/0042-6822(64)90296-X	81	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70936	10.1371/journal.pone.0070936	http://dx.doi.org/10.1371/journal.pone.0070936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951045	gold, Green Published, Green Submitted			2022-12-27	WOS:000323097300068
J	Taya, S; Windridge, D; Osman, M				Taya, Shuichiro; Windridge, David; Osman, Magda			Trained Eyes: Experience Promotes Adaptive Gaze Control in Dynamic and Uncertain Visual Environments	PLOS ONE			English	Article							MOVEMENTS	Current eye-tracking research suggests that our eyes make anticipatory movements to a location that is relevant for a forthcoming task. Moreover, there is evidence to suggest that with more practice anticipatory gaze control can improve. However, these findings are largely limited to situations where participants are actively engaged in a task. We ask: does experience modulate anticipative gaze control while passively observing a visual scene? To tackle this we tested people with varying degrees of experience of tennis, in order to uncover potential associations between experience and eye movement behaviour while they watched tennis videos. The number, size, and accuracy of saccades (rapid eye-movements) made around 'events,' which is critical for the scene context (i.e. hit and bounce) were analysed. Overall, we found that experience improved anticipatory eye-movements while watching tennis clips. In general, those with extensive experience showed greater accuracy of saccades to upcoming event locations; this was particularly prevalent for events in the scene that carried high uncertainty (i.e. ball bounces). The results indicate that, even when passively observing, our gaze control system utilizes prior relevant knowledge in order to anticipate upcoming uncertain event locations.	[Taya, Shuichiro] Taisho Univ, Dept Human Sci, Tokyo, Japan; [Windridge, David; Osman, Magda] Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England; [Osman, Magda] Univ London, Queen Mary Coll, Sch Biol & Chem Sci, London, England	University of Surrey; University of London; Queen Mary University London	Osman, M (corresponding author), Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England.	m.osman@qmul.ac.uk		osman, magda/0000-0003-1480-6657; Windridge, David/0000-0001-5507-8516	Engineering and Physical Sciences Research Council [EP/F069626/1]; EPSRC [EP/F069421/1, EP/F069626/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F069421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from Engineering and Physical Sciences Research Council (EP/F069626/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Furneaux S, 1999, P ROY SOC B-BIOL SCI, V266, P2435, DOI 10.1098/rspb.1999.0943; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Howard CJ, 2010, PSYCHON B REV, V17, P710, DOI 10.3758/PBR.17.5.710; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Jovancevic-Misic J, 2009, J NEUROSCI, V29, P6234, DOI 10.1523/JNEUROSCI.5570-08.2009; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Pelz JB, 2001, VISION RES, V41, P3587, DOI 10.1016/S0042-6989(01)00245-0; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Rotman G, 2006, J NEUROPHYSIOL, V96, P1358, DOI 10.1152/jn.00227.2006; Shalom DE, 2011, VISION RES, V51, P1262, DOI 10.1016/j.visres.2011.03.017; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Taya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039060; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71	26	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71371	10.1371/journal.pone.0071371	http://dx.doi.org/10.1371/journal.pone.0071371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200UV	23951147	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300109
J	Fang, F; Liu, GC; Zhou, XH; Yang, S; Reich, HN; Williams, V; Hu, A; Pan, J; Konvalinka, A; Oudit, GY; Scholey, JW; John, R				Fang, Fei; Liu, George Chu; Zhou, Xiaohua; Yang, Stuart; Reich, Heather Naomi; Williams, Vanessa; Hu, Amanda; Pan, Janice; Konvalinka, Ana; Oudit, Gavin Yadram; Scholey, James William; John, Rohan			Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ISCHEMIA/REPERFUSION INJURY; MOUSE MODEL; KIDNEY; INHIBITION; EXPRESSION; RECEPTORS; FAILURE; SYSTEM; ACTIVATION	Ischemia-reperfusion (I/R) is a model of acute kidney injury (AKI) that is characterized by vasoconstriction, oxidative stress, apoptosis and inflammation. Previous studies have shown that activation of the renin-angiotensin system (RAS) may contribute to these processes. Angiotensin converting enzyme 2 (ACE2) metabolizes angiotensin II (Ang II) to angiotensin-(1-7), and recent studies support a beneficial role for ACE2 in models of chronic kidney disease. However, the role of ACE2 in models of AKI has not been fully elucidated. In order to test the hypothesis that ACE2 plays a protective role in AKI we assessed I/R injury in wild-type (WT) mice and ACE2 knock-out (ACE2 KO) mice. ACE2 KO and WT mice exhibited similar histologic injury scores and measures of kidney function at 48 hours after reperfusion. Loss of ACE2 was associated with increased neutrophil, macrophage, and T cell infiltration in the kidney. mRNA levels for pro-inflammatory cytokines, interleukin-1 beta, interleukin-6 and tumour necrosis factor-a, as well as chemokines macrophage inflammatory protein 2 and monocyte chemoattractant protein-1, were increased in ACE2 KO mice compared to WT mice. Changes in inflammatory cell infiltrates and cytokine expression were also associated with greater apoptosis and oxidative stress in ACE2 KO mice compared to WT mice. These data demonstrate a protective effect of ACE2 in I/R AKI.	[Fang, Fei; Liu, George Chu; Zhou, Xiaohua; Williams, Vanessa; Hu, Amanda; Pan, Janice; Konvalinka, Ana; Scholey, James William] Univ Toronto, Dept Med, Toronto, ON, Canada; [Fang, Fei; Liu, George Chu; Zhou, Xiaohua; Williams, Vanessa; Hu, Amanda; Pan, Janice; Konvalinka, Ana; Scholey, James William] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Yang, Stuart; Reich, Heather Naomi; Scholey, James William] Univ Hlth Network, Dept Med, Div Nephrol, Toronto, ON, Canada; [Yang, Stuart; Reich, Heather Naomi; Scholey, James William; John, Rohan] Univ Toronto, Toronto, ON, Canada; [Oudit, Gavin Yadram] Univ Alberta, Dept Med, Div Cardiol, Mazanlowski Alberta Heart Inst, Edmonton, AB, Canada; [John, Rohan] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto	John, R (corresponding author), Univ Hlth Network, Dept Pathol, Toronto, ON, Canada.	rohan.john@uhn.on.ca	Konvalinka, Ana/ABE-9480-2020; Konvalinka, Ana/AAH-9581-2020; Williams, Vanessa/J-8090-2019	Konvalinka, Ana/0000-0001-6672-355X; Williams, Vanessa/0000-0003-4626-8320; John, Rohan/0000-0001-7946-3013	Canadian Institutes for Health Research (CIHR) [43971]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (CIHR), grant number 43971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF636, DOI 10.1152/ajprenal.2000.279.4.F636; Batlle D, 2008, CURR OPIN NEPHROL HY, V17, P250, DOI 10.1097/MNH.0b013e3282f945c2; Batlle D, 2012, KIDNEY INT, V81, P520, DOI 10.1038/ki.2011.381; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Chawla LS, 2012, KIDNEY INT; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; de Zeeuw D, 2006, LANCET, V367, P899, DOI 10.1016/S0140-6736(06)68374-8; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Doi K, 2004, KIDNEY INT, V65, P1714, DOI 10.1111/j.1523-1755.2004.00567.x; Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Farrar CA, 2004, AM J PATHOL, V164, P133, DOI 10.1016/S0002-9440(10)63104-5; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P128, DOI 10.1097/01.ASN.0000040596.23073.01; Kontogiannis J, 1998, AM J PHYSIOL-RENAL, V274, pF79, DOI 10.1152/ajprenal.1998.274.1.F79; Lai CF, 2012, CRIT CARE, V16, DOI 10.1186/cc11419; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liu GC, 2012, AM J PHYSIOL-RENAL, V302, pF784, DOI 10.1152/ajprenal.00455.2011; Liu Z, 2012, LAB INVEST, V92, P650, DOI 10.1038/labinvest.2012.2; LONG GW, 1993, J SURG RES, V54, P254, DOI 10.1006/jsre.1993.1040; Magnusson M O, 1983, Kidney Int Suppl, V16, pS324; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Peeters Patrick, 2004, Curr Opin Crit Care, V10, P489, DOI 10.1097/01.ccx.0000146119.46547.05; Quadri SM, 2005, AM J TRANSPLANT, V5, P292, DOI 10.1111/j.1600-6143.2004.00701.x; Rey-Parra GJ, 2012, J MOL MED, V90, P637, DOI 10.1007/s00109-012-0859-2; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Singbartl K, 2004, J MOL MED, V82, P91, DOI 10.1007/s00109-003-0498-8; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Sutton TA, 2003, AM J PHYSIOL-RENAL, V285, pF191, DOI 10.1152/ajprenal.00042.2003; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; Tilney NL, 1997, TRANSPLANTATION, V64, P945, DOI 10.1097/00007890-199710150-00001; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zimmerman D, 2012, CLIN SCI, V123, P333, DOI 10.1042/CS20120111	54	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71433	10.1371/journal.pone.0071433	http://dx.doi.org/10.1371/journal.pone.0071433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951161	Green Published, Green Submitted, gold			2022-12-27	WOS:000326473200047
J	Erdsack, N; Dehnhardt, G; Hanke, W				Erdsack, Nicola; Dehnhardt, Guido; Hanke, Wolf			Coping with Heat: Function of The Natal Coat of Cape Fur Seal (Arctocephalus Pusillus Pusillus) Pups in Maintaining Core Body Temperature	PLOS ONE			English	Article							CALLORHINUS-URSINUS; THERMAL-PROPERTIES; INSULATION; GALAPAGOENSIS; SURVIVAL; ONTOGENY; WINDOWS; CLIMATE; ISLAND; WATER	Cape fur seal (Arctocephalus pusillus) pups spend the first weeks of life exclusively or mainly ashore. They are exposed to intense solar radiation and high temperatures for long time periods, which results in temperatures up to at least 80 degrees C on their black natal coat. To test the hypothesis that the natal coat has a crucial function in coping with these extreme conditions, we investigated the insulating properties of the natal coat in six captive newborn Cape fur seals during the first 50 days after birth. The natal fur differs from the adult fur not only in colour, but also in density, structure, and water repellence. We measured temperature on the fur surface and within the fur, as well as skin and rectal temperature under varying environmental conditions, comparable to the species' habitat. Experiments were designed to not influence the spontaneous behaviour of the pups. Rectal temperature was constant as long as the pups stayed dry, even during long-lasting intense solar radiation for up to 3 h. Skin temperature remained close to rectal temperature as long as the fur was dry, while with wet fur, skin temperature was significantly reduced as well. Our results show that the natal coat provides an effective insulation against overheating. The severely reduced insulation of wet natal fur against cold supports the assumption that the natal fur is an adaptation to the pups' terrestrial phase of life.	[Erdsack, Nicola; Dehnhardt, Guido; Hanke, Wolf] Univ Rostock, Inst Biosci Sensory & Cognit Ecol, D-18055 Rostock, Germany	University of Rostock	Hanke, W (corresponding author), Univ Rostock, Inst Biosci Sensory & Cognit Ecol, D-18055 Rostock, Germany.	wolf.hanke@uni-rostock.de	Erdsack, Nicola/R-4064-2019	Erdsack, Nicola/0000-0002-8590-3609	VolkswagenStiftung; Landesgraduiertenforderung Mecklenburg-Vorpommern	VolkswagenStiftung(Volkswagen); Landesgraduiertenforderung Mecklenburg-Vorpommern	This study was funded by a grant from the VolkswagenStiftung to GD and the Landesgraduiertenforderung Mecklenburg-Vorpommern to NE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschoff J., 1982, COMPANION ANIMAL PHY, P173; Baker JD, 2000, CAN J ZOOL, V78, P100, DOI 10.1139/cjz-78-1-100; BARTHOLOMEW G. A., 1956, JOUR MAMMAL, V37, P327, DOI 10.2307/1376731; BARTHOLOMEW GA, 1954, J MAMMAL, V35, P211, DOI 10.2307/1376035; BLIX AS, 1979, AM J PHYSIOL, V236, pR322, DOI 10.1152/ajpregu.1979.236.5.R322; BONNER W, 2004, SEALS SEA LIONS WORL; Cuyler Christine, 2004, Rangifer, V24, P7; David J.H.M., 1986, P126; DEVILLIERS DJ, 1992, S AFR J MARINE SCI, V12, P881; Donohue MJ, 2000, J EXP BIOL, V203, P1003; Erdsack N, 2012, J THERM BIOL, V37, P537, DOI 10.1016/j.jtherbio.2012.06.002; FRISCH J, 1974, COMP BIOCHEM PHYSIOL, V47, P403, DOI 10.1016/0300-9629(74)90002-4; FRISCH J, 1968, ACTA PHYSIOL SCAND, V74, P637, DOI 10.1111/j.1748-1716.1968.tb04274.x; GRAV HJ, 1976, CAN J PHYSIOL PHARM, V54, P409, DOI 10.1139/y76-057; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; IRVING L., 1962, PHYSIOL ZOOL, V35, P275; IRVING L, 1954, J APPL PHYSIOL, V6, P667, DOI 10.1152/jappl.1954.6.11.667; Irving L, 1973, SPECIAL ASPECTS THER, P47; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; King JE., 1983, SEALS WORLD BRIT MUS; Kvadsheim PH, 2002, MAR MAMMAL SCI, V18, P952, DOI 10.1111/j.1748-7692.2002.tb01084.x; LIMBERGER D, 1986, OECOLOGIA, V69, P53, DOI 10.1007/BF00399037; LITTLE GJ, 1995, MAR MAMMAL SCI, V11, P480, DOI 10.1111/j.1748-7692.1995.tb00671.x; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; Mauck B, 2003, J EXP BIOL, V206, P1727, DOI 10.1242/jeb.00348; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Rand RW, 1967, CAPE FUR SEAL ARCTOC, P1; Rotherham LS, 2005, AUST J ZOOL, V53, P295, DOI 10.1071/ZO04075; SCHEFFER VB, 1964, J MORPHOL, V115, P291, DOI 10.1002/jmor.1051150211; SCHEFFER VB, 1953, GROWTH, V17, P129; Scheffer VB, 1962, PELAGE SURFACE TOPOG, P206; Schmidt-Nielsen K., 1997, Animal physiology: adaptation and environment.; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; SOKOLOV W., 1960, JOUR MORPHOL, V107, P285, DOI 10.1002/jmor.1051070304; SOKOLOV W, 1962, NATURE, V195, P464, DOI 10.1038/195464a0; Stewardson CL, 2012, S AFR GEOGR J, V94, P22, DOI 10.1080/03736245.2012.667626; TARASOFF FJ, 1970, CAN J ZOOLOG, V48, P821, DOI 10.1139/z70-144; TRITES AW, 1990, FUNCT ECOL, V4, P753, DOI 10.2307/2389442; WEBB DR, 1984, J THERM BIOL, V9, P189, DOI 10.1016/0306-4565(84)90020-2; WHITTOW GC, 1972, PHYSIOL ZOOL, V45, P68, DOI 10.1086/physzool.45.1.30155928	40	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72081	10.1371/journal.pone.0072081	http://dx.doi.org/10.1371/journal.pone.0072081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951287	Green Published, gold, Green Submitted			2022-12-27	WOS:000323124000078
J	Gafner, L; Dalessi, S; Escher, E; Pyrowolakis, G; Bergmann, S; Basler, K				Gafner, Lucia; Dalessi, Sascha; Escher, Eliane; Pyrowolakis, George; Bergmann, Sven; Basler, Konrad			Manipulating the Sensitivity of Signal-Induced Repression: Quantification and Consequences of Altered Brinker Gradients	PLOS ONE			English	Article							DPP MORPHOGEN GRADIENT; DROSOPHILA; TRANSCRIPTION; TARGET; CONVERSION; MECHANISM; COMPLEX; GENES; MAD	Traditionally, the analysis of gene regulatory regions suffered from the caveat that it was restricted to artificial contexts (e. g. reporter constructs of limited size). With the advent of the BAC recombineering technique, genomic constructs can now be generated to test regulatory elements in their endogenous environment. The expression of the transcriptional repressor brinker (brk) is negatively regulated by Dpp signaling. Repression is mediated by small sequence motifs, the silencer elements (SEs), that are present in multiple copies in the regulatory region of brk. In this work, we manipulated the SEs in the brk locus. We precisely quantified the effects of the individual SEs on the Brk gradient in the wing disc by employing a 1D data extraction method, followed by the quantification of the data with reference to an internal control. We found that mutating the SEs results in an expansion of the brk expression domain. However, even after mutating all predicted SEs, repression could still be observed in regions of maximal Dpp levels. Thus, our data point to the presence of additional, low affinity binding sites in the brk locus.	[Gafner, Lucia; Escher, Eliane; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dalessi, Sascha; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Dalessi, Sascha; Bergmann, Sven] SIB, Lausanne, Switzerland; [Pyrowolakis, George] Univ Freiburg, Dept Dev Biol, D-79106 Freiburg, Germany; [Pyrowolakis, George] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Zurich; University of Lausanne; Swiss Institute of Bioinformatics; University of Freiburg; University of Freiburg	Pyrowolakis, G (corresponding author), Univ Freiburg, Dept Dev Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	g.pyrowolakis@biologie.uni-freiburg.de; sven.bergmann@unil.ch; konrad.basler@imls.uzh.ch		Bergmann, Sven/0000-0002-6785-9034; Basler, Konrad/0000-0003-3534-1529	Swiss National Science Foundation; European Research Council; SystemsX.ch initiative; Excellence Initiative of the German Federal and State Governments [EXC 294]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); SystemsX.ch initiative; Excellence Initiative of the German Federal and State Governments	This work was supported by the Swiss National Science Foundation and the European Research Council, the SystemsX.ch initiative within the framework of the WingX Project and the Excellence Initiative of the German Federal and State Governments (EXC 294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEV CELL, V15, P11, DOI 10.1016/j.devcel.2008.06.006; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Rebeiz M, 2012, DEV BIOL, V362, P282, DOI 10.1016/j.ydbio.2011.12.011; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068; Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71224	10.1371/journal.pone.0071224	http://dx.doi.org/10.1371/journal.pone.0071224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23951114	Green Published, gold, Green Accepted			2022-12-27	WOS:000323124000043
J	Reddish, P; Fischer, R; Bulbulia, J				Reddish, Paul; Fischer, Ronald; Bulbulia, Joseph			Let's Dance Together: Synchrony, Shared Intentionality and Cooperation	PLOS ONE			English	Article							BEHAVIORAL SYNCHRONY; MOVEMENT SYNCHRONY; MUSIC; SELF; KINDNESS; RAPPORT	Previous research has shown that the matching of rhythmic behaviour between individuals (synchrony) increases cooperation. Such synchrony is most noticeable in music, dance and collective rituals. As well as the matching of behaviour, such collective performances typically involve shared intentionality: performers actively collaborate to produce joint actions. Over three experiments we examined the importance of shared intentionality in promoting cooperation from group synchrony. Experiment 1 compared a condition in which group synchrony was produced through shared intentionality to conditions in which synchrony or asynchrony were created as a by-product of hearing the same or different rhythmic beats. We found that synchrony combined with shared intentionality produced the greatest level of cooperation. To examinef the importance of synchrony when shared intentionality is present, Experiment 2 compared a condition in which participants deliberately worked together to produce synchrony with a condition in which participants deliberately worked together to produce asynchrony. We found that synchrony combined with shared intentionality produced the greatest level of cooperation. Experiment 3 manipulated both the presence of synchrony and shared intentionality and found significantly greater cooperation with synchrony and shared intentionality combined. Path analysis supported a reinforcement of cooperation model according to which perceiving synchrony when there is a shared goal to produce synchrony provides immediate feedback for successful cooperation so reinforcing the group's cooperative tendencies. The reinforcement of cooperation model helps to explain the evolutionary conservation of traditional music and dance performances, and furthermore suggests that the collectivist values of such cultures may be an essential part of the mechanisms by which synchrony galvanises cooperative behaviours.	[Reddish, Paul; Fischer, Ronald] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Reddish, Paul; Bulbulia, Joseph] Masaryk Univ, Lab Expt Res Relig, Brno, Czech Republic; [Bulbulia, Joseph] Victoria Univ Wellington, Sch Art Hist Class & Religious Studies, Wellington, New Zealand	Victoria University Wellington; Masaryk University Brno; Victoria University Wellington	Reddish, P (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	paulreddishnz@gmail.com	Fischer, Ronald/G-6447-2017	Fischer, Ronald/0000-0002-3055-3955; Bulbulia, Joseph/0000-0002-5861-2056	Victoria University URF Grant [8-3046-108855]; European Social Fund [CZ.1.07/2.3.00/20.048]; state budget of the Czech Republic	Victoria University URF Grant; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This research was supported by Victoria University URF Grant (#8-3046-108855). The Laboratory for Experimental Research of Religion at Masaryk University (LEVYNA, CZ.1.07/2.3.00/20.048, co-financed by the European Social Fund and the state budget of the Czech Republic) supported Paul Reddish. The Interacting Minds Project and Religion Cognition and Culture Unit at Aarhus University supported Joseph Bulbulia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DS, 2009, NATURE, V460, P695, DOI 10.1038/460695a; ANDREONI J, 1995, AM ECON REV, V85, P891; ANSHEL A, 1988, J MUSIC THER, V25, P145, DOI 10.1093/jmt/25.3.145; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Benzon W, 2001, BEETHOVENS ANVIL MUS; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Binmore K., 1998, GAME THEORY SOCIAL C; Bispham J, 2010, MUSIC SCI, P29; Blacking John, 1973, MUSICAL IS MAN; Boer D, 2012, PSYCHOL MUSIC, V40, P179, DOI 10.1177/0305735610381885; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Brown D. E., 1991, HUMAN UNIVERSALS; Brown S, 2000, PERSP ETHOL, V13, P231; Bulbulia J, 2012, BIOL PHILOS, V27, P1, DOI 10.1007/s10539-011-9295-x; Calcott B, 2008, BIOL PHILOS, V23, P179, DOI 10.1007/s10539-007-9095-5; CAMPBELL DT, 1958, BEHAV SCI, V3, P14, DOI 10.1002/bs.3830030103; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; CLAYTON M., 2004, EUROPEAN STUDIES ETH, V1, P1; Cohen E, 2014, RELIG BRAIN BEHAV, V4, P20, DOI 10.1080/2153599X.2012.741075; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; CONDON WS, 1967, J PSYCHIAT RES, V5, P221, DOI 10.1016/0022-3956(67)90004-0; Cross I, 2001, ANN NY ACAD SCI, V930, P28, DOI 10.1111/j.1749-6632.2001.tb05723.x; Cross I., 2009, OXFORD HDB MUSIC PSY, P3; Cross I., 1999, MUSIC MIND SCI PP, P10; DITTMANN AT, 1969, J PERS SOC PSYCHOL, V11, P98, DOI 10.1037/h0027035; Durkheim E., 1965, ELEMENTARY FORCES RE; Ehrenreich B., 2007, DANCING STREETS HIST; Ellis H., 1923, DANCE LIFE; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Freeman W, 2000, ORIGINS OF MUSIC, P411; Friedman S., 1994, EXPT METHODS PRIMER, DOI 10.1017/cbo9781139174176; Giles H, 2009, GROUP PROCESS INTERG, V12, P291, DOI 10.1177/1368430209102840; Gorer G, 1972, FUNCTION DANCE HUMAN, P21; Grosse Ernst, 1894, BEGINNINGS ART; HADAR U, 1985, J NONVERBAL BEHAV, V9, P214, DOI 10.1007/BF00986881; Hagen EH, 2003, HUM NATURE-INT BIOS, V14, P21, DOI 10.1007/s12110-003-1015-z; Haidt J, 2008, J LEGAL STUD, V37, pS133, DOI 10.1086/529447; HANNA JL, 1979, CURR ANTHROPOL, V20, P313, DOI 10.1086/202269; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Houser D, 2002, AM ECON REV, V92, P1062, DOI 10.1257/00028280260344605; Hove MJ, 2008, BEHAV BRAIN SCI, V31, P29, DOI 10.1017/S0140525X07003202; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kenny D. A., 2006, DYADIC DATA ANAL; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kokal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027272; Kuper H., 1947, AFRICAN ARISTOCRACY; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Lange Roderyk, 1975, NATURE DANCE ANTHR P; Levitin D. J., 2008, WORLD 6 SONGS MUSICA; Lomax A., 1968, FOLK SONG STYLE CULT; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; McNeill W. H., 1995, KEEPING TOGETHER TIM; Miles LK, 2010, J EXP SOC PSYCHOL, V46, P457, DOI 10.1016/j.jesp.2009.12.006; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Mithen S., 2005, SINGING NEANDERTHALS; Mitkidis P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064776, DOI 10.1371/J0URNAL.P0NE.0064776]; Muthen B.O., 2004, MPLUS TECHNICAL APPE; Muthen L. K., 2010, MPLUS USERS GUIDE VE; Naruse K, 2000, PERCEPT MOTOR SKILL, V91, P729, DOI 10.2466/PMS.91.7.729-740; Newell BR, 2013, BEHAV BRAIN IN PRESS; Radcliffe -Brown A.R., 1948, ANDAMAN ISLANDERS; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; ROEDERER JG, 1984, MUSIC PERCEPT, V1, P350; RUTTER DR, 1977, EUR J SOC PSYCHOL, V7, P29, DOI 10.1002/ejsp.2420070104; Schachner A., 2010, P POST PRES INT C MU; Schelling T.C., 1960, STRATEGY CONFLICT; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Semin GR, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P1; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Spencer Paul, 1985, SOC DANCE SOCIAL ANT, P1; Swann WB, 2009, J PERS SOC PSYCHOL, V96, P995, DOI 10.1037/a0013668; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2007, DEVELOPMENTAL SCI, V10, P121, DOI 10.1111/j.1467-7687.2007.00573.x; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; WARNER RM, 1987, J NONVERBAL BEHAV, V11, P57, DOI 10.1007/BF00990958; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28	87	225	227	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e71182	10.1371/journal.pone.0071182	http://dx.doi.org/10.1371/journal.pone.0071182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	200ZE	23951106	Green Submitted, gold, Green Published			2022-12-27	WOS:000323109700085
J	White, MJV; Glenn, M; Gomer, RH				White, Michael J. V.; Glenn, Melissa; Gomer, Richard H.			Trypsin Potentiates Human Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM-AMYLOID-P; PROTEINASE-ACTIVATED RECEPTORS; COLORECTAL-CANCER; CIRCULATING FIBROCYTES; PULMONARY-FIBROSIS; HUMAN COLON; CELL LINES; EXPRESSION; INFLAMMATION; WOUNDS	Trypsin-containing topical treatments can be used to speed wound healing, although the mechanism of action is unknown. To help form granulation tissue and heal wounds, monocytes leave the circulation, enter the wound tissue, and differentiate into fibroblast-like cells called fibrocytes. We find that 20 to 200 ng/ml trypsin (concentrations similar to those used in wound dressings) potentiates the differentiation of human monocytes to fibrocytes in cell culture. Adding trypsin inhibitors increases the amount of trypsin needed to potentiate fibrocyte differentiation, suggesting that the potentiating effect is dependent on trypsin proteolytic activity. Proteases with other site specificities such as pepsin, endoprotease GluC, and chymotrypsin do not potentiate fibrocyte differentiation. This potentiation requires the presence of albumin in the culture medium, and tryptic fragments of human or bovine albumin also potentiate fibrocyte differentiation. These results suggest that topical trypsin speeds wound healing by generating tryptic fragments of albumin, which in turn potentiate fibrocyte differentiation.	[White, Michael J. V.; Glenn, Melissa; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; White, Michael/0000-0002-9615-2249	National Institutes of Health (NIH) [R01HL083029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01HL083029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Anigstein L, 1959, WOUND HEALING AGENT; Anthony D, 2011, J TISSUE VIABILITY, V20, P89, DOI 10.1016/j.jtv.2011.04.001; APPEL W, 1986, CLIN BIOCHEM, V19, P317, DOI 10.1016/S0009-9120(86)80002-9; Beitz JM, 2005, OSTOMY WOUND MANAG, V51, P52; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Borgono CA, 2004, MOL CANCER RES, V2, P257; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; BUNDY HF, 1959, J BIOL CHEM, V234, P1124; BUNDY HF, 1958, J CLIN INVEST, V37, P947, DOI 10.1172/JCI103689; Carson Stanley N, 2003, Ostomy Wound Manage, V49, P60; CETRULO GI, 1953, JAMA-J AM MED ASSOC, V152, P605, DOI 10.1001/jama.1953.63690070001010; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Collins N, 2001, Adv Skin Wound Care, V14, P235, DOI 10.1097/00129334-200109000-00009; Coulson-Thomas VJ, 2011, CELL TISSUE RES, V346, P223, DOI 10.1007/s00441-011-1254-y; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Drapeau G R, 1977, Methods Enzymol, V47, P189; Drapeau G R, 1976, Methods Enzymol, V45, P469; Drew Philip, 2007, Int Wound J, V4, P149, DOI 10.1111/j.1742-481X.2007.00337.x; Dunn B M, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2103s25; Elzer KL, 2008, INTEGR CANCER THER, V7, P282, DOI 10.1177/1534735408327250; Fields RC, 2003, AM J PATHOL, V162, P1817, DOI 10.1016/S0002-9440(10)64316-7; Fortney DZ, 1996, COMPOSITIONS CONTAIN; Fujimoto D, 2006, J SURG ONCOL, V93, P139, DOI 10.1002/jso.20420; GREEN NM, 1953, J BIOL CHEM, V205, P535; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; HIRAHARA F, 1995, INT J CANCER, V63, P176, DOI 10.1002/ijc.2910630205; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Hurd T, 2009, INT WOUND J, V6, P287, DOI 10.1111/j.1742-481X.2009.00615.x; Iizaka S, 2011, CLIN NUTR, V30, P738, DOI 10.1016/j.clnu.2011.07.003; James TJ, 2000, WOUND REPAIR REGEN, V8, P264, DOI 10.1046/j.1524-475x.2000.00264.x; KOIVUNEN E, 1991, INT J CANCER, V47, P592, DOI 10.1002/ijc.2910470419; Li W, 2009, J BIOL CHEM, V284, P218, DOI 10.1074/jbc.M806267200; MacNaughton WK, 2005, MEM I OSWALDO CRUZ, V100, P211, DOI 10.1590/S0074-02762005000900036; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; Mall M, 2002, AM J PHYSIOL-GASTR L, V282, pG200, DOI 10.1152/ajpgi.00137.2001; Martin GJ, 1961, WOUND HEALING COMPOS; Miyata S, 1999, J BIOCHEM, V125, P1067, DOI 10.1093/oxfordjournals.jbchem.a022388; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Nakamura K, 2009, ANTICANCER RES, V29, P1685; OHTA T, 1994, BRIT J CANCER, V69, P152, DOI 10.1038/bjc.1994.25; Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Pritchard DI, 2011, TREATMENT WOUNDS; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Russell Thomas M, 2012, Methods Mol Biol, V900, P327, DOI 10.1007/978-1-60761-720-4_16; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Shao ZM, 2000, ONCOGENE, V19, P4337, DOI 10.1038/sj.onc.1203785; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Srinivasaiah N, 2007, J Wound Care, V16, P413; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Vergnolle N, 2004, BRIT J PHARMACOL, V141, P1264, DOI 10.1038/sj.bjp.0705750; Vowden Kathryn R, 2009, J Tissue Viability, V18, P7, DOI 10.1016/j.jtv.2008.11.004; Vowden Kathryn R, 2009, J Tissue Viability, V18, P2, DOI 10.1016/j.jtv.2008.11.003; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Williams D F, 2000, J Wound Ostomy Continence Nurs, V27, P216, DOI 10.1067/mjw.2000.107875; Yamamoto H, 2003, J PATHOL, V199, P176, DOI 10.1002/path.1277	73	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e70795	10.1371/journal.pone.0070795	http://dx.doi.org/10.1371/journal.pone.0070795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951012	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700055
J	Carson, V; Ridgers, ND; Howard, BJ; Winkler, EAH; Healy, GN; Owen, N; Dunstan, DW; Salmon, J				Carson, Valerie; Ridgers, Nicola D.; Howard, Bethany J.; Winkler, Elisabeth A. H.; Healy, Genevieve N.; Owen, Neville; Dunstan, David W.; Salmon, Jo			Light-Intensity Physical Activity and Cardiometabolic Biomarkers in US Adolescents	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; ACCELEROMETER OUTPUT; SPANISH ADOLESCENTS; SEDENTARY TIME; RISK-FACTORS; CHILDREN; YOUTH; MODERATE; CALIBRATION; FATNESS	Background: The minimal physical activity intensity that would confer health benefits among adolescents is unknown. The purpose of this study was to examine the associations of accelerometer-derived light-intensity (split into low and high) physical activity, and moderate-to vigorous-intensity physical activity with cardiometabolic biomarkers in a large population-based sample. Methods: The study is based on 1,731 adolescents, aged 12-19 years from the 2003/04 and 2005/06 National Health and Nutrition Examination Survey. Low light-intensity activity (100-799 counts/min), high light-intensity activity (800 counts/min to,4 METs) and moderate-to vigorous-intensity activity (>= 4 METs, Freedson age-specific equation) were accelerometer-derived. Cardiometabolic biomarkers, including waist circumference, systolic blood pressure, diastolic blood pressure, HDL-cholesterol, and C-reactive protein were measured. Triglycerides, LDL-cholesterol, insulin, glucose, and homeostatic model assessments of beta-cell function (HOMA-%B) and insulin sensitivity (HOMA-%S) were also measured in a fasting sub-sample (n = 807). Results: Adjusted for confounders, each additional hour/day of low light-intensity activity was associated with 0.59 (95% CI: 1.18-0.01) mmHG lower diastolic blood pressure. Each additional hour/day of high light-intensity activity was associated with 1.67 (2.94-0.39) mmHG lower diastolic blood pressure and 0.04 (0.001-0.07) mmol/L higher HDL-cholesterol. Each additional hour/day of moderate-to vigorous-intensity activity was associated with 3.54 (5.73-1.35) mmHG lower systolic blood pressure, 5.49 (1.11-9.77)% lower waist circumference, 25.87 (6.08-49.34)% lower insulin, and 16.18 (4.92-28.53)% higher HOMA-%S. Conclusions: Time spent in low light-intensity physical activity and high light-intensity physical activity had some favorable associations with biomarkers. Consistent with current physical activity recommendations for adolescents, moderate-to vigorous-intensity activity had favorable associations with many cardiometabolic biomarkers. While increasing MVPA should still be a public health priority, further studies are needed to identify dose-response relationships for light-intensity activity thresholds to inform future recommendations and interventions for adolescents.	[Carson, Valerie] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Ridgers, Nicola D.; Dunstan, David W.; Salmon, Jo] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Activ & Nutr Res, Melbourne, Vic, Australia; [Howard, Bethany J.; Owen, Neville; Dunstan, David W.] Deakin Univ, Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Winkler, Elisabeth A. H.; Healy, Genevieve N.; Owen, Neville; Dunstan, David W.] Univ Queensland, Sch Populat Hlth, Canc Prevent Res Ctr, Brisbane, Qld, Australia; [Owen, Neville] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Owen, Neville] Univ Melbourne, Alfred Hosp, Dept Med, Melbourne, Vic, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Dunstan, David W.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	University of Alberta; Deakin University; Baker Heart and Diabetes Institute; Deakin University; University of Queensland; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Western Australia; Monash University	Carson, V (corresponding author), Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada.	vlcarson@ualberta.ca	Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Owen, Neville/K-5986-2012; Healy, Genevieve/A-7408-2008; Salmon, Jo/C-1226-2009; Bisgaard, Hans/N-4761-2016; Ridgers, Nicola/B-2092-2013; Ridgers, Nicola/AGN-1339-2022; Carson, Valerie/ABG-2853-2021; Salmon, Jo/X-2630-2019	Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820; Healy, Genevieve/0000-0001-7093-7892; Salmon, Jo/0000-0002-4734-6354; Bisgaard, Hans/0000-0003-4131-7592; Ridgers, Nicola/0000-0001-5713-3515; Carson, Valerie/0000-0002-3009-3282; Salmon, Jo/0000-0002-4734-6354; Stokholm, Jakob/0000-0003-4989-9769	Endeavour Research Fellowship; Australian Research Council (ARC) Discovery Early Career Researcher Award; National Health and Medical Research Council (NHMRC) Training Fellowship [569861]; NHMRC [569940, 1003960]; Victorian Government's Operational Infrastructure Support Program; ARC Future Fellowship; NHMRC Principal Research Fellowship [1026216]	Endeavour Research Fellowship; Australian Research Council (ARC) Discovery Early Career Researcher Award(Australian Research Council); National Health and Medical Research Council (NHMRC) Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; ARC Future Fellowship(Australian Research Council); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	VC was supported by Endeavour Research Fellowship; NDR is supported by an Australian Research Council (ARC) Discovery Early Career Researcher Award; GNH is supported by a National Health and Medical Research Council (NHMRC) [number 569861] Training Fellowship; NO is supported by a NHMRC Program Grant [number 569940], a Senior Principal Research Fellowship [number 1003960], and the Victorian Government's Operational Infrastructure Support Program; DD is supported by an ARC Future Fellowship; and JS is supported by a NHMRC Principal Research Fellowship [number 1026216]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires L, 2010, J PHYS ACT HEALTH, V7, P54, DOI 10.1123/jpah.7.1.54; Australian Government Department of Health and Aging, PHYS ACT GUIDL; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Colley Rachel C, 2011, Health Rep, V22, P15; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Evenson KR, 2008, J PHYS ACT HEALTH, V5, pS1, DOI 10.1123/jpah.5.s1.s1; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Martinez-Gomez D, 2009, NUTR HOSP, V24, P226; Martinez-Gomez D, 2010, AM J HUM BIOL, V22, P750, DOI 10.1002/ajhb.21076; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Moliner-Urdiales D, 2009, INT J OBESITY, V33, P1126, DOI 10.1038/ijo.2009.139; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2012, MED SCI SPORT EXER, V44, P1801, DOI 10.1249/MSS.0b013e318258ac11; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; *US DEP HHS, DIET GUID AM; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	33	175	178	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71417	10.1371/journal.pone.0071417	http://dx.doi.org/10.1371/journal.pone.0071417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23951157	gold, Green Published			2022-12-27	WOS:000326473200045
J	Xiao, Y; Xia, W; Yang, YD; Mason, AS; Lei, XT; Ma, ZL				Xiao, Yong; Xia, Wei; Yang, Yaodong; Mason, Annaliese S.; Lei, Xintao; Ma, Zilong			Characterization and Evolution of Conserved MicroRNA through Duplication Events in Date Palm (Phoenix dactylifera)	PLOS ONE			English	Article							GENOME SEQUENCE; BLACK COTTONWOOD; PLANT MICRORNAS; ORIGINS; BIOGENESIS; DIVERGENCE; BIRTH	MicroRNAs (miRNAs) are important regulators of gene expression at the post-transcriptional level in a wide range of species. Highly conserved miRNAs regulate ancestral transcription factors common to all plants, and control important basic processes such as cell division and meristem function. We selected 21 conserved miRNA families to analyze the distribution and maintenance of miRNAs. Recently, the first genome sequence in Palmaceae was released: date palm (Phoenix dactylifera). We conducted a systematic miRNA analysis in date palm, computationally identifying and characterizing the distribution and duplication of conserved miRNAs in this species compared to other published plant genomes. A total of 81 miRNAs belonging to 18 miRNA families were identified in date palm. The majority of miRNAs in date palm and seven other well-studied plant species were located in intergenic regions and located 4 to 5 kb away from the nearest protein-coding genes. Sequence comparison showed that 67% of date palm miRNA members were present in duplicated segments, and that 135 pairs of miRNA-containing segments were duplicated in Arabidopsis, tomato, orange, rice, apple, poplar and soybean with a high similarity of non coding sequences between duplicated segments, indicating genomic duplication was a major force for expansion of conserved miRNAs. Duplicated miRNA pairs in date palm showed divergence in pre-miRNA sequence and in number of promoters, implying that these duplicated pairs may have undergone divergent evolution. Comparisons between date palm and the seven other plant species for the gain/loss of miR167 loci in an ancient segment shared between monocots and dicots suggested that these conserved miRNAs were highly influenced by and diverged as a result of genomic duplication events.	[Xiao, Yong; Xia, Wei; Yang, Yaodong; Lei, Xintao] Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China; [Mason, Annaliese S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Mason, Annaliese S.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia; [Ma, Zilong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; University of Queensland; University of Queensland; Chinese Academy of Tropical Agricultural Sciences	Yang, YD (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China.	ydyang@tocri.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [31101179]; Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute [CATAS- ITBB120506]; Australian Research Council Early Career Researcher Award [DE120100668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute; Australian Research Council Early Career Researcher Award(Australian Research Council)	This work was supported by grants from the National Natural Science Foundation of China (No. 31101179), the Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China (2011), the National Nonprofit Institute Research Grant of CATAS- ITBB120506, and Australian Research Council Early Career Researcher Award (DE120100668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Djerbi S, 2005, PLANTA, V221, P739, DOI 10.1007/s00425-005-1498-4; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034092; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028073	40	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71435	10.1371/journal.pone.0071435	http://dx.doi.org/10.1371/journal.pone.0071435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23799122	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000057
J	Xiao, Y; Xu, AM; Hui, XY; Zhou, PC; Li, X; Zhong, H; Tang, WL; Huang, G; Zhou, ZG				Xiao, Yang; Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang			Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; INSULIN-RESISTANCE; RETINOL-BINDING-PROTEIN-4; INFLAMMATION; OBESITY; EXPRESSION; FAMILY	Background: The lipocalin family proteins, including lipocalin-2 and retinol-binding protein 4 (RBP4), are adipokines closely associated with obesity-related metabolic disorders. In this study, we evaluated the association of serum lipocalin-2 and RBP4 with intima-media thickness (IMT) and subclinical atherosclerosis in type 2 diabetic patients. Methods and Results: Serum levels of lipocalin-2 and RBP4 were measured in 284 type 2 diabetic patients. Subclinical atherosclerosis was assessed by IMT at carotid, femoral and iliac arteries with ultrasound. Patients with subclinical atherosclerosis showed significantly higher circulating concentrations of lipocalin-2 and RBP4 when compared to those without [112.9 (86.4 to 202.1) mu g/L versus 77.2(55.0-150.4) mu g/L, 37.1(32.3-40.8) mg/L versus 23.2(20.1-29.2) mg/L, respectively; P = 0.002, P<0.001, respectively]. Moreover, positive correlations were observed between carotid IMT and lipocalin-2 (r = 0.170, P = 0.018) or RBP4 (r = 0.132, P = 0.040), femoral IMT and lipocalin-2 (r = 0.160, P = 0.027), as well as between iliac IMT and RBP4 (r = 0.241, P<0.001). Multiple logistic regression analysis further demonstrated that these two adipokines were independent risk factors for subclinical atherosclerosis in type 2 diabetes. Conclusion: Circulating levels of lipocalin-2 and RBP4 are positively correlated with carotid IMT and subclinical atherosclerosis in type 2 diabetes, which suggests a potential role of these two lipid-binding chaperones in the pathogenesis of vascular complications of diabetes.	[Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China; [Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Hunan Key Lab Med Epigen,Minist Educ, Changsha, Hunan, Peoples R China; [Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xiao, Yang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Central South University; Central South University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Zhou, ZG (corresponding author), Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National key technology RD program [2012BAI02B04]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1195]; Hunan Provincial Natural Science Foundation of China [11JJ7005]; National Natural Science Foundation of China [81170725, 81200600]; Hong Kong Collaborative Research Fund [HKU/CRF/10]; Research Fund for the Doctoral Program of Higher Education of China [20110162120014]; Fundamental Research Funds for the Central University [2011QNZT176]	National key technology RD program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Collaborative Research Fund; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central University	This work is supported by the National key technology R&D program (2012BAI02B04), Program for Changjiang Scholars and Innovative Research Team in University (IRT1195), Hunan Provincial Natural Science Foundation of China (11JJ7005), the National Natural Science Foundation of China (Grant No. 81170725, to Z.Z.), Hong Kong Collaborative Research Fund (HKU/CRF/10, to A.X.), the National Natural Science Foundation of China (Grant No. 81200600), the Research Fund for the Doctoral Program of Higher Education of China (20110162120014), and the Fundamental Research Funds for the Central University (2011QNZT176, to Y.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Balbarini A, 2000, ANGIOLOGY, V51, P269; Barazzoni R, 2011, CLIN ENDOCRINOL OXF; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Bratt T, 1999, BBA-GEN SUBJECTS, V1472, P262, DOI 10.1016/S0304-4165(99)00131-2; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kotliar Carol, 2008, J Cardiometab Syndr, V3, P60, DOI 10.1111/j.1559-4572.2008.07957.x; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu JT, 2011, BR J PHARM; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Park SE, 2009, ATHEROSCLEROSIS, V204, P23, DOI 10.1016/j.atherosclerosis.2008.08.012; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solini A, 2009, AM J HYPERTENS, V22, P1001, DOI 10.1038/ajh.2009.116; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816	36	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66607	10.1371/journal.pone.0066607	http://dx.doi.org/10.1371/journal.pone.0066607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799122	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800042
J	Chen, X; Zhang, Z; Visser, RGF; Broekgaarden, C; Vosman, B				Chen, Xi; Zhang, Zhao; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben			Overexpression of IRM1 Enhances Resistance to Aphids in Arabidopsis thaliana	PLOS ONE			English	Article							GREEN PEACH APHID; INSECT-RESISTANCE; DEFENSE RESPONSES; XYLEM INGESTION; MYZUS-PERSICAE; PLANT DEFENSE; ACTIVATION; PENETRATION; GENE; PATHOGEN	Aphids are insects that cause direct damage to crops by the removal of phloem sap, but more importantly they spread devastating viruses. Aphids use their sophisticated mouthpart (i.e. stylet) to feed from the phloem sieve elements of the host plant. To identify genes that affect host plant resistance to aphids, we previously screened an Arabidopsis thaliana activation tag mutant collection. In such mutants, tagged genes are overexpressed by a strong 35S enhancer adjacent to the natural promoter, resulting in a dominant gain-of-function phenotype. We previously identified several of these mutants on which the aphid Myzus persicae showed a reduced population development compared with wild type. In the present study we show that the gene responsible for the phenotype of one of the mutants is At5g65040 and named this gene Increased Resistance to Myzus persicae 1 (IRM1). Overexpression of the cloned IRM1 gene conferred a phenotype identical to that of the original mutant. Conversely, an IRM1 knockout mutant promoted aphid population development compared to the wild type. We performed Electrical Penetration Graph analysis to investigate how probing and feeding behaviour of aphids was affected on plants that either overexpressed IRM1 or contained a knockout mutation in this gene. The EPG results indicated that the aphids encounter resistance factors while reaching for the phloem on the overexpressing line. This resistance mechanism also affected other aphid species and is suggested to be of mechanical nature. Interestingly, genetic variation for IRM1 expression in response to aphid attack was observed. Upon aphid attack the expression of IRM1 was initially (after 6 hours) induced in ecotype Wassilewskija followed by suppression. In Columbia-0, IRM1 expression was already suppressed six hours after the start of the infestation. The resistance conferred by the overexpression of IRM1 in A. thaliana trades off with plant growth.	[Chen, Xi; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Zhang, Zhao] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Broekgaarden, C (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	colette.broekgaarden@wur.nl	Zhang, Zhao/J-1615-2019; Vosman, Ben/C-5494-2013; Visser, Richard GF/B-3423-2012; Wang, Cheng/O-7206-2016	Zhang, Zhao/0000-0002-7323-5500; Vosman, Ben/0000-0003-4942-8342; Visser, Richard GF/0000-0002-0213-4016; Zhang, Chunni/0000-0002-7329-7162; Wang, Cheng/0000-0002-1834-2119	Chinese scholarship council; Wageningen UR Plant Breeding	Chinese scholarship council(China Scholarship Council); Wageningen UR Plant Breeding	The work was financially supported by the Chinese scholarship council (http://en.csc.edu.cn/). The work was additionally funded by Wageningen UR Plant Breeding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, PLANT CELL ENVIRON, V34, P1191, DOI 10.1111/j.1365-3040.2011.02317.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Chen X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-33; Civolani S, 2010, B INSECTOL, V63, P265; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couldridge C, 2007, B ENTOMOL RES, V97, P523, DOI 10.1017/S0007485307005160; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Firdaus S, 2011, PLANT BREEDING, V130, P708, DOI 10.1111/j.1439-0523.2011.01894.x; Halarewicz A, 2012, B INSECTOL, V65, P77; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ichikawa T, 2003, PLANT J, V36, P421, DOI 10.1046/j.1365-313X.2003.01876.x; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Karam GN, 2005, ANN BOT-LONDON, V95, P1179, DOI 10.1093/aob/mci130; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Nalam VJ, 2012, PLANT CELL, V24, P1643, DOI 10.1105/tpc.111.094110; Pegadaraju V, 2007, PLANT J, V52, P332, DOI 10.1111/j.1365-313X.2007.03241.x; Powell G, 2002, ENTOMOL EXP APPL, V104, P103, DOI 10.1023/A:1021234412475; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Simmons AT, 2005, EUPHYTICA, V144, P313, DOI 10.1007/s10681-005-8002-x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Stafford Candice A., 2012, Communicative & Integrative Biology, V5, P43; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tjallingii W.F., 1990, P89; Tjallingii WF, 2010, ENTOMOL EXP APPL, V135, P193, DOI 10.1111/j.1570-7458.2010.00983.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhu LC, 2011, J ECON ENTOMOL, V104, P2068, DOI 10.1603/EC11203	47	43	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70914	10.1371/journal.pone.0070914	http://dx.doi.org/10.1371/journal.pone.0070914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951039	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300067
J	Bischoff, AL; Folsgaard, NV; Carson, CG; Stokholm, J; Pedersen, L; Holmberg, M; Bisgaard, A; Birch, S; Tsai, TF; Bisgaard, H				Bischoff, Anne Louise; Folsgaard, Nilofar Vahman; Carson, Charlotte Giwercman; Stokholm, Jakob; Pedersen, Louise; Holmberg, Maria; Bisgaard, Amalie; Birch, Sune; Tsai, Theodore F.; Bisgaard, Hans			Altered Response to A(H1N1)pnd09 Vaccination in Pregnant Women: A Single Blinded Randomized Controlled Trial	PLOS ONE			English	Article							INFLUENZA VACCINATION; ANTIBODY-RESPONSE; VIRUS; IMMUNOGENICITY; IMMUNIZATION; PROTECTION; INFECTION; OUTCOMES; MOTHERS; IMPACT	Background: Pregnant women were suspected to be at particular risk when H1N1pnd09 influenza became pandemic in 2009. Our primary objective was to compare the immune responses conferred by MF59 (R)-adjuvanted vaccine (Focetria (R)) in H1N1pnd09-naive pregnant and non-pregnant women. The secondary aims were to compare influences of dose and adjuvant on the immune response. Methods: The study was nested in the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC(2010)) pregnancy cohort in 2009-2010 and conducted as a single-blinded block-randomised [1: 1: 1] controlled clinical trial in pregnant women after gestational week 20: (1) 7.5 mu g H1N1pnd09 antigen with MF59-adjuvant (Pa7.5 mu g); (2) 3.75 mu g antigen half MF59-adjuvanted (Pa3.75 mu g); (3) 15 mu g antigen unadjuvanted (P15 mu g); and in non-pregnant women receiving (4) 7.5 mu g antigen full adjuvanted (NPa7.5 mu g). Blood samples were collected at baseline, 3 weeks, 3 and 10 months after vaccination, adverse events were recorded prospectively. Results: 58 pregnant women were allocated to Pa7.5 mu g and 149 non-pregnant women were recruited to NPa7.5 mu g. The sero-conversion rate was significantly increased in non-pregnant (NPa7.5 mu g) compared with pregnant (Pa7.5 mu g) women (OR = 2.48 [1.03-5.95], p = 0.04) and geometric mean titers trended towards being higher, but this difference was not statistically significant (ratio 1.27 [0.85-1.93], p = 0.23). The significant titer increase rate showed no difference between pregnant (Pa7.5 mu g) and non-pregnant (NPa7.5 mu g) groups (OR = 0.49 [0.13-1.85], p = 0.29). Conclusion: Our study suggests the immune response to the 7.5 mu g MF59-adjuvanted Focetria (R) H1N1pnd09 vaccine in pregnant women may be diminished compared with non-pregnant women.	[Bischoff, Anne Louise; Folsgaard, Nilofar Vahman; Carson, Charlotte Giwercman; Stokholm, Jakob; Pedersen, Louise; Holmberg, Maria; Bisgaard, Amalie; Birch, Sune; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Gentofte, Denmark; [Tsai, Theodore F.] Novartis Vaccines, Cambridge, MA USA	University of Copenhagen; Novartis	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Gentofte, Denmark.	bisgaard@copsac.com	Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Owen, Neville/K-5986-2012; Healy, Genevieve/A-7408-2008; Salmon, Jo/C-1226-2009; Bisgaard, Hans/N-4761-2016; Ridgers, Nicola/B-2092-2013; Ridgers, Nicola/AGN-1339-2022; Carson, Valerie/ABG-2853-2021; Salmon, Jo/X-2630-2019	Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820; Healy, Genevieve/0000-0001-7093-7892; Salmon, Jo/0000-0002-4734-6354; Bisgaard, Hans/0000-0003-4131-7592; Ridgers, Nicola/0000-0001-5713-3515; Carson, Valerie/0000-0002-3009-3282; Salmon, Jo/0000-0002-4734-6354; Stokholm, Jakob/0000-0003-4989-9769	Novartis Vaccines and Diagnostics GmbH, Marburg, Germany	Novartis Vaccines and Diagnostics GmbH, Marburg, Germany	The nested vaccine study is funded by Novartis Vaccines and Diagnostics GmbH, Marburg, Germany, who provided vaccines and funding as an unrestricted institutional grant. The Copenhagen Prospective Study on Asthma in Childhood is funded by private and public research funds (see www.copsac.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TFT is employed by Novartis Vaccines. The nested vaccine study is funded by Novartis Vaccines and Diagnostics GmbH, Marburg, Germany, who provided vaccines and funding as an unrestricted institutional grant. The main Copenhagen Prospective Study on Asthma in Childhood birth cohort study is funded by private and public research funds (see www.copsac.com). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	[Anonymous], 2008, GUIDELINE DOSSIER ST; [Anonymous], 2011, ANN INTERN MED, V155, P733; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Brent RL, 2006, REPROD TOXICOL, V21, P383, DOI 10.1016/j.reprotox.2005.09.009; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Fisher BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033048; Folsgaard NV, 2012, AM J RESP CRIT CARE, V185, P275, DOI 10.1164/rccm.201108-1471OC; Fox KA, 2011, CURR PHARM BIOTECHNO, V12, P789; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Gasparini R, 2010, INT J CLIN PRACT, V64, P432, DOI 10.1111/j.1742-1241.2009.02309.x; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hatz C, RANDOMIZED IN PRESS; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; HULKA JF, 1964, OBSTET GYNECOL, V23, P830; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Lancaster PAL, 2011, CONGENIT ANOM, V51, P2, DOI 10.1111/j.1741-4520.2010.00311.x; Luteijn JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-819; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; MURRAY DL, 1979, J CLIN MICROBIOL, V10, P184, DOI 10.1128/JCM.10.2.184-187.1979; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/erv.11.23, 10.1586/ERV.11.23]; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Oster ME, 2011, J PEDIATR-US, V158, P990, DOI 10.1016/j.jpeds.2010.11.058; Palmer DF, 1975, IMMUNOLOGY SERIES, V1975, P25; Partridge J, 2010, VACCINE, V28, P4709, DOI 10.1016/j.vaccine.2010.04.083; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Puleston RL, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14550-01; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Strategic Advisory Group of Experts on Immunization, 2009, WEEKLY EPIDEMIOLOGIC, V84, P301; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Yamaguchi K, 2009, J MED VIROL, V81, P1923, DOI 10.1002/jmv.21620; Yates L, 2010, Health Technol Assess, V14, P109, DOI 10.3310/hta14340-02; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729	54	175	178	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e56700	10.1371/journal.pone.0056700	http://dx.doi.org/10.1371/journal.pone.0056700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	23951157	Green Submitted, Green Published, gold			2022-12-27	WOS:000317908700002
J	Guo, FD; Liu, CL; Xia, H; Bi, YP; Zhao, CZ; Zhao, SZ; Hou, L; Li, FG; Wang, XJ				Guo, Fengdan; Liu, Chuanliang; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Li, Fuguang; Wang, Xingjun			Induced Expression of AtLEC1 and AtLEC2 Differentially Promotes Somatic Embryogenesis in Transgenic Tobacco Plants	PLOS ONE			English	Article							AUXIN RESPONSE FACTORS; TRANSCRIPTION FACTOR; LEAFY COTYLEDON1; MERISTEM GENE; ARABIDOPSIS; ETHYLENE; ENCODES; LEAFY-COTYLEDON1; BIOSYNTHESIS; MAINTENANCE	Arabidopsis LEAFY COTYLEDON (LEC) genes, AtLEC1 and AtLEC2, are important embryonic regulators that play key roles in morphogenesis and maturation phases during embryo development. Ectopic expression of AtLEC1 and AtLEC2 in tobacco caused abnormality in transgenic seedling. When transgenic seeds germinated on medium containing 30 mM DEX, LEC1 transgenic seedlings were ivory and fleshy, with unexpanded cotyledons, stubby hypocotyls, short roots and no obvious callus formation at the shoot meristem position. While LEC2 transgenic seedlings formed embryonic callus on the shoot apical meristem and somatic embryo-like structures emerged from the surface of the callus. When callus were transferred to hormone free MS0 medium more shoots were regenerated from each callus. However, shoot formation was not observed in LEC1 overexpressors. To investigate the mechanisms of LEC2 in somatic embryogenesis, we studied global gene expression by digital gene expression profiling analysis. The results indicated that ectopic expression of LEC2 genes induced accumulation of embryo-specific proteins such as seed storage proteins, late embryogenesis abundant (LEA) proteins, fatty acid biosynthetic enzymes, products of steroid biosynthesis related genes and key regulatory genes of the embryo development. Genes of plant-specific transcription factors such as NAC domain protein, AP2 and GRAS family, resistance-related as well as salicylic acid signaling related genes were up-regulated in LEC2 transgenic seedlings. Ectopi c expression of LEC2 induced large number of somatic embryo formation and shoot regeneration but 20 d DEX induction of LEC1 is not sufficient to induce somatic embryogenesis and shoot formation. Our data provide new information to understand the mechanisms on LEC2 gene's induction of somatic embryogenesis.	[Guo, Fengdan; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Wang, Xingjun] Shandong Acad Agr Sci, High Tech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Liu, Chuanliang; Li, Fuguang] Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Guo, Fengdan; Bi, Yuping; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Normal University	Li, FG (corresponding author), Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China.	aylifug@163.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022	Zhang, Tong/0000-0003-1148-4322; Ju, Feng/0000-0003-4137-5928	genetically modified organisms breeding major projects [2011ZX08010-004]; National Natural Science Foundation of China [30871324, 31000720, 31101427]; Shandong Province Natural Science Foundation [ZR2010CZ002, ZR2011CZ002, ZR2010CQ008]; Shandong Province "Taishan Scholar'' foundation [tshw20100416]	genetically modified organisms breeding major projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province "Taishan Scholar'' foundation	This study was supported by genetically modified organisms breeding major projects (2011ZX08010-004); National Natural Science Foundation of China (30871324, 31000720, 31101427); Shandong Province Natural Science Foundation (ZR2010CZ002, ZR2011CZ002, ZR2010CQ008); and Shandong Province "Taishan Scholar'' foundation (tshw20100416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Harding EW, 2003, PLANT PHYSIOL, V133, P653, DOI 10.1104/pp.103.023499; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; HORSCH RB, 1986, P NATL ACAD SCI USA, V83, P2571, DOI 10.1073/pnas.83.8.2571; Imin N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-110; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Karami Omid, 2009, J Chem Biol, V2, P177, DOI 10.1007/s12154-009-0028-4; Kumar V, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-1; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; ROUSTAN JP, 1990, BIOL PLANTARUM, V32, P273, DOI 10.1007/BF02886947; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shkolnik-Inbar D, 2011, PLANT SIGNAL BEHAV, V6, P694, DOI 10.4161/psb.6.5.14978; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	44	109	117	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71714	10.1371/journal.pone.0071714	http://dx.doi.org/10.1371/journal.pone.0071714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	24146837	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300146
J	Abdallah, K; Artola, A; Monconduit, L; Dallel, R; Luccarini, P				Abdallah, Khaled; Artola, Alain; Monconduit, Lenaic; Dallel, Radhouane; Luccarini, Philippe			Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats	PLOS ONE			English	Article							DIENCEPHALIC DOPAMINE NEURONS; TOOTH-PULP STIMULATION; MEDULLARY DORSAL HORN; PARAVENTRICULAR NUCLEUS; BRAIN-STEM; ELECTRICAL-STIMULATION; LATERAL HYPOTHALAMUS; RETROCHIASMATIC AREA; SUPRACHIASMATIC NUCLEUS; ANTINOCICEPTIVE ACTIONS	Several lines of evidence suggest that the hypothalamus is involved in trigeminal pain processing. However, the organization of descending hypothalamic projections to the spinal trigeminal nucleus caudalis (Sp5C) remains poorly understood. Microinjections of the retrograde tracer, fluorogold (FG), into the Sp5C, in rats, reveal that five hypothalamic nuclei project to the Sp5C: the paraventricular nucleus, the lateral hypothalamic area, the perifornical hypothalamic area, the A11 nucleus and the retrochiasmatic area. Descending hypothalamic projections to the Sp5C are bilateral, except those from the paraventricular nucleus which exhibit a clear ipsilateral predominance. Moreover, the density of retrogradely FG-labeled neurons in the hypothalamus varies according to the dorso-ventral localization of the Sp5C injection site. There are much more labeled neurons after injections into the ventrolateral part of the Sp5C (where ophthalmic afferents project) than after injections into its dorsomedial or intermediate parts (where mandibular and maxillary afferents, respectively, project). These results demonstrate that the organization of descending hypothalamic projections to the spinal dorsal horn and Sp5C are different. Whereas the former are ipsilateral, the latter are bilateral. Moreover, hypothalamic projections to the Sp5C display somatotopy, suggesting that these projections are preferentially involved in the processing of meningeal and cutaneous inputs from the ophthalmic branch of the trigeminal nerve in rats. Therefore, our results suggest that the control of trigeminal and spinal dorsal horn processing of nociceptive information by hypothalamic neurons is different and raise the question of the role of bilateral, rather than unilateral, hypothalamic control.	[Abdallah, Khaled; Artola, Alain; Monconduit, Lenaic; Dallel, Radhouane; Luccarini, Philippe] Univ Auvergne, Clermont Univ, NEURO DOL, INSERM,U1107, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Dallel, R (corresponding author), Univ Auvergne, Clermont Univ, NEURO DOL, INSERM,U1107, BP 10448, Clermont Ferrand, France.	radhouane.dallel@udamail.fr; Philippe.luccarini@udamail.fr	Dallel, Radhouane/W-4599-2017; monconduit, lenaic/GYV-2004-2022	Dallel, Radhouane/0000-0001-7494-116X; monconduit, lenaic/0000-0001-8856-3809; ARTOLA, Alain/0000-0003-4717-4297; Luccarini, philippe/0000-0002-7213-0088	Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Enseignement Superieur et de la Recherche; Universite d'Auvergne-Clermont-Ferrand; Region Auvergne	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Universite d'Auvergne-Clermont-Ferrand; Region Auvergne(Region Auvergne-Rhone-Alpes)	The work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Enseignement Superieur et de la Recherche, Universite d'Auvergne-Clermont-Ferrand and Region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bellasio S, 2003, EUR J PHARMACOL, V482, P127, DOI 10.1016/j.ejphar.2003.09.017; Benjamin L, 2004, NEUROBIOL DIS, V16, P500, DOI 10.1016/j.nbd.2004.03.015; BERK ML, 1981, BRAIN RES, V226, P1, DOI 10.1016/0006-8993(81)91079-9; BERKOWITZ BA, 1982, J PHARMACOL EXP THER, V220, P329; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; BROTON JG, 1988, J NEUROPHYSIOL, V59, P1575, DOI 10.1152/jn.1988.59.5.1575; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; CARD JP, 1989, J COMP NEUROL, V284, P135, DOI 10.1002/cne.902840110; CECHETTO DF, 1988, J COMP NEUROL, V272, P579, DOI 10.1002/cne.902720410; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; Chiou LC, 2010, CURR PHARM DESIGN, V16, P3089, DOI 10.2174/138161210793292483; DADO RJ, 1990, BRAIN RES, V533, P329, DOI 10.1016/0006-8993(90)91358-N; Dafny N, 1996, NEUROSCIENCE, V70, P449, DOI 10.1016/0306-4522(95)00358-4; Denuelle M, 2007, HEADACHE, V47, P1418, DOI 10.1111/j.1526-4610.2007.00776.x; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Fontaine D, 2010, BRAIN, V133, P1214, DOI 10.1093/brain/awq041; Franco ACJ, 1996, BRAZ J MED BIOL RES, V29, P1531; Gura EV, 2000, NEUROPHYSIOLOGY+, V32, P371, DOI 10.1023/A:1010487932269; HAMBA M, 1990, BRAIN RES BULL, V25, P355, DOI 10.1016/0361-9230(90)90220-T; Holland PR, 2006, EUR J NEUROSCI, V24, P2825, DOI 10.1111/j.1460-9568.2006.05168.x; Holle D, 2011, CURR PAIN HEADACHE R, V15, P101, DOI 10.1007/s11916-010-0166-y; Holstege JC, 1996, J COMP NEUROL, V376, P631, DOI 10.1002/(SICI)1096-9861(19961223)376:4<631::AID-CNE10>3.0.CO;2-P; HOSOYA Y, 1979, EXP BRAIN RES, V35, P315; HOSOYA Y, 1980, EXP BRAIN RES, V40, P79; HOSOYA Y, 1981, NEUROSCI LETT, V24, P111, DOI 10.1016/0304-3940(81)90232-9; HU JW, 1990, PAIN, V41, P331, DOI 10.1016/0304-3959(90)90010-B; IWATA K, 1992, J COMP NEUROL, V321, P404, DOI 10.1002/cne.903210308; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Leone M, 2001, NEW ENGL J MED, V345, P1428, DOI 10.1056/NEJM200111083451915; Leone M, 2013, PAIN, V154, P89, DOI 10.1016/j.pain.2012.09.011; LEVINE JD, 1991, J COMP NEUROL, V306, P344, DOI 10.1002/cne.903060210; Li JL, 1997, J COMP NEUROL, V378, P508, DOI 10.1002/(SICI)1096-9861(19970224)378:4<508::AID-CNE6>3.0.CO;2-6; Malick A, 1998, J COMP NEUROL, V400, P125, DOI 10.1002/(SICI)1096-9861(19981012)400:1<125::AID-CNE9>3.0.CO;2-B; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; MATSUMOTO N, 1993, LIFE SCI, V53, P1235, DOI 10.1016/0024-3205(93)90542-B; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; Mazzuca M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00003; Meng ID, 1997, J NEUROPHYSIOL, V77, P43, DOI 10.1152/jn.1997.77.1.43; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Mogil JS, 2011, NAT NEUROSCI, V14, P1569, DOI 10.1038/nn.2941; MOLANDER C, 1989, J COMP NEUROL, V289, P375, DOI 10.1002/cne.902890303; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; MORITA N, 1977, BRAIN RES, V134, P158, DOI 10.1016/0006-8993(77)90934-9; Newman HM, 1996, J COMP NEUROL, V365, P640, DOI 10.1002/(SICI)1096-9861(19960219)365:4<640::AID-CNE10>3.0.CO;2-L; NILAVER G, 1980, NEUROENDOCRINOLOGY, V30, P150, DOI 10.1159/000122991; Nylen A, 2001, BRAIN RES, V908, P10, DOI 10.1016/S0006-8993(01)02539-2; Ondo WG, 2000, MOVEMENT DISORD, V15, P154, DOI 10.1002/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q; Pappas SS, 2010, J COMP NEUROL, V518, P2423, DOI 10.1002/cne.22340; PASQUIER DA, 1979, BRAIN RES BULL, V4, P765, DOI 10.1016/0361-9230(79)90010-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peterlin BL, 2010, HEADACHE, V50, P631, DOI 10.1111/j.1526-4610.2009.01554.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Portillo F, 1998, J CHEM NEUROANAT, V14, P95, DOI 10.1016/S0891-0618(97)10022-9; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; RABOISSON P, 1995, J NEUROPHYSIOL, V73, P496, DOI 10.1152/jn.1995.73.2.496; Rainero I, 2011, J HEADACHE PAIN, V12, P193, DOI 10.1007/s10194-011-0314-8; RUDOMIN P, 1965, ARCH ITAL BIOL, V103, P60; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAPER CB, 2012, HYPOTHALAMUS HUMAN N, P549; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P721, DOI 10.1177/38.5.2332627; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Shafton AD, 1998, BRAIN RES, V801, P239, DOI 10.1016/S0006-8993(98)00587-3; SHIGENAGA Y, 1973, BRAIN RES, V63, P402, DOI 10.1016/0006-8993(73)90113-3; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; STEPHAN FK, 1981, NEUROSCIENCE, V6, P2625, DOI 10.1016/0306-4522(81)90108-1; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1979, J COMP NEUROL, V188, P87, DOI 10.1002/cne.901880108; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROSCI LETT, V17, P307, DOI 10.1016/0304-3940(80)90041-5; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Ter Horst GJ, 2001, CEPHALALGIA, V21, P963, DOI 10.1046/j.1468-2982.2001.00285.x; TRUESDELL LS, 1987, PHYSIOL BEHAV, V39, P727, DOI 10.1016/0031-9384(87)90257-5; van den Pol AN, 1999, J NEUROSCI, V19, P3171; WAGNER CK, 1993, J NEUROENDOCRINOL, V5, P545, DOI 10.1111/j.1365-2826.1993.tb00520.x; WANG Q, 1990, BRAIN RES, V526, P221, DOI 10.1016/0006-8993(90)91225-6; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; Wei H, 2009, PHARMACOL RES, V59, P355, DOI 10.1016/j.phrs.2009.01.001; Yang J, 2006, BRAIN RES, V1069, P127, DOI 10.1016/j.brainres.2005.11.045; YIRMIYA R, 1990, BRAIN RES, V537, P169, DOI 10.1016/0006-8993(90)90354-E; YOSHIDA A, 1991, J COMP NEUROL, V307, P609, DOI 10.1002/cne.903070408; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubrzycka M, 2008, PHYSIOL RES, V57, P769, DOI 10.33549/physiolres.931287; Zubrzycka M, 2005, BRAIN RES, V1051, P112, DOI 10.1016/j.brainres.2005.05.058	98	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e73022	10.1371/journal.pone.0073022	http://dx.doi.org/10.1371/journal.pone.0073022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	23951340	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700140
J	Wang, MH; Li, JX; Lim, GE; Johnson, JD				Wang, Minghu; Li, Jiaxu; Lim, Gareth E.; Johnson, James D.			Is Dynamic Autocrine Insulin Signaling Possible? A Mathematical Model Predicts Picomolar Concentrations of Extracellular Monomeric Insulin within Human Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL MASS; INJECTED SOLUBLE INSULIN; SUBCUTANEOUS INJECTION; PHARMACOKINETIC MODEL; ENDOGENOUS INSULIN; GLUCOSE; RECEPTOR; SECRETION; APOPTOSIS; ANALOGS	Insulin signaling is essential for beta-cell survival and proliferation in vivo. Insulin also has potent mitogenic and anti-apoptotic actions on cultured beta-cells, with maximum effect in the high picomolar range and diminishing effect at high nanomolar doses. In order to understand whether these effects of insulin are constitutive or can be subjected to physiological modulation, it is essential to estimate the extracellular concentration of monomeric insulin within an intact islet. Unfortunately, the in vivo concentration of insulin monomers within the islet cannot be measured directly with current technology. Here, we present the first mathematical model designed to estimate the levels of monomeric insulin within the islet extracellular space. Insulin is released as insoluble crystals that exhibit a delayed dissociation into hexamers, dimers, and eventually monomers, which only then can act as signaling ligands. The rates at which different forms of insulin dissolve in vivo have been estimated from studies of peripheral insulin injection sites. We used this and other information to formulate a mathematical model to estimate the local insulin concentration within a single islet as a function of glucose. Model parameters were estimated from existing literature. Components of the model were validated using experimental data, if available. Model analysis predicted that the majority of monomeric insulin in the islet is that which has been returned from the periphery, and the concentration of intra-islet monomeric insulin varies from similar to 50-300 pM when glucose is in the physiological range. Thus, our results suggest that the local concentration of monomeric insulin within the islet is in the picomolar 'sweet spot' range of insulin doses that activate the insulin receptor and have the most potent effects on beta-cells in vitro. Together with experimental data, these estimations support the concept that autocrine/ paracrine insulin signalling within the islet is dynamic, rather than constitutive and saturated.	[Wang, Minghu; Li, Jiaxu] Univ Louisville, Dept Math, Louisville, KY 40292 USA; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of Louisville; University of British Columbia; University of British Columbia	Li, JX (corresponding author), Univ Louisville, Dept Math, Louisville, KY 40292 USA.	jiaxu.li@louisville.edu; jimjohn@mail.ubc.ca	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	DOE (Department of Energy's) [DE-EM000197]; National Institutes of Health/National Institute of Dental and Craniofacial Research grant [R01-DE019243]; National Institutes of Health/National Institute of Environmental Health Sciences [P30-ES014443]; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research; Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	DOE (Department of Energy's); National Institutes of Health/National Institute of Dental and Craniofacial Research grant; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Minghu Wang and Jiaxu Li were supported in part by DOE (Department of Energy's) grant DE-EM000197. Jiaxu Li is also supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant R01-DE019243, and National Institutes of Health/National Institute of Environmental Health Sciences grant P30-ES014443. James D. Johnson and Gareth E. Lim were supported by the Canadian Institutes for Health Research, the Juvenile Diabetes Research Foundation, the Michael Smith Foundation for Health Research, and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Evert M, 2004, CANCER RES, V64, P8093, DOI 10.1158/0008-5472.CAN-04-2040; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; HORUK R, 1979, NATURE, V279, P439, DOI 10.1038/279439a0; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Johnson JD, 2008, CELL CYCLE, V7, P1343, DOI 10.4161/cc.7.10.5865; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Li JX, 2012, MATH BIOSCI, V235, P128, DOI 10.1016/j.mbs.2011.11.005; Li JX, 2009, DISCRETE CONT DYN-B, V12, P401, DOI 10.3934/dcdsb.2009.12.401; Li J, 2009, MATH BIOSCI ENG, V6, P41, DOI 10.3934/mbe.2009.6.41; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim GE, 2013, DIABETOLOGIA; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; MOSEKILDE E, 1989, J PHARMACOKINET BIOP, V17, P67, DOI 10.1007/BF01059088; Nyman LR, 2008, J CLIN INVEST; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Smith H.L., 1995, MATH SURVEYS MONOGR; Soeborg T, 2009, EUR J PHARM SCI, V36, P78, DOI 10.1016/j.ejps.2008.10.018; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Tarin C, 2005, IEEE T BIO-MED ENG, V52, P1994, DOI 10.1109/TBME.2005.857681; TRAJANOSKI Z, 1993, BIOMED TECH, V38, P224, DOI 10.1515/bmte.1993.38.9.224; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Ueki K, 2003, DIABETES, V52, pA42; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	58	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64860	10.1371/journal.pone.0064860	http://dx.doi.org/10.1371/journal.pone.0064860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798995	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300004
J	Wang, MJ; Yuan, DJ; Gao, WH; Li, Y; Tan, JF; Zhang, XL				Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong			A Comparative Genome Analysis of PME and PMEI Families Reveals the Evolution of Pectin Metabolism in Plant Cell Walls	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METHYLESTERASE; GENE; SEQUENCE; DUPLICATION; POLYPLOIDY; INHIBITORS; KNOWLEDGE; DISPLAY	Pectins are fundamental polysaccharides in the plant primary cell wall. Pectins are synthesized and secreted to cell walls as highly methyl-esterified polymers and then demethyl-esterified by pectin methylesterases (PMEs), which are spatially regulated by pectin methylesterase inhibitors (PMEIs). Although PME and PMEI genes are pivotal in plant cell wall formation, few studies have focused on the evolutionary patterns of the PME and PMEI gene families. In this study, the gene origin, evolution, and expression diversity of these two families were systematically analyzed using 11 representative species, including algae, bryophytes, lycophytes and flowering land plants. The results show that 1) for the two subfamilies (PME and proPME) of PME, the origin of the PME subfamily is consistent with the appearance of pectins in early charophyte cell walls, 2) Whole genome duplication (WGD) and tandem duplication contribute to the expansion of proPME and PMEI families in land plants, 3) Evidence of selection pressure shows that the proPME and PMEI families have rapidly evolved, particularly the PMEI family in vascular plants, and 4) Comparative expression profile analysis of the two families indicates that the eudicot Arabidopsis and monocot rice have different expression patterns. In addition, the gene structure and sequence analyses show that the origin of the PMEI domain may be derived from the neofunctionalization of the pro domain after WGD. This study will advance the evolutionary understanding of the PME and PMEI families and plant cell wall development.	[Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yuan, DJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	robert@mail.hzau.edu.cn; xlzhang@mail.hzau.edu.cn	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	National Natural Science Foundation of China [31230056]; National Basic Research Program [2010CB126001]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was financially supported by the National Natural Science Foundation of China (NO. 31230056) and National Basic Research Program (2010CB126001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao Jun, 2012, PLoS One, V7, pe46944, DOI 10.1371/journal.pone.0046944; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Wang CM, 2012, PLANT PHYSIOL, V158, P1523, DOI 10.1104/pp.111.192203; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	66	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72082	10.1371/journal.pone.0072082	http://dx.doi.org/10.1371/journal.pone.0072082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23798995	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300177
J	Wang, CJ; Song, XD; Li, YJ; Han, F; Gao, SY; Wang, XZ; Xie, SY; Lv, CJ				Wang, Congjie; Song, Xiaodong; Li, Youjie; Han, Fang; Gao, Shuyan; Wang, Xiaozhi; Xie, Shuyang; Lv, Changjun			Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-beta 1/Smad3 Pathway via miR-140 Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MONOCLONAL-ANTIBODY; CELLS; SMAD3; INHIBITION; MODEL; FIBROBLASTS; TISSUE	Abnormal TGF-beta 1/Smad3 activation plays an important role in the pathogenesis of pulmonary fibrosis, which can be prevented by paclitaxel (PTX). This study aimed to investigate an antifibrotic effect of the low-dose PTX (10 to 50 nM in vitro, and 0.6 mg/kg in vivo). PTX treatment resulted in phenotype reversion of epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) with increase of miR-140. PTX resulted in an amelioration of bleomycin (BLM)-induced pulmonary fibrosis in rats with reduction of the wet lung weight to body weight ratios and the collagen deposition. Our results further demonstrated that PTX inhibited the effect of TGF-beta 1 on regulating the expression of Smad3 and phosphorylated Smad3 (p-Smad3), and restored the levels of E-cadherin, vimentin and alpha-SMA. Moreover, lower miR-140 levels were found in idiopathic pulmonary fibrosis (IPF) patients, TGF-beta 1-treated AECs and BLM-instilled rat lungs. Through decreasing Smad3/p-Smad3 expression and upregulating miR-140, PTX treatment could significantly reverse the EMT of AECs and prevent pulmonary fibrosis of rats. The action of PTX to ameliorate TGF-beta 1-induced EMT was promoted by miR-140, which increased E-cadherin levels and reduced the expression of vimentin, Smad3 and p-Smad3. Collectively, our results demonstrate that low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-beta 1/Smad3 pathway via upregulating miR-140.	[Wang, Congjie; Han, Fang; Gao, Shuyan; Lv, Changjun] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Song, Xiaodong] Binzhou Med Univ, Med Res Ctr, Yantai, Peoples R China; [Li, Youjie; Gao, Shuyan; Xie, Shuyang] Binzhou Med Univ, Key Lab Tumor Mol Biol, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Wang, Xiaozhi] Binzhou Med Univ, Affiliated Hosp, Dept Resp Med, Binzhou, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Binzhou Medical University	Lv, CJ (corresponding author), Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China.	shuyangxie@yahoo.com.cn	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [81273957]; Taishan Scholar Project; Important Project of Science and Technology of Shandong Province [2010GWZ20254, 2011GHY11501];  [NCET-10-0919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project; Important Project of Science and Technology of Shandong Province; 	This work was supported by the National Natural Science Foundation of China (Grant No. 81273957), NCET-10-0919, "Taishan Scholar Project" and Important Project of Science and Technology of Shandong Province (Grant No. 2010GWZ20254, 2011GHY11501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ALLEN EM, 1977, J IMMUNOL, V119, P343; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HS, 2007, J SURG RES, V141, P183, DOI 10.1016/j.jss.2006.12.558; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hay ED, 1995, ACTA ANAT, V154, P8; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Liu SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047482; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MCDONALD JA, 1986, J CLIN INVEST, V78, P1237, DOI 10.1172/JCI112707; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681, DOI 10.1164/ajrccm.161.5.9907104; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sharma SK, 1996, AM J RESP CRIT CARE, V154, P193, DOI 10.1164/ajrccm.154.1.8680680; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THRALL RS, 1979, AM J PATHOL, V95, P117; Tran PL, 1997, J CLIN INVEST, V99, P608, DOI 10.1172/JCI119203; Uhal Bruce D., 1998, American Journal of Physiology, V275, pL1192; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	68	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70725	10.1371/journal.pone.0070725	http://dx.doi.org/10.1371/journal.pone.0070725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967091	Green Published, Green Submitted, gold			2022-12-27	WOS:000323378000012
J	Wang, C; Tian, LL; Li, S; Li, HB; Zhou, Y; Wang, H; Yang, QZ; Ma, LJ; Shang, DJ				Wang, Che; Tian, Li-Li; Li, Song; Li, Hui-Bing; Zhou, Yang; Wang, He; Yang, Qing-Zhu; Ma, Li-Jie; Shang, De-Jing			Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CHINESE BROWN FROG; SYSTEMIC INOCULATION; RANA-CHENSINENSIS; TUMOR-GROWTH; APOPTOSIS; DEATH; LINES; PHOSPHATIDYLSERINE; MITOCHONDRIA	Temporin-1CEa is an antimicrobial peptide isolated from the skin secretions of the Chinese brown frog (Rana chensinensis). We have previously reported the rapid and broad-spectrum anticancer activity of temporin-1CEa in vitro. However, the detailed mechanisms for temporin-1CEa-induced cancer cell death are still weakly understood. In the present study, the mechanisms of temporin-1CEa-induced rapid cytotoxicity on two human breast cancer cell lines, MDA-MB-231 and MCF-7, were investigated. The MTT assay and the LDH leakage assay indicated that one-hour of incubation with temporin-1CEa led to cytotoxicity in a dose-dependent manner. The morphological observation using electronic microscopes suggested that one-hour exposure of temporin-1CEa resulted in profound morphological changes in both MDA-MB-231 and MCF-7 cells. The membrane-disrupting property of temporin-1CEa was further characterized by induction of cell-surface exposure of phosphatidylserine, elevation of plasma membrane permeability and rapid depolarization of transmembrane potential. Moreover, temporin-1CEa evoked intracellular calcium ion and reactive oxygen species (ROS) elevations as well as collapse of mitochondrial membrane potential (Delta phi m). In summary, the present study indicates that temporin-1CEa triggers rapid cell death in breast cancer cells. This rapid cytotoxic activity might be mediated by both membrane destruction and intracellular calcium mechanism.	[Wang, Che; Tian, Li-Li; Wang, He; Yang, Qing-Zhu; Shang, De-Jing] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Wang, Che; Li, Hui-Bing; Zhou, Yang; Ma, Li-Jie] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian, Peoples R China; [Li, Song] Dalian Univ Technol, Lab Biophys & Pharmacol, Sch Phys & Optoelect Engn, Dalian, Peoples R China; [Shang, De-Jing] Liaoning Normal Univ, Fac Life Sci, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Liaoning Normal University	Shang, DJ (corresponding author), Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	dejingshang@yahoo.com	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [30970352, 81202448, 31272314]; Scientific Research Fund of Liaoning Provincial Education Department [L2012382]; Program for Liaoning Innovative Research Team in University [LT2012019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Liaoning Provincial Education Department; Program for Liaoning Innovative Research Team in University	This work was supported by the National Natural Science Foundation of China (30970352, 81202448 and 31272314), the Scientific Research Fund of Liaoning Provincial Education Department (L2012382), and the Program for Liaoning Innovative Research Team in University (LT2012019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lin VCL, 2003, AM J PATHOL, V162, P1781, DOI 10.1016/S0002-9440(10)64313-1; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Segura C, 2007, BIOCHEM BIOPH RES CO, V353, P908, DOI 10.1016/j.bbrc.2006.12.113; Shang DJ, 2009, ZOOL SCI, V26, P220, DOI 10.2108/zsj.26.220; Steinstraesser L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018321; Sureda FX, 1997, CYTOMETRY, V28, P74, DOI 10.1002/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; UTSUGI T, 1991, CANCER RES, V51, P3062; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang C, 2012, BIOCHIMIE, V94, P434, DOI 10.1016/j.biochi.2011.08.011; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806	36	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60462	10.1371/journal.pone.0060462	http://dx.doi.org/10.1371/journal.pone.0060462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23967091	gold, Green Published			2022-12-27	WOS:000319109800052
